PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Takahashi, T; Shirai, Y; Kosaka, T; Hosoya, H				Takahashi, Toshiyuki; Shirai, Yohji; Kosaka, Toshikazu; Hosoya, Hiroshi			Arrest of Cytoplasmic Streaming Induces Algal Proliferation in Green Paramecia	PLOS ONE			English	Article								A green ciliate Paramecium bursaria, bearing several hundreds of endosymbiotic algae, demonstrates rotational microtubule-based cytoplasmic streaming, in which cytoplasmic granules and endosymbiotic algae flow in a constant direction. However, its physiological significance is still unknown. We investigated physiological roles of cytoplasmic streaming in P. bursaria through host cell cycle using video-microscopy. Here, we found that cytoplasmic streaming was arrested in dividing green paramecia and the endosymbiotic algae proliferated only during the arrest of cytoplasmic streaming. Interestingly, arrest of cytoplasmic streaming with pressure or a microtubule drug also induced proliferation of endosymbiotic algae independently of host cell cycle. Thus, cytoplasmic streaming may control the algal proliferation in P. bursaria. Furthermore, confocal microscopic observation revealed that a division septum was formed in the constricted area of a dividing paramecium, producing arrest of cytoplasmic streaming. This is a first report to suggest that cytoplasmic streaming controls proliferation of eukaryotic cells.	[Takahashi, Toshiyuki; Shirai, Yohji; Kosaka, Toshikazu; Hosoya, Hiroshi] Hiroshima Univ, Grad Sch Biol Sci, Hiroshima, Japan	Hiroshima University	Hosoya, H (corresponding author), Hiroshima Univ, Grad Sch Biol Sci, Hiroshima, Japan.	hhosoya@hiroshima-u.ac.jp	Takahashi, Toshiyuki/J-7660-2015	Takahashi, Toshiyuki/0000-0001-8976-7707	Hiroshima University	Hiroshima University	Funding: Grant from Hiroshima University	Badrinath AS, 2003, DEV BIOL, V258, P70, DOI 10.1016/S0012-1606(03)00102-7; Bramhill D, 1997, ANNU REV CELL DEV BI, V13, P395, DOI 10.1146/annurev.cellbio.13.1.395; COHEN J, 1984, CELL MOTIL CYTOSKEL, V4, P443, DOI 10.1002/cm.970040605; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Gonda K, 1999, J CELL SCI, V112, P3619; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Hosoya H, 1995, ZOOL SCI, V12, P807, DOI 10.2108/zsj.12.807; Jurgens G, 2005, TRENDS CELL BIOL, V15, P277, DOI 10.1016/j.tcb.2005.03.005; Kuroiwa T, 2006, BBA-MOL CELL RES, V1763, P510, DOI 10.1016/j.bbamcr.2006.03.007; Miyagishima S, 2005, J PLANT RES, V118, P295, DOI 10.1007/s10265-005-0226-2; Nishida K, 2005, MOL BIOL CELL, V16, P2493, DOI 10.1091/mbc.e05-01-0068; Nishihara N, 1998, PROTOPLASMA, V203, P91, DOI 10.1007/BF01280591; Nishihara N, 1999, CELL MOTIL CYTOSKEL, V43, P85, DOI 10.1002/(SICI)1097-0169(1999)43:2<85::AID-CM1>3.0.CO;2-5; Numata O, 2001, CELL STRUCT FUNCT, V26, P593, DOI 10.1247/csf.26.593; Okamoto N, 2005, SCIENCE, V310, P287, DOI 10.1126/science.1116125; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Shimmen T, 2004, CURR OPIN CELL BIOL, V16, P68, DOI 10.1016/j.ceb.2003.11.009; Takahashi T, 2005, TOXICOL IN VITRO, V19, P99, DOI 10.1016/j.tiv.2004.06.012; TAKAHASHI T, 2005, NEW TECHNOL MED, V6, P50	20	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1352	10.1371/journal.pone.0001352	http://dx.doi.org/10.1371/journal.pone.0001352			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159235	gold, Green Submitted, Green Published			2022-12-27	WOS:000207459700009
J	Velasco, R; Zharkikh, A; Troggio, M; Cartwright, DA; Cestaro, A; Pruss, D; Pindo, M; FitzGerald, LM; Vezzulli, S; Reid, J; Malacarne, G; Iliev, D; Coppola, G; Wardell, B; Micheletti, D; Macalma, T; Facci, M; Mitchell, JT; Perazzolli, M; Eldredge, G; Gatto, P; Oyzerski, R; Moretto, M; Gutin, N; Stefanini, M; Chen, Y; Segala, C; Davenport, C; Dematte, L; Mraz, A; Battilana, J; Stormo, K; Costa, F; Tao, QZ; Si-Ammour, A; Harkins, T; Lackey, A; Perbost, C; Taillon, B; Stella, A; Solovyev, V; Fawcett, JA; Sterck, L; Vandepoele, K; Grando, SM; Toppo, S; Moser, C; Lanchbury, J; Bogden, R; Skolnick, M; Sgaramella, V; Bhatnagar, SK; Fontana, P; Gutin, A; Van de Peer, Y; Salamini, F; Viola, R				Velasco, Riccardo; Zharkikh, Andrey; Troggio, Michela; Cartwright, Dustin A.; Cestaro, Alessandro; Pruss, Dmitry; Pindo, Massimo; FitzGerald, Lisa M.; Vezzulli, Silvia; Reid, Julia; Malacarne, Giulia; Iliev, Diana; Coppola, Giuseppina; Wardell, Bryan; Micheletti, Diego; Macalma, Teresita; Facci, Marco; Mitchell, Jeff T.; Perazzolli, Michele; Eldredge, Glenn; Gatto, Pamela; Oyzerski, Rozan; Moretto, Marco; Gutin, Natalia; Stefanini, Marco; Chen, Yang; Segala, Cinzia; Davenport, Christine; Dematte, Lorenzo; Mraz, Amy; Battilana, Juri; Stormo, Keith; Costa, Fabrizio; Tao, Quanzhou; Si-Ammour, Azeddine; Harkins, Tim; Lackey, Angie; Perbost, Clotilde; Taillon, Bruce; Stella, Alessandra; Solovyev, Victor; Fawcett, Jeffrey A.; Sterck, Lieven; Vandepoele, Klaas; Grando, Stella M.; Toppo, Stefano; Moser, Claudio; Lanchbury, Jerry; Bogden, Robert; Skolnick, Mark; Sgaramella, Vittorio; Bhatnagar, Satish K.; Fontana, Paolo; Gutin, Alexander; Van de Peer, Yves; Salamini, Francesco; Viola, Roberto			A High Quality Draft Consensus Sequence of the Genome of a Heterozygous Grapevine Variety	PLOS ONE			English	Article							VITIS-VINIFERA L.; GENETIC-LINKAGE MAP; MADS-BOX GENE; QUANTITATIVE TRAIT LOCUS; TRANSCRIPTION FACTOR; PROANTHOCYANIDIN SYNTHESIS; NONHOST RESISTANCE; MOLECULAR ANALYSIS; DEFENSE RESPONSES; DUPLICATION	Background. Worldwide, grapes and their derived products have a large market. The cultivated grape species Vitis vinifera has potential to become a model for fruit trees genetics. Like many plant species, it is highly heterozygous, which is an additional challenge to modern whole genome shotgun sequencing. In this paper a high quality draft genome sequence of a cultivated clone of V. vinifera Pinot Noir is presented. Principal Findings. We estimate the genome size of V. vinifera to be 504.6 Mb. Genomic sequences corresponding to 477.1 Mb were assembled in 2,093 metacontigs and 435.1 Mb were anchored to the 19 linkage groups (LGs). The number of predicted genes is 29,585, of which 96.1% were assigned to LGs. This assembly of the grape genome provides candidate genes implicated in traits relevant to grapevine cultivation, such as those influencing wine quality, via secondary metabolites, and those connected with the extreme susceptibility of grape to pathogens. Single nucleotide polymorphism ( SNP) distribution was consistent with a diffuse haplotype structure across the genome. Of around 2,000,000 SNPs, 1,751,176 were mapped to chromosomes and one or more of them were identified in 86.7% of anchored genes. The relative age of grape duplicated genes was estimated and this made possible to reveal a relatively recent Vitis-specific large scale duplication event concerning at least 10 chromosomes (duplication not reported before). Conclusions. Sanger shotgun sequencing and highly efficient sequencing by synthesis (SBS), together with dedicated assembly programs, resolved a complex heterozygous genome. A consensus sequence of the genome and a set of mapped marker loci were generated. Homologous chromosomes of Pinot Noir differ by 11.2% of their DNA (hemizygous DNA plus chromosomal gaps). SNP markers are offered as a tool with the potential of introducing a new era in the molecular breeding of grape.	[Velasco, Riccardo; Troggio, Michela; Cartwright, Dustin A.; Cestaro, Alessandro; Pindo, Massimo; Vezzulli, Silvia; Malacarne, Giulia; Coppola, Giuseppina; Micheletti, Diego; Facci, Marco; Perazzolli, Michele; Gatto, Pamela; Moretto, Marco; Stefanini, Marco; Segala, Cinzia; Dematte, Lorenzo; Battilana, Juri; Costa, Fabrizio; Si-Ammour, Azeddine; Grando, Stella M.; Moser, Claudio; Fontana, Paolo; Viola, Roberto] IASMA Res Ctr, San Michele All Adige, Trento, Italy; [Zharkikh, Andrey; Cartwright, Dustin A.; Pruss, Dmitry; FitzGerald, Lisa M.; Reid, Julia; Iliev, Diana; Wardell, Bryan; Macalma, Teresita; Mitchell, Jeff T.; Eldredge, Glenn; Oyzerski, Rozan; Gutin, Natalia; Chen, Yang; Davenport, Christine; Lanchbury, Jerry; Skolnick, Mark; Bhatnagar, Satish K.; Gutin, Alexander] Myriad Genet Inc, Salt Lake City, UT USA; [Perbost, Clotilde; Taillon, Bruce] 454 Life Sci Corp, Branford, CT USA; [Harkins, Tim; Lackey, Angie] Roche Diagnost Corp, Roche Appl Sci, Indianapolis, IN USA; [Mraz, Amy; Stormo, Keith; Tao, Quanzhou; Bogden, Robert] Amplicon Express Inc, Pullman, WA USA; [Fawcett, Jeffrey A.; Sterck, Lieven; Vandepoele, Klaas; Van de Peer, Yves] Gent Univ VIB, Dept Plant Syst Biol, Ghent, Belgium; [Toppo, Stefano] Univ Padua, Dept Biol Chem, Padua, Italy; [Solovyev, Victor] Univ London, Dept Comp Sci, Egham, Surrey, England; [Stella, Alessandra; Sgaramella, Vittorio; Salamini, Francesco] Technol Pk Lodi, Lodi, Italy	Fondazione Edmund Mach; Myriad Genetics, Inc; Roche Holding; Flanders Institute for Biotechnology (VIB); Ghent University; University of Padua; University of London; Royal Holloway University London	Velasco, R (corresponding author), IASMA Res Ctr, San Michele All Adige, Trento, Italy.	riccardo.velasco@iasma.it	stella, Alessandra/AAG-6401-2021; Solovyev, Victor/C-4614-2013; Malacarne, Giulia/A-5349-2012; Toppo, Stefano/Z-5479-2019; Stefanini, Marco/AGD-6778-2022; Vandepoele, Klaas/E-7514-2010; Malacarne, Giulia/N-4244-2015; Sterck, Lieven/A-9439-2016; Moser, Claudio/B-4686-2010; Perazzolli, Michele/B-3636-2012; Grando, Maria Stella/D-5448-2011; Viola, Roberto/D-2277-2010; Van de Peer, Yves/AAE-7666-2019; Fawcett, Jeffrey/B-4145-2008; Velasco, Riccardo/G-8710-2011; stella, Alessandra/ABB-1952-2021; Van de Peer, Yves/D-4388-2009; Stella, Alessandra/AAY-7322-2020; Viola, Roberto/F-3657-2014	stella, Alessandra/0000-0003-2850-3964; Solovyev, Victor/0000-0001-8885-493X; Toppo, Stefano/0000-0002-0246-3119; Stefanini, Marco/0000-0001-7829-0528; Vandepoele, Klaas/0000-0003-4790-2725; Malacarne, Giulia/0000-0003-1439-5958; Sterck, Lieven/0000-0001-7116-4000; Moser, Claudio/0000-0002-9141-7850; Perazzolli, Michele/0000-0001-7218-9963; Grando, Maria Stella/0000-0002-6889-1968; Van de Peer, Yves/0000-0003-4327-3730; stella, Alessandra/0000-0003-2850-3964; Van de Peer, Yves/0000-0003-4327-3730; Cestaro, Alessandro/0000-0003-1439-5165; Velasco, Riccardo/0000-0002-8760-5031; Costa, Fabrizio/0000-0003-1416-1078; Fawcett, Jeffrey/0000-0003-3907-2135; Micheletti, Diego/0000-0001-9175-9853; Si Ammour, Azeddine/0000-0002-5504-4444; Viola, Roberto/0000-0002-8202-8503; Moretto, Marco/0000-0003-4555-7243; Vezzulli, Silvia/0000-0002-1447-486X; Pindo, Massimo/0000-0002-8516-9010	Province of Trento, Italy	Province of Trento, Italy(Autonomous Province of Trento)	This work has been funded by the Province of Trento, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Blondon AF, 2005, THEOR APPL GENET, V110, P1363, DOI 10.1007/s00122-005-1924-9; Adam-Blondon AF, 2004, THEOR APPL GENET, V109, P1017, DOI 10.1007/s00122-004-1704-y; Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Akkurt M, 2007, MOL BREEDING, V19, P103, DOI 10.1007/s11032-006-9047-9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Bai JF, 2002, GENOME RES, V12, P1871, DOI 10.1101/gr.454902; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Belhadj A, 2006, J AGR FOOD CHEM, V54, P9119, DOI 10.1021/jf0618022; Bogs J, 2006, PLANT PHYSIOL, V140, P279, DOI 10.1104/pp.105.073262; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Brown JWS, 2001, RNA, V7, P1817; Brunner S, 2005, PLANT CELL, V17, P343, DOI 10.1105/tpc.104.025627; Burns J, 2000, J AGR FOOD CHEM, V48, P220, DOI 10.1021/jf9909757; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Byrne KP, 2007, GENETICS, V175, P1341, DOI 10.1534/genetics.106.066951; Cartwright DA, 2007, GENETICS, V176, P2521, DOI 10.1534/genetics.106.063982; Chandler M, 2002, MOBILE DNA, V2, P305; Chen ZY, 2006, PLANT MOL BIOL, V60, P583, DOI 10.1007/s11103-005-5082-x; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Dalbo MA, 2001, J AM SOC HORTIC SCI, V126, P83, DOI 10.21273/JASHS.126.1.83; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Di Gaspero G, 2007, THEOR APPL GENET, V114, P1249, DOI 10.1007/s00122-007-0516-2; Doucleff M, 2004, THEOR APPL GENET, V109, P1178, DOI 10.1007/s00122-004-1728-3; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fischer BM, 2004, THEOR APPL GENET, V108, P501, DOI 10.1007/s00122-003-1445-3; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; Fujita A, 2006, BIOSCI BIOTECH BIOCH, V70, P632, DOI 10.1271/bbb.70.632; Geekiyanage S, 2007, PLANT BIOTECHNOL REP, V1, P11, DOI 10.1007/s11816-006-0001-4; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Grando MS, 2003, THEOR APPL GENET, V106, P1213, DOI 10.1007/s00122-002-1170-3; Grant M, 2006, CURR OPIN PLANT BIOL, V9, P414, DOI 10.1016/j.pbi.2006.05.013; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hall D, 2007, PLANT J, V49, P579, DOI 10.1111/j.1365-313X.2006.02987.x; HARBORNE JB, 1991, ECOLOGICAL CHEM BIOC, P399; HENIKOFF S, 1994, J MOL BIOL, V243, P574, DOI 10.1016/0022-2836(94)90032-9; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Jeandet P, 2002, J AGR FOOD CHEM, V50, P2731, DOI 10.1021/jf011429s; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kikkert JR, 2005, IN VITRO CELL DEV-PL, V41, P232, DOI 10.1079/IVP2004609; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; LEVADOUX L., 1956, Annales de l'Amelioration des Plantes, V6, P59; LEWIS WH, 1979, POLYPLOIDY BIOL RELE, P241; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Lichtenthaler HK, 1997, PHYSIOL PLANTARUM, V101, P643, DOI 10.1111/j.1399-3054.1997.tb01049.x; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; LODHI MA, 1995, THEOR APPL GENET, V90, P11, DOI 10.1007/BF00220990; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Lowe KM, 2006, THEOR APPL GENET, V112, P1582, DOI 10.1007/s00122-006-0264-8; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luan F, 2002, PHYTOCHEMISTRY, V60, P451, DOI 10.1016/S0031-9422(02)00147-4; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin DM, 2004, PHYTOCHEMISTRY, V65, P1223, DOI 10.1016/j.phytochem.2004.03.018; Mattivi F, 2002, ANN NY ACAD SCI, V957, P37, DOI 10.1111/j.1749-6632.2002.tb02904.x; Mauricio R, 2003, GENETICS, V163, P735; McCaskill D, 1998, TRENDS BIOTECHNOL, V16, P349, DOI 10.1016/S0167-7799(98)01231-1; McGovern PE, 2003, ANCIENT WINE SEARCH; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Meyers BC, 1998, PLANT CELL, V10, P1833, DOI 10.1105/tpc.10.11.1833; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OLMO HP, 1979, EVOLUTION CROP PLANT; Panagiotakos DB, 2004, MED SCI MONITOR, V10, pRA193; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Richly E, 2002, MOL BIOL EVOL, V19, P76, DOI 10.1093/oxfordjournals.molbev.a003984; Richter H, 2005, PHYSIOL MOL PLANT P, V67, P248, DOI 10.1016/j.pmpp.2006.03.001; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rodriguez-Uribe L, 2006, J EXP BOT, V57, P1391, DOI 10.1093/jxb/erj118; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; SCHRODER G, 1988, EUR J BIOCHEM, V172, P161, DOI 10.1111/j.1432-1033.1988.tb13868.x; Shen JD, 2006, GENETICS, V172, P1243, DOI 10.1534/genetics.105.047290; Shiu SH, 2005, PLANT PHYSIOL, V139, P18, DOI 10.1104/pp.105.065110; Simillion C, 2004, GENOME RES, V14, P1095, DOI 10.1101/gr.2179004; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; SPARVOLI F, 1994, PLANT MOL BIOL, V24, P743, DOI 10.1007/BF00029856; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tobler Andreas R, 2005, J Biomol Tech, V16, P398; Troggio M, 2007, GENETICS, V176, P2637, DOI 10.1534/genetics.106.067462; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van de Peer Y, 2001, J MOL EVOL, V53, P436, DOI 10.1007/s002390010233; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang BB, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r102; Wang QC, 2005, PLANT SCI, V168, P565, DOI 10.1016/j.plantsci.2004.09.033; Waterhouse AL, 2002, ANN NY ACAD SCI, V957, P21, DOI 10.1111/j.1749-6632.2002.tb02903.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhu QH, 2007, BIOINFORMATICS, V23, P1307, DOI 10.1093/bioinformatics/btm113	129	778	859	8	184	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1326	10.1371/journal.pone.0001326	http://dx.doi.org/10.1371/journal.pone.0001326			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18094749	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459600014
J	Kreis, S; Philippidou, D; Margue, C; Rolvering, C; Haan, C; Dumoutier, L; Renauld, JC; Behrmann, I				Kreis, Stephanie; Philippidou, Demetra; Margue, Christiane; Rolvering, Catherine; Haan, Claude; Dumoutier, Laure; Renauld, Jean-Christophe; Behrmann, Iris			Recombinant Interleukin-24 Lacks Apoptosis-Inducing Properties in Melanoma Cells	PLOS ONE			English	Article								IL-24, also known as melanoma differentiation antigen 7 (mda-7), is a member of the IL-10 family of cytokines and is mainly produced by Th-2 cells as well as by activated monocytes. Binding of IL-24 to either of its two possible heterodimeric receptors IL-20R1/IL-20R2 and IL-22R/IL-20R2 activates STAT3 and/or STAT1 in target tissues such as lung, testis, ovary, keratinocytes and skin. To date, the physiological properties of IL-24 are still not well understood but available data suggest that IL-24 affects epidermal functions by increasing proliferation of dermal cells. In stark contrast to its "normal'' and physiological behaviour, IL-24 has been reported to selectively and efficiently kill a vast variety of cancer cells, especially melanoma cells, independent of receptor expression and Jak-STAT signalling. These intriguing properties have led to the development of adenovirally-expressed IL-24, which is currently being evaluated in clinical trials. Using three different methods, we have analysed a large panel of melanoma cell lines with respect to IL-24 and IL-24 receptor expression and found that none of the investigated cell lines expressed sufficient amounts of functional receptor pairs and therefore did not react to IL-24 stimulation with Jak/STAT activation. Results for three cell lines contrasted with previous studies, which reported presence of IL-24 receptors and activation of STAT3 following IL-24 stimulation. Furthermore, evaluating four different sources and modes of IL-24 administration (commercial recombinant IL-24, bacterially expressed GST-IL-24 fusion protein, IL-24 produced from transfected Hek cells, transiently over-expressed IL-24) no induction or increase in cell death was detected when compared to appropriate control treatments. Thus, we conclude that the cytokine IL-24 itself has no cancer-specific apoptosis-inducing properties in melanoma cells.	[Kreis, Stephanie; Philippidou, Demetra; Margue, Christiane; Rolvering, Catherine; Haan, Claude; Behrmann, Iris] Univ Luxembourg, LBPI, Life Sci Res Unit, Luxembourg, Luxembourg; [Dumoutier, Laure; Renauld, Jean-Christophe] Univ Louvain, Ludwig Inst Canc Res, Brussels, Belgium	University of Luxembourg; Ludwig Institute for Cancer Research; Universite Catholique Louvain	Kreis, S (corresponding author), Univ Luxembourg, LBPI, Life Sci Res Unit, Luxembourg, Luxembourg.	stephanie.kreis@uni.lu	; Renauld, Jean-Christophe/B-7268-2012	Kreis, Stephanie/0000-0003-1865-3889; Behrmann, Iris/0000-0003-3688-3645; Dumoutier, Laure/0000-0002-6645-684X; Renauld, Jean-Christophe/0000-0003-1736-2131	University of Luxembourg [R1F107L02]	University of Luxembourg	The study was financed by grant R1F107L02 from the University of Luxembourg.	Allen M, 2005, INT J IMMUNOGENET, V32, P375, DOI 10.1111/j.1744-313X.2005.00540.x; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Caudell EG, 2002, J IMMUNOL, V168, P6041, DOI 10.4049/jimmunol.168.12.6041; Chada S, 2005, MOL THER, V11, P724, DOI 10.1016/j.ymthe.2004.12.021; Chada S, 2004, MOL THER, V10, P1085, DOI 10.1016/j.ymthe.2004.08.020; Chada S, 2004, INT IMMUNOPHARMACOL, V4, P649, DOI 10.1016/j.intimp.2004.01.017; Dent P, 2005, J CELL BIOCHEM, V95, P712, DOI 10.1002/jcb.20502; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Dumoutier L, 2002, EUR CYTOKINE NETW, V13, P5; Ekmekcioglu S, 2003, MOL CANCER THER, V2, P9; Ekmekcioglu S, 2001, INT J CANCER, V94, P54, DOI 10.1002/ijc.1437; Ellerhorst JA, 2002, J CLIN ONCOL, V20, P1069, DOI 10.1200/JCO.2002.20.4.1069; Fisher PB, 2005, CANCER RES, V65, P10128, DOI 10.1158/0008-5472.CAN-05-3127; GUPTA P, 2006, PHARM THER; Gupta P, 2006, CANCER RES, V66, P8182, DOI 10.1158/0008-5472.CAN-06-0577; Gupta P, 2006, PHARMACOL THERAPEUT, V111, P596, DOI 10.1016/j.pharmthera.2005.11.005; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Huang EY, 2001, ONCOGENE, V20, P7051, DOI 10.1038/sj.onc.1204897; Jiang HP, 1995, ONCOGENE, V11, P2477; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P9160, DOI 10.1073/pnas.93.17.9160; Kortylewski M, 2004, J INVEST DERMATOL, V122, P414, DOI 10.1046/j.0022-202X.2004.22237.x; Kortylewski M, 1999, ONCOGENE, V18, P3742, DOI 10.1038/sj.onc.1202708; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Lebedeva IV, 2005, MOL THER, V11, P4, DOI 10.1016/j.ymthe.2004.08.012; Lebedeva IV, 2002, ONCOGENE, V21, P708, DOI 10.1038/sj.onc.1205116; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LU C, 1992, P NATL ACAD SCI USA, V89, P9215, DOI 10.1073/pnas.89.19.9215; Namiki S, 2003, BIOCHEM BIOPH RES CO, V305, P592, DOI 10.1016/S0006-291X(03)00807-6; Novak JP, 2002, J BIOL CHEM, V277, P47517, DOI 10.1074/jbc.M205114200; Pataer A, 2005, MOL THER, V11, P717, DOI 10.1016/j.ymthe.2005.01.018; Poindexter NJ, 2005, J LEUKOCYTE BIOL, V78, P745, DOI 10.1189/jlb.0205116; Sarkar D, 2005, P NATL ACAD SCI USA, V102, P14034, DOI 10.1073/pnas.0506837102; Sarkar D, 2002, P NATL ACAD SCI USA, V99, P10054, DOI 10.1073/pnas.152327199; Sauane M, 2004, ONCOGENE, V23, P7679, DOI 10.1038/sj.onc.1207958; Sauane M, 2004, CANCER RES, V64, P2988, DOI 10.1158/0008-5472.CAN-04-0200; Sauane M, 2003, J CELL PHYSIOL, V196, P334, DOI 10.1002/jcp.10309; Sauane M, 2003, CYTOKINE GROWTH F R, V14, P35, DOI 10.1016/S1359-6101(02)00074-6; Sauane M, 2006, CANCER RES, V66, P11869, DOI 10.1158/0008-5472.CAN-06-1887; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Sieger KA, 2004, MOL THER, V9, P355, DOI 10.1016/j.ymthe.2003.11.014; SU Z, 2005, ONCOGENE; Su ZZ, 2003, ONCOGENE, V22, P1164, DOI 10.1038/sj.onc.1206062; Su ZZ, 2005, ONCOGENE, V24, P7552, DOI 10.1038/sj.onc.1208911; Su ZZ, 1998, P NATL ACAD SCI USA, V95, P14400, DOI 10.1073/pnas.95.24.14400; Tong AW, 2005, MOL THER, V11, P160, DOI 10.1016/j.ymthe.2004.09.021; Wang M, 2005, IMMUNOLOGY, V114, P166, DOI 10.1111/j.1365-2567.2005.02094.x; Wang M, 2002, J BIOL CHEM, V277, P7341, DOI 10.1074/jbc.M106043200; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Yacoub A, 2004, CANCER BIOL THER, V3, P739, DOI 10.4161/cbt.3.8.968; ZHENG M, 2006, CANC IMMUNOL IMMUNOT	51	29	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1300	10.1371/journal.pone.0001300	http://dx.doi.org/10.1371/journal.pone.0001300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074024	Green Published, gold			2022-12-27	WOS:000207459500019
J	Torres, M; Fernandez-Fuentes, N; Fiser, A; Casadevall, A				Torres, Marcela; Fernandez-Fuentes, Narcis; Fiser, Andras; Casadevall, Arturo			Exchanging Murine and Human Immunoglobulin Constant Chains Affects the Kinetics and Thermodynamics of Antigen Binding and Chimeric Antibody Autoreactivity	PLOS ONE			English	Article								Mouse-human chimeric antibodies composed of murine variable (V) and human (C) chains are useful therapeutic reagents. Consequently, we investigated whether heterologous C-regions from mice and humans affected specificity and affinity, and determined the contribution of CH glycosylation to antigen binding. The interaction of a 12-mer peptide mimetic with monoclonal antibody (mAb) 18B7 to Cryptococcus neoformans glucuronoxylomannan, and its chimeric (ch) and deglycosylated forms were studied by surface plasmon resonance. The equilibrium and rate association constants for the chAb were higher than for mAb 18B7. V region affinity was not affected by CH region glycosylation whereas heterologous C region of the same isotype altered the Ab binding affinity and the specificity for self-antigens. Structural models displayed local differences that implied changes on the connectivity of residues. These findings suggest that V region conformational changes can be dictated by the CH domains through an allosteric effect involving networks of highly connected amino acids.	[Torres, Marcela; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Fernandez-Fuentes, Narcis; Fiser, Andras] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Casadevall, A (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	casadeva@aecom.yu.edu		Fernandez-Fuentes, Narcis/0000-0002-6421-1080	NIH [GM62519-04, AI033142, AI033774, AI052733, HL059842]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033142, R01AI052733, R01AI033142, R01AI033774] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was funded by NIH grants GM62519-04 (to AF) and AI033142, AI033774, AI052733, and HL059842 (to AC).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRADEN BC, 1995, FASEB J, V9, P9, DOI 10.1096/fasebj.9.1.7821765; Butler M, 2003, GLYCOBIOLOGY, V13, P601, DOI 10.1093/glycob/cwg079; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; Fernandez C, 1997, SCAND J IMMUNOL, V45, P231, DOI 10.1046/j.1365-3083.1997.d01-397.x; FERNANDEZFUENTE.N, 2007, NUCL ACIDS IN PRESS; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gala FA, 2002, J BIOL CHEM, V277, P29005, DOI 10.1074/jbc.M203258200; Greenspan NS, 2001, ADV CANCER RES, V80, P147, DOI 10.1016/S0065-230X(01)80015-4; GREENSPAN NS, 1997, CONCEPTS CHEM CONT C, P383; Hindley Siobhan A., 1993, Biochemical Society Transactions, V21, p337S; HUBER R, 1976, H-S Z PHYSIOL CHEM, V357, P614; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Knight DM, 1995, MOL IMMUNOL, V32, P1271, DOI 10.1016/0161-5890(95)00085-2; Larsen RA, 2005, ANTIMICROB AGENTS CH, V49, P952, DOI 10.1128/AAC.49.3.952-958.2005; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lipschultz CA, 2002, J MOL RECOGNIT, V15, P44, DOI 10.1002/jmr.559; McCloskey N, 1996, IMMUNOLOGY, V88, P169, DOI 10.1111/j.1365-2567.1996.tb00001.x; McLean GR, 2002, J IMMUNOL, V169, P1379, DOI 10.4049/jimmunol.169.3.1379; McLean GR, 2000, MOL IMMUNOL, V37, P837, DOI 10.1016/S0161-5890(00)00101-2; MORELOCK MM, 1994, J BIOL CHEM, V269, P13048; NOSE M, 1983, P NATL ACAD SCI-BIOL, V80, P6632, DOI 10.1073/pnas.80.21.6632; POLLACK M, 1995, INFECT IMMUN, V63, P4481, DOI 10.1128/IAI.63.11.4481-4488.1995; Pritsch O, 1996, J CLIN INVEST, V98, P2235, DOI 10.1172/JCI119033; Radaev S, 2001, J BIOL CHEM, V276, P16478, DOI 10.1074/jbc.M100351200; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; ROTHMAN RJ, 1989, BIOCHEMISTRY-US, V28, P1377, DOI 10.1021/bi00429a065; SCHREIBER JR, 1993, J INFECT DIS, V167, P221, DOI 10.1093/infdis/167.1.221; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; SUTTON BJ, 1983, BIOCHEM SOC T, V11, P130, DOI 10.1042/bst0110130; TAO MH, 1989, J IMMUNOL, V143, P2595; Torres M, 2005, J IMMUNOL, V174, P2132, DOI 10.4049/jimmunol.174.4.2132; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; WALLICK SC, 1988, J EXP MED, V168, P1099, DOI 10.1084/jem.168.3.1099; Wang F, 2006, MOL IMMUNOL, V43, P987, DOI 10.1016/j.molimm.2005.05.013; WRIGHT A, 1994, J EXP MED, V180, P1087, DOI 10.1084/jem.180.3.1087; WRIGHT A, 1991, EMBO J, V10, P2717, DOI 10.1002/j.1460-2075.1991.tb07819.x; Wright A, 1997, TRENDS BIOTECHNOL, V15, P26, DOI 10.1016/S0167-7799(96)10062-7; WRIGHT JF, 1990, J BIOL CHEM, V265, P10506	46	31	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1310	10.1371/journal.pone.0001310	http://dx.doi.org/10.1371/journal.pone.0001310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074033	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459500028
J	Achour, A; Biquard, JM; Krsmanovic, V; M'Bika, JP; Ficheux, D; Sikorska, M; Cozzone, AJ				Achour, Ammar; Biquard, Jean-Michel; Krsmanovic, Velibor; M'Bika, Jean-Pierre; Ficheux, Damien; Sikorska, Marianna; Cozzone, Alain J.			Induction of Human Immunodeficiency Virus (HIV-1) Envelope Specific Cell-Mediated Immunity by a Non-Homologous Synthetic Peptide	PLOS ONE			English	Article								Background. Cell mediated immunity, including efficient CTL response, is required to prevent HIV-1 from cell-to-cell transmission. In previous investigations, we have shown that B1 peptide derived by Fourier transformation of HIV-1 primary structures and sharing no sequence homology with the parent proteins was able to generate antiserum which recognizes envelope and Tat proteins. Here we have investigated cellular immune response towards a novel non-homologous peptide, referred to as cA1 peptide. Methodology/Principal Findings. The 20 amino acid sequence of cA1 peptide was predicted using the notion of peptide hydropathic properties; the peptide is encoded by the complementary anti-sense DNA strand to the sense strand of previously described non-homologous A1 peptide. In this report we demonstrate that the cA1 peptide can be a target for major histocompatibility complex (MHC) class I-restricted cytotoxic T lymphocytes in HIV-1-infected or envelope-immunized individuals. The cA1 peptide is recognized in association with different MHC class I allotypes and could prime in vitro CTLs, derived from gp160-immunized individuals capable to recognize virus variants. Conclusions/Significance. For the first time a theoretically designed immunogen involved in broad-based cell-immune memory activation is described. Our findings may thus contribute to the advance in vaccine research by describing a novel strategy to develop a synthetic AIDS vaccine.	[Achour, Ammar; Biquard, Jean-Michel; M'Bika, Jean-Pierre] Univ Paris 05, Ctr Univ St Peres, Lab Interferons, Paris, France; [Krsmanovic, Velibor] Univ Lyon 1, Mol Biol Lab, F-69365 Lyon, France; [Ficheux, Damien] IFR 128 Biosci Lyon Gerland, Lyon, France; [Sikorska, Marianna] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Cozzone, Alain J.] UCBL, CNRS, UMR 5086, Inst Biol & Chim Prot, Lyon, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; National Research Council Canada; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Achour, A (corresponding author), Univ Paris 05, Ctr Univ St Peres, Lab Interferons, Paris, France.	ammar.achour@univ-paris5.fr			Centre National de la Recherche Scientifique, (CNRS, France); National Research Council (NRC, Canada); Association pour le Developpement des Biotherapies experimentales ADBEA (Paris, France)	Centre National de la Recherche Scientifique, (CNRS, France)(Centre National de la Recherche Scientifique (CNRS)); National Research Council (NRC, Canada); Association pour le Developpement des Biotherapies experimentales ADBEA (Paris, France)	This research was supported by Centre National de la Recherche Scientifique, (CNRS, France), National Research Council (NRC, Canada) and Association pour le Developpement des Biotherapies experimentales ADBEA (Paris, France).	Achour A, 2003, VIROLOGY, V315, P245, DOI 10.1016/S0042-6822(03)00535-X; ACHOUR A, 1993, VACCINE, V11, P699, DOI 10.1016/0264-410X(93)90251-R; ACHOUR A, 1990, P NATL ACAD SCI USA, V87, P7045, DOI 10.1073/pnas.87.18.7045; Achour A, 1996, J VIROL, V70, P6741, DOI 10.1128/JVI.70.10.6741-6750.1996; ACHOUR A, 1994, AIDS RES HUM RETROV, V10, P19, DOI 10.1089/aid.1994.10.19; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; BEX F, 1994, BLOOD, V84, P3317; Biquard JM, 2003, AIDS, V17, P2001, DOI 10.1097/00002030-200309050-00026; BIRO J, 1981, MED HYPOTHESES, V7, P981, DOI 10.1016/0306-9877(81)90094-3; BIRO J, 1981, MED HYPOTHESES, V7, P995, DOI 10.1016/0306-9877(81)90095-5; BLALOCK JE, 1990, TRENDS BIOTECHNOL, V8, P140, DOI 10.1016/0167-7799(90)90159-U; BLALOCK JE, 1984, BIOCHEM BIOPH RES CO, V121, P203, DOI 10.1016/0006-291X(84)90707-1; BLALOCK JE, 1986, BIOCHEM J, V234, P679, DOI 10.1042/bj2340679; BOHR H, 1988, FEBS LETT, V241, P223, DOI 10.1016/0014-5793(88)81066-4; BORK P, 1990, EUR J BIOCHEM, V191, P347, DOI 10.1111/j.1432-1033.1990.tb19129.x; BOST KL, 1985, BIOCHEM BIOPH RES CO, V128, P1373, DOI 10.1016/0006-291X(85)91092-7; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; CLARKE BL, 1991, ANTISENSE NUCLEIC AC, P169; CORNETTE JL, 1987, J MOL BIOL, V195, P659, DOI 10.1016/0022-2836(87)90189-6; COSIC I, 1986, BIOCHEM BIOPH RES CO, V141, P831, DOI 10.1016/S0006-291X(86)80248-0; COSIC I, 1992, EUR J BIOCHEM, V205, P613, DOI 10.1111/j.1432-1033.1992.tb16819.x; COSIC I, 1994, MOL CELL BIOCHEM, V130, P1, DOI 10.1007/BF01084262; COSIC I, 1991, EUR J BIOCHEM, V198, P113, DOI 10.1111/j.1432-1033.1991.tb15993.x; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; FORSDYKE DR, 1995, J MOL EVOL, V41, P582; GOTCH FM, 1986, J EXP MED, V165, P408; HEINE V, 1973, THEORY PSEUDOPOTENTI; HERTZ GZ, 1990, COMPUT APPL BIOSCI, V6, P81; Ivanovic V, 2004, MED HYPOTHESES, V62, P727, DOI 10.1016/j.mehy.2003.11.027; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; KENNETH C, 1992, J IMMUNOL, V149, P2560; Krsmanovic V, 1998, J PEPT RES, V52, P410; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; MCLACHLAN AD, 1983, J MOL BIOL, V164, P605, DOI 10.1016/0022-2836(83)90053-0; Meckler L.B., 1969, BIOFIZIKA, V14, P581; MERINO E, 1994, NUCLEIC ACIDS RES, V22, P1903, DOI 10.1093/nar/22.10.1903; NAKAI K, 1988, PROTEIN ENG, V2, P93, DOI 10.1093/protein/2.2.93; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PICARD O, 1992, J ACQ IMMUN DEF SYND, V5, P539; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; RICHARDS FM, 1988, PROTEINS, V3, P71, DOI 10.1002/prot.340030202; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SUNNARBORG A, 1990, J BACTERIOL, V172, P2642, DOI 10.1128/jb.172.5.2642-2649.1990; TAKAHASHI H, 1989, J EXP MED, V170, P2023, DOI 10.1084/jem.170.6.2023; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Tropsha Alexander, 1992, Journal of Molecular Recognition, V5, P43, DOI 10.1002/jmr.300050202; VELJKOVIC V, 1987, CANCER BIOCHEM BIOPH, V9, P139; VELJKOVIC V, 1972, PHYS REV LETT, V29, P105, DOI 10.1103/PhysRevLett.29.105; Veljkovic V., 1980, THEORETICAL APPROACH	55	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1214	10.1371/journal.pone.0001214	http://dx.doi.org/10.1371/journal.pone.0001214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043730	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459300004
J	Mao, L; Zabel, C; Herrmann, M; Nolden, T; Mertes, F; Magnol, L; Chabert, C; Hartl, D; Herault, Y; Delabar, JM; Manke, T; Himmelbauer, H; Klose, J				Mao, Lei; Zabel, Claus; Herrmann, Marion; Nolden, Tobias; Mertes, Florian; Magnol, Laetitia; Chabert, Caroline; Hartl, Daniela; Herault, Yann; Delabar, Jean Maurice; Manke, Thomas; Himmelbauer, Heinz; Klose, Joachim			Proteomic Shifts in Embryonic Stem Cells with Gene Dose Modifications Suggest the Presence of Balancer Proteins in Protein Regulatory Networks	PLOS ONE			English	Article								Large numbers of protein expression changes are usually observed in mouse models for neurodegenerative diseases, even when only a single gene was mutated in each case. To study the effect of gene dose alterations on the cellular proteome, we carried out a proteomic investigation on murine embryonic stem cells that either overexpressed individual genes or displayed aneuploidy over a genomic region encompassing 14 genes. The number of variant proteins detected per cell line ranged between 70 and 110, and did not correlate with the number of modified genes. In cell lines with single gene mutations, up and down-regulated proteins were always in balance in comparison to parental cell lines regarding number as well as concentration of differentially expressed proteins. In contrast, dose alteration of 14 genes resulted in an unequal number of up and down-regulated proteins, though the balance was kept at the level of protein concentration. We propose that the observed protein changes might partially be explained by a proteomic network response. Hence, we hypothesize the existence of a class of "balancer'' proteins within the proteomic network, defined as proteins that buffer or cushion a system, and thus oppose multiple system disturbances. Through database queries and resilience analysis of the protein interaction network, we found that potential balancer proteins are of high cellular abundance, possess a low number of direct interaction partners, and show great allelic variation. Moreover, balancer proteins contribute more heavily to the network entropy, and thus are of high importance in terms of system resilience. We propose that the "elasticity'' of the proteomic regulatory network mediated by balancer proteins may compensate for changes that occur under diseased conditions.	[Mao, Lei; Zabel, Claus; Herrmann, Marion; Hartl, Daniela; Klose, Joachim] Charite Univ Med Berlin, Inst Human Genet, Berlin, Germany; [Mao, Lei; Nolden, Tobias; Mertes, Florian; Manke, Thomas; Himmelbauer, Heinz] Max Planck Inst Mol Genet, Berlin, Germany; [Magnol, Laetitia; Herault, Yann] CNRS Uni Orleans, UMR6218, IEM, Inst Transgenose, Orleans, France; [Chabert, Caroline; Delabar, Jean Maurice] Univ Paris 07, EA 3508, Paris, France	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; UDICE-French Research Universities; Universite Paris Cite	Mao, L (corresponding author), Charite Univ Med Berlin, Inst Human Genet, Berlin, Germany.	lei.mao@charite.de	Manke, Thomas/L-9075-2019; Herault, Yann/B-5500-2012	Herault, Yann/0000-0001-7049-6900; Manke, Thomas/0000-0003-3702-0868; Nolden, Tobias/0000-0002-8996-5612	German National Genome Research Network (NGFN); EU [37627]; Lejeune foundation; Volkswagen Foundation	German National Genome Research Network (NGFN); EU(European Commission); Lejeune foundation; Volkswagen Foundation(Volkswagen)	This work was co-supported by the German National Genome Research Network (NGFN) program established by the German Ministry for Education and Research (BMBF), and by the EU grant 37627 "AnEUploidy''. C. Chabert and L. Magnol were supported by a Lejeune foundation grant. T. Manke was supported by a grant from the Volkswagen Foundation.	Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; Brault V, 2006, PLOS GENET, V2, P911, DOI 10.1371/journal.pgen.0020086; BROWN GC, 1991, J THEOR BIOL, V153, P195, DOI 10.1016/S0022-5193(05)80422-9; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chan SK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-227; Chung SM, 2002, STEM CELLS, V20, P139, DOI 10.1634/stemcells.20-2-139; Demetrius L, 2004, THEOR POPUL BIOL, V65, P211, DOI 10.1016/j.tpb.2003.12.002; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Huang JF, 2006, LIVER INT, V26, P54; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Klose J, 1999, METH MOL B, V112, P147; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; Lopes C, 2003, BIOCHEM BIOPH RES CO, V305, P915, DOI 10.1016/S0006-291X(03)00867-2; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Manke T, 2006, J R SOC INTERFACE, V3, P843, DOI 10.1098/rsif.2006.0140; Mao L, 2006, EXP GERONTOL, V41, P11, DOI 10.1016/j.exger.2005.09.012; MILLER RM, 2007, EXP NEUROL, V23, P23; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; NEBRICH G, 2007, ELECTROPHORESIS, V19, P19; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Periquet M, 2005, J NEUROCHEM, V95, P1259, DOI 10.1111/j.1471-4159.2005.03442.x; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Testa Giuseppe, 2004, Methods Mol Biol, V256, P123; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Zabel C, 2004, INT REV NEUROBIOL, V61, P241; Zabel C, 2006, J PROTEOME RES, V5, P1948, DOI 10.1021/pr0601077; Zhang HL, 2007, BIOCHEM BIOPH RES CO, V352, P456, DOI 10.1016/j.bbrc.2006.11.031	44	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1218	10.1371/journal.pone.0001218	http://dx.doi.org/10.1371/journal.pone.0001218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043732	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459300006
J	Vandewalle, G; Schmidt, C; Albouy, G; Sterpenich, V; Darsaud, A; Rauchs, G; Berken, PY; Balteau, E; Degueldre, C; Luxen, A; Maquet, P; Dijk, DJ				Vandewalle, Gilles; Schmidt, Christina; Albouy, Genevieve; Sterpenich, Virginie; Darsaud, Annabelle; Rauchs, Geraldine; Berken, Pierre-Yves; Balteau, Evelyne; Degueldre, Christian; Luxen, Andre; Maquet, Pierre; Dijk, Derk-Jan			Brain Responses to Violet, Blue, and Green Monochromatic Light Exposures in Humans: Prominent Role of Blue Light and the Brainstem	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; SUPRACHIASMATIC NUCLEUS; HIGH-SENSITIVITY; ACTION SPECTRUM; MELANOPSIN; MELATONIN; SLEEP; ILLUMINATION; PROJECTIONS; EXPRESSION	Background. Relatively long duration retinal light exposure elicits nonvisual responses in humans, including modulation of alertness and cognition. These responses are thought to be mediated in part by melanopsin-expressing retinal ganglion cells which are more sensitive to blue light than violet or green light. The contribution of the melanopsin system and the brain mechanisms involved in the establishment of such responses to light remain to be established. Methodology/Principal Findings. We exposed 15 participants to short duration (50 s) monochromatic violet (430 nm), blue (473 nm), and green (527 nm) light exposures of equal photon flux (10(13) ph/cm(2)/s) while they were performing a working memory task in fMRI. At light onset, blue light, as compared to green light, increased activity in the left hippocampus, left thalamus, and right amygdala. During the task, blue light, as compared to violet light, increased activity in the left middle frontal gyrus, left thalamus and a bilateral area of the brainstem consistent with activation of the locus coeruleus. Conclusion/Significance. These results support a prominent contribution of melanopsin-expressing retinal ganglion cells to brain responses to light within the very first seconds of an exposure. The results also demonstrate the implication of the brainstem in mediating these responses in humans and speak for a broad involvement of light in the regulation of brain function.	[Vandewalle, Gilles; Schmidt, Christina; Albouy, Genevieve; Sterpenich, Virginie; Darsaud, Annabelle; Rauchs, Geraldine; Balteau, Evelyne; Degueldre, Christian; Luxen, Andre; Maquet, Pierre] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Berken, Pierre-Yves] Univ Liege, Dept Phys, Hololab, Liege, Belgium; [Maquet, Pierre] Ctr Hosp Univ Liege, Dept Neurol, Liege, Belgium; [Dijk, Derk-Jan] Univ Surrey, Surrey Sleep Res Ctr, Guildford GU2 5XH, Surrey, England	University of Liege; University of Liege; University of Liege; University of Surrey	Maquet, P (corresponding author), Univ Liege, Cyclotron Res Ctr, Liege, Belgium.	pmaquet@ulg.ac.be	ALBOUY, Genevieve/K-5350-2015; ALBOUY, Genevieve/P-4723-2019; RAUCHS, Géraldine/L-7921-2015; Dijk, Derk-Jan/D-8387-2011	ALBOUY, Genevieve/0000-0002-5437-023X; ALBOUY, Genevieve/0000-0002-5437-023X; RAUCHS, Géraldine/0000-0001-7128-2189; Sterpenich, Virginie/0000-0002-2125-833X; Vandewalle, Gilles/0000-0003-2483-2752; , Pierre/0000-0003-3106-3357	Belgian Fond National de la Recherche Scientifique (F.N.R.S.), La Fondation Medicale Reine Elisabeth; University of Liege, Interuniversity Attraction Pole [P5/04]; Wellcome Trust [GR069714MA]	Belgian Fond National de la Recherche Scientifique (F.N.R.S.), La Fondation Medicale Reine Elisabeth(Fonds de la Recherche Scientifique - FNRS); University of Liege, Interuniversity Attraction Pole(University of LiegeBelgian Federal Science Policy Office); Wellcome Trust(Wellcome TrustEuropean Commission)	Funding: This study was supported by the Belgian Fond National de la Recherche Scientifique (F.N.R.S.), La Fondation Medicale Reine Elisabeth, the University of Liege, Interuniversity Attraction Pole P5/04, and by the Wellcome Trust-GR069714MA (DJD). GV, CS, VS, AD, GR and PM are supported by the F.N.R.S.	Aggelopoulos NC, 2000, J PHYSIOL-LONDON, V523, P211, DOI 10.1111/j.1469-7793.2000.t01-1-00211.x; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Amaral DG, 1992, AMYGDALA NEUROBIOLOG, P465; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brainard GC, 2001, J NEUROSCI, V21, P6405; Braver TS, 2001, NEUROIMAGE, V14, P48, DOI 10.1006/nimg.2001.0791; BUCK SL, 2003, VISUAL NEUROSCIENCES, P863; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cajochen C, 2006, CHRONOBIOL INT, V23, P461, DOI 10.1080/07420520500545813; Cajochen C, 2006, EUR J NEUROSCI, V23, P1082, DOI 10.1111/j.1460-9568.2006.04613.x; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Castle M, 2005, NEUROSCIENCE, V134, P657, DOI 10.1016/j.neuroscience.2005.04.031; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dijk DJ, 2002, J APPL PHYSIOL, V92, P852, DOI 10.1152/japplphysiol.00924.2001; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Foucher JR, 2004, NEUROIMAGE, V22, P688, DOI 10.1016/j.neuroimage.2004.01.048; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; GREENWOOD KM, 1994, ERGONOMICS, V37, P377, DOI 10.1080/00140139408963653; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Horne JA, 1976, INT J CHRONOBIOL, V4, P97; International Commission of Non-Ionizing Radiation Protection (ICNIRP), 1997, HEALTH PHYS, V73, P539; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; JONES BE, 2003, FRONT BIOSCI, pS438; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Lockley SW, 2006, SLEEP, V29, P161; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Meijer JH, 1998, J NEUROSCI, V18, P9078; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Morin LP, 2005, J COMP NEUROL, V487, P204, DOI 10.1002/cne.20546; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Munch M, 2006, AM J PHYSIOL-REG I, V290, pR1421, DOI 10.1152/ajpregu.00478.2005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Perrin F, 2004, CURR BIOL, V14, P1842, DOI 10.1016/j.cub.2004.09.082; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Revell VL, 2006, NEUROSCI LETT, V399, P96, DOI 10.1016/j.neulet.2006.01.032; Sander D, 2005, NEUROIMAGE, V28, P848, DOI 10.1016/j.neuroimage.2005.06.023; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Sollars PJ, 2003, VISUAL NEUROSCI, V20, P601, DOI 10.1017/S0952523803206027; Solomon SG, 2007, NAT REV NEUROSCI, V8, P276, DOI 10.1038/nrn2094; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443; Sterpenich V, 2006, J NEUROSCI, V26, P7416, DOI 10.1523/JNEUROSCI.1001-06.2006; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; VANDEWALLE G, 2007, CEREBRAL CORTEX; Vandewalle G, 2006, CURR BIOL, V16, P1616, DOI 10.1016/j.cub.2006.06.031; Wirz-Justice A, 2004, SCIENCE, V303, P467	61	159	161	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1247	10.1371/journal.pone.0001247	http://dx.doi.org/10.1371/journal.pone.0001247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043754	Green Published, gold			2022-12-27	WOS:000207459300028
J	An, XP; Lu, J; Huang, JD; Zhang, BZ; Liu, DB; Zhang, X; Chen, JH; Zhou, YS; Tong, YG				An, Xiaoping; Lu, Jun; Huang, Jian-dong; Zhang, Baozhong; Liu, Dabin; Zhang, Xin; Chen, Jinhui; Zhou, Yusen; Tong, Yigang			Rapid Assembly of Multiple-Exon cDNA Directly from Genomic DNA	PLOS ONE			English	Article								Background. Polymerase chain reaction (PCR) is extensively applied in gene cloning. But due to the existence of introns, low copy number of particular genes and high complexity of the eukaryotic genome, it is usually impossible to amplify and clone a gene as a full-length sequence directly from the genome by ordinary PCR based techniques. Cloning of cDNA instead of genomic DNA involves multiple steps: harvest of tissues that express the gene of interest, RNA isolation, cDNA synthesis (reverse transcription), and PCR amplification. To simplify the cloning procedures and avoid the problems caused by ubiquitously distributed durable RNases, we have developed a novel strategy allowing the cloning of any cDNA or open reading frame (ORF) with wild type sequence in any spliced form from a single genomic DNA preparation. Methodology. Our "Genomic DNA Splicing'' technique contains the following steps: first, all exons of the gene are amplified from a genomic DNA preparation, using software-optimized, highly efficient primers residing in flanking introns. Next, the tissue-specific exon sequences are assembled into one full-length sequence by overlapping PCR with deliberately designed primers located at the splicing sites. Finally, software-optimized outmost primers are exploited for efficient amplification of the assembled full-length products. Conclusions. The "Genomic DNA Splicing'' protocol avoids RNA preparation and reverse transcription steps, and the entire assembly process can be finished within hours. Since genomic DNA is more stable than RNA, it may be a more practical cloning strategy for many genes, especially the ones that are very large and difficult to generate a full length cDNA using oligo-dT primed reverse transcription. With this technique, we successfully cloned the full-length wild type coding sequence of human polymeric immunoglobulin receptor, which is 2295 bp in length and composed of 10 exons.	[Huang, Jian-dong] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [An, Xiaoping; Zhang, Baozhong; Liu, Dabin; Zhang, Xin; Chen, Jinhui; Zhou, Yusen; Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Lu, Jun] Capital Med Univ, Beijing YouAn Hosp, Beijing, Peoples R China	University of Hong Kong; Beijing Institute of Microbiology & Epidemiology; Capital Medical University	Huang, JD (corresponding author), Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	jdhuang@hkucc.hku.hk; tongyg@nic.bmi.ac.cn	Liu, Dabin/GNH-2648-2022; /C-4277-2009	/0000-0001-7531-2816; Tong, Yigang/0000-0002-8503-8045; Liu, Dabin/0000-0002-3811-8317	National High Technology Research and Development Program of China [2001AA215361]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work is supported by National High Technology Research and Development Program of China (2001AA215361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHISTYAKOV D A, 1991, Molekulyarnaya Biologiya (Moscow), V25, P1273; DILLON PJ, 1990, BIOTECHNIQUES, V9, P298; Gao WT, 2004, BIOTECHNOL PROGR, V20, P443, DOI 10.1021/bp0300467; GOEDDEL DV, 1979, P NATL ACAD SCI USA, V76, P106, DOI 10.1073/pnas.76.1.106; HAYASHI N, 1994, BIOTECHNIQUES, V17, P310; HEYNEKER HL, 1976, NATURE, V263, P748, DOI 10.1038/263748a0; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; ITAKURA K, 1977, SCIENCE, V198, P1056, DOI 10.1126/science.412251; LEBEDENKO EN, 1991, NUCLEIC ACIDS RES, V19, P6757, DOI 10.1093/nar/19.24.6757; MANDECKI W, 1990, GENE, V94, P103, DOI 10.1016/0378-1119(90)90474-6; MANDECKI W, 1988, GENE, V68, P101, DOI 10.1016/0378-1119(88)90603-8; PRODROMOU C, 1992, PROTEIN ENG, V5, P827, DOI 10.1093/protein/5.8.827; SANDHU GS, 1992, BIOTECHNIQUES, V12, P14; Sandhu KS, 2005, BIOINFORMATICS, V21, P2091, DOI 10.1093/bioinformatics/bti304; Schageman JJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r36; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; VANDENBROECK K, 1991, BIOCHEM BIOPH RES CO, V180, P1408, DOI 10.1016/S0006-291X(05)81353-1; Withers-Martinez C, 1999, PROTEIN ENG, V12, P1113, DOI 10.1093/protein/12.12.1113; Wu Xiaolin, 2006, Appl Bioinformatics, V5, P119, DOI 10.2165/00822942-200605020-00007; Xiong AS, 2006, NAT PROTOC, V1, P791, DOI 10.1038/nprot.2006.103; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Xiong AS, 2005, J APPL MICROBIOL, V98, P418, DOI 10.1111/j.1365-2672.2004.02476.x; Xiong AS, 2004, J BIOCHEM MOL BIOL, V37, P282; Young L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh058; [朱晓峰 ZHU Xiaofeng], 2007, [中国生物工程杂志, Journal of Chinese Biotechnology], V27, P86	27	13	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1179	10.1371/journal.pone.0001179	http://dx.doi.org/10.1371/journal.pone.0001179			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000550	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459100021
J	Makunin, IV; Pheasant, M; Simons, C; Mattick, JS				Makunin, Igor V.; Pheasant, Michael; Simons, Cas; Mattick, John S.			Orthologous MicroRNA Genes Are Located in Cancer-Associated Genomic Regions in Human and Mouse	PLOS ONE			English	Article							RETROVIRAL INSERTIONAL MUTAGENESIS; C-MYC; IDENTIFICATION; BIOGENESIS; ACTIVATION; ONCOGENES; CISTRON; MIRNAS	Background. MicroRNAs (miRNAs) are short non-coding RNAs that regulate differentiation and development in many organisms and play an important role in cancer. Methodology/Principal Findings. Using a public database of mapped retroviral insertion sites from various mouse models of cancer we demonstrate that MLV-derived retroviral inserts are enriched in close proximity to mouse miRNA loci. Clustered inserts from cancer-associated regions (Common Integration Sites, CIS) have a higher association with miRNAs than non-clustered inserts. Ten CIS-associated miRNA loci containing 22 miRNAs are located within 10 kb of known CIS insertions. Only one CIS-associated miRNA locus overlaps a RefSeq protein-coding gene and six loci are located more than 10 kb from any RefSeq gene. CIS-associated miRNAs on average are more conserved in vertebrates than miRNAs associated with non-CIS inserts and their human homologs are also located in regions perturbed in cancer. In addition we show that miRNA genes are enriched around promoter and/or terminator regions of RefSeq genes in both mouse and human. Conclusions/Significance. We provide a list of ten miRNA loci potentially involved in the development of blood cancer or brain tumors. There is independent experimental support from other studies for the involvement of miRNAs from at least three CIS-associated miRNA loci in cancer development.	[Makunin, Igor V.; Pheasant, Michael; Simons, Cas; Mattick, John S.] Univ Queensland, Inst Mol Biosci, Special Res Ctr Funct & Appl Genom, Australian Res Council ARC, Brisbane, Qld, Australia	University of Queensland	Mattick, JS (corresponding author), Univ Queensland, Inst Mol Biosci, Special Res Ctr Funct & Appl Genom, Australian Res Council ARC, Brisbane, Qld, Australia.	j.mattick@imb.uq.edu.au	Mattick, John/ABH-6130-2020; Pheasant, Michael/A-7564-2008; Simons, Cas/A-7905-2011; Mattick, John S/I-7789-2012	Mattick, John/0000-0002-7680-7527; Pheasant, Michael/0000-0001-9781-7655; Simons, Cas/0000-0003-3147-8042; Mattick, John S/0000-0002-7680-7527	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bijl J, 2005, GENE DEV, V19, P224, DOI 10.1101/gad.1268505; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim R, 2003, J VIROL, V77, P2056, DOI 10.1128/JVI.77.3.2056-2062.2003; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lum AM, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-5; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Sevignani C, 2007, P NATL ACAD SCI USA, V104, P8017, DOI 10.1073/pnas.0702177104; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simons C, 2006, GENOME RES, V16, P164, DOI 10.1101/gr4624306; Slape C, 2007, CANCER RES, V67, P5148, DOI 10.1158/0008-5472.CAN-07-0075; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Wang CL, 2006, P NATL ACAD SCI USA, V103, P18680, DOI 10.1073/pnas.0609030103; Xi YG, 2007, CANCER INFORM, V3, P245; Yamashita N, 2005, BRIT J HAEMATOL, V131, P495, DOI 10.1111/j.1365-2141.2005.05793.x; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	29	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1133	10.1371/journal.pone.0001133	http://dx.doi.org/10.1371/journal.pone.0001133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17989771	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459000017
J	Zhang, Y; Liu, C; Zhu, LY; Jiang, XH; Chen, X; Qi, XQ; Liang, XY; Jin, S; Zhang, PX; Li, QG; Wang, DJ; Liu, XF; Zeng, K; Zhang, JF; Xiang, Y; Zhang, CY				Zhang, Yan; Liu, Chang; Zhu, Lingyun; Jiang, Xiaohong; Chen, Xi; Qi, Xiaoqiang; Liang, Xiangying; Jin, Sonia; Zhang, Peixiang; Li, Qingguo; Wang, Dongjin; Liu, Xiaofeng; Zeng, Ke; Zhang, Junfeng; Xiang, Yang; Zhang, Chen-Yu			PGC-1 alpha Inhibits Oleic Acid Induced Proliferation and Migration of Rat Vascular Smooth Muscle Cells	PLOS ONE			English	Article								Background. Oleic acid (OA) stimulates vascular smooth muscle cell (VSMC) proliferation and migration. The precise mechanism is still unclear. We sought to investigate the effects of peroxisome proliferator-activated receptor gamma (PPAR gamma) coactivator-1 alpha (PGC-1 alpha) on OA-induced VSMC proliferation and migration. Principal Findings. Oleate and palmitate, the most abundant monounsaturated fatty acid and saturated fatty acid in plasma, respectively, differently affect the mRNA and protein levels of PGC-1 alpha in VSMCs. OA treatment resulted in a reduction of PGC-1 alpha expression, which may be responsible for the increase in VSMC proliferation and migration caused by this fatty acid. In fact, overexpression of PGC-1 alpha prevented OA-induced VSMC proliferation and migration while suppression of PGC-1 alpha by siRNA enhanced the effects of OA. In contrast, palmitic acid (PA) treatment led to opposite effects. This saturated fatty acid induced PGC-1 alpha expression and prevented OA-induced VSMC proliferation and migration. Mechanistic study demonstrated that the effects of PGC-1 alpha on VSMC proliferation and migration result from its capacity to prevent ERK phosphorylation. Conclusions. OA and PA regulate PGC-1 alpha expression in VSMCs differentially. OA stimulates VSMC proliferation and migration via suppression of PGC-1 alpha expression while PA reverses the effects of OA by inducing PGC-1 alpha expression. Upregulation of PGC-1 alpha in VSMCs provides a potential novel strategy in preventing atherosclerosis.	[Zhang, Yan; Liu, Chang; Zhu, Lingyun; Jiang, Xiaohong; Chen, Xi; Qi, Xiaoqiang; Liang, Xiangying; Zhang, Peixiang; Liu, Xiaofeng; Zeng, Ke; Zhang, Junfeng; Xiang, Yang; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Ctr, Nanjing 210008, Peoples R China; [Jin, Sonia] MIT, Cambridge, MA 02139 USA; [Li, Qingguo; Wang, Dongjin] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Thorac Surg, Nanjing 210008, Peoples R China	Nanjing University; Massachusetts Institute of Technology (MIT); Nanjing University	Zhang, JF (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Ctr, Nanjing 210008, Peoples R China.	jfzhang@nju.edu.cn; xiangy@nju.edu.cn; cyzhang@nju.edu.cn		/0000-0002-0420-4508	National Natural Science Foundation of China [30225037, 30471991, 30570731]; 973 Program of China [2006CB503909, 2004CB518603]; "111" Project; Natural Science Foundation of Jangsu Province [BK2004082, BK2006714]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); "111" Project(Ministry of Education, China - 111 Project); Natural Science Foundation of Jangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Natural Science Foundation of China (no. 30225037, 30471991, 30570731), the 973 Program of China (no. 2006CB503909, 2004CB518603), the "111" Project, and the Natural Science Foundation of Jangsu Province (no. BK2004082, BK2006714).	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; Crunkhorn S, 2007, J BIOL CHEM, V282, P15439, DOI 10.1074/jbc.M611214200; DAVDA RK, 1995, HYPERTENSION, V26, P764, DOI 10.1161/01.HYP.26.5.764; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Egan BM, 1996, HYPERTENSION, V27, P723, DOI 10.1161/01.HYP.27.3.723; Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; Goetze S, 2001, J CARDIOVASC PHARM, V38, P909, DOI 10.1097/00005344-200112000-00013; GORDON D, 1986, CIRC RES, V59, P633, DOI 10.1161/01.RES.59.6.633; Greene EL, 2001, HYPERTENSION, V37, P308, DOI 10.1161/01.HYP.37.2.308; GROTENDORST GR, 1981, P NATL ACAD SCI-BIOL, V78, P3669, DOI 10.1073/pnas.78.6.3669; HAOURIGUI M, 1993, ENDOCRINOLOGY, V133, P183, DOI 10.1210/en.133.1.183; Hennes MMI, 1996, HYPERTENSION, V28, P120, DOI 10.1161/01.HYP.28.1.120; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Hsueh WA, 2001, ARTERIOSCL THROM VAS, V21, P1891, DOI 10.1161/hq1201.100261; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Larrouy D, 1999, INT J OBESITY, V23, P1327, DOI 10.1038/sj.ijo.0801106; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lu G, 1996, CIRC RES, V79, P611, DOI 10.1161/01.RES.79.3.611; Lu G, 1998, HYPERTENSION, V32, P1003, DOI 10.1161/01.HYP.32.6.1003; MAJACK RA, 1984, J CELL PHYSIOL, V118, P253, DOI 10.1002/jcp.1041180306; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MARSHALL NJ, 1995, GROWTH REGULAT, V5, P69; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Oda N, 1999, J CELL PHYSIOL, V178, P121, DOI 10.1002/(SICI)1097-4652(199902)178:2<121::AID-JCP1>3.3.CO;2-6; PEIRIS AN, 1989, ANN INTERN MED, V110, P867, DOI 10.7326/0003-4819-110-11-867; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sarkar R, 1996, CIRC RES, V78, P225, DOI 10.1161/01.RES.78.2.225; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Staels B, 2005, CURR MED RES OPIN, V21, pS13, DOI 10.1185/030079905X36440; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Sylvester AM, 1998, J CLIN INVEST, V101, P940, DOI 10.1172/JCI1630; Wakino S, 2000, J BIOL CHEM, V275, P22435, DOI 10.1074/jbc.M910452199; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2003, DEV CELL, V5, P73, DOI 10.1016/S1534-5807(03)00170-9; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang PX, 2005, FEBS LETT, V579, P1446, DOI 10.1016/j.febslet.2005.01.046	49	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1137	10.1371/journal.pone.0001137	http://dx.doi.org/10.1371/journal.pone.0001137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987121	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459000021
J	Langergraber, KE; Siedel, H; Mitani, JC; Wrangham, RW; Reynolds, V; Hunt, K; Vigilant, L				Langergraber, Kevin E.; Siedel, Heike; Mitani, John C.; Wrangham, Richard W.; Reynolds, Vernon; Hunt, Kevin; Vigilant, Linda			The Genetic Signature of Sex-Biased Migration in Patrilocal Chimpanzees and Humans	PLOS ONE			English	Article								A large body of theoretical work suggests that analyses of variation at the maternally inherited mitochondrial (mt)DNA and the paternally inherited non-recombining portion of the Y chromosome (NRY) are a potentially powerful way to reveal the differing migratory histories of men and women across human societies. However, the few empirical studies comparing mtDNA and NRY variation and known patterns of sex-biased migration have produced conflicting results. Here we review some methodological reasons for these inconsistencies, and take them into account to provide an unbiased characterization of mtDNA and NRY variation in chimpanzees, one of the few mammalian taxa where males routinely remain in and females typically disperse from their natal groups. We show that patterns of mtDNA and NRY variation are more strongly contrasting in patrilocal chimpanzees compared with patrilocal human societies. The chimpanzee data we present here thus provide a valuable comparative benchmark of the patterns of mtDNA and NRY variation to be expected in a society with extremely female-biased dispersal.	[Langergraber, Kevin E.; Mitani, John C.] Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA; [Siedel, Heike; Vigilant, Linda] Max Planck Inst Evolutionary Anthropol, Primatol Dept, Leipzig, Germany; [Wrangham, Richard W.] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Reynolds, Vernon] Univ Oxford, Sch Anthropol, Oxford, England; [Hunt, Kevin] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA	University of Michigan System; University of Michigan; Max Planck Society; Harvard University; University of Oxford; Indiana University System; Indiana University Bloomington	Langergraber, KE (corresponding author), Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA.	klangerg@umich.edu	Hunt, Kevin/L-6018-2019; Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284	U.S. National Science Foundation [BCS0215622, IOB-0516644, BCS-0416125]; National Sciences and Engineering Research Council of Canada; L.S.B. Leakey Foundation; Wenner-Gren Foundation; Max Planck Society; University of Michigan; Detroit Zoological Institute; Royal Zoological Society of Scotland; National Geographic Society	U.S. National Science Foundation(National Science Foundation (NSF)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); L.S.B. Leakey Foundation; Wenner-Gren Foundation; Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Michigan(University of Michigan System); Detroit Zoological Institute; Royal Zoological Society of Scotland; National Geographic Society(National Geographic Society)	This study was funded by the U.S. National Science Foundation (BCS0215622, IOB-0516644, BCS-0416125), the National Sciences and Engineering Research Council of Canada, the L.S.B. Leakey Foundation, the Wenner-Gren Foundation, the Max Planck Society, the University of Michigan, the Detroit Zoological Institute, the Royal Zoological Society of Scotland, and the National Geographic Society. None of these funders were involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Altmann J, 1996, P NATL ACAD SCI USA, V93, P5797, DOI 10.1073/pnas.93.12.5797; Alvarez HP, 2004, KINSHIP AND BEHAVIOR IN PRIMATES, P420; [Anonymous], 1967, KINSHIP AND MARRIAGE; Chaix R, 2007, CURR BIOL, V17, P43, DOI 10.1016/j.cub.2006.10.058; Clutton-Brock T. H., 1988, REPROD SUCCESS; Eriksson J, 2006, MOL ECOL, V15, P939, DOI 10.1111/j.1365-294X.2006.02845.x; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Gagneux P, 2001, PHILOS T R SOC B, V356, P889, DOI 10.1098/rstb.2001.0865; Hammond RL, 2006, P ROY SOC B-BIOL SCI, V273, P479, DOI 10.1098/rspb.2005.3257; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hill K., 1996, ACHE LIFE HIST; Howell Nancy, 1979, DEMOGRAPHY D KUNG; Irons William, 2000, ADAPTATION HUMAN BEH, P223; Kano T., 1992, LAST APE; Kayser M, 2003, AM J HUM GENET, V72, P281, DOI 10.1086/346065; Kumar V, 2006, PLOS GENET, V2, P420, DOI 10.1371/journal.pgen.0020053; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Mitani JC, 2002, EVOL ANTHROPOL, V11, P9, DOI 10.1002/evan.10008; MULDER MB, 1988, REPROD SUCCESS, P419; MURDOCH GP, 1981, ATLAS WORLD CULTURES; Nei M., 1987, MOL EVOLUTIONARY GEN; Nishida T, 2003, AM J PRIMATOL, V59, P99, DOI 10.1002/ajp.10068; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Rhine RJ, 2000, AM J PRIMATOL, V51, P229, DOI 10.1002/1098-2345(200008)51:4<229::AID-AJP2>3.0.CO;2-C; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Strassmann Beverly I., 2003, P177; SWEDELL L, 2006, STRATEGIES SEX SURVI; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wilder JA, 2004, MOL BIOL EVOL, V21, P2047, DOI 10.1093/molbev/msh214; Wilder JA, 2004, NAT GENET, V36, P1122, DOI 10.1038/ng1428; Wilkins JF, 2006, BIOESSAYS, V28, P290, DOI 10.1002/bies.20378; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017	34	72	72	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e973	10.1371/journal.pone.0000973	http://dx.doi.org/10.1371/journal.pone.0000973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912352	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455900011
J	Lee, WM; Kiesner, C; Pappas, T; Lee, I; Grindle, K; Jartti, T; Jakiela, B; Lemanske, RF; Shult, PA; Gern, JE				Lee, Wai-Ming; Kiesner, Christin; Pappas, Tressa; Lee, Iris; Grindle, Kris; Jartti, Tuomas; Jakiela, Bogdan; Lemanske, Robert F., Jr.; Shult, Peter A.; Gern, James E.			A Diverse Group of Previously Unrecognized Human Rhinoviruses Are Common Causes of Respiratory Illnesses in Infants	PLOS ONE			English	Article								Background. Human rhinoviruses (HRVs) are the most prevalent human pathogens, and consist of 101 serotypes that are classified into groups A and B according to sequence variations. HRV infections cause a wide spectrum of clinical outcomes ranging from asymptomatic infection to severe lower respiratory symptoms. Defining the role of specific strains in various HRV illnesses has been difficult because traditional serology, which requires viral culture and neutralization tests using 101 serotype-specific antisera, is insensitive and laborious. Methods and Findings. To directly type HRVs in nasal secretions of infants with frequent respiratory illnesses, we developed a sensitive molecular typing assay based on phylogenetic comparisons of a 260-bp variable sequence in the 5' noncoding region with homologous sequences of the 101 known serotypes. Nasal samples from 26 infants were first tested with a multiplex PCR assay for respiratory viruses, and HRV was the most common virus found (108 of 181 samples). Typing was completed for 101 samples and 103 HRVs were identified. Surprisingly, 54 (52.4%) HRVs did not match any of the known serotypes and had 12-35% nucleotide divergence from the nearest reference HRVs. Of these novel viruses, 9 strains (17 HRVs) segregated from HRVA, HRVB and human enterovirus into a distinct genetic group ("C''). None of these new strains could be cultured in traditional cell lines. Conclusions. By molecular analysis, over 50% of HRV detected in sick infants were previously unrecognized strains, including 9 strains that may represent a new HRV group. These findings indicate that the number of HRV strains is considerably larger than the 101 serotypes identified with traditional diagnostic techniques, and provide evidence of a new HRV group.	[Lee, Wai-Ming; Pappas, Tressa; Lee, Iris; Grindle, Kris; Jartti, Tuomas; Jakiela, Bogdan; Lemanske, Robert F., Jr.; Gern, James E.] Univ Wisconsin, Dept Pediat & Med, Madison, WI 53706 USA; [Kiesner, Christin; Shult, Peter A.] Univ Wisconsin, Wisconsin State Lab Hyg, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Lee, WM (corresponding author), Univ Wisconsin, Dept Pediat & Med, Madison, WI 53706 USA.	wlee5@wisc.edu	Jakiela, Bogdan/CAA-1861-2022	Jakiela, Bogdan/0000-0003-0444-981X	NIAID/NIH [NO1-AI-25496]; NHLBI [P01 HL070831]; NIAID [U19 AI070503-01]; NIH/NCRR University of Wisconsin General Clinical Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025496, U19AI070503] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NCRR University of Wisconsin General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIAID/NIH NO1-AI-25496, NHLBI P01 HL070831, NIAID U19 AI070503-01 and NIH/NCRR University of Wisconsin General Clinical Research Center Sponsors/ funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Andeweg AC, 1999, J CLIN MICROBIOL, V37, P524, DOI 10.1128/JCM.37.3.524-530.1999; Blomqvist S, 2002, J CLIN MICROBIOL, V40, P4218, DOI 10.1128/JCM.40.11.4218-4223.2002; CALLAHAN PL, 1985, P NATL ACAD SCI USA, V82, P732, DOI 10.1073/pnas.82.3.732; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; COUCH RB, 2001, FIELDS VIROLOGY, P777; Deffernez C, 2004, J CLIN MICROBIOL, V42, P3212, DOI 10.1128/JCM.42.7.3212-3218.2004; DUECHLER M, 1987, P NATL ACAD SCI USA, V84, P2605, DOI 10.1073/pnas.84.9.2605; Gern JE, 2002, PEDIAT ALLERG IMM-UK, V13, P386, DOI 10.1034/j.1399-3038.2002.01093.x; Gern JE, 2002, AM J MED, V112, p19S; Graat JM, 2003, J CLIN EPIDEMIOL, V56, P1218, DOI 10.1016/S0895-4356(03)00171-9; Gwaltney Jack M. Jr., 2002, P995; HAMPARIAN VV, 1987, VIROLOGY, V159, P191; Harris JR, 2005, J VIROL, V79, P5363, DOI 10.1128/JVI.79.9.5363-5373.2005; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Hershenson MB, 2006, AM J RESP CRIT CARE, V174, P1284, DOI 10.1164/rccm.200609-1387ED; Holmes EC, 1998, BRIT MED BULL, V54, P533; HUGHES PJ, 1988, J GEN VIROL, V69, P49, DOI 10.1099/0022-1317-69-1-49; Johnston NW, 2005, J ALLERGY CLIN IMMUN, V115, P132, DOI 10.1016/j.jaci.2004.09.025; JOHNSTON SL, 1993, J CLIN MICROBIOL, V31, P111, DOI 10.1128/JCM.31.1.111-117.1993; KAPIKIAN A Z, 1971, Virology, V43, P524, DOI 10.1016/0042-6822(71)90329-1; KAPIKIAN A Z, 1967, Nature (London), V213, P761; Kistler AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-40; KOPECKA H, 1995, VIRUS RES, V38, P125, DOI 10.1016/0168-1702(95)00055-U; Laine P, 2005, J GEN VIROL, V86, P697, DOI 10.1099/vir.0.80445-0; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Lee WM, 2007, J CLIN MICROBIOL, V45, P2626, DOI 10.1128/JCM.02501-06; LEE WM, 1995, VIRUS GENES, V9, P177, DOI 10.1007/BF01702661; LEE WM, 1993, J VIROL, V67, P2110, DOI 10.1128/JVI.67.4.2110-2122.1993; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Loens K, 2003, J CLIN MICROBIOL, V41, P1971, DOI 10.1128/JCM.41.5.1971-1976.2003; Louie JK, 2005, CLIN INFECT DIS, V41, P262, DOI 10.1086/430915; McCormack GP, 2002, REV MED VIROL, V12, P221, DOI 10.1002/rmv.355; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; Monto AS, 2001, CLIN THER, V23, P1615, DOI 10.1016/S0149-2918(01)80133-8; Monto AS, 2002, AM J MED, V112, p4S; MONTO AS, 1987, J INFECT DIS, V156, P43, DOI 10.1093/infdis/156.1.43; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Oberste MS, 2000, J CLIN MICROBIOL, V38, P1170, DOI 10.1128/JCM.38.3.1170-1174.2000; Palacios G, 2002, J CLIN MICROBIOL, V40, P182, DOI 10.1128/JCM.40.1.182-192.2002; PELON W, 1957, P SOC EXP BIOL MED, V94, P262; Pitkaranta A, 1998, ANN MED, V30, P529; PRICE WH, 1956, P NATL ACAD SCI USA, V42, P892, DOI 10.1073/pnas.42.12.892; Rotbart HA, 2000, ARCH FAM MED, V9, P913, DOI 10.1001/archfami.9.9.913; Rueckert RR, 1996, VIROLOGY, P609; Savolainen C, 2004, J GEN VIROL, V85, P2271, DOI 10.1099/vir.0.79897-0; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; SKERN T, 1985, NUCLEIC ACIDS RES, V13, P2111, DOI 10.1093/nar/13.6.2111; STANWAY G, 1984, NUCLEIC ACIDS RES, V12, P7859, DOI 10.1093/nar/12.20.7859; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turner RB, 2007, J INFECT DIS, V195, P765, DOI 10.1086/511829; van Benten I, 2003, PEDIAT ALLERG IMM-UK, V14, P363, DOI 10.1034/j.1399-3038.2003.00064.x; Winther B, 2006, J MED VIROL, V78, P644, DOI 10.1002/jmv.20588; Witwer C, 2001, NUCLEIC ACIDS RES, V29, P5079, DOI 10.1093/nar/29.24.5079	58	231	242	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e966	10.1371/journal.pone.0000966	http://dx.doi.org/10.1371/journal.pone.0000966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912345	Green Published, gold			2022-12-27	WOS:000207455900004
J	Nittala, A; Ghosh, S; Wang, XJ				Nittala, Aparna; Ghosh, Soumitra; Wang, Xujing			Investigating the Role of Islet Cytoarchitecture in Its Oscillation Using a New beta-Cell Cluster Model	PLOS ONE			English	Article							PULSATILE INSULIN; ELECTRICAL-ACTIVITY; PANCREATIC-ISLETS; CA2+ OSCILLATIONS; IDENTIFIED ALPHA; GAP-JUNCTIONS; SECRETION; SYNCHRONIZATION; MODULATION; SINGLE	The oscillatory insulin release is fundamental to normal glycemic control. The basis of the oscillation is the intercellular coupling and bursting synchronization of beta cells in each islet. The functional role of islet beta cell mass organization with respect to its oscillatory bursting is not well understood. This is of special interest in view of the recent finding of islet cytoarchitectural differences between human and animal models. In this study we developed a new hexagonal closest packing (HCP) cell cluster model. The model captures more accurately the real islet cell organization than the simple cubic packing (SCP) cluster that is conventionally used. Using our new model we investigated the functional characteristics of beta-cell clusters, including the fraction of cells able to burst f(b), the synchronization index lambda of the bursting beta cells, the bursting period T-b, the plateau fraction p(f), and the amplitude of intracellular calcium oscillation [Ca]. We determined their dependence on cluster architectural parameters including number of cells n(beta), number of inter-beta cell couplings of each beta cell n(c), and the coupling strength g(c). We found that at low values of n(beta), n(c) and g(c), the oscillation regularity improves with their increasing values. This functional gain plateaus around their physiological values in real islets, at n(beta) similar to 100, n(c) similar to 6 and g(c) similar to 200 pS. In addition, normal beta-cell clusters are robust against significant perturbation to their architecture, including the presence of non-beta cells or dead beta cells. In clusters with n(beta) > similar to 100, coordinated beta-cell bursting can be maintained at up to 70% of beta-cell loss, which is consistent with laboratory and clinical findings of islets. Our results suggest that the bursting characteristics of a beta-cell cluster depend quantitatively on its architecture in a non-linear fashion. These findings are important to understand the islet bursting phenomenon and the regulation of insulin secretion, under both physiological and pathological conditions.	[Nittala, Aparna; Ghosh, Soumitra; Wang, Xujing] Med Coll Wisconsin, Childrens Hosp Wisconsin, Max McGee Natl Res Ctr Juvenile Diabet, Human & Mol Genet Ctr,Childrens Res Inst, Milwaukee, WI 53226 USA	Children's Hospital of Wisconsin; Medical College of Wisconsin	Wang, XJ (corresponding author), Med Coll Wisconsin, Childrens Hosp Wisconsin, Max McGee Natl Res Ctr Juvenile Diabet, Human & Mol Genet Ctr,Childrens Res Inst, Milwaukee, WI 53226 USA.	xwang@mcw.edu			Children's Hospital Foundation; Children's Research Institute of Wisconsin; Children's Hospital of Wisconsin	Children's Hospital Foundation; Children's Research Institute of Wisconsin; Children's Hospital of Wisconsin	This work is supported in part by a special fund from Children's Hospital Foundation, Children's Research Institute of Wisconsin and Children's Hospital of Wisconsin.	Aguirre J, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041910; Allagnat F, 2005, J CELL SCI, V118, P5335, DOI 10.1242/jcs.02600; Allefeld C, 2004, INT J BIFURCAT CHAOS, V14, P417, DOI 10.1142/S0218127404009521; Andreu E, 1997, J PHYSIOL-LONDON, V498, P753, DOI 10.1113/jphysiol.1997.sp021899; Atwater I., 1996, DIABETES MELLITUS FU; Atwater I., 1989, INSULIN SECRETION; Bergsten P, 2000, DIABETES-METAB RES, V16, P179, DOI 10.1002/1520-7560(200005/06)16:3<179::AID-DMRR115>3.3.CO;2-3; Bertram R, 2004, BIOPHYS J, V87, P3074, DOI 10.1529/biophysj.104.049262; BERTRAM R, 1995, BIOPHYS J, V68, P2323, DOI 10.1016/S0006-3495(95)80414-5; Bertram R, 2000, BIOPHYS J, V79, P2880, DOI 10.1016/S0006-3495(00)76525-8; Bertuzzi F, 2007, DIABETES CARE, V30, P410, DOI 10.2337/dc06-1233; BINGLEY PJ, 1992, DIABETOLOGIA, V35, P32, DOI 10.1007/BF00400849; BRATUSCHMARRAIN PR, 1986, DIABETES, V35, P922, DOI 10.2337/diabetes.35.8.922; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; CHAY TR, 1988, BIOPHYS J, V54, P427, DOI 10.1016/S0006-3495(88)82976-X; CHAY TR, 1983, BIOPHYS J, V42, P181, DOI 10.1016/S0006-3495(83)84384-7; De Vries G, 2000, J THEOR BIOL, V207, P513, DOI 10.1006/jtbi.2000.2193; De Vries G, 2001, B MATH BIOL, V63, P371, DOI 10.1006/bulm.2001.0228; FALKE LC, 1989, FEBS LETT, V251, P167, DOI 10.1016/0014-5793(89)81448-6; FOULIS AK, 1987, J PATHOL, V152, P141, DOI 10.1002/path.1711520302; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gylfe E, 2000, UPSALA J MED SCI, V105, P35, DOI 10.1517/03009734000000054; HELLMAN B, 1994, DIABETOLOGIA, V37, pS11, DOI 10.1007/BF00400821; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Inoguchi Toyoshi, 2001, Medical Electron Microscopy, V34, P86, DOI 10.1007/s007950170002; Jo J, 2005, BIOPHYS J, V89, P1534, DOI 10.1529/biophysj.104.053181; Jonkers FC, 1999, J PHYSIOL-LONDON, V520, P839, DOI 10.1111/j.1469-7793.1999.00839.x; Kinard TA, 1999, BIOPHYS J, V76, P1423, DOI 10.1016/S0006-3495(99)77303-0; Le Gurun S, 2003, J BIOL CHEM, V278, P37690, DOI 10.1074/jbc.M212382200; Lehmann R, 2007, DIABETES, V56, P594, DOI 10.2337/db06-0779; LINN T, 1991, IMMUN INFEKT, V19, P164; MacDonald PE, 2006, PLOS BIOL, V4, P167, DOI 10.1371/journal.pbio.0040049; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; MacGregor RR, 2006, AM J PHYSIOL-ENDOC M, V290, pE771, DOI 10.1152/ajpendo.00097.2005; MATTHEWS DR, 1983, DIABETES, V32, P617, DOI 10.2337/diabetes.32.7.617; MATTHEWS EK, 1975, J PHYSIOL-LONDON, V246, P421, DOI 10.1113/jphysiol.1975.sp010897; MEARS D, 1995, J MEMBRANE BIOL, V146, P163; MEISSNER HP, 1974, PFLUG ARCH EUR J PHY, V351, P195, DOI 10.1007/BF00586918; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Nlend Rachel Nlend, 2006, Archives of Physiology and Biochemistry, V112, P74, DOI 10.1080/13813450600712019; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; PAOLISSO G, 1988, J CLIN ENDOCR METAB, V66, P1220, DOI 10.1210/jcem-66-6-1220; PAOLISSO G, 1988, ANN MED INTERNE, V139, P144; Pedersen MG, 2005, BIOPHYS J, V89, P107, DOI 10.1529/biophysj.104.055681; Pedersen MG, 2005, J THEOR BIOL, V235, P1, DOI 10.1016/j.jtbi.2005.01.025; PEREZARMENDARIZ M, 1991, BIOPHYS J, V59, P76, DOI 10.1016/S0006-3495(91)82200-7; Porksen N, 2002, DIABETES, V51, pS245, DOI 10.2337/diabetes.51.2007.S245; Quesada I, 2006, DIABETES, V55, P2463, DOI 10.2337/db06-0272; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rocheleau JV, 2006, PLOS BIOL, V4, P221, DOI 10.1371/journal.pbio.0040026; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Rosenblum M., 2001, HDB BIOL PHYS, V4, P279; SAMOLS E, 1990, METABOLISM, V39, P55, DOI 10.1016/0026-0495(90)90212-U; SANCHEZANDRES JV, 1995, J PHYSIOL-LONDON, V486, P223, DOI 10.1113/jphysiol.1995.sp020804; SANTOS RM, 1987, FEBS LETT, V220, P342, DOI 10.1016/0014-5793(87)80843-8; Sato T, 2002, DIABETES, V51, P1565, DOI 10.2337/diabetes.51.5.1565; Schafer C, 1999, PHYS REV E, V60, P857, DOI 10.1103/PhysRevE.60.857; Schmitz O, 1997, AM J PHYSIOL-ENDOC M, V272, pE218, DOI 10.1152/ajpendo.1997.272.2.E218; SHERMAN A, 1991, BIOPHYS J, V59, P547, DOI 10.1016/S0006-3495(91)82271-8; Sherman A, 1996, AM J PHYSIOL-ENDOC M, V271, pE362, DOI 10.1152/ajpendo.1996.271.2.E362; SHERMAN A, 1988, BIOPHYS J, V54, P411, DOI 10.1016/S0006-3495(88)82975-8; SMITH PA, 1990, FEBS LETT, V261, P187, DOI 10.1016/0014-5793(90)80667-8; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; STAGNER JI, 1985, AM J PHYSIOL, V248, pE522, DOI 10.1152/ajpendo.1985.248.5.E522; Valdeolmillos M, 1996, J PHYSIOL-LONDON, V493, P9, DOI 10.1113/jphysiol.1996.sp021361; VELDHUIS JD, 1987, P NATL ACAD SCI USA, V84, P7686, DOI 10.1073/pnas.84.21.7686; WARD GM, 1987, DRUGS, V33, P156, DOI 10.2165/00003495-198733020-00004; Wierschem K, 2004, J THEOR BIOL, V228, P513, DOI 10.1016/j.jtbi.2004.02.022; YARIMIZU K, 1992, DIABETES RES CLIN PR, V17, P27, DOI 10.1016/0168-8227(92)90040-X; Zarkovic M, 2004, AM J PHYSIOL-ENDOC M, V287, pE340, DOI 10.1152/ajpendo.00069.2004; Zarkovic M, 1999, EUR J ENDOCRINOL, V141, P494, DOI 10.1530/eje.0.1410494; Zimliki CL, 2004, BIOPHYS J, V87, P193, DOI 10.1529/biophysj.103.038471	75	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e983	10.1371/journal.pone.0000983	http://dx.doi.org/10.1371/journal.pone.0000983			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912360	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455900019
J	Sponner, A; Vater, W; Monajembashi, S; Unger, E; Grosse, F; Weisshart, K				Sponner, Alexander; Vater, Wolfram; Monajembashi, Shamci; Unger, Eberhard; Grosse, Frank; Weisshart, Klaus			Composition and Hierarchical Organisation of a Spider Silk	PLOS ONE			English	Article							SKIN-CORE STRUCTURE; DRAGLINE SILK; MECHANICAL-PROPERTIES; PROTEIN-COMPONENTS; MICROSTRUCTURE; MORPHOLOGY; SEQUENCE; GLYCOPROTEINS; ORIENTATION; FIBERS	Albeit silks are fairly well understood on a molecular level, their hierarchical organisation and the full complexity of constituents in the spun fibre remain poorly defined. Here we link morphological defined structural elements in dragline silk of Nephila clavipes to their biochemical composition and physicochemical properties. Five layers of different make-ups could be distinguished. Of these only the two core layers contained the known silk proteins, but all can vitally contribute to the mechanical performance or properties of the silk fibre. Understanding the composite nature of silk and its supra-molecular organisation will open avenues in the production of high performance fibres based on artificially spun silk material.	[Sponner, Alexander] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Sponner, Alexander; Vater, Wolfram; Monajembashi, Shamci; Unger, Eberhard; Grosse, Frank; Weisshart, Klaus] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany	University of Oxford; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Weisshart, K (corresponding author), Carl Zeiss MicroImaging GmbH, Jena, Germany.	weisshart@zeiss.de			Bundesministerium fur Forschung und Bildung [BMBF FKZ 0311130]; Bundesministerium fur Landwirtschaft [BML FKZ 98NR049]; Thueringer Ministerium fur Wissenschaft, Forschung und Kultur [TMWFK B307-99-001]; European Commission [MTKD-CT-2004-014533]	Bundesministerium fur Forschung und Bildung(Federal Ministry of Education & Research (BMBF)); Bundesministerium fur Landwirtschaft; Thueringer Ministerium fur Wissenschaft, Forschung und Kultur; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by Bundesministerium fur Forschung und Bildung (BMBF FKZ 0311130), Bundesministerium fur Landwirtschaft (BML FKZ 98NR049), Thueringer Ministerium fur Wissenschaft, Forschung und Kultur (TMWFK B307-99-001) and European Commission (MTKD-CT-2004-014533).	Augsten K, 2000, SCANNING, V22, P12; Augsten K, 1999, SCANNING, V21, P77; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315; CRAIG CC, 2003, TRACING EVOLUTION MO; Denny M.W., 1980, Symposia of the Society for Experimental Biology, P247; Dicko C, 2004, BIOMACROMOLECULES, V5, P704, DOI 10.1021/bm034307c; Garb JE, 2006, SCIENCE, V312, P1762, DOI 10.1126/science.1127946; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0; Gosline JM, 1999, J EXP BIOL, V202, P3295; Gould SAC, 1999, INT J BIOL MACROMOL, V24, P151, DOI 10.1016/S0141-8130(99)00003-3; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005; Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q; Knight DP, 2001, BIOMACROMOLECULES, V2, P323, DOI 10.1021/bm0001446; Knight DP, 2000, INT J BIOL MACROMOL, V27, P205, DOI 10.1016/S0141-8130(00)00124-0; KNIGHT DP, 2001, BIOL LIQUID CRYSTAL, P302; KOVOOR J, 1986, Revue Arachnologique, V7, P15; Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780; LI SFY, 1994, J VAC SCI TECHNOL A, V12, P1891, DOI 10.1116/1.578978; LI SFY, 1994, BIOPHYS J, V66, P1209, DOI 10.1016/S0006-3495(94)80903-8; Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmat1534; Miller LD, 1999, INT J BIOL MACROMOL, V24, P159, DOI 10.1016/S0141-8130(99)00024-0; Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b; Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7; PESCHKE T, 1989, J MICROSC-OXFORD, V156, P191, DOI 10.1111/j.1365-2818.1989.tb02918.x; Porter D, 2005, EUR PHYS J E, V16, P199, DOI 10.1140/epje/e2005-00021-2; Riekel C, 2000, BIOMACROMOLECULES, V1, P622, DOI 10.1021/bm000047c; Rousseau ME, 2007, J AM CHEM SOC, V129, P3897, DOI 10.1021/ja067471r; Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a; Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335; Schulz S, 2001, LIPIDS, V36, P637, DOI 10.1007/s11745-001-0768-7; SEEGER S, 1991, CYTOMETRY, V12, P497, DOI 10.1002/cyto.990120606; Shao Z, 1999, POLYMER, V40, P4709, DOI 10.1016/S0032-3861(99)00072-5; Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84; Sponner A, 2005, NAT MATER, V4, P772, DOI 10.1038/nmat1493; Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k; Sponner A, 2004, BIOMACROMOLECULES, V5, P840, DOI 10.1021/bm034378b; Thiel BL, 1997, BIOPOLYMERS, V41, P703, DOI 10.1002/(SICI)1097-0282(199706)41:7<703::AID-BIP1>3.0.CO;2-T; THIEL BL, 1994, BIOPOLYMERS, V34, P1089, DOI 10.1002/bip.360340812; Thiel BL, 1997, J MICROSC-OXFORD, V185, P179, DOI 10.1046/j.1365-2818.1997.d01-607.x; Tian MZ, 2005, BIOCHEMISTRY-US, V44, P8006, DOI 10.1021/bi050366u; van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299; Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6; Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P147, DOI 10.1098/rspb.1996.0023; Vollrath F, 2005, WOODH PUBL TEXT, P245; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590	52	134	136	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e998	10.1371/journal.pone.0000998	http://dx.doi.org/10.1371/journal.pone.0000998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912375	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455900034
J	Beckstrom-Sternberg, SM; Auerbach, RK; Godbole, S; Pearson, JV; Beckstrom-Sternberg, JS; Deng, ZM; Munk, C; Kubota, K; Zhou, Y; Bruce, D; Noronha, J; Scheuermann, RH; Wang, AH; Wei, XY; Wang, JJ; Hao, J; Wagner, DM; Brettin, TS; Brown, N; Gilna, P; Keim, PS				Beckstrom-Sternberg, Stephen M.; Auerbach, Raymond K.; Godbole, Shubhada; Pearson, John V.; Beckstrom-Sternberg, James S.; Deng, Zuoming; Munk, Christine; Kubota, Kristy; Zhou, Yan; Bruce, David; Noronha, Jyothi; Scheuermann, Richard H.; Wang, Aihui; Wei, Xianying; Wang, Jianjun; Hao, Jicheng; Wagner, David M.; Brettin, Thomas S.; Brown, Nancy; Gilna, Paul; Keim, Paul S.			Complete Genomic Characterization of a Pathogenic A.II Strain of Francisella tularensis Subspecies tularensis	PLOS ONE			English	Article							UNITED-STATES; VIRULENCE; SEQUENCE; PROTEIN; IDENTIFICATION; ALIGNMENT; GENES; ATTENUATION; TULAREMIA	Francisella tularensis is the causative agent of tularemia, which is a highly lethal disease from nature and potentially from a biological weapon. This species contains four recognized subspecies including the North American endemic F. tularensis subsp. tularensis (type A), whose genetic diversity is correlated with its geographic distribution including a major population subdivision referred to as A.I and A.II. The biological significance of the A.I - A.II genetic differentiation is unknown, though there are suggestive ecological and epidemiological correlations. In order to understand the differentiation at the genomic level, we have determined the complete sequence of an A.II strain (WY96-3418) and compared it to the genome of Schu S4 from the A.I population. We find that this A.II genome is 1,898,476 bp in size with 1,820 genes, 1,303 of which code for proteins. While extensive genomic variation exists between "WY96'' and Schu S4, there is only one whole gene difference. This one gene difference is a hypothetical protein of unknown function. In contrast, there are numerous SNPs (3,367), small indels (1,015), IS element differences (7) and large chromosomal rearrangements (31), including both inversions and translocations. The rearrangement borders are frequently associated with IS elements, which would facilitate intragenomic recombination events. The pathogenicity island duplicated regions (DR1 and DR2) are essentially identical in WY96 but vary relative to Schu S4 at 60 nucleotide positions. Other potential virulence-associated genes (231) varied at 559 nucleotide positions, including 357 non-synonymous changes. Molecular clock estimates for the divergence time between A.I and A.II genomes for different chromosomal regions ranged from 866 to 2131 years before present. This paper is the first complete genomic characterization of a member of the A.II clade of Francisella tularensis subsp. tularensis.	[Beckstrom-Sternberg, Stephen M.; Hao, Jicheng; Keim, Paul S.] Translat Genom Res Inst, Pathogen Genom Div, Phoenix, AZ USA; [Beckstrom-Sternberg, Stephen M.; Auerbach, Raymond K.; Beckstrom-Sternberg, James S.; Wagner, David M.; Keim, Paul S.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Godbole, Shubhada; Noronha, Jyothi; Scheuermann, Richard H.] Univ Texas SW Med Ctr Dallas, BioHlth Base, Dallas, TX 75390 USA; [Pearson, John V.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ USA; [Deng, Zuoming; Wang, Aihui; Wei, Xianying; Wang, Jianjun] Northrop Grumman Informat Technol, BioHealthBase, Rockville, MD USA; [Munk, Christine; Bruce, David; Brettin, Thomas S.; Brown, Nancy; Gilna, Paul] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Munk, Christine; Bruce, David; Brettin, Thomas S.; Brown, Nancy; Gilna, Paul] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Kubota, Kristy; Zhou, Yan] Ctr Dis Control & Prevent, Ft Collins, CO USA	Translational Genomics Research Institute; Northern Arizona University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Translational Genomics Research Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Centers for Disease Control & Prevention - USA	Keim, PS (corresponding author), Translat Genom Res Inst, Pathogen Genom Div, Phoenix, AZ USA.	Paul.Keim@nau.edu	Pearson, John V/F-2249-2011; Keim, Paul S/A-2269-2010; Wagner, David M/A-5125-2010; Gilna, Paul/I-3608-2016	Pearson, John V/0000-0003-0904-4598; Gilna, Paul/0000-0002-6542-0191; Scheuermann, Richard H./0000-0003-1355-892X; Wagner, David/0000-0003-2684-6007	Cowden Endowment for Microbiology NAU; NIAID/NIH [HHSN266200400041C]; ADB [N01-AI-40041]	Cowden Endowment for Microbiology NAU; NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ADB	PSK was supported by The Cowden Endowment for Microbiology NAU. SG, ZD, JN, RS, AW, XW, and JW were supported by NIAID/NIH Contract Number: HHSN266200400041C, ADB Contract Number: N01-AI-40041. Genome sequencing was funded by the Intelligence Technology Innovation Center.	ACHTMAN M, 2004, YERSINIA MOL CELLULA; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AUERBACH RK, 2006, THESIS NO ARIZONA U, P72; Barns SM, 2005, APPL ENVIRON MICROB, V71, P5494, DOI 10.1128/AEM.71.9.5494-5500.2005; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; *CDC, 2003, KEY FACTS TUL; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Farlow J, 2005, EMERG INFECT DIS, V11, P1835, DOI 10.3201/eid1112.050728; Forslund AL, 2006, MOL MICROBIOL, V59, P1818, DOI 10.1111/j.1365-2958.2006.05061.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; HARRIS S, 1991, CRIME LAW SOCIAL CH, V15, P171; Harris S., 1992, ANN N Y ACAD SCI, V666, P21; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; KEIM PS, 2007, ANN N Y ACAD SCI; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LSUFJEV NG, 1983, INT J SYSTEMATIC BAC, V33, P872; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Petrosino JF, 2006, J BACTERIOL, V188, P6977, DOI 10.1128/JB.00506-06; POLARD P, 1991, J MOL BIOL, V222, P465, DOI 10.1016/0022-2836(91)90490-W; Rohmer L, 2006, INFECT IMMUN, V74, P6895, DOI 10.1128/IAI.01006-06; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Twine SM, 2006, MICROB PATHOGENESIS, V40, P133, DOI 10.1016/j.micpath.2005.12.004	40	41	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e947	10.1371/journal.pone.0000947	http://dx.doi.org/10.1371/journal.pone.0000947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895988	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455800026
J	Roure, A; Rothbacher, U; Robin, F; Kalmar, E; Ferone, G; Lamy, C; Missero, C; Mueller, F; Lemaire, P				Roure, Agnes; Rothbaecher, Ute; Robin, Francois; Kalmar, Eva; Ferone, Giustina; Lamy, Clement; Missero, Caterina; Mueller, Ferenc; Lemaire, Patrick			A Multicassette Gateway Vector Set for High Throughput and Comparative Analyses in Ciona and Vertebrate Embryos	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; SONIC-HEDGEHOG; DNA CLONING; MESODERM; RECOMBINATION; TRANSCRIPTION; CHORDATE; ENHANCER; SYSTEM	Background. The past few years have seen a vast increase in the amount of genomic data available for a growing number of taxa, including sets of full length cDNA clones and cis-regulatory sequences. Large scale cross-species comparisons of protein function and cis-regulatory sequences may help to understand the emergence of specific traits during evolution. Principal Findings. To facilitate such comparisons, we developed a Gateway compatible vector set, which can be used to systematically dissect cis-regulatory sequences, and overexpress wild type or tagged proteins in a variety of chordate systems. It was developed and first characterised in the embryos of the ascidian Ciona intestinalis, in which large scale analyses are easier to perform than in vertebrates, owing to the very efficient embryo electroporation protocol available in this organism. Its use was then extended to fish embryos and cultured mammalian cells. Conclusion. This versatile vector set opens the way to the mid-to large-scale comparative analyses of protein function and cis-regulatory sequences across chordate evolution. A complete user manual is provided as supplemental material.	[Roure, Agnes; Rothbaecher, Ute; Robin, Francois; Lamy, Clement; Lemaire, Patrick] Univ Mediterranee, CNRS, Inst Biol Dev Marseille Luminy, UMR 6216, Marseille, France; [Kalmar, Eva; Mueller, Ferenc] Forschungszentrum Karlsruhe, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany; [Ferone, Giustina; Missero, Caterina] CEINGE Biotecnol Avanzate SCarl Ctr Genet Engn, Naples, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; Karlsruhe Institute of Technology; CEINGE Biotecnologie Avanzate	Roure, A (corresponding author), Univ Mediterranee, CNRS, Inst Biol Dev Marseille Luminy, UMR 6216, Marseille, France.	roure@ibdm.univ-mrs.fr; lemaire@ibdm.univ-mrs.fr	Lemaire, Patrick/B-5560-2012; Robin, François/B-4784-2013; Robin, Francois B/ABI-2581-2020; Kalmár, Éva/AAD-6515-2022; Rothbächer, Ute/G-2688-2013; Rothbächer, Ute/AAB-6901-2022; Lemaire, Patrick/P-8228-2019; Muller, Ferenc/C-6426-2009	Lemaire, Patrick/0000-0003-4925-2009; Robin, François/0000-0002-2420-2593; Robin, Francois B/0000-0002-2420-2593; Kalmár, Éva/0000-0003-4616-8047; Rothbächer, Ute/0000-0002-9989-6139; Rothbächer, Ute/0000-0002-9989-6139; Lemaire, Patrick/0000-0003-4925-2009; Missero, Caterina/0000-0003-0905-5123; mueller, ferenc/0000-0002-0996-774X	CNRS; European commission; GIS de la Genomique Marine	CNRS(Centre National de la Recherche Scientifique (CNRS)); European commission(European CommissionEuropean Commission Joint Research Centre); GIS de la Genomique Marine	This work was supported by CNRS and by grants from the European commission (Transcode to PL, FM and CM; Embryos against cancer, Marine genomics Europe to PL) and the GIS de la Genomique Marine to PL.	Antonini D, 2006, MOL CELL BIOL, V26, P3308, DOI 10.1128/MCB.26.8.3308-3318.2006; Bertrand V, 2003, CELL, V115, P615, DOI 10.1016/S0092-8674(03)00928-0; Brand L, 2006, PLANT PHYSIOL, V141, P1194, DOI 10.1104/pp.106.081299; Brasch MA, 2004, GENOME RES, V14, P2001, DOI 10.1101/gr.2769804; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Conklin E.G., 1905, J ACAD NAT SCI PHILA, V12, P1, DOI DOI 10.5962/BHL.TITLE.4801; Corbo JC, 1997, DEVELOPMENT, V124, P589; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Erives A, 1998, DEV BIOL, V194, P213, DOI 10.1006/dbio.1997.8810; Ertzer R, 2007, DEV BIOL, V301, P578, DOI 10.1016/j.ydbio.2006.11.004; Fanelli A, 2003, DEV BIOL, V263, P12, DOI 10.1016/S0012-1606(03)00397-X; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hope IA, 2004, GENOME RES, V14, P2070, DOI 10.1101/gr.2463804; Ikuta T, 2004, P NATL ACAD SCI USA, V101, P15118, DOI 10.1073/pnas.0401389101; Kim SH, 1998, DEVELOPMENT, V125, P4681; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Kusakabe T, 2005, ZOOL SCI, V22, P129, DOI 10.2108/zsj.22.129; Lamy C, 2006, DEVELOPMENT, V133, P2835, DOI 10.1242/dev.02448; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Locascio A, 1999, DEVELOPMENT, V126, P4737; Marcellini S, 2003, DEV BIOL, V260, P352, DOI 10.1016/S0012-1606(03)00244-6; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Muller F, 1999, DEVELOPMENT, V126, P2103; MULLER F, 1993, FEBS LETT, V324, P27, DOI 10.1016/0014-5793(93)81525-5; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Oda H, 2001, J CELL SCI, V114, P493; Oda-Ishii I, 2005, DEVELOPMENT, V132, P1663, DOI 10.1242/dev.01707; Ohno M, 1999, MOL CELL BIOL, V19, P2051; Pasini A, 2006, PLOS BIOL, V4, P1173, DOI 10.1371/journal.pbio.0040225; Poulain M, 2006, DEVELOPMENT, V133, P2189, DOI 10.1242/dev.02387; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Rottinger E, 2006, DEVELOPMENT, V133, P4341, DOI 10.1242/dev.02603; Ruvinsky I, 2003, DEVELOPMENT, V130, P5133, DOI 10.1242/dev.00711; Sasaki Y, 2004, J BIOTECHNOL, V107, P233, DOI 10.1016/j.jbiotec.2003.10.001; SASAKI Y, 2005, J BIOTECHNOL; Satou Y, 2002, GENESIS, V33, P153, DOI 10.1002/gene.10119; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Tarsitano M, 2006, FASEB J, V20, P227, DOI 10.1096/fj.05-4147com; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yahata K, 2005, J BIOTECHNOL, V118, P123, DOI 10.1016/j.jbiotec.2005.02.020	51	94	95	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e916	10.1371/journal.pone.0000916	http://dx.doi.org/10.1371/journal.pone.0000916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878951	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455700024
J	Abdel-Latief, M				Abdel-Latief, Mohatmed			A Family of Chemoreceptors in Tribolium castaneum (Tenebrionidae: Coleoptera)	PLOS ONE			English	Article							CANDIDATE TASTE RECEPTORS; OLFACTORY RECEPTORS; DROSOPHILA-MELANOGASTER; MOLECULAR-BIOLOGY; MALARIA MOSQUITO; ODORANT; GENE; EXPRESSION; MAP; IDENTIFICATION	Chemoperception in invertebrates is mediated by a family of G-protein-coupled receptors (GPCR). To date nothing is known about the molecular mechanisms of chemoperception in coleopteran species. Recently the genome of Tribolium castaneum was sequenced for use as a model species for the Coleoptera. Using blast searches analyses of the T. castaneum genome with previously predicted amino acid sequences of insect chemoreceptor genes, a putative chemoreceptor family consisting of 62 gustatory receptors (Grs) and 26 olfactory receptors (Ors) was identified. The receptors have seven transmembrane domains (7TMs) and all belong to the GPCR receptor family. The expression of the T. castaneum chemoreceptor genes was investigated using quantification real-time RT-PCR and in situ whole mount RT-PCR analysis in the antennae, mouth parts, and prolegs of the adults and larvae. All of the predicted TcasGrs were expressed in the labium, maxillae, and prolegs of the adults but TcasGr13, 19, 28, 47, 62, 98, and 61 were not expressed in the prolegs. The TcasOrs were localized only in the antennae and not in any of the beetles gustatory organs with one exception; the TcasOr16 (like DmelOr83b), which was localized in the antennae, labium, and prolegs of the beetles. A group of six TcasGrs that presents a lineage with the sugar receptors subfamily in Drosophila melanogaster were localized in the lacinia of the Tribolium larvae. TcasGr1, 3, and 39, presented an ortholog to CO2 receptors in D. melanogaster and Anopheles gambiae was recorded. Low expression of almost all of the predicted chemoreceptor genes was observed in the head tissues that contain the brains and suboesophageal ganglion (SOG). These findings demonstrate the identification of a chemoreceptor family in Tribolium, which is evolutionarily related to other insect species.	Free Univ Berlin, Dept Appl Zool, Inst Biol, D-1000 Berlin, Germany	Free University of Berlin	Abdel-Latief, M (corresponding author), Free Univ Berlin, Dept Appl Zool, Inst Biol, D-1000 Berlin, Germany.	mohatmed@zedat.fu-berlin.de			Free University of Berlin; Department of Applied Zoology/Animal Ecology	Free University of Berlin; Department of Applied Zoology/Animal Ecology	The research was supported by the Free University of Berlin, Department of Applied Zoology/Animal Ecology.	Abdel-Latief M, 2007, INSECT BIOCHEM MOLEC, V37, P999, DOI 10.1016/j.ibmb.2007.05.007; Alekseev M., 2006, ENTOMOL REV, V86, P638; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; BEHAN M, 1978, INT J INSECT MORPHOL, V7, P221, DOI 10.1016/0020-7322(78)90005-3; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Ghaninia M, 2007, ARTHROPOD STRUCT DEV, V36, P23, DOI 10.1016/j.asd.2006.06.004; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; HARBACH RE, 1977, J INSECT PHYSIOL, V23, P1121, DOI 10.1016/0022-1910(77)90143-3; Heinbockel T, 1996, J INSECT PHYSIOL, V42, P565, DOI 10.1016/0022-1910(95)00133-6; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Jacquin-Joly E, 2004, J CHEM ECOL, V30, P2359, DOI 10.1007/s10886-004-7941-3; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; MICNDOO NE, 1915, BIOL BULL, V28, P407; Otaki JM, 2003, J THEOR BIOL, V223, P27, DOI 10.1016/S0022-5193(03)00068-7; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rutzler M, 2005, J COMP PHYSIOL A, V191, P777, DOI 10.1007/s00359-005-0044-y; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Trematerra P, 2000, ENTOMOL EXP APPL, V94, P195, DOI 10.1023/A:1003929810978; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Zhong D, 2004, J HERED, V95, P53, DOI 10.1093/jhered/esh012	48	48	50	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1319	10.1371/journal.pone.0001319	http://dx.doi.org/10.1371/journal.pone.0001319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091992	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459600007
J	Cohen, R; Marom, M; Atlas, D				Cohen, Roy; Marom, Merav; Atlas, Daphne			Depolarization-Evoked Secretion Requires Two Vicinal Transmembrane Cysteines of Syntaxin 1A	PLOS ONE			English	Article								Background. The interactions of the voltage-gated Ca2+ channel (VGCC) with syntaxin 1A (Sx 1A), Synaptosome-associated protein of 25 kD (SNAP-25), and synaptotagmin, couple electrical excitation to evoked secretion. Two vicinal Cys residues, Cys 271 and Cys 272 in the Sx 1A transmembrane domain, are highly conserved and participate in modulating channel kinetics. Each of the Sx1A Cys mutants, differently modify the kinetics of Cav1.2, and neuronal Cav2.2 calcium channel. Methodology/Principle Findings. We examined the effects of various Sx1A Cys mutants and the syntaxin isoforms 2, 3, and 4 each of which lack vicinal Cys residues, on evoked secretion, monitoring capacitance transients in a functional release assay. Membrane capacitance in Xenopus oocytes co-expressing Cav1.2, Sx1A, SNAP-25 and synaptotagmin, which is Bot C- and Bot A-sensitive, was elicited by a double 500 ms depolarizing pulse to 0 mV. The evoked-release was obliterated when a single Cys Sx1A mutant or either one of the Sx isoforms were substituted for Sx 1A, demonstrating the essential role of vicinal Cys residues in the depolarization mediated process. Protein expression and confocal imaging established the level of the mutated proteins in the cell and their targeting to the plasma membrane. Conclusions/Significance. We propose a model whereby the two adjacent transmembranal Cys residues of Sx 1A, lash two calcium channels. Consistent with the necessity of a minimal fusion complex termed the excitosome, each Sx1A is in a complex with SNAP-25, Syt1, and the Ca2+ channel. A Hill coefficient >2 imply that at least three excitosome complexes are required for generating a secreting hetero-oligomer protein complex. This working model suggests that a fusion pore that opens during membrane depolarization could be lined by alternating transmembrane segments of Sx1A and VGCC. The functional coupling of distinct amino acids of Sx 1A with VGCC appears to be essential for depolarization-evoked secretion.	[Cohen, Roy; Marom, Merav; Atlas, Daphne] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Atlas, D (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	datlas@vms.huji.ac.il			Lili Safra Foundation; Mrs. Betty Pfeffer and G.H. Gerson Fund	Lili Safra Foundation; Mrs. Betty Pfeffer and G.H. Gerson Fund	We acknowledge the Lili Safra Foundation, Mrs. Betty Pfeffer and G.H. Gerson Fund for (DA). Funding only.	Arien H, 2003, J BIOL CHEM, V278, P29231, DOI 10.1074/jbc.M301401200; Atlas D, 2001, CELL MOL NEUROBIOL, V21, P717, DOI 10.1023/A:1015104105262; Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; Bement WM, 2000, J EXP ZOOL, V286, P767, DOI 10.1002/(SICI)1097-010X(20000601)286:7<767::AID-JEZ11>3.0.CO;2-L; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Bonanno G, 2000, BRIT J PHARMACOL, V129, P1780, DOI 10.1038/sj.bjp.0703251; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Chen XC, 2006, BIOPHYS J, V90, P2062, DOI 10.1529/biophysj.105.071415; Cohen R, 2005, BIOPHYS J, V89, P4364, DOI 10.1529/biophysj.105.064642; Cohen R, 2004, NEUROSCIENCE, V128, P831, DOI 10.1016/j.neuroscience.2004.07.027; COHEN R, 2007, METHODS MOL IN PRESS; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fisher TE, 2001, PROG BIOPHYS MOL BIO, V77, P269, DOI 10.1016/S0079-6107(01)00017-7; FROST SC, 1985, J BIOL CHEM, V260, P2646; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Jarvis SE, 2005, CELL CALCIUM, V37, P483, DOI 10.1016/j.ceca.2005.01.017; Jarvis SE, 2002, J BIOL CHEM, V277, P44399, DOI 10.1074/jbc.M206902200; Kang Y, 2002, DIABETOLOGIA, V45, P231, DOI 10.1007/s00125-001-0718-0; Lerner I, 2006, J NEUROCHEM, V97, P116, DOI 10.1111/j.1471-4159.2006.03709.x; Melia TJ, 2007, FEBS LETT, V581, P2131, DOI 10.1016/j.febslet.2007.02.066; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Morgans CW, 1996, J NEUROSCI, V16, P6713; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Pickett JA, 2007, BIOCHEM BIOPH RES CO, V359, P599, DOI 10.1016/j.bbrc.2007.05.128; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; Schmitt BM, 2002, BIOPHYS J, V82, P1345, DOI 10.1016/S0006-3495(02)75490-8; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Sherry DM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-54; SMITH SJ, 1993, J PHYSIOL-LONDON, V472, P573, DOI 10.1113/jphysiol.1993.sp019963; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Song HT, 2003, J NEUROPHYSIOL, V89, P1143, DOI 10.1152/jn.00482.2002; Spurlin BA, 2004, DIABETES, V53, P2223, DOI 10.2337/diabetes.53.9.2223; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Stigliani S, 2003, J NEUROCHEM, V85, P409, DOI 10.1046/j.1471-4159.2003.01689.x; Sun L, 2006, EUR J NEUROSCI, V23, P1391, DOI 10.1111/j.1460-9568.2006.04653.x; Szule JA, 2004, SCIENCE, V306; Tobi D, 1998, RECEPTOR CHANNEL, V6, P89; TOONEN RF, 2007, TRENDS NEUROSCI; Trus M, 2001, NEUROSCIENCE, V104, P599, DOI 10.1016/S0306-4522(01)00083-5; TRUS M, 2007, BIOCHEMISTR IN PRESS; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Volchuk A, 1996, MOL BIOL CELL, V7, P1075, DOI 10.1091/mbc.7.7.1075; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wiser O, 1997, FEBS LETT, V404, P203, DOI 10.1016/S0014-5793(97)00130-0; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wiser O, 2002, P NATL ACAD SCI USA, V99, P3968, DOI 10.1073/pnas.052017299; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200; Yang SN, 1999, P NATL ACAD SCI USA, V96, P10164, DOI 10.1073/pnas.96.18.10164; YOSHIDA S, 1992, J PHYSIOL-LONDON, V458, P307, DOI 10.1113/jphysiol.1992.sp019419; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0	58	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1273	10.1371/journal.pone.0001273	http://dx.doi.org/10.1371/journal.pone.0001273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060067	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459400020
J	Iser, WB; Wolkow, CA				Iser, Wendy B.; Wolkow, Catherine A.			DAF-2/Insulin-Like Signaling in C. elegans Modifies Effects of Dietary Restriction and Nutrient Stress on Aging, Stress and Growth	PLOS ONE			English	Article								Background. Dietary restriction (DR) and reduced insulin/IGF-I-like signaling (IIS) are two regimens that promote longevity in a variety of organisms. Genetic analysis in C. elegans nematodes has shown that DR and IIS couple to distinct cellular signaling pathways. However, it is not known whether these pathways ultimately converge on overlapping or distinct targets to extend lifespan. Principal Findings. We investigated this question by examining additional effects of DR in wildtype animals and in daf-2 mutants with either moderate or severe IIS deficits. Surprisingly, DR and IIS had opposing effects on these physiological processes. First, DR induced a stress-related change in intestinal vesicle trafficking, termed the FIRE response, which was suppressed in daf-2 mutants. Second, DR did not strongly affect expression of a daf-2- and stress-responsive transcriptional reporter. Finally, DR-related growth impairment was suppressed in daf-2 mutants. Conclusions. These findings reveal that an important biological function of DAF-2/IIS is to enhance growth and survival under nutrient-limited conditions. However, we also discovered that levels of DAF-2 pathway activity modified the effects of DR on longevity. Thus, while DR and IIS clearly affect lifespan through independent targets, there may also be some prolongevity targets that are convergently regulated by these pathways.	[Iser, Wendy B.; Wolkow, Catherine A.] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Wolkow, CA (corresponding author), NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	wolkowca@grc.nia.nih.gov			NIA Intramural Research Program; New Scholar in Aging Award from the Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [Z01AG000320] Funding Source: NIH RePORTER	NIA Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); New Scholar in Aging Award from the Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the NIA Intramural Research Program and by a New Scholar in Aging Award from the Ellison Medical Foundation (CAW). Funding sources were not involved in any aspect of the study or manuscript preparation and submission.	BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; Gami MS, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-45; Gems D, 1998, GENETICS, V150, P129; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Iser WB, 2007, DEV BIOL, V303, P434, DOI 10.1016/j.ydbio.2006.04.467; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kodama E, 2006, GENE DEV, V20, P2955, DOI 10.1101/gad.1479906; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Leiers BR, 2003, FREE RADICAL BIO MED, V34, P1405, DOI 10.1016/S0891-5849(03)00102-3; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Masoro EJ, 1998, EXP GERONTOL, V33, P61, DOI 10.1016/S0531-5565(97)00071-5; McCulloch D, 2003, EXP GERONTOL, V38, P129, DOI 10.1016/S0531-5565(02)00147-X; Morck C, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-39; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Olsen A, 2006, BIOGERONTOLOGY, V7, P221, DOI 10.1007/s10522-006-9018-x; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; SWANSON MM, 1981, DEV BIOL, V84, P27, DOI 10.1016/0012-1606(81)90367-5; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2003, MOL BIOL CELL, V14, P2972, DOI 10.1091/mbc.E03-01-0858; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Walker GA, 2001, J GERONTOL A-BIOL, V56, pB281, DOI 10.1093/gerona/56.7.B281; Weinkove D, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-1	44	25	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1240	10.1371/journal.pone.0001240	http://dx.doi.org/10.1371/journal.pone.0001240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043747	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459300021
J	Satoh, K; Doi, K; Nagata, T; Kishimoto, N; Suzuki, K; Otomo, Y; Kawai, J; Nakamura, M; Hirozane-Kishikawa, T; Kanagawa, S; Arakawa, T; Takahashi-Iida, J; Murata, M; Ninomiya, N; Sasaki, D; Fukuda, S; Tagami, M; Yamagata, H; Kurita, K; Kamiya, K; Yamamoto, M; Kikuta, A; Bito, T; Fujitsuka, N; Ito, K; Kanamori, H; Choi, IR; Nagamura, Y; Matsumoto, T; Murakami, K; Matsubara, K; Carninci, P; Hayashizaki, Y; Kikuchi, S				Satoh, Kouji; Doi, Koji; Nagata, Toshifumi; Kishimoto, Naoki; Suzuki, Kohji; Otomo, Yasuhiro; Kawai, Jun; Nakamura, Mari; Hirozane-Kishikawa, Tomoko; Kanagawa, Saeko; Arakawa, Takahiro; Takahashi-Iida, Juri; Murata, Mitsuyoshi; Ninomiya, Noriko; Sasaki, Daisuke; Fukuda, Shiro; Tagami, Michihira; Yamagata, Harumi; Kurita, Kanako; Kamiya, Kozue; Yamamoto, Mayu; Kikuta, Ari; Bito, Takahito; Fujitsuka, Nahoko; Ito, Kazue; Kanamori, Hiroyuki; Choi, Il-Ryong; Nagamura, Yoshiaki; Matsumoto, Takashi; Murakami, Kazuo; Matsubara, Ken-ichi; Carninci, Piero; Hayashizaki, Yoshihide; Kikuchi, Shoshi			Gene Organization in Rice Revealed by Full-Length cDNA Mapping and Gene Expression Analysis through Microarray	PLOS ONE			English	Article							IN-VITRO TRANSCRIPTS; INFORMATION RESOURCE; DRAFT SEQUENCE; NONCODING RNAS; GENOME; ANNOTATION; DATABASE; MODEL; CENTROMERE; REGIONS	Rice (Oryza sativa L.) is a model organism for the functional genomics of monocotyledonous plants since the genome size is considerably smaller than those of other monocotyledonous plants. Although highly accurate genome sequences of indica and japonica rice are available, additional resources such as full-length complementary DNA (FL-cDNA) sequences are also indispensable for comprehensive analyses of gene structure and function. We cross-referenced 28.5K individual loci in the rice genome defined by mapping of 578K FL-cDNA clones with the 56K loci predicted in the TIGR genome assembly. Based on the annotation status and the presence of corresponding cDNA clones, genes were classified into 23K annotated expressed (AE) genes, 33K annotated non-expressed (ANE) genes, and 5.5K non-annotated expressed (NAE) genes. We developed a 60mer oligo-array for analysis of gene expression from each locus. Analysis of gene structures and expression levels revealed that the general features of gene structure and expression of NAE and ANE genes were considerably different from those of AE genes. The results also suggested that the cloning efficiency of rice FL-cDNA is associated with the transcription activity of the corresponding genetic locus, although other factors may also have an effect. Comparison of the coverage of FL-cDNA among gene families suggested that FL-cDNA from genes encoding rice- or eukaryote-specific domains, and those involved in regulatory functions were difficult to produce in bacterial cells. Collectively, these results indicate that rice genes can be divided into distinct groups based on transcription activity and gene structure, and that the coverage bias of FL-cDNA clones exists due to the incompatibility of certain eukaryotic genes in bacteria.	[Satoh, Kouji; Doi, Koji; Nagata, Toshifumi; Kishimoto, Naoki; Nagamura, Yoshiaki; Matsumoto, Takashi; Kikuchi, Shoshi] Natl Inst Agrobiol Sci, Div Genome & Biodivers Res, Tsukuba, Ibaraki, Japan; [Suzuki, Kohji] Hitachi Software Engn, Shinagawa Ku, Tokyo, Japan; [Otomo, Yasuhiro; Murakami, Kazuo; Matsubara, Ken-ichi] FAIS, Lab Genome Sequencing & Anal Grp, Tsukuba, Ibaraki, Japan; [Matsubara, Ken-ichi] Nara Inst Sci & Technol, Nara, Japan; [Kawai, Jun; Nakamura, Mari; Hirozane-Kishikawa, Tomoko; Kanagawa, Saeko; Arakawa, Takahiro; Takahashi-Iida, Juri; Murata, Mitsuyoshi; Ninomiya, Noriko; Sasaki, Daisuke; Fukuda, Shiro; Tagami, Michihira; Carninci, Piero; Hayashizaki, Yoshihide] RIKEN Yokohama Inst, Genom Sci Ctr, Genome Explorat Res Grp, Kanagawa, Japan; [Kawai, Jun; Carninci, Piero; Hayashizaki, Yoshihide] RIKEN Wako Inst, Genome Sci Lab, Wako, Saitama, Japan; [Yamagata, Harumi; Kurita, Kanako; Kamiya, Kozue; Yamamoto, Mayu; Kikuta, Ari; Bito, Takahito; Fujitsuka, Nahoko; Ito, Kazue; Kanamori, Hiroyuki] Inst Soc Technoinnovat Agr Forestry & Fisheries, Tsukuba, Ibaraki, Japan; [Choi, Il-Ryong] DAPO, Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Manila, Philippines	National Institute of Agrobiological Sciences - Japan; Hitachi Limited; Nara Institute of Science & Technology; RIKEN; RIKEN; CGIAR; International Rice Research Institute (IRRI)	Kikuchi, S (corresponding author), Natl Inst Agrobiol Sci, Div Genome & Biodivers Res, Tsukuba, Ibaraki, Japan.	skikuchi@nias.affrc.go.jp	Doi, Koji/D-1298-2009; Kawai, Jun/A-6451-2016; Carninci, Piero/K-1568-2014; Hayashizaki, Yoshihide/N-6590-2015	Doi, Koji/0000-0002-6027-1799; Carninci, Piero/0000-0001-7202-7243; Fukuda, Shiro/0000-0002-0065-662X	BRAIN; Ministry of Agriculture, Forestry and Fisheries (MAFF); MAFF; Consultative Group for International Agricultural Research (CGIAR)	BRAIN; Ministry of Agriculture, Forestry and Fisheries (MAFF)(Ministry of Agriculture Forestry & Fisheries - Japan); MAFF(Ministry of Agriculture Forestry & Fisheries - Japan); Consultative Group for International Agricultural Research (CGIAR)	This study was supported by a Rice Genome Full-Length cDNA Library Construction Project grant from BRAIN and by the Rice Genome Simulator Project from the Ministry of Agriculture, Forestry and Fisheries (MAFF), Japan; additional funding was received through a QTL project on Green Techno from MAFF and the Generation Challenge program funded by several international donors of the Consultative Group for International Agricultural Research (CGIAR).	Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Choi IR, 1999, PHYTOPATHOLOGY, V89, P1182, DOI 10.1094/PHYTO.1999.89.12.1182; Costa FF, 2007, GENE, V386, P1, DOI 10.1016/j.gene.2006.09.028; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gibbings JG, 2003, PLANT BIOTECHNOL J, V1, P271, DOI 10.1046/j.1467-7652.2003.00026.x; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gojobori T, 2007, GENOME RES, V17, P175, DOI 10.1101/gr.5509507; Hashimoto S, 2004, NAT BIOTECHNOL, V22, P1146, DOI 10.1038/nbt998; Imanishi T., 2004, PLOS BIOL, V2; Jaiswal P, 2006, NUCLEIC ACIDS RES, V34, pD717, DOI 10.1093/nar/gkj154; Jakab G, 1997, J GEN VIROL, V78, P3141, DOI 10.1099/0022-1317-78-12-3141; Johansen IE, 1996, P NATL ACAD SCI USA, V93, P12400, DOI 10.1073/pnas.93.22.12400; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Lin HN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r41; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mizuno H, 2006, PLANT J, V46, P206, DOI 10.1111/j.1365-313X.2006.02684.X; Mizuno H, 2006, DNA RES, V13, P267, DOI 10.1093/dnares/dsm001; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NADEAU K, 1993, J BIOL CHEM, V268, P1479; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; Ohyanagi H, 2006, NUCLEIC ACIDS RES, V34, pD741, DOI 10.1093/nar/gkj094; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Ren XY, 2006, TRENDS GENET, V22, P528, DOI 10.1016/j.tig.2006.08.008; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P224, DOI 10.1093/nar/gkg076; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Sugawara H, 2007, NUCLEIC ACIDS RES, V35, pD13, DOI 10.1093/nar/gkl908; Wu JZ, 2002, PLANT CELL, V14, P525, DOI 10.1105/tpc.010274; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yan HH, 2007, CHROMOSOME RES, V15, P77, DOI 10.1007/s10577-006-1104-z; Yan HH, 2006, PLANT CELL, V18, P2123, DOI 10.1105/tpc.106.043794; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang JW, 2005, PLANT J, V42, P772, DOI 10.1111/j.1365-313X.2005.02408.x; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao WM, 2004, NUCLEIC ACIDS RES, V32, pD377, DOI 10.1093/nar/gkh085; Zhou Yan, 2003, Genomics Proteomics & Bioinformatics, V1, P26	45	42	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1235	10.1371/journal.pone.0001235	http://dx.doi.org/10.1371/journal.pone.0001235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043742	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459300016
J	Zhu, XF; Cooper, RS				Zhu, Xiaofeng; Cooper, Richard S.			Admixture Mapping Provides Evidence of Association of the VNN1 Gene with Hypertension	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ETHNIC-DIFFERENCES; PROSTATE-CANCER; COMMON VARIANT; BLOOD-PRESSURE; DISEASE; LINKAGE; DISCOVERY; LOCUS; SUSCEPTIBILITY	Migration patterns in modern societies have created the opportunity to use population admixture as a strategy to identify susceptibility genes. To implement this strategy, we genotyped a highly informative ancestry marker panel of 2270 single nucleotide polymorphisms in a random population sample of African Americans (N = 1743), European Americans (N = 1000) and Mexican Americans (N = 581). We then examined the evidence for over-transmission of specific loci to cases from one of the two ancestral populations. Hypertension cases and controls were defined based on standard clinical criteria. Both case-only and case-control analyses were performed among African Americans. With the genome-wide markers we replicated the findings identified in our previous admixture mapping study on chromosomes 6 and 21 [1]. For case-control analysis we then genotyped 51 missense SNPs in 36 genes spaced across an 18.3 Mb region. Further analyses demonstrated that the missense SNP rs2272996 (or N131S) in the VNN1 gene was significantly associated with hypertension in African Americans and the association was replicated in Mexican Americans; a non-significant opposite association was observed in European Americans. This SNP also accounted for most of the evidence observed in the admixture analysis on chromosome 6. Despite these encouraging results, susceptibility loci for hypertension have been exceptionally difficult to localize and confirmation by independent studies will be necessary to establish these findings.	[Zhu, Xiaofeng] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Cooper, Richard S.] Loyola Univ, Stritch Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA	Case Western Reserve University; Loyola University Chicago	Zhu, XF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	xzhu1@darwin.case.edu	Zhu, Xiaofeng/O-6874-2019	Zhu, Xiaofeng/0000-0003-0037-411X	National Human Genome Research Institute [HG003054]; National Heart, Lung, and Blood Institute [HL074166]; Donald W. Reynolds Clinical Cardiovascular Center at UT Southwestern, Dallas, TX; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074166] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003054] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Donald W. Reynolds Clinical Cardiovascular Center at UT Southwestern, Dallas, TX; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants (HG003054) from the National Human Genome Research Institute, (HL074166) from the National Heart, Lung, and Blood Institute, the Donald W. Reynolds Clinical Cardiovascular Center at UT Southwestern, Dallas, TX.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Bouzekri N, 2004, EUR J HUM GENET, V12, P460, DOI 10.1038/sj.ejhg.5201166; Cooper RS, 1996, ANN EPIDEMIOL, V6, P173, DOI 10.1016/1047-2797(96)00009-9; CURRAN JE, 2007, AM J HUM GENET, P62; Darvasi A, 2005, NAT GENET, V37, P118, DOI 10.1038/ng0205-118; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Falush D, 2003, GENETICS, V164, P1567; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Halder Indrani, 2003, Human Genomics, V1, P52; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; Montana G, 2004, AM J HUM GENET, V75, P771, DOI 10.1086/425281; Nakajima T, 2004, AM J HUM GENET, V74, P898, DOI 10.1086/420793; Nievergelt CM, 2005, CURR HYPERTENS REP, V7, P31, DOI 10.1007/s11906-005-0052-x; Oparil S, 2003, ANN INTERN MED, V139, P761, DOI 10.7326/0003-4819-139-9-200311040-00011; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pitari G, 2000, FEBS LETT, V483, P149, DOI 10.1016/S0014-5793(00)02110-4; Pritchard JK, 2000, GENETICS, V155, P945; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Samani NJ, 2003, AM J HYPERTENS, V16, P167, DOI 10.1016/S0895-7061(02)03244-2; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Tang H, 2006, NAT GENET, V38, P13, DOI 10.1038/ng0106-13; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WARD R, 1990, HYPERTENSION PATHOPH, P81; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhang C, 2004, GENET EPIDEMIOL, V27, P225, DOI 10.1002/gepi.20021; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510; Zhu XF, 2004, AM J HUM GENET, V74, P1136, DOI 10.1086/421329; Zhu XF, 2001, AM J HUM GENET, V68, P1139, DOI 10.1086/320104; Zhu XF, 2006, HUM GENET, V120, P431, DOI 10.1007/s00439-006-0224-z	51	44	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1244	10.1371/journal.pone.0001244	http://dx.doi.org/10.1371/journal.pone.0001244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043751	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459300025
J	Burgess, IF; Lee, PN; Matlock, G				Burgess, Ian F.; Lee, Peter N.; Matlock, Geraldine			Randomised, Controlled, Assessor Blind Trial Comparing 4% Dimeticone Lotion with 0.5% Malathion Liquid for Head Louse Infestation	PLOS ONE			English	Article								Background. Malathion 0.5% has been the most prescribed pediculicide in the United Kingdom for around 10 years, and is widely used in Europe and North America. Anecdotal reports suggest malathion treatments are less effective than formerly, but this has not been confirmed clinically. This study was designed to determine whether malathion is still effective and if 4% dimeticone lotion is a more effective treatment for head louse infestation. Methodology/Principal Findings. We designed this study as an assessor blinded, randomised, controlled, parallel group trial involving 58 children and 15 adults with active head louse infestation. Each participant received two applications 7 days apart of either 4% dimeticone lotion, applied for 8 hours or overnight, or 0.5% malathion liquid applied for 12 hours or overnight. All treatment and check-up visits were conducted in participants' homes. Cure of infestation was defined as no evidence of head lice after the second treatment. Some people were found free from lice but later reinfested. Worst case, intention to treat, analysis found dimeticone was significantly more effective than malathion, with 30/43 (69.8%) participants cured using dimeticone compared with 10/30 (33.3%) using malathion (p < 0.01, difference 36.4%, 95% confidence interval 14.7% to 58.2%). Per protocol analysis showed cure rates of 30/39 (76.9%) and 10/29 (34.5%) respectively. Irritant reactions were observed in only two participants, both treated with malathion. Conclusions/Significance. We concluded that, although malathion liquid is still effective for some people, dimeticone lotion offers a significantly more effective alternative treatment for most people. Trial Registration. Controlled-Trials.com ISRCTN47755726 [http://www.controlled-trials.com/ISRCTN47755726/head+lice]	[Burgess, Ian F.; Matlock, Geraldine] Insect Res & Dev Ltd, Med Entomol Ctr, Royston, England; [Lee, Peter N.] PN Lee Stat & Comp Ltd, Sutton, Surrey, England	PN Lee Statistics & Computing Ltd	Burgess, IF (corresponding author), Insect Res & Dev Ltd, Med Entomol Ctr, Royston, England.	ian@insectresearch.com	Burgess, Ian/N-2977-2013	Burgess, Ian/0000-0003-0747-3938; Lee, Peter/0000-0002-8244-1904	Thornton & Ross Ltd, Huddersfield, UK	Thornton & Ross Ltd, Huddersfield, UK	The study was financially supported by Thornton & Ross Ltd, Huddersfield, UK, who undertook no role in the design, execution, or interpretation of the study. The decision to submit for publication was that of the authors. The sponsors have approved submission of the manuscript in accordance with the terms of the study protocol.	*BRIT NAT FORM, 2007, BNF 53 SEC 13 10 4 P, P622; Burgess I., 1991, Pharmaceutical Journal, V247, P630; Burgess I. F., 1999, Proceedings of the 3rd International Conference on Urban Pests. Czech University of Agriculture, Prague, Czech Republic, 19-22 July 1999., P249; Burgess Ian F., 1995, Advances in Parasitology, V36, P271, DOI 10.1016/S0065-308X(08)60493-5; Burgess IF, 2005, BRIT MED J, V330, P1423, DOI 10.1136/bmj.38497.506481.8F; CHOSIDOW O, 1994, LANCET, V344, P1724, DOI 10.1016/S0140-6736(94)92884-3; DODD CS, 2003, COCHRANE DATABASE SY; Downs AMR, 1999, PARASITOL TODAY, V15, P1, DOI 10.1016/S0169-4758(98)01361-1; Downs AMR, 2005, ARCH DERMATOL, V141, P1318, DOI 10.1001/archderm.141.10.1318-a; Downs AMR, 1999, BRIT J DERMATOL, V141, P508, DOI 10.1046/j.1365-2133.1999.03046.x; Hill N, 2005, BRIT MED J, V331, P384, DOI 10.1136/bmj.38537.468623.E0; LANG JD, 1975, THESIS TUCSON U ARIZ, P116; *LOND NEW DRUGS GR, 2007, HEDR LYCL SPR AW TRE; MUMCUOGLU KY, 2006, J DRUGS DERMATOL, V5, P415; *NAT LIB HLTH, CLIN KNOWL SUMM FORM; Plastow L, 2001, J CLIN NURS, V10, P775, DOI 10.1046/j.1365-2702.2001.00541.x; Roberts RJ, 2000, LANCET, V356, P540, DOI 10.1016/S0140-6736(00)02578-2; Thomas DR, 2006, ARCH DIS CHILD, V91, P777, DOI 10.1136/adc.2005.091280	18	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1127	10.1371/journal.pone.0001127	http://dx.doi.org/10.1371/journal.pone.0001127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987114	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459000011
J	Holloway, AK; Begun, DJ				Holloway, Alisha K.; Begun, David J.			Rampant Adaptive Evolution in Regions of Proteins with Unknown Function in Drosophila simulans	PLOS ONE			English	Article								Adaptive protein evolution is pervasive in Drosophila. Genomic studies, thus far, have analyzed each protein as a single entity. However, the targets of adaptive events may be localized to particular parts of proteins, such as protein domains or regions involved in protein folding. We compared the population genetic mechanisms driving sequence polymorphism and divergence in defined protein domains and non-domain regions. Interestingly, we find that non-domain regions of proteins are more frequent targets of directional selection. Protein domains are also evolving under directional selection, but appear to be under stronger purifying selection than non-domain regions. Non-domain regions of proteins clearly play a major role in adaptive protein evolution on a genomic scale and merit future investigations of their functional properties.	[Holloway, Alisha K.; Begun, David J.] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; [Holloway, Alisha K.; Begun, David J.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Holloway, AK (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA.	akholloway@ucdavis.edu	Holloway, Alisha/H-9574-2013	Holloway, Alisha/0000-0001-9810-389X	National Science Foundation [0434670]; National Institutes of Health [R01 GM071926]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071926] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is based upon work supported by the National Science Foundation to AKH (0434670) and by the National Institutes of Health to DJB (R01 GM071926).	Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Begun DJ, 2000, GENETICS, V154, P1231; Bierne N, 2004, MOL BIOL EVOL, V21, P1350, DOI 10.1093/molbev/msh134; Cooper JL, 2004, MOL BIOL EVOL, V21, P1712, DOI 10.1093/molbev/msh179; Eyre-Walker A, 2006, TRENDS ECOL EVOL, V21, P569, DOI 10.1016/j.tree.2006.06.015; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; NEI M, 1986, MOL BIOL EVOL, V3, P418; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Schmidt PS, 2000, P NATL ACAD SCI USA, V97, P10861, DOI 10.1073/pnas.190338897; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Welch JJ, 2006, GENETICS, V173, P821, DOI 10.1534/genetics.106.056911; YANG ZH, 1994, MOL BIOL EVOL, V11, P316	14	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1113	10.1371/journal.pone.0001113	http://dx.doi.org/10.1371/journal.pone.0001113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971876	gold, Green Published			2022-12-27	WOS:000207458700030
J	Liedvogel, M; Maeda, K; Henbest, K; Schleicher, E; Simon, T; Timmel, CR; Hore, PJ; Mouritsen, H				Liedvogel, Miriam; Maeda, Kiminori; Henbest, Kevin; Schleicher, Erik; Simon, Thomas; Timmel, Christiane R.; Hore, P. J.; Mouritsen, Henrik			Chemical Magnetoreception: Bird Cryptochrome 1a Is Excited by Blue Light and Forms Long-Lived Radical-Pairs	PLOS ONE			English	Article							DYNAMIC NUCLEAR-POLARIZATION; DEPENDENT MAGNETORECEPTION; MIGRATORY ORIENTATION; ELECTRON-TRANSFER; MAGNETIC COMPASS; DNA PHOTOLYASE; RED-LIGHT; MECHANISM; PHOTOACTIVATION	Cryptochromes (Cry) have been suggested to form the basis of light-dependent magnetic compass orientation in birds. However, to function as magnetic compass sensors, the cryptochromes of migratory birds must possess a number of key biophysical characteristics. Most importantly, absorption of blue light must produce radical pairs with lifetimes longer than about a microsecond. Cryptochrome 1a (gwCry1a) and the photolyase-homology-region of Cry1 (gwCry1-PHR) from the migratory garden warbler were recombinantly expressed and purified from a baculovirus/Sf9 cell expression system. Transient absorption measurements show that these flavoproteins are indeed excited by light in the blue spectral range leading to the formation of radicals with millisecond lifetimes. These biophysical characteristics suggest that gwCry1a is ideally suited as a primary light-mediated, radical-pair-based magnetic compass receptor.	[Liedvogel, Miriam; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, IBU, VW Nachswuchgrp Anim Nav, D-2900 Oldenburg, Germany; [Liedvogel, Miriam] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Maeda, Kiminori; Timmel, Christiane R.] Univ Oxford, Inorgan Chem Lab, Oxford OX1 3PS, England; [Henbest, Kevin; Hore, P. J.] Univ Oxford, Phys & Theoret Chem Lab, Oxford OX1 3PS, England; [Schleicher, Erik] Free Univ Berlin, Inst Expt Phys, Berlin, Germany; [Simon, Thomas] DIARECT AG, Freiburg, Germany	Carl von Ossietzky Universitat Oldenburg; University of Oxford; University of Oxford; University of Oxford; Free University of Berlin	Mouritsen, H (corresponding author), Carl von Ossietzky Univ Oldenburg, IBU, VW Nachswuchgrp Anim Nav, D-2900 Oldenburg, Germany.	henrik.mouritsen@uni-oldenburg.de	Liedvogel, Miriam/S-8341-2019; Maeda, Kiminori/A-3500-2012; Liedvogel, Miriam/HDM-7933-2022; Hore, Peter/R-1923-2017; Schleicher, Erik/C-9951-2010; Liedvogel, Miriam/D-5418-2015; Mouritsen, Henrik/A-5401-2010; Timmel, Christiane/GLU-4087-2022	Hore, Peter/0000-0002-8863-570X; Liedvogel, Miriam/0000-0002-8372-8560; Mouritsen, Henrik/0000-0001-7082-4839; Timmel, Christiane/0000-0003-1828-7700; Schleicher, Erik/0000-0003-2953-050X	VolkswagenStiftung; Deutsche Forschungsgemeinschaft [FOR 701 TP6, MO 1408/1-2, FOR 526 TP6]; University of Oldenburg; EPSRC; Human Frontier Science Programme; EMF Biological Research Trust; Royal Society; Engineering and Physical Sciences Research Council [GR/T05424/01] Funding Source: researchfish	VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Oldenburg; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Human Frontier Science Programme(Human Frontier Science Program); EMF Biological Research Trust(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding: This work was supported by the VolkswagenStiftung (Nachwuchsgruppe and Lichtenberg-Professorship grants to HM), the Deutsche Forschungsgemeinschaft (FOR 701 TP6 and MO 1408/1-2 grants to HM; FOR 526 TP6 to ES), the University of Oldenburg (HM), the EPSRC (PJH and CRT), the Human Frontier Science Programme (CRT and KM), the EMF Biological Research Trust (PJH, CRT and KH), and the Royal Society (University Research Fellowship to CRT). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; BLISSARD GW, 1990, ANNU REV ENTOMOL, V35, P127, DOI 10.1146/annurev.en.35.010190.001015; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; BROADHURST RW, 1991, BIOCHEMISTRY-US, V30, P405, DOI 10.1021/bi00216a015; Brocklehurst B, 2002, CHEM SOC REV, V31, P301, DOI 10.1039/b107250c; Byrdin M, 2003, P NATL ACAD SCI USA, V100, P8676, DOI 10.1073/pnas.1531645100; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Cintolesi F, 2003, CHEM PHYS, V294, P385, DOI 10.1016/S0301-0104(03)00320-3; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; Gindt YM, 1999, BIOCHEMISTRY-US, V38, P3857, DOI 10.1021/bi981191+; Giovani B, 2003, NAT STRUCT BIOL, V10, P489, DOI 10.1038/nsb933; Henbest KB, 2004, J AM CHEM SOC, V126, P8102, DOI 10.1021/ja048220q; HORE PJ, 1983, BIOCHEMISTRY-US, V22, P1906, DOI 10.1021/bi00277a026; Johnsen S, 2007, J EXP BIOL, V210, P3171, DOI 10.1242/jeb.007567; JORNS MS, 1984, BIOCHEMISTRY-US, V23, P2673, DOI 10.1021/bi00307a021; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Mouritsen H, 2004, CURR BIOL, V14, P1946, DOI 10.1016/j.cub.2004.10.025; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Rodgers CT, 2005, J PHYS CHEM A, V109, P5035, DOI 10.1021/jp050765z; SALIKHOV K, 1984, SPIN POLARIZATION MA, P22; Sancar A, 2000, ANNU REV BIOCHEM, V69, P31, DOI 10.1146/annurev.biochem.69.1.31; SANCAR A, 1994, BIOCHEMISTRY-US, V33, P2, DOI 10.1021/bi00167a001; SCHNEIDER T, 1994, J EXP BIOL, V194, P255; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; Solov'yov IA, 2007, BIOPHYS J, V92, P2711, DOI 10.1529/biophysj.106.097139; STEINER UE, 1989, CHEM REV, V89, P51, DOI 10.1021/cr00091a003; Thalau P, 2005, NATURWISSENSCHAFTEN, V92, P86, DOI 10.1007/s00114-004-0595-8; Timmel CR, 2001, CHEM PHYS LETT, V334, P387, DOI 10.1016/S0009-2614(00)01436-6; Weaver JC, 2000, NATURE, V405, P707, DOI 10.1038/35015128; Weber S, 2002, P NATL ACAD SCI USA, V99, P1319, DOI 10.1073/pnas.032469399; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko W, 2004, J EXP BIOL, V207, P1193, DOI 10.1242/jeb.00873; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; WILTSCHKO W, 1995, J COMP PHYSIOL A, V177, P363; Woodward JR, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.077602; YASUI A, 1994, EMBO J, V13, P6143, DOI 10.1002/j.1460-2075.1994.tb06961.x	49	142	145	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1106	10.1371/journal.pone.0001106	http://dx.doi.org/10.1371/journal.pone.0001106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971869	Green Published, Green Submitted, gold			2022-12-27	WOS:000207458700023
J	Qu, J; Liu, GH; Wu, KY; Han, PW; Wang, P; Li, JM; Zhang, X; Chen, C				Qu, Jing; Liu, Guang-Hui; Wu, Kaiyuan; Han, Peiwei; Wang, Peng; Li, Jiangmei; Zhang, Xu; Chen, Chang			Nitric Oxide Destabilizes Pias3 and Regulates Sumoylation	PLOS ONE			English	Article								Small ubiquitin-related protein modifiers (SUMO) modification is an important mechanism for posttranslational regulation of protein function. However, it is largely unknown how the sumoylation pathway is regulated. Here, we report that nitric oxide (NO) causes global hyposumoylation in mammalian cells. Both SUMO E2 conjugating enzyme Ubc9 and E3 ligase protein inhibitor of activated STAT3 (Pias3) were targets for S-nitrosation. S-nitrosation did not interfere with the SUMO conjugating activity of Ubc9, but promoted Pias3 degradation by facilitating its interaction with tripartite motif-containing 32 (Trim32), a ubiquitin E3 ligase. On the one hand, NO promoted Trim32-mediated Pias3 ubiquitination. On the other hand, NO enhanced the stimulatory effect of Pias3 on Trim32 autoubiquitination. The residue Cys459 of Pias3 was identified as a target site for S-nitrosation. Mutation of Cys459 abolished the stimulatory effect of NO on the Pias3-Trim32 interaction, indicating a requirement of S-nitrosation at Cys459 for positive regulation of the Pias3-Trim32 interplay. This study reveals a novel crosstalk between S-nitrosation, ubiquitination, and sumoylation, which may be crucial for NO-related physiological and pathological processes.	[Liu, Guang-Hui] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; Chinese Acad Sci, Grad Sch, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, GH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	ghliu@scripps.edu; changchen@moon.ibp.ac.cn	Qu, Jing/ABB-9088-2020; wu, kaiyuan/AAD-6635-2020	qu, jing/0000-0002-3988-5067; chen, chang/0000-0003-1008-1062; wu, kaiyuan/0000-0001-7395-4524; , Xu/0000-0002-8103-8486	National Basic Research Program of China [2006CB911000, 2005CB522804, 2006CB503900]; National Natural Science Foundation of China [30270352, 30770512]; Knowledge Innovation Program of the Chinese Academy of Sciences	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	Funding: This research was supported by the National Basic Research Program of China (2006CB911000, 2005CB522804 and 2006CB503900), the National Natural Science Foundation of China (No. 30270352 and 30770512) and the Knowledge Innovation Program of the Chinese Academy of Sciences.	Albor A, 2006, J BIOL CHEM, V281, P25850, DOI 10.1074/jbc.M601655200; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; DEPAUX A, 2007, ONCOGENE; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Iwasaki K, 2007, J BIOL CHEM, V282, P22335, DOI 10.1074/jbc.M701477200; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Jang HD, 2004, J BIOL CHEM, V279, P24873, DOI 10.1074/jbc.M313018200; Jones MC, 2006, P NATL ACAD SCI USA, V103, P16272, DOI 10.1073/pnas.0603002103; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Liu GH, 2006, MOL BIOL CELL, V17, P1822, DOI 10.1091/mbc.E05-10-0979; Lyst MJ, 2006, EMBO J, V25, P5317, DOI 10.1038/sj.emboj.7601404; Man JH, 2006, NUCLEIC ACIDS RES, V34, P5552, DOI 10.1093/nar/gkl691; Matsuura T, 2005, EXP CELL RES, V308, P65, DOI 10.1016/j.yexcr.2005.04.022; Navarro-Lerida I, 2004, J BIOL CHEM, V279, P55682, DOI 10.1074/jbc.M406621200; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Qu J, 2007, NUCLEIC ACIDS RES, V35, P2522, DOI 10.1093/nar/gkl1163; Saitoh H, 2002, J BIOL CHEM, V277, P4755, DOI 10.1074/jbc.M104453200; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782	30	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1085	10.1371/journal.pone.0001085	http://dx.doi.org/10.1371/journal.pone.0001085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17987106	gold, Green Published, Green Submitted			2022-12-27	WOS:000207458700004
J	Kawamura, N; Kugimiya, F; Oshima, Y; Ohba, S; Ikeda, T; Saito, T; Shinoda, Y; Kawasaki, Y; Ogata, N; Hoshi, K; Akiyama, T; Chen, WS; Hay, N; Tobe, K; Kadowaki, T; Azuma, Y; Tanaka, S; Nakamura, K; Chung, U; Kawaguchi, H				Kawamura, Naohiro; Kugimiya, Fumitaka; Oshima, Yasushi; Ohba, Shinsuke; Ikeda, Toshiyuki; Saito, Taku; Shinoda, Yusuke; Kawasaki, Yosuke; Ogata, Naoshi; Hoshi, Kazuto; Akiyama, Toru; Chen, William S.; Hay, Nissim; Tobe, Kazuyuki; Kadowaki, Takashi; Azuma, Yoshiaki; Tanaka, Sakae; Nakamura, Kozo; Chung, Ung-il; Kawaguchi, Hiroshi			Akt1 in Osteoblasts and Osteoclasts Controls Bone Remodeling	PLOS ONE			English	Article								Bone mass and turnover are maintained by the coordinated balance between bone formation by osteoblasts and bone resorption by osteoclasts, under regulation of many systemic and local factors. Phosphoinositide-dependent serine-threonine protein kinase Akt is one of the key players in the signaling of potent bone anabolic factors. This study initially showed that the disruption of Akt1, a major Akt in osteoblasts and osteoclasts, in mice led to low-turnover osteopenia through dysfunctions of both cells. Ex vivo cell culture analyses revealed that the osteoblast dysfunction was traced to the increased susceptibility to the mitochondria-dependent apoptosis and the decreased transcriptional activity of runt-related transcription factor 2 (Runx2), a master regulator of osteoblast differentiation. Notably, our findings revealed a novel role of Akt1/forkhead box class O (FoxO) 3a/Bim axis in the apoptosis of osteoblasts: Akt1 phosphorylates the transcription factor FoxO3a to prevent its nuclear localization, leading to impaired transactivation of its target gene Bim which was also shown to be a potent proapoptotic molecule in osteoblasts. The osteoclast dysfunction was attributed to the cell autonomous defects of differentiation and survival in osteoclasts and the decreased expression of receptor activator of nuclear factor-kappa B ligand ( RANKL), a major determinant of osteoclastogenesis, in osteoblasts. Akt1 was established as a crucial regulator of osteoblasts and osteoclasts by promoting their differentiation and survival to maintain bone mass and turnover. The molecular network found in this study will provide a basis for rational therapeutic targets for bone disorders.	[Kawamura, Naohiro; Kugimiya, Fumitaka; Oshima, Yasushi; Ikeda, Toshiyuki; Saito, Taku; Shinoda, Yusuke; Kawasaki, Yosuke; Ogata, Naoshi; Hoshi, Kazuto; Akiyama, Toru; Tanaka, Sakae; Nakamura, Kozo; Kawaguchi, Hiroshi] Univ Tokyo, Fac Med, Dept Sensory & Motor Syst Med, Tokyo 113, Japan; [Ohba, Shinsuke; Chung, Ung-il] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Tokyo 113, Japan; [Chen, William S.] Univ Kansas, Transgen & Knockout Mouse Lab, Lawrence, KS 66045 USA; [Hay, Nissim] Univ Illinois, Coll Med, Dept Mol Genet, Chicago, IL USA; [Tobe, Kazuyuki; Kadowaki, Takashi] Univ Tokyo, Fac Med, Dept Metab Dis, Tokyo 113, Japan; [Azuma, Yoshiaki] Teijin Inst Biomed Res, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Kansas; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Tokyo	Kawaguchi, H (corresponding author), Univ Tokyo, Fac Med, Dept Sensory & Motor Syst Med, Tokyo 113, Japan.	kawaguchi-ort@h.u-tokyo.ac.jp	Akiyama, Toru/AAA-5887-2020; Kawamura, Naohiro/J-8372-2019; Ikeda, Toshiyuki/GVS-5588-2022; Tanaka, Sakae/Y-3061-2019	Akiyama, Toru/0000-0001-9493-4768; Tanaka, Sakae/0000-0001-9210-9414; Ohba, Shinsuke/0000-0002-6874-8539	Japanese Ministry of Education, Culture, Sports, Science, and Technology [17390410]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#17390410). The sponsor had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Akune T, 2002, J CELL BIOL, V159, P147, DOI 10.1083/jcb.200204046; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; CANALIS E, 1989, J CLIN INVEST, V83, P60, DOI 10.1172/JCI113885; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huang BK, 2000, J BONE MINER RES, V15, P188, DOI 10.1359/jbmr.2000.15.2.188; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Niu TH, 2005, GENE, V361, P38, DOI 10.1016/j.gene.2005.07.016; Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Rosen CJ, 1997, BONE, V21, P217, DOI 10.1016/S8756-3282(97)00143-9; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Thrailkill KM, 2005, AM J PHYSIOL-ENDOC M, V289, pE735, DOI 10.1152/ajpendo.00159.2005; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Yamada T, 2006, NAT MED, V12, P665, DOI 10.1038/nm1409; Yamaguchi M, 2005, ENDOCRINOLOGY, V146, P2620, DOI 10.1210/en.2004-1511; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	40	194	208	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1058	10.1371/journal.pone.0001058	http://dx.doi.org/10.1371/journal.pone.0001058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957242	Green Published, gold, Green Submitted			2022-12-27	WOS:000207458500005
J	Swirski, FK; Berger, CR; Figueiredo, JL; Mempel, TR; von Andrian, UH; Pittet, MJ; Weissleder, R				Swirski, Filip K.; Berger, Cedric R.; Figueiredo, Jose-Luiz; Mempel, Thorsten R.; von Andrian, Ulrich H.; Pittet, Mikael J.; Weissleder, Ralph			A Near-Infrared Cell Tracker Reagent for Multiscopic In Vivo Imaging and Quantification of Leukocyte Immune Responses	PLOS ONE			English	Article								The complexity of the tumor microenvironment necessitates that cell behavior is studied in a broad, multi-scale context. Although tomographic and microscopy-based far and near infrared fluorescence (NIRF, >650 nm) imaging methods offer high resolution, sensitivity, and depth penetration, there has been a lack of optimized NIRF agents to label and track cells in their native environments at different scales. In this study we labeled mammalian leukocytes with VivoTag 680 (VT680), an amine reactive N-hydroxysuccinimide (NHS) ester of a (benz) indolium-derived far red fluorescent probe. We show that VT680 diffuses into leukocytes within minutes, covalently binds to cellular components, remains internalized for days in vitro and in vivo, and does not transfer fluorescence to adjacent cells. It is biocompatible, keeps cells fully functional, and fluoresces at high intensities. In a tumor model of cytotoxic T lymphocyte (CTL) immunotherapy, we track and quantify VT680-labeled cells longitudinally at the whole-body level with fluorescence-mediated molecular tomography (FMT), within tissues at single cell resolutions by multiphoton and confocal intravital microscopy, and ex vivo by flow cytometry. Thus, this approach is suitable to monitor cells at multiple resolutions in real time in their native environments by NIR-based fluorescence imaging.	[Swirski, Filip K.; Berger, Cedric R.; Figueiredo, Jose-Luiz; Pittet, Mikael J.; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA USA; [Swirski, Filip K.; Berger, Cedric R.; Figueiredo, Jose-Luiz; Pittet, Mikael J.; Weissleder, Ralph] Harvard Univ, Sch Med, Charlestown, MA USA; [Mempel, Thorsten R.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA USA; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Pittet, Mikael J.; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Swirski, FK (corresponding author), Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA USA.		von Andrian, Ulrich H/A-5775-2008; Pittet, Mikael/ABD-6300-2021; Swirski, Filip/AAF-1340-2019	Swirski, Filip/0000-0002-3163-9152; Berger, Cedric/0000-0003-2086-7392; /0000-0003-0828-4143	NIH [U54 CA126515, P01A154904, U01 HL080731, R24 CA69246, P50-CA086355]; American Heart Association [0525866T]; Novartis Foundation; Human Frontier Science Program Organization [LT00369/2003]; NATIONAL CANCER INSTITUTE [U54CA126515, P01CA069246, P50CA086355] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069259] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Novartis Foundation(Novartis); Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grants U54 CA126515, P01A154904, U01 HL080731 and R24 CA69246 (to RW), P50-CA086355 ( to RW and MJP). FKS was supported by a post-doctoral fellowship from American Heart Association (0525866T). CRB was supported by a fellowship from Novartis Foundation ( formerly the Ciba-Geigy Jubilee Foundation). MJP was supported by the Human Frontier Science Program Organization (LT00369/2003).	Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Hanson HL, 2000, IMMUNITY, V13, P265, DOI 10.1016/S1074-7613(00)00026-1; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; LEHR HA, 1993, LAB INVEST, V68, P388; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Pittet MJ, 2007, P NATL ACAD SCI USA, V104, P12457, DOI 10.1073/pnas.0704460104; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123	18	52	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1075	10.1371/journal.pone.0001075	http://dx.doi.org/10.1371/journal.pone.0001075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957257	Green Published, gold			2022-12-27	WOS:000207458500020
J	Adamska, M; Degnan, SM; Green, KM; Adamski, M; Craigie, A; Larroux, C; Degnan, BM				Adamska, Maja; Degnan, Sandie M.; Green, Kathryn M.; Adamski, Marcin; Craigie, Alina; Larroux, Claire; Degnan, Bernard M.			Wnt and TGF-beta Expression in the Sponge Amphimedon queenslandica and the Origin of Metazoan Embryonic Patterning	PLOS ONE			English	Article							DEVELOPMENTAL EXPRESSION; SPEMANNS ORGANIZER; GENE FAMILY; EVOLUTION; PHYLOGENY; DEMOSPONGE; RECEPTOR; POLARITY; SUPERFAMILY; COMPLEXITY	Background. The origin of metazoan development and differentiation was contingent upon the evolution of cell adhesion, communication and cooperation mechanisms. While components of many of the major cell signalling pathways have been identified in a range of sponges (phylum Porifera), their roles in development have not been investigated and remain largely unknown. Here, we take the first steps toward reconstructing the developmental signalling systems used in the last common ancestor to living sponges and eumetazoans by studying the expression of genes encoding Wnt and TGF-beta signalling ligands during the embryonic development of a sponge. Methodology/Principal Findings. Using resources generated in the recent sponge Amphimedon queenslandica (Demospongiae) genome project, we have recovered genes encoding Wnt and TGF-beta signalling ligands that are critical in patterning metazoan embryos. Both genes are expressed from the earliest stages of Amphimedon embryonic development in highly dynamic patterns. At the time when the Amphimedon embryos begin to display anterior-posterior polarity, Wnt expression becomes localised to the posterior pole and this expression continues until the swimming larva stage. In contrast, TGF-beta expression is highest at the anterior pole. As in complex animals, sponge Wnt and TGF-beta expression patterns intersect later in development during the patterning of a sub-community of cells that form a simple tissue-like structure, the pigment ring. Throughout development, Wnt and TGF-beta are expressed radially along the anterior-posterior axis. Conclusions/Significance. We infer from the expression of Wnt and TGF-beta in Amphimedon that the ancestor that gave rise to sponges, cnidarians and bilaterians had already evolved the capacity to direct the formation of relatively sophisticated body plans, with axes and tissues. The radially symmetrical expression patterns of Wnt and TGF-beta along the anterior-posterior axis of sponge embryos and larvae suggest that these signalling pathways contributed to establishing axial polarity in the very first metazoans.	[Adamska, Maja; Degnan, Sandie M.; Green, Kathryn M.; Adamski, Marcin; Craigie, Alina; Larroux, Claire; Degnan, Bernard M.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld, Australia	University of Queensland	Degnan, BM (corresponding author), Univ Queensland, Sch Integrat Biol, Brisbane, Qld, Australia.	b.degnan@uq.edu.au	Adamska, Maja/M-4128-2014; Degnan, Sandie/G-7338-2012; Larroux, Claire/U-7981-2017; Adamska, Maja/L-3306-2015	Degnan, Sandie/0000-0001-8003-0426; Larroux, Claire/0000-0002-3503-4150; Degnan, Bernard/0000-0001-7573-8518; Adamska, Maja/0000-0002-4223-8450	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council. The ARC played no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	ADAMSKA M, 2007, CURR BIOL IN PRESS; Adell T, 2003, FEBS LETT, V554, P363, DOI 10.1016/S0014-5793(03)01190-6; Adell T, 2007, CELL BIOL INT, V31, P939, DOI 10.1016/j.cellbi.2007.03.003; Borchiellini C, 2001, J EVOLUTION BIOL, V14, P171, DOI 10.1046/j.1420-9101.2001.00244.x; Botting JP, 2005, P NATL ACAD SCI USA, V102, P1554, DOI 10.1073/pnas.0405867102; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Brusca RC, 2003, INVERTEBRATES; Cavalier-Smith T, 2003, J MOL EVOL, V56, P540, DOI 10.1007/s00239-002-2424-z; CavalierSmith T, 1996, CAN J ZOOL, V74, P2031, DOI 10.1139/z96-231; COHEN B, 1993, DEVELOPMENT, V117, P597; Davidson EH, 2006, REG GEN GEN REG; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Degnan BM, 2005, INTEGR COMP BIOL, V45, P335, DOI 10.1093/icb/45.2.335; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Flowers VL, 2004, DEV DYNAM, V231, P727, DOI 10.1002/dvdy.20194; Green J, 2002, DEV DYNAM, V225, P392, DOI 10.1002/dvdy.10170; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Hayward DC, 2002, P NATL ACAD SCI USA, V99, P8106, DOI 10.1073/pnas.112021499; Holland LZ, 2000, DEV GENES EVOL, V210, P522, DOI 10.1007/s004270000089; Jackson DJ, 2007, SCIENCE, V316, P1893, DOI 10.1126/science.1141560; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Larroux C, 2006, EVOL DEV, V8, P150, DOI 10.1111/j.1525-142X.2006.00086.x; Larroux C, 2007, CURR BIOL, V17, P706, DOI 10.1016/j.cub.2007.03.008; Lee PN, 2006, SEMIN CELL DEV BIOL, V17, P157, DOI 10.1016/j.semcdb.2006.05.002; Leys SP, 2002, INVERTEBR BIOL, V121, P171; Li CW, 1998, SCIENCE, V279, P879, DOI 10.1126/science.279.5352.879; Liu ZH, 1999, J COMB OPTIM, V3, P5, DOI 10.1023/A:1009841719644; Manuel M, 2003, SYST BIOL, V52, P311, DOI 10.1080/10635150390196966; Martindale MQ, 2005, NAT REV GENET, V6, P917, DOI 10.1038/nrg1725; Matus DQ, 2006, P NATL ACAD SCI USA, V103, P11195, DOI 10.1073/pnas.0601257103; Maves L, 1998, DEVELOPMENT, V125, P115; MCPHERRON AC, 1993, J BIOL CHEM, V268, P3444; Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998; Miller DJ, 2005, TRENDS GENET, V21, P536, DOI 10.1016/j.tig.2005.08.002; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; OZKAYNAK E, 1992, J BIOL CHEM, V267, P25220; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Reinhardt B, 2004, DEV BIOL, V267, P43, DOI 10.1016/j.ydbio.2003.10.031; Rentzsch F, 2006, DEV BIOL, V296, P375, DOI 10.1016/j.ydbio.2006.06.003; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Soshnikova N, 2003, GENE DEV, V17, P1963, DOI 10.1101/gad.263003; Suga H, 1999, FEBS LETT, V453, P346, DOI 10.1016/S0014-5793(99)00749-8; Watabe T, 1995, GENE DEV, V9, P3038, DOI 10.1101/gad.9.24.3038; Wolpert L, 1996, TRENDS GENET, V12, P359, DOI 10.1016/S0168-9525(96)80019-9; Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239	48	154	159	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1031	10.1371/journal.pone.0001031	http://dx.doi.org/10.1371/journal.pone.0001031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925879	Green Published, Green Submitted, gold			2022-12-27	WOS:000207456000030
J	Genton, B; Pluschke, G; Degen, L; Kammer, AR; Westerfeld, N; Okitsu, SL; Schroller, S; Vounatsou, P; Mueller, MM; Tanner, M; Zurbriggen, R				Genton, Blaise; Pluschke, Gerd; Degen, Lukas; Kammer, Andreas R.; Westerfeld, Nicole; Okitsu, Shinji L.; Schroller, Sandro; Vounatsou, Penelope; Mueller, Markus M.; Tanner, Marcel; Zurbriggen, Rinaldo			A Randomized Placebo-Controlled Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Synthetic Peptides in Healthy Adult Volunteers	PLOS ONE			English	Article								Background and Objectives. Influenza virosomes represent an innovative human-compatible antigen delivery system that has already proven its suitability for subunit vaccine design. The aim of the study was to proof the concept that virosomes can also be used to elicit high titers of antibodies against synthetic peptides. The specific objective was to demonstrate the safety and immunogenicity of two virosome-formulated P. falciparum protein derived synthetic peptide antigens given in two different doses alone or in combination. Methodology/Principal Findings. The design was a single blind, randomized, placebo controlled, dose-escalating study involving 46 healthy Caucasian volunteers aged 18-45 years. Five groups of 8 subjects received virosomal formulations containing 10 mu g or 50 mu g of AMA 49-CPE, an apical membrane antigen-1 (AMA-1) derived synthetic phospatidylethanolamine (PE)-peptide conjugate or 10 ug or 50 ug of UK39, a circumsporozoite protein (CSP) derived synthetic PE-peptide conjugate or 50 ug of both antigens each. A control group of 6 subjects received unmodified virosomes. Virosomal formulations of the antigens (designated PEV301 and PEV302 for the AMA-1 and the CSP virosomal vaccine, respectively) or unmodified virosomes were injected i. m. on days 0, 60 and 180. In terms of safety, no serious or severe adverse events (AEs) related to the vaccine were observed. 11/46 study participants reported 16 vaccine related local AEs. Of these 16 events, all being pain, 4 occurred after the 1(st), 7 after the 2(nd) and 5 after the 3(rd) vaccination. 6 systemic AEs probably related to the study vaccine were reported after the 1(st) injection, 10 after the 2(nd) and 6 after the 3(rd). Generally, no difference in the distribution of the systemic AEs between either the doses applied (10 respectively 50 mu g) or the synthetic antigen vaccines (PEV301 and PEV302) used for immunization was found. In terms of immunogenicity, both PEV301 and PEV302 elicited already after two injections a synthetic peptide-specific antibody response in all volunteers immunized with the appropriate dose. In the case of PEV301 the 50 mu g antigen dose was associated with a higher mean antibody titer and seroconversion rate than the 10 mu g dose. In contrast, for PEV302 mean titer and seroconversion rate were higher with the lower dose. Combined delivery of PEV301 and PEV302 did not interfere with the development of an antibody response to either of the two antigens. No relevant antibody responses against the two malaria antigens were observed in the control group receiving unmodified virosomes. Conclusions. The present study demonstrates that three immunizations with the virosomal malaria vaccine components PEV301 or/and PEV302 (containing 10 mu g or 50 mu g of antigen) are safe and well tolerated. At appropriate antigen doses seroconversion rates of 100% were achieved. Two injections may be sufficient for eliciting an appropriate immune response, at least in individuals with pre-existing anti-malarial immunity. These results justify further development of a final multi-stage virosomal vaccine formulation incorporating additional malaria antigens. Trial Registration. ClinicalTrials. gov NCT00400101	[Genton, Blaise; Pluschke, Gerd; Okitsu, Shinji L.; Vounatsou, Penelope; Mueller, Markus M.; Tanner, Marcel] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Degen, Lukas; Schroller, Sandro] Univ Basel Hosp, Clin Res Ctr, CH-4031 Basel, Switzerland; [Kammer, Andreas R.; Westerfeld, Nicole; Zurbriggen, Rinaldo] Pev Biotech Ltd, Bern, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Genton, B (corresponding author), Swiss Trop Inst, CH-4002 Basel, Switzerland.	blaise.genton@unibas.ch	Degen, Lukas/D-2121-2010	Vounatsou, Penelope/0000-0002-4904-5352	Pevion Biotech	Pevion Biotech	Funding: The clinical trial was funded by Pevion Biotech. Three authors (RZ, ARK, NW) were employees of this company and were involved in study design (RZ), immunology experiments (ARK, NW), paper writing (RZ) and decision to submit (RZ). The first and second authors were not employed by the company, had access to all data and take responsibility for the accuracy of the analyses and the manuscript.	Aguado Teresa, 1999, Vaccine, V17, P2321; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Bisang C, 1998, J AM CHEM SOC, V120, P7439, DOI 10.1021/ja980444j; Bovier PA, 2005, VACCINE, V23, P2424, DOI 10.1016/j.vaccine.2004.11.024; Clarke Paul D, 2006, Travel Med Infect Dis, V4, P313, DOI 10.1016/j.tmaid.2006.01.001; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Ghasparian A, 2006, CHEM COMMUN, P174, DOI 10.1039/b510812h; Good MF, 2005, TRENDS PARASITOL, V21, P29, DOI 10.1016/j.pt.2004.10.006; Kashala O, 2002, VACCINE, V20, P2263, DOI 10.1016/S0264-410X(02)00115-9; Kato K, 2005, P NATL ACAD SCI USA, V102, P5552, DOI 10.1073/pnas.0501594102; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; MAYORGA PO, 2003, J INFECT DIS, V188, P671; Moreno R, 2001, CHEMBIOCHEM, V2, P838, DOI 10.1002/1439-7633(20011105)2:11<838::AID-CBIC838>3.0.CO;2-4; Mueller MS, 2003, INFECT IMMUN, V71, P4749, DOI 10.1128/IAI.71.8.4749-4758.2003; OKITSU SL, 2007, CHEM BIOL IN PRESS; Pancharoen C, 2005, CLIN INFECT DIS, V41, P1537, DOI 10.1086/497266; Pfeiffer B, 2003, ANGEW CHEM INT EDIT, V42, P2368, DOI 10.1002/anie.200250348; Pfeiffer B, 2001, CHIMIA, V55, P334; Pink J Richard, 2004, Vaccine, V22, P2097, DOI 10.1016/j.vaccine.2004.01.021; Poltl-Frank F, 1999, CLIN EXP IMMUNOL, V117, P496; Zurbriggen R, 2003, VACCINE, V21, P921, DOI 10.1016/S0264-410X(02)00541-8	21	45	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1018	10.1371/journal.pone.0001018	http://dx.doi.org/10.1371/journal.pone.0001018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925866	gold, Green Published			2022-12-27	WOS:000207456000017
J	Szulkin, M; Sheldon, BC				Szulkin, Marta; Sheldon, Ben C.			The Environmental Dependence of Inbreeding Depression in a Wild Bird Population	PLOS ONE			English	Article								Background. Inbreeding depression occurs when the offspring produced as a result of matings between relatives show reduced fitness, and is generally understood as a consequence of the elevated expression of deleterious recessive alleles. How inbreeding depression varies across environments is of importance for the evolution of inbreeding avoidance behaviour, and for understanding extinction risks in small populations. However, inbreeding-by-environment (IxE) interactions have rarely been investigated in wild populations. Methodology/Principal Findings. We analysed 41 years of breeding events from a wild great tit (Parus major) population and used 11 measures of the environment to categorise environments as relatively good or poor, testing whether these measures influenced inbreeding depression. Although inbreeding always, and environmental quality often, significantly affected reproductive success, there was little evidence for statistically significant IxE interactions at the level of individual analyses. However, point estimates of the effect of the environment on inbreeding depression were sometimes considerable, and we show that variation in the magnitude of the IxE interaction across environments is consistent with the expectation that this interaction is more marked across environmental axes with a closer link to overall fitness, with the environmental dependence of inbreeding depression being elevated under such conditions. Hence, our analyses provide evidence for an environmental dependence of the inbreeding x environment interaction: effectively an IxExE. Conclusions/Significance. Overall, our analyses suggest that IxE interactions may be substantial in wild populations, when measured across relevant environmental contrasts, although their detection for single traits may require very large samples, or high rates of inbreeding.	[Szulkin, Marta; Sheldon, Ben C.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England	University of Oxford	Szulkin, M (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	marta.szulkin@zoo.ox.ac.uk	Szulkin, Marta/J-8118-2012; Sheldon, Ben C/A-8056-2010	Szulkin, Marta/0000-0002-7355-5846; Sheldon, Ben C/0000-0002-5240-7828	Christopher Welch Trust; Queen's College	Christopher Welch Trust; Queen's College	Marta Szulkin was funded by the Christopher Welch Trust and The Queen's College.	Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Bijlsma R, 1999, J EVOLUTION BIOL, V12, P1125, DOI 10.1046/j.1420-9101.1999.00113.x; BLAKEY JK, 1994, IBIS, V136, P457, DOI 10.1111/j.1474-919X.1994.tb01122.x; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; CLOBERT J, 1988, J ANIM ECOL, V57, P287, DOI 10.2307/4779; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Da Silva A, 2006, CONSERV GENET, V7, P371, DOI 10.1007/s10592-005-9048-y; Gardner M, 2001, EVOLUTION, V55, P1609, DOI 10.1111/j.0014-3820.2001.tb00680.x; Hauser TP, 1996, EVOLUTION, V50, P1119, DOI 10.2307/2410652; Husband BC, 1996, EVOLUTION, V50, P54, DOI [10.2307/2410780, 10.1111/j.1558-5646.1996.tb04472.x]; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Joron M, 2003, NATURE, V424, P191, DOI 10.1038/nature01713; Keller LF, 2002, EVOLUTION, V56, P1229, DOI 10.1111/j.0014-3820.2002.tb01434.x; KONDRASHOV AS, 1994, P ROY SOC B-BIOL SCI, V258, P221, DOI 10.1098/rspb.1994.0166; Kristensen TN, 2003, CONSERV GENET, V4, P453, DOI 10.1023/A:1024763013798; Kruuk LEB, 2002, P ROY SOC B-BIOL SCI, V269, P1581, DOI 10.1098/rspb.2002.2049; Lynch M., 1998, GENETICS ANAL QUANTI; Marr AB, 2006, J ANIM ECOL, V75, P1406, DOI 10.1111/j.1365-2656.2006.01165.x; Marshall TC, 2002, P ROY SOC B-BIOL SCI, V269, P1533, DOI 10.1098/rspb.2002.2035; McCleery RH, 2004, AM NAT, V164, pE62, DOI 10.1086/422660; McCune AR, 2004, P ROY SOC B-BIOL SCI, V271, P2025, DOI 10.1098/rspb.2004.2787; Meagher S, 2000, P NATL ACAD SCI USA, V97, P3324, DOI 10.1073/pnas.060284797; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; NORMAN JK, 1995, EVOLUTION, V49, P297, DOI 10.1111/j.1558-5646.1995.tb02242.x; Pemberton J, 2004, TRENDS ECOL EVOL, V19, P613, DOI 10.1016/j.tree.2004.09.010; Perrins C.M., 1979, BRIT TITS; Reed DH, 2007, ANIM CONSERV, V10, P275, DOI 10.1111/j.1469-1795.2007.00120.x; Reed DH, 2007, CONSERV GENET, V8, P1061, DOI 10.1007/s10592-006-9260-4; Roff DA, 2002, EVOLUTION, V56, P768, DOI 10.1111/j.0014-3820.2002.tb01387.x; Roff DA, 2006, EVOLUTION, V60, P1981, DOI 10.1111/j.0014-3820.2006.tb01836.x; Slate J, 2004, HEREDITY, V93, P255, DOI 10.1038/sj.hdy.6800485; Szulkin M, 2007, J EVOLUTION BIOL, V20, P1531, DOI 10.1111/j.1420-9101.2007.01325.x; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Wilkin TA, 2006, J ANIM ECOL, V75, P604, DOI 10.1111/j.1365-2656.2006.01078.x	35	31	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1027	10.1371/journal.pone.0001027	http://dx.doi.org/10.1371/journal.pone.0001027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925875	gold, Green Published, Green Submitted			2022-12-27	WOS:000207456000026
J	Desy, MC; Theoret, H				Desy, Marie-Christine; Theoret, Hugo			Modulation of Motor Cortex Excitability by Physical Similarity with an Observed Hand Action	PLOS ONE			English	Article								The passive observation of hand actions is associated with increased motor cortex excitability, presumably reflecting activity within the human mirror neuron system (MNS). Recent data show that in-group ethnic membership increases motor cortex excitability during observation of culturally relevant hand gestures, suggesting that physical similarity with an observed body part may modulate MNS responses. Here, we ask whether the MNS is preferentially activated by passive observation of hand actions that are similar or dissimilar to self in terms of sex and skin color. Transcranial magnetic stimulation-induced motor evoked potentials were recorded from the first dorsal interosseus muscle while participants viewed videos depicting index finger movements made by female or male participants with black or white skin color. Forty-eight participants equally distributed in terms of sex and skin color participated in the study. Results show an interaction between self-attributes and physical attributes of the observed hand in the right motor cortex of female participants, where corticospinal excitability is increased during observation of hand actions in a different skin color than that of the observer. Our data show that specific physical properties of an observed action modulate motor cortex excitability and we hypothesize that in-group/out-group membership and self-related processes underlie these effects.	[Theoret, Hugo] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Hop St Justine, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; Universite de Montreal	Theoret, H (corresponding author), Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada.	hugo.theoret@umontreal.ca		Theoret, Hugo/0000-0002-7458-8797	National Sciences and Engineering Research of Canada; Fonds de Recherche en Sante du Quebec	National Sciences and Engineering Research of Canada; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the National Sciences and Engineering Research of Canada and the Fonds de Recherche en Sante du Quebec.	Aziz-Zadeh L, 2002, EXP BRAIN RES, V144, P127, DOI 10.1007/s00221-002-1037-5; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Berlucchi G, 1997, TRENDS NEUROSCI, V20, P560, DOI 10.1016/S0166-2236(97)01136-3; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cheng YW, 2006, NEUROREPORT, V17, P1115, DOI 10.1097/01.wnr.0000223393.59328.21; Cheng YW, 2007, NEUROREPORT, V18, P887, DOI 10.1097/WNR.0b013e3280ebb486; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cross SE, 1997, PSYCHOL BULL, V122, P5, DOI 10.1037/0033-2909.122.1.5; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; Eberhardt JL, 2005, AM PSYCHOL, V60, P181, DOI 10.1037/0003-066X.60.2.181; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fourkas AD, 2006, EXP BRAIN RES, V168, P143, DOI 10.1007/s00221-005-0076-0; Gallese V, 2003, PSYCHOPATHOLOGY, V36, P171, DOI 10.1159/000072786; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Guimond S, 2006, J PERS SOC PSYCHOL, V90, P221, DOI 10.1037/0022-3514.90.2.221; Hardin EE, 2004, J CROSS CULT PSYCHOL, V35, P327, DOI 10.1177/0022022104264125; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; Hughes M, 2003, SOC PSYCHOL QUART, V66, P384, DOI 10.2307/1519836; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Molnar-Szakacs I, 2005, EUR J NEUROSCI, V21, P2000, DOI 10.1111/j.1460-9568.2005.04019.x; Molnar-Szakacs I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000626; Patuzzo S, 2003, NEUROPSYCHOLOGIA, V41, P1272, DOI 10.1016/S0028-3932(02)00293-2; Richeson JA, 2003, NAT NEUROSCI, V6, P1323, DOI 10.1038/nn1156; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Robbins JM, 2005, PERS SOC PSYCHOL REV, V9, P32, DOI 10.1207/s15327957pspr0901_3; Rossini PM, 1998, ELECTROEN CLIN NEURO, V106, P180, DOI 10.1016/S0013-4694(97)00097-7; Schutz-Bosbach S, 2006, CURR BIOL, V16, P1830, DOI 10.1016/j.cub.2006.07.048; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Theoret H, 2004, COGNITIVE BRAIN RES, V20, P54, DOI 10.1016/j.cogbrainres.2004.01.003; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; Urgesi C, 2006, EUR J NEUROSCI, V23, P2522, DOI 10.1111/j.1460-9568.2006.04772.x; van Baaren RB, 2003, J PERS SOC PSYCHOL, V84, P1093, DOI 10.1037/0022-3514.84.5.1093	46	44	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e971	10.1371/journal.pone.0000971	http://dx.doi.org/10.1371/journal.pone.0000971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912350	Green Published, gold			2022-12-27	WOS:000207455900009
J	Gold, MC; Robinson, TL; Cook, MS; Byrd, LK; Ehlinger, HD; Lewinsohn, DM; Lewinsohn, DA				Gold, Marielle C.; Robinson, Tammie L.; Cook, Matthew S.; Byrd, Laura K.; Ehlinger, Heather D.; Lewinsohn, David M.; Lewinsohn, Deborah A.			Human Neonatal Dendritic Cells Are Competent in MHC Class I Antigen Processing and Presentation	PLOS ONE			English	Article								Neonates are clearly more susceptible to severe disease following infection with a variety of pathogens than are adults. However, the causes for this are unclear and are often attributed to immunological immaturity. While several aspects of immunity differ between adults and neonates, the capacity of dendritic cells in neonates to process and present antigen to CD8(+) T cells remains to be addressed. We used human CD8(+) T cell clones to compare the ability of neonatal and adult monocyte-derived dendritic cells to present or process and present antigen using the MHC class I pathway. Specifically, we assessed the ability of dendritic cells to present antigenic peptide, present an HLA-E-restricted antigen, process and present an MHC class I-restricted antigen through the classical MHC class I pathway, and cross present cell-associated antigen via MHC class I. We found no defect in neonatal dendritic cells to perform any of these processing and presentation functions and conclude that the MHC class I antigen processing and presentation pathway is functional in neonatal dendritic cells and hence may not account for the diminished control of pathogens.	[Gold, Marielle C.; Lewinsohn, David M.] Oregon Hlth & Sci Univ, Dept Pulm & Crit Care Med, Portland, OR 97201 USA; [Gold, Marielle C.; Lewinsohn, David M.] Portland VA Med Ctr, Portland, OR USA; [Robinson, Tammie L.; Cook, Matthew S.; Byrd, Laura K.; Ehlinger, Heather D.; Lewinsohn, Deborah A.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University	Gold, MC (corresponding author), Oregon Hlth & Sci Univ, Dept Pulm & Crit Care Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	goldm@ohsu.edu	; Lewinsohn, David/I-4936-2013	Slater, Marielle/0000-0003-2505-3291; Lewinsohn, David/0000-0001-9906-9494	NIH [5R01 AI054474]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054474] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH 5R01 AI054474; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Aksoy E, 2007, BLOOD, V109, P2887, DOI 10.1182/blood-2006-06-027862; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Canaday DH, 2006, CELL IMMUNOL, V243, P96, DOI 10.1016/j.cellimm.2007.01.003; Dadaglio G, 2002, J IMMUNOL, V168, P2219, DOI 10.4049/jimmunol.168.5.2219; Fonteneau JF, 2003, BLOOD, V102, P4448, DOI 10.1182/blood-2003-06-1801; Goriely S, 2001, J IMMUNOL, V166, P2141, DOI 10.4049/jimmunol.166.3.2141; HARPER JMM, 1978, J VIROL, V26, P646, DOI 10.1128/JVI.26.3.646-659.1978; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Heinzel AS, 2002, J EXP MED, V196, P1473, DOI 10.1084/jem.20020609; Kennedy PTF, 2006, HEPATOLOGY, V43, P602, DOI 10.1002/hep.21081; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Lewinsohn DA, 2003, AM J RESP CRIT CARE, V168, P1346, DOI 10.1164/rccm.200306-837OC; Lewinsohn DA, 2002, AM J RESP CRIT CARE, V166, P843, DOI 10.1164/rccm.2110094; Lewinsohn DM, 2000, J IMMUNOL, V165, P925, DOI 10.4049/jimmunol.165.2.925; Liu E, 2001, BRIT J HAEMATOL, V113, P240, DOI 10.1046/j.1365-2141.2001.02720.x; Marchant A, 1999, J IMMUNOL, V163, P2249; Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.1111/j.1365-2249.2005.02799.x; Marchant A, 2000, CURR OPIN INFECT DIS, V13, P241, DOI 10.1097/00001432-200006000-00007; RIDDELL SR, 1992, SCIENCE, V257, P238; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Schibler KR, 2002, ACTA PAEDIATR, V91, P9, DOI 10.1080/080352502320764148; Shen LJ, 2006, CURR OPIN IMMUNOL, V18, P85, DOI 10.1016/j.coi.2005.11.003; Sun CM, 2005, IMMUNITY, V22, P467, DOI 10.1016/j.immuni.2005.02.008; Sun CM, 2003, BLOOD, V102, P585, DOI 10.1182/blood-2002-09-2966; Upham JW, 2002, INFECT IMMUN, V70, P6583, DOI 10.1128/IAI.70.12.6583-6588.2002; Vekemans J, 2001, EUR J IMMUNOL, V31, P1531, DOI 10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1; Velilla PA, 2006, CLIN IMMUNOL, V121, P251, DOI 10.1016/j.clim.2006.08.010; Wong OH, 2005, IMMUNOLOGY, V116, P13, DOI 10.1111/j.1365-2567.2005.02191.x; Wong P, 2003, ANNU REV IMMUNOL, V21, P29, DOI 10.1146/annurev.immunol.21.120601.141114; Wright PF, 1998, VACCINE, V16, P1355, DOI 10.1016/S0264-410X(98)00091-7	32	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e957	10.1371/journal.pone.0000957	http://dx.doi.org/10.1371/journal.pone.0000957			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895997	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455800035
J	Dawson, WK; Fujiwara, K; Kawai, G				Dawson, Wayne K.; Fujiwara, Kazuya; Kawai, Gota			Prediction of RNA Pseudoknots Using Heuristic Modeling with Mapping and Sequential Folding	PLOS ONE			English	Article								Predicting RNA secondary structure is often the first step to determining the structure of RNA. Prediction approaches have historically avoided searching for pseudoknots because of the extreme combinatorial and time complexity of the problem. Yet neglecting pseudoknots limits the utility of such approaches. Here, an algorithm utilizing structure mapping and thermodynamics is introduced for RNA pseudoknot prediction that finds the minimum free energy and identifies information about the flexibility of the RNA. The heuristic approach takes advantage of the 5' to 3' folding direction of many biological RNA molecules and is consistent with the hierarchical folding hypothesis and the contact order model. Mapping methods are used to build and analyze the folded structure for pseudoknots and to add important 3D structural considerations. The program can predict some well known pseudoknot structures correctly. The results of this study suggest that many functional RNA sequences are optimized for proper folding. They also suggest directions we can proceed in the future to achieve even better results.	[Dawson, Wayne K.; Fujiwara, Kazuya; Kawai, Gota] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 275, Japan	Chiba Institute of Technology	Dawson, WK (corresponding author), Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 275, Japan.	wayne.dawson@it-chiba.ac.jp	Dawson, Wayne/AAY-5576-2020	Dawson, Wayne/0000-0001-7751-7778	Ministry of Education, Culture, Sports, Science and Technology (Japan)	Ministry of Education, Culture, Sports, Science and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from Monbusho ( The Ministry of Education, Culture, Sports, Science and Technology ( Japan)). The sponsor played no role in the decisions, design, study, or interpretation of the results of this work.	Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; BRUCCOLERI RE, 1988, COMPUT APPL BIOSCI, V4, P167; Cao S, 2006, NUCLEIC ACIDS RES, V34, P2634, DOI 10.1093/nar/gkl346; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Dawson W, 2006, NUCLEOS NUCLEOT NUCL, V25, P171, DOI 10.1080/15257770500446915; Doshi KJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-105; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1457, DOI 10.1038/nbt1104-1457; Felden B, 1996, RNA, V2, P201; Flory P. J, 1953, PRINCIPLES POLYM CHE; Hendrix DK, 2005, Q REV BIOPHYS, V38, P221, DOI 10.1017/S0033583506004215; Huttenhofer A, 2005, TRENDS GENET, V21, P289, DOI 10.1016/j.tig.2005.03.007; Kolk MH, 1998, SCIENCE, V280, P434, DOI 10.1126/science.280.5362.434; KUMAR PKR, 1992, NUCLEIC ACIDS RES, V20, P3919, DOI 10.1093/nar/20.15.3919; Lescoute A, 2006, NUCLEIC ACIDS RES, V34, P6587, DOI 10.1093/nar/gkl963; Lyngso RB, 2000, J COMPUT BIOL, V7, P409, DOI 10.1089/106652700750050862; Makarov DE, 2002, P NATL ACAD SCI USA, V99, P3535, DOI 10.1073/pnas.052713599; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Misra VK, 2001, P NATL ACAD SCI USA, V98, P12456, DOI 10.1073/pnas.221234598; Nameki N, 1999, NUCLEIC ACIDS RES, V27, P3667, DOI 10.1093/nar/27.18.3667; Plant EP, 2005, PLOS BIOL, V3, P1012, DOI 10.1371/journal.pbio.0030172; Reeder J, 2006, J BIOTECHNOL, V124, P41, DOI 10.1016/j.jbiotec.2006.01.034; Rivas E, 1999, J MOL BIOL, V285, P2053, DOI 10.1006/jmbi.1998.2436; Schlax PJ, 2001, J BIOL CHEM, V276, P38494, DOI 10.1074/jbc.M106934200; Schultes EA, 2005, NAT STRUCT MOL BIOL, V12, P1130, DOI 10.1038/nsmb1014; Sosnick TR, 2004, J MOL BIOL, V342, P1359, DOI 10.1016/j.jmb.2004.08.002; Su MC, 2005, NUCLEIC ACIDS RES, V33, P4265, DOI 10.1093/nar/gki731; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Torres-Larios A, 2005, NATURE, V437, P584, DOI 10.1038/nature04074; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Xayaphoummine A, 2003, P NATL ACAD SCI USA, V100, P15310, DOI 10.1073/pnas.2536430100	30	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e905	10.1371/journal.pone.0000905	http://dx.doi.org/10.1371/journal.pone.0000905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878940	gold, Green Submitted, Green Published			2022-12-27	WOS:000207455700013
J	Martin-Cuadrado, AB; Lopez-Garcia, P; Alba, JC; Moreira, D; Monticelli, L; Strittmatter, A; Gottschalk, G; Rodriguez-Valera, F				Martin-Cuadrado, Ana-Belen; Lopez-Garcia, Purificacion; Alba, Juan-Carlos; Moreira, David; Monticelli, Luis; Strittmatter, Axel; Gottschalk, Gerhard; Rodriguez-Valera, Francisco			Metagenomics of the Deep Mediterranean, a Warm Bathypelagic Habitat	PLOS ONE			English	Article							COMMUNITY GENOMICS; DIVERSITY; REVEALS; SEA; SEQUENCE; ARCHAEAL; BACTERIA; DEPTH; IDENTIFICATION; PHOTOTROPHY	Background. Metagenomics is emerging as a powerful method to study the function and physiology of the unexplored microbial biosphere, and is causing us to re-evaluate basic precepts of microbial ecology and evolution. Most marine metagenomic analyses have been nearly exclusively devoted to photic waters. Methodology/Principal Findings. We constructed a metagenomic fosmid library from 3,000 m-deep Mediterranean plankton, which is much warmer (similar to 14 degrees C) than waters of similar depth in open oceans (similar to 2 degrees C). We analyzed the library both by phylogenetic screening based on 16S rRNA gene amplification from clone pools and by sequencing both insert extremities of ca. 5,000 fosmids. Genome recruitment strategies showed that the majority of high scoring pairs corresponded to genomes from Rhizobiales within the Alphaproteobacteria, Cenarchaeum symbiosum, Planctomycetes, Acidobacteria, Chloroflexi and Gammaproteobacteria. We have found a community structure similar to that found in the aphotic zone of the Pacific. However, the similarities were significantly higher to the mesopelagic (500-700 m deep) in the Pacific than to the single 4000 m deep sample studied at this location. Metabolic genes were mostly related to catabolism, transport and degradation of complex organic molecules, in agreement with a prevalent heterotrophic lifestyle for deep-sea microbes. However, we observed a high percentage of genes encoding dehydrogenases and, among them, cox genes, suggesting that aerobic carbon monoxide oxidation may be important in the deep ocean as an additional energy source. Conclusions/Significance. The comparison of metagenomic libraries from the deep Mediterranean and the Pacific ALOHA water column showed that bathypelagic Mediterranean communities resemble more mesopelagic communities in the Pacific, and suggests that, in the absence of light, temperature is a major stratifying factor in the oceanic water column, overriding pressure at least over 4000 m deep. Several chemolithotrophic metabolic pathways could supplement organic matter degradation in this most depleted habitat.	[Martin-Cuadrado, Ana-Belen; Alba, Juan-Carlos; Rodriguez-Valera, Francisco] Univ Miguel Hernandez, Div Microbiol, Alacant, Spain; [Lopez-Garcia, Purificacion; Moreira, David] Univ Paris 11, CNRS, Unite Ecol Systemat & Evolut, F-91405 Orsay, France; [Monticelli, Luis] CNR, Ist Ambiente Marino Costiero, Sez Messina, Messina, Italy; [Strittmatter, Axel; Gottschalk, Gerhard] Univ Gottingen, Inst Mikrobiol & Genet, Lab Genomanal, Gottingen, Germany	Universidad Miguel Hernandez de Elche; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); University of Gottingen	Rodriguez-Valera, F (corresponding author), Univ Miguel Hernandez, Div Microbiol, Alacant, Spain.	frvalera@umh.es	Moreira, David/F-7445-2012; Rodriguez-Valera, Francisco/M-2782-2013; Lopez-Garcia, Purificacion/B-6775-2012	Moreira, David/0000-0002-2064-5354; Rodriguez-Valera, Francisco/0000-0002-9809-2059; Lopez-Garcia, Purificacion/0000-0002-0927-0651	European Commission [QLK3-CT-2002-02056]; MEC ( Spain) [CTM2005-04564]; French Centre National de la Recherche Scientifique (CNRS)	European Commission(European CommissionEuropean Commission Joint Research Centre); MEC ( Spain)(Spanish Government); French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the GEMINI (QLK3-CT-2002-02056) project of the European Commission, and MEC ( Spain) (CTM2005-04564) to FRV and by an ATIP project of the French Centre National de la Recherche Scientifique (CNRS) to PLG.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aluwihare LI, 2005, SCIENCE, V308, P1007, DOI 10.1126/science.1108925; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Campanaro S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-122; D'Amico S, 2002, PHILOS T R SOC B, V357, P917, DOI 10.1098/rstb.2002.1105; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Falkowski PG, 2002, SCI AM, V287, P54, DOI 10.1038/scientificamerican0802-54; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Fuhrman JA, 1997, MAR ECOL PROG SER, V150, P275, DOI 10.3354/meps150275; Gade D, 2004, MICROB ECOL, V47, P243, DOI 10.1007/s00248-003-1016-9; Garcia-Martinez J, 2000, MOL ECOL, V9, P935, DOI 10.1046/j.1365-294x.2000.00953.x; Gardener BBM, 1998, APPL ENVIRON MICROB, V64, P4944; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Greaves RB, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-18; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ingalls AE, 2006, P NATL ACAD SCI USA, V103, P6442, DOI 10.1073/pnas.0510157103; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kato C, 1998, APPL ENVIRON MICROB, V64, P1510; King GM, 2007, NAT REV MICROBIOL, V5, P107, DOI 10.1038/nrmicro1595; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LAURO FM, 2007, PROKARYOTIC LIFESTYL; Lopez-Garcia P, 2004, ENVIRON MICROBIOL, V6, P19, DOI 10.1046/j.1462-2920.2003.00533.x; Lopez-Garcia P, 2001, FEMS MICROBIOL ECOL, V36, P193, DOI 10.1016/S0168-6496(01)00133-7; Lopez-Lopez A, 2005, ENVIRON MICROBIOL, V7, P649, DOI 10.1111/j.1462-2920.2005.00733.x; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Moreira D, 2006, MICROBIOL-SGM, V152, P505, DOI 10.1099/mic.0.28254-0; Moreira D, 2004, ENVIRON MICROBIOL, V6, P959, DOI 10.1111/j.1462-2920.2004.00644.x; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; MUELLER LD, 1982, GENET RES, V40, P127, DOI 10.1017/S0016672300019005; MURPHY PJ, 1988, P NATL ACAD SCI USA, V85, P9133, DOI 10.1073/pnas.85.23.9133; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Quaiser A, 2003, MOL MICROBIOL, V50, P563, DOI 10.1046/j.1365-2958.2003.03707.x; ROBINSON AR, 2001, MEDITERRANEAN SEA CI, P1789; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sanderman J, 2005, TREATISE ON GEOCHEMISTRY, VOL 8: BIOGEOCHEMISTRY, P249; Schlesner H, 2004, INT J SYST EVOL MICR, V54, P1567, DOI 10.1099/ijs.0.63113-0; Selje N, 2004, NATURE, V427, P445, DOI 10.1038/nature02272; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ussery DW, 2004, MICROBIOL-SGM, V150, P3519, DOI 10.1099/mic.0.27628-0; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Weber CF, 2007, APPL ENVIRON MICROB, V73, P1266, DOI 10.1128/AEM.01724-06; Worden AZ, 2006, TRENDS MICROBIOL, V14, P331, DOI 10.1016/j.tim.2006.06.008; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zaballos M, 2006, FEMS MICROBIOL ECOL, V56, P389, DOI 10.1111/j.1574-6941.2006.00060.x	55	162	168	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e914	10.1371/journal.pone.0000914	http://dx.doi.org/10.1371/journal.pone.0000914			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878949	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455700022
J	Viebig, NK; Levin, E; Dechavanne, S; Rogerson, SJ; Gysin, J; Smith, JD; Scherf, A; Gamain, B				Viebig, Nicola K.; Levin, Emily; Dechavanne, Sebastien; Rogerson, Stephen J.; Gysin, Jurg; Smith, Joseph D.; Scherf, Artur; Gamain, Benoit			Disruption of Var2csa Gene Impairs Placental Malaria Associated Adhesion Phenotype	PLOS ONE			English	Article								Infection with Plasmodium falciparum during pregnancy is one of the major causes of malaria related morbidity and mortality in newborn and mothers. The complications of pregnancy-associated malaria result mainly from massive adhesion of Plasmodium falciparum-infected erythrocytes (IE) to chondroitin sulfate A (CSA) present in the placental intervillous blood spaces. Var2CSA, a member of the P. falciparum erythrocyte membrane protein 1 (PfEMP1) family is the predominant parasite ligand mediating CSA binding. However, experimental evidence suggests that other host receptors, such as hyaluronic acid (HA) and the neonatal Fc receptor, may also support placental binding. Here we used parasites in which var2csa was genetically disrupted to evaluate the contribution of these receptors to placental sequestration and to identify additional adhesion receptors that may be involved in pregnancy-associated malaria. By comparison to the wild-type parasites, the FCR3 Delta var2csa mutants could not be selected for HA adhesion, indicating that var2csa is not only essential for IE cytoadhesion to the placental receptor CSA, but also to HA. However, further studies using different pure sources of HA revealed that the previously observed binding results from CSA contamination in the bovine vitreous humor HA preparation. To identify CSA-independent placental interactions, FCR3 Delta var2csa mutant parasites were selected for adhesion to the human placental trophoblastic BeWo cell line. BeWo selected parasites revealed a multi-phenotypic adhesion population expressing multiple var genes. However, these parasites did not cytoadhere specifically to the syncytiotrophoblast lining of placental cryosections and were not recognized by sera from malaria-exposed women in a parity dependent manner, indicating that the surface molecules present on the surface of the BeWo selected population are not specifically expressed during the course of pregnancy-associated malaria. Taken together, these results demonstrate that the placental malaria associated phenotype can not be restored in FCR3 Delta var2csa mutant parasites and highlight the key role of var2CSA in pregnancy malaria pathogenesis and for vaccine development.	[Viebig, Nicola K.; Scherf, Artur; Gamain, Benoit] Inst Pasteur, Unite Biol Interact Hote Parasite, Paris, France; [Viebig, Nicola K.; Scherf, Artur; Gamain, Benoit] CNRS, Paris, France; [Levin, Emily; Smith, Joseph D.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Dechavanne, Sebastien; Gysin, Jurg] Univ Aix Marseille 2, Unite Parasitol Expt, Marseille, France; [Rogerson, Stephen J.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3052, Australia	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Center for Infectious Disease Research; UDICE-French Research Universities; Aix-Marseille Universite; Royal Melbourne Hospital; University of Melbourne	Scherf, A (corresponding author), Inst Pasteur, Unite Biol Interact Hote Parasite, Paris, France.	ascherf@pasteur.fr; bgamain@pasteur.fr	Scherf, Artur/A-9674-2014; Dechavanne, Sebastien/AAL-8108-2021; Gamain, Benoit/N-9985-2017	Gamain, Benoit/0000-0002-8255-2145; Scherf, Artur/0000-0003-2411-3328; Dechavanne, Sebastien/0000-0001-9400-1976; Rogerson, Stephen/0000-0003-4287-1982	Bill and Melinda Gates Foundation [ndegree 29202]; FP6 [LSHP-CT-2004-503578]; National Health and Medical Research Council of Australia; Pasteur-Sanofi Fonds Dedies [Ndegree 8]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); FP6(European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Pasteur-Sanofi Fonds Dedies	This work was supported by grants from the Bill and Melinda Gates Foundation ( grant n degrees 29202) as part of the Pregnancy Malaria vaccine consortium, the FP6-funded network of excellence BIOMALPAR program (LSHP-CT-2004-503578), the National Health and Medical Research Council of Australia and the Pasteur-Sanofi Fonds Dedies N degrees 8.	APLIN JD, 1992, J CELL SCI, V103, P435; Avril M, 2004, MICROBES INFECT, V6, P249, DOI 10.1016/j.micinf.2003.12.007; Baruch DI, 1997, BLOOD, V90, P3766, DOI 10.1182/blood.V90.9.3766; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Beeson JG, 2004, J INFECT DIS, V189, P169, DOI 10.1086/380975; Beeson JG, 2002, INT J PARASITOL, V32, P1245, DOI 10.1016/S0020-7519(02)00097-8; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Chai WG, 2001, INFECT IMMUN, V69, P420, DOI 10.1128/IAI.69.1.420-425.2001; Duffy MF, 2005, MOL MICROBIOL, V56, P774, DOI 10.1111/j.1365-2958.2005.04577.x; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Ellinger I, 1999, EUR J IMMUNOL, V29, P733, DOI 10.1002/(SICI)1521-4141(199903)29:03<733::AID-IMMU733>3.0.CO;2-C; Flick K, 2001, SCIENCE, V293, P2098, DOI 10.1126/science.1062891; Fried M, 2000, EXP PARASITOL, V95, P75, DOI 10.1006/expr.2000.4510; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fried M, 2006, EXP PARASITOL, V113, P36, DOI 10.1016/j.exppara.2005.12.003; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Kristoffersen E K, 1996, APMIS Suppl, V64, P5; Kristoffersen EK, 1996, EUR J IMMUNOL, V26, P505, DOI 10.1002/eji.1830260234; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lelievre J, 2005, EXP PARASITOL, V109, P195, DOI 10.1016/j.exppara.2004.11.012; Lucchi NW, 2006, PLACENTA, V27, P384, DOI 10.1016/j.placenta.2005.04.009; Lyden TW, 2001, J IMMUNOL, V166, P3882, DOI 10.4049/jimmunol.166.6.3882; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Muthusamy A, 2007, AM J PATHOL, V170, P1989, DOI 10.2353/ajpath.2007.061238; Noviyanti R, 2001, MOL BIOCHEM PARASIT, V114, P227, DOI 10.1016/S0166-6851(01)00266-3; Rasti N, 2006, P NATL ACAD SCI USA, V103, P13795, DOI 10.1073/pnas.0601519103; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Valiyaveettil M, 2001, EXP PARASITOL, V99, P57, DOI 10.1006/expr.2001.4642; Viebig NK, 2006, EXP PARASITOL, V112, P121, DOI 10.1016/j.exppara.2005.09.007; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; *WHO, 2003, B WORLD HEALTH ORGAN, V81, P472	47	60	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e910	10.1371/journal.pone.0000910	http://dx.doi.org/10.1371/journal.pone.0000910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878945	gold, Green Published			2022-12-27	WOS:000207455700018
J	Ukena, SN; Singh, A; Dringenberg, U; Engelhardt, R; Seidler, U; Hansen, W; Bleich, A; Bruder, D; Franzke, A; Rogler, G; Suerbaum, S; Buer, J; Gunzer, F; Westendorf, AM				Ukena, Sya N.; Singh, Anurag; Dringenberg, Ulrike; Engelhardt, Regina; Seidler, Ursula; Hansen, Wiebke; Bleich, Andre; Bruder, Dunja; Franzke, Anke; Rogler, Gerhard; Suerbaum, Sebastian; Buer, Jan; Gunzer, Florian; Westendorf, Astrid M.			Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity	PLOS ONE			English	Article								Background. Probiotics are proposed to positively modulate the intestinal epithelial barrier formed by intestinal epithelial cells (IECs) and intercellular junctions. Disruption of this border alters paracellular permeability and is a key mechanism for the development of enteric infections and inflammatory bowel diseases (IBDs). Methodology and Principal Findings. To study the in vivo effect of probiotic Escherichia coli Nissle 1917 (EcN) on the stabilization of the intestinal barrier under healthy conditions, germfree mice were colonized with EcN or K12 E. coli strain MG1655. IECs were isolated and analyzed for gene and protein expression of the tight junction molecules ZO-1 and ZO-2. Then, in order to analyze beneficial effects of EcN under inflammatory conditions, the probiotic was orally administered to BALB/c mice with acute dextran sodium sulfate (DSS) induced colitis. Colonization of gnotobiotic mice with EcN resulted in an up-regulation of ZO-1 in IECs at both mRNA and protein levels. EcN administration to DSS-treated mice reduced the loss of body weight and colon shortening. In addition, infiltration of the colon with leukocytes was ameliorated in EcN inoculated mice. Acute DSS colitis did not result in an anion secretory defect, but abrogated the sodium absorptive function of the mucosa. Additionally, intestinal barrier function was severely affected as evidenced by a strong increase in the mucosal uptake of Evans blue in vivo. Concomitant administration of EcN to DSS treated animals resulted in a significant protection against intestinal barrier dysfunction and IECs isolated from these mice exhibited a more pronounced expression of ZO-1. Conclusion and Significance. This study convincingly demonstrates that probiotic EcN is able to mediate up-regulation of ZO-1 expression in murine IECs and confer protection from the DSS colitis-associated increase in mucosal permeability to luminal substances.	[Ukena, Sya N.; Hansen, Wiebke; Westendorf, Astrid M.] Helmholtz Ctr Infect Res, Dept Mucosal Immun, Braunschweig, Germany; [Ukena, Sya N.; Franzke, Anke; Suerbaum, Sebastian] Hannover Med Sch, Dept Haematol Haemostaseol & Oncol, D-3000 Hannover, Germany; [Singh, Anurag; Dringenberg, Ulrike; Engelhardt, Regina; Seidler, Ursula] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany; [Bleich, Andre] Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany; [Bleich, Andre] Hannover Med Sch, Ctr Anim Facil, D-3000 Hannover, Germany; [Bruder, Dunja] Helmholtz Ctr Infect Res, Immune Regulat Grp, Braunschweig, Germany; [Rogler, Gerhard] Univ Zurich Hosp, Dept Internal Med, Gastroenterol & Hepatol Unit, Zurich, Switzerland; [Buer, Jan] Univ Hosp Essen, Inst Med Microbiol, Essen, Germany; [Gunzer, Florian] Tech Univ Dresden, Inst Med Microbiol & Hyg, Fac Med Carl Gustav Carus, D-8027 Dresden, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; University of Zurich; University Zurich Hospital; University of Duisburg Essen; Technische Universitat Dresden	Ukena, SN (corresponding author), Helmholtz Ctr Infect Res, Dept Mucosal Immun, Braunschweig, Germany.	Florian.Gunzer@tu-dresden.de	Rogler, Gerhard/O-5308-2015; Westendorf, Astrid M./AAX-1937-2020; Seidler, Ursula/HII-8049-2022; Franzke, Anke/AAE-7883-2021	Rogler, Gerhard/0000-0002-1733-9188; Seidler, Ursula/0000-0002-9600-2769; Hansen, Wiebke/0000-0002-6020-0886; Buer, Jan/0000-0002-7602-1698; Singh, Anurag Kumar/0000-0003-0818-0993	Deutsche Forschungsgemeinschaft [SFB 621]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: Supported by grants from the Deutsche Forschungsgemeinschaft (SFB 621).	Alberda C, 2007, AM J CLIN NUTR, V85, P816, DOI 10.1093/ajcn/85.3.816; Barmeyer C, 2004, AM J PHYSIOL-GASTR L, V286, pG244, DOI 10.1152/ajpgi.00141.2003; BLEICH A, 2007, INT J EXP PATHO 1113; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Dotan I, 2005, CURR OPIN GASTROEN, V21, P426; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Fasano A, 1997, J CLIN INVEST, V99, P1158, DOI 10.1172/JCI119271; FASANO A, 1991, P NATL ACAD SCI USA, V88, P5242, DOI 10.1073/pnas.88.12.5242; Grabig A, 2006, INFECT IMMUN, V74, P4075, DOI 10.1128/IAI.01449-05; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Gunzer Florian, 2003, Methods Mol Med, V73, P307; HAVENAAR R, 1992, LACTIC ACID BACTERIA, P209; Henker J, 2007, EUR J PEDIATR, V166, P311, DOI 10.1007/s00431-007-0419-x; Hollander D, 1999, Curr Gastroenterol Rep, V1, P410, DOI 10.1007/s11894-999-0023-5; Ivanov Andrei I, 2004, Novartis Found Symp, V263, P115; JEPSON MA, 1995, INFECT IMMUN, V63, P356, DOI 10.1128/IAI.63.1.356-359.1995; Jepson MA, 2000, INFECT IMMUN, V68, P7202, DOI 10.1128/IAI.68.12.7202-7208.2000; KAPEMBWA MS, 1991, CLIN SCI, V81, P327, DOI 10.1042/cs0810327; Kawachiya T, 2005, INT J MOL MED, V15, P417; Kruis W, 1997, ALIMENT PHARM THER, V11, P853, DOI 10.1046/j.1365-2036.1997.00225.x; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; LEVINE MM, 1988, INFECT IMMUN, V56, P161, DOI 10.1128/IAI.56.1.161-167.1988; Ma TY, 2005, AM J PHYSIOL-GASTR L, V288, pG422, DOI 10.1152/ajpgi.00412.2004; McCarthy J, 2003, GUT, V52, P975, DOI 10.1136/gut.52.7.975; Nejdfors P, 1998, SCAND J GASTROENTERO, V33, P749; Parassol N, 2005, RES MICROBIOL, V156, P256, DOI 10.1016/j.resmic.2004.09.013; Philpott DJ, 1998, INFECT IMMUN, V66, P1680, DOI 10.1128/IAI.66.4.1680-1687.1998; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; RENE E, 1989, DIGEST DIS SCI, V34, P773, DOI 10.1007/BF01540353; Resta-Lenert S, 2005, AM J PHYSIOL-GASTR L, V289, pG153, DOI 10.1152/ajpgi.00395.2004; Resta-Lenert S, 2003, GUT, V52, P988, DOI 10.1136/gut.52.7.988; Rogler G, 1998, LAB INVEST, V78, P889; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Sartor RB, 1997, ALIMENT PHARM THERAP, V11, P53; Schmitz H, 2002, AIDS, V16, P983, DOI 10.1097/00002030-200205030-00004; Schmitz H, 1999, GASTROENTEROLOGY, V116, P301, DOI 10.1016/S0016-5085(99)70126-5; Schultz M, 2004, CLIN DIAGN LAB IMMUN, V11, P372, DOI 10.1128/CDLI.11.2.372-378.2004; Schultz M, 2002, INFLAMM BOWEL DIS, V8, P71, DOI 10.1097/00054725-200203000-00001; Schurmann G, 1999, INT J COLORECTAL DIS, V14, P41, DOI 10.1007/s003840050181; Seidler U, 2006, ANN NY ACAD SCI, V1072, P262, DOI 10.1196/annals.1326.024; SMITH PD, 1988, ANN INTERN MED, V108, P328, DOI 10.7326/0003-4819-108-3-328; Spyridonidis A, 2004, AM J PATHOL, V164, P1147, DOI 10.1016/S0002-9440(10)63203-8; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Stockmann M, 1998, AIDS, V12, P43, DOI 10.1097/00002030-199801000-00006; Walsh-Reitz MM, 2005, AM J PHYSIOL-GASTR L, V289, pG163, DOI 10.1152/ajpgi.00013.2005; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Westendorf AM, 2005, FEMS IMMUNOL MED MIC, V43, P373, DOI 10.1016/j.femsim.2004.10.023; Whiting CV, 2005, INFLAMM BOWEL DIS, V11, P340, DOI 10.1097/01.MIB.0000164016.98913.7c; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Wu ZY, 1996, MICROB PATHOGENESIS, V21, P111, DOI 10.1006/mpat.1996.0047; Wu ZY, 2000, CELL MICROBIOL, V2, P11, DOI 10.1046/j.1462-5822.2000.00025.x; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Zyrek AA, 2007, CELL MICROBIOL, V9, P804, DOI 10.1111/j.1462-5822.2006.00836.x	56	316	375	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1308	10.1371/journal.pone.0001308	http://dx.doi.org/10.1371/journal.pone.0001308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074031	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459500026
J	Zhou, L; Wang, J; Zhang, LH				Zhou, Lian; Wang, Jing; Zhang, Lian-Hui			Modulation of Bacterial Type III Secretion System by a Spermidine Transporter Dependent Signaling Pathway	PLOS ONE			English	Article								Background. Many gram-negative bacterial pathogens employ Type III secretion systems (T3SS) to inject effector proteins into host cells in infectious processes. Methodology/Principal Findings. By screening a transposon mutant library of P. aeruginosa, we found that mutation of spuDEFGH, which encode a major spermidine uptake system, abolished the expression of the exsCEBA operon that codes for key T3SS regulators under inducing conditions (low calcium). Whole genome microarray analysis revealed that inactivation of the spermidine uptake system significantly decreased the transcriptional expression of most, if not all, T3SS genes. Consistently, the spermidine uptake mutants showed decreased expression of the T3SS genes in responding to host cell extract and attenuated cytotoxicity. Furthermore, exogenous addition of spermidine to the wild type strain PAO1 enhanced the expression of exsCEBA and also the effector protein genes. Conclusion/Significance. Cumulatively, these data have depicted a novel spermidine transporter-dependent signaling pathway, which appears to play an essential role in modulation of T3SS expression in P. aeruginosa.	[Zhou, Lian; Wang, Jing; Zhang, Lian-Hui] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Zhang, Lian-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore	Zhang, LH (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	lianhui@imcb.a-star.edu.sg			Agency of Science, Technology and Research (A*Star), Singapore	Agency of Science, Technology and Research (A*Star), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency of Science, Technology and Research (A*Star), Singapore.	Becher A, 2000, BIOTECHNIQUES, V29, P948, DOI 10.2144/00295bm04; BODEY GP, 1983, REV INFECT DIS, V5, P279; CAETANOANNOLES G, 1993, PCR METH APPL, V28, P85; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Frank DW, 1997, MOL MICROBIOL, V26, P621, DOI 10.1046/j.1365-2958.1997.6251991.x; FrithzLindsten E, 1997, MOL MICROBIOL, V25, P1125, DOI 10.1046/j.1365-2958.1997.5411905.x; Galan JE, 1996, ANNU REV CELL DEV BI, V12, P221, DOI 10.1146/annurev.cellbio.12.1.221; Ganesan AK, 1998, J BIOL CHEM, V273, P7332, DOI 10.1074/jbc.273.13.7332; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Goehring UM, 1999, J BIOL CHEM, V274, P36369, DOI 10.1074/jbc.274.51.36369; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; HOVEY AK, 1995, J BACTERIOL, V177, P4427, DOI 10.1128/jb.177.15.4427-4436.1995; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Igarashi K, 2001, RES MICROBIOL, V152, P271, DOI 10.1016/S0923-2508(01)01198-6; Igarashi K, 1999, BIOCHEM J, V344, P633, DOI 10.1042/0264-6021:3440633; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Krall R, 2000, INFECT IMMUN, V68, P6066, DOI 10.1128/IAI.68.10.6066-6068.2000; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; Larque E, 2007, NUTRITION, V23, P87, DOI 10.1016/j.nut.2006.09.006; Laskowski MA, 2004, MOL MICROBIOL, V54, P1090, DOI 10.1111/j.1365-2958.2004.04331.x; Lee J, 2001, P NATL ACAD SCI USA, V98, P289, DOI 10.1073/pnas.011265298; Lu CD, 2002, J BACTERIOL, V184, P3765, DOI 10.1128/JB.184.14.3765-3773.2002; Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638; Moss J, 2001, INFECT IMMUN, V69, P1185, DOI 10.1128/IAI.69.2.1185-1188.2001; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Sambrook J, 1987, MOL CLONING LAB MANU; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sun JJ, 2003, J BIOL CHEM, V278, P32794, DOI 10.1074/jbc.M304290200; Urbanowski ML, 2005, P NATL ACAD SCI USA, V102, P9930, DOI 10.1073/pnas.0504405102; Vallis AJ, 1999, INFECT IMMUN, V67, P914, DOI 10.1128/IAI.67.2.914-920.1999; Vallis AJ, 1999, INFECT IMMUN, V67, P2040; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4; Wu WH, 2004, J BACTERIOL, V186, P7575, DOI 10.1128/JB.186.22.7575-7585.2004; Yahr TL, 2006, MOL MICROBIOL, V62, P631, DOI 10.1111/j.1365-2958.2006.05412.x; Yahr TL, 1996, MOL MICROBIOL, V22, P991, DOI 10.1046/j.1365-2958.1996.01554.x; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; ZHANG LH, 1991, J BACTERIOL, V173, P1867, DOI 10.1128/jb.173.6.1867-1872.1991; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176	43	51	56	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1291	10.1371/journal.pone.0001291	http://dx.doi.org/10.1371/journal.pone.0001291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074016	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459500010
J	Baumgartner, BG; Orpinell, M; Duran, J; Ribas, V; Burghardt, HE; Bach, D; Villar, AV; Paz, JC; Gonzalez, M; Camps, M; Oriola, J; Rivera, F; Palacin, M; Zorzano, A				Baumgartner, Bernhard G.; Orpinell, Meritxell; Duran, Jordi; Ribas, Vicent; Burghardt, Hans E.; Bach, Daniel; Victoria Villar, Ana; Paz, Jose C.; Gonzalez, Meritxell; Camps, Marta; Oriola, Josep; Rivera, Francisca; Palacin, Manuel; Zorzano, Antonio			Identification of a Novel Modulator of Thyroid Hormone Receptor-Mediated Action	PLOS ONE			English	Article								Background. Diabetes is characterized by reduced thyroid function and altered myogenesis after muscle injury. Here we identify a novel component of thyroid hormone action that is repressed in diabetic rat muscle. Methodology/Principal Findings. We have identified a gene, named DOR, abundantly expressed in insulin-sensitive tissues such as skeletal muscle and heart, whose expression is highly repressed in muscle from obese diabetic rats. DOR expression is up-regulated during muscle differentiation and its loss-of-function has a negative impact on gene expression programmes linked to myogenesis or driven by thyroid hormones. In agreement with this, DOR enhances the transcriptional activity of the thyroid hormone receptor TR alpha 1. This function is driven by the N-terminal part of the protein. Moreover, DOR physically interacts with TR alpha 1 and to T-3-responsive promoters, as shown by ChIP assays. T-3 stimulation also promotes the mobilization of DOR from its localization in nuclear PML bodies, thereby indicating that its nuclear localization and cellular function may be related. Conclusions/Significance. Our data indicate that DOR modulates thyroid hormone function and controls myogenesis. DOR expression is down-regulated in skeletal muscle in diabetes. This finding may be of relevance for the alterations in muscle function associated with this disease.	[Baumgartner, Bernhard G.; Orpinell, Meritxell; Duran, Jordi; Ribas, Vicent; Burghardt, Hans E.; Bach, Daniel; Victoria Villar, Ana; Paz, Jose C.; Gonzalez, Meritxell; Camps, Marta; Palacin, Manuel; Zorzano, Antonio] Univ Barcelona, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Baumgartner, Bernhard G.; Orpinell, Meritxell; Duran, Jordi; Ribas, Vicent; Burghardt, Hans E.; Bach, Daniel; Victoria Villar, Ana; Paz, Jose C.; Gonzalez, Meritxell; Camps, Marta; Palacin, Manuel; Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Oriola, Josep; Rivera, Francisca] Hosp Clin Barcelona, Serv Hormonal, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Zorzano, A (corresponding author), Univ Barcelona, Inst Res Biomed IRB Barcelona, Barcelona, Spain.	azorzano@pcb.ub.es	Duran, Jordi/J-7298-2017; Duran, Jordi/AGP-2068-2022; Zorzano, Antonio/R-5479-2018; Paz, Jose Carlos/I-5783-2015; Ribas, Vicent/K-1390-2014; Villar, Ana/I-5190-2015; Camps, Marta/F-6557-2016	Duran, Jordi/0000-0002-8342-4882; Paz, Jose Carlos/0000-0001-9684-9735; Ribas, Vicent/0000-0003-3380-2256; Villar, Ana/0000-0003-4588-9598; Camps, Marta/0000-0001-5392-1792; Palacin, Manuel/0000-0002-8670-293X	Ministerio de Educacion y Ciencia ( MEC) [SAF2005-00445]; Generalitat de Catalunya [2005SGR00947]; Instituto de Salud Carlos III [ISCIII-RETIC RD06]	Ministerio de Educacion y Ciencia ( MEC)(Spanish GovernmentEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study was supported by research grants from the Ministerio de Educacion y Ciencia ( MEC) ( SAF2005-00445), the Generalitat de Catalunya ( 2005SGR00947), and the Instituto de Salud Carlos III ( ISCIII-RETIC RD06, REDIMET).	ALBAGLICURIEL O, 1993, DIFFERENTIATION, V52, P201, DOI 10.1111/j.1432-0436.1993.tb00632.x; Aughsteen AA, 2006, J PANCREAS, V7, P382; Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; CARNAC G, 1992, MOL ENDOCRINOL, V6, P1185, DOI 10.1210/me.6.8.1185; CHAO TT, 1976, CELL TISSUE RES, V168, P239, DOI 10.1007/BF00215880; Chubb SAP, 2005, CLIN ENDOCRINOL, V62, P480, DOI 10.1111/j.1365-2265.2005.02246.x; COLLIE ESR, 1992, CELL GROWTH DIFFER, V3, P31; Dong CH, 2003, AM J HUM GENET, V72, P115, DOI 10.1086/345648; DOWNES M, 1993, CELL GROWTH DIFFER, V4, P901; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Enrique-Tarancon G, 2000, BIOCHEM J, V350, P171, DOI 10.1042/0264-6021:3500171; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; FOWDEN AL, 1995, REPROD FERT DEVELOP, V7, P351, DOI 10.1071/RD9950351; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; Greenman RL, 2005, DIABETES CARE, V28, P1425, DOI 10.2337/diacare.28.6.1425; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Isogai Y, 2003, CURR OPIN CELL BIOL, V15, P296, DOI 10.1016/S0955-0674(03)00052-8; Iwasaki N, 2003, DIABETES, V52, P209, DOI 10.2337/diabetes.52.1.209; IZUMO S, 1986, SCIENCE, V231, P597, DOI 10.1126/science.3945800; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; KABADI UM, 1984, J AM GERIATR SOC, V32, P375, DOI 10.1111/j.1532-5415.1984.tb02043.x; KLUEBER KM, 1994, ANAT REC, V239, P18, DOI 10.1002/ar.1092390104; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; MARCHAL S, 1995, EXP CELL RES, V220, P1, DOI 10.1006/excr.1995.1285; MCINTOSH LM, 1994, MUSCLE NERVE, V17, P444, DOI 10.1002/mus.880170413; Moreno H, 2003, J BIOL CHEM, V278, P40557, DOI 10.1074/jbc.M306609200; MUSCAT GEO, 1995, BIOESSAYS, V17, P211, DOI 10.1002/bies.950170307; MUSCAT GEO, 1994, NUCLEIC ACIDS RES, V22, P583, DOI 10.1093/nar/22.4.583; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; OPPENHEIMER JH, 1987, ENDOCR REV, V8, P288, DOI 10.1210/edrv-8-3-288; Pernitsky AN, 1996, BIOCHEM CELL BIOL, V74, P315, DOI 10.1139/o96-034; Ros-Baro A, 2001, P NATL ACAD SCI USA, V98, P12050, DOI 10.1073/pnas.211341698; Santalucia T, 2001, J MOL BIOL, V314, P195, DOI 10.1006/jmbi.2001.5091; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Sharma D, 2000, MOL ENDOCRINOL, V14, P2001, DOI 10.1210/me.14.12.2001; Sharma D, 2002, P NATL ACAD SCI USA, V99, P7934, DOI 10.1073/pnas.122004799; Smithson MJ, 1998, DIABETIC MED, V15, P148, DOI 10.1002/(SICI)1096-9136(199802)15:2<148::AID-DIA540>3.0.CO;2-H; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vinals F, 1997, J BIOL CHEM, V272, P12913, DOI 10.1074/jbc.272.20.12913; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Watada H, 2000, P NATL ACAD SCI USA, V97, P9443, DOI 10.1073/pnas.97.17.9443; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wu WS, 2001, MOL CELL BIOL, V21, P2259, DOI 10.1128/MCB.21.7.2259-2268.2001; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zaidi SK, 2005, EMBO REP, V6, P128, DOI 10.1038/sj.embor.7400337	52	38	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1183	10.1371/journal.pone.0001183	http://dx.doi.org/10.1371/journal.pone.0001183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030323	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459200002
J	Gaume, L; Forterre, Y				Gaume, Laurence; Forterre, Yoel			A Viscoelastic Deadly Fluid in Carnivorous Pitcher Plants	PLOS ONE			English	Article								Background. The carnivorous plants of the genus Nepenthes, widely distributed in the Asian tropics, rely mostly on nutrients derived from arthropods trapped in their pitcher-shaped leaves and digested by their enzymatic fluid. The genus exhibits a great diversity of prey and pitcher forms and its mechanism of trapping has long intrigued scientists. The slippery inner surfaces of the pitchers, which can be waxy or highly wettable, have so far been considered as the key trapping devices. However, the occurrence of species lacking such epidermal specializations but still effective at trapping insects suggests the possible implication of other mechanisms. Methodology/Principal Findings. Using a combination of insect bioassays, highspeed video and rheological measurements, we show that the digestive fluid of Nepenthes rafflesiana is highly viscoelastic and that this physical property is crucial for the retention of insects in its traps. Trapping efficiency is shown to remain strong even when the fluid is highly diluted by water, as long as the elastic relaxation time of the fluid is higher than the typical time scale of insect movements. Conclusions/Significance. This finding challenges the common classification of Nepenthes pitchers as simple passive traps and is of great adaptive significance for these tropical plants, which are often submitted to high rainfalls and variations in fluid concentration. The viscoelastic trap constitutes a cryptic but potentially widespread adaptation of Nepenthes species and could be a homologous trait shared through common ancestry with the sundew (Drosera) flypaper plants. Such large production of a highly viscoelastic biopolymer fluid in permanent pools is nevertheless unique in the plant kingdom and suggests novel applications for pest control.	[Gaume, Laurence] CNRS, UMR AMAP 5120, Montpellier, France; [Forterre, Yoel] Univ Aix Marseille 1, CNRS, IUSTI, UMR 6595, Marseille, France	CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Gaume, L (corresponding author), CNRS, UMR AMAP 5120, Montpellier, France.	lgaume@cirad.fr; Yoel.Forterre@polytech.univ-mrs.fr			University Montpellier II and by the French national agency of research (ANR)	University Montpellier II and by the French national agency of research (ANR)(French National Research Agency (ANR))	The work was supported by a grant "Young researcher and innovative project'' from the University Montpellier II and by the French national agency of research (ANR) "Young researcher program: Interaction fluide-structure chez les plantes''. The study funders played no role in designing the study, data collection/analysis or preparation of the manuscript.	ALBERT VA, 1992, SCIENCE, V257, P1491, DOI 10.1126/science.1523408; Balland M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021911; Bergeron V, 2000, NATURE, V405, P772, DOI 10.1038/35015525; Bird RB, 1987, DYNAMICS POLYMERIC L, V1; Bohn HF, 2004, P NATL ACAD SCI USA, V101, P14138, DOI 10.1073/pnas.0405885101; Bush JWM, 2006, ANNU REV FLUID MECH, V38, P339, DOI 10.1146/annurev.fluid.38.050304.092157; CHEEK M, 2001, PUBLICATION DEP NATL, V15, P1; Clarke C., 1997, NEPENTHES OF BORNEO; Clarke C.M., 2001, NEPENTHES SUMATRA PE; Darwin C., 1875, INSECTIVOROUS PLANTS; DENNY M, 1980, NATURE, V285, P160, DOI 10.1038/285160a0; DIGIUSTO B, FUNCTIONAL IN PRESS; Drelich J., 2006, MEASUREMENT INTERFAC, V2nd; Ellison AM, 2003, ADV ECOL RES, V33, P1, DOI 10.1016/S0065-2504(03)33009-0; Entov VM, 1997, J NON-NEWTON FLUID, V72, P31, DOI 10.1016/S0377-0257(97)00022-0; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Gaume L, 2004, ARTHROPOD STRUCT DEV, V33, P103, DOI 10.1016/j.asd.2003.11.005; Gaume L, 2002, NEW PHYTOL, V156, P479, DOI 10.1046/j.1469-8137.2002.00530.x; Gaume L, 2006, J TROP ECOL, V22, P341, DOI 10.1017/S0266467405003111; Gorb E, 2005, J EXP BIOL, V208, P4651, DOI 10.1242/jeb.01939; Gorb SN, 2000, ARTHROPOD STRUCT DEV, V29, P129, DOI 10.1016/S1467-8039(00)00020-7; GOWDA DC, 1982, PHYTOCHEMISTRY, V21, P2297, DOI 10.1016/0031-9422(82)85194-7; Grotberg JB, 2001, ANNU REV BIOMED ENG, V3, P421, DOI 10.1146/annurev.bioeng.3.1.421; GU YP, 2006, ENCY SURFACE COLLOID; HEPBURN JS, 1927, WAGNER FREE I SCI, V11, P35; HOLDGATE MW, 1955, J EXP BIOL, V32, P591; Juniper B. E., 1989, CARNIVOROUS PLANTS; Juniper BE., 1962, NEW SCI, V13, P75; Kato M., 1993, Tropical Zoology, V6, P11; Larson R. G., 1999, STRUCTURE RHEOLOGY C, P443; Lauga E, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2751388; Lide D., 2004, HDB CHEM PHYS; Lloyd F.E., 1942, CARNIVOROUS PLANTS; Moran JA, 1996, J ECOL, V84, P515, DOI 10.2307/2261474; MORTON JF, 1990, J ETHNOPHARMACOL, V29, P245, DOI 10.1016/0378-8741(90)90036-S; Read DB, 2003, NEW PHYTOL, V157, P315, DOI 10.1046/j.1469-8137.2003.00665.x; Riedel M, 2007, PLANTA, V225, P1517, DOI 10.1007/s00425-006-0437-3; Rodd LE, 2005, APPL RHEOL, V15, P12, DOI 10.1515/arh-2005-0001; Salmon B., 1993, CARNIVOROUS PLANT NE, V23, P101; Vogel S., 1994, LIFE MOVING FLUIDS P	40	85	88	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1185	10.1371/journal.pone.0001185	http://dx.doi.org/10.1371/journal.pone.0001185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030325	Green Submitted, gold, Green Published			2022-12-27	WOS:000207459200004
J	Schneider, BS; Mcgee, CE; Jordan, JM; Stevenson, HL; Soong, L; Higgs, S				Schneider, Bradley S.; McGee, Charles E.; Jordan, Jeffrey M.; Stevenson, Heather L.; Soong, Lynn; Higgs, Stephen			Prior Exposure to Uninfected Mosquitoes Enhances Mortality in Naturally-Transmitted West Nile Virus Infection	PLOS ONE			English	Article								Background. The global emergence of West Nile virus (WNV) has highlighted the importance of mosquito-borne viruses. These are inoculated in vector saliva into the vertebrate skin and circulatory system. Arthropod-borne (arbo) viruses such as WNV are transmitted to vertebrates as an infectious mosquito probes the skin for blood, depositing the virus and saliva into the skin and circulation. Growing evidence has demonstrated that arthropod, and recently mosquito, saliva can have a profound effect on pathogen transmission efficiency, pathogenesis, and disease course. A potentially important aspect of natural infections that has been ignored is that in nature vertebrates are typically exposed to the feeding of uninfected mosquitoes prior to the mosquito that transmits WNV. The possibility that pre-exposure to mosquito saliva might modulate WNV infection was explored. Principal Findings. Here we report that sensitization to mosquito saliva exacerbates viral infection. Prior exposure of mice to mosquito feeding resulted in increased mortality following WNV infection. This aggravated disease course was associated with enhanced early viral replication, increased interleukin-10 expression, and elevated influx of WNV-susceptible cell types to the inoculation site. This exacerbated disease course was mimicked by passive transfer of mosquito-sensitized serum. Significance. This is the first report that sensitization to arthropod saliva can exacerbate arthropod-borne infection, contrary to previous studies with parasite and bacteria infections. This research suggests that in addition to the seroreactivity of the host to virus, it is important to take into account the immune response to vector feeding.	[Schneider, Bradley S.; McGee, Charles E.; Jordan, Jeffrey M.; Stevenson, Heather L.; Soong, Lynn; Higgs, Stephen] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA; [Soong, Lynn] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Schneider, Bradley S.] Inst Pasteur, Paris, France	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Higgs, S (corresponding author), Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA.	sthiggs@utmb.edu		Stevenson, Heather/0000-0002-0645-7621; Schneider, Bradley S/0000-0001-7642-0018	Centers for Disease Control Fellowship Training Program in Vector-Borne Infectious Diseases [T01/CCT622892]; Zelda Zinn Casper Scholarship; Arthur V. Simmang Scholarship; Pasteur Foundation, New York, NY; National Institutes of Health [R01AI47246, AI47246]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047246] Funding Source: NIH RePORTER	Centers for Disease Control Fellowship Training Program in Vector-Borne Infectious Diseases; Zelda Zinn Casper Scholarship; Arthur V. Simmang Scholarship; Pasteur Foundation, New York, NY; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	B. S. Schneider, C. E. McGee, and H. L. Stevenson were supported by the Centers for Disease Control Fellowship Training Program in Vector-Borne Infectious Diseases T01/CCT622892. B. S. Schneider was also aided by the generous support of the Zelda Zinn Casper Scholarship and the Arthur V. Simmang Scholarship, and is currently funded by the Pasteur Foundation, New York, NY. This research was supported by the National Institutes of Health grant number R01AI47246 and, in part, by the National Institutes of Health grant number AI47246 to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley DWC, 2003, VIROLOGY, V309, P190, DOI 10.1016/S0042-6822(03)00150-8; Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941; Belkaid Y, 1996, J IMMUNOL METHODS, V199, P5, DOI 10.1016/S0022-1759(96)00117-2; Brady MT, 2003, EUR J IMMUNOL, V33, P3448, DOI 10.1002/eji.200324251; Busch MP, 2006, EMERG INFECT DIS, V12, P395, DOI 10.3201/eid1203.051287; Byrne SN, 2001, J INVEST DERMATOL, V117, P702, DOI 10.1046/j.0022-202x.2001.01454.x; Chambers TJ, 2003, ADV VIRUS RES, V60, P273, DOI 10.1016/S0065-3527(03)60008-4; CHAMBERS TJ, 2003, FLAVIVIRUSES PATHOGE, P486; Chen YL, 1998, INT ARCH ALLERGY IMM, V116, P269, DOI 10.1159/000023955; Donovan MJ, 2007, INFECT IMMUN, V75, P2523, DOI 10.1128/IAI.01928-06; Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261; Ejrnaes M, 2006, J EXP MED; ENK AH, 1993, J IMMUNOL, V151, P2390; Griffiths PD, 2002, REV MED VIROL, V12, P197, DOI 10.1002/rmv.364; Higgs S, 2005, P NATL ACAD SCI USA, V102, P8871, DOI 10.1073/pnas.0503835102; Johnston LJ, 2000, J INVEST DERMATOL, V114, P560, DOI 10.1046/j.1523-1747.2000.00904.x; Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351; Limesand KH, 2000, PARASITE IMMUNOL, V22, P461, DOI 10.1046/j.1365-3024.2000.00326.x; MACATONIA SE, 1993, J IMMUNOL, V150, P3755; Peng ZK, 2004, ANN ALLERG ASTHMA IM, V93, P553, DOI 10.1016/S1081-1206(10)61262-8; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; ROSSIGNOL PA, 1984, AM J TROP MED HYG, V33, P17, DOI 10.4269/ajtmh.1984.33.17; Salek-Ardakani S, 2002, VIROLOGY, V304, P342, DOI 10.1006/viro.2002.1716; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565; SCHNEIDER BS, TO1CCT622892; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; SITATI EM, 2006, J VIROL; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436; TURELL MJ, 1995, J MED ENTOMOL, V32, P563, DOI 10.1093/jmedent/32.4.563; Vanlandingham DL, 2004, AM J TROP MED HYG, V71, P120, DOI 10.4269/ajtmh.2004.71.120; Wasserman HA, 2004, PARASITE IMMUNOL, V26, P295, DOI 10.1111/j.0141-9838.2004.00712.x; Wikel SK, 1997, INFECT IMMUN, V65, P335, DOI 10.1128/IAI.65.1.335-338.1997	34	55	58	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1171	10.1371/journal.pone.0001171	http://dx.doi.org/10.1371/journal.pone.0001171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000543	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459100013
J	Cable, JM; Enquist, BJ; Moses, ME				Cable, Jessica M.; Enquist, Brian J.; Moses, Melanie E.			The Allometry of Host- Pathogen Interactions	PLOS ONE			English	Article								Background. Understanding the mechanisms that control rates of disease progression in humans and other species is an important area of research relevant to epidemiology and to translating studies in small laboratory animals to humans. Body size and metabolic rate influence a great number of biological rates and times. We hypothesize that body size and metabolic rate affect rates of pathogenesis, specifically the times between infection and first symptoms or death. Methods and Principal Findings. We conducted a literature search to find estimates of the time from infection to first symptoms (t(S)) and to death (t(D)) for five pathogens infecting a variety of bird and mammal hosts. A broad sampling of diseases (1 bacterial, 1 prion, 3 viruses) indicates that pathogenesis is controlled by the scaling of host metabolism. We find that the time for symptoms to appear is a constant fraction of time to death in all but one disease. Our findings also predict that many population-level attributes of disease dynamics are likely to be expressed as dimensionless quantities that are independent of host body size. Conclusions and Significance. Our results show that much variability in host pathogenesis can be described by simple power functions consistent with the scaling of host metabolic rate. Assessing how disease progression is controlled by geometric relationships will be important for future research. To our knowledge this is the first study to report the allometric scaling of host/pathogen interactions.	[Cable, Jessica M.] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Enquist, Brian J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Moses, Melanie E.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA	University of Wyoming; University of Arizona; University of New Mexico	Cable, JM (corresponding author), Univ Wyoming, Dept Bot, Laramie, WY 82071 USA.	jcable1@uwyo.edu	Enquist, Brian J/B-6436-2008	Enquist, Brian J/0000-0002-6124-7096	NSF CAREER Award [NSF DEB-0133974]; IH COBRE Center for Evolutionary and Theoretical Immunology [NIH P20 RR018754]; University of Arizona, Department of Ecology and Evolutionary Biology; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER	NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); IH COBRE Center for Evolutionary and Theoretical Immunology; University of Arizona, Department of Ecology and Evolutionary Biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	BJE was supported by an NSF CAREER Award (NSF DEB-0133974). MEM was supported by a subproject of the NIH COBRE Center for Evolutionary and Theoretical Immunology (NIH P20 RR018754). JMC was supported with funding from the University of Arizona, Department of Ecology and Evolutionary Biology.	Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Bartholomew G.A., 1981, P45; BROWN MF, 2007, AM J PHYSL REGUL INT; Calder WAI., 1996, SIZE FUNCTION LIFE H; Charnov Eric L., 1993, P1; DeLeo GA, 1996, NATURE, V379, P720, DOI 10.1038/379720a0; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; DOBSON GP, 1995, P NATL ACAD SCI USA, V92, P7317, DOI 10.1073/pnas.92.16.7317; ELSE PL, 1985, AM J PHYSIOL, V248, pR415, DOI 10.1152/ajpregu.1985.248.4.R415; ENQUIST LW, 1999, PRINCIPLES VIROLOGY; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Harvey P. H., 1991, COMPARATIVE METHOD E; KLEIBER MAX, 1932, HILGARDIA, V6, P315; MATHIEU O, 1981, RESP PHYSIOL, V44, P113, DOI 10.1016/0034-5687(81)90079-7; Nee S, 2005, SCIENCE, V309, P1236, DOI 10.1126/science.1114488; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Savage VM, 2007, P NATL ACAD SCI USA, V104, P4718, DOI 10.1073/pnas.0611235104; Savage VM, 2006, SCIENCE, V312, p198B, DOI 10.1126/science.1123679; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Schmidt-Nielson K., 1984, SCALING WHY IS ANIMA; Silva M, 1998, J MAMMAL, V79, P20, DOI 10.2307/1382839; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Tella JL, 2002, P ROY SOC B-BIOL SCI, V269, P1059, DOI 10.1098/rspb.2001.1951; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026	29	41	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1130	10.1371/journal.pone.0001130	http://dx.doi.org/10.1371/journal.pone.0001130			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987117	gold, Green Submitted, Green Published			2022-12-27	WOS:000207459000014
J	Iwami, T; Kishida, O; Nishimura, K				Iwami, Tadashi; Kishida, Osamu; Nishimura, Kinya			Direct and Indirect Induction of a Compensatory Phenotype that Alleviates the Costs of an Inducible Defense	PLOS ONE			English	Article								Organisms often exhibit phenotypic plasticity in multiple traits in response to impending environmental change. Multiple traits phenotypic plasticity is complex syndrome brought on by causal relations in ecological and physiological context. Larvae of the salamander Hynobius retardatus exhibit inducible phenotypic plasticity of two traits, when at risk of predation by dragonfly larvae. One induced phenotype is an adaptive defense behaviour, i.e., stasis at the bottom of water column, directly triggered by the predation risk. Another one is a compensatory phenotype, i.e., enlarged external gills, for an unavoidable cost (hypoxia) associated with the induced defense. We identified two ways by which this compensatory phenotype could be induced. The compensatory phenotype is induced in response to not only the associated hypoxic conditions resulting from the induced defense but also the most primary but indirect cause, presence of the predator.	[Iwami, Tadashi; Kishida, Osamu; Nishimura, Kinya] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan	Hokkaido University	Nishimura, K (corresponding author), Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan.	kinya@fish.hokudai.ac.jp	Kishida, Osamu/B-7970-2011		Ministry of Education, Culture, Sports, Science and Technology [16370008, 18657006, 19370005, 09035]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding: This work was supported by Grants-in-Aid for Scientific Research (nos. 16370008, 18657006, 19370005) to KN from the Ministry of Education, Culture, Sports, Science and Technology, and in part by a Grant-in-Aid for a Young Research Scientists (no. 09035) to OK. The sponsors did not have any role of the scientific activity itself.	Andersson J, 2006, P ROY SOC B-BIOL SCI, V273, P431, DOI 10.1098/rspb.2005.3343; ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; BOND AN, 1960, DEV BIOL, V2, P1, DOI 10.1016/0012-1606(60)90013-0; BURGGREN W, 1983, J EXP BIOL, V105, P191; CLARK CW, 1992, AM NAT, V139, P521, DOI 10.1086/285342; Crowder WC, 1998, J EXP ZOOL, V280, P121, DOI 10.1002/(SICI)1097-010X(19980201)280:2<121::AID-JEZ3>3.0.CO;2-Q; DODSON SI, 1974, LIMNOL OCEANOGR, V19, P721, DOI 10.4319/lo.1974.19.5.0721; Edmunds M., 1974, DEFENCE ANIMALS; FEDER ME, 1983, J EXP BIOL, V104, P79; IWASAWA H, 1991, Japanese Journal of Herpetology, V14, P39; Kishida O, 2006, ECOLOGY, V87, P1599, DOI 10.1890/0012-9658(2006)87[1599:RPPIAP]2.0.CO;2; Kishida O, 2006, J ANIM ECOL, V75, P705, DOI 10.1111/j.1365-2656.2006.01091.x; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lind J, 2005, BEHAV ECOL, V16, P945, DOI 10.1093/beheco/ari075; McIntyre PB, 2000, OECOLOGIA, V125, P301, DOI 10.1007/s004420000451; Schmidt BR, 2006, EVOL ECOL RES, V8, P1301; SKELLY DK, 1994, ANIM BEHAV, V47, P465, DOI 10.1006/anbe.1994.1063; SKELLY DK, 1992, ECOLOGY, V73, P704, DOI 10.2307/1940779; Stoks R, 2005, J ANIM ECOL, V74, P708, DOI 10.1111/j.1365-2656.2005.00969.x; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; ULTSCH GR, 1976, RESP PHYSIOL, V26, P357, DOI 10.1016/0034-5687(76)90006-2; Ultsch GR, 1999, TADPOLES, P189; Vonesh JR, 2005, ECOLOGY, V86, P1580, DOI 10.1890/04-0535; WEBER JM, 1983, CAN J FISH AQUAT SCI, V40, P1583, DOI 10.1139/f83-183; WEST NH, 1982, RESP PHYSIOL, V47, P165, DOI 10.1016/0034-5687(82)90109-8; WHITFORD WG, 1965, PHYSIOL ZOOL, V38, P228, DOI 10.1086/physzool.38.3.30152835; WOOD SC, 1980, AM ZOOL, V20, P163	28	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1084	10.1371/journal.pone.0001084	http://dx.doi.org/10.1371/journal.pone.0001084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971850	Green Published, gold, Green Submitted			2022-12-27	WOS:000207458700003
J	Schooling, CM; Lam, TH; Thomas, GN; Cowling, BJ; Heys, M; Janus, ED; Leung, GM				Schooling, C. Mary; Lam, Tai Hing; Thomas, G. Neil; Cowling, Benjamin J.; Heys, Michelle; Janus, Edward D.; Leung, Gabriel M.		Hong Kong Cardiovasc Risk Factor P	Growth Environment and Sex Differences in Lipids, Body Shape and Diabetes Risk	PLOS ONE			English	Article								Background. Sex differences in lipids and body shape, but not diabetes, increase at puberty. Hong Kong Chinese are mainly first or second generation migrants from China, who have shared an economically developed environment for years, but grew up in very different environments in Hong Kong or contemporaneously undeveloped Guangdong, China. We assessed if environment during growth had sex-specific associations with lipids and body shape, but not diabetes. Methodology and Principal Findings. We used multivariable regression in a population-based cross-sectional study, undertaken from 1994 to 1996, of 2537 Hong Kong Chinese residents aged 25 to 74 years with clinical measurements of ischaemic heart disease (IHD) risk, including HDL-cholesterol, ApoB, diabetes and obesity. Waist-hip ratio was higher ( mean difference 0.01, 95% CI 0.001 to 0.02) in men, who had grown up in an economically developed rather than undeveloped environment, as was apolipoprotein B (0.05 g/L, 95% CI 0.001 to 0.10), adjusted for age, socio-economic status and lifestyle. In contrast, the same comparison was associated in women with lower waist-hip ratio (20.01, 95% CI 20.001 to 20.02) and higher HDL-cholesterol ( 0.05 mmol/L, 95% CI 0.0004 to 0.10). The associations in men and women were significantly different (p-values, 0.001). There were no such differences for diabetes. Conclusions. Growth in a developed environment with improved nutrition may promote higher sex-steroids at puberty producing an atherogenic lipid profile and male fat pattern in men but the opposite in women, with tracking of increased male IHD risk into adult life.	[Schooling, C. Mary; Lam, Tai Hing; Thomas, G. Neil; Cowling, Benjamin J.; Heys, Michelle; Leung, Gabriel M.] Univ Hong Kong, Dept Community Med, Pokfulam, Hong Kong, Peoples R China; [Schooling, C. Mary; Lam, Tai Hing; Thomas, G. Neil; Cowling, Benjamin J.; Heys, Michelle; Leung, Gabriel M.] Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China; [Janus, Edward D.] Univ Hong Kong, Clin Biochem Unit, Pokfulam, Hong Kong, Peoples R China; [Janus, Edward D.] Western Hosp, Dept Med, Footscray, Vic, Australia	University of Hong Kong; University of Hong Kong; University of Hong Kong; Western Hospital	Schooling, CM (corresponding author), Univ Hong Kong, Dept Community Med, Pokfulam, Hong Kong, Peoples R China.	cms1@hkucc.hku.hk	Janus, Edward/AAU-8652-2020; Leung, Gabriel Matthew/C-4336-2009; Thomas, G. Neil/A-1879-2013; Schooling, Catherine Mary/C-4386-2009; Cowling, Benjamin John/C-4263-2009; Lam, Tai Hing/C-4317-2009	Thomas, G. Neil/0000-0002-2777-1847; Cowling, Benjamin John/0000-0002-6297-7154; Lam, Tai Hing/0000-0002-2033-9971; Leung, Gabriel/0000-0002-2503-6283; Schooling, Mary/0000-0001-9933-5887	Hong Kong Health Services Research Committee (HSRC) [411026]; University of Hong Kong Committee on Research and Conference; Hong Kong Research Grants Council [407/94m]; Hong Kong Society for the Aged	Hong Kong Health Services Research Committee (HSRC); University of Hong Kong Committee on Research and Conference(University of Hong Kong); Hong Kong Research Grants Council(Hong Kong Research Grants Council); Hong Kong Society for the Aged	The study was supported by the Hong Kong Health Services Research Committee (HSRC# 411026), the University of Hong Kong Committee on Research and Conference Grants, the Hong Kong Research Grants Council (grant 407/94m) and the Hong Kong Society for the Aged. The funding source had no involvement in the design, collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Adam CL, 1997, J REPROD FERTIL, V111, P121, DOI 10.1530/jrf.0.1110121; Arslanian S, 1997, J CLIN ENDOCR METAB, V82, P3213, DOI 10.1210/jc.82.10.3213; Avendano M, 2006, HEART, V92, P461, DOI 10.1136/hrt.2005.065532; Ballantyne C, 2005, EUR HEART J, V26, P2224, DOI 10.1093/eurheartj/ehi373; BERENSON GS, 1981, AM J EPIDEMIOL, V113, P157, DOI 10.1093/oxfordjournals.aje.a113080; Butters H.R., 1939, REPORT LABOUR LABOUR; Campbell BC, 2004, ANN HUM BIOL, V31, P213, DOI 10.1080/03014460310001656604; Dahlman C.J., 2001, CHINA KNOWLEDGE EC S; Donnan Stuart P. B., 1994, Annals of Epidemiology, V4, P46; Dorgan JF, 2003, J NATL CANCER I, V95, P132, DOI 10.1093/jnci/95.2.132; Dorgan JF, 2006, J CLIN ENDOCR METAB, V91, P3992, DOI 10.1210/jc.2006-0109; Ezeamama AE, 2006, SOC SCI MED, V63, P2533, DOI 10.1016/j.socscimed.2006.06.023; Freire RD, 2003, BRIT J NUTR, V89, P705, DOI 10.1079/BJN2002824; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Gonzalez MA, 1998, INT J EPIDEMIOL, V27, P350, DOI 10.1093/ije/27.3.350; Goran MI, 2001, DIABETES, V50, P2444, DOI 10.2337/diabetes.50.11.2444; Hauspie RC, 1997, ACTA PAEDIATR, V86, P20; Hero M, 2006, EUR J ENDOCRINOL, V155, P453, DOI 10.1530/eje.1.02226; *HONG KONG GOV, 1955, HONG KONG ANN REP 19; Janghorbani M, 2003, ADDICTION, V98, P215, DOI 10.1046/j.1360-0443.2003.00268.x; JAROSS W, 1981, ENDOKRINOLOGIE, V78, P28; Kim MH, 2005, INT J EPIDEMIOL, V34, P1266, DOI 10.1093/ije/dyi175; KIRKLAND RT, 1987, JAMA-J AM MED ASSOC, V257, P502, DOI 10.1001/jama.257.4.502; Lam TH, 1999, ATHEROSCLEROSIS, V143, P405, DOI 10.1016/S0021-9150(98)00294-9; Langenberg C, 2006, AM J PUBLIC HEALTH, V96, P2216, DOI 10.2105/AJPH.2004.049429; Lawlor DA, 2002, BRIT MED J, V325, P311, DOI 10.1136/bmj.325.7359.311; Lawlor DA, 2001, BRIT MED J, V323, P541, DOI 10.1136/bmj.323.7312.541; MADDISON A, 2003, DEV CTR STUDIES; Manor O, 2004, ANN EPIDEMIOL, V14, P453, DOI 10.1016/j.annepidem.2003.10.011; MARMOT M, 1992, CORONARY HEART DIS E, P3; Moran A, 2002, J CLIN ENDOCR METAB, V87, P4817, DOI 10.1210/jc.2002-020517; Morrison JA, 2003, J PEDIATR-US, V142, P637, DOI 10.1067/mpd.2003.246; NGO TW, 2003, HONG KONG READER SOC, P543; Nikiforov SV, 1998, AM J PUBLIC HEALTH, V88, P1348, DOI 10.2105/AJPH.88.9.1348; NOLAN CJ, 1990, J ANIM SCI, V68, P1087, DOI 10.2527/1990.6841087x; Ovesen L, 2006, ANN NUTR METAB, V50, P317, DOI 10.1159/000094294; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Pollitt RA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-7; Roemmich JN, 1999, AM J HUM BIOL, V11, P209, DOI 10.1002/(SICI)1520-6300(1999)11:2&lt;209::AID-AJHB9&gt;3.0.CO;2-G; RONNEKLEIV OK, 1978, BIOL REPROD, V19, P414, DOI 10.1095/biolreprod19.2.414; Saad RJ, 2001, J CLIN ENDOCR METAB, V86, P4881, DOI 10.1210/jc.86.10.4881; Schooling M, 2004, INT J EPIDEMIOL, V33, P1219, DOI 10.1093/ije/dyh221; Seidell Jacob C, 2005, Semin Vasc Med, V5, P3, DOI 10.1055/s-2005-871737; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; SLOB AK, 1979, BRIT J NUTR, V41, P231, DOI 10.1079/BJN19790032; SMITH GD, 2004, LIFE COURSE APPROACH, P77, DOI DOI 10.1093/ACPROF:OSO/9780198578154.001.0001; SRINIVASAN SR, 1985, METABOLISM, V34, P861, DOI 10.1016/0026-0495(85)90111-8; STOZICKY F, 1991, ACTA PAEDIATR SCAND, V80, P1139, DOI 10.1111/j.1651-2227.1991.tb11801.x; Tsang S., 2004, MODERN HIST HONG KON; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; *WHO MONICA PROJ, 1988, WORLD HLTH STAT Q, V41, P115; Wickman S, 2002, EUR J ENDOCRINOL, V146, P339, DOI 10.1530/eje.0.1460339; WONG SL, 1992, J EPIDEMIOL COMMUN H, V46, P148, DOI 10.1136/jech.46.2.148; Yu ZJ, 2002, J CLIN EPIDEMIOL, V55, P143, DOI 10.1016/S0895-4356(01)00451-6; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	57	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1070	10.1371/journal.pone.0001070	http://dx.doi.org/10.1371/journal.pone.0001070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957253	gold, Green Published, Green Submitted			2022-12-27	WOS:000207458500016
J	Treweek, TM; Ecroyd, H; Williams, DM; Meehan, S; Carver, JA; Walker, MJ				Treweek, Teresa M.; Ecroyd, Heath; Williams, Danielle M.; Meehan, Sarah; Carver, John A.; Walker, Mark J.			Site-Directed Mutations in the C-Terminal Extension of Human alpha B-Crystallin Affect Chaperone Function and Block Amyloid Fibril Formation	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; IN-VITRO; MOLECULAR CHAPERONE; KAPPA-CASEIN; OLIGOMERIZATION; FLUORESCENCE; BINDING; PHOSPHORYLATION; IDENTIFICATION; SPECTROSCOPY	Background. Alzheimer's, Parkinson's and Creutzfeldt-Jakob disease are associated with inappropriate protein deposition and ordered amyloid fibril assembly. Molecular chaperones, including alpha B-crystallin, play a role in the prevention of protein deposition. Methodology/Principal Findings. A series of site-directed mutants of the human molecular chaperone, alpha B-crystallin, were constructed which focused on the flexible C-terminal extension of the protein. We investigated the structural role of this region as well as its role in the chaperone function of alpha B-crystallin under different types of protein aggregation, i.e. disordered amorphous aggregation and ordered amyloid fibril assembly. It was found that mutation of lysine and glutamic acid residues in the C-terminal extension of alpha B-crystallin resulted in proteins that had improved chaperone activity against amyloid fibril forming target proteins compared to the wild-type protein. Conclusions/Significance. Together, our results highlight the important role of the C-terminal region of alpha B-crystallin in regulating its secondary, tertiary and quaternary structure and conferring thermostability to the protein. The capacity to genetically modify alpha B-crystallin for improved ability to block amyloid fibril formation provides a platform for the future use of such engineered molecules in treatment of diseases caused by amyloid fibril formation.	[Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Treweek, Teresa M.] Univ Wollongong, Dept Chem, Wollongong, NSW 2500, Australia; [Treweek, Teresa M.] Univ Wollongong, Grad Sch Med, Wollongong, NSW 2500, Australia; [Ecroyd, Heath; Williams, Danielle M.; Carver, John A.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA, Australia; [Meehan, Sarah] Univ Cambridge, Univ Chem Lab, Cambridge, England	University of Wollongong; University of Wollongong; University of Wollongong; University of Adelaide; University of Cambridge	Walker, MJ (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia.	mwalker@uow.edu.au	Walker, Mark J./F-6940-2011; Ecroyd, Heath/E-7140-2015; Carver, John Adrian/J-3825-2014	Carver, John Adrian/0000-0002-2441-8108; Walker, Mark/0000-0001-7423-2769; Ecroyd, Heath/0000-0001-7574-0044	National Health and Medical Research Council (NHMRC) of Australia; Australian Research Council; Australian Postgraduate Award; Royal Society	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government); Royal Society(Royal Society of London)	This work was supported by grants (to JAC) from the National Health and Medical Research Council (NHMRC) of Australia and the Australian Research Council. TT was supported by an Australian Postgraduate Award, HE is supported by an NHMRC Peter Doherty Postdoctoral Training Fellowship and SM was supported by a Royal Society International Fellowship.	Andley UP, 1996, J BIOL CHEM, V271, P31973, DOI 10.1074/jbc.271.50.31973; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Aquilina JA, 2005, J BIOL CHEM, V280, P14485, DOI 10.1074/jbc.M500135200; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Bera S, 2002, BIOCHEMISTRY-US, V41, P297, DOI 10.1021/bi011010v; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; Cambillau C, 2000, J BIOL CHEM, V275, P32383, DOI 10.1074/jbc.C000497200; CARVER JA, 1992, FEBS LETT, V311, P143, DOI 10.1016/0014-5793(92)81386-Z; CARVER JA, 1995, BBA-PROTEIN STRUCT M, V1252, P251, DOI 10.1016/0167-4838(95)00146-L; Carver JA, 1996, EXP EYE RES, V63, P639, DOI 10.1006/exer.1996.0158; Carver JA, 1998, INT J BIOL MACROMOL, V22, P197, DOI 10.1016/S0141-8130(98)00017-8; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; COPELAND R, 1994, SPECTROSCOPIC PROBES; Das BK, 1997, BIOCHEM BIOPH RES CO, V236, P370, DOI 10.1006/bbrc.1997.6950; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Farrell HM, 2003, J PROTEIN CHEM, V22, P259, DOI 10.1023/A:1025020503769; Fernando P, 2000, CELL STRESS CHAPERON, V5, P148, DOI 10.1379/1466-1268(2000)005<0148:FCOXSH>2.0.CO;2; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Giese KC, 2005, P NATL ACAD SCI USA, V102, P18896, DOI 10.1073/pnas.0506169103; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hatters DM, 2001, J BIOL CHEM, V276, P33755, DOI 10.1074/jbc.M105285200; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Kamei A, 2000, BIOL PHARM BULL, V23, P226; Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101; Karshikoff A, 1998, PROTEIN ENG, V11, P867, DOI 10.1093/protein/11.10.867; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1074, P201, DOI 10.1016/0304-4165(91)90062-L; KELLEY MJ, 1993, J BIOL CHEM, V268, P18844; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; Kreil DP, 2001, NUCLEIC ACIDS RES, V29, P1608, DOI 10.1093/nar/29.7.1608; KRONMAN MJ, 1971, PHOTOCHEM PHOTOBIOL, V14, P113, DOI 10.1111/j.1751-1097.1971.tb06157.x; Kudva YC, 1997, FEBS LETT, V416, P117, DOI 10.1016/S0014-5793(97)01180-0; Kumar LVS, 1999, J BIOL CHEM, V274, P24137, DOI 10.1074/jbc.274.34.24137; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; Liang JJN, 2000, FEBS LETT, V484, P98, DOI 10.1016/S0014-5793(00)02136-0; Liao JH, 2002, BIOCHEM BIOPH RES CO, V297, P309, DOI 10.1016/S0006-291X(02)02185-X; Lindner RA, 1998, EUR J BIOCHEM, V258, P170, DOI 10.1046/j.1432-1327.1998.2580170.x; Lindner RA, 2000, EUR J BIOCHEM, V267, P1923, DOI 10.1046/j.1432-1327.2000.01188.x; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; OCHI N, 1991, BIOCHEM BIOPH RES CO, V179, P1030, DOI 10.1016/0006-291X(91)91922-Y; Pasta SY, 2004, MOL VIS, V10, P655; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; RANDALL LL, 1992, SCIENCE, V257, P241, DOI 10.1126/science.1631545; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Sathish HA, 2004, J BIOL CHEM, V279, P16425, DOI 10.1074/jbc.M313402200; Sathish HA, 2003, J BIOL CHEM, V278, P44214, DOI 10.1074/jbc.M307578200; Smulders RHPH, 1996, J BIOL CHEM, V271, P29060, DOI 10.1074/jbc.271.46.29060; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stege GJJ, 1999, BIOCHEM BIOPH RES CO, V262, P152, DOI 10.1006/bbrc.1999.1167; Studer S, 2002, EUR J BIOCHEM, V269, P3578, DOI 10.1046/j.1432-1033.2002.03049.x; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Syme CD, 2002, EUR J BIOCHEM, V269, P148, DOI 10.1046/j.0014-2956.2001.02633.x; TAKEMOTO L, 1993, BIOCHEM J, V297, P653; Thampi P, 2003, BIOCHEMISTRY-US, V42, P11857, DOI 10.1021/bi030129w; Thorn DC, 2005, BIOCHEMISTRY-US, V44, P17027, DOI 10.1021/bi051352r; Treweek TM, 2003, AUST J CHEM, V56, P357, DOI 10.1071/CH03031; van Rijk AF, 2000, OPHTHALMOLOGICA, V214, P7, DOI 10.1159/000027468; VANMONTFORT RLM, 2001, NATURE STRUCT BIOL; White HE, 2006, STRUCTURE, V14, P1197, DOI 10.1016/j.str.2006.05.021; Young JC, 1997, FEBS LETT, V418, P139, DOI 10.1016/S0014-5793(97)01363-X	69	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1046	10.1371/journal.pone.0001046	http://dx.doi.org/10.1371/journal.pone.0001046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940610	Green Published, Green Submitted, gold			2022-12-27	WOS:000207456100014
J	Makareeva, E; Leikin, S				Makareeva, Elena; Leikin, Sergey			Procollagen Triple Helix Assembly: An Unconventional Chaperone-Assisted Folding Paradigm	PLOS ONE			English	Article								Fibers composed of type I collagen triple helices form the organic scaffold of bone and many other tissues, yet the energetically preferred conformation of type I collagen at body temperature is a random coil. In fibers, the triple helix is stabilized by neighbors, but how does it fold? The observations reported here reveal surprising features that may represent a new paradigm for folding of marginally stable proteins. We find that human procollagen triple helix spontaneously folds into its native conformation at 30-34 degrees C but not at higher temperatures, even in an environment emulating Endoplasmic Reticulum (ER). ER-like molecular crowding by nonspecific proteins does not affect triple helix folding or aggregation of unfolded chains. Common ER chaperones may prevent aggregation and misfolding of procollagen C-propeptide in their traditional role of binding unfolded polypeptide chains. However, such binding only further destabilizes the triple helix. We argue that folding of the triple helix requires stabilization by preferential binding of chaperones to its folded, native conformation. Based on the triple helix folding temperature measured here and published binding constants, we deduce that HSP47 is likely to do just that. It takes over 20 HSP47 molecules to stabilize a single triple helix at body temperature. The required 50-200 mu M concentration of free HSP47 is not unusual for heat-shock chaperones in ER, but it is 100 times higher than used in reported in vitro experiments, which did not reveal such stabilization.	[Makareeva, Elena; Leikin, Sergey] NICHHD, Sect Phys Biochem, Dept Hlth & Human Serv, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Leikin, S (corresponding author), NICHHD, Sect Phys Biochem, Dept Hlth & Human Serv, NIH, Bethesda, MD 20892 USA.	leikins@mail.nih.gov	Makareeva, Elena/F-5183-2011; Leikin, Sergey/A-5518-2008	Makareeva, Elena/0000-0002-5815-0760; Leikin, Sergey/0000-0001-7095-0739	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000256] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000256] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Beck K, 1996, J BIOL CHEM, V271, P21566, DOI 10.1074/jbc.271.35.21566; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Brooks DA, 1999, SEMIN CELL DEV BIOL, V10, P441, DOI 10.1006/scdb.1999.0314; BRUCKNER P, 1984, EUR J BIOCHEM, V140, P397, DOI 10.1111/j.1432-1033.1984.tb08115.x; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BRUCKNER P, 1984, EUR J BIOCHEM, V140, P391, DOI 10.1111/j.1432-1033.1984.tb08114.x; Byers PH, 2001, PHILOS T ROY SOC B, V356, P151, DOI 10.1098/rstb.2000.0760; Cabral WA, 2005, J BIOL CHEM, V280, P19259, DOI 10.1074/jbc.M414698200; Cabral WA, 2003, J BIOL CHEM, V278, P10006, DOI 10.1074/jbc.M212523200; CABRAL WA, 2007, HUM MUTAT; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; DAVIS JM, 1989, J BIOL CHEM, V264, P8956; DOLZ R, 1990, STRUCTURE MOL BIOL P; Du F, 2006, J MOL BIOL, V364, P469, DOI 10.1016/j.jmb.2006.09.018; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Emerson RO, 2006, J CELL BIOCHEM, V98, P701, DOI 10.1002/jcb.20867; FESSLER L I, 1974, Journal of Supramolecular Structure, V2, P103, DOI 10.1002/jss.400020205; FIEDLERNAGY C, 1982, J BIOL CHEM, V257, P9181; FIEDLERNAGY C, 1981, ARCH BIOCHEM BIOPHYS, V212, P668, DOI 10.1016/0003-9861(81)90411-2; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; JAIN N, 1994, BIOCHEM J, V304, P61, DOI 10.1042/bj3040061; KOCH G, 1986, J CELL SCI, V86, P217; Koide T, 2006, J BIOL CHEM, V281, P3432, DOI 10.1074/jbc.M509707200; Koide T, 2006, J BIOL CHEM, V281, P11177, DOI 10.1074/jbc.M601369200; Koide T, 2000, J BIOL CHEM, V275, P27957; KUDO H, 1994, EXP CELL RES, V212, P219, DOI 10.1006/excr.1994.1137; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; KURKINEN M, 1984, J BIOL CHEM, V259, P5915; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Macdonald JR, 2001, J BIOL CHEM, V276, P25399, DOI 10.1074/jbc.M102471200; Makareeva E, 2006, J BIOL CHEM, V281, P6463, DOI 10.1074/jbc.M511830200; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Martin J, 1997, P NATL ACAD SCI USA, V94, P1107, DOI 10.1073/pnas.94.4.1107; Martinek N, 2007, J DENT RES, V86, P296, DOI 10.1177/154405910708600402; MCBRIDE DJ, 1992, MATRIX, V12, P256; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; MILES CA, 1995, J MOL BIOL, V245, P437, DOI 10.1006/jmbi.1994.0035; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; Persikov AV, 2002, P NATL ACAD SCI USA, V99, P1101, DOI 10.1073/pnas.042707899; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Qu YX, 2002, BIOPHYS CHEM, V101, P155, DOI 10.1016/S0301-4622(02)00148-5; Satoh M, 1996, J CELL BIOL, V133, P469, DOI 10.1083/jcb.133.2.469; Sauk JJ, 2005, FRONT BIOSCI-LANDMRK, V10, P107, DOI 10.2741/1513; Tasab M, 2000, EMBO J, V19, P2204, DOI 10.1093/emboj/19.10.2204; Thomson CA, 2000, BIOCHEM J, V349, P877, DOI 10.1042/bj3490877; Thomson CA, 2003, PROTEIN SCI, V12, P1792, DOI 10.1110/ps.0236903; Tokuriki N, 2004, PROTEIN SCI, V13, P125, DOI 10.1110/ps.03288104; van den Berg B, 2000, EMBO J, V19, P3870, DOI 10.1093/emboj/19.15.3870; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	56	45	45	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1029	10.1371/journal.pone.0001029	http://dx.doi.org/10.1371/journal.pone.0001029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925877	gold, Green Published, Green Submitted			2022-12-27	WOS:000207456000028
J	Xiao, QZ; Kiechl, S; Patel, S; Oberhollenzer, F; Weger, S; Mayr, A; Metzler, B; Reindl, M; Hu, YH; Willeit, J; Xu, QB				Xiao, Qingzhong; Kiechl, Stefan; Patel, Seema; Oberhollenzer, Friedrich; Weger, Siegfried; Mayr, Agnes; Metzler, Bernhard; Reindl, Markus; Hu, Yanhua; Willeit, Johann; Xu, Qingbo			Endothelial Progenitor Cells, Cardiovascular Risk Factors, Cytokine Levels and Atherosclerosis - Results from a Large Population-Based Study	PLOS ONE			English	Article								Background. EPC number and functionality are assumed to reflect the endogenous vascular repair capacity with the EPC pool declining in higher ages and being exhausted by unfavorable life-style and risk factors. This intriguing and clinically highly relevant concept, however, has so far been derived from small case-control studies and patient series. Methodology and Principle Findings. In the population-based Bruneck Study EPC number and EPC-colony forming units (EPC-CFU) were assessed as part of the fourth follow-up evaluation (2005) in 571 and 542 subjects, respectively. EPC number declined with age (p = 0.013), was significantly lower in women (p = 0.006) and higher in subjects on statin, hormone replacement or ACE inhibitor/angiotensin-receptor blockers, and correlated positively with moderate alcohol consumption. Unexpectedly, a positive relation between EPC number and several vascular risk factors emerged. In a step forward multivariate linear regression analysis EPC number was independently related with SDF1 alpha, MMP-9, triglycerides, alcohol consumption, and Hba1c. EPC-CFU in turn was related to SDF1 alpha and diastolic blood pressure. Moreover, EPC number showed a significant positive association with the Framingham risk score (P = 0.001). Finally, there was an inverse association between EPC number and common carotid artery intima-media thickness (p = 0.02) and the carotid artery atherosclerosis score (p = 0.059). Conclusions. Our population-based data confirm the decline of EPC number with advancing age and lend first epidemiological support to a role of SDF-1 alpha and MMP9 in EPC differentiation, mobilization and homing, but are conflict with the view that EPC number is unfavorably affected by cardiovascular risk factors. EPC number increases with the cardiovascular risk estimated by the Framingham risk score (FRS), which in the absence of similar changes for EPC-CFU. Finally, we demonstrate a significant inverse association between EPC number and extent of carotid atherosclerosis even though this association was only of moderate strength and not entirely consistent in other vascular territories.	[Xiao, Qingzhong; Patel, Seema; Hu, Yanhua; Xu, Qingbo] Univ London, Kings Coll London, Div Cardiovasc, London, England; [Kiechl, Stefan; Weger, Siegfried; Reindl, Markus; Willeit, Johann] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Oberhollenzer, Friedrich] Hosp Bruneck, Dept Internal Med, Brunico, Italy; [Mayr, Agnes] Hosp Bruneck, Dept Lab Med, Brunico, Italy; [Metzler, Bernhard] Med Univ Innsbruck, Dept Internal Med, Innsbruck, Austria	University of London; King's College London; Medical University of Innsbruck; Medical University of Innsbruck	Xu, QB (corresponding author), Univ London, Kings Coll London, Div Cardiovasc, London, England.	qingbo.xu@kcl.ac.uk	Reindl, Markus/ABE-5880-2020	Reindl, Markus/0000-0003-2817-1402	British Heart Foundation; Oak Foundation	British Heart Foundation(British Heart Foundation); Oak Foundation	This work was supported by grants from British Heart Foundation and Oak Foundation.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Choi JH, 2004, ARTERIOSCL THROM VAS, V24, P1246, DOI 10.1161/01.ATV.0000133488.56221.4a; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; George J, 2004, EUR HEART J, V25, P1003, DOI 10.1016/j.ehj.2004.03.026; George J, 2003, ARTERIOSCL THROM VAS, V23, pE57, DOI 10.1161/01.ATV.0000107029.65274.db; Ghani U, 2005, STROKE, V36, P151, DOI 10.1161/01.STR.0000149944.15406.16; Gill M, 2001, CIRC RES, V88, P167; Grisar J, 2005, CIRCULATION, V111, P204, DOI 10.1161/01.CIR.0000151875.21836.AE; Handgretinger R, 2003, ANN NY ACAD SCI, V996, P141, DOI 10.1111/j.1749-6632.2003.tb03242.x; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Imanishi T, 2005, J HYPERTENS, V23, P1831, DOI 10.1097/01.hjh.0000183524.73746.1b; Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kiechl S, 1999, CIRCULATION, V99, P614, DOI 10.1161/01.CIR.99.5.614; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kondo T, 2004, ARTERIOSCL THROM VAS, V24, P1442, DOI 10.1161/01.ATV.0000135655.52088.c5; Kong DL, 2004, CIRCULATION, V110, P2039, DOI 10.1161/01.CIR.0000143161.01901.BD; Kunz GA, 2006, AM HEART J, V152, P190, DOI 10.1016/j.ahj.2006.02.001; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; Levy BI, 2005, HYPERTENSION, V45, P491, DOI 10.1161/01.HYP.0000159196.10515.b5; Powell TM, 2005, ARTERIOSCL THROM VAS, V25, P296, DOI 10.1161/01.ATV.0000151690.43777.e4; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Scheubel RJ, 2003, J AM COLL CARDIOL, V42, P2073, DOI 10.1016/j.jacc.2003.07.025; Seeger FH, 2005, CIRCULATION, V111, P1184, DOI 10.1161/01.CIR.0000157156.85397.A1; Spyridopoulos I, 2004, CIRCULATION, V110, P3136, DOI 10.1161/01.CIR.0000142866.50300.EB; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Verma S, 2004, CIRCULATION, V109, P2058, DOI 10.1161/01.CIR.0000127577.63323.24; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Xu QB, 2000, CIRCULATION, V102, P14, DOI 10.1161/01.CIR.102.1.14; XU QB, 1993, LANCET, V341, P255, DOI 10.1016/0140-6736(93)92613-X; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433; Young PP, 2002, P NATL ACAD SCI USA, V99, P11951, DOI 10.1073/pnas.182215799	43	130	136	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e975	10.1371/journal.pone.0000975	http://dx.doi.org/10.1371/journal.pone.0000975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925881	Green Published, Green Submitted, gold			2022-12-27	WOS:000207456000001
J	Griez, EJ; Colasanti, A; van Diest, R; Salamon, E; Schruers, K				Griez, Eric J.; Colasanti, Alessandro; van Diest, Rob; Salamon, Ewa; Schruers, Koen			Carbon Dioxide Inhalation Induces Dose-Dependent and Age-Related Negative Affectivity	PLOS ONE			English	Article							35-PERCENT CO2 CHALLENGE; PANIC DISORDER; SEROTONERGIC NEURONS; SEX-DIFFERENCES; SENSITIVITY; HYPERSENSITIVITY; PREVALENCE; REACTIVITY; RELATIVES; RESPONSES	Background. Carbon dioxide inhalation is known to induce an emotion similar to spontaneous panic in Panic Disorder patients. The affective response to carbon dioxide in healthy subjects was not clearly characterized yet. Methodology/Principal Findings. Sixty-four healthy subjects underwent a double inhalation of four mixtures containing respectively 0, 9, 17.5 and 35% CO2 in compressed air, following a double blind, cross-over, randomized design. Affective responses were assessed according to DSM IV criteria for panic, using an Electronic Visual Analogue Scale and the Panic Symptom List. It was demonstrated that carbon dioxide challenges induced a dose dependent negative affect (p<0.0001). This affect was semantically identical to the DSM IV definition of panic. Older individuals were subjectively less sensitive to Carbon Dioxide (p<0.05). Conclusions/Significance. CO2 induced affectivity may lay on a continuum with pathological panic attacks. Consistent with earlier suggestions that panic is a false biological alarm, the affective response to CO2 may be part of a protective system triggered by suffocation and acute metabolic distress.	[Griez, Eric J.; Colasanti, Alessandro; van Diest, Rob; Salamon, Ewa; Schruers, Koen] Univ Maastricht, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Griez, Eric J.] SUNY Syracuse, Upstate Med Univ, Dept Psychiat & Behav Neurosci, Syracuse, NY USA	Maastricht University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Griez, EJ (corresponding author), Univ Maastricht, Dept Psychiat & Neuropsychol, Maastricht, Netherlands.	Eric.Griez@pn.unimaas.nl	Schruers, Koen/AAV-2922-2021	Schruers, Koen/0000-0003-0134-406X; Colasanti, Alessandro/0000-0001-6017-801X				[Anonymous], 2000, DSM 4 TR DIAGN STAT; Bailey JE, 2005, DEPRESS ANXIETY, V21, P18, DOI 10.1002/da.20048; Banzett RB, 1996, RESP PHYSIOL, V103, P19, DOI 10.1016/0034-5687(95)00050-X; Bertani A, 1997, J CLIN PSYCHOPHARM, V17, P97, DOI 10.1097/00004714-199704000-00006; Bringager CB, 2004, PSYCHOSOMATICS, V45, P69, DOI 10.1176/appi.psy.45.1.69; Caldirola D, 1997, PSYCHIAT RES, V71, P41, DOI 10.1016/S0165-1781(97)00038-3; Coryell W, 1997, BIOL PSYCHIAT, V41, P259, DOI 10.1016/S0006-3223(97)87457-4; Coryell W, 2006, J AFFECT DISORDERS, V92, P63, DOI 10.1016/j.jad.2005.12.045; COX BJ, 1994, COMPR PSYCHIAT, V35, P349, DOI 10.1016/0010-440X(94)90274-7; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Damasio A.R., 2000, FEELING WHAT HAPPENS; Fleet RP, 2000, PSYCHOSOMATICS, V41, P311, DOI 10.1176/appi.psy.41.4.311; Flint AJ, 1998, AM J PSYCHIAT, V155, P283; Gater R, 1998, ARCH GEN PSYCHIAT, V55, P405, DOI 10.1001/archpsyc.55.5.405; GRIEZ E, 1990, PSYCHIAT RES, V31, P193, DOI 10.1016/0165-1781(90)90121-K; GRIEZ E, 1990, AM J PSYCHIAT, V147, P796; Griez E, 1998, J PSYCHOSOM RES, V45, P493, DOI 10.1016/S0022-3999(98)00027-0; Kelly MM, 2006, BEHAV RES THER, V44, P1421, DOI 10.1016/j.brat.2005.10.012; KLEIN DF, 1993, ARCH GEN PSYCHIAT, V50, P306; KRYSTAL JH, 1992, ACTA PSYCHIAT SCAND, V85, P77, DOI 10.1111/j.1600-0447.1992.tb01447.x; LAWLOR BA, 1989, PSYCHIAT RES, V29, P1, DOI 10.1016/0165-1781(89)90181-9; Liotti M, 2001, P NATL ACAD SCI USA, V98, P2035, DOI 10.1073/pnas.98.4.2035; Meuret AE, 2006, J PSYCHIAT RES, V40, P520, DOI 10.1016/j.jpsychires.2005.09.006; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Papp LA, 1997, AM J PSYCHIAT, V154, P1557; Perna G, 1999, J CLIN PSYCHIAT, V60, P379, DOI 10.4088/JCP.v60n0606; PERNA G, 1995, J AFFECT DISORDERS, V33, P189, DOI 10.1016/0165-0327(94)00088-Q; PERNA G, 1995, AM J PSYCHIAT, V152, P85; Perna G, 2004, PSYCHIAT RES, V125, P277, DOI 10.1016/j.psychres.2003.12.017; PERNA G, 1995, AM J PSYCHIAT, V152, P623; Poma SZ, 2005, J PSYCHOPHARMACOL, V19, P494, DOI 10.1177/0269881105056533; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Schruers K, 2000, PSYCHIAT RES, V93, P179, DOI 10.1016/S0165-1781(00)00117-7; Severson CA, 2003, NAT NEUROSCI, V6, P1139, DOI 10.1038/nn1130; Sheikh JI, 2004, AM J GERIAT PSYCHIAT, V12, P102, DOI 10.1176/appi.ajgp.12.1.102; van Beek N, 2000, BIOL PSYCHIAT, V47, P830, DOI 10.1016/S0006-3223(99)00265-6; VERBURG C, 1994, ACTA PSYCHIAT SCAND, V90, P420, DOI 10.1111/j.1600-0447.1994.tb01617.x; Verburg K, 1998, PSYCHIAT RES, V78, P207, DOI 10.1016/S0165-1781(98)00009-2; VERBURG K, 1995, AM J PSYCHIAT, V152, P1081; VERBURG K, 2001, ANXIETY DISORDERS IN, P341; Yamamoto M, 2002, LIFE SCI, V71, P751, DOI 10.1016/S0024-3205(02)01745-9	41	59	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e987	10.1371/journal.pone.0000987	http://dx.doi.org/10.1371/journal.pone.0000987			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912364	gold, Green Published			2022-12-27	WOS:000207455900023
J	Jullien, N; Goddard, I; Selmi-Ruby, S; Fina, JL; Cremer, H; Herman, JP				Jullien, Nicolas; Goddard, Isabelle; Selmi-Ruby, Samia; Fina, Jean-Luc; Cremer, Harold; Herman, Jean-Paul			Conditional Transgenesis Using Dimerizable Cre (DiCre)	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; NEONATAL TREATMENT; DNA RECOMBINATION; MOUSE LINE; MICE; PROTEIN; TAMOXIFEN; BRAIN	Cre recombinase is extensively used to engineer the genome of experimental animals. However, its usefulness is still limited by the lack of an efficient temporal control over its activity. We have recently developed a conceptually new approach to regulate Cre recombinase, that we have called Dimerizable Cre or DiCre. It is based on splitting Cre into two inactive moieties and fusing them to FKBP12 (FK506-binding protein) and FRB (binding domain of the FKBP12-rapamycin associated protein), respectively. These latter can be efficiently hetero-dimerized by rapamycin, leading to the reinstatement of Cre activity. We have been able to show, using in vitro approaches, that this ligand-induced dimerization is an efficient way to regulate Cre activity, and presents a low background activity together with a high efficiency of recombination following dimerization. To test the in vivo performance of this system, we have, in the present work, knocked-in DiCre into the Rosa26 locus of mice. To evaluate the performance of the DiCre system, mice have been mated with indicator mice (Z/EG or R26R) and Cre-induced recombination was examined following activation of DiCre by rapamycin during embryonic development or after birth of progenies. No recombination could be observed in the absence of treatment of the animals, indicating a lack of background activity of DiCre in the absence of rapamycin. Postnatal rapamycin treatment (one to five daily injection, 10 mg/kg i.p) induced recombination in a number of different tissues of progenies such as liver, heart, kidney, muscle, etc. On the other hand, recombination was at a very low level following in utero treatment of DiCrexR26R mice. In conclusion, DiCre has indeed the potentiality to be used to establish conditional Cre-deleter mice. An added advantage of this system is that, contrary to other modulatable Cre systems, it offers the possibility of obtaining regulated recombination in a combinatorial manner, i.e. induce recombination at any desired time-point specifically in cells characterized by the simultaneous expression of two different promoters.	[Jullien, Nicolas; Herman, Jean-Paul] Univ Aix Marseille 2, CNRS, UMR 6544, ICNE, Marseille, France; [Goddard, Isabelle; Fina, Jean-Luc] Inst Federatif Rech Jean Roche, Fac Med Nord, Ctr Transgenese, Marseille, France; [Selmi-Ruby, Samia] Univ Lyon 1, Fac Med RTH Laennec, INSERM, UMR 664, F-69365 Lyon, France; [Cremer, Harold] Univ Aix Marseille 2, CNRS, UMR 6216, IBDML, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Herman, JP (corresponding author), Univ Aix Marseille 2, CNRS, UMR 6544, ICNE, Marseille, France.	jean-paul.herman@univmed.fr	selmi-ruby, Samia/L-3509-2016; RUBY, Samia/T-1131-2019; Jullien, Nicolas/O-1947-2015	RUBY, Samia/0000-0001-9491-9285; Jullien, Nicolas/0000-0001-8273-2106; Cremer, Harold/0000-0002-8673-5176	CNRS; Universite de la Mediterranee; European community through the network of excellence NeuroNE; Association Francaise contre les Myopathies (AFM)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de la Mediterranee; European community through the network of excellence NeuroNE; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	Funding: This work was supported by institutional funding from the CNRS and Universite de la Mediterranee. HC has been supported by the European community through the network of excellence NeuroNE and the Association Francaise contre les Myopathies (AFM).	AUSABEL FM, 2007, CURRENT PROTOCOLS MO; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Casanova E, 2003, GENESIS, V37, P25, DOI 10.1002/gene.10227; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Csaba G, 2001, PHARMACOL RES, V43, P531, DOI 10.1006/phrs.2001.0818; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Easton JB, 2004, EXPERT OPIN THER TAR, V8, P551, DOI 10.1517/14728222.8.6.551; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gallant-Haidner HL, 2000, THER DRUG MONIT, V22, P31, DOI 10.1097/00007691-200002000-00006; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; HAMEYER D, 2007, PHYSL GENOMICS; Hentges KE, 2001, P NATL ACAD SCI USA, V98, P13796, DOI 10.1073/pnas.241184198; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Iuliucci JD, 2001, J CLIN PHARMACOL, V41, P870, DOI 10.1177/00912700122010771; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Kellendonk C, 1996, NUCLEIC ACIDS RES, V24, P1404, DOI 10.1093/nar/24.8.1404; Kellendonk C, 1999, J MOL BIOL, V285, P175, DOI 10.1006/jmbi.1998.2307; Kisseberth WC, 1999, DEV BIOL, V214, P128, DOI 10.1006/dbio.1999.9417; Kwan KM, 2002, GENESIS, V32, P49, DOI 10.1002/gene.10068; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Miyoshi G, 2006, CURR OPIN NEUROBIOL, V16, P577, DOI 10.1016/j.conb.2006.08.013; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 2003, MANIPULATING MOUSE E; Naik K, 2006, J MOL ENDOCRINOL, V37, P63, DOI 10.1677/jme.1.02053; Napoli KL, 1997, CLIN BIOCHEM, V30, P135, DOI 10.1016/S0009-9120(96)00157-9; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Pollock R, 2002, CURR OPIN BIOTECH, V13, P459, DOI 10.1016/S0958-1669(02)00373-7; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Sclafani AM, 2006, GENESIS, V44, P336, DOI 10.1002/dvg.20220; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; StOnge L, 1996, NUCLEIC ACIDS RES, V24, P3875, DOI 10.1093/nar/24.19.3875; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Utomo ARH, 1999, NAT BIOTECHNOL, V17, P1091, DOI 10.1038/15073; Vancutsem PM, 1997, TERATOLOGY, V56, P220, DOI 10.1002/(SICI)1096-9926(199709)56:3<220::AID-TERA5>3.3.CO;2-D; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Xu YW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm559; Yazawa S, 2003, COMP BIOCHEM PHYS A, V136, P391, DOI 10.1016/S1095-6433(03)00197-1; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	54	41	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1355	10.1371/journal.pone.0001355	http://dx.doi.org/10.1371/journal.pone.0001355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159238	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459700012
J	Arvand, M; Feil, EJ; Giladi, M; Boulouis, HJ; Viezens, J				Arvand, Mardjan; Feil, Edward J.; Giladi, Michael; Boulouis, Henri-Jean; Viezens, Juliane			Multi-Locus Sequence Typing of Bartonella henselae Isolates from Three Continents Reveals Hypervirulent and Feline-Associated Clones	PLOS ONE			English	Article							CAT-SCRATCH DISEASE; DOMESTIC CATS; NATURAL-POPULATION; RISK-FACTORS; PREVALENCE; DNA; BACTEREMIA; IDENTIFICATION; RELATEDNESS; DIVERSITY	Bartonella henselae is a zoonotic pathogen and the causative agent of cat scratch disease and a variety of other disease manifestations in humans. Previous investigations have suggested that a limited subset of B. henselae isolates may be associated with human disease. In the present study, 182 human and feline B. henselae isolates from Europe, North America and Australia were analysed by multi-locus sequence typing (MLST) to detect any associations between sequence type (ST), host species and geographical distribution of the isolates. A total of 14 sequence types were detected, but over 66% (16/24) of the isolates recovered from human disease corresponded to a single genotype, ST1, and this type was detected in all three continents. In contrast, 27.2% (43/158) of the feline isolates corresponded to ST7, but this ST was not recovered from humans and was restricted to Europe. The difference in host association of STs 1 (human) and 7 (feline) was statistically significant (P <= 0.001). eBURST analysis assigned the 14 STs to three clonal lineages, which contained two or more STs, and a singleton comprising ST7. These groups were broadly consistent with a neighbour-joining tree, although splits decomposition analysis was indicative of a history of recombination. These data indicate that B. henselae lineages differ in their virulence properties for humans and contribute to a better understanding of the population structure of B. henselae.	[Arvand, Mardjan; Viezens, Juliane] Univ Rostock, Inst Med Mikrobiol Virol & Hyg, Rostock, Germany; [Feil, Edward J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Giladi, Michael] Tel Aviv Med Ctr & Sch Med, Bernard Pridan Lab Mol Biol Infect Dis, Tel Aviv, Israel; [Boulouis, Henri-Jean] Ecole Natl Vet Alfort, Unite Mixte Rech, Maisons Alfort, France	University of Rostock; University of Bath; Tel Aviv University; Sackler Faculty of Medicine; Ecole Nationale Veterinaire d'Alfort (ENVA)	Arvand, M (corresponding author), Univ Rostock, Inst Med Mikrobiol Virol & Hyg, Rostock, Germany.	mardjan.arvand@med.uni-rostock.de	Giladi, Michael/GVU-6295-2022; Giladi, Michael/AAQ-6176-2020		Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was supported by a grant from the Deutsche Forschungsgemeinschaft to MA.	Arvand M, 2006, J CLIN MICROBIOL, V44, P2288, DOI 10.1128/JCM.00239-06; Arvand M, 1998, CLIN INFECT DIS, V26, P1296, DOI 10.1086/516348; Arvand M, 2001, J CLIN MICROBIOL, V39, P743, DOI 10.1128/JCM.39.2.743-746.2001; Arvand M, 2007, INT J MED MICROBIOL, V297, P255, DOI 10.1016/j.ijmm.2007.02.001; Avidor B, 2001, AM J CLIN PATHOL, V115, P900, DOI 10.1309/Y468-82G5-ACHW-YRMV; Bergmans AMC, 1996, J CLIN MICROBIOL, V34, P254, DOI 10.1128/JCM.34.2.254-260.1996; Bergmans AMC, 1997, J CLIN MICROBIOL, V35, P2256, DOI 10.1128/JCM.35.9.2256-2261.1997; Birtles RJ, 2002, VET REC, V151, P225, DOI 10.1136/vr.151.8.225; Branley J, 1996, PATHOLOGY, V28, P262, DOI 10.1080/00313029600169124; CHOMEL BB, 1995, J CLIN MICROBIOL, V33, P2445, DOI 10.1128/JCM.33.9.2445-2450.1995; Dillon B, 2002, J CLIN MICROBIOL, V40, P4691, DOI 10.1128/JCM.40.12.4691-4699.2002; DOLAN MJ, 1993, ANN INTERN MED, V118, P331, DOI 10.7326/0003-4819-118-5-199303010-00002; Drancourt M, 1996, LANCET, V347, P441, DOI 10.1016/S0140-6736(96)90012-4; Ehrenborg C, 2000, J CLIN MICROBIOL, V38, P682, DOI 10.1128/JCM.38.2.682-687.2000; Fabbi M, 2004, J CLIN MICROBIOL, V42, P264, DOI 10.1128/JCM.42.1.264-268.2004; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2004, CURR OPIN MICROBIOL, V7, P308, DOI 10.1016/j.mib.2004.04.002; Guptill L, 2004, J CLIN MICROBIOL, V42, P652, DOI 10.1128/JCM.42.2.652-659.2004; Guptill L, 1997, J INFECT DIS, V176, P206, DOI 10.1086/514026; Gurfield AN, 2001, VET MICROBIOL, V80, P185, DOI 10.1016/S0378-1135(01)00304-2; Heller R, 1997, J CLIN MICROBIOL, V35, P1327, DOI 10.1128/JCM.35.6.1327-1331.1997; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iredell J, 2003, J CLIN MICROBIOL, V41, P5071, DOI 10.1128/JCM.41.11.5071-5079.2003; KOEHLER JE, 1992, NEW ENGL J MED, V327, P1625, DOI 10.1056/NEJM199212033272303; La Scola B, 2002, J CLIN MICROBIOL, V40, P2002, DOI 10.1128/JCM.40.6.2002-2008.2002; Lindroos H, 2006, J BACTERIOL, V188, P7426, DOI 10.1128/JB.00472-06; Margileth A M, 1993, Adv Pediatr Infect Dis, V8, P1; Melter O, 2003, VET MICROBIOL, V93, P261, DOI 10.1016/S0378-1135(03)00032-4; Renesto P, 2001, J CLIN MICROBIOL, V39, P430, DOI 10.1128/JCM.39.2.430-437.2001; RODRIGUEZBARRADAS MC, 1995, J CLIN MICROBIOL, V33, P1089, DOI 10.1128/JCM.33.5.1089-1093.1995; Sander A, 1997, J CLIN MICROBIOL, V35, P584, DOI 10.1128/JCM.35.3.584-587.1997; Sander A, 1999, J CLIN MICROBIOL, V37, P993, DOI 10.1128/JCM.37.4.993-997.1999; Sander A, 1998, J CLIN MICROBIOL, V36, P2973, DOI 10.1128/JCM.36.10.2973-2981.1998; SLATER LN, 1990, NEW ENGL J MED, V323, P1587, DOI 10.1056/NEJM199012063232303; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30; Zeaiter Z, 2002, J CLIN MICROBIOL, V40, P1023, DOI 10.1128/JCM.40.3.1023-1030.2002	37	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1346	10.1371/journal.pone.0001346	http://dx.doi.org/10.1371/journal.pone.0001346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18094753	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459600028
J	Gumbiner-Russo, LM; Rosenberg, SM				Gumbiner-Russo, Laura M.; Rosenberg, Susan M.			Physical Analyses of E. coli Heteroduplex Recombination Products In Vivo: On the Prevalence of 5 ' and 3 ' Patches	PLOS ONE			English	Article							DOUBLE-STRAND-BREAK; HOT-SPOT CHI; STRUCTURE-SPECIFIC ENDONUCLEASE; LAMBDA RAP PROTEIN; ESCHERICHIA-COLI; PHAGE-LAMBDA; HOMOLOGOUS RECOMBINATION; BACTERIOPHAGE-LAMBDA; RECBC ENZYME; SINGLE-STRAND	Background. Homologous recombination in Escherichia coli creates patches (non-crossovers) or splices ( half crossovers), each of which may have associated heteroduplex DNA. Heteroduplex patches have recombinant DNA in one strand of the duplex, with parental flanking markers. Which DNA strand is exchanged in heteroduplex patches reflects the molecular mechanism of recombination. Several models for the mechanism of E. coli RecBCD-mediated recombinational double-strand-end (DSE) repair specify that only the 3'-ending strand invades the homologous DNA, forming heteroduplex in that strand. There is, however, in vivo evidence that patches are found in both strands. Methodology/Principle Findings. This paper re-examines heteroduplex-patch-strand polarity using phage lambda and the lambda dv plasmid as DNA substrates recombined via the E. coli RecBCD system in vivo. These DNAs are mutant for lambda recombination functions, including orf and rap, which were functional in previous studies. Heteroduplexes are isolated, separated on polyacrylamide gels, and quantified using Southern blots for heteroduplex analysis. This method reveals that heteroduplexes are still found in either 5' or 3' DNA strands in approximately equal amounts, even in the absence of orf and rap. Also observed is an independence of the RuvC Holliday-junction endonuclease on patch formation, and a slight but statistically significant alteration of patch polarity by recD mutation. Conclusions/Significance. These results indicate that orf and rap did not contribute to the presence of patches, and imply that patches occurring in both DNA strands reflects the molecular mechanism of recombination in E. coli. Most importantly, the lack of a requirement for RuvC implies that endonucleolytic resolution of Holliday junctions is not necessary for heteroduplex-patch formation, contrary to predictions of all of the major previous models. This implies that patches are not an alternative resolution of the same intermediate that produces splices, and do not bear on models for splice formation. We consider two mechanisms that use DNA replication instead of endonucleolytic resolution for formation of heteroduplex patches in either DNA strand: synthesis-dependent-strand annealing and a strand-assimilation mechanism.	[Gumbiner-Russo, Laura M.; Rosenberg, Susan M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Rosenberg, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	smr@bcm.tmc.edu		Rosenberg, Susan M./0000-0003-1444-473X	National Cancer Institute [R01-CA85777]; NATIONAL CANCER INSTITUTE [R01CA085777] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute grant R01-CA85777.	Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Anderson DG, 1997, GENES CELLS, V2, P117, DOI 10.1046/j.1365-2443.1997.1130311.x; ARBER W, 1983, COLD SPRING HARBOR M, P433; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BACHMANN BJ, 1996, ESCHERICHIA COLI SAL, P2460; BIEK DP, 1986, J BACTERIOL, V167, P594, DOI 10.1128/jb.167.2.594-603.1986; Bolt EL, 2002, MOL CELL, V10, P187, DOI 10.1016/S1097-2765(02)00560-9; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; CAMPBELL A, 1971, BACTERIOPHAGE LAMBDA, P13; CARRAWAY M, 1993, J BACTERIOL, V175, P3972, DOI 10.1128/JB.175.13.3972-3980.1993; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COHEN A, 1986, J BACTERIOL, V167, P327, DOI 10.1128/jb.167.1.327-335.1986; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; DABERT P, 1992, P NATL ACAD SCI USA, V89, P12073, DOI 10.1073/pnas.89.24.12073; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P1480, DOI 10.1093/nar/gkh317; DOWER NA, 1981, P NATL ACAD SCI-BIOL, V78, P7033, DOI 10.1073/pnas.78.11.7033; DUTREIX M, 1991, J MOL BIOL, V219, P645, DOI 10.1016/0022-2836(91)90661-O; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; FEISS M, 1983, LAMBDA, V2, P305; Friedman-Ohana R, 1998, P NATL ACAD SCI USA, V95, P6909, DOI 10.1073/pnas.95.12.6909; GANESAN S, 1993, J MOL BIOL, V229, P67, DOI 10.1006/jmbi.1993.1008; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Goldberg A R, 1969, Virology, V38, P200, DOI 10.1016/0042-6822(69)90148-2; Gumbiner-Russo LM, 2001, GENE, V273, P97, DOI 10.1016/S0378-1119(01)00565-0; HAGEMANN AT, 1991, GENETICS, V129, P611; Harris RS, 1996, GENETICS, V142, P681; HARRIS RS, 1994, SCIENCE, V264, P258, DOI 10.1126/science.8146657; HOLBECK SL, 1992, GENETICS, V132, P879; HOLLIFIELD WC, 1987, MOL GEN GENET, V210, P248, DOI 10.1007/BF00325690; JORDAN H, 1997, FOCUS, V19, P60; KONFORTI BB, 1987, P NATL ACAD SCI USA, V84, P690, DOI 10.1073/pnas.84.3.690; KONFORTI BB, 1990, J BIOL CHEM, V265, P6916; KOPPEN A, 1995, P NATL ACAD SCI USA, V92, P6249, DOI 10.1073/pnas.92.14.6249; KORANGY F, 1994, BIOCHEMISTRY-US, V33, P9552, DOI 10.1021/bi00198a022; KORANGY F, 1993, BIOCHEMISTRY-US, V32, P4873, DOI 10.1021/bi00069a024; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Leung WY, 1997, P NATL ACAD SCI USA, V94, P6851, DOI 10.1073/pnas.94.13.6851; LICHTEN M, 1990, P NATL ACAD SCI USA, V87, P7653, DOI 10.1073/pnas.87.19.7653; LLOYD RG, 1991, J BACTERIOL, V173, P5414, DOI 10.1128/jb.173.17.5414-5418.1991; LLOYD RG, 1993, NUCLEIC ACIDS RES, V21, P1719, DOI 10.1093/nar/21.8.1719; LLOYD RG, 1996, ESCHERICHIA COLI SAL, V2, P2236; Lopez CR, 2005, MOL MICROBIOL, V58, P80, DOI 10.1111/j.1365-2958.2005.04812.x; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; MAGNER DB, 2006, THESIS; Martinez-Morales F, 1999, J BACTERIOL, V181, P7143, DOI 10.1128/JB.181.22.7143-7148.1999; Mason JC, 2004, J BIOL CHEM, V279, P41611, DOI 10.1074/jbc.M407981200; Maxwell KL, 2005, P NATL ACAD SCI USA, V102, P11260, DOI 10.1073/pnas.0503399102; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; McIlwraith MJ, 2001, J MOL BIOL, V305, P23, DOI 10.1006/jmbi.2000.4268; Miesel L, 1996, J BACTERIOL, V178, P3146, DOI 10.1128/jb.178.11.3146-3155.1996; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Motamedi MR, 1999, GENE DEV, V13, P2889, DOI 10.1101/gad.13.21.2889; MURPHY KC, 1991, J BACTERIOL, V173, P5808, DOI 10.1128/jb.173.18.5808-5821.1991; MURRAY NE, 1974, NATURE, V251, P476, DOI 10.1038/251476a0; MYERS RS, 1995, P NATL ACAD SCI USA, V92, P6244, DOI 10.1073/pnas.92.14.6244; MYERS RS, 1994, ANNU REV GENET, V28, P49, DOI 10.1146/annurev.ge.28.120194.000405; NAG DK, 1990, GENETICS, V125, P753; NAGAMINE CM, 1989, AM J HUM GENET, V45, P337; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; PALAS KM, 1990, J BIOL CHEM, V265, P3447; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PARKER BO, 1992, P NATL ACAD SCI USA, V89, P1730, DOI 10.1073/pnas.89.5.1730; PEARSON RK, 1988, GENETICS, V118, P13; Poteete AR, 2002, J BACTERIOL, V184, P4626, DOI 10.1128/JB.184.16.4626-4629.2002; Razavy H, 1996, GENETICS, V142, P333; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; RINKEN R, 1992, J BACTERIOL, V174, P5424, DOI 10.1128/JB.174.16.5424-5429.1992; ROSENBERG SM, 1991, BIOCHIMIE, V73, P385, DOI 10.1016/0300-9084(91)90105-A; ROSENBERG SM, 1985, GENE, V38, P165, DOI 10.1016/0378-1119(85)90215-X; ROSENBERG SM, 1987, CELL, V48, P855, DOI 10.1016/0092-8674(87)90082-1; ROSENBERG SM, 1988, GENETICS, V120, P7; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; Sambrook J., 2001, MOL CLONING LAB MANU; SAWITZKE JA, 1992, GENETICS, V130, P7; Sawitzke JA, 1997, GENETICS, V147, P357; SAWITZKE JA, 1994, J BACTERIOL, V176, P6730, DOI 10.1128/JB.176.21.6730-6737.1994; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Sharples GJ, 2004, J MOL BIOL, V340, P739, DOI 10.1016/j.jmb.2004.05.030; Sharples GJ, 1998, P NATL ACAD SCI USA, V95, P13507, DOI 10.1073/pnas.95.23.13507; Shiao T, 2004, HUM MOL GENET, V13, P1873, DOI 10.1093/hmg/ddh204; SIDDIQI I, 1991, GENETICS, V128, P7; SIGNER ER, 1968, J MOL BIOL, V34, P261, DOI 10.1016/0022-2836(68)90251-9; SILBERSTEIN Z, 1993, GENETICS, V133, P439; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Smith G. R., 1981, STADLER GENET S, V13, P25; SMITH GR, 1985, BIOESSAYS, V2, P244, DOI 10.1002/bies.950020603; SMITH GR, 1984, COLD SPRING HARB SYM, V49, P485, DOI 10.1101/SQB.1984.049.01.055; STAHL FW, 1975, J MOL BIOL, V94, P203, DOI 10.1016/0022-2836(75)90078-9; STAHL FW, 1995, GENETICS, V139, P1107; STITT BL, 1989, J BACTERIOL, V171, P3872, DOI 10.1128/jb.171.7.3872-3880.1989; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TAYLOR AF, 1985, J MOL BIOL, V185, P431, DOI 10.1016/0022-2836(85)90414-0; TAYLOR AF, 1988, GENETIC RECOMBINATIO, P231; THALER DS, 1989, GENOME, V31, P53, DOI 10.1139/g89-013; THALER DS, 1988, ANNU REV GENET, V22, P169, DOI 10.1146/annurev.ge.22.120188.001125; THALER DS, 1987, GENETICS, V116, P501; Wang JD, 2000, J BIOL CHEM, V275, P507, DOI 10.1074/jbc.275.1.507; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P; WHITE RL, 1974, P NATL ACAD SCI USA, V71, P1544, DOI 10.1073/pnas.71.4.1544; WOLD MS, 1982, P NATL ACAD SCI-BIOL, V79, P6176, DOI 10.1073/pnas.79.20.6176; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zissler J, 1971, BACTERIOPHAGE LAMBDA, P455	113	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1242	10.1371/journal.pone.0001242	http://dx.doi.org/10.1371/journal.pone.0001242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043749	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459300023
J	Lee, S; Horn, V; Julien, E; Liu, Y; Wysocka, J; Bowerman, B; Hengartner, MO; Herr, W				Lee, Soyoung; Horn, Virginie; Julien, Eric; Liu, Yi; Wysocka, Joanna; Bowerman, Bruce; Hengartner, Michael O.; Herr, Winship			Epigenetic Regulation of Histone H3 Serine 10 Phosphorylation Status by HCF-1 Proteins in C. elegans and Mammalian Cells	PLOS ONE			English	Article							VIRUS VP16-INDUCED COMPLEX; CAENORHABDITIS-ELEGANS; REVERSE GENETICS; FAMILY; ASSOCIATION; DROSOPHILA; VP16; DEFECTS; RB; METHYLTRANSFERASE	Background. The human herpes simplex virus (HSV) host cell factor HCF-1 is a transcriptional coregulator that associates with both histone methyl-and acetyltransferases, and a histone deacetylase and regulates cell proliferation and division. In HSV-infected cells, HCF-1 associates with the viral protein VP16 to promote formation of a multiprotein-DNA transcriptional activator complex. The ability of HCF proteins to stabilize this VP16-induced complex has been conserved in diverse animal species including Drosophila melanogaster and Caenorhabditis elegans suggesting that VP16 targets a conserved cellular function of HCF-1. Methodology/Principal Findings. To investigate the role of HCF proteins in animal development, we have characterized the effects of loss of the HCF-1 homolog in C. elegans, called Ce HCF-1. Two large hcf-1 deletion mutants (pk924 and ok559) are viable but display reduced fertility. Loss of Ce HCF-1 protein at reduced temperatures (e.g., 12uC), however, leads to a high incidence of embryonic lethality and early embryonic mitotic and cytokinetic defects reminiscent of mammalian cell-division defects upon loss of HCF-1 function. Even when viable, however, at normal temperature, mutant embryos display reduced levels of phospho-histone H3 serine 10 (H3S10P), a modification implicated in both transcriptional and mitotic regulation. Mammalian cells with defective HCF-1 also display defects inmitotic H3S10P status. Conclusions/Significance. These results suggest that HCF-1 proteins possess conserved roles in the regulation of cell division and mitotic histone phosphorylation.	[Horn, Virginie; Herr, Winship] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Lee, Soyoung; Julien, Eric; Liu, Yi; Wysocka, Joanna; Hengartner, Michael O.; Herr, Winship] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Lee, Soyoung] SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA; [Bowerman, Bruce] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Lausanne; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Oregon	Herr, W (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	Winship.Herr@unil.ch	JULIEN, ERIC/Y-5873-2019; Hengartner, Michael O/E-6235-2011; Herr, Winship/E-6491-2012; Lee, Soyoung/T-6669-2019; Lee, Soyoung/AHC-5032-2022	JULIEN, ERIC/0000-0003-2976-666X; Herr, Winship/0000-0002-3606-4546; Lee, Soyoung/0000-0002-4614-2931; Hengartner, Michael/0000-0002-7584-596X	NIGMS [GM 45498]; Swiss National Science Foundation; University of Lausanne; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S15GM045498] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Lausanne; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIGMS grant GM 45498, the Swiss National Science Foundation, and the University of Lausanne. The sponsors or funders were not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Ajuh PM, 2000, NUCLEIC ACIDS RES, V28, P678, DOI 10.1093/nar/28.3.678; Beltran S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r67; BORK P, 1994, J MOL BIOL, V236, P1277, DOI 10.1016/0022-2836(94)90056-6; BRENNER S, 1974, GENETICS, V77, P71; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; FERGUSON EL, 1989, GENETICS, V123, P109; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Guelman S, 2006, MOL CELL BIOL, V26, P871, DOI 10.1128/MCB.26.3.871-882.2006; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Izeta A, 2003, EUR J CELL BIOL, V82, P495, DOI 10.1078/0171-9335-00341; Izeta A, 2003, GENE, V305, P175, DOI 10.1016/S0378-1119(03)00380-9; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Johnson KM, 1999, J VIROL, V73, P3930, DOI 10.1128/JVI.73.5.3930-3940.1999; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; KRISTIE TM, 1989, EMBO J, V8, P4229, DOI 10.1002/j.1460-2075.1989.tb08608.x; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lee S, 2001, J VIROL, V75, P12402, DOI 10.1128/JVI.75.24.12402-12411.2001; Liu Y, 1999, MOL CELL BIOL, V19, P909; Lu R, 1998, J VIROL, V72, P6291, DOI 10.1128/JVI.72.8.6291-6297.1998; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Mahajan SS, 2003, J CELL PHYSIOL, V194, P117, DOI 10.1002/jcp.10193; Miller DM, 1995, METHOD CELL BIOL, V48, P365; OEGEMA K, 2006, C ELEGANS, DOI DOI 10.1895/WORMBOOK.1.72.1; Plasterk RHA, 1995, METHOD CELL BIOL, V48, P59; Reilly PT, 2002, EXP CELL RES, V277, P119, DOI 10.1006/excr.2002.5551; Reilly PT, 2002, MOL CELL BIOL, V22, P6767, DOI 10.1128/MCB.22.19.6767-6778.2002; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; SPECTOR DL, 1986, EXP CELL RES, V163, P87, DOI 10.1016/0014-4827(86)90560-4; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; WILSON AC, 1993, COLD SPRING HARB SYM, V58, P167, DOI 10.1101/SQB.1993.058.01.021; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2001, BIOCHEMISTRY-US, V40, P5786, DOI 10.1021/bi010086o; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	44	19	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1213	10.1371/journal.pone.0001213	http://dx.doi.org/10.1371/journal.pone.0001213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043729	Green Published, Green Accepted, gold			2022-12-27	WOS:000207459300003
J	Lang, KS; Hegazy, AN; Lang, PA; Eschli, B; Lohning, M; Hengartner, H; Zinkernagel, RM; Recher, M				Lang, Karl S.; Hegazy, Ahmed N.; Lang, Philipp A.; Eschli, Bruno; Loehning, Max; Hengartner, Hans; Zinkernagel, Rolf M.; Recher, Mike			"Negative Vaccination'' by Specific CD4(+) T Cell Tolerisation Enhances Virus-Specific Protective Antibody Responses	PLOS ONE			English	Article							NEUTRALIZING ANTIBODY; MEMORY; INFECTION; PERSISTENCE; EXHAUSTION; EFFECTOR; IMMUNITY; MICE; HYPERGAMMAGLOBULINEMIA; LYMPHOCYTES	Background. Cooperation of CD4(+) T helper cells with specific B cells is crucial for protective vaccination against pathogens by inducing long-lived neutralizing antibody responses. During infection with persistence-prone viruses, prolonged virus replication correlates with low neutralizing antibody responses. We recently described that a viral mutant of lymphocytic choriomeningitis virus (LCMV), which lacks a T helper epitope, counterintuitively induced an enhanced protective antibody response. Likewise, partial depletion of the CD4(+) T cell compartment by using anti-CD4 antibodies enhanced protective antibodies. Principal Findings. Here we have developed a protocol to selectively reduce the CD4(+) T cell response against viral CD4(+) T cell epitopes. We demonstrate that in vivo treatment with LCMV-derived MHC-II peptides induced non-responsiveness of specific CD4(+) T cells without affecting CD4(+) T cell reactivity towards other antigens. This was associated with accelerated virus-specific neutralizing IgG-antibody responses. In contrast to a complete absence of CD4(+) T cell help, tolerisation did not impair CD8(+) T cell responses. Conclusions. This result reveals a novel "negative vaccination'' strategy where specific CD4(+) T cell unresponsiveness may be used to enhance the delayed protective antibody responses in chronic virus infections.	[Lang, Karl S.; Hegazy, Ahmed N.; Lang, Philipp A.; Eschli, Bruno; Loehning, Max; Hengartner, Hans; Zinkernagel, Rolf M.; Recher, Mike] Univ Zurich Hosp, Inst Expt Immunol, Dept Pathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Lang, KS (corresponding author), Univ Zurich Hosp, Inst Expt Immunol, Dept Pathol, CH-8091 Zurich, Switzerland.	karlslang@gmail.com	Löhning, Max/AAL-2967-2021; Lang, Karl S/R-2505-2016	Löhning, Max/0000-0001-6382-7281; Hegazy, Ahmed N./0000-0002-2946-8251; Recher, Mike/0000-0002-9121-6936; Lang, Karl/0000-0001-9783-7605	Swiss National Science Foundation [3100A0-100779, 3100A0-100068]; Deutsche Forschungsgemeinschaft (DFG) [LA1419/1-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Swiss National Science Foundation grants to Hans Hengartner N degrees 3100A0-100779 and Rolf Zinkernagel N degrees 3100A0-100068, and the Deutsche Forschungsgemeinschaft (DFG) LA1419/1-1 to Karl Lang.	Ada G, 2001, NEW ENGL J MED, V345, P1042, DOI 10.1056/NEJMra011223; AICHELE P, 1995, J EXP MED, V182, P261, DOI 10.1084/jem.182.1.261; Brundler MA, 1996, EUR J IMMUNOL, V26, P2257, DOI 10.1002/eji.1830260943; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Ciurea A, 2000, P NATL ACAD SCI USA, V97, P2749, DOI 10.1073/pnas.040558797; COHEN J, 1993, SCIENCE, V262, P980, DOI 10.1126/science.8235635; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; ESCHLI B, 2007, J VIROL; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hunziker L, 2003, NAT IMMUNOL, V4, P343, DOI 10.1038/ni911; Inchauspe Genevieve, 2003, Clin Liver Dis, V7, P243, DOI 10.1016/S1089-3261(02)00067-3; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kaplan DE, 2007, GASTROENTEROLOGY, V132, P654, DOI 10.1053/j.gastro.2006.11.044; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Lang KS, 2005, EUR J IMMUNOL, V35, P738, DOI 10.1002/eji.200425828; LEHMANNGRUBE F, 1993, J VIROL, V67, P332, DOI 10.1128/JVI.67.1.332-339.1993; Marusic S, 1997, J EXP MED, V186, P507, DOI 10.1084/jem.186.4.507; Matter M, 2006, J EXP MED, V203, P2145, DOI 10.1084/jem.20060651; Meyer MF, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-58; MOSKOPHIDIS D, 1992, J VIROL, V66, P3661, DOI 10.1128/JVI.66.6.3661-3668.1992; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Mullen GED, 2006, VACCINE, V24, P2497, DOI 10.1016/j.vaccine.2005.12.034; Pinschewer DD, 2004, J CLIN INVEST, V114, P988, DOI 10.1172/JCI200422374; Recher M, 2004, NAT IMMUNOL, V5, P934, DOI 10.1038/ni1102; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Staprans SI, 2004, P NATL ACAD SCI USA, V101, P13026, DOI 10.1073/pnas.0404739101; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Thomson M, 2003, J VIROL, V77, P862, DOI 10.1128/JVI.77.2.862-870.2003; Unsoeld H, 2002, J IMMUNOL, V169, P638, DOI 10.4049/jimmunol.169.2.638; von Reyn CF, 2005, LANCET INFECT DIS, V5, P132; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394	36	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1162	10.1371/journal.pone.0001162	http://dx.doi.org/10.1371/journal.pone.0001162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000535	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459100005
J	Al-Sakere, B; Andre, F; Bernat, C; Connault, E; Opolon, P; Davalos, RV; Rubinsky, B; Mir, LM				Al-Sakere, Bassim; Andre, Franck; Bernat, Claire; Connault, Elisabeth; Opolon, Paule; Davalos, Rafael V.; Rubinsky, Boris; Mir, Lluis M.			Tumor Ablation with Irreversible Electroporation	PLOS ONE			English	Article								We report the first successful use of irreversible electroporation for the minimally invasive treatment of aggressive cutaneous tumors implanted in mice. Irreversible electroporation is a newly developed non-thermal tissue ablation technique in which certain short duration electrical fields are used to permanently permeabilize the cell membrane, presumably through the formation of nanoscale defects in the cell membrane. Mathematical models of the electrical and thermal fields that develop during the application of the pulses were used to design an efficient treatment protocol with minimal heating of the tissue. Tumor regression was confirmed by histological studies which also revealed that it occurred as a direct result of irreversible cell membrane permeabilization. Parametric studies show that the successful outcome of the procedure is related to the applied electric field strength, the total pulse duration as well as the temporal mode of delivery of the pulses. Our best results were obtained using plate electrodes to deliver across the tumor 80 pulses of 100 mu s at 0.3 Hz with an electrical field magnitude of 2500 V/cm. These conditions induced complete regression in 12 out of 13 treated tumors, (92%), in the absence of tissue heating. Irreversible electroporation is thus a new effective modality for non-thermal tumor ablation.	[Al-Sakere, Bassim; Andre, Franck; Bernat, Claire; Connault, Elisabeth; Opolon, Paule; Mir, Lluis M.] Inst Gustave Roussy, CNRS, UMR 8121, Villejuif, France; [Al-Sakere, Bassim; Andre, Franck; Bernat, Claire; Connault, Elisabeth; Opolon, Paule; Mir, Lluis M.] Univ Paris Sud, UMR 8121, Villejuif, France; [Davalos, Rafael V.] Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, Blacksburg, VA USA; [Rubinsky, Boris] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Rubinsky, Boris] Univ Calif Berkeley, Grad Program Biophys, Berkeley, CA 94720 USA; [Rubinsky, Boris] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Rubinsky, Boris] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, Ctr Bioengn Serv Humanity & Soc, Jerusalem, Israel	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Virginia Polytechnic Institute & State University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Hebrew University of Jerusalem	Mir, LM (corresponding author), Inst Gustave Roussy, CNRS, UMR 8121, Villejuif, France.	luismir@igr.fr	Davalos, Rafael/F-9012-2011; Rubinsky, Boris/B-4439-2010; MIR, Lluis M/AAJ-9110-2020; Sano, Michael/E-1715-2011	Rubinsky, Boris/0000-0002-2794-1543; , Lluis/0000-0002-8671-9467	CNRS; IGR; U. S. National Institutes of Health (NIH) [NIH R01 RR018961]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR018961] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); IGR; U. S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants of CNRS and IGR. BR was supported in part by the U. S. National Institutes of Health (NIH) under Grant NIH R01 RR018961. The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sakere B, 2007, TECHNOL CANCER RES T, V6, P301, DOI 10.1177/153303460700600406; Andre F, 2004, GENE THER, V11, pS33, DOI 10.1038/sj.gt.3302367; BECKER SM, 2006, ASME, V128, P76; Beebe SJ, 2003, DNA CELL BIOL, V22, P785, DOI 10.1089/104454903322624993; BELEHRAD.J, 1972, INT J CANCER, V27, P461, DOI 10.1002/ijc.2910090302; BELEHRADEK M, 1993, CANCER-AM CANCER SOC, V72, P3694, DOI 10.1002/1097-0142(19931215)72:12<3694::AID-CNCR2820721222>3.0.CO;2-2; DAMIANOU CA, 1995, IEEE T ULTRASON FERR, V42, P182, DOI 10.1109/58.365232; Davalos R, 2000, MICROSCALE THERM ENG, V4, P147; Davalos RV, 2003, BIOELECTROCHEMISTRY, V61, P99, DOI 10.1016/j.bioelechem.2003.07.001; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; de Baere T, 2006, CARDIOVASC INTER RAD, V29, P650, DOI 10.1007/s00270-005-0187-9; Deng JD, 2003, BIOPHYS J, V84, P2709, DOI 10.1016/S0006-3495(03)75076-0; Deng ZS, 2001, PHYSICA A, V300, P521, DOI 10.1016/S0378-4371(01)00373-9; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Gothelf A, 2003, CANCER TREAT REV, V29, P371, DOI 10.1016/S0305-7372(03)00073-2; Gowrishankar TR, 2006, BIOCHEM BIOPH RES CO, V349, P643, DOI 10.1016/j.bbrc.2006.08.097; HALM EW, 1978, CANCER, V42, P2591; Huang Y, 1999, BIOMED MICRODEVICES, V2, P145, DOI 10.1023/A:1009901821588; INCROPERA FP, 2002, INTRO HEAT TRANSFER, pCH5; Martin RCG, 2006, AM SURGEON, V72, P391; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Miklavcic D, 2000, BBA-GEN SUBJECTS, V1523, P73, DOI 10.1016/S0304-4165(00)00101-X; Miklavcic D, 1998, BIOPHYS J, V74, P2152, DOI 10.1016/S0006-3495(98)77924-X; Miklavcic D, 2006, EJC SUPPL, V4, P45, DOI 10.1016/j.ejcsup.2006.08.006; Miller L, 2005, TECHNOL CANCER RES T, V4, P699, DOI 10.1177/153303460500400615; Mir LM, 2006, EJC SUPPL, V4, P14, DOI 10.1016/j.ejcsup.2006.08.003; Mir LM, 2005, ADV GENET, V54, P83, DOI 10.1016/S0065-2660(05)54005-7; MIR LM, 1991, EUR J CANCER, V27, P68, DOI 10.1016/0277-5379(91)90064-K; Mir LM, 2001, BIOELECTROCHEMISTRY, V53, P1, DOI 10.1016/S0302-4598(00)00112-4; Mir LM, 1998, BRIT J CANCER, V77, P2336, DOI 10.1038/bjc.1998.388; Mohamed F, 2004, J SURG ONCOL, V88, P14, DOI 10.1002/jso.20117; Mouraviev V, 2006, CURR OPIN UROL, V16, P152, DOI 10.1097/01.mou.0000193393.54598.9f; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; ONIK G, 1991, CANCER, V67, P901, DOI 10.1002/1097-0142(19910215)67:4<901::AID-CNCR2820670408>3.0.CO;2-Z; ONIK GM, 1993, CANCER, V72, P1291, DOI 10.1002/1097-0142(19930815)72:4<1291::AID-CNCR2820720423>3.0.CO;2-I; ORLOWSKI S, 1993, BIOCHIM BIOPHYS ACTA, V1154, P51, DOI 10.1016/0304-4157(93)90016-H; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; SAPARETO SA, 1984, INT J RADIAT ONCOL, V10, P787, DOI 10.1016/0360-3016(84)90379-1; Sersa G, 2003, CANC THER, V1, P133; Sersa G, 2006, EJC SUPPL, V4, P52, DOI 10.1016/j.ejcsup.2006.08.007; SWARUP A, 1991, BIOELECTROMAGNETICS, V12, P1, DOI 10.1002/bem.2250120102; *UKCCCR, BR J CANC, V77, P1; WHITE FM, 1988, APPENDIX C PROPERTIE, P672; WHITFIELD W, 1988, J ROYAL SOC HLTH, V1, P1	44	329	366	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1135	10.1371/journal.pone.0001135	http://dx.doi.org/10.1371/journal.pone.0001135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17989772	Green Published, gold			2022-12-27	WOS:000207459000019
J	Li, J; Zeng, XH; Mo, HY; Rolen, U; Gao, YF; Zhang, XS; Chen, QY; Zhang, L; Zeng, MS; Li, MZ; Huang, WL; Wang, XN; Zeng, YX; Masucci, MG				Li, Jiang; Zeng, Xue-hui; Mo, Hao-yuan; Rolen, Ulrika; Gao, Yan-fang; Zhang, Xiao-shi; Chen, Qiu-yan; Zhang, Li; Zeng, Mu-sheng; Li, Man-zhi; Huang, Wen-lin; Wang, Xiao-ning; Zeng, Yi-xin; Masucci, Maria G.			Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LATENT MEMBRANE-PROTEIN; ADOPTIVE TRANSFER; SOUTHERN CHINESE; CELL RESPONSES; BLOOD; INTERLEUKIN-10; INHIBITION; EXPRESSION; SUPPRESSION	Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV) associated malignancy with high prevalence in Southern Chinese. In order to assess whether defects of EBV-specific immunity may contribute to the tumor, the phenotype and function of circulating T-cells and tumor infiltrating lymphocytes (TILs) were investigated in untreated NPC patients. Circulating naive CD(3+)CD45RA(+) and CD4(+)CD25(-) cells were decreased, while activated CD4(+)CD25(+) T-cells and CD3(-)CD16(+) NK-cells were increased in patients compared to healthy donors. The frequency of T-cells recognizing seven HLA-A2 restricted epitopes in LMP1 and LMP2 was lower in the patients and remained low after stimulation with autologous EBV-carrying cells. TILs expanded in low doses of IL-2 exhibited an increase of CD3(+)CD4(+), CD3(+)CD45RO(+) and CD4(+)CD25(+) cells and 2 to 5 fold higher frequency of LMP1 and LMP2 tetramer positive cells compared to peripheral blood. EBV-specific cytotoxicity could be reactivated from the blood of most patients, whereas the TILs lacked cytotoxic activity and failed to produce IFN gamma upon specific stimulation. Thus, EBV-specific rejection responses appear to be functionally inactivated at the tumor site in NPC.	[Li, Jiang; Zeng, Mu-sheng; Li, Man-zhi; Huang, Wen-lin; Zeng, Yi-xin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jiang; Mo, Hao-yuan; Gao, Yan-fang; Zhang, Xiao-shi; Chen, Qiu-yan; Zhang, Li; Zeng, Mu-sheng; Li, Man-zhi; Huang, Wen-lin; Zeng, Yi-xin] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jiang; Mo, Hao-yuan; Gao, Yan-fang; Zhang, Xiao-shi; Chen, Qiu-yan; Zhang, Li; Zeng, Mu-sheng; Li, Man-zhi; Huang, Wen-lin; Zeng, Yi-xin] Sun Yat Sen Univ, Ctr Canc, Dept Biotherapy, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jiang; Mo, Hao-yuan; Gao, Yan-fang; Zhang, Xiao-shi; Chen, Qiu-yan; Zhang, Li; Zeng, Mu-sheng; Li, Man-zhi; Huang, Wen-lin; Zeng, Yi-xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jiang; Mo, Hao-yuan; Gao, Yan-fang; Zhang, Xiao-shi; Chen, Qiu-yan; Zhang, Li; Zeng, Mu-sheng; Li, Man-zhi; Huang, Wen-lin; Zeng, Yi-xin] Sun Yat Sen Univ, Ctr Canc, Dept Radiotherapy, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Xue-hui; Wang, Xiao-ning] Technol Univ So China, Sch Biotechnol, Inst Mol Immunol, Guangzhou, Guangdong, Peoples R China; [Rolen, Ulrika; Masucci, Maria G.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Karolinska Institutet	Zeng, YX (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China.	zengyxi@mail.sysu.edu.cn; maria.masucci@ki.se	huang, wen/GXW-0661-2022; Masucci, Maria/AAC-6666-2019	Masucci, Maria/0000-0002-5541-2809; zeng, musheng/0000-0003-3509-5591	Guangdong Province Natural Fund [04300284]; International Joint Project grant [2005B50301007]; NSFC; Research Grant Council of Hong Kong joint research fund [30418003]; NSF of China [30170872]; Swedish Cancer Society; Swedish Foundation for International Scientific Cooperation (STINT)	Guangdong Province Natural Fund; International Joint Project grant; NSFC(National Natural Science Foundation of China (NSFC)); Research Grant Council of Hong Kong joint research fund; NSF of China(National Natural Science Foundation of China (NSFC)); Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for International Scientific Cooperation (STINT)	We wish to thank Zhan Pen for assistance with FACS analysis, and Dr. Lu-lu Xiao for HLA typing. This study was supported by grants from the Guangdong Province Natural Fund (04300284), International Joint Project grant (2005B50301007), NSFC and the Research Grant Council of Hong Kong joint research fund (30418003) and NSF of China (30170872); and by grants from the Swedish Cancer Society and the Swedish Foundation for International Scientific Cooperation (STINT) (to MGM).	Ansell SM, 2002, BLOOD, V99, P67, DOI 10.1182/blood.V99.1.67; Asselin-Paturel C, 1999, GENE THER, V6, P606, DOI 10.1038/sj.gt.3300841; Blake N, 1997, IMMUNITY, V7, P791, DOI 10.1016/S1074-7613(00)80397-0; Brooks JM, 2000, J VIROL, V74, P1801, DOI 10.1128/JVI.74.4.1801-1809.2000; BROOKS L, 1992, J VIROL, V66, P2689, DOI 10.1128/JVI.66.5.2689-2697.1992; Burgos JS, 2005, MED ONCOL, V22, P113, DOI 10.1385/MO:22:2:113; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Chen WH, 2004, CELL MOL IMMUNOL, V1, P328; Comoli P, 2004, ANN ONCOL, V15, P113, DOI 10.1093/annonc/mdh027; Dolcetti R, 2006, PROGRESS IN VIRUS RESEARCH, P191; Dukers DF, 2000, J IMMUNOL, V165, P663, DOI 10.4049/jimmunol.165.2.663; Fang CY, 2004, J IMMUNOL METHODS, V287, P21, DOI 10.1016/j.jim.2004.01.021; Favre N, 1997, J IMMUNOL METHODS, V204, P57, DOI 10.1016/S0022-1759(97)00033-1; Feldman AL, 2002, INT J CANCER, V99, P149, DOI 10.1002/ijc.10292; FRISAN T, 1995, BLOOD, V86, P1493, DOI 10.1182/blood.V86.4.1493.bloodjournal8641493; Goldsmith DB, 2002, CLIN OTOLARYNGOL, V27, P61, DOI 10.1046/j.0307-7772.2001.00529.x; GUSTAFSSON A, BLOOD IN PRESS; Herbst H, 1996, BLOOD, V87, P2918, DOI 10.1182/blood.V87.7.2918.bloodjournal8772918; Heslop HE, 1996, NAT MED, V2, P551, DOI 10.1038/nm0596-551; Hislop AD, 2002, J EXP MED, V195, P893, DOI 10.1084/jem.20011692; HO JH, 1978, IARC SCI PUBL, P99; HU LF, 1991, J VIROL, V65, P1558, DOI 10.1128/JVI.65.3.1558-1567.1991; Jimenez R, 2005, CYTOKINE, V32, P45, DOI 10.1016/j.cyto.2005.07.009; Khanna R, 1998, CANCER RES, V58, P310; Kis LL, 2006, BLOOD, V107, P2928, DOI 10.1182/blood-2005-06-2569; LEE AG, 1993, LIPOSOME TECHNOLOGY, V2, P1; Lee TV, 2000, J INTERF CYTOK RES, V20, P391, DOI 10.1089/107999000312333; LEVINE AM, 1994, ANN ONCOL, V5, pS29, DOI 10.1093/annonc/5.suppl_2.S29; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Linehan DC, 2005, IMMUNOL RES, V32, P155, DOI 10.1385/IR:32:1-3:155; Mould RF, 2002, BRIT J RADIOL, V75, P307, DOI 10.1259/bjr.75.892.750307; NAKAGOMI H, 1994, INT J CANCER, V57, P240, DOI 10.1002/ijc.2910570218; Ogino T, 2007, INT J CANCER, V120, P2401, DOI 10.1002/ijc.22334; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Shao JY, 2004, CANCER, V100, P1162, DOI 10.1002/cncr.20099; Straathof KCM, 2005, BLOOD, V105, P1898, DOI 10.1182/blood-2004-07-2975; STRANG G, 1987, EUR J IMMUNOL, V17, P1007, DOI 10.1002/eji.1830170717; Tatsumi-Tamori A, 2000, ANN OTO RHINOL LARYN, V109, P1125, DOI 10.1177/000348940010901208; THORN RM, 1974, J IMMUNOL METHODS, V4, P301, DOI 10.1016/0022-1759(74)90073-8; Vockerodt M, 2001, VIROLOGY, V280, P183, DOI 10.1006/viro.2000.0768; WALLACE LE, 1982, EUR J IMMUNOL, V12, P1012, DOI 10.1002/eji.1830121206; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; Wang RF, 2006, SEMIN CANCER BIOL, V16, P106, DOI 10.1016/j.semcancer.2005.11.004; Wei WZ, 2004, CANCER IMMUNOL IMMUN, V53, P73, DOI 10.1007/s00262-003-0444-1; Whitney BM, 2002, J MED VIROL, V67, P359, DOI 10.1002/jmv.10073; Wolfl M, 2004, CYTOM PART A, V57A, P120, DOI 10.1002/cyto.a.10116; Yin Y, 2003, SCIENCE, V301, P1371, DOI 10.1126/science.1088902; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zeng YX, 2002, SEMIN CANCER BIOL, V12, P443, DOI 10.1016/S1044579X02000871	49	78	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1122	10.1371/journal.pone.0001122	http://dx.doi.org/10.1371/journal.pone.0001122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987110	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459000006
J	Dicko, A; Diemert, DJ; Sagara, I; Sogoba, M; Niambele, MB; Assadou, MH; Guindo, O; Kamate, B; Baby, M; Sissoko, M; Malkin, EM; Fay, MP; Thera, MA; Miura, K; Dolo, A; Diallo, DA; Mullen, GE; Long, CA; Saul, A; Doumbo, O; Miller, LH				Dicko, Alassane; Diemert, David J.; Sagara, Issaka; Sogoba, Moussa; Niambele, Mohamed B.; Assadou, Mahamadoun H.; Guindo, Ousmane; Kamate, Beh; Baby, Mounirou; Sissoko, Mady; Malkin, Elissa M.; Fay, Michael P.; Thera, Mahamadou A.; Miura, Kazutoyo; Dolo, Amagana; Diallo, Dapa A.; Mullen, Gregory E.; Long, Carole A.; Saul, Allan; Doumbo, Ogobara; Miller, Louis H.			Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; CANDIDATE MALARIA VACCINE; IN-VITRO; INVASION; MEROZOITES; PROTECTION; MONKEYS; YOELII; SAFETY; TRIAL	Background. Apical Membrane Antigen 1 (AMA1) of Plasmodium falciparum merozoites is a leading blood-stage malaria vaccine candidate. Protection of Aotus monkeys after vaccination with AMA1 correlates with antibody responses. Study Design/Results. A randomized, controlled, double-blind phase 1 clinical trial was conducted in 54 healthy Malian adults living in an area of intense seasonal malaria transmission to assess the safety and immunogenicity of the AMA1-C1 malaria vaccine. AMA1-C1 contains an equal mixture of yeast-expressed recombinant proteins based on sequences from the FVO and 3D7 clones of P. falciparum, adsorbed on Alhydrogel. The control vaccine was the hepatitis B vaccine (Recombivax). Participants were enrolled into 1 of 3 dose cohorts (n = 18 per cohort) and randomized 2: 1 to receive either AMA1-C1 or Recombivax. Participants in the first, second, and third cohorts randomized to receive AMA1-C1 were vaccinated with 5, 20 and 80 mg of AMA1-C1, respectively. Vaccinations were administered on days 0, 28, and 360, and participants were followed until 6 months after the final vaccination. AMA1-C1 was well tolerated; no vaccine-related severe or serious adverse events were observed. AMA1 antibody responses to the 80 mg dose increased rapidly from baseline levels by days 14 and 28 after the first vaccination and continued to increase after the second vaccination. After a peak 14 days following the second vaccination, antibody levels decreased to baseline levels one year later at the time of the third vaccination that induced little or no increase in antibody levels. Conclusions. Although the AMA1-C1 vaccine candidate was well-tolerated and induced antibody responses to both vaccine and non-vaccine alleles, the antibody response after a third dose given at one year was lower than the response to the initial vaccinations. Additionally, post-vaccination increases in anti-AMA1 antibody levels were not associated with significant changes in in vitro growth inhibition of P. falciparum. Trial Registration. Clinicaltrials.gov NCT00343005	[Diemert, David J.; Malkin, Elissa M.; Miura, Kazutoyo; Mullen, Gregory E.; Long, Carole A.; Saul, Allan; Miller, Louis H.] NIAID, Malaria Vaccine Dev Branch, NIH, Bethesda, MD 20892 USA; [Dicko, Alassane; Sagara, Issaka; Sogoba, Moussa; Niambele, Mohamed B.; Assadou, Mahamadoun H.; Guindo, Ousmane; Kamate, Beh; Baby, Mounirou; Sissoko, Mady; Thera, Mahamadou A.; Dolo, Amagana; Diallo, Dapa A.; Doumbo, Ogobara] Univ Bamako, Dept Hematol, Malaria Res & Training Ctr, Bamako, Mali; [Dicko, Alassane; Sagara, Issaka; Sogoba, Moussa; Niambele, Mohamed B.; Assadou, Mahamadoun H.; Guindo, Ousmane; Kamate, Beh; Baby, Mounirou; Sissoko, Mady; Thera, Mahamadou A.; Dolo, Amagana; Diallo, Dapa A.; Doumbo, Ogobara] Univ Bamako, Dept Parasitol, Malaria Res & Training Ctr, Bamako, Mali; [Fay, Michael P.] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Bamako; University of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Miller, LH (corresponding author), NIAID, Malaria Vaccine Dev Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	lmiller@niaid.nih.gov	Saul, Allan/ABH-2091-2020; Miura, Kazutoyo/AAY-9751-2020; Diemert, David/AAQ-3353-2020; Fay, Michael P/A-2974-2008; Saul, Allan J/I-6968-2013	Saul, Allan/0000-0003-0665-4091; Miura, Kazutoyo/0000-0003-4455-2432; Fay, Michael P/0000-0002-8643-9625; Saul, Allan J/0000-0003-0665-4091; Diemert, David/0000-0002-2789-0512; Thera, Mahamadou A/0000-0002-2679-035X	National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001020, ZIAAI000241, ZIAAI001001, ZIAAI001020, Z01AI000241, Z01AI001001] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Site development and the conduct of the trial were directly supported by the Intramural Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Bojang KA, 2005, VACCINE, V23, P4148, DOI 10.1016/j.vaccine.2005.03.019; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; Cortes A, 2003, INFECT IMMUN, V71, P1416, DOI 10.1128/IAI.71.3.1416-1426.2003; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; Dicko A, 2004, BLOOD, V104, P1198, DOI 10.1182/blood-2003-11-3884; Doherty JF, 1999, AM J TROP MED HYG, V61, P865, DOI 10.4269/ajtmh.1999.61.865; Dutta S, 2003, P NATL ACAD SCI USA, V100, P12295, DOI 10.1073/pnas.2032858100; Fay MP, 2005, BIOSTATISTICS, V6, P171, DOI 10.1093/biostatistics/kxh027; Howell SA, 2001, J BIOL CHEM, V276, P31311, DOI 10.1074/jbc.M103076200; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 2000, MOL BIOCHEM PARASIT, V109, P147, DOI 10.1016/S0166-6851(00)00250-4; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Mullen GED, 2006, VACCINE, V24, P2497, DOI 10.1016/j.vaccine.2005.12.034; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Polley SD, 2001, GENETICS, V158, P1505; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; THOMAS AW, 1984, MOL BIOCHEM PARASIT, V13, P187, DOI 10.1016/0166-6851(84)90112-9; TRAGER W, 1984, J PROTOZOOL, V31, P562; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103; Wykes M, 2006, PARASITE IMMUNOL, V28, P31, DOI 10.1111/j.1365-3024.2006.00768.x; Wykes MN, 2005, J IMMUNOL, V175, P2510, DOI 10.4049/jimmunol.175.4.2510	28	52	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1045	10.1371/journal.pone.0001045	http://dx.doi.org/10.1371/journal.pone.0001045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940609	gold, Green Published, Green Submitted			2022-12-27	WOS:000207456100013
J	Guezou, A; Pozo, P; Buddenhagen, C				Guezou, Anne; Pozo, Paola; Buddenhagen, Christopher			Preventing Establishment: An Inventory of Introduced Plants in Puerto Villamil, Isabela Island, Galapagos	PLOS ONE			English	Article								As part of an island-wide project to identify and eradicate potentially invasive plant species before they become established, a program of inventories is being carried out in the urban and agricultural zones of the four inhabited islands in Galapagos. This study reports the results of the inventory from Puerto Villamil, a coastal village representing the urban zone of Isabela Island. We visited all 1193 village properties to record the presence of the introduced plants. In addition, information was collected from half of the properties to determine evidence for potential invasiveness of the plant species. We recorded 261 vascular taxa, 13 of which were new records for Galapagos. Most of the species were intentionally grown (cultivated) (73.3%) and used principally as ornamentals. The most frequent taxa we encountered were Cocos nucifera (coconut tree) (22.1%) as a cultivated plant and Paspalum vaginatum (salt water couch) (13.2%) as a non cultivated plant. In addition 39 taxa were naturalized. On the basis of the invasiveness study, we recommend five species for eradication (Abutilon dianthum, Datura inoxia, Datura metel, Senna alata and Solanum capsicoides), one species for hybridization studies (Opuntia ficus-indica) and three species for control (Furcraea hexapetala, Leucaena leucocephala and Paspalum vaginatum).	[Guezou, Anne; Pozo, Paola; Buddenhagen, Christopher] Charles Darwin Res Stn, Puerto Ayora, Galapagos, Ecuador; [Buddenhagen, Christopher] Univ Hawaii Manoa, Pacific Cooperat Studies Unit, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Buddenhagen, C (corresponding author), Charles Darwin Res Stn, Puerto Ayora, Galapagos, Ecuador.	cbuddenhagen@gmail.com	Buddenhagen, Christopher/J-3942-2019	Buddenhagen, Christopher/0000-0002-3016-1054	 [ECU/00/G31]		This work was accomplished with the support of Project ECU/00/G31 Control of Invasive Species in the Galapagos Archipelago, a donation from the Global Environment Facility (GEF) to the Ecuadorian Government, represented by the Ministry of Environment. The Project is implemented by the United Nations Development Programme (UNDP) and is executed by the Galapagos National Park Service (GNPS), Charles Darwin Foundation (CDF), National Institute for Galapagos (INGALA) and Ecuadorian Service for Agriculture and Livestock Sanitation Galapagos (SESA-Galapagos). Funders did not play any role in the study design.	[Anonymous], 1995, PLANT INVADERS; Buddenhagen C., 2005, Galapagos Research, V63, P32; FOSBERG FR, 1972, CARELESS TECHNOLOGY, P869; FRYXELL P, 1992, FLORA ECUADOR BERLIN, V118; GRAVEZ V, 2004, CONTRIBUCION CONOCIM; HUSSEY B, 1997, W WEEDS GUIDE WEEDS, P218; *I PAC ISL FOR, 2004, PAC ISL EC RISK PIER; Jorgensen P. M., 1999, CATALOGUE VASCULAR P; Mabberley DJ, 1997, PLANT BOOK; Mauchamp A, 1997, CONSERV BIOL, V11, P260, DOI 10.1046/j.1523-1739.1997.95356.x; Nel JL, 2004, S AFR J SCI, V100, P53; PROANO ME, 2007, INFORM GALAPAGOS 200, P31; Randall JM, 2000, US FOR SERV RMRS-P, V5, P64; Randall R. P., 2000, Plant Protection Quarterly, V15, P109; Rejmanek M., 2005, Invasive alien species: a new synthesis, P161; *SPEC SURV COMM, 2000, IUCN GUID PREV BIOD; Staples GW., 2005, TROPICAL GARDEN FLOR; SWEARINGEN J, 2005, ALIEN PLANT INVADERS; Tye A, 2006, BIOL INVASIONS, V8, P201, DOI 10.1007/s10530-004-3574-2; TYE A, 2007, INFORM GALAPAGOS 200, P101; TYE A, 2007, INFORM GALAPAGOS 200, P137; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Wang X., 1996, J PROF ASSOC CACTUS, V1, P49; Wiggins IL, 1971, FLORA GALAPAGOS ISLA; WITTENBERG R, 2001, ESPECIES EXOTICAS IN; *WWF, 2006, NAT LIST NAT INV POT	26	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1042	10.1371/journal.pone.0001042	http://dx.doi.org/10.1371/journal.pone.0001042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940606	Green Submitted, Green Published, gold			2022-12-27	WOS:000207456100010
J	Sporns, O; Honey, CJ; Kotter, R				Sporns, Olaf; Honey, Christopher J.; Kotter, Rolf			Identification and Classification of Hubs in Brain Networks	PLOS ONE			English	Article								Brain regions in the mammalian cerebral cortex are linked by a complex network of fiber bundles. These inter-regional networks have previously been analyzed in terms of their node degree, structural motif, path length and clustering coefficient distributions. In this paper we focus on the identification and classification of hub regions, which are thought to play pivotal roles in the coordination of information flow. We identify hubs and characterize their network contributions by examining motif fingerprints and centrality indices for all regions within the cerebral cortices of both the cat and the macaque. Motif fingerprints capture the statistics of local connection patterns, while measures of centrality identify regions that lie on many of the shortest paths between parts of the network. Within both cat and macaque networks, we find that a combination of degree, motif participation, betweenness centrality and closeness centrality allows for reliable identification of hub regions, many of which have previously been functionally classified as polysensory or multimodal. We then classify hubs as either provincial (intra-cluster) hubs or connector (inter-cluster) hubs, and proceed to show that lesioning hubs of each type from the network produces opposite effects on the small-world index. Our study presents an approach to the identification and classification of putative hub regions in brain networks on the basis of multiple network attributes and charts potential links between the structural embedding of such regions and their functional roles.	[Sporns, Olaf; Honey, Christopher J.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Sporns, Olaf; Honey, Christopher J.] Indiana Univ, Program Cognit Sci, Bloomington, IN USA; [Kotter, Rolf] Radboud Univ Nijmegen, Dept Cognit Neurosci, Sect Neurophysiol & Neuroinformat, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kotter, Rolf] Univ Dusseldorf, C&O Vogt Brain Res Inst, Dusseldorf, Germany; [Kotter, Rolf] Univ Dusseldorf, Inst Anat 2, Dusseldorf, Germany	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Radboud University Nijmegen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Sporns, O (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	osporns@indiana.edu	Sporns, Olaf/A-1667-2010; Honey, Christopher/C-3105-2015; Honey, Christopher/AAF-3616-2021; Bullmore, Ed/C-1706-2012	Sporns, Olaf/0000-0001-7265-4036; Honey, Christopher/0000-0002-0745-5089; Honey, Christopher/0000-0002-0745-5089; Bullmore, Ed/0000-0002-8955-8283	DFG [KO 1560/6-2]; J.S. McDonnell Foundation	DFG(German Research Foundation (DFG)); J.S. McDonnell Foundation	RK acknowledges support by the DFG KO 1560/6-2. OS, CH and RK were supported by the J.S. McDonnell Foundation. We thank Aviad Rubinstein for help in implementing graph analysis methods.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Artzy-Randrup Y, 2004, SCIENCE, V305; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; DACOSTA L, 2006, EUR PHYS J B, V48, P567; De Weerd P, 2003, EUR J NEUROSCI, V18, P1671, DOI 10.1046/j.1460-9568.2003.02862.x; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Friston KJ, 2002, ANNU REV NEUROSCI, V25, P221, DOI 10.1146/annurev.neuro.25.112701.142846; Fuster J., 2015, PREFRONTAL CORTEX, V5th; GLEICH D, 2006, MATLABBGL; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hilgetag Claus C., 2002, P295; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Kaiser M, 2004, BIOL CYBERN, V90, P311, DOI 10.1007/s00422-004-0479-1; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kasthuri N, 2007, NAT METHODS, V4, P307, DOI 10.1038/nmeth0407-307; Kotter R, 2005, PHILOS T R SOC B, V360, P751, DOI 10.1098/rstb.2005.1625; Kotter R, 2004, NEUROINFORMATICS, V2, P127; Kotter R, 2003, NEURAL NETWORKS, V16, P1261, DOI 10.1016/j.neunet.2003.06.002; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Masuda N, 2004, BIOL CYBERN, V90, P302, DOI 10.1007/s00422-004-0471-9; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; SCHILLER PH, 1995, NATURE, V376, P342, DOI 10.1038/376342a0; SCHILLER PH, 1991, SCIENCE, V251, P1251, DOI 10.1126/science.2006413; Sommer MA, 2001, J NEUROPHYSIOL, V85, P1673, DOI 10.1152/jn.2001.85.4.1673; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O., 2002, NEUROSCIENCE DATABAS, P171; Sporns O, 2006, BIOSYSTEMS, V85, P55, DOI 10.1016/j.biosystems.2006.02.008; Stein BE., 1993, MERGING SENSES; Stephan KE, 2000, PHILOS T R SOC B, V355, P111, DOI 10.1098/rstb.2000.0552; Stephan KE, 2001, PHILOS T ROY SOC B, V356, P1159, DOI 10.1098/rstb.2001.0908; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Vezoli J, 2004, NEUROSCIENTIST, V10, P476, DOI 10.1177/1073858404268478; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999	70	801	806	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1049	10.1371/journal.pone.0001049	http://dx.doi.org/10.1371/journal.pone.0001049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940613	Green Published, gold, Green Submitted			2022-12-27	WOS:000207456100017
J	Goswami, A				Goswami, Anjali			Phylogeny, Diet, and Cranial Integration in Australodelphian Marsupials	PLOS ONE			English	Article							PHENOTYPIC COVARIANCE STRUCTURE; MORPHOLOGICAL INTEGRATION; DEVELOPMENTAL INTEGRATION; CRANIOFACIAL DEVELOPMENT; MATRIX CORRELATION; VARIATION PATTERNS; CLADISTIC-ANALYSIS; EVOLUTION; MODULARITY; HETEROCHRONY	Studies of morphological integration provide valuable information on the correlated evolution of traits and its relationship to long-term patterns of morphological evolution. Thus far, studies of morphological integration in mammals have focused on placentals and have demonstrated that similarity in integration is broadly correlated with phylogenetic distance and dietary similarity. Detailed studies have also demonstrated a significant correlation between developmental relationships among structures and adult morphological integration. However, these studies have not yet been applied to marsupial taxa, which differ greatly from placentals in reproductive strategy and cranial development and could provide the diversity necessary to assess the relationships among phylogeny, ecology, development, and cranial integration. This study presents analyses of morphological integration in 20 species of australodelphian marsupials, and shows that phylogeny is significantly correlated with similarity of morphological integration in most clades. Size-related correlations have a significant affect on results, particularly in Peramelia, which shows a striking decrease in similarity of integration among species when size is removed. Diet is not significantly correlated with similarity of integration in any marsupial clade. These results show that marsupials differ markedly from placental mammals in the relationships of cranial integration, phylogeny, and diet, which may be related to the accelerated development of the masticatory apparatus in marsupials.	[Goswami, Anjali] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Goswami, Anjali] Field Museum, Dept Geol, Chicago, IL USA	University of Chicago; Field Museum of Natural History (Chicago)	Goswami, A (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	agos06@esc.cam.ac.uk	Goswami, Anjali/B-3440-2010		National Science Foundation [0308765]; Field Museum's Women-in-Science Fellowship; Society of Vertebrate Paleontology Predoctoral Fellowship; American Museum of Natural History; University of Chicago Hinds Fund	National Science Foundation(National Science Foundation (NSF)); Field Museum's Women-in-Science Fellowship; Society of Vertebrate Paleontology Predoctoral Fellowship; American Museum of Natural History; University of Chicago Hinds Fund	This research was supported by the National Science Foundation under Grant # 0308765, the Field Museum's Women-in-Science Fellowship, the Society of Vertebrate Paleontology Predoctoral Fellowship, the American Museum of Natural History collections study grant, and the University of Chicago Hinds Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2000, AM J PHYS ANTHROPOL, V111, P489, DOI 10.1002/(SICI)1096-8644(200004)111:4<489::AID-AJPA5>3.0.CO;2-U; Ackermann RR, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P302; Amrine-Madsen H, 2003, MOL PHYLOGENET EVOL, V28, P186, DOI 10.1016/S1055-7903(03)00122-2; [Anonymous], 1999, WALKERS MAMMALS WORL; Asher RJ, 2004, MOL PHYLOGENET EVOL, V33, P240, DOI 10.1016/j.ympev.2004.05.004; Baker Michelle L., 2004, Journal of Mammalian Evolution, V11, P1, DOI 10.1023/B:JOMM.0000029143.39776.ec; Bolker JA, 2000, AM ZOOL, V40, P770, DOI 10.1668/0003-1569(2000)040[0770:MIDAWI]2.0.CO;2; CHEVERUD JM, 1982, EVOLUTION, V36, P499, DOI 10.1111/j.1558-5646.1982.tb05070.x; CHEVERUD JM, 1989, EVOLUTION, V43, P1737, DOI 10.1111/j.1558-5646.1989.tb02623.x; CHEVERUD JM, 1995, AM NAT, V145, P63, DOI 10.1086/285728; Cheverud JM, 1996, AM ZOOL, V36, P44; Emerson SB, 1998, Q REV BIOL, V73, P141, DOI 10.1086/420182; Goswami A, 2006, EVOLUTION, V60, P169; Goswami A, 2007, EVOL DEV, V9, P290, DOI 10.1111/j.1525-142X.2007.00161.x; Goswami A, 2006, AM NAT, V168, P270, DOI 10.1086/505758; Groves C.P., 1990, P1; Horovitz I, 2003, CLADISTICS, V19, P181, DOI 10.1016/S0748-3007(03)00045-8; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Klingenberg CP, 1996, SYST BIOL, V45, P135, DOI 10.2307/2413611; KRAJEWSKI C, 2000, ZOOL J LINN SOC, V130; MANLY B, 1997, RANDOMIZATION BOOTST, P488; Marroig G, 2004, J EVOLUTION BIOL, V17, P144, DOI 10.1046/j.1420-9101.2003.00653.x; Marroig G, 2001, EVOLUTION, V55, P2576; MYERS P, 2000, CARNIVORA; Nilsson MA, 2004, GENE, V340, P189, DOI 10.1016/j.gene.2004.07.040; Nunn CL, 1998, AM NAT, V152, P82, DOI 10.1086/286151; Olson E. C., 1958, MORPHOLOGICAL INTEGR; Pigliucci M., 2004, PHENOTYPIC INTEGRATI; Ruedas LA, 2005, J MAMMAL, V86, P353, DOI 10.1644/BER-117.1; Schlosser G, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P1; Smith KK, 2006, DEV DYNAM, V235, P1181, DOI 10.1002/dvdy.20676; Smith KK, 2001, BIOL J LINN SOC, V73, P169, DOI 10.1006/bijl.2001.0535; Smith KK, 2001, J ANAT, V199, P121, DOI 10.1017/S0021878201008202; Smith KK, 1997, EVOLUTION, V51, P1663, DOI 10.1111/j.1558-5646.1997.tb01489.x; Steppan SJ, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P325; Steppan SJ, 1997, EVOLUTION, V51, P571, DOI 10.1111/j.1558-5646.1997.tb02444.x; Steppan SJ, 1997, EVOLUTION, V51, P587, DOI 10.1111/j.1558-5646.1997.tb02445.x; Szalay F. S., 1994, EVOLUTIONARY HIST MA; VERMEIJ GJ, 1973, SYST ZOOL, V22, P466, DOI 10.2307/2412953; Wagner GP, 1996, AM ZOOL, V36, P36; Wagner GP, 1995, LECT NOTES ARTIF INT, V929, P317; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Westerman Michael, 1999, Journal of Mammalian Evolution, V6, P271, DOI 10.1023/A:1020565724799; Wroe S, 2000, J MAMMAL, V81, P1008, DOI 10.1644/1545-1542(2000)081<1008:CAODMP>2.0.CO;2; Wroe S, 2007, EVOLUTION, V61, P1251, DOI 10.1111/j.1558-5646.2007.00101.x; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR, P443; Zelditch ML, 2001, BEYOND HETEROCHRONY, P145; ZELDITCH ML, 1988, EVOLUTION, V42, P28, DOI 10.1111/j.1558-5646.1988.tb04105.x; Zelditch ML, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P274; ZELDITCH ML, 1989, EVOLUTION, V43, P814, DOI 10.1111/j.1558-5646.1989.tb05179.x; ZELDITCH ML, 1989, J MAMMAL, V70, P477, DOI 10.2307/1381419	51	29	29	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e995	10.1371/journal.pone.0000995	http://dx.doi.org/10.1371/journal.pone.0000995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912372	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455900031
J	Ni, M; Yu, JH				Ni, Min; Yu, Jae-Hyuk			A Novel Regulator Couples Sporogenesis and Trehalose Biogenesis in Aspergillus nidulans	PLOS ONE			English	Article								Trehalose is a compatible osmolyte produced by bacteria, fungi, insects and plants to protect the integrity of cells against various environmental stresses. Spores, the reproductive, survival and infection bodies of fungi require high amounts of trehalose for long-term survival. Here, via a gain-of-function genetic screen, we identify the novel regulator VosA that couples the formation of spores and focal trehalose biogenesis in the model fungus Aspergillus nidulans. The vosA gene is expressed specifically during the formation of both sexual and asexual spores (conidia). Levels of vosA mRNA and protein are high in both types of spore. The deletion of vosA results in the lack of trehalose in spores, a rapid loss of the cytoplasm, organelles and viability of spores, and a dramatic reduction in tolerance of conidia to heat and oxidative stress. Moreover, the absence of vosA causes uncontrolled activation of asexual development, whereas the enhanced expression of vosA blocks sporulation, suggesting that VosA also functions in negative-feedback regulation of sporogenesis. VosA localizes in the nucleus of mature conidia and its C-terminal region contains a potential transcription activation domain, indicating that it may function as a transcription factor primarily controlling the late process of sporulation including trehalose biogenesis. VosA is conserved in most fungi and may define a new fungus-specific transcription factor family.	[Ni, Min; Yu, Jae-Hyuk] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Ni, Min; Yu, Jae-Hyuk] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Yu, JH (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	jyu1@wisc.edu	Yu, Jae-Hyuk/A-2343-2008	Yu, Jae-Hyuk/0000-0002-6530-8407	Hatch [WIS04667]; National Science Foundation [MCB-0421863, IOS-0640067]	Hatch(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF))	This work was supported by Hatch (WIS04667) and National Science Foundation grants (MCB-0421863 and IOS-0640067) to JHY. The sponsors or funders did not play any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; AGATEP R, 1998, TECHNICAL TIPS ONLIN, V1, P51; AGUIRRE J, 1990, EXP MYCOL, V14, P290, DOI 10.1016/0147-5975(90)90026-P; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; [Anonymous], 2003, J OCCUP ENVIRON MED, V45, P470; ARAMAYO R, 1990, NUCLEIC ACIDS RES, V18, P3415, DOI 10.1093/nar/18.11.3415; Borgia PT, 1996, MOL MICROBIOL, V20, P1287, DOI 10.1111/j.1365-2958.1996.tb02647.x; BOYLAN MT, 1987, MOL CELL BIOL, V7, P3113, DOI 10.1128/MCB.7.9.3113; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Crameri R, 2006, CHEM IMMUNOL ALLERGY, V91, P121; Crowe JH, 2007, ADV EXP MED BIOL, V594, P143; d'Enfert C, 1999, MOL MICROBIOL, V32, P471, DOI 10.1046/j.1365-2958.1999.01327.x; dEnfert C, 1997, MOL MICROBIOL, V24, P203, DOI 10.1046/j.1365-2958.1997.3131693.x; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; Fillinger S, 2001, MICROBIOL-SGM, V147, P1851, DOI 10.1099/00221287-147-7-1851; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; GWYNNE DI, 1987, GENE, V51, P205, DOI 10.1016/0378-1119(87)90309-X; Han KH, 2004, MOL MICROBIOL, V53, P529, DOI 10.1111/j.1365-2958.2004.04163.x; James P, 1996, GENETICS, V144, P1425; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kato N, 2003, EUKARYOT CELL, V2, P1178, DOI 10.1128/EC.2.6.1178-1186.2003; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Li SJ, 2006, MOL MICROBIOL, V62, P1418, DOI 10.1111/j.1365-2958.2006.05447.x; LINGAPPA BT, 1959, PLANT PHYSIOL, V34, P466, DOI 10.1104/pp.34.4.466; Mah JH, 2006, EUKARYOT CELL, V5, P1585, DOI 10.1128/EC.00192-06; MARSHALL MA, 1991, MOL CELL BIOL, V11, P55, DOI 10.1128/MCB.11.1.55; MAYORGA ME, 1992, MOL GEN GENET, V235, P205, DOI 10.1007/BF00279362; MIMS CW, 1988, PROTOPLASMA, V144, P132, DOI 10.1007/BF01637246; MIRABITO PM, 1989, CELL, V57, P859, DOI 10.1016/0092-8674(89)90800-3; Momany M, 2001, MOL CELLULAR BIOL FI, P119; Osherov N, 2000, FUNGAL GENET BIOL, V31, P181, DOI 10.1006/fgbi.2000.1236; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; PUNT PJ, 1991, J BIOTECHNOL, V17, P19, DOI 10.1016/0168-1656(91)90024-P; Seo JA, 2006, GENETICS, V172, P1535, DOI 10.1534/genetics.105.052258; Seo JA, 2003, GENETICS, V165, P1083; SEWALL TC, 1990, DEV BIOL, V138, P499, DOI 10.1016/0012-1606(90)90215-5; STRINGER MA, 1991, GENE DEV, V5, P1161, DOI 10.1101/gad.5.7.1161; Takeshita N, 2002, BIOCHEM BIOPH RES CO, V298, P103, DOI 10.1016/S0006-291X(02)02418-X; TIMBERLAKE WE, 1994, ASPERGILLUS 50 YEARS, P383; Ursic D, 2004, NUCLEIC ACIDS RES, V32, P2441, DOI 10.1093/nar/gkh561; WIESER J, 1995, GENE DEV, V9, P491, DOI 10.1101/gad.9.4.491; Yamada O, 1999, J BIOSCI BIOENG, V87, P424, DOI 10.1016/S1389-1723(99)80089-9; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Yu JH, 1996, CURR GENET, V29, P549, DOI 10.1007/s002940050084	48	172	190	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e970	10.1371/journal.pone.0000970	http://dx.doi.org/10.1371/journal.pone.0000970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912349	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455900008
J	Richard, FJ; Tarpy, DR; Grozinger, CM				Richard, Freddie-Jeanne; Tarpy, David R.; Grozinger, Christina M.			Effects of Insemination Quantity on Honey Bee Queen Physiology	PLOS ONE			English	Article							APIS-MELLIFERA L; MANDIBULAR GLAND PHEROMONE; MATING FREQUENCY; GENE-EXPRESSION; BEHAVIOR; HYMENOPTERA; EVOLUTION; FLUID; POLYANDRY; PROTEINS	Mating has profound effects on the physiology and behavior of female insects, and in honey bee (Apis mellifera) queens, these changes are permanent. Queens mate with multiple males during a brief period in their early adult lives, and shortly thereafter they initiate egg-laying. Furthermore, the pheromone profiles of mated queens differ from those of virgins, and these pheromones regulate many different aspects of worker behavior and colony organization. While it is clear that mating causes dramatic changes in queens, it is unclear if mating number has more subtle effects on queen physiology or queen-worker interactions; indeed, the effect of multiple matings on female insect physiology has not been broadly addressed. Because it is not possible to control the natural mating behavior of queens, we used instrumental insemination and compared queens inseminated with semen from either a single drone (single-drone inseminated, or SDI) or 10 drones (multi-drone inseminated, or MDI). We used observation hives to monitor attraction of workers to SDI or MDI queens in colonies, and cage studies to monitor the attraction of workers to virgin, SDI, and MDI queen mandibular gland extracts (the main source of queen pheromone). The chemical profiles of the mandibular glands of virgin, SDI, and MDI queens were characterized using GC-MS. Finally, we measured brain expression levels in SDI and MDI queens of a gene associated with phototaxis in worker honey bees (Amfor). Here, we demonstrate for the first time that insemination quantity significantly affects mandibular gland chemical profiles, queen-worker interactions, and brain gene expression. Further research will be necessary to elucidate the mechanistic bases for these effects: insemination volume, sperm and seminal protein quantity, and genetic diversity of the sperm may all be important factors contributing to this profound change in honey bee queen physiology, queen behavior, and social interactions in the colony.	[Richard, Freddie-Jeanne; Tarpy, David R.; Grozinger, Christina M.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Richard, Freddie-Jeanne; Grozinger, Christina M.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Richard, Freddie-Jeanne; Tarpy, David R.; Grozinger, Christina M.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Grozinger, CM (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	cmgrozin@ncsu.edu		Richard, Freddie-Jeanne/0000-0002-2796-1181	USDA-NRI; DRT [200635607-16625]; Eastern Apiculture Society	USDA-NRI(United States Department of Agriculture (USDA)); DRT; Eastern Apiculture Society	This work was supported by a USDA-NRI grant to CMG and DRT (200635607-16625) and the Eastern Apiculture Society.	APSEGAITE V, 1999, PHEROMONES, V9, P27; Baer B, 2000, J CHEM ECOL, V26, P1869, DOI 10.1023/A:1005596707591; Baer B, 2001, P NATL ACAD SCI USA, V98, P3926, DOI 10.1073/pnas.061027998; Ben-Shahar Y, 2005, J COMP PHYSIOL A, V191, P987, DOI 10.1007/s00359-005-0025-1; Ben-Shahar Y, 2003, J EXP BIOL, V206, P2507, DOI 10.1242/jeb.00442; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; BLUM MURRAY S., 1962, ANN ENTOMOL SOC AMER, V55, P135; Brockmann A, 2006, J CHEM ECOL, V32, P657, DOI 10.1007/s10886-005-9027-2; Butler C. G., 1963, Journal of Apicultural Research London, V2, P14; Chapman T, 2004, PEPTIDES, V25, P1477, DOI 10.1016/j.peptides.2003.10.023; Collins AM, 2004, INSECT MOL BIOL, V13, P141, DOI 10.1111/j.0962-1075.2004.00469.x; Crozier R.H., 1996, EVOLUTION SOCIAL INS; DADE HA, 1978, ANATOMY DISSECTION H; FAHRBACH SE, 1995, NEUROBIOL LEARN MEM, V63, P181, DOI 10.1006/nlme.1995.1019; Free J. B., 1987, PHEROMONES SOCIAL BE; GARY NE, 1962, SCIENCE, V136, P773, DOI 10.1126/science.136.3518.773; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Grozinger CM, 2007, NATURWISSENSCHAFTEN, V94, P375, DOI 10.1007/s00114-006-0197-8; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Harano K, 2005, NATURWISSENSCHAFTEN, V92, P310, DOI 10.1007/s00114-005-0631-3; Heifetz Y, 2000, CURR BIOL, V10, P99, DOI 10.1016/S0960-9822(00)00288-8; HIGO HA, 1992, CAN ENTOMOL, V124, P409, DOI 10.4039/Ent124409-2; Hoover SER, 2005, INSECT SOC, V52, P6, DOI 10.1007/s00040-004-0772-y; Hoover SER, 2003, NATURWISSENSCHAFTEN, V90, P477, DOI 10.1007/s00114-003-0462-z; KAFTANOGLU O, 1982, J APICULT RES, V21, P3, DOI 10.1080/00218839.1982.11100508; KAMINSKI LA, 1990, J CHEM ECOL, V16, P841, DOI 10.1007/BF01016494; Keeling CI, 2003, P NATL ACAD SCI USA, V100, P4486, DOI 10.1073/pnas.0836984100; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; Klenk M, 2004, APIDOLOGIE, V35, P371, DOI 10.1051/apido:2004029; Laidlaw HH., 1997, QUEEN REARING BEE BR; LAIDLAW HH, 1977, INSTRUMENTAL INSEMIN; LOBO JA, 1993, ETHOL ECOL EVOL, V5, P337, DOI 10.1080/08927014.1993.9523021; Melathopoulos AP, 1996, CAN ENTOMOL, V128, P263, DOI 10.4039/Ent128263-2; Morgan SM, 1998, BEHAV BRAIN RES, V91, P115, DOI 10.1016/S0166-4328(97)00118-6; Mueller JL, 2004, P NATL ACAD SCI USA, V101, P13542, DOI 10.1073/pnas.0405579101; NIJHOUT HF, 1984, J INSECT PHYSIOL, V30, P629, DOI 10.1016/0022-1910(84)90047-7; OLDROYD BP, 1992, ANN ENTOMOL SOC AM, V85, P335, DOI 10.1093/aesa/85.3.335; Oldroyd BP, 1997, BEHAV ECOL SOCIOBIOL, V40, P17, DOI 10.1007/s002650050311; Oldroyd BP, 1998, ANN ENTOMOL SOC AM, V91, P700, DOI 10.1093/aesa/91.5.700; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; PANKIW T, 1995, INSECT SOC, V42, P371, DOI 10.1007/BF01242165; Pankiw T, 2000, NATURWISSENSCHAFTEN, V87, P487, DOI 10.1007/s001140050764; PANKIW T, 1994, J INSECT BEHAV, V7, P1, DOI 10.1007/BF01989823; PETTIS JS, 1995, INSECT SOC, V42, P113, DOI 10.1007/BF01242447; PETTIS JS, 1995, ANN ENTOMOL SOC AM, V88, P580, DOI 10.1093/aesa/88.4.580; Plettner E, 1997, J CHEM ECOL, V23, P363, DOI 10.1023/B:JOEC.0000006365.20996.a2; RIDDIFORD LM, 1973, BIOL BULL-US, V144, P162, DOI 10.2307/1540153; Ringo J, 1996, ANNU REV ENTOMOL, V41, P473, DOI 10.1146/annurev.en.41.010196.002353; ROTH LM, 1962, SCIENCE, V138, P1267, DOI 10.1126/science.138.3546.1267; Schluns H, 2005, ANIM BEHAV, V70, P125, DOI 10.1016/j.anbehav.2004.11.005; Seeley TD, 1985, HONEYBEE ECOLOGY STU; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SLESSOR KN, 1988, NATURE, V332, P354, DOI 10.1038/332354a0; SLESSOR KN, 1990, J CHEM ECOL, V16, P851, DOI 10.1007/BF01016495; SUGAWARA T, 1986, J INSECT PHYSIOL, V32, P485, DOI 10.1016/0022-1910(86)90010-7; Tanaka ED, 2004, ARTHROPOD STRUCT DEV, V33, P431, DOI 10.1016/j.asd.2004.06.006; Tarpy DR, 2002, ANN ENTOMOL SOC AM, V95, P513, DOI 10.1603/0013-8746(2002)095[0513:SEEPAE]2.0.CO;2; Tarpy DR, 2006, NATURWISSENSCHAFTEN, V93, P195, DOI 10.1007/s00114-006-0091-4; Tarpy DR, 2002, BEHAV ECOL SOCIOBIOL, V52, P143, DOI 10.1007/s00265-002-0498-7; Tarpy DR, 2000, AM NAT, V155, P820, DOI 10.1086/303358; Tomanek B, 1996, J APICULT RES, V35, P3, DOI 10.1080/00218839.1996.11100907; Tram U, 1998, P NATL ACAD SCI USA, V95, P4051, DOI 10.1073/pnas.95.7.4051; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Winston M.L., 1991, BIOL HONEY BEE; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7; WOYCIECHOWSKI M, 1987, J THEOR BIOL, V128, P317, DOI 10.1016/S0022-5193(87)80074-7; Woyke J, 1995, J APICULT RES, V34, P105, DOI 10.1080/00218839.1995.11100895; WOYKE J, 1983, J APICULT RES, V22, P150, DOI 10.1080/00218839.1983.11100579; WOYKE J, 1966, WHICH IS MOST SUITAB, P12	71	77	77	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e980	10.1371/journal.pone.0000980	http://dx.doi.org/10.1371/journal.pone.0000980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912357	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455900016
J	Akhras, MS; Unemo, M; Thiyagarajan, S; Nyren, P; Davis, RW; Fire, AZ; Pourmand, N				Akhras, Michael S.; Unemo, Magnus; Thiyagarajan, Sreedevi; Nyren, Pal; Davis, Ronald W.; Fire, Andrew Z.; Pourmand, Nader			Connector Inversion Probe Technology: A Powerful One-Primer Multiplex DNA Amplification System for Numerous Scientific Applications	PLOS ONE			English	Article							NEISSERIA-GONORRHOEAE; ISOTHERMAL AMPLIFICATION; CIPROFLOXACIN RESISTANCE; GYRASE GENE; QUANTIFICATION; SEQUENCES; OLIGONUCLEOTIDES; MUTATIONS; INDICATOR; RNA	We combined components of a previous assay referred to as Molecular Inversion Probe (MIP) with a complete gap filling strategy, creating a versatile powerful one-primer multiplex amplification system. As a proof-of-concept, this novel method, which employs a Connector Inversion Probe (CIPer), was tested as a genetic tool for pathogen diagnosis, typing, and antibiotic resistance screening with two distinct systems: i) a conserved sequence primer system for genotyping Human Papillomavirus (HPV), a cancer-associated viral agent and ii) screening for antibiotic resistance mutations in the bacterial pathogen Neisseria gonorrhoeae. We also discuss future applications and advances of the CIPer technology such as integration with digital amplification and next-generation sequencing methods. Furthermore, we introduce the concept of two-dimension informational barcodes, i. e. "multiplex multiplexing padlocks'' (MMPs). For the readers' convenience, we also provide an on-line tutorial with user-interface software application CIP creator 1.0.1, for custom probe generation from virtually any new or established primer-pairs.	[Akhras, Michael S.; Thiyagarajan, Sreedevi; Davis, Ronald W.; Pourmand, Nader] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Akhras, Michael S.; Nyren, Pal] Royal Inst Technol, Dept Biotechnol, Stockholm, Sweden; [Unemo, Magnus] Orebro Univ Hosp, Dept Clin Microbiol, Natl Reference Lab Pathogen Neisseria, Orebro, Sweden; [Fire, Andrew Z.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Fire, Andrew Z.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Pourmand, Nader] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	Stanford University; Royal Institute of Technology; Orebro University; Stanford University; Stanford University; University of California System; University of California Santa Cruz	Pourmand, N (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.	pourmand@stanford.edu	Unemo, Magnus/ABD-6653-2021	Fire, Andrew/0000-0001-6217-8312; Pourmand, Nader/0000-0003-0251-9060	National Institutes of Health [PO1-HG000205]; Hans Werthe'n Foundation; Sixten Gemzeus Scholarship Foundation; Foundation Blanceflor Boncompagni-Ludovisi, nee Bildt; Fulbright Commission; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hans Werthe'n Foundation; Sixten Gemzeus Scholarship Foundation; Foundation Blanceflor Boncompagni-Ludovisi, nee Bildt; Fulbright Commission; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by a grant from National Institutes of Health (PO1-HG000205). Michael S. Akhras was supported by Hans Werthe'n Foundation; Sixten Gemzeus Scholarship Foundation; The Foundation Blanceflor Boncompagni-Ludovisi, nee Bildt; and the The Fulbright Commission.	ABRAVAYA K, 1995, NUCLEIC ACIDS RES, V23, P675, DOI 10.1093/nar/23.4.675; Akhras MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000223; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Ben-Dov E, 2006, APPL ENVIRON MICROB, V72, P6902, DOI 10.1128/AEM.00849-06; Bennett ST, 2005, PHARMACOGENOMICS, V6, P373, DOI 10.1517/14622416.6.4.373; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Borodina TA, 2003, ANAL BIOCHEM, V318, P309, DOI 10.1016/S0003-2697(03)00250-1; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; Chavali S, 2005, BIOINFORMATICS, V21, P3918, DOI 10.1093/bioinformatics/bti633; Csako G, 2006, CLIN CHIM ACTA, V363, P6, DOI 10.1016/j.cccn.2005.07.009; Dafforn A, 2004, BIOTECHNIQUES, V37, P854, DOI 10.2144/04375PF01; DAHL F, 2007, P NATL ACAD SCI US; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641; Fredriksson S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm078; Gharizadeh B, 2005, INT J ANTIMICROB AG, V26, P486, DOI 10.1016/j.ijantimicag.2005.08.017; Gharizadeh B, 2006, J BIOTECHNOL, V124, P504, DOI 10.1016/j.jbiotec.2006.01.025; Gharizadeh B, 2006, MOL CELL PROBE, V20, P230, DOI 10.1016/j.mcp.2006.01.002; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Jarvius J, 2006, NAT METHODS, V3, P725, DOI 10.1038/NMETH916; Ji HL, 2006, CANCER RES, V66, P7910, DOI 10.1158/0008-5472.CAN-06-0595; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Lindback E, 2005, INT J STD AIDS, V16, P142, DOI 10.1258/0956462053057675; Lindback E, 2006, APMIS, V114, P837, DOI 10.1111/j.1600-0463.2006.apm_495.x; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mitani Y, 2007, NAT METHODS, V4, P257, DOI 10.1038/NMETH1007; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Nilsson M, 2006, TRENDS BIOTECHNOL, V24, P83, DOI 10.1016/j.tibtech.2005.12.005; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; OKAZAKI R, 1968, P NATL ACAD SCI USA, V59, P598, DOI 10.1073/pnas.59.2.598; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Thiyagarajan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-500; Unemo M, 2007, APMIS, V115, P231, DOI 10.1111/j.1600-0463.2007.apm_487.x; Wang YK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni177	45	21	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e915	10.1371/journal.pone.0000915	http://dx.doi.org/10.1371/journal.pone.0000915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878950	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455700023
J	Back, M; Hlawaty, H; Labat, C; Michel, JB; Brink, C				Baeck, Magnus; Hlawaty, Hanna; Labat, Carlos; Michel, Jean-Baptiste; Brink, Charles			The Oral Cavity and Age: A Site of Chronic Inflammation?	PLOS ONE			English	Article								Background. Aging may be accompanied by a low grade chronic up-regulation of inflammatory mediators. A variety of endogenous locally released mediators as well as inflammatory cells have been reported in the human oral cavity. The aim of this investigation was to determine the presence of different classes of inflammatory mediators in human saliva and correlate the levels with age. Methodology and Principal Findings. Unstimulated whole buccal salivary samples were obtained in the morning from 94 healthy volunteers within 30 minutes after waking. None of the participants had taken aspirin in the week prior to the saliva collection. Lysozyme activity, eicosanoid levels (prostaglandin E-2 and leukotriene B-4) and MMP-9 activity were measured. The antimicrobial activity (lysozyme activity) was not correlated with age whereas PGE(2) levels were markedly correlated with age (r = 0.29; P<0.05; n = 56). Saliva from healthy subjects (<40 years) compared with data derived from older volunteers (>40 years) demonstrated a significant increase in the mean values for PGE(2) and MMP-9 activity with age. In addition, significant correlations were observed between LTB4 and PGE(2) (r = 0.28; P<0.05; n = 56) and between LTB4 levels and MMP-9 activity in smokers (r = 0.78; P<0.001; n = 15). Conclusions/Significance. The presence of significant levels and activity of inflammatory mediators in saliva suggests that the oral cavity of healthy subjects may be in a constant low state of inflammation associated with age.	[Baeck, Magnus; Hlawaty, Hanna; Michel, Jean-Baptiste; Brink, Charles] Univ Paris 07, Bichat Hosp, INSERM, U698, Paris, France; [Hlawaty, Hanna] Univ Paris 13, Inst Galilee UP13, F-93430 Villetaneuse, France; [Labat, Carlos] INSERM, U684, Nancy, France; [Labat, Carlos] Henri Poincare Univ, Nancy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Universite de Lorraine	Brink, C (corresponding author), Univ Paris 07, Bichat Hosp, INSERM, U698, Paris, France.	charlesbrink@hotmail.com	Labat, Carlos/F-7492-2010; Michel, Jean-Baptiste/AAH-9336-2020; Back, Magnus/E-4879-2011	Labat, Carlos/0000-0002-5275-3405; Back, Magnus/0000-0003-0853-5141; Hlawaty, Hanna/0000-0003-3877-4266; Hlawaty, Hanna/0000-0002-4758-0941	University of Paris 13 (Institut Galilee UP13, Villetauneuse, France); Leducq Transatlantic Network of Excellence on Atherothrombosis Research; French National Academy of Medicine; French-Swedish Foundation; INSERM	University of Paris 13 (Institut Galilee UP13, Villetauneuse, France); Leducq Transatlantic Network of Excellence on Atherothrombosis Research; French National Academy of Medicine; French-Swedish Foundation; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Funding: HH was supported by a PhD scholarship from University of Paris 13 (Institut Galilee UP13, Villetauneuse, France). This study was supported by the Leducq Transatlantic Network of Excellence on Atherothrombosis Research, the French National Academy of Medicine, the French-Swedish Foundation and INSERM.	Back M, 2007, ATHEROSCLEROSIS, V193, P389, DOI 10.1016/j.atherosclerosis.2006.07.003; Badier-Commander C, 2000, J PATHOL, V192, P105, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH670>3.0.CO;2-1; Berry KAZ, 2003, J BIOL CHEM, V278, P24449, DOI 10.1074/jbc.M300856200; Bjorne H, 2005, CRIT CARE MED, V33, P1722, DOI 10.1097/01.CCM.0000171304.59502.AA; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Cesari M, 2003, AM J CARDIOL, V92, P522, DOI 10.1016/S0002-9149(03)00718-5; Fennerty MB, 2002, CRIT CARE MED, V30, pS351, DOI 10.1097/00003246-200206001-00002; FRANKEN C, 1989, J HISTOCHEM CYTOCHEM, V37, P493, DOI 10.1177/37.4.2926127; Gaber F, 2006, EUR RESPIR J, V28, P1229, DOI 10.1183/09031936.00151905; GIBBONS RJ, 1966, J DENT RES, V45, P877, DOI 10.1177/00220345660450036201; GREEN FA, 1987, ARCH BIOCHEM BIOPHYS, V257, P321, DOI 10.1016/0003-9861(87)90572-8; HARRIES AD, 1982, BRIT MED J, V284, P706, DOI 10.1136/bmj.284.6317.706; KLOCKARS M, 1975, J HISTOCHEM CYTOCHEM, V23, P932, DOI 10.1177/23.12.1104708; LOE H, 1971, J DENT RES, V50, P256, DOI 10.1177/00220345710500021701; MAKELA M, 1994, J DENT RES, V73, P1397, DOI 10.1177/00220345940730080201; METZGER K, 1995, FREE RADICAL BIO MED, V18, P185, DOI 10.1016/0891-5849(94)00108-V; OFFENBACHER S, 1986, J PERIODONTAL RES, V21, P101, DOI 10.1111/j.1600-0765.1986.tb01443.x; OLSON BL, 1985, J DENT RES, V64, P826, DOI 10.1177/00220345850640050901; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Rao RK, 1997, DIGEST DIS SCI, V42, P2175, DOI 10.1023/A:1018855525989; RIGAS B, 1983, ARCH ORAL BIOL, V28, P1031, DOI 10.1016/0003-9969(83)90058-4; RIGAS B, 1983, ARCH ORAL BIOL, V28, P1135, DOI 10.1016/0003-9969(83)90171-1; RIGAS B, 1983, BIOCHEM BIOPH RES CO, V115, P201, DOI 10.1016/0006-291X(83)90989-0; Roger P, 1999, MEDIAT INFLAMM, V8, P319, DOI 10.1080/09629359990333; Rosin M, 1999, Clin Oral Investig, V3, P133, DOI 10.1007/s007840050091; Sarosiek J, 1996, GASTROENTEROLOGY, V110, P675, DOI 10.1053/gast.1996.v110.pm8608875; SCHIOTT C R, 1970, Journal of Periodontal Research, V5, P36; STUCHELL RN, 1983, J DENT RES, V62, P552, DOI 10.1177/00220345830620050701; TENOVUO J, 1987, J DENT RES, V66, P475, DOI 10.1177/00220345870660021501; Tjaderhane L, 1998, J DENT RES, V77, P1622, DOI 10.1177/00220345980770081001; Tsai CC, 1998, J DENT, V26, P97, DOI 10.1016/S0300-5712(96)00084-X; Westerlund U, 1996, J DENT RES, V75, P1553, DOI 10.1177/00220345960750080601; WOOLWEAVER DA, 1972, J DENT RES, V51, P929, DOI 10.1177/00220345720510043401; WUWANG CY, 1992, PROSTAG LEUKOTR ESS, V47, P101, DOI 10.1016/0952-3278(92)90144-8; Yeh CK, 1997, ARCH ORAL BIOL, V42, P25, DOI 10.1016/S0003-9969(96)00104-5; ZIJLSTRA FJ, 1992, AGENTS ACTIONS, pC53	36	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1351	10.1371/journal.pone.0001351	http://dx.doi.org/10.1371/journal.pone.0001351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159234	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459700008
J	Franklin, DW; So, U; Burdet, E; Kawato, M				Franklin, David W.; So, Udell; Burdet, Etienne; Kawato, Mitsuo			Visual Feedback Is Not Necessary for the Learning of Novel Dynamics	PLOS ONE			English	Article								Background. When learning to perform a novel sensorimotor task, humans integrate multi-modal sensory feedback such as vision and proprioception in order to make the appropriate adjustments to successfully complete the task. Sensory feedback is used both during movement to control and correct the current movement, and to update the feed-forward motor command for subsequent movements. Previous work has shown that adaptation to stable dynamics is possible without visual feedback. However, it is not clear to what degree visual information during movement contributes to this learning or whether it is essential to the development of an internal model or impedance controller. Methodology/Principle Findings. We examined the effects of the removal of visual feedback during movement on the learning of both stable and unstable dynamics in comparison with the case when both vision and proprioception are available. Subjects were able to learn to make smooth movements in both types of novel dynamics after learning with or without visual feedback. By examining the endpoint stiffness and force after learning it could be shown that subjects adapted to both types of dynamics in the same way whether they were provided with visual feedback of their trajectory or not. The main effects of visual feedback were to increase the success rate of movements, slightly straighten the path, and significantly reduce variability near the end of the movement. Conclusions/Significance. These findings suggest that visual feedback of the hand during movement is not necessary for the adaptation to either stable or unstable novel dynamics. Instead vision appears to be used to fine-tune corrections of hand trajectory at the end of reaching movements.	[Franklin, David W.] Natl Inst Informat & Commun Technol, Keihanna Sci City, Kyoto, Japan; [Franklin, David W.; So, Udell; Kawato, Mitsuo] ATR Computat Neurosci Labs, Keihanna Sci City, Kyoto, Japan; [Franklin, David W.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Burdet, Etienne] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	National Institute of Information & Communications Technology (NICT) - Japan; University of Cambridge; Imperial College London	Franklin, DW (corresponding author), Natl Inst Informat & Commun Technol, Keihanna Sci City, Kyoto, Japan.	dwf25@cam.ac.uk	Franklin, David/A-2371-2009	Franklin, David/0000-0001-9530-0820; Burdet, Etienne/0000-0002-2123-0185	NICT, Japan; DWF; NSERC, Canada	NICT, Japan; DWF; NSERC, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by funding from NICT, Japan. DWF was supported in part by a fellowship from NSERC, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKESON CG, 1985, J NEUROSCI, V5, P2318; Bedard P, 2004, EXP BRAIN RES, V158, P75, DOI 10.1007/s00221-004-1874-5; Bernier PM, 2006, NEUROREPORT, V17, P1421, DOI 10.1097/01.wnr.0000233096.13032.34; Bernier PM, 2006, J MOTOR BEHAV, V38, P331, DOI 10.3200/JMBR.38.5.331-338; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Brenner E, 2003, SPATIAL VISION, V16, P365, DOI 10.1163/156856803322467581; Burdet E, 2006, BIOL CYBERN, V94, P20, DOI 10.1007/s00422-005-0025-9; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Burdet E, 1998, BIOL CYBERN, V78, P307, DOI 10.1007/s004220050435; Burdet E, 2000, J BIOMECH, V33, P1705, DOI 10.1016/S0021-9290(00)00142-1; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; CORDO P, 1994, J NEUROPHYSIOL, V71, P1848, DOI 10.1152/jn.1994.71.5.1848; DiZio P, 2000, J NEUROPHYSIOL, V84, P2175, DOI 10.1152/jn.2000.84.4.2175; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin DW, 2004, J NEUROPHYSIOL, V92, P3097, DOI 10.1152/jn.00364.2004; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; Ghahramani Z, 1997, NATURE, V386, P392, DOI 10.1038/386392a0; GHEZ C, 1995, J NEUROPHYSIOL, V73, P361, DOI 10.1152/jn.1995.73.1.361; GHEZ C, 1995, CAN J PHYSIOL PHARM, V73, P273, DOI 10.1139/y95-038; GIELEN CCAM, 1988, J PHYSIOL-LONDON, V407, P275, DOI 10.1113/jphysiol.1988.sp017415; Gomi H, 1998, J NEUROSCI, V18, P8965; Gomi H, 1997, BIOL CYBERN, V76, P163, DOI 10.1007/s004220050329; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; GORDON J, 1995, J NEUROPHYSIOL, V73, P347, DOI 10.1152/jn.1995.73.1.347; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; HOGAN N, 1985, BIOL CYBERN, V52, P315, DOI 10.1007/BF00355754; HOGAN N, 1984, IEEE T AUTOMAT CONTR, V29, P681, DOI 10.1109/TAC.1984.1103644; IVALDI FAM, 1985, J NEUROSCI, V5, P2732; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; Koshland GF, 2000, EXP BRAIN RES, V132, P485; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Lateiner JE, 2003, EXP BRAIN RES, V151, P446, DOI 10.1007/s00221-003-1503-8; Mattar AAG, 2007, J NEUROPHYSIOL, V97, P220, DOI 10.1152/jn.00736.2006; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; MIALL RC, 1995, EXP BRAIN RES, V103, P421; MILNER TE, 1990, NEUROSCIENCE, V35, P365, DOI 10.1016/0306-4522(90)90090-Q; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osu R, 2004, NAT NEUROSCI, V7, P111, DOI 10.1038/nn1184; Osu R, 2003, J NEUROPHYSIOL, V90, P3255, DOI 10.1152/jn.00073.2003; PELISSON D, 1986, EXP BRAIN RES, V62, P303; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; Safstrom D, 2004, LEARN MEMORY, V11, P356, DOI 10.1101/lm.71804; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; Sainburg RL, 2003, J NEUROPHYSIOL, V89, P401, DOI 10.1152/jn.00243.2002; Sarlegna F, 2004, EXP BRAIN RES, V157, P468, DOI 10.1007/s00221-004-1860-y; Saunders JA, 2004, J NEUROSCI, V24, P3223, DOI 10.1523/JNEUROSCI.4319-03.2004; Saunders JA, 2003, EXP BRAIN RES, V152, P341, DOI 10.1007/s00221-003-1525-2; Scheidt RA, 2005, J NEUROPHYSIOL, V93, P3200, DOI 10.1152/jn.00947.2004; Selen LPJ, 2005, BIOL CYBERN, V93, P373, DOI 10.1007/s00422-005-0015-y; Selen LPJ, 2006, EXP BRAIN RES, V172, P129, DOI 10.1007/s00221-005-0320-7; Sergio LE, 1998, EXP BRAIN RES, V122, P157, DOI 10.1007/s002210050503; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; SOECHTING JF, 1988, J NEUROPHYSIOL, V59, P1296, DOI 10.1152/jn.1988.59.4.1296; Takahashi CD, 2001, J NEUROPHYSIOL, V86, P1047, DOI 10.1152/jn.2001.86.2.1047; Tong C, 2002, J NEUROSCI, V22, P1108, DOI 10.1523/JNEUROSCI.22-03-01108.2002; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Vetter P, 2000, J NEUROPHYSIOL, V84, P1026, DOI 10.1152/jn.2000.84.2.1026; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	63	64	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1336	10.1371/journal.pone.0001336	http://dx.doi.org/10.1371/journal.pone.0001336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18092002	gold, Green Published			2022-12-27	WOS:000207459600020
J	Huang, AM; Rudelius, M; Sharan, S; McAllister, JM; Raffeld, M; Christenson, LK; Sterneck, E				Huang, A-Mei; Rudelius, Martina; Sharan, Shikha; McAllister, Jan M.; Raffeld, Mark; Christenson, Lane K.; Sterneck, Esta			The Cebpd (C/EBP delta) Gene Is Induced by Luteinizing Hormones in Ovarian Theca and Interstitial Cells But Is Not Essential for Mouse Ovary Function	PLOS ONE			English	Article								The CCAAT/enhancer binding protein (CEBP) family of transcription factors includes five genes. In the ovary, both Cebpa and Cebpb are essential for granulosa cell function. In this study we have explored the role of the Cebpd gene in ovarian physiology by expression and functional studies. Here we report that Cebpd (C/EBPd) is expressed in the mouse ovary in a highly restricted temporal and spatial pattern. In response to luteinizing hormone (LH/hCG), CEBPD expression is transiently induced in interstitial cells and in theca cells of follicles from the primary to pre-ovulatory stage, and overlaps in part with expression of the alpha-smooth muscle actin protein. Efficient down-regulation of CEBPD was dependent on a functional Cebpb gene. Proliferating human theca cells in culture also express Cebpd. Cells from patients with polycystic ovarian syndrome (PCOS) exhibited higher Cebpd expression levels. However, deletion of Cebpd in mice had no overt effect on ovarian physiology and reproductive function. Very little is known at present about the molecular mechanisms underlying theca/interstitial cell functions. The expression pattern of CEBPD reported here identifies a novel functional unit of mouse theca cells of primary through tertiary follicles responding to LH/hCG together with a subset of interstitial cells. This acute stimulation of CEBPD expression may be exploited to further characterize the hormonal regulation and function of theca and interstitial cells.	[Huang, A-Mei; Sharan, Shikha; Sterneck, Esta] NCI, Ctr Canc Res, Frederick, MD 21701 USA; [Rudelius, Martina; Raffeld, Mark] NCI, Pathol Lab, Bethesda, MD 20892 USA; [McAllister, Jan M.] Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA USA; [Christenson, Lane K.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Kansas; University of Kansas Medical Center	Sterneck, E (corresponding author), NCI, Ctr Canc Res, Frederick, MD 21701 USA.	sterneck@ncifcrf.gov	Christenson, Lane K/G-6435-2013	Sterneck, Esta/0000-0001-7716-8766; Huang, A-Mei/0000-0003-3723-0443	Intramural Research Program of the NIH; National Cancer Institute; National Institutes of Child Health and Human Development [HD045519]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD045519] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, and the National Institutes of Child Health and Human Development (HD045519; L.K.C).	Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Billiard J, 2001, J BIOL CHEM, V276, P31238, DOI 10.1074/jbc.M103634200; Breed DR, 1997, ENDOCRINOLOGY, V138, P5527, DOI 10.1210/en.138.12.5527; Carvalho CRO, 2003, ENDOCRINOLOGY, V144, P638, DOI 10.1210/en.2002-220706; Cassel TN, 2000, AM J RESP CELL MOL, V22, P469, DOI 10.1165/ajrcmb.22.4.3916; Chiang MC, 1997, COMP BIOCHEM PHYS A, V116, P361, DOI 10.1016/S0300-9629(96)00375-1; Christenson LK, 2001, J BIOL CHEM, V276, P27392, DOI 10.1074/jbc.M101650200; Fukuoka T, 1999, J BIOL CHEM, V274, P25576, DOI 10.1074/jbc.274.36.25576; Gigliotti AP, 2003, EXP BIOL MED, V228, P278, DOI 10.1177/153537020322800306; GUDERMANN T, 1992, MOL ENDOCRINOL, V6, P272, DOI 10.1210/me.6.2.272; Huang AM, 2004, ONCOGENE, V23, P1549, DOI 10.1038/sj.onc.1207285; Jansen E, 2004, MOL ENDOCRINOL, V18, P3050, DOI 10.1210/me.2004-0074; Mizutani T, 2001, MOL ENDOCRINOL, V15, P1693, DOI 10.1210/me.15.10.1693; Nelson VL, 1999, MOL ENDOCRINOL, V13, P946, DOI 10.1210/me.13.6.946; Nelson VL, 2001, J CLIN ENDOCR METAB, V86, P5925, DOI 10.1210/jc.86.12.5925; O'Rourke JP, 1999, J BIOL CHEM, V274, P16582, DOI 10.1074/jbc.274.23.16582; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Richards JS, 2001, ENDOCRINOLOGY, V142, P2184, DOI 10.1210/en.142.6.2184; RICKLES RJ, 1988, J BIOL CHEM, V263, P1563; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Russell DL, 2003, MOL ENDOCRINOL, V17, P520, DOI 10.1210/me.2002-0066; Sekar N, 2001, ENDOCRINOLOGY, V142, P2921, DOI 10.1210/en.142.7.2921; SIROIS J, 1992, J BIOL CHEM, V267, P11586; Sterneck E, 1996, J NEUROCHEM, V67, P1365; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Sterneck E, 2000, SERONO SYMP, P277; Sugahara K, 1999, CELL TISSUE RES, V297, P261, DOI 10.1007/s004410051354; Takiguchi M, 1998, INT J EXP PATHOL, V79, P369, DOI 10.1046/j.1365-2613.1998.00082.x; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; TESSAROLLO L, 1995, METHOD ENZYMOL, V254, P419; TEUBNER A, 1994, CELL TISSUE RES, V276, P535, DOI 10.1007/BF00343950; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Tremblay JJ, 2003, J STEROID BIOCHEM, V85, P291, DOI 10.1016/S0960-0760(03)00211-5; Umayahara Y, 1997, J BIOL CHEM, V272, P31793, DOI 10.1074/jbc.272.50.31793; Wood JR, 2003, J BIOL CHEM, V278, P26380, DOI 10.1074/jbc.M300688200	37	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1334	10.1371/journal.pone.0001334	http://dx.doi.org/10.1371/journal.pone.0001334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18092000	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459600018
J	So, PW; Yu, WS; Kuo, YT; Wasserfall, C; Goldstone, AP; Bell, JD; Frost, G				So, Po-Wah; Yu, Wei-Sheng; Kuo, Yu-Ting; Wasserfall, Clive; Goldstone, Anthony P.; Bell, Jimmy D.; Frost, Gary			Impact of Resistant Starch on Body Fat Patterning and Central Appetite Regulation	PLOS ONE			English	Article								Background. Adipose tissue patterning has a major influence on the risk of developing chronic disease. Environmental influences on both body fat patterning and appetite regulation are not fully understood. This study was performed to investigate the impact of resistant starch (RS) on adipose tissue deposition and central regulation of appetite in mice. Methodology and Principle Findings. Forty mice were randomised to a diet supplemented with either the high resistant starch (HRS), or the readily digestible starch (LRS). Using 1 H magnetic resonance (MR) methods, whole body adiposity, intrahepatocellular lipids (IHCL) and intramyocellular lipids (IMCL) were measured. Manganese-enhanced MRI (MEMRI) was used to investigate neuronal activity in hypothalamic regions involved in appetite control when fed ad libitum. At the end of the interventional period, adipocytes were isolated from epididymal adipose tissue and fasting plasma collected for hormonal and adipokine measurement. Mice on the HRS and LRS diet had similar body weights although total body adiposity, subcutaneous and visceral fat, IHCL, plasma leptin, plasma adiponectin plasma insulin/glucose ratios was significantly greater in the latter group. Adipocytes isolated from the LRS group were significantly larger and had lower insulin-stimulated glucose uptake. MEMRI data obtained from the ventromedial and paraventricular hypothalamic nuclei suggests a satiating effect of the HRS diet despite a lower energy intake. Conclusion and Significance. Dietary RS significantly impacts on adipose tissue patterning, adipocyte morphology and metabolism, glucose and insulin metabolism, as well as affecting appetite regulation, supported by changes in neuronal activity in hypothalamic appetite regulation centres which are suggestive of satiation.	[Frost, Gary] Univ Surrey, Sch Biomed & Mol Sci, Dept Nutr Dietet & Food Sci, Guildford GU2 5XH, Surrey, England; [So, Po-Wah] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Imaging Sci Dept, Biol Imaging Ctr, London, England; [Yu, Wei-Sheng; Kuo, Yu-Ting; Goldstone, Anthony P.; Bell, Jimmy D.] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Imaging Sci Dept, Mol Imaging Grp, London, England; [Kuo, Yu-Ting] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung Med Univ Hosp,Dept Med Imaging, Kaohsiung, Taiwan; [Kuo, Yu-Ting] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung Med Univ Hosp,Dept Radiol, Kaohsiung, Taiwan; [Wasserfall, Clive] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA	University of Surrey; Imperial College London; Imperial College London; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; State University System of Florida; University of Florida	Frost, G (corresponding author), Univ Surrey, Sch Biomed & Mol Sci, Dept Nutr Dietet & Food Sci, Guildford GU2 5XH, Surrey, England.	g.frost@surrey.ac.uk	wasserfall, clive/J-9078-2012; Wasserfall, Clive/ABF-9385-2020; So, Po-Wah/B-5892-2012; So, Po-Wah/AAJ-5501-2020	wasserfall, clive/0000-0002-3522-8932; Wasserfall, Clive/0000-0002-3522-8932; So, Po-Wah/0000-0003-3449-8532; Bell, Jimmy/0000-0003-3804-1281; Goldstone, Anthony/0000-0001-8179-7071	MRC; BBSRC; Wellcome Trust; Medical Research Council [MC_U120061305] Funding Source: researchfish; MRC [MC_U120061305] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: The MRC and BBSRC are acknowledged for financial support. The Wellcome Trust is acknowledged for funding the Biological Imaging Centre facility and Ivan Nelson Olivares Coronel por inspiratio. None of the funders had any influence on the conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Anderson GH, 2003, NUTR REV, V61, pS17, DOI 10.1301/nr.2003.may.S17-S26; BJORNTORP P, 1985, ANN INTERN MED, V103, P994, DOI 10.7326/0003-4819-103-6-994; Bouche C, 2002, DIABETES CARE, V25, P822, DOI 10.2337/diacare.25.5.822; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Chaudhri OB, 2006, BIOCHEM BIOPH RES CO, V350, P298, DOI 10.1016/j.bbrc.2006.09.033; *DEFRA, 2006, FAM FOOD REP EXP FOO; Degawa-Yamauchi M, 2005, OBES RES, V13, P662, DOI 10.1038/oby.2005.74; Delzenne NM, 2005, BRIT J NUTR, V93, pS157, DOI 10.1079/BJN20041342; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Frost G, 1996, METABOLISM, V45, P669, DOI 10.1016/S0026-0495(96)90129-8; Frost G, 1998, METABOLISM, V47, P1245, DOI 10.1016/S0026-0495(98)90331-6; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Huypens P, 2006, HORM METAB RES, V38, P486, DOI 10.1055/s-2006-949520; Kabir M, 1998, J NUTR, V128, P35, DOI 10.1093/jn/128.1.35; Kasim-Karakas SE, 2006, AM J CLIN NUTR, V83, P774, DOI 10.1093/ajcn/83.4.774; Keenan MJ, 2006, OBESITY, V14, P1523, DOI 10.1038/oby.2006.176; KUO Y, 2007, J NEUROSCIE IN PRESS; Kuo YT, 2006, NMR BIOMED, V19, P1028, DOI 10.1002/nbm.1070; Lee K, 2005, ENDOCRINOLOGY, V146, P3, DOI 10.1210/en.2004-0968; Ludwig DS, 2003, LIPIDS, V38, P117, DOI 10.1007/s11745-003-1040-x; Ludwig DS, 1999, JAMA-J AM MED ASSOC, V282, P1539, DOI 10.1001/jama.282.16.1539; MacLean PS, 2006, AM J PHYSIOL-REG I, V290, pR1577, DOI 10.1152/ajpregu.00810.2005; MacLean PS, 2004, AM J PHYSIOL-REG I, V287, pR288, DOI 10.1152/ajpregu.00010.2004; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; Mystkowski P, 2000, INT J OBESITY, V24, P719, DOI 10.1038/sj.ijo.0801231; Nowak L, 2005, AM J HYPERTENS, V18, P1470, DOI 10.1016/j.amjhyper.2005.05.026; Pagano G, 2002, HEPATOLOGY, V35, P367, DOI 10.1053/jhep.2002.30690; Pawlak DB, 2004, LANCET, V364, P778, DOI 10.1016/S0140-6736(04)16937-7; Paxinos G., 2001, MOUSE BRAIN STEREOTA, P1; Peraldi P, 1996, J BIOL CHEM, V271, P13018, DOI 10.1074/jbc.271.22.13018; Perez C, 2004, DIABETES, V53, P347, DOI 10.2337/diabetes.53.2.347; Robertson MD, 2007, P NUTR SOC, V66, P351, DOI 10.1017/S0029665107005617; Robertson MD, 2005, AM J CLIN NUTR, V82, P559, DOI 10.1093/ajcn/82.3.559; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; So PW, 2005, INT J OBESITY, V29, P603, DOI 10.1038/sj.ijo.0802917; Thomas EL, 2005, GUT, V54, P122, DOI 10.1136/gut.2003.036566; Ueno N, 2004, ENDOCRINOLOGY, V145, P4176, DOI 10.1210/en.2004-0262; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; *WHO, 2007, OB HLTH; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Yao MJ, 2001, NUTR REV, V59, P247; Zhang Y, 2002, BBA-MOL CELL BIOL L, V1584, P115, DOI 10.1016/S1388-1981(02)00298-6	44	91	96	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1309	10.1371/journal.pone.0001309	http://dx.doi.org/10.1371/journal.pone.0001309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074032	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459500027
J	Agca, C; Donkin, SS				Agca, Cansu; Donkin, Shawn S.			Expression of Pyruvate Carboxylase mRNA Variants in Liver of Dairy Cattle at Calving	PLOS ONE			English	Article								Background. Bovine liver expresses six pyruvate carboxylase (PC) transcript variants, bPC5'A, bPC5'B, bPC5'C, bPC5'D, bPC5'E, and bPC5'F, which only differ at the 5' untranslated region (UTR) and contain a common coding region. The objective of this experiment was to determine the profile and abundance of PC transcripts in bovine liver at calving. Methodology/Principal Findings. A ribonuclease protection assay (RPA) protocol was developed to simplify analysis of these variants and investigate the changes in abundance of each 5' UTR transcript relative to total PC mRNA. Liver biopsy samples collected from seven cows on +1 d relative to calving were analyzed by RPA to determine the profile in PC 5' UTR variants. Results show that all six bovine PC 5' UTR variants are detected at calving. Data indicate that bovine PC 5' UTR variant A is the most abundant, variants C and E are least abundant and expression of variants B, D and F is intermediate at calving. Conclusions. This manuscript describes a simplified RPA method that quantifies the abundance of six PC transcripts by using two riboprobes. The lack of uniformity in the pattern of PC 5' UTR variants at calving suggests an additional complexity for control of bovine PC mRNA expression at calving that may be the result of transcriptional controls, variation in mRNA processing, or a combination of these processes.	[Agca, Cansu; Donkin, Shawn S.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Donkin, SS (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	sdonkin@purdue.edu		Donkin, Shawn/0000-0003-3571-4946	Purdue University Agricultural Research Programs [17,457]; USDA Cooperative State Research, Education, and Extension Service [2001-35206-11265];  [NC-1009]	Purdue University Agricultural Research Programs; USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); 	This project was supported in part through funds from the Purdue University Agricultural Research Programs (paper no. 17,457) as a contribution to North Central Regional project NC-1009 and was supported by National Research Initiative Competitive Grant no. 2001-35206-11265 from the USDA Cooperative State Research, Education, and Extension Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca C, 2004, ANIM BIOTECHNOL, V15, P47, DOI 10.1081/ABIO-120037897; Bradford BJ, 2005, J NUTR, V135, P2206, DOI 10.1093/jn/135.9.2206; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Greenfield RB, 2000, J DAIRY SCI, V83, P1228, DOI 10.3168/jds.S0022-0302(00)74989-7; Hartwell JR, 2001, J DAIRY SCI, V84, P490, DOI 10.3168/jds.S0022-0302(01)74499-2; Jiang HL, 2001, GENE, V265, P45, DOI 10.1016/S0378-1119(01)00356-0; Jitrapakdee S, 2006, CELL MOL LIFE SCI, V63, P843, DOI 10.1007/s00018-005-5410-y; Jitrapakdee S, 1996, BIOCHEM BIOPH RES CO, V223, P695, DOI 10.1006/bbrc.1996.0958; Jitrapakdee S, 2001, BIOCHEM BIOPH RES CO, V287, P411, DOI 10.1006/bbrc.2001.5599; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; Jitrapakdee S, 1997, J BIOL CHEM, V272, P20522, DOI 10.1074/jbc.272.33.20522; Jitrapakdee S, 1998, J BIOL CHEM, V273, P34422, DOI 10.1074/jbc.273.51.34422; KrausFriedmann N, 1996, METABOLISM, V45, P389, DOI 10.1016/S0026-0495(96)90296-6; LOPEZCASILLAS F, 1992, METABOLISM, V41, P201, DOI 10.1016/0026-0495(92)90154-3; Parker EM, 1999, J NEUROCHEM, V73, P913, DOI 10.1046/j.1471-4159.1999.0730913.x; PEKHLETSKY RI, 1992, MOL CELL ENDOCRINOL, V90, P103, DOI 10.1016/0303-7207(92)90107-H; REYNOLDS CK, 1988, J DAIRY SCI, V71, P1803, DOI 10.3168/jds.S0022-0302(88)79749-0; She P, 1999, J DAIRY SCI, V82, P1118, DOI 10.3168/jds.S0022-0302(99)75335-X; Velez JC, 2005, J DAIRY SCI, V88, P2938, DOI 10.3168/jds.S0022-0302(05)72974-X; WEINBERG MB, 1979, J BIOL CHEM, V254, P9492	20	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1270	10.1371/journal.pone.0001270	http://dx.doi.org/10.1371/journal.pone.0001270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060064	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459400017
J	Dong, T; Moran, E; Nguyen, VC; Simmons, C; Luhn, K; Peng, YC; Wills, B; Nguyen, PD; Le, TTT; Tran, TH; McMichael, A; Farrar, J; Rowland-Jones, S				Dong, Tao; Moran, Edward; Nguyen Vinh Chau; Simmons, Cameron; Luhn, Kerstin; Peng, Yanchun; Wills, Bridget; Nguyen Phuong Dung; Le Thi Thu Thao; Tran Tinh Hien; McMichael, Andrew; Farrar, Jeremy; Rowland-Jones, Sarah			High Pro-Inflammatory Cytokine Secretion and Loss of High Avidity Cross-Reactive Cytotoxic T-Cells during the Course of Secondary Dengue Virus Infection	PLOS ONE			English	Article							ORIGINAL ANTIGENIC SIN; FACTOR-ALPHA LEVELS; ANTIBODY-RESPONSE; LYMPHOCYTES; ACTIVATION; CTL; PATHOGENESIS; APOPTOSIS; DELETION; IMMUNOPATHOGENESIS	Background. Dengue is one of the most important human diseases transmitted by an arthropod vector and the incidence of dengue virus infection has been increasing - over half the world's population now live in areas at risk of infection. Most infections are asymptomatic, but a subset of patients experience a potentially fatal shock syndrome characterised by plasma leakage. Severe forms of dengue are epidemiologically associated with repeated infection by more than one of the four dengue virus serotypes. Generally attributed to the phenomenon of antibody-dependent enhancement, recent observations indicate that T-cells may also influence disease phenotype. Methods and Findings. Virus-specific cytotoxic T lymphocytes (CTL) showing high level cross reactivity between dengue serotypes could be expanded from blood samples taken during the acute phase of secondary dengue infection. These could not be detected in convalescence when only CTL populations demonstrating significant serotype specificity were identified. Dengue cross-reactive CTL clones derived from these patients were of higher avidity than serotype-specific clones and produced much higher levels of both type 1 and certain type 2 cytokines, many previously implicated in dengue pathogenesis. Conclusion. Dengue serotype cross-reactive CTL clones showing high avidity for antigen produce higher levels of inflammatory cytokines than serotype-specific clones. That such cells cannot be expanded from convalescent samples suggests that they may be depleted, perhaps as a consequence of activation-induced cell death. Such high avidity cross-reactive memory CTL may produce inflammatory cytokines during the course of secondary infection, contributing to the pathogenesis of vascular leak. These cells appear to be subsequently deleted leaving a more serotype-specific memory CTL pool. Further studies are needed to relate these cellular observations to disease phenotype in a large group of patients. If confirmed they have significant implications for understanding the role of virus-specific CTL in pathogenesis of dengue disease.	[Dong, Tao; Moran, Edward; Luhn, Kerstin; Peng, Yanchun; McMichael, Andrew; Rowland-Jones, Sarah] John Radcliffe Hosp, Weatherall Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DU, England; [Simmons, Cameron; Wills, Bridget; Nguyen Phuong Dung; Farrar, Jeremy] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; [Nguyen Vinh Chau; Le Thi Thu Thao; Tran Tinh Hien] Hosp Trop Dis, Ho Chi Minh City, Vietnam	University of Oxford; University of Oxford	Dong, T (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DU, England.	tao.dong@imm.ox.ac.uk; edward.moran@imm.ox.ac.uk	Simmons, Cameron P/ABA-3896-2021; Farrar, Jeremy J./HGA-7610-2022	Simmons, Cameron P/0000-0002-9039-7392; Wills, Bridget/0000-0001-9086-8804; Farrar, Jeremy/0000-0002-2700-623X; Dong, Tao/0000-0003-3545-3758	Medical Research Council, UK; Wellcome Trust; European Molecular Biology Organisation; Medical Research Council [MC_U137884180, G0600520] Funding Source: researchfish; MRC [MC_U137884180, G0600520] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Molecular Biology Organisation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council, UK ( T. D., Y. C. P., A. M., S. R. J.) and the Wellcome Trust (N. V. C, C. S., B. W., N. P. D., J. F.). K. L. has a long-term fellowship from the European Molecular Biology Organisation. E. M. is a Wellcome Trust Clinical Research Training fellow.	Alexander-Miller MA, 1998, J EXP MED, V188, P1391, DOI 10.1084/jem.188.8.1391; AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Bashyam HS, 2006, J IMMUNOL, V176, P2817, DOI 10.4049/jimmunol.176.5.2817; Brehm MA, 2004, CELL MICROBIOL, V6, P411, DOI 10.1111/j.1462-5822.2004.00390.x; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Choi EML, 2003, J IMMUNOL, V171, P5116, DOI 10.4049/jimmunol.171.10.5116; Dong T, 1996, EUR J IMMUNOL, V26, P335, DOI 10.1002/eji.1830260210; Dong T, 2004, J EXP MED, V200, P1547, DOI 10.1084/jem.20032044; Drake DR, 2005, J IMMUNOL, V175, P1507, DOI 10.4049/jimmunol.175.3.1507; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311; HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830; HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324; Hober D, 1998, J MED VIROL, V54, P210, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt;210::AID-JMV12&gt;3.0.CO;2-L; KANMITCHELL JBB, 2004, J IMMUNOL       0401, P5249; Kittigul L, 2000, J VIROL METHODS, V90, P51, DOI 10.1016/S0166-0934(00)00215-9; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; KURANE I, 1991, J CLIN INVEST, V88, P1473, DOI 10.1172/JCI115457; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; MA H, 2000, J IMMUNOL       0601, P5698; Ma HL, 2001, CELL IMMUNOL, V214, P89, DOI 10.1006/cimm.2001.1884; McKee MD, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-35; Molldrem JJ, 2003, J CLIN INVEST, V111, P639, DOI 10.1172/JCI200316398; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; Mustafa AS, 2001, FEMS IMMUNOL MED MIC, V30, P229, DOI 10.1111/j.1574-695X.2001.tb01575.x; Perez AB, 2004, J MED VIROL, V73, P230, DOI 10.1002/jmv.20080; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Price DA, 1998, CURR BIOL, V8, P355, DOI 10.1016/S0960-9822(98)70138-1; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; Rothman AL, 2003, ADV VIRUS RES, V60, P397, DOI 10.1016/S0065-3527(03)60010-2; Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Snyder JT, 2003, CURR HIV RES, V1, P287, DOI 10.2174/1570162033485230; Speiser DE, 1996, EUR J IMMUNOL, V26, P3055, DOI 10.1002/eji.1830261235; Sytwu HK, 1996, IMMUNITY, V5, P17, DOI 10.1016/S1074-7613(00)80306-4; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693; Vazquez S, 2003, CLIN DIAGN LAB IMMUN, V10, P1074, DOI 10.1128/CDLI.10.6.1074-1077.2003; WHO, 1997, DENG HAEM FEV DIAGN; Xu XN, 2001, IMMUNITY, V14, P591, DOI 10.1016/S1074-7613(01)00133-9; Zeh HJ, 1999, J IMMUNOL, V162, P989; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; Zivny J, 1999, J IMMUNOL, V163, P2754	51	76	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1192	10.1371/journal.pone.0001192	http://dx.doi.org/10.1371/journal.pone.0001192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060049	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459400001
J	Lotscher, M; Recher, M; Lang, KS; Navarini, A; Hunziker, L; Santimaria, R; Glatzel, M; Schwarz, P; Boni, J; Zinkernagel, RM				Loetscher, Marius; Recher, Mike; Lang, Karl S.; Navarini, Alexander; Hunziker, Lukas; Santimaria, Roger; Glatzel, Markus; Schwarz, Petra; Boeni, Juerg; Zinkernagel, Rolf M.			Induced Prion Protein Controls Immune-Activated Retroviruses in the Mouse Spleen	PLOS ONE			English	Article								The prion protein (PrP) is crucially involved in transmissible spongiform encephalopathies (TSE), but neither its exact role in disease nor its physiological function are known. Here we show for mice, using histological, immunochemical and PCR-based methods, that stimulation of innate resistance was followed by appearance of numerous endogenous retroviruses and ensuing PrP up-regulation in germinal centers of the spleen. Subsequently, the activated retroviruses disappeared in a PrP-dependent manner. Our results reveal the regular involvement of endogenous retroviruses in murine immune responses and provide evidence for an essential function of PrP in the control of the retroviral activity. The interaction between PrP and ubiquitous endogenous retroviruses may allow new interpretations of TSE pathophysiology and explain the evolutionary conservation of PrP.	[Loetscher, Marius; Recher, Mike; Lang, Karl S.; Navarini, Alexander; Hunziker, Lukas; Santimaria, Roger; Zinkernagel, Rolf M.] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Glatzel, Markus; Schwarz, Petra] Univ Zurich, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Boeni, Juerg] Univ Zurich, Swiss Natl Ctr Retroviruses, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich	Lotscher, M (corresponding author), CSL Behring AG, Bern, Switzerland.	marius.loetscher@cslbehring.com	Boeni, Juerg/B-8386-2015; Lang, Karl S/R-2505-2016; Glatzel, Markus/V-8844-2019; Navarini, Alexander/C-5504-2014; Glatzel, Markus/G-3356-2011	Glatzel, Markus/0000-0002-7720-8817; Navarini, Alexander/0000-0001-7059-632X; Glatzel, Markus/0000-0002-7720-8817; Lang, Karl/0000-0001-9783-7605; Recher, Mike/0000-0002-9121-6936; Hunziker, Lukas/0000-0003-0081-8518	Swiss National Science Foundation; Novartis Stiftung; EMDO Stiftung Zurich; Jubilaumsstiftung der Schweizerischen Mobiliar Genossenschaft	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Stiftung; EMDO Stiftung Zurich; Jubilaumsstiftung der Schweizerischen Mobiliar Genossenschaft	The work was supported in part by grants from the Swiss National Science Foundation, the Novartis Stiftung, the EMDO Stiftung Zurich, and the Jubilaumsstiftung der Schweizerischen Mobiliar Genossenschaft (all to ML).	Adler V, 2003, J MOL BIOL, V332, P47, DOI 10.1016/S0022-2836(03)00919-7; Baker CA, 2004, J NEUROVIROL, V10, P29, DOI 10.1080/13550280490261761; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Boni J, 1996, J MED VIROL, V49, P23, DOI 10.1002/(SICI)1096-9071(199605)49:1&lt;23::AID-JMV4&gt;3.0.CO;2-M; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Chesebro B, 2003, BRIT MED BULL, V66, P1, DOI 10.1093/bmb/66.1.1; Corcoran LM, 1999, J IMMUNOL, V163, P5836; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; EVANS LH, 1990, J VIROL, V64, P6176, DOI 10.1128/JVI.64.12.6176-6183.1990; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; Leblanc P, 2004, J MOL BIOL, V337, P1035, DOI 10.1016/j.jmb.2004.02.007; Leblanc P, 2006, EMBO J, V25, P2674, DOI 10.1038/sj.emboj.7601162; Lee KH, 2006, BIOCHEM BIOPH RES CO, V349, P122, DOI 10.1016/j.bbrc.2006.08.016; Lotscher M, 2003, J IMMUNOL, V170, P6040, DOI 10.4049/jimmunol.170.12.6040; Lower R, 1999, TRENDS MICROBIOL, V7, P350, DOI 10.1016/S0966-842X(99)01565-6; McVicar DW, 2002, J IMMUNOL, V169, P1721, DOI 10.4049/jimmunol.169.4.1721; Mironov A, 2003, J NEUROSCI, V23, P7183, DOI 10.1523/JNEUROSCI.23-18-07183.2003; MORONI C, 1977, NATURE, V269, P600, DOI 10.1038/269600a0; Nelson PN, 2003, J CLIN PATHOL-MOL PA, V56, P11, DOI 10.1136/mp.56.1.11; Nishida N, 2005, SCIENCE, V310, P493, DOI 10.1126/science.1118155; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; SAKAGUCHI S, 1995, J VIROL, V69, P7586, DOI 10.1128/JVI.69.12.7586-7592.1995; Sayer NM, 2004, J BIOL CHEM, V279, P13102, DOI 10.1074/jbc.M310928200; Stengel A, 2006, BIOCHEM BIOPH RES CO, V343, P825, DOI 10.1016/j.bbrc.2006.03.021; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; WEISSMANN C, 1991, NATURE, V352, P679, DOI 10.1038/352679a0; WESTERGARD L, 2007, BIOCHIM BIOPHYS ACTA, V2, P2; White P, 2002, J IMMUNOL, V168, P869, DOI 10.4049/jimmunol.168.2.869; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831	36	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1158	10.1371/journal.pone.0001158	http://dx.doi.org/10.1371/journal.pone.0001158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987132	Green Published, gold			2022-12-27	WOS:000207459000040
J	Sass, C; Little, DP; Stevenson, DW; Specht, CD				Sass, Chodon; Little, Damon P.; Stevenson, Dennis Wm.; Specht, Chelsea D.			DNA Barcoding in the Cycadales: Testing the Potential of Proposed Barcoding Markers for Species Identification of Cycads	PLOS ONE			English	Article							CHLOROPLAST GENOME; LAND PLANTS; NUCLEAR; GENE; ALIGNMENT; TAXONOMY; SEQUENCE; RATES; TERM; TALE	Barcodes are short segments of DNA that can be used to uniquely identify an unknown specimen to species, particularly when diagnostic morphological features are absent. These sequences could offer a new forensic tool in plant and animal conservation-especially for endangered species such as members of the Cycadales. Ideally, barcodes could be used to positively identify illegally obtained material even in cases where diagnostic features have been purposefully removed or to release confiscated organisms into the proper breeding population. In order to be useful, a DNA barcode sequence must not only easily PCR amplify with universal or near-universal reaction conditions and primers, but also contain enough variation to generate unique identifiers at either the species or population levels. Chloroplast regions suggested by the Plant Working Group of the Consortium for the Barcode of Life (CBoL), and two alternatives, the chloroplast psbA-trnH intergenic spacer and the nuclear ribosomal internal transcribed spacer (nrITS), were tested for their utility in generating unique identifiers for members of the Cycadales. Ease of amplification and sequence generation with universal primers and reaction conditions was determined for each of the seven proposed markers. While none of the proposed markers provided unique identifiers for all species tested, nrITS showed the most promise in terms of variability, although sequencing difficulties remain a drawback. We suggest a workflow for DNA barcoding, including database generation and management, which will ultimately be necessary if we are to succeed in establishing a universal DNA barcode for plants.	[Sass, Chodon; Specht, Chelsea D.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Little, Damon P.; Stevenson, Dennis Wm.] New York Bot Garden, Cullman Program Mol Systemat Studies, Bronx, NY 10458 USA	University of California System; University of California Berkeley; New York Botanical Garden	Specht, CD (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	cdspecht@nature.berkeley.edu	赵, 鹏/B-8401-2009	Specht, Chelsea/0000-0001-7746-512X	University of California; Berkeley College of Natural Resources; Committee on Research; Department of Plant and Microbial Biology	University of California(University of California System); Berkeley College of Natural Resources; Committee on Research; Department of Plant and Microbial Biology	Funding: Partial funds were provided by University of California, Berkeley College of Natural Resources, the Committee on Research, and the Department of Plant and Microbial Biology. The funders had no involvement in the design and conduct of the study, in the collection, analysis and interpretation of the data, or in the preparation, review or approval of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chaw SM, 2005, MOL PHYLOGENET EVOL, V37, P214, DOI 10.1016/j.ympev.2005.01.006; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; *CITES, 2007, CONV INT TRAD END SP; DasGupa B, 2005, BIOINFORMATICS, V21, P3424, DOI 10.1093/bioinformatics/bti547; Dasgupta Bhaskar, 2005, Int J Bioinform Res Appl, V1, P145, DOI 10.1504/IJBRA.2005.007574; DONALDSON JS, 2003, CYCADS STATUS SURVEY; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Driscoll HE, 2007, AM J BOT, V94, P1413, DOI 10.3732/ajb.94.8.1413; Ebach MC, 2005, BIOSCIENCE, V55, P822; Gompert Z, 2006, MOL ECOL, V15, P1759, DOI 10.1111/j.1365-294X.2006.02905.x; Gonzalez D, 2002, SYST BOT, V27, P654; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hermsen EJ, 2006, AM J BOT, V93, P724, DOI 10.3732/ajb.93.5.724; HILL K, 2004, WORLD LIST CYCADE; Hill KD, 2003, INT J PLANT SCI, V164, P933, DOI 10.1086/378538; Jakob SS, 2006, MOL BIOL EVOL, V23, P1602, DOI 10.1093/molbev/msl018; JONES DL, 1993, CYCADS WORLD; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; LIDHOLM J, 1991, NUCLEIC ACIDS RES, V19, P2881, DOI 10.1093/nar/19.11.2881; LIDHOLM J, 1991, MOL GEN GENET, V226, P345, DOI 10.1007/BF00260645; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Maggini F, 1998, PLANT SYST EVOL, V213, P199, DOI 10.1007/BF00985200; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Presting GG, 2006, CAN J BOT, V84, P1434, DOI 10.1139/B06-117; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Stoeckle M, 2003, BIOSCIENCE, V53, P796, DOI 10.1641/0006-3568(2003)053[0796:TDATBC]2.0.CO;2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Whitelock L. M., 2002, The cycads; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wolf PG, 2003, DNA RES, V10, P59, DOI 10.1093/dnares/10.2.59	44	205	240	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1154	10.1371/journal.pone.0001154	http://dx.doi.org/10.1371/journal.pone.0001154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987130	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459000036
J	Branduardi, P; Fossati, T; Sauer, M; Pagani, R; Mattanovich, D; Porro, D				Branduardi, Paola; Fossati, Tiziana; Sauer, Michael; Pagani, Roberto; Mattanovich, Diethard; Porro, Danilo			Biosynthesis of Vitamin C by Yeast Leads to Increased Stress Resistance	PLOS ONE			English	Article								Background. In industrial large scale bio-reactions micro-organisms are generally exposed to a variety of environmental stresses, which might be detrimental for growth and productivity. Reactive oxygen species (ROS) play a key role among the common stress factors-directly-through incomplete reduction of O-2 during respiration, or indirectly-caused by other stressing factors. Vitamin C or L-ascorbic acid acts as a scavenger of ROS, thereby potentially protecting cells from harmful oxidative products. While most eukaryotes synthesize ascorbic acid, yeast cells produce erythro-ascorbic acid instead. The actual importance of this antioxidant substance for the yeast is still a subject of scientific debate. Methodology/Principal Findings. We set out to enable Saccharomyces cerevisiae cells to produce ascorbic acid intracellularly to protect the cells from detrimental effects of environmental stresses. We report for the first time the biosynthesis of L-ascorbic acid from D-glucose by metabolically engineered yeast cells. The amount of L-ascorbic acid produced leads to an improved robustness of the recombinant cells when they are subjected to stress conditions as often met during industrial fermentations. Not only resistance against oxidative agents as H2O2 is increased, but also the tolerance to low pH and weak organic acids at low pH is increased. Conclusions/Significance. This platform provides a new tool whose commercial applications may have a substantial impact on bio-industrial production of Vitamin C. Furthermore, we propose S. cerevisiae cells endogenously producing vitamin C as a cellular model to study the genesis/protection of ROS as well as genotoxicity.	[Branduardi, Paola; Fossati, Tiziana; Pagani, Roberto; Porro, Danilo] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Sauer, Michael; Mattanovich, Diethard] Univ Appl Sci, Sch Bioengn, Vienna, Austria; [Sauer, Michael; Mattanovich, Diethard] Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, Vienna, Austria	University of Milano-Bicocca; University of Natural Resources & Life Sciences, Vienna	Porro, D (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy.	danilo.porro@unimib.it	Sauer, Michael/A-4735-2009	Sauer, Michael/0000-0003-0510-2447; PORRO, DANILO/0000-0001-5723-3700; Mattanovich, Diethard/0000-0002-0907-4167	Tate and Lyle North America; University of Milano Bicocca	Tate and Lyle North America; University of Milano Bicocca	Funding: This work was partially supported by Tate and Lyle North America and the University of Milano Bicocca (Far 60%). No contribution was given.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bai ZH, 2003, CRIT REV BIOTECHNOL, V23, P267, DOI 10.1080/07388550390449294; Banhegyi G, 1997, FREE RADICAL BIO MED, V23, P793, DOI 10.1016/S0891-5849(97)00062-2; Brambilla L, 1999, FEMS MICROBIOL LETT, V171, P133, DOI 10.1111/j.1574-6968.1999.tb13423.x; Branduardi P, 2004, FEMS YEAST RES, V4, P493, DOI 10.1016/S1567-1356(03)00200-9; Bremus C, 2006, J BIOTECHNOL, V124, P196, DOI 10.1016/j.jbiotec.2006.01.010; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hancock RD, 2000, FEMS MICROBIOL LETT, V186, P245, DOI 10.1016/S0378-1097(00)00155-5; Hancock RD, 2002, TRENDS BIOTECHNOL, V20, P299, DOI 10.1016/S0167-7799(02)01991-1; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Huh WK, 1998, MOL MICROBIOL, V30, P895, DOI 10.1046/j.1365-2958.1998.01133.x; Huh WK, 2001, INFECT IMMUN, V69, P3939, DOI 10.1128/IAI.69.6.3939-3946.2001; KLIS FM, 1994, YEAST, V10, P851, DOI 10.1002/yea.320100702; KNEKT P, 1991, AM J EPIDEMIOL, V134, P471, DOI 10.1093/oxfordjournals.aje.a116118; LEVINE M, 1986, NEW ENGL J MED, V314, P892, DOI 10.1056/NEJM198604033141407; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Mattanovich D, 2004, J BIOTECHNOL, V113, P121, DOI 10.1016/j.jbiotec.2004.04.035; MINET M, 1992, PLANT J, V2, P417; Naidu KA, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-7; O'Brien TJ, 2003, MUTAT RES-FUND MOL M, V533, P3, DOI 10.1016/j.mrfmmm.2003.09.006; PADH H, 1990, BIOCHEM CELL BIOL, V68, P1166, DOI 10.1139/o90-173; PADH H, 1991, NUTR REV, V49, P65, DOI 10.1111/j.1753-4887.1991.tb07407.x; Pastuszak I, 1998, J BIOL CHEM, V273, P30165, DOI 10.1074/jbc.273.46.30165; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Sambrook J., 2002, MOL CLONING LAB MANU; SASAKI DT, 1987, CYTOMETRY, V8, P413, DOI 10.1002/cyto.990080411; Sauer M, 2004, APPL ENVIRON MICROB, V70, P6086, DOI 10.1128/AEM.70.10.6086-6091.2004; Spickett CM, 2000, FREE RADICAL BIO MED, V28, P183, DOI 10.1016/S0891-5849(99)00214-2; SULLIVAN MX, 1955, ASS OFF AGR CHEM, V38, P514; Survase SA, 2006, FOOD TECHNOL BIOTECH, V44, P381; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Trommer H, 2002, PHARM RES-DORDR, V19, P982, DOI 10.1023/A:1016414422106; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Xiao AF, 2006, APPL MICROBIOL BIOT, V72, P837, DOI 10.1007/s00253-006-0338-1	37	71	74	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1092	10.1371/journal.pone.0001092	http://dx.doi.org/10.1371/journal.pone.0001092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971855	Green Published, Green Submitted, gold			2022-12-27	WOS:000207458700009
J	Fouquet, A; Gilles, A; Vences, M; Marty, C; Blanc, M; Gemmell, NJ				Fouquet, Antoine; Gilles, Andre; Vences, Miguel; Marty, Christian; Blanc, Michel; Gemmell, Neil J.			Underestimation of Species Richness in Neotropical Frogs Revealed by mtDNA Analyses	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; GENETIC-DIVERGENCE; AMPHIBIAN DECLINES; DNA; SPECIATION; BIOGEOGRAPHY; DIVERSITY; ANURA; PHYLOGEOGRAPHY; POPULATIONS	Background. Amphibians are rapidly vanishing. At the same time, it is most likely that the number of amphibian species is highly underestimated. Recent DNA barcoding work has attempted to define a threshold between intra- and inter-specific genetic distances to help identify candidate species. In groups with high extinction rates and poorly known species boundaries, like amphibians, such tools may provide a way to rapidly evaluate species richness. Methodology. Here we analyse published and new 16S rDNA sequences from 60 frog species of Amazonia-Guianas to obtain a minimum estimate of the number of undescribed species in this region. We combined isolation by distance, phylogenetic analyses, and comparison of molecular distances to evaluate threshold values for the identification of candidate species among these frogs. Principal Findings. In most cases, geographically distant populations belong to genetically highly distinct lineages that could be considered as candidate new species. This was not universal among the taxa studied and thus widespread species of Neotropical frogs really do exist, contrary to previous assumptions. Moreover, the many instances of paraphyly and the wide overlap between distributions of inter- and intra-specific distances reinforce the hypothesis that many cryptic species remain to be described. In our data set, pairwise genetic distances below 0.02 are strongly correlated with geographical distances. This correlation remains statistically significant until genetic distance is 0.05, with no such relation thereafter. This suggests that for higher distances allopatric and sympatric cryptic species prevail. Based on our analyses, we propose a more inclusive pairwise genetic distance of 0.03 between taxa to target lineages that could correspond to candidate species. Conclusions. Using this approach, we identify 129 candidate species, two-fold greater than the 60 species included in the current study. This leads to estimates of around 170 to 460 frog taxa unrecognized in Amazonia-Guianas. Significance. As a consequence the global amphibian decline detected especially in the Neotropics may be worse than realised.	[Fouquet, Antoine; Gemmell, Neil J.] Univ Canterbury, Sch Biol Sci, Mol Ecol Lab, Christchurch 1, New Zealand; [Fouquet, Antoine; Gilles, Andre] Univ Aix Marseille 1, Ctr St Charles, EA EGEE Evolut Genome Environm 3781, Marseille, France; [Vences, Miguel] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Evolutionary Biol, D-3300 Braunschweig, Germany; [Blanc, Michel] RN2 PK35, Roura, French Guiana	University of Canterbury; UDICE-French Research Universities; Aix-Marseille Universite; Braunschweig University of Technology	Fouquet, A (corresponding author), Univ Canterbury, Sch Biol Sci, Mol Ecol Lab, Christchurch 1, New Zealand.	afo23@student.canterbury.ac.nz	Vences, Miguel/E-5573-2010; 赵, 鹏/B-8401-2009; Gemmell, Neil J/C-6774-2009	Gemmell, Neil J/0000-0003-0671-3637; Fouquet, Antoine/0000-0003-4060-0281; Vences, Miguel/0000-0003-0747-0817	College of Science, University of Canterbury, New Zealand Postgraduate Study Abroad Award; ECOFOR	College of Science, University of Canterbury, New Zealand Postgraduate Study Abroad Award; ECOFOR	AF is supported by a Scholarship from the College of Science, University of Canterbury. Field work was also supported by University of Canterbury College of Science, New Zealand Postgraduate Study Abroad Award and the EGEE laboratory which was supported by an ECOFOR grant.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; BERVEN KA, 1990, EVOLUTION, V44, P2047, DOI 10.1111/j.1558-5646.1990.tb04310.x; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Boistel Renaud, 2006, Acta Herpetologica, V1, P1; Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; BUSH MB, 1994, J BIOGEOGR, V21, P5, DOI 10.2307/2845600; Campbell JA, 2000, HERPETOL MONOGR, V14, P186, DOI 10.2307/1467048; Chek AA, 2003, EVOL ECOL RES, V5, P69; Chek AA, 2001, MOL PHYLOGENET EVOL, V18, P370, DOI 10.1006/mpev.2000.0889; CHERRY LM, 1977, AM ZOOL, V17, P910; CHERRY LM, 1978, SCIENCE, V200, P209, DOI 10.1126/science.635583; Collins AC, 2000, INT J PRIMATOL, V21, P421, DOI 10.1023/A:1005487802312; Collins JP, 2005, PHILOS T R SOC B, V360, P309, DOI 10.1098/rstb.2004.1588; Cortes-Ortiz L, 2003, MOL PHYLOGENET EVOL, V26, P64, DOI 10.1016/S1055-7903(02)00308-1; Crawford AJ, 2005, MOL PHYLOGENET EVOL, V35, P536, DOI 10.1016/j.ympev.2005.03.006; de Queiroz K, 1999, SPECIES, P49; DRAPER NR, 1990, APPL REGRESSION ANAL; Dubois A, 2005, ALYTES, V22, P19; Duellman W.E., 1982, P389; DUELLMAN WE, 2004, CUSCO AMAZONICO LIVE; Duellman WE, 1999, PATTERNS DISTRIBUTIO; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Emerson S.B., 1986, FIELDIANA ZOOL, V43, P1; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fouquet A, 2007, MOL PHYLOGENET EVOL, V43, P567, DOI 10.1016/j.ympev.2006.12.006; FRAILEY C D, 1988, Acta Amazonica, V18, P119; Fromhage L, 2004, MOL PHYLOGENET EVOL, V31, P308, DOI 10.1016/j.ympev.2003.07.009; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Garda AA, 2007, MOL PHYLOGENET EVOL, V44, P104, DOI 10.1016/j.ympev.2006.11.028; Gascon C, 1998, BIOTROPICA, V30, P104, DOI 10.1111/j.1744-7429.1998.tb00373.x; Gemmell NJ, 1996, TRENDS GENET, V12, P338, DOI 10.1016/S0168-9525(96)80005-9; Glaw Frank, 1998, Herpetological Review, V29, P11; Grant T, 2006, B AM MUS NAT HIST, P6; Grau ET, 2005, MOL PHYLOGENET EVOL, V35, P637, DOI 10.1016/j.ympev.2004.12.004; HACKETT SJ, 1990, AUK, V107, P473; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J., 1990, P45; Haffer J, 1997, BIODIVERS CONSERV, V6, P451, DOI 10.1023/A:1018320925954; Hanken J, 1999, TRENDS ECOL EVOL, V14, P7, DOI 10.1016/S0169-5347(98)01534-1; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kohler J, 2005, BIOSCIENCE, V55, P693, DOI 10.1641/0006-3568(2005)055[0693:NAAGCA]2.0.CO;2; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Kusano T, 1999, HERPETOL J, V9, P9; LESCURE J, 2000, PATRIMOINES NATURELS, V45, P388; Lougheed SC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-23; Lymberakis P, 2007, MOL PHYLOGENET EVOL, V44, P115, DOI 10.1016/j.ympev.2007.03.009; LYNCH JD, 1979, ITS ORIGIN EVOLUTION, P189; Martin PR, 2004, EVOLUTION, V58, P938; Meegaskumbura M, 2002, SCIENCE, V298, P379, DOI 10.1126/science.298.5592.379; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Mulcahy DG, 2006, J BIOGEOGR, V33, P1889, DOI 10.1111/j.1365-2699.2006.01546.x; Noonan BP, 2005, MOL ECOL, V14, P3017, DOI 10.1111/j.1365-294X.2005.02624.x; Noonan BP, 2006, J BIOGEOGR, V33, P1007, DOI 10.1111/j.1365-2699.2006.01483.x; Nores M, 1999, J BIOGEOGR, V26, P475, DOI 10.1046/j.1365-2699.1999.t01-1-00311.x; Parra-Olea G, 2001, P NATL ACAD SCI USA, V98, P7888, DOI 10.1073/pnas.131203598; PECHMANN JHK, 1994, HERPETOLOGICA, V50, P65; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pounds JA, 2004, NATURE, V427, P107, DOI 10.1038/427107a; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; READING CJ, 1991, J ZOOL, V225, P201, DOI 10.1111/j.1469-7998.1991.tb03811.x; Roberts JL, 2006, MOL PHYLOGENET EVOL, V41, P149, DOI 10.1016/j.ympev.2006.05.005; Roy D, 2002, J BIOSCIENCES, V27, P187, DOI 10.1007/BF02704906; Salazar-Bravo J, 2001, MOL PHYLOGENET EVOL, V20, P173, DOI 10.1006/mpev.2001.0965; Salducci MD, 2005, CR BIOL, V328, P1009, DOI 10.1016/j.crvi.2005.07.005; SHUBIN NH, 1995, NATURE, V377, P49, DOI 10.1038/377049a0; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; SMITH MA, 2007, MOL ECOLOGY IN PRESS; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Suatoni E, 2006, MOL PHYLOGENET EVOL, V41, P86, DOI 10.1016/j.ympev.2006.04.025; SWOFFORD DL, 1997, TEST VERSION 4 0 0D6; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van de Peer Y, 1998, NUCLEIC ACIDS RES, V26, P179, DOI 10.1093/nar/26.1.179; Veith M, 2003, MOL PHYLOGENET EVOL, V26, P310, DOI 10.1016/S1055-7903(02)00324-X; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vences M., 2006, HERPETOLOGICA BONNEN, P193; VENCES M, 2007, AMPHIBIAN BIOL, V7; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; WAKE DB, 1991, AM NAT, V138, P543, DOI 10.1086/285234; Wollenberg KC, 2006, COPEIA, P623, DOI 10.1643/0045-8511(2006)6[623:PVSROL]2.0.CO;2; Wynn A, 2001, TROP ZOOL, V14, P255, DOI 10.1080/03946975.2001.10531157; Young B.E., 2004, DISAPPEARING JEWELS	93	423	440	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1109	10.1371/journal.pone.0001109	http://dx.doi.org/10.1371/journal.pone.0001109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971872	Green Published, Green Submitted, gold			2022-12-27	WOS:000207458700026
J	Huang, YM; Genova, G; Roberts, M; Jackson, FR				Huang, Yanmei; Genova, Ginka; Roberts, Mary; Jackson, F. Rob			The LARK RNA-Binding Protein Selectively Regulates the Circadian Eclosion Rhythm by Controlling E74 Protein Expression	PLOS ONE			English	Article								Despite substantial progress in defining central components of the circadian pacemaker, the output pathways coupling the clock to rhythmic physiological events remain elusive. We previously showed that LARK is a Drosophila RNA-binding protein which functions downstream of the clock to mediate behavioral outputs. To better understand the roles of LARK in the circadian system, we sought to identify RNA molecules associated with it, in vivo, using a three-part strategy to (1) capture RNA ligands by immunoprecipitation, (2) visualize the captured RNAs using whole-genome microarrays, and (3) identify functionally relevant targets through genetic screens. We found that LARK is associated with a large number of RNAs, in vivo, consistent with its broad expression pattern. Overexpression of LARK increases protein abundance for certain targets without affecting RNA level, suggesting a translational regulatory role for the RNA-binding protein. Phenotypic screens of target-gene mutants have identified several with rhythm-specific circadian defects, indicative of effects on clock output pathways. In particular, a hypomorphic mutation in the E74 gene, E74(BG01805), was found to confer an early-eclosion phenotype reminiscent of that displayed by a mutant with decreased LARK gene dosage. Molecular analyses demonstrate that E74A protein shows diurnal changes in abundance, similar to LARK. In addition, the E74(BG01805) allele enhances the lethal phenotype associated with a lark null mutation, whereas overexpression of LARK suppresses the early eclosion phenotype of E74(BG01805), consistent with the idea that E74 is a target, in vivo. Our results suggest a model wherein LARK mediates the transfer of temporal information from the molecular oscillator to different output pathways by interacting with distinct RNA targets.	[Huang, Yanmei; Genova, Ginka; Roberts, Mary; Jackson, F. Rob] Tufts Univ, Sch Med, Dept Neurosci, Ctr Neurosci Res, Boston, MA 02111 USA	Tufts University	Jackson, FR (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Ctr Neurosci Res, Boston, MA 02111 USA.	rob.jackson@tufts.edu		Huang, Yanmei/0000-0003-0450-9173	Tufts University School of Medicine;  [NIH R01 HL59873];  [NIH P30 NS047243]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	Tufts University School of Medicine; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: This research was supported by NIH R01 HL59873, NIH P30 NS047243 and funds from Tufts University School of Medicine.	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; ASHBURNER M, 1990, CELL, V61, P1, DOI 10.1016/0092-8674(90)90205-S; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Collins BH, 2004, P NATL ACAD SCI USA, V101, P1945, DOI 10.1073/pnas.0308240100; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Emery IF, 1997, P NATL ACAD SCI USA, V94, P4092, DOI 10.1073/pnas.94.8.4092; Enright AJ, 2004, GENOME BIOL, V5; Fang YS, 2007, GENE DEV, V21, P1506, DOI 10.1101/gad.1541607; FLETCHER JC, 1995, DEVELOPMENT, V121, P1455; Fletcher JC, 1997, P NATL ACAD SCI USA, V94, P4582, DOI 10.1073/pnas.94.9.4582; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gauthier SA, 2006, J EXP BIOL, V209, P1803, DOI 10.1242/jeb.02202; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Helfrich-Forster C, 2005, METHOD ENZYMOL, V393, P439, DOI 10.1016/S0076-6879(05)93021-8; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Jackson FR, 2005, METHOD ENZYMOL, V393, P663, DOI 10.1016/S0076-6879(05)93035-8; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kar A, 2006, J BIOL CHEM, V281, P24479, DOI 10.1074/jbc.M603971200; Kojima S, 2007, P NATL ACAD SCI USA, V104, P1859, DOI 10.1073/pnas.0607567104; Kraves S, 2006, NAT NEUROSCI, V9, P212, DOI 10.1038/nn1633; Kuhlman SJ, 2006, J BIOL RHYTHM, V21, P470, DOI 10.1177/0748730406294316; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Lin JC, 2005, MOL CELL BIOL, V25, P10111, DOI 10.1128/MCB.25.22.10111-10121.2005; Lin JC, 2007, P NATL ACAD SCI USA, V104, P2235, DOI 10.1073/pnas.0611015104; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; LOROS JJ, 1989, SCIENCE, V243, P385, DOI 10.1126/science.2563175; Lukacsovich T, 2001, GENETICS, V157, P727; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; McNeil GP, 1998, NEURON, V20, P297, DOI 10.1016/S0896-6273(00)80457-2; Mehler MF, 2006, J PHYSIOL-LONDON, V575, P333, DOI 10.1113/jphysiol.2006.113191; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; MUNROE SD, 1995, ROLES E74 PROTEINS E; Myers EM, 2003, CURR BIOL, V13, P526, DOI 10.1016/S0960-9822(03)00167-2; Newby LM, 1996, J NEUROBIOL, V31, P117, DOI 10.1002/(SICI)1097-4695(199609)31:1<117::AID-NEU10>3.0.CO;2-I; NEWBY LM, 1993, GENETICS, V135, P1077; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Plante I, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/64347; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Schroeder AJ, 2003, J NEUROGENET, V17, P139; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Silver R, 2005, METHOD ENZYMOL, V393, P451, DOI 10.1016/S0076-6879(05)93022-X; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Staiger D, 2003, PLANT J, V33, P361, DOI 10.1046/j.1365-313X.2003.01629.x; Staiger D, 2001, PHILOS T R SOC B, V356, P1755, DOI 10.1098/rstb.2001.0964; Steel CGH, 2006, COMP BIOCHEM PHYS A, V144, P351, DOI 10.1016/j.cbpa.2006.02.018; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; Taghert PH, 2006, J BIOL RHYTHM, V21, P445, DOI 10.1177/0748730406293910; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; THUMMEL CS, 1990, BIOESSAYS, V12, P561, DOI 10.1002/bies.950121202; THUMMEL CS, 1992, SCIENCE, V255, P39, DOI 10.1126/science.1553530; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Vitalini MW, 2006, J BIOL RHYTHM, V21, P432, DOI 10.1177/0748730406294396; Ying Shao-Yao, 2006, V342, P1, DOI 10.1385/1-59745-123-1:1; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zhang XL, 2000, J NEUROBIOL, V45, P14, DOI 10.1002/1097-4695(200010)45:1<14::AID-NEU2>3.0.CO;2-X	68	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1107	10.1371/journal.pone.0001107	http://dx.doi.org/10.1371/journal.pone.0001107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971870	Green Published, Green Submitted, gold			2022-12-27	WOS:000207458700024
J	van Hooft, P; Greyling, BJ; Prins, HHT; Getz, WM; Jolles, AE; Bastos, ADS				van Hooft, Pim; Greyling, Barend J.; Prins, Herbert H. T.; Getz, Wayne M.; Jolles, Anna E.; Bastos, Armanda D. S.			Selection at the Y Chromosome of the African Buffalo Driven by Rainfall	PLOS ONE			English	Article								Selection coefficients at the mammalian Y chromosome typically do not deviate strongly from neutrality. Here we show that strong balancing selection, maintaining intermediate frequencies of DNA sequence variants, acts on the Y chromosome in two populations of African buffalo (Syncerus caffer). Significant correlations exist between sequence variant frequencies and annual rainfall in the years before conception, with five- to eightfold frequency changes over short time periods. Annual rainfall variation drives the balancing of sequence variant frequencies, probably by affecting parental condition. We conclude that sequence variants confer improved male reproductive success after either dry or wet years, making the population composition and dynamics very sensitive to climate change. The mammalian Y chromosome, interacting with ecological processes, may affect male reproductive success much more strongly than previously thought.	[van Hooft, Pim; Greyling, Barend J.; Getz, Wayne M.; Bastos, Armanda D. S.] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [van Hooft, Pim; Prins, Herbert H. T.] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Jolles, Anna E.] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA; [Jolles, Anna E.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	University of Pretoria; Wageningen University & Research; University of California System; University of California Berkeley; Oregon State University; Oregon State University	van Hooft, P (corresponding author), Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa.	pim.vanhooft@wur.nl	Bastos, Armanda/B-6357-2009; Getz, Wayne/I-4521-2013	Bastos, Armanda/0000-0002-9223-4204; Jolles, Anna/0000-0003-3074-9912; Prins, Herbert/0000-0003-1131-5107; Getz, Wayne/0000-0001-8784-9354	US NIH/NSF Ecology of Infectious Disease Grant; University of Pretoria	US NIH/NSF Ecology of Infectious Disease Grant; University of Pretoria	Funding: This research was supported by an US NIH/NSF Ecology of Infectious Disease Grant awarded to WMG. Support for PVH was a post-doctoral bursary from the University of Pretoria.	Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Bourgarel M, 2002, AFR J ECOL, V40, P186, DOI 10.1046/j.1365-2028.2002.00377.x; Caron A, 2003, ECOL APPL, V13, P1338, DOI 10.1890/02-5266; Carson HL, 2003, P NATL ACAD SCI USA, V100, P6584, DOI 10.1073/pnas.0732174100; Charbonnel N, 2005, HEREDITY, V95, P377, DOI 10.1038/sj.hdy.6800735; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P5677, DOI 10.1073/pnas.101456898; Cross PC, 2005, ANIM BEHAV, V69, P499, DOI 10.1016/j.anbehav.2004.08.006; Cummins J, 2001, REPROD FERT DEVELOP, V13, P533, DOI 10.1071/RD01064; El-Wishy AB, 2007, ANIM REPROD SCI, V97, P216, DOI 10.1016/j.anireprosci.2006.03.003; Georgiadis NJ, 2007, BIOL CONSERV, V137, P461, DOI 10.1016/j.biocon.2007.03.005; Govender N, 2006, J APPL ECOL, V43, P748, DOI 10.1111/j.1365-2664.2006.01184.x; Hellborg L, 2004, MOL BIOL EVOL, V21, P158, DOI 10.1093/molbev/msh008; Hoerling M, 2006, J CLIMATE, V19, P3989, DOI 10.1175/JCLI3842.1; James WH, 1998, J THEOR BIOL, V192, P113, DOI 10.1006/jtbi.1998.0649; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Jolles AE, 2005, ECOLOGY, V86, P2358, DOI 10.1890/05-0038; JOLLES AE, 2004, THESIS PRINCETON U P; Liu WS, 2003, CYTOGENET GENOME RES, V102, P53, DOI 10.1159/000075725; Liu WS, 2002, MAMM GENOME, V13, P320, DOI 10.1007/s00335-001-2133-8; MILLS MGL, 1995, WILDLIFE RES, V22, P75, DOI 10.1071/WR9950075; Ogutu JO, 2005, AFR J ECOL, V43, P332, DOI 10.1111/j.1365-2028.2005.00587.x; Owen-Smith N, 2005, J ANIM ECOL, V74, P774, DOI 10.1111/j.1365-2656.2005.00974.x; Prins HHT, 1996, ECOLOGY BEHAV AFRICA; Quintana-Murci L, 2001, FORENSIC SCI INT, V118, P169, DOI 10.1016/S0379-0738(01)00387-5; Rodwell TC, 2001, J MAMMAL, V82, P231, DOI 10.1644/1545-1542(2001)082&lt;0231:EOPEOB&gt;2.0.CO;2; Roldan ERS, 1999, TRENDS ECOL EVOL, V14, P58, DOI 10.1016/S0169-5347(98)01567-5; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Visscher DR, 2004, J ZOOL, V264, P111, DOI 10.1017/S0952836904005436; Whyte Ian, 2006, Gnusletter, V24, P14	32	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1086	10.1371/journal.pone.0001086	http://dx.doi.org/10.1371/journal.pone.0001086			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971851	gold, Green Published			2022-12-27	WOS:000207458700005
J	Norden, N; Chave, J; Belbenoit, P; Caubere, A; Chatelet, P; Forget, PM; Thebaud, C				Norden, Natalia; Chave, Jerome; Belbenoit, Pierre; Caubere, Adeline; Chatelet, Patrick; Forget, Pierre-Michel; Thebaud, Christophe			Mast Fruiting Is a Frequent Strategy in Woody Species of Eastern South America	PLOS ONE			English	Article							ANNUAL SEED PRODUCTION; RAIN-FOREST TREES; EL-NINO; PHENOLOGY; RECRUITMENT; DISPERSAL; PREDATION; PATTERNS; ECTOMYCORRHIZAL; CAESALPINIACEAE	Background. It is thought that mast seeding is a rare reproductive strategy in the tropics, since tropical climates are less variable, and fruit consumers tend to be more generalist in these regions. However, previous tests of this hypothesis were based on only few tropical datasets, and none from tropical South America. Moreover, reproductive strategies have been quantified based on the coefficient of variation of interannual seed production, an index that potentially confounds masting and high interannual variability in seed production. Methodology/Principal Findings. We developed a new approach to model the monthly variability in seed production for 28 tree species, and 20 liana species monitored during 5 years in a tropical forest of Central French Guiana. We found that 23% of the species showed a masting pattern, 54% an annual fruiting pattern, and 23% an irregular fruiting pattern. The majority of masting species were trees ( 8 out of 11), most of them animal-dispersed. The classification into reproductive strategies based on the coefficient of variation was inconsistent with our results in nearly half of the cases. Conclusions/Significance. Our study is the first to clearly evidence the frequency of the masting strategy in a tropical forest community of Eastern South America. The commonness of the masting strategy in tropical plants may promote species coexistence through storage dynamics.	[Norden, Natalia; Chave, Jerome; Thebaud, Christophe] Univ Toulouse 3, Lab Evolut & Diversite Biol, CNRS, UMR 5174, F-31062 Toulouse, France; [Belbenoit, Pierre; Caubere, Adeline; Forget, Pierre-Michel] CNRS MNHN, UMR 5176, Dept Ecol & Gest Biodiversite, Brunoy, France; [Chatelet, Patrick] CNRS Guyane, UPS 2561, Stn Etud Nouragues, Cayenne, French Guiana	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Museum National d'Histoire Naturelle (MNHN)	Chave, J (corresponding author), Univ Toulouse 3, Lab Evolut & Diversite Biol, CNRS, UMR 5174, F-31062 Toulouse, France.	chave@cict.fr	Thébaud, Christophe/N-3916-2016; Forget, Pierre-Michel/B-4355-2009	Thébaud, Christophe/0000-0002-8586-1234; Forget, Pierre-Michel/0000-0002-9252-974X	CNRS; MNHN (Plan pluriformation 'Ecologie Fonctionnelle et Developpement Durable'); Action Concertee Incitative Jeunes Chercheurs of the French research Ministry	CNRS(Centre National de la Recherche Scientifique (CNRS)); MNHN (Plan pluriformation 'Ecologie Fonctionnelle et Developpement Durable'); Action Concertee Incitative Jeunes Chercheurs of the French research Ministry	Financial support was provided by the CNRS, the MNHN (Plan pluriformation 'Ecologie Fonctionnelle et Developpement Durable') and through a grant Action Concertee Incitative Jeunes Chercheurs of the French research Ministry to JC.	ASHTON PS, 1988, AM NAT, V132, P44, DOI 10.1086/284837; AUGSPURGER CK, 1983, J ECOL, V71, P759, DOI 10.2307/2259591; Boggan J., 1997, CHECKLIST PLANTS GUI; BONGERS F, 2001, NOURAGUES DYNAMICS P; Brearley FQ, 2007, J ECOL, V95, P828, DOI 10.1111/j.1365-2745.2007.01258.x; Burgess P. F., 1972, Malayan Forester, V35, P103; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; CHAN TT, 1980, MALAYSIAN FORESTER, V43, P132; Chauvet S, 2004, J TROP ECOL, V20, P1, DOI 10.1017/S0266467404006121; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Connell JH, 2000, ECOLOGY, V81, P568, DOI 10.1890/0012-9658(2000)081[0568:SDOTTY]2.0.CO;2; Croat T.B., 1978, FLORA BARRO COLORADO; Curran LM, 2000, ECOL MONOGR, V70, P129, DOI 10.1890/0012-9615(2000)070[0129:ETOTSS]2.0.CO;2; Curran LM, 2000, ECOL MONOGR, V70, P101, DOI 10.1890/0012-9615(2000)070[0101:VRTSVI]2.0.CO;2; Curran LM, 1999, SCIENCE, V286, P2184, DOI 10.1126/science.286.5447.2184; Dalling JW, 2002, J ECOL, V90, P714, DOI 10.1046/j.1365-2745.2002.00706.x; Feer F, 2002, BIOTROPICA, V34, P555, DOI 10.1111/j.1744-7429.2002.tb00574.x; Forget PM, 1999, J TROP ECOL, V15, P61, DOI 10.1017/S026646749900067X; FRANKIE GW, 1974, J ECOL, V62, P881, DOI 10.2307/2258961; GENTRY A H, 1974, Biotropica, V6, P64, DOI 10.2307/2989698; Hamann A, 2004, J ECOL, V92, P24, DOI 10.1111/j.1365-2745.2004.00845.x; Henkel TW, 2005, NEW PHYTOL, V167, P543, DOI 10.1111/j.1469-8137.2005.01431.x; Herrera CM, 1998, AM NAT, V152, P576, DOI 10.1086/286191; JANZEN D H, 1974, Biotropica, V6, P69, DOI 10.2307/2989823; Jones FA, 2005, AM NAT, V166, P543, DOI 10.1086/491661; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Koenig WD, 2000, AM NAT, V155, P59, DOI 10.1086/303302; Koenig WD, 2003, OIKOS, V102, P581, DOI 10.1034/j.1600-0706.2003.12272.x; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; MORI SA, 2002, GUIDE VASCULAR PLA 2; Newbery DM, 2006, NEW PHYTOL, V170, P561, DOI 10.1111/j.1469-8137.2006.01691.x; Newbery DM, 2005, NEW PHYTOL, V167, P324, DOI 10.1111/j.1469-8137.2005.01468.x; NEWSTROM LE, 1994, BIOTROPICA, V26, P141, DOI 10.2307/2388804; Norden N, 2007, J ECOL, V95, P507, DOI 10.1111/j.1365-2745.2007.01221.x; R Development Core Team, 2006, R LANG ENV STAT COMP; RATIARISON S, 2003, STRATEGIES FRUCTIFIC; Ropelewski CF, 1996, J CLIMATE, V9, P1043, DOI 10.1175/1520-0442(1996)009<1043:QSOPR>2.0.CO;2; SABATIER D, 1985, REV ECOL-TERRE VIE, V40, P289; Sakai S, 2002, BIOL J LINN SOC, V75, P233, DOI 10.1111/j.1095-8312.2002.tb01424.x; Sakai S, 2001, POPUL ECOL, V43, P77, DOI 10.1007/PL00012018; Sakai S, 2006, AM J BOT, V93, P1134, DOI 10.3732/ajb.93.8.1134; SARMIENTO G, 1983, ECOSYSTEMS WORLD B, V14, P219; Schauber EM, 2002, ECOLOGY, V83, P1214, DOI 10.1890/0012-9658(2002)083[1214:MBENZP]2.0.CO;2; SHIBATA M, 1995, ECOLOGY, V76, P1099, DOI 10.2307/1940918; Shibata M, 2002, ECOLOGY, V83, P1727, DOI 10.1890/0012-9658(2002)083[1727:SASPBP]2.0.CO;2; Sun IF, 2007, J ECOL, V95, P818, DOI 10.1111/j.1365-2745.2007.01235.x; TERSTEEGE H, 1991, VEGETATIO, V95, P177; VANROOSEMALEN MGM, 1985, FRUITS GUIANAN FLORA; Wright SJ, 2006, ECOL LETT, V9, P35, DOI 10.1111/j.1461-0248.2005.00851.x; Wright SJ, 2005, ECOLOGY, V86, P848, DOI 10.1890/03-0750	52	53	54	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1079	10.1371/journal.pone.0001079	http://dx.doi.org/10.1371/journal.pone.0001079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957261	Green Published, Green Submitted, gold			2022-12-27	WOS:000207458500024
J	Valente, D; Golani, I; Mitra, PP				Valente, Dan; Golani, Ilan; Mitra, Partha P.			Analysis of the Trajectory of Drosophila melanogaster in a Circular Open Field Arena	PLOS ONE			English	Article								Background. Obtaining a complete phenotypic characterization of a freely moving organism is a difficult task, yet such a description is desired in many neuroethological studies. Many metrics currently used in the literature to describe locomotor and exploratory behavior are typically based on average quantities or subjectively chosen spatial and temporal thresholds. All of these measures are relatively coarse-grained in the time domain. It is advantageous, however, to employ metrics based on the entire trajectory that an organism takes while exploring its environment. Methodology/Principal Findings. To characterize the locomotor behavior of Drosophila melanogaster, we used a video tracking system to record the trajectory of a single fly walking in a circular open field arena. The fly was tracked for two hours. Here, we present techniques with which to analyze the motion of the fly in this paradigm, and we discuss the methods of calculation. The measures we introduce are based on spatial and temporal probability distributions and utilize the entire time-series trajectory of the fly, thus emphasizing the dynamic nature of locomotor behavior. Marginal and joint probability distributions of speed, position, segment duration, path curvature, and reorientation angle are examined and related to the observed behavior. Conclusions/Significance. The measures discussed in this paper provide a detailed profile of the behavior of a single fly and highlight the interaction of the fly with the environment. Such measures may serve as useful tools in any behavioral study in which the movement of a fly is an important variable and can be incorporated easily into many setups, facilitating high-throughput phenotypic characterization.	[Valente, Dan; Mitra, Partha P.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Golani, Ilan] Tel Aviv Univ, Dept Zool, Fac Life Sci, IL-69978 Tel Aviv, Israel	Cold Spring Harbor Laboratory; Tel Aviv University	Valente, D (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	valente@cshl.edu		Mitra, Partha/0000-0001-8818-6804	Dart Neuroscience	Dart Neuroscience	This research was funded by an award from Dart Neuroscience, LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Clark DA, 2007, J NEUROPHYSIOL, V97, P1903, DOI 10.1152/jn.00892.2006; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CRAWLEY JN, 2000, WHATS WRONG MY MOUSE, P329; Drai D, 2001, NEUROSCI BIOBEHAV R, V25, P409, DOI 10.1016/S0149-7634(01)00022-7; Drai D, 2000, J NEUROSCI METH, V96, P119, DOI 10.1016/S0165-0270(99)00194-6; Draper I, 2007, DEV NEUROBIOL, V67, P378, DOI 10.1002/dneu.20355; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Hen I, 2004, J NEUROSCI METH, V133, P161, DOI 10.1016/j.jneumeth.2003.10.013; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kafkafi N, 2005, P NATL ACAD SCI USA, V102, P4619, DOI 10.1073/pnas.0409554102; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lipkind D, 2004, J APPL PHYSIOL, V97, P347, DOI 10.1152/japplphysiol.00148.2004; Loader C., 1999, LOCAL REGRESSION LIK; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; MARGULIES C, 2005, CURR BIOL, V15, pR713; Martin JR, 1999, J COMP PHYSIOL A, V184, P73, DOI 10.1007/s003590050307; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Martin JR, 2003, BEHAV PROCESS, V64, P145, DOI 10.1016/S0376-6357(03)00132-3; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Rothenfluh A, 2002, CURR OPIN NEUROBIOL, V12, P639, DOI 10.1016/S0959-4388(02)00380-X; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; VALENTE D, 2007, IEEE MULTIM IN PRESS; Wolf FW, 2002, J NEUROSCI, V22, P11035	33	60	60	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1083	10.1371/journal.pone.0001083	http://dx.doi.org/10.1371/journal.pone.0001083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957265	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000207458500028
J	Walther, FJ; Waring, AJ; Hernandez-Juviel, JM; Gordon, LM; Schwan, AL; Jung, CL; Chang, YS; Wang, ZD; Notter, RH				Walther, Frans J.; Waring, Alan J.; Hernandez-Juviel, Jose M.; Gordon, Larry M.; Schwan, Adrian L.; Jung, Chun-Ling; Chang, Yusuo; Wang, Zhengdong; Notter, Robert H.			Dynamic Surface Activity of a Fully Synthetic Phospholipase-Resistant Lipid/Peptide Lung Surfactant	PLOS ONE			English	Article							PROTEINS SP-B; EUROPEAN CONSENSUS CONFERENCE; BRONCHOALVEOLAR LAVAGE FLUID; N-TERMINAL SEGMENT; PULMONARY SURFACTANT; DIFFERENTIAL SENSITIVITY; HYDROPHOBIC PROTEINS; EXOGENOUS SURFACTANT; MONOMOLECULAR LAYERS; SECONDARY STRUCTURE	Background. This study examines the surface activity and resistance to phospholipase degradation of a fully-synthetic lung surfactant containing a novel diether phosphonolipid (DEPN-8) plus a 34 amino acid peptide (Mini-B) related to native surfactant protein (SP)-B. Activity studies used adsorption, pulsating bubble, and captive bubble methods to assess a range of surface behaviors, supplemented by molecular studies using Fourier transform infrared (FTIR) spectroscopy, circular dichroism (CD), and plasmon resonance. Calf lung surfactant extract (CLSE) was used as a positive control. Results. DEPN-8+ 1.5% (by wt.) Mini-B was fully resistant to degradation by phospholipase A(2) (PLA(2)) in vitro, while CLSE was severely degraded by this enzyme. Mini-B interacted with DEPN-8 at the molecular level based on FTIR spectroscopy, and had significant plasmon resonance binding affinity for DEPN-8. DEPN-8+ 1.5% Mini-B had greatly increased adsorption compared to DEPN-8 alone, but did not fully equal the very high adsorption of CLSE. In pulsating bubble studies at a low phospholipid concentration of 0.5 mg/ml, DEPN-8+ 1.5% Mini-B and CLSE both reached minimum surface tensions,1 mN/m after 10 min of cycling. DEPN-8 (2.5 mg/ml)+ 1.5% Mini-B and CLSE (2.5 mg/ml) also reached minimum surface tensions,1 mN/m at 10 min of pulsation in the presence of serum albumin (3 mg/ml) on the pulsating bubble. In captive bubble studies, DEPN-8+ 1.5% Mini-B and CLSE both generated minimum surface tensions,1 mN/m on 10 successive cycles of compression/expansion at quasi-static and dynamic rates. Conclusions. These results show that DEPN-8 and 1.5% Mini-B form an interactive binary molecular mixture with very high surface activity and the ability to resist degradation by phospholipases in inflammatory lung injury. These characteristics are promising for the development of related fully-synthetic lipid/peptide exogenous surfactants for treating diseases of surfactant deficiency or dysfunction.	[Walther, Frans J.; Waring, Alan J.; Hernandez-Juviel, Jose M.; Gordon, Larry M.] Harbor Univ Calif Los Angeles UCLA, Los Angeles Biomed Res Inst, Med Ctr, Torrance, CA USA; [Walther, Frans J.] Leiden Univ, Dept Pediat, Med Ctr, Leiden, Netherlands; [Waring, Alan J.; Jung, Chun-Ling] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Schwan, Adrian L.] Univ Guelph, Dept Chem, Guelph, ON N1G 2W1, Canada; [Chang, Yusuo; Wang, Zhengdong; Notter, Robert H.] Univ Rochester, Dept Pediat, Rochester, NY USA; [Notter, Robert H.] Univ Rochester, Dept Environm Med, Rochester, NY USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California Los Angeles; University of Guelph; University of Rochester; University of Rochester	Walther, FJ (corresponding author), Harbor Univ Calif Los Angeles UCLA, Los Angeles Biomed Res Inst, Med Ctr, Torrance, CA USA.	fwalther@lumc.nl		Schwan, Adrian/0000-0003-3362-9633; Walther, Frans/0000-0003-1931-159X	National Institutes of Health [HL-56176, HL-55534]; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center [800310-11-23, 512973-00-00]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056176, R01HL055534, R01HL092158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors gratefully acknowledge the financial support of the National Institutes of Health through grants HL-56176 and HL-55534 and the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center through grants 800310-11-23 and 512973-00-00. NIH and LA BioMed had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Ackerman SJ, 2003, CHEST, V123, p355S, DOI 10.1378/chest.123.3_suppl.355S; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Artigas A, 1998, INTENS CARE MED, V24, P378, DOI 10.1007/s001340050585; Attalah HL, 2003, EUR RESPIR J, V21, P1040, DOI 10.1183/09031936.03.00093002; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CAILLON E, 1983, J BACTERIOL, V153, P1348, DOI 10.1128/JB.153.3.1348-1351.1983; *CAL APPL BIOS, 1990, INTR CLEAV TECHN, P10; CARPINO LA, 1995, J ORG CHEM, V60, P7718, DOI 10.1021/jo00129a005; Chang YS, 2005, CHEM PHYS LIPIDS, V137, P77, DOI 10.1016/j.chemphyslip.2005.07.002; Chang YS, 2004, BIOORG MED CHEM LETT, V14, P5983, DOI 10.1016/j.bmcl.2004.10.001; CHESS P, 2005, LUNG INJURY MECH PAT, P617; CURSTEDT T, 1987, EUR J BIOCHEM, V168, P255, DOI 10.1111/j.1432-1033.1987.tb13414.x; ENHORNING G, 1992, J APPL PHYSIOL, V73, P941, DOI 10.1152/jappl.1992.73.3.941; ENHORNING G, 1977, J APPL PHYSIOL, V43, P198, DOI 10.1152/jappl.1977.43.2.198; FIELDS C G, 1991, Peptide Research, V4, P95; Gordon LM, 2002, BBA-BIOMEMBRANES, V1559, P96, DOI 10.1016/S0005-2736(01)00443-6; Gordon LM, 2000, J PEPT RES, V55, P330, DOI 10.1034/j.1399-3011.2000.00693.x; Gordon LM, 1996, PROTEIN SCI, V5, P1662, DOI 10.1002/pro.5560050820; Goss CH, 2003, CRIT CARE MED, V31, P1607, DOI 10.1097/01.CCM.0000063475.65751.1D; Griese M, 1999, EUR RESPIR J, V13, P1455, DOI 10.1034/j.1399-3003.1999.13f36.x; HALL SB, 1992, J APPL PHYSIOL, V72, P1708, DOI 10.1152/jappl.1992.72.5.1708; HALL SB, 1993, J APPL PHYSIOL, V75, P468, DOI 10.1152/jappl.1993.75.1.468; HALL SB, 1994, J LIPID RES, V35, P1386; HALL SB, 1992, AM REV RESPIR DIS, V145, P24, DOI 10.1164/ajrccm/145.1.24; Holm BA, 1999, PEDIATR RES, V46, P85, DOI 10.1203/00006450-199907000-00015; HOLM BA, 1991, J APPL PHYSIOL, V71, P317, DOI 10.1152/jappl.1991.71.1.317; HOLM BA, 1985, CHEM PHYS LIPIDS, V38, P287, DOI 10.1016/0009-3084(85)90022-2; Johansson J, 1998, BIOL NEONATE, V74, P9, DOI 10.1159/000047029; JOHNSON WC, 1990, PROTEIN-STRUCT FUNCT, V7, P214; KIM DK, 1995, AM J PHYSIOL-LUNG C, V269, pL109, DOI 10.1152/ajplung.1995.269.1.L109; Kostopanagiotou G, 2003, HEPATOLOGY, V37, P1130, DOI 10.1053/jhep.2003.50185; Lewis JF, 2003, CRIT CARE MED, V31, pS324, DOI 10.1097/01.CCM.0000057911.19145.9F; LIN WHC, 1989, SYNTHESIS PURIFICATI; MALCOLM JD, 1980, CAN J CHEM ENG, V58, P151, DOI 10.1002/cjce.5450580203; Nakos G, 2005, CRIT CARE MED, V33, P772, DOI 10.1097/01.CCM.0000158519.80090.74; Notter R. H., 2005, LUNG INJURY MECH PAT; NOTTER RH, 1982, PEDIATR RES, V16, P515, DOI 10.1203/00006450-198207000-00003; NOTTER RH, 1983, CHEM PHYS LIPIDS, V33, P67, DOI 10.1016/0009-3084(83)90009-9; Notter RH, 2002, CHEM PHYS LIPIDS, V114, P21, DOI 10.1016/S0009-3084(01)00197-9; Notter RH, 1997, REV CHEM ENG, V13, P1; NOTTER RH, 2000, LUNG SURFACTANTS BAS; Notter RH, 2007, BIOORG MED CHEM LETT, V17, P113, DOI 10.1016/j.bmcl.2006.09.083; OOSTERLAKENDIJKSTERHUIS MA, 1991, BIOCHEMISTRY-US, V30, P10965, DOI 10.1021/bi00109a022; OOSTERLAKENDIJKSTERHUIS MA, 1991, BIOCHEMISTRY-US, V30, P8276, DOI 10.1021/bi00247a024; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; REVAK SD, 1988, J CLIN INVEST, V81, P826, DOI 10.1172/JCI113391; Rubenfeld GD, 2003, CRIT CARE MED, V31, pS276, DOI 10.1097/01.CCM.0000057904.62683.2B; SARIN VK, 1990, P NATL ACAD SCI USA, V87, P2633, DOI 10.1073/pnas.87.7.2633; SCHOEL WM, 1994, BBA-GEN SUBJECTS, V1200, P281, DOI 10.1016/0304-4165(94)90169-4; SEEGER W, 1992, AM J PHYSIOL, V262, pL286, DOI 10.1152/ajplung.1992.262.3.L286; SEEGER W, 1993, EUR RESPIR J, V6, P971; Sreerama N, 1999, PROTEIN SCI, V8, P370; TOUCHSTONE JC, 1980, LIPIDS, V15, P61, DOI 10.1007/BF02534120; Touqui L, 1999, MOL MED TODAY, V5, P244, DOI 10.1016/S1357-4310(99)01470-7; TURCOTTE JG, 1991, BIOCHIM BIOPHYS ACTA, V1084, P1, DOI 10.1016/0005-2760(91)90048-M; TURCOTTE JG, 1977, BIOCHIM BIOPHYS ACTA, V488, P235, DOI 10.1016/0005-2760(77)90181-3; VADAS P, 1984, J LAB CLIN MED, V104, P873; Wang Z, 2003, AM J PHYSIOL-LUNG C, V285, pL550, DOI 10.1152/ajplung.00346.2002; WANG Z, 2005, LUNG INJURY MECH PAT, P297; WANG Z, 2007, AM J RESP C IN PRESS; Wang ZD, 1996, J LIPID RES, V37, P1749; Wang ZD, 1998, AM J RESP CRIT CARE, V158, P28, DOI 10.1164/ajrccm.158.1.9709041; WANG ZD, 1995, J LIPID RES, V36, P1283; Wang ZD, 1996, J LIPID RES, V37, P790; WARING A, 1989, Peptide Research, V2, P308; Waring AJ, 2005, J PEPT RES, V66, P364, DOI 10.1111/j.1399-3011.2005.00300.x; Waring AJ, 1996, PEPTIDE RES, V9, P28; Willson DF, 2005, JAMA-J AM MED ASSOC, V293, P470, DOI 10.1001/jama.293.4.470; YU SH, 1988, BIOCHIM BIOPHYS ACTA, V961, P337	70	22	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1039	10.1371/journal.pone.0001039	http://dx.doi.org/10.1371/journal.pone.0001039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940603	gold, Green Published, Green Submitted			2022-12-27	WOS:000207456100007
J	Macri, S; Pasquali, P; Bonsignore, LT; Pieretti, S; Cirulli, F; Chiarotti, F; Laviola, G				Macri, Simone; Pasquali, Paolo; Bonsignore, Luca Tommaso; Pieretti, Stefano; Cirulli, Francesca; Chiarotti, Flavia; Laviola, Giovanni			Moderate Neonatal Stress Decreases Within-Group Variation in Behavioral, Immune and HPA Responses in Adult Mice	PLOS ONE			English	Article								Background. The significance of behavioral neuroscience and the validity of its animal models of human pathology largely depend on the possibility to replicate a given finding across different laboratories. Under the present test and housing conditions, this axiom fails to resist the challenge of experimental validation. When several mouse strains are tested on highly standardized behavioral test batteries in different laboratories, significant strain x lab interactions are often detected. This limitation, predominantly due to elevated within-group variability observed in control subjects, increases the number of animals needed to address fine experimental questions. Laboratory rodents display abnormal stress and fear reactions to experimental testing, which might depend on the discrepancy between the stability of the neonatal environment and the challenging nature of the adult test and housing conditions. Methodology/Principal Findings. Stimulating neonatal environments (e. g. brief maternal separations, increased foraging demands or maternal corticosterone supplementation) reduce stress and fear responses in adulthood. Here we tested whether reduced fearfulness associated with experimental testing would also reduce inter-individual variation. In line with our predictions, we show that a moderate elevation in neonatal corticosterone through maternal milk significantly reduces fear responses and inter-individual variability (average 44%) in adult mouse offspring. Conclusions/Significance. We observed reduced variation in pain perception, novelty preference, hormonal stress response and resistance to pathogen infection. This suggests that the results of this study may apply to a relatively broad spectrum of neuro-behavioral domains. Present findings encourage a reconsideration of the basic principles of neonatal housing systems to improve the validity of experimental models and reduce the number of animals used.	[Macri, Simone; Bonsignore, Luca Tommaso; Cirulli, Francesca; Chiarotti, Flavia; Laviola, Giovanni] Ist Super Sanita, Sect Behav Neurosci, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Pasquali, Paolo] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, I-00161 Rome, Italy; [Pieretti, Stefano] Ist Super Sanita, Dept Drug Res & Evaluat, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Laviola, G (corresponding author), Ist Super Sanita, Sect Behav Neurosci, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	giovanni.laviola@iss.it	Cirulli, Francesca/B-1581-2013; Bonsignore, Luca Tommaso/B-1594-2013; Laviola, Giovanni/K-4392-2016; Chiarotti, Flavia/K-7970-2016; Laviola, Giovanni/AAA-2391-2022; Pasquali, Paolo/C-1111-2008; Pieretti, Stefano/I-8634-2018	Cirulli, Francesca/0000-0001-9440-1873; Laviola, Giovanni/0000-0003-0388-0835; Chiarotti, Flavia/0000-0003-0084-6914; Laviola, Giovanni/0000-0003-0388-0835; Pasquali, Paolo/0000-0003-4704-0731; Pieretti, Stefano/0000-0001-5926-6194; Macri, Simone/0000-0003-2946-4784	ISSNIH [0F14]; NARSAD	ISSNIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD)	Funding: The study has been partly supported by the collaborative program ISSNIH 0F14 to Giovanni Laviola and Francesca Cirulli and by a NARSAD grant for young investigators to Simone Macri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani W, 1998, BEHAV NEUROSCI, V112, P1152, DOI 10.1037/0735-7044.112.5.1152; Bardo MT, 1993, EXP CLIN PSYCHOPHARM, V1, P101, DOI 10.1037/1064-1297.1.1-4.101; Barnard CJ, 1996, PHYSIOL BEHAV, V60, P1223, DOI 10.1016/S0031-9384(96)00174-6; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; BIGGERSTAFF S, 1992, PHYSIOL BEHAV, V52, P485, DOI 10.1016/0031-9384(92)90335-Y; Caldji C, 2000, NEUROPSYCHOPHARMACOL, V22, P219, DOI 10.1016/S0893-133X(99)00110-4; CALHOUN JB, 1962, SCI AM, V206, P139; Cameron NM, 2005, NEUROSCI BIOBEHAV R, V29, P843, DOI 10.1016/j.neubiorev.2005.03.022; CAPONE F, 2005, CURRENT PROTOCOLS TO; CARTER RB, 1991, PAIN, V47, P211, DOI 10.1016/0304-3959(91)90207-E; CATALANI A, 1993, BRAIN RES, V624, P209, DOI 10.1016/0006-8993(93)90079-3; Catalani A, 2000, NEUROSCIENCE, V100, P319, DOI 10.1016/S0306-4522(00)00277-3; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Visser L, 2006, GENES BRAIN BEHAV, V5, P458, DOI 10.1111/j.1601-183X.2005.00181.x; Fluttert M, 2000, LAB ANIM, V34, P372, DOI 10.1258/002367700780387714; Galsworthy MJ, 2005, BEHAV BRAIN RES, V157, P211, DOI 10.1016/j.bbr.2004.06.021; Garner JP, 2005, ILAR J, V46, P106, DOI 10.1093/ilar.46.2.106; GRIEBEL G, 1993, BEHAV PHARMACOL, V4, P637; Hager R, 2006, BIOL LETT-UK, V2, P253, DOI 10.1098/rsbl.2006.0457; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Leonhardt M, 2007, HORM BEHAV, V51, P77, DOI 10.1016/j.yhbeh.2006.08.008; Macri S, 2004, EUR J NEUROSCI, V20, P1017, DOI 10.1111/j.1460-9568.2004.03541.x; Macri S, 2007, ANIM BEHAV, V73, P171, DOI 10.1016/j.anbehav.2006.03.029; Macri S, 2006, HORM BEHAV, V50, P667, DOI 10.1016/j.yhbeh.2006.06.015; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Pasquali P, 2003, INFECT IMMUN, V71, P2326, DOI 10.1128/IAI.71.5.2326-2330.2003; PIERETTI S, 1991, BEHAV NEUROSCI, V105, P215, DOI 10.1037/0735-7044.105.1.215; Pieretti S, 1999, LIFE SCI, V65, P1381, DOI 10.1016/S0024-3205(99)00377-X; Plone MA, 1996, PAIN, V66, P265, DOI 10.1016/0304-3959(96)03048-5; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Pryce CR, 2003, NEUROSCI BIOBEHAV R, V27, P57, DOI 10.1016/S0149-7634(03)00009-5; Roy V, 2004, BEHAV BRAIN RES, V154, P439, DOI 10.1016/j.bbr.2004.03.010; Sapolsky R.M., 2004, WHY ZEBRAS DONT GET, V3rd ed.; Schmidt M, 2003, INT J DEV NEUROSCI, V21, P125, DOI 10.1016/S0736-5748(03)00030-3; Smotherman W. P., 1980, MATERNAL INFLUENCES, P201; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Tsai PP, 2003, LAB ANIM-UK, V37, P314, DOI 10.1258/002367703322389889; Wahlsten D, 2006, P NATL ACAD SCI USA, V103, P16364, DOI 10.1073/pnas.0605342103; Wolfer DP, 2004, NATURE, V432, P821, DOI 10.1038/432821a; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5; Yorty JL, 2004, J NEUROIMMUNOL, V150, P48, DOI 10.1016/j.jneuroim.2004.01.012	42	52	53	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1015	10.1371/journal.pone.0001015	http://dx.doi.org/10.1371/journal.pone.0001015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925863	Green Submitted, Green Published, gold			2022-12-27	WOS:000207456000014
J	Podtschaske, M; Benary, U; Zwinger, S; Hofer, T; Radbruch, A; Baumgrass, R				Podtschaske, Miriam; Benary, Uwe; Zwinger, Sandra; Hoefer, Thomas; Radbruch, Andreas; Baumgrass, Ria			Digital NFATc2 Activation per Cell Transforms Graded T Cell Receptor Activation into an All-or-None IL-2 Expression	PLOS ONE			English	Article								The expression of interleukin-2 (IL-2) is a key event in T helper (Th) lymphocyte activation, controlling both, the expansion and differentiation of effector Th cells as well as the activation of regulatory T cells. We demonstrate that the strength of TCR stimulation is translated into the frequency of memory Th cells expressing IL-2 but not into the amount of IL-2 per cell. This molecular switch decision for IL-2 expression per cell is located downstream of the cytosolic Ca(2+) level. Here we show that in a single activated Th cell, NFATc2 activation is digital but NF-kappa B activation is graded after graded T cell receptor (TCR) signaling. Subsequently, NFATc2 translocates into the nucleus in an all-or-none fashion per cell, transforming the strength of TCR-stimulation into the number of nuclei positive for NFATc2 and IL-2 transcription. Thus, the described NFATc2 switch regulates the number of Th cells actively participating in an immune response.	[Podtschaske, Miriam; Benary, Uwe; Radbruch, Andreas; Baumgrass, Ria] German Rheumatism Res Ctr, Berlin, Germany; [Zwinger, Sandra] Humboldt Univ, Charite, Inst Med Immunol, Berlin, Germany; [Hoefer, Thomas] Humboldt Univ, Dept Theoret Biophys, Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Baumgrass, R (corresponding author), German Rheumatism Res Ctr, Berlin, Germany.	baumgrass@drfz.de	Höfer, Thomas/G-5665-2013	Höfer, Thomas/0000-0003-3560-8780; Baumgrass, Ria/0000-0002-3289-1608; Radbruch, Andreas/0000-0001-5753-0000; Benary, Uwe/0000-0001-7801-8639	State of Berlin; RB DRFZ Berlin; German Federal Ministry of Education and Research (BMBF) [NGFN II, SIPAGE, 01GS0413]; Deutsche Forschungsgemeinschaft [SFB650]	State of Berlin; RB DRFZ Berlin; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by a grant of the State of Berlin to AR and RB DRFZ Berlin, by the German Federal Ministry of Education and Research (BMBF) (NGFN II, SIPAGE, 01GS0413), and by the Deutsche Forschungsgemeinschaft (SFB650).	Assenmacher M, 1998, EUR J IMMUNOL, V28, P1534, DOI 10.1002/(SICI)1521-4141(199805)28:05<1534::AID-IMMU1534>3.0.CO;2-R; Baumgrass R, 2004, J BIOL CHEM, V279, P2470, DOI 10.1074/jbc.M304754200; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; Castellanos MD, 2002, EUR J IMMUNOL, V32, P3108; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; GarciaSanz JA, 1996, J EXP MED, V184, P159, DOI 10.1084/jem.184.1.159; GARRITY PA, 1994, MOL CELL BIOL, V14, P2159, DOI 10.1128/MCB.14.3.2159; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Harber M, 2000, Expert Rev Mol Med, V2, P1, DOI 10.1017/S1462399400002143; Kiani A, 2001, BLOOD, V98, P1480, DOI 10.1182/blood.V98.5.1480; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; LOUIS M, 2002, SCI STKE, pPE33; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Pirone JR, 2004, J THEOR BIOL, V226, P111, DOI 10.1016/j.jtbi.2003.08.008; Powell JD, 1998, IMMUNOL REV, V165, P287, DOI 10.1111/j.1600-065X.1998.tb01246.x; Rachmilewitz J, 2002, TRENDS IMMUNOL, V23, P592, DOI 10.1016/S1471-4906(02)02342-6; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; Rudensky AY, 2006, CELL, V126, P253, DOI 10.1016/j.cell.2006.07.005; Salazar C, 2003, J MOL BIOL, V327, P31, DOI 10.1016/S0022-2836(03)00085-8; Saparov A, 1999, IMMUNITY, V11, P271, DOI 10.1016/S1074-7613(00)80102-8; Scheffold A, 1998, EUR CYTOKINE NETW, V9, P5; Schimpl A, 2002, CYTOKINE GROWTH F R, V13, P369, DOI 10.1016/S1359-6101(02)00022-9; Serfling E, 2004, INT J BIOCHEM CELL B, V36, P1166, DOI 10.1016/j.biocel.2003.07.002; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Sojka DK, 2004, J IMMUNOL, V172, P6136, DOI 10.4049/jimmunol.172.10.6136; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Zinkernagel RM, 2001, SCIENCE, V293, P251, DOI 10.1126/science.1063005; Zinkernagel RM, 2000, SEMIN IMMUNOL, V12, P163, DOI 10.1006/smim.2000.0253	44	52	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e935	10.1371/journal.pone.0000935	http://dx.doi.org/10.1371/journal.pone.0000935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895976	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455800014
J	Borghans, JAM; Molgaard, A; de Boer, RJ; Kesmir, C				Borghans, Jose A. M.; Molgaard, Anne; de Boer, Rob J.; Kesmir, Can			HLA Alleles Associated with Slow Progression to AIDS Truly Prefer to Present HIV-1 p24	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTES; CELL RESPONSES; GAG PROTEIN; VACCINIA VIRUS; TYPE-1 GAG; VIRAL LOAD; ESCAPE; SEQUENCE; EPITOPE	Background. The mechanism behind the association between human leukocyte antigen (HLA) molecules and the rate of HIV-1 disease progression is still poorly understood. Recent data suggest that "protective'' HLA molecules, i.e. those associated with a low HIV-1 viral load and relatively slow disease progression, tend to present epitopes from the Gag capsid protein. Although this suggests that preferential targeting of Gag delays disease progression, the apparent preference for Gag could also be a side-effect of the relatively high immunogenicity of the protein. Methods and Findings. To separate cause and effect, we predicted HIV-1 epitopes from the whole genome of HIV-1, and found that protective HLA alleles have a true preference for the p24 Gag protein, while non-protective HLA alleles preferentially target HIV-1 Nef. In line with this, we found a significant negative correlation between the predicted affinity of the best-binding p24 epitopes and the relative hazard of HIV-1 disease progression for a large number of HLA molecules. When the epitopes targeted by protective HLA alleles were mapped to the known p24 structure, we found that mutations in these epitopes are likely to disturb the p24 dimer structure, which is expected to severely reduce the fitness of the virus. Conclusions. Our results suggest that the intrinsic preference of different HLA molecules to present p24 peptides explains why some HLA molecules are more protective than others.	[Kesmir, Can] Univ Utrecht, Acad Biomed Ctr, Utrecht, Netherlands; [Borghans, Jose A. M.] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands; [Molgaard, Anne; Kesmir, Can] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark	Utrecht University; Utrecht University; Utrecht University Medical Center; Technical University of Denmark	Kesmir, C (corresponding author), Univ Utrecht, Acad Biomed Ctr, Utrecht, Netherlands.	c.kesmir@uu.nl	Kesmir, Can/B-9410-2011; de Boer, Rob/B-6050-2011	de Boer, Rob/0000-0002-2130-691X	Netherlands Organization for Scientific Research (NWO) [050.50.202, 916.36.003, 016.048.603]; AIDS Fonds Netherlands [7011]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); AIDS Fonds Netherlands	This work was financially supported by the Netherlands Organization for Scientific Research (NWO, grants 050.50.202, 916.36.003 and 016.048.603), and by AIDS Fonds Netherlands (grant 7011).	Accola MA, 2000, J VIROL, V74, P5395, DOI 10.1128/JVI.74.12.5395-5402.2000; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Balla-Jhagjhoorsingh SS, 1999, J IMMUNOL, V162, P2308; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Buseyne F, 2002, J INFECT DIS, V186, P1589, DOI 10.1086/345482; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Frahm N, 2005, J VIROL, V79, P10218, DOI 10.1128/JVI.79.16.10218-10225.2005; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Frater AJ, 2007, J VIROL, V81, P6742, DOI 10.1128/JVI.00022-07; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Gillespie GMA, 2002, AIDS, V16, P961, DOI 10.1097/00002030-200205030-00002; Goulder PJR, 1997, AIDS, V11, P536; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Jansen CA, 2005, EUR J IMMUNOL, V35, P150, DOI 10.1002/eji.200425487; Johnson MC, 2002, J VIROL, V76, P11177, DOI 10.1128/JVI.76.22.11177-11185.2002; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Kesmir C, 2002, PROTEIN ENG, V15, P287, DOI 10.1093/protein/15.4.287; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Klein MR, 1998, J GEN VIROL, V79, P2191, DOI 10.1099/0022-1317-79-9-2191; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Lichterfeld M, 2004, AIDS, V18, P1383, DOI 10.1097/01.aids.0000131329.51633.a3; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; NIXON DF, 1988, NATURE, V336, P484, DOI 10.1038/336484a0; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; Novitsky V, 2002, J VIROL, V76, P5435, DOI 10.1128/JVI.76.11.5435-5451.2002; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741; Peyerl FW, 2004, J VIROL, V78, P13901, DOI 10.1128/JVI.78.24.13901-13910.2004; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Scherer A, 2004, P NATL ACAD SCI USA, V101, P12266, DOI 10.1073/pnas.0404091101; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Streeck H, 2007, J VIROL, V81, P7725, DOI 10.1128/JVI.00708-07; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Wagner R, 1999, J IMMUNOL, V162, P3727; Zhang YQ, 1998, J VIROL, V72, P1782, DOI 10.1128/JVI.72.3.1782-1789.1998; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	60	77	78	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e920	10.1371/journal.pone.0000920	http://dx.doi.org/10.1371/journal.pone.0000920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878955	gold, Green Published			2022-12-27	WOS:000207455700028
J	Kauramaki, J; Jaaskelainen, IP; Sams, M				Kauramaki, Jaakko; Jaaskelainen, Iiro P.; Sams, Mikko			Selective Attention Increases Both Gain and Feature Selectivity of the Human Auditory Cortex	PLOS ONE			English	Article							LATERAL INTERACTIONS; UNEXPECTED TONES; MODULATION; FREQUENCY; PLASTICITY; SENSITIVITY; INHIBITION; ACTIVATION; STIMULUS; HEARING	Background. An experienced car mechanic can often deduce what's wrong with a car by carefully listening to the sound of the ailing engine, despite the presence of multiple sources of noise. Indeed, the ability to select task-relevant sounds for awareness, whilst ignoring irrelevant ones, constitutes one of the most fundamental of human faculties, but the underlying neural mechanisms have remained elusive. While most of the literature explains the neural basis of selective attention by means of an increase in neural gain, a number of papers propose enhancement in neural selectivity as an alternative or a complementary mechanism. Methodology/Principal Findings. Here, to address the question whether pure gain increase alone can explain auditory selective attention in humans, we quantified the auditory cortex frequency selectivity in 20 healthy subjects by masking 1000-Hz tones by continuous noise masker with parametrically varying frequency notches around the tone frequency (i.e., a notched-noise masker). The task of the subjects was, in different conditions, to selectively attend to either occasionally occurring slight increments in tone frequency (1020 Hz), tones of slightly longer duration, or ignore the sounds. In line with previous studies, in the ignore condition, the global field power (GFP) of event-related brain responses at 100 ms from the stimulus onset to the 1000-Hz tones was suppressed as a function of the narrowing of the notch width. During the selective attention conditions, the suppressant effect of the noise notch width on GFP was decreased, but as a function significantly different from a multiplicative one expected on the basis of simple gain model of selective attention. Conclusions/Significance. Our results suggest that auditory selective attention in humans cannot be explained by a gain model, where only the neural activity level is increased, but rather that selective attention additionally enhances auditory cortex frequency selectivity.	[Kauramaki, Jaakko; Jaaskelainen, Iiro P.; Sams, Mikko] Aalto Univ, Lab Computat Engn, FIN-02150 Espoo, Finland	Aalto University	Kauramaki, J (corresponding author), Aalto Univ, Lab Computat Engn, FIN-02150 Espoo, Finland.	Jaakko.Kauramaki@tkk.fi	Sams, Mikko E/G-7060-2012; Jaaskelainen, Iiro P/C-7392-2012; Kauramäki, Jaakko/G-6962-2012	Jaaskelainen, Iiro P/0000-0001-6001-6950; Kauramaki, Jaakko/0000-0002-6019-7920	Academy of Finland [206368, 212261, 213470]; National Institutes of Health [RO1-HD040712]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040712] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was financially supported by the Academy of Finland ( grant nos. 206368, 212261, 213470) and by the National Institutes of Health ( grant no. RO1-HD040712).	Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Alho K, 1999, COGNITIVE BRAIN RES, V7, P335, DOI 10.1016/S0926-6410(98)00036-6; Alho K, 2003, COGNITIVE BRAIN RES, V17, P201, DOI 10.1016/S0926-6410(03)00091-0; ARTHUR DL, 1991, ELECTROEN CLIN NEURO, V78, P348, DOI 10.1016/0013-4694(91)90097-N; BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; DAI HP, 1991, J ACOUST SOC AM, V89, P2837, DOI 10.1121/1.400721; DAI HP, 1991, J ACOUST SOC AM, V89, P1816, DOI 10.1121/1.401015; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Engelien A, 2000, BRAIN, V123, P532, DOI 10.1093/brain/123.3.532; Fishman YI, 2006, J NEUROPHYSIOL, V96, P1105, DOI 10.1152/jn.00124.2006; Freeman E, 2003, CURR BIOL, V13, P985, DOI 10.1016/S0960-9822(03)00333-6; Freeman E, 2001, NAT NEUROSCI, V4, P1032, DOI 10.1038/nn728; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; FRITZ JB, 2007, HEAR RES IN PRESS; Fujiki N, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0003.2002; Fujiwara N, 1998, COGNITIVE BRAIN RES, V7, P99, DOI 10.1016/S0926-6410(98)00014-7; Grady CL, 1997, NEUROREPORT, V8, P2511, DOI 10.1097/00001756-199707280-00019; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Huang LQ, 2005, VISION RES, V45, P1201, DOI 10.1016/j.visres.2004.10.024; Hugdahl K, 1999, NEUROPSYCHOLOGIA, V37, P431, DOI 10.1016/S0028-3932(98)00101-8; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Jancke L, 1999, NEUROSCI LETT, V266, P125, DOI 10.1016/S0304-3940(99)00288-8; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Lutkenhoner B, 2007, HEARING RES, V228, P188, DOI 10.1016/j.heares.2007.02.011; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; NAATANEN R, 1988, ELECTROEN CLIN NEURO, V69, P523, DOI 10.1016/0013-4694(88)90164-2; Naatanen R., 2018, ATTENTION BRAIN FUNC; Neelon MF, 2006, BRAIN RES, V1118, P94, DOI 10.1016/j.brainres.2006.08.006; Norena A, 2000, HEARING RES, V149, P24, DOI 10.1016/S0378-5955(00)00158-1; Ozaki I, 2004, CLIN NEUROPHYSIOL, V115, P1592, DOI 10.1016/j.clinph.2004.02.011; Pantev C, 1999, BRAIN RES, V842, P192, DOI 10.1016/S0006-8993(99)01835-1; PATTERSON RD, 1976, J ACOUST SOC AM, V59, P640, DOI 10.1121/1.380914; Pernier J, 1994, HUM BRAIN MAPP, V2, P159; Perrot X, 2006, CEREB CORTEX, V16, P941, DOI 10.1093/cercor/bhj035; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; RIF J, 1991, ELECTROEN CLIN NEURO, V79, P464, DOI 10.1016/0013-4694(91)90166-2; Rinne T, 2005, HUM BRAIN MAPP, V26, P94, DOI 10.1002/hbm.20123; SAMS M, 1994, HEARING RES, V75, P67, DOI 10.1016/0378-5955(94)90057-4; Slotnick SD, 2003, NEUROIMAGE, V19, P1602, DOI 10.1016/S1053-8119(03)00187-3; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Suga N, 1997, J NEUROPHYSIOL, V77, P2098, DOI 10.1152/jn.1997.77.4.2098; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Wiegrebe L, 1996, HEARING RES, V100, P171, DOI 10.1016/0378-5955(96)00111-6; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; WOLDORFF MG, 1991, ELECTROEN CLIN NEURO, V79, P170, DOI 10.1016/0013-4694(91)90136-R; Wright BA, 2005, J ACOUST SOC AM, V117, P1299, DOI 10.1121/1.1855771; WRIGHT BA, 1994, J ACOUST SOC AM, V95, P939, DOI 10.1121/1.410011; Wright BA, 2004, PERCEPT PSYCHOPHYS, V66, P508, DOI 10.3758/BF03194897; WRIGHT BA, 1994, J ACOUST SOC AM, V95, P931, DOI 10.1121/1.410010; Xiao ZJ, 2002, NAT NEUROSCI, V5, P57, DOI 10.1038/nn786; Zatorre RJ, 1999, NEUROIMAGE, V10, P544, DOI 10.1006/nimg.1999.0491	61	63	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e909	10.1371/journal.pone.0000909	http://dx.doi.org/10.1371/journal.pone.0000909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878944	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455700017
J	Szczurko, O; Cooley, K; Busse, JW; Seely, D; Bernhardt, B; Guyatt, GH; Zhou, Q; Mills, EJ				Szczurko, Orest; Cooley, Kieran; Busse, Jason W.; Seely, Dugald; Bernhardt, Bob; Guyatt, Gordon H.; Zhou, Qi; Mills, Edward J.			Naturopathic Care for Chronic Low Back Pain: A Randomized Trial	PLOS ONE			English	Article								Objective. Chronic low back pain represents a substantial cost to employers through benefits coverage and days missed due to incapacity. We sought to explore the effectiveness of Naturopathic care on chronic low back pain. Methods. This study was a randomized clinical trial. We randomized 75 postal employees with low back pain of longer than six weeks duration to receive Naturopathic care (n = 39) or standardized physiotherapy (n = 36) over a period of 12 weeks. The study was conducted in clinics on-site in postal outlets. Participants in the Naturopathic care group received dietary counseling, deep breathing relaxation techniques and acupuncture. The control intervention received education and instruction on physiotherapy exercises using an approved education booklet. We measured low back pain using the Oswestry disability questionnaire as the primary outcome measure, and quality of life using the SF-36 in addition to low back range of motion, weight loss, and Body Mass Index as secondary outcomes. Results. Sixty-nine participants (92%) completed eight weeks or greater of the trial. Participants in the Naturopathic care group reported significantly lower back pain (-6.89, 95% CI. -9.23 to -3.54, p=<0.0001) as measured by the Oswestry questionnaire. Quality of life was also significantly improved in the group receiving Naturopathic care in all domains except for vitality. Differences for the aggregate physical component of the SF-36 was 8.47 (95% CI, 5.05 to 11.87, p=<0.0001) and for the aggregate mental component was 7.0 (95% CI, 2.25 to 11.75, p=0.0045). All secondary outcomes were also significantly improved in the group receiving Naturopathic care: spinal flexion (p<0.0001), weight-loss (p=0.0052) and Body Mass Index (20.52, 95% CI, -0.96 to -0.08, p=0.01). Conclusions. Naturopathic care provided significantly greater improvement than physiotherapy advice for patients with chronic low back pain. Trial Registration. Controlled-Trials.com ISRCTN41920953	[Busse, Jason W.; Guyatt, Gordon H.; Zhou, Qi; Mills, Edward J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Szczurko, Orest; Cooley, Kieran; Seely, Dugald; Bernhardt, Bob] Canadian Coll Naturopath Med, Div Clin Epidemiol, Toronto, ON, Canada	McMaster University	Mills, EJ (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	millsej@mcmaster.ca	Zhou, Qi/GSM-9583-2022; Cooley, Kieran/L-3080-2019; Busse, Jason/CAH-3696-2022	Cooley, Kieran/0000-0001-7960-6504; Busse, Jason/0000-0002-0178-8712	Canada Post Corporation; Canadian Union of Postal Workers	Canada Post Corporation; Canadian Union of Postal Workers	Funding was provided by the Canada Post Corporation and Canadian Union of Postal Workers.	Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Bombardier C, 2001, J RHEUMATOL, V28, P431; Boon Heather S, 2004, BMC Complement Altern Med, V4, P14, DOI 10.1186/1472-6882-4-14; Cherkin Daniel C, 2002, J Am Board Fam Pract, V15, P463; Cherkin DC, 1998, NEW ENGL J MED, V339, P1021, DOI 10.1056/NEJM199810083391502; Frost H, 2004, BRIT MED J, V329, P708, DOI 10.1136/bmj.38216.868808.7C; Goetzel RZ, 2003, J OCCUP ENVIRON MED, V45, P5, DOI 10.1097/00043764-200301000-00007; Goldby LJ, 2006, SPINE, V31, P1083, DOI 10.1097/01.brs.0000216464.37504.64; Hopman WM, 2000, CAN MED ASSOC J, V163, P265; Jonas WB, 1998, JAMA-J AM MED ASSOC, V280, P1616, DOI 10.1001/jama.280.18.1616; Lind BK, 2005, SPINE, V30, P1454, DOI 10.1097/01.brs.0000166527.18442.10; Maetzel A, 2002, BEST PRACT RES CL RH, V16, P23, DOI 10.1053/berh.2001.0204; Manheimer E, 2005, ANN INTERN MED, V142, P651, DOI 10.7326/0003-4819-142-8-200504190-00014; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Schulz KF, 2002, LANCET, V359, P696, DOI 10.1016/S0140-6736(02)07816-9; STRATFORD PW, 1994, PHYS THER, V74, P528, DOI 10.1093/ptj/74.6.528; Udermann Brian E, 2004, Spine J, V4, P425, DOI 10.1016/j.spinee.2004.01.016	17	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e919	10.1371/journal.pone.0000919	http://dx.doi.org/10.1371/journal.pone.0000919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878954	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455700027
J	Peterson, L; Nanda, K; Opoku, BK; Ampofo, WK; Owusu-Amoako, M; Boakye, AY; Rountree, W; Troxler, A; Dominik, R; Roddy, R; Dorflinger, L				Peterson, Leigh; Nanda, Kavita; Opoku, Baafuor Kofi; Ampofo, William Kwabena; Owusu-Amoako, Margaret; Boakye, Andrew Yiadom; Rountree, Wes; Troxler, Amanda; Dominik, Rosalie; Roddy, Ronald; Dorflinger, Laneta			SAVVY (R) (C31G) Gel for Prevention of HIV infection in Women: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Ghana	PLOS ONE			English	Article							NONOXYNOL-9	Objective. The objective of this trial was to determine the effectiveness of 1.0% C31G (SAVVY) in preventing male-to-female vaginal transmission of HIV infection among women at high risk. Methodology/Principal Findings. This was a Phase 3, double-blind, randomized, placebo-controlled trial. Participants made up to 12 monthly visits for HIV testing, adverse event reporting, and study product supply. The study was conducted between March 2004 and February 2006 in Accra and Kumasi, Ghana. We enrolled 2142 HIV-negative women at high risk of HIV infection, and randomized them to SAVVY or placebo gel. Main outcome measures were the incidence of HIV-1 and HIV-2 infection as determined by detection of HIV antibodies from oral mucosal transudate specimens and adverse events. We accrued 790 person-years of follow-up in the SAVVY group and 772 person-years in the placebo group. No clinically significant differences in the overall frequency of adverse events, abnormal pelvic examination findings, or abnormal laboratory results were seen between treatment groups. However, more participants in the SAVVY group reported reproductive tract adverse events than in the placebo group (13.0% versus 9.4%). Seventeen HIV seroconversions occurred; eight in participants randomized to SAVVY and nine in participants receiving placebo. The Kaplan-Meier estimates of the cumulative probability of HIV infection through 12 months were 0.010 in the SAVVY group and 0.011 in the placebo group (p = 0.731), with a hazard ratio (SAVVY versus placebo) of 0.88 (95% confidence interval 0.33, 2.27). Because of a lower-than-expected HIV incidence, we were unable to achieve the required number of HIV infections (66) to obtain the desired study power. Conclusions/Significance. SAVVY was not associated with increased adverse events overall, but was associated with higher reporting of reproductive adverse events. Our data are insufficient to conclude whether SAVVY is effective at preventing HIV infection relative to placebo. Trial Registration. ClinicalTrials. gov NCT00129532	[Peterson, Leigh; Nanda, Kavita; Rountree, Wes; Troxler, Amanda; Dominik, Rosalie; Dorflinger, Laneta] Family Hlth Int, Durham, NC USA; [Opoku, Baafuor Kofi; Boakye, Andrew Yiadom] Kwame Nkrumah Univ Sci & Technol, Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Ampofo, William Kwabena; Owusu-Amoako, Margaret] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; [Roddy, Ronald] Duke Clin Res Inst, Durham, NC USA	Kwame Nkrumah University Science & Technology; University of Ghana; Duke University	Nanda, K (corresponding author), Family Hlth Int, Durham, NC USA.	KNanda@fhi.org	Opoku, Baafuor/AGR-4953-2022	Nanda, Kavita/0000-0001-7650-2929				Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5; *BIOS INC, 2005, INV BROCH 1 C31G; Krebs FC, 2000, ANTIMICROB AGENTS CH, V44, P1954, DOI 10.1128/AAC.44.7.1954-1960.2000; Mauck CK, 2004, CONTRACEPTION, V70, P221, DOI 10.1016/j.contraception.2003.12.008; Mauck CK, 2004, CONTRACEPTION, V70, P233, DOI 10.1016/j.contraception.2004.04.010; Mauck CK, 2004, CONTRACEPTION, V70, P227, DOI 10.1016/j.contraception.2004.02.001; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; NIRUTHISARD S, 1991, SEX TRANSM DIS, V18, P176, DOI 10.1097/00007435-199107000-00010; RODDY RE, 1993, INT J STD AIDS, V4, P165, DOI 10.1177/095646249300400308; Trussell J, 2005, CONTRACEPTION, V72, P408, DOI 10.1016/j.contraception.2005.06.063; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8	11	160	161	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1312	10.1371/journal.pone.0001312	http://dx.doi.org/10.1371/journal.pone.0001312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091987	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459600001
J	Bankston, JR; Yue, M; Chung, WD; Spyres, M; Pass, RH; Silver, E; Sampson, KJ; Kass, RS				Bankston, John R.; Yue, Minerva; Chung, Wendy; Spyres, Meghan; Pass, Robert H.; Silver, Eric; Sampson, Kevin J.; Kass, Robert S.			A Novel and Lethal De Novo LQT-3 Mutation in a Newborn with Distinct Molecular Pharmacology and Therapeutic Response	PLOS ONE			English	Article								Background. SCN5A encodes the alpha-subunit (Na(v)1.5) of the principle Na+ channel in the human heart. Genetic lesions in SCN5A can cause congenital long QT syndrome (LQTS) variant 3 (LQT-3) in adults by disrupting inactivation of the Nav1.5 channel. Pharmacological targeting of mutation-altered Na+ channels has proven promising in developing a gene-specific therapeutic strategy to manage specifically this LQTS variant. SCN5A mutations that cause similar channel dysfunction may also contribute to sudden infant death syndrome ( SIDS) and other arrhythmias in newborns, but the prevalence, impact, and therapeutic management of SCN5A mutations may be distinct in infants compared with adults. Methods and Results. Here, in a multidisciplinary approach, we report a de novo SCN5A mutation (F1473C) discovered in a newborn presenting with extreme QT prolongation and differential responses to the Na+ channel blockers flecainide and mexiletine. Our goal was to determine the Na+ channel phenotype caused by this severe mutation and to determine whether distinct effects of different Na+ channel blockers on mutant channel activity provide a mechanistic understanding of the distinct therapeutic responsiveness of the mutation carrier. Sequence analysis of the proband revealed the novel missense SCN5A mutation (F1473C) and a common variant in KCNH2 (K897T). Patch clamp analysis of HEK 293 cells transiently transfected with wild-type or mutant Na+ channels revealed significant changes in channel biophysics, all contributing to the proband's phenotype as predicted by in silico modeling. Furthermore, subtle differences in drug action were detected in correcting mutant channel activity that, together with both the known genetic background and age of the patient, contribute to the distinct therapeutic responses observed clinically. Significance. The results of our study provide further evidence of the grave vulnerability of newborns to Na+ channel defects and suggest that both genetic background and age are particularly important in developing a mutation-specific therapeutic personalized approach to manage disorders in the young.	[Bankston, John R.; Yue, Minerva; Sampson, Kevin J.; Kass, Robert S.] Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Pharmacol, New York, NY 10027 USA; [Chung, Wendy; Pass, Robert H.; Silver, Eric] Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Pediat, New York, NY USA	Columbia University; Columbia University	Kass, RS (corresponding author), Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Pharmacol, New York, NY 10027 USA.	rsk20@columbia.edu	Bankston, John/I-7429-2019	Bankston, John/0000-0002-9478-2335	NIH [1R01 HL-56810-10]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056810, T35HL007616] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the NIH (1R01 HL-56810-10 to RSK).	Abriel H, 2001, CIRC RES, V88, P740, DOI 10.1161/hh0701.089668; Ackerman MJ, 2003, MAYO CLIN PROC, V78, P1479, DOI 10.4065/78.12.1479; Ackerman MJ, 2001, JAMA-J AM MED ASSOC, V286, P2264, DOI 10.1001/jama.286.18.2264; Anson BD, 2004, AM J PHYSIOL-HEART C, V286, pH2434, DOI 10.1152/ajpheart.00891.2003; Arnestad M, 2007, CIRCULATION, V115, P361, DOI 10.1161/CIRCULATIONAHA.106.658021; Benhorin J, 2000, CIRCULATION, V101, P1698; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Bezzina CR, 2003, CARDIOVASC RES, V59, P27, DOI 10.1016/S0008-6363(03)00342-0; Clancy CE, 2003, CIRCULATION, V107, P2233, DOI 10.1161/01.CIR.0000069273.51375.BD; Clancy CE, 2002, J CLIN INVEST, V110, P1251, DOI 10.1172/JCI200215928; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Crotti L, 2005, CIRCULATION, V112, P1251, DOI 10.1161/CIRCULATIONAHA.105.549071; Fredj S, 2006, BRIT J PHARMACOL, V148, P16, DOI 10.1038/sj.bjp.0706709; Kambouris NG, 1998, CIRCULATION, V97, P640, DOI 10.1161/01.CIR.97.7.640; Kass RS, 2006, HANDB EXP PHARMACOL, V171, P287; Kehl HG, 2004, CIRCULATION, V109, pE205, DOI 10.1161/01.CIR.0000128874.43908.CA; Koo SH, 2006, BRIT J CLIN PHARMACO, V61, P301, DOI 10.1111/j.1365-2125.2005.02545.x; Lerche H, 1997, J PHYSIOL-LONDON, V505, P345, DOI 10.1111/j.1469-7793.1997.345bb.x; Liu HJ, 2003, J GEN PHYSIOL, V121, P199, DOI 10.1085/jgp.20028723; Medeiros-Domingo A, 2007, CIRCULATION, V116, P134, DOI 10.1161/CIRCULATIONAHA.106.659086; Miura M, 2003, PEDIATR CARDIOL, V24, P70, DOI 10.1007/s00246-002-0169-5; Moss AJ, 2005, ANN NONINVAS ELECTRO, V10, P59, DOI 10.1111/j.1542-474X.2005.00077.x; Moss AJ, 2005, J CLIN INVEST, V115, P2018, DOI 10.1172/JCI25537; Nagashima M, 2001, J MOL CELL CARDIOL, V33, P533, DOI 10.1006/jmcc.2000.1327; Nagatomo T, 2000, MOL PHARMACOL, V57, P101; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Nerbonne JM, 1998, J NEUROBIOL, V37, P37, DOI 10.1002/(SICI)1097-4695(199810)37:1<37::AID-NEU4>3.0.CO;2-9; Obreztchikova MN, 2003, CARDIOVASC RES, V59, P339, DOI 10.1016/S0008-6363(03)00360-2; Paavonen KJ, 2003, CARDIOVASC RES, V59, P603, DOI 10.1016/S0008-6363(03)00458-9; Paul AA, 2002, BRIT J PHARMACOL, V136, P717, DOI 10.1038/sj.bjp.0704784; Plant LD, 2006, J CLIN INVEST, V116, P430, DOI 10.1172/JCI25618; Ruan YF, 2007, CIRCULATION, V116, P1137, DOI 10.1161/CIRCULATIONAHA.107.707877; Schulze-Bahr E, 2004, HEART, V90, P13, DOI 10.1136/heart.90.1.13; Schwartz PJ, 2007, HEART RHYTHM, V4, P740, DOI 10.1016/j.hrthm.2007.03.035; Schwartz PJ, 2000, NEW ENGL J MED, V343, P262, DOI 10.1056/NEJM200007273430405; SCHWARTZ PJ, 1995, CIRCULATION, V92, P3381, DOI 10.1161/01.CIR.92.12.3381; Ten Harkel ADJ, 2005, EUROPACE, V7, P77, DOI 10.1016/j.eupc.2004.09.007; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Vatta M, 2006, CIRCULATION, V114, P2104, DOI 10.1161/CIRCULATIONAHA.106.635268; Wang DW, 2007, CIRCULATION, V115, P368, DOI 10.1161/CIRCULATIONAHA.106.646513; Wang DW, 1996, J MOL CELL CARDIOL, V28, P893, DOI 10.1006/jmcc.1996.0084; Wang DW, 1997, J CLIN INVEST, V99, P1714, DOI 10.1172/JCI119335; Wedekind H, 2001, CIRCULATION, V104, P1158, DOI 10.1161/hc3501.095361	43	43	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1258	10.1371/journal.pone.0001258	http://dx.doi.org/10.1371/journal.pone.0001258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060054	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459400007
J	Dewan, I; Kulathinal, S				Dewan, Isha; Kulathinal, Sangita			On Testing Dependence between Time to Failure and Cause of Failure when Causes of Failure Are Missing	PLOS ONE			English	Article								The hypothesis of independence between the failure time and the cause of failure is studied by using the conditional probabilities of failure due to a specific cause given that there is no failure up to certain fixed time. In practice, there are situations when the failure times are available for all units but the causes of failures might be missing for some units. We propose tests based on U-statistics to test for independence of the failure time and the cause of failure in the competing risks model when all the causes of failure cannot be observed. The asymptotic distribution is normal in each case. Simulation studies look at power comparisons for the proposed tests for two families of distributions. The one-sided and the two-sided tests based on Kendall type statistic perform exceedingly well in detecting departures from independence.	[Kulathinal, Sangita] Indic Soc Educ & Dev, Nasik, India; [Dewan, Isha] Indian Stat Inst, New Delhi 110016, India	Indian Statistical Institute; Indian Statistical Institute Delhi	Kulathinal, S (corresponding author), Indic Soc Educ & Dev, Nasik, India.	sangita.kulathinal@inseed.org						[Anonymous], 2000, SAS STAT US GUID VER; Cooke RM, 1996, RELIAB ENG SYST SAFE, V51, P209, DOI 10.1016/0951-8320(95)00118-2; Dewan I, 2004, SCAND J STAT, V31, P79, DOI 10.1111/j.1467-9469.2004.00374.x; Dewanji A, 2003, BIOMETRICS, V59, P1063, DOI 10.1111/j.0006-341X.2003.00122.x; DEWANJI A, 1992, BIOMETRIKA, V79, P855, DOI 10.1093/biomet/79.4.855; DINSE GE, 1986, J AM STAT ASSOC, V81, P328, DOI 10.2307/2289220; Goetghebeur E, 1995, BIOMETRIKA, V82, P821, DOI 10.2307/2337347; GOETGHEBEUR E, 1990, BIOMETRIKA, V77, P207, DOI 10.2307/2336064; KODELL RL, 1987, COMMUN STAT THEORY, V16, P2565, DOI 10.1080/03610928708829523; Kundu D, 2000, J STAT PLAN INFER, V87, P221, DOI 10.1016/S0378-3758(99)00193-7; LAPIDUS G, 1994, ACCIDENT ANAL PREV, V26, P535, DOI 10.1016/0001-4575(94)90044-2; Lu KF, 2005, LIFETIME DATA ANAL, V11, P29, DOI 10.1007/s10985-004-5638-0; MIYAKAWA M, 1984, IEEE T RELIAB, V33, P293, DOI 10.1109/TR.1984.5221828; NAIR VN, 1993, REVIEW, V61, P169; Puri Madan Lal, 1971, WILEY PUBLICATION MA; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739	16	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1255	10.1371/journal.pone.0001255	http://dx.doi.org/10.1371/journal.pone.0001255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060052	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459400004
J	Dong, CZ; Qian, ZL; Jia, PL; Wang, Y; Huang, W; Li, YX				Dong, Changzheng; Qian, Ziliang; Jia, Peilin; Wang, Ying; Huang, Wei; Li, Yixue			Gene-Centric Characteristics of Genome-Wide Association Studies	PLOS ONE			English	Article							CONSERVED ELEMENTS; SNPS; PORTABILITY; SELECTION; COVERAGE; MUTATION; DISEASE; VARIANT; RISK; LOCI	Background. The high-throughput genotyping chips have contributed greatly to genome-wide association (GWA) studies to identify novel disease susceptibility single nucleotide polymorphisms ( SNPs). The high-density chips are designed using two different SNP selection approaches, the direct gene-centric approach, and the indirect quasi-random SNPs or linkage disequilibrium (LD)-based tagSNPs approaches. Although all these approaches can provide high genome coverage and ascertain variants in genes, it is not clear to which extent these approaches could capture the common genic variants. It is also important to characterize and compare the differences between these approaches. Methodology/Principal Findings. In our study, by using both the Phase II HapMap data and the disease variants extracted from OMIM, a gene-centric evaluation was first performed to evaluate the ability of the approaches in capturing the disease variants in Caucasian population. Then the distribution patterns of SNPs were also characterized in genic regions, evolutionarily conserved introns and nongenic regions, ontologies and pathways. The results show that, no mater which SNP selection approach is used, the current high-density SNP chips provide very high coverage in genic regions and can capture most of known common disease variants under HapMap frame. The results also show that the differences between the direct and the indirect approaches are relatively small. Both have similar SNP distribution patterns in these gene-centric characteristics. Conclusions/Significance. This study suggests that the indirect approaches not only have the advantage of high coverage but also are useful for studies focusing on various functional SNPs either in genes or in the conserved regions that the direct approach supports. The study and the annotation of characteristics will be helpful for designing and analyzing GWA studies that aim to identify genetic risk factors involved in common diseases, especially variants in genes and conserved regions.	[Dong, Changzheng; Wang, Ying; Huang, Wei] Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China; [Dong, Changzheng; Qian, Ziliang; Jia, Peilin; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Bioinformat Ctr, Shanghai, Peoples R China; [Dong, Changzheng; Qian, Ziliang; Jia, Peilin] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Huang, Wei] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai 200030, Peoples R China; [Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences	Huang, W (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China.	huangwei@chgc.sh.cn; yxli@sibs.ac.cn	Jia, Peilin/B-4519-2013		National Basic Research Program of China [2006CB910700, 2004CB720103, 2004CB518606, 2003CB715901, 2004CB518605]; National High-Tech RD Program (863) [2006AA02Z334]; National Science Fund for Distinguished Young Scholars [30625019]; Chinese High-Tech Program [2006AA020706]; Shanghai Science and Technology Committee [06XD14015]	National Basic Research Program of China(National Basic Research Program of China); National High-Tech RD Program (863)(National High Technology Research and Development Program of China); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Chinese High-Tech Program; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	YL was supported by grants from National Basic Research Program of China (2006CB910700, 2004CB720103, 2004CB518606, 2003CB715901) and National High-Tech R&D Program (863)(2006AA02Z334). WH was supported by National Science Fund for Distinguished Young Scholars ( 30625019), the National Basic Research Program (2004CB518605), Chinese High-Tech Program (2006AA020706), and Shanghai Science and Technology Committee (06XD14015). None of these institutions play any direct or indirect role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Akey JM, 2001, HUM GENET, V108, P516, DOI 10.1007/s004390100524; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; [Anonymous], ONLINE MENDELIAN INH; [Anonymous], DBSNP; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auro K, 2007, PLOS GENET, V3, P1244, DOI 10.1371/journal.pgen.0030120; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bielinsky AK, 2001, CURR BIOL, V11, P1427, DOI 10.1016/S0960-9822(01)00444-4; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Fredman D, 2002, NUCLEIC ACIDS RES, V30, P387, DOI 10.1093/nar/30.1.387; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gonzalez-Neira A, 2006, GENOME RES, V16, P323, DOI 10.1101/gr.4138406; Grice EA, 2005, HUM MOL GENET, V14, P3837, DOI 10.1093/hmg/ddi408; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Huang W, 2006, P NATL ACAD SCI USA, V103, P1418, DOI 10.1073/pnas.0510360103; Hughes JR, 2005, P NATL ACAD SCI USA, V102, P9830, DOI 10.1073/pnas.0503401102; JARUZELSKA J, 1995, J BIOL CHEM, V270, P20370, DOI 10.1074/jbc.270.35.20370; Jorgenson E, 2006, NAT REV GENET, V7, P885, DOI 10.1038/nrg1962; Kanchisa M., 2006, NUCLEIC ACIDS RES, V34, pD354; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Nicolae DL, 2006, PLOS GENET, V2, P665, DOI 10.1371/journal.pgen.0020067; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; PROIA RL, 1982, P NATL ACAD SCI-BIOL, V79, P6360, DOI 10.1073/pnas.79.20.6360; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shin JT, 2005, NUCLEIC ACIDS RES, V33, P5437, DOI 10.1093/nar/gki853; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Tantoso E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-238; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Willer CJ, 2006, GENET EPIDEMIOL, V30, P180, DOI 10.1002/gepi.20131; Wiltshire S, 2006, EUR J HUM GENET, V14, P1209, DOI 10.1038/sj.ejhg.5201678; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; NHLBI PROGRAM GENOMI; ENTREZ GENE	47	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1262	10.1371/journal.pone.0001262	http://dx.doi.org/10.1371/journal.pone.0001262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060058	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459400011
J	von Ahlfen, S; Missel, A; Bendrat, K; Schlumpberger, M				von Ahlfen, Silke; Missel, Andreas; Bendrat, Klaus; Schlumpberger, Martin			Determinants of RNA Quality from FFPE Samples	PLOS ONE			English	Article								The large archives of formalin-fixed paraffin-embedded (FFPE) tissue specimens that exist are a highly valuable source of sample material for molecular biological analysis, including gene expression profiling. However, current data on adverse effects of standard pathological practice on the usefulness of biomolecular analytes obtained from such archived specimens is largely anecdotal. Here, we present a systematic examination of the most relevant parameters for integrity and useability of RNA obtained from FFPE samples, including storage time and conditions, fixation time, and specimen size. The results are particularly relevant for any application relying on cDNA synthesis as an initial step of the procedure, such as RT-PCR, and microarray analysis.	[von Ahlfen, Silke; Missel, Andreas; Schlumpberger, Martin] QIAGEN GmbH, Hilden, Germany	QIAGEN GmbH	Schlumpberger, M (corresponding author), QIAGEN GmbH, Hilden, Germany.	martin.schlumpberger@qiagen.com			QIAGEN GmbH	QIAGEN GmbH	SvA, AM, and MS are employees of QIAGEN GmbH.	Bhudevi B, 2003, J VIROL METHODS, V109, P25, DOI 10.1016/S0166-0934(03)00040-5; BRESTERS D, 1994, J VIROL METHODS, V48, P267, DOI 10.1016/0166-0934(94)90125-2; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; DEMPSTER WT, 1960, AM J ANAT, V107, P59, DOI 10.1002/aja.1001070105; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Krafft AE, 1997, MOL DIAGN, V2, P217, DOI 10.1016/S1084-8592(97)80032-X; KRAUS E, 1976, H-S Z PHYSIOL CHEM, V357, P233; Lewis F, 2001, J PATHOL, V195, P66, DOI 10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F; Macabeo-Ong M, 2002, MODERN PATHOL, V15, P979, DOI 10.1097/01.MP.0000026054.62220.FC; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Werner M, 2000, AM J SURG PATHOL, V24, P1016, DOI 10.1097/00000478-200007000-00014	12	258	268	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1261	10.1371/journal.pone.0001261	http://dx.doi.org/10.1371/journal.pone.0001261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060057	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459400010
J	Koo, BK; Yoon, MJ; Yoon, KJ; Im, SK; Kim, YY; Kim, CH; Suh, PG; Jan, YN; Kong, YY				Koo, Bon-Kyoung; Yoon, Mi-Jeong; Yoon, Ki-Jun; Im, Sun-Kyoung; Kim, Yoon-Young; Kim, Cheol-Hee; Suh, Pann-Ghill; Jan, Yuh Nung; Kong, Young-Yun			An Obligatory Role of Mind Bomb-1 in Notch Signaling of Mammalian Development	PLOS ONE			English	Article								Background. The Notch signaling pathway is an evolutionarily conserved intercellular signaling module essential for cell fate specification that requires endocytosis of Notch ligands. Structurally distinct E3 ubiquitin ligases, Neuralized (Neur) and Mind bomb (Mib), cooperatively regulate the endocytosis of Notch ligands in Drosophila. However, the respective roles of the mammalian E3 ubiquitin ligases, Neur1, Neur2, Mib1, and Mib2, in mammalian development are poorly understood. Methodology/Principal Findings. Through extensive use of mammalian genetics, here we show that Neur1 and Neur2 double mutants and Mib2 2/2 mice were viable and grossly normal. In contrast, conditional inactivation of Mib1 in various tissues revealed the representative Notch phenotypes: defects of arterial specification as deltalike4 mutants, abnormal cerebellum and skin development as jagged1 conditional mutants, and syndactylism as jagged2 mutants. Conclusions/Significance. Our data provide the first evidence that Mib1 is essential for Jagged as well as Deltalike ligand-mediated Notch signaling in mammalian development, while Neur1, Neur2, and Mib2 are dispensable.	[Koo, Bon-Kyoung; Yoon, Mi-Jeong; Yoon, Ki-Jun; Im, Sun-Kyoung; Kim, Yoon-Young; Suh, Pann-Ghill; Kong, Young-Yun] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, Kyungbuk, South Korea; [Kim, Cheol-Hee] Chungnam Natl Univ, Dept Biol, Taejon, South Korea; [Jan, Yuh Nung] Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA USA; [Jan, Yuh Nung] Univ Calif San Francisco, Dept Biochem, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Pohang University of Science & Technology (POSTECH); Chungnam National University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Kong, YY (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, Kyungbuk, South Korea.	ykong@postech.ac.kr	Yoon, Ki-Jun/S-8170-2018; Koo, Bon-Kyoung/V-5219-2017; Suh, Pann-Ghill/F-3610-2010	Koo, Bon-Kyoung/0000-0002-4134-8033; Jan, Yuh Nung/0000-0003-1367-6299; Yoon, Ki-Jun/0000-0003-2985-2541; Kim, Cheol-Hee/0000-0002-3019-0699	Ministry of Science and Technology, the Republic of Korea [M103KV010021-06K220102110]; Ministry of Science & Technology in Korea [FG06-42-1]; Korea Science and Engineering Foundation	Ministry of Science and Technology, the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaMinistry of Science & Technology (MOST), Republic of Korea); Ministry of Science & Technology in Korea(Ministry of Science & Technology (MOST), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This research was supported by a grant (M103KV010021-06K220102110) from Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Science and Technology, the Republic of Korea. This work was also supported by (FG06-42-1) of the 21C Frontier Functional Human Genome Project from the Ministry of Science & Technology in Korea and the Vascular System Research center grant from the Korea Science and Engineering Foundation	Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barsi JC, 2005, MECH DEVELOP, V122, P1106, DOI 10.1016/j.mod.2005.06.005; BOULIANNE GL, 1991, EMBO J, V10, P2975, DOI 10.1002/j.1460-2075.1991.tb07848.x; Commisso C, 2007, MOL BIOL CELL, V18, P1, DOI 10.1091/mbc.E06-08-0753; Deblandre GA, 2001, DEV CELL, V1, P795, DOI 10.1016/S1534-5807(01)00091-0; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Fitzgerald K, 1995, DEVELOPMENT, V121, P4275; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Klein AL, 2004, DEV BIOL, V266, P161, DOI 10.1016/j.ydbio.2003.10.017; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lai EC, 2005, DEVELOPMENT, V132, P2319, DOI 10.1242/dev.01825; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; Lind D, 2005, J NEUROSCI RES, V79, P295, DOI 10.1002/jnr.20354; Lutolf S, 2002, DEVELOPMENT, V129, P373; Macias D, 1997, DEVELOPMENT, V124, P1109; Pan YH, 2005, DEV BIOL, V286, P472, DOI 10.1016/j.ydbio.2005.08.037; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Ruan YL, 2001, P NATL ACAD SCI USA, V98, P9907, DOI 10.1073/pnas.171321098; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Sidow A, 1997, NATURE, V389, P722, DOI 10.1038/39587; Song R, 2006, J BIOL CHEM, V281, P36391, DOI 10.1074/jbc.M606601200; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Sun X, 1996, DEVELOPMENT, V122, P2465; Sun X, 1997, DEVELOPMENT, V124, P3439; Vollrath B, 2001, MOL CELL BIOL, V21, P7481, DOI 10.1128/MCB.21.21.7481-7494.2001; Weller M, 2006, DEV NEUROSCI-BASEL, V28, P70, DOI 10.1159/000090754; WHEATLEY SC, 1993, DEVELOPMENT, V119, P295; Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2; Yeh E, 2001, CURR BIOL, V11, P1675, DOI 10.1016/S0960-9822(01)00527-9; Zhang CJ, 2007, DEV BIOL, V305, P14, DOI 10.1016/j.ydbio.2007.01.034; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738	47	95	96	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1221	10.1371/journal.pone.0001221	http://dx.doi.org/10.1371/journal.pone.0001221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043734	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459300008
J	Mutschelknauss, M; Kummer, M; Muser, J; Feinstein, SB; Meyer, PM; Biedermann, BC				Mutschelknauss, Marcus; Kummer, Marco; Muser, Juergen; Feinstein, Steve B.; Meyer, Peter M.; Biedermann, Barbara C.			Individual Assessment of Arteriosclerosis by Empiric Clinical Profiling	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; RISK-ASSESSMENT STRATEGIES; CORONARY-HEART-DISEASE; CARDIOVASCULAR EVENTS; VULNERABLE PATIENT; BIOMARKERS; PREDICTION; OBESITY; ATHEROSCLEROSIS; DEFINITIONS	Background. Arteriosclerosis is a common cause of chronic morbidity and mortality. Myocardial infarction, stroke or other cardiovascular events identify vulnerable patients who suffer from symptomatic arteriosclerosis. Biomarkers to identify vulnerable patients before cardiovascular events occur are warranted to improve care for affected individuals. We tested how accurately basic clinical data can describe and assess the activity of arteriosclerosis in the individual patient. Methodology/Principal Findings. 269 in-patients who were treated for various conditions at the department of general medicine of an academic tertiary care center were included in a cross-sectional study. Personal history and clinical examination were obtained. When paraclinical tests were performed, the results were added to the dataset. The numerical variables in the clinical examination were statistically compared between patients with proven symptomatic arteriosclerosis (n = 100) and patients who had never experienced cardiovascular events in the past (n = 110). 25 variables were different between these two patient groups and contributed to the disease activity score. The percentile distribution of these variables defined the empiric clinical profile. Anthropometric data, signs of arterial, cardiac and renal disease, systemic inflammation and health economics formed the major categories of the empiric clinical profile that described an individual patient's disease activity. The area under the curve of the receiver operating curve for symptomatic arteriosclerosis was 0.891 (95% CI 0.799-0.983) for the novel disease activity score compared to 0.684 (95% CI 0.600-0.769) for the 10-year risk calculated according to the Framingham score. In patients suffering from symptomatic arteriosclerosis, the disease activity score deteriorated more rapidly after two years of follow-up (from 1.25 to 1.48, P = 0.005) compared to age- and sex-matched individuals free of cardiovascular events (from 1.09 to 1.19, P = 0.125). Conclusions/Significance. Empiric clinical profiling and the disease activity score that are based on accessible, available and affordable clinical data are valid markers for symptomatic arteriosclerosis.	[Biedermann, Barbara C.] Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland; [Mutschelknauss, Marcus; Kummer, Marco; Muser, Juergen] Kantonsspital Bruderholz, Univ Dept Med, Bruderholz, Switzerland; [Feinstein, Steve B.; Meyer, Peter M.] Rush Univ, Med Ctr, Dept Prevent Med, Chicago, IL 60612 USA	University of Basel; Kantonsspital Baselland; Rush University	Biedermann, BC (corresponding author), Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland.	barbara.biedermann@ksbh.ch			Swiss National Science Foundation [3200-664121]; SCORE-Fellowship; European Union [LSHM-CT-2004-005206]; Stiftung fur Medizinische Forschung, Basel, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SCORE-Fellowship; European Union(European Commission); Stiftung fur Medizinische Forschung, Basel, Switzerland	This work was supported by the Swiss National Science Foundation (Grant-Nr. 3200-664121, SCORE-Fellowship to BCB), by the European Union MOLSTROKE (Molecular basis of vascular events leading to thrombotic stroke) project, LSHM-CT-2004-005206, and by the Stiftung fur Medizinische Forschung, Basel, Switzerland. The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Burke AP, 2003, J AM COLL CARDIOL, V41, p240A; Carr MC, 2004, J CLIN ENDOCR METAB, V89, P2601, DOI 10.1210/jc.2004-0432; Chade AR, 2005, HYPERTENSION, V45, P1042, DOI 10.1161/01.HYP.0000167121.14254.a0; Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273; Doobay AV, 2005, ARTERIOSCL THROM VAS, V25, P1463, DOI 10.1161/01.ATV.0000168911.78624.b7; Einstein AJ, 2007, CIRCULATION, V116, P1290, DOI 10.1161/CIRCULATIONAHA.107.688101; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Fleming C, 2005, ANN INTERN MED, V142, P203, DOI 10.7326/0003-4819-142-3-200502010-00012; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hayoz D, 2005, J INTERN MED, V258, P238, DOI 10.1111/j.1365-2796.2005.01536.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Mark Daniel B., 2003, Journal of the American College of Cardiology, V41, P1906, DOI 10.1016/S0735-1097(03)00362-0; McDermott MM, 2001, J GEN INTERN MED, V16, P384, DOI 10.1046/j.1525-1497.2001.016006384.x; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; NAGHAVI M, 2006, AM J CARDIOL, V98, P2, DOI DOI 10.1016/J.AMJCARD.2006.03.002; Ohman EM, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.11.004; Pasternak Richard C., 2003, Journal of the American College of Cardiology, V41, P1863, DOI 10.1016/S0735-1097(03)00358-9; Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980; Redberg Rita F., 2003, Journal of the American College of Cardiology, V41, P1886, DOI 10.1016/S0735-1097(03)00360-7; Revkin JH, 2007, PHARMACOL REV, V59, P40, DOI 10.1124/pr.59.1.1; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Stoll M, 2001, SCIENCE, V294, P1723, DOI 10.1126/science.1062117; Sukhija R, 2005, AM J CARDIOL, V96, P825, DOI 10.1016/j.amjcard.2005.05.029; VANGAAL LF, 1989, J AM COLL NUTR, V8, P504; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Wilson PW, 2003, J AM COLL CARDIOL, V41, p267A; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1215	10.1371/journal.pone.0001215	http://dx.doi.org/10.1371/journal.pone.0001215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043731	gold, Green Submitted, Green Published			2022-12-27	WOS:000207459300005
J	Pinto, J; Lynd, A; Vicente, JL; Santolamazza, F; Randle, NP; Gentile, G; Moreno, M; Simard, F; Charlwood, JD; do Rosario, VE; Caccone, A; della Torre, A; Donnelly, MJ				Pinto, Joaeo; Lynd, Amy; Vicente, Jose L.; Santolamazza, Federica; Randle, Nadine P.; Gentile, Gabriele; Moreno, Marta; Simard, Frederic; Charlwood, Jacques Derek; do Rosario, Virgilio E.; Caccone, Adalgisa; della Torre, Alessandra; Donnelly, Martin J.			Multiple Origins of Knockdown Resistance Mutations in the Afrotropical Mosquito Vector Anopheles gambiae	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; INSECTICIDE RESISTANCE; STATISTICAL-METHOD; MOLECULAR-FORMS; KDR MUTATION; DIFFERENTIATION; S.S.; POPULATIONS; IDENTIFICATION; COALESCENT	How often insecticide resistance mutations arise in natural insect populations is a fundamental question for understanding the evolution of resistance and also for modeling its spread. Moreover, the development of resistance is regarded as a favored model to study the molecular evolution of adaptive traits. In the malaria vector Anopheles gambiae two point mutations (L1014F and L1014S) in the voltage-gated sodium channel gene, that confer knockdown resistance (kdr) to DDT and pyrethroid insecticides, have been described. In order to determine whether resistance alleles result from single or multiple mutation events, genotyping of the kdr locus and partial sequencing of the upstream intron-1 was performed on a total of 288 A. gambiae S-form collected from 28 localities in 15 countries. Knockdown resistance alleles were found to be widespread in West Africa with co-occurrence of both 1014S and 1014F in West-Central localities. Differences in intron-1 haplotype composition suggest that kdr alleles may have arisen from at least four independent mutation events. Neutrality tests provided evidence for a selective sweep acting on this genomic region, particularly in West Africa. The frequency and distribution of these kdr haplotypes varied geographically, being influenced by an interplay between different mutational occurrences, gene flow and local selection. This has important practical implications for the management and sustainability of malaria vector control programs.	[Pinto, Joaeo; Vicente, Jose L.; do Rosario, Virgilio E.] Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Tropicais, Lisbon, Portugal; [Pinto, Joaeo; Lynd, Amy; Randle, Nadine P.; Donnelly, Martin J.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Santolamazza, Federica; della Torre, Alessandra] Univ Roma La Sapienza, Dipartimento Sci Sanita Pubbl, Sez Parassitol, Ist Pasteur,Fdn Cecni Bolognetti, Rome, Italy; [Gentile, Gabriele] Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy; [Moreno, Marta] Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain; [Simard, Frederic] Org Coordinat Lutte Endemies Afr Cent, Yaounde, Cameroon; [Simard, Frederic] Inst Rech Dev, Yaounde, Cameroon; [Charlwood, Jacques Derek] DBL Inst Hlth Res & Dev, Charlottenlund, Denmark; [Caccone, Adalgisa] Yale Univ, Yale Inst Biospher Studies, New Haven, CT USA; [Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Liverpool School of Tropical Medicine; University of Liverpool; Sapienza University Rome; University of Rome Tor Vergata; Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Institut de Recherche pour le Developpement (IRD); Yale University; Yale University	Pinto, J (corresponding author), Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Tropicais, Lisbon, Portugal.	jpinto@ihmt.unl.pt	Lynd, Amy/C-8938-2013; SIMARD, Frederic/J-9489-2016; Moreno, Marta/AAW-8848-2020; Caccone, Adalgisa/AAE-4238-2021; Lynd, Amy/AAE-9640-2020; Frederic, SIMARD/AFV-5001-2022; Pinto, Joao/C-2208-2012; Vicente, José/I-2126-2012; Gentile, Gabriele/E-8945-2013; J., Pinto/H-6177-2019	SIMARD, Frederic/0000-0002-2871-5329; Moreno, Marta/0000-0002-9091-5612; Caccone, Adalgisa/0000-0002-8949-9260; Lynd, Amy/0000-0001-6054-0525; Frederic, SIMARD/0000-0002-2871-5329; Pinto, Joao/0000-0001-8572-7708; Gentile, Gabriele/0000-0002-1045-6816; J., Pinto/0000-0001-8572-7708; Donnelly, Martin/0000-0001-5218-1497; Santolamazza, Federica/0000-0001-5029-6733	Foundation of Science and Technology-FEDER, Portugal [POCTI/ESP/44837/2002, SFRH/BPD/10086/2002]; UNICEF/UNDP/World Bank/WHO; YIBS-Ecosave; NIH [NIH RO1AI046018]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046018] Funding Source: NIH RePORTER	Foundation of Science and Technology-FEDER, Portugal; UNICEF/UNDP/World Bank/WHO(World Health Organization); YIBS-Ecosave; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received financial support by the Foundation of Science and Technology-FEDER, Portugal (POCTI/ESP/44837/2002) and by the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. JP was funded by Foundation of Science and Technology-FEDER, Portugal (SFRH/BPD/10086/2002). AC was also supported by YIBS-Ecosave funds and by the NIH grant NIH RO1AI046018.	Alon M, 2006, INSECT BIOCHEM MOLEC, V36, P71, DOI 10.1016/j.ibmb.2005.10.007; Andreev D, 1999, J MOL EVOL, V48, P615, DOI 10.1007/PL00006504; Anstead JA, 2005, INSECT BIOCHEM MOLEC, V35, P249, DOI 10.1016/j.ibmb.2004.12.004; Chandre F, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P319; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CRANDALL KA, 1993, GENETICS, V134, P959; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Etang J, 2006, AM J TROP MED HYG, V74, P795, DOI 10.4269/ajtmh.2006.74.795; Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gentile G, 2004, INSECT MOL BIOL, V13, P371, DOI 10.1111/j.0962-1075.2004.00494.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HUDSON RR, 1985, GENETICS, V111, P147; Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809; Lehmann T, 1998, MOL BIOL EVOL, V15, P264, DOI 10.1093/oxfordjournals.molbev.a025923; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Li N, 2003, GENETICS, V165, P2213; Lynd A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-16; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Newcomb RD, 2005, J MOL EVOL, V60, P207, DOI 10.1007/s00239-004-0104-x; PERRET C, 2006, ATLAS REGIONAL INTEG; Pinto J, 2006, MED VET ENTOMOL, V20, P27, DOI 10.1111/j.1365-2915.2006.00611.x; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; Reimer LJ, 2005, INSECT MOL BIOL, V14, P683, DOI 10.1111/j.1365-2583.2005.00599.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x; Slotman MA, 2006, AM J TROP MED HYG, V74, P641, DOI 10.4269/ajtmh.2006.74.641; STEPHAN W, 1989, GENETICS, V121, P89, DOI 10.1093/genetics/121.1.89; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1992, GENETICS, V132, P619; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; Wandiga SO, 2001, PURE APPL CHEM, V73, P1147, DOI 10.1351/pac200173071147; Weill M, 2000, INSECT MOL BIOL, V9, P451, DOI 10.1046/j.1365-2583.2000.00206.x; Weissmann G, 2006, FASEB J, V20, P2427, DOI 10.1096/fj.06-1201ufm; Yawson AE, 2007, GENETICS, V175, P751, DOI 10.1534/genetics.106.065888	43	93	95	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1243	10.1371/journal.pone.0001243	http://dx.doi.org/10.1371/journal.pone.0001243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043750	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459300024
J	Sandmann, T; Cohen, SM				Sandmann, Thomas; Cohen, Stephen M.			Identification of Novel Drosophila melanogaster MicroRNAs	PLOS ONE			English	Article								MicroRNAs (miRNAs) are small non-coding RNAs with important regulatory roles in post-transcriptional regulation of metazoan development, homeostasis and disease. The full set of miRNAs is not known for any species and it is believed that many await discovery. The recent assembly of 15 insect genomes has provided the opportunity to identify novel miRNAs in the fruit fly, Drosophila melanogaster. We have performed a computational screen for novel microRNAs in Drosophila melanogaster by searching for phylogenetically conserved putative pre-miRNA structures. The ability of predicted novel miRNA precursors to be processed to produce miRNAs was experimentally verified in S2 cells and in several cases their endogenous expression at was validated by Northern blots. After experimental validation, the predictions were cross-checked with reference to a newly released set of small RNA sequences. Combining both datasets allowed us to identify 53 novel miRNA loci in the fruit fly genome 22 of which we had predicted computationally. This significantly expands the set of known miRNAs in Drosophila melanogaster. Most novel miRNAs contain unique seed sequences not found in other Drosophila miRNAs and are therefore expected to regulate novel sets of target genes. This data provides the basis for future genetic analysis of miRNA function and will aid the discovery of orthologous sequences in other species.	[Sandmann, Thomas; Cohen, Stephen M.] Natl Univ Singapore, Dept Biol Sci, Temasek Lifesci Lab, Singapore 117548, Singapore; [Sandmann, Thomas; Cohen, Stephen M.] European Mol Biol Lab, Heidelberg, Germany	National University of Singapore; European Molecular Biology Laboratory (EMBL)	Cohen, SM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Temasek Lifesci Lab, Singapore 117548, Singapore.	cohen@tll.org.sg	Cohen, Stephen M/G-9930-2011	Cohen, Stephen M/0000-0003-2858-9163; Sandmann, Thomas/0000-0002-6601-8890	European Molecular Biology Laboratory, Heidelberg Germany; Temasek Life Sciences Laboratory	European Molecular Biology Laboratory, Heidelberg Germany; Temasek Life Sciences Laboratory(National University of Singapore)	Funding: This work was supported by the European Molecular Biology Laboratory, Heidelberg Germany and by the Temasek Life Sciences Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-228; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BUSHATI N, 2007, ANN REV CELL DEV BIO; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Celniker SE, 2003, ANNU REV GENOM HUM G, V4, P89, DOI 10.1146/annurev.genom.4.070802.110323; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; HE L, 2007, NATURE; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; OKAMURA K, 2007, CELL; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RUBY J, 2007, NATURE; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507	42	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1265	10.1371/journal.pone.0001265	http://dx.doi.org/10.1371/journal.pone.0001265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043761	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459300035
J	Tsukamoto-Yasui, M; Sasaki, T; Matsumoto, W; Hasegawa, A; Toyoda, T; Usami, A; Kubota, Y; Ochiai, T; Hori, T; Matsuki, N; Ikegaya, Y				Tsukamoto-Yasui, Masako; Sasaki, Takuya; Matsumoto, Wataru; Hasegawa, Ayako; Toyoda, Takeshi; Usami, Atsushi; Kubota, Yuichi; Ochiai, Taku; Hori, Tomokatsu; Matsuki, Norio; Ikegaya, Yuji			Active Hippocampal Networks Undergo Spontaneous Synaptic Modification	PLOS ONE			English	Article								The brain is self-writable; as the brain voluntarily adapts itself to a changing environment, the neural circuitry rearranges its functional connectivity by referring to its own activity. How the internal activity modifies synaptic weights is largely unknown, however. Here we report that spontaneous activity causes complex reorganization of synaptic connectivity without any external (or artificial) stimuli. Under physiologically relevant ionic conditions, CA3 pyramidal cells in hippocampal slices displayed spontaneous spikes with bistable slow oscillations of membrane potential, alternating between the so-called UP and DOWN states. The generation of slow oscillations did not require fast synaptic transmission, but their patterns were coordinated by local circuit activity. In the course of generating spontaneous activity, individual neurons acquired bidirectional long-lasting synaptic modification. The spontaneous synaptic plasticity depended on a rise in intracellular calcium concentrations of postsynaptic cells, but not on NMDA receptor activity. The direction and amount of the plasticity varied depending on slow oscillation patterns and synapse locations, and thus, they were diverse in a network. Once this global synaptic refinement occurred, the same neurons now displayed different patterns of spontaneous activity, which in turn exhibited different levels of synaptic plasticity. Thus, active networks continuously update their internal states through ongoing synaptic plasticity. With computational simulations, we suggest that with this slow oscillation-induced plasticity, a recurrent network converges on a more specific state, compared to that with spike timing-dependent plasticity alone.	[Tsukamoto-Yasui, Masako; Sasaki, Takuya; Matsumoto, Wataru; Hasegawa, Ayako; Toyoda, Takeshi; Usami, Atsushi; Matsuki, Norio; Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan; [Kubota, Yuichi; Ochiai, Taku; Hori, Tomokatsu] Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, Tokyo, Japan; [Ikegaya, Yuji] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan	University of Tokyo; Tokyo Women's Medical University; Japan Science & Technology Agency (JST)	Ikegaya, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan.	ikegaya@mol.f.u-tokyo.ac.jp	Sasaki, Takuya/J-3283-2015	Hori, Tomokatsu/0000-0001-7611-896X; Ikegaya, Yuji/0000-0003-2260-8191	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18021008, 17023015, 17650090, 17689004, 19659013]; Sumitomo Foundation [050038]; Takeda Science Foundation; Asahi Glass Foundation; Research Foundation for Pharmaceutical Sciences	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Asahi Glass Foundation; Research Foundation for Pharmaceutical Sciences	Funding: This work was supported in part by a Grant-in-Aid for Science Research on Priority Areas (Elucidation of neural network function in the brain: No. 18021008, No. 17023015), a Grant-in-Aid for Science Research (No. 17650090, No. 17689004, No. 19659013) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Sumitomo Foundation (No. 050038), the Takeda Science Foundation, the Asahi Glass Foundation, and the Research Foundation for Pharmaceutical Sciences.	Amaral David G., 1995, P443; ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; BENARI Y, 1988, J PHYSIOL-LONDON, V404, P365, DOI 10.1113/jphysiol.1988.sp017294; Best PJ, 2001, ANNU REV NEUROSCI, V24, P459, DOI 10.1146/annurev.neuro.24.1.459; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bland BH, 2005, EXP NEUROL, V195, P458, DOI 10.1016/j.expneurol.2005.06.007; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; COLOM LV, 1987, BRAIN RES, V422, P277, DOI 10.1016/0006-8993(87)90934-6; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Debanne D, 1999, J NEUROSCI, V19, P10664, DOI 10.1523/JNEUROSCI.19-24-10664.1999; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; EVARTS EV, 1964, J NEUROPHYSIOL, V27, P152, DOI 10.1152/jn.1964.27.2.152; Hahn TTG, 2007, P NATL ACAD SCI USA, V104, P5169, DOI 10.1073/pnas.0700222104; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; HOPFIELD JJ, 1982, P NATL ACAD SCI USA, V79, P2558; Hu B, 2005, J NEUROPHYSIOL, V93, P316, DOI 10.1152/jn.00172.2004; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Ivenshitz M, 2006, J NEUROSCI, V26, P1199, DOI 10.1523/JNEUROSCI.2964-05.2006; JONES HC, 1987, J PHYSIOL-LONDON, V383, P441; Kamme F, 2003, J NEUROSCI, V23, P3607; Kirov SA, 1999, J NEUROSCI, V19, P2876; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Le Be JV, 2006, P NATL ACAD SCI USA, V103, P13214, DOI 10.1073/pnas.0604691103; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; McNay EC, 2004, J NEUROSCI METH, V132, P35, DOI 10.1016/j.jneumeth.2003.08.014; Mehta MR, 2007, NAT NEUROSCI, V10, P13, DOI 10.1038/nn0107-13; MOGHADDAM B, 1987, BRAIN RES, V406, P337, DOI 10.1016/0006-8993(87)90803-1; MOGHADDAM B, 1989, J NEUROCHEM, V53, P652, DOI 10.1111/j.1471-4159.1989.tb07383.x; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; NICHOLSON C, 1977, P NATL ACAD SCI USA, V74, P1287, DOI 10.1073/pnas.74.3.1287; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; PSARROPOULOU C, 1990, BRAIN RES, V508, P70, DOI 10.1016/0006-8993(90)91119-2; Raman IM, 1999, ANN NY ACAD SCI, V868, P93, DOI 10.1111/j.1749-6632.1999.tb11279.x; ROBINSON HPC, 1991, BIOPHYS J, V59, P295, DOI 10.1016/S0006-3495(91)82223-8; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SANSEVERINO E R, 1973, Brain Research, V54, P225; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SOMJEN GG, 1985, J NEUROPHYSIOL, V53, P1098, DOI 10.1152/jn.1985.53.4.1098; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; Takahashi N, 2007, NEUROSCI RES, V58, P219, DOI 10.1016/j.neures.2007.03.001; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; WILSON CJ, 1981, BRAIN RES, V220, P67, DOI 10.1016/0006-8993(81)90211-0; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; YAMAGUCHI T, 1986, Bulletin of Tokyo Medical and Dental University, V33, P1; Yuste R, 2005, NAT REV NEUROSCI, V6, P477, DOI 10.1038/nrn1686; ZHANG ET, 1990, J CEREBR BLOOD F MET, V10, P136, DOI 10.1038/jcbfm.1990.18; Zhang Y, 1998, J NEUROSCI, V18, P9256	75	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1250	10.1371/journal.pone.0001250	http://dx.doi.org/10.1371/journal.pone.0001250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043757	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459300031
J	Tuefferd, M; Couturier, J; Penault-Llorca, F; Vincent-Salomon, A; Broet, P; Guastalla, JP; Allouache, D; Combe, M; Weber, B; Pujade-Lauraine, E; Camilleri-Broet, S				Tuefferd, Marianne; Couturier, Jerome; Penault-Llorca, Frederique; Vincent-Salomon, Anne; Broet, Philippe; Guastalla, Jean-Paul; Allouache, Djelila; Combe, Martin; Weber, Beatrice; Pujade-Lauraine, Eric; Camilleri-Broet, Sophie			HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; HER-2/NEU GENE AMPLIFICATION; PHASE-II TRIAL; PROGNOSTIC-SIGNIFICANCE; MONOCLONAL-ANTIBODY; PROTEIN EXPRESSION; OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; TRASTUZUMAB; ERBB2	Background. Despite a typically good response to first-line combination chemotherapy, the prognosis for patients with advanced ovarian cancer remains poor because of acquired chemoresistance. The use of targeted therapies such as trastuzumab may potentially improve outcomes for patients with ovarian cancer. HER2 overexpression/amplification has been reported in ovarian cancer, but the exact percentage of HER2-positive tumors varies widely in the literature. In this study, HER2 gene status was evaluated in a large, multicentric series of 320 patients with advanced ovarian cancer, including 243 patients enrolled in a multicenter prospective clinical trial of paclitaxel/carboplatin-based chemotherapy. Methodology/Principal Findings. The HER2 status of primary tumors and metastases was evaluated by both immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) analysis of paraffin-embedded tissue on conventional slides. The prognostic impact of HER2 expression was analyzed. HER2 gene was overexpressed and amplified in 6.6% of analyzed tumors. Despite frequent intratumoral heterogeneity, no statistically significant difference was detected between primary tumors and corresponding metastases. Conclusions/Significance. Our results show that the decision algorithm usually used in breast cancer (IHC as a screening test, with equivocal results confirmed by FISH) is appropriate in ovarian cancer. In contrast to previous series, HER2-positive status did not influence outcome in the present study, possibly due to the fact that patients in our study received paclitaxel/carboplatin-based chemotherapy. This raises the question of whether HER2 status and paclitaxel sensitively are linked.	[Tuefferd, Marianne; Broet, Philippe; Pujade-Lauraine, Eric; Camilleri-Broet, Sophie] Univ Paris Sud, JE2492, IFR69, Villejuif, France; [Pujade-Lauraine, Eric; Camilleri-Broet, Sophie] AP HP, Fac Paris Descartes, Paris, France; [Weber, Beatrice] Ctr Alexis Vautrin, Vandoeuvre Les Nancy, France; [Penault-Llorca, Frederique] Ctr Jean Perrin, Dept Pathol, Clermont Ferrand, France; [Vincent-Salomon, Anne] Inst Curie, Serv Pathol, Paris, France; [Couturier, Jerome] Inst Curie, Serv Genet Oncol, Paris, France; [Guastalla, Jean-Paul] Ctr Leon Berard, F-69373 Lyon, France; [Combe, Martin] Ctr Hosp, Serv Med Interne Oncol, Le Mans, France; [Allouache, Djelila] Ctr Francois Baclesse, F-14021 Caen, France	UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Institut de cancerologie de Lorraine (ICL); UNICANCER; Centre Jean Perrin; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Centre Leon Berard; Centre Hospitalier Le Mans; UNICANCER; Centre Francois Baclesse	Camilleri-Broet, S (corresponding author), Univ Paris Sud, JE2492, IFR69, Villejuif, France.	camilleri@vjf.inserm.fr		BROET, PHILIPPE/0000-0001-9122-2810	Roche Pharmaceuticals; Janssen Pharmaceutica (Beerse, Belgium)	Roche Pharmaceuticals(Roche Holding); Janssen Pharmaceutica (Beerse, Belgium)(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This work was supported by Roche Pharmaceuticals. M. Tuefferd was supported by Janssen Pharmaceutica (Beerse, Belgium).	Aigner A, 2000, TOXICOLOGY, V144, P221, DOI 10.1016/S0300-483X(99)00210-3; Barrett C, 2007, J CLIN PATHOL, V60, P690, DOI 10.1136/jcp.2006.039602; BERCHUCK A, 1990, CANCER RES, V50, P4087; Bookman MA, 2003, J CLIN ONCOL, V21, P283, DOI 10.1200/JCO.2003.10.104; Camilleri-Broet S, 2004, ANN ONCOL, V15, P104, DOI 10.1093/annonc/mdh021; Cloven NG, 2004, GYNECOL ONCOL, V92, P160, DOI 10.1016/j.ygyno.2003.09.030; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Couturier J, 2000, MODERN PATHOL, V13, P1238, DOI 10.1038/modpathol.3880228; Ellis IO, 2004, J CLIN PATHOL, V57, P233, DOI 10.1136/jcp.2003.007724; Erkinheimo TL, 2004, CLIN CANCER RES, V10, P538, DOI 10.1158/1078-0432.CCR-0132-03; FAJAC A, 1995, INT J CANCER, V64, P146, DOI 10.1002/ijc.2910640213; FELIP E, 1995, CANCER, V75, P2147, DOI 10.1002/1097-0142(19950415)75:8<2147::AID-CNCR2820750818>3.0.CO;2-8; Ferrandina G, 2002, GYNECOL ONCOL, V85, P305, DOI 10.1006/gyno.2002.6620; Goff BA, 1998, GYNECOL ONCOL, V70, P378, DOI 10.1006/gyno.1998.5094; Gouvea AP, 2006, APPL IMMUNOHISTO M M, V14, P103, DOI 10.1097/01.pai.0000155794.64525.11; Hogdall EVS, 2003, CANCER-AM CANCER SOC, V98, P66, DOI 10.1002/cncr.11476; Kupryjanczyk J, 2004, BRIT J CANCER, V91, P1916, DOI 10.1038/sj.bjc.6602238; Lassus H, 2004, GYNECOL ONCOL, V92, P31, DOI 10.1016/j.ygyno.2003.10.010; Lee CH, 2005, INT J GYNECOL PATHOL, V24, P147, DOI 10.1097/01.PGP.0000152026.39268.57; Mano MS, 2004, GYNECOL ONCOL, V92, P887, DOI 10.1016/j.ygyno.2003.12.010; Martin M, 2005, NEW ENGL J MED, V352, P2302, DOI 10.1056/NEJMoa043681; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Mayr D, 2006, HISTOPATHOLOGY, V48, P149, DOI 10.1111/j.1365-2559.2005.02306.x; MEDEN H, 1994, INT J GYNECOL PATHOL, V13, P45, DOI 10.1097/00004347-199401000-00006; Nielsen JS, 2004, INT J GYNECOL CANCER, V14, P1086, DOI 10.1111/j.1048-891X.2004.14606.x; Ozols RF, 2006, SEMIN ONCOL, V33, pS3, DOI 10.1053/j.seminoncol.2006.03.011; Perez EA, 2006, J CLIN ONCOL, V24, P3032, DOI 10.1200/JCO.2005.03.4744; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Press MF, 2002, J CLIN ONCOL, V20, P3095, DOI 10.1200/JCO.2002.09.094; Press MF, 2005, CLIN CANCER RES, V11, P6598, DOI 10.1158/1078-0432.CCR-05-0636; Pritchard KI, 2006, NEW ENGL J MED, V354, P2103, DOI 10.1056/NEJMoa054504; Serrano-Olvera A, 2006, CANCER TREAT REV, V32, P180, DOI 10.1016/j.ctrv.2006.01.001; SINGLETON TP, 1994, CANCER-AM CANCER SOC, V73, P1460, DOI 10.1002/1097-0142(19940301)73:5<1460::AID-CNCR2820730523>3.0.CO;2-Z; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tokunaga Eriko, 2006, Int J Clin Oncol, V11, P199, DOI 10.1007/s10147-006-0575-4; Tubbs RR, 2001, J CLIN ONCOL, V19, P2714, DOI 10.1200/JCO.2001.19.10.2714; Verri E, 2005, ONCOLOGY-BASEL, V68, P154, DOI 10.1159/000086958; Vincent-Salomon A, 2003, HISTOPATHOLOGY, V42, P337, DOI 10.1046/j.1365-2559.2003.01598.x; Wolff AC, 2007, J CLIN ONCOL, V25, P4021, DOI 10.1200/JCO.2007.11.4363; Yamauchi H, 2001, J CLIN ONCOL, V19, P2334, DOI 10.1200/JCO.2001.19.8.2334; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Young SR, 1996, GENE CHROMOSOME CANC, V16, P130, DOI 10.1002/(SICI)1098-2264(199606)16:2<130::AID-GCC7>3.0.CO;2-0	43	118	126	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1138	10.1371/journal.pone.0001138	http://dx.doi.org/10.1371/journal.pone.0001138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987122	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459000022
J	Sharot, T; Verfaellie, M; Yonelinas, AP				Sharot, Tali; Verfaellie, Mieke; Yonelinas, Andrew P.			How Emotion Strengthens the Recollective Experience: A Time-Dependent Hippocampal Process	PLOS ONE			English	Article								Emotion significantly strengthens the subjective recollective experience even when objective accuracy of the memory is not improved. Here, we examine if this modulation is related to the effect of emotion on hippocampal-dependent memory consolidation. Two critical predictions follow from this hypothesis. First, since consolidation is assumed to take time, the enhancement in the recollective experience for emotional compared to neutral memories should become more apparent following a delay. Second, if the emotion advantage is critically dependent on the hippocampus, then the effects should be reduced in amnesic patients with hippocampal damage. To test these predictions we examined the recollective experience for emotional and neutral photos at two retention intervals (Experiment 1), and in amnesics and controls (Experiment 2). Emotional memories were associated with an enhancement in the recollective experience that was greatest after a delay, whereas familiarity was not influenced by emotion. In amnesics with hippocampal damage the emotion effect on recollective experience was reduced. Surprisingly, however, these patients still showed a general memory advantage for emotional compared to neutral items, but this effect was manifest primarily as a facilitation of familiarity. The results support the consolidation hypothesis of recollective experience, but suggest that the effects of emotion on episodic memory are not exclusively hippocampally mediated. Rather, emotion may enhance recognition by facilitating familiarity when recollection is impaired due to hippocampal damage.	[Sharot, Tali] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Verfaellie, Mieke] Boston Dept Vet Affairs, Memory Disorders Res Ctr, Boston, MA USA; [Verfaellie, Mieke] Boston Univ, Sch Med, Boston, MA 02118 USA; [Yonelinas, Andrew P.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of London; University College London; Boston University; University of California System; University of California Davis	Sharot, T (corresponding author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England.	t.sharot@fil.ion.ucl.ac.uk		Yonelinas, Andrew/0000-0002-9580-4997; Verfaellie, Mieke/0000-0001-5535-4584	Margaret and Herman Sokol Postdcotoral Fellowship;  [MH059352];  [NH57681]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059352] Funding Source: NIH RePORTER	Margaret and Herman Sokol Postdcotoral Fellowship; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding: This study was supported by grant MH059352 to APY, NH57681 to MV, and the Margaret and Herman Sokol Postdcotoral Fellowship to TS.	Adolphs R, 2005, NAT NEUROSCI, V8, P512, DOI 10.1038/nn1413; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; [Anonymous], 1974, CONT DEV MATH PSYCHO; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102; Fenker DB, 2005, EUR J NEUROSCI, V21, P1993, DOI 10.1111/j.1460-9568.2005.04033.x; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Hamann SB, 1997, NEUROPSYCHOLOGY, V11, P104; Hodges H, 1996, NEUROSCIENCE, V72, P959, DOI 10.1016/0306-4522(96)00004-8; KAN IP, NEUROPSYCHO IN PRESS; Kensinger EA, 2003, MEM COGNITION, V31, P1169, DOI 10.3758/BF03195800; Kensinger EA, 2004, COGN AFFECT BEHAV NE, V4, P1, DOI 10.3758/CABN.4.1.1; LaBar KS, 2005, BEHAV NEUROSCI, V119, P677, DOI 10.1037/0735-7044.119.3.677; Lang P. J., 1999, INT AFFECTIVE PICTUR; Macmillan N. A., 1991, DETECTION THEORY USE; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; McGaugh J.L., 1992, HDB EMOTION MEMORY R, P269; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Ochsner KN, 2000, J EXP PSYCHOL GEN, V129, P242, DOI 10.1037//0096-3445.129.2.242; Packard MG, 1998, NEUROBIOL LEARN MEM, V69, P163, DOI 10.1006/nlme.1997.3815; Paz R, 2006, NAT NEUROSCI, V9, P1321, DOI 10.1038/nn1771; RAJARAM S, 1993, MEM COGNITION, V21, P89, DOI 10.3758/BF03211168; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Richardson MP, 2004, NAT NEUROSCI, V7, P278, DOI 10.1038/nn1190; Seidman LJ, 2002, ARCH GEN PSYCHIAT, V59, P839, DOI 10.1001/archpsyc.59.9.839; Sharot T, 2004, NAT NEUROSCI, V7, P1376, DOI 10.1038/nn1353; SHAROT T, 2007, COGNITION IN PRESS; Sharot T, 2007, P NATL ACAD SCI USA, V104, P389, DOI 10.1073/pnas.0609230103; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stefanacci L, 1996, J COMP NEUROL, V375, P552; Talarico JM, 2003, PSYCHOL SCI, V14, P455, DOI 10.1111/1467-9280.02453; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Verfaellie M, 2000, NEUROPSYCHOLOGIA, V38, P484, DOI 10.1016/S0028-3932(99)00089-5; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; YONELINAS AP, 1995, J MEM LANG, V34, P622, DOI 10.1006/jmla.1995.1028; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	40	60	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1068	10.1371/journal.pone.0001068	http://dx.doi.org/10.1371/journal.pone.0001068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971848	Green Published, Green Submitted, gold			2022-12-27	WOS:000207458700001
J	Wang, XG; Revskaya, E; Bryan, RA; Strickler, HD; Burk, RD; Casadevall, A; Dadachova, E				Wang, Xing Guo; Revskaya, Ekaterina; Bryan, Ruth A.; Strickler, Howard D.; Burk, Robert D.; Casadevall, Arturo; Dadachova, Ekaterina			Treating Cancer as an Infectious Disease-Viral Antigens as Novel Targets for Treatment and Potential Prevention of Tumors of Viral Etiology	PLOS ONE			English	Article								Background. Nearly 20% of human cancers worldwide have an infectious etiology with the most prominent examples being hepatitis B and C virus-associated hepatocellular carcinoma and human papilloma virus-associated cervical cancer. There is an urgent need to find new approaches to treatment and prevention of virus-associated cancers. Methodology/Principal Findings. Viral antigens have not been previously considered as targets for treatment or prevention of virus-associated cancers. We hypothesized that it was possible to treat experimental HPV16-associated cervical cancer ( CC) and Hepatitis B-associated hepatocellular carcinoma (HCC) by targeting viral antigens expressed on cancer cells with radiolabeled antibodies to viral antigens. Treatment of experimental CC and HCC tumors with 188 Re-labeled mAbs to E6 and HBx viral proteins, respectively, resulted in significant and dose-dependent retardation of tumor growth in comparison with untreated mice or mice treated with unlabeled antibodies. Conclusions/Significance. This strategy is fundamentally different from the prior uses of radioimmunotherapy in oncology, which targeted tumor-associated human antigens and promises increased specificity and minimal toxicity of treatment. It also raises an exciting possibility to prevent virus-associated cancers in chronically infected patients by eliminating cells infected with oncogenic viruses before they transform into cancer.	[Wang, Xing Guo; Revskaya, Ekaterina; Bryan, Ruth A.; Dadachova, Ekaterina] Albert Einstein Coll Med, Dept Nucl Med, Bronx, NY 10467 USA; [Strickler, Howard D.; Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Burk, Robert D.; Casadevall, Arturo; Dadachova, Ekaterina] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Casadevall, Arturo] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Dadachova, E (corresponding author), Albert Einstein Coll Med, Dept Nucl Med, Bronx, NY 10467 USA.	edadacho@aecom.yu.edu	Dadachova, Ekaterina/I-7838-2013		NIH [AI60507, AI33774, AI33142, AI52733, HL59842, U54 AI157158, CA078527, AI-51519]; Albert Einstein College of Medicine Comprehensive Cancer Center; Center for AIDS Research at the Albert Einstein College of Medicine; NATIONAL CANCER INSTITUTE [R01CA078527, U01CA078527] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060507, R01AI033774, R37AI033142, R56AI060507, R01AI052733, R01AI033142, P30AI051519] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine Comprehensive Cancer Center; Center for AIDS Research at the Albert Einstein College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	E. Dadachova is supported by the NIH grant AI60507; A. Casadevall - by the NIH grants AI33774, AI33142, AI52733, HL59842, and U54 AI157158; R. D. Burk by the NIH grant CA078527. This work was supported in part by the Albert Einstein College of Medicine Comprehensive Cancer Center and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center funded by the National Institutes of Health (NIH AI-51519).	Arbach H, 2006, J VIROL, V80, P845, DOI 10.1128/JVI.80.2.845-853.2006; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; Casadevall A, 2007, EXPERT OPIN BIOL TH, V7, P595, DOI 10.1517/14712598.7.5.595; Cesarman E, 2007, CURR TOP MICROBIOL, V312, P263; CHEN FM, 1989, CANCER RES, V49, P4578; Dadachova E, 2006, Q J NUCL MED MOL IM, V50, P193; Dadachova E, 2003, P NATL ACAD SCI USA, V100, P10942, DOI 10.1073/pnas.1731272100; Dadachova E, 2006, PLOS MED, V3, P2094, DOI 10.1371/journal.pmed.0030427; Dadachova E, 2007, CANCER BIOTHER RADIO, V22, P303, DOI 10.1089/cbr.2007.344; El-Aneed A, 2006, ANTICANCER RES, V26, P3293; Hwang GY, 2003, J CLIN MICROBIOL, V41, P5598, DOI 10.1128/JCM.41.12.5598-5603.2003; Jones EE, 2006, CURR MOL MED, V6, P795; Kaminski MS, 2005, NEW ENGL J MED, V352, P441, DOI 10.1056/NEJMoa041511; Kehmeier E, 2002, VIROLOGY, V299, P72, DOI 10.1006/viro.2002.1502; Lupberger J, 2007, WORLD J GASTROENTERO, V13, P74, DOI 10.3748/wjg.v13.i1.74; Milenic DE, 2004, NAT REV DRUG DISCOV, V3, P488, DOI 10.1038/nrd1413; Mortreux F, 2003, LEUKEMIA, V17, P26, DOI 10.1038/sj.leu.2402777; Oh KJ, 2004, J VIROL, V78, P5338, DOI 10.1128/JVI.78.10.5338-5346.2004; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Reifenberg K, 1999, J VIROL, V73, P10399, DOI 10.1128/JVI.73.12.10399-10405.1999; Schlecht NF, 2005, ONCOL REP, V14, P1239; Schweitzer AD, 2007, MELANOMA RES, V17, P291, DOI 10.1097/CMR.0b013e3282eeeae7; Sharkey RM, 2005, J NUCL MED, V46, p115S; Sharkey RM, 1997, INT J CANCER, V72, P477, DOI 10.1002/(SICI)1097-0215(19970729)72:3<477::AID-IJC16>3.0.CO;2-9; Yang JS, 2005, WORLD J GASTROENTERO, V11, P4098, DOI 10.3748/wjg.v11.i26.4098; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556	28	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1114	10.1371/journal.pone.0001114	http://dx.doi.org/10.1371/journal.pone.0001114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971877	Green Submitted, gold, Green Published			2022-12-27	WOS:000207458700031
J	Barbour, JD; Sauer, MM; Sharp, ER; Garrison, KE; Long, BR; Tomiyama, H; Bassichetto, KC; Oliveira, SM; Abbate, MC; Nixon, DF; Kallas, EG				Barbour, Jason D.; Sauer, Mariana M.; Sharp, Elizabeth R.; Garrison, Keith E.; Long, Brian R.; Tomiyama, Helena; Bassichetto, Katia C.; Oliveira, Solange M.; Abbate, Maria C.; Nixon, Douglas F.; Kallas, Esper G.			HIV-1/HSV-2 Co-Infected Adults in Early HIV-1 Infection Have Elevated CD4+T Cell Counts	PLOS ONE			English	Article								Introduction. HIV-1 is often acquired in the presence of pre-existing co-infections, such as Herpes Simplex Virus 2 (HSV-2). We examined the impact of HSV-2 status at the time of HIV-1 acquisition for its impact on subsequent clinical course, and total CD4+ T cell phenotypes. Methods. We assessed the relationship of HSV-1/HSV-2 co-infection status on CD4+ T cell counts and HIV-1 RNA levels over time prior in a cohort of 186 treatment naive adults identified during early HIV-1 infection. We assessed the activation and differentiation state of total CD4+ T cells at study entry by HSV-2 status. Results. Of 186 recently HIV-1 infected persons, 101 (54%) were sero-positive for HSV-2. There was no difference in initial CD8+ T cell count, or differences between the groups for age, gender, or race based on HSV-2 status. Persons with HIV-1/HSV-2 co-infection sustained higher CD4+ T cell counts over time (+69 cells/ul greater (SD = 33.7, p = 0.04) than those with HIV-1 infection alone (Figure 1), after adjustment for HIV-1 RNA levels (-57 cells per 1 log(10) higher HIV-1 RNA, p<0.0001). We did not observe a relationship between HSV-2 infection status with plasma HIV-1 RNA levels over time. HSV-2 acquistion after HIV-1 acquisition had no impact on CD4+ count or viral load. We did not detect differences in CD4+ T cell activation or differentiation state by HSV-2+ status. Discussion. We observed no effect of HSV-2 status on viral load. However, we did observe that treatment naive, recently HIV-1 infected adults co-infected with HSV-2+ at the time of HIV-1 acquisition had higher CD4+ T cell counts over time. If verified in other cohorts, this result poses a striking paradox, and its public health implications are not immediately clear.	[Sauer, Mariana M.; Tomiyama, Helena; Kallas, Esper G.] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil; [Barbour, Jason D.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA; [Sharp, Elizabeth R.; Garrison, Keith E.; Long, Brian R.; Nixon, Douglas F.] Univ Calif San Francisco, Dept Expt Med, San Francisco, CA USA; [Bassichetto, Katia C.; Oliveira, Solange M.; Abbate, Maria C.] Sao Paula City Hlth Syst, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kallas, EG (corresponding author), Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil.	kallas.dmed@epm.br	Nixon, Douglas/AAU-5734-2020; Kallas, Esper G/C-9539-2012	Nixon, Douglas/0000-0002-2801-1786; Kallas, Esper/0000-0003-2026-6925	Brazilian Program for STD and AIDS, Ministry of Health [914/BRA/3014 UNESCO/Kallas]; Sao Paulo City Health Department [2004-0.168.922-7/Kallas]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/15856-9/Kallas]; NIAID/NIH [AI066917/Barbour, AI064520/Nixon]; John E. Fogarty International Center [D43 TW00003]; AIDS Research Institute of the AIDS Biology Program at UCSF; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Brazilian Ministry of Education; FOGARTY INTERNATIONAL CENTER [D43TW000003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, K01AI066917, P01AI064520] Funding Source: NIH RePORTER	Brazilian Program for STD and AIDS, Ministry of Health; Sao Paulo City Health Department; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); John E. Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); AIDS Research Institute of the AIDS Biology Program at UCSF; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Ministry of Education; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported with funding from the Brazilian Program for STD and AIDS, Ministry of Health (914/BRA/3014 UNESCO/Kallas), the Sao Paulo City Health Department (2004-0.168.922-7/Kallas), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (04/15856-9/Kallas), the NIAID/NIH (AI066917/Barbour), (AI064520/Nixon) the John E. Fogarty International Center (D43 TW00003), The AIDS Research Institute of the AIDS Biology Program at UCSF. M. M. S. was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazilian Ministry of Education.	Barcy S, 2001, J IMMUNOL, V166, P6242, DOI 10.4049/jimmunol.166.10.6242; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bosnjak L, 2005, J IMMUNOL, V174, P2220, DOI 10.4049/jimmunol.174.4.2220; Brown EL, 2006, AM J EPIDEMIOL, V164, P733, DOI 10.1093/aje/kwj270; Cachay ER, 2007, J INFECT DIS, V195, P1270, DOI 10.1086/513568; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Cunningham Anthony L, 2004, J HIV Ther, V9, P9; FILHO DJ, 2007, AIDS RES HU IN PRESS; Jones CA, 2003, J VIROL, V77, P11139, DOI 10.1128/JVI.77.20.11139-11149.2003; Kallas Esper Georges, 2004, Braz J Infect Dis, V8, P399, DOI 10.1590/S1413-86702004000600003; Mark KE, 2007, J INFECT DIS, V195, P1324, DOI 10.1086/513276; Mikloska Z, 2001, J VIROL, V75, P5958, DOI 10.1128/JVI.75.13.5958-5964.2001; Milligan GN, 1997, VIROLOGY, V229, P259, DOI 10.1006/viro.1997.8441; MILLIGAN GN, 1995, VIROLOGY, V212, P481, DOI 10.1006/viro.1995.1506; Milligan GN, 1998, J IMMUNOL, V160, P6093; Morrow RA, 2003, AM J CLIN PATHOL, V120, P839, DOI [10.1039/AKWHF62YYJ054HA6, 10.1309/AKWHF62YYJ054HA6]; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; REBBAPRAGADA A, 2006, AIDS 2006 16 INT AID; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Schacker T, 2002, J INFECT DIS, V186, P1718, DOI 10.1086/345771; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915	22	19	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1080	10.1371/journal.pone.0001080	http://dx.doi.org/10.1371/journal.pone.0001080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957262	Green Published, gold, Green Submitted			2022-12-27	WOS:000207458500025
J	Crossland, MD; Dakin, SC; Bex, PJ				Crossland, Michael D.; Dakin, Steven C.; Bex, Peter J.			Illusory Stimuli Can Be Used to Identify Retinal Blind Spots	PLOS ONE			English	Article								Background. Identification of visual field loss in people with retinal disease is not straightforward as people with eye disease are frequently unaware of substantial deficits in their visual field, as a consequence of perceptual completion ("filling-in'') of affected areas. Methodology. We attempted to induce a compelling visual illusion known as the induced twinkle after-effect (TwAE) in eight patients with retinal scotomas. Half of these patients experience filling-in of their scotomas such that they are unaware of the presence of their scotoma, and conventional campimetric techniques can not be used to identify their vision loss. The region of the TwAE was compared to microperimetry maps of the retinal lesion. Principal Findings. Six of our eight participants experienced the TwAE. This effect occurred in three of the four people who filled-in their scotoma. The boundary of the TwAE showed good agreement with the boundary of lesion, as determined by microperimetry. Conclusion. For the first time, we have determined vision loss by asking patients to report the presence of an illusory percept in blind areas, rather than the absence of a real stimulus. This illusory technique is quick, accurate and not subject to the effects of filling-in.	[Crossland, Michael D.; Dakin, Steven C.] Univ Coll London UCL, Inst Ophthalmol, London, England; [Bex, Peter J.] Harvard Univ, Schepens Eye Res Inst, Cambridge, MA 02138 USA	University of London; University College London; Harvard University; Schepens Eye Research Institute	Crossland, MD (corresponding author), Univ Coll London UCL, Inst Ophthalmol, London, England.	m.crossland@ucl.ac.uk	Crossland, Michael D/B-5600-2008; Dakin, Steven/B-7610-2008	Crossland, Michael D/0000-0001-6833-6043; Dakin, Steven/0000-0002-3548-9104	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; AMSLER M, 1947, OPHTHALMOLOGICA, V114, P248, DOI 10.1159/000300476; AULHORN E, 1989, P 8 INT PER SOC M OC; Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; Bellmann C, 2004, OPHTHALMOLOGY, V111, P2265, DOI 10.1016/j.ophtha.2004.06.019; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chen CC, 2005, NEUROIMAGE, V24, P802, DOI 10.1016/j.neuroimage.2004.09.021; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; Crossland MD, 2005, OPHTHALMOLOGY, V112, P1579, DOI 10.1016/j.ophtha.2005.03.027; Crossland M, 2007, BRIT J OPHTHALMOL, V91, P391, DOI 10.1136/bjo.2006.095315; CULHAM LE, 1993, CLIN VISION SCI, V8, P551; DEWEERD P, 1995, NATURE, V377, P731, DOI 10.1038/377731a0; Evans J., 1996, HEALTH TRENDS, V28, P5; GERRITS HJM, 1969, VISION RES, V9, P439, DOI 10.1016/0042-6989(69)90092-3; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; HARDAGE L, 1995, VISION RES, V35, P757, DOI 10.1016/0042-6989(94)00167-K; Huk AC, 2002, J NEUROSCI, V22, P7195; Kolb M, 1995, Ger J Ophthalmol, V4, P228; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Mendola JD, 2006, J COGNITIVE NEUROSCI, V18, P363, DOI 10.1162/089892906775990624; Morgan MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000256; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; RAMACHANDRAN VS, 1993, VISION RES, V33, P717, DOI 10.1016/0042-6989(93)90191-X; Reich LN, 2000, VISION RES, V40, P805, DOI 10.1016/S0042-6989(99)00215-1; Rubin GS, 1997, INVEST OPHTH VIS SCI, V38, P557; Schiefer U, 1998, VISION RES, V38, P1303, DOI 10.1016/S0042-6989(97)00254-X; SCHUCHARD RA, 1993, ARCH OPHTHALMOL-CHIC, V111, P776, DOI 10.1001/archopht.1993.01090060064024; SERGENT J, 1988, BRAIN, V111, P347, DOI 10.1093/brain/111.2.347; Sunness JS, 2004, OPHTHALMOLOGY, V111, P1595, DOI 10.1016/j.ophtha.2003.12.050; Timberlake GT, 2005, OPTOMETRY VISION SCI, V82, P177, DOI 10.1097/01.OPX.0000156311.49058.C8; TIMBERLAKE GT, 1986, INVEST OPHTH VIS SCI, V27, P1137; Tyler CW, 1998, PERCEPTION, V27, P203, DOI 10.1068/p270203; WEIL RS, 2007, P NATL ACAD SCI US; WHITE JM, 1990, INVEST OPHTH VIS SCI, V31, P1149; Whittaker S., 1986, DEV ORDER VISUAL SYS; Zaksas D, 2005, J NEUROPHYSIOL, V94, P4156, DOI 10.1152/jn.00505.2005	39	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1060	10.1371/journal.pone.0001060	http://dx.doi.org/10.1371/journal.pone.0001060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957244	Green Published, gold, Green Submitted			2022-12-27	WOS:000207458500007
J	Caceda, ER; Kochel, TJ				Caceda, Edna R.; Kochel, Tadeusz J.			Application of Modified Shell Vial Culture Procedure for Arbovirus Detection	PLOS ONE			English	Article								The isolation of arboviruses from patient's low titer sera can be difficult. Here we compared the detection efficiency of Dengue (DEN), Yellow Fever (YF), Saint Louis Encephalitis (SLE), West Nile (WN), Ilheus (ILH), Group C (GC), Oropouche (ORO), Mayaro (MAY) and Venezuela Encephalitis Equine (VEE) viruses using a Modified Shell Vial Culture (MSVC) protocol to a Standard Cell Culture (SCC) protocol. First the MSVC and SCC protocols were compared using five dilutions for each of the following stock viruses: DEN-1, DEN-2, DEN-3, DEN-4, YF, SLE, WN, ILH, GC, ORO, MAY and VEE. Next, patients' original sera from which viruses (DEN-1, DEN-2, DEN-3, YF, GC, ORO, MAY and VEE) had been previously isolated were compare by the two methods using five sera dilutions. In addition, seven sera that were positive for DEN-3 by RT-PCR and negative by SCC were processed by MSVC. The MSVC protocol was consistently 1-2 logs higher virus dilution more sensitive for virus detection than the SCC protocol for all stock Flaviviruses tested (DEN-1, DEN-2, DEN-3, DEN-4, YF, SLE, WN and ILH). MSVC was equal to or one log more sensitive for virus detection than SCC for the stock Bunyaviruses (GC and ORO). For the stock Alphavirus MAY, MSVC was equally or one log more sensitive for virus detection than SCC, while for VEE SCC was equally or one log more sensitive for virus detection than MSVC. MSVC was consistently one to two sera dilutions more sensitive than SCC for the detection of Flaviviruses from patients' sera. Both methods were approximately equally sensitive for the detection of Bunyaviruses from patients' sera and equal or one dilution less sensitive for the detection of Alphaviruses from patients' sera. Additionally, MSVC detected DEN virus in five of seven DEN-3 RT-PCR positive, SCC negative patients' sera.	[Caceda, Edna R.; Kochel, Tadeusz J.] Amer Embassy, Naval Med Res Ctr Detachment, Lima, Peru		Kochel, TJ (corresponding author), Amer Embassy, Naval Med Res Ctr Detachment, Lima, Peru.	Tad.Kochel@med.navy.mil			United States Department of Defense [847705.82000.25GB.B0016]	United States Department of Defense(United States Department of Defense)	This study was funded by the United States Department of Defense Global Emerging Infections Systems Research Program, WORK UNIT NUMBER: 847705.82000.25GB.B0016. The sponsor had no role in this study other than providing funding.	BULLER RS, 1995, CLIN DIAGN VIROL, V3, P317, DOI 10.1016/0928-0197(94)00048-Y; Crist GA, 2004, DIAGN MICR INFEC DIS, V49, P173, DOI 10.1016/j.diagmicrobio.2004.03.008; Engler HD, 1997, J CLIN MICROBIOL, V35, P2165, DOI 10.1128/JCM.35.8.2165-2167.1997; JOHNSTON SLG, 1990, J CLIN MICROBIOL, V28, P2394, DOI 10.1128/JCM.28.11.2394-2397.1990; LEE SHS, 1992, J VIROL METHODS, V39, P39, DOI 10.1016/0166-0934(92)90123-U; RANGAIAH JS, 2006, VIROL J, V3, P2; Roche RR, 2000, J CLIN MICROBIOL, V38, P3508, DOI 10.1128/JCM.38.9.3508-3510.2000; Steed L L, 1994, Clin Diagn Virol, V2, P181, DOI 10.1016/0928-0197(94)90021-3; Whistler T, 1997, CLIN DIAGN VIROL, V7, P193, DOI 10.1016/S0928-0197(97)00270-5	9	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1034	10.1371/journal.pone.0001034	http://dx.doi.org/10.1371/journal.pone.0001034			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940598	Green Published, gold, Green Submitted			2022-12-27	WOS:000207456100002
J	Diaz, LA; Foss, CA; Thornton, K; Nimmagadda, S; Endres, CJ; Uzuner, O; Seyler, TM; Ulrich, SD; Conway, J; Bettegowda, C; Agrawal, N; Cheong, I; Zhang, XS; Ladenson, PW; Vogelstein, BN; Mont, MA; Zhou, SB; Kinzler, KW; Vogelstein, B; Pomper, MG				Diaz, Luis A., Jr.; Foss, Catherine A.; Thornton, Katherine; Nimmagadda, Sridhar; Endres, Christopher J.; Uzuner, Ovsev; Seyler, Thorsten M.; Ulrich, Slif D.; Conway, Janet; Bettegowda, Chetan; Agrawal, Nishant; Cheong, Ian; Zhang, Xiaosong; Ladenson, Paul W.; Vogelstein, Barry N.; Mont, Michael A.; Zhou, Shibin; Kinzler, Kenneth W.; Vogelstein, Bert; Pomper, Martin G.			Imaging of Musculoskeletal Bacterial Infections by [I-124]FIAU-PET/CT	PLOS ONE			English	Article								Background. Traditional imaging techniques for the localization and monitoring of bacterial infections, although reasonably sensitive, suffer from a lack of specificity. This is particularly true for musculoskeletal infections. Bacteria possess a thymidine kinase (TK) whose substrate specificity is distinct from that of the major human TK. The substrate specificity difference has been exploited to develop a new imaging technique that can detect the presence of viable bacteria. Methodology/Principal Findings. Eight subjects with suspected musculoskeletal infections and one healthy control were studied by a combination of [I-124]FIAU-positron emission tomography and CT ([I-124]FIAU-PET/CT). All patients with proven musculoskeletal infections demonstrated positive [I-124] FIAU-PET/CT signals in the sites of concern at two hours after radiopharmaceutical administration. No adverse reactions with FIAU were observed. Conclusions/Significance. [I-124]FIAU-PET/CT is a promising new method for imaging bacterial infections.	[Foss, Catherine A.; Nimmagadda, Sridhar; Endres, Christopher J.; Uzuner, Ovsev; Pomper, Martin G.] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Diaz, Luis A., Jr.; Thornton, Katherine; Bettegowda, Chetan; Agrawal, Nishant; Cheong, Ian; Zhang, Xiaosong; Vogelstein, Barry N.; Zhou, Shibin; Kinzler, Kenneth W.; Vogelstein, Bert] Ludwig Ctr Canc Genet & Therapeut Johns Hopkins, Howard Hughes Med Inst, Baltimore, MD USA; [Seyler, Thorsten M.; Ulrich, Slif D.; Conway, Janet; Mont, Michael A.] Sinai Hosp, Rubin Inst Adv Orthoped, Ctr Joint Preservat & Reconstruct, Baltimore, MD 21215 USA; [Ladenson, Paul W.] Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Baltimore, MD 21205 USA; [Diaz, Luis A., Jr.; Thornton, Katherine; Bettegowda, Chetan; Agrawal, Nishant; Cheong, Ian; Zhang, Xiaosong; Zhou, Shibin; Kinzler, Kenneth W.; Vogelstein, Bert; Pomper, Martin G.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Sinai Hospital of Baltimore; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Pomper, MG (corresponding author), Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	mpomper@jhmi.edu	Nimmagadda, Sridhar/D-6135-2011	Nimmagadda, Sridhar/0000-0002-6413-7191; Cheong, Ian/0000-0002-3062-6878; Diaz, Luis/0000-0002-7079-8914	NIH [CA62924, CA92871]; The Virginia and D. K. Ludwig Fund for Cancer Research; Johns Hopkins Alliance for Science and Technology Development; NATIONAL CANCER INSTITUTE [P50CA062924] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Virginia and D. K. Ludwig Fund for Cancer Research; Johns Hopkins Alliance for Science and Technology Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: NIH grants CA62924, CA92871, The Virginia and D. K. Ludwig Fund for Cancer Research and the Johns Hopkins Alliance for Science and Technology Development	Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Akhtar MS, 2005, J NUCL MED, V46, P567; Bauer TW, 2006, J BONE JOINT SURG AM, V88A, P869, DOI 10.2106/JBJS.E.01149; Becker W, 2001, Lancet Infect Dis, V1, P326, DOI 10.1016/S1473-3099(01)00146-3; Benitez A, 2006, Q J NUCL MED MOL IM, V50, P147; Bettegowda C, 2005, P NATL ACAD SCI USA, V102, P1145, DOI 10.1073/pnas.0408861102; BRUCE A, 1980, SCAND J CLIN LAB INV, V40, P461, DOI 10.3109/00365518009101869; Buscombe JR, 2006, Q J NUCL MED MOL IM, V50, P99; Capriotti G, 2006, NUCL MED COMMUN, V27, P757, DOI 10.1097/01.mnm.0000230065.85705.b3; Crymes William B Jr, 2004, J Nucl Med Technol, V32, P12; Dang LH, 2001, P NATL ACAD SCI USA, V27, P27; De Winter F, 2004, EUR J NUCL MED MOL I, V31, P233, DOI 10.1007/s00259-003-1349-0; Diaz LA, 2005, TOXICOL SCI, V88, P562, DOI 10.1093/toxsci/kfi316; Dumarey N, 2002, EUR J NUCL MED MOL I, V29, P530, DOI 10.1007/s00259-001-0749-2; Fu DX, 2007, CLIN CANCER RES, V13, P1453, DOI 10.1158/1078-0432.CCR-06-2295; Gemmel F, 2004, NUCL MED COMMUN, V25, P277, DOI 10.1097/00006231-200403000-00011; Jacobs A, 2001, J NUCL MED, V42, P467; Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454; Larikka MJ, 2003, J NUCL MED, V44, P1368; Love C, 2004, J NUCL MED, V45, P1864; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Machens HG, 1996, MICROSURG, V17, P272, DOI 10.1002/(SICI)1098-2752(1996)17:5<272::AID-MICR7>3.0.CO;2-L; MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702; Nimmagadda S, 2007, J NUCL MED, V48, P655, DOI 10.2967/jnumed.106.036830; PALESTRO CJ, 1990, J NUCL MED, V31, P1950; Parvizi J, 2006, J BONE JOINT SURG AM, V88A, P138, DOI 10.2106/JBJS.F.00609; Sarda L, 2003, J NUCL MED, V44, P920; Stumpe KDM, 2006, Q J NUCL MED MOL IM, V50, P131; Stumpe KDM, 2006, EUR J NUCL MED MOL I, V33, P1218, DOI 10.1007/s00259-006-0127-1; Toms AD, 2006, J BONE JOINT SURG BR, V88B, P149, DOI 10.1302/0301-620X.88B2.17058; Vinjamuri S, 1996, LANCET, V347, P233, DOI 10.1016/S0140-6736(96)90407-9; Wang JH, 1996, ANTIMICROB AGENTS CH, V40, P1555, DOI 10.1128/AAC.40.6.1555	32	71	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1007	10.1371/journal.pone.0001007	http://dx.doi.org/10.1371/journal.pone.0001007			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925855	gold, Green Published, Green Submitted			2022-12-27	WOS:000207456000006
J	Kent, C; Azanchi, R; Smith, B; Chu, A; Levine, J				Kent, Clement; Azanchi, Reza; Smith, Ben; Chu, Adrienne; Levine, Joel			A Model-Based Analysis of Chemical and Temporal Patterns of Cuticular Hydrocarbons in Male Drosophila melanogaster	PLOS ONE			English	Article								Drosophila Cuticular Hydrocarbons (CH) influence courtship behaviour, mating, aggregation, oviposition, and resistance to desiccation. We measured levels of 24 different CH compounds of individual male D. melanogaster hourly under a variety of environmental (LD/DD) conditions. Using a model-based analysis of CH variation, we developed an improved normalization method for CH data, and show that CH compounds have reproducible cyclic within-day temporal patterns of expression which differ between LD and DD conditions. Multivariate clustering of expression patterns identified 5 clusters of co-expressed compounds with common chemical characteristics. Turnover rate estimates suggest CH production may be a significant metabolic cost. Male cuticular hydrocarbon expression is a dynamic trait influenced by light and time of day; since abundant hydrocarbons affect male sexual behavior, males may present different pheromonal profiles at different times and under different conditions.	[Kent, Clement; Azanchi, Reza; Smith, Ben; Chu, Adrienne; Levine, Joel] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Levine, J (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	jlevine@utm.utoronto.ca	Kent, Clement F./B-9982-2008; Smith, Ben PC/GXZ-8778-2022	Kent, Clement F./0000-0003-4994-0098; Smith, Benjamin/0000-0003-0651-9420	Canada Research Chair award; CIHR [FRN 74665]	Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canada Research Chair award to JDL and by a grant from the CIHR (FRN 74665) to JDL.	Bartholomew DKM, 1999, LATENT VARIABLE MODE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blows MW, 1998, AM NAT, V152, P826, DOI 10.1086/286211; Blows MW, 2004, AM NAT, V163, P329, DOI 10.1086/381941; Chertemps T, 2006, INSECT MOL BIOL, V15, P465, DOI 10.1111/j.1365-2583.2006.00658.x; Chertemps T, 2005, BIOCHEM BIOPH RES CO, V333, P1066, DOI 10.1016/j.bbrc.2005.06.015; Chertemps T, 2007, P NATL ACAD SCI USA, V104, P4273, DOI 10.1073/pnas.0608142104; CLARK AG, 1989, GENETICS, V123, P131; COBB M, 1990, ANIM BEHAV, V39, P1058, DOI 10.1016/S0003-3472(05)80778-X; Cox T. F, 1994, MULTIDIMENSIONAL SCA; Coyne JA, 1996, GENETICS, V143, P1689; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Dallerac R, 2000, P NATL ACAD SCI USA, V97, P9449, DOI 10.1073/pnas.150243997; Dowse H.B., 1987, Journal of Biological Rhythms, V2, P65, DOI 10.1177/074873048700200106; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; Ferveur JF, 1996, GENET RES, V67, P211, DOI 10.1017/S0016672300033693; Foley B, 2007, GENETICS, V175, P1465, DOI 10.1534/genetics.106.065771; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; GIBBS A, 1995, COMP BIOCHEM PHYS B, V112, P243, DOI 10.1016/0305-0491(95)00081-X; Ginzel MD, 2003, CHEMOECOLOGY, V13, P135, DOI 10.1007/s00049-003-0239-z; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; JALLON J, 1997, J INSECT PHYSL, V43, P1111; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Labeur C, 2002, GENETICA, V114, P269, DOI 10.1023/A:1016223000650; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; Loehlin JC, 2004, LATENT VARIABLE MODE; Marcillac F, 2005, GENETICS, V171, P1617, DOI 10.1534/genetics.104.033159; MARKOWITZ H, 1970, PORTOFOLIO SELECTION; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Mas F, 2005, J CHEM ECOL, V31, P2747, DOI 10.1007/s10886-005-7570-5; Nicholls D.F., 1982, RANDOM COEFFICIENT A; R Development Core Team, 2006, R LANG ENV STAT COMP; Rouault J, 2000, GENETICA, V110, P117, DOI 10.1023/A:1017987220814; Rouault JD, 2004, GENETICA, V120, P195, DOI 10.1023/B:GENE.0000017641.75820.49; Skroblin A, 2006, J EVOLUTION BIOL, V19, P35, DOI 10.1111/j.1420-9101.2005.00986.x; Soroker V, 2000, J INSECT PHYSIOL, V46, P1097, DOI 10.1016/S0022-1910(99)00219-X; Takahashi A, 2001, P NATL ACAD SCI USA, V98, P3920, DOI 10.1073/pnas.061465098; THOMSON G, 1948, FACTORIAL ANAL HUMAN; Ueyama M, 2005, INSECT BIOCHEM MOLEC, V35, P911, DOI 10.1016/j.ibmb.2005.03.007; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	45	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e962	10.1371/journal.pone.0000962	http://dx.doi.org/10.1371/journal.pone.0000962			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17896002	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455800040
J	Parekkadan, B; van Poll, D; Suganuma, K; Carter, EA; Berthiaume, F; Tilles, AW; Yarmush, ML				Parekkadan, Biju; van Poll, Daan; Suganuma, Kazuhiro; Carter, Edward A.; Berthiaume, Francois; Tilles, Arno W.; Yarmush, Martin L.			Mesenchymal Stem Cell-Derived Molecules Reverse Fulminant Hepatic Failure	PLOS ONE			English	Article								Modulation of the immune system may be a viable alternative in the treatment of fulminant hepatic failure (FHF) and can potentially eliminate the need for donor hepatocytes for cellular therapies. Multipotent bone marrow-derived mesenchymal stem cells (MSCs) have been shown to inhibit the function of various immune cells by undefined paracrine mediators in vitro. Yet, the therapeutic potential of MSC-derived molecules has not been tested in immunological conditions in vivo. Herein, we report that the administration of MSC-derived molecules in two clinically relevant forms-intravenous bolus of conditioned medium (MSC-CM) or extracorporeal perfusion with a bioreactor containing MSCs (MSC-EB)-can provide a significant survival benefit in rats undergoing FHF. We observed a cell mass-dependent reduction in mortality that was abolished at high cell numbers indicating a therapeutic window. Histopathological analysis of liver tissue after MSC-CM treatment showed dramatic reduction of panlobular leukocytic infiltrates, hepatocellular death and bile duct duplication. Furthermore, we demonstrate using computed tomography of adoptively transferred leukocytes that MSC-CM functionally diverts immune cells from the injured organ indicating that altered leukocyte migration by MSC-CM therapy may account for the absence of immune cells in liver tissue. Preliminary analysis of the MSC secretome using a protein array screen revealed a large fraction of chemotactic cytokines, or chemokines. When MSC-CM was fractionated based on heparin binding affinity, a known ligand for all chemokines, only the heparin-bound eluent reversed FHF indicating that the active components of MSC-CM reside in this fraction. These data provide the first experimental evidence of the medicinal use of MSC-derived molecules in the treatment of an inflammatory condition and support the role of chemokines and altered leukocyte migration as a novel therapeutic modality for FHF.	[Parekkadan, Biju; van Poll, Daan; Suganuma, Kazuhiro; Carter, Edward A.; Berthiaume, Francois; Tilles, Arno W.; Yarmush, Martin L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med & Surg Serv, Boston, MA 02115 USA; [Parekkadan, Biju; van Poll, Daan; Suganuma, Kazuhiro; Carter, Edward A.; Berthiaume, Francois; Tilles, Arno W.; Yarmush, Martin L.] Shriners Hosp Children, Boston, MA USA; [Parekkadan, Biju; Yarmush, Martin L.] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA USA; [van Poll, Daan] Univ Utrecht, Univ Med Ctr, Dept Surg, Utrecht, Netherlands	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Utrecht University; Utrecht University Medical Center	Yarmush, ML (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med & Surg Serv, Boston, MA 02115 USA.	ireis@sbi.org	Berthiaume, Francois/ABD-2139-2020	Yarmush, Martin/0000-0003-4986-8444; Parekkadan, Biju/0000-0002-3408-8085	National Science Foundation; Michael van Vlooten foundation; National Institutes of Health [K08 DK66040, K18 DK076819, R01 DK43371]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043371, K18DK076819, K08DK066040] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Michael van Vlooten foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	BP was supported by a National Science Foundation predoctoral fellowship. DVP was supported by a fellowship from the Michael van Vlooten foundation. This work was partially supported by grants from the National Institutes of Health (K08 DK66040, K18 DK076819 and R01 DK43371) and the Shriners Hospitals for Children.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Dazzi F, 2006, BLOOD REV, V20, P161, DOI 10.1016/j.blre.2005.11.002; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; PAREKKADAN B, 2007, BIOCH BIOPH IN PRESS; Shinoda M, 2007, J SURG RES, V137, P130, DOI 10.1016/j.jss.2006.08.009; Shinoda M, 2006, TISSUE ENG, V12, P1313, DOI 10.1089/ten.2006.12.1313; Shito M, 2001, DIGEST DIS SCI, V46, P1700, DOI 10.1023/A:1010653504568; Strain AJ, 2002, SCIENCE, V295, P1005, DOI 10.1126/science.1068660; Zhang YM, 2004, STEM CELLS, V22, P1256, DOI 10.1634/stemcells.2004-0173	15	402	486	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e941	10.1371/journal.pone.0000941	http://dx.doi.org/10.1371/journal.pone.0000941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895982	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455800020
J	Salemi, M; Burkhardt, BR; Gray, RR; Ghaffari, G; Sleasman, JW; Goodenow, MM				Salemi, Marco; Burkhardt, Brant R.; Gray, Rebecca R.; Ghaffari, Guity; Sleasman, John W.; Goodenow, Maureen M.			Phylodynamics of HIV-1 in Lymphoid and Non-Lymphoid Tissues Reveals a Central Role for the Thymus in Emergence of CXCR4-Using Quasispecies	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PERIPHERAL-BLOOD; CORECEPTOR USAGE; CELL TURNOVER; ENVELOPE GENE; ENV V1; EVOLUTION; RECOMBINATION; INFECTION; BRAIN	Background. During HIV-1 infection coreceptor switch from CCR5-(R5)-to CXCR4 (X4)-using viruses is associated with disease progression. X4 strains of HIV-1 are highly cytopathic to immature thymocytes. Virtually no studies have evaluated the HIV-1 quasispecies present in vivo within thymic and lymphoid tissues or the evolutionary relationship between R5 and X4 viruses in tissues and peripheral blood. Methodology/Principal Findings. High-resolution phylodynamic analysis was applied to virus envelope quasispecies in longitudinal peripheral blood mononuclear cells (PBMCs) and lymphoid and non-lymphoid tissues collected post mortem from therapy naive children with AIDS. There were three major findings. First, continued evolution of R5 viruses in PBMCs, spleen and lymph nodes involved multiple bottlenecks, independent of coreceptor switch, resulting in fitter quasispecies driven by positive selection. Second, evolution of X4 strains appeared to be a sequential process requiring the initial fixation of positively selected mutations in V1-V2 and C2 domains of R5 variants before the emergence of high charge V3 X4 variants. Third, R5 viruses persisted after the emergence of CXCR4-using strains, which were found predominantly but not exclusively in the thymus. Conclusions/Significance. Our data indicate that the evolution of X4 strains is a multi-step, temporally structured process and that the thymus may play an important role in the evolution/amplification of coreceptor variants. Development of new therapeutic protocols targeting virus in the thymus could be important to control HIV-1 infection prior to advanced disease.	[Salemi, Marco; Burkhardt, Brant R.; Gray, Rebecca R.; Ghaffari, Guity; Goodenow, Maureen M.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Gray, Rebecca R.] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Ghaffari, Guity; Goodenow, Maureen M.] Univ Florida, Dept Pediat, Div Immunol Rheumatol & Infect Dis, Gainesville, FL 32611 USA; [Sleasman, John W.] Univ S Florida, Dept Pediat, Div Rheumatol Allergy & Immunol, St Petersburg, FL 33701 USA; [Sleasman, John W.] Univ S Florida, All Childrens Hosp, St Petersburg, FL 33701 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Salemi, M (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	salemi@pathology.ufl.edu; goodenow@ufl.edu			PHS R01 [HD032259, AI047723, AI065265]; General Clinical Research Center of the University of Florida [MO1-RR00082]; University of Florida Children's Miracle Network; Center for Research in Pediatric Immune Deficiency; Laura McClamma Research; Pediatric Clinical Research Center; University of South Florida; Maternal and Child Health Bureau [R60 MC 00003-01]; Department of Health and Human Services; Health Resources and Services Administration; Robert A. Good Chair for Immunology; Stephany W. Holloway University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032259] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065265, R01AI047723] Funding Source: NIH RePORTER	PHS R01; General Clinical Research Center of the University of Florida; University of Florida Children's Miracle Network; Center for Research in Pediatric Immune Deficiency; Laura McClamma Research; Pediatric Clinical Research Center; University of South Florida; Maternal and Child Health Bureau; Department of Health and Human Services; Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Robert A. Good Chair for Immunology; Stephany W. Holloway University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research was supported by PHS R01 awards HD032259, AI047723, and AI065265; General Clinical Research Center of the University of Florida MO1-RR00082; University of Florida Children's Miracle Network; Center for Research in Pediatric Immune Deficiency; Laura McClamma Research Fellowship; Pediatric Clinical Research Center of All Children's Hospital, University of South Florida, and the Maternal and Child Health Bureau, R60 MC 00003-01, Department of Health and Human Services, Health Resources and Services Administration; Robert A. Good Chair for Immunology (JWS) and Stephany W. Holloway University Chair for AIDS Research (MMG).	Alves K, 2002, AIDS RES HUM RETROV, V18, P161, DOI 10.1089/08892220252779700; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Briggs DR, 2000, AIDS, V14, P2937, DOI 10.1097/00002030-200012220-00016; Brooks DG, 2001, NAT MED, V7, P459, DOI 10.1038/86531; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; BURKHARDT B, 1999, PROMEGA NOTES, V71, P30; CANN AJ, 1992, J VIROL, V66, P305, DOI 10.1128/JVI.66.1.305-309.1992; Chang J, 1998, AIDS RES HUM RETROV, V14, P25, DOI 10.1089/aid.1998.14.25; Chene L, 1999, J VIROL, V73, P7533; Cho MW, 1998, J VIROL, V72, P2509, DOI 10.1128/JVI.72.3.2509-2515.1998; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Clevestig P, 2005, AIDS RES HUM RETROV, V21, P371, DOI 10.1089/aid.2005.21.371; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Craigo JK, 2004, AIDS RES HUM RETROV, V20, P1196, DOI 10.1089/aid.2004.20.1196; Dion ML, 2004, IMMUNITY, V21, P757, DOI 10.1016/j.immuni.2004.10.013; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Douek DC, 2001, J IMMUNOL, V167, P6663, DOI 10.4049/jimmunol.167.11.6663; Douek DC, 2000, VACCINE, V18, P1638, DOI 10.1016/S0264-410X(99)00499-5; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards CTT, 2006, GENETICS, V174, P1441, DOI 10.1534/genetics.105.052019; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; FOUCHIER RAM, 1995, J CLIN MICROBIOL, V33, P906, DOI 10.1128/JCM.33.4.906-911.1995; Ghaffari G, 2005, J VIROL, V79, P13250, DOI 10.1128/JVI.79.21.13250-13261.2005; Goodenow MM, 2006, J LEUKOCYTE BIOL, V80, P965, DOI 10.1189/jlb.0306148; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Ho SH, 2007, J VIROL, V81, P8621, DOI 10.1128/JVI.00759-07; HOWELL RM, 1991, AIDS RES HUM RETROV, V7, P869, DOI 10.1089/aid.1991.7.869; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; KISELYEVA Y, 2007, J VIROL; Kitchen SG, 1997, J VIROL, V71, P6928, DOI 10.1128/JVI.71.9.6928-6934.1997; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Kourtis AP, 1996, NEW ENGL J MED, V335, P1431, DOI 10.1056/NEJM199611073351904; Lamers S, 2004, BIOINFORMATICS, V20, P436, DOI 10.1093/bioinformatics/btg445; LAMERS SL, 1993, J VIROL, V67, P3951, DOI 10.1128/JVI.67.7.3951-3960.1993; Lamers SL, 1996, AIDS RES HUM RETROV, V12, P1169, DOI 10.1089/aid.1996.12.1169; LEINO L, 1991, BONE MARROW TRANSPL, V8, P339; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Mild M, 2007, J VIROL, V81, P3369, DOI 10.1128/JVI.01295-06; Milich L, 1997, VIROLOGY, V239, P108, DOI 10.1006/viro.1997.8821; Morris A, 1999, J VIROL, V73, P8720, DOI 10.1128/JVI.73.10.8720-8731.1999; Nickle DC, 2003, J VIROL, V77, P5540, DOI 10.1128/JVI.77.9.5540-5546.2003; Pastore C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006; PICKER LJ, 1992, ANNU REV IMMUNOL, V10, P561, DOI 10.1146/annurev.immunol.10.1.561; Pontow S, 2001, J VIROL, V75, P11503, DOI 10.1128/JVI.75.23.11503-11514.2001; Poss M, 1998, J VIROL, V72, P8240, DOI 10.1128/JVI.72.10.8240-8251.1998; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Ribeiro RM, 2006, J VIROL, V80, P802, DOI 10.1128/JVI.80.2.802-809.2006; ROSENZWEIG M, 1993, AIDS, V7, P1601, DOI 10.1097/00002030-199312000-00009; Salemi M, 2005, J VIROL, V79, P11343, DOI 10.1128/JVI.79.17.11343-11352.2005; Salminen M, 2003, PHYLOGENETIC HDB PRA, P348; Shah M, 2006, AIDS RES HUM RETROV, V22, P177, DOI 10.1089/aid.2006.22.177; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shapshak P, 1999, AIDS RES HUM RETROV, V15, P811, DOI 10.1089/088922299310719; Shriner D, 2004, GENETICS, V166, P1155, DOI 10.1534/genetics.166.3.1155; Shriner D, 2004, GENETICS, V167, P1573, DOI 10.1534/genetics.103.023382; SIMPSON JG, 1975, CLIN EXP IMMUNOL, V19, P261; SLATKIN M, 1989, GENETICS, V123, P603; SMIT TK, 2004, INDEPENDENT EVOLUTIO; STAMATATOS L, 1993, J VIROL, V67, P5635, DOI 10.1128/JVI.67.9.5635-5639.1993; SWOFFORD D, 2003, PHYLOGENETIC HDB PRA, P160; Tuttle DL, 1998, J VIROL, V72, P4962, DOI 10.1128/JVI.72.6.4962-4969.1998; Tuttle DL, 2002, AIDS RES HUM RETROV, V18, P353, DOI 10.1089/088922202753519133; Uittenbogaart CH, 2000, AIDS, V14, P1317, DOI 10.1097/00002030-200007070-00003; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zaitseva MB, 1998, J IMMUNOL, V161, P3103; Zhang LQ, 1998, J VIROL, V72, P5035, DOI 10.1128/JVI.72.6.5035-5045.1998	79	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e950	10.1371/journal.pone.0000950	http://dx.doi.org/10.1371/journal.pone.0000950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895991	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455800029
J	Statnikov, A; Li, C; Aliferis, CF				Statnikov, Alexander; Li, Chun; Aliferis, Constantin F.			Effects of Environment, Genetics and Data Analysis Pitfalls in an Esophageal Cancer Genome-Wide Association Study	PLOS ONE			English	Article								Background. The development of new high-throughput genotyping technologies has allowed fast evaluation of single nucleotide polymorphisms (SNPs) on a genome-wide scale. Several recent genome-wide association studies employing these technologies suggest that panels of SNPs can be a useful tool for predicting cancer susceptibility and discovery of potentially important new disease loci. Methodology/Principal Findings. In the present paper we undertake a careful examination of the relative significance of genetics, environmental factors, and biases of the data analysis protocol that was used in a previously published genome-wide association study. That prior study reported a nearly perfect discrimination of esophageal cancer patients and healthy controls on the basis of only genetic information. On the other hand, our results strongly suggest that SNPs in this dataset are not statistically linked to the phenotype, while several environmental factors and especially family history of esophageal cancer (a proxy to both environmental and genetic factors) have only a modest association with the disease. Conclusions/Significance. The main component of the previously claimed strong discriminatory signal is due to several data analysis pitfalls that in combination led to the strongly optimistic results. Such pitfalls are preventable and should be avoided in future studies since they create misleading conclusions and generate many false leads for subsequent research.	[Statnikov, Alexander; Aliferis, Constantin F.] Vanderbilt Univ, Dept Biomed Informat, Discovery Syst Lab, Nashville, TN 37235 USA; [Li, Chun; Aliferis, Constantin F.] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Li, Chun] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA; [Aliferis, Constantin F.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Aliferis, CF (corresponding author), Vanderbilt Univ, Dept Biomed Informat, Discovery Syst Lab, Nashville, TN 37235 USA.	constantin.aliferis@vanderbilt.edu	Li, Chun/B-8388-2012; Li, Chun/R-1095-2019	Li, Chun/0000-0002-8819-2443	 [R01 LM007948-01]; NATIONAL LIBRARY OF MEDICINE [R01LM007948] Funding Source: NIH RePORTER	; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The work was in part supported by grant R01 LM007948-01. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliferis CF, 2006, CANCER INFORM, V2, P133; [Anonymous], 2003, ROC GRAPHS NOTES PRA; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Batista GEAPA, 2003, APPL ARTIF INTELL, V17, P519, DOI 10.1080/08839510390219309; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Ellis NA, 2006, GENET EPIDEMIOL, V30, P48, DOI 10.1002/gepi.20101; Engle LJ, 2006, ONCOGENE, V25, P1594, DOI 10.1038/sj.onc.1209368; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Hu N, 2005, CANCER RES, V65, P2542, DOI 10.1158/0008-5472.CAN-04-3247; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Ling C., 2003, P 18 INT JOINT C ART; Little R.J.A., 2002, STAT ANAL MISSING DA; Mitra N, 2004, CANCER RES, V64, P8116, DOI 10.1158/0008-5472.CAN-04-1411; Nicolae DL, 2006, PLOS GENET, V2, P665, DOI 10.1371/journal.pgen.0020067; Rudd MF, 2006, GENOME RES, V16, P693, DOI 10.1101/gr.5120106; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Vapnik V., 1998, STAT LEARNING THEORY; WADDELL M, 2005, P 5 ACM SIGKDD WORKS; Wagner M, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-26; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522	30	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e958	10.1371/journal.pone.0000958	http://dx.doi.org/10.1371/journal.pone.0000958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895998	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455800036
J	Zi, ZK; Klipp, E				Zi, Zhike; Klipp, Edda			Constraint-Based Modeling and Kinetic Analysis of the Smad Dependent TGF-beta Signaling Pathway	PLOS ONE			English	Article								Background. Investigation of dynamics and regulation of the TGF-beta signaling pathway is central to the understanding of complex cellular processes such as growth, apoptosis, and differentiation. In this study, we aim at using systems biology approach to provide dynamic analysis on this pathway. Methodology/Principal Findings. We proposed a constraint-based modeling method to build a comprehensive mathematical model for the Smad dependent TGF-beta signaling pathway by fitting the experimental data and incorporating the qualitative constraints from the experimental analysis. The performance of the model generated by constraint-based modeling method is significantly improved compared to the model obtained by only fitting the quantitative data. The model agrees well with the experimental analysis of TGF-beta pathway, such as the time course of nuclear phosphorylated Smad, the subcellular location of Smad and signal response of Smad phosphorylation to different doses of TGF-beta. Conclusions/Significance. The simulation results indicate that the signal response to TGF-beta is regulated by the balance between clathrin dependent endocytosis and non-clathrin mediated endocytosis. This model is useful to be built upon as new precise experimental data are emerging. The constraint-based modeling method can also be applied to quantitative modeling of other signaling pathways.	[Zi, Zhike; Klipp, Edda] Max Planck Inst Mol Genet, Berlin, Germany; [Klipp, Edda] Humboldt Univ, Inst Biol, Berlin, Germany	Max Planck Society; Humboldt University of Berlin	Klipp, E (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	klipp@molgen.mpg.de	Zi, Zhike/B-4185-2012; Zi, Zhike/I-2756-2019	Zi, Zhike/0000-0002-7601-915X	IMPRS for Computational Biology and Scientific Computing; European Commission [LSHG-CT-2005-518254]	IMPRS for Computational Biology and Scientific Computing; European Commission(European CommissionEuropean Commission Joint Research Centre)	Z. Zi is supported by PhD program of the IMPRS for Computational Biology and Scientific Computing. This work was supported by ENFIN, a Network of Excellence funded by the European Commission within its FP6 Programme, under the thematic area "Life sciences, genomics and biotechnology for health", contract number LSHG-CT-2005-518254.	Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Melke P, 2006, BIOPHYS J, V91, P4368, DOI [10.1529/biophysj.105.080408, 10.1529/biophysj.106.080408]; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1; Runarsson TP, 2000, IEEE T EVOLUT COMPUT, V4, P284, DOI 10.1109/4235.873238; Savini I, 2000, BIOCHEM J, V345, P665, DOI 10.1042/0264-6021:3450665; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Swameye I, 2003, P NATL ACAD SCI USA, V100, P1028, DOI 10.1073/pnas.0237333100; Vilar JMG, 2006, PLOS COMPUT BIOL, V2, P36, DOI 10.1371/journal.pcbi.0020003; WAKEFIELD LM, 1987, J CELL BIOL, V105, P965, DOI 10.1083/jcb.105.2.965; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Xu L, 2000, NAT CELL BIOL, V2, P559, DOI 10.1038/35019649; Zi Z, 2006, BIOINFORMATICS, V22, P2704, DOI 10.1093/bioinformatics/btl443	30	64	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e936	10.1371/journal.pone.0000936	http://dx.doi.org/10.1371/journal.pone.0000936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895977	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455800015
J	McDevitt, MR; Chattopadhyay, D; Jaggi, JS; Finn, RD; Zanzonico, PB; Villa, C; Rey, D; Mendenhall, J; Batt, CA; Njardarson, JT; Scheinberg, DA				McDevitt, Michael R.; Chattopadhyay, Debjit; Jaggi, Jaspreet S.; Finn, Ronald D.; Zanzonico, Pat B.; Villa, Carlos; Rey, Diego; Mendenhall, Juana; Batt, Carl A.; Njardarson, Jon T.; Scheinberg, David A.			PET Imaging of Soluble Yttrium-86-Labeled Carbon Nanotubes in Mice	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; IN-VIVO; BIODISTRIBUTION; PURIFICATION; CARCINOMA; CLEARANCE; IN-111	Background. The potential medical applications of nanomaterials are shaping the landscape of the nanobiotechnology field and driving it forward. A key factor in determining the suitability of these nanomaterials must be how they interface with biological systems. Single walled carbon nanotubes (CNT) are being investigated as platforms for the delivery of biological, radiological, and chemical payloads to target tissues. CNT are mechanically robust graphene cylinders comprised of sp(2)-bonded carbon atoms and possessing highly regular structures with defined periodicity. CNT exhibit unique mechanochemical properties that can be exploited for the development of novel drug delivery platforms. In order to evaluate the potential usefulness of this CNT scaffold, we undertook an imaging study to determine the tissue biodistribution and pharmacokinetics of prototypical DOTA-functionalized CNT labeled with yttrium-86 and indium-111 (Y-86-CNT and In-111-CNT, respectively) in a mouse model. Methodology and Principal Findings. The Y-86-CNT construct was synthesized from amine-functionalized, water-soluble CNT by covalently attaching multiple copies of DOTA chelates and then radiolabeling with the positron-emitting metal-ion, yttrium-86. A gamma-emitting In-111-CNT construct was similarly prepared and purified. The constructs were characterized spectroscopically, microscopically, and chromatographically. The whole-body distribution and clearance of yttrium-86 was characterized at 3 and 24 hours post-injection using positron emission tomography (PET). The yttrium-86 cleared the blood within 3 hours and distributed predominantly to the kidneys, liver, spleen and bone. Although the activity that accumulated in the kidney cleared with time, the whole-body clearance was slow. Differential uptake in these target tissues was observed following intraveneous or intraperitoneal injection. Conclusions. The whole-body PET images indicated that the major sites of accumulation of activity resulting from the administration of Y-86-CNT were the kidney, liver, spleen, and to a much less extent the bone. Blood clearance was rapid and could be beneficial in the use of short-lived radionuclides in diagnostic applications.	[McDevitt, Michael R.; Chattopadhyay, Debjit; Jaggi, Jaspreet S.; Finn, Ronald D.; Zanzonico, Pat B.; Villa, Carlos; Scheinberg, David A.] Mem Sloan Kettering Canc Ctr, Dept Med, Mol Pharmacol & Chem Dept, New York, NY 10021 USA; [McDevitt, Michael R.; Chattopadhyay, Debjit; Jaggi, Jaspreet S.; Finn, Ronald D.; Zanzonico, Pat B.; Villa, Carlos; Scheinberg, David A.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [McDevitt, Michael R.; Chattopadhyay, Debjit; Jaggi, Jaspreet S.; Finn, Ronald D.; Zanzonico, Pat B.; Villa, Carlos; Scheinberg, David A.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Rey, Diego] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Mendenhall, Juana; Batt, Carl A.] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Njardarson, Jon T.] Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University	McDevitt, MR (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Mol Pharmacol & Chem Dept, 1275 York Ave, New York, NY 10021 USA.	m-mcdevitt@ski.mskcc.org; d-scheinberg@mskcc.org			NIH [CA55349, CA33049, 1R24CA83084]; Tudor and Glades Foundation; Commonwealth Cancer Foundation for Research; Experimental Therapeutics Center; Cornell University/Ludwig Institute for Cancer Research; Laurie Strauss Foundation; NATIONAL CANCER INSTITUTE [R01CA055349, R24CA083084, P01CA033049, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tudor and Glades Foundation; Commonwealth Cancer Foundation for Research; Experimental Therapeutics Center; Cornell University/Ludwig Institute for Cancer Research; Laurie Strauss Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The support of NIH CA55349, CA33049, 1R24CA83084, the Tudor and Glades Foundation, the Commonwealth Cancer Foundation for Research, the Experimental Therapeutics Center, The Cornell University/Ludwig Institute for Cancer Research Partnership, and the Laurie Strauss Foundation for funding.	Arnold K, 2006, PHYS STATUS SOLIDI B, V243, P3073, DOI 10.1002/pssb.200669196; Brouwers AH, 2004, J NUCL MED, V45, P327; BullardDillard R, 1996, BIOORG CHEM, V24, P376, DOI 10.1006/bioo.1996.0032; Cagle DW, 1999, P NATL ACAD SCI USA, V96, P5182, DOI 10.1073/pnas.96.9.5182; Cherukuri P, 2004, J AM CHEM SOC, V126, P15638, DOI 10.1021/ja0466311; Cherukuri P, 2006, P NATL ACAD SCI USA, V103, P18882, DOI 10.1073/pnas.0609265103; Dadachova E, 1999, NUCL MED BIOL, V26, P977, DOI 10.1016/S0969-8051(99)00054-2; Dresselhaus MS, 2001, TOP APPL PHYS, V80, P1; ESTEBAN JM, 1987, J NUCL MED, V28, P861; Finn RD, 1999, AIP CONF PROC, V475, P991; Georgakilas V, 2002, CHEM COMMUN, P3050, DOI 10.1039/b209843a; Hu H, 2003, J PHYS CHEM B, V107, P13838, DOI 10.1021/jp035719i; Huang WJ, 2002, NANO LETT, V2, P231, DOI [10.1021/nl010083x, 10.1021/n1010083x]; Itkis ME, 2005, J AM CHEM SOC, V127, P3439, DOI 10.1021/ja043061w; Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; Lin Y, 2005, J PHYS CHEM B, V109, P14779, DOI 10.1021/jp053073j; Lovqvist A, 2001, J NUCL MED, V42, P1281; LUI Z, 2007, NATURE NANOTECH, V2, P47; McDevitt MR, 2007, J NUCL MED, V48, P1180, DOI 10.2967/jnumed.106.039131; McDevitt MR, 2001, SCIENCE, V294, P1537, DOI 10.1126/science.1064126; MOFFAT DB, 1981, J CLIN PATHOL, V34, P1197, DOI 10.1136/jcp.34.11.1197; Ohlson M, 2001, AM J PHYSIOL-RENAL, V281, pF103, DOI 10.1152/ajprenal.2001.281.1.F103; Panhuis MIH, 2003, CHEM BIOL, V10, P897, DOI 10.1016/j.chembiol.2003.10.005; Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c; Pantarotto D, 2003, J AM CHEM SOC, V125, P6160, DOI 10.1021/ja034342r; RUEGG CL, 1990, CANCER RES, V50, P4221; SARIN VK, 1981, ANAL BIOCHEM, V117, P147, DOI 10.1016/0003-2697(81)90704-1; Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103; von Schulthess GK, 2006, RADIOLOGY, V238, P405, DOI 10.1148/radiol.2382041977; Wang HF, 2004, J NANOSCI NANOTECHNO, V4, P1019, DOI 10.1166/jnn.2004.146; Yu ZH, 2001, J PHYS CHEM B, V105, P1123, DOI 10.1021/jp003081u; Zhao B, 2001, J AM CHEM SOC, V123, P11673, DOI 10.1021/ja010488j	33	143	149	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e907	10.1371/journal.pone.0000907	http://dx.doi.org/10.1371/journal.pone.0000907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878942	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455700015
J	Proulx, SR; Nuzhdin, S; Promislow, DEL				Proulx, Stephen R.; Nuzhdin, Sergey; Promislow, Daniel E. L.			Direct Selection on Genetic Robustness Revealed in the Yeast Transcriptome	PLOS ONE			English	Article								Background. Evolutionary theory predicts that organisms should evolve the ability to produce high fitness phenotypes in the face of environmental disturbances (environmental robustness) or genetic mutations (genetic robustness). While several studies have uncovered mechanisms that lead to both environmental and genetic robustness, we have yet to understand why some components of the genome are more robust than others. According to evolutionary theory, environmental and genetic robustness will have different responses to selective forces. Selection on environmental robustness for a trait is expected to be strong and related to the fitness costs of altering that trait. In contrast to environmental robustness, selection on genetic robustness for a trait is expected to be largely independent of the fitness cost of altering the trait and instead should correlate with the standing genetic variation for the trait that can potentially be buffered. Several mechanisms that provide both environmental and genetic robustness have been described, and this correlation could be explained by direct selection on both forms of robustness (direct selection hypothesis), or through selection on environmental robustness and a correlated response in genetic robustness (congruence hypothesis). Methodology/Principal Findings. Using both published and novel data on gene expression in the yeast Saccharomyces cerevisiae, we find that genetic robustness is correlated with environmental robustness across the yeast genome as predicted by the congruence hypothesis. However, we also show that environmental robustness, but not genetic robustness, is related to per-gene fitness effects. In contrast, genetic robustness is significantly correlated with network position, suggesting that genetic robustness has been under direct selection. Conclusions/Significance. We observed a significant correlation between our measures of genetic and environmental robustness, in agreement with the congruence hypothesis. However, this correlation alone cannot explain the co-variance of genetic robustness with position in the protein interaction network. We therefore conclude that direct selection on robustness has played a role in the evolution of genetic robustness in the transcriptome.	[Proulx, Stephen R.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Nuzhdin, Sergey] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; [Nuzhdin, Sergey] Univ So Calif, Los Angeles, CA USA; [Promislow, Daniel E. L.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	Iowa State University; University of California System; University of California Davis; University of Southern California; University System of Georgia; University of Georgia	Proulx, SR (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	proulx@iastate.edu	Proulx, Stephen R/A-8160-2008; Proulx, Stephen/C-9213-2009	Proulx, Stephen/0000-0003-0307-1907; Promislow, Daniel/0000-0001-7088-4495	Ellison Medical Foundation; NIH [5R01GM076643]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076643] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DP is funded by a Senior Scholar award from the Ellison Medical Foundation. SN was funded by NIH grant 5R01GM076643.	Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r23; Burch CL, 2004, GENETICS, V167, P559, DOI 10.1534/genetics.103.021196; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; De Nooy W., 2005, EXPLORATORY SOCIAL N; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; DEMPSTER ER, 1955, COLD SPRING HARB SYM, V20, P25, DOI 10.1101/SQB.1955.020.01.005; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GAVRILETS S, 1994, EVOLUTION, V48, P1478, DOI [10.2307/2410242, 10.1111/j.1558-5646.1994.tb02190.x]; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Guldener U, 2005, NUCLEIC ACIDS RES, V33, pD364, DOI 10.1093/nar/gki053; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Hansen TF, 2006, EVOLUTION, V60, P1523; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Kawecki TJ, 2000, EVOLUTION, V54, P1, DOI 10.1111/j.0014-3820.2000.tb00001.x; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; LEVINS R, 1966, AM NAT, V100, P585, DOI 10.1086/282452; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Promislow D, 2005, AM NAT, V165, P515, DOI 10.1086/429161; Proulx SR, 2005, AM NAT, V165, P147, DOI 10.1086/426873; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Rice SH, 1998, EVOLUTION, V52, P647, DOI 10.1111/j.1558-5646.1998.tb03690.x; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; SCHMALHAUSEN H, 1949, FACTORS EVOLUTION; STEARNS SC, 1994, EVOLUTION, V48, P1438, DOI 10.1111/j.1558-5646.1994.tb02186.x; STEARNS SC, 1995, J EVOLUTION BIOL, V8, P539, DOI 10.1046/j.1420-9101.1995.8050539.x; Stearns SC, 2002, P NATL ACAD SCI USA, V99, P10229, DOI 10.1073/pnas.172388999; Steppan SJ, 2002, TRENDS ECOL EVOL, V17, P320, DOI 10.1016/S0169-5347(02)02505-3; THODAY JM, 1953, SYM SOC EXP BIOL, V7, P96; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; WADDINGTON C, 1961, ADV GENET, V10, P257, DOI 10.1016/S0065-2660(08)60119-4; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner A, 1999, J EXP ZOOL, V285, P119; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]	49	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e911	10.1371/journal.pone.0000911	http://dx.doi.org/10.1371/journal.pone.0000911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878946	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455700019
J	Chan, CHF; Camacho-Leal, P; Stanners, CP				Chan, Carlos H. F.; Camacho-Leal, Pilar; Stanners, Clifford P.			Colorectal Hyperplasia and Dysplasia Due to Human Carcinoembryonic Antigen (CEA) Family Member Expression in Transgenic Mice	PLOS ONE			English	Article							HUMAN TUMOR-MARKER; CELL-ADHESION; CANCER CELLS; INTEGRIN; COLON; CEACAM6; DIFFERENTIATION; MODEL; APOPTOSIS; POLYPS	CEA and CEACAM6 are immunoglobulin family intercellular adhesion molecules that are up-regulated without structural mutations in approximately 70% of human cancers. Results in in vitro systems showing tumorigenic effects for these molecules suggest that this correlation could indicate an instrumental role in tumorigenesis. To test whether this applies in vivo, transgenic mice harboring 187 kb of the human genome containing four CEA family member genes including the CEA and CEACAM6 genes were created and their copy numbers increased by mating until colonocyte expression levels reached levels seen in human colorectal carcinomas. The colonocyte surface level of integrin alpha 5 and the activation of AKT increased progressively with the expression levels of CEA/CEACAM6. Colonic crypts showed a progressive increase in colonocyte proliferation, an increase in crypt fission, and a strong inhibition of both differentiation and anoikis/apoptosis. All transgenic mice showed massively enlarged colons comprising a continuous mosaic of severe hyperplasia, dysplasia and serrated adenomatous morphology. These results suggest that up-regulated non-mutated adhesion molecules could have a significant instrumental role in human cancer.	[Chan, Carlos H. F.; Camacho-Leal, Pilar; Stanners, Clifford P.] McGill Univ, Dept Biochem, McGill Canc Ctr, Montreal, PQ, Canada	McGill University	Chan, CHF (corresponding author), McGill Univ, Dept Biochem, McGill Canc Ctr, Montreal, PQ, Canada.	carlos.chan@mcgill.ca; cliff.stanners@mcgill.ca		Chan, Carlos HF/0000-0003-3656-2470	National Cancer Institute of Canada; Canadian Cancer Society; Canadian Institutes of Health Research; National Science Council (CONACYT) of Mexico	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Council (CONACYT) of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)Ministry of Science and Technology, Taiwan)	Funding: This work was supported by grants from the National Cancer Institute of Canada with funds from the Canadian Cancer Society, and by the Canadian Institutes of Health Research. CHFC was supported by a MD/PhD studentship from the Canadian Institutes of Health Research. PC was supported by a studentship from the National Science Council (CONACYT) of Mexico.	ALLARD WJ, 1994, CANCER RES, V54, P1227; Baker K, 2004, J CLIN PATHOL, V57, P1089, DOI 10.1136/jcp.2004.016600; BALLESTA AM, 1995, TUMOR BIOL, V16, P32, DOI 10.1159/000217926; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Camacho-Leal P, 2007, J CELL PHYSIOL, V211, P791, DOI 10.1002/jcp.20989; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chan CHF, 2006, CARCINOGENESIS, V27, P1909, DOI 10.1093/carcin/bgl040; Chan CHF, 2004, MOL THER, V9, P775, DOI 10.1016/j.ymthe.2004.03.009; CHEVINSKY AH, 1991, SEMIN SURG ONCOL, V7, P162, DOI 10.1002/ssu.2980070309; Clarke P, 1998, CANCER RES, V58, P1469; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Duxbury MS, 2004, ANN SURG, V240, P667, DOI 10.1097/01.sla.0000140755.97224.9a; Duxbury MS, 2004, CANCER RES, V64, P3987, DOI 10.1158/0008-5472.CAN-04-0424; Duxbury MS, 2004, BIOCHEM BIOPH RES CO, V317, P133, DOI 10.1016/j.bbrc.2004.03.018; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; EADESPERNER AM, 1994, CANCER RES, V54, P4169; EIDELMAN FJ, 1993, J CELL BIOL, V123, P467, DOI 10.1083/jcb.123.2.467; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Goldstein NS, 2006, AM J CLIN PATHOL, V125, P146, DOI 10.1309/87BD0C6UCGUG126J; Grossmann J, 2001, CELL GROWTH DIFFER, V12, P147; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hammarstrom S, 1998, CELL ADHES COMMUN S, V5, P1; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ilantzis C, 1997, LAB INVEST, V76, P703; Ilantzis C, 2002, NEOPLASIA, V4, P151, DOI 10.1038/sj.neo.7900201; Jantscheff P, 2003, J CLIN ONCOL, V21, P3638, DOI 10.1200/JCO.2003.55.135; Jass JR, 2002, GASTROENTEROLOGY, V123, P862, DOI 10.1053/gast.2002.35392; JASS JR, 1984, CANCER-AM CANCER SOC, V53, P510, DOI 10.1002/1097-0142(19840201)53:3<510::AID-CNCR2820530324>3.0.CO;2-O; Jones SM, 2006, NAT REV CANCER, V6, P175, DOI 10.1038/nrc1817; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Leconte A, 1999, BRIT J CANCER, V80, P1373, DOI 10.1038/sj.bjc.6690531; LYNCH MJ, 1969, MED LAB TECHNOLOGY C; Mandir N, 2005, INT J EXP PATHOL, V86, P125, DOI 10.1111/j.0959-9673.2005.00422.x; Maxwell P, 1999, BRIT J BIOMED SCI, V56, P209; Nicholson TB, 2006, J CELL BIOL, V175, P647, DOI 10.1083/jcb.200605001; Ordonez C, 2000, CANCER RES, V60, P3419; Ordonez C, 2007, J CELL PHYSIOL, V210, P757, DOI 10.1002/jcp.20887; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; PRETLOW TP, 1994, GASTROENTEROLOGY, V107, P1719, DOI 10.1016/0016-5085(94)90812-5; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; RIJKERS T, 1994, TRANSGENIC RES, V3, P203, DOI 10.1007/BF02336773; Rojas M, 1996, CELL GROWTH DIFFER, V7, P655; Schoenthaler SJ, 2000, J ALTERN COMPLEM MED, V6, P7, DOI 10.1089/acm.2000.6.7; Screaton RA, 1997, J CELL BIOL, V137, P939, DOI 10.1083/jcb.137.4.939; Screaton RA, 2000, J CELL BIOL, V150, P613, DOI 10.1083/jcb.150.3.613; Soeth E, 2001, CLIN CANCER RES, V7, P2022; SPECTOR DL, 1998, CELL LAB MANUAL; Stanners CP, 1998, CELL ADHES COMMUN S, V5, P141; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Taheri M, 2003, J BIOL CHEM, V278, P14632, DOI 10.1074/jbc.M212500200; Thompson JA, 1997, INT J CANCER, V72, P197, DOI 10.1002/(SICI)1097-0215(19970703)72:1<197::AID-IJC28>3.0.CO;2-F; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wirth T, 2002, CLIN EXP METASTAS, V19, P155, DOI 10.1023/A:1014566127493; ZHOU H, 1993, CANCER RES, V53, P3817; Zimmermann W, 1998, CELL ADHES COMMUN S, V5, P31	57	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1353	10.1371/journal.pone.0001353	http://dx.doi.org/10.1371/journal.pone.0001353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159236	Green Submitted, gold, Green Published			2022-12-27	WOS:000207459700010
J	Bauer, JA; Lupica, JA; Schmidt, H; Morrison, BH; Haney, RM; Masci, RK; Lee, RM; DiDonato, JA; Lindner, DJ				Bauer, Joseph A.; Lupica, Joseph A.; Schmidt, Heidi; Morrison, Bei H.; Haney, Rebecca M.; Masci, Rhonda K.; Lee, Rebecca M.; DiDonato, Joseph A.; Lindner, Daniel J.			Nitrosylcobalamin Potentiates the Anti-Neoplastic Effects of Chemotherapeutic Agents via Suppression of Survival Signaling	PLOS ONE			English	Article							NF-KAPPA-B; AKT/PROTEIN KINASE-B; NITRIC-OXIDE; TRANSCRIPTION FACTOR; INDUCED APOPTOSIS; CONSTITUTIVE ACTIVATION; ANTITUMOR-ACTIVITY; RELA/P65 SUBUNIT; S-NITROSYLATION; DNA-BINDING	Background. Nitrosylcobalamin (NO-Cbl) is a chemotherapeutic pro-drug derived from vitamin B12 that preferentially delivers nitric oxide (NO) to tumor cells, based upon increased receptor expression. NO-Cbl induces Apo2L/TRAIL-mediated apoptosis and inhibits survival signaling in a variety of malignant cell lines. Chemotherapeutic agents often simultaneously induce an apoptotic signal and activation of NF-kappa B, which has the undesired effect of promoting cell survival. The specific aims of this study were to 1) measure the anti-tumor effects of NO-Cbl alone and in combination with conventional chemotherapeutic agents, and to 2) examine the mechanism of action of NO-Cbl as a single agent and in combination therapy. Methodology. Using anti-proliferative assays, electrophoretic mobility shift assay (EMSA), immunoblot analysis and kinase assays, we demonstrate an increase in the effectiveness of chemotherapeutic agents in combination with NO-Cbl as a result of suppressed NF-kappa B activation. Results. Eighteen chemotherapeutic agents were tested in combination with NOCbl, in thirteen malignant cell lines, resulting in a synergistic anti-proliferative effect in 78% of the combinations tested. NO-Cbl pre-treatment resulted in decreased NF-kappa B DNA binding activity, inhibition of I kappa B kinase (IKK) enzymatic activity, decreased AKT activation, increased caspase-8 and PARP cleavage, and decreased cellular XIAP protein levels. Conclusion. The use of NO-Cbl to inhibit survival signaling may enhance drug efficacy by preventing concomitant activation of NF-kappa B or AKT.	[Bauer, Joseph A.; Schmidt, Heidi; Morrison, Bei H.; Haney, Rebecca M.; Masci, Rhonda K.; Lee, Rebecca M.; Lindner, Daniel J.] Cleveland Clin Fdn, Ctr Hematol & Oncol Mol Therapeut, Taussig Canc Ctr, Cleveland, OH 44195 USA; [Lupica, Joseph A.; DiDonato, Joseph A.] Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Lupica, Joseph A.] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Lindner, Daniel J.] Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation	Bauer, JA (corresponding author), Cleveland Clin Fdn, Ctr Hematol & Oncol Mol Therapeut, Taussig Canc Ctr, 9500 Euclid Ave, Cleveland, OH 44195 USA.	bauerj@ccf.org; lindned@ccf.org	Hazen, Stanley L/ABD-5845-2021; Lindner, Daniel/ABB-5440-2020	Lupica, Joseph/0000-0003-1476-037X; Bauer, Joseph/0000-0003-4972-6008	Public Health Service [CA095020]; National Cancer Institute [CA84406]; NATIONAL CANCER INSTITUTE [R01CA084406, R01CA095020] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was supported by Public Health Service grant CA095020 to D.J.L. and CA84406 to J.A.D. from the National Cancer Institute and gifts from the Mareb Foundation, the Reuter Foundation, and the Charles R. Jelm Foundation to J.A.B.	Arlt A, 2001, ONCOGENE, V20, P859, DOI 10.1038/sj.onc.1204168; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bauer JA, 1998, ANTI-CANCER DRUG, V9, P239, DOI 10.1097/00001813-199803000-00006; Bauer JA, 2002, J NATL CANCER I, V94, P1010; Bava SV, 2005, J BIOL CHEM, V280, P6301, DOI 10.1074/jbc.M410647200; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; Buchholz TA, 2005, CLIN CANCER RES, V11, P8398, DOI 10.1158/1078-0432.CCR-05-0885; Chawla-Sarkar M, 2003, J BIOL CHEM, V278, P39461, DOI 10.1074/jbc.M306111200; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Collins DA, 1997, J NUCL MED, V38, P717; Collins DA, 2000, MAYO CLIN PROC, V75, P568, DOI 10.4065/75.6.568; COOPERMAN JM, 1960, J BIOL CHEM, V235, P191; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Das KC, 1997, J BIOL CHEM, V272, P14914, DOI 10.1074/jbc.272.23.14914; DelaTorre A, 1997, BIOCHEM BIOPH RES CO, V238, P703, DOI 10.1006/bbrc.1997.7279; Dhawan P, 2002, CANCER RES, V62, P7335; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; DiDonato JA, 2000, METHOD ENZYMOL, V322, P393; Dong QG, 2002, ONCOGENE, V21, P6510, DOI 10.1038/sj.onc.1205848; Fahy BN, 2004, J AM COLL SURGEONS, V198, P591, DOI 10.1016/j.jamcollsurg.2003.12.005; FLODH H, 1968, INT J CANCER, V3, P694, DOI 10.1002/ijc.2910030518; Gasparian AV, 2002, J CELL SCI, V115, P141; Hochwald SN, 2003, AM SURGEON, V69, P15; Huang Y, 2002, MOL PHARMACOL, V61, P105, DOI 10.1124/mol.61.1.105; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Khwaja A, 1999, NATURE, V401, P33, DOI 10.1038/43354; Kim D, 2002, J BIOCHEM MOL BIOL, V35, P106; Kim SH, 2007, ANN NY ACAD SCI, V1095, P82, DOI 10.1196/annals.1397.012; Kroncke KD, 2000, FASEB J, V14, P166; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; Mabuchi S, 2004, CLIN CANCER RES, V10, P7645, DOI 10.1158/1078-0432.CCR-04-0958; Mabuchi S, 2004, J BIOL CHEM, V279, P23477, DOI 10.1074/jbc.M313709200; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Manderscheid M, 2001, J AM SOC NEPHROL, V12, P1151, DOI 10.1681/ASN.V1261151; Mannick JB, 2004, FREE RADICAL RES, V38, P1, DOI 10.1080/10715760310001629065; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Mocellin S, 2007, MED RES REV, V27, P317, DOI 10.1002/med.20092; Murphy MP, 1999, BBA-BIOENERGETICS, V1411, P401, DOI 10.1016/S0005-2728(99)00029-8; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Ozes ON, 1999, NATURE, V401, P82; Park SW, 2005, MOL CELL PROTEOMICS, V4, P300, DOI 10.1074/mcp.M400195-MCP200; Ray A, 2007, CELL MOL BIOL, V53, P3, DOI 10.1170/T771; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Seetharam B, 2000, Vitam Horm, V59, P337, DOI 10.1016/S0083-6729(00)59012-8; Seetharam B, 1999, J NUTR, V129, P1761, DOI 10.1093/jn/129.10.1761; Sharma V, 2007, CURR MED CHEM, V14, P1061, DOI 10.2174/092986707780362844; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Storling J, 2005, DIABETOLOGIA, V48, P2039, DOI 10.1007/s00125-005-1912-2; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Tang Z, 2006, MOL CELL BIOL, V26, P5588, DOI 10.1128/MCB.00199-06; Tergaonkar V, 2003, MOL CELL BIOL, V23, P8070, DOI 10.1128/MCB.23.22.8070-8083.2003; Uetsuka H, 2003, EXP CELL RES, V289, P27, DOI 10.1016/S0014-4827(03)00223-4; VOLK T, 1995, BIOCHEM BIOPH RES CO, V213, P196, DOI 10.1006/bbrc.1995.2116; Waldow T, 2006, NITRIC OXIDE-BIOL CH, V15, P103, DOI 10.1016/j.niox.2005.12.005; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Weldon CB, 2001, SURGERY, V130, P143, DOI 10.1067/msy.2001.115512; Wink DA, 1996, ARCH BIOCHEM BIOPHYS, V331, P241, DOI 10.1006/abbi.1996.0304; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Yeh PY, 2003, BIOCHEM PHARMACOL, V66, P25, DOI 10.1016/S0006-2952(03)00250-8; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200; Yuan ZQ, 2000, ONCOGENE, V19, P2324, DOI 10.1038/sj.onc.1203598; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	76	23	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1313	10.1371/journal.pone.0001313	http://dx.doi.org/10.1371/journal.pone.0001313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074035	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459500030
J	Francis, PJ; Schultz, DW; Hamon, S; Ott, J; Weleber, RG; Klein, ML				Francis, Peter J.; Schultz, Dennis W.; Hamon, Sara; Ott, Jurg; Weleber, Richard G.; Klein, Michael L.			Haplotypes in the Complement Factor H (CFH) Gene: Associations with Drusen and Advanced Age-Related Macular Degeneration	PLOS ONE			English	Article								Background. Age-related macular degeneration (AMD), the leading cause of blindness in the Western world, is a complex disease that affects people over 50 years old. The complement factor H (CFH) gene has been repeatedly shown to be a major factor in determining susceptibility to the advanced form of the condition. We aimed to better understand the functional role of this gene in the AMD disease process and assess whether it is associated with earlier forms of the disease. Methodology/Principal Findings. We genotyped SNPs at the CFH gene locus in three independent populations with AMD: (a) extended families where at least 3 family members had AMD; (b) sporadic cases of advanced AMD and (c) cases from the Age-Related Eye Disease Study (AREDS). We investigated polymorphisms and haplotypes in and around the CFH gene to assess their role in AMD. CFH is associated with early/intermediate and advanced AMD in both familial and sporadic cases. In our populations, the CFH SNP, rs2274700, is most strongly associated with AMD and when incorporated into a haplotype with the Y402H SNP and rs1061147, the strongest association is observed (p < 10(-9)). Conclusions/Significance. Our results, reproduced in three populations that represent the spectrum of AMD cases, provide evidence that the CFH gene is associated with drusen as well as with advanced AMD. We also identified novel susceptibility and protective haplotypes in the AMD populations.	[Francis, Peter J.; Schultz, Dennis W.; Weleber, Richard G.; Klein, Michael L.] Oregon Hlth & Sci Univ, Casey Eye Inst, Macular Degenerat Ctr, Portland, OR 97201 USA; [Hamon, Sara; Ott, Jurg] Rockefeller Univ, New York, NY 10021 USA	Oregon Health & Science University; Rockefeller University	Francis, PJ (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Macular Degenerat Ctr, Portland, OR 97201 USA.	francisp@ohsu.edu			National Institutes of Health (NIH) National Eye Institute [R01-EY12203]; Foundation Fighting Blindness, Owing Mills, Md; Macular Vision Research Foundation; Macular Degeneration Center Research Fund, Casey Eye Institute, Portland, Oregon Health & Science University; Research to Prevent Blindness, New York, NY; PHS [5 M01 RR000334]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000334] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012203] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness, Owing Mills, Md; Macular Vision Research Foundation; Macular Degeneration Center Research Fund, Casey Eye Institute, Portland, Oregon Health & Science University; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by grants from the National Institutes of Health (NIH) National Eye Institute R01-EY12203 (MK); the Foundation Fighting Blindness, Owing Mills, Md (PF, RGW, DWS); the Macular Vision Research Foundation (DWS); the Macular Degeneration Center Research Fund, Casey Eye Institute, Portland, Oregon Health & Science University (MK), and Research to Prevent Blindness, New York, NY (unrestricted grant to Casey Eye Institute, Career Development Award to PF). Support was also provided by PHS Grant 5 M01 RR000334 (JO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Barral S, 2006, INVEST OPHTH VIS SCI, V47, P5453, DOI 10.1167/iovs.06-0655; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kassoff A, 1999, CONTROL CLIN TRIALS, V20, P573; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Schultz Dennis W, 2005, Ophthalmic Genet, V26, P101, DOI 10.1080/13816810590968023; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154	27	71	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1197	10.1371/journal.pone.0001197	http://dx.doi.org/10.1371/journal.pone.0001197			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043728	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459300002
J	Ferquel, E; de Haro, L; Jan, V; Guillemin, I; Jourdain, S; Teynie, A; d'Alayer, J; Choumet, V				Ferquel, Elisabeth; de Haro, Luc; Jan, Virginie; Guillemin, Isabelle; Jourdain, Sabine; Teynie, Alexandre; d'Alayer, Jacques; Choumet, Valerie			Reappraisal of Vipera aspis Venom Neurotoxicity	PLOS ONE			English	Article								Background. The variation of venom composition with geography is an important aspect of intraspecific variability in the Vipera genus, although causes of this variability remain unclear. The diversity of snake venom is important both for our understanding of venomous snake evolution and for the preparation of relevant antivenoms to treat envenomations. A geographic intraspecific variation in snake venom composition was recently reported for Vipera aspis aspis venom in France. Since 1992, cases of human envenomation after Vipera aspis aspis bites in south-east France involving unexpected neurological signs were regularly reported. The presence of genes encoding PLA(2) neurotoxins in the Vaa snake genome led us to investigate any neurological symptom associated with snake bites in other regions of France and in neighboring countries. In parallel, we used several approaches to characterize the venom PLA(2) composition of the snakes captured in the same areas. Methodology/Principal Findings. We conducted an epidemiological survey of snake bites in various regions of France. In parallel, we carried out the analysis of the genes and the transcripts encoding venom PLA(2)s. We used SELDI technology to study the diversity of PLA(2) in various venom samples. Neurological signs (mainly cranial nerve disturbances) were reported after snake bites in three regions of France: Languedoc-Roussillon, Midi-Pyrenees and Provence-Alpes-Cote d'Azur. Genomes of Vipera aspis snakes from south-east France were shown to contain ammodytoxin isoforms never described in the genome of Vipera aspis from other French regions. Surprisingly, transcripts encoding venom neurotoxic PLA(2)s were found in snakes of Massif Central region. Accordingly, SELDI analysis of PLA(2) venom composition confirmed the existence of population of neurotoxic Vipera aspis snakes in the west part of the Massif Central mountains. Conclusions/Significance. The association of epidemiological studies to genetic, biochemical and immunochemical analyses of snake venoms allowed a good evaluation of the potential neurotoxicity of snake bites. A correlation was found between the expression of neurological symptoms in humans and the intensity of the cross-reaction of venoms with anti-ammodytoxin antibodies, which is correlated with the level of neurotoxin (vaspin and/or ammodytoxin) expression in the venom. The origin of the two recently identified neurotoxic snake populations is discussed according to venom PLA(2) genome and transcriptome data.	[Ferquel, Elisabeth; Jan, Virginie; Guillemin, Isabelle; Choumet, Valerie] Inst Pasteur, Unite Venins, Paris, France; [de Haro, Luc] Hop Salvator, Ctr Antipoison, Marseille, France; [Jourdain, Sabine] Ciphergen, Paris, France; [Teynie, Alexandre] Ctr Rech Theix, UENC INRA, St Genes Champanelle, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Aix-Marseille Universite; INRAE	Choumet, V (corresponding author), Unite Biochim & Biol Mol Insectes, Paris, France.	vchoumet@pasteur.fr	de Haro, Luc/AAT-2911-2020	de Haro, Luc/0000-0003-2250-6312	Institut Pasteur ( Programmes Transversaux de Recherche)	Institut Pasteur ( Programmes Transversaux de Recherche)	Financial support was provided by Institut Pasteur ( Programmes Transversaux de Recherche).	AUDEBERT F, 1992, TOXICON, V30, P599, DOI 10.1016/0041-0101(92)90854-X; Banumathi S, 2001, ACTA CRYSTALLOGR D, V57, P1552, DOI 10.1107/S0907444901013543; BEAR PM, 1990, PROPOS MORSURES VIPE; Beer E, 1998, TOXICON, V36, P697, DOI 10.1016/S0041-0101(97)00168-2; Beer E, 1998, TOXICON, V36, P729, DOI 10.1016/S0041-0101(97)00138-4; Carlsson M, 2004, MOL ECOL, V13, P3147, DOI 10.1111/j.1365-294X.2004.02315.x; CHABERT JM, 1977, LYON MEDITERRANCE ME, V4, P259; CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9; Chippaux JP, 1998, TOXICON, V36, P823, DOI 10.1016/S0041-0101(97)00160-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; CHOUMET V, 1991, TOXICON, V29, P441, DOI 10.1016/0041-0101(91)90018-M; Creer S, 2003, J MOL EVOL, V56, P317, DOI 10.1007/s00239-002-2403-4; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; Daltry JC, 1996, TOXICON, V34, P67, DOI 10.1016/0041-0101(95)00122-0; de Haro L, 2002, HUM EXP TOXICOL, V21, P137, DOI 10.1191/0960327102ht226oa; de Haro L., 1994, REV PRATICIEN MED GE, V265, P20; DUGUY R, 1979, Bulletin de la Societe d'Histoire Naturelle de Toulouse, V115, P359; DUPUY F, 1975, ENVENIMATION VIPERIN; Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328; FRY BG, 2007, MOL CELL PROTEOMICS; Garrigues T, 2005, MOL PHYLOGENET EVOL, V35, P35, DOI 10.1016/j.ympev.2004.11.004; GLENN J L, 1978, Toxicon, V16, P81, DOI 10.1016/0041-0101(78)90065-X; Guillemin I, 2003, EUR J BIOCHEM, V270, P2697, DOI 10.1046/j.1432-1033.2003.03629.x; Ivanovski G, 2002, TOXICON, V40, P543, DOI 10.1016/S0041-0101(01)00250-1; Jakubowski JA, 2005, J EXP BIOL, V208, P2873, DOI 10.1242/jeb.01713; Jan V, 2002, FEBS LETT, V527, P263, DOI 10.1016/S0014-5793(02)03205-2; JAN VM, 2007, PHOSPHOLIPASE A2 DIV, DOI DOI 10.1016/J.TOXICON.2007.07.024; JOUGLARD J, 1970, J MED STRASBOURG ERE; Komori Y, 1996, ARCH BIOCHEM BIOPHYS, V327, P303, DOI 10.1006/abbi.1996.0126; Kordis D, 1997, EUR J BIOCHEM, V246, P772, DOI 10.1111/j.1432-1033.1997.00772.x; MANCHEVA I, 1984, H-S Z PHYSIOL CHEM, V365, P885, DOI 10.1515/bchm2.1984.365.2.885; MEBS D, 1984, TOXICON, V22, P831, DOI 10.1016/0041-0101(84)90170-3; Mukherjee AK, 1998, COMP BIOCHEM PHYS A, V119, P621, DOI 10.1016/S1095-6433(97)00475-3; Orsini P, 1998, PRESSE MED, V27, P1277; Perbandt M, 1997, FEBS LETT, V412, P573, DOI 10.1016/S0014-5793(97)00853-3; POZIO E, 1988, TROP MED PARASITOL, V39, P62; PUIG J, 1995, J SMALL ANIM PRACT, V36, P333, DOI 10.1111/j.1748-5827.1995.tb02942.x; Radonic V, 1997, MIL MED, V162, P179, DOI 10.1093/milmed/162.3.179; RADVANYI F, 1989, ANAL BIOCHEM, V177, P103, DOI 10.1016/0003-2697(89)90022-5; RIOUL P, 2001, EVALUATION UTILISATI; RITONJA A, 1985, BIOCHIM BIOPHYS ACTA, V828, P306, DOI 10.1016/0167-4838(85)90312-7; Saint Girons H., 1984, Bulletin de la Societe d'Histoire Naturelle de Toulouse, V119, P81; Sasa M, 1999, TOXICON, V37, P249, DOI 10.1016/S0041-0101(98)00121-4; Seiberras S, 2002, PRESSE MED, V31, P262; Shashidharamurthy R, 2002, MOL CELL BIOCHEM, V229, P93, DOI 10.1023/A:1017972511272; Stoebner PE, 2001, PRESSE MED, V30, P220; Thomas L, 2006, TOXICON, V48, P23, DOI 10.1016/j.toxicon.2006.04.007; Ursenbacher S, 2006, MOL PHYLOGENET EVOL, V38, P546, DOI 10.1016/j.ympev.2005.08.004; VORDERWU L, 2005, NATURE METHODS, V2, P393; WATT G, 1986, NEW ENGL J MED, V315, P1444, DOI 10.1056/NEJM198612043152303; ZECCHINI B, 1992, SERPENTS FRANCE SYST	51	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1194	10.1371/journal.pone.0001194	http://dx.doi.org/10.1371/journal.pone.0001194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030329	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459200008
J	Shamaei-Tousi, A; D'Aiuto, F; Nibali, L; Steptoe, A; Coates, ARM; Parkar, M; Donos, N; Henderson, B				Shamaei-Tousi, Alireza; D'Aiuto, Francesco; Nibali, Luigi; Steptoe, Andrew; Coates, Anthony R. M.; Parkar, Mohamed; Donos, Nikos; Henderson, Brian			Differential Regulation of Circulating Levels of Molecular Chaperones in Patients Undergoing Treatment for Periodontal Disease	PLOS ONE			English	Article								Background. Evidence is emerging that molecular chaperones, in addition to their intracellular protein folding actions, can act as intercellular signaling proteins with an ability to modulate leukocyte function. Recent evidence has also shown that these proteins can exist in the circulation and may be involved in disease pathogenesis. We have used periodontitis and its treatment as a model of inflammation in the human to determine its effects on levels of circulating HSP10, HSP60 and BiP. Methodology/Principal Findings. A group of periodontal patients and matched controls were examined at the beginning of the study and then at 1 day and 6 months following periodontal or control therapy. Plasma levels of HSP10, HSP60 and BiP were measured by immunoassay and related to other plasma measures of inflammation. Periodontal patients had significantly less circulating levels of HSP10 or BiP compared with the controls. In contrast, more periodontal patients had intermediate levels of HSP60. Treatment of the periodontitis caused an increase in plasma levels of HSP10 although it had no effect on BiP. Treatment had no influence of HSP60 levels. Plasma HSP10 levels after therapy correlated with markers of periodontal clinical improvement. Conclusions/Significance. Circulating levels of molecular chaperones are influenced by local inflammation. HSP10 is known to be an anti-inflammatory factor. The marked decrease of this circulating protein in active inflammation and its recovery post-treatment suggests that it may have a role in controlling periodontal inflammation.	[Shamaei-Tousi, Alireza; Henderson, Brian] UCL, UCL Eastman Dent Inst, Div Microbial Dis, London, England; [Shamaei-Tousi, Alireza; Coates, Anthony R. M.] Univ London St Georges Hosp, Sch Med, London SW17 0RE, England; [D'Aiuto, Francesco; Nibali, Luigi; Parkar, Mohamed; Donos, Nikos] UCL, UCL Eastman Dent Inst & Hosp, Periodontol Unit, London, England; [Steptoe, Andrew] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London; St Georges University London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Shamaei-Tousi, A (corresponding author), UCL, UCL Eastman Dent Inst, Div Microbial Dis, London, England.	ashamaei@sgul.ac.uk	Steptoe, Andrew/Y-2440-2019	Coates, Anthony/0000-0001-8052-3175; Steptoe, Andrew/0000-0001-7808-4943	British Heart Foundation [PG/03/029]; ARMC	British Heart Foundation(British Heart Foundation); ARMC	We are grateful to the British Heart Foundation ( grant PG/03/029) for support to BH, AS, ARMC and for financial support for AS-T.	Athanasas-Platsis S, 2003, J NEUROL SCI, V214, P27, DOI 10.1016/S0022-510X(03)00170-9; Brownlie RJ, 2006, ARTHRITIS RHEUM-US, V54, P854, DOI 10.1002/art.21654; CAVANAGH AC, 1994, EUR J BIOCHEM, V222, P551, DOI 10.1111/j.1432-1033.1994.tb18897.x; Corrigall VM, 2004, ARTHRITIS RHEUM-US, V50, P1164, DOI 10.1002/art.20134; D'Aiuto F, 2005, INFLAMM RES, V54, P412, DOI 10.1007/s00011-005-1375-4; D'Aiuto F, 2004, J PERIODONTAL RES, V39, P294, DOI 10.1111/j.1600-0765.2004.00741.x; D'Aiuto F, 2004, J DENT RES, V83, P156, DOI 10.1177/154405910408300214; D'Aiuto F, 2006, AM HEART J, V151, P977, DOI 10.1016/j.ahj.2005.06.018; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; Feng ZM, 2006, PERIODONTOL 2000, V40, P50, DOI 10.1111/j.1600-0757.2005.00148.x; Frostegard Johan, 2005, P195, DOI 10.1017/CBO9780511546310.013; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Halcox JPJ, 2005, ARTERIOSCL THROM VAS, V25, pE141, DOI 10.1161/01.ATV.0000185832.34992.ff; Hansen JJ, 2003, HUM GENET, V112, P71, DOI 10.1007/s00439-002-0837-9; Henderson B, 2005, MOL CHAPERONES CELL; Henderson Brian, 2005, P78, DOI 10.1017/CBO9780511546310.006; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Leppa S, 1997, ANN MED, V29, P73, DOI 10.3109/07853899708998745; Lewthwaite J, 2002, CIRCULATION, V106, P196, DOI 10.1161/01.CIR.0000021121.26290.2C; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Maguire M, 2002, CELL STRESS CHAPERON, V7, P317, DOI 10.1379/1466-1268(2002)007<0317:CUISOC>2.0.CO;2; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; MORTON H, 1977, LANCET, V1, P394; Nibali L, 2006, J CLIN PERIODONTOL, V33, P529, DOI 10.1111/j.1600-051X.2006.00952.x; Pockley AG, 1999, CELL STRESS CHAPERON, V4, P29, DOI 10.1054/csac.1998.0121; Pockley AG, 2003, HYPERTENSION, V42, P235, DOI 10.1161/01.HYP.0000086522.13672.23; Pockley AG, 2000, HYPERTENSION, V36, P303, DOI 10.1161/01.HYP.36.2.303; SHAMAEITOUSI A, 2006, EUR HEART J; SHAMAEITOUSI A, 2007, CELL STRESS IN PRESS; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Vanags D, 2006, LANCET, V368, P855, DOI 10.1016/S0140-6736(06)69210-6; Xu QB, 2000, CIRCULATION, V102, P14, DOI 10.1161/01.CIR.102.1.14; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423; Zhu JH, 2003, ARTERIOSCL THROM VAS, V23, P1055, DOI 10.1161/01.ATV.0000074899.60898.FD; Zugel U, 1999, IMMUNOBIOLOGY, V201, P22	38	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1198	10.1371/journal.pone.0001198	http://dx.doi.org/10.1371/journal.pone.0001198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030332	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000207459200011
J	Laguri, C; Sadir, R; Rueda, P; Baleux, F; Gans, P; Arenzana-Seisdedos, F; Lortat-Jacob, H				Laguri, Cedric; Sadir, Rabia; Rueda, Patricia; Baleux, Francoise; Gans, Pierre; Arenzana-Seisdedos, Fernando; Lortat-Jacob, Hugues			The Novel CXCL12 gamma Isoform Encodes an Unstructured Cationic Domain Which Regulates Bioactivity and Interaction with Both Glycosaminoglycans and CXCR4	PLOS ONE			English	Article								Background. CXCL12 alpha, a chemokine that importantly promotes the oriented cell migration and tissue homing of many cell types, regulates key homeostatic functions and pathological processes through interactions with its cognate receptor (CXCR4) and heparan sulfate (HS). The alternative splicing of the cxcl12 gene generates a recently identified isoform, CXCL12 gamma, which structure/function relationships remain unexplored. The high occurrence of basic residues that characterize this isoform suggests however that it could feature specific regulation by HS. Methodology/Principal Findings. Using surface plasmon resonance and NMR spectroscopy, as well as chemically and recombinantly produced chemokines, we show here that CXCL12 gamma first 68 amino acids adopt a structure closely related to the well described a isoform, followed by an unfolded C-terminal extension of 30 amino acids. Remarkably, 60 % of these residues are either lysine or arginine, and most of them are clustered in typical HS binding sites. This provides the chemokine with the highest affinity for HP ever observed (Kd = 0.9 nM), and ensures a strong retention of the chemokine at the cell surface. This was due to the unique combination of two cooperative binding sites, one strictly required, found in the structured domain of the protein, the other one being the C-terminus which essentially functions by enhancing the half life of the complexes. Importantly, this peculiar C-terminus also regulates the balance between HS and CXCR4 binding, and consequently the biological activity of the chemokine. Conclusions/Significance. Together these data describe an unusual binding process that gives rise to an unprecedented high affinity between a chemokine and HS. This shows that the c isoform of CXCL12, which features unique structural and functional properties, is optimized to ensure its strong retention at the cell surface. Thus, depending on the chemokine isoform to which it binds, HS could differentially orchestrate the CXCL12 mediated directional cell kinesis.	[Laguri, Cedric; Sadir, Rabia; Gans, Pierre; Lortat-Jacob, Hugues] CNRS, UJF, CEA, UMR 5075,IBS, Grenoble, France; [Rueda, Patricia; Arenzana-Seisdedos, Fernando] Inst Pasteur, INSERM, Unite Pathogenie Virale Mol 819, F-75724 Paris, France; [Baleux, Francoise] Inst Pasteur, Unite Chim Organ, URA 2128, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lortat-Jacob, H (corresponding author), CNRS, UJF, CEA, UMR 5075,IBS, Grenoble, France.	Hugues.Lortat-Jacob@ibs.fr	Arenzana-Seisdedos, Fernando/E-5835-2016	Rueda, Patricia/0000-0003-1553-0840; laguri, cedric/0000-0002-5429-6914	Agence Nationale de la Recherche (ANR); ANR; Junta de Andalucia (Spain)	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); Junta de Andalucia (Spain)(Junta de Andalucia)	This work was supported by a grant from the Agence Nationale de la Recherche (ANR). CL is supported by a post doctoral fellowship from the ANR. PR is a fellowship recipient from the FPDI program supported by the Junta de Andalucia (Spain).	Agace WW, 2000, CURR BIOL, V10, P325, DOI 10.1016/S0960-9822(00)00380-8; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Baryshnikova OK, 2006, PROTEIN SCI, V15, P2568, DOI 10.1110/ps.062255806; Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Crane-Robinson C, 2006, TRENDS BIOCHEM SCI, V31, P547, DOI 10.1016/j.tibs.2006.08.006; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gleichmann M, 2000, EUR J NEUROSCI, V12, P1857, DOI 10.1046/j.1460-9568.2000.00048.x; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Ohnishi Y, 2000, J INTERF CYTOK RES, V20, P691, DOI 10.1089/10799900050116390; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ottiger M, 1998, J MAGN RESON, V134, P365, DOI 10.1006/jmre.1998.1546; Pablos JL, 1999, AM J PATHOL, V155, P1577, DOI 10.1016/S0002-9440(10)65474-0; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sadir R, 2004, J BIOL CHEM, V279, P43854, DOI 10.1074/jbc.M405392200; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Sweeney EA, 2002, BLOOD, V99, P44, DOI 10.1182/blood.V99.1.44; VanHaverbeke C, 2004, BIOCHEM J, V384, P93, DOI 10.1042/BJ20040757; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881	41	81	83	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1110	10.1371/journal.pone.0001110	http://dx.doi.org/10.1371/journal.pone.0001110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971873	gold, Green Published, Green Submitted			2022-12-27	WOS:000207458700027
J	van Vliet, MH; Klijn, CN; Wessels, LFA; Reinders, MJT				van Vliet, Martin H.; Klijn, Christiaan N.; Wessels, Lodewyk F. A.; Reinders, Marcel J. T.			Module-Based Outcome Prediction Using Breast Cancer Compendia	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; MICROARRAY	Background. The availability of large collections of microarray datasets (compendia), or knowledge about grouping of genes into pathways (gene sets), is typically not exploited when training predictors of disease outcome. These can be useful since a compendium increases the number of samples, while gene sets reduce the size of the feature space. This should be favorable from a machine learning perspective and result in more robust predictors. Methodology. We extracted modules of regulated genes from gene sets, and compendia. Through supervised analysis, we constructed predictors which employ modules predictive of breast cancer outcome. To validate these predictors we applied them to independent data, from the same institution (intra-dataset), and other institutions (inter-dataset). Conclusions. We show that modules derived from single breast cancer datasets achieve better performance on the validation data compared to gene-based predictors. We also show that there is a trend in compendium specificity and predictive performance: modules derived from a single breast cancer dataset, and a breast cancer specific compendium perform better compared to those derived from a human cancer compendium. Additionally, the module-based predictor provides a much richer insight into the underlying biology. Frequently selected gene sets are associated with processes such as cell cycle, E2F regulation, DNA damage response, proteasome and glycolysis. We analyzed two modules related to cell cycle, and the OCT1 transcription factor, respectively. On an individual basis, these modules provide a significant separation in survival subgroups on the training and independent validation data.	[van Vliet, Martin H.; Klijn, Christiaan N.; Wessels, Lodewyk F. A.; Reinders, Marcel J. T.] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Informat & Commun Theory Grp, Delft, Netherlands; [van Vliet, Martin H.; Klijn, Christiaan N.; Wessels, Lodewyk F. A.] Netherlands Canc Inst, Bioinformat & Stat Grp, Dept Mol Biol, Amsterdam, Netherlands	Delft University of Technology; Netherlands Cancer Institute	van Vliet, MH (corresponding author), Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Informat & Commun Theory Grp, Delft, Netherlands.	M.H.vanVliet@TUDelft.nl		Klijn, Christiaan/0000-0003-0878-4121	Netherlands Genomics Initiative (NGI)	Netherlands Genomics Initiative (NGI)	This work was part of the BioRange programme of the Netherlands Bioinformatics Centre (NBIC), which is supported by a BSIK grant through the Netherlands Genomics Initiative (NGI).	[Anonymous], MSIGDB; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Dorningos P., 1996, ICML; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jiang HY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-81; Jin TR, 1999, INT J CANCER, V81, P104, DOI 10.1002/(SICI)1097-0215(19990331)81:1<104::AID-IJC18>3.0.CO;2-Q; Kim RD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r70; Malin S, 2005, NUCLEIC ACIDS RES, V33, P4618, DOI 10.1093/nar/gki744; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shen RL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-94; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; TANAY A, 2005, MOL SYSTEMS BIOL, V1; Teschendorff AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r101; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429	23	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1047	10.1371/journal.pone.0001047	http://dx.doi.org/10.1371/journal.pone.0001047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940611	Green Published, gold, Green Submitted			2022-12-27	WOS:000207456100015
J	Zimmer, J; Bausinger, H; Andres, E; Donato, L; Hanau, D; Hentges, F; Moretta, A; de la Salle, H				Zimmer, Jacques; Bausinger, Huguette; Andres, Emmanuel; Donato, Lionel; Hanau, Daniel; Hentges, Francois; Moretta, Alessandro; de la Salle, Henri			Phenotypic Studies of Natural Killer Cell Subsets in Human Transporter Associated with Antigen Processing Deficiency	PLOS ONE			English	Article								Peripheral blood natural killer (NK) cells from patients with transporter associated with antigen processing (TAP) deficiency are hyporesponsive. The mechanism of this defect is unknown, but the phenotype of TAP-deficient NK cells is almost normal. However, we noticed a high percentage of CD56(bright) cells among total NK cells from two patients. We further investigated TAP-deficient NK cells in these patients and compared them to NK cells from two other TAP-deficient patients with no clinical symptoms and to individuals with chronic inflammatory diseases other than TAP deficiency (chronic lung diseases or vasculitis). Peripheral blood mononuclear cells isolated from venous blood were stained with fluorochrome-conjugated antibodies and the phenotype of NK cells was analyzed by flow cytometry. In addition, (51)Chromium release assays were performed to assess the cytotoxic activity of NK cells. In the symptomatic patients, CD56(bright) NK cells represented 28% and 45%, respectively, of all NK cells (higher than in healthy donors). The patients also displayed a higher percentage of CD56(dim) CD16(-) NK cells than controls. Interestingly, this unusual NK cell subtype distribution was not found in the two asymptomatic TAP-deficient cases, but was instead present in several of the other patients. Over-expression of the inhibitory receptor CD94/NKG2A by TAP-deficient NK cells was confirmed and extended to the inhibitory receptor ILT2 (CD85j). These inhibitory receptors were not involved in regulating the cytotoxicity of TAP-deficient NK cells. We conclude that expansion of the CD56(bright) NK cell subtype in peripheral blood is not a hallmark of TAP deficiency, but can be found in other diseases as well. This might reflect a reaction of the immune system to pathologic conditions. It could be interesting to investigate the relative distribution of NK cell subsets in various respiratory and autoimmune diseases.	[Zimmer, Jacques; Hentges, Francois] CRP Sante, Lab Immunogenet Allergol, Luxembourg, Luxembourg; [Bausinger, Huguette; Hanau, Daniel; de la Salle, Henri] INSERM, U725, Strasbourg, France; [Bausinger, Huguette; Hanau, Daniel; de la Salle, Henri] Univ Strasbourg 1, Strasbourg, France; [Bausinger, Huguette; Hanau, Daniel; de la Salle, Henri] Etab Francais Sang Alsace, Strasbourg, France; [Andres, Emmanuel] Hop Univ Strasbourg, Serv Med Interne, Clin Med B, Strasbourg, France; [Donato, Lionel] Hop Univ Strasbourg, Serv Pediat, Strasbourg, France; [Moretta, Alessandro] Univ Genoa, Dipartimento Med Sperimentale, Sez Istol, Genoa, Italy	Luxembourg Institute of Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Genoa	Zimmer, J (corresponding author), CRP Sante, Lab Immunogenet Allergol, Luxembourg, Luxembourg.	jacques.zimmer@crp-sante.lu	Andres, E/AAY-3767-2020; De La Salle, Henri/H-9353-2016; Andres, Emmanuel/AAX-1502-2020	De La Salle, Henri/0000-0001-5136-0776; Andres, Emmanuel/0000-0002-7914-7616; Zimmer, Jacques/0000-0002-7118-6944	"CRP-Sante'', Luxembourg; "Ministere de la Culture, de l'Enseignement Superieur et de la Recherche'' (Ministry of Culture, Higher Education and Research) of Luxembourg [BFR 96/003]	"CRP-Sante'', Luxembourg; "Ministere de la Culture, de l'Enseignement Superieur et de la Recherche'' (Ministry of Culture, Higher Education and Research) of Luxembourg	The "Laboratoire d'Immunogenetique-Allergologie'' is supported by an institutional grant from the "CRP-Sante'', Luxembourg. The work of Jacques Zimmer was partially financed by a grant (BFR 96/003) from the "Ministere de la Culture, de l'Enseignement Superieur et de la Recherche'' (Ministry of Culture, Higher Education and Research) of Luxembourg.	Andre P, 2000, P NATL ACAD SCI USA, V97, P3400, DOI 10.1073/pnas.040569797; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Cac NN, 2006, J ALLERGY CLIN IMMUN, V118, P526, DOI 10.1016/j.jaci.2006.04.023; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Carson William, 1996, Methods (Orlando), V9, P327, DOI 10.1006/meth.1996.0038; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; de la Salle H, 1999, PRIMARY IMMUNODEFICIENCY DISEASES, P181; De la Salle H, 2002, CLIN EXP IMMUNOL, V128, P525, DOI 10.1046/j.1365-2249.2002.01862.x; de la Salle H, 1999, J CLIN INVEST, V103, pR9, DOI 10.1172/JCI5687; DELASALLE H, 1994, SCIENCE, V265, P237, DOI 10.1126/science.7517574; Dogu F, 2006, PARASITOL INT, V55, P219, DOI 10.1016/j.parint.2006.02.003; Donato L, 1997, REV FR ALLERGOL, V37, P127, DOI 10.1016/S0335-7457(97)80035-4; DONATO L, 1995, J PEDIATR-US, V127, P895, DOI 10.1016/S0022-3476(95)70024-2; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Furukawa H, 1999, J CLIN INVEST, V103, P755, DOI 10.1172/JCI5335; Gromme M, 2002, MOL IMMUNOL, V39, P181, DOI 10.1016/S0161-5890(02)00101-3; Jacobs R, 2001, EUR J IMMUNOL, V31, P3121, DOI 10.1002/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kubo T, 2006, SCAND J INFECT DIS, V38, P1122, DOI 10.1080/00365540600740520; Kumar V, 2005, NAT REV IMMUNOL, V5, P363, DOI 10.1038/nri1603; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; MAEDA H, 1985, IMMUNOGENETICS, V21, P549, DOI 10.1007/BF00395879; Markel G, 2004, BLOOD, V103, P1770, DOI 10.1182/blood-2003-06-2114; Matamoros N, 2001, CLIN EXP IMMUNOL, V125, P274, DOI 10.1046/j.1365-2249.2001.01595.x; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; NAGLER A, 1989, J IMMUNOL, V143, P3183; O'Connor GM, 2006, IMMUNOLOGY, V117, P1, DOI 10.1111/j.1365-2567.2005.02256.x; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Parissiadis A, 2005, BRIT J OPHTHALMOL, V89, P1661, DOI 10.1136/bjo.2005.078097; Plebani A, 1996, J AM ACAD DERMATOL, V35, P814, DOI 10.1016/S0190-9622(96)90091-2; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Saraste M, 2007, NEUROL SCI, V28, P121, DOI 10.1007/s10072-007-0803-3; Shibata F, 2007, EUR J HAEMATOL, V79, P81, DOI 10.1111/j.1600-0609.2007.00874.x; Sivori S, 1996, EUR J IMMUNOL, V26, P2487, DOI 10.1002/eji.1830261032; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Vitale M, 2002, BLOOD, V99, P1723, DOI 10.1182/blood.V99.5.1723; Wendt K, 2006, J LEUKOCYTE BIOL, V80, P1529, DOI 10.1189/jlb.0306191; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369; Zimmer J, 2005, QJM-INT J MED, V98, P719, DOI 10.1093/qjmed/hci112; Zimmer J, 1998, J EXP MED, V187, P117, DOI 10.1084/jem.187.1.117; Zimmer J, 1999, EUR J IMMUNOL, V29, P1286, DOI 10.1002/(SICI)1521-4141(199904)29:04<1286::AID-IMMU1286>3.0.CO;2-L	44	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1033	10.1371/journal.pone.0001033	http://dx.doi.org/10.1371/journal.pone.0001033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940597	Green Published, Green Submitted, gold			2022-12-27	WOS:000207456100001
J	Romano, CM; de Melo, FL; Corsini, MAB; Holmes, EC; Zanotto, PMDA				Romano, Camila M.; de Melo, Fernando L.; Corsini, Marco Aurelio B.; Holmes, Edward C.; Zanotto, Paolo M. de A.			Demographic Histories of ERV-K in Humans, Chimpanzees and Rhesus Monkeys	PLOS ONE			English	Article								We detected 19 complete endogenous retroviruses of the K family in the genome of rhesus monkey (Macaca mulatta; RhERV-K) and 12 full length elements in the genome of the common chimpanzee (Pan troglodytes; CERV-K). These sequences were compared with 55 human HERV-K and 20 CERV-K reported previously, producing a total data set of 106 full-length ERV-K genomes. Overall, 61% of the human elements compared to 21% of the chimpanzee and 47% of rhesus elements had estimated integration times less than 4.5 million years before present (MYBP), with an average integration times of 7.8 MYBP, 13.4 MYBP and 10.3 MYBP for HERV-K, CERV-K and RhERV-K, respectively. By excluding those ERV-K sequences generated by chromosomal duplication, we used 63 of the 106 elements to compare the population dynamics of ERV-K among species. This analysis indicated that both HERV-K and RhERV-K had similar demographic histories, including markedly smaller effective population sizes, compared to CERV-K. We propose that these differing ERV-K dynamics reflect underlying differences in the evolutionary ecology of the host species, such that host ecology and demography represent important determinants of ERV-K dynamics.	[Romano, Camila M.; de Melo, Fernando L.; Corsini, Marco Aurelio B.; Zanotto, Paolo M. de A.] Univ Sao Paulo, Biomed Sci Inst ICBII, Dept Microbiol, Lab Mol Evolut & Bioinformat, BR-05508 Sao Paulo, Brazil; [Holmes, Edward C.] Penn State Univ, Dept Biol, Mueller Lab, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Holmes, Edward C.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Universidade de Sao Paulo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Zanotto, PMDA (corresponding author), Univ Sao Paulo, Biomed Sci Inst ICBII, Dept Microbiol, Lab Mol Evolut & Bioinformat, BR-05508 Sao Paulo, Brazil.	pzanotto@usp.br	Melo, Fernando Lucas/U-6535-2017; Holmes, Edward/Y-2789-2019; Romano, Camila M/C-8185-2013; de A. Zanotto, Paolo M./B-9286-2019; Holmes, Edward/GVR-9499-2022; Romano, Camila/ABC-2883-2020	Melo, Fernando Lucas/0000-0002-9591-0239; Holmes, Edward/0000-0001-9596-3552; de A. Zanotto, Paolo M./0000-0002-8167-0625; Romano, Camila/0000-0003-4550-1987	VGDN [00/04205-6]; CAPES; CNPq	VGDN; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding: This research was funded by VGDN program FAPESP (00/04205-6). CMR and FLM hold a CAPES doctorate fellowship (DO) and PMAZ holds a CNPq PQ Research Scholarship.	Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Belshaw R, 2005, J VIROL, V79, P12507, DOI 10.1128/JVI.79.19.12507-12514.2005; Belshaw R, 2004, P NATL ACAD SCI USA, V101, P4894, DOI 10.1073/pnas.0307800101; Belshaw R, 2005, BIOINFORMATICS, V21, P122, DOI 10.1093/bioinformatics/bth459; Bernard J., 1988, EUKARYOTE GENOME DEV, DOI [10.1007/978-94-011-5991-3, DOI 10.1007/978-94-011-5991-3]; Boeke J. D., 1997, P343; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; Crombach A, 2007, MOL BIOL EVOL, V24, P1130, DOI 10.1093/molbev/msm033; Deceliere G, 2005, GENETICS, V169, P467, DOI 10.1534/genetics.104.032243; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; DRUMMOND AJ, 2003, BEAST V1 0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; GHERMAN A, 2007, PLOS GENETI IN PRESS; Johnson WE, 1999, P NATL ACAD SCI USA, V96, P10254, DOI 10.1073/pnas.96.18.10254; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le Rouzic A, 2005, GENETICS, V169, P1033, DOI 10.1534/genetics.104.031211; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; LOWER R, 1993, P NATL ACAD SCI USA, V90, P4480, DOI 10.1073/pnas.90.10.4480; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Medstrand P, 1998, J VIROL, V72, P9782, DOI 10.1128/JVI.72.12.9782-9787.1998; Nuzhdin SV, 1999, GENETICA, V107, P129, DOI 10.1023/A:1003957323876; OHTA T, 1986, GENETICS, V113, P145; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Promislow DEL, 1999, P ROY SOC B-BIOL SCI, V266, P1555, DOI 10.1098/rspb.1999.0815; PURVIS A, 1995, P ROY SOC B-BIOL SCI, V260, P329, DOI 10.1098/rspb.1995.0100; Romano CM, 2006, ARCH VIROL, V151, P2215, DOI 10.1007/s00705-006-0792-1; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schulte AM, 1996, P NATL ACAD SCI USA, V93, P14759, DOI 10.1073/pnas.93.25.14759; SEINO S, 1992, MOL BIOL EVOL, V9, P193; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tsitrone A, 1999, GENET RES, V74, P159, DOI 10.1017/S0016672399003997; Whitlock MC, 2003, GENETICS, V164, P767; Wisotzkey RG, 1997, CHROMOSOMA, V106, P465, DOI 10.1007/s004120050268	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1026	10.1371/journal.pone.0001026	http://dx.doi.org/10.1371/journal.pone.0001026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925874	Green Submitted, Green Published, gold			2022-12-27	WOS:000207456000025
J	Wu, HQ; Neilson, JR; Kumar, P; Manocha, M; Shankar, P; Sharp, PA; Manjunath, N				Wu, Haoquan; Neilson, Joel R.; Kumar, Priti; Manocha, Monika; Shankar, Premlata; Sharp, Phillip A.; Manjunath, N.			miRNA Profiling of Naive, Effector and Memory CD8 T Cells	PLOS ONE			English	Article							MICRORNA EXPRESSION; RNA-INTERFERENCE; POSTTRANSCRIPTIONAL REGULATION; ENDOGENOUS SIRNAS; NUCLEAR EXPORT; DIFFERENTIATION; QUANTIFICATION; MATURATION; GENERATION; GENES	microRNAs have recently emerged as master regulators of gene expression during development and cell differentiation. Although profound changes in gene expression also occur during antigen-induced T cell differentiation, the role of miRNAs in the process is not known. We compared the miRNA expression profiles between antigen-specific naive, effector and memory CD8+ T cells using 3 different methods-small RNA cloning, miRNA microarray analysis and real-time PCR. Although many miRNAs were expressed in all the T cell subsets, the frequency of 7 miRNAs (miR-16, miR-21, miR-142-3p, miR-142-5p, miR-150, miR-15b and let-7f) alone accounted for similar to 60% of all miRNAs, and their expression was several fold higher than the other expressed miRNAs. Global downregulation of miRNAs (including 6/7 dominantly expressed miRNAs) was observed in effector T cells compared to naive cells and the miRNA expression levels tended to come back up in memory T cells. However, a few miRNAs, notably miR-21 were higher in effector and memory T cells compared to naive T cells. These results suggest that concomitant with profound changes in gene expression, miRNA profile also changes dynamically during T cell differentiation. Sequence analysis of the cloned mature miRNAs revealed an extensive degree of end polymorphism. While 3' end polymorphisms dominated, heterogeneity at both ends, resembling drosha/dicer processing shift was also seen in miR-142, suggesting a possible novel mechanism to generate new miRNA and/or to diversify miRNA target selection. Overall, our results suggest that dynamic changes in the expression of miRNAs may be important for the regulation of gene expression during antigen-induced T cell differentiation. Our study also suggests possible novel mechanisms for miRNA biogenesis and function.	[Wu, Haoquan; Kumar, Priti; Manocha, Monika; Shankar, Premlata; Manjunath, N.] Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; [Wu, Haoquan; Kumar, Priti; Manocha, Monika; Shankar, Premlata; Manjunath, N.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Neilson, Joel R.; Sharp, Phillip A.] MIT, Ctr Canc Res, Cambridge, MA 02139 USA; [Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Manjunath, N (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	swamy@cbrinstitute.org	Kumar, Priti/C-5699-2009	Wu, Haoquan/0000-0001-9386-3187; Neilson, Joel R./0000-0002-3408-608X; Kumar, Priti/0000-0002-6901-5601	NIH [U19 AI 056900, R21 AI 066197]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056900, R21AI066197] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by NIH grant U19 AI 056900 and R21 AI 066197 to N. M.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Borkhardt A, 2006, NEW ENGL J MED, V354, P524; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; FULCI V, 2007, BLOOD; Gourley TS, 2004, SEMIN IMMUNOL, V16, P323, DOI 10.1016/j.smim.2004.08.013; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; KRISHNA KM, 1998, IMMUNITY, V8, P177; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Weninger W, 2002, IMMUNOL REV, V186, P221, DOI 10.1034/j.1600-065X.2002.18618.x; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	53	387	429	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1020	10.1371/journal.pone.0001020	http://dx.doi.org/10.1371/journal.pone.0001020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925868	Green Published, Green Submitted, gold			2022-12-27	WOS:000207456000019
J	Kording, KP; Beierholm, U; Ma, WJ; Quartz, S; Tenenbaum, JB; Shams, L				Koerding, Konrad P.; Beierholm, Ulrik; Ma, Wei Ji; Quartz, Steven; Tenenbaum, Joshua B.; Shams, Ladan			Causal Inference in Multisensory Perception	PLOS ONE			English	Article							VENTRILOQUISM; INTEGRATION; INFORMATION; VISION; MODELS; TOUCH	Perceptual events derive their significance to an animal from their meaning about the world, that is from the information they carry about their causes. The brain should thus be able to efficiently infer the causes underlying our sensory events. Here we use multisensory cue combination to study causal inference in perception. We formulate an ideal-observer model that infers whether two sensory cues originate from the same location and that also estimates their location(s). This model accurately predicts the nonlinear integration of cues by human subjects in two auditory-visual localization tasks. The results show that indeed humans can efficiently infer the causal structure as well as the location of causes. By combining insights from the study of causal inference with the ideal-observer approach to sensory cue combination, we show that the capacity to infer causal structure is not limited to conscious, high-level cognition; it is also performed continually and effortlessly in perception.	[Beierholm, Ulrik; Quartz, Steven] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Koerding, Konrad P.] Northwestern Univ, Rehabil Inst Chicago, Chicago, IL 60611 USA; [Ma, Wei Ji] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA; [Tenenbaum, Joshua B.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Shams, Ladan] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA	California Institute of Technology; Northwestern University; Shirley Ryan AbilityLab; University of Rochester; Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles	Beierholm, U (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	beierh@caltech.edu	Beierholm, Ulrik/D-3919-2014; Kording, Konrad P/A-1233-2007	Beierholm, Ulrik/0000-0002-7296-7996; Kording, Konrad P/0000-0001-8408-4499; Ma, Wei Ji/0000-0002-9835-9083	DFG Heisenberg Stipend; David and Lucille Packard Foundation; Moore Foundation; P. E. Newton Career Development Chair; UCLA Academic senate and Career development	DFG Heisenberg Stipend; David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Moore Foundation(Gordon and Betty Moore Foundation); P. E. Newton Career Development Chair; UCLA Academic senate and Career development	KPK was supported by a DFG Heisenberg Stipend. UB and SQ were supported by the David and Lucille Packard Foundation as well as by the Moore Foundation. JBT was supported by the P. E. Newton Career Development Chair. LS was supported by UCLA Academic senate and Career development grants.	Adams WJ, 2004, NAT NEUROSCI, V7, P1057, DOI 10.1038/nn1312; Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bertelson P, 2000, NEUROPSYCHOLOGIA, V38, P1634, DOI 10.1016/S0028-3932(00)00067-1; Bresciani JP, 2006, J VISION, V6, P554, DOI 10.1167/6.5.2; Buehner MJ, 2003, J EXP PSYCHOL LEARN, V29, P1119, DOI 10.1037/0278-7393.29.6.1119; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CHOE CS, 1975, PERCEPT PSYCHOPHYS, V18, P55, DOI 10.3758/BF03199367; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; ERNST MO, 2007, J VISION IN PRESS; Gepshtein S, 2005, J VISION, V5, P1013, DOI 10.1167/5.11.7; GHAHRAMANI Z, 1995, COMPUTATIONAL PSYCHO; Gigerenzer G, 2001, Nebr Symp Motiv, V47, P113; Gopnik A, 2004, PSYCHOL REV, V111, P3, DOI 10.1037/0033-295X.111.1.3; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Griffiths TL, 2005, COGNITIVE PSYCHOL, V51, P334, DOI 10.1016/j.cogpsych.2005.05.004; Hairston WD, 2003, J COGNITIVE NEUROSCI, V15, P20, DOI 10.1162/089892903321107792; Hatfield Gary, 1990, NATURAL NORMATIVE TH; Helmholtz H., 1954, SENSATIONS TONE PHYS; JACK CE, 1973, PERCEPT MOTOR SKILL, V37, P967, DOI 10.2466/pms.1973.37.3.967; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Knill DC, 2003, VISION RES, V43, P831, DOI 10.1016/S0042-6989(03)00003-8; Kording KP, 2004, P NATL ACAD SCI USA, V101, P9839, DOI 10.1073/pnas.0308394101; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; McDonald Patrick J., 2003, Perspectives on Science, V11, P170, DOI 10.1162/106361403322495885; Munhall KG, 1996, PERCEPT PSYCHOPHYS, V58, P351, DOI 10.3758/BF03206811; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Recanzone GH, 2003, J NEUROPHYSIOL, V89, P1078, DOI 10.1152/jn.00706.2002; Reynolds JH, 1999, NEURON, V24, P19, DOI 10.1016/S0896-6273(00)80819-3; Roach NW, 2006, P ROY SOC B-BIOL SCI, V273, P2159, DOI 10.1098/rspb.2006.3578; Roskies AL, 1999, NEURON, V24, P7, DOI 10.1016/S0896-6273(00)80817-X; Rowland B, 2007, EXP BRAIN RES, V180, P153, DOI 10.1007/s00221-006-0847-2; Saxe R, 2005, PSYCHOL SCI, V16, P995, DOI 10.1111/j.1467-9280.2005.01649.x; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Sobel DM, 2004, COGNITIVE SCI, V28, P303, DOI 10.1016/j.cogsci.2003.11.001; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; THURLOW WR, 1973, PERCEPT MOTOR SKILL, V36, P1171, DOI 10.2466/pms.1973.36.3c.1171; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Waldmann MR, 2000, J EXP PSYCHOL LEARN, V26, P53, DOI 10.1037/0278-7393.26.1.53; Wallace MT, 2004, EXP BRAIN RES, V158, P252, DOI 10.1007/s00221-004-1899-9; WARREN DH, 1981, PERCEPT PSYCHOPHYS, V30, P557, DOI 10.3758/BF03202010; WARREN DH, 1971, J EXP PSYCHOL, V90, P206, DOI 10.1037/h0031545; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818	45	584	585	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e943	10.1371/journal.pone.0000943	http://dx.doi.org/10.1371/journal.pone.0000943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895984	gold, Green Published, Green Accepted			2022-12-27	WOS:000207455800022
J	Um, SY; McDonald, TV				Um, Sung Yon; McDonald, Thomas V.			Differential Association between HERG and KCNE1 or KCNE2	PLOS ONE			English	Article							LONG-QT SYNDROME; CARDIAC POTASSIUM CURRENT; MINK-RELATED PEPTIDE-1; ENDOPLASMIC-RETICULUM; BREFELDIN-A; I-KS; LANGE-NIELSEN; MOLECULAR-INTERACTIONS; MEMBRANE-PROTEINS; GOLGI PROTEINS	The small proteins encoded by KCNE1 and KCNE2 have both been proposed as accessory subunits for the HERG channel. Here we report our investigation into the cell biology of the KCNE-HERG interaction. In a co-expression system, KCNE1 was more readily co-precipitated with co-expressed HERG than was KCNE2. When forward protein trafficking was prevented (either by Brefeldin A or engineering an ER-retention/retrieval signal onto KCNE cDNA) the intracellular abundance of KCNE2 and its association with HERG markedly increased relative to KCNE1. HERG co-localized more completely with KCNE1 than with KCNE2 in all the membrane-processing compartments of the cell (ER, Golgi and plasma membrane). By surface labeling and confocal immunofluorescence, KCNE2 appeared more abundant at the cell surface compared to KCNE1, which exhibited greater co-localization with the ER-marker calnexin. Examination of the extracellular culture media showed that a significant amount of KCNE2 was extracellular (both soluble and membrane-vesicle-associated). Taken together, these results suggest that during biogenesis of channels HERG is more likely to assemble with KCNE1 than KCNE2 due to distinctly different trafficking rates and retention in the cell rather than differences in relative affinity. The final channel subunit constitution, in vivo, is likely to be determined by a combination of relative cell-to-cell expression rates and differential protein processing and trafficking.	[Um, Sung Yon; McDonald, Thomas V.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Um, Sung Yon; McDonald, Thomas V.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	McDonald, TV (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	mcdonald@aecom.yu.edu			NIH/NHLBI; AHA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075615] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH/NHLBI (Funding source only), AHA (Funding source only)	Abbott G W, 2001, Mol Interv, V1, P95; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Bianchi L, 1999, HUM MOL GENET, V8, P1499, DOI 10.1093/hmg/8.8.1499; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; CHANDRASEKHAR KD, 2006, J BIOL CHEM; Chen HJ, 2003, NEURON, V40, P15, DOI 10.1016/S0896-6273(03)00570-1; Chen YH, 1997, J CELL BIOL, V138, P891, DOI 10.1083/jcb.138.4.891; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; Duggal P, 1998, CIRCULATION, V97, P142, DOI 10.1161/01.CIR.97.2.142; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Finley MR, 2002, AM J PHYSIOL-HEART C, V283, pH126, DOI 10.1152/ajpheart.00622.2001; Franco D, 2001, CARDIOVASC RES, V52, P65, DOI 10.1016/S0008-6363(01)00349-2; Friederich P, 2004, BRIT J ANAESTH, V92, P93, DOI 10.1093/bja/aeh026; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Grunnet M, 2002, J PHYSIOL-LONDON, V542, P119, DOI 10.1113/jphysiol.2002.017301; Jiang M, 2004, CIRCULATION, V109, P1783, DOI 10.1161/01.CIR.0000124225.43852.50; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kosolapov A, 2003, J BIOL CHEM, V278, P4305, DOI 10.1074/jbc.M209422200; Kramer B, 2005, BLOOD CELL MOL DIS, V35, P136, DOI 10.1016/j.bcmd.2005.06.006; Krumerman A, 2004, AM J PHYSIOL-CELL PH, V286, pC1453, DOI 10.1152/ajpcell.00275.2003; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lewis A, 2004, J BIOL CHEM, V279, P7884, DOI 10.1074/jbc.M310501200; Li XB, 2006, J CELL MOL MED, V10, P364, DOI 10.1111/j.1582-4934.2006.tb00405.x; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Lu Y, 2003, J PHYSIOL-LONDON, V551, P253, DOI 10.1113/jphysiol.2003.046045; Lundquist AL, 2006, GENOMICS, V87, P119, DOI 10.1016/j.ygeno.2005.09.004; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; MASIBAY AS, 1993, J BIOL CHEM, V268, P9908; Mazhari R, 2001, CIRC RES, V89, P33, DOI 10.1161/hh1301.093633; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Park KH, 2003, FASEB J, V17, DOI 10.1096/fj.03-0577fje; PELHAM HRB, 1993, CELL, V75, P603, DOI 10.1016/0092-8674(93)90479-A; Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Porto-Carreiro I, 2005, BLOOD CELL MOL DIS, V35, P143, DOI 10.1016/j.bcmd.2005.06.013; Pourrier M, 2003, CIRC RES, V93, P189, DOI 10.1161/01.RES.0000084851.60947.B5; Qu JH, 2004, J BIOL CHEM, V279, P43497, DOI 10.1074/jbc.M405018200; ROEPKE TK, 2006, J BIOL CHEM; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tinel N, 2000, FEBS LETT, V480, P137, DOI 10.1016/S0014-5793(00)01918-9; Tu LW, 1999, BIOPHYS J, V76, P2004, DOI 10.1016/S0006-3495(99)77358-3; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; WANG S, 1996, P 5 CHIN C GLAC GEOC, V1, P17; Watson RT, 2001, AM J PHYSIOL-CELL PH, V281, pC215, DOI 10.1152/ajpcell.2001.281.1.C215; Weerapura M, 2002, J PHYSIOL-LONDON, V540, P15, DOI 10.1113/jphysiol.2001.013296; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	62	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e933	10.1371/journal.pone.0000933	http://dx.doi.org/10.1371/journal.pone.0000933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895974	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455800012
J	Marshall, HM; Ronen, K; Berry, C; Llano, M; Sutherland, H; Saenz, D; Bickmore, W; Poeschla, E; Bushman, FD				Marshall, Heather M.; Ronen, Keshet; Berry, Charles; Llano, Manuel; Sutherland, Heidi; Saenz, Dyana; Bickmore, Wendy; Poeschla, Eric; Bushman, Frederic D.			Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting	PLOS ONE			English	Article								Background. To replicate, lentiviruses such as HIV must integrate DNA copies of their RNA genomes into host cell chromosomes. Lentiviral integration is favored in active transcription units, which allows efficient viral gene expression after integration, but the mechanisms directing integration targeting are incompletely understood. A cellular protein, PSIP1/LEDGF/p75, binds tightly to the lentiviral-encoded integrase protein (IN), and has been reported to be important for HIV infectivity and integration targeting. Methodology. Here we report studies of lentiviral integration targeting in 1) human cells with intensified RNAi knockdowns of PSIP1/LEDGF/p75, and 2) murine cells with homozygous gene trap mutations in the PSIP1/LEDGF/p75 locus. Infections with vectors derived from equine infections anemia virus (EIAV) and HIV were compared. Integration acceptor sites were analyzed by DNA bar coding and pyrosequencing. Conclusions/Significance. In both PSIP1/LEDGF/p75-depleted cell lines, reductions were seen in lentiviral infectivity compared to controls. For the human cells, integration was reduced in transcription units in the knockdowns, and this reduction was greater than in our previous studies of human cells less completely depleted for PSIP1/LEDGF/p75. For the homozygous mutant mouse cells, similar reductions in integration in transcription units were seen, paralleling a previous study of a different mutant mouse line. Integration did not become random, however-integration in transcription units in both cell types was still favored, though to a reduced degree. New trends also appeared, including favored integration near CpG islands. In addition, we carried out a bioinformatic study of 15 HIV integration site data sets in different cell types, which showed that the frequency of integration in transcription units was correlated with the cell-type specific levels of PSIP1/LEDGF/p75 expression.	[Marshall, Heather M.; Ronen, Keshet; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Berry, Charles; Saenz, Dyana] Univ Calif San Diego, Dept Family, San Diego, CA 92103 USA; [Sutherland, Heidi; Bickmore, Wendy] MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Llano, Manuel; Poeschla, Eric] Mayo Clin, Coll Med, Program Mol Med, Rochester, MN USA	University of Pennsylvania; University of California System; University of California San Diego; University of Edinburgh; Mayo Clinic	Bushman, FD (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	bushman@mail.med.upenn.edu	Bickmore, Wendy A/C-7314-2013	Bickmore, Wendy A/0000-0001-6660-7735; Bushman, Frederic/0000-0003-4740-4056; Sutherland, Heidi/0000-0002-8512-1498	NIH [AI52845, AI66290, AI47536]; Tietze Foundation; James B. Pendleton Charitable Trust; The Penn Genomics Institute; Robin and Frederic Withington;  [T32 07229-33];  [AI007632]; Medical Research Council [MC_U127527202] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI047536, T32AI007632, U19AI066290, R01AI047536, R01AI052845, R01AI077344] Funding Source: NIH RePORTER; MRC [MC_U127527202] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tietze Foundation; James B. Pendleton Charitable Trust; The Penn Genomics Institute; Robin and Frederic Withington; ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by NIH grants AI52845, AI66290, AI47536, the Tietze Foundation, the James B. Pendleton Charitable Trust, The Penn Genomics Institute, and Robin and Frederic Withington. Keshet Ronen was supported by T32 07229-33. Heather Marshall was supported by AI007632.	Barr SD, 2005, J VIROL, V79, P12035, DOI 10.1128/JVI.79.18.12035-12044.2005; Barr SD, 2006, MOL THER, V14, P218, DOI 10.1016/j.ymthe.2006.03.012; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Bisgrove Dwayne, 2005, Expert Rev Anti Infect Ther, V3, P805, DOI 10.1586/14787210.3.5.805; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Bushman FD, 2001, LATERAL DNA TRANSFER; Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Carteau S, 1998, J VIROL, V72, P4005, DOI 10.1128/JVI.72.5.4005-4014.1998; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Ciuffi A, 2006, MOL THER, V13, P366, DOI 10.1016/j.ymthe.2005.10.009; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Ciuffi A, 2006, HUM GENE THER, V17, P960, DOI 10.1089/hum.2006.17.960; Coffin J, 1997, RETROVIRUSES; Crise B, 2005, J VIROL, V79, P12199, DOI 10.1128/JVI.79.19.12199-12204.2005; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hacker CV, 2006, MOL THER, V14, P536, DOI 10.1016/j.ymthe.2006.06.006; Hematti P, 2004, PLOS BIOL, V2, P2183, DOI 10.1371/journal.pbio.0020423; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Kang YB, 2006, J VIROL, V80, P8820, DOI 10.1128/JVI.00719-06; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; MacNeil A, 2006, J VIROL, V80, P7316, DOI 10.1128/JVI.00604-06; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miller DG, 2005, J VIROL, V79, P11434, DOI 10.1128/JVI.79.17.11434-11442.2005; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Olsen JC, 1998, GENE THER, V5, P1481, DOI 10.1038/sj.gt.3300768; PRYCIAK PM, 1992, EMBO J, V11, P291, DOI 10.1002/j.1460-2075.1992.tb05052.x; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Stevens SW, 1996, J VIROL, V70, P6459, DOI 10.1128/JVI.70.9.6459-6462.1996; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Zielske SP, 2006, J VIROL, V80, P7275, DOI 10.1128/JVI.02470-05	66	182	185	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1340	10.1371/journal.pone.0001340	http://dx.doi.org/10.1371/journal.pone.0001340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18092005	Green Published, gold			2022-12-27	WOS:000207459600023
J	Higgs, BW; Mohtashemi, M; Grinsdale, J; Kawamura, LM				Higgs, Brandon W.; Mohtashemi, Mojdeh; Grinsdale, Jennifer; Kawamura, L. Masae			Early Detection of Tuberculosis Outbreaks among the San Francisco Homeless: Trade-Offs Between Spatial Resolution and Temporal Scale	PLOS ONE			English	Article								Background. San Francisco has the highest rate of tuberculosis (TB) in the U. S. with recurrent outbreaks among the homeless and marginally housed. It has been shown for syndromic data that when exact geographic coordinates of individual patients are used as the spatial base for outbreak detection, higher detection rates and accuracy are achieved compared to when data are aggregated into administrative regions such as zip codes and census tracts. We examine the effect of varying the spatial resolution in the TB data within the San Francisco homeless population on detection sensitivity, timeliness, and the amount of historical data needed to achieve better performance measures. Methods and Findings. We apply a variation of space-time permutation scan statistic to the TB data in which a patient's location is either represented by its exact coordinates or by the centroid of its census tract. We show that the detection sensitivity and timeliness of the method generally improve when exact locations are used to identify real TB outbreaks. When outbreaks are simulated, while the detection timeliness is consistently improved when exact coordinates are used, the detection sensitivity varies depending on the size of the spatial scanning window and the number of tracts in which cases are simulated. Finally, we show that when exact locations are used, smaller amount of historical data is required for training the model. Conclusion. Systematic characterization of the spatio-temporal distribution of TB cases can widely benefit real time surveillance and guide public health investigations of TB outbreaks as to what level of spatial resolution results in improved detection sensitivity and timeliness. Trading higher spatial resolution for better performance is ultimately a tradeoff between maintaining patient confidentiality and improving public health when sharing data. Understanding such tradeoffs is critical to managing the complex interplay between public policy and public health. This study is a step forward in this direction.	[Higgs, Brandon W.; Mohtashemi, Mojdeh] Mitre Corp, Mclean, VA USA; [Mohtashemi, Mojdeh] MIT, Dept Comp Sci, Cambridge, MA 02139 USA; [Grinsdale, Jennifer; Kawamura, L. Masae] San Francisco Dept Publ Hlth, TB Control Sect, San Francisco, CA USA	MITRE Corporation; Massachusetts Institute of Technology (MIT); San Francisco Department of Public Health	Higgs, BW (corresponding author), Mitre Corp, Mclean, VA USA.	bhiggs100@yahoo.com		Higgs, Brandon/0000-0002-2951-0245	MITRE internal research program	MITRE internal research program	This work was funded exclusively by the MITRE internal research program.	[Anonymous], 1995, CONTROL COMMUNICABLE; DWASS M, 1957, ANN MATH STAT, V29; Ginsberg AM, 2000, CLIN INFECT DIS, V30, pS233, DOI 10.1086/313867; Gregorio David I, 2005, Int J Health Geogr, V4, P6, DOI 10.1186/1476-072X-4-6; Gregorio DI, 2002, INT J CANCER, V100, P194, DOI 10.1002/ijc.10431; Kleinman KP, 2005, EPIDEMIOL INFECT, V133, P409, DOI 10.1017/S0950268804003528; Klovdahl AS, 2001, SOC SCI MED, V52, P681, DOI 10.1016/S0277-9536(00)00170-2; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lewis MD, 2002, AM J PREV MED, V23, P180, DOI 10.1016/S0749-3797(02)00490-7; Mandl KD, 2004, J AM MED INFORM ASSN, V11, P141, DOI 10.1197/jamia.M1356; MCELROY PD, 2003, INT J TUBERC LUNG, pS486; Mohtashemi M, 2007, STAT MED, V26, P5203, DOI 10.1002/sim.2872; Mohtashemi M, 2006, J THEOR BIOL, V241, P954, DOI 10.1016/j.jtbi.2006.01.031; NAUS JI, 1965, J AM STAT ASSOC, V60, P532, DOI 10.2307/2282688; NEILL DB, 2003, ADV IN NEURAL INFORM, V16; Olson KL, 2006, AM J PUBLIC HEALTH, V96, P2002, DOI 10.2105/AJPH.2005.069526; Reis BY, 2003, P NATL ACAD SCI USA, V100, P1961, DOI 10.1073/pnas.0335026100; Sheehan T J, 2000, J Public Health Manag Pract, V6, P48; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; vanDeutekom H, 1997, CLIN INFECT DIS, V25, P1071, DOI 10.1086/516072; WALLENSTEIN S, 1980, AM J EPIDEMIOL, V111, P367, DOI 10.1093/oxfordjournals.aje.a112908; WEINSTOCK MA, 1981, INT J EPIDEMIOL, V10, P289, DOI 10.1093/ije/10.3.289; World Health Organization, 2004, WORLD HLTH REP 2004	25	23	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1284	10.1371/journal.pone.0001284	http://dx.doi.org/10.1371/journal.pone.0001284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074010	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459500003
J	Stolarczyk, E; Le Gall, M; Even, P; Houllier, A; Serradas, P; Brot-Laroche, E; Leturque, A				Stolarczyk, Emilie; Le Gall, Maude; Even, Patrick; Houllier, Anne; Serradas, Patricia; Brot-Laroche, Edith; Leturque, Armelle			Loss of Sugar Detection by GLUT2 Affects Glucose Homeostasis in Mice	PLOS ONE			English	Article								Background. Mammals must sense the amount of sugar available to them and respond appropriately. For many years attention has focused on intracellular glucose sensing derived from glucose metabolism. Here, we studied the detection of extracellular glucose concentrations in vivo by invalidating the transduction pathway downstream from the transporter-detector GLUT2 and measured the physiological impact of this pathway. Methodology/Principal Findings. We produced mice that ubiquitously express the largest cytoplasmic loop of GLUT2, blocking glucose-mediated gene expression in vitro without affecting glucose metabolism. Impairment of GLUT2-mediated sugar detection transiently protected transgenic mice against starvation and streptozotocin-induced diabetes, suggesting that both low- and high-glucose concentrations were not detected. Transgenic mice favored lipid oxidation, and oral glucose was slowly cleared from blood due to low insulin production, despite massive urinary glucose excretion. Kidney adaptation was characterized by a lower rate of glucose reabsorption, whereas pancreatic adaptation was associated with a larger number of small islets. Conclusions/Significance. Molecular invalidation of sugar sensing in GLUT2-loop transgenic mice changed multiple aspects of glucose homeostasis, highlighting by a top-down approach, the role of membrane glucose receptors as potential therapeutic targets.	[Stolarczyk, Emilie; Le Gall, Maude; Houllier, Anne; Serradas, Patricia; Brot-Laroche, Edith; Leturque, Armelle] Univ Paris 06, Ctr Rech Cordeliers, UMR S 872, Paris, France; [Stolarczyk, Emilie; Le Gall, Maude; Houllier, Anne; Serradas, Patricia; Brot-Laroche, Edith; Leturque, Armelle] Univ Paris 05, UMR S 872, Paris, France; [Stolarczyk, Emilie; Le Gall, Maude; Houllier, Anne; Serradas, Patricia; Brot-Laroche, Edith; Leturque, Armelle] INSERM, U872, Paris, France; [Even, Patrick] AgroParisTech, French Natl Inst Agr Res, UMR Nutr Physiol & Ingest Behav 914, CRNH IdF, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Leturque, A (corresponding author), Univ Paris 06, Ctr Rech Cordeliers, UMR S 872, Paris, France.	armelle.leturque@crc.jussieu.fr	Le Gall, Maude/C-3917-2017; Serradas, Patricia/R-2185-2017; Le Gall, Maude/W-2593-2019; Leturque, Armelle/Q-9437-2017	Le Gall, Maude/0000-0002-5372-4585; Serradas, Patricia/0000-0002-6652-9746; Le Gall, Maude/0000-0002-5372-4585; Leturque, Armelle/0000-0001-6570-6387; Even, Patrick/0000-0001-5733-3023; HOULLIER, ANNE/0000-0002-4153-2535	CNRS; INSERM; UPMC; ALFEDIAM Merck Lipha; Benjamin Delessert; PNRD; French MRT; Fondation pour la Recherche Medicale fellowships	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC; ALFEDIAM Merck Lipha; Benjamin Delessert; PNRD; French MRT; Fondation pour la Recherche Medicale fellowships(Fondation pour la Recherche Medicale)	EBL and AL are grateful to CNRS, INSERM and UPMC for support. AL is recipient of ALFEDIAM Merck Lipha grant. MLG is an INSERM fellow and recipient of Benjamin Delessert and PNRD grants. ES is recipient of the French MRT and the Fondation pour la Recherche Medicale fellowships.	Bady I, 2006, DIABETES, V55, P988, DOI 10.2337/diabetes.55.04.06.db05-1386; Bandyopadhyay G, 2000, J BIOL CHEM, V275, P40817, DOI 10.1074/jbc.M007920200; Bernard C, 1998, DIABETES, V47, P1058, DOI 10.2337/diabetes.47.7.1058; Bernard C, 1999, FASEB J, V13, P1195, DOI 10.1096/fasebj.13.10.1195; Berry GT, 2005, MOL GENET METAB, V86, P473, DOI 10.1016/j.ymgme.2005.09.010; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; CHICK WL, 1973, DIABETES, V22, P687, DOI 10.2337/diab.22.9.687; Dai CS, 2005, AM J PATHOL, V167, P429, DOI 10.1016/S0002-9440(10)62987-2; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Even PC, 2003, AM J PHYSIOL-REG I, V284, pR751, DOI 10.1152/ajpregu.00268.2002; EVEN PC, 1994, NEUROSCI BIOBEHAV R, V18, P435, DOI 10.1016/0149-7634(94)90056-6; EVEN PC, 1991, PHYSIOL BEHAV, V49, P177, DOI 10.1016/0031-9384(91)90252-J; GIDDINGS SJ, 1981, J CLIN INVEST, V67, P952, DOI 10.1172/JCI110145; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Gouyon F, 2003, J PHYSIOL-LONDON, V552, P823, DOI 10.1113/jphysiol.2003.049247; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Guillam MT, 2000, DIABETES, V49, P1485, DOI 10.2337/diabetes.49.9.1485; Guillemain G, 2000, J CELL SCI, V113, P841; Guillemain G, 2002, BIOCHEM J, V364, P201, DOI 10.1042/bj3640201; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Hull R, 2005, DIABETOLOGIA, V48, P1350, DOI 10.1007/s00125-005-1772-9; ITOH N, 1980, NATURE, V283, P100, DOI 10.1038/283100a0; Izzedine H, 2003, AM J KIDNEY DIS, V41, P292, DOI 10.1053/ajkd.2003.50037; Jouannot E, 2006, ULTRASOUND MED BIOL, V32, P183, DOI 10.1016/j.ultrasmedbio.2005.10.008; Kaiser N, 2003, J PEDIATR ENDOCR MET, V16, P5, DOI 10.1515/JPEM.2003.16.1.5; Martinet W, 2006, AUTOPHAGY, V2, P55, DOI 10.4161/auto.2217; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; Menzel R, 1998, DIABETIC MED, V15, P816, DOI 10.1002/(SICI)1096-9136(199810)15:10<816::AID-DIA714>3.0.CO;2-P; MEUGNIER E, 2007, DIABETES; NIELSEN DA, 1985, J BIOL CHEM, V260, P3585; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Path G, 2006, AM J PHYSIOL-ENDOC M, V291, pE1168, DOI 10.1152/ajpendo.00436.2005; Poitout V, 2004, ANN ENDOCRINOL-PARIS, V65, P37, DOI 10.1016/S0003-4266(04)95628-4; Pontoglio M, 2000, EMBO REP, V1, P359, DOI 10.1093/embo-reports/kvd071; Quinet EM, 2004, J LIPID RES, V45, P1929, DOI 10.1194/jlr.M400257-JLR200; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Santer R, 1998, EUR J PEDIATR, V157, P783, DOI 10.1007/s004310050937; Schuit F, 2002, DIABETES, V51, pS326, DOI 10.2337/diabetes.51.2007.S326; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Skelly RH, 1996, DIABETES, V45, P37, DOI 10.2337/diabetes.45.1.37; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Teegarden D, 2005, J NUTR, V135, P2749, DOI 10.1093/jn/135.12.2749; Towle HC, 2005, TRENDS ENDOCRIN MET, V16, P489, DOI 10.1016/j.tem.2005.10.003; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; VOURETCRAVIARI V, 1993, BIOCHEM J, V289, P209, DOI 10.1042/bj2890209; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; WELSH M, 1985, J BIOL CHEM, V260, P3590; Wicksteed B, 2003, J BIOL CHEM, V278, P42080, DOI 10.1074/jbc.M303509200; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Yvan-Charvet L, 2005, DIABETES, V54, P991, DOI 10.2337/diabetes.54.4.991	56	31	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1288	10.1371/journal.pone.0001288	http://dx.doi.org/10.1371/journal.pone.0001288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074013	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459500007
J	Wang, JH; Valo, Z; Smith, D; Singer-Sam, J				Wang, Jinhui; Valo, Zuzana; Smith, David; Singer-Sam, Judith			Monoallelic Expression of Multiple Genes in the CNS	PLOS ONE			English	Article							ALLELE-SPECIFIC EXPRESSION; ASYNCHRONOUS REPLICATION; METHYLATION STATUS; PRADER-WILLI; CPG ISLANDS; MOUSE; PATTERNS; INTERLEUKIN-2; HIPPOCAMPAL; EVOLUTION	The inheritance pattern of a number of major genetic disorders suggests the possible involvement of genes that are expressed from one allele and silent on the other, but such genes are difficult to detect. Since DNA methylation in regulatory regions is often a mark of gene silencing, we modified existing microarray-based assays to detect both methylated and unmethylated DNA sequences in the same sample, a variation we term the MAUD assay. We probed a 65 Mb region of mouse Chr 7 for gene-associated sequences that show two distinct DNA methylation patterns in the mouse CNS. Selected genes were then tested for allele-specific expression in clonal neural stem cell lines derived from reciprocal F1 (C57BL/6xJF1) hybrid mice. In addition, using a separate approach, we directly analyzed allele-specific expression of a group of genes interspersed within clusters of OlfR genes, since the latter are subject to allelic exclusion. Altogether, of the 500 known genes in the chromosomal region surveyed, five show monoallelic expression, four identified by the MAUD assay (Agc1, p (pink-eyed dilution), P4ha3 and Thrsp), and one by its proximity to OlfR genes (Trim12). Thrsp (thyroid hormone responsive SPOT14 homolog) is expressed in hippocampus, but the human protein homolog, S14, has also been implicated in aggressive breast cancer. Monoallelic expression of the five genes is not coordinated at a chromosome-wide level, but rather regulated at individual loci. Taken together, our results suggest that at least 1% of previously untested genes are subject to allelic exclusion, and demonstrate a dual approach to expedite their identification.	[Wang, Jinhui; Valo, Zuzana; Singer-Sam, Judith] City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA; [Smith, David] City Hope Natl Med Ctr, Beckman Res Inst, Div Informat Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Singer-Sam, J (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA.	jsam@coh.org	Smith, David/A-4115-2017	Smith, David/0000-0001-9644-2353	NIH NIMH [R21 MH073754]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH073754] Funding Source: NIH RePORTER	NIH NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH NIMH grant R21 MH073754 to JS.	Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Allen E, 2003, P NATL ACAD SCI USA, V100, P9940, DOI 10.1073/pnas.1737401100; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Chai JH, 2001, MAMM GENOME, V12, P813, DOI 10.1007/s00335-001-2083-1; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Gabriel JM, 1998, MAMM GENOME, V9, P788, DOI 10.1007/s003359900868; Gimelbrant AA, 2005, J BIOL CHEM, V280, P1354, DOI 10.1074/jbc.M411283200; Gimelbrant AA, 2006, GENOME RES, V16, P723, DOI 10.1101/gr.5023706; Glusman G, 2000, GENOMICS, V63, P227, DOI 10.1006/geno.1999.6030; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Goldmit M, 2004, IMMUNOL REV, V200, P197, DOI 10.1111/j.0105-2896.2004.00158.x; Grillasca JP, 1997, FEBS LETT, V401, P38, DOI 10.1016/S0014-5793(96)01433-0; Hanel ML, 2001, MOL CELL BIOL, V21, P2384, DOI 10.1128/MCB.21.7.2384-2392.2001; Held W, 1997, EUR J IMMUNOL, V27, P2876, DOI 10.1002/eji.1830271120; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Mann JR, 2000, CRIT REV EUKAR GENE, V10, P241; Moncur JT, 1998, P NATL ACAD SCI USA, V95, P6989, DOI 10.1073/pnas.95.12.6989; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Pfister S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm094; Pham NV, 1998, BRAIN RES, V810, P1, DOI 10.1016/S0006-8993(98)00783-5; Rhoades KL, 2000, CURR BIOL, V10, P789, DOI 10.1016/S0960-9822(00)00565-0; RIMM IJ, 1989, MOL BIOL MED, V6, P355; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; RITTENHOUSE E, 1978, J EMBRYOL EXP MORPH, V43, P71; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Rodin SN, 2003, J MOL EVOL, V56, P718, DOI 10.1007/s00239-002-2446-6; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Sano Y, 2001, GENOME RES, V11, P1833, DOI 10.1101/gr.194301; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Shen SI, 1998, MOL GENET METAB, V63, P96, DOI 10.1006/mgme.1997.2668; Singh N, 2003, NAT GENET, V33, P339, DOI 10.1038/ng1102; Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102; Torrey EF, 1994, SCHIZOPHRENIA MANIC, P274; Van den Diepstraten C, 2003, CIRCULATION, V108, P508, DOI 10.1161/01.CIR.0000080883.53863.5C; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604	43	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1293	10.1371/journal.pone.0001293	http://dx.doi.org/10.1371/journal.pone.0001293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074017	Green Submitted, gold, Green Published			2022-12-27	WOS:000207459500012
J	Bourguet, D; Delmotte, F; Franck, P; Guillemaud, T; Reboud, X; Vacher, C; Walker, AS				Bourguet, Denis; Delmotte, Francois; Franck, Pierre; Guillemaud, Thomas; Reboud, Xavier; Vacher, Corinne; Walker, Anne-Sophie		REX Consortium	Structure of the Scientific Community Modelling the Evolution of Resistance	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; ANTIBIOTIC-RESISTANCE; POPULATION-GENETICS; DYNAMICS; LESSONS	Faced with the recurrent evolution of resistance to pesticides and drugs, the scientific community has developed theoretical models aimed at identifying the main factors of this evolution and predicting the efficiency of resistance management strategies. The evolutionary forces considered by these models are generally similar for viruses, bacteria, fungi, plants or arthropods facing drugs or pesticides, so interaction between scientists working on different biological organisms would be expected. We tested this by analysing co-authorship and co-citation networks using a database of 187 articles published from 1977 to 2006 concerning models of resistance evolution to all major classes of pesticides and drugs. These analyses identified two main groups. One group, led by ecologists or agronomists, is interested in agricultural crop or stock pests and diseases. It mainly uses a population genetics approach to model the evolution of resistance to insecticidal proteins, insecticides, herbicides, antihelminthic drugs and miticides. By contrast, the other group, led by medical scientists, is interested in human parasites and mostly uses epidemiological models to study the evolution of resistance to antibiotic and antiviral drugs. Our analyses suggested that there is also a small scientific group focusing on resistance to antimalaria drugs, and which is only poorly connected with the two larger groups. The analysis of cited references indicates that each of the two large communities publishes its research in a different set of literature and has its own keystone references: citations with a large impact in one group are almost never cited by the other. We fear the lack of exchange between the two communities might slow progress concerning resistance evolution which is currently a major issue for society.	[Vacher, Corinne] INRA, UMR Biodiversite Genes & Communautes BioGeCo 1210, F-33140 Villenave Dornon, France; [Walker, Anne-Sophie] INRA, UMR BIOGER CPP 1290, F-78026 Versailles, France; [Bourguet, Denis] INRA, UMR Ctr Biol & Gest Populat CBGP, F-34988 Montferrier Sur Lez, France; [Delmotte, Francois] INRA, UMR Sante Vegetale, F-33140 Villenave Dornon, France; [Franck, Pierre] INRA, UR Plantes & Syst Culture Horticoles 1115, F-84000 Avignon, France; [Guillemaud, Thomas] INRA, UMR ROSE 1112, F-06903 Sophia Antipolis, France; [Reboud, Xavier] INRA, UMR Biol & Gest Adventices 1210, F-21065 Dijon, France	INRAE; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut de Recherche pour le Developpement (IRD); INRAE; INRAE; INRAE; INRAE	Vacher, C (corresponding author), INRA, UMR Biodiversite Genes & Communautes BioGeCo 1210, F-33140 Villenave Dornon, France.	cvacher@bordeaux.inra.fr	Delmotte, Francois/B-4728-2013; Vacher, Corinne/Q-3182-2019; Vacher, Corinne/J-1777-2012; guillemaud, thomas/B-4899-2012; Vacher, Corinne/ABG-8163-2020	Delmotte, Francois/0000-0002-7138-8239; Vacher, Corinne/0000-0003-3023-6113; guillemaud, thomas/0000-0003-0451-1644; Vacher, Corinne/0000-0003-3023-6113; Bourguet, Denis/0000-0002-2109-5323	Departement Sante des Plantes et Environnement (SPE) of the Institut National de la Recherche Agronomique (INRA)	Departement Sante des Plantes et Environnement (SPE) of the Institut National de la Recherche Agronomique (INRA)	Financial support for this study was provided by the Departement Sante des Plantes et Environnement (SPE) of the Institut National de la Recherche Agronomique (INRA).	ANDERSON R M, 1991; [Anonymous], 1986, PESTICIDE RESISTANCE; [Anonymous], [No title captured]; AUBER D, 2002, GRAPH DRAWING, P488; Austin DJ, 1999, PHILOS T R SOC B, V354, P721, DOI 10.1098/rstb.1999.0425; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P6971, DOI 10.1073/pnas.94.13.6971; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P12106, DOI 10.1073/pnas.94.22.12106; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Clarke T, 2003, NATURE, V425, P225, DOI 10.1038/425225a; COMINS HN, 1977, J THEOR BIOL, V64, P177, DOI 10.1016/0022-5193(77)90119-9; CSARDI G, 2006, IGRAPH IGRAPH CLASS; D'Alessandro U, 2001, TROP MED INT HEALTH, V6, P845, DOI 10.1046/j.1365-3156.2001.00819.x; Finch R, 2006, CLIN MICROBIOL INFEC, V12, P3, DOI 10.1111/j.1469-0691.2006.01624.x; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Guillemot D, 1999, CURR OPIN MICROBIOL, V2, P494, DOI 10.1016/S1369-5274(99)00006-5; Hastings IM, 2004, TRENDS PARASITOL, V20, P512, DOI 10.1016/j.pt.2004.08.006; Hastings IM, 2001, TROP MED INT HEALTH, V6, P883, DOI 10.1046/j.1365-3156.2001.00800.x; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Koella JC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-3; Levin BR, 1997, CLIN INFECT DIS, V24, pS9, DOI 10.1093/clinids/24.Supplement_1.S9; Levin BR, 2002, NETH J MED, V60, P58; Levin BR, 2001, CLIN INFECT DIS, V33, pS161, DOI 10.1086/321843; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Marrone PG, 1999, OUTLOOK AGR, V28, P149, DOI 10.5367/000000099101292917; MAY RM, 1988, PHILOS T R SOC B, V318, P129, DOI 10.1098/rstb.1988.0002; Maynard-Smith J., 1998, EVOLUTIONARY GENETIC; MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384; Mielke P. W., 2001, PERMUTATION METHODS; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; Nowak MA, 1997, J THEOR BIOL, V184, P205, DOI 10.1006/jtbi.1996.0307; Oksanen J., 2006, VEGAN COMMUNITY ECOL; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peck SL, 2001, TRENDS MICROBIOL, V9, P286, DOI 10.1016/S0966-842X(01)02042-X; Prado PI, 2004, J ANIM ECOL, V73, P1168, DOI 10.1111/j.0021-8790.2004.00891.x; R Development Core Team, 2006, R LANG ENV STAT COMP; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; Stewart FM, 1998, THEOR POPUL BIOL, V53, P152, DOI 10.1006/tpbi.1997.1352	41	11	12	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1275	10.1371/journal.pone.0001275	http://dx.doi.org/10.1371/journal.pone.0001275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060069	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459400022
J	Nagai, A; Kim, WK; Lee, HJ; Jeong, HS; Kim, KS; Hong, SH; Park, IH; Kim, SU				Nagai, Atsushi; Kim, Woo K.; Lee, Hong J.; Jeong, Han S.; Kim, Kwang S.; Hong, Seok H.; Park, In H.; Kim, Seung U.			Multilineage Potential of Stable Human Mesenchymal Stem Cell Line Derived from Fetal Marrow	PLOS ONE			English	Article							PROMOTES FUNCTIONAL RECOVERY; CEREBRAL-ARTERY OCCLUSION; IN-VITRO DIFFERENTIATION; BONE-MARROW; STROMAL CELLS; INTRACEREBRAL HEMORRHAGE; RAT MODEL; BRAIN TRANSPLANTATION; PROGENITOR CELLS; ADULT-RAT	Human bone marrow contains two major cell types, hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs). MSCs possess self-renewal capacity and pluripotency defined by their ability to differentiate into osteoblasts, chondrocytes, adipocytes and muscle cells. MSCs are also known to differentiate into neurons and glial cells in vitro, and in vivo following transplantation into the brain of animal models of neurological disorders including ischemia and intracerebral hemorrhage (ICH) stroke. In order to obtain sufficient number and homogeneous population of human MSCs, we have clonally isolated permanent and stable human MSC lines by transfecting primary cell cultures of fetal human bone marrow MSCs with a retroviral vector encoding v-myc gene. One of the cell lines, HM3.B10 (B10), was found to differentiate into neural cell types including neural stem cells, neurons, astrocytes and oligodendrocytes in vitro as shown by expression of genetic markers for neural stem cells ( nestin and Musashi1), neurons ( neurofilament protein, synapsin and MAP2), astrocytes ( glial fibrillary acidic protein, GFAP) and oligodendrocytes ( myelin basic protein, MBP) as determined by RT-PCR assay. In addition, B10 cells were found to differentiate into neural cell types as shown by immunocytochical demonstration of nestin ( for neural stem cells), neurofilament protein and beta-tubulin III ( neurons) GFAP ( astrocytes), and galactocerebroside ( oligodendrocytes). Following brain transplantation in mouse ICH stroke model, B10 human MSCs integrate into host brain, survive, differentiate into neurons and astrocytes and induce behavioral improvement in the ICH animals. B10 human MSC cell line is not only a useful tool for the studies of organogenesis and specifically for the neurogenesis, but also provides a valuable source of cells for cell therapy studies in animal models of stroke and other neurological disorders.	[Nagai, Atsushi; Kim, Woo K.; Lee, Hong J.; Jeong, Han S.; Kim, Kwang S.; Hong, Seok H.; Kim, Seung U.] Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC V6T 1W5, Canada; [Nagai, Atsushi] Shimane Univ, Sch Med, Dept Lab Med, Izumo, Shimane, Japan; [Kim, Woo K.; Lee, Hong J.; Park, In H.; Kim, Seung U.] Gachon Univ, Gil Hosp, Inst Regnerat Med, Inchon, South Korea; [Jeong, Han S.] Chonnam Natl Univ, Sch Med, Dept Physiol, Kwangju, South Korea	University of British Columbia; Shimane University; Gachon University; Chonnam National University	Kim, SU (corresponding author), Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC V6T 1W5, Canada.	sukim@interchange.ubc.ca		Jeong, Han-Seong/0000-0001-6921-6625; Nagai, Atsushi/0000-0002-9280-8044	Korean Government (MOST) [M10641050001-06N4105-00110]; Canadian Myelin Research Initiative	Korean Government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government); Canadian Myelin Research Initiative	This study was supported by the Korean Government (MOST M10641050001-06N4105-00110) and the Canadian Myelin Research Initiative.	Acampora D, 2001, PROG NEUROBIOL, V64, P69, DOI 10.1016/S0301-0082(00)00042-3; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; Borlongan CV, 2005, LIFE SCI, V76, P1503, DOI 10.1016/j.lfs.2004.09.022; Borlongan CV, 2004, STROKE, V35, P2206, DOI 10.1161/01.STR.0000138954.25825.0b; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Cau E, 1997, DEVELOPMENT, V124, P1611; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Cho T, 2002, NEUROREPORT, V13, P1447, DOI 10.1097/00001756-200208070-00020; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Ehtesham M, 2004, NEOPLASIA, V6, P287, DOI 10.1593/neo.03427; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Gajovic S, 1997, DIFFERENTIATION, V62, P187; Gebel JM, 2000, NEUROL CLIN, V18, P419, DOI 10.1016/S0733-8619(05)70200-0; Good P, 1998, GENOMICS, V52, P382, DOI 10.1006/geno.1998.5456; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Inagawa T, 2002, NEUROSURG REV, V25, P237, DOI 10.1007/s10143-002-0222-0; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jiang YH, 2003, P NATL ACAD SCI USA, V100, P11854, DOI 10.1073/pnas.1834196100; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim BJ, 2002, NEUROREPORT, V13, P1185, DOI 10.1097/00001756-200207020-00023; Kim Seung U, 2002, Methods Mol Biol, V198, P55; Kim SU, 2006, NEUROPATHOLOGY, V26, P129, DOI 10.1111/j.1440-1789.2006.00688.x; KIM SU, 1986, J NEUROSCI RES, V15, P303, DOI 10.1002/jnr.490150303; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; KIM SU, 1983, BRAIN RES, V274, P79, DOI 10.1016/0006-8993(83)90522-X; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Krause DS, 2002, GENE THER, V9, P754, DOI 10.1038/sj.gt.3301760; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Lee HJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000156; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lee ST, 2005, NEUROSCI RES, V52, P243, DOI 10.1016/j.neures.2005.03.016; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Meng XL, 2003, J NEUROSCI RES, V74, P266, DOI 10.1002/jnr.10764; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Modo M, 2002, BRAIN RES, V958, P70, DOI 10.1016/S0006-8993(02)03463-7; Morgenstern LB, 2005, STROKE, V36, pE23, DOI 10.1161/01.STR.0000155685.77775.4c; Nagai A, 2001, NEUROBIOL DIS, V8, P1057, DOI 10.1006/nbdi.2001.0437; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ourednik V, 2001, SCIENCE, V293, P1820, DOI 10.1126/science.1060580; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Schmidt NO, 2005, NEOPLASIA, V7, P623, DOI 10.1593/neo.04781; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Snyder SH, 1998, NEURON, V21, P283, DOI 10.1016/S0896-6273(00)80538-3; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; Steiner JP, 1997, P NATL ACAD SCI USA, V94, P2019, DOI 10.1073/pnas.94.5.2019; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Sun LX, 2004, J CLIN INVEST, V113, P1364, DOI 10.1172/JCI200420001; Terzic J, 1999, INT J DEV BIOL, V43, P501; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wieczorek G, 2003, CELL TISSUE RES, V311, P227, DOI 10.1007/s00441-002-0671-3; Woitge Henning W., 1999, Current Opinion in Rheumatology, V11, P218, DOI 10.1097/00002281-199905000-00011; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004; Zhang WR, 1999, NEUROSCI LETT, V276, P161, DOI 10.1016/S0304-3940(99)00848-4; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	83	104	114	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1272	10.1371/journal.pone.0001272	http://dx.doi.org/10.1371/journal.pone.0001272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060066	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459400019
J	Bull, TJ; Gilbert, SC; Sridhar, S; Linedale, R; Dierkes, N; Sidi-Boumedine, K; Hermon-Taylor, J				Bull, Tim J.; Gilbert, Sarah C.; Sridhar, Saranya; Linedale, Richard; Dierkes, Nicola; Sidi-Boumedine, Karim; Hermon-Taylor, John			A Novel Multi-Antigen Virally Vectored Vaccine against Mycobacterium avium Subspecies paratuberculosis	PLOS ONE			English	Article								Background. Mycobacterium avium subspecies paratuberculosis causes systemic infection and chronic intestinal inflammation in many species including primates. Humans are exposed through milk and from sources of environmental contamination. Hitherto, the only vaccines available against Mycobacterium avium subspecies paratuberculosis have been limited to veterinary use and comprised attenuated or killed organisms. Methods. We developed a vaccine comprising a fusion construct designated HAV, containing components of two secreted and two cell surface Mycobacterium avium subspecies paratuberculosis proteins. HAV was transformed into DNA, human Adenovirus 5 (Ad5) and Modified Vaccinia Ankara (MVA) delivery vectors. Full length expression of the predicted 95 kDa fusion protein was confirmed. Principal Findings. Vaccination of naive and Mycobacterium avium subspecies paratuberculosis infected C57BL/6 mice using DNA-prime/MVA-boost or Ad5-prime/MVA-boost protocols was highly immunogenic resulting in significant IFN-gamma ELISPOT responses by splenocytes against recombinant vaccine antigens and a range of HAV specific peptides. This included strong recognition of a T-cell epitope GFAEINPIA located near the C-terminus of the fusion protein. Antibody responses to recombinant vaccine antigens and HAV specific peptides but not GFAEINPIA, also occurred. No immune recognition of vaccine antigens occurred in any sham vaccinated Mycobacterium avium subspecies paratuberculosis infected mice. Vaccination using either protocol significantly attenuated pre-existing Mycobacterium avium subspecies paratuberculosis infection measured by qPCR in spleen and liver and the Ad5-prime/MVA-boost protocol also conferred some protection against subsequent challenge. No adverse effects of vaccination occurred in any of the mice. Conclusions/Significance. A range of modern veterinary and clinical vaccines for the treatment and prevention of disease caused by Mycobacterium avium subspecies paratuberculosis are needed. The present vaccine proved to be highly immunogenic without adverse effect in mice and both attenuated pre-existing Mycobacterium avium subspecies paratuberculosis infection and conferred protection against subsequent challenge. Further studies of the present vaccine in naturally infected animals and humans are indicated.	[Bull, Tim J.; Linedale, Richard; Dierkes, Nicola; Sidi-Boumedine, Karim; Hermon-Taylor, John] St Georges Univ London, Dept Cardiovasc Sci Surg, London, England; [Gilbert, Sarah C.; Sridhar, Saranya] Univ Oxford, Nuffield Dept Med, Wellcome Trust Ctr Human Genet, Oxford, England	St Georges University London; University of Oxford; Wellcome Centre for Human Genetics	Hermon-Taylor, J (corresponding author), St Georges Univ London, Dept Cardiovasc Sci Surg, London, England.	jhermon@sgul.ac.uk	Gilbert, Sarah C./H-2857-2019	Gilbert, Sarah C./0000-0002-6823-9750; Sidi-Boumedine, Karim/0000-0003-2746-9629; Sridhar, Saranya/0000-0002-4267-3102	MRC/NERC; National Association of Crohn's and Colitis; Action Medical Research	MRC/NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Medical Research Council UK (MRC)); National Association of Crohn's and Colitis; Action Medical Research	Support for this work was contributed by grants from the MRC/NERC, National Association of Crohn's and Colitis, Action Medical Research and multiple trusts and private donors. The funders had no role in the study design and conduct, data collection and analysis, decision to publish, or in the preparation of the manuscript.	Autschbach F, 2005, GUT, V54, P944, DOI 10.1136/gut.2004.045526; Basagoudanavar SH, 2006, VET RES COMMUN, V30, P357, DOI 10.1007/s11259-006-3253-0; Begg DJ, 2005, VACCINE, V23, P4999, DOI 10.1016/j.vaccine.2005.05.031; BUERGELT CD, 1978, VET PATHOL, V15, P196, DOI 10.1177/030098587801500206; Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; Bull TJ, 2000, VET MICROBIOL, V77, P453, DOI 10.1016/S0378-1135(00)00330-8; Chacon O, 2004, ANNU REV MICROBIOL, V58, P329, DOI 10.1146/annurev.micro.58.030603.123726; CHIODINI RJ, 1993, J COMP PATHOL, V109, P309, DOI 10.1016/S0021-9975(08)80295-2; Clarke CJ, 1997, J COMP PATHOL, V116, P217, DOI 10.1016/S0021-9975(97)80001-1; Clarke CJ, 1996, J COMP PATHOL, V114, P419, DOI 10.1016/S0021-9975(96)80017-X; Corn JL, 2005, APPL ENVIRON MICROB, V71, P6963, DOI 10.1128/AEM.71.11.6963-6967.2005; Corpa JM, 2000, VET REC, V146, P195, DOI 10.1136/vr.146.7.195; Dupont C, 2005, J MED MICROBIOL, V54, P1083, DOI 10.1099/jmm.0.46163-0; Eckstein TM, 2003, MICROBIOL-SGM, V149, P2797, DOI 10.1099/mic.0.26528-0; Ellingson JLE, 2005, J FOOD PROTECT, V68, P966, DOI 10.4315/0362-028X-68.5.966; Estcourt MJ, 2005, EUR J IMMUNOL, V35, P2532, DOI 10.1002/eji.200535184; Feller M, 2007, LANCET INFECT DIS, V7, P607, DOI 10.1016/S1473-3099(07)70211-6; Gearry RB, 2006, INFLAMM BOWEL DIS, V12, P936, DOI 10.1097/01.mib.0000231572.88806.b9; Greig A, 1999, J CLIN MICROBIOL, V37, P1746, DOI 10.1128/JCM.37.6.1746-1751.1999; Gwozdz JM, 2000, AUST VET J, V78, P560, DOI 10.1111/j.1751-0813.2000.tb11902.x; Hanke T, 1998, VACCINE, V16, P426, DOI 10.1016/S0264-410X(97)00296-X; Hanke T, 1998, VACCINE, V16, P439, DOI 10.1016/S0264-410X(97)00226-0; Hermon-Taylor J, 2000, CAN J GASTROENTEROL, V14, P521, DOI 10.1155/2000/798305; Hildebrand H, 2003, GUT, V52, P1432, DOI 10.1136/gut.52.10.1432; Huntley JF, 2005, INFECT IMMUN, V73, P6877, DOI 10.1128/IAI.73.10.6877-6884.2005; Kalis CHJ, 2001, AM J VET RES, V62, P270, DOI 10.2460/ajvr.2001.62.270; Koets A, 2006, VACCINE, V24, P2550, DOI 10.1016/j.vaccine.2005.12.019; KORMENDY B, 1994, VET MICROBIOL, V41, P117, DOI 10.1016/0378-1135(94)90141-4; LARSEN AB, 1978, AM J VET RES, V39, P65; Mackintosh CG, 2005, NEW ZEAL VET J, V53, P216, DOI 10.1080/00480169.2005.36549; Manning EJB, 2001, REV SCI TECH OIE, V20, P133, DOI 10.20506/rst.20.1.1275; Marri PR, 2006, FEMS MICROBIOL REV, V30, P906, DOI 10.1111/j.1574-6976.2006.00041.x; McShane H, 2001, INFECT IMMUN, V69, P681, DOI 10.1128/IAI.69.2.681-686.2001; Mullerad J, 2002, MED MICROBIOL IMMUN, V190, P179, DOI 10.1007/s00430-001-0104-z; Mullerad J, 2003, MICROB PATHOGENESIS, V34, P81, DOI 10.1016/S0882-4010(02)00209-7; Mura M, 2006, APPL ENVIRON MICROB, V72, P854, DOI 10.1128/AEM.72.1.854-859.2006; Muskens J, 2002, VET MICROBIOL, V86, P269, DOI 10.1016/S0378-1135(02)00006-8; Naser SA, 1998, CURR MICROBIOL, V37, P373, DOI 10.1007/s002849900396; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Olsen I, 2000, INFECT IMMUN, V68, P801, DOI 10.1128/IAI.68.2.801-808.2000; Pickup RW, 2006, APPL ENVIRON MICROB, V72, P4067, DOI 10.1128/AEM.02490-05; Pickup RW, 2005, APPL ENVIRON MICROB, V71, P2130, DOI 10.1128/AEM.71.4.2130-2139.2005; Raizman EA, 2005, CAN J VET RES, V69, P32; Reddacliff L, 2006, VET MICROBIOL, V115, P77, DOI 10.1016/j.vetmic.2005.12.021; RIEMANN HP, 1983, ADV VET SCI COMP MED, V27, P481; Rigden RC, 2006, J MED MICROBIOL, V55, P1735, DOI 10.1099/jmm.0.46785-0; Romero C, 2005, INFLAMM BOWEL DIS, V11, P116, DOI 10.1097/00054725-200502000-00004; SANDERSON JD, 1992, GUT, V33, P145, DOI 10.1136/gut.33.2.145; SAXEGAARD F, 1985, VET REC, V116, P439, DOI 10.1136/vr.116.16.439; SCANU AM, 2007, J CLIN MICR IN PRESS, V45; Sechi LA, 2006, VACCINE, V24, P229, DOI 10.1016/j.vaccine.2005.08.086; Sechi LA, 2005, AM J GASTROENTEROL, V100, P1529, DOI 10.1111/j.1572-0241.2005.41415.x; Sheridan JM, 2003, J MOL MICROB BIOTECH, V5, P57, DOI 10.1159/000068723; Shin SJ, 2005, INFECT IMMUN, V73, P5074, DOI 10.1128/IAI.73.8.5074-5085.2005; SIGURDSSON B, 1960, AM J VET RES, V21, P54; Singh SV, 2007, VACCINE, V25, P7102, DOI 10.1016/j.vaccine.2007.07.054; STUART P, 1965, BRIT VET J, V121, P289, DOI 10.1016/S0007-1935(17)41102-X; SWEENEY RW, 1992, J CLIN MICROBIOL, V30, P166, DOI 10.1128/JCM.30.1.166-171.1992; Tizard M, 1998, MICROBIOL-SGM, V144, P3413, DOI 10.1099/00221287-144-12-3413; TIZARD MLV, 1992, J GEN MICROBIOL, V138, P1729, DOI 10.1099/00221287-138-8-1729; Turunen P, 2006, INFLAMM BOWEL DIS, V12, P677, DOI 10.1097/00054725-200608000-00002; vanSchaik G, 1996, VET REC, V139, P624; Vind I, 2006, AM J GASTROENTEROL, V101, P1274, DOI 10.1111/j.1572-0241.2006.00552.x; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; WENTINK GH, 1994, J VET MED B, V41, P517, DOI 10.1111/j.1439-0450.1994.tb00258.x; Whittington RJ, 2005, APPL ENVIRON MICROB, V71, P5304, DOI 10.1128/AEM.71.9.5304-5308.2005; Whittington RJ, 2004, APPL ENVIRON MICROB, V70, P2989, DOI 10.1128/AEM.70.5.2989-3004.2004; WILESMITH JW, 1982, BRIT VET J, V138, P321, DOI 10.1016/S0007-1935(17)31037-0; Withers-Martinez C, 1999, PROTEIN ENG, V12, P1113, DOI 10.1093/protein/12.12.1113	69	26	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1229	10.1371/journal.pone.0001229	http://dx.doi.org/10.1371/journal.pone.0001229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043737	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000207459300011
J	Choi, K; Creighton, CJ; Stivers, D; Fujimoto, N; Kurie, JM				Choi, Kuicheon; Creighton, Chad J.; Stivers, David; Fujimoto, Nobukazu; Kurie, Jonathan M.			Transcriptional Profiling of Non-Small Cell Lung Cancer Cells with Activating EGFR Somatic Mutations	PLOS ONE			English	Article								Background. Activating somatic mutations in epidermal growth factor receptor (EGFR) confer unique biologic features to non-small cell lung cancer (NSCLC) cells, but the transcriptional mediators of EGFR in this subgroup of NSCLC have not been fully elucidated. Methodology/Principal Findings. Here we used genetic and pharmacologic approaches to elucidate the transcriptomes of NSCLC cell lines. We transcriptionally profiled a panel of EGFR-mutant and -wild-type NSCLC cell lines cultured in the presence or absence of an EGFR tyrosine kinase inhibitor. Hierarchical analysis revealed that the cell lines segregated on the basis of EGFR mutational status (mutant versus wild-type), and expression signatures were identified by supervised analysis that distinguished the cell lines based on mutational status (wild-type versus mutant) and type of mutation (L858R versus D746-750). Using an EGFR mutation-specific expression signature as a probe, we mined the gene expression profiles of two independent cohorts of NSCLC patients and found the signature in a subset. EGFR tyrosine kinase inhibitor treatment regulated the expression of multiple genes, and pharmacologic inhibition of the protein products of two of them (PTGS2 and EphA2) inhibited anchorage-independent growth in EGFR-mutant NSCLC cells. Conclusions/Significance. We have elucidated genes not previously associated with EGFR-mutant NSCLC, two of which enhanced the clonogenicity of these cells, distinguishing these mediators from others previously shown to maintain cell survival. These findings have potential clinical relevance given the availability of pharmacologic tools to inhibit the protein products of these genes.	[Choi, Kuicheon; Fujimoto, Nobukazu; Kurie, Jonathan M.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Stivers, David] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Kurie, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA.	jkurie@mdanderson.org	Fujimoto, Nobukazu/U-8488-2019	Fujimoto, Nobukazu/0000-0002-4516-0433	National Cancer Institute [P50 CA70907, P30 CA125123, R01 CA117965]; NATIONAL CANCER INSTITUTE [R01CA117965, P50CA070907, P30CA125123] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute grants P50 CA70907, P30 CA125123, and R01 CA117965.	Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Creighton C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r46; Creighton CJ, 2006, CANCER RES, V66, P3903, DOI 10.1158/0008-5472.CAN-05-4363; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fujimoto K, 2001, AM J RESP CELL MOL, V25, P233, DOI 10.1165/ajrcmb.25.2.4275; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Lavergne E, 2003, CANCER RES, V63, P7468; LIU M, 2007, AM J RESP CELL MOL B; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Riely GJ, 2006, CLIN CANCER RES, V12, P7232, DOI 10.1158/1078-0432.CCR-06-0658; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Shulby SA, 2004, CANCER RES, V64, P4693, DOI 10.1158/0008-5472.CAN-03-3437; Song LX, 2006, CANCER RES, V66, P5542, DOI 10.1158/0008-5472.CAN-05-4620; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Walker-Daniels J, 2003, AM J PATHOL, V162, P1037, DOI 10.1016/S0002-9440(10)63899-0; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wu R, 2005, CLIN CANCER RES, V11, P6155, DOI 10.1158/1078-0432.CCR-04-2664; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang J, 2007, AM J PATHOL, V170, P366, DOI 10.2353/ajpath.2007.060706	38	23	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1226	10.1371/journal.pone.0001226	http://dx.doi.org/10.1371/journal.pone.0001226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030354	gold, Green Submitted, Green Published			2022-12-27	WOS:000207459200033
J	Gondek, LP; Dunbar, AJ; Szpurka, H; McDevitt, MA; Maciejewski, JP				Gondek, Lukasz P.; Dunbar, Andrew J.; Szpurka, Hadrian; McDevitt, Michael A.; Maciejewski, Jaroslaw P.			SNP Array Karyotyping Allows for the Detection of Uniparental Disomy and Cryptic Chromosomal Abnormalities in MDS/MPD-U and MPD	PLOS ONE			English	Article								We applied single nucleotide polymorphism arrays (SNP-A) to study karyotypic abnormalities in patients with atypical myeloproliferative syndromes (MPD), including myeloproliferative/myelodysplastic syndrome overlap both positive and negative for the JAK2 V617F mutation and secondary acute myeloid leukemia (AML). In typical MPD cases (N = 8), which served as a control group, those with a homozygous V617F mutation showed clear uniparental disomy (UPD) of 9p using SNP-A. Consistent with possible genomic instability, in 19/30 MDS/MPD-U patients, we found additional lesions not identified by metaphase cytogenetics. In addition to UPD9p, we also have detected UPD affecting other chromosomes, including 1 (2/30), 11 (4/30), 12 (1/30) and 22 (1/30). Transformation to AML was observed in 8/30 patients. In 5 V617F+ patients who progressed to AML, we show that SNP-A can allow for the detection of two modes of transformation: leukemic blasts evolving from either a wild-type jak2 precursor carrying other acquired chromosomal defects, or from a V617F+ mutant progenitor characterized by UPD9p. SNP-A-based detection of cryptic lesions in MDS/MPD-U may help explain the clinical heterogeneity of this disorder.	[Gondek, Lukasz P.; Dunbar, Andrew J.; Szpurka, Hadrian; Maciejewski, Jaroslaw P.] Cleveland Clin, Expt Hematol & Hematopoiesis Sect, Taussig Canc Ctr, Cleveland, OH 44106 USA; [McDevitt, Michael A.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [McDevitt, Michael A.] Sidney Kimmel Canc Ctr, Baltimore, MD USA	Cleveland Clinic Foundation; Johns Hopkins University	Maciejewski, JP (corresponding author), Cleveland Clin, Expt Hematol & Hematopoiesis Sect, Taussig Canc Ctr, Cleveland, OH 44106 USA.	maciejj@ccf.org			NIH [R01 HL082983, U54 RR019391, K24 HL077522]; Robert Duggan Cancer Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019391] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082983, K24HL077522] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Duggan Cancer Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH R01 HL082983(JPM), U54 RR019391(JPM), K24 HL077522(JPM) and a charitable donation from Robert Duggan Cancer Research Fund.	Adeyinka A, 2003, HEMATOL ONCOL CLIN N, V17, P1129, DOI 10.1016/S0889-8588(03)00087-X; Andersen CL, 2007, CARCINOGENESIS, V28, P38, DOI 10.1093/carcin/bgl086; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Cabello AI, 2005, LEUKEMIA RES, V29, P365, DOI 10.1016/j.leukres.2004.07.014; Campbell PJ, 2006, BLOOD, V108, P3548, DOI 10.1182/blood-2005-12-013748; Dingli D, 2006, CANCER-AM CANCER SOC, V106, P1985, DOI 10.1002/cncr.21868; Frohling S, 2006, BLOOD, V107, P1242, DOI 10.1182/blood-2005-09-3644; GONDEK L, 2007, BLOOD IN PRESS; Gondek LP, 2007, LEUKEMIA, V21, P2058, DOI 10.1038/sj.leu.2404745; Harir N, 2007, BLOOD, V109, P1678, DOI 10.1182/blood-2006-01-029918; Harris NL, 1999, J CLIN ONCOL, V17, P3835, DOI 10.1200/JCO.1999.17.12.3835; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Lee JW, 2006, ONCOGENE, V25, P1434, DOI 10.1038/sj.onc.1209163; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Lippert E, 2006, BLOOD, V108, P1865, DOI 10.1182/blood-2006-01-013540; MOHAMEDALI A, 2007, BLOOD IN PRESS; Morison IM, 2002, BLOOD, V99, P375, DOI 10.1182/blood.V99.1.375; Najfeld V, 2002, BRIT J HAEMATOL, V119, P558, DOI 10.1046/j.1365-2141.2002.03763.x; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Nigro JM, 2001, AM J PATHOL, V158, P1253, DOI 10.1016/S0002-9440(10)64076-X; Nyga R, 2005, BIOCHEM J, V390, P359, DOI 10.1042/BJ20041523; Pei JM, 2006, CANCER GENET CYTOGEN, V170, P65, DOI 10.1016/j.cancergencyto.2006.05.002; Raghavan M, 2005, CANCER RES, V65, P375; SHAFFER LG, 2005, TOMMERUP N INT SYSTE; Steensma DP, 2006, LEUKEMIA, V20, P971, DOI 10.1038/sj.leu.2404206; Steensma DP, 2005, BLOOD, V106, P1207, DOI 10.1182/blood-2005-03-1183; Szpurka H, 2006, BLOOD, V108, P2173, DOI 10.1182/blood-2006-02-005751; Tefferi A, 2005, CANCER, V104, P1656, DOI 10.1002/cncr.21358; Theocharides A, 2007, BLOOD, V110, P375, DOI 10.1182/blood-2006-12-062125; Tiu R, 2007, LEUKEMIA, V21, P1648, DOI 10.1038/sj.leu.2404757; VARDIMAN JW, 2001, WHO CLASSIFICATION T, P45; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88	39	71	76	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1225	10.1371/journal.pone.0001225	http://dx.doi.org/10.1371/journal.pone.0001225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030353	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459200032
J	Grandjean, V; Yaman, R; Cuzin, F; Rassoulzadegan, M				Grandjean, Valerie; Yaman, Ruken; Cuzin, Francois; Rassoulzadegan, Minoo			Inheritance of an Epigenetic Mark: The CpG DNA Methyltransferase 1 Is Required for De Novo Establishment of a Complex Pattern of Non-CpG Methylation	PLOS ONE			English	Article								Site-specific methylation of cytosines is a key epigenetic mark of vertebrate DNA. While a majority of the methylated residues are in the symmetrical (meC)pG:Gp(meC) configuration, a smaller, but significant fraction is found in the CpA, CpT and CpC asymmetric (non-CpG) dinucleotides. CpG methylation is reproducibly maintained by the activity of the DNA methyltransferase 1 (Dnmt1) on the newly replicated hemimethylated substrates (meC)pG:GpC. On the other hand, establishment and hereditary maintenance of non-CpG methylation patterns have not been analyzed in detail. We previously reported the occurrence of site- and allele-specific methylation at both CpG and non-CpG sites. Here we characterize a hereditary complex of non-CpG methylation, with the transgenerational maintenance of three distinct profiles in a constant ratio, associated with extensive CpG methylation. These observations raised the question of the signal leading to the maintenance of the pattern of asymmetric methylation. The complete non-CpG pattern was reinstated at each generation in spite of the fact that the majority of the sperm genomes contained either none or only one methylated non-CpG site. This observation led us to the hypothesis that the stable CpG patterns might act as blueprints for the maintenance of non-CpG DNA methylation. As predicted, non-CpG DNA methylation profiles were abrogated in a mutant lacking Dnmt1, the enzymes responsible for CpG methylation, but not in mutants defective for either Dnmt3a or Dnmt2.	[Grandjean, Valerie; Yaman, Ruken; Cuzin, Francois; Rassoulzadegan, Minoo] Fac Med Nice, INSERM, U636, Nice, France; [Grandjean, Valerie; Yaman, Ruken; Cuzin, Francois; Rassoulzadegan, Minoo] Equipe Labellisee Ligue Natl Canc, Nice, France; [Grandjean, Valerie; Yaman, Ruken; Cuzin, Francois; Rassoulzadegan, Minoo] Univ Nice Sophia Antipolis, Lab Genet Dev Normal & Pathol, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Grandjean, V (corresponding author), Fac Med Nice, INSERM, U636, Nice, France.	grandjea@unice.fr	Hu, Ruogu/B-2203-2008; Grandjean, Valerie/O-3935-2016; Rassoulzadegan, Minoo/O-7939-2016	Valerie, GRANDJEAN/0000-0003-1661-7411	Ligue Nationale Francaise Contre le Cancer	Ligue Nationale Francaise Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by a grant from the Ligue Nationale Francaise Contre le Cancer to Minoo Rassoulzadegan.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Cherry SR, 1999, P NATL ACAD SCI USA, V96, P10788, DOI 10.1073/pnas.96.19.10788; Dodge JE, 2002, GENE, V289, P41, DOI 10.1016/S0378-1119(02)00469-9; Gardiner-Garden M, 1998, MOL CELL BIOL, V18, P3350, DOI 10.1128/MCB.18.6.3350; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Imamura T, 2005, J BIOL CHEM, V280, P20171, DOI 10.1074/jbc.M501749200; Kouidou S, 2006, MUTAT RES-FUND MOL M, V599, P167, DOI 10.1016/j.mrfmmm.2006.03.002; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, COLD SPRING HARB SYM, V58, P297, DOI 10.1101/SQB.1993.058.01.035; MEYER P, 1994, EMBO J, V13, P2084, DOI 10.1002/j.1460-2075.1994.tb06483.x; Mund C, 2004, BIOCHEM J, V378, P763, DOI 10.1042/BJ20031567; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Pelissier T, 2000, RNA, V6, P55, DOI 10.1017/S135583820099201X; Pittoggi C, 1999, J CELL SCI, V112, P3537; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Rassoulzadegan M, 2002, EMBO J, V21, P440, DOI 10.1093/emboj/21.3.440; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; White GP, 2002, J IMMUNOL, V168, P2820, DOI 10.4049/jimmunol.168.6.2820	24	62	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1136	10.1371/journal.pone.0001136	http://dx.doi.org/10.1371/journal.pone.0001136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17989773	gold, Green Submitted, Green Published			2022-12-27	WOS:000207459000020
J	Lachaux, JP; Jerbi, K; Bertrand, O; Minotti, L; Hoffmann, D; Schoendorff, B; Kahane, P				Lachaux, Jean-Philippe; Jerbi, Karim; Bertrand, Olivier; Minotti, Lorella; Hoffmann, Dominique; Schoendorff, Benjamin; Kahane, Philippe			A Blueprint for Real-Time Functional Mapping via Human Intracranial Recordings	PLOS ONE			English	Article								Background. The surgical treatment of patients with intractable epilepsy is preceded by a pre-surgical evaluation period during which intracranial EEG recordings are performed to identify the epileptogenic network and provide a functional map of eloquent cerebral areas that need to be spared to minimize the risk of post-operative deficits. A growing body of research based on such invasive recordings indicates that cortical oscillations at various frequencies, especially in the gamma range (40 to 150 Hz), can provide efficient markers of task-related neural network activity. Principal Findings. Here we introduce a novel real-time investigation framework for mapping human brain functions based on online visualization of the spectral power of the ongoing intracranial activity. The results obtained with the first two implanted epilepsy patients who used the proposed online system illustrate its feasibility and utility both for clinical applications, as a complementary tool to electrical stimulation for presurgical mapping purposes, and for basic research, as an exploratory tool used to detect correlations between behavior and oscillatory power modulations. Furthermore, our findings suggest a putative role for high gamma oscillations in higher-order auditory processing involved in speech and music perception. Conclusion/Significance. The proposed real-time setup is a promising tool for presurgical mapping, the investigation of functional brain dynamics, and possibly for neurofeedback training and brain computer interfaces.	[Lachaux, Jean-Philippe; Jerbi, Karim; Bertrand, Olivier; Schoendorff, Benjamin] INSERM, U821, F-69500 Lyon, France; [Lachaux, Jean-Philippe; Jerbi, Karim; Bertrand, Olivier] Inst Federatif Neurosci, F-69000 Lyon, France; [Lachaux, Jean-Philippe; Jerbi, Karim; Bertrand, Olivier] Univ Lyon 1, F-69000 Lyon, France; [Jerbi, Karim] Coll France, CNRS, Lab Physiol Percept & Act, F-75231 Paris, France; [Minotti, Lorella; Kahane, Philippe] Grenoble Hosp, Dept Neurol, Grenoble, France; [Minotti, Lorella; Kahane, Philippe] Grenoble Hosp, INSERM, U704, Grenoble, France; [Hoffmann, Dominique] Grenoble Hosp, Dept Neurosurg, Grenoble, France; [Hoffmann, Dominique] Grenoble Hosp, INSERM, U318, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Lachaux, JP (corresponding author), INSERM, U821, F-69500 Lyon, France.	lachaux@lyon.inserm.fr	Lachaux, Jean-Philippe/K-1681-2017; Bertrand, Olivier/B-6165-2008; KAHANE, PHILIPPE/P-5669-2016	Bertrand, Olivier/0000-0003-0733-7979; 	Agence Nationale de la Recherche (ANR); Reseau National des Technologies Logicielles (RNTL); Neurobotics project (EU FET) [FP6-IST-001917]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Reseau National des Technologies Logicielles (RNTL); Neurobotics project (EU FET)	Funding: This work was supported by the Agence Nationale de la Recherche (ANR) and by the Reseau National des Technologies Logicielles (RNTL) via the Open-ViBE project, as well as the Neurobotics project (EU FET Neurobotics FP6-IST-001917).	Aoki F, 1999, CLIN NEUROPHYSIOL, V110, P524, DOI 10.1016/S1388-2457(98)00064-9; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Bartolomei F, 2004, NEUROLOGY, V63, P858, DOI 10.1212/01.WNL.0000137037.56916.3F; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; BIDETCAULET A, 2003, NEUROIMAGE, V19, P1554; Birbaumer N, 2006, PROG BRAIN RES, V159, P369, DOI 10.1016/S0079-6123(06)59024-7; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Brovelli A, 2005, NEUROIMAGE, V28, P154, DOI 10.1016/j.neuroimage.2005.05.045; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; CHATRIAN GE, 1960, ELECTROEN CLIN NEURO, V12, P167, DOI 10.1016/0013-4694(60)90070-5; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Crone NE, 2001, NEUROLOGY, V57, P2045, DOI 10.1212/WNL.57.11.2045; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Edwards E, 2005, J NEUROPHYSIOL, V94, P4269, DOI 10.1152/jn.00324.2005; Fecteau S, 2004, NEUROIMAGE, V23, P840, DOI 10.1016/j.neuroimage.2004.09.019; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Graimann B, 2004, IEEE T BIO-MED ENG, V51, P954, DOI 10.1109/TBME.2004.826671; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Humphries C, 2005, HUM BRAIN MAPP, V26, P128, DOI 10.1002/hbm.20148; Jack A. I, 2004, TRUSTING SUBJECT USE; Kahane P, 2003, ANN NEUROL, V54, P615, DOI 10.1002/ana.10726; KAHANE P, 2004, HDB CLIN NEUROPHYSIO; Kahane P, 1993, NEUROPHYSIOL CLIN, V22, P305; Kahane P, 2006, EPILEPTIC DISORD, V8, pS16; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kim DS, 2004, NEUROIMAGE, V21, P876, DOI 10.1016/j.neuroimage.2003.10.018; Kubler A, 2005, NEUROLOGY, V64, P1775, DOI 10.1212/01.WNL.0000158616.43002.6D; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Lachaux JP, 2003, J PHYSIOLOGY-PARIS, V97, P613, DOI 10.1016/j.jphysparis.2004.01.018; Lachaux JP, 2002, NEUROPHYSIOL CLIN, V32, P157, DOI 10.1016/S0987-7053(02)00301-5; Lachaux JP, 2000, EUR J NEUROSCI, V12, P2608, DOI 10.1046/j.1460-9568.2000.00163.x; LACHAUX JP, 2005, NEUROIMAGE IN PRESS; LACHAUX JP, 2007, HUM BRAIN MAPP; Le Van Quyen M, 2003, BIOL RES, V36, P67, DOI 10.4067/S0716-97602003000100006; LESSER R, 1994, J CLIN NEUROPHYSIOL, V11, P191, DOI 10.1097/00004691-199403000-00004; LESSER RP, 1987, J CLIN NEUROPHYSIOL, V4, P27, DOI 10.1097/00004691-198701000-00003; Lesser RP, 1998, EPILEPSIA, V39, pS69, DOI 10.1111/j.1528-1157.1998.tb05127.x; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Liegeois-Chauvel C, 2004, CEREB CORTEX, V14, P731, DOI 10.1093/cercor/bhh033; Lobel E, 2001, J NEUROSURG, V95, P804, DOI 10.3171/jns.2001.95.5.0804; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; LUDERS HO, 1995, ADV NEUROL, V67, P115; Lutz A, 2002, P NATL ACAD SCI USA, V99, P1586, DOI 10.1073/pnas.032658199; MAINY N, 2007, HUM BRAIN MAPP; Mainy N, 2007, HUM BRAIN MAPP, V28, P183, DOI 10.1002/hbm.20264; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Penfield W, 1954, EPILEPSY FUNCTIONAL; Petitmengin C., 2006, PHENOMENOL COGN SCI, V5, P229, DOI [10.1007/sll097-006-9022-2, DOI 10.1007/S11097-006-9022-2, 10.1007/s11097-006-9022-2]; Petitot Jean, 1999, NATURALIZING PHENOME; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 2003, CLIN NEUROPHYSIOL, V114, P1226, DOI 10.1016/S1388-2457(03)00067-1; Pfurtscheller G., 2006, NEUROIMAGE; Pfurtscheller G, 2006, PROG BRAIN RES, V159, P433, DOI 10.1016/S0079-6123(06)59028-4; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Sinai A, 2005, BRAIN, V128, P1556, DOI 10.1093/brain/awh491; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Szurhaj W, 2005, EUR J NEUROSCI, V21, P1223, DOI 10.1111/j.1460-9568.2005.03966.x; Talairach J., 1988, COPLANAR STEREOTAXIC; Tallon-Baudry C, 2005, CEREB CORTEX, V15, P654, DOI 10.1093/cercor/bhh167; Tanji K, 2005, J NEUROSCI, V25, P3287, DOI 10.1523/JNEUROSCI.4948-04.2005; Thompson E, 2001, TRENDS COGN SCI, V5, P418, DOI 10.1016/S1364-6613(00)01750-2; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Varela Francisco, 1999, VIEW 1 PERSON METHOD; Varela Francisco J., 1996, J CONSCIOUSNESS STUD, V3, P330; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	77	61	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1094	10.1371/journal.pone.0001094	http://dx.doi.org/10.1371/journal.pone.0001094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971857	gold, Green Published			2022-12-27	WOS:000207458700011
J	Elser, JJ; Kyle, MM; Smith, MS; Nagy, JD				Elser, James J.; Kyle, Marcia M.; Smith, Marilyn S.; Nagy, John D.			Biological Stoichiometry in Human Cancer	PLOS ONE			English	Article								Background. A growing tumor in the body can be considered a complex ecological and evolutionary system. A new eco-evolutionary hypothesis (the "Growth Rate Hypothesis'', GRH) proposes that tumors have elevated phosphorus (P) demands due to increased allocation to P-rich nucleic acids, especially ribosomal RNA, to meet the protein synthesis demands of accelerated proliferation. Methodology/Principal Findings. We determined the elemental (C, N, P) and nucleic acid contents of paired malignant and normal tissues from colon, lung, liver, or kidney for 121 patients. Consistent with the GRH, lung and colon tumors were significantly higher (by approximately two-fold) in P content (fraction of dry weight) and RNA content and lower in nitrogen (N): P ratio than paired normal tissue, and P in RNA contributed a significantly larger fraction of total biomass P in malignant relative to normal tissues. Furthermore, patient-specific differences for % P between malignant and normal tissues were positively correlated with such differences for % RNA, both for the overall data and within three of the four organ sites. However, significant differences in % P and % RNA between malignant and normal tissues were not seen in liver and kidney and, overall, RNA contributed only similar to 11% of total tissue P content. Conclusions/Significance. Data for lung and colon tumors provide support for the GRH in human cancer. The two-fold amplification of P content in colon and lung tumors may set the stage for potential P-limitation of their proliferation, as such differences often do for rapidly growing biota in ecosystems. However, data for kidney and liver do not support the GRH. To account for these conflicting observations, we suggest that local environments in some organs select for neoplastic cells bearing mutations increasing cell division rate ("r-selected,'' as in colon and lung) while conditions elsewhere may select for reduced mortality rate ("K-selected,'' as in liver and kidney).	[Elser, James J.; Kyle, Marcia M.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Smith, Marilyn S.] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA; [Nagy, John D.] Scottsdale Community Coll, Dept Biol, Scottsdale, AZ USA	Arizona State University; Arizona State University-Tempe; University of Kansas; University of Kansas Medical Center	Elser, JJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	j.elser@asu.edu	Elser, James/A-7082-2008; Elser, James J/AAL-6199-2020	Elser, James/0000-0002-1460-2155; Elser, James J/0000-0002-1460-2155	National Science Foundation/National Institutes of Health [NSF DMS-0342388]; NIH [NSF DMS-0342325, NIH GM060792]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060792] Funding Source: NIH RePORTER	National Science Foundation/National Institutes of Health(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a National Science Foundation/National Institutes of Health grant (NSF DMS-0342388) to JJE and JDN and by NSF/NIH and NIH grants (NSF DMS-0342325 and NIH GM060792) to MSS.	Amanzadeh J, 2006, NAT CLIN PRACT NEPHR, V2, P136, DOI 10.1038/ncpneph0124; APHA- American Public Health Association, 2005, AM PUBL HLTH ASS STA, V21; Cha YI, 2007, ANNU REV MED, V58, P239, DOI 10.1146/annurev.med.57.121304.131253; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Ciarmatori S, 2001, MOL CELL BIOL, V21, P5806, DOI 10.1128/MCB.21.17.5806-5814.2001; Clegg LX, 2002, ARCH INTERN MED, V162, P1985, DOI 10.1001/archinte.162.17.1985; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Elser JJ, 2003, BIOSCIENCE, V53, P1112, DOI 10.1641/0006-3568(2003)053[1112:BSAEPO]2.0.CO;2; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P11923, DOI 10.1073/pnas.0504756102; Greaves M, 2007, NAT REV CANCER, V7, P213, DOI 10.1038/nrc2071; GU W, 1993, P NATL ACAD SCI USA, V90, P2935, DOI 10.1073/pnas.90.7.2935; JEWELL S, 2002, AM J CLIN PATHOL, V118, P1; Kumar R, 2000, BONE, V27, P333, DOI 10.1016/S8756-3282(00)00334-3; MAC ARTHUR ROBERT H., 1967; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mutter GL, 2001, CANCER RES, V61, P4311; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Shu KX, 2007, COLLOID SURFACE B, V55, P10, DOI 10.1016/j.colsurfb.2006.11.003; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444	23	57	58	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1028	10.1371/journal.pone.0001028	http://dx.doi.org/10.1371/journal.pone.0001028			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925876	Green Published, Green Submitted, gold			2022-12-27	WOS:000207456000027
J	Schulz, TJ; Glaubitz, M; Kuhlow, D; Thierbach, R; Birringer, M; Steinberg, P; Pfeiffer, AFH; Ristow, M				Schulz, Tim J.; Glaubitz, Markus; Kuhlow, Doreen; Thierbach, Rene; Birringer, Marc; Steinberg, Pablo; Pfeiffer, Andreas F. H.; Ristow, Michael			Variable Expression of Cre Recombinase Transgenes Precludes Reliable Prediction of Tissue-Specific Gene Disruption by Tail-Biopsy Genotyping	PLOS ONE			English	Article								The Cre/loxP-system has become the system of choice for the generation of conditional so-called knockout mouse strains, i.e. the tissue-specific disruption of expression of a certain target gene. We here report the loss of expression of Cre recombinase in a transgenic mouse strain with increasing number of generations. This eventually led to the complete abrogation of gene expression of the inserted Cre cDNA while still being detectable at the genomic level. Conversely, loss of Cre expression caused an incomplete or even complete lack of disruption for the protein under investigation. As Cre expression in the tissue of interest in most cases cannot be addressed in vivo during the course of a study, our findings implicate the possibility that individual tail-biopsy genotypes may not necessarily indicate the presence or absence of gene disruption. This indicates that sustained post hoc analyses in regards to efficacy of disruption for every single study group member may be required.	[Schulz, Tim J.; Birringer, Marc; Ristow, Michael] Univ Jena, Inst Nutr, Jena, Germany; [Schulz, Tim J.; Glaubitz, Markus; Kuhlow, Doreen; Pfeiffer, Andreas F. H.; Ristow, Michael] German Inst Human Nutr, Potsdam, Germany; [Thierbach, Rene; Steinberg, Pablo] Univ Potsdam, Inst Nutr, Potsdam, Germany	Friedrich Schiller University of Jena; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Potsdam	Ristow, M (corresponding author), Univ Jena, Inst Nutr, Jena, Germany.	mristow@mristow.org	Pfeiffer, Andreas F.H./AAJ-2311-2020; Ristow, Michael/O-9858-2014; Schulz, Tim/F-4842-2013	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Ristow, Michael/0000-0003-2109-2453; Schulz, Tim/0000-0002-8413-3972; Birringer, Marc/0000-0003-0343-4704				BAKER WK, 1968, ADV GENET, V14, P133, DOI 10.1016/S0065-2660(08)60426-5; Dobie KW, 1996, P NATL ACAD SCI USA, V93, P6659, DOI 10.1073/pnas.93.13.6659; Feng YQ, 2001, MOL CELL BIOL, V21, P298, DOI 10.1128/MCB.21.1.298-309.2001; FLANAGAN JR, 1989, MOL CELL BIOL, V9, P739, DOI 10.1128/MCB.9.2.739; Garrick D, 1996, NUCLEIC ACIDS RES, V24, P4902, DOI 10.1093/nar/24.24.4902; Goldman IL, 2004, MED SCI MONITOR, V10, pRA274; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; HAMANAKA S, 2006, MOL THER; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Robertson G, 1996, NUCLEIC ACIDS RES, V24, P1465, DOI 10.1093/nar/24.8.1465; Shoichet SA, 2002, HUM MOL GENET, V11, P815, DOI 10.1093/hmg/11.7.815; SINGH PB, 1994, J CELL SCI, V107, P2653; Siomi MC, 2005, RNA, V11, P1004, DOI 10.1261/rna.2280105; SPOFFORD JB, 1959, P NATL ACAD SCI USA, V45, P1003, DOI 10.1073/pnas.45.7.1003; Swindle CS, 2004, J BIOL CHEM, V279, P34, DOI 10.1074/jbc.M309128200; Thierbach R, 2005, HUM MOL GENET, V14, P3857, DOI 10.1093/hmg/ddi410	22	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1013	10.1371/journal.pone.0001013	http://dx.doi.org/10.1371/journal.pone.0001013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925861	Green Submitted, Green Published, gold			2022-12-27	WOS:000207456000012
J	Tarnopolsky, M; Zimmer, A; Paikin, J; Safdar, A; Aboud, A; Pearce, E; Roy, B; Doherty, T				Tarnopolsky, Mark; Zimmer, Andrew; Paikin, Jeremy; Safdar, Adeel; Aboud, Alissa; Pearce, Erin; Roy, Brian; Doherty, Timothy			Creatine Monohydrate and Conjugated Linoleic Acid Improve Strength and Body Composition Following Resistance Exercise in Older Adults	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; C-REACTIVE PROTEIN; FAT MASS; SATELLITE CELL; ELDERLY-MEN; LIPID-PEROXIDATION; ORAL CREATINE; INSULIN SENSITIVITY; METABOLIC SYNDROME; OXIDATIVE STRESS	Aging is associated with lower muscle mass and an increase in body fat. We examined whether creatine monohydrate (CrM) and conjugated linoleic acid (CLA) could enhance strength gains and improve body composition (i.e., increase fat-free mass (FFM); decrease body fat) following resistance exercise training in older adults (>65 y). Men (N = 19) and women (N = 20) completed six months of resistance exercise training with CrM (5g/d)+CLA (6g/d) or placebo with randomized, double blind, allocation. Outcomes included: strength and muscular endurance, functional tasks, body composition (DEXA scan), blood tests (lipids, liver function, CK, glucose, systemic inflammation markers (IL-6, C-reactive protein)), urinary markers of compliance (creatine/creatinine), oxidative stress (8-OH-2dG, 8-isoP) and bone resorption (N-telopeptides). Exercise training improved all measurements of functional capacity (P < 0.05) and strength (P < 0.001), with greater improvement for the CrM+CLA group in most measurements of muscular endurance, isokinetic knee extension strength, FFM, and lower fat mass (P < 0.05). Plasma creatinine (P < 0.05), but not creatinine clearance, increased for CrM+CLA, with no changes in serum CK activity or liver function tests. Together, this data confirms that supervised resistance exercise training is safe and effective for increasing strength in older adults and that a combination of CrM and CLA can enhance some of the beneficial effects of training over a six-month period.	[Tarnopolsky, Mark; Zimmer, Andrew; Paikin, Jeremy; Safdar, Adeel; Aboud, Alissa; Pearce, Erin] McMaster Univ, Dept Pediat & Med, Hamilton, ON, Canada; [Roy, Brian] Brock Univ, Dept Phys Educ & Kinesiol, St Catharines, ON L2S 3A1, Canada; [Doherty, Timothy] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; [Doherty, Timothy] Univ Western Ontario, Dept Phys Med & Rehabil, London, ON, Canada	McMaster University; Brock University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Tarnopolsky, M (corresponding author), McMaster Univ, Dept Pediat & Med, Hamilton, ON, Canada.	tarnopol@mcmaster.ca	Roy, Brian/V-6612-2019; Doherty, Timothy/H-3576-2015	Roy, Brian/0000-0003-4638-5586; Hatcher, Erin/0000-0002-3638-4742; Safdar, Adeel/0000-0003-2469-0467	Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded entirely by the Canadian Institute of Health Research.	Banz WJ, 2003, EXP BIOL MED, V228, P434, DOI 10.1177/153537020322800414; Basu S, 2000, CLIN SCI, V99, P511, DOI 10.1042/cs0990511; Belury MA, 2002, ANNU REV NUTR, V22, P505, DOI 10.1146/annurev.nutr.22.021302.121842; Bermon S, 1998, ACTA PHYSIOL SCAND, V164, P147, DOI 10.1046/j.1365-201X.1998.00427.x; Blankson H, 2000, J NUTR, V130, P2943, DOI 10.1093/jn/130.12.2943; Bluher M, 2006, J CLIN ENDOCR METAB, V91, P2310, DOI 10.1210/jc.2005-2556; Borst SE, 2004, AGE AGEING, V33, P548, DOI 10.1093/ageing/afh201; BOYDEN TW, 1993, ARCH INTERN MED, V153, P97, DOI 10.1001/archinte.153.1.97; Brose A, 2003, J GERONTOL A-BIOL, V58, P11; Bruun JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE961, DOI 10.1152/ajpendo.00506.2005; Busetto L, 2001, NUTR METAB CARDIOVAS, V11, P195; Castaneda C, 2002, DIABETES CARE, V25, P2335, DOI 10.2337/diacare.25.12.2335; Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1; CHARETTE SL, 1991, J APPL PHYSIOL, V70, P1912, DOI 10.1152/jappl.1991.70.5.1912; Chilibeck PD, 2002, CAN J PHYSIOL PHARM, V80, P941, DOI 10.1139/y02-126; Chrusch MJ, 2001, MED SCI SPORT EXER, V33, P2111, DOI 10.1097/00005768-200112000-00021; Dangott B, 2000, INT J SPORTS MED, V21, P13, DOI 10.1055/s-2000-8848; Dreyer HC, 2006, MUSCLE NERVE, V33, P242, DOI 10.1002/mus.20461; Dunstan DW, 2002, DIABETES CARE, V25, P1729, DOI 10.2337/diacare.25.10.1729; Eijnde BO, 2003, J APPL PHYSIOL, V95, P818, DOI 10.1152/japplphysiol.00891.2002; Fatouros IG, 2005, J CLIN ENDOCR METAB, V90, P5970, DOI 10.1210/jc.2005-0261; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Gaullier JM, 2005, J NUTR, V135, P778; Gaullier JM, 2004, AM J CLIN NUTR, V79, P1118; Gerber I, 2005, Eur Cell Mater, V10, P8; Gillette-Goyonnet S, 2003, MECH AGEING DEV, V124, P311, DOI 10.1016/S0047-6374(02)00198-7; Green JS, 2004, METABOLISM, V53, P1192, DOI 10.1016/j.metabol.2004.04.008; Halbert JA, 1999, EUR J CLIN NUTR, V53, P514, DOI 10.1038/sj.ejcn.1600784; Hespel P, 2001, J PHYSIOL-LONDON, V536, P625, DOI 10.1111/j.1469-7793.2001.0625c.xd; Kelley DS, 2004, LIPIDS, V39, P135, DOI 10.1007/s11745-004-1211-9; Kim HK, 2005, J NUTR SCI VITAMINOL, V51, P8, DOI 10.3177/jnsv.51.8; Kohrt WM, 2001, INT J SPORT NUTR EXE, V11, pS137, DOI 10.1123/ijsnem.11.s1.s137; Kreider RB, 1998, MED SCI SPORT EXER, V30, P73, DOI 10.1097/00005768-199801000-00011; Kreider RB, 2002, J STRENGTH COND RES, V16, P325; Lambert CP, 2002, J CLIN ENDOCR METAB, V87, P2100, DOI 10.1210/jc.87.5.2100; Lau EMC, 2005, J GERONTOL A-BIOL, V60, P213, DOI 10.1093/gerona/60.2.213; Louis M, 2003, MUSCLE NERVE, V27, P604, DOI 10.1002/mus.10355; Luukinen H, 1997, J AM GERIATR SOC, V45, P1302, DOI 10.1111/j.1532-5415.1997.tb02928.x; Mackey AL, 2007, SCAND J MED SCI SPOR, V17, P34, DOI 10.1111/j.1600-0838.2006.00534.x; Marcell TJ, 2005, METABOLISM, V54, P533, DOI 10.1016/j.metabol.2004.11.008; McAnulty SR, 2005, FREE RADICAL RES, V39, P1219, DOI 10.1080/10725760500317536; Mihic S, 2000, MED SCI SPORT EXER, V32, P291, DOI 10.1097/00005768-200002000-00007; Monzillo LU, 2003, OBES RES, V11, P1048, DOI 10.1038/oby.2003.144; Mullins Nicole M, 2005, Nutr Metab (Lond), V2, P19, DOI 10.1186/1743-7075-2-19; NEWMAN AB, 2003, J AM GERIATR SOC, V51, P1602, DOI DOI 10.1046/J.1532-5415.2003.51534.X; O'Leary VB, 2006, J APPL PHYSIOL, V100, P1584, DOI 10.1152/japplphysiol.01336.2005; Olsen S, 2006, J PHYSIOL-LONDON, V573, P525, DOI 10.1113/jphysiol.2006.107359; Onat A, 2004, INT J OBESITY, V28, P1018, DOI 10.1038/sj.ijo.0802695; Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024; Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002; Parise G, 2001, J APPL PHYSIOL, V91, P1041, DOI 10.1152/jappl.2001.91.3.1041; Poortmans JR, 1999, MED SCI SPORT EXER, V31, P1108, DOI 10.1097/00005768-199908000-00005; Poortmans JR, 1997, EUR J APPL PHYSIOL O, V76, P566, DOI 10.1007/s004210050291; Riserus U, 2004, AM J CLIN NUTR, V80, P279; Riserus U, 2002, CIRCULATION, V106, P1925, DOI 10.1161/01.CIR.0000033589.15413.48; RODRIGUEZ MC, 2006, MUSCLE NERVE; Sartorio A, 2001, J ENDOCRINOL INVEST, V24, P882, DOI 10.1007/BF03343946; Sebedio JL, 2001, LIPIDS, V36, P575, DOI 10.1007/s11745-001-0759-8; Shadid S, 2006, J CLIN ENDOCR METAB, V91, P3418, DOI 10.1210/jc.2006-0015; Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888; SINGH B, 2006, CLIN CHIM ACTA; SKELTON DA, 1995, J AM GERIATR SOC, V43, P1081, DOI 10.1111/j.1532-5415.1995.tb07004.x; Sturnieks DL, 2004, J RHEUMATOL, V31, P2272; Taaffe DR, 1999, J AM GERIATR SOC, V47, P1208, DOI 10.1111/j.1532-5415.1999.tb05201.x; Takahashi Y, 2003, BBA-MOL CELL BIOL L, V1631, P265, DOI 10.1016/S1388-1981(03)00038-6; Tarnopolsky MA, 2004, NEUROLOGY, V62, P1771, DOI 10.1212/01.WNL.0000125178.18862.9D; Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C; Tarnopolsky MA, 2001, MED SCI SPORT EXER, V33, P2044, DOI 10.1097/00005768-200112000-00011; Tricon S, 2005, P NUTR SOC, V64, P171, DOI 10.1079/PNS2005418; Vierck JL, 2003, MED SCI SPORT EXER, V35, P769, DOI 10.1249/01.MSS.0000065005.96298.01; Vincent KR, 2002, MED SCI SPORT EXER, V34, P17, DOI 10.1097/00005768-200201000-00004; Volek JS, 1999, MED SCI SPORT EXER, V31, P1147, DOI 10.1097/00005768-199908000-00011; Wang YW, 2004, INT J OBESITY, V28, P941, DOI 10.1038/sj.ijo.0802641; Watson TA, 2005, INT J SPORT NUTR EXE, V15, P131, DOI 10.1123/ijsnem.15.2.131; Wendel AA, 2006, LIPIDS, V41, P241, DOI 10.1007/s11745-006-5093-7; Whigham LD, 2004, FOOD CHEM TOXICOL, V42, P1701, DOI 10.1016/j.fct.2004.06.008; Willoughby DS, 2001, MED SCI SPORT EXER, V33, P1674, DOI 10.1097/00005768-200110000-00010; Wilund KR, 2002, METABOLISM, V51, P774, DOI 10.1053/meta.2002.32730; Xu XF, 2003, J NUTR, V133, P663, DOI 10.1093/jn/133.3.663	79	107	110	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e991	10.1371/journal.pone.0000991	http://dx.doi.org/10.1371/journal.pone.0000991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912368	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455900027
J	Ortega, R; Cloetens, P; Deves, G; Carmona, A; Bohic, S				Ortega, Richard; Cloetens, Peter; Deves, Guillaume; Carmona, Asuncion; Bohic, Sylvain			Iron Storage within Dopamine Neurovesicles Revealed by Chemical Nano-Imaging	PLOS ONE			English	Article								Altered homeostasis of metal ions is suspected to play a critical role in neurodegeneration. However, the lack of analytical technique with sufficient spatial resolution prevents the investigation of metals distribution in neurons. An original experimental setup was developed to perform chemical element imaging with a 90 nm spatial resolution using synchrotron-based X-ray fluorescence. This unique spatial resolution, combined to a high brightness, enables chemical element imaging in subcellular compartments. We investigated the distribution of iron in dopamine producing neurons because iron-dopamine compounds are suspected to be formed but have yet never been observed in cells. The study shows that iron accumulates into dopamine neurovesicles. In addition, the inhibition of dopamine synthesis results in a decreased vesicular storage of iron. These results indicate a new physiological role for dopamine in iron buffering within normal dopamine producing cells. This system could be at fault in Parkinson's disease which is characterized by an increased level of iron in the substancia nigra pars compacta and an impaired storage of dopamine due to the disruption of vesicular trafficking. The re-distribution of highly reactive dopamine-iron complexes outside neurovesicles would result in an enhanced death of dopaminergic neurons.	[Ortega, Richard; Deves, Guillaume] Univ Bordeaux 1, CNRS, Cellular Chem Imaging & Speciat Grp, Gradignan, France; [Cloetens, Peter] European Synchrotron Radiat Facil, Xray Imaging Grp, F-38043 Grenoble, France; [Carmona, Asuncion] Univ Seville, Ctr Nacl Aceleradores, Seville, Spain; [Bohic, Sylvain] European Synchrotron Radiat Facil, Grenoble Inst Neurosci, INSERM, Equipe Rayonnement Synchrotron & Rech Med,U836, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; European Synchrotron Radiation Facility (ESRF); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Centro Nacional de Aceleradores (CNA); European Synchrotron Radiation Facility (ESRF); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Ortega, R (corresponding author), Univ Bordeaux 1, CNRS, Cellular Chem Imaging & Speciat Grp, Gradignan, France.	ortega@cenbg.in2p3.fr	Cloetens, Peter/AAJ-6131-2020; Guillaume, Devès/R-9727-2019; BOHIC, Sylvain/F-6464-2013	Cloetens, Peter/0000-0002-4129-9091; Guillaume, Devès/0000-0002-3401-8351; BOHIC, Sylvain/0000-0001-6355-7592; Ortega, Richard/0000-0003-1692-5406; Carmona, Asuncion/0000-0002-9253-4581	CNRS (Centre National de la Recherche Scientifique); ESRF (European Synchrotron Radiation Facility); European program of integrated action Picasso	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); ESRF (European Synchrotron Radiation Facility); European program of integrated action Picasso	This work was supported by fundings from the CNRS (Centre National de la Recherche Scientifique); the ESRF (European Synchrotron Radiation Facility); and the European program of integrated action Picasso.	Ben Shachar D, 2004, NEUROPHARMACOLOGY, V46, P254, DOI 10.1016/j.neuropharm.2003.09.005; Bohic S, 2001, APPL PHYS LETT, V78, P3544, DOI 10.1063/1.1366362; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Clarke SJ, 2006, NAT MATER, V5, P409, DOI 10.1038/nmat1631; DEXTER DT, 1987, LANCET, V2, P1219; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; FALCK B, 1962, J HISTOCHEM CYTOCHEM, V10, P348, DOI 10.1177/10.3.348; Gaeta A, 2005, BRIT J PHARMACOL, V146, P1041, DOI 10.1038/sj.bjp.0706416; GALVANI P, 1995, TOXICOL IN VITRO, V9, P365, DOI 10.1016/0887-2333(95)00031-3; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Griffiths PD, 1999, BRAIN, V122, P667, DOI 10.1093/brain/122.4.667; Hignette O, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1928191; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; KASTNER A, 1993, BRAIN RES, V606, P341, DOI 10.1016/0006-8993(93)91005-D; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Ke Y, 2003, LANCET NEUROL, V2, P246, DOI 10.1016/S1474-4422(03)00353-3; KIRKPATRICK P, 1948, J OPT SOC AM, V38, P766, DOI 10.1364/JOSA.38.000766; Lashuel HA, 2006, ACS CHEM BIOL, V1, P420, DOI 10.1021/cb600331e; Linert W, 2000, J INORG BIOCHEM, V79, P319, DOI 10.1016/S0162-0134(99)00238-X; LIU YJ, 1994, J CELL BIOL, V127, P1419, DOI 10.1083/jcb.127.5.1419; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Mori F, 2006, J NEUROPATH EXP NEUR, V65, P808, DOI 10.1097/01.jnen.0000230520.47768.1a; Ortega R, 1996, CELL MOL BIOL, V42, P77; Ortega R, 2004, ANAL CHEM, V76, P309, DOI 10.1021/ac035037r; Paris I, 2005, CHEM RES TOXICOL, V18, P415, DOI 10.1021/tx0497144; Quintana C, 2006, J STRUCT BIOL, V153, P42, DOI 10.1016/j.jsb.2005.11.001; Reaney SH, 2005, TOXICOL APPL PHARM, V205, P271, DOI 10.1016/j.taap.2004.10.013; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; Rouault TA, 2001, NAT GENET, V28, P299, DOI 10.1038/91036; Smythies J, 1999, NEUROTOX RES, V1, P27, DOI 10.1007/BF03033337; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; TISCHLER AS, 1978, LAB INVEST, V39, P77; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang PJ, 2005, J STRUCT BIOL, V150, P144, DOI 10.1016/j.jsb.2005.01.007; ZIEROLD K, 1984, HISTOCHEMISTRY, V80, P333, DOI 10.1007/BF00495413	35	127	128	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e925	10.1371/journal.pone.0000925	http://dx.doi.org/10.1371/journal.pone.0000925			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895967	gold, Green Published			2022-12-27	WOS:000207455800005
J	Apidianakis, Y; Mindrinos, MN; Xiao, WZ; Tegos, GP; Papisov, MI; Hamblin, MR; Davis, RW; Tompkins, RG; Rahme, LG				Apidianakis, Yiorgos; Mindrinos, Michael N.; Xiao, Wenzhong; Tegos, George P.; Papisov, Michail I.; Hamblin, Michael R.; Davis, Ronald W.; Tompkins, Ronald G.; Rahme, Laurence G.			Involvement of Skeletal Muscle Gene Regulatory Network in Susceptibility to Wound Infection Following Trauma	PLOS ONE			English	Article								Despite recent advances in our understanding the pathophysiology of trauma, the basis of the predisposition of trauma patients to infection remains unclear. A Drosophila melanogaster/Pseudomonas aeruginosa injury and infection model was used to identify host genetic components that contribute to the hyper-susceptibility to infection that follows severe trauma. We show that P. aeruginosa compromises skeletal muscle gene (SMG) expression at the injury site to promote infection. We demonstrate that activation of SMG structural components is under the control of cJun-N-terminal Kinase (JNK) Kinase, Hemipterous (Hep), and activation of this pathway promotes local resistance to P. aeruginosa in flies and mice. Our study links SMG expression and function to increased susceptibility to infection, and suggests that P. aeruginosa affects SMG homeostasis locally by restricting SMG expression in injured skeletal muscle tissue. Local potentiation of these host responses, and/or inhibition of their suppression by virulent P. aeruginosa cells, could lead to novel therapies that prevent or treat deleterious and potentially fatal infections in severely injured individuals.	[Apidianakis, Yiorgos; Tompkins, Ronald G.; Rahme, Laurence G.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Tegos, George P.; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Apidianakis, Yiorgos; Tompkins, Ronald G.; Rahme, Laurence G.] Shriners Burn Inst, Boston, MA 02114 USA; [Mindrinos, Michael N.; Xiao, Wenzhong; Davis, Ronald W.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Tegos, George P.; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Papisov, Michail I.] Massachusetts Gen Hosp, Dept Radiol, Div Nucl Med, Lab Mol Bioengn, Boston, MA 02114 USA; [Rahme, Laurence G.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Stanford University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Rahme, LG (corresponding author), Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.	rahme@amber.mgh.harvard.edu	Hamblin, Mike/AAB-2511-2022; Apidianakis, Yiorgos/ABF-7464-2020; Tegos, George/C-8830-2011; Hamblin, Michael R/H-2758-2019	Apidianakis, Yiorgos/0000-0002-7465-3560; Hamblin, Michael R/0000-0001-6431-4605; Papisov, Mikhail/0000-0003-4716-2122; xiao, wenzhong/0000-0003-4944-6380	Shriners Research [8892]; Shriners Post-doctoral Fellowship; NIH [AI050875];  [DK43351];  [DK57521]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK043351] Funding Source: NIH RePORTER	Shriners Research; Shriners Post-doctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This work was supported by the Shriners Research grant #8892 to LGR. YA was supported by a Shriners Post-doctoral Fellowship, MRH by NIH Grant AI050875 and electron microscopy core by grants DK43351 and DK57521.	Apidianakis Y, 2005, P NATL ACAD SCI USA, V102, P2573, DOI 10.1073/pnas.0409588102; Baldini RL, 2002, METHOD ENZYMOL, V358, P3; Baue AE, 1998, SHOCK, V10, P79, DOI 10.1097/00024382-199808000-00001; BEALL C, 1992, BIOCHEM GENET, V30, P515, DOI 10.1007/BF01037590; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Clayton JD, 1998, J MUSCLE RES CELL M, V19, P117, DOI 10.1023/A:1005304527563; COX DR, 1972, J R STAT SOC B, V187, P220; D'Argenio DA, 2001, J BACTERIOL, V183, P1466, DOI 10.1128/JB.183.4.1466-1471.2001; Delaney JR, 2006, EMBO J, V25, P3068, DOI 10.1038/sj.emboj.7601182; FERNANDES J, 1991, DEVELOPMENT, V113, P67; FRANCIOSA H, 1995, INSECT BIOCHEM MOLEC, V25, P311, DOI 10.1016/0965-1748(94)00053-K; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; HALDANE JBS, 1956, EXPERIENTIA, V12, P205, DOI 10.1007/BF02170512; Hamblin MR, 2003, J INFECT DIS, V187, P1717, DOI 10.1086/375244; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; Harden N, 2005, SCIENCE, V308, P364, DOI 10.1126/science.1112050; Herranz R, 2004, GENE EXPR PATTERNS, V4, P183, DOI 10.1016/j.modgep.2003.09.008; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Jais PH, 2005, GENET MED, V7, P83, DOI 10.1097/01.GIM.0000153665.55420.C3; Jasper H, 2001, DEV CELL, V1, P579, DOI 10.1016/S1534-5807(01)00045-4; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kaplan EL, 1958, J AM STAT ASSOC, V53, P562; Lau GW, 2003, INFECT IMMUN, V71, P4059, DOI 10.1128/IAI.71.7.4059-4066.2003; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Padfield KE, 2005, P NATL ACAD SCI USA, V102, P5368, DOI 10.1073/pnas.0501211102; Papa S, 2004, J CELL SCI, V117, P5197, DOI 10.1242/jcs.01483; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x; Stronach BE, 1999, ONCOGENE, V18, P6172, DOI 10.1038/sj.onc.1203125; Tsuda M, 2005, EMBO REP, V6, P1082, DOI 10.1038/sj.embor.7400537; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904	41	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1356	10.1371/journal.pone.0001356	http://dx.doi.org/10.1371/journal.pone.0001356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159239	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459700013
J	Shea, BJ; Bouter, LM; Peterson, J; Boers, M; Andersson, N; Ortiz, Z; Ramsay, T; Bai, A; Shukla, VK; Grimshaw, JM				Shea, Beverley J.; Bouter, Lex M.; Peterson, Joan; Boers, Maarten; Andersson, Neil; Ortiz, Zulma; Ramsay, Tim; Bai, Annie; Shukla, Vijay K.; Grimshaw, Jeremy M.			External Validation of a Measurement Tool to Assess Systematic Reviews (AMSTAR)	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; PROTON PUMP INHIBITOR; GASTROESOPHAGEAL-REFLUX DISEASE; SHORT-TERM TREATMENT; GASTRIC-ULCER; H-2-RECEPTOR ANTAGONISTS; METHODOLOGICAL QUALITY; ERADICATION TREATMENT; DUODENAL-ULCER; RELAPSE RATES	Background. Thousands of systematic reviews have been conducted in all areas of health care. However, the methodological quality of these reviews is variable and should routinely be appraised. AMSTAR is a measurement tool to assess systematic reviews. Methodology. AMSTAR was used to appraise 42 reviews focusing on therapies to treat gastro-esophageal reflux disease, peptic ulcer disease, and other acid-related diseases. Two assessors applied the AMSTAR to each review. Two other assessors, plus a clinician and/or methodologist applied a global assessment to each review independently. Conclusions. The sample of 42 reviews covered a wide range of methodological quality. The overall scores on AMSTAR ranged from 0 to 10 (out of a maximum of 11) with a mean of 4.6 (95% CI: 3.7 to 5.6) and median 4.0 (range 2.0 to 6.0). The inter-observer agreement of the individual items ranged from moderate to almost perfect agreement. Nine items scored a kappa of >0.75 ( 95% CI: 0.55 to 0.96). The reliability of the total AMSTAR score was excellent: kappa 0.84 (95% CI: 0.67 to 1.00) and Pearson's R 0.96 (95% CI: 0.92 to 0.98). The overall scores for the global assessment ranged from 2 to 7 (out of a maximum score of 7) with a mean of 4.43 (95% CI: 3.6 to 5.3) and median 4.0 (range 2.25 to 5.75). The agreement was lower with a kappa of 0.63 ( 95% CI: 0.40 to 0.88). Construct validity was shown by AMSTAR convergence with the results of the global assessment: Pearson's R 0.72 (95% CI: 0.53 to 0.84). For the AMSTAR total score, the limits of agreement were 20.1961.38. This translates to a minimum detectable difference between reviews of 0.64 'AMSTAR points'. Further validation of AMSTAR is needed to assess its validity, reliability and perceived utility by appraisers and end users of reviews across a broader range of systematic reviews.	[Shea, Beverley J.; Andersson, Neil] CIET, Ottawa, ON, Canada; [Shea, Beverley J.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Inst Res Extramural Med, Amsterdam, Netherlands; [Bouter, Lex M.] Vrije Univ Amsterdam, Execut Board, Amsterdam, Netherlands; [Peterson, Joan; Ramsay, Tim; Grimshaw, Jeremy M.] Univ Ottawa, Ottawa Hlth Res Inst, Clin Epidemiol Program, Ottawa, ON K1N 6N5, Canada; [Boers, Maarten] Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands; [Andersson, Neil] Univ Autonoma Guerrero, Ctr Invest Enfermedades Trop, Acapulco, Mexico; [Ortiz, Zulma] Natl Acad Med Buenos Aires, Epidemiol Res Inst, Buenos Aires, DF, Argentina; [Bai, Annie; Shukla, Vijay K.] CADTH, Ottawa, ON, Canada	University of Ottawa; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Ottawa; Ottawa Hospital Research Institute; Vrije Universiteit Amsterdam; Buenos Aires National Academy of Medicine; IIE - Instituto de Investigaciones Epidemiologicas	Shea, BJ (corresponding author), CIET, Ottawa, ON, Canada.	bshea@ciet.org	Bouter, Lex/X-1003-2019; Grimshaw, Jeremy/D-8726-2013; Andersson, Neil/G-2248-2011	Bouter, Lex/0000-0002-2659-5482; Ramsay, Tim/0000-0001-8478-8170; Grimshaw, Jeremy/0000-0001-8015-8243				BAMBERG P, 1992, J GASTROEN HEPATOL, V7, P577, DOI 10.1111/j.1440-1746.1992.tb01489.x; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Bero Lisa A, 2005, J Am Coll Dent, V72, P4; Biondi-Zoccai GGL, 2006, BMJ-BRIT MED J, V332, P202, DOI 10.1136/bmj.38693.516782.7C; Bland J. M., 1987, BIOCH CLIN, V11, P399, DOI DOI 10.1016/J.IJNURSTU.2009.10.001; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Calvet X, 2000, ALIMENT PHARM THER, V14, P603; Carlsson R, 1997, ALIMENT PHARM THER, V11, P473, DOI 10.1046/j.1365-2036.1997.00167.x; Caro JJ, 2001, CLIN THER, V23, P998, DOI 10.1016/S0149-2918(01)80087-4; Chiba N, 1997, GASTROENTEROLOGY, V112, P1798, DOI 10.1053/gast.1997.v112.pm9178669; Chiba N, 1997, CAN J GASTROENTEROL, V11, P646; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COHEN J, 1960, EDUC PSYCHOL MEAS, P622; Cook RJ, 1995, CAN J STAT, V23, P333, DOI 10.2307/3315378; Danesh J, 2000, ARCH INTERN MED, V160, P1192, DOI 10.1001/archinte.160.8.1192; DELANEY B, 2000, HEALTH TECHNOL ASSES, V4, P189; DELANEY B, 2000, HEALTH TECHNOL ASSES, V4, pR1; DELANEY BC, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001961; DiMario F, 1996, DIGEST DIS SCI, V41, P1108; DOLANMULLEN P, 2006, ANNU REV PUBL HEALTH, V27, P81; ERIKSSON S, 1995, EUR J GASTROEN HEPAT, V7, P467; Fischbach LA, 2002, INT J EPIDEMIOL, V31, P128, DOI 10.1093/ije/31.1.128; Ford AC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003840.pub4; Gene E, 2003, ALIMENT PHARM THER, V17, P1137, DOI 10.1046/j.1365-2036.2003.01566.x; GIBSON PG, 2005, COCHRANE DB SYST REV, P1; Gisbert JP, 2000, ALIMENT PHARM THER, V14, P1319, DOI 10.1046/j.1365-2036.2000.00844.x; Hopkins RJ, 1996, GASTROENTEROLOGY, V110, P1244, DOI 10.1053/gast.1996.v110.pm8613015; Huang JQ, 1999, ALIMENT PHARM THERAP, V13, P719, DOI 10.1046/j.1365-2036.1999.00530.x; Huang JQ, 2002, LANCET, V359, P14, DOI 10.1016/S0140-6736(02)07273-2; JOVELL AJ, 1998, CLIN PRACTICE GUIDEL; Klok RM, 2003, ALIMENT PHARM THER, V17, P1237, DOI 10.1046/j.1365-2036.2003.01562.x; Laheij RJF, 1999, ALIMENT PHARM THERAP, V13, P857; Laine L, 2001, ANN INTERN MED, V134, P361, DOI 10.7326/0003-4819-134-5-200103060-00008; Leodolter A, 2001, ALIMENT PHARM THER, V15, P1949, DOI 10.1046/j.1365-2036.2001.01109.x; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; MACLURE M, 1987, AM J EPIDEMIOL, V126, P161, DOI 10.1093/aje/126.2.161; McGinn TG, 2002, USERS GUIDE MED LIT, P461; Meade MO, 2000, AM J RESP CRIT CARE, V161, P85, DOI 10.1164/ajrccm.161.1.9809003; Moayyedi P, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002096.pub2, 10.1002/14651858.CD002096.pub4]; Moayyedi P, 2001, J APPL MICROBIOL, V90, p126S, DOI 10.1046/j.1365-2672.2001.01361.x; Moayyedi P, 2000, BRIT MED J, V321, P659, DOI 10.1136/bmj.321.7262.659; MOAYYEDI P, 2005, COCHRANE DB SYST REV; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; MULDER CJJ, 1990, SCAND J GASTROENTERO, V25, P62, DOI 10.3109/00365529009093152; Oderda G, 2000, ALIMENT PHARM THER, V14, P59, DOI 10.1046/j.1365-2036.2000.03102.x; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; POYNARD T, 1995, EUR J GASTROEN HEPAT, V7, P661; Rostom A, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002296, DOI 10.1002/14651858.CD002296]; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; Schmid C H, 1999, Am J Ther, V6, P25, DOI 10.1097/00045391-199901000-00005; Shea B, 2002, EVAL HEALTH PROF, V25, P116, DOI 10.1177/0163278702025001008; SHEA B, 2001, ASSESSING QUALITY RE, P122; SHEA B, 1999, THESIS U OTTAWA; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; SHIAU JY, 2002, EFFICACY PROTON PUMP; SINGH S, 2006, DEV EVIDENCE BASED B; TREPANIER EF, 1998, CAN J CLIN PHARM, V5, P67; UEBERSAX JS, 1987, PSYCHOL BULL, V101, P140, DOI 10.1037/0033-2909.101.1.140; Unge P, 1996, SCAND J GASTROENTERO, V31, P27, DOI 10.3109/00365529609094747; Unge P, 1998, EUR J SURG, V164, P16, DOI 10.1080/11024159850191391; Unge P, 1997, GASTROENTEROLOGY, V113, pS131, DOI 10.1016/S0016-5085(97)80027-3; Vallve M, 2002, ALIMENT PHARM THER, V16, P1149, DOI 10.1046/j.1365-2036.2002.01270.x; van Pinxteren B, 2003, J GEN INTERN MED, V18, P755, DOI 10.1046/j.1525-1497.2003.20833.x; van Pinxteren B, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD002095.PUB2, 10.1002/14651858.cd002095.pub2]; VANZANTEN SJOV, 1994, CAN MED ASSOC J, V150, P189; Young D, 2005, AM J HEALTH-SYST PH, V62, P342, DOI 10.1093/ajhp/62.4.342	70	377	394	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1350	10.1371/journal.pone.0001350	http://dx.doi.org/10.1371/journal.pone.0001350			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159233	Green Published, gold			2022-12-27	WOS:000207459700007
J	Quignon, P; Herbin, L; Cadieu, E; Kirkness, EF; Hedan, B; Mosher, DS; Galibert, F; Andre, C; Ostrander, EA; Hitte, C				Quignon, Pascale; Herbin, Laetitia; Cadieu, Edouard; Kirkness, Ewen F.; Hedan, Benoit; Mosher, Dana S.; Galibert, Francis; Andre, Catherine; Ostrander, Elaine A.; Hitte, Christophe			Canine Population Structure: Assessment and Impact of Intra-Breed Stratification on SNP-Based Association Studies	PLOS ONE			English	Article								Background. In canine genetics, the impact of population structure on whole genome association studies is typically addressed by sampling approximately equal numbers of cases and controls from dogs of a single breed, usually from the same country or geographic area. However one way to increase the power of genetic studies is to sample individuals of the same breed but from different geographic areas, with the expectation that independent meiotic events will have shortened the presumed ancestral haplotype around the mutation differently. Little is known, however, about genetic variation among dogs of the same breed collected from different geographic regions. Methodology/Principal Findings. In this report, we address the magnitude and impact of genetic diversity among common breeds sampled in the U.S. and Europe. The breeds selected, including the Rottweiler, Bernese mountain dog, flat-coated retriever, and golden retriever, share susceptibility to a class of soft tissue cancers typified by malignant histiocytosis in the Bernese mountain dog. We genotyped 722 SNPs at four unlinked loci (between 95 and 271 per locus) on canine chromosome 1 (CFA1). We showed that each population is characterized by distinct genetic diversity that can be correlated with breed history. When the breed studied has a reduced intra-breed diversity, the combination of dogs from international locations does not increase the rate of false positives and potentially increases the power of association studies. However, over-sampling cases from one geographic location is more likely to lead to false positive results in breeds with significant genetic diversity. Conclusions. These data provide new guidelines for association studies using purebred dogs that take into account population structure.	[Quignon, Pascale; Cadieu, Edouard; Mosher, Dana S.; Ostrander, Elaine A.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Herbin, Laetitia; Hedan, Benoit; Galibert, Francis; Andre, Catherine; Hitte, Christophe] Univ Rennes 1, CNRS, UMR Genet & Dev 6061, IFR140, CS-34317 Rennes, France; [Kirkness, Ewen F.] J Craig Venter Inst, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; J. Craig Venter Institute	Ostrander, EA (corresponding author), NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	eostrand@mail.nih.gov; hitte@univ-rennes1.fr	Fiumefreddo, Andrea/T-2977-2019	Hitte, Christophe/0000-0003-1714-437X; Ostrander, Elaine/0000-0001-6075-9738	American Kennel Club Canine Health Foundation; French Centre National de la Recherche Scientifique (CNRS); National Human Genome Research Institute; National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200325, Z01HG200325] Funding Source: NIH RePORTER	American Kennel Club Canine Health Foundation; French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank the American Kennel Club Canine Health Foundation, the French Centre National de la Recherche Scientifique (CNRS) and the intramural program of the National Human Genome Research Institute of the National Institutes of Health for supporting this work.	Acland GM, 1998, P NATL ACAD SCI USA, V95, P3048, DOI 10.1073/pnas.95.6.3048; Acland GM, 1999, GENOMICS, V59, P134, DOI 10.1006/geno.1999.5842; Affolter VK, 2002, VET PATHOL, V39, P74, DOI 10.1354/vp.39-1-74; AMERICAN KC, 1998, COMPLETE DOG BOOK KR; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chase K, 2006, INT J IMMUNOGENET, V33, P179, DOI 10.1111/j.1744-313X.2006.00593.x; Chase K, 2002, P NATL ACAD SCI USA, V99, P9930, DOI 10.1073/pnas.152333099; GALIBERT F, 2007, COMP BIOC D IN PRESS; Galibert F, 2006, M S-MED SCI, V22, P806, DOI 10.1051/medsci/20062210806; GOLDSTEIN O, 2006, GENOMICS, V18, P18; Guldbrandtsen B, 2000, J HERED, V91, P178, DOI 10.1093/jhered/91.2.178; HEDAN B, 2006, BMC VET RES, V27, P9; Hitte C, 2005, NAT REV GENET, V6, P643, DOI 10.1038/nrg1658; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; Leegwater PA, 2007, J HERED, V98, P549, DOI 10.1093/jhered/esm022; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lowe JK, 2003, GENOMICS, V82, P86, DOI 10.1016/S0888-7543(03)00078-8; MOORE PF, 1986, VET PATHOL, V23, P1; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Ostrander EA, 2005, GENOME RES, V15, P1706, DOI 10.1101/gr.3736605; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Parker HG, 2007, GENOME RES, V17, P1562, DOI 10.1101/gr.6772807; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Ramsey IK, 1996, VET REC, V138, P440, DOI 10.1136/vr.138.18.440; ROSIN A, 1986, J AM VET MED ASSOC, V188, P1041; Sambrook J., 2002, MOL CLONING LAB MANU; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; SCHMIDT ML, 1993, VET QUART, V15, P117, DOI 10.1080/01652176.1993.9694387; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; WAYNE RK, 2007, LESSONS LEARNED DOG; Zhang K, 2003, BIOINFORMATICS, V19, P1300, DOI 10.1093/bioinformatics/btg142	38	54	56	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1324	10.1371/journal.pone.0001324	http://dx.doi.org/10.1371/journal.pone.0001324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091995	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459600012
J	Dheekollu, J; Deng, Z; Wiedmer, A; Weitzman, MD; Lieberman, PM				Dheekollu, Jayaraju; Deng, Zhong; Wiedmer, Andreas; Weitzman, Matthew D.; Lieberman, Paul M.			A Role for MRE11, NBS1, and Recombination Junctions in Replication and Stable Maintenance of EBV Episomes	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; ORIGIN RECOGNITION COMPLEX; DNA-DAMAGE RESPONSE; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; LATENT ORIGIN; IN-VITRO; ORIP; PROTEIN; INITIATION	Recombination-like structures formed at origins of DNA replication may contribute to replication fidelity, sister chromatid cohesion, chromosome segregation, and overall genome stability. The Epstein-Barr Virus (EBV) origin of plasmid replication ( OriP) provides episomal genome stability through a poorly understood mechanism. We show here that recombinational repair proteins MRE11 and NBS1 are recruited to the Dyad Symmetry (DS) region of OriP in a TRF2- and cell cycle-dependent manner. Depletion of MRE11 or NBS1 by siRNA inhibits OriP replication and destabilized viral episomes. OriP plasmid maintenance was defective in MRE11 and NBS1 hypomorphic fibroblast cell lines and only integrated, non-episomal forms of EBV were detected in a lympoblastoid cell line derived from an NBS1-mutated individual. Two-dimensional agarose gel analysis of OriP DNA revealed that recombination-like structures resembling Holliday-junctions form at OriP in mid S phase. MRE11 and NBS1 association with DS coincided with replication fork pausing and origin activation, which preceded the formation of recombination structures. We propose that NBS1 and MRE11 promote replication-associated recombination junctions essential for EBV episomal maintenance and genome stability.	[Dheekollu, Jayaraju; Deng, Zhong; Wiedmer, Andreas; Lieberman, Paul M.] Wistar Inst Anat & Biol, Philadelphia, PA USA; [Weitzman, Matthew D.] Salk Inst Biol Studies, La Jolla, CA USA	The Wistar Institute; Salk Institute	Lieberman, PM (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA USA.	lieberman@wistar.org			NIH [CA93606]; PA Department of Health;  [DAMD17-03-1-0313]; NATIONAL CANCER INSTITUTE [R01CA093606] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PA Department of Health; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	DAMD17-03-1-0313, NIH CA93606, PA Department of Health	Allers T, 2000, Nucleic Acids Res, V28, pe6, DOI 10.1093/nar/28.2.e6; Atanasiu C, 2006, EMBO REP, V7, P716, DOI 10.1038/sj.embor.7400730; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Benard M, 2001, MOL CELL, V7, P971, DOI 10.1016/S1097-2765(01)00237-4; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Chaudhuri B, 2001, P NATL ACAD SCI USA, V98, P10085, DOI 10.1073/pnas.181347998; Davis PK, 2001, BIOTECHNIQUES, V30, P1322, DOI 10.2144/01306rv01; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; De Lange T, 2000, COLD SPRING HARB SYM, V65, P265, DOI 10.1101/sqb.2000.65.265; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Deng Z, 2003, J VIROL, V77, P11992, DOI 10.1128/JVI.77.22.11992-12001.2003; Deng Z, 2002, MOL CELL, V9, P493, DOI 10.1016/S1097-2765(02)00476-8; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; DHAR V, 1991, MOL CELL BIOL, V11, P6268, DOI 10.1128/MCB.11.12.6268; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Eppink B, 2006, EXP CELL RES, V312, P2660, DOI 10.1016/j.yexcr.2006.06.011; Ermakova OV, 1996, J BIOL CHEM, V271, P33009, DOI 10.1074/jbc.271.51.33009; FOUCHE N, 2006, J BIOL CHEM; GAHN TA, 1989, CELL, V58, P527, DOI 10.1016/0092-8674(89)90433-9; Gerhardt J, 2006, MOL CELL BIOL, V26, P7731, DOI 10.1128/MCB.01392-06; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; GULLEY ML, 1992, CANCER, V70, P185, DOI 10.1002/1097-0142(19920701)70:1<185::AID-CNCR2820700129>3.0.CO;2-J; Hadden JM, 2001, NAT STRUCT BIOL, V8, P62; HARRISON JC, 2006, SURVIVING BREAKUP DN; Humme S, 2003, P NATL ACAD SCI USA, V100, P10989, DOI 10.1073/pnas.1832776100; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Julien MD, 2004, VIROLOGY, V326, P317, DOI 10.1016/j.virol.2004.05.026; Kanda T, 2007, J CELL SCI, V120, P1529, DOI 10.1242/jcs.03434; Kapoor P, 2005, MOL CELL BIOL, V25, P4934, DOI 10.1128/MCB.25.12.4934-4945.2005; Kieff E., 1996, FIELDS VIROLOGY, V2, P2343; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; Lee MA, 1999, J VIROL, V73, P2974, DOI 10.1128/JVI.73.4.2974-2982.1999; Liberi G, 2006, METHOD ENZYMOL, V409, P442, DOI 10.1016/S0076-6879(05)09026-9; Lilley CE, 2005, P NATL ACAD SCI USA, V102, P5844, DOI 10.1073/pnas.0501916102; LITTLE RD, 1995, MOL CELL BIOL, V15, P2893; Lopes M, 2003, MOL CELL, V12, P1499, DOI 10.1016/S1097-2765(03)00473-8; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Maser RS, 2004, DNA REPAIR, V3, P979, DOI 10.1016/j.dnarep.2004.05.009; MULLER B, 1990, NUCLEIC ACIDS RES, V18, P5633, DOI 10.1093/nar/18.19.5633; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nasmyth K, 2004, PHILOS T R SOC B, V359, P99, DOI 10.1098/rstb.2003.1417; NILLER HH, 1995, J BIOL CHEM, V270, P12864, DOI 10.1074/jbc.270.21.12864; Norio P, 2004, PLOS BIOL, V2, P816, DOI 10.1371/journal.pbio.0020152; Norio P, 2001, SCIENCE, V294, P2361, DOI 10.1126/science.1064603; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Pichierri P, 2004, EMBO J, V23, P3154, DOI 10.1038/sj.emboj.7600277; RAWLINS DR, 1985, CELL, V42, P859, DOI 10.1016/0092-8674(85)90282-X; RICKINSON AB, 1996, EPSTEIN BARR VIRUS F, P2397; Ritzi M, 2003, J CELL SCI, V116, P3971, DOI 10.1242/jcs.00708; Schepers A, 2001, EMBO J, V20, P4588, DOI 10.1093/emboj/20.16.4588; Sears J, 2004, J VIROL, V78, P11487, DOI 10.1128/JVI.78.21.11487-11505.2004; Segurado M, 2002, MOL CELL, V10, P907, DOI 10.1016/S1097-2765(02)00684-6; Shimada K, 2007, CELL, V128, P85, DOI 10.1016/j.cell.2006.11.045; Stansel RM, 2001, EMBO J, V20, P5532; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Sugden B, 2001, CURR TOP MICROBIOL, V258, P3; Tauchi H, 2002, NATURE, V420, P93, DOI 10.1038/nature01125; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Vogel M, 1998, BIOTECHNIQUES, V24, P540; Wang LD, 2005, J CELL BIOCHEM, V94, P247, DOI 10.1002/jcb.20324; Wang P, 2005, J VIROL, V79, P13298, DOI 10.1128/JVI.79.21.13298-13309.2005; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; Yates JL, 2000, J VIROL, V74, P4512, DOI 10.1128/JVI.74.10.4512-4522.2000; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhou J, 2005, EMBO J, V24, P1406, DOI 10.1038/sj.emboj.7600609; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	72	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1257	10.1371/journal.pone.0001257	http://dx.doi.org/10.1371/journal.pone.0001257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18040525	Green Submitted, gold, Green Published			2022-12-27	WOS:000207459400006
J	Kelly, CR; Grinband, J; Hirsch, J				Kelly, Christopher R.; Grinband, Jack; Hirsch, Joy			Repeated Exposure to Media Violence Is Associated with Diminished Response in an Inhibitory Frontolimbic Network	PLOS ONE			English	Article								Background. Media depictions of violence, although often claimed to induce viewer aggression, have not been shown to affect the cortical networks that regulate behavior. Methodology/Principal Findings. Using functional magnetic resonance imaging ( fMRI), we found that repeated exposure to violent media, but not to other equally arousing media, led to both diminished response in right lateral orbitofrontal cortex (right ItOFC) and a decrease in right ItOFC-amygdala interaction. Reduced function in this network has been previously associated with decreased control over a variety of behaviors, including reactive aggression. Indeed, we found reduced right ItOFC responses to be characteristic of those subjects that reported greater tendencies toward reactive aggression. Furthermore, the violence-induced reduction in right ItOFC response coincided with increased throughput to behavior planning regions. Conclusions. These novel findings establish that even short-term exposure to violent media can result in diminished responsiveness of a network associated with behaviors such as reactive aggression.	[Kelly, Christopher R.; Grinband, Jack; Hirsch, Joy] Columbia Univ, Neurol Inst, Funct MRI Res Ctr, Dept Radiol, New York, NY 10027 USA; [Hirsch, Joy] Columbia Univ, Neurol Inst, Dept Psychol, New York, NY USA; [Grinband, Jack; Hirsch, Joy] Columbia Univ, Neurol Inst, Dept Neurosci, New York, NY USA; [Kelly, Christopher R.] Columbia Univ, Neurol Inst, Coll Phys & Surg, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University	Kelly, CR (corresponding author), Columbia Univ, Neurol Inst, Funct MRI Res Ctr, Dept Radiol, New York, NY 10027 USA.	crk2002@columbia.edu; jg2269@columbia.edu; jh2155@columbia.edu	Grinband, Jack/AAX-7675-2020	Grinband, Jack/0000-0001-7658-6755; Hirsch, Joy/0000-0002-1418-6489	James S. McDonnell Foundation; Whitehall Radiology Fellowship	James S. McDonnell Foundation; Whitehall Radiology Fellowship	Work was supported via grants from the James S. McDonnell Foundation and the Whitehall Radiology Fellowship (JG), as well as start-up training funds (JH).	Anderson CA, 2000, J PERS SOC PSYCHOL, V78, P772, DOI 10.1037//0022-3514.78.4.772; Anderson CA, 2002, SCIENCE, V295, P2377, DOI 10.1126/science.1070765; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Averill J.R., 1982, ANGER AGGRESSION ESS; Berthoz S, 2002, BRAIN, V125, P1696, DOI 10.1093/brain/awf190; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Bufkin JL, 2005, TRAUMA VIOLENCE ABUS, V6, P176, DOI 10.1177/1524838005275089; Bushman BJ, 1998, J APPL PSYCHOL, V83, P969, DOI 10.1037/0021-9010.83.6.969; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; FEDERMAN J, 1998, NATL TELEVISION VIOL; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; GOYER PF, 1994, NEUROPSYCHOPHARMACOL, V10, P21, DOI 10.1038/npp.1994.3; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Huesmann LR, 2003, DEV PSYCHOL, V39, P201, DOI 10.1037/0012-1649.39.2.201; Johnson JG, 2002, SCIENCE, V295, P2468, DOI 10.1126/science.1062929; Kandel E., 2000, PRINCIPLES NEURAL SC; Kim E, 2002, NEUROREHABILITATION, V17, P297; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; PETRIDES M, 1994, HDB NEUROPSYCHOLOGY; Raine A, 1998, BEHAV SCI LAW, V16, P319, DOI 10.1002/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G; Singer MI, 1998, J AM ACAD CHILD PSY, V37, P1041, DOI 10.1097/00004583-199810000-00014; Smith SK, 2004, POPUL RES POLICY REV, V23, P1, DOI 10.1023/B:POPU.0000019918.24143.c9; STARKSTEIN SE, 2000, FRONTAL SUBCORTICAL; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Zillmann D, 1999, J APPL SOC PSYCHOL, V29, P145, DOI 10.1111/j.1559-1816.1999.tb01379.x	35	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1268	10.1371/journal.pone.0001268	http://dx.doi.org/10.1371/journal.pone.0001268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060062	Green Published, gold			2022-12-27	WOS:000207459400015
J	Keller, EF; Harel, D				Keller, Evelyn Fox; Harel, David			Beyond the Gene	PLOS ONE			English	Article							DNA	This paper is a response to the increasing difficulty biologists find in agreeing upon a definition of the gene, and indeed, the increasing disarray in which that concept finds itself. After briefly reviewing these problems, we propose an alternative to both the concept and the word gene-an alternative that, like the gene, is intended to capture the essence of inheritance, but which is both richer and more expressive. It is also clearer in its separation of what the organism statically is (what it tangibly inherits) and what it dynamically does (its functionality and behavior). Our proposal of a genetic functor, or genitor, is a sweeping extension of the classical genotype/phenotype paradigm, yet it appears to be faithful to the findings of contemporary biology, encompassing many of the recently emerging- and surprisingly complex-links between structure and functionality.	[Harel, David] Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel; [Keller, Evelyn Fox] MIT, Program Sci Technol & Soc, Cambridge, MA 02139 USA	Weizmann Institute of Science; Massachusetts Institute of Technology (MIT)	Harel, D (corresponding author), Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel.	dharel@weizmann.ac.il			EPSRC; EPSRC [EP/E031161/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E031161/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Evelyn Fox Keller's work was carried out while she was in Paris as Chaire Blaise Pascal, at REHSEIS. David Harel's work was carried out during a visit to the School of Informatics at the University of Edinburgh, which was supported by a grant from the EPSRC.	[Anonymous], 2005, PLAUSIBILITY LIFE; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BORGES JL, 1941, LIB BABEL; Brenner S, 2000, SCIENCE, V287, P2173, DOI 10.1126/science.287.5461.2173; Clarke EM, 1999, MODEL CHECKING, P1; Gingeras TR, 2007, GENOME RES, V17, P682, DOI 10.1101/gr.6525007; GOLDENFELD N, 2007, BIOL NEXT REVOLUTION; Harel D., 2003, Bulletin of the European Association for Theoretical Computer Science, P226; HAREL D, 1985, NATO ASI SERIES F, V13, P477; HAREL D, 2001, COMPUTERS LTD WHAT T; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Keller Evelyn Fox, 2000, CENTURY GENE; King DG, 1997, ENDEAVOUR, V21, P36, DOI 10.1016/S0160-9327(97)01005-3; Klein RJ, 2002, P NATL ACAD SCI USA, V99, P7542, DOI 10.1073/pnas.112063799; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Pearson H, 2006, NATURE, V441, P398, DOI 10.1038/441398a; Pennisi E, 2003, SCIENCE, V300, P282, DOI 10.1126/science.300.5617.282; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Snyder M, 2003, SCIENCE, V300, P258, DOI 10.1126/science.1084354; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Yuh CH, 2001, DEVELOPMENT, V128, P617	23	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1231	10.1371/journal.pone.0001231	http://dx.doi.org/10.1371/journal.pone.0001231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043738	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459300012
J	Mathews, JD; McCaw, CT; McVernon, J; McBryde, ES; McCaw, JM				Mathews, John D.; McCaw, Christopher T.; McVernon, Jodie; McBryde, Emma S.; McCaw, James M.			A Biological Model for Influenza Transmission: Pandemic Planning Implications of Asymptomatic Infection and Immunity	PLOS ONE			English	Article							A VIRUS-INFECTION; STRATEGIES; HOUSEHOLD; OUTBREAK; FAMILY	Background. The clinical attack rate of influenza is influenced by prior immunity and mixing patterns in the host population, and also by the proportion of infections that are asymptomatic. This complexity makes it difficult to directly estimate R-0 from the attack rate, contributing to uncertainty in epidemiological models to guide pandemic planning. We have modelled multiple wave outbreaks of influenza from different populations to allow for changing immunity and asymptomatic infection and to make inferences about R-0. Data and Methods. On the island of Tristan da Cunha (TdC), 96% of residents reported illness during an H3N2 outbreak in 1971, compared with only 25% of RAF personnel in military camps during the 1918 H1N1 pandemic. Monte Carlo Markov Chain (MCMC) methods were used to estimate model parameter distributions. Findings. We estimated that most islanders on TdC were non-immune (susceptible) before the first wave, and that almost all exposures of susceptible persons caused symptoms. The median R0 of 6.4 (95% credibility interval 3.7-10.7) implied that most islanders were exposed twice, although only a minority became ill in the second wave because of temporary protection following the first wave. In contrast, only 51% of RAF personnel were susceptible before the first wave, and only 38% of exposed susceptibles reported symptoms. R0 in this population was also lower [2.9 (2.3-4.3)], suggesting reduced viral transmission in a partially immune population. Interpretation. Our model implies that the RAF population was partially protected before the summer pandemic wave of 1918, arguably because of prior exposure to interpandemic influenza. Without such protection, each symptomatic case of influenza would transmit to between 2 and 10 new cases, with incidence initially doubling every 12 days. Containment of a novel virus could be more difficult than hitherto supposed.	[Mathews, John D.; McCaw, Christopher T.; McVernon, Jodie; McCaw, James M.] Univ Melbourne, Murdoch Childrens Res Inst, Vaccine & Immunisat Res Grp, Parkville, Vic 3052, Australia; [Mathews, John D.; McCaw, Christopher T.; McVernon, Jodie; McCaw, James M.] Univ Melbourne, Sch Populat Hlth, Parkville, Vic 3052, Australia; [McBryde, Emma S.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Ctr Clin Res Excellence Infect Dis, Parkville, Vic 3050, Australia; [McBryde, Emma S.] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of Melbourne	McCaw, JM (corresponding author), Univ Melbourne, Murdoch Childrens Res Inst, Vaccine & Immunisat Res Grp, Parkville, Vic 3052, Australia.	jamesm@unimelb.edu.au	McBryde, Emma/D-2220-2018	McBryde, Emma/0000-0002-9570-9172; Mathews, John/0000-0001-9029-7140; McCaw, James/0000-0002-2452-3098; McVernon, Jodie/0000-0001-9774-1961	National Health and Medical Research Council (NHMRC) [400588, 454645, 358425, 359238]; Centre for Clinical Research Excellence in Infectious Diseases [219275]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Centre for Clinical Research Excellence in Infectious Diseases	External funding was received from the National Health and Medical Research Council (NHMRC) (Project Grant Nos 400588 and 454645, Capacity Building Grant No 358425 and Centre for Clinical Research Excellence in Infectious Diseases No 219275). Jodie McVernon is supported by an NHMRC Australian Training Research Fellowship (No 359238).	ANDERSON R M, 1991; ARMSTRONG C, 1921, PUBLIC HLTH REPORTS, V36; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; CALEY P, 2007, J R SOC INTERFACE; Cox RJ, 2006, VACCINE, V24, P6577, DOI 10.1016/j.vaccine.2006.05.041; CROSBY A, 2003, SAMOA ALASKA AM FORG, pCH12; DAVIS LE, 1970, AM J EPIDEMIOL, V92, P240, DOI 10.1093/oxfordjournals.aje.a121203; Dowdle WR, 2006, EMERG INFECT DIS, V12, P34, DOI 10.3201/eid1201.051013; DUDLEY S, 1926, MED RES COUNCIL SPEC, V111; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Frost W H, 2006, Public Health Rep, V121 Suppl 1, P149; Frost W.H., 2006, PUBLIC HEALTH REP, V121, P148; GELMAN A, 2004, BAYSESIAN DATA ANAL; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Halloran ME, 2007, AM J EPIDEMIOL, V165, P212, DOI 10.1093/aje/kwj362; Hope-Simpson R.E., 1992, TRANSMISSION EPIDEMI; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; MANTLE J, 1973, J HYG-CAMBRIDGE, V71, P89, DOI 10.1017/S0022172400046246; McVernon J, 2007, INFLUENZA OTHER RESP, V1, P43, DOI 10.1111/j.1750-2659.2007.00008.x; *MIN HLTH, 1920, REP PUBL HLTH MED SU, V4; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Nishiura H, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-20; Reid AH, 2004, NAT REV MICROBIOL, V2, P909, DOI 10.1038/nrmicro1027; Roberts MG, 2007, J R SOC INTERFACE, V4, P325, DOI 10.1098/rsif.2006.0176; ROBERTS MG, 2007, J MATH BIOL; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Tamura SI, 2005, JPN J INFECT DIS, V58, P195	35	73	76	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1220	10.1371/journal.pone.0001220	http://dx.doi.org/10.1371/journal.pone.0001220			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043733	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000207459300007
J	Heiny, AT; Miotto, O; Srinivasan, KN; Khan, AM; Zhang, GL; Brusic, V; Tan, TW; August, JT				Heiny, A. T.; Miotto, Olivo; Srinivasan, Kellathur N.; Khan, Asif M.; Zhang, G. L.; Brusic, Vladimir; Tan, Tin Wee; August, J. Thomas			Evolutionarily Conserved Protein Sequences of Influenza A Viruses, Avian and Human, as Vaccine Targets	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; MHC CLASS-I; PROTECTIVE IMMUNITY; CELL EPITOPES; DNA VACCINE; CTL EPITOPES; PEPTIDE; INFECTION; BINDING; IMMUNIZATION	Background. Influenza A viruses generate an extreme genetic diversity through point mutation and gene segment exchange, resulting in many new strains that emerge from the animal reservoirs, among which was the recent highly pathogenic H5N1 virus. This genetic diversity also endows these viruses with a dynamic adaptability to their habitats, one result being the rapid selection of genomic variants that resist the immune responses of infected hosts. With the possibility of an influenza A pandemic, a critical need is a vaccine that will recognize and protect against any influenza A pathogen. One feasible approach is a vaccine containing conserved immunogenic protein sequences that represent the genotypic diversity of all current and future avian and human influenza viruses as an alternative to current vaccines that address only the known circulating virus strains. Methodology/Principal Findings. Methodologies for large-scale analysis of the evolutionary variability of the influenza A virus proteins recorded in public databases were developed and used to elucidate the amino acid sequence diversity and conservation of 36,343 sequences of the 11 viral proteins of the recorded virus isolates of the past 30 years. Technologies were also applied to identify the conserved amino acid sequences from isolates of the past decade, and to evaluate the predicted human lymphocyte antigen (HLA) supertype-restricted class I and II T-cell epitopes of the conserved sequences. Fifty-five (55) sequences of 9 or more amino acids of the polymerases (PB2, PB1, and PA), nucleoprotein (NP), and matrix 1 (M1) proteins were completely conserved in at least 80%, many in 95 to 100%, of the avian and human influenza A virus isolates despite the marked evolutionary variability of the viruses. Almost all (50) of these conserved sequences contained putative supertype HLA class I or class II epitopes as predicted by 4 peptide-HLA binding algorithms. Additionally, data of the Immune Epitope Database (IEDB) include 29 experimentally identified HLA class I and II T-cell epitopes present in 14 of the conserved sequences. Conclusions/Significance. This study of all reported influenza A virus protein sequences, avian and human, has identified 55 highly conserved sequences, most of which are predicted to have immune relevance as T-cell epitopes. This is a necessary first step in the design and analysis of a polyepitope, pan-influenza A vaccine. In addition to the application described herein, these technologies can be applied to other pathogens and to other therapeutic modalities designed to attack DNA, RNA, or protein sequences critical to pathogen function.	[Srinivasan, Kellathur N.; August, J. Thomas] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA; [Heiny, A. T.; Miotto, Olivo; Khan, Asif M.; Tan, Tin Wee] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Miotto, Olivo] Natl Univ Singapore, Inst Syst Sci, Singapore 117595, Singapore; [Srinivasan, Kellathur N.] Hlth Sci Author, Ctr Drug Adm, Prod Evaluat & Registrat Div, Singapore, Singapore; [Khan, Asif M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Zhang, G. L.] Inst Infocomm Res, Singapore, Singapore; [Brusic, Vladimir] Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02115 USA	Johns Hopkins University; National University of Singapore; National University of Singapore; Health Sciences Authority (HSA); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); Harvard University; Dana-Farber Cancer Institute	August, JT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA.	taugust@bs.jhmi.edu	Khan, Mohammad Asif/F-4663-2010; Tan, Tin Wee/B-8963-2009; Brusic, Vladimir/B-1478-2008; Khan, M. Asif/ABE-7839-2021; Miotto, Olivo/AAE-7124-2019	Khan, Mohammad Asif/0000-0001-9202-279X; Tan, Tin Wee/0000-0002-4062-2854; Brusic, Vladimir/0000-0003-0523-5266; Khan, M. Asif/0000-0001-9202-279X; Miotto, Olivo/0000-0001-8060-6771	National Institute of Allergy and Infectious Diseases; National Institutes of Health; Department of Health and Human Services, USA [5 U19 AI56541, HHSN2662-00400085C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056541] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The development of the computational tools reported herein was supported by in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, USA, under Grant No. 5 U19 AI56541 and Contract No. HHSN2662-00400085C.	Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; ASKONAS BA, 1988, ANN NY ACAD SCI, V532, P230, DOI 10.1111/j.1749-6632.1988.tb36342.x; BENACERRAF B, 1978, J IMMUNOL, V120, P1809; Bian HJ, 2004, METHODS, V34, P468, DOI 10.1016/j.ymeth.2004.06.002; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Blaney JE, 1998, J VIROL, V72, P9567, DOI 10.1128/JVI.72.12.9567-9574.1998; Botten J, 2007, J VIROL, V81, P2307, DOI 10.1128/JVI.02063-06; Brusic V, 2004, PHARMACOGENOMICS, V5, P597, DOI 10.1517/14622416.5.6.597; Bui HH, 2005, IMMUNOGENETICS, V57, P304, DOI 10.1007/s00251-005-0798-y; CASTRUCCI MR, 1994, J VIROL, V68, P3486, DOI 10.1128/JVI.68.6.3486-3490.1994; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Coleman JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-9; Corbet S, 2003, J GEN VIROL, V84, P2409, DOI 10.1099/vir.0.19152-0; COX NJ, 2005, TOPLEY WILSONS MICRO, V1, pCH32; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; De Groot AS, 2005, VACCINE, V23, P2136, DOI 10.1016/j.vaccine.2005.01.097; de Jong JC, 2000, J INFECTION, V40, P218, DOI 10.1053/jinf.2000.0652; DELVAL M, 1991, J VIROL, V65, P3641, DOI 10.1128/JVI.65.7.3641-3646.1991; Doytchinova IA, 2005, J IMMUNOL, V174, P7085, DOI 10.4049/jimmunol.174.11.7085; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.iy.12.040194.001145; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FELTKAMP MCW, 1995, EUR J IMMUNOL, V25, P2638, DOI 10.1002/eji.1830250935; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Fomsgaard A, 1999, VACCINE, V18, P681, DOI 10.1016/S0264-410X(99)00279-0; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Fu TM, 1999, J IMMUNOL, V162, P4163; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Gonzalez-Aseguinolaza G, 2003, J VIROL, V77, P11859, DOI 10.1128/JVI.77.21.11859-11866.2003; HAMMER J, 1993, CELL, V74, P197, DOI 10.1016/0092-8674(93)90306-B; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; HARTY JT, 1992, J EXP MED, V175, P1531, DOI 10.1084/jem.175.6.1531; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Khan AM, 2006, CELL IMMUNOL, V244, P141, DOI 10.1016/j.cellimm.2007.02.005; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; KLAVINSKIS LS, 1989, J VIROL, V63, P4311, DOI 10.1128/JVI.63.10.4311-4316.1989; LAMB JR, 1987, HUM IMMUNOL, V19, P79, DOI 10.1016/0198-8859(87)90096-6; Lambkin Robert, 2004, Am J Pharmacogenomics, V4, P293, DOI 10.2165/00129785-200404050-00002; LAPOSTA VJ, 1993, J VIROL, V67, P3497, DOI 10.1128/JVI.67.6.3497-3506.1993; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; LAWSON CM, 1994, J VIROL, V68, P3505, DOI 10.1128/JVI.68.6.3505-3511.1994; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Mazumder R, 2007, VIRUS GENES, V35, P175, DOI 10.1007/s11262-007-0103-2; MCMICHAEL AJ, 1989, ADV EXP MED BIOL, V257, P109; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S7; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; Moorthy VS, 2004, J INFECT DIS, V189, P2213, DOI 10.1086/421118; Moskophidis D, 1998, J EXP MED, V188, P223, DOI 10.1084/jem.188.2.223; Nickle DC, 2007, PLOS COMPUT BIOL, V3, P754, DOI 10.1371/journal.pcbi.0030075; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Oukka M, 1996, J IMMUNOL, V157, P3039; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Plotnicky H, 2003, VIROLOGY, V309, P320, DOI 10.1016/S0042-6822(03)00072-2; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; SIDNEY J, 1995, J IMMUNOL, V154, P247; Snyder JT, 2004, J VIROL, V78, P7052, DOI 10.1128/JVI.78.13.7052-7060.2004; Stemmer C, 1999, J BIOL CHEM, V274, P5550, DOI 10.1074/jbc.274.9.5550; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Thakar MR, 2005, J INFECT DIS, V192, P749, DOI 10.1086/432547; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; TOWNSEND ARM, 1987, IMMUNOL RES, V6, P80, DOI 10.1007/BF02918106; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; Treanor J, 2004, NEW ENGL J MED, V351, P2037, DOI 10.1056/NEJMp048290; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Tsuji M, 1998, J VIROL, V72, P6907, DOI 10.1128/JVI.72.8.6907-6910.1998; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; Uscher-Pines L, 2006, PLOS MED, V3, P1721, DOI 10.1371/journal.pmed.0030436; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; VANBLEEK GM, 1991, P NATL ACAD SCI USA, V88, P11032, DOI 10.1073/pnas.88.24.11032; Wilson CC, 2003, J IMMUNOL, V171, P5611, DOI 10.4049/jimmunol.171.10.5611; Yokomaku Y, 2004, J VIROL, V78, P1324, DOI 10.1128/JVI.78.3.1324-1332.2004; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002; Zhang GL, 2005, NUCLEIC ACIDS RES, V33, pW172, DOI 10.1093/nar/gki452	91	129	146	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1190	10.1371/journal.pone.0001190	http://dx.doi.org/10.1371/journal.pone.0001190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030326	Green Published, gold			2022-12-27	WOS:000207459200005
J	Tschritter, O; Hennige, AM; Preissl, H; Porubska, K; Schafer, SA; Lutzenberger, W; Machicao, F; Birbaumer, N; Fritsche, A; Haring, HU				Tschritter, Otto; Hennige, Anita M.; Preissl, Hubert; Porubska, Katarina; Schaefer, Silke A.; Lutzenberger, Werner; Machicao, Fausto; Birbaumer, Niels; Fritsche, Andreas; Haering, Hans-Ulrich			Cerebrocortical Beta Activity in Overweight Humans Responds to Insulin Detemir	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; OBESITY; MEMORY; PROTRACTION; MECHANISM; TRANSPORT; ALBUMIN; WEIGHT; PLASMA; TISSUE	Background. Insulin stimulates cerebrocortical beta and theta activity in lean humans. This effect is reduced in obese individuals indicating cerebrocortical insulin resistance. In the present study we tested whether insulin detemir is a suitable tool to restore the cerebral insulin response in overweight humans. This approach is based on studies in mice where we could recently demonstrate increased brain tissue concentrations of insulin and increased insulin signaling in the hypothalamus and cerebral cortex following peripheral injection of insulin detemir. Methodology/Principal Findings. We studied activity of the cerebral cortex using magnetoencephalography in 12 lean and 34 overweight non-diabetic humans during a 2-step hyperinsulinemic euglycemic clamp (each step 90 min) with human insulin (HI) and saline infusion (S). In 10 overweight subjects we additionally performed the euglycemic clamp with insulin detemir (D). While human insulin administration did not change cerebrocortical activity relative to saline (p = 0.90) in overweight subjects, beta activity increased during D administration (basal 59 +/- 3 fT, 1(st) step 62 +/- 3 fT, 2(nd) step 66 +/- 5, p = 0.001, D vs. HI). As under this condition glucose infusion rates were lower with D than with HI (p = 0.003), it can be excluded that the cerebral effect is the consequence of a systemic effect. The total effect of insulin detemir on beta activity was not different from the human insulin effect in lean subjects (p = 0.78). Conclusions/Significance. Despite cerebrocortical resistance to human insulin, insulin detemir increased beta activity in overweight human subjects similarly as human insulin in lean subjects. These data suggest that the decreased cerebral beta activity response in overweight subjects can be restored by insulin detemir.	[Tschritter, Otto; Hennige, Anita M.; Schaefer, Silke A.; Machicao, Fausto; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med 4, Tubingen, Germany; [Preissl, Hubert; Porubska, Katarina; Lutzenberger, Werner; Birbaumer, Niels] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Preissl, Hubert] Univ Arkansas Med Sci, Coll Med, Dept Obstet & Gynecol, Little Rock, AR 72205 USA; [Porubska, Katarina] Univ Eye Hosp, Dept Neuroophthalmol, Tubingen, Germany; [Birbaumer, Niels] NINDS, NIH, Bethesda, MD 20892 USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Arkansas System; University of Arkansas Medical Sciences; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Haring, HU (corresponding author), Univ Tubingen, Dept Internal Med 4, Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Preißl, Hubert/E-9070-2012	Preißl, Hubert/0000-0002-8859-4661; Birbaumer, Niels/0000-0002-6786-5127	Deutsche Forschungsgemeinschaft ( DFG) [KFO114]; NovoNordisk, Copenhagen, Denmark	Deutsche Forschungsgemeinschaft ( DFG)(German Research Foundation (DFG)); NovoNordisk, Copenhagen, Denmark(Novo Nordisk)	This is an investigator initiated study. The study has been supported by a grant of the Deutsche Forschungsgemeinschaft ( DFG) as a part of the project "Klinische Forschergruppe 114'' ( KFO114) and by a research grant of NovoNordisk, Copenhagen, Denmark. NovoNordisk provided information about pharmacokinetics of insulin detemir for intravenous application. The funders had no further role in study design, collection and analysis of data, decision to publish, or preparation of the manuscript.	BAURA GD, 1993, J CLIN INVEST, V92, P1824, DOI 10.1172/JCI116773; Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Biessels GJ, 1998, BRAIN RES, V800, P125, DOI 10.1016/S0006-8993(98)00510-1; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; BRUNING JC, 2000, REPROD SCI, V289, P2122; Dea MK, 2002, DIABETES, V51, P762, DOI 10.2337/diabetes.51.3.762; Ellmerer M, 2000, AM J PHYSIOL-ENDOC M, V278, pE352, DOI 10.1152/ajpendo.2000.278.2.E352; Fritsche A, 2004, INT J OBESITY, V28, pS41, DOI 10.1038/sj.ijo.0802749; Havelund S, 2004, PHARM RES-DORDR, V21, P1498, DOI 10.1023/B:PHAM.0000036926.54824.37; Hennige AM, 2006, DIABETOLOGIA, V49, P1274, DOI 10.1007/s00125-006-0192-9; Kaiyala KJ, 2000, DIABETES, V49, P1525, DOI 10.2337/diabetes.49.9.1525; Kurtzhals P, 2004, INT J OBESITY, V28, pS23, DOI 10.1038/sj.ijo.0802746; Lutzenberger W, 2002, J NEUROSCI, V22, P5630; Messier Claude, 2005, Neural Plasticity, V12, P311, DOI 10.1155/NP.2005.311; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Novitski N, 2004, COGNITIVE BRAIN RES, V20, P26, DOI 10.1016/j.cogbrainres.2003.12.011; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Okamoto H, 2005, J CLIN INVEST, V115, P1314, DOI 10.1172/JCI200523096; Pitcher H, 2006, LANCET NEUROL, V5, P388, DOI 10.1016/S1474-4422(06)70434-3; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Porte D, 1998, DIABETOLOGIA, V41, P863, DOI 10.1007/s001250051002; Sauseng P, 2004, NEUROSCI LETT, V354, P123, DOI 10.1016/j.neulet.2003.10.002; SCHWARTZ MW, 1991, J CLIN INVEST, V88, P1272, DOI 10.1172/JCI115431; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seyfert S, 2002, J NEUROL, V249, P1021, DOI 10.1007/s00415-002-0777-2; Tschritter O, 2007, DIABETOLOGIA, V50, P2602, DOI 10.1007/s00125-007-0839-1; Tschritter O, 2006, P NATL ACAD SCI USA, V103, P12103, DOI 10.1073/pnas.0604404103; Vardy ERLC, 2006, EXPERT REV NEUROTHER, V6, P695, DOI 10.1586/14737175.6.5.695; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Woods SC, 2003, CURR PHARM DESIGN, V9, P795, DOI 10.2174/1381612033455323	30	40	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1196	10.1371/journal.pone.0001196	http://dx.doi.org/10.1371/journal.pone.0001196			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030331	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459200010
J	di Magliano, MP; Biankin, AV; Heiser, PW; Cano, DA; Gutierrez, PJA; Deramaudt, T; Segara, D; Dawson, AC; Kench, JG; Henshall, SM; Sutherland, RL; Dlugosz, A; Rustgi, AK; Hebrok, M				di Magliano, Marina Pasca; Biankin, Andrew V.; Heiser, Patrick W.; Cano, David A.; Gutierrez, Pedro J. A.; Deramaudt, Therese; Segara, Davendra; Dawson, Amanda C.; Kench, James G.; Henshall, Susan M.; Sutherland, Robert L.; Dlugosz, Andrzej; Rustgi, Anil K.; Hebrok, Matthias			Common Activation of Canonical Wnt Signaling in Pancreatic Adenocarcinoma	PLOS ONE			English	Article								Pancreatic ductal adenocarcinoma (PDA) is an extremely aggressive malignancy, which carries a dismal prognosis. Activating mutations of the Kras gene are common to the vast majority of human PDA. In addition, recent studies have demonstrated that embryonic signaling pathway such as Hedgehog and Notch are inappropriately upregulated in this disease. The role of another embryonic signaling pathway, namely the canonical Wnt cascade, is still controversial. Here, we use gene array analysis as a platform to demonstrate general activation of the canonical arm of the Wnt pathway in human PDA. Furthermore, we provide evidence for Wnt activation in mouse models of pancreatic cancer. Our results also indicate that Wnt signaling might be activated downstream of Hedgehog signaling, which is an early event in PDA evolution. Wnt inhibition blocked proliferation and induced apoptosis of cultured adenocarcinoma cells, thereby providing evidence to support the development of novel therapeutical strategies for Wnt inhibition in pancreatic adenocarcinoma.	[di Magliano, Marina Pasca; Heiser, Patrick W.; Cano, David A.; Gutierrez, Pedro J. A.; Hebrok, Matthias] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA; [Biankin, Andrew V.; Segara, Davendra; Dawson, Amanda C.; Kench, James G.; Henshall, Susan M.; Sutherland, Robert L.] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; [Biankin, Andrew V.] Bankstown Hosp, Dept Surg, Sydney, NSW, Australia; [Deramaudt, Therese; Rustgi, Anil K.] Univ Penn, Dept Genet, Div Gastroenterol, Philadelphia, PA 19104 USA; [Dlugosz, Andrzej] Univ Michigan, Dept Dermatol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Pennsylvania; University of Michigan System; University of Michigan	Hebrok, M (corresponding author), Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA.	mhebrok@diabetes.ucsf.edu	Sutherland, Robert L/A-8378-2008; Cano, David A./B-8013-2015; Dawson, Amanda Caroline/ABC-2878-2021	Cano, David A./0000-0001-6264-3288; Dawson, Amanda Caroline/0000-0003-2447-3251; Biankin, Andrew/0000-0002-0362-5597; Pasca di Magliano, Marina/0000-0001-9632-9035; Heiser, Patrick/0000-0002-8831-4973; Kench, James Geoffrey/0000-0001-8687-4988	National Pancreas Foundation; Ministerio de Educacion, Cultura y Deporte, of the Spanish Government; Juvenile Diabetes Research Foundation; NIH [DK60694, CA112537- 01]; National Health and Medical Research Council of Australia; St. Vincent's Clinic Foundation; Cancer Institute NSW; Royal Australasian College of Surgeons; R.T. Hall Trust; UCSF Comprehensive Cancer Center; Lustgarten Foundation	National Pancreas Foundation; Ministerio de Educacion, Cultura y Deporte, of the Spanish Government(Spanish Government); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); St. Vincent's Clinic Foundation; Cancer Institute NSW; Royal Australasian College of Surgeons; R.T. Hall Trust; UCSF Comprehensive Cancer Center; Lustgarten Foundation	MP is supported by a grant from the National Pancreas Foundation. DAC was supported by a postdoctoral fellowship from the Ministerio de Educacion, Cultura y Deporte, of the Spanish Government and a postdoctoral fellowship from the Juvenile Diabetes Research Foundation. Research in AKR's laboratory is supported by grants from the National Pancreas Foundation and the NIH (DK60694). Research in AVB's laboratory is supported by the National Health and Medical Research Council of Australia, the St. Vincent's Clinic Foundation, the Cancer Institute NSW, the Royal Australasian College of Surgeons and the R.T. Hall Trust. AVB and SMH are supported by Cancer Institute NSW Fellowships. Research in MH's laboratory was supported by grants from the UCSF Comprehensive Cancer Center, a Lustgarten Foundation grant, and an NIH grant (CA112537- 01).	Abraham SC, 2002, AM J PATHOL, V160, P1361, DOI 10.1016/S0002-9440(10)62563-1; Al-Aynati MM, 2004, CLIN CANCER RES, V10, P1235, DOI 10.1158/1078-0432.CCR-03-0087; Anderson CB, 2002, P NATL ACAD SCI USA, V99, P8683, DOI 10.1073/pnas.122235399; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Biankin AV, 2003, PATHOLOGY, V35, P14, DOI 10.1080/003130202201472; Biankin AV, 2001, CANCER RES, V61, P8830; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Deramaudt TB, 2006, MOL CELL BIOL, V26, P4185, DOI 10.1128/MCB.01055-05; Dessimoz J, 2005, CURR BIOL, V15, P1677, DOI 10.1016/j.cub.2005.08.037; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hebrok M, 2003, MECH DEVELOP, V120, P45, DOI 10.1016/S0925-4773(02)00331-3; Hecht A, 2000, EMBO REP, V1, P24, DOI 10.1093/embo-reports/kvd012; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Heller RS, 2002, DEV DYNAM, V225, P260, DOI 10.1002/dvdy.10157; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Jaffee EM, 1998, CANCER J SCI AM, V4, P194; Kawahira H, 2005, DEV BIOL, V280, P111, DOI 10.1016/j.ydbio.2005.01.008; KLIMSTRA DS, 1994, AM J PATHOL, V145, P1547; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Lowy AM, 2003, ANN SURG ONCOL, V10, P284, DOI 10.1245/ASO.2003.05.003; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; MURTAUGH LC, 2005, BETA CATENIN ESSENTI; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Papadopoulou S, 2005, DIABETES, V54, P2844, DOI 10.2337/diabetes.54.10.2844; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Qualtrough D, 2004, INT J CANCER, V110, P831, DOI 10.1002/ijc.20227; ROESSLER E, 2005, HUM MOL GENET; Rozenblum E, 1997, CANCER RES, V57, P1731; RULIFSON IC, 2007, P NATL ACAD IN PRESS; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Tago K, 2000, GENE DEV, V14, P1741; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Wells JM, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-4; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607	52	166	171	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1155	10.1371/journal.pone.0001155	http://dx.doi.org/10.1371/journal.pone.0001155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17982507	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459000037
J	Shaham, S				Shaham, Shai			Counting Mutagenized Genomes and Optimizing Genetic Screens in Caenorhabditis elegans	PLOS ONE			English	Article								In genetic screens, the number of mutagenized gametes examined is an important parameter for evaluating screen progress, the number of genes of a given mutable phenotype, gene size, cost, and labor. Since genetic screens often entail examination of thousands or tens of thousands of animals, strategies for optimizing genetics screens are important for minimizing effort while maximizing the number of mutagenized gametes examined. To date, such strategies have not been described for genetic screens in the nematode Caenorhabditis elegans. Here we review general principles of genetic screens in C. elegans, and use a modified binomial strategy to obtain a general expression for the number of mutagenized gametes examined in a genetic screen. We use this expression to calculate optimal screening parameters for a large range of genetic screen types. In addition, we developed a simple online genetic-screen-optimization tool that can be used independently of this paper. Our results demonstrate that choosing the optimal F2-to-F1 screening ratio can significantly improve screen efficiency.	Rockefeller Univ, Lab Dev Genet, New York, NY 10021 USA	Rockefeller University	Shaham, S (corresponding author), Rockefeller Univ, Lab Dev Genet, 1230 York Ave, New York, NY 10021 USA.	shaham@rockefeller.edu			NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the NIH to SS. SS is a Klingenstein fellow in the neurosciences and a Monique Weill-Caulier Scholar.	Anderson P, 1995, METHOD CELL BIOL, V48, P31; BENIAN GM, 1989, NATURE, V342, P45, DOI 10.1038/342045a0; BRENNER S, 1974, GENETICS, V77, P71; ELLIS RE, 1991, GENETICS, V129, P79; Greene EA, 2003, GENETICS, V164, P731; GREENWALD IS, 1980, GENETICS, V96, P147; HOWELL AM, 1990, GENETICS, V126, P583; JOHNSEN RC, 1991, GENETICS, V129, P735; JOHNSEN RC, 1997, C ELEGANS, V2, P79; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; MENEELY PM, 1979, GENETICS, V92, P99; PASTINK A, 1991, MOL GEN GENET, V229, P213, DOI 10.1007/BF00272158; SNOW ET, 1984, J BIOL CHEM, V259, P8095	15	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1117	10.1371/journal.pone.0001117	http://dx.doi.org/10.1371/journal.pone.0001117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17989770	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459000005
J	Yesson, C; Brewer, PW; Sutton, T; Caithness, N; Pahwa, JS; Burgess, M; Gray, WA; White, RJ; Jones, AC; Bisby, FA; Culham, A				Yesson, Chris; Brewer, Peter W.; Sutton, Tim; Caithness, Neil; Pahwa, Jaspreet S.; Burgess, Mikhaila; Gray, W. Alec; White, Richard J.; Jones, Andrew C.; Bisby, Frank A.; Culham, Alastair			How Global Is the Global Biodiversity Information Facility?	PLOS ONE			English	Article								There is a concerted global effort to digitize biodiversity occurrence data from herbarium and museum collections that together offer an unparalleled archive of life on Earth over the past few centuries. The Global Biodiversity Information Facility provides the largest single gateway to these data. Since 2004 it has provided a single point of access to specimen data from databases of biological surveys and collections. Biologists now have rapid access to more than 120 million observations, for use in many biological analyses. We investigate the quality and coverage of data digitally available, from the perspective of a biologist seeking distribution data for spatial analysis on a global scale. We present an example of automatic verification of geographic data using distributions from the International Legume Database and Information Service to test empirically, issues of geographic coverage and accuracy. There are over 1/2 million records covering 31% of all Legume species, and 84% of these records pass geographic validation. These data are not yet a global biodiversity resource for all species, or all countries. A user will encounter many biases and gaps in these data which should be understood before data are used or analyzed. The data are notably deficient in many of the world's biodiversity hotspots. The deficiencies in data coverage can be resolved by an increased application of resources to digitize and publish data throughout these most diverse regions. But in the push to provide ever more data online, we should not forget that consistent data quality is of paramount importance if the data are to be useful in capturing a meaningful picture of life on Earth.	[Yesson, Chris; Brewer, Peter W.; Sutton, Tim; Caithness, Neil; Bisby, Frank A.; Culham, Alastair] Univ Reading, Plant Sci Labs, Sch Biol Sci, Reading, Berks, England; [Pahwa, Jaspreet S.; Burgess, Mikhaila; Gray, W. Alec; White, Richard J.; Jones, Andrew C.] Cardiff Univ, Sch Comp Sci, Cardiff, S Glam, Wales	University of Reading; Cardiff University	Culham, A (corresponding author), Univ Reading, Plant Sci Labs, Sch Biol Sci, Reading, Berks, England.	a.culham@reading.ac.uk	Yesson, Chris/Q-1196-2017; Burgess, Mikhaila/AAZ-2064-2021; Culham, Alastair/AAP-8192-2021	Yesson, Chris/0000-0002-6731-4229; Burgess, Mikhaila/0000-0001-6367-4676; Culham, Alastair/0000-0002-7440-0133; Caithness, Neil/0000-0002-6234-4285	BBSRC [45/BEP17792]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	BBSRC (grant 45/BEP17792 for BiodiversityWorld) employed some authors whilst writing manuscript. University of Reading studentship for CY.	Bisby FA, 2000, SCIENCE, V289, P2309, DOI 10.1126/science.289.5488.2309; Brummitt R.K., 2001, WORLD GEOGRAPHIC SCH, V2; Chapman A.D., 2006, GUIDE BEST PRACTICES; Chapman AD., 2005, PRINCIPLES METHODS D; Edwards JL, 2004, BIOSCIENCE, V54, P485; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Lane M. A., 2007, GBIF STRATEGIC OPERA; Lughadha EN, 2005, PHILOS T ROY SOC B, V360, P359, DOI 10.1098/rstb.2004.1596; Meier R, 2004, CONSERV BIOL, V18, P478, DOI 10.1111/j.1523-1739.2004.00233.x; Mittermeier R, 2005, HOTSPOTS REVISITED E; Pennisi E, 2000, SCIENCE, V289, P2306, DOI 10.1126/science.289.5488.2306; Ponder WF, 2001, CONSERV BIOL, V15, P648, DOI 10.1046/j.1523-1739.2001.015003648.x; Roskov Y., 2005, ILDIS WORLD DATABASE; Sanchez-Cordero V, 2000, P NATL ACAD SCI USA, V97, P7074, DOI 10.1073/pnas.97.13.7074; Shaffer HB, 1998, TRENDS ECOL EVOL, V13, P27, DOI 10.1016/S0169-5347(97)01177-4; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Wheeler QD, 2004, BIOSCIENCE, V54, P717; Yesson C, 2006, SYST BIOL, V55, P785, DOI 10.1080/1063515060081570; Yesson C, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-72	19	217	229	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1124	10.1371/journal.pone.0001124	http://dx.doi.org/10.1371/journal.pone.0001124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987112	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000207459000008
J	Cheng, C; Fabrizio, P; Ge, HY; Wei, M; Longo, VD; Li, LM				Cheng, Chao; Fabrizio, Paola; Ge, Huanying; Wei, Min; Longo, Valter D.; Li, Lei M.			Significant and Systematic Expression Differentiation in Long-Lived Yeast Strains	PLOS ONE			English	Article								Background. Recent studies suggest that the regulation of longevity may be partially conserved in many eukaryotes ranging from yeast to mammals. The three yeast mutants sch9 Delta, ras2 Delta, tor1 Delta show extended chronological life span up to three folds. Our aim is to dissect the mechanisms that lead to the yeast life span extension. Methodology/Principal Findings. We obtain gene expression profiles of sch9 Delta, ras2 Delta, tor1 Delta as well as that for a wild type at day 2.5 in SDC medium using Affymetrix Yeast2.0 arrays. To accurately estimate the expression differentiation between the wild type and the long-lived mutants, we use sub-array normalization followed by a variant of the median-polishing summarization. The results are validated by the probe sets of S. pombe on the same chips. To translate the differentiation into changes of biological activities, we make statistical inference by integrating the expression profiles with biological gene subsets defined by Gene Ontology, KEGG pathways, and cellular localization of proteins. Other than subset-versus-other comparisons, we also make local comparisons between two directly-related gene subsets such as cytosolic and mitochondrial ribosomes. Our consensus is obtained by cross-examination of these inferences. The significant and systematic differentiation in the three long-lived strains includes: lower transcriptional activities; down-regulation of TCA cycle and oxidative phosphorylation versus up-regulation of the KEGG pathway Glycolysis/Gluconeogenesis; the overall reduction of mitochondrial activities. We also report some different expression patterns such as reduction of the activities relating to mitosis in ras2 Delta. Conclusions/Significance. The modification of energy pathways and modification of compartment activities such as down-regulation of mitochondrial ribosome proteins versus up-regulation of cytosolic ribosome proteins are directly associated with the life span extension in yeast. The results provide a new and systematic S. cerevisiae version of the free radical theory from the perspective of functional genomics.	[Cheng, Chao; Ge, Huanying; Li, Lei M.] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA; [Fabrizio, Paola; Wei, Min; Longo, Valter D.] Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA; [Li, Lei M.] Univ So Calif, Dept Math, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Li, LM (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.	lilei@usc.edu	Li, Lei M/C-7196-2009; Wei, Min/GSI-8510-2022	Li, Lei M/0000-0002-6571-1079; fabrizio, paola/0000-0002-1144-7727; Wei, Min/0000-0002-2649-9271	NIH [R01 GM75308-01, P50 HG002790]; Center of Excellence in Genome Science at University of Southern California; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075308] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Genome Science at University of Southern California; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work is supported by the grant R01 GM75308-01 from NIH, and is partially supported by Center of Excellence in Genome Science at University of Southern California, the NIH P50 HG002790 grant.	Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cheng C, 2005, NUCLEIC ACIDS RES, V33, P5565, DOI 10.1093/nar/gki844; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenkins NL, 2004, P ROY SOC B-BIOL SCI, V271, P2523, DOI 10.1098/rspb.2004.2897; Kaeberlein M, 2005, MECH AGEING DEV, V126, P491, DOI 10.1016/j.mad.2004.10.007; Kaeberlein M, 2005, MECH AGEING DEV, V126, P17, DOI 10.1016/j.mad.2004.09.013; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; KIRKWOOD TBL, 1988, CIBA F SYMP, V134, P193; Kirkwood TBL, 2002, MECH AGEING DEV, V123, P737, DOI 10.1016/S0047-6374(01)00419-5; KIRKWOOD TBL, 1992, AM J CLIN NUTR, V55, P1191; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; LI LM, 2007, DNA MICROARRAY NORMA; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Longo VD, 2005, NAT REV GENET, V6, DOI 10.1038/nrg1706; MORISHITA T, 1995, SCIENCE, V270, P1213, DOI 10.1126/science.270.5239.1213; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Partridge L, 2001, EXP GERONTOL, V36, P641, DOI 10.1016/S0531-5565(00)00232-1; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Schadt EE, 2000, J CELL BIOCHEM, V80, P192; Schneper L, 2004, EUKARYOT CELL, V3, P108, DOI 10.1128/EC.3.1.108-120.2004; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tukey JW, 1977, EXPLORATORY DATA ANA	34	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1095	10.1371/journal.pone.0001095	http://dx.doi.org/10.1371/journal.pone.0001095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971858	Green Submitted, gold, Green Published			2022-12-27	WOS:000207458700012
J	Suwanarusk, R; Russell, B; Chavchich, M; Chalfein, F; Kenangalem, E; Kosaisavee, V; Prasetyorini, B; Piera, KA; Barends, M; Brockman, A; Lek-Uthai, U; Anstey, NM; Tjitra, E; Nosten, F; Cheng, Q; Price, RN				Suwanarusk, Rossarin; Russell, Bruce; Chavchich, Marina; Chalfein, Ferryanto; Kenangalem, Enny; Kosaisavee, Varakorn; Prasetyorini, Budi; Piera, Kim A.; Barends, Marion; Brockman, Alan; Lek-Uthai, Usa; Anstey, Nicholas M.; Tjitra, Emiliana; Nosten, Francois; Cheng, Qin; Price, Ric N.			Chloroquine Resistant Plasmodium vivax: In Vitro Characterisation and Association with Molecular Polymorphisms	PLOS ONE			English	Article							WESTERN BORDER; SULFADOXINE-PYRIMETHAMINE; MALARIA; FALCIPARUM; SENSITIVITY; PAPUA; GENE; ANTIMALARIALS; ARTEMISININ; POPULATION	Background. Treatment failure of chloroquine for P. vivax infections has reached high levels in the eastern provinces of Indonesia, however, in vitro characterization of chloroquine resistance and its associated molecular profile have yet to be determined. Methods. Using a modified schizont maturation assay we investigated the in vitro chloroquine susceptibility profile and molecular polymorphisms of P. vivax isolates collected from Papua, Indonesia, where high levels of clinical chloroquine treatment failure have been reported, and from Thailand, where chloroquine treatment is generally effective. Results. The geometric mean chloroquine IC50 for P. vivax isolates from Papua (n = 145) was 312 nM [95% CI: 237-411 nM] compared to 46.8 nM [95% CI: 34.7-63.1 nM] from Thailand (n = 81); p<0.001. Correlating with the known clinical efficacy of the area, a cut off for chloroquine resistance was defined as 220nM, a level exceeded in 13.6% (11/81) of Thai isolates and 65% (94/145) of Papuan isolates; p<0.001. Several sequence polymorphisms in pvcrt-o and pvmdr1, and difference in pvmdr1 copy number were identified. A Y976F mutation in pvmdr1 was present in 96% (123/128) of Papuan isolates and 25% (17/69) of Thai isolates; p<0.001. Overall, the geometric mean chloroquine IC50 in isolates with the Y976F mutation was 283 nM [95% CI: 211379], compared to 44.5 nM [95% CI: 31.3-63.4] in isolates with the wild type; p<0.001. Pvmdr1 amplification occurred in 23% (15/66) of Thai isolates compared to none (0/104) of Indonesian isolates (p<0.001), but was not associated with increased chloroquine resistance after controlling for geographical location. Conclusions. In vitro susceptibility testing of P. vivax discriminates between populations with differing levels of clinical efficacy of chloroquine. The pvmdr1 polymorphism at Y976F may provide a useful tool to highlight areas of emerging chloroquine resistance, although further studies defining its clinical correlates are needed.	[Suwanarusk, Rossarin; Russell, Bruce; Piera, Kim A.; Brockman, Alan; Anstey, Nicholas M.; Price, Ric N.] Menzies Sch Hlth Res, Div Infect Dis, Int Hlth Program, Darwin, NT, Australia; [Suwanarusk, Rossarin; Russell, Bruce; Piera, Kim A.; Brockman, Alan; Anstey, Nicholas M.; Price, Ric N.] Charles Darwin Univ, Darwin, NT 0909, Australia; [Chavchich, Marina; Cheng, Qin] Australian Army Malaria Inst, Dept Drug Resistance & Diagnost, Brisbane, Qld, Australia; [Chalfein, Ferryanto; Kenangalem, Enny] Natl Inst Hlth Res & Dev, Timika, Indonesia; [Chalfein, Ferryanto; Kenangalem, Enny] Menzies Sch Hlth, Malaria Res Program, Timika, Indonesia; [Kenangalem, Enny] Dist Minist Hlth, Timika, Papua, Indonesia; [Kosaisavee, Varakorn; Lek-Uthai, Usa] Mahidol Univ, Fac Publ Hlth, Dept Parasitol, Bangkok 10700, Thailand; [Prasetyorini, Budi; Tjitra, Emiliana] Minist Hlth, Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Nosten, Francois] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Barends, Marion; Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Tak Province, Thailand; [Price, Ric N.] John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Vaccinol & Trop Med, Oxford OX3 9DU, England	Charles Darwin University; Menzies School of Health Research; Charles Darwin University; QIMR Berghofer Medical Research Institute; National Institute of Health Research & Development - Indonesia; Ministry of Health - Indonesia; Mahidol University; Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia; Mahidol University; Mahidol University; University of Oxford	Price, RN (corresponding author), Menzies Sch Hlth Res, Div Infect Dis, Int Hlth Program, Darwin, NT, Australia.	rnp@menzies.edu.au	Nosten, Francois/AAC-5509-2019; Russell, Bruce/A-9240-2011; Cheng, Qin/AAO-2198-2020; Suwanarusk, Rossarin/E-2115-2013	Nosten, Francois/0000-0002-7951-0745; Russell, Bruce/0000-0003-2333-4348; Cheng, Qin/0000-0001-7776-4437; Suwanarusk, Rossarin/0000-0002-7310-245X; Price, Richard/0000-0003-2000-2874	The Wellcome Trust (UK); NHMRC (Australia)	The Wellcome Trust (UK)(Wellcome Trust); NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	Funding: The Wellcome Trust (UK) and NHMRC (Australia)	Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; BAIRD JK, 1991, AM J TROP MED HYG, V44, P547, DOI 10.4269/ajtmh.1991.44.547; Baird JK, 1996, T ROY SOC TROP MED H, V90, P409, DOI 10.1016/S0035-9203(96)90526-X; Brega S, 2005, J INFECT DIS, V191, P272, DOI 10.1086/426830; Bruce MC, 1999, AM J TROP MED HYG, V61, P518, DOI 10.4269/ajtmh.1999.61.518; Chotivanich K, 2004, AM J TROP MED HYG, V70, P395, DOI 10.4269/ajtmh.2004.70.395; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Figtree M, 2000, MOL BIOCHEM PARASIT, V108, P53, DOI 10.1016/S0166-6851(00)00204-8; Fryauff DJ, 1998, AM J TROP MED HYG, V59, P513, DOI 10.4269/ajtmh.1998.59.513; GUTHMANN JP, 2007, TROP MED IN IN PRESS; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Kurcer MA, 2006, ANN TROP MED PARASIT, V100, P109, DOI 10.1179/136485906X86284; Looareesuwan S, 1999, ANN TROP MED PARASIT, V93, P225, DOI 10.1080/00034989958474; Luxemburger C, 1999, T ROY SOC TROP MED H, V93, P433, DOI 10.1016/S0035-9203(99)90149-9; MARLARTHAN, 1995, T ROY SOC TROP MED H, V89, P307, DOI 10.1016/0035-9203(95)90556-1; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; MURPHY GS, 1993, LANCET, V341, P96, DOI 10.1016/0140-6736(93)92568-E; Nomura T, 2001, J INFECT DIS, V183, P1653, DOI 10.1086/320707; Padley D, 2003, ANN TROP MED PARASIT, V97, P131, DOI 10.1179/000349803125002977; Phan GT, 2002, TROP MED INT HEALTH, V7, P858, DOI 10.1046/j.1365-3156.2002.00948.x; Phillips EJ, 1996, CLIN INFECT DIS, V23, P1171, DOI 10.1093/clinids/23.5.1171; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; PRICE RN, 2007, AM J TROP M IN PRESS; Ratcliff A, 2007, LANCET, V369, P757, DOI 10.1016/S0140-6736(07)60160-3; Ratcliff A, 2007, T ROY SOC TROP MED H, V101, P351, DOI 10.1016/j.trstmh.2006.06.008; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; RIECKMANN KH, 1989, LANCET, V2, P1183, DOI 10.1016/S0140-6736(89)91792-3; Russell BM, 2003, ANTIMICROB AGENTS CH, V47, P170, DOI 10.1128/AAC.47.1.170-173.2003; Sa JM, 2005, EXP PARASITOL, V109, P256, DOI 10.1016/j.exppara.2004.12.005; Sa JM, 2006, MOL BIOCHEM PARASIT, V150, P219, DOI 10.1016/j.molbiopara.2006.08.006; Soto J, 2001, AM J TROP MED HYG, V65, P90, DOI 10.4269/ajtmh.2001.65.90; Sumawinata IW, 2003, AM J TROP MED HYG, V68, P416, DOI 10.4269/ajtmh.2003.68.416; Tasanor O, 2002, ACTA TROP, V83, P49, DOI 10.1016/S0001-706X(02)00056-6; Tjitra E, 2002, ANTIMICROB AGENTS CH, V46, P3947, DOI 10.1128/AAC.46.12.3947-3953.2002	34	161	165	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1089	10.1371/journal.pone.0001089	http://dx.doi.org/10.1371/journal.pone.0001089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971853	Green Published, gold			2022-12-27	WOS:000207458700007
J	Cowell, IG; Sunter, NJ; Singh, PB; Austin, CA; Durkacz, BW; Tilby, MJ				Cowell, Ian G.; Sunter, Nicola J.; Singh, Prim B.; Austin, Caroline A.; Durkacz, Barbara W.; Tilby, Michael J.			gamma H2AX Foci Form Preferentially in Euchromatin after Ionising-Radiation	PLOS ONE			English	Article								Background. The histone variant histone H2A. X comprises up to 25% of the H2A complement in mammalian cells. It is rapidly phosphorylated following exposure of cells to double-strand break (DSB) inducing agents such as ionising radiation. Within minutes of DSB generation, H2AX molecules are phosphorylated in large chromatin domains flanking DNA double-strand breaks (DSBs); these domains can be observed by immunofluorescence microscopy and are termed gamma H2AX foci. H2AX phosphorylation is believed to have a role mounting an efficient cellular response to DNA damage. Theoretical considerations suggest an essentially random chromosomal distribution of X-ray induced DSBs, and experimental evidence does not consistently indicate otherwise. However, we observed an apparently uneven distribution of gamma H2AX foci following X-irradiation with regions of the nucleus devoid of foci. Methodology/Principle Findings. Using immunofluorescence microscopy, we show that focal phosphorylation of histone H2AX occurs preferentially in euchromatic regions of the genome following X-irradiation. H2AX phosphorylation has also been demonstrated previously to occur at stalled replication forks induced by UV radiation or exposure to agents such as hydroxyurea. In this study, treatment of S-phase cells with hydroxyurea lead to efficient H2AX phosphorylation in both euchromatin and heterochromatin at times when these chromatin compartments were undergoing replication. This suggests a block to H2AX phosphorylation in heterochromatin that is at least partially relieved by ongoing DNA replication. Conclusions/Significance. We discus a number of possible mechanisms that could account for the observed pattern of H2AX phosphorylation. Since gamma H2AX is regarded as forming a platform for the recruitment or retention of other DNA repair and signaling molecules, these findings imply that the processing of DSBs in heterochromatin differs from that in euchromatic regions. The differential responses of heterochromatic and euchromatic compartments of the genome to DSBs will have implications for understanding the processes of DNA repair in relation to nuclear and chromatin organization.	[Cowell, Ian G.; Sunter, Nicola J.; Austin, Caroline A.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Singh, Prim B.] Forschungszentrum, Div Tumour Biol, Borstel, Germany; [Durkacz, Barbara W.; Tilby, Michael J.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Cowell, IG (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	i.g.cowell@ncl.ac.uk	Singh, Prim/G-1088-2014	Singh, Prim/0000-0002-9571-0974; Austin, Caroline/0000-0002-1921-5947; Cowell, Ian/0000-0002-8606-0447	Breast Cancer Campaign [2002/343]; Leukaemia Research fund [0361]; Association for International Cancer Research [05-179]	Breast Cancer Campaign; Leukaemia Research fund; Association for International Cancer Research	This work was supported by the Breast Cancer Campaign (2002/343) and the Leukaemia Research fund (0361) and the Association for International Cancer Research (05-179).	Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, CELL CYCLE, V3, P149; BRENNER DJ, 1992, INT J RADIAT BIOL, V61, P737, DOI 10.1080/09553009214551591; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Cowell IG, 2005, BIOCHEM PHARMACOL, V71, P13, DOI 10.1016/j.bcp.2005.09.029; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Fernandez-Capetillo O, 2004, J EXP MED, V199, P1671, DOI 10.1084/jem.20032247; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; KARAGIANNIS TC, 2007, ONCOGENE; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Martinez-Lopez W, 2004, CYTOGENET GENOME RES, V104, P182, DOI 10.1159/000077486; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Puerto S, 2001, MUTAGENESIS, V16, P291, DOI 10.1093/mutage/16.4.291; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SAUNDERS WS, 1993, J CELL SCI, V104, P573; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Singh PB, 2002, J STRUCT BIOL, V140, P10, DOI 10.1016/S1047-8477(02)00536-1; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; TENHAGEN KG, 1990, MOL CELL BIOL, V10, P6348, DOI 10.1128/MCB.10.12.6348; Wang HY, 2005, J CELL PHYSIOL, V202, P492, DOI 10.1002/jcp.20141; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Ward J.F., 1985, RAD RES S, pS103; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; WARTERS RL, 1992, RADIAT RES, V130, P309, DOI 10.2307/3578376; WREGGETT KA, 1994, CYTOGENET CELL GENET, V66, P99, DOI 10.1159/000133676; Wu R, 2005, MOL BIOL CELL, V16, P2872, DOI 10.1091/mbc.e04-11-0997	39	178	184	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1057	10.1371/journal.pone.0001057	http://dx.doi.org/10.1371/journal.pone.0001057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957241	Green Published, Green Submitted, gold			2022-12-27	WOS:000207458500004
J	Weiss, WR; Kumar, A; Jiang, G; Williams, J; Bostick, A; Conteh, S; Fryauff, D; Aguiar, J; Singh, M; O'Hagan, DT; Ulmer, JB; Richie, TL				Weiss, Walter R.; Kumar, Anita; Jiang, George; Williams, Jackie; Bostick, Anthony; Conteh, Solomon; Fryauff, David; Aguiar, Joao; Singh, Manmohan; O'Hagan, Derek T.; Ulmer, Jeffery B.; Richie, Thomas L.			Protection of Rhesus Monkeys by a DNA Prime/Poxvirus Boost Malaria Vaccine Depends on Optimal DNA Priming and Inclusion of Blood Stage Antigens	PLOS ONE			English	Article								Background. We have previously described a four antigen malaria vaccine consisting of DNA plasmids boosted by recombinant poxviruses which protects a high percentage of rhesus monkeys against Plasmodium knowlesi (Pk) malaria. This is a multi-stage vaccine that includes two pre-erythrocytic antigens, PkCSP and PkSSP2(TRAP), and two erythrocytic antigens, PkAMA-1 and PkMSP-1(42kD). The present study reports three further experiments where we investigate the effects of DNA dose, timing, and formulation. We also compare vaccines utilizing only the pre-erythrocytic antigens with the four antigen vaccine. Methodology. In three experiments, rhesus monkeys were immunized with malaria vaccines using DNA plasmid injections followed by boosting with poxvirus vaccine. A variety of parameters were tested, including formulation of DNA on poly-lactic co-glycolide (PLG) particles, varying the number of DNA injections and the amount of DNA, varying the interval between the last DNA injection to the poxvirus boost from 7 to 21 weeks, and using vaccines with from one to four malaria antigens. Monkeys were challenged with Pk sporozoites given iv 2 to 4 weeks after the poxvirus injection, and parasitemia was measured by daily Giemsa stained blood films. Immune responses in venous blood samples taken after each vaccine injection were measured by ELIspot production of interferon-gamma, and by ELISA. Conclusions. 1) the number of DNA injections, the formulation of the DNA plasmids, and the interval between the last DNA injection and the poxvirus injection are critical to vaccine efficacy. However, the total dose used for DNA priming is not as important; 2) the blood stage antigens PkAMA-1 and PkMSP-1 were able to protect against high parasitemias as part of a genetic vaccine where antigen folding is not well defined; 3) immunization with PkSSP2 DNA inhibited immune responses to PkCSP DNA even when vaccinations were given into separate legs; and 4) in a counter-intuitive result, higher interferon-gamma ELIspot responses to the PkCSP antigen correlated with earlier appearance of parasites in the blood, despite the fact that PkCSP vaccines had a protective effect.	[Weiss, Walter R.; Kumar, Anita; Jiang, George; Conteh, Solomon; Fryauff, David; Aguiar, Joao; Richie, Thomas L.] USN, Med Res Ctr, Silver Spring, MD USA; [Williams, Jackie; Bostick, Anthony] Walter Reed Army Inst Res, Silver Spring, MD USA; [Singh, Manmohan; O'Hagan, Derek T.; Ulmer, Jeffery B.] Chiron Corp, Emeryville, CA 94608 USA	United States Department of Defense; United States Navy; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Novartis	Weiss, WR (corresponding author), USN, Med Res Ctr, Silver Spring, MD USA.	weissw@nmrc.navy.mil	O'Hagan, Derek/AAV-1850-2021	Richie, Thomas/0000-0002-2946-5456	DOD funds allocated to the Naval Medical Research Center [6000.RAD1.F.A0309]	DOD funds allocated to the Naval Medical Research Center	This work was supported by DOD funds allocated to the Naval Medical Research Center (work unit number 6000.RAD1.F.A0309).	Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Anderson RJ, 2004, J IMMUNOL, V172, P3094, DOI 10.4049/jimmunol.172.5.3094; Bacon DJ, 2007, HUM VACCINES, V3, P48, DOI 10.4161/hv.3.2.3833; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Ballou W Ripley, 2005, Expert Opin Emerg Drugs, V10, P489, DOI 10.1517/14728214.10.3.489; Ballou WR, 2004, AM J TROP MED HYG, V71, P239; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; Bejon P, 2006, INFECT IMMUN, V74, P6331, DOI 10.1128/IAI.00774-06; Blair PL, 2005, CURR TOP MICROBIOL, V295, P417; Carucci DJ, 2002, INT J PARASITOL, V32, P1539, DOI 10.1016/S0020-7519(02)00181-9; COLLINS CR, 2006, J BIOL CHEM; Dunachie SJ, 2006, INFECT IMMUN, V74, P5933, DOI 10.1128/IAI.00590-06; Enosse S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010005; Epstein JE, 2004, VACCINE, V22, P1592, DOI 10.1016/j.vaccine.2004.01.031; Epstein JE, 2002, HUM GENE THER, V13, P1551, DOI 10.1089/10430340260201644; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fluck C, 2004, INFECT IMMUN, V72, P6300, DOI 10.1128/IAI.72.11.6300-6305.2004; Fluck C, 2007, INFECT GENET EVOL, V7, P44, DOI 10.1016/j.meegid.2006.03.006; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Genton B, 2000, VACCINE, V18, P2504, DOI 10.1016/S0264-410X(00)00036-0; Giersing B, 2005, INFECT IMMUN, V73, P3963, DOI 10.1128/IAI.73.7.3963-3970.2005; Gilbert SC, 2002, VACCINE, V20, P1039, DOI 10.1016/S0264-410X(01)00450-9; Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042; Hill AVS, 2006, NAT REV IMMUNOL, V6, P21, DOI 10.1038/nri1746; HOFFMAN SL, 1994, VACCINE, V12, P1529, DOI 10.1016/0264-410X(94)90078-7; Imoukhuede EB, 2006, VACCINE, V24, P6526, DOI 10.1016/j.vaccine.2006.06.022; Krzych U, 2005, CURR TOP MICROBIOL, V297, P1; Kumar A, 2001, J IMMUNOL METHODS, V247, P49, DOI 10.1016/S0022-1759(00)00310-0; Le TP, 2000, VACCINE, V18, P1893, DOI 10.1016/S0264-410X(99)00407-7; LE TP, 1999, VACCINE IN PRESS; Mahanty S, 2003, J EXP BIOL, V206, P3781, DOI 10.1242/jeb.00646; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Moore AC, 2004, IMMUNOL REV, V199, P126, DOI 10.1111/j.0105-2896.2004.00138.x; O'Hagan D, 2001, J VIROL, V75, P9037, DOI 10.1128/JVI.75.19.9037-9043.2001; O'Hagan DT, 2006, METHODS, V40, P10, DOI 10.1016/j.ymeth.2006.05.017; Ockenhouse CF, 2006, VACCINE, V24, P3009, DOI 10.1016/j.vaccine.2005.11.028; Otten GR, 2005, J VIROL, V79, P8189, DOI 10.1128/JVI.79.13.8189-8200.2005; Rogers WO, 2002, INFECT IMMUN, V70, P4329, DOI 10.1128/IAI.70.8.4329-4335.2002; Rogers WO, 2001, INFECT IMMUN, V69, P5565, DOI 10.1128/IAI.69.9.5565-5572.2001; Sacci JB, 2005, MOL BIOCHEM PARASIT, V142, P177, DOI 10.1016/j.molbiopara.2005.03.018; SACCI JB, 2000, LASER CAPTURE MICROD; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Sedegah M, 2004, GENES IMMUN, V5, P553, DOI 10.1038/sj.gene.6364125; Sedegah M, 2004, GENE THER, V11, P448, DOI 10.1038/sj.gt.3302139; Sedegah M, 2002, INFECT IMMUN, V70, P3493, DOI 10.1128/IAI.70.7.3493-3499.2002; Sedegah M, 1998, P NATL ACAD SCI USA, V95, P7648, DOI 10.1073/pnas.95.13.7648; Sedegah M, 2000, J IMMUNOL, V164, P5905, DOI 10.4049/jimmunol.164.11.5905; Shimp RL, 2006, PROTEIN EXPRES PURIF, V50, P58, DOI 10.1016/j.pep.2006.06.018; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Stowers AW, 2002, P NATL ACAD SCI USA, V99, P339, DOI 10.1073/pnas.012590199; Tsai CW, 2006, J BIOTECHNOL, V121, P458, DOI 10.1016/j.jbiotec.2005.08.025; Walsh DS, 2006, VACCINE, V24, P4167, DOI 10.1016/j.vaccine.2006.02.041; Walsh DS, 2004, AM J TROP MED HYG, V70, P499, DOI 10.4269/ajtmh.2004.70.499; Walther M, 2006, INFECT IMMUN, V74, P2706, DOI 10.1128/IAI.74.5.2706-2716.2006; Wang RB, 2004, J IMMUNOL, V172, P5561, DOI 10.4049/jimmunol.172.9.5561; Wang RB, 2005, INFECT IMMUN, V73, P2863, DOI 10.1128/IAI.73.5.2863-2872.2005; Wang RB, 2001, P NATL ACAD SCI USA, V98, P10817, DOI 10.1073/pnas.181123498; Webster DP, 2006, VACCINE, V24, P3026, DOI 10.1016/j.vaccine.2005.10.058; Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102; Xie H, 2005, INFECT IMMUN, V73, P828, DOI 10.1128/IAI.73.2.828-833.2005; Zhang ZG, 2006, ACTA BIOCH BIOPH SIN, V38, P403, DOI 10.1111/j.1745-7270.2006.00178.x	66	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1063	10.1371/journal.pone.0001063	http://dx.doi.org/10.1371/journal.pone.0001063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957247	gold, Green Published, Green Submitted			2022-12-27	WOS:000207458500010
J	Young, TM; Tsai, M; Tian, B; Mathews, MB; Pe'ery, T				Young, Tara M.; Tsai, Michael; Tian, Bin; Mathews, Michael B.; Pe'ery, Tsafi			Cellular mRNA Activates Transcription Elongation by Displacing 7SK RNA	PLOS ONE			English	Article								The positive transcription elongation factor P-TEFb is a pivotal regulator of gene expression in higher cells. Originally identified in Drosophila, attention was drawn to human P-TEFb by the discovery of its role as an essential cofactor for HIV-1 transcription. It is recruited to HIV transcription complexes by the viral transactivator Tat, and to cellular transcription complexes by a plethora of transcription factors. P-TEFb activity is negatively regulated by sequestration in a complex with the HEXIM proteins and 7SK RNA. The mechanism of P-TEFb release from the inhibitory complex is not known. We report that P-TEFb-dependent transcription from the HIV promoter can be stimulated by the mRNA encoding HIC, the human I-mfa domain-containing protein. The 3'-untranslated region of HIC mRNA is necessary and sufficient for this action. It forms complexes with P-TEFb and displaces 7SK RNA from the inhibitory complex in cells and cell extracts. A 314-nucleotide sequence near the 3' end of HIC mRNA has full activity and contains a predicted structure resembling the 3'-terminal hairpin of 7SK that is critical for P-TEFb binding. This represents the first example of a cellular mRNA that can regulate transcription via P-TEFb. Our findings offer a rationale for 7SK being an RNA transcriptional regulator and suggest a practical means for enhancing gene expression.	[Young, Tara M.; Tsai, Michael; Tian, Bin; Mathews, Michael B.; Pe'ery, Tsafi] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Pe'ery, Tsafi] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Tian, Bin; Mathews, Michael B.; Pe'ery, Tsafi] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Mathews, MB (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA.	mathews@umdnj.edu; peeryts@umdnj.edu		Tian, Bin/0000-0001-8903-8256	National Institutes of Health [AI055331, AI034552]; Foundation of UMDNJ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034552, R21AI055331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of UMDNJ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by grants from the National Institutes of Health, AI055331 to Tsafi Pe'ery and AI034552 to Michael B. Mathews, and from the Foundation of UMDNJ to Tsafi Pe'ery. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagella L, 1998, J CELL PHYSIOL, V177, P206, DOI 10.1002/(SICI)1097-4652(199811)177:2<206::AID-JCP2>3.3.CO;2-W; Barboric M, 2005, PLOS BIOL, V3, P200, DOI 10.1371/journal.pbio.0030076; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Bird G, 2004, MOL CELL BIOL, V24, P8963, DOI 10.1128/MCB.24.20.8963-8969.2004; Bres V, 2005, GENE DEV, V19, P1211, DOI 10.1101/gad.1291705; Byers SA, 2005, J BIOL CHEM, V280, P16360, DOI 10.1074/jbc.M500424200; Condeelis J, 2005, BIOL CELL, V97, P97; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Egloff S, 2006, MOL CELL BIOL, V26, P630, DOI 10.1128/MCB.26.2.630-642.2006; Flores OL, 1999, P NATL ACAD SCI USA, V96, P7208, DOI 10.1073/pnas.96.13.7208; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Foskett SM, 2001, J VIROL, V75, P1220, DOI 10.1128/JVI.75.3.1220-1228.2001; Fraldi A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-42; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Garriga J, 1998, ONCOGENE, V17, P3093, DOI 10.1038/sj.onc.1202548; Guiguen A, 2007, EMBO J, V26, P1552, DOI 10.1038/sj.emboj.7601627; Havgaard JH, 2005, BIOINFORMATICS, V21, P1815, DOI 10.1093/bioinformatics/bti279; Hogg JR, 2007, RNA, V13, P868, DOI 10.1261/rna.565207; Hoque M, 2003, MOL CELL BIOL, V23, P1688, DOI 10.1128/MCB.23.5.1688-1702.2003; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Kino T, 2002, J BIOL CHEM, V277, P2396, DOI 10.1074/jbc.M106312200; Kulkarni PA, 2004, RECENT PROG HORM RES, V59, P125, DOI 10.1210/rp.59.1.125; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; Kusano S, 2002, MOL CELL BIOL, V22, P6393, DOI 10.1128/MCB.22.18.6393-6405.2002; Kyburz A, 2003, NUCLEIC ACIDS RES, V31, P3936, DOI 10.1093/nar/gkg478; Lee DK, 2001, J BIOL CHEM, V276, P9978, DOI 10.1074/jbc.M002285200; Li QT, 2007, NUCLEIC ACIDS RES, V35, P2503, DOI 10.1093/nar/gkm150; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Lis JT, 2000, GENE DEV, V14, P792; Majello B, 1999, ONCOGENE, V18, P4598, DOI 10.1038/sj.onc.1202822; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mizutani T, 2001, MOL ENDOCRINOL, V15, P1693, DOI 10.1210/me.15.10.1693; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Neo SY, 2000, BIOCHEM BIOPH RES CO, V272, P144, DOI 10.1006/bbrc.2000.2751; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Pan WJ, 2006, J CELL SCI, V119, P4850, DOI 10.1242/jcs.03257; Pan WJ, 2005, P NATL ACAD SCI USA, V102, P17378, DOI 10.1073/pnas.0505922102; Pei Y, 2006, MOL CELL BIOL, V26, P777, DOI 10.1128/MCB.26.3.777-788.2006; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Ramanathan Y, 1999, J VIROL, V73, P5448, DOI 10.1128/JVI.73.7.5448-5458.1999; Rosonina E, 2004, RNA, V10, P581, DOI 10.1261/rna.5207204; Sano M, 2002, NAT MED, V8, P1310, DOI 10.1038/nm778; Sano M, 2003, CELL CYCLE, V2, P99, DOI 10.4161/cc.2.2.332; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Snider L, 2005, MOL CELL BIOL, V25, P5061, DOI 10.1128/MCB.25.12.5061-5072.2005; Snider L, 2001, MOL CELL BIOL, V21, P1866, DOI 10.1128/MCB.21.5.1866-1873.2001; Taube R, 2002, MOL CELL BIOL, V22, P321, DOI 10.1128/MCB.22.1.321-331.2002; Thebault S, 2000, EUR J CELL BIOL, V79, P834, DOI 10.1078/0171-9335-00111; Thebault S, 2000, J BIOL CHEM, V275, P4848, DOI 10.1074/jbc.275.7.4848; VANHERREWEGHE E, 2007, EMBO J; Wang Q, 2007, J MOL BIOL, V367, P630, DOI 10.1016/j.jmb.2007.01.020; WASSARMAN DA, 1991, MOL CELL BIOL, V11, P3432, DOI 10.1128/MCB.11.7.3432; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Yang XZ, 1997, P NATL ACAD SCI USA, V94, P12331, DOI 10.1073/pnas.94.23.12331; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2005, J BIOL CHEM, V280, P16368, DOI 10.1074/jbc.M500912200; Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Young TM, 2003, MOL CELL BIOL, V23, P6373, DOI 10.1128/MCB.23.18.6373-6384.2003; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	72	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1010	10.1371/journal.pone.0001010	http://dx.doi.org/10.1371/journal.pone.0001010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925858	Green Published, gold, Green Submitted			2022-12-27	WOS:000207456000009
J	Azuma, M; Embree, LJ; Sabaawy, H; Hickstein, DD				Azuma, Mizuki; Embree, Lisa J.; Sabaawy, Hatem; Hickstein, Dennis D.			Ewing Sarcoma Protein Ewsr1 Maintains Mitotic Integrity and Proneural Cell Survival in the Zebrafish Embryo	PLOS ONE			English	Article								Background. The Ewing sarcoma breakpoint region 1 gene (EWSR1), also known as EWS, is fused to a number of different partner genes as a result of chromosomal translocation in diverse sarcomas. Despite the involvement of EWSR1 in these diverse sarcomas, the in vivo function of wild type EWSR1 remains unclear. Principal Findings. We identified two zebrafish EWSR1 orthologues, ewsr1a and ewsr1b, and demonstrate that both genes are expressed maternally, and are expressed ubiquitously throughout zebrafish embryonic development. Morpholino induced knockdown of both zebrafish ewsr1 genes led to mitotic defects with multipolar or otherwise abnormal mitotic spindles starting from the bud stage (10 hour post-fertilization (hpf)). The abnormalities in mitotic spindles were followed by p53-mediated apoptosis in the developing central nervous system (CNS) leading to a reduction in the number of proneural cells, disorganization of neuronal networks, and embryonic lethality by 5 days post-fertilization. siRNA silencing of EWSR1 in Hela cells resulted in mitotic defects accompanied by apoptotic cell death, indicating that the role of EWSR1 is conserved between zebrafish and human. Conclusions. Ewsr1 maintains mitotic integrity and proneural cell survival in early zebrafish development.	[Azuma, Mizuki; Embree, Lisa J.; Sabaawy, Hatem; Hickstein, Dennis D.] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Azuma, M (corresponding author), NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	azumam@mail.nih.gov			NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [K22CA120626] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research	ALLENDE ML, 1994, DEV BIOL, V166, P509, DOI 10.1006/dbio.1994.1334; Aman P, 1996, GENOMICS, V37, P1, DOI 10.1006/geno.1996.0513; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Araya N, 2003, J BIOL CHEM, V278, P5427, DOI 10.1074/jbc.M210234200; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Concha ML, 1998, DEVELOPMENT, V125, P983; Ensor E, 2001, J BIOL CHEM, V276, P5204, DOI 10.1074/jbc.M007068200; Gascoyne DM, 2004, ONCOGENE, V23, P3830, DOI 10.1038/sj.onc.1207497; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Gross A, 2005, J BIOENERG BIOMEMBR, V37, P113, DOI 10.1007/s10863-005-6222-3; Kawahara A, 2002, DEV BIOL, V248, P107, DOI 10.1006/dbio.2002.0709; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Li HJ, 2007, J CLIN INVEST, V117, P1314, DOI 10.1172/JCI31222; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Smith MD, 1998, J BIOL CHEM, V273, P16715, DOI 10.1074/jbc.273.27.16715; Smith MD, 2001, MOL CELL NEUROSCI, V17, P460, DOI 10.1006/mcne.2000.0927; Strahle U, 1996, INT J DEV BIOL, V40, P929; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; Xia SJ, 2005, EUR J CANCER, V41, P2513, DOI 10.1016/j.ejca.2005.08.003; Yang L, 2000, J BIOL CHEM, V275, P37612, DOI 10.1074/jbc.M005739200; Zakaryan RP, 2006, J MOL BIOL, V363, P27, DOI 10.1016/j.jmb.2006.08.018	31	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e979	10.1371/journal.pone.0000979	http://dx.doi.org/10.1371/journal.pone.0000979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912356	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455900015
J	Pincet, F				Pincet, Frederic			Membrane Recruitment of Scaffold Proteins Drives Specific Signaling	PLOS ONE			English	Article								Cells must give the right response to each stimulus they receive. Scaffolding, a signaling process mediated by scaffold proteins, participates in the decoding of the cues by specifically directing signal transduction. The aim of this paper is to describe the molecular mechanisms of scaffolding, i.e. the principles by which scaffold proteins drive a specific response of the cell. Since similar scaffold proteins are found in many species, they evolved according to the purpose of each organism. This means they require adaptability. In the usual description of the mechanisms of scaffolding, scaffold proteins are considered as reactors where molecules involved in a cascade of reactions are simultaneously bound with the right orientation to meet and interact. This description is not realistic: (i) it is not verified by experiments and (ii) timing and orientation constraints make it complex which seems to contradict the required adaptability. A scaffold protein, Ste5, is used in the MAPK pathway of Saccharomyces Cerevisiae for the cell to provide a specific response to stimuli. The massive amount of data available for this pathway makes it ideal to investigate the actual mechanisms of scaffolding. Here, a complete treatment of the chemical reactions allows the computation of the distributions of all the proteins involved in the MAPK pathway when the cell receives various cues. These distributions are compared to several experimental results. It turns out that the molecular mechanisms of scaffolding are much simpler and more adaptable than previously thought in the reactor model. Scaffold proteins bind only one molecule at a time. Then, their membrane recruitment automatically drives specific, amplified and localized signal transductions. The mechanisms presented here, which explain how the membrane recruitment of a protein can produce a drastic change in the activity of cells, are generic and may be commonly used in many biological processes.	Ecole Normale Super, Phys Stat Lab, F-75231 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Pincet, F (corresponding author), Ecole Normale Super, Phys Stat Lab, 24 Rue Lhomond, F-75231 Paris, France.	pincet@lps.ens.fr		PINCET, FREDERIC/0000-0002-4243-2157				Bardwell L, 1996, MOL CELL BIOL, V16, P3637; Bardwell L, 2007, BIOPHYS J, V92, P3425, DOI 10.1529/biophysj.106.090084; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Behrmann I, 2004, J BIOL CHEM, V279, P35486, DOI 10.1074/jbc.M404202200; Ben-Romano R, 2004, DIABETOLOGIA, V47, P1107, DOI 10.1007/s00125-004-1408-5; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Breitkreutz A, 2002, TRENDS CELL BIOL, V12, P254, DOI 10.1016/S0962-8924(02)02284-5; Breitkreutz A, 2001, CURR BIOL, V11, P1266, DOI 10.1016/S0960-9822(01)00370-0; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; CHOI KY, 1994, CELL, V78, P499; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Collins RN, 2003, MOL CELL, V12, P1064, DOI 10.1016/S1097-2765(03)00445-3; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Dard N, 2006, BIOESSAYS, V28, P146, DOI 10.1002/bies.20351; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Elion EA, 2005, SCIENCE, V307, P687, DOI 10.1126/science.1109500; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; FERRELL JE, 2000, SCI STKE, pPE1; Flatauer LJ, 2005, MOL CELL BIOL, V25, P1793, DOI 10.1128/MCB.25.5.1793-1803.2005; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hyvola N, 2006, EMBO J, V25, P3750, DOI 10.1038/sj.emboj.7601274; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Kawasaki M, 2005, CURR OPIN STRUC BIOL, V15, P681, DOI 10.1016/j.sbi.2005.10.015; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Kohler F, 2005, NAT IMMUNOL, V6, P204, DOI 10.1038/ni1163; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Komarova NL, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100031; Kurzbauer R, 2004, P NATL ACAD SCI USA, V101, P10984, DOI 10.1073/pnas.0403435101; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Li X, 2006, BIOCHEM J, V394, P427, DOI 10.1042/BJ20051560; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Matsuoka S, 2006, J CELL SCI, V119, P1071, DOI 10.1242/jcs.02824; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; NODA Y, 2006, J CELL BIOCH; Padival AK, 2004, MOL CELL BIOCHEM, V258, P129, DOI 10.1023/B:MCBI.0000012847.86529.07; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Philip F, 2004, BIOCHEMISTRY-US, V43, P11691, DOI 10.1021/bi049381+; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Stahelin RV, 2006, J BIOL CHEM, V281, P39396, DOI 10.1074/jbc.M607079200; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Urs NM, 2005, J CELL SCI, V118, P5291, DOI 10.1242/jcs.02634; Wang TL, 2006, BIOCHEM BIOPH RES CO, V350, P413, DOI 10.1016/j.bbrc.2006.09.064; Wang X, 2006, BIOPHYS J, V90, P1961, DOI 10.1529/biophysj.105.073874; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; WHITEWAY MS, 1995, SCIENCE, V269, P1572, DOI 10.1126/science.7667635; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	58	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e977	10.1371/journal.pone.0000977	http://dx.doi.org/10.1371/journal.pone.0000977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912354	gold, Green Published			2022-12-27	WOS:000207455900013
J	Stetson, C; Fiesta, MP; Eagleman, DM				Stetson, Chess; Fiesta, Matthew P.; Eagleman, David M.			Does Time Really Slow Down during a Frightening Event?	PLOS ONE			English	Article								Observers commonly report that time seems to have moved in slow motion during a life-threatening event. It is unknown whether this is a function of increased time resolution during the event, or instead an illusion of remembering an emotionally salient event. Using a hand-held device to measure speed of visual perception, participants experienced free fall for 31 m before landing safely in a net. We found no evidence of increased temporal resolution, in apparent conflict with the fact that participants retrospectively estimated their own fall to last 36% longer than others' falls. The duration dilation during a frightening event, and the lack of concomitant increase in temporal resolution, indicate that subjective time is not a single entity that speeds or slows, but instead is composed of separable subcomponents. Our findings suggest that time-slowing is a function of recollection, not perception: a richer encoding of memory may cause a salient event to appear, retrospectively, as though it lasted longer.	[Eagleman, David M.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Eagleman, David M.] Baylor Coll Med, Dept Psychiat, Houston, TX 77030 USA; [Stetson, Chess] CALTECH, Pasadena, CA 91125 USA; [Stetson, Chess; Fiesta, Matthew P.] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; California Institute of Technology; University of Texas System; University of Texas Health Science Center Houston	Eagleman, DM (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	eagleman@bcm.edu			NIH [RO1 NS053960]; Army Research Laboratory Cooperative Agreement Number [W911NF-07-2-0023]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053960] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Laboratory Cooperative Agreement Number; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH RO1 NS053960 and Army Research Laboratory Cooperative Agreement Number W911NF-07-2-0023	Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Curran S, 2000, HUM PSYCHOPHARM CLIN, V15, P103, DOI 10.1002/(SICI)1099-1077(200003)15:2<103::AID-HUP149>3.0.CO;2-7; Davalos DB, 2003, BRAIN COGNITION, V52, P295, DOI 10.1016/S0278-2626(03)00157-X; DILOLLO V, 1977, NATURE, V267; Eagleman DM, 2005, J NEUROSCI, V25, P10369, DOI 10.1523/JNEUROSCI.3487-05.2005; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; FRISHMAN LJ, 1987, J GEN PHYSIOL, V89, P599, DOI 10.1085/jgp.89.4.599; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Keysers C, 2001, J COGNITIVE NEUROSCI, V13, P90, DOI 10.1162/089892901564199; Matell MS, 2004, BEHAV NEUROSCI, V118, P150, DOI 10.1037/0735-7044.118.1.150; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; PARIYADATH V, 1977, EFFECT PRED IN PRESS; Riesen JM, 2001, J NEUROL, V248, P27, DOI 10.1007/s004150170266; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; Yamazaki T, 2005, NEURAL COMPUT, V17, P1032, DOI 10.1162/0899766053491850; Yarrow K, 2001, NATURE, V414, P302, DOI 10.1038/35104551	20	96	100	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1295	10.1371/journal.pone.0001295	http://dx.doi.org/10.1371/journal.pone.0001295			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074019	Green Published, Green Accepted, gold			2022-12-27	WOS:000207459500014
J	Barot, S; Blouin, M; Fontaine, S; Jouquet, P; Lata, JC; Mathieu, J				Barot, Sebastien; Blouin, Manuel; Fontaine, Sebastien; Jouquet, Pascal; Lata, Jean-Christophe; Mathieu, Jerome			A Tale of Four Stories: Soil Ecology, Theory, Evolution and the Publication System	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; CARBON; POPULATION; STRATEGY; MINERALIZATION; ORGANISMS; PROTOZOA; LIFE	Background. Soil ecology has produced a huge corpus of results on relations between soil organisms, ecosystem processes controlled by these organisms and links between belowground and aboveground processes. However, some soil scientists think that soil ecology is short of modelling and evolutionary approaches and has developed too independently from general ecology. We have tested quantitatively these hypotheses through a bibliographic study (about 23000 articles) comparing soil ecology journals, generalist ecology journals, evolutionary ecology journals and theoretical ecology journals. Findings. We have shown that soil ecology is not well represented in generalist ecology journals and that soil ecologists poorly use modelling and evolutionary approaches. Moreover, the articles published by a typical soil ecology journal (Soil Biology and Biochemistry) are cited by and cite low percentages of articles published in generalist ecology journals, evolutionary ecology journals and theoretical ecology journals. Conclusion. This confirms our hypotheses and suggests that soil ecology would benefit from an effort towards modelling and evolutionary approaches. This effort should promote the building of a general conceptual framework for soil ecology and bridges between soil ecology and general ecology. We give some historical reasons for the parsimonious use of modelling and evolutionary approaches by soil ecologists. We finally suggest that a publication system that classifies journals according to their Impact Factors and their level of generality is probably inadequate to integrate "particularity" (empirical observations) and "generality" (general theories), which is the goal of all natural sciences. Such a system might also be particularly detrimental to the development of a science such as ecology that is intrinsically multidisciplinary.	[Barot, Sebastien; Blouin, Manuel; Jouquet, Pascal] IRD, UMR 137, Bondy, France; [Fontaine, Sebastien] INRA, Unite Agron, Clermont Ferrand, France; [Lata, Jean-Christophe] Univ Paris 11, UMR 8079, Orsay, France; [Mathieu, Jerome] Univ Paris 06, UMR 137, Bondy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut de Recherche pour le Developpement (IRD); INRAE; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite	Barot, S (corresponding author), IRD, UMR 137, Bondy, France.	barot@bondy.ird.fr	mathieu, jerome/B-8478-2008; Lata, Jean-Christophe/A-8733-2008; barot, sébastien/A-8447-2012; Blouin, Manuel/K-6013-2019	mathieu, jerome/0000-0002-9106-6106; barot, sébastien/0000-0002-5910-538X; Blouin, Manuel/0000-0002-3928-9070; Jouquet, Pascal/0000-0002-4189-5133	ANR [JC05_52230]	ANR(French National Research Agency (ANR))	Funding: Our work has been supported by the programme "jeune chercheur 2005" of the ANR (SolEcoEvo project, JC05_52230).	Bardgett R. D., 2005, The biology of soil: a community and ecosystem approach; Bardgett R.D., 2005, Biological Diversity and Function in Soil; Barnes R. S. K, 1991, FUNDAMENTALS AQUATIC; Barot S, 2007, FUNCT ECOL, V21, P1, DOI 10.1111/j.1365-2435.2006.01225.x; Bonkowski M, 2004, NEW PHYTOL, V162, P617, DOI 10.1111/j.1469-8137.2004.01066.x; CLARHOLM M, 1985, SOIL BIOL BIOCHEM, V17, P181, DOI 10.1016/0038-0717(85)90113-0; Crawford JW, 2005, TRENDS ECOL EVOL, V20, P81, DOI 10.1016/j.tree.2004.11.014; Crawley M. J., 1996, PLANT ECOLOGY; Daufresne T, 2005, P NATL ACAD SCI USA, V102, P9212, DOI 10.1073/pnas.0406427102; Deleage Jean-Paul, 1991, HIST ECOLOGIE; DERUITER PC, 1993, J APPL ECOL, V30, P95, DOI 10.2307/2404274; Dodds WK, 2002, FRESHWATER ECOLOGY C; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; FAGERSTROM T, 1987, OIKOS, V50, P258, DOI 10.2307/3566010; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Fitter AH, 2005, J ECOL, V93, P231, DOI 10.1111/j.0022-0477.2005.00990.x; Fontaine S, 2005, ECOL LETT, V8, P1075, DOI 10.1111/j.1461-0248.2005.00813.x; GILL DS, 1991, ECOL MONOGR, V61, P183, DOI 10.2307/1943007; Goddard MR, 2003, ECOL LETT, V6, P594, DOI 10.1046/j.1461-0248.2003.00478.x; Graham MH, 2002, ECOLOGY, V83, P1481; GUREVITCH J, 2006, ECOLOGY PLANTS; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; Lavelle P., 2001, SOIL ECOLOGY; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Leimu R, 2005, TRENDS ECOL EVOL, V20, P28, DOI 10.1016/j.tree.2004.10.010; LEVINS R, 1966, AM SCI, V54, P421; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; MARTEL YA, 1974, SOIL SCI SOC AM J, V38, P501, DOI 10.2136/sssaj1974.03615995003800030033x; MAY RM, 1981, AM ZOOL, V21, P903; McArthur J.V., 2006, MICROBIAL ECOLOGY EV; Nobis M, 2004, OIKOS, V106, P411, DOI 10.1111/j.0030-1299.2004.13496.x; Odenbaugh J, 2006, BIOL PHILOS, V21, P607, DOI 10.1007/s10539-006-9049-3; OHTONEN R, 1997, SOIL BIOL BIOCHEM, V29, P1549; Pennisi E, 2004, SCIENCE, V304, P1620, DOI 10.1126/science.304.5677.1620; Pickett STA, 2007, ECOLOGICAL UNDERSTAN; Price PW., 1997, INSECT ECOLOGY, V3rd edn; Rumpel C, 2002, ORG GEOCHEM, V33, P1131, DOI 10.1016/S0146-6380(02)00088-8; SCHOWALTER TD, 2000, INSECT ECOLOGY ECOSY; Setala H, 1998, APPL SOIL ECOL, V9, P25, DOI 10.1016/S0929-1393(98)00049-3; SIQUEIRA JO, 1991, CRIT REV PLANT SCI, V10, P63, DOI 10.1080/07352689109382307; Staddon PL, 2004, TRENDS ECOL EVOL, V19, P148, DOI 10.1016/j.tree.2003.12.003; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Tunlid A, 1999, OIKOS, V85, P177, DOI 10.2307/3546484; Turchin P, 2001, OIKOS, V94, P17, DOI 10.1034/j.1600-0706.2001.11310.x; Wardle DA, 1996, SOIL BIOL BIOCHEM, V28, P1549, DOI 10.1016/S0038-0717(96)00293-3; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; WARDLE DA, 2002, INTRO COMMUNITY ECOS, P1; Weisberg M, 2006, BIOL PHILOS, V21, P623, DOI 10.1007/s10539-006-9051-9	50	29	30	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1248	10.1371/journal.pone.0001248	http://dx.doi.org/10.1371/journal.pone.0001248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043755	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459300029
J	Briva, A; Vadasz, I; Lecuona, E; Welch, LC; Chen, JW; Dada, LA; Trejo, HE; Dumasius, V; Azzam, ZS; Myrianthefs, PM; Batlle, D; Gruenbaum, Y; Sznajder, JI				Briva, Arturo; Vadasz, Istvan; Lecuona, Emilia; Welch, Lynn C.; Chen, Jiwang; Dada, Laura A.; Trejo, Humberto E.; Dumasius, Vidas; Azzam, Zaher S.; Myrianthefs, Pavlos M.; Batlle, Daniel; Gruenbaum, Yosef; Sznajder, Jacob I.			High CO2 Levels Impair Alveolar Epithelial Function Independently of pH	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; CARBON-DIOXIDE; RESPIRATORY-FAILURE; INDUCED ENDOCYTOSIS; FLUID TRANSPORT; K-ATPASE; KINASE-C; LUNG; NA,K-ATPASE; CELLS	Background. In patients with acute respiratory failure, gas exchange is impaired due to the accumulation of fluid in the lung airspaces. This life-threatening syndrome is treated with mechanical ventilation, which is adjusted to maintain gas exchange, but can be associated with the accumulation of carbon dioxide in the lung. Carbon dioxide (CO2) is a by-product of cellular energy utilization and its elimination is affected via alveolar epithelial cells. Signaling pathways sensitive to changes in CO2 levels were described in plants and neuronal mammalian cells. However, it has not been fully elucidated whether non-neuronal cells sense and respond to CO2. The Na, K-ATPase consumes similar to 40% of the cellular metabolism to maintain cell homeostasis. Our study examines the effects of increased pCO(2) on the epithelial Na, K-ATPase a major contributor to alveolar fluid reabsorption which is a marker of alveolar epithelial function. Principal Findings. We found that short-term increases in pCO(2) impaired alveolar fluid reabsorption in rats. Also, we provide evidence that non-excitable, alveolar epithelial cells sense and respond to high levels of CO2, independently of extracellular and intracellular pH, by inhibiting Na,K-ATPase function, via activation of PKC zeta which phosphorylates the Na,K-ATPase, causing it to endocytose from the plasma membrane into intracellular pools. Conclusions. Our data suggest that alveolar epithelial cells, through which CO2 is eliminated in mammals, are highly sensitive to hypercapnia. Elevated CO2 levels impair alveolar epithelial function, independently of pH, which is relevant in patients with lung diseases and altered alveolar gas exchange.	[Briva, Arturo; Vadasz, Istvan; Lecuona, Emilia; Welch, Lynn C.; Chen, Jiwang; Dada, Laura A.; Trejo, Humberto E.; Dumasius, Vidas; Azzam, Zaher S.; Myrianthefs, Pavlos M.; Gruenbaum, Yosef; Sznajder, Jacob I.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Batlle, Daniel] Northwestern Univ, Feinberg Sch Med, Div Nephrol, Chicago, IL 60611 USA; [Briva, Arturo] Univ Republica, Fac Med, Dept Fisiopatol, Montevideo, Uruguay; [Vadasz, Istvan] Univ Giessen, Lung Ctr, Giessen, Germany; [Azzam, Zaher S.] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Azzam, Zaher S.] Technion Israel Inst Technol, Res Inst, Haifa, Israel; [Myrianthefs, Pavlos M.] Univ Athens, KAT Gen Hosp, Intens Care Unit, Athens, Greece; [Gruenbaum, Yosef] Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Universidad de la Republica, Uruguay; Justus Liebig University Giessen; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; National & Kapodistrian University of Athens; Hebrew University of Jerusalem	Sznajder, JI (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA.	j-sznajder@northwestern.edu	Vadasz, Istvan/AAO-8288-2021; Myrianthefs, Pavlos/AAF-4388-2019	Myrianthefs, Pavlos/0000-0002-8830-031X; Vadasz, Istvan/0000-0003-1370-9783	 [HL-85534];  [T32-HL76139];  [DFG/SFB 547]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085534, T32HL076139] Funding Source: NIH RePORTER	; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported in part by: HL-85534, T32-HL76139 and DFG/SFB 547.	*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; AVERY WG, 1970, AM J MED, V48, P320, DOI 10.1016/0002-9343(70)90062-8; BATLLE DC, 1991, AM J PHYSIOL, V261, pC845, DOI 10.1152/ajpcell.1991.261.5.C845; BERTORELLO AM, 1990, NATURE, V347, P386, DOI 10.1038/347386a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN J, 2007, CARBONIC ANHYDRASE 2; CHERNIACK NS, 1970, PHYSIOL REV, V50, P196, DOI 10.1152/physrev.1970.50.2.196; Chibalin AV, 1999, J BIOL CHEM, V274, P1920, DOI 10.1074/jbc.274.4.1920; Comellas AP, 2006, CIRC RES, V98, P1314, DOI 10.1161/01.RES.0000222418.99976.1d; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; Dada LA, 2003, CRIT CARE MED, V31, pS248, DOI 10.1097/01.CCM.0000057895.22008.EC; Dumasius V, 2001, CIRC RES, V89, P907, DOI 10.1161/hh2201.100204; Efendiev R, 1999, FEBS LETT, V456, P45, DOI 10.1016/S0014-5793(99)00925-4; Feschenko MS, 1997, J BIOL CHEM, V272, P17726, DOI 10.1074/jbc.272.28.17726; Garcia A, 2000, J BIOL CHEM, V275, P9385, DOI 10.1074/jbc.275.13.9385; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kregenow DA, 2002, EUR RESPIR J, V20, P6, DOI 10.1183/09031936.02.00400802; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laffey JG, 2004, AM J RESP CRIT CARE, V169, P46, DOI 10.1164/rccm.200205-394OC; Laffey JG, 1999, LANCET, V354, P1283, DOI 10.1016/S0140-6736(99)02388-0; Lang JD, 2000, AM J PHYSIOL-LUNG C, V279, pL994, DOI 10.1152/ajplung.2000.279.5.L994; Lang JD, 2005, AM J RESP CRIT CARE, V171, P147, DOI 10.1164/rccm.200302-305OC; Lecuona E, 2006, FASEB J, V20, P2618, DOI 10.1096/fj.06-6503fje; Litvan J, 2006, J BIOL CHEM, V281, P19892, DOI 10.1074/jbc.M602064200; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; Mutlu GM, 2005, AM J PHYSIOL-LUNG C, V289, pL685, DOI 10.1152/ajplung.00247.2005; ODONOVAN R, 1991, NEPHRON, V57, P416, DOI 10.1159/000186305; Pfeiffer B, 2002, CRIT CARE MED, V30, P285, DOI 10.1097/00003246-200202000-00003; Putnam RW, 2004, AM J PHYSIOL-CELL PH, V287, pC1493, DOI 10.1152/ajpcell.00282.2004; Ridge KM, 2003, CIRC RES, V92, P453, DOI 10.1161/01.RES.0000059414.10360.F2; Ridge KM, 2002, MOL BIOL CELL, V13, P1381, DOI 10.1091/mbc.01-07-0323; Ridge KM, 1997, AM J PHYSIOL-LUNG C, V273, pL246, DOI 10.1152/ajplung.1997.273.1.L246; RUTSCHMAN DH, 1993, J APPL PHYSIOL, V75, P1574, DOI 10.1152/jappl.1993.75.4.1574; SAUMON G, 1993, J APPL PHYSIOL, V74, P1; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; Skou JC, 1998, BIOSCIENCE REP, V18, P155, DOI 10.1023/A:1020196612909; Vertrees RA, 2004, CHEST, V125, P1472, DOI 10.1378/chest.125.4.1472; Wang XR, 2003, CIRC RES, V92, P1225, DOI 10.1161/01.RES.0000075601.95738.6D; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Zhou YH, 2005, P NATL ACAD SCI USA, V102, P3875, DOI 10.1073/pnas.0500423102	45	92	95	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1238	10.1371/journal.pone.0001238	http://dx.doi.org/10.1371/journal.pone.0001238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043745	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459300019
J	Havlioglu, N; Wang, J; Fushimi, K; Vibranovski, MD; Kan, ZY; Gish, W; Fedorov, A; Long, MY; Wu, JY				Havlioglu, Necat; Wang, Jun; Fushimi, Kazuo; Vibranovski, Maria D.; Kan, Zhengyan; Gish, Warren; Fedorov, Alexei; Long, Manyuan; Wu, Jane Y.			An Intronic Signal for Alternative Splicing in the Human Genome	PLOS ONE			English	Article							RNA; SEQUENCE; IDENTIFICATION; APOPTOSIS; ELEMENT; GENE; MECHANISM; ENHANCERS; PROTEINS; RESOURCE	An important level at which the expression of programmed cell death (PCD) genes is regulated is alternative splicing. Our previous work identified an intronic splicing regulatory element in caspase-2 (casp-2) gene. This 100-nucleotide intronic element, In100, consists of an upstream region containing a decoy 3' splice site and a downstream region containing binding sites for splicing repressor PTB. Based on the signal of In100 element in casp-2, we have detected the In100-like sequences as a family of sequence elements associated with alternative splicing in the human genome by using computational and experimental approaches. A survey of human genome reveals the presence of more than four thousand In100-like elements in 2757 genes. These In100-like elements tend to locate more frequent in intronic regions than exonic regions. EST analyses indicate that the presence of In100- like elements correlates with the skipping of their immediate upstream exons, with 526 genes showing exon skipping in such a manner. In addition, In100-like elements are found in several human caspase genes near exons encoding the caspase active domain. RT-PCR experiments show that these caspase genes indeed undergo alternative splicing in a pattern predicted to affect their functional activity. Together, these results suggest that the In100-like elements represent a family of intronic signals for alternative splicing in the human genome.	[Wang, Jun; Vibranovski, Maria D.; Long, Manyuan] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Havlioglu, Necat] St Louis Univ, Dept Pathol, St Louis, MO 63103 USA; [Fushimi, Kazuo; Wu, Jane Y.] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Lurie Comprehens Canc Ctr,Dept Neurol, Chicago, IL 60611 USA; [Kan, Zhengyan; Gish, Warren] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Fedorov, Alexei] Med Univ Ohio, Dept Med, Toledo, OH USA; [Fedorov, Alexei] Med Univ Ohio, Program Bioinformat & Proteom Genom, Toledo, OH USA	University of Chicago; Saint Louis University; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Washington University (WUSTL)	Long, MY (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	mlong@midway.uchicago.edu; jane-wu@northwestern.edu	Gish, Warren/C-8123-2012; Vibranovski, Maria D./C-5599-2013	Vibranovski, Maria/0000-0001-8313-9726	NIH [EY014576, AG17518, GM070967, GM065429]; Muscular Dystrophy Association; Leukemia Society of America; NSF [MCB0238168]; Packard Fellowship for Science and Engineering; Pew Latin America Fellowship; NATIONAL EYE INSTITUTE [R01EY014576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070967, R01GM065429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Leukemia Society of America(Leukemia and Lymphoma Society); NSF(National Science Foundation (NSF)); Packard Fellowship for Science and Engineering; Pew Latin America Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This work was supported by grants to JYW from NIH (EY014576; AG17518, GM070967) and Muscular Dystrophy Association. JYW was also supported by a Scholar Award from the Leukemia Society of America. ML was supported by NIH (GM065429), NSF CAREER Award (MCB0238168) and Packard Fellowship for Science and Engineering. MDV was supported by Pew Latin America Fellowship.	Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Boyce M, 2004, CELL DEATH DIFFER, V11, P29, DOI 10.1038/sj.cdd.4401339; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chabot B, 2003, Prog Mol Subcell Biol, V31, P59; Cote J, 2001, J BIOL CHEM, V276, P8535, DOI 10.1074/jbc.M008924200; Cote J, 2001, P NATL ACAD SCI USA, V98, P938, DOI 10.1073/pnas.031564098; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Fu XD, 2004, CELL, V119, P736, DOI 10.1016/j.cell.2004.11.039; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Horiuchi T, 2000, BIOCHEM BIOPH RES CO, V272, P877, DOI 10.1006/bbrc.2000.2841; Huang YH, 2001, BIOCHEM BIOPH RES CO, V283, P762, DOI 10.1006/bbrc.2001.4871; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jiang ZH, 1998, P NATL ACAD SCI USA, V95, P9155, DOI 10.1073/pnas.95.16.9155; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Ladd AN, 2002, GENOME BIOL, V3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Long MY, 1998, P NATL ACAD SCI USA, V95, P219, DOI 10.1073/pnas.95.1.219; LOU H, 1995, MOL CELL BIOL, V15, P7135; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; Minovitsky S, 2005, NUCLEIC ACIDS RES, V33, P714, DOI 10.1093/nar/gki210; Miriami E, 2003, NUCLEIC ACIDS RES, V31, P1974, DOI 10.1093/nar/gkg279; SIEBEL CW, 1992, GENE DEV, V6, P1386, DOI 10.1101/gad.6.8.1386; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Srinivasula SM, 1999, CANCER RES, V59, P999; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wu J Y, 2003, Prog Mol Subcell Biol, V31, P153; WU JY, 2004, ENCY MOL CELL BIOL M, V1, P125; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zhang XHF, 2005, METHODS, V37, P292, DOI 10.1016/j.ymeth.2005.07.011; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zorio DAR, 1997, MOL CELL BIOL, V17, P946, DOI 10.1128/MCB.17.2.946	43	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1246	10.1371/journal.pone.0001246	http://dx.doi.org/10.1371/journal.pone.0001246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043753	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459300027
J	Lu, TL; Chang, JL; Liang, CC; You, LR; Chen, CM				Lu, Tsai-Ling; Chang, Junn-Liang; Liang, Chih-Chia; You, Li-Ru; Chen, Chun-Ming			Tumor Spectrum, Tumor Latency and Tumor Incidence of the Pten-Deficient Mice	PLOS ONE			English	Article							SUPPRESSOR GENE; CELL-PROLIFERATION; EMBRYONIC-DEVELOPMENT; NEGATIVE REGULATION; COWDEN-SYNDROME; STEM-CELLS; IN-VITRO; PROSTATE; PTEN/MMAC1; INACTIVATION	Background. Pten functionally acts as a tumor suppressor gene. Lately, tissue-specific ablation of Pten gene in mice has elucidated the role of Pten in different tumor progression models. However, a temporally controlled Pten loss in all adult tissues to examine susceptibility of various tissues to Pten-deficient tumorigenesis has not been addressed yet. Our goal was to explore the genesis of Pten-deficient malignancies in multiple tissue lineages of the adult mouse. Methods and Findings. We utilized an inducible Cre/loxP system to delete Pten exon 5 in the systemic organs of ROSA26 (R26)-CreER(T);Pten(fx/fx) mice. On reaching 45 weeks 4OHT-induced Pten loss, we found that the R26-CreER(T); Pten(fx/fx) mice developed a variety of malignancies. Overall tumor mean latency was 17 weeks in the Pten-deficient mice. Interestingly, mutant females developed malignancies more quickly at 10 similar to 11 weeks compared with a tumor latency of 21 weeks for mutant males. Lymphoma incidence (76.9% in females; 40.0% in males) was higher than the other malignancies found in the mutant mice. Mutant males developed prostate (20.0%), intestinal cancer (35.0%) and squamous cell carcinoma (10.0%), whereas the mutant females developed squamous cell carcinoma (15.4%) and endometrial cancer (46.1%) in addition to lymphomas. Furthermore, we tested the pharmacological inhibition of the PTEN downstream effectors using LY294002 on Pten-deficient prostate hyperplasia. Our data revealed that, indeed, the prostate hyperplasia resulting from the induced Pten loss was significantly suppressed by LY294002 (p = 0.007). Conclusions. Through monitoring a variety of Pten-deficient tumor formation, our results revealed that the lymphoid lineages and the epithelium of the prostate, endometrium, intestine and epidermis are highly susceptible to tumorigenesis after the Pten gene is excised. Therefore, this R26-CreER(T); Pten(fx/fx) mouse model may provide an entry point for understanding the role of Pten in the tumorigenesis of different organs and extend the search for potential therapeutic approaches to prevent Pten-deficient malignancies.	[Lu, Tsai-Ling; Liang, Chih-Chia; Chen, Chun-Ming] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Lu, Tsai-Ling; Liang, Chih-Chia; Chen, Chun-Ming] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Chang, Junn-Liang] Taoyuan Armed Forces Gen Hosp, Dept Pathol, Lungtan, Taoyuan County, Taiwan; [You, Li-Ru] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, CM (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.	cmchen@ym.edu.tw		You, Li-Ru/0000-0003-1775-0097; Chen, Chun-Ming/0000-0001-8873-7602	Ministry of Education, Aim for the Top University Plan; National Science Council, Taiwan (NSC) [95-2320-B-010-004, 95-2320-B-010-014, 96-3112-B-010-016]; Research Foundation of Taoyuan Armed Forces General Hospital [9519, 9612]	Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan); Research Foundation of Taoyuan Armed Forces General Hospital	Supported by the Ministry of Education, Aim for the Top University Plan and the National Science Council, Taiwan, (NSC 95-2320-B-010-004, NSC 95-2320-B-010-014 and NSC 96-3112-B-010-016) to C-MC. Supported by the Research Foundation of Taoyuan Armed Forces General Hospital (9519 and 9612) to J-LC.	Abate-Shen C, 2003, CANCER RES, V63, P3886; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Badea TC, 2003, J NEUROSCI, V23, P2314; Bondar VM, 2002, MOL CANCER THER, V1, P989; Cairns P, 1997, CANCER RES, V57, P4997; Chen CM, 2004, ONCOGENE, V23, P7722, DOI 10.1038/sj.onc.1208037; Chen CM, 2004, GENE DEV, V18, P320, DOI 10.1101/gad.1162204; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hu LM, 2000, CLIN CANCER RES, V6, P880; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; Kwan KM, 2002, GENESIS, V32, P49, DOI 10.1002/gene.10068; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Milam MR, 2007, AM J OBSTET GYNECOL, V196, P247, DOI 10.1016/j.ajog.2006.10.872; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Risinger JI, 1997, CANCER RES, V57, P4736; Sakai A, 1998, BLOOD, V92, P3410, DOI 10.1182/blood.V92.9.3410.421a06_3410_3415; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2000, CANCER RES, V60, P3605; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Teng DHF, 1997, CANCER RES, V57, P5221; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	44	25	25	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1237	10.1371/journal.pone.0001237	http://dx.doi.org/10.1371/journal.pone.0001237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043744	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459300018
J	Fimbel, EJ; Arguin, M				Fimbel, Eric J.; Arguin, Martin			Myocontrol in Aging	PLOS ONE			English	Article							INFORMATION CAPACITY; MOTOR SYSTEM; ADULT AGE; MOVEMENTS; COGNITION; BRAIN; TASKS; UNIT	Myoelectric (EMG) signals are used in assistive technology for prostheses, computer and domestic control. An experimental study previously conducted with young participants was replicated with elderly persons in order to assess the effect of age on the ability to control myoelectric amplitude (or myocontrol). Participants performed pointing tasks as the myoelectric amplitude was captured by a surface electrode in two modalities (sustained: stabilize the amplitude after reaching the desired level; impulsion: return immediately to resting amplitude). There was a significant decrease of performance with Age. However, the patterns of performance of young and aged were noticeably similar. The Impulsion modality was difficult (high rates of failure) and the speed-accuracy trade-offs predicted by Fitts' law were absent (bow-shaped patterns as function of target amplitude instead of logarithmic increase). Conversely, the reach phase of the Sustained modality followed the predictions of Fitts' law. However, the slope of the regression line with Fitts' index of difficulty was quite steeper in aged than in young participants. These findings suggest that 1) all participants, young and aged, adapt their reaching strategies to the anticipated state (sustained amplitude or not) and/or to the difficulty of the task, 2) myocontrol in aged persons is more fragile, i.e., performance is markedly degraded as the difficulty of the task increases. However, when individual performance was examined, some aged individuals were found to perform as well as the young participants, congruently with the literature on good aging.	[Fimbel, Eric J.] Fatronik Fdn Res Ctr, Lab Cognit & Facteurs Humains, EA 497, Inst Cognit, Bordeaux, France; [Fimbel, Eric J.] Inst Univ Geriatr Montreal, Montreal, PQ, Canada; [Arguin, Martin] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Fimbel, EJ (corresponding author), Fatronik Fdn Res Ctr, Lab Cognit & Facteurs Humains, EA 497, Inst Cognit, Bordeaux, France.	efimbel@fatronik.ca		Arguin, Martin/0000-0002-1036-2932	CIHR [109291]; VRQ [2200-099]	CIHR(Canadian Institutes of Health Research (CIHR)); VRQ	CIHR grant 109291 (Canada) and VRQ grant 2200-099 (Quebec). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERARDELLI A, 1996, BRAIN, P551; Billon M, 2000, NEUROSCI LETT, V286, P49, DOI 10.1016/S0304-3940(00)01089-2; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Chen Yu-Luen, 2002, Journal of Medical Engineering and Technology, V26, P173, DOI 10.1080/03091900210127933; Chin CA, 2006, BIOMED SCI INSTRUM, V42, P249; DARLING WG, 1987, J MOTOR BEHAV, V19, P291; DARLING WG, 1989, NEUROBIOL AGING, V10, P149, DOI 10.1016/0197-4580(89)90024-9; Doherty E, 1999, Cyberpsychol Behav, V2, P249, DOI 10.1089/cpb.1999.2.249; DOHERTY TJ, 1993, CAN J APPL PHYSIOL, V18, P331, DOI 10.1139/h93-029; Fimbel EJ, 2006, HUM MOVEMENT SCI, V25, P165, DOI 10.1016/j.humov.2005.12.001; FITTS PM, 1964, J EXP PSYCHOL, V67, P103, DOI 10.1037/h0045689; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; HALLETT M, 1975, J NEUROL NEUROSUR PS, V38, P1154, DOI 10.1136/jnnp.38.12.1154; Ketcham CJ, 2002, J GERONTOL B-PSYCHOL, V57, pP54, DOI 10.1093/geronb/57.1.P54; Kramer AF, 2006, J APPL PHYSIOL, V101, P1237, DOI 10.1152/japplphysiol.00500.2006; Lexell J, 1997, J NUTR, V127, pS1011, DOI 10.1093/jn/127.5.1011S; Light C. M., 2002, Journal of Medical Engineering and Technology, V26, P139, DOI 10.1080/03091900210142459; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; McDowd J., 2000, HDB AGING COGNITION, P221; MCKENZIE IS, 1992, HUMAN COMPUTER INTER, V7, P91; Olafsdottir H, 2007, CLIN BIOMECH, V22, P44, DOI 10.1016/j.clinbiomech.2006.08.005; Reaz MBI, 2006, BIOL PROCED ONLINE, V8, P11, DOI [10.1251/bpo115, 10.1251/bpo124]; ROMENY BMT, 1994, EXPT NEUROLOGY, V85, P631; Sale MV, 2005, J APPL PHYSIOL, V99, P1483, DOI 10.1152/japplphysiol.00371.2005; SALTHOUSE TA, 1982, J EXP PSYCHOL GEN, V111, P176, DOI 10.1037/0096-3445.111.2.176; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Shim JK, 2004, J APPL PHYSIOL, V97, P213, DOI 10.1152/japplphysiol.00045.2004; So RHY, 1999, HUM FACTORS, V41, P474, DOI 10.1518/001872099779611067; Stefanov DH, 2004, IEEE T NEUR SYS REH, V12, P228, DOI 10.1109/TNSRE.2004.828423; Steriadis C. E., 2003, ACM Transactions on Computer-Human Interaction, V10, P87, DOI 10.1145/772047.772049; Ward NS, 2006, AGEING RES REV, V5, P239, DOI 10.1016/j.arr.2006.04.003; WOODWORTH RS, 1999, PSYCHOL REV, V3; Yamada H, 2000, J Hum Ergol (Tokyo), V29, P7; Yamada H, 2002, PERCEPT MOTOR SKILL, V95, P10, DOI 10.2466/PMS.95.5.10-14; Yan JH, 2000, EXP AGING RES, V26, P393, DOI 10.1080/036107300750015778; Zecca M, 2002, Crit Rev Biomed Eng, V30, P459, DOI 10.1615/CritRevBiomedEng.v30.i456.80	37	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1219	10.1371/journal.pone.0001219	http://dx.doi.org/10.1371/journal.pone.0001219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030349	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459200028
J	Bernacer, J; Prensa, L; Gimenez-Amaya, JM				Bernacer, Javier; Prensa, Lucia; Manuel Gimenez-Amaya, Jose			Cholinergic Interneurons Are Differentially Distributed in the Human Striatum	PLOS ONE			English	Article								Background. The striatum (caudate nucleus, CN, and putamen, Put) is a group of subcortical nuclei involved in planning and executing voluntary movements as well as in cognitive processes. Its neuronal composition includes projection neurons, which connect the striatum with other structures, and interneurons, whose main roles are maintaining the striatal organization and the regulation of the projection neurons. The unique electrophysiological and functional properties of the cholinergic interneurons give them a crucial modulating function on the overall striatal response. Methodology/Principle Findings. This study was carried out using stereological methods to examine the volume and density (cells/mm(3)) of these interneurons, as visualized by choline acetyltransferase (ChAT) immunoreactivity, in the following territories of the CN and Put of nine normal human brains: 1) precommissural head; 2) postcommissural head; 3) body; 4) gyrus and 5) tail of the CN; 6) precommissural and 7) postcommissural Put. The distribution of ChAT interneurons was analyzed with respect to the topographical, functional and chemical territories of the dorsal striatum. The CN was more densely populated by cholinergic neurons than the Put, and their density increased along the anteroposterior axis of the striatum with the CN body having the highest neuronal density. The associative territory of the dorsal striatum was by far the most densely populated. The striosomes of the CN precommissural head and the postcommissural Put contained the greatest number of ChAT-ir interneurons. The intrastriosomal ChAT-ir neurons were abundant on the periphery of the striosomes throughout the striatum. Conclusions/Significance. All these data reveal that cholinergic interneurons are differentially distributed in the distinct topographical and functional territories of the human dorsal striatum, as well as in its chemical compartments. This heterogeneity may indicate that the posterior aspects of the CN require a special integration of information by interneurons. Interestingly, these striatal regions have been very much left out in functional studies.	[Bernacer, Javier; Prensa, Lucia; Manuel Gimenez-Amaya, Jose] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain	Autonomous University of Madrid	Gimenez-Amaya, JM (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain.	josemanuel.gimenezamaya@uam.es	Bernacer, Javier/P-5810-2014; Waldvogel, Henry/D-6691-2012	Bernacer, Javier/0000-0002-4341-9763; Waldvogel, Henry/0000-0003-2165-8568; Prensa Sepulveda, Lucia/0000-0003-2217-3271	Ministerio de Educacion y Ciencia [BFI2003-02909]; Comunidad de Madrid; Ministerio de Educacion y Ciencia	Ministerio de Educacion y Ciencia(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Ministerio de Educacion y Ciencia(Spanish Government)	Ministerio de Educacion y Ciencia (BFI2003-02909). JB was supported by the Comunidad de Madrid (FPI-CAM) and LP is supported by the Ramon y Cajal program of the Ministerio de Educacion y Ciencia.	AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; AOSAKI T, 1994, J NEUROSCI, V14, P3969; Apicella P, 2002, EUR J NEUROSCI, V16, P2017, DOI 10.1046/j.1460-9568.2002.02262.x; Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; Benke T, 2003, NEUROCASE, V9, P70, DOI 10.1076/neur.9.1.70.14374; Bernacer J, 2005, J COMP NEUROL, V489, P311, DOI 10.1002/cne.20616; BERNACER J, 2007, J NEURAL TRANSM, DOI DOI 10.1007/S00702-00007-00803-00708; BERNACER J, 2005, 1808 SOC NEUR; BERTORELLI R, 1990, J NEUROCHEM, V54, P2145, DOI 10.1111/j.1471-4159.1990.tb04922.x; BJUGN R, 1993, J COMP NEUROL, V328, P406, DOI 10.1002/cne.903280307; Brauer K, 2000, BRAIN RES, V858, P151, DOI 10.1016/S0006-8993(00)01938-7; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; CAVADA C, 1991, NEUROSCIENCE, V42, P683, DOI 10.1016/0306-4522(91)90037-O; Centonze D, 1999, BRAIN RES REV, V31, P1, DOI 10.1016/S0165-0173(99)00018-1; Cerasa A, 2005, NEUROSCI LETT, V373, P32, DOI 10.1016/j.neulet.2004.09.076; CHANG HT, 1988, BRAIN RES BULL, V21, P295, DOI 10.1016/0361-9230(88)90244-4; Cragg SJ, 2006, TRENDS NEUROSCI, V29, P125, DOI 10.1016/j.tins.2006.01.003; DEBOER P, 1992, N-S ARCH PHARMACOL, V345, P144, DOI 10.1007/BF00165729; DeBoer P, 1996, J PHARMACOL EXP THER, V277, P775; DIFIGLIA M, 1976, BRAIN RES, V114, P245, DOI 10.1016/0006-8993(76)90669-7; FLAHERTY AW, 1994, J NEUROSCI, V14, P599; Flaherty AW, 1995, J NEUROPHYSIOL, V74, P2638, DOI 10.1152/jn.1995.74.6.2638; Fudge JL, 2002, J NEUROSCI, V22, P10078; Fudge JL, 2002, NEUROSCIENCE, V110, P257, DOI 10.1016/S0306-4522(01)00546-2; Galarraga E, 1999, J NEUROSCI, V19, P3629, DOI 10.1523/jneurosci.19-09-03629.1999; Gimenez-Amaya JM, 2000, HISTOL HISTOPATHOL, V15, P1285, DOI 10.14670/HH-15.1285; GIMENEZAMAYA JM, 1995, J COMP NEUROL, V354, P127, DOI 10.1002/cne.903540109; GRAVELAND GA, 1985, J COMP NEUROL, V234, P317, DOI 10.1002/cne.902340304; GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723, DOI 10.1073/pnas.75.11.5723; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Holt DJ, 1999, NEUROSCIENCE, V94, P21, DOI 10.1016/S0306-4522(99)00279-1; Holt DJ, 1997, J COMP NEUROL, V384, P1, DOI 10.1002/(SICI)1096-9861(19970721)384:1<1::AID-CNE1>3.0.CO;2-5; Holt DJ, 2005, BIOL PSYCHIAT, V58, P408, DOI 10.1016/j.biopsych.2005.04.007; Holt DJ, 1996, NEUROSCIENCE, V74, P67, DOI 10.1016/0306-4522(96)00094-2; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P580; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Koikkalainen J, 2007, NEUROIMAGE, V34, P85, DOI 10.1016/j.neuroimage.2006.08.039; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; KUBOTA Y, 1987, BRAIN RES, V413, P179, DOI 10.1016/0006-8993(87)90167-3; KUNZLE H, 1975, BRAIN RES, V88, P195, DOI 10.1016/0006-8993(75)90384-4; LAPPER SR, 1992, NEUROSCIENCE, V51, P533, DOI 10.1016/0306-4522(92)90293-B; LEHERICY S, 1989, P NATL ACAD SCI USA, V86, P8580, DOI 10.1073/pnas.86.21.8580; Lehericy S, 2006, CEREB CORTEX, V16, P149, DOI 10.1093/cercor/bhi089; Mai J.K., 1997, ATLAS HUMAN BRAIN; Martin R, 2000, J HISTOCHEM CYTOCHEM, V48, P1121, DOI 10.1177/002215540004800809; Mayhew TM, 1996, J ANAT, V188, P1; McFarland NR, 2001, J COMP NEUROL, V429, P321, DOI 10.1002/1096-9861(20000108)429:2<321::AID-CNE11>3.0.CO;2-A; McFarland NR, 2000, J NEUROSCI, V20, P3798, DOI 10.1523/JNEUROSCI.20-10-03798.2000; Mengual E, 1999, J CHEM NEUROANAT, V16, P187; MESULAM MM, 1984, NEUROSCIENCE, V12, P669, DOI 10.1016/0306-4522(84)90163-5; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Pakhotin P, 2007, J NEUROSCI, V27, P391, DOI 10.1523/JNEUROSCI.3709-06.2007; PARENT A, 1990, TRENDS NEUROSCI, V13, P254, DOI 10.1016/0166-2236(90)90105-J; Perez-Rosello T, 2005, J NEUROPHYSIOL, V93, P2507, DOI 10.1152/jn.00853.2004; Picconi B, 2006, NEUROBIOL DIS, V22, P143, DOI 10.1016/j.nbd.2005.10.009; PINEDA JC, 1995, EUR J PHARMACOL, V281, P271, DOI 10.1016/0014-2999(95)00263-K; Prensa L, 1999, J COMP NEUROL, V413, P603; Prensa L, 2003, J COMP NEUROL, V460, P345, DOI 10.1002/cne.10627; Raghavan R., 1997, ELECT CLIN BRAIN ATL; Rakovska A, 2002, NEUROCHEM INT, V40, P269, DOI 10.1016/S0197-0186(01)00037-7; Rakovska A, 2003, BRAIN RES BULL, V61, P529, DOI 10.1016/S0361-9230(03)00192-8; Raz N, 2003, AM J NEURORADIOL, V24, P1849; Roberts RC, 1996, J COMP NEUROL, V374, P523; ROBERTSON GS, 1994, NEUROSCIENCE, V59, P375, DOI 10.1016/0306-4522(94)90603-3; SADIKOT AF, 1992, J COMP NEUROL, V320, P228, DOI 10.1002/cne.903200207; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; SELDEN N, 1994, NEUROSCIENCE, V60, P621, DOI 10.1016/0306-4522(94)90491-X; SELEMON LD, 1985, J NEUROSCI, V5, P776; SMITH Y, 1986, NEUROSCIENCE, V18, P347, DOI 10.1016/0306-4522(86)90159-4; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; VIZI ES, 1977, POL J PHARMACOL PHAR, V29, P201; Waldvogel HJ, 2004, J COMP NEUROL, V470, P339, DOI 10.1002/cne.20005; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Warren NM, 2005, BRAIN, V128, P239, DOI 10.1093/brain/awh391; WILSON CJ, 1990, J NEUROSCI, V10, P508; WOOLF NJ, 1981, BRAIN RES BULL, V7, P487, DOI 10.1016/0361-9230(81)90004-6; WREFORD NG, 1995, MICROSC RES TECHNIQ, V32, P423, DOI 10.1002/jemt.1070320505; Wu Y, 2000, BRAIN RES, V863, P182, DOI 10.1016/S0006-8993(00)02135-1; Yamada H, 2004, J NEUROSCI, V24, P3500, DOI 10.1523/JNEUROSCI.0068-04.2004; YELNIK J, 1991, J COMP NEUROL, V313, P273, DOI 10.1002/cne.903130207	85	50	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1174	10.1371/journal.pone.0001174	http://dx.doi.org/10.1371/journal.pone.0001174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18080007	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459100016
J	Ghosh, T; Pandey, N; Maitra, A; Brahmachari, SK; Pillai, B				Ghosh, Tanay; Pandey, Neeraj; Maitra, Arindam; Brahmachari, Samir K.; Pillai, Beena			A Role for Voltage-Dependent Anion Channel Vdac1 in Polyglutamine-Mediated Neuronal Cell Death	PLOS ONE			English	Article								Expansion of trinucleotide repeats in coding and non-coding regions of genes is associated with sixteen neurodegenerative disorders. However, the molecular effects that lead to neurodegeneration have remained elusive. We have explored the role of transcriptional dysregulation by TATA-box binding protein (TBP) containing an expanded polyglutamine stretch in a mouse neuronal cell culture based model. We find that mouse neuronal cells expressing a variant of human TBP harboring an abnormally expanded polyQ tract not only form intranuclear aggregates, but also show transcription dysregulation of the voltage dependent anion channel, Vdac1, increased cytochrome c release from the mitochondria and upregulation of genes involved in localized neuronal translation. On the other hand, unfolded protein response seemed to be unaffected. Consistent with an increased transcriptional effect, we observe an elevated promoter occupancy by TBP in vivo in TATA containing and TATA-less promoters of differentially expressed genes. Our study suggests a link between transcriptional dysfunction and cell death in trinucleotide repeat mediated neuronal dysfunction through voltage dependent anion channel, Vdac1, which has been recently recognized as a critical determinant of cell death.	[Ghosh, Tanay; Pandey, Neeraj; Brahmachari, Samir K.; Pillai, Beena] IGIB, New Delhi, India; [Maitra, Arindam] Ctr Genom Applicat, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Pillai, B (corresponding author), IGIB, New Delhi, India.	beenapillai@igib.res		Pandey, Neeraj/0000-0003-4872-7201; Pillai, Beena/0000-0002-9302-9878	Department of Science and Technology (DST), India; Council of Scientific and Industrial Research (CSIR)	Department of Science and Technology (DST), India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This research was supported by grants from the Department of Science and Technology (DST), India. TG is a recipient of senior research fellowship from Council of Scientific and Industrial Research (CSIR). The funders played no role in design and conducting of the study, or in the collection, analysis or interpretation of the data. The same is the case for the preparation, review and approval of the manuscript. The funders did not provide the publication fee.	BUHAMAD S, 2006, P NATL ACAD SCI USA, V103, P5787; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Gill G, 1992, CURR OPIN GENET DEV, V2, P236, DOI 10.1016/S0959-437X(05)80279-5; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1927, DOI 10.1093/hmg/11.17.1927; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McMurray CT, 2001, TRENDS NEUROSCI, V24, pS32, DOI 10.1016/S0166-2236(00)01997-4; Nahon E, 2005, FEBS LETT, V579, P5105, DOI 10.1016/j.febslet.2005.08.020; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Ruan QM, 2004, HUM MOL GENET, V13, P669, DOI 10.1093/hmg/ddh082; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shoshan-Barmatz V, 2004, BBA-BIOENERGETICS, V1657, P105, DOI 10.1016/j.bbabio.2004.02.009; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; Stevanin G, 2003, BRAIN, V126, P1599, DOI 10.1093/brain/awg155; Van Roon-Mom WMC, 2005, NEUROSCIENCE, V133, P863, DOI 10.1016/j.neuroscience.2005.03.024; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964; Zuhlke C, 2001, EUR J HUM GENET, V9, P160, DOI 10.1038/sj.ejhg.5200617	30	58	60	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1170	10.1371/journal.pone.0001170	http://dx.doi.org/10.1371/journal.pone.0001170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000542	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459100012
J	Loza, MJ; McCall, CE; Li, LW; Isaacs, WB; Xu, JF; Chang, BL				Loza, Matthew J.; McCall, Charles E.; Li, Liwu; Isaacs, William B.; Xu, Jianfeng; Chang, Bao-Li			Assembly of Inflammation-Related Genes for Pathway-Focused Genetic Analysis	PLOS ONE			English	Article								Recent identifications of associations between novel variants in inflammation-related genes and several common diseases emphasize the need for systematic evaluations of these genes in disease susceptibility. Considering that many genes are involved in the complex inflammation responses and many genetic variants in these genes have the potential to alter the functions and expression of these genes, we assembled a list of key inflammation-related genes to facilitate the identification of genetic associations of diseases with an inflammation-related etiology. We first reviewed various phases of inflammation responses, including the development of immune cells, sensing of danger, influx of cells to sites of insult, activation and functional responses of immune and non-immune cells, and resolution of the immune response. Assisted by the Ingenuity Pathway Analysis, we then identified 17 functional sub-pathways that are involved in one or multiple phases. This organization would greatly increase the chance of detecting gene-gene interactions by hierarchical clustering of genes with their functional closeness in a pathway. Finally, as an example application, we have developed tagging single nucleotide polymorphism (tSNP) arrays for populations of European and African descent to capture all the common variants of these key inflammation-related genes. Assays of these tSNPs have been designed and assembled into two Affymetrix ParAllele customized chips, one each for European (12,011 SNPs) and African (21,542 SNPs) populations. These tSNPs have greater coverage for these nflammation-related genes compared to the existing genome-wide arrays, particularly in the African population. These tSNP arrays can facilitate systematic evaluation of inflammation pathways in disease susceptibility. For additional applications, other genotyping platforms could also be employed. For existing genome-wide association data, this list of key inflammation-related genes and associated subpathways can facilitate comprehensive inflammation pathway-focused association analyses.	[Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Dept Epidemiol & Prevent, Winston Salem, NC 27109 USA; [Loza, Matthew J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Ctr Human Genom, Winston Salem, NC 27103 USA; [Li, Liwu] Virginia Polytech Inst & State Univ, Dept Biol, Blacksburg, VA 24061 USA; [Isaacs, William B.] Johns Hopkins Univ, Dept Urol, Inst Med, Baltimore, MD USA; [Isaacs, William B.] Johns Hopkins Univ, Inst Med, Dept Oncol, Baltimore, MD USA; [Chang, Bao-Li] Wake Forest Univ, Bowman Gray Sch Med, Dept Pediat Med, Ctr Human Genom, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Virginia Polytechnic Institute & State University; Johns Hopkins University; Johns Hopkins University; Wake Forest University; Wake Forest Baptist Medical Center	Xu, JF (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Dept Epidemiol & Prevent, Winston Salem, NC 27109 USA.	jxu@wfubmc.edu; bchang@wfubmc.edu		Li, Liwu/0000-0001-8870-5299; Loza, Matthew/0000-0002-8609-118X	National Heart, Lung, and Blood Institute-Women's Health Initiative [HHSN268200764321C]; National Cancer Institute [CA119069, CA105055]; NATIONAL CANCER INSTITUTE [R01CA105055, R01CA119069] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute-Women's Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study is supported by National Heart, Lung, and Blood Institute-Women's Health Initiative HHSN268200764321C, National Cancer Institute CA119069 and CA105055.	Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; Aoki Takeshi, 2006, J Hum Genet, V51, P677, DOI 10.1007/s10038-006-0007-3; Calder PC, 2006, PROSTAG LEUKOTR ESS, V75, P197, DOI 10.1016/j.plefa.2006.05.012; Conley YP, 2006, HUM MOL GENET, V15, P3206, DOI 10.1093/hmg/ddl396; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cox DG, 2004, BRIT J CANCER, V91, P339, DOI 10.1038/sj.bjc.6601906; De Bakker Paul I W, 2006, Pac Symp Biocomput, P478, DOI 10.1142/9789812701626_0044; DINU V, 2007, GENET EPIDEMIOL; Dode C, 2002, AM J HUM GENET, V70, P1498, DOI 10.1086/340786; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; Forrester JS, 2005, MED HYPOTHESES, V65, P227, DOI 10.1016/j.mehy.2005.03.010; GAUDET MM, 2007, HUM GENET; Goronzy JJ, 2005, IMMUNOL REV, V204, P55, DOI 10.1111/j.0105-2896.2005.00245.x; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Hedelin M, 2007, INT J CANCER, V120, P398, DOI 10.1002/ijc.22319; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Howson JMM, 2007, DIABETOLOGIA, V50, P741, DOI 10.1007/s00125-007-0603-6; James SP, 2005, J ALLERGY CLIN IMMUN, V115, P25, DOI 10.1016/j.jaci.2004.11.011; Johansson A, 2007, HUM GENET, V122, P141, DOI 10.1007/s00439-007-0379-2; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Koh WP, 2004, BRIT J CANCER, V90, P1760, DOI 10.1038/sj.bjc.6601797; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; Lee YH, 2006, EUR J HUM GENET, V14, P364, DOI 10.1038/sj.ejhg.5201566; Lin HJ, 2002, CANCER EPIDEM BIOMAR, V11, P1305; LOZA MJ, 2007, J ALLERGY C IN PRESS; Montpetit A, 2006, PLOS GENET, V2, P282, DOI 10.1371/journal.pgen.0020027; Mueller JC, 2005, AM J HUM GENET, V76, P387, DOI 10.1086/427925; Neuman MG, 2007, TRANSL RES, V149, P173, DOI 10.1016/j.trsl.2006.11.009; Oostenbrug LE, 2006, DIGEST LIVER DIS, V38, P834, DOI 10.1016/j.dld.2006.06.042; Payne F, 2007, J LEUKOCYTE BIOL, V81, P581, DOI 10.1189/jlb.0906577; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Rahman P, 2006, ANN RHEUM DIS, V65, P919, DOI 10.1136/ard.2005.039164; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Shahedi K, 2006, INT J CANCER, V119, P668, DOI 10.1002/ijc.21864; Siezen CLE, 2006, INT J CANCER, V119, P297, DOI 10.1002/ijc.21858; Siezen CLE, 2005, CARCINOGENESIS, V26, P449, DOI 10.1093/carcin/bgh336; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Tenesa A, 2006, EUR J HUM GENET, V14, P357, DOI 10.1038/sj.ejhg.5201554; Touitou I, 2001, EUR J HUM GENET, V9, P473, DOI 10.1038/sj.ejhg.5200658; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Ulrich CM, 2006, NAT REV CANCER, V6, P130, DOI 10.1038/nrc1801; Willer CJ, 2006, GENET EPIDEMIOL, V30, P180, DOI 10.1002/gepi.20131; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; XU Z, 2007, EUR J HUM GENET; Zheng SL, 2006, PROSTATE, V66, P1556, DOI 10.1002/pros.20496	52	79	80	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1035	10.1371/journal.pone.0001035	http://dx.doi.org/10.1371/journal.pone.0001035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940599	Green Published, Green Submitted, gold			2022-12-27	WOS:000207456100003
J	Walsh, LA; Carere, DA; Cooper, CA; Damjanovski, S				Walsh, Logan A.; Carere, Deanna A.; Cooper, Colin A.; Damjanovski, Sashko			Membrane Type-1 Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases-2 RNA Levels Mimic Each Other during Xenopus laevis Metamorphosis	PLOS ONE			English	Article								Matrix metalloproteinases (MMPs) and their endogenous inhibitors TIMPs (tissue inhibitors of MMPs), are two protein families that work together to remodel the extracellular matrix (ECM). TIMPs serve not only to inhibit MMP activity, but also aid in the activation of MMPs that are secreted as inactive zymogens. Xenopus laevis metamorphosis is an ideal model for studying MMP and TIMP expression levels because all tissues are remodeled under the control of one molecule, thyroid hormone. Here, using RT-PCR analysis, we examine the metamorphic RNA levels of two membrane-type MMPs (MT1-MMP, MT3-MMP), two TIMPs (TIMP-2, TIMP-3) and a potent gelatinase (Gel-A) that can be activated by the combinatory activity of a MT-MMP and a TIMP. In the metamorphic tail and intestine the RNA levels of TIMP-2 and MT1-MMP mirror each other, and closely resemble that of Gel-A as all three are elevated during periods of cell death and proliferation. Conversely, MT3-MMP and TIMP-3 do not have similar RNA level patterns nor do they mimic the RNA levels of the other genes examined. Intriguingly, TIMP-3, which has been shown to have anti-apoptotic activity, is found at low levels in tissues during periods of apoptosis.	[Walsh, Logan A.; Carere, Deanna A.; Cooper, Colin A.; Damjanovski, Sashko] Univ Western Ontario, Dept Biol, London, ON, Canada	Western University (University of Western Ontario)	Damjanovski, S (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	sdamjano@uwo.ca	Damjanovski, Sashko/N-8728-2015	Damjanovski, Sashko/0000-0002-3479-721X; Walsh, Logan/0000-0001-8771-2577; Carere, Deanna Alexis/0000-0003-3965-686X	NSERC; Ontario Graduate Scholarship	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This research was supported by an NSERC Discovery Grant to SD, and Ontario Graduate Scholarship funding to LW and CC. The research funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvelo Francisco, 2006, Invest. clín, V47, P185; Crump D, 2002, ENVIRON HEALTH PERSP, V110, P1199, DOI 10.1289/ehp.021101199; Damjanovski S, 1999, CELL RES, V9, P91, DOI 10.1038/sj.cr.7290009; Damjanovski S, 2000, FASEB J, V14, P503, DOI 10.1096/fasebj.14.3.503; Damjanovski S, 2001, DEV DYNAM, V221, P37, DOI 10.1002/dvdy.1123; Das B, 2006, DEV BIOL, V291, P342, DOI 10.1016/j.ydbio.2005.12.032; DODD MHI, 1976, BIOL METAMORPHOSIS, P467; FU L, 2006, J BIOL CHEM; GROSS J, 1965, P NATL ACAD SCI USA, V54, P1197, DOI 10.1073/pnas.54.4.1197; Hammoud L, 2006, BIOCHEM CELL BIOL, V84, P167, DOI 10.1139/O05-175; Hasebe T, 2006, CELL TISSUE RES, V324, P105, DOI 10.1007/s00441-005-0099-7; Hasebe T, 2007, MECH DEVELOP, V124, P11, DOI 10.1016/j.mod.2006.09.001; Ishizuya-Oka A, 2000, J CELL BIOL, V150, P1177, DOI 10.1083/jcb.150.5.1177; Ishizuya-Oka A, 2001, DIFFERENTIATION, V69, P27, DOI 10.1046/j.1432-0436.2001.690103.x; Jung JC, 2002, DEV DYNAM, V223, P402, DOI 10.1002/dvdy.10069; Kang TB, 2002, CANCER RES, V62, P675; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nieuwkoop PD, 1956, NORMAL TABLE XENOPUS, P243; Pickard B, 2004, CELL RES, V14, P389, DOI 10.1038/sj.cr.7290239; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 2001, PROG NUCLEIC ACID RE, V65, P53; Shi YB, 1998, INT J DEV BIOL, V42, P107; Somiari SB, 2006, CANCER LETT, V233, P98, DOI 10.1016/j.canlet.2005.03.003; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Walsh LA, 2007, INT J DEV BIOL, V51, P389, DOI 10.1387/ijdb.062253lw	26	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e1000	10.1371/journal.pone.0001000	http://dx.doi.org/10.1371/journal.pone.0001000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912339	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455900036
J	Kurakin, A; Swistowski, A; Wu, SC; Bredesen, DE				Kurakin, Alexei; Swistowski, Andrzej; Wu, Susan C.; Bredesen, Dale E.			The PDZ Domain as a Complex Adaptive System	PLOS ONE			English	Article							PROTEIN INTERACTIONS; PEPTIDE RECOGNITION; SELF-ORGANIZATION; SH3 DOMAINS; PROMISCUITY; SELECTIVITY; CLASSIFICATION; SPECIFICITY; DYNAMICS; MODULES	Specific protein associations define the wiring of protein interaction networks and thus control the organization and functioning of the cell as a whole. Peptide recognition by PDZ and other protein interaction domains represents one of the best-studied classes of specific protein associations. However, a mechanistic understanding of the relationship between selectivity and promiscuity commonly observed in the interactions mediated by peptide recognition modules as well as its functional meaning remain elusive. To address these questions in a comprehensive manner, two large populations of artificial and natural peptide ligands of six archetypal PDZ domains from the synaptic proteins PSD95 and SAP97 were generated by target-assisted iterative screening (TAIS) of combinatorial peptide libraries and by synthesis of proteomic fragments, correspondingly. A comparative statistical analysis of affinity-ranked artificial and natural ligands yielded a comprehensive picture of known and novel PDZ ligand specificity determinants, revealing a hitherto unappreciated combination of specificity and adaptive plasticity inherent to PDZ domain recognition. We propose a reconceptualization of the PDZ domain in terms of a complex adaptive system representing a flexible compromise between the rigid order of exquisite specificity and the chaos of unselective promiscuity, which has evolved to mediate two mutually contradictory properties required of such higher order sub-cellular organizations as synapses, cell junctions, and others - organizational structure and organizational plasticity/adaptability. The generalization of this reconceptualization in regard to other protein interaction modules and specific protein associations is consistent with the image of the cell as a complex adaptive macromolecular system as opposed to clockwork.	[Kurakin, Alexei; Swistowski, Andrzej; Wu, Susan C.; Bredesen, Dale E.] Buck Inst Age Res, Novato, CA USA	Buck Institute for Research on Aging	Kurakin, A (corresponding author), Buck Inst Age Res, Novato, CA USA.	ak@alexeikurakin.org			NIH [NS33376]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by NS33376 from the NIH to D. E. B.	Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Basdevant N, 2006, J AM CHEM SOC, V128, P12766, DOI 10.1021/ja060830y; Bezprozvanny I, 2001, FEBS LETT, V509, P457, DOI 10.1016/S0014-5793(01)03214-8; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Castagnoli L, 2004, FEBS LETT, V567, P74, DOI 10.1016/j.febslet.2004.03.116; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Dev KK, 2004, NAT REV DRUG DISCOV, V3, P1047, DOI 10.1038/nrd1578; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fujita A, 2000, BIOCHEM BIOPH RES CO, V269, P1, DOI 10.1006/bbrc.1999.1893; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Harris BZ, 2001, J CELL SCI, V114, P3219; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Inoue A, 2003, CURR OPIN NEUROBIOL, V13, P332, DOI 10.1016/S0959-4388(03)00077-1; Kay BK, 2000, FEBS LETT, V480, P55, DOI 10.1016/S0014-5793(00)01778-6; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kurakin A, 2005, BIOL CHEM, V386, P247, DOI 10.1515/BC.2005.030; Kurakin A, 2002, J BIOMOL STRUCT DYN, V19, P1015, DOI 10.1080/07391102.2002.10506805; Kurakin A, 2007, J MOL RECOGNIT, V20, P205, DOI 10.1002/jmr.839; Kurakin A, 2007, J MOL RECOGNIT, V20, P39, DOI 10.1002/jmr.809; Kurakin Alexei, 2004, Methods Mol Biol, V264, P47; Kurakin AV, 2003, J BIOL CHEM, V278, P34102, DOI 10.1074/jbc.M305264200; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Mayer BJ, 2001, J CELL SCI, V114, P1253; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Piserchio A, 2002, J BIOL CHEM, V277, P6967, DOI 10.1074/jbc.M109453200; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Sudol M, 1998, ONCOGENE, V17, P1469, DOI 10.1038/sj.onc.1202182; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; Vaccaro P, 2002, FEBS LETT, V512, P345, DOI 10.1016/S0014-5793(02)02220-2; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Zucconi A, 2000, FEBS LETT, V480, P49, DOI 10.1016/S0014-5793(00)01777-4	41	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e953	10.1371/journal.pone.0000953	http://dx.doi.org/10.1371/journal.pone.0000953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895993	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455800031
J	Costford, SR; Kavaslar, N; Ahituv, N; Chaudhry, SN; Schackwitz, WS; Dent, R; Pennacchio, LA; McPherson, R; Harper, ME				Costford, Sheila R.; Kavaslar, Nihan; Ahituv, Nadav; Chaudhry, Shehla N.; Schackwitz, Wendy S.; Dent, Robert; Pennacchio, Len A.; McPherson, Ruth; Harper, Mary-Ellen			Gain-of-Function R225W Mutation in Human AMPK gamma(3) Causing Increased Glycogen and Decreased Triglyceride in Skeletal Muscle	PLOS ONE			English	Article								Background. AMP-activated protein kinase (AMPK) is a heterotrimeric enzyme that is evolutionarily conserved from yeast to mammals and functions to maintain cellular and whole body energy homeostasis. Studies in experimental animals demonstrate that activation of AMPK in skeletal muscle protects against insulin resistance, type 2 diabetes and obesity. The regulatory gamma(3) subunit of AMPK is expressed exclusively in skeletal muscle; however, its importance in controlling overall AMPK activity is unknown. While evidence is emerging that gamma subunit mutations interfere specifically with AMP activation, there remains some controversy regarding the impact of gamma subunit mutations [1-3]. Here we report the first gain-of-function mutation in the muscle-specific regulatory gamma(3) subunit in humans. Methods and Findings. We sequenced the exons and splice junctions of the AMPK gamma(3) gene (PRKAG3) in 761 obese and 759 lean individuals, identifying 87 sequence variants including a novel R225W mutation in subjects from two unrelated families. The gamma(3) R225W mutation is homologous in location to the gamma(2)R302Q mutation in patients with Wolf-Parkinson-White syndrome and to the gamma(3)R225Q mutation originally linked to an increase in muscle glycogen content in purebred Hampshire Rendement Napole (RN-) pigs. We demonstrate in differentiated muscle satellite cells obtained from the vastus lateralis of R225W carriers that the mutation is associated with an approximate doubling of both basal and AMP-activated AMPK activities. Moreover, subjects bearing the R225W mutation exhibit a similar to 90% increase of skeletal muscle glycogen content and a similar to 30% decrease in intramuscular triglyceride (IMTG). Conclusions. We have identified for the first time a mutation in the skeletal muscle-specific regulatory gamma(3) subunit of AMPK in humans. The gamma(3)R225W mutation has significant functional effects as demonstrated by increases in basal and AMP-activated AMPK activities, increased muscle glycogen and decreased IMTG. Overall, these findings are consistent with an important regulatory role for AMPK gamma(3) in human muscle energy metabolism.	[Costford, Sheila R.; Chaudhry, Shehla N.; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Kavaslar, Nihan; McPherson, Ruth] Univ Ottawa, Inst Heart, Atherosclerosis Res Grp, Ottawa, ON, Canada; [Kavaslar, Nihan; McPherson, Ruth] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada; [Dent, Robert] Ottawa Hosp, Weight Management Clin, Ottawa, ON, Canada; [Ahituv, Nadav; Schackwitz, Wendy S.; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Schackwitz, Wendy S.] US DOE, Joint Genome Inst, Walnut Creek, CA USA	University of Ottawa; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; Ottawa Hospital Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	Maryellen.Harper@uottawa.ca	Schackwitz, Wendy/GXH-9536-2022	Pennacchio, Len/0000-0002-8748-3732; Ahituv, Nadav/0000-0002-7434-8144; Harper, Mary-Ellen/0000-0003-3864-5886	Heart and Stroke Foundation of Ontario [NA-5413]; Department of Energy [DE-AC02-05CH11231]; University of California	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Department of Energy(United States Department of Energy (DOE)); University of California(University of California System)	This research was supported by a grant (# NA-5413) from the Heart and Stroke Foundation of Ontario ( to R. McPherson and M-E Harper) and was partially conducted at the E.O. Lawrence Berkeley National Laboratory, and performed under Department of Energy Contract DE-AC02-05CH11231, University of California.	Ahituv N, 2006, HUM MOL GENET, V15, P387, DOI 10.1093/hmg/ddi455; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Andersson L, 2003, BIOCHEM SOC T, V31, P232, DOI 10.1042/BST0310232; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Barnes BR, 2005, DIABETES, V54, P3484, DOI 10.2337/diabetes.54.12.3484; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199; Buhl ES, 2001, DIABETES, V50, P12, DOI 10.2337/diabetes.50.1.12; Burwinkel B, 2005, AM J HUM GENET, V76, P1034, DOI 10.1086/430840; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; DYCK JRB, 2006, J PHYSIOL-LONDON; Frosig C, 2004, AM J PHYSIOL-ENDOC M, V286, pE411, DOI 10.1152/ajpendo.00317.2003; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006; Gollob MH, 2001, CIRCULATION, V104, P3030, DOI 10.1161/hc5001.102111; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Hamilton SR, 2001, FEBS LETT, V500, P163, DOI 10.1016/S0014-5793(01)02602-3; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2000, METH MOL B, V99, P63; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hedegaard J, 2004, PROTEOMICS, V4, P2448, DOI 10.1002/pmic.200300761; INGHAM KC, 1990, METHOD ENZYMOL, V182, P301; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Lang TM, 2000, GENOMICS, V70, P258, DOI 10.1006/geno.2000.6376; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Nielsen JN, 2003, J APPL PHYSIOL, V94, P631, DOI 10.1152/japplphysiol.00642.2002; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Wojtaszewski JFP, 2005, J PHYSIOL-LONDON, V564, P563, DOI 10.1113/jphysiol.2005.082669; Yu HY, 2006, AM J PHYSIOL-ENDOC M, V291, pE557, DOI 10.1152/ajpendo.00073.2006; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	41	66	67	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e903	10.1371/journal.pone.0000903	http://dx.doi.org/10.1371/journal.pone.0000903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878938	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455700011
J	Liu, ZJ; Zheng, XL; Wang, J; Wang, EK				Liu, Zuojia; Zheng, Xiliang; Wang, Jin; Wang, Erkang			Molecular Analysis of Thymopentin Binding to HLA-DR Molecules	PLOS ONE			English	Article								Thymopentin (TP5) triggers an immune response by contacting with T cells; however the molecular basis of how TP5 achieves this process remains incompletely understood. According to the main idea of immunomodulation, we suppose that it would be necessary for TP5 to form complex with human class II major histocompatibility complex DR molecules (HLA-DR) before TP5 interacts with T cells. The uptake of TP5 by EBV-transformed B cells expressing HLA-DR molecules and the histogram of fluorescence intensities were observed by using fluorescent-labeled TP5, testifying the direct binding of TP5 to HLA-DR. The binding specificity was confirmed by the inhibition with unlabeled TP5, suggesting the recognition of TP5 by HLA-DR. To confirm the interaction between TP5 and HLA-DR, the complex formation was predicted by using various modeling strategies including six groups of trials with different parameters, alanine substitutions of TP5, and the mutants of HLA-DR. The results demonstrated that TP5 and its alanine substitutions assumed distinct conformations when they bound to HLA-DR. The observation further showed that there was flexibility in how the peptide bound within the binding cleft. Also, the molecular analysis supplemented a newly important discovery to the effect of Val anchor on TP5 binding HLA-DR, and revealed the important effects of Glu11 and Asn62 on the recognition of TP5. These results demonstrated the capability of TP5 to associate with HLA-DR in living antigen presenting cells (APC), thereby providing a new and promising strategy to understand the immunomodulation mechanism induced by TP5 and to design potential immunoregulatory polypeptides.	[Liu, Zuojia; Zheng, Xiliang; Wang, Jin; Wang, Erkang] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, EK (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China.	ekwang@ciac.jl.cn	, 汪尔康/P-1748-2019		National Natural Science Foundation of China [20575063, 90713022, 20735003]; Chinese Academy of Sciences [KJCX2.YW.H09]; National Science Foundation Career Award; American Chemical Society Petroleum Research Fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation Career Award(National Science Foundation (NSF)); American Chemical Society Petroleum Research Fund(American Chemical Society)	Funding: This work was supported by the National Natural Science Foundation of China with the Grant No. 20575063, 90713022, 20735003 and Chinese Academy of Sciences KJCX2.YW.H09. J.W thanks National Science Foundation Career Award and American Chemical Society Petroleum Research Fund for financial supports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARVINTE T, 1993, J BIOL CHEM, V268, P6415; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; Bodey B, 2000, INT J IMMUNOPHARMACO, V22, P261, DOI 10.1016/S0192-0561(99)00084-3; Bouvier M, 1998, PROTEINS, V33, P97, DOI 10.1002/(SICI)1097-0134(19981001)33:1<97::AID-PROT9>3.0.CO;2-I; BUUS S, 1987, SCIENCE, V235, P1353, DOI 10.1126/science.2435001; CEPELLINI R, 1989, NATURE, V339, P392; CLARE BA, 2006, J IMMUNOL, V176, P4622; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; GEORGE AH, 1985, ARCH BIOCHEM BIOPHYS, V242, P248; GOLDSTEIN G, 1979, SCIENCE, V204, P1309, DOI 10.1126/science.451537; GREY HM, 1985, IMMUNOL TODAY, V6, P101, DOI 10.1016/0167-5699(85)90025-8; GUILLET JG, 1986, NATURE, V324, P260, DOI 10.1038/324260a0; HAMMER J, 1995, J EXP MED, V181, P1847, DOI 10.1084/jem.181.5.1847; HAWARD W, 1991, CELL, V67, P105; JENSEN PE, 1991, J EXP MED, V174, P111; JENSEN PE, 1990, J EXP MED, V171, P779; KAI W, 1995, P NATL ACAD SCI USA, V92, P11935; Krebs S, 1998, Pharm Acta Helv, V73, P173, DOI 10.1016/S0031-6865(98)00021-1; Lazavecchia AA, 1992, NATURE, V357, P249; Liu S, 2004, PROTEINS, V56, P93, DOI 10.1002/prot.20019; LUESCHER IF, 1988, P NATL ACAD SCI USA, V85, P871, DOI 10.1073/pnas.85.3.871; MASHA FH, 1998, J IMMUNOL, V160, P4386; MASHA HA, 1994, P NATI ACAD SCI US, V91, P4872; McFarland BJ, 1999, BIOCHEMISTRY-US, V38, P16663, DOI 10.1021/bi991393l; MEHLER EL, 1991, PROTEIN ENG, V4, P903, DOI 10.1093/protein/4.8.903; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; ROBERT B, 1990, INT IMMUNOL, V2, P443; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15050, DOI 10.1073/pnas.96.26.15050; Sherman MA, 1997, CELL IMMUNOL, V182, P1, DOI 10.1006/cimm.1997.1219; Singh VK, 1998, IMMUNOL RES, V17, P345, DOI 10.1007/BF02786456; Solmajer T, 1990, Drug Des Deliv, V6, P213; SPECK SH, 1987, PROG NUCLEIC ACID RE, V34, P189, DOI 10.1016/S0079-6603(08)60496-1; SUNDAL E, 1994, ARZNEIMITTEL-FORSCH, V44-2, P866; TARA MCH, 2001, J IMMUNOL, V167, P4207; THEODORE S, 1996, P NATL ACAD SCI USA, V93, P734; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WATTS TH, 1986, P NATL ACAD SCI USA, V83, P9660, DOI 10.1073/pnas.83.24.9660	42	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1348	10.1371/journal.pone.0001348	http://dx.doi.org/10.1371/journal.pone.0001348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159232	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459700006
J	Grewe, J; Weckstrom, M; Egelhaaf, M; Warzecha, AK				Grewe, Jan; Weckstrom, Matti; Egelhaaf, Martin; Warzecha, Anne-Kathrin			Information and Discriminability as Measures of Reliability of Sensory Coding	PLOS ONE			English	Article							NOISE; SIGNALS; COMMUNICATION; TRANSMISSION; GAIN	Response variability is a fundamental issue in neural coding because it limits all information processing. The reliability of neuronal coding is quantified by various approaches in different studies. In most cases it is largely unclear to what extent the conclusions depend on the applied reliability measure, making a comparison across studies almost impossible. We demonstrate that different reliability measures can lead to very different conclusions even if applied to the same set of data: in particular, we applied information theoretical measures (Shannon information capacity and Kullback-Leibler divergence) as well as a discrimination measure derived from signal-detection theory to the responses of blowfly photoreceptors which represent a well established model system for sensory information processing. We stimulated the photoreceptors with white noise modulated light intensity fluctuations of different contrasts. Surprisingly, the signal-detection approach leads to a safe discrimination of the photoreceptor response even when the response signal-to-noise ratio (SNR) is well below unity whereas Shannon information capacity and also Kullback-Leibler divergence indicate a very low performance. Applying different measures, can, therefore, lead to very different interpretations concerning the system's coding performance. As a consequence of the lower sensitivity compared to the signal-detection approach, the information theoretical measures overestimate internal noise sources and underestimate the importance of photon shot noise. We stress that none of the used measures and, most likely no other measure alone, allows for an unbiased estimation of a neuron's coding properties. Therefore the applied measure needs to be selected with respect to the scientific question and the analyzed neuron's functional context.	[Grewe, Jan; Egelhaaf, Martin; Warzecha, Anne-Kathrin] Univ Bielefeld, Dept Neurobiol, Bielefeld, Germany; [Grewe, Jan; Warzecha, Anne-Kathrin] Univ Munster, Psychol Inst 2, Munster, Germany; [Weckstrom, Matti] Univ Oulu, Dept Biophys, Oulu, Finland; [Weckstrom, Matti] Univ Oulu, Bioctr Oulu, Oulu, Finland	University of Bielefeld; University of Munster; University of Oulu; University of Oulu	Grewe, J (corresponding author), Univ Bielefeld, Dept Neurobiol, Bielefeld, Germany.	jan.grewe@uni-bielefeld.de	Egelhaaf, Martin/A-9824-2010	Egelhaaf, Martin/0000-0002-9336-4270; Grewe, Jan/0000-0002-6254-2425	Volkswagen-Stiftung	Volkswagen-Stiftung(Volkswagen)	JG and AKW are funded by a grant of the Volkswagen-Stiftung which has no role in the design/conductance of the project.	Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Chichilnisky EJ, 2005, J NEUROSCI, V25, P318, DOI 10.1523/JNEUROSCI.2339-04.2005; Dayan P, 2001, COMPUTATIONAL NEUROS; Dunn FA, 2006, J NEUROSCI, V26, P3959, DOI 10.1523/JNEUROSCI.5148-05.2006; EGELHAAF M, 1993, COMP BIOCHEM PHYS A, V104, P659, DOI 10.1016/0300-9629(93)90144-S; Gabbiani F, 1996, NATURE, V384, P564, DOI 10.1038/384564a0; Green D. M., 1974, SIGNAL DETECTION THE; Grewe J, 2003, J NEUROSCI, V23, P10776; Haag J, 1997, J NEUROSCI, V17, P4809; HECHT S, 1942, ENERGY QUANTA VISION, P819; HOWARD J, 1987, PROC R SOC SER B-BIO, V231, P415, DOI 10.1098/rspb.1987.0053; JUUSOLA M, 1995, J GEN PHYSIOL, V105, P117, DOI 10.1085/jgp.105.1.117; Kern R, 2005, PLOS BIOL, V3, P1130, DOI 10.1371/journal.pbio.0030171; Koch K, 2004, CURR BIOL, V14, P1523, DOI 10.1016/j.cub.2004.08.060; Kretzberg J, 2001, J COMPUT NEUROSCI, V11, P153, DOI 10.1023/A:1012845700075; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LAUGHLIN SB, 1982, J PHYSIOL-LONDON, V332, P25, DOI 10.1113/jphysiol.1982.sp014398; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; Passaglia CL, 2004, J NEUROPHYSIOL, V91, P1217, DOI 10.1152/jn.00796.2003; Shannon CE, 1998, P IEEE, V86, P447, DOI 10.1109/JPROC.1998.659497; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Simmons PJ, 2005, J NEUROSCI, V25, P7529, DOI 10.1523/JNEUROSCI.1119-05.2005; van Hateren JH, 2001, VISION RES, V41, P1851, DOI 10.1016/S0042-6989(01)00052-9; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0	25	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1328	10.1371/journal.pone.0001328	http://dx.doi.org/10.1371/journal.pone.0001328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091998	Green Published, gold			2022-12-27	WOS:000207459600016
J	Finkelman, BS; Viboud, C; Koelle, K; Ferrari, MJ; Bharti, N; Grenfell, BT				Finkelman, Brian S.; Viboud, Cecile; Koelle, Katia; Ferrari, Matthew J.; Bharti, Nita; Grenfell, Bryan T.			Global Patterns in Seasonal Activity of Influenza A/H3N2, A/H1N1, and B from 1997 to 2005: Viral Coexistence and Latitudinal Gradients	PLOS ONE			English	Article							EVOLUTION; H3N2; EPIDEMIOLOGY; SUBTYPE	Despite a mass of research on the epidemiology of seasonal influenza, overall patterns of infection have not been fully described on broad geographic scales and for specific types and subtypes of the influenza virus. Here we provide a descriptive analysis of laboratory-confirmed influenza surveillance data by type and subtype (A/H3N2, A/H1N1, and B) for 19 temperate countries in the Northern and Southern hemispheres from 1997 to 2005, compiled from a public database maintained by WHO (FluNet). Key findings include patterns of large scale co-occurrence of influenza type A and B, interhemispheric synchrony for subtype A/H3N2, and latitudinal gradients in epidemic timing for type A. These findings highlight the need for more countries to conduct year-round viral surveillance and report reliable incidence data at the type and subtype level, especially in the Tropics.	[Finkelman, Brian S.; Ferrari, Matthew J.; Bharti, Nita; Grenfell, Bryan T.] Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, Eberly Coll Sci, University Pk, PA 16802 USA; [Viboud, Cecile; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Koelle, Katia] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Michigan System; University of Michigan	Finkelman, BS (corresponding author), Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, Eberly Coll Sci, University Pk, PA 16802 USA.	bsf143@psu.edu		Bharti, Nita/0000-0003-1940-7794; Finkelman, Brian/0000-0002-4348-8208	Schreyer Honors College Summer 2007 Research Scholarship	Schreyer Honors College Summer 2007 Research Scholarship	Funding for this work was provided by the Schreyer Honors College Summer 2007 Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; FOUCHIER R, 2007, RECOMMENDED LAB TEST; Greene SK, 2006, AM J EPIDEMIOL, V163, P316, DOI 10.1093/aje/kwj040; HOPESIMPSON RE, 1981, J HYG-CAMBRIDGE, V86, P35, DOI 10.1017/S0022172400068728; KILBOURNE ED, 1961, NATURE, V195, P1129; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Lin YP, 2004, VIRUS RES, V103, P47, DOI 10.1016/j.virusres.2004.02.011; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nguyen-Van-Tam JS, 1998, TXB INFLUENZA, P181; Roberts MG, 2001, ECOLOGY WILDLIFE DIS, P63; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; SONOGUCHI T, 1986, J INFECT DIS, V153, P33, DOI 10.1093/infdis/153.1.33; SONOGUCHI T, 1985, J INFECT DIS, V151, P81, DOI 10.1093/infdis/151.1.81; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Xia YC, 2005, J R STAT SOC C-APPL, V54, P659, DOI 10.1111/j.1467-9876.2005.05383.x	23	161	165	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1296	10.1371/journal.pone.0001296	http://dx.doi.org/10.1371/journal.pone.0001296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074020	gold, Green Published			2022-12-27	WOS:000207459500015
J	Amin, N; van Duijn, CM; Aulchenko, YS				Amin, Najaf; van Duijn, Cornelia M.; Aulchenko, Yurii S.			A Genomic Background Based Method for Association Analysis in Related Individuals	PLOS ONE			English	Article								Background. Feasibility of genotyping of hundreds and thousands of single nucleotide polymorphisms ( SNPs) in thousands of study subjects have triggered the need for fast, powerful, and reliable methods for genome-wide association analysis. Here we consider a situation when study participants are genetically related (e.g. due to systematic sampling of families or because a study was performed in a genetically isolated population). Of the available methods that account for relatedness, the Measured Genotype (MG) approach is considered the 'gold standard'. However, MG is not efficient with respect to time taken for the analysis of genome-wide data. In this context we proposed a fast two-step method called Genome-wide Association using Mixed Model and Regression ( GRAMMAR) for the analysis of pedigree-based quantitative traits. This method certainly overcomes the drawback of time limitation of the measured genotype ( MG) approach, but pays in power. One of the major drawbacks of both MG and GRAMMAR, is that they crucially depend on the availability of complete and correct pedigree data, which is rarely available. Methodology. In this study we first explore type 1 error and relative power of MG, GRAMMAR, and Genomic Control ( GC) approaches for genetic association analysis. Secondly, we propose an extension to GRAMMAR i.e. GRAMMAR-GC. Finally, we propose application of GRAMMAR-GC using the kinship matrix estimated through genomic marker data, instead of ( possibly missing and/or incorrect) genealogy. Conclusion. Through simulations we show that MG approach maintains high power across a range of heritabilities and possible pedigree structures, and always outperforms other contemporary methods. We also show that the power of our proposed GRAMMAR-GC approaches to that of the 'gold standard' MG for all models and pedigrees studied. We show that this method is both feasible and powerful and has correct type 1 error in the context of genome-wide association analysis in related individuals.	[Amin, Najaf; van Duijn, Cornelia M.; Aulchenko, Yurii S.] Erasmus Univ Med Ctr MC Rotterdam, Dept Epidemiol & Biostat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Aulchenko, YS (corresponding author), Erasmus Univ Med Ctr MC Rotterdam, Dept Epidemiol & Biostat, Rotterdam, Netherlands.	i.aoultchenko@erasmusmc.nl	Aulchenko, Yurii/M-8270-2013; Amin, Najaf N/D-1859-2012	Aulchenko, Yurii/0000-0002-7899-1575; Van Duijn, Cornelia/0000-0002-2374-9204; Amin, Najaf/0000-0002-8944-1771	European Special Population Network [FP6]; Netherlands organization for scientific research (NWO); Russian Foundation for Basic Research (RFBR); Stichting MS; Higher Education Commission of Pakistan	European Special Population Network; Netherlands organization for scientific research (NWO)(Netherlands Organization for Scientific Research (NWO)); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Stichting MS; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	This work was supported by European Special Population Network grant (FP6) and a joint grant from Netherlands organization for scientific research (NWO) and Russian Foundation for Basic Research (RFBR). YSA was supported by a grant from "Stichting MS". NA received support from Higher Education Commission of Pakistan.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; Gilmour A. R., 2002, ASREML USER GUIDE RE; Havill LM, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S91; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Isaacs A, 2007, EUR J EPIDEMIOL, V22, P99, DOI 10.1007/s10654-006-9103-0; Lange C, 2002, AM J HUM GENET, V71, P1330, DOI 10.1086/344696; Lange K, 2005, GENET EPIDEMIOL, V29, P36, DOI 10.1002/gepi.20073; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Majumder PP, 2005, J CLIN INVEST, V115, P1419, DOI 10.1172/JCI24757; Pardo LM, 2005, ANN HUM GENET, V69, P288, DOI 10.1046/j.1529-8817.2005.00162.x; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SING CF, 1985, AM J HUM GENET, V37, P268; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Zollner S, 2005, GENETICS, V169, P1071, DOI 10.1534/genetics.104.031799	22	188	193	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1274	10.1371/journal.pone.0001274	http://dx.doi.org/10.1371/journal.pone.0001274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060068	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459400021
J	Caws, M; Ha, DTM; Torok, E; Campbell, J; Thu, DDA; Chau, TTH; Chau, NV; Chinh, NT; Farrar, J				Caws, Maxine; Dang Thi Minh Ha; Torok, Estee; Campbell, James; Do Dang Anh Thu; Tran Thi Hong Chau; Nguyen van Vinh Chau; Nguyen Tran Chinh; Farrar, Jeremy			Evaluation of the MODS Culture Technique for the Diagnosis of Tuberculous Meningitis	PLOS ONE			English	Article							DRUG-SUSCEPTIBILITY ASSAY; ADULTS	Background. Tuberculous meningitis (TBM) is a devastating condition. The rapid instigation of appropraite chemotherapy is vital to reduce morbidity and mortality. However rapid diagnosis remains elusive; smear microscopy has extremely low sensitivity on cerebrospinal fluid (CSF) in most laboratories and PCR requires expertise with advanced infrastructure and has sensitivity of only around 60% under optimal conditions. Neither technique allows for the microbiological isolation of M. tuberculosis and subsequent drug susceptibility testing. We evaluated the recently developed microscopic observation drug susceptibility (MODS) assay format for speed and accuracy in diagnosing TBM. Methodology/Principal Findings. Two hundred and thirty consecutive CSF samples collected from 156 patients clinically suspected of TBM on presentation at a tertiary referal hospital in Vietnam were enrolled into the study over a five month period and tested by Ziehl-Neelsen (ZN) smear, MODS, Mycobacterial growth Indicator tube (MGIT) and Lowenstein-Jensen (LJ) culture. Sixty-one samples were from patients already on TB therapy for >1day and 19 samples were excluded due to untraceable patient records. One hundred and fifty samples from 137 newly presenting patients remained. Forty-two percent (n = 57/137) of patients were deemed to have TBM by clinical diagnostic and microbiological criteria (excluding MODS). Sensitivity by patient against clinical gold standard for ZN smear, MODS MGIT and LJ were 52.6%, 64.9%, 70.2% and 70.2%, respectively. Specificity of all microbiological techniques was 100%. Positive and negative predictive values for MODS were 100% and 78.7%, respectively for HIV infected patients and 100% and 82.1% for HIV negative patients. The median time to positive was 6 days (interquartile range 5-7), significantly faster than MGIT at 15.5 days (interquartile range 12-24), and LJ at 24 days (interquartile range 18-35 days) (P<0.01). Conclusions. We have shown MODS to be a sensitive, rapid technique for the diagnosis of TBM with high sensitivity, ease of performance and low cost (0.53 USD/sample).	[Caws, Maxine; Dang Thi Minh Ha; Torok, Estee; Campbell, James; Do Dang Anh Thu; Farrar, Jeremy] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; [Dang Thi Minh Ha] Pham Ngoc Thach Hosp TB & Lung Dis, Ho Chi Minh City, Vietnam; [Caws, Maxine; Torok, Estee; Campbell, James; Farrar, Jeremy] Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LJ, England	University of Oxford; University of Oxford	Caws, M (corresponding author), Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam.	mcaws@hotmail.com	Farrar, Jeremy J./HGA-7610-2022	Caws, Maxine/0000-0002-9109-350X; Torok, Mili Estee/0000-0001-9098-8590; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust. The funding body had no role in the design, conduct, collection, analysis and interpretation of the data or the preparation, review or approval of the manuscript.	KENNEDY DH, 1979, JAMA-J AM MED ASSOC, V241, P264, DOI 10.1001/jama.241.3.264; MOORE DA, 2006, DIAGN MICROBIOL INFE; Moore DAJ, 2004, J CLIN MICROBIOL, V42, P4432, DOI 10.1128/JCM.42.10.4432-4437.2004; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Pai M, 2003, LANCET INFECT DIS, V3, P633, DOI 10.1016/S1473-3099(03)00772-2; Piersimoni C, 2006, J CLIN MICROBIOL, V44, P20, DOI 10.1128/JCM.44.1.20-28.2006; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2004, J CLIN MICROBIOL, V42, P996, DOI 10.1128/JCM.42.3.996-1002.2004; Thwaites GE, 2004, J CLIN MICROBIOL, V42, P378, DOI 10.1128/JCM.42.1.378-379.2004; Thwaites GE, 2005, J INFECT DIS, V192, P79, DOI 10.1086/430616; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3	11	42	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1173	10.1371/journal.pone.0001173	http://dx.doi.org/10.1371/journal.pone.0001173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000545	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459100015
J	Cox, HS; Kalon, S; Allamuratova, S; Sizaire, V; Tigay, ZN; Rusch-Gerdes, S; Karimovich, HA; Kebede, Y; Mills, C				Cox, Helen S.; Kalon, Stobdan; Allamuratova, Sholpan; Sizaire, Vinciane; Tigay, Zinaida N.; Ruesch-Gerdes, Sabine; Karimovich, Hamraev A.; Kebede, Yared; Mills, Clair			Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures	PLOS ONE			English	Article								Background. A pilot programme to treat multidrug-resistant TB (MDR-TB) was implemented in Karakalpakstan, Uzbekistan in 2003. This region has particularly high levels of MDR-TB, with 13% and 40% among new and previously treated cases, respectively. Methodology. This study describes the treatment process and outcomes for the first cohort of patients enrolled in the programme, between October 2003 and January 2005. Confirmed MDR-TB cases were treated with an individualised, second-line drug regimen based on drug susceptibility test results, while suspected MDR-TB cases were treated with a standardised regimen pending susceptibility results. Principal Findings. Of 108 MDR-TB patients, 87 were started on treatment during the study period. Of these, 33 (38%) were infected with strains resistant to at least one second-line drug at baseline, but none had initial ofloxacin resistance. Treatment was successful for 54 (62%) patients, with 13 (15%) dying during treatment, 12 (14%) defaulting and 8 (8%) failing treatment. Poor clinical condition and baseline second-line resistance contributed to treatment failure or death. Treatment regimens were changed in 71 (82%) patients due to severe adverse events or drug resistance. Adverse events were most commonly attributed to cycloserine, ethionamide and p-aminosalicylic acid. Extensively drug resistant TB (XDR-TB) was found among 4 of the 6 patients who failed treatment and were still alive in November 2006. Conclusions. While acceptable treatment success was achieved, the complexity of treatment and the development of XDR-TB among treatment failures are important issues to be addressed when considering scaling up MDR-TB treatment.	[Cox, Helen S.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia; [Kebede, Yared; Mills, Clair] Med Sans Frontieres, Amsterdam, Netherlands; [Sizaire, Vinciane] Med Sans Frontieres, London, England; [Kalon, Stobdan; Allamuratova, Sholpan] Med Sans Frontieres, Tashkent, Uzbekistan; [Tigay, Zinaida N.; Karimovich, Hamraev A.] Minist Hlth, Karakalpakstan, Uzbekistan; [Ruesch-Gerdes, Sabine] Natl Reference Ctr Mycobacteria, Forchungszentrum Borstel, Borstel, Germany	Burnet Institute; Doctors Without Borders; Doctors Without Borders	Cox, HS (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia.	hcox@burnet.edu.au		Cox, Helen/0000-0002-6538-7192	Medecins Sans Frontieres, Holland; Ministry of Health in Karakalpakstan; National Reference Center for Mycobacteria in Germany	Medecins Sans Frontieres, Holland; Ministry of Health in Karakalpakstan; National Reference Center for Mycobacteria in Germany	The MDR-TB program is funded primarily by Medecins Sans Frontieres, Holland, with contributions in kind from the Ministry of Health in Karakalpakstan and the National Reference Center for Mycobacteria in Germany. All the authors are connected to these three organisations, with the exception of the principal author who is currently employed elsewhere.	[Anonymous], 2006, M WHO GLOB TASK FORC; Ataniyazova O., 2001, Acta Paediatrica, V90, P589, DOI 10.1080/080352501750197791; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Cox HS, 2004, EMERG INFECT DIS, V10, P865, DOI 10.3201/eid1005.030718; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Kent PT, 1985, GUIDE LEVEL 3 LAB; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; Olle-Goig JE, 2005, INT J TUBERC LUNG D, V9, P765; Organization WH, 1997, WHOTB97229; Small I, 2001, LANCET, V358, P1649; World Health Organization, 2003, TREATM TUB GUID NAT	14	79	83	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1126	10.1371/journal.pone.0001126	http://dx.doi.org/10.1371/journal.pone.0001126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987113	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459000010
J	Pan, A; Sun, JQ; Chen, YQ; Ye, XW; Li, HX; Yu, ZJ; Wang, YF; Gu, WJ; Zhang, XY; Chen, XF; Demark-Wahnefried, W; Liu, Y; Lin, X				Pan, An; Sun, Jianqin; Chen, Yanqiu; Ye, Xingwang; Li, Huaixing; Yu, Zhijie; Wang, Yanfang; Gu, Wenjia; Zhang, Xinyi; Chen, Xiafei; Demark-Wahnefried, Wendy; Liu, Yong; Lin, Xu			Effects of a Flaxseed-Derived Lignan Supplement in Type 2 Diabetic Patients: A Randomized, Double-Blind, Cross-Over Trial	PLOS ONE			English	Article							SECOISOLARICIRESINOL DIGLUCOSIDE; LIQUID-CHROMATOGRAPHY; SOY PROTEIN; PLASMA; PHYTOESTROGENS; CHOLESTEROL; WOMEN; METAANALYSIS; ISOFLAVONES; CANCER	Background. Flaxseed consumption has been shown to improve blood lipids in humans and flaxseed-derived lignan has been shown to enhance glycemic control in animals. The study aimed to investigate the effect of a flaxseed-derived lignan supplement on glycemic control, lipid profiles and insulin sensitivity in type 2 diabetic patients. Methodology/Principal Findings. This was a randomized, double-blind, placebo-controlled, cross-over trial and it was conducted between April and December 2006 in Shanghai, China. Seventy-three type 2 diabetic patients with mild hypercholesterolemia were enrolled into the study. Patients were randomized to supplementation with flaxseed-derived lignan capsules (360 mg lignan per day) or placebo for 12 weeks, separated by an 8-week wash-out period. HbA1c, lipid profiles, insulin resistance index and inflammatory factors were measured. Sixty-eight completed the study and were included in the analyses. The lignan supplement significantly improved glycemic control as measured by HbA(1c) (-0.10 +/- 60.65 % vs. 0.09 +/- 0.52 %, P=0.001) compared to placebo; however, no significant changes were observed in fasting glucose and insulin concentrations, insulin resistance and blood lipid profiles. Urinary excretion of lignan metabolites (enterodiol and enterolactone) was significantly higher after the lignan supplement intervention compared to baseline (14.2 +/- 18.1 vs. 1.2 +/- 2.4 mu g/mL, P < 0.001). Data also suggested minimal competition between lignan and isoflavones for bioavailability when measured by the excretion concentrations. Conclusions/Significance. Daily lignan supplementation resulted in modest, yet statistically significant improvements in glycemic control in type 2 diabetic patients without apparently affecting fasting glucose, lipid profiles and insulin sensitivity. Further studies are needed to validate these findings and explore the efficacy of lignans on type 2 diabetes. Trial Registration. ClinicalTrials.gov NCT00363233	[Pan, An; Ye, Xingwang; Li, Huaixing; Yu, Zhijie; Wang, Yanfang; Gu, Wenjia; Liu, Yong; Lin, Xu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Pan, An; Ye, Xingwang; Li, Huaixing; Yu, Zhijie; Wang, Yanfang; Gu, Wenjia; Liu, Yong; Lin, Xu] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Sun, Jianqin; Chen, Yanqiu; Zhang, Xinyi; Chen, Xiafei] Fudan Univ, Huadong Hosp, Shanghai 200433, Peoples R China; [Demark-Wahnefried, Wendy] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Fudan University; University of Texas System; UTMD Anderson Cancer Center	Lin, X (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	xlin@sibs.ac.cn	Pan, An/C-5572-2011; Ye, Xingwang/D-5193-2011	Pan, An/0000-0002-1089-7945; 	Chinese Academy of Sciences [KSCX1-YX-02, 04DZ14007, KSCX2-2-25]; Ministry of Science and Technology of China; Frutarom Netherlands BV; Veenendaal; Netherlands and Jarrow Formulas Inc., Los Angeles; NATIONAL CANCER INSTITUTE [R01CA085740] Funding Source: NIH RePORTER	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Frutarom Netherlands BV; Veenendaal; Netherlands and Jarrow Formulas Inc., Los Angeles; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by grants KSCX1-YX-02, 04DZ14007, KSCX2-2-25 and 973 Program 2006CB503900 from the Major Project of Knowledge Innovation Program of the Chinese Academy of Sciences, the Science and Technology Commission of Shanghai Municipality, Knowledge Innovation Program of the Chinese Academy of Sciences, and the Ministry of Science and Technology of China, respectively. Study capsules were donated by Frutarom Netherlands BV, Veenendaal, the Netherlands and Jarrow Formulas Inc., Los Angeles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; ANDERSON JW, 1995, NEW ENGL J MED, V333, P276, DOI 10.1056/NEJM199508033330502; Arjmandi BH, 1998, NUTR RES, V18, P1203, DOI 10.1016/S0271-5317(98)00100-6; Bhathena SJ, 2002, AM J CLIN NUTR, V76, P1191, DOI 10.1093/ajcn/76.6.1191; Blake GJ, 2004, ARCH INTERN MED, V164, P757, DOI 10.1001/archinte.164.7.757; Bloedon LT, 2004, NUTR REV, V62, P18, DOI [10.1301/nr.2004.jan.18&ndash;27, 10.1111/j.1753-4887.2004.tb00002.x]; Brown L, 1999, AM J CLIN NUTR, V69, P30; CUNNANE SC, 1995, AM J CLIN NUTR, V61, P62, DOI 10.1093/ajcn/61.1.62; CUNNANE SC, 1993, BRIT J NUTR, V69, P443, DOI 10.1079/BJN19930046; Dai Q, 2002, CANCER EPIDEM BIOMAR, V11, P815; Demark-Wahnefried W, 2001, UROLOGY, V58, P47, DOI 10.1016/S0090-4295(01)01014-7; Duncan AM, 2003, BEST PRACT RES CL EN, V17, P253, DOI 10.1016/S1521-690X(02)00103-3; Gonzalez S, 2007, DIABETES CARE, V30, P1871, DOI 10.2337/dc06-1814; Haffner SM, 1998, DIABETES CARE, V21, P160, DOI 10.2337/diacare.21.1.160; Hallund J, 2006, J NUTR, V136, P112, DOI 10.1093/jn/136.1.112; Jayagopal V, 2002, DIABETES CARE, V25, P1709, DOI 10.2337/diacare.25.10.1709; Jenkins DJA, 1999, AM J CLIN NUTR, V69, P395; Johnsson P, 2000, J AGR FOOD CHEM, V48, P5216, DOI 10.1021/jf0005871; Kaur Jasjeet, 2002, Am J Ther, V9, P510, DOI 10.1097/00045391-200211000-00009; Kilpatrick ES, 2000, J CLIN PATHOL, V53, P335, DOI 10.1136/jcp.53.5.335; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kurzer MS, 1997, ANNU REV NUTR, V17, P353, DOI 10.1146/annurev.nutr.17.1.353; Lemay A, 2002, OBSTET GYNECOL, V100, P495, DOI 10.1016/S0029-7844(02)02123-3; Lucas EA, 2002, J CLIN ENDOCR METAB, V87, P1527, DOI 10.1210/jc.87.4.1527; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nurmi T, 2003, J CHROMATOGR B, V798, P101, DOI 10.1016/j.jchromb.2003.09.018; Prasad K, 2000, MOL CELL BIOCHEM, V209, P89, DOI 10.1023/A:1007079802459; Prasad K, 1999, CIRCULATION, V99, P1355, DOI 10.1161/01.CIR.99.10.1355; Prasad K, 2005, ATHEROSCLEROSIS, V179, P269, DOI 10.1016/j.atherosclerosis.2004.11.012; Prasad K, 2001, J LAB CLIN MED, V138, P32, DOI 10.1067/mlc.2001.115717; Prasad K., 2002, INT J ANGIOL, V11, P107, DOI [10.1007/BF01616377, DOI 10.1007/BF01616377]; Thomas BF, 2001, J CHROMATOGR B, V760, P191, DOI 10.1016/S0378-4347(01)00269-9; Uehara M, 2000, BIOFACTORS, V12, P217, DOI 10.1002/biof.5520120134; Zhan SY, 2005, AM J CLIN NUTR, V81, P397	34	111	118	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1148	10.1371/journal.pone.0001148	http://dx.doi.org/10.1371/journal.pone.0001148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987126	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459000031
J	Ding, K; McDonough, SJ; Kullo, IJ				Ding, Keyue; McDonough, Samantha J.; Kullo, Iftikhar J.			Evidence for Positive Selection in the C-terminal Domain of the Cholesterol Metabolism Gene PCSK9 Based on Phylogenetic Analysis in 14 Primate Species	PLOS ONE			English	Article								Background. Cholesterol homeostasis is maintained through finely tuned mechanisms regulating intestinal absorption, hepatic biosynthesis and secretion as well as plasma clearance. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secreted enzyme of the serine protease family that reduces cellular uptake of plasma low-density lipoprotein (LDL) cholesterol by promoting LDL receptor (LDL-R) degradation. Species-specific positive selection has been noted in the LDLR promoter, leading to differential expression of LDLR among primates. Whether PCSK9 experienced significant selective pressure to maintain a functional relationship with its target protein, LDL-R, is unknown. Methodology/Principal Findings. We compiled the sequences of the coding regions of PCSK9 from 14 primate species in the clade of Hominoids, Old World monkeys and New World monkeys. To detect selective pressure at the protein level, the ratios of nonsynonymous/synonymous substitution rate (d(N)/d(S)) under different evolutionary models were calculated across the phylogeny of PCSK9. Maximum likelihood analyses of d(N)/d(S) ratios for the aligned coding region sequences among 14 primate species indicated that PCSK9 was subject to a strong functional constraint (i.e., purifying selection). However, positive selection was noted in the functional carboxyl-terminal (C-terminal) domain in many branches across the phylogeny, especially in the lineage leading to the orangutan. Furthermore, at least five positively selected amino acids were detected in this lineage using the branch-site model A. In a sliding-window analysis, several d(N)/d(S) peaks in the C-terminal domain in both the human and the orangutan branches were noted. Conclusions. These results suggest that among primates, differential selective pressure has shaped evolutionary patterns in the functional domains of PCSK9, an important regulator of cholesterol homeostasis.	[Ding, Keyue; McDonough, Samantha J.; Kullo, Iftikhar J.] Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Kullo, IJ (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA.	kullo.iftikhar@mayo.edu		Ding, Keyue/0000-0002-3496-6415	Mayo Foundation; NIH [HL75794]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075794] Funding Source: NIH RePORTER	Mayo Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This work was supported by funds from the Mayo Foundation and NIH grant HL75794.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Attie AD, 2005, CELL METAB, V1, P290, DOI 10.1016/j.cmet.2005.04.006; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Bingham B, 2006, CYTOM PART A, V69A, P1123, DOI 10.1002/cyto.a.20346; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Choi SS, 2003, GENOME RES, V13, P2252, DOI 10.1101/gr.1431603; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Crissey SD, 1999, ZOO BIOL, V18, P551, DOI 10.1002/(SICI)1098-2361(1999)18:6&lt;551::AID-ZOO9&gt;3.0.CO;2-S; Ding K, 2006, GENET EPIDEMIOL, V30, P557, DOI 10.1002/gepi.20169; Elagoz A, 2002, J BIOL CHEM, V277, P11265, DOI 10.1074/jbc.M109011200; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Fleagle JG, 1999, P NATL ACAD SCI USA, V96, P1157, DOI 10.1073/pnas.96.3.1157; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Hahn MW, 2004, GENETICS, V167, P867, DOI 10.1534/genetics.103.025726; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Huttley GA, 2000, NAT GENET, V25, P410, DOI 10.1038/78092; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kullo IJ, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-48; Lalanne F, 2005, J LIPID RES, V46, P1312, DOI 10.1194/jlr.M400396-JLR200; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Lynn DJ, 2005, GENETICS, V170, P1189, DOI 10.1534/genetics.104.039040; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; MBIKAY M, 2007, MED HYPOTHESES; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; Nakajima T, 2004, AM J HUM GENET, V74, P898, DOI 10.1086/420793; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Nei M., 2000, MOL EVOLUTION PHYLOG; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nielsen R, 1998, GENETICS, V148, P929; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Perry GH, 2007, MOL BIOL EVOL, V24, P853, DOI 10.1093/molbev/msm002; Poirier S, 2006, J NEUROCHEM, V98, P838, DOI 10.1111/j.1471-4159.2006.03928.x; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Rockman MV, 2004, CURR BIOL, V14, P1531, DOI 10.1016/j.cub.2004.08.051; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schaner P, 2001, NAT GENET, V27, P318, DOI 10.1038/85893; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2006, BIOL CHEM, V387, P871, DOI 10.1515/BC.2006.110; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shioji K, 2004, J HUM GENET, V49, P109, DOI 10.1007/s10038-003-0114-3; Sun XM, 2005, HUM MOL GENET, V14, P1161, DOI 10.1093/hmg/ddi128; Tall AR, 2006, NEW ENGL J MED, V354, P1310, DOI 10.1056/NEJMe068026; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; Yue P, 2006, HUM MUTAT, V27, P460, DOI 10.1002/humu.20316; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	73	20	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1098	10.1371/journal.pone.0001098	http://dx.doi.org/10.1371/journal.pone.0001098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971861	Green Published, Green Submitted, gold			2022-12-27	WOS:000207458700015
J	Jalili, M; Lavoie, S; Deppen, P; Meuli, R; Do, KQ; Cuenod, M; Hasler, M; De Feo, O; Knyazeva, MG				Jalili, Mahdi; Lavoie, Suzie; Deppen, Patricia; Meuli, Reto; Do, Kim Q.; Cuenod, Michel; Hasler, Martin; De Feo, Oscar; Knyazeva, Maria G.			Dysconnection Topography in Schizophrenia Revealed with State-Space Analysis of EEG	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; HUMAN CEREBRAL-CORTEX; MAGNETIC-RESONANCE; TEMPORAL-LOBE; NEGATIVE SYMPTOMS; PLANUM TEMPORALE; BRAIN-DAMAGE; AUDITORY HALLUCINATIONS; PSYCHIATRIC-DISORDERS; ONSET SCHIZOPHRENIA	Background. The dysconnection hypothesis has been proposed to account for pathophysiological mechanisms underlying schizophrenia. Widespread structural changes suggesting abnormal connectivity in schizophrenia have been imaged. A functional counterpart of the structural maps would be the EEG synchronization maps. However, due to the limits of currently used bivariate methods, functional correlates of dysconnection are limited to the isolated measurements of synchronization between preselected pairs of EEG signals. Methods/Results. To reveal a whole-head synchronization topography in schizophrenia, we applied a new method of multivariate synchronization analysis called S-estimator to the resting dense-array ( 128 channels) EEG obtained from 14 patients and 14 controls. This method determines synchronization from the embedding dimension in a state-space domain based on the theoretical consequence of the cooperative behavior of simultaneous time series-the shrinking of the state-space embedding dimension. The S-estimator imaging revealed a specific synchronization landscape in schizophrenia patients. Its main features included bilaterally increased synchronization over temporal brain regions and decreased synchronization over the postcentral/parietal region neighboring the midline. The synchronization topography was stable over the course of several months and correlated with the severity of schizophrenia symptoms. In particular, direct correlations linked positive, negative, and general psychopathological symptoms to the hyper-synchronized temporal clusters over both hemispheres. Along with these correlations, general psychopathological symptoms inversely correlated within the hypo-synchronized postcentral midline region. While being similar to the structural maps of cortical changes in schizophrenia, the S-maps go beyond the topography limits, demonstrating a novel aspect of the abnormalities of functional cooperation: namely, regionally reduced or enhanced connectivity. Conclusion/Significance. The new method of multivariate synchronization significantly boosts the potential of EEG as an imaging technique compatible with other imaging modalities. Its application to schizophrenia research shows that schizophrenia can be explained within the concept of neural dysconnection across and within large-scale brain networks.	[Meuli, Reto; Knyazeva, Maria G.] CHU Vaudois, Dept Radiol, Lausanne, Switzerland; [Lavoie, Suzie; Deppen, Patricia; Meuli, Reto; Do, Kim Q.; Cuenod, Michel; Knyazeva, Maria G.] Univ Lausanne, Lausanne, Switzerland; [Jalili, Mahdi; Hasler, Martin] Ecole Polytech Fed Lausanne, IC Sch Comp & Commun Sci, Lab Nonlinear Syst ICLANOS, CH-1015 Lausanne, Switzerland; [Lavoie, Suzie; Deppen, Patricia; Do, Kim Q.; Cuenod, Michel] CHU Vaudois, Ctr Psychiat Neurosci, Dept Psychiat, Lausanne, Switzerland; [De Feo, Oscar] Natl Univ Ireland Univ Coll Cork, Cork, Ireland; [Knyazeva, Maria G.] CHU Vaudois, Dept Neurol, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University College Cork; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Knyazeva, MG (corresponding author), CHU Vaudois, Dept Radiol, Lausanne, Switzerland.	Maria.Knyazeva@chuv.ch	Do, Kim Q./G-6694-2016	Do, Kim Q./0000-0003-1968-1646	Interdisciplinary FBM-UNIL	Interdisciplinary FBM-UNIL	This work was supported by the Interdisciplinary FBM-UNIL grant to MG Knyazeva.	Allefeld C, 2004, INT J BIFURCAT CHAOS, V14, P417, DOI 10.1142/S0218127404009521; Anderson JE, 2002, SCHIZOPHR RES, V58, P123, DOI 10.1016/S0920-9964(01)00372-3; Andreasen NC, 1995, EUR NEUROPSYCHOPHARM, V5, P37, DOI 10.1016/0924-977X(95)00028-N; BARTA PE, 1990, AM J PSYCHIAT, V147, P1457; Bartzokis G, 2005, AM J PSYCHIAT, V162, P1229, DOI 10.1176/appi.ajp.162.6.1229-a; Beasley CL, 2005, SCHIZOPHR RES, V73, P69, DOI 10.1016/j.schres.2004.08.011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop C. M, 2006, PATTERN RECOGNITION; Bleuler E., 1911, DEMENTIA PRAECOX GRO; Boccaletti S, 2002, PHYS REP, V366, P1, DOI 10.1016/S0370-1573(02)00137-0; BROOMHEAD DS, 1986, PHYSICA D, V20, P217, DOI 10.1016/0167-2789(86)90031-X; Carmeli C, 2005, NEUROIMAGE, V25, P339, DOI 10.1016/j.neuroimage.2004.11.049; CARMELI C, 2006, ASSESSING COOEPRATIV; CARMELI C, 2006, ASSESSING DEPENDENCE; Celka P, 2006, PHYSIOL MEAS, V27, P737, DOI 10.1088/0967-3334/27/8/008; Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386; CUTTING J, 1992, BRIT J PSYCHIAT, V160, P583, DOI 10.1192/bjp.160.5.583; DeLisi LE, 1998, PSYCHIAT RES-NEUROIM, V84, P75, DOI 10.1016/S0925-4927(98)00047-X; DeLisi Lynn E, 2006, Dialogues Clin Neurosci, V8, P71; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; FLAUM M, 1995, AM J PSYCHIAT, V152, P704; FLORHENRY P, 1984, BIOL PSYCHOL, V19, P257, DOI 10.1016/0301-0511(84)90042-5; Ford JM, 2002, BIOL PSYCHIAT, V51, P485, DOI 10.1016/S0006-3223(01)01335-X; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Gallagher S, 2004, PSYCHOPATHOLOGY, V37, P8, DOI 10.1159/000077014; Gaser C, 1999, NEUROIMAGE, V10, P107, DOI 10.1006/nimg.1999.0458; Gibbons J.D., 2003, NONPARAMETRIC STAT I; Giuliani NR, 2005, SCHIZOPHR RES, V74, P135, DOI 10.1016/j.schres.2004.08.019; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldstein JM, 1999, ARCH GEN PSYCHIAT, V56, P537, DOI 10.1001/archpsyc.56.6.537; Greenstein D, 2006, J CHILD PSYCHOL PSYC, V47, P1003, DOI 10.1111/j.1469-7610.2006.01658.x; Guevara R, 2005, NEUROINFORMATICS, V3, P301, DOI 10.1385/NI:3:4:301; Gur RE, 2000, ARCH GEN PSYCHIAT, V57, P769, DOI 10.1001/archpsyc.57.8.769; HAGLUND MM, 1992, NATURE, V358, P668, DOI 10.1038/358668a0; Heilman KM, 1998, J CLIN NEUROPHYSIOL, V15, P409, DOI 10.1097/00004691-199809000-00005; Higashima M, 2006, CLIN EEG NEUROSCI, V37, P10, DOI 10.1177/155005940603700104; Hoffman R E, 1991, J Neuropsychiatry Clin Neurosci, V3, P169; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Honey GD, 2002, SCHIZOPHR RES, V53, P45, DOI 10.1016/S0920-9964(01)00154-2; Hubl D, 2004, ARCH GEN PSYCHIAT, V61, P658, DOI 10.1001/archpsyc.61.7.658; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Innocenti GM, 2003, MOL PSYCHIATR, V8, P261, DOI 10.1038/sj.mp.4001205; Kantz H., 2004, NONLINEAR TIME SERIE; Kasai K, 2003, ARCH GEN PSYCHIAT, V60, P766, DOI 10.1001/archpsyc.60.8.766; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Klemm E, 1996, PSYCHIAT RES-NEUROIM, V68, P1, DOI 10.1016/S0925-4927(96)02837-5; Knyazeva MG, 2006, NEUROIMAGE, V29, P593, DOI 10.1016/j.neuroimage.2005.07.045; Knyazeva MG, 1999, J NEUROPHYSIOL, V82, P3095, DOI 10.1152/jn.1999.82.6.3095; Koeda T, 1995, ELECTROEN CLIN NEURO, V95, P397, DOI 10.1016/0013-4694(95)00171-9; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Kucharska-Pietura K, 2006, PROG BRAIN RES, V156, P467, DOI 10.1016/S0079-6123(06)56026-1; KYLE NL, 1988, PSYCHIAT CLIN N AM, V11, P367; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Mann K, 1997, BIOL PSYCHIAT, V42, P655, DOI 10.1016/S0006-3223(96)00497-0; McCarley RW, 1999, BIOL PSYCHIAT, V45, P1099, DOI 10.1016/S0006-3223(99)00018-9; Merrin EL, 1996, SCHIZOPHR RES, V19, P151, DOI 10.1016/0920-9964(96)88522-7; MERRIN EL, 1989, BIOL PSYCHIAT, V25, P60, DOI 10.1016/0006-3223(89)90147-9; Mitchell RLC, 2005, BRAIN, V128, P963, DOI 10.1093/brain/awh466; NAGASE Y, 1992, BIOL PSYCHIAT, V32, P1028, DOI 10.1016/0006-3223(92)90064-7; Nestor PG, 2007, SCHIZOPHR RES, V91, P103, DOI 10.1016/j.schres.2006.11.025; Norman RMG, 1997, BRIT J PSYCHIAT, V170, P411, DOI 10.1192/bjp.170.5.411; Nunez PL, 2001, HUM BRAIN MAPP, V13, P125, DOI 10.1002/hbm.1030; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; OSHIMA K, 2006, STATE CHANGE DETECTI; PAKKENBERG B, 1987, BRIT J PSYCHIAT, V151, P744, DOI 10.1192/bjp.151.6.744; Pell MD, 2006, PROG BRAIN RES, V156, P303, DOI 10.1016/S0079-6123(06)56017-0; Pikovsky A., 2003, SYNCHRONIZATION UNIV; Pinkofsky HB, 1997, CLIN ELECTROENCEPHAL, V28, P155, DOI 10.1177/155005949702800307; Potkin SG, 2002, AM J PSYCHIAT, V159, P227, DOI 10.1176/appi.ajp.159.2.227; Quiroga RQ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041903; Rapoport JL, 1999, ARCH GEN PSYCHIAT, V56, P649, DOI 10.1001/archpsyc.56.7.649; ROBERTS GW, 1990, BIOL PSYCHIAT, V28, P127, DOI 10.1016/0006-3223(90)90630-K; Ross ED, 2001, J NEUROL NEUROSUR PS, V70, P597, DOI 10.1136/jnnp.70.5.597; SCOTT TF, 1993, J NEUROPSYCH CLIN N, V5, P287; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; SELEMON LD, 1995, ARCH GEN PSYCHIAT, V52, P805; SHAW JC, 1983, PSYCHOL MED, V13, P299, DOI 10.1017/S0033291700050911; SHENTON ME, 1992, NEW ENGL J MED, V327, P604, DOI 10.1056/NEJM199208273270905; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Spencer KM, 2003, J NEUROSCI, V23, P7407; Srinivasan R, 2006, PROG BRAIN RES, V159, P29, DOI 10.1016/S0079-6123(06)59003-X; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Strang G., 2003, INTRO LINEAR ALGEBRA, DOI 10.4324/9780203788219; Suzuki M, 2002, SCHIZOPHR RES, V55, P41, DOI 10.1016/S0920-9964(01)00224-9; Takahashi T, 2007, PSYCHIAT RES-NEUROIM, V154, P209, DOI 10.1016/j.pscychresns.2006.10.001; Tauscher J, 1998, BIOL PSYCHIAT, V44, P438, DOI 10.1016/S0006-3223(97)00428-9; Thompson PM, 2001, P NATL ACAD SCI USA, V98, P11650, DOI 10.1073/pnas.201243998; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; Uranova NA, 2007, INT J NEUROPSYCHOPH, V10, P537, DOI 10.1017/S1461145707007626; Vidal CN, 2006, ARCH GEN PSYCHIAT, V63, P25, DOI 10.1001/archpsyc.63.1.25; Wada Y, 1998, CLIN ELECTROENCEPHAL, V29, P170, DOI 10.1177/155005949802900408; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wiesenfeldt M, 2001, INT J BIFURCAT CHAOS, V11, P2217, DOI 10.1142/S0218127401003231; Winterer G, 2001, SCHIZOPHR RES, V49, P129, DOI 10.1016/S0920-9964(00)00128-6; Woods BT, 1998, AM J PSYCHIAT, V155, P1661, DOI 10.1176/ajp.155.12.1661; Yeragani VK, 2006, PSYCHIAT RES, V141, P53, DOI 10.1016/j.psychres.2005.07.016; Zhou SY, 2007, SCHIZOPHR RES, V89, P35, DOI 10.1016/j.schres.2006.08.032	101	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1059	10.1371/journal.pone.0001059	http://dx.doi.org/10.1371/journal.pone.0001059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957243	Green Published, gold			2022-12-27	WOS:000207458500006
J	Compagno, D; Merle, C; Morin, A; Gilbert, C; Mathieu, JRR; Bozec, A; Mauduit, C; Benahmed, M; Cabon, F				Compagno, Daniel; Merle, Carole; Morin, Aurelie; Gilbert, Cristele; Mathieu, Jacques R. R.; Bozec, Aline; Mauduit, Claire; Benahmed, Mohammed; Cabon, Florence			SIRNA-Directed In Vivo Silencing of Androgen Receptor Inhibits the Growth of Castration-Resistant Prostate Carcinomas	PLOS ONE			English	Article							CANCER CELLS; GENE-EXPRESSION; PANCREATIC ADENOCARCINOMA; ANGIOGENESIS INHIBITOR; INTERFERING RNA; SERTOLI-CELLS; LNCAP MODEL; ACTIVATION; THROMBOSPONDIN-1; TESTOSTERONE	Background. Prostate carcinomas are initially dependent on androgens, and castration or androgen antagonists inhibit their growth. After some time though, tumors become resistant and recur with a poor prognosis. The majority of resistant tumors still expresses a functional androgen receptor (AR), frequently amplified or mutated. Methodology/Principal Findings. To test the hypothesis that AR is not only expressed, but is still a key therapeutic target in advanced carcinomas, we injected siRNA targeting AR into mice bearing exponentially growing castration-resistant tumors. Quantification of siRNA into tumors and mouse tissues demonstrated their efficient uptake. This uptake silenced AR in the prostate, testes and tumors. AR silencing in tumors strongly inhibited their growth, and importantly, also markedly repressed the VEGF production and angiogenesis. Conclusions/Significance. Our results demonstrate that carcinomas resistant to hormonal manipulations still depend on the expression of the androgen receptor for their development in vivo. The siRNA-directed silencing of AR, which allows targeting overexpressed as well as mutated isoforms, triggers a strong antitumoral and antiangiogenic effect. siRNA-directed silencing of this key gene in advanced and resistant prostate tumors opens promising new therapeutic perspectives and tools.	[Compagno, Daniel; Merle, Carole; Morin, Aurelie; Gilbert, Cristele; Mathieu, Jacques R. R.; Cabon, Florence] Univ Paris Sud, CNRS, FRE2944, Inst Andre Lwoff, Villejuif, France; [Bozec, Aline; Mauduit, Claire; Benahmed, Mohammed] INSERM, U406, F-69008 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm)	Cabon, F (corresponding author), Univ Paris Sud, CNRS, FRE2944, Inst Andre Lwoff, Villejuif, France.	fcabon@vjf.cnrs.fr		Compagno, Daniel/0000-0002-7589-7217	Fondation de l'Avenir; Association pour la Recherche sur les Tumeurs de la Prostate; Association pour la Recherche sur le Cancer; MJENR [03L270]	Fondation de l'Avenir; Association pour la Recherche sur les Tumeurs de la Prostate; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); MJENR	Funding: This work was supported by grants to FC from Fondation de l'Avenir, Association pour la Recherche sur les Tumeurs de la Prostate, Association pour la Recherche sur le Cancer and a grant 03L270 from the MJENR.	Bakin RE, 2003, CANCER RES, V63, P1975; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; BELTINGER C, 1995, J CLIN INVEST, V95, P1814, DOI 10.1172/JCI117860; Benbrahim-Tallaa L, 2002, BIOL REPROD, V66, P1734, DOI 10.1095/biolreprod66.6.1734; Braasch DA, 2004, BIOORG MED CHEM LETT, V14, P1139, DOI 10.1016/j.bmcl.2003.12.074; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Cheng H, 2006, CANCER RES, V66, P10613, DOI 10.1158/0008-5472.CAN-06-0028; Colombel M, 2005, CANCER RES, V65, P300; Culig Z, 2005, ENDOCR-RELAT CANCER, V12, P229, DOI 10.1677/erc.1.00775a; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; DEHM SM, 2006, J BIOL CHEM; Doll JA, 2001, PROSTATE, V49, P293, DOI 10.1002/pros.10025; Duxbury MS, 2005, BIOCHEM BIOPH RES CO, V331, P459, DOI 10.1016/j.bbrc.2005.03.199; Duxbury MS, 2004, BRIT J CANCER, V91, P1384, DOI 10.1038/sj.bjc.6602113; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Filleur S, 2003, CANCER RES, V63, P3919; Florin A, 2005, ENDOCRINOLOGY, V146, P1532, DOI 10.1210/en.2004-0834; Furutani T, 2005, BIOSCI BIOTECH BIOCH, V69, P2236, DOI 10.1271/bbb.69.2236; Ghosh PM, 2005, ENDOCR-RELAT CANCER, V12, P119, DOI 10.1677/erc.1.00835; Gonzalez-Herrera IG, 2006, FASEB J, V20, P476, DOI 10.1096/fj.04-3314fje; Gregory CW, 2001, CANCER RES, V61, P2892; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Heidel JD, 2004, NAT BIOTECHNOL, V22, P1579, DOI 10.1038/nbt1038; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Liao XB, 2005, MOL CANCER THER, V4, P505, DOI 10.1158/1535-7163.MCT-04-0313; Mabjeesh NJ, 2003, CLIN CANCER RES, V9, P2416; Marques JT, 2005, NAT BIOTECHNOL, V23, P1399, DOI 10.1038/nbt1161; Mendoza N, 2002, CANCER RES, V62, P5485; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Mostaghel EA, 2007, CANCER RES, V67, P5033, DOI 10.1158/0008-5472.CAN-06-3332; Nakayama T, 2000, LAB INVEST, V80, P1789, DOI 10.1038/labinvest.3780190; Nupponen NN, 2004, GENE CHROMOSOME CANC, V39, P119, DOI 10.1002/gcc.10308; O'Dwyer PJ, 1999, CLIN CANCER RES, V5, P3977; Ocker M, 2005, GUT, V54, P1298, DOI 10.1136/gut.2004.056192; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Sirotnak FM, 2004, MOL CARCINOGEN, V41, P150, DOI 10.1002/mc.20051; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stewart RJ, 2001, J UROLOGY, V165, P688, DOI 10.1097/00005392-200102000-00095; THALMANN GN, 1994, CANCER RES, V54, P2577; Wegiel B, 2005, ONCOGENE, V24, P6385, DOI 10.1038/sj.onc.1208795; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303	53	50	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1006	10.1371/journal.pone.0001006	http://dx.doi.org/10.1371/journal.pone.0001006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925854	Green Submitted, Green Published, gold			2022-12-27	WOS:000207456000005
J	Lim, JH; Jono, H; Koga, T; Woo, CH; Ishinaga, H; Bourne, P; Xu, HD; Ha, UH; Xu, HD; Li, JD				Lim, Jae Hyang; Jono, Hirofumi; Koga, Tomoaki; Woo, Chang-Hoon; Ishinaga, Hajime; Bourne, Patricia; Xu, Haodong; Ha, Un-Hwan; Xu, Haidong; Li, Jian-Dong			Tumor Suppressor CYLD Acts as a Negative Regulator for Non-Typeable Haemophilus influenza-Induced Inflammation in the Middle Ear and Lung of Mice	PLOS ONE			English	Article								Non-typeable Haemophilus influenza (NTHi) is an important human pathogen causing respiratory tract infections in both adults and children. NTHi infections are characterized by inflammation, which is mainly mediated by nuclear transcription factor kappaB (NF-kappa B)-dependent production of inflammatory mediators. The deubiquitinating enzyme cylindromatosis (CYLD), loss of which was originally reported to cause a benign human syndrome called cylindromatosis, has been identified as a key negative regulator for NF-kappa B in vitro. However, little is known about the role of CYLD in bacteria-induced inflammation in vivo. Here, we provided direct evidence for the negative role of CYLD in NTHi-induced inflammation of the mice in vivo. Our data demonstrated that CYLD is induced by NTHi in the middle ear and lung of mice. NTHi-induced CYLD, in turn, negatively regulates NTHi-induced NF-kappa B activation through deubiquitinating TRAF6 and 7 and down-regulates inflammation. Our data thus indicate that CYLD acts as a negative regulator for NF-kappa B-dependent inflammation in vivo, hence protecting the host against detrimental inflammatory response to NTHi infection.	[Lim, Jae Hyang; Jono, Hirofumi; Koga, Tomoaki; Ishinaga, Hajime; Ha, Un-Hwan; Xu, Haidong; Li, Jian-Dong] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Woo, Chang-Hoon] Univ Rochester, Med Ctr, Cardiovasc Res Inst, Rochester, NY 14642 USA; [Bourne, Patricia; Xu, Haodong] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Li, JD (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	Jian-Dong_Li@urmc.rochester.edu	Ha, Un-Hwan/ABH-8017-2020; xu, hao/GWQ-7394-2022	Lim, Jae Hyang/0000-0003-0972-9271; Li, Jian-Dong/0000-0002-5593-050X; Ha, Un-Hwan/0000-0001-9182-7000	National Institute of Health [DC004562, DC005843]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004562, R01DC005843] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from National Institute of Health DC004562 and DC005843 to J. D. Li.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998; Fukushima T, 2007, P NATL ACAD SCI USA, V104, P6371, DOI 10.1073/pnas.0700548104; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gutierrez PP, 2002, J INVEST DERMATOL, V119, P527, DOI 10.1046/j.1523-1747.2002.01839.x; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Kim S, 2005, AM J PHYSIOL-LUNG C, V289, pL1049, DOI 10.1152/ajplung.00388.2004; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100; Kweon SM, 2006, BIOCHEM BIOPH RES CO, V351, P368, DOI 10.1016/j.bbrc.2006.10.052; Leonard N, 2001, J CLIN PATHOL, V54, P689, DOI 10.1136/jcp.54.9.689; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Murphy T F, 2000, Semin Respir Infect, V15, P41; Murphy TF, 2006, CURR OPIN INFECT DIS, V19, P225, DOI 10.1097/01.qco.0000224815.89363.15; Rao VK, 1999, FEMS MICROBIOL REV, V23, P99, DOI 10.1016/S0168-6445(98)00039-4; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Sakai A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-2; Sethi S, 2000, NEW ENGL J MED, V343, P1969; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Watanabe T, 2004, P NATL ACAD SCI USA, V101, P3563, DOI 10.1073/pnas.0400557101; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746	40	72	76	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1032	10.1371/journal.pone.0001032	http://dx.doi.org/10.1371/journal.pone.0001032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925880	gold, Green Submitted, Green Published			2022-12-27	WOS:000207456000031
J	Gabanella, F; Butchbach, MER; Saieva, L; Carissimi, C; Burghes, AHM; Pellizzoni, L				Gabanella, Francesca; Butchbach, Matthew E. R.; Saieva, Luciano; Carissimi, Claudia; Burghes, Arthur H. M.; Pellizzoni, Livio			Ribonucleoprotein Assembly Defects Correlate with Spinal Muscular Atrophy Severity and Preferentially Affect a Subset of Spliceosomal snRNPs	PLOS ONE			English	Article								Spinal muscular atrophy (SMA) is a motor neuron disease caused by reduced levels of the survival motor neuron (SMN) protein. SMN together with Gemins2-8 and unrip proteins form a macromolecular complex that functions in the assembly of small nuclear ribonucleoproteins (snRNPs) of both the major and the minor splicing pathways. It is not known whether the levels of spliceosomal snRNPs are decreased in SMA. Here we analyzed the consequence of SMN deficiency on snRNP metabolism in the spinal cord of mouse models of SMA with differing phenotypic severities. We demonstrate that the expression of a subset of Gemin proteins and snRNP assembly activity are dramatically reduced in the spinal cord of severe SMA mice. Comparative analysis of different tissues highlights a similar decrease in SMN levels and a strong impairment of snRNP assembly in tissues of severe SMA mice, although the defect appears smaller in kidney than in neural tissue. We further show that the extent of reduction in both Gemin proteins expression and snRNP assembly activity in the spinal cord of SMA mice correlates with disease severity. Remarkably, defective SMN complex function in snRNP assembly causes a significant decrease in the levels of a subset of snRNPs and preferentially affects the accumulation of U11 snRNP-a component of the minor spliceosome-in tissues of severe SMA mice. Thus, impairment of a ubiquitous function of SMN changes the snRNP profile of SMA tissues by unevenly altering the normal proportion of endogenous snRNPs. These findings are consistent with the hypothesis that SMN deficiency affects the splicing machinery and in particular the minor splicing pathway of a rare class of introns in SMA.	[Gabanella, Francesca; Saieva, Luciano; Carissimi, Claudia; Pellizzoni, Livio] Dulbecco Telethon Inst, Inst Cell Biol, Rome, Italy; [Butchbach, Matthew E. R.; Burghes, Arthur H. M.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Saieva, Luciano; Pellizzoni, Livio] Columbia Univ, Med Ctr, Dept Pathol, Ctr Motor Neuron Biol & Dis, New York, NY USA	Fondazione Telethon; Dulbecco Telethon Institute (DTI); University System of Ohio; Ohio State University; Columbia University	Pellizzoni, L (corresponding author), Dulbecco Telethon Inst, Inst Cell Biol, Rome, Italy.	lp2284@columbia.edu	carissimi, claudia/AAU-7414-2021; Gabanella, Francesca/AAY-3290-2020	carissimi, claudia/0000-0002-9885-2855; Butchbach, Matthew/0000-0003-2912-6400; Gabanella, Francesca/0000-0001-5536-5160; Burghes, Arthur/0000-0001-9031-1555; Pellizzoni, Livio/0000-0002-9168-5628	Telethon-Italy [TCP 02011]; "Compagnia di San Paolo"; Muscular Dystrophy Association-USA; NINDS [NS038650]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038650] Funding Source: NIH RePORTER	Telethon-Italy(Fondazione Telethon); "Compagnia di San Paolo"(Compagnia di San Paolo); Muscular Dystrophy Association-USA(Muscular Dystrophy Association); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funds from Telethon-Italy (TCP 02011), "Compagnia di San Paolo" and the Muscular Dystrophy Association-USA to LP, Families of SMA to MERB, and NINDS (NS038650) to AHMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Butchbach M.E.R., 2004, DRUG DISCOV TODAY DI, V1, P151, DOI [10.1016/j.ddmod.2004.07.001, DOI 10.1016/j.ddmod.2004.07.001, DOI 10.1016/J.DDMOD.2004.07.001]; Butchbach MER, 2007, J NEUROSCI METH, V161, P285, DOI 10.1016/j.jneumeth.2006.11.002; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Carissimi C, 2006, J BIOL CHEM, V281, P37009, DOI 10.1074/jbc.M607505200; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Flink MT, 2003, J BIOENERG BIOMEMBR, V35, P697, DOI 10.1023/B:JOBB.0000008033.02320.10; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Frugier T, 2002, CURR OPIN GENET DEV, V12, P294, DOI 10.1016/S0959-437X(02)00301-5; Frugier T, 2000, HUM MOL GENET, V9, P849, DOI 10.1093/hmg/9.5.849; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Helmken C, 2003, HUM GENET, V114, P11, DOI 10.1007/s00439-003-1025-2; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kuyumcu-Martinez NM, 2006, PROG MOLEC, V44, P133; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Levine A, 2001, NUCLEIC ACIDS RES, V29, P4006, DOI 10.1093/nar/29.19.4006; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Lueck JD, 2007, AM J PHYSIOL-CELL PH, V292, pC1291, DOI 10.1152/ajpcell.00336.2006; Lueck JD, 2007, J GEN PHYSIOL, V129, P79, DOI 10.1085/jgp.200609635; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2003, J CELL BIOL, V160, P41, DOI 10.1083/jcb.200208079; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; MONTZKA KA, 1988, P NATL ACAD SCI USA, V85, P8885, DOI 10.1073/pnas.85.23.8885; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Patel AA, 2002, EMBO J, V21, P3804, DOI 10.1093/emboj/cdf297; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Sendtner M, 2001, CURR OPIN NEUROL, V14, P629, DOI 10.1097/00019052-200110000-00012; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Sumner Charlotte J, 2006, NeuroRx, V3, P235, DOI 10.1016/j.nurx.2006.01.010; Vincent A, 2006, NEURON, V52, P123, DOI 10.1016/j.neuron.2006.09.024; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Wu Q, 1999, MOL CELL BIOL, V19, P3225; Yong J, 2004, MOL CELL BIOL, V24, P2747, DOI 10.1128/MCB.24.7.2747-2756.2004; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006	67	246	250	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e921	10.1371/journal.pone.0000921	http://dx.doi.org/10.1371/journal.pone.0000921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895963	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455800001
J	Zhang, SL; Wang, JW; Tseng, H				Zhang, Shengliang; Wang, Junwen; Tseng, Hung			Basonuclin Regulates a Subset of Ribosomal RNA Genes in HaCaT Cells	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; ZINC-FINGER PROTEIN; FACTOR TIF-IA; RDNA TRANSCRIPTION; FACTOR UBF; PHOSPHORYLATION; PROMOTER; DNA; KERATINOCYTES; RB	Basonuclin (Bnc1), a cell-type-specific ribosomal RNA (rRNA) gene regulator, is expressed mainly in keratinocytes of stratified epithelium and gametogenic cells of testis and ovary. Previously, basonuclin was shown in vitro to interact with rRNA gene (rDNA) promoter at three highly conserved sites. Basonuclin's high affinity binding site overlaps with the binding site of a dedicated and ubiquitous Pol I transcription regulator, UBF, suggesting that their binding might interfere with each other if they bind to the same promoter. Knocking-down basonuclin in mouse oocytes eliminated approximately one quarter of RNA polymerase I (Pol I) transcription foci, without affecting the BrU incorporation of the remaining ones, suggesting that basonuclin might regulate a subset of rDNA. Here we show, via chromatin immunoprecipitation (ChIP), that basonuclin is associated with rDNA promoters in HaCaT cells, a spontaneously established human keratinocyte line. Immunoprecipitation data suggest that basonuclin is in a complex that also contains the subunits of Pol I (RPA194, RPA116), but not UBF. Knocking-down basonuclin in HaCaT cells partially impairs the association of RPA194 to rDNA promoter, but not that of UBF. Basonuclin-deficiency also reduces the amount of 47S pre-rRNA, but this effect can be seen only after cell-proliferation related rRNA synthesis has subsided at a higher cell density. DNA sequence of basonuclin-bound rDNA promoters shows single nucleotide polymorphisms (SNPs) that differ from those associated with UBF-bound promoters, suggesting that basonuclin and UBF interact with different subsets of promoters. In conclusion, our results demonstrate basonuclin's functional association with rDNA promoters and its interaction with Pol I in vivo. Our data also suggest that basonuclin-Pol I complex transcribes a subset of rDNA.	[Zhang, Shengliang; Tseng, Hung] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Wang, Junwen] Univ Penn, Dept Genet, Ctr Bioinformat, Philadelphia, PA 19104 USA; [Wang, Junwen] Univ Penn, Dept Comp & Informat Sci, Philadelphia, PA 19104 USA; [Tseng, Hung] Univ Penn, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Tseng, H (corresponding author), Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA.	htsengpe@mail.med.upenn.edu	Wang, Junwen/C-4432-2009; Wang, Junwen/D-3700-2011	Wang, Junwen/0000-0002-4432-4707	NIH [AG14456]; NATIONAL INSTITUTE ON AGING [R01AG014456] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grant AG14456 to HT. The funding agency played no role in the design, conduct and report of this study.	BECKMANN H, 1995, SCIENCE, V270, P1506, DOI 10.1126/science.270.5241.1506; BELL SP, 1990, GENE DEV, V4, P943, DOI 10.1101/gad.4.6.943; Bodem J, 2000, EMBO REP, V1, P171, DOI 10.1093/embo-reports/kvd032; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BROWN DD, 1968, SCIENCE, V160, P272, DOI 10.1126/science.160.3825.272; BUTTGEREIT D, 1985, NUCLEIC ACIDS RES, V13, P8165, DOI 10.1093/nar/13.22.8165; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Ciarmatori S, 2001, MOL CELL BIOL, V21, P5806, DOI 10.1128/MCB.21.17.5806-5814.2001; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; COPENHAVER GP, 1994, NUCLEIC ACIDS RES, V22, P2651, DOI 10.1093/nar/22.13.2651; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DECAPOA A, 1985, HUM GENET, V69, P212, DOI 10.1007/BF00293027; DECAPOA A, 1985, J CELL SCI, V74, P21; DECAPOA A, 1986, HORM METAB RES, V18, P574, DOI 10.1055/s-2007-1012376; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Green H, 2005, MOL B INT U, P207; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; HAAF T, 1991, EXP CELL RES, V193, P78, DOI 10.1016/0014-4827(91)90540-B; HALTINER MM, 1986, MOL CELL BIOL, V6, P227, DOI 10.1128/MCB.6.1.227; Hannan KM, 2000, ONCOGENE, V19, P3487, DOI 10.1038/sj.onc.1203690; Hannan KM, 2000, ONCOGENE, V19, P4988, DOI 10.1038/sj.onc.1203875; Iuchi S, 1997, P NATL ACAD SCI USA, V94, P7948, DOI 10.1073/pnas.94.15.7948; Iuchi S, 1999, P NATL ACAD SCI USA, V96, P9628, DOI 10.1073/pnas.96.17.9628; JONES MH, 1988, P NATL ACAD SCI USA, V85, P669, DOI 10.1073/pnas.85.3.669; LEARNED R M, 1982, Journal of Molecular and Applied Genetics, V1, P575; Lin CY, 2002, CURR BIOL, V12, P2142, DOI 10.1016/S0960-9822(02)01389-1; Ma J, 2006, DEVELOPMENT, V133, P2053, DOI 10.1242/dev.02371; Matsuzaki K, 1997, GENE, V195, P87, DOI 10.1016/S0378-1119(97)00176-5; Mayer C, 2005, GENE DEV, V19, P933, DOI 10.1101/gad.333205; MORRIS JF, 1991, ONCOGENE, V6, P2339; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; PERKOWSKA E, 1968, NATURE, V217, P649, DOI 10.1038/217649a0; PIKAARD CS, 1990, MOL CELL BIOL, V10, P3810, DOI 10.1128/MCB.10.7.3810; RAUSCHER FJ, 1993, FASEB J, V7, P896, DOI 10.1096/fasebj.7.10.8393820; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Stefanovsky VY, 2001, MOL CELL, V8, P1063, DOI 10.1016/S1097-2765(01)00384-7; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tian QJ, 2001, DEVELOPMENT, V128, P407; Tseng H, 1998, Front Biosci, V3, pD985; TSENG H, 1994, J CELL BIOL, V126, P495, DOI 10.1083/jcb.126.2.495; Tseng H, 1999, J CELL SCI, V112, P3039; Tseng H, 2006, BIOESSAYS, V28, P719, DOI 10.1002/bies.20430; VOIT R, 1995, NUCLEIC ACIDS RES, V23, P2593, DOI 10.1093/nar/23.14.2593; Voit R, 1999, EMBO J, V18, P1891, DOI 10.1093/emboj/18.7.1891; Voit R, 1997, MOL CELL BIOL, V17, P4230, DOI 10.1128/MCB.17.8.4230; Voit R, 2001, P NATL ACAD SCI USA, V98, P13631, DOI 10.1073/pnas.231071698; Wang JW, 2006, BIOCHEM BIOPH RES CO, V348, P1261, DOI 10.1016/j.bbrc.2006.07.198; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Yuan XJ, 2002, EMBO REP, V3, P1082, DOI 10.1093/embo-reports/kvf212	51	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e902	10.1371/journal.pone.0000902	http://dx.doi.org/10.1371/journal.pone.0000902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878937	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455700010
J	Hinney, A; Nguyen, TT; Scherag, A; Friedel, S; Bronner, G; Muller, TD; Grallert, H; Illig, T; Wichmann, HE; Rief, W; Schafer, H; Hebebrand, J				Hinney, Anke; Nguyen, Thuy Trang; Scherag, Andre; Friedel, Susann; Broenner, Guenter; Mueller, Timo Dirk; Grallert, Harald; Illig, Thomas; Wichmann, H. -Erich; Rief, Winfried; Schaefer, Helmut; Hebebrand, Johannes			Genome Wide Association (GWA) Study for Early Onset Extreme Obesity Supports the Role of Fat Mass and Obesity Associated Gene (FTO) Variants	PLOS ONE			English	Article							LIPOPROTEIN RECEPTOR GENE; CHILDHOOD OBESITY; ADULT OBESITY; INDEX	Background. Obesity is a major health problem. Although heritability is substantial, genetic mechanisms predisposing to obesity are not very well understood. We have performed a genome wide association study (GWA) for early onset (extreme) obesity. Methodology/Principal Findings. a) GWA (Genome-Wide Human SNP Array 5.0 comprising 440,794 single nucleotide polymorphisms) for early onset extreme obesity based on 487 extremely obese young German individuals and 442 healthy lean German controls; b) confirmatory analyses on 644 independent families with at least one obese offspring and both parents. We aimed to identify and subsequently confirm the 15 SNPs (minor allele frequency >= 10%) with the lowest p-values of the GWA by four genetic models: additive, recessive, dominant and allelic. Six single nucleotide polymorphisms (SNPs) in FTO ( fat mass and obesity associated gene) within one linkage disequilibrium (LD) block including the GWA SNP rendering the lowest p-value (rs1121980; log-additive model: nominal p = 1.13x10(-7), corrected p = 0.0494; odds ratio (OR)(CT) 1.67, 95% confidence interval (CI) 1.22-2.27; OR(TT) 2.76, 95% CI 1.88-4.03) belonged to the 15 SNPs showing the strongest evidence for association with obesity. For confirmation we genotyped 11 of these in the 644 independent families (of the six FTO SNPs we chose only two representing the LD bock). For both FTO SNPs the initial association was confirmed (both Bonferroni corrected p<0.01). However, none of the nine non-FTO SNPs revealed significant transmission disequilibrium. Conclusions/Significance. Our GWA for extreme early onset obesity substantiates that variation in FTO strongly contributes to early onset obesity. This is a further proof of concept for GWA to detect genes relevant for highly complex phenotypes. We concurrently show that nine additional SNPs with initially low p-values in the GWA were not confirmed in our family study, thus suggesting that of the best 15 SNPs in the GWA only the FTO SNPs represent true positive findings.	[Hinney, Anke; Friedel, Susann; Broenner, Guenter; Mueller, Timo Dirk; Hebebrand, Johannes] Univ Duisburg Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [Nguyen, Thuy Trang; Schaefer, Helmut] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; [Scherag, Andre] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Grallert, Harald; Illig, Thomas; Wichmann, H. -Erich] GSF Forschungszentrum Umwelt & Gesundheit, Inst Epidemiol, Munich, Germany; [Rief, Winfried] Univ Marburg, Dept Clin Psychol & Psychotherapy, Marburg, Germany	University of Duisburg Essen; Philipps University Marburg; University of Duisburg Essen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Philipps University Marburg	Hinney, A (corresponding author), Univ Duisburg Essen, Dept Child & Adolescent Psychiat, Essen, Germany.	anke.hinney@uni-due.de	Müller, Timo D./AAZ-4445-2020; Rief, Winfried/ABD-4994-2021; Wichmann, Heinz Erich/AAA-5695-2022; Grallert, Harald/B-3424-2013; Scherag, Andre/B-3805-2014; Hinney, Anke/D-6953-2011	Rief, Winfried/0000-0002-7019-2250; Hinney, Anke/0000-0001-5659-0706; Muller, Timo/0000-0002-0624-9339; Scherag, Andre/0000-0002-9406-4704	Bundesministerium fur Bildung und Forschung [NGFN2 01GS0482, 01GS0483, 01GP0259, 01GP0209]; Deutsche Forschungsgemeinschaft [HE 1446/4-1]; European Union [FP6 LSHMCT-2003-503041]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	Funding: This work was supported by grants from the Bundesministerium fur Bildung und Forschung (NGFN2 01GS0482, 01GS0483 and 01GP0259, 01GP0209), the Deutsche Forschungsgemeinschaft (HE 1446/4-1) and the European Union (FP6 LSHMCT-2003-503041). The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Christensen K, 2007, NEW ENGL J MED, V356, P1094, DOI 10.1056/NEJMp068126; Deng HW, 2000, J CLIN ENDOCR METAB, V85, P2748, DOI 10.1210/jc.85.8.2748; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Edwards BJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-18; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Garner C, 2007, GENET EPIDEMIOL, V31, P288, DOI 10.1002/gepi.20209; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Mattevi VS, 2000, HUM GENET, V106, P546, DOI 10.1007/s004390050023; Okura T, 2003, INT J OBESITY, V27, P1020, DOI 10.1038/sj.ijo.0802378; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Scott WJ, 2007, RES J BIOTECHNOL, V2, P5; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Vollmert C, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040931; ZEE RYL, 1995, CLIN GENET, V47, P118	17	400	420	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1361	10.1371/journal.pone.0001361	http://dx.doi.org/10.1371/journal.pone.0001361			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159244	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459700018
J	Pietersen, CY; Bosker, FJ; Doorduin, J; Jongsma, ME; Postema, F; Haas, JV; Johnson, MP; Koch, T; Vladusich, T; den Boer, JA				Pietersen, Charmaine Y.; Bosker, Fokko J.; Doorduin, Janine; Jongsma, Minke E.; Postema, Folkert; Haas, Joseph V.; Johnson, Michael P.; Koch, Tineke; Vladusich, Tony; den Boer, Johan A.			An Animal Model of Emotional Blunting in Schizophrenia	PLOS ONE			English	Article								Schizophrenia is often associated with emotional blunting-the diminished ability to respond to emotionally salient stimuli-particularly those stimuli representative of negative emotional states, such as fear. This disturbance may stem from dysfunction of the amygdala, a brain region involved in fear processing. The present article describes a novel animal model of emotional blunting in schizophrenia. This model involves interfering with normal fear processing (classical conditioning) in rats by means of acute ketamine administration. We confirm, in a series of experiments comprised of cFos staining, behavioral analysis and neurochemical determinations, that ketamine interferes with the behavioral expression of fear and with normal fear processing in the amygdala and related brain regions. We further show that the atypical antipsychotic drug clozapine, but not the typical antipsychotic haloperidol nor an experimental glutamate receptor 2/3 agonist, inhibits ketamine's effects and retains normal fear processing in the amygdala at a neurochemical level, despite the observation that fear-related behavior is still inhibited due to ketamine administration. Our results suggest that the relative resistance of emotional blunting to drug treatment may be partially due to an inability of conventional therapies to target the multiple anatomical and functional brain systems involved in emotional processing. A conceptual model reconciling our findings in terms of neurochemistry and behavior is postulated and discussed.	[Pietersen, Charmaine Y.; Bosker, Fokko J.; Doorduin, Janine; Jongsma, Minke E.; Postema, Folkert; Koch, Tineke; Vladusich, Tony; den Boer, Johan A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Grad Sch Behav & Cognit Neurosci, Groningen, Netherlands; [Haas, Joseph V.; Johnson, Michael P.] Eli Lilly & Co, Indianapolis, IN 46285 USA	University of Groningen; Eli Lilly	Pietersen, CY (corresponding author), McLean Hosp, 115 Mill St, Belmont, MA 02178 USA.	charmspiet@hotmail.com		Doorduin, Janine/0000-0003-2925-9959	Eli Lilly and Company; University of Groningen	Eli Lilly and Company(Eli Lilly); University of Groningen	Funding: Eli Lilly and Company provided the compound LY 379268 for the study and for helped with the statistical analysis (J Haas). Eli Lilly has also approved the manuscript. Sandoz Pharma, Basel donated clozapine. Funding for the study was from my own research budget obtained from the University of Groningen.	Abekawa T, 2007, N-S ARCH PHARMACOL, V375, P261, DOI 10.1007/s00210-007-0154-x; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Aleman A, 2005, PROG NEUROBIOL, V77, P283, DOI 10.1016/j.pneurobio.2005.11.005; BAKSHI VP, 1994, J PHARMACOL EXP THER, V271, P787; BOLLES RC, 1976, ANIM LEARN BEHAV, V4, P6, DOI 10.3758/BF03211975; Borowski TB, 1998, BEHAV NEUROSCI, V112, P952, DOI 10.1037/0735-7044.112.4.952; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cartmell J, 1999, J PHARMACOL EXP THER, V291, P161; Castner SA, 2003, BIOL PSYCHIAT, V54, P105, DOI 10.1016/S0006-3223(03)00292-0; Coyle JT, 2004, PSYCHOPHARMACOLOGY, V174, P32, DOI 10.1007/s00213-003-1709-2; DALY DA, 1993, NEUROSCI LETT, V152, P61, DOI 10.1016/0304-3940(93)90483-2; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Duncan GE, 1998, BRAIN RES, V812, P65, DOI 10.1016/S0006-8993(98)00926-3; Dunn MJ, 2006, PSYCHOPHARMACOLOGY, V188, P183, DOI 10.1007/s00213-006-0488-y; Edwards J, 2001, SCHIZOPHR RES, V48, P235, DOI 10.1016/S0920-9964(00)00099-2; Exner C, 2004, SCHIZOPHR RES, V71, P493, DOI 10.1016/j.schres.2004.02.023; Fahim C, 2005, PSYCHIAT RES-NEUROIM, V140, P1, DOI 10.1016/j.pscychresns.2005.06.003; FANSELOW MS, 1994, BEHAV NEUROSCI, V108, P210, DOI 10.1037/0735-7044.108.1.210; FARBER NB, 1993, BIOL PSYCHIAT, V34, P119, DOI 10.1016/0006-3223(93)90265-F; FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Gao YJ, 2004, PAIN, V110, P343, DOI 10.1016/j.pain.2004.04.030; Goosens KA, 2003, BEHAV NEUROSCI, V117, P738, DOI 10.1037/0735-7044.117.4.738; Grace AA, 2000, BRAIN RES REV, V31, P330, DOI 10.1016/S0165-0173(99)00049-1; Greba Q, 2000, BEHAV NEUROSCI, V114, P262, DOI 10.1037//0735-7044.114.2.262; Gur RE, 2002, AM J PSYCHIAT, V159, P1992, DOI 10.1176/appi.ajp.159.12.1992; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; Harich S, 2007, PSYCHOPHARMACOLOGY, V192, P511, DOI 10.1007/s00213-007-0742-y; Heinz A, 2000, NERVENARZT, V71, P54, DOI 10.1007/s001150050008; Heresco-Levy U, 2003, PROG NEURO-PSYCHOPH, V27, P1113, DOI 10.1016/j.pnpbp.2003.09.007; Hofer E, 2001, SCHIZOPHR RES, V51, P127, DOI 10.1016/S0920-9964(00)00118-3; Holahan MR, 2002, NEUROBIOL LEARN MEM, V77, P250, DOI 10.1006/nlme.2001.4012; Homayoun L, 2005, J NEUROPHYSIOL, V93, P1989, DOI 10.1152/jn.00875.2004; Imre G, 2006, BRAIN RES BULL, V69, P338, DOI 10.1016/j.brainresbull.2006.01.010; Inoue T, 2000, PHARMACOL BIOCHEM BE, V66, P573, DOI 10.1016/S0091-3057(00)00254-9; Johnson DE, 2005, EUR J PHARMACOL, V506, P209, DOI 10.1016/j.ejphar.2004.11.015; Johnson DM, 2000, BRAIN RES, V857, P66, DOI 10.1016/S0006-8993(99)02388-4; JOHNSON LR, 1994, NEUROSCIENCE, V61, P851, DOI 10.1016/0306-4522(94)90408-1; Johnston PJ, 2001, BIOL PSYCHOL, V58, P203, DOI 10.1016/S0301-0511(01)00114-4; Jones HM, 2002, BRIT J PSYCHIAT, V181, P271, DOI 10.1192/bjp.181.4.271; Joyal CC, 2003, BIOL PSYCHIAT, V54, P1302, DOI 10.1016/S0006-3223(03)00597-3; KANE JM, 1989, J CLIN PSYCHIAT, V50, P322; Kapur S, 2003, J PHARMACOL EXP THER, V305, P625, DOI 10.1124/jpet.102.046987; Kapur S, 2002, MOL PSYCHIATR, V7, P837, DOI 10.1038/sj.mp.4001093; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; Kleim JA, 1996, J NEUROSCI, V16, P4529; Koo JW, 2004, J NEUROSCI, V24, P7654, DOI 10.1523/JNEUROSCI.1644-04.2004; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; LEVINSON DF, 1991, CLIN THER, V13, P326; Lindefors N, 1997, BRAIN RES, V759, P205, DOI 10.1016/S0006-8993(97)00255-2; Lorrain DS, 2003, NEUROSCIENCE, V117, P697, DOI 10.1016/S0306-4522(02)00652-8; Ma JY, 2006, PROG NEURO-PSYCHOPH, V30, P647, DOI 10.1016/j.pnpbp.2005.11.040; Marcotte ER, 2001, J PSYCHIATR NEUROSCI, V26, P395; Maren S, 1996, NEURON, V16, P237, DOI 10.1016/S0896-6273(00)80041-0; Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029; MILIKEN GA, 1992, ANAL MESSY DATA, V1; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; Montgomery D. C., 1984, DESIGN ANAL EXPT; Niu L, 2004, PSYCHIAT RES-NEUROIM, V132, P41, DOI 10.1016/j.pscychresns.2004.06.002; OCARROLL RE, 1995, SCHIZOPHR RES, V15, P299, DOI 10.1016/0920-9964(94)00052-A; OLNEY JW, 1994, J CLIN PSYCHIAT, V55, P43; Paradiso S, 2003, AM J PSYCHIAT, V160, P1775, DOI 10.1176/appi.ajp.160.10.1775; Pare D, 2003, ANN NY ACAD SCI, V985, P78; PEROUTKA SJ, 1980, AM J PSYCHIAT, V137, P1518; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Pietersen CY, 2006, PROG NEURO-PSYCHOPH, V30, P1209, DOI 10.1016/j.pnpbp.2006.02.019; Pol HEH, 2001, ARCH GEN PSYCHIAT, V58, P1118; Rex A, 1998, PHARMACOL BIOCHEM BE, V59, P677, DOI 10.1016/S0091-3057(97)00461-9; REYNOLDS GP, 1983, NATURE, V305, P527, DOI 10.1038/305527a0; Reynolds SM, 2003, EUR J NEUROSCI, V17, P2187, DOI 10.1046/j.1460-9568.2003.02642.x; Rushe TM, 1999, SCHIZOPHR RES, V35, P85, DOI 10.1016/S0920-9964(98)00117-0; Sachdev P, 2000, PSYCHIAT CLIN NEUROS, V54, P105, DOI 10.1046/j.1440-1819.2000.00644.x; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Savonenko A, 2003, LEARN MEMORY, V10, P293, DOI 10.1101/lm.58803; Schauz C, 2000, LEARN MEMORY, V7, P393, DOI 10.1101/lm.33800; Schmajuk NA, 2001, HIPPOCAMPUS, V11, P599, DOI 10.1002/hipo.1074; Sharma V, 2003, BIPOLAR DISORD, V5, P48, DOI 10.1111/j.1399-2406.2003.00062.x; Sharp JW, 1997, BRAIN RES, V758, P51, DOI 10.1016/S0006-8993(97)00025-5; Shors TJ, 1998, LEARN MEMORY, V5, P220; Swanson CJ, 2005, NAT REV DRUG DISCOV, V4, P131, DOI 10.1038/nrd1630; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; Takahashi H, 2004, NEUROIMAGE, V22, P1247, DOI 10.1016/j.neuroimage.2004.03.028; Taylor SF, 2002, SCHIZOPHR RES, V58, P159, DOI 10.1016/S0920-9964(01)00403-0; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; Verma A, 1996, J NEUROSCI, V16, P373; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Yagi K, 1998, NEUROSCI RES, V30, P279, DOI 10.1016/S0168-0102(98)00008-X; YAMAMOTO BK, 1994, J NEUROSCI, V14, P4159	91	23	24	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1360	10.1371/journal.pone.0001360	http://dx.doi.org/10.1371/journal.pone.0001360			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159243	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459700017
J	Steinfartz, S; Glaberman, S; Lanterbecq, D; Marquez, C; Rassmann, K; Caccone, A				Steinfartz, Sebastian; Glaberman, Scott; Lanterbecq, Deborah; Marquez, Cruz; Rassmann, Kornelia; Caccone, Adalgisa			Genetic Impact of a Severe El Nino Event on Galapagos Marine Iguanas (Amblyrhynchus cristatus)	PLOS ONE			English	Article								The El Nino-Southern Oscillation (ENSO) is a major source of climatic disturbance, impacting the dynamics of ecosystems worldwide. Recent models predict that human-generated rises in green-house gas levels will cause an increase in the strength and frequency of El Nino warming events in the next several decades, highlighting the need to understand the potential biological consequences of increased ENSO activity. Studies have focused on the ecological and demographic implications of El Nino in a range of organisms, but there have been few systematic attempts to measure the impact of these processes on genetic diversity in populations. Here, we evaluate whether the 1997-1998 El Nino altered the genetic composition of Galapagos marine iguana populations from eleven islands, some of which experienced mortality rates of up to 90% as a result of El Nino warming. Specifically, we measured the temporal variation in microsatellite allele frequencies and mitochondrial DNA diversity (mtDNA) in samples collected before (1991/1993) and after (2004) the El Nino event. Based on microsatellite data, only one island (Marchena) showed signatures of a genetic bottleneck, where the harmonic mean of the effective population size (N(e)) was estimated to be less than 50 individuals during the period between samplings. Substantial decreases in mtDNA variation between time points were observed in populations from just two islands (Marchena and Genovesa). Our results suggests that, for the majority of islands, a single, intense El Nino event did not reduce marine iguana populations to the point where substantial neutral genetic diversity was lost. In the case of Marchena, simultaneous changes to both nuclear and mitochondrial DNA variation may also be the result of a volcanic eruption on the island in 1991. Therefore, studies that seek to evaluate the genetic impact of El Nino must also consider the confounding or potentially synergistic effect of other environmental and biological forces shaping populations.	[Steinfartz, Sebastian; Glaberman, Scott; Lanterbecq, Deborah; Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, Yale Inst Biospher Studies, New Haven, CT 06520 USA; [Marquez, Cruz] Charles Darwin Res Stn, Santa Cruz, Galapagos, Ecuador	Yale University	Steinfartz, S (corresponding author), Univ Bielefeld, Unit Mol Ecol & Behav, Bielefeld, Germany.	sebastian.steinfartz@uni-bielefeld.de; scott.glaberman@gmail.com	Caccone, Adalgisa/AAE-4238-2021; Lanterbecq, Deborah/ABD-4115-2021	Caccone, Adalgisa/0000-0002-8949-9260; Steinfartz, Sebastian/0000-0001-5347-3969; Glaberman, Scott/0000-0003-0594-4732; Lanterbecq, Deborah/0000-0002-1104-9227	German Research Community [STE 1130/2-1, STE 1130/2-2]; Belgian American Educational Foundation; The Yale Institute for Biospheric studies	German Research Community(German Research Foundation (DFG)); Belgian American Educational Foundation; The Yale Institute for Biospheric studies	Sampling was made possible through a grant from the National Geographic Society to AC. SS has been supported by a fellowship of the German Research Community ( DFG; STE 1130/2-1 and STE 1130/2-2). DL has been supported by a postdoctoral fellowship of the Belgian American Educational Foundation. The Yale Institute for Biospheric studies supported this project through funds to AC.	Akst EP, 2002, CONSERV GENET, V3, P375, DOI 10.1023/A:1020555303124; Allendorf F., 2007, CONSERVATION GENETIC; BARBER RT, 1986, NATURE, V319, P279, DOI 10.1038/319279a0; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; Beheregaray LB, 2003, SCIENCE, V302, P75, DOI 10.1126/science.1087486; Berthier P, 2002, GENETICS, V160, P741; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; Depaulis F, 1998, MOL BIOL EVOL, V15, P1788, DOI 10.1093/oxfordjournals.molbev.a025905; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fauvelot C, 2006, J HERED, V97, P367, DOI 10.1093/jhered/esl010; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; FREELAND JR, 2005, MOL BIOL; Glynn P.W., 1988, Annual Review of Ecology and Systematics, V19, P309, DOI 10.1146/annurev.es.19.110188.001521; Hale KA, 2007, ANIM CONSERV, V10, P2, DOI 10.1111/j.1469-1795.2006.00059.x; Hanley TC, 2005, MOL ECOL NOTES, V5, P599, DOI 10.1111/j.1471-8286.2005.01004.x; Hansen MM, 1996, EVOLUTION, V50, P454, DOI [10.2307/2410816, 10.1111/j.1558-5646.1996.tb04508.x]; Holmgren M, 2001, TRENDS ECOL EVOL, V16, P89, DOI 10.1016/S0169-5347(00)02052-8; LANDE R, 1994, EVOLUTION, V48, P1460, DOI [10.2307/2410240, 10.1111/j.1558-5646.1994.tb02188.x]; LAURIE WA, 1990, J ANIM ECOL, V59, P515, DOI 10.2307/4878; Luikart G, 1998, MOL ECOL, V7, P963, DOI 10.1046/j.1365-294x.1998.00414.x; Mackie RI, 2004, PHYSIOL BIOCHEM ZOOL, V77, P127, DOI 10.1086/383498; Martinez EA, 2003, J PHYCOL, V39, P504, DOI 10.1046/j.1529-8817.2003.02191.x; NEI M, 1981, GENETICS, V98, P625; Nei M., 1987, MOL EVOLUTIONARY GEN; Peel D., 2004, NEESTIMATOR SOFTWARE; PHILANDER SGH, 1983, NATURE, V302, P295, DOI 10.1038/302295a0; Rassmann K, 1997, MOL ECOL, V6, P437, DOI 10.1046/j.1365-294X.1997.00209.x; Richards C, 1996, CONSERV BIOL, V10, P832, DOI 10.1046/j.1523-1739.1996.10030832.x; Riedinger MA, 2002, J PALEOLIMNOL, V27, P1, DOI 10.1023/A:1013514408468; Romero LM, 2001, P NATL ACAD SCI USA, V98, P7366, DOI 10.1073/pnas.131091498; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; *SMITHS I, 1991, LAVA CIRCUMFERENTIAL; Spencer CC, 2000, MOL ECOL, V9, P1517, DOI 10.1046/j.1365-294x.2000.01031.x; Steinfartz S, 2006, MOL ECOL NOTES, V6, P927, DOI 10.1111/j.1471-8286.2006.01402.x; Tessier N, 1999, MOL ECOL, V8, P169, DOI 10.1046/j.1365-294X.1999.00547.x; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; TRILLMICH F, 1985, OECOLOGIA, V67, P19, DOI 10.1007/BF00378445; Vargas FH, 2006, BIOL CONSERV, V127, P107, DOI 10.1016/j.biocon.2005.08.001; Wang CZ, 2006, PROG OCEANOGR, V69, P239, DOI 10.1016/j.pocean.2006.03.004; WAPLES RS, 1989, GENETICS, V121, P379; Wikelski M, 2003, INTEGR COMP BIOL, V43, P376, DOI 10.1093/icb/43.3.376; Wikelski M, 2002, NATURE, V417, P607, DOI 10.1038/417607a; Wikelski M, 1997, EVOLUTION, V51, P922, DOI 10.1111/j.1558-5646.1997.tb03673.x; Wikelski M, 1996, ANIM BEHAV, V52, P581, DOI 10.1006/anbe.1996.0199; Wikelski M., 2004, IGUANA, V11, P191	47	23	24	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1285	10.1371/journal.pone.0001285	http://dx.doi.org/10.1371/journal.pone.0001285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074011	gold, Green Submitted, Green Published			2022-12-27	WOS:000207459500004
J	Wang-Sattler, R; Blandin, S; Ning, Y; Blass, C; Dolo, G; Toure, YT; della Torre, A; Lanzaro, GC; Steinmetz, LM; Kafatos, FC; Zheng, LB				Wang-Sattler, Rui; Blandin, Stephanie; Ning, Ye; Blass, Claudia; Dolo, Guimogo; Toure, Yeya T.; della Torre, Alessandra; Lanzaro, Gregory C.; Steinmetz, Lars M.; Kafatos, Fotis C.; Zheng, Liangbiao			Mosaic Genome Architecture of the Anopheles gambiae Species Complex	PLOS ONE			English	Article							INTEGRATED GENETIC-MAP; MALARIA VECTOR; INCIPIENT SPECIATION; POPULATION-STRUCTURE; RECOMBINATION RATE; CHROMOSOMAL FORMS; X-CHROMOSOME; DIFFERENTIATION; MICROSATELLITE; INTROGRESSION	Background. Attempts over the last three decades to reconstruct the phylogenetic history of the Anopheles gambiae species complex have been important for developing better strategies to control malaria transmission. Methodology. We used fingerprint genotyping data from 414 field-collected female mosquitoes at 42 microsatellite loci to infer the evolutionary relationships of four species in the A. gambiae complex, the two major malaria vectors A. gambiae sensu stricto (A. gambiae s.s.) and A. arabiensis, as well as two minor vectors, A. merus and A. melas. Principal Findings. We identify six taxonomic units, including a clear separation of West and East Africa A. gambiae s.s. S molecular forms. We show that the phylogenetic relationships vary widely between different genomic regions, thus demonstrating the mosaic nature of the genome of these species. The two major malaria vectors are closely related and closer to A. merus than to A. melas at the genome-wide level, which is also true if only autosomes are considered. However, within the Xag inversion region of the X chromosome, the M and two S molecular forms are most similar to A. merus. Near the X centromere, outside the Xag region, the two S forms are highly dissimilar to the other taxa. Furthermore, our data suggest that the centromeric region of chromosome 3 is a strong discriminator between the major and minor malaria vectors. Conclusions. Although further studies are needed to elucidate the basis of the phylogenetic variation among the different regions of the genome, the preponderance of sympatric admixtures among taxa strongly favor introgression of different genomic regions between species, rather than lineage sorting of ancestral polymorphism, as a possible mechanism.	[Dolo, Guimogo; Toure, Yeya T.] Univ Mali, Fac Med Pharm & Odontostomatol, Bamako, Mali; [della Torre, Alessandra] Univ Roma La Sapienza, Sez Parassitol, Dipartimento Sci Santia Pubbl, Rome, Italy; [Lanzaro, Gregory C.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Kafatos, Fotis C.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Sect Infect & Immun, London, England; [Zheng, Liangbiao] Shanghai Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Wang-Sattler, Rui; Blandin, Stephanie; Ning, Ye; Blass, Claudia; Steinmetz, Lars M.] European Mol Biol Lab, Heidelberg, Germany	University of Bamako; Sapienza University Rome; University of California System; University of California Davis; Imperial College London; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; European Molecular Biology Laboratory (EMBL)	Wang-Sattler, R (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Epidemiol, Neuherberg, Germany.	rui.wang-sattler@gsf.de; f.kafatos@imperial.ac.uk	Blandin, Stephanie/ABH-2267-2021; Wang-Sattler, Rui/B-5354-2014; Blandin, Stephanie/I-2786-2016	Blandin, Stephanie/0000-0003-4566-1200; Wang-Sattler, Rui/0000-0002-8794-8229; Blandin, Stephanie/0000-0003-4566-1200; Steinmetz, Lars/0000-0002-3962-2865	Deutsche Forschungsgemeinschaft [SFB 544, STE 1422/2-1]; John D. and Catherine T. MacArthur Foundation; NIH [AI40408]; Italian Ministry for University and Research; EMBO; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040408] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); John D. and Catherine T. MacArthur Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by the Deutsche Forschungsgemeinschaft (SFB 544 to FCK and STE 1422/2-1 to LMS), the John D. and Catherine T. MacArthur Foundation (FCK), the NIH grant AI40408 (GCL and LZ), the Italian Ministry for University and Research, PRIN 2005 programme (AdT), and the EMBO long-term fellowship (SB).	Archak S, 2007, NUCLEIC ACIDS RES, V35, pD36, DOI 10.1093/nar/gkl778; Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; BESANSKY NJ, 1994, P NATL ACAD SCI USA, V91, P6885, DOI 10.1073/pnas.91.15.6885; Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; Caccone A, 1998, GENETICS, V150, P807; Chandre F, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P319; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; DAVIDSON G, 1965, RIV MALARIOL, V43, P167; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; dellaTorre A, 1997, GENETICS, V146, P239; Dimopoulos G, 1996, GENETICS, V143, P953; Edillo FE, 2002, J MED ENTOMOL, V39, P70, DOI 10.1603/0022-2585-39.1.70; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Garcia BA, 1996, GENETICS, V143, P1313; Gentile G, 2002, GENETICS, V161, P1561; Gentile G, 2001, INSECT MOL BIOL, V10, P25, DOI 10.1046/j.1365-2583.2001.00237.x; HE X, 1998, CORRES ANAL, P345; HE X, 1998, PRINCIPAL COMPONENT, P281; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hunt RH, 1998, T ROY SOC TROP MED H, V92, P231, DOI 10.1016/S0035-9203(98)90761-1; Kumar V., 1994, Insect Molecular Biology, V3, P41, DOI 10.1111/j.1365-2583.1994.tb00149.x; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Lehmann T, 1996, HEREDITY, V77, P192, DOI 10.1038/hdy.1996.124; Machado CA, 2003, P ROY SOC B-BIOL SCI, V270, P1193, DOI 10.1098/rspb.2003.2333; Pombi M, 2006, AM J TROP MED HYG, V75, P901, DOI 10.4269/ajtmh.2006.75.901; Powell JR, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P101; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103; Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x; Slotman MA, 2005, AM J TROP MED HYG, V73, P326, DOI 10.4269/ajtmh.2005.73.326; Slotman MA, 2006, GENETICS, V174, P2081, DOI 10.1534/genetics.106.059949; Stump AD, 2005, P NATL ACAD SCI USA, V102, P15930, DOI 10.1073/pnas.0508161102; Stump AD, 2005, GENETICS, V169, P1509, DOI 10.1534/genetics.104.035303; Taylor C, 2001, GENETICS, V157, P743; Thomasova D, 2002, P NATL ACAD SCI USA, V99, P8179, DOI 10.1073/pnas.082235599; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Turner TL, 2007, MOL BIOL EVOL, V24, P2132, DOI 10.1093/molbev/msm143; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; UEBERLA K, 1977, FAKTORENANALYSE; Wang R, 2001, P NATL ACAD SCI USA, V98, P10769, DOI 10.1073/pnas.191003598; Wang R, 1999, PARASITOL TODAY, V15, P33, DOI 10.1016/S0169-4758(98)01360-X; Weill M, 2000, INSECT MOL BIOL, V9, P451, DOI 10.1046/j.1365-2583.2000.00206.x; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; ZHENG LB, 1993, SCIENCE, V261, P605, DOI 10.1126/science.8342025; Zheng LB, 1996, GENETICS, V143, P941; Zheng LB, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-16	53	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1249	10.1371/journal.pone.0001249	http://dx.doi.org/10.1371/journal.pone.0001249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043756	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459300030
J	Fan, SC; Fang, F; Zhang, XG; Zhang, MQ				Fan, Shicai; Fang, Fang; Zhang, Xuegong; Zhang, Michael Q.			Putative Zinc Finger Protein Binding Sites Are Over-Represented in the Boundaries of Methylation-Resistant CpG Islands in the Human Genome	PLOS ONE			English	Article							DNA METHYLATION; COMPREHENSIVE ANALYSIS; CHROMATIN-STRUCTURE; MOUSE EMBRYO; PATTERNS; PROMOTER; GENES; SP1; HYPOMETHYLATION; PREDICTION	Background. Majority of CpG dinucleotides in mammalian genomes tend to undergo DNA methylation, but most CpG islands are resistant to such epigenetic modification. Understanding about mechanisms that may lead to the methylation resistance of CpG islands is still very poor. Methodology/Principal Findings. Using the genome-scale in vivo DNA methylation data from human brain, we investigated the flanking sequence features of methylation-resistant CpG islands, and discovered that there are several over-represented putative Transcription Factor Binding Sites (TFBSs) in methylation-resistant CpG islands, and a specific group of zinc finger protein binding sites are over-represented in boundary regions (similar to 400 bp) flanking such CpG islands. About 77% of the over-represented putative TFBSs are conserved among human, mouse and rat. We also observed the enrichment of 4 histone methylations in methylation-resistant CpG islands or their boundaries. Conclusions/Significance. Our results suggest a possible mechanism that certain putative zinc finger protein binding sites over-represented in the boundary regions of the methylation-resistant CpG islands may block the spreading of methylation into these islands, and those TFBSs over-represented within the islands may both reinforce the methylation blocking and promote transcription. Some histone modifications may also enhance the immunity of the CpG islands against DNA methylation by augmenting these TFs' binding. We speculate that the dynamical equilibrium between methylation spreading and blocking is likely to be responsible for the establishment and maintenance of the relatively stable DNA methylation pattern in human somatic cells.	[Fan, Shicai; Fang, Fang; Zhang, Xuegong; Zhang, Michael Q.] Tsinghua Univ, Dept Automat, TNLIST, MOE Key Lab Bioinformat & Bioinformat Div, Beijing 100084, Peoples R China; [Zhang, Michael Q.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Fan, Shicai] Univ Elect Sci & Technol China, Sch Automat Engn, Chengdu 610054, Peoples R China	Tsinghua University; Cold Spring Harbor Laboratory; University of Electronic Science & Technology of China	Zhang, MQ (corresponding author), Tsinghua Univ, Dept Automat, TNLIST, MOE Key Lab Bioinformat & Bioinformat Div, Beijing 100084, Peoples R China.	mzhang@cshl.edu		FANG, FANG/0000-0001-9829-2934	NSFC [60540420569, 30625012]; National Basic Research Program of China [2004CB518605]; NIH [HG01696]; Changjiang Scholar Award of China; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER	NSFC(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Changjiang Scholar Award of China; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported in part by NSFC grants 60540420569 ( MQZ and XZ) and 30625012 ( XZ), the National Basic Research Program of China ( 2004CB518605) ( XZ and MQZ), NIH grant HG01696 ( MQZ) and the Changjiang Scholar Award of China ( MQZ).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bhasin M, 2005, FEBS LETT, V579, P4302, DOI 10.1016/j.febslet.2005.07.002; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; Bock C, 2006, PLOS GENET, V2, P243, DOI 10.1371/journal.pgen.0020026; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Butcher DT, 2004, INT J CANCER, V111, P669, DOI 10.1002/ijc.20324; Caiafa P, 2005, J CELL BIOCHEM, V94, P257, DOI 10.1002/jcb.20325; Das R, 2006, P NATL ACAD SCI USA, V103, P10713, DOI 10.1073/pnas.0602949103; Fang F, 2006, BIOINFORMATICS, V22, P2204, DOI 10.1093/bioinformatics/btl377; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Fisher RA, 1935, J R STAT SOC, V98, P39, DOI 10.2307/2342435; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Grunau C, 2000, HUM MOL GENET, V9, P2651, DOI 10.1093/hmg/9.18.2651; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hansen RS, 2000, HUM MOL GENET, V9, P2575, DOI 10.1093/hmg/9.18.2575; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Issa JP, 1999, CRIT REV ONCOL HEMAT, V32, P31, DOI 10.1016/S1040-8428(99)00019-0; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Lewin, 2004, GENES-BASEL; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; MELANIE E, 1982, NUCLEIC ACIDS RES, V10, P2709; Millar DS, 2000, J BIOL CHEM, V275, P24893, DOI 10.1074/jbc.M906538199; MONK M, 1987, DEVELOPMENT, V99, P371; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; Mummaneni P, 1998, NUCLEIC ACIDS RES, V26, P5163, DOI 10.1093/nar/26.22.5163; Ogishima T, 2005, ONCOGENE, V24, P6765, DOI 10.1038/sj.onc.1208811; PFEIFER GP, 1990, P NATL ACAD SCI USA, V87, P8252, DOI 10.1073/pnas.87.21.8252; Piotrowski A, 2006, GENE CHROMOSOME CANC, V45, P656, DOI 10.1002/gcc.20331; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2003, THERIOGENOLOGY, V59, P21, DOI 10.1016/S0093-691X(02)01269-4; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Schones DE, 2005, BIOINFORMATICS, V21, P307, DOI 10.1093/bioinformatics/bth480; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Smith AD, 2005, BIOINFORMATICS, V21, pI403, DOI 10.1093/bioinformatics/bti1043; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Turker MS, 1999, SEMIN CANCER BIOL, V9, P329, DOI 10.1006/scbi.1999.0133; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Yu J, 2003, CELL RES, V13, P319, DOI 10.1038/sj.cr.7290177	56	13	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1184	10.1371/journal.pone.0001184	http://dx.doi.org/10.1371/journal.pone.0001184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030324	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459200003
J	Tempel-Brami, C; Pinkas, I; Scherz, A; Salomon, Y				Tempel-Brami, Catherine; Pinkas, Iddo; Scherz, Avigdor; Salomon, Yoram			Detection of Light Images by Simple Tissues as Visualized by Photosensitized Magnetic Resonance Imaging	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; MELANOMA TUMORS; BOLD; TOOKAD; ONLINE; GROWTH; MRI	In this study, we show how light can be absorbed by the body of a living rat due to an injected pigment circulating in the blood stream. This process is then physiologically translated in the tissue into a chemical signature that can be perceived as an image by magnetic resonance imaging (MRI). We previously reported that illumination of an injected photosynthetic bacteriochlorophyll-derived pigment leads to a generation of reactive oxygen species, upon oxygen consumption in the blood stream. Consequently, paramagnetic deoxyhemoglobin accumulating in the illuminated area induces changes in image contrast, detectable by a Blood Oxygen Level Dependent (BOLD)-MRI protocol, termed photosensitized (ps)MRI. Here, we show that laser beam pulses synchronously trigger BOLD-contrast transients in the tissue, allowing representation of the luminous spatiotemporal profile, as a contrast map, on the MR monitor. Regions with enhanced BOLD-contrast (7-61 fold) were deduced as illuminated, and were found to overlap with the anatomical location of the incident light. Thus, we conclude that luminous information can be captured and translated by typical oxygen exchange processes in the blood of ordinary tissues, and made visible by psMRI (Fig. 1). This process represents a new channel for communicating environmental light into the body in certain analogy to light absorption by visual pigments in the retina where image perception takes place in the central nervous system. Potential applications of this finding may include: non-invasive intra-operative light guidance and follow-up of photodynamic interventions, determination of light diffusion in opaque tissues for optical imaging and possible assistance to the blind.	[Tempel-Brami, Catherine; Salomon, Yoram] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Pinkas, Iddo; Scherz, Avigdor] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Salomon, Y (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	yoram.salomon@weizmann.ac.il	Pinkas, Iddo/I-7970-2019	Pinkas, Iddo/0000-0001-7434-9844	Steba Biotech and Negma ( France)	Steba Biotech and Negma ( France)	This work was supported by Steba Biotech and Negma ( France).	Abramovitch R, 1999, CANCER RES, V59, P5012; Brandis A, 2005, PHOTOCHEM PHOTOBIOL, V81, P983, DOI 10.1562/2004-12-01-RA-389R1.1; Brandis Alexander S., 2006, V25, P485; Gross S, 2003, NAT MED, V9, P1327, DOI 10.1038/nm940; Harel N, 2006, J MAGN RESON IMAGING, V23, P945, DOI 10.1002/jmri.20576; Jones RA, 1996, MAGNET RESON MED, V35, P489, DOI 10.1002/mrm.1910350407; Kelleher DK, 2003, BRIT J CANCER, V89, P2333, DOI 10.1038/sj.bjc.6601457; Koudinova NV, 2003, INT J CANCER, V104, P782, DOI 10.1002/ijc.11002; Krishna MC, 2001, SEMIN RADIAT ONCOL, V11, P58, DOI 10.1053/srao.2001.18104; Logothetis NK, 2004, MAGN RESON IMAGING, V22, P1517, DOI 10.1016/j.mri.2004.10.018; MADARBALAKIRSKI N, 2005, THESIS WEIZMANN I SC; Mazor O, 2005, PHOTOCHEM PHOTOBIOL, V81, P342, DOI 10.1562/2004-06-14-RA-199.1; MITCHELL DG, 1999, MRI PRINCIPLES; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Neeman M, 2002, J CELL BIOCHEM, P11, DOI 10.1002/jcb.10399; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Pekar JJ, 2006, IEEE ENG MED BIOL, V25, P24, DOI 10.1109/MEMB.2006.1607665; Posen Y, 2005, J CELL SCI, V118, P1957, DOI 10.1242/jcs.02323; Prasad PV, 1996, CIRCULATION, V94, P3271, DOI 10.1161/01.CIR.94.12.3271; Preise D, 2003, NEOPLASIA, V5, P475, DOI 10.1016/S1476-5586(03)80031-3; Tatum JL, 2006, INT J RADIAT BIOL, V82, P699, DOI 10.1080/09553000601002324; TEMPELBRAMI C, 2005, BOLD CONTRAST DYNAMI; Testoni PA, 2007, THESCIENTIFICWORLDJO, V7, P87, DOI 10.1100/tsw.2007.29; Tyszka JM, 2005, CURR OPIN BIOTECH, V16, P93, DOI 10.1016/j.copbio.2004.11.004; Vakrat-Haglili Y, 2005, J AM CHEM SOC, V127, P6487, DOI 10.1021/ja046210j; Wacker CM, 1999, MAGN RESON MATER PHY, V8, P48; Weersink RA, 2005, J PHOTOCH PHOTOBIO B, V79, P211, DOI 10.1016/j.jphotobiol.2005.01.008; Zilberstein J, 1997, PHOTOCHEM PHOTOBIOL, V65, P1012, DOI 10.1111/j.1751-1097.1997.tb07962.x; Zilberstein J, 2001, PHOTOCHEM PHOTOBIOL, V73, P257, DOI 10.1562/0031-8655(2001)073<0257:ATOSMT>2.0.CO;2	29	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1191	10.1371/journal.pone.0001191	http://dx.doi.org/10.1371/journal.pone.0001191			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030327	gold, Green Submitted, Green Published			2022-12-27	WOS:000207459200006
J	Gotzek, D; Shoemaker, DD; Ross, KG				Gotzek, Dietrich; Shoemaker, D. DeWayne; Ross, Kenneth G.			Molecular Variation at a Candidate Gene Implicated in the Regulation of Fire Ant Social Behavior	PLOS ONE			English	Article							AMINO-ACID SITES; SOLENOPSIS-INVICTA HYMENOPTERA; DETECTING POSITIVE SELECTION; EPISODIC ADAPTIVE EVOLUTION; CODON-SUBSTITUTION MODELS; INTEGRATED SOFTWARE; POPULATION-GENETICS; ORGANIZATION; DNA; POLYMORPHISM	The fire ant Solenopsis invicta and its close relatives display an important social polymorphism involving differences in colony queen number. Colonies are headed by either a single reproductive queen (monogyne form) or multiple queens (polygyne form). This variation in social organization is associated with variation at the gene Gp-9, with monogyne colonies harboring only B-like allelic variants and polygyne colonies always containing b-like variants as well. We describe naturally occurring variation at Gp-9 in fire ants based on 185 full-length sequences, 136 of which were obtained from S. invicta collected over much of its native range. While there is little overall differentiation between most of the numerous alleles observed, a surprising amount is found in the coding regions of the gene, with such substitutions usually causing amino acid replacements. This elevated coding-region variation may result from a lack of negative selection acting to constrain amino acid replacements over much of the protein, different mutation rates or biases in coding and non-coding sequences, negative selection acting with greater strength on non-coding than coding regions, and/or positive selection acting on the protein. Formal selection analyses provide evidence that the latter force played an important role in the basal b-like lineages coincident with the emergence of polygyny. While our data set reveals considerable paraphyly and polyphyly of S. invicta sequences with respect to those of other fire ant species, the b-like alleles of the socially polymorphic species are monophyletic. An expanded analysis of colonies containing alleles of this clade confirmed the invariant link between their presence and expression of polygyny. Finally, our discovery of several unique alleles bearing various combinations of b-like and B-like codons allows us to conclude that no single b-like residue is completely predictive of polygyne behavior and, thus, potentially causally involved in its expression. Rather, all three typical b-like residues appear to be necessary.	[Ross, Kenneth G.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Gotzek, Dietrich] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Shoemaker, D. DeWayne] ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL USA	University System of Georgia; University of Georgia; University of Lausanne; United States Department of Agriculture (USDA)	Ross, KG (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	kenross@uga.edu		Shoemaker, DeWayne/0000-0003-3659-8393	Georgia Agricultural Experiment Stations (University of Georgia); United States Department of Agriculture	Georgia Agricultural Experiment Stations (University of Georgia); United States Department of Agriculture(United States Department of Agriculture (USDA))	Partial funding for this research came from the Georgia Agricultural Experiment Stations (University of Georgia) and grants from the United States Department of Agriculture to DDS and KGR.	Ahrens ME, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-35; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Bofkin L, 2007, MOL BIOL EVOL, V24, P513, DOI 10.1093/molbev/msl178; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Chen YP, 2003, SOUTHWEST ENTOMOL, V28, P27; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Eyre-Walker A, 2006, TRENDS ECOL EVOL, V21, P569, DOI 10.1016/j.tree.2006.06.015; FILIPSKI J, 1988, J THEOR BIOL, V134, P159, DOI 10.1016/S0022-5193(88)80199-1; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; Golding GB, 1998, MOL BIOL EVOL, V15, P355, DOI 10.1093/oxfordjournals.molbev.a025932; GOTZEK D, 2007, J INS BEHAV IN PRESS; Gotzek D, 2007, Q REV BIOL, V82, P201, DOI 10.1086/519965; Haddrill PR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r67; Hallar BL, 2007, GENETICA, V131, P69, DOI 10.1007/s10709-006-9114-5; HEDRICK PW, 2004, GENETICS POPULATION; Ho JWK, 2006, BIOINFORMATICS, V22, P2162, DOI 10.1093/bioinformatics/btl283; Huelsenbeck JP, 2004, J MOL EVOL, V58, P661, DOI 10.1007/s00239-004-2588-9; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Imyanitov EN, 2002, BIOTECHNIQUES, V33, P484, DOI 10.2144/02333bm04_11841a; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Keller L, 2002, CURR BIOL, V12, pR180, DOI 10.1016/S0960-9822(02)00737-6; Ko WY, 2006, GENETICS, V174, P349, DOI 10.1534/genetics.105.054346; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Krieger MJB, 2005, MOL BIOL EVOL, V22, P2090, DOI 10.1093/molbev/msi203; Krieger MJB, 2005, BIOESSAYS, V27, P91, DOI 10.1002/bies.20129; Krieger MJB, 1997, MOL ECOL, V6, P997, DOI 10.1046/j.1365-294X.1997.00264.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LARGET B, 2005, STAT METHODS MOL EVO; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; MADDISON WP, 2006, MESQUITE MODULAR SYS; MEILLOUR PNL, 2003, INSECT PHEROMONE BIO, P509; Mescher MC, 2003, ANN ENTOMOL SOC AM, V96, P810, DOI 10.1603/0013-8746(2003)096[0810:DOTTSF]2.0.CO;2; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Nachman MW, 2005, GENETICA, V123, P125, DOI 10.1007/s10709-004-2723-y; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nei M., 2000, MOL EVOLUTION PHYLOG; Nielsen R, 1998, GENETICS, V148, P929; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Parry-Smith DJ, 1998, GENE, V221, pGC57, DOI 10.1016/S0378-1119(97)00650-1; Phillips PC, 2005, GENETICA, V123, P15, DOI 10.1007/s10709-004-2704-1; Pitts JP, 2005, ZOOL SCR, V34, P493, DOI 10.1111/j.1463-6409.2005.00203.x; PITTS JP, 2007, ZOOTAXA IN PRESS; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ronquist F., 2005, MRBAYES 3 1 MANUAL; Rooney AP, 1999, MOL BIOL EVOL, V16, P706, DOI 10.1093/oxfordjournals.molbev.a026153; Rosenberg NA, 2003, EVOLUTION, V57, P1465, DOI 10.1554/03-012; Ross KG, 2007, BIOL J LINN SOC, V92, P541, DOI 10.1111/j.1095-8312.2007.00853.x; Ross KG, 2005, MOL ECOL, V14, P3419, DOI 10.1111/j.1365-294X.2005.02661.x; Ross KG, 1997, GENETICS, V147, P643; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Ross KG, 1997, GENETICS, V145, P961; Ross KG, 1998, P NATL ACAD SCI USA, V95, P14232, DOI 10.1073/pnas.95.24.14232; Ross KG, 2003, GENETICS, V165, P1853; Ross KG, 2002, BEHAV ECOL SOCIOBIOL, V51, P287, DOI [10.1007/s00265-001-0431-5, 10.1007/S00265-001-0431-5]; ROSS KG, 1993, GENETICS, V135, P843; Rousset F, 1997, GENETICS, V145, P1219; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scheffler K, 2005, MOL BIOL EVOL, V22, P2531, DOI 10.1093/molbev/msi250; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shoemaker DD, 2006, ANN ENTOMOL SOC AM, V99, P1213, DOI 10.1603/0013-8746(2006)99[1213:PGOTIF]2.0.CO;2; Shoemaker DD, 2006, MOL PHYLOGENET EVOL, V38, P200, DOI 10.1016/j.ympev.2005.07.014; SIKES DS, 2001, SOFTWARE MANUAL PAUP; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tschinkel WR, 2006, FIRE ANTS; Vasemagi A, 2005, MOL ECOL, V14, P3623, DOI 10.1111/j.1365-294X.2005.02690.x; VOGT RG, 2005, ENDOCRINOLOGY, V3, P753; Wagner GP, 2004, MOL BIOL EVOL, V21, P2116, DOI 10.1093/molbev/msh221; Wheat CW, 2006, MOL BIOL EVOL, V23, P499, DOI 10.1093/molbev/msj062; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang JZ, 1997, MOL BIOL EVOL, V14, P1335, DOI 10.1093/oxfordjournals.molbev.a025743	92	22	32	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1088	10.1371/journal.pone.0001088	http://dx.doi.org/10.1371/journal.pone.0001088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987107	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459000001
J	Kalis, M; Leveen, P; Lyssenko, V; Almgren, P; Groop, L; Cilio, CM				Kalis, Martins; Leveen, Per; Lyssenko, Valeriya; Almgren, Peter; Groop, Leif; Cilio, Corrado M.			Variants in the FFAR1 Gene Are Associated with Beta Cell Function	PLOS ONE			English	Article								Background. The FFAR1 receptor is expressed mainly in pancreatic beta cells and is activated by medium to long chain free fatty acids (FFAs), as well as by thiazolidinediones, resulting in elevated Ca2+ concentrations and promotion of insulin secretion. These properties suggest that FFAR1 could be a mediator of lipotoxicity and a potential candidate gene for Type 2 diabetes (T2D). We therefore investigated whether variations at the FFAR1 locus are associated with T2D and beta cell function. Methodology/Principal Findings. We re-sequenced the FFAR1 region in 96 subjects (48 healthy and 48 T2D individuals) and found 13 single nucleotide polymorphisms (SNPs) 8 of which were not previously described. Two SNPs located in the upstream region of the FFAR1 gene (rs1978013 and rs1978014) were chosen and genotyped in 1929 patients with T2D and 1405 healthy control subjects. We observed an association of rs1978013 and rs1978014 with insulinogenic index in males (p = 0.024) and females (p = 0.032), respectively. After Bonferroni corrections, no association with T2D was found in the case-control material, however a haplotype consisting of the T-G alleles conferred protection against T2D (p = 0.0010). Conclusions/Significance. Variation in the FFAR1 gene may contribute to impaired beta cell function in T2D.	[Kalis, Martins; Leveen, Per; Cilio, Corrado M.] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Cellular Autoimmun Unit, Malmo, Sweden; [Lyssenko, Valeriya; Almgren, Peter; Groop, Leif] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital	Cilio, CM (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Cellular Autoimmun Unit, Malmo, Sweden.	corrado.cilio@med.lu.se			UMAS Foundations; Diabetes Program at Lund University; Albert Pahlssons Foundation; Swedish Research Council; Sigrid Juselius Foundation; Folkhalsan Research Foundation; Swedish Diabetes Research Foundation; Juvenile Diabetes Research Foundation [11-2004-38]	UMAS Foundations; Diabetes Program at Lund University; Albert Pahlssons Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Folkhalsan Research Foundation; Swedish Diabetes Research Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This study was supported by UMAS Foundations, Diabetes Program at Lund University, Albert Pahlssons Foundation, Swedish Research Council, Sigrid Juselius Foundation, Folkhalsan Research Foundation and Swedish Diabetes Research Foundation. CMC is supported by Juvenile Diabetes Research Foundation (Grant 11-2004-38).	Ahren B, 2005, CURR MOL MED, V5, P275, DOI 10.2174/1566524053766004; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; An P, 2005, DIABETES, V54, P909, DOI 10.2337/diabetes.54.3.909; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chu WS, 2007, DIABETES, V56, P856, DOI 10.2337/db06-1305; *DAL LAB WHIT I, 2007, HAPL; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Del Prato S, 2004, HORM METAB RES, V36, P775, DOI 10.1055/s-2004-826163; Elbein SC, 2002, DIABETES, V51, P528, DOI 10.2337/diabetes.51.2.528; ESKIN E, 2006, HAP HAPLOTYPE ANAL S; *GEN, 2007, MATINSPECTOR; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Groop L, 2000, INT J CLIN PRACT, P3; Groop L, 1996, DIABETES, V45, P1585, DOI 10.2337/diabetes.45.11.1585; Guo YF, 2006, J CLIN ENDOCR METAB, V91, P4001, DOI 10.1210/jc.2006-0549; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; Hamid YH, 2005, DIABETIC MED, V22, P74, DOI 10.1111/j.1464-5491.2005.01505.x; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; Hevener A, 2002, DIABETES, V51, P1907, DOI 10.2337/diabetes.51.6.1907; Ho E, 1999, P SOC EXP BIOL MED, V222, P205, DOI 10.1046/j.1525-1373.1999.d01-137.x; Itoh Y, 2005, HEPATOL RES, V33, P171, DOI 10.1016/j.hepres.2005.09.028; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; JACHEZ B, 1988, IMMUNOLOGY, V64, P31; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; LankatButtgereit B, 1997, PEPTIDES, V18, P617, DOI 10.1016/S0196-9781(97)00001-6; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; LeRoith D, 2002, AM J MED, V113, p3S; Malhotra A, 2007, DIABETES, V56, P890, DOI 10.2337/db06-1057; Manco M, 2004, DIABETES OBES METAB, V6, P402, DOI 10.1111/j.1462-8902.2004.00356.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mori Y, 2002, DIABETES, V51, P1247, DOI 10.2337/diabetes.51.4.1247; Ogawa T, 2005, METABOLISM, V54, P296, DOI 10.1016/j.metabol.2004.09.008; Panhuysen CIM, 2003, DIABETOLOGIA, V46, P579, DOI 10.1007/s00125-003-1066-z; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; PURCELL S, 2003, GENETIC POWER CALCUL; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Sawzdargo M, 1997, BIOCHEM BIOPH RES CO, V239, P543, DOI 10.1006/bbrc.1997.7513; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Steppel Jeanne H, 2004, Curr Diab Rep, V4, P169, DOI 10.1007/s11892-004-0019-3; Svoboda M, 1999, MOL GENET METAB, V68, P258, DOI 10.1006/mgme.1999.2913; TOMITA T, 2006, DIABETOLOGIA; van Tilburg JHO, 2003, J CLIN ENDOCR METAB, V88, P2223, DOI 10.1210/jc.2002-021252	45	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1090	10.1371/journal.pone.0001090	http://dx.doi.org/10.1371/journal.pone.0001090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987108	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459000002
J	Herron-Olson, L; Fitzgerald, JR; Musser, JM; Kapur, V				Herron-Olson, Lisa; Fitzgerald, J. Ross; Musser, James M.; Kapur, Vivek			Molecular Correlates of Host Specialization in Staphylococcus aureus	PLOS ONE			English	Article								Background. The majority of Staphylococcus aureus isolates that are recovered from either serious infections in humans or from mastitis in cattle represent genetically distinct sets of clonal groups. Moreover, population genetic analyses have provided strong evidence of host specialization among S. aureus clonal groups associated with human and ruminant infection. However, the molecular basis of host specialization in S. aureus is not understood. Methodology/Principal Findings. We sequenced the genome of strain ET3-1, a representative isolate of a common bovine mastitis-causing S. aureus clone. Strain ET3-1 encodes several genomic elements that have not been previously identified in S. aureus, including homologs of virulence factors from other Gram-positive pathogens. Relative to the other sequenced S. aureus associated with human infection, allelic variation in ET3-1 was high among virulence and surface-associated genes involved in host colonization, toxin production, iron metabolism, antibiotic resistance, and gene regulation. Interestingly, a number of well-characterized S. aureus virulence factors, including protein A and clumping factor A, exist as pseudogenes in ET3-1. Whole-genome DNA microarray hybridization revealed considerable similarity in the gene content of highly successful S. aureus clones associated with bovine mastitis, but not among those clones that are only infrequently recovered from bovine hosts. Conclusions/Significance. Whole genome sequencing and comparative genomic analyses revealed a set of molecular genetic features that distinguish clones of highly successful bovine-associated S. aureus optimized for mastitis pathogenesis in cattle from those that infect human hosts or are only infrequently recovered from bovine sources. Further, the results suggest that modern bovine specialist clones diverged from a common ancestor resembling human-associated S. aureus clones through a combination of foreign DNA acquisition and gene decay.	[Herron-Olson, Lisa; Kapur, Vivek] Univ Minnesota, Dept Microbiol Vet Pathobiol, St Paul, MN 55108 USA; [Herron-Olson, Lisa; Kapur, Vivek] Univ Minnesota, Biomed Genom Ctr, St Paul, MN 55108 USA; [Fitzgerald, J. Ross] Univ Edinburgh, Lab Bacterial Evolut & Pathogenesis, Edinburgh, Midlothian, Scotland; [Musser, James M.] Methodist Hosp, Ctr Mol & Translat Human Infect Dis Res, Res Inst, Houston, TX 77030 USA; [Musser, James M.] Methodist Hosp, Dept Pathol, Houston, TX 77030 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Edinburgh; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Kapur, V (corresponding author), Univ Minnesota, Dept Microbiol Vet Pathobiol, St Paul, MN 55108 USA.	vkapur@umn.edu	Kapur, Vivek/F-7610-2013	Kapur, Vivek/0000-0002-9648-0138	USDA-NRI Sustaining Animal Health; Well-Being Program; NIH NIGMS Biological Process Technology Institute [GM08347]; University of Minnesota Martha Kunze Graduate Fellowship	USDA-NRI Sustaining Animal Health; Well-Being Program; NIH NIGMS Biological Process Technology Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Minnesota Martha Kunze Graduate Fellowship	This research was funded by a competitive award from the USDA-NRI Sustaining Animal Health and Well-Being Program (to VK). LHO was supported by NIH NIGMS Biological Process Technology Institute fellowship GM08347 and University of Minnesota Martha Kunze Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson KL, 2006, AM J VET RES, V67, P1185, DOI 10.2460/ajvr.67.7.1185; Arvidson S, 2001, INT J MED MICROBIOL, V291, P159, DOI 10.1078/1438-4221-00112; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Barrio MB, 2006, MICROBES INFECT, V8, P2068, DOI 10.1016/j.micinf.2006.03.004; Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; Bayliss CD, 2001, J CLIN INVEST, V107, P657, DOI 10.1172/JCI12557; Beres SB, 2004, P NATL ACAD SCI USA, V101, P11833, DOI 10.1073/pnas.0404163101; Berriman Matt, 2003, Briefings in Bioinformatics, V4, P124, DOI 10.1093/bib/4.2.124; Bitter W, 1998, NATURE, V391, P499, DOI 10.1038/35166; Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; Brouillette E, 2003, MICROB PATHOGENESIS, V35, P159, DOI 10.1016/S0882-4010(03)00112-8; CIFRIAN E, 1994, J DAIRY SCI, V77, P970, DOI 10.3168/jds.S0022-0302(94)77033-8; Clarke SR, 2002, INFECT IMMUN, V70, P6680, DOI 10.1128/IAI.70.12.6680-6687.2002; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cucarella C, 2004, INFECT IMMUN, V72, P2177, DOI 10.1128/IAI.72.4.2177-2185.2004; Dego OK, 2002, VET QUART, V24, P181, DOI 10.1080/01652176.2002.9695135; Eiglmeier K, 2001, LEPROSY REV, V72, P387; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Erskine RJ, 2002, J DAIRY SCI, V85, P1111, DOI 10.3168/jds.S0022-0302(02)74172-6; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fitzgerald JR, 1997, EPIDEMIOL INFECT, V119, P261, DOI 10.1017/S0950268897007802; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Fitzgerald JR, 2001, J BACTERIOL, V183, P63, DOI 10.1128/JB.183.1.63-70.2001; Fueyo JM, 2005, J CLIN MICROBIOL, V43, P1278, DOI 10.1128/JCM.43.3.1278-1284.2005; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gilot P, 2004, J CLIN MICROBIOL, V42, P1265, DOI 10.1128/JCM.42.3.1265-1269.2004; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Haveri M, 2005, J CLIN MICROBIOL, V43, P959, DOI 10.1128/JCM.43.2.959-961.2005; Herron LL, 2002, INFECT IMMUN, V70, P3978, DOI 10.1128/IAI.70.7.3978-3981.2002; Herron-Olson L, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng107; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Iandolo JJ, 2002, GENE, V289, P109, DOI 10.1016/S0378-1119(02)00481-X; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; KAPUR V, 1995, J CLIN MICROBIOL, V33, P376, DOI 10.1128/JCM.33.2.376-380.1995; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Leitner G, 2003, FEMS IMMUNOL MED MIC, V35, P99, DOI 10.1016/S0928-8244(02)00458-3; LINDSAY JA, 1994, INFECT IMMUN, V62, P2309, DOI 10.1128/IAI.62.6.2309-2314.1994; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lowy FD, 2000, TRENDS MICROBIOL, V8, P341, DOI 10.1016/S0966-842X(00)01803-5; Luong TT, 2002, J BACTERIOL, V184, P3623, DOI 10.1128/JB.184.13.3623-3629.2002; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; MCCARTHY JEG, 1990, TRENDS GENET, V6, P78, DOI 10.1016/0168-9525(90)90098-Q; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Musser J. M., 1990, MOL BIOL STAPHYLOCOC, P59; MUSSER JM, 1990, P NATL ACAD SCI USA, V87, P225, DOI 10.1073/pnas.87.1.225; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; O'Brien DP, 2006, J BIOL CHEM, V281, P13317, DOI 10.1074/jbc.M601805200; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Rainard P, 2003, CLIN DIAGN LAB IMMUN, V10, P272, DOI 10.1128/CDLI.10.2.272-277.2003; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Reinoso E, 2004, MICROBIOL RES, V159, P245, DOI 10.1016/j.micres.2004.04.002; REINOSO E, 2006, MICROBIOL RES; Retzer MD, 1996, J BIOL CHEM, V271, P1166, DOI 10.1074/jbc.271.2.1166; Schuberth HJ, 2001, VET MICROBIOL, V82, P187, DOI 10.1016/S0378-1135(01)00386-8; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Swofford DL, 2001, SYST BIOL, V50, P525, DOI 10.1080/106351501750435086; Takeuchi S, 2001, VET MICROBIOL, V79, P267, DOI 10.1016/S0378-1135(00)00354-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tikofsky LL, 2003, MICROB DRUG RESIST, V9, pS39; TRIVIER D, 1995, FEMS MICROBIOL LETT, V127, P195; Trivier D, 1996, FEMS MICROBIOL LETT, V141, P117, DOI 10.1111/j.1574-6968.1996.tb08373.x; Vasudevan P, 2003, VET MICROBIOL, V92, P179, DOI 10.1016/S0378-1135(02)00360-7; Wells SJ, 1998, J DAIRY SCI, V81, P3029, DOI 10.3168/jds.S0022-0302(98)75867-9; Wilson DJ, 1999, J DAIRY SCI, V82, P1664, DOI 10.3168/jds.S0022-0302(99)75395-6; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005; Wright JS, 2005, J BACTERIOL, V187, P5585, DOI 10.1128/JB.187.16.5585-5594.2005; Yamada T, 2005, VET MICROBIOL, V110, P97, DOI 10.1016/j.vetmic.2005.07.006; Zadoks R, 2000, J CLIN MICROBIOL, V38, P1931, DOI 10.1128/JCM.38.5.1931-1939.2000; Zou D, 2000, BIOSCI BIOTECH BIOCH, V64, P2631, DOI 10.1271/bbb.64.2631	76	184	831	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1120	10.1371/journal.pone.0001120	http://dx.doi.org/10.1371/journal.pone.0001120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971880	Green Published, gold, Green Submitted			2022-12-27	WOS:000207458700034
J	Slot, JC; Hibbett, DS				Slot, Jason C.; Hibbett, David S.			Horizontal Transfer of a Nitrate Assimilation Gene Cluster and Ecological Transitions in Fungi: A Phylogenetic Study	PLOS ONE			English	Article							NITRITE REDUCTASE; SUPERNUMERARY CHROMOSOME; HYPOCREA-JECORINA; SELFISH OPERONS; EVOLUTION; TRICHODERMA; EXPRESSION; INFERENCE; NITROGEN; MRBAYES	High affinity nitrate assimilation genes in fungi occur in a cluster (fHANT-AC) that can be coordinately regulated. The clustered genes include nrt2, which codes for a high affinity nitrate transporter; euknr, which codes for nitrate reductase; and NAD(P)H-nir, which codes for nitrite reductase. Homologs of genes in the fHANT-AC occur in other eukaryotes and prokaryotes, but they have only been found clustered in the oomycete Phytophthora (heterokonts). We performed independent and concatenated phylogenetic analyses of homologs of all three genes in the fHANT-AC. Phylogenetic analyses limited to fungal sequences suggest that the fHANT-AC has been transferred horizontally from a basidiomycete (mushrooms and smuts) to an ancestor of the ascomycetous mold Trichoderma reesei. Phylogenetic analyses of sequences from diverse eukaryotes and eubacteria, and cluster structure, are consistent with a hypothesis that the fHANT-AC was assembled in a lineage leading to the oomycetes and was subsequently transferred to the Dikarya (Ascomycota+Basidiomycota), which is a derived fungal clade that includes the vast majority of terrestrial fungi. We propose that the acquisition of high affinity nitrate assimilation contributed to the success of Dikarya on land by allowing exploitation of nitrate in aerobic soils, and the subsequent transfer of a complete assimilation cluster improved the fitness of T. reesei in a new niche. Horizontal transmission of this cluster of functionally integrated genes supports the "selfish operon" hypothesis for maintenance of gene clusters.	[Slot, Jason C.; Hibbett, David S.] Clark Univ, Dept Biol, Worcester, MA 01610 USA	Clark University	Slot, JC (corresponding author), Clark Univ, Dept Biol, Worcester, MA 01610 USA.	jslot@clarku.edu	Slot, Jason/L-5500-2018; Slot, Jason/E-4802-2011		National Science Foundation Doctoral Dissertation Improvement [DEB0608017]	National Science Foundation Doctoral Dissertation Improvement(National Science Foundation (NSF))	Funding: This work was made possible by a National Science Foundation Doctoral Dissertation Improvement grant (DEB0608017, to DSH and JCS). The National Science Foundation played no role in the production of data or of the manuscript and this manuscript does not imply its approval of the research or publication of the results.	Abe Y, 2002, MOL GENET GENOMICS, V267, P636, DOI 10.1007/s00438-002-0697-y; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailly J, 2007, NEW PHYTOL, V175, P155, DOI 10.1111/j.1469-8137.2007.02066.x; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Brito N, 1996, BIOCHEM J, V317, P89, DOI 10.1042/bj3170089; CARBONE I, 2007, MOL ECOL; Celar F, 2003, BIOL CONTROL, V28, P19, DOI 10.1016/S1049-9644(03)00049-5; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Fleetwood DJ, 2007, APPL ENVIRON MICROB, V73, P2571, DOI 10.1128/AEM.00257-07; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Han YN, 2001, PLANT J, V25, P305, DOI 10.1046/j.1365-313x.2001.00969.x; He CZ, 1998, GENETICS, V150, P1459; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Howlett BJ, 2007, CURR BIOL, V17, pR87, DOI 10.1016/j.cub.2006.11.047; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jargeat P, 2003, CURR GENET, V43, P199, DOI 10.1007/s00294-003-0387-2; Jayaraj J., 1998, Journal of Mycology and Plant Pathology, V28, P23; JOHNSTONE IL, 1990, GENE, V90, P181, DOI 10.1016/0378-1119(90)90178-T; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kavanaugh LA, 2006, MOL BIOL EVOL, V23, P1879, DOI 10.1093/molbev/msl070; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Laich F, 2002, APPL ENVIRON MICROB, V68, P1211, DOI 10.1128/AEM.68.3.1211-1219.2002; Lawrence J, 1999, CURR OPIN GENET DEV, V9, P642, DOI 10.1016/S0959-437X(99)00025-8; Lawrence JG, 1997, TRENDS MICROBIOL, V5, P355, DOI 10.1016/S0966-842X(97)01110-4; LEYVAL C, 1991, NEW PHYTOL, V119, P93, DOI 10.1111/j.1469-8137.1991.tb01011.x; Lieckfeldt E, 2000, MYCOLOGIA, V92, P374, DOI 10.2307/3761493; LUQUE I, 1993, PLANT MOL BIOL, V21, P1201, DOI 10.1007/BF00023618; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Muro-Pastor MI, 1999, EMBO J, V18, P1584, DOI 10.1093/emboj/18.6.1584; OSTRIKOVA NA, 1983, APPL BIOCHEM MICROB, V19, P392; Price MN, 2005, GENOME RES, V15, P809, DOI 10.1101/gr.3368805; PUNT PJ, 1995, MOL CELL BIOL, V15, P5688; QUESADA A, 1993, MOL GEN GENET, V240, P387, DOI 10.1007/BF00280390; Randall TA, 2005, MOL PLANT MICROBE IN, V18, P229, DOI 10.1094/MPMI-18-0229; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Rocha-Ramirez V, 2002, EUKARYOT CELL, V1, P594, DOI 10.1128/EC.1.4.594-605.2002; Rosewich UL, 2000, ANNU REV PHYTOPATHOL, V38, P325, DOI 10.1146/annurev.phyto.38.1.325; Saikia R., 2001, Environment and Ecology, V19, P849; Samuels GJ, 2006, PHYTOPATHOLOGY, V96, P195, DOI 10.1094/PHYTO-96-0195; Sarrocco S, 2006, MYCOL RES, V110, P179, DOI 10.1016/j.mycres.2005.08.005; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Seiboth B, 2005, APPL ENVIRON MICROB, V71, P851, DOI 10.1128/AEM.71.2.851-857.2005; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SLOT JC, 2007, MOL BIOL EVOL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stemmler SJ, 2003, EUR J SOIL SCI, V54, P725, DOI 10.1046/j.1351-0754.2003.0571.x; Stolz JF, 2002, CHEMBIOCHEM, V3, P198, DOI 10.1002/1439-7633(20020301)3:2/3<198::AID-CBIC198>3.0.CO;2-C; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsuda A, 2003, SCIENCE, V300, P958, DOI 10.1126/science.1082000; Wakelin SA, 1999, NEW ZEAL J AGR RES, V42, P337, DOI 10.1080/00288233.1999.9513383; Walton JD, 2000, FUNGAL GENET BIOL, V30, P167, DOI 10.1006/fgbi.2000.1224; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584; Zhang S, 2004, APPL ENVIRON MICROB, V70, P6875, DOI 10.1128/AEM.70.11.6875-6883.2004	56	101	108	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1097	10.1371/journal.pone.0001097	http://dx.doi.org/10.1371/journal.pone.0001097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971860	Green Submitted, Green Published, gold			2022-12-27	WOS:000207458700014
J	Yoo, MH; Xu, XM; Carlson, BA; Patterson, AD; Gladyshev, VN; Hatfield, DL				Yoo, Min-Hyuk; Xu, Xue-Ming; Carlson, Bradley A.; Patterson, Andrew D.; Gladyshev, Vadim N.; Hatfield, Dolph L.			Targeting Thioredoxin Reductase 1 Reduction in Cancer Cells Inhibits Self-Sufficient Growth and DNA Replication	PLOS ONE			English	Article								Thioredoxin reductase 1 (TR1) is a major redox regulator in mammalian cells. As an important antioxidant selenoprotein, TR1 is thought to participate in cancer prevention, but is also known to be over-expressed in many cancer cells. Numerous cancer drugs inhibit TR1, and this protein has been proposed as a target for cancer therapy. We previously reported that reduction of TR1 levels in cancer cells reversed many malignant characteristics suggesting that deficiency in TR1 function is antitumorigenic. The molecular basis for TR1's role in cancer development, however, is not understood. Herein, we found that, among selenoproteins, TR1 is uniquely overexpressed in cancer cells and its knockdown in a mouse cancer cell line driven by oncogenic k-ras resulted in morphological changes characteristic of parental (normal) cells, without significant effect on cell growth under normal growth conditions. When grown in serum-deficient medium, TR1 deficient cancer cells lose self-sufficiency of growth, manifest a defective progression in their S phase and a decreased expression of DNA polymerase a, an enzyme important in DNA replication. These observations provide evidence that TR1 is critical for self-sufficiency in growth signals of malignant cells, that TR1 acts largely as a pro-cancer protein and it is indeed a primary target in cancer therapy.	[Yoo, Min-Hyuk; Xu, Xue-Ming; Carlson, Bradley A.; Patterson, Andrew D.; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Nebraska System; University of Nebraska Lincoln	Hatfield, DL (corresponding author), NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	hatfield@mail.nih.gov	Patterson, Andrew/ABF-1575-2020; Gladyshev, Vadim N/A-9894-2013; Patterson, Andrew/G-3852-2012; Gladyshev, Vadim N/J-6187-2013	Patterson, Andrew/0000-0003-2073-0070; Patterson, Andrew/0000-0003-2073-0070; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [CA080946, GM065204]; National Cancer Institute; Center for Cancer Research; PRAT Fellowship; NIGMS; NATIONAL CANCER INSTITUTE [R01CA080946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM065204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PRAT Fellowship; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, and by NIH grants CA080946 and GM065204 to VNG. ADP was sponsored by the PRAT Fellowship, NIGMS, NIH.	Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Biaglow JE, 2005, CANCER BIOL THER, V4, P6; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Diwadkar-Navsariwala V, 2006, P NATL ACAD SCI USA, V103, P8179, DOI 10.1073/pnas.0508218103; Fujino G, 2006, SEMIN CANCER BIOL, V16, P427, DOI 10.1016/j.semcancer.2006.09.003; Gladyshev VN, 1999, P NATL ACAD SCI USA, V96, P835, DOI 10.1073/pnas.96.3.835; Gladyshev VN, 1998, J BIOL CHEM, V273, P8910, DOI 10.1074/jbc.273.15.8910; Gromer S, 2005, CELL MOL LIFE SCI, V62, P2414, DOI 10.1007/s00018-005-5143-y; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hatfield D.L., 2002, SELENIUM ITS MOL BIO, V36, P235, DOI 10.1080/10715760290006394; HOLMGREN A, 2006, SELENIUM ITS MOL BIO, P183; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; Koc A, 2006, J BIOL CHEM, V281, P15058, DOI 10.1074/jbc.M601968200; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; MULLER EGD, 1994, J BIOL CHEM, V269, P24466; Nguyen P, 2006, CANCER LETT, V236, P164, DOI 10.1016/j.canlet.2005.04.028; NODA M, 1983, P NATL ACAD SCI-BIOL, V80, P5602, DOI 10.1073/pnas.80.18.5602; NODA M, 1992, BIOCHEM J, V283, P347; Novoselov SV, 2005, ONCOGENE, V24, P8003, DOI 10.1038/sj.onc.1208940; Pavlov YI, 2006, INT REV CYTOL, V255, P41, DOI 10.1016/S0074-7696(06)55002-8; Rundlof AK, 2004, ANTIOXID REDOX SIGN, V6, P41, DOI 10.1089/152308604771978336; Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004; Yoo MH, 2006, J BIOL CHEM, V281, P13005, DOI 10.1074/jbc.C600012200	26	102	104	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1112	10.1371/journal.pone.0001112	http://dx.doi.org/10.1371/journal.pone.0001112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971875	gold, Green Submitted, Green Published			2022-12-27	WOS:000207458700029
J	Akashi, H; Goel, P; John, A				Akashi, Hiroshi; Goel, Piyush; John, Anoop			Ancestral Inference and the Study of Codon Bias Evolution: Implications for Molecular Evolutionary Analyses of the Drosophila melanogaster Subgroup	PLOS ONE			English	Article								Reliable inference of ancestral sequences can be critical to identifying both patterns and causes of molecular evolution. Robustness of ancestral inference is often assumed among closely related species, but tests of this assumption have been limited. Here, we examine the performance of inference methods for data simulated under scenarios of codon bias evolution within the Drosophila melanogaster subgroup. Genome sequence data for multiple, closely related species within this subgroup make it an important system for studying molecular evolutionary genetics. The effects of asymmetric and lineage-specific substitution rates (i.e., varying levels of codon usage bias and departures from equilibrium) on the reliability of ancestral codon usage was investigated. Maximum parsimony inference, which has been widely employed in analyses of Drosophila codon bias evolution, was compared to an approach that attempts to account for uncertainty in ancestral inference by weighting ancestral reconstructions by their posterior probabilities. The latter approach employs maximum likelihood estimation of rate and base composition parameters. For equilibrium and most non-equilibrium scenarios that were investigated, the probabilistic method appears to generate reliable ancestral codon bias inferences for molecular evolutionary studies within the D. melanogaster subgroup. These reconstructions are more reliable than parsimony inference, especially when codon usage is strongly skewed. However, inference biases are considerable for both methods under particular departures from stationarity (i.e., when adaptive evolution is prevalent). Reliability of inference can be sensitive to branch lengths, asymmetry in substitution rates, and the locations and nature of lineage-specific processes within a gene tree. Inference reliability, even among closely related species, can be strongly affected by ( potentially unknown) patterns of molecular evolution in lineages ancestral to those of interest.	[Akashi, Hiroshi; Goel, Piyush; John, Anoop] Penn State Univ, Inst Mol Evolutionary Genet, Dept Biol, State Coll, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Akashi, H (corresponding author), Penn State Univ, Inst Mol Evolutionary Genet, Dept Biol, State Coll, PA USA.	akashi@psu.edu			US National Science Foundation	US National Science Foundation(National Science Foundation (NSF))	This research is supported by a grant from the US National Science Foundation.	Akashi H, 2006, GENETICS, V172, P1711, DOI 10.1534/genetics.105.049676; Akashi H, 1997, GENETICS, V146, P295; AKASHI H, 1994, GENETICS, V136, P927; AKASHI H, 1995, GENETICS, V139, P1067; Akashi H, 1999, GENETICS, V151, P221; Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Akashi H, 1996, GENETICS, V144, P1297; Alvarez-Valin F, 2004, MOL PHYLOGENET EVOL, V31, P788, DOI 10.1016/j.ympev.2004.01.016; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Arndt PF, 2007, GENE, V390, P75, DOI 10.1016/j.gene.2006.11.022; Arndt PF, 2003, MOL BIOL EVOL, V20, P1887, DOI 10.1093/molbev/msg204; Bachtrog D, 2003, GENETICS, V165, P1221; Bartolome C, 2005, GENETICS, V169, P1495, DOI 10.1534/genetics.104.033068; Baudry E, 2003, GENETICS, V165, P1619; Begun DJ, 2002, GENETICS, V162, P1725; Begun DJ, 2001, MOL BIOL EVOL, V18, P1343, DOI 10.1093/oxfordjournals.molbev.a003918; Belle EMS, 2004, J MOL EVOL, V58, P653, DOI 10.1007/s00239-004-2587-x; Blanchette M, 2004, GENOME RES, V14, P2412, DOI 10.1101/gr.2800104; Bustamante CD, 2002, NATURE, V416, P531, DOI 10.1038/416531a; Bustamante CD, 2001, GENETICS, V159, P1779; COLLINS TM, 1994, SYST BIOL, V43, P482, DOI 10.2307/2413547; Comeron JM, 2005, MOL BIOL EVOL, V22, P2519, DOI 10.1093/molbev/msi246; Comeron JM, 2002, GENETICS, V161, P389; DuMont VB, 2004, GENETICS, V167, P171, DOI 10.1534/genetics.167.1.171; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; Duret L, 2002, GENETICS, V162, P1837; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Eanes WF, 1996, GENETICS, V144, P1027; Eyre-Walker A, 1998, J MOL EVOL, V47, P686, DOI 10.1007/PL00006427; Fay JC, 2000, GENETICS, V155, P1405; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Galtier N, 1998, MOL BIOL EVOL, V15, P871, DOI 10.1093/oxfordjournals.molbev.a025991; Galtier N, 2000, J MOL EVOL, V50, P224, DOI 10.1007/s002399910025; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hernandez RD, 2007, MOL BIOL EVOL, V24, P1792, DOI 10.1093/molbev/msm108; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Iida K, 2000, GENE, V261, P93, DOI 10.1016/S0378-1119(00)00482-0; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kanaya S, 2001, J MOL EVOL, V53, P290, DOI 10.1007/s002390010219; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; Kliman RM, 1999, J MOL EVOL, V49, P343, DOI 10.1007/PL00006557; Kliman RM, 1998, J MOL EVOL, V46, P534, DOI 10.1007/PL00006334; Ko WY, 2006, GENETICS, V174, P349, DOI 10.1534/genetics.105.054346; Ko WY, 2003, J MOL EVOL, V57, P562, DOI 10.1007/s00239-003-2510-x; Krishnan NM, 2004, MOL BIOL EVOL, V21, P1871, DOI 10.1093/molbev/msh198; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; Li Wen-Hsiung, 1997; Llopart A, 1999, GENETICS, V152, P269; Llopart A, 2000, GENETICS, V155, P1245; LONG MY, 1993, SCIENCE, V260, P91, DOI 10.1126/science.7682012; MASIDE X, 2007, GENETICS; Maside XL, 2004, CURR BIOL, V14, P150, DOI 10.1016/j.cub.2003.12.055; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean GAT, 1999, J MOL EVOL, V49, P63, DOI 10.1007/PL00006535; McVean GAT, 1999, GENET RES, V74, P145, DOI 10.1017/S0016672399003912; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; Moriyama EN, 1998, NUCLEIC ACIDS RES, V26, P3188, DOI 10.1093/nar/26.13.3188; Moriyama EN, 1997, J MOL EVOL, V45, P514, DOI 10.1007/PL00006256; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 2002, SYST BIOL, V51, P729, DOI 10.1080/10635150290102393; Nielsen R, 2007, MOL BIOL EVOL, V24, P228, DOI 10.1093/molbev/msl146; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Perez JA, 2003, MOL BIOL EVOL, V20, P1867, DOI 10.1093/molbev/msg199; PERNA NT, 1995, MOL BIOL EVOL, V12, P359; Pollard DA, 2006, PLOS GENET, V2, P1634, DOI 10.1371/journal.pgen.0020173; Power IL, 2003, AGROFOREST SYST, V57, P225, DOI 10.1023/A:1024838311287; Presgraves DC, 2005, CURR BIOL, V15, P1651, DOI 10.1016/j.cub.2005.07.065; Qin H, 2004, GENETICS, V168, P2245, DOI 10.1534/genetics.104.030866; Ree RH, 1998, SYST BIOL, V47, P582, DOI 10.1080/106351598260590; Rodriguez-Trelles F, 2000, J MOL EVOL, V50, P1; Rodriguez-Trelles F, 1999, GENETICS, V153, P339; Rodriguez-Trelles F, 2000, MOL BIOL EVOL, V17, P1710, DOI 10.1093/oxfordjournals.molbev.a026269; SAWYER SA, 1987, P NATL ACAD SCI USA, V84, P6225, DOI 10.1073/pnas.84.17.6225; SHARP PM, 1995, PHILOS T R SOC B, V349, P241, DOI 10.1098/rstb.1995.0108; SHIELDS DC, 1988, MOL BIOL EVOL, V5, P704; Smith NGC, 2002, J MOL EVOL, V55, P197, DOI 10.1007/s00239-002-2316-2; Snedecor G.W., 1989, AMES IOWA STATE U PR; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Takano-Shimizu T, 2001, MOL BIOL EVOL, V18, P606, DOI 10.1093/oxfordjournals.molbev.a003841; Takano-Shimizu T, 1999, GENETICS, V153, P1285; Templeton AR, 1996, GENETICS, V144, P1263; Webster MT, 2003, MOL BIOL EVOL, V20, P278, DOI 10.1093/molbev/msg037; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; WONG A, 2006, MOL PHYLOGENET EVOL; Wright SI, 2004, MOL BIOL EVOL, V21, P1719, DOI 10.1093/molbev/msh191; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; YANG ZH, 1995, MOL BIOL EVOL, V12, P451; Zhang JZ, 1997, J MOL EVOL, V44, pS139, DOI 10.1007/PL00000067; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zhang Z, 2002, GENETICS, V161, P1187	93	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1065	10.1371/journal.pone.0001065	http://dx.doi.org/10.1371/journal.pone.0001065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957249	Green Submitted, gold, Green Published			2022-12-27	WOS:000207458500012
J	Conboy, CM; Spyrou, C; Thorne, NP; Wade, EJ; Barbosa-Morais, NL; Wilson, MD; Bhattacharjee, A; Young, RA; Tavare, S; Lees, JA; Odom, DT				Conboy, Caitlin M.; Spyrou, Christiana; Thorne, Natalie P.; Wade, Elizabeth J.; Barbosa-Morais, Nuno L.; Wilson, Michael D.; Bhattacharjee, Arindam; Young, Richard A.; Tavare, Simon; Lees, Jacqueline A.; Odom, Duncan T.			Cell Cycle Genes Are the Evolutionarily Conserved Targets of the E2F4 Transcription Factor	PLOS ONE			English	Article							PROTEIN COMPLEX; IN-VIVO; ELEGANS; BINDING; IDENTIFICATION; SPECIFICITY; ANTAGONISM; EXPRESSION; DISTINCT; MODEL	Maintaining quiescent cells in G0 phase is achieved in part through the multiprotein subunit complex known as DREAM, and in human cell lines the transcription factor E2F4 directs this complex to its cell cycle targets. We found that E2F4 binds a highly overlapping set of human genes among three diverse primary tissues and an asynchronous cell line, which suggests that tissue-specific binding partners and chromatin structure have minimal influence on E2F4 targeting. To investigate the conservation of these transcription factor binding events, we identified the mouse genes bound by E2f4 in seven primary mouse tissues and a cell line. E2f4 bound a set of mouse genes that was common among mouse tissues, but largely distinct from the genes bound in human. The evolutionarily conserved set of E2F4 bound genes is highly enriched for functionally relevant regulatory interactions important for maintaining cellular quiescence. In contrast, we found minimal mRNA expression perturbations in this core set of E2f4 bound genes in the liver, kidney, and testes of E2f4 null mice. Thus, the regulatory mechanisms maintaining quiescence are robust even to complete loss of conserved transcription factor binding events.	[Conboy, Caitlin M.; Spyrou, Christiana; Thorne, Natalie P.; Barbosa-Morais, Nuno L.; Wilson, Michael D.; Tavare, Simon; Odom, Duncan T.] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England; [Spyrou, Christiana] Univ Cambridge, Stat Lab, Dept Pure Math & Math Stat, Cambridge CB2 1SB, England; [Thorne, Natalie P.; Tavare, Simon] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 9EW, England; [Wade, Elizabeth J.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Bhattacharjee, Arindam] Agilent Technol, Andover, MA USA; [Young, Richard A.; Lees, Jacqueline A.] MIT, Dept Biol, Cambridge, MA USA; [Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of Connecticut; Agilent Technologies; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Odom, DT (corresponding author), Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England.	duncan.odom@cancer.org.uk	Wilson, Michael D/K-6294-2014; Young, Richard A/F-6495-2012; Barbosa-Morais, Nuno L/I-2743-2013	Wilson, Michael D/0000-0002-4015-3066; Young, Richard A/0000-0001-8855-8647; Barbosa-Morais, Nuno L/0000-0002-1215-0538; Odom, Duncan/0000-0001-6201-5599; Conboy, Caitlin/0000-0001-8280-056X	NIH [N01DK92310, NCRR ICR U4Z RR16606, U19DK6125, U42RR16597]; EPSRC; CRUK; JDRF [6-2006-1099]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR016597, U42RR016606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK092310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); CRUK(Cancer Research UK); JDRF(Juvenile Diabetes Research Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from NIH (DTO, JL, EF, RAY), EPSRC ( CS) and CRUK (DTO, ST, NPT, NBM). Tissue distribution programs were generously supported by the JDRF (6-2006-1099) and NIH (N01DK92310; NCRR ICR U4Z RR16606; U19DK6125; U42RR16597).	Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bolstad BM CF, 2005, QUALITY ASSESSMENT A; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Ceol CJ, 2006, GENETICS, V173, P709, DOI 10.1534/genetics.106.056465; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dudoit S, 2002, GENOME BIOL, V3; Fay DS, 2000, GENESIS, V26, P279, DOI 10.1002/(SICI)1526-968X(200004)26:4<279::AID-GENE100>3.0.CO;2-C; Frolov MV, 2001, GENE DEV, V15, P2146, DOI 10.1101/gad.903901; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; Giangrande PH, 2004, GENE DEV, V18, P2941, DOI 10.1101/gad.1239304; Giangrande PH, 2004, EMBO J, V23, P1336, DOI 10.1038/sj.emboj.7600134; Harrison MM, 2006, P NATL ACAD SCI USA, V103, P16782, DOI 10.1073/pnas.0608461103; Huber P. H., 1981, ROBUST STAT; Humbert PO, 2000, MOL CELL, V6, P281, DOI 10.1016/S1097-2765(00)00029-0; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Khaitovich P, 2005, GENETICS, V170, P929, DOI 10.1534/genetics.104.037135; Kinross KM, 2006, BLOOD, V108, P886, DOI 10.1182/blood-2005-09-008656; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; Korenjak M, 2006, CURR MOL MED, V6, P705; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Lonnstedt I, 2002, STAT SINICA, V12, P31; MacIsaac KD, 2006, BIOINFORMATICS, V22, P423, DOI 10.1093/bioinformatics/bti815; Moberg K, 1996, MOL CELL BIOL, V16, P1436; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; *R COR DEV TEAM, 2005, R LANG ENV STAT COMP; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Rempel RE, 2000, MOL CELL, V6, P293, DOI 10.1016/S1097-2765(00)00030-7; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stevens C, 2003, ARCH BIOCHEM BIOPHYS, V412, P157, DOI 10.1016/S0003-9861(03)00054-7; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi Y, 2000, GENE DEV, V14, P804; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; [No title captured]	43	45	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1061	10.1371/journal.pone.0001061	http://dx.doi.org/10.1371/journal.pone.0001061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957245	Green Published, Green Submitted, gold			2022-12-27	WOS:000207458500008
J	Santamaria, L; Rodriguez-Perez, J; Larrinaga, AR; Pias, B				Santamaria, Luis; Rodriguez-Perez, Javier; Larrinaga, Asier R.; Pias, Beatriz			Predicting Spatial Patterns of Plant Recruitment Using Animal-Displacement Kernels	PLOS ONE			English	Article							BIRD-DISPERSED TREE; SEED DISPERSAL; GUT PASSAGE; SCALE; RAIN; ESTABLISHMENT; CONSEQUENCES; GERMINATION; LIMITATION; MODELS	For plants dispersed by frugivores, spatial patterns of recruitment are primarily influenced by the spatial arrangement and characteristics of parent plants, the digestive characteristics, feeding behaviour and movement patterns of animal dispersers, and the structure of the habitat matrix. We used an individual-based, spatially-explicit framework to characterize seed dispersal and seedling fate in an endangered, insular plant-disperser system: the endemic shrub Daphne rodriguezii and its exclusive disperser, the endemic lizard Podarcis lilfordi. Plant recruitment kernels were chiefly determined by the disperser's patterns of space utilization (i.e. the lizard's displacement kernels), the position of the various plant individuals in relation to them, and habitat structure (vegetation cover vs. bare soil). In contrast to our expectations, seed gut-passage rate and its effects on germination, and lizard speed-of-movement, habitat choice and activity rhythm were of minor importance. Predicted plant recruitment kernels were strongly anisotropic and fine-grained, preventing their description using one-dimensional, frequency-distance curves. We found a general trade-off between recruitment probability and dispersal distance; however, optimal recruitment sites were not necessarily associated to sites of maximal adult-plant density. Conservation efforts aimed at enhancing the regeneration of endangered plant-disperser systems may gain in efficacy by manipulating the spatial distribution of dispersers (e. g. through the creation of refuges and feeding sites) to create areas favourable to plant recruitment.	[Santamaria, Luis; Rodriguez-Perez, Javier; Larrinaga, Asier R.] CSIC UIB, IMEDEA, Mediterranean Inst Adv Studies, Esporles, Mallorca, Spain; [Pias, Beatriz] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona; Universidad Rey Juan Carlos	Santamaria, L (corresponding author), CSIC UIB, IMEDEA, Mediterranean Inst Adv Studies, Esporles, Mallorca, Spain.	luis.santamaria@uib.es	Larrinaga, Asier/B-3826-2013; Javier Rodríguez-Pérez, Ph.D. Biology/C-9773-2009; Santamaria, Luis/C-1438-2012; Traveset, Anna V/D-7802-2011; Pías, Beatriz/ABF-9948-2020	Larrinaga, Asier/0000-0001-6813-8784; Javier Rodríguez-Pérez, Ph.D. Biology/0000-0002-1292-9090; Santamaria, Luis/0000-0002-5072-2912; Pías, Beatriz/0000-0002-1136-8914	British Ecological Society [2272]; Spanish Ministry of Science and Technology [FP-2001-1819]	British Ecological Society; Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Funding: Funding to LSG by the British Ecological Society (Small Ecological Project Grant no. 2272) and to JRP by the Spanish Ministry of Science and Technology (FP-2001-1819) is gratefully acknowledged.	Alcantara JM, 2000, ECOLOGY, V81, P1937, DOI 10.1890/0012-9658(2000)081[1937:FSTSPA]2.0.CO;2; Alcantara JM, 2003, J EVOLUTION BIOL, V16, P1168, DOI 10.1046/j.1420-9101.2003.00618.x; BEYER HL, 2004, HAWTHS ANAL TOOLS; Clark CJ, 2005, ECOLOGY, V86, P2684, DOI 10.1890/04-1325; ERIKSSON O, 1992, OECOLOGIA, V91, P360, DOI 10.1007/BF00317624; Escudero A, 2005, J VEG SCI, V16, P383, DOI 10.1111/j.1654-1103.2005.tb02377.x; Figuerola J, 2005, AM J BOT, V92, P696, DOI 10.3732/ajb.92.4.696; Garcia D, 2005, J ECOL, V93, P693, DOI 10.1111/j.1365-2745.2005.01004.x; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Hardesty BD, 2006, ECOL LETT, V9, P516, DOI 10.1111/j.1461-0248.2006.00897.x; Harper J. L., 1977, Population biology of plants.; HERRERA CM, 1994, ECOL MONOGR, V64, P315, DOI 10.2307/2937165; Hickey JR, 1999, OIKOS, V87, P499, DOI 10.2307/3546814; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Holbrook KM, 2000, OECOLOGIA, V125, P249, DOI 10.1007/s004420000445; Holbrook KM, 2002, ECOGRAPHY, V25, P745, DOI 10.1034/j.1600-0587.2002.250610.x; HOLBROOK KM, 2006, SEED DISPERSAL THEOR; Jones FA, 2005, AM NAT, V166, P543, DOI 10.1086/491661; Jordano P, 2000, ECOL MONOGR, V70, P591, DOI 10.1890/0012-9615(2000)070[0591:SDETQC]2.0.CO;2; Jordano Pedro, 2002, P305, DOI 10.1079/9780851995250.0305; Katul GG, 2005, AM NAT, V166, P368, DOI 10.1086/432589; Kollmann Johannes, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P29, DOI 10.1078/1433-8319-00003; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; Maestre FT, 2003, ECOSYSTEMS, V6, P630, DOI 10.1007/s10021-002-0222-5; *MATHS INC, 1999, S PLUS 2000 GUID STA; Morales JM, 2006, ECOLOGY, V87, P1489, DOI 10.1890/0012-9658(2006)87[1489:TEOPDA]2.0.CO;2; MURRAY KG, 1988, ECOL MONOGR, V58, P271, DOI 10.2307/1942541; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Quinn G, 2002, EXPT DESIGN DATA ANA, P556; REYES T, 2003, OECOLOGIA, V136, P296; Riera N, 2002, J BIOGEOGR, V29, P713, DOI 10.1046/j.1365-2699.2002.00719.x; Robertson AW, 2006, FUNCT ECOL, V20, P58, DOI 10.1111/j.1365-2435.2005.01057.x; Rodgers A. R., 2005, HRT HOME RANGE TOOLS; RODRIGUEZPEREZ J, 2006, THESIS U BALEARIC IS; Saez Encarna, 1995, Herpetological Review, V26, P121; SAIN SR, 1994, THESIS RICE U TEXAS; SALVADOR A, 2006, LAGARTIJA BALEAR POD; Samuels IA, 2005, FUNCT ECOL, V19, P365, DOI 10.1111/j.1365-2435.2005.00973.x; SAS Institute, 2000, SAS STAT SOFTW US GU; SCHUPP EW, 1993, VEGETATIO, V108, P15; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Sun C, 1997, OECOLOGIA, V112, P94, DOI 10.1007/s004420050288; Travers C, 2005, J PERS DISORD, V19, P1, DOI 10.1521/pedi.19.1.1.62181; Traveset A, 1997, OECOLOGIA, V111, P241, DOI 10.1007/PL00008816; Traveset Anna, 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P151, DOI 10.1078/1433-8319-00057; Traveset Anna, 2002, P339, DOI 10.1079/9780851995250.0339; VENABLE DL, 1993, VEGETATIO, V108, P31; Verdu M, 2005, ECOLOGY, V86, P1385, DOI 10.1890/04-1647; Wehncke EV, 2003, J ECOL, V91, P677, DOI 10.1046/j.1365-2745.2003.00798.x; Wenny DG, 2000, ECOL MONOGR, V70, P331, DOI 10.1890/0012-9615(2000)070[0331:SDSPAS]2.0.CO;2; Wenny DG, 1998, P NATL ACAD SCI USA, V95, P6204, DOI 10.1073/pnas.95.11.6204; WESCOTT DA, 2000, OECOLOGIA, V102, P249; Westcott DA, 2005, OECOLOGIA, V146, P57, DOI 10.1007/s00442-005-0178-1; Westcott DA, 2000, OECOLOGIA, V122, P249, DOI 10.1007/PL00008853; WILLSON MF, 1993, VEGETATIO, V108, P261	55	28	29	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1008	10.1371/journal.pone.0001008	http://dx.doi.org/10.1371/journal.pone.0001008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925856	gold, Green Published			2022-12-27	WOS:000207456000007
J	Wang, Q; Pang, YP				Wang, Qi; Pang, Yuan-Ping			Normal-Mode-Analysis-Monitored Energy Minimization Procedure for Generating Small-Molecule Bound Conformations	PLOS ONE			English	Article							DYNAMICS SIMULATIONS; SELECTION; PROTEIN; INDUCTION; PROGRAM; EUDOC	The energy minimization of a small molecule alone does not automatically stop at a local minimum of the potential energy surface of the molecule if the minimum is shallow, thus leading to folding of the molecule and consequently hampering the generation of the bound conformation of a guest in the absence of its host. This questions the practicality of virtual screening methods that use conformations at local minima of their potential energy surfaces (local minimum conformations) as potential bound conformations. Here we report a normal-mode-analysis-monitored energy minimization (NEM) procedure that generates local minimum conformations as potential bound conformations. Of 22 selected guest-host complex crystal structures with guest structures possessing up to four rotatable bonds, all complexes were reproduced, with guest mass-weighted root mean square deviations of <1.0 angstrom, through docking with the NEM-generated guest local minimum conformations. An analysis of the potential energies of these local minimum conformations showed that 22 (100%), 18 (82%), 16 (73%), and 12 (55%) of the 22 guest bound conformations in the crystal structures had conformational strain energies of less than or equal to 3.8, 2.0, 0.6, and 0.0 kcal/mol, respectively. These results suggest that (1) the NEM procedure can generate small-molecule bound conformations, and (2) guests adopt low-strain-energy conformations for complexation, thus supporting the virtual screening methods that use local minimum conformations.	[Wang, Qi; Pang, Yuan-Ping] Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN 55905 USA	Mayo Clinic	Pang, YP (corresponding author), Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN 55905 USA.	pang@mayo.edu		Pang, Yuan-Ping/0000-0003-0838-2560	U. S. Army Medical Research Acquisition Activity [W81XWH-04-2-0001]; National Institutes of Health [5R01AI054574-03, 5R01GM061300-06]; Mayo Graduate School; Mayo Foundation for Medical Education and Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061300] Funding Source: NIH RePORTER	U. S. Army Medical Research Acquisition Activity; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; Mayo Foundation for Medical Education and Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by the U. S. Army Medical Research Acquisition Activity (W81XWH-04-2-0001), the National Institutes of Health (5R01AI054574-03 and 5R01GM061300-06), Mayo Graduate School, and the Mayo Foundation for Medical Education and Research.	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Beusen DD, 1996, J MOL STRUC-THEOCHEM, V370, P157, DOI 10.1016/S0166-1280(96)04565-4; Bostrom J, 1998, J COMPUT AID MOL DES, V12, P383, DOI 10.1023/A:1008007507641; Bruns RF, 1996, TRENDS PHARMACOL SCI, V17, P189, DOI 10.1016/0165-6147(96)20027-6; BURGEN ASV, 1981, FED PROC, V40, P2723; Case D.A, 1999, MOL BIOL+, V18, P329, DOI [10.1007/0-306-47089-6, DOI 10.1007/0-306-47089-6]; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dammkoehler RA, 1995, J COMPUT AID MOL DES, V9, P491, DOI 10.1007/BF00124320; Frisch M J, 1999, GAUSSIAN 98 REVISION; Hinsen Konrad, 2006, P1; JENSEN F, 1998, INTRO COMPUTATIONAL, P312; Kenakin T, 1996, TRENDS PHARMACOL SCI, V17, P190, DOI 10.1016/0165-6147(96)20026-4; KOSHLAND DE, 1994, ANGEW CHEM INT EDIT, V33, P2375; LEACH AR, 1991, REV COMPUTATIONAL CH, V2, P1; Oelschlaeger P, 2003, BIOCHEMISTRY-US, V42, P8945, DOI 10.1021/bi0300332; Pang YP, 2007, CLIN PHARMACOL THER, V81, P30, DOI 10.1038/sj.clpt.6100030; Pang YP, 2001, J COMPUT CHEM, V22, P1750, DOI 10.1002/jcc.1129; Pang YP, 2004, PROTEINS, V57, P747, DOI 10.1002/prot.20249; Pang YP, 1997, J MOL MODEL, V3, P240, DOI 10.1007/s008940050036; PANG YP, 2007, IBM J RES D IN PRESS; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Smith LJ, 2002, PROTEINS, V48, P487, DOI 10.1002/prot.10144; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Wang Q, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000820; Wang Q, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000531; Zagrovic B, 2002, J MOL BIOL, V323, P927, DOI 10.1016/S0022-2836(02)00997-X	29	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1025	10.1371/journal.pone.0001025	http://dx.doi.org/10.1371/journal.pone.0001025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925873	Green Published, gold, Green Submitted			2022-12-27	WOS:000207456000024
J	Dabney, AR; Storey, JD				Dabney, Alan R.; Storey, John D.			Optimality Driven Nearest Centroid Classification from Genomic Data	PLOS ONE			English	Article							VARIABLE SELECTION TECHNIQUES; DISCRIMINANT-ANALYSIS; GENE; CANCER; PREDICTION	Nearest-centroid classifiers have recently been successfully employed in high-dimensional applications, such as in genomics. A necessary step when building a classifier for high-dimensional data is feature selection. Feature selection is frequently carried out by computing univariate scores for each feature individually, without consideration for how a subset of features performs as a whole. We introduce a new feature selection approach for high-dimensional nearest centroid classifiers that instead is based on the theoretically optimal choice of a given number of features, which we determine directly here. This allows us to develop a new greedy algorithm to estimate this optimal nearest-centroid classifier with a given number of features. In addition, whereas the centroids are usually formed from maximum likelihood estimates, we investigate the applicability of high-dimensional shrinkage estimates of centroids. We apply the proposed method to clinical classification based on gene-expression microarrays, demonstrating that the proposed method can outperform existing nearest centroid classifiers.	[Dabney, Alan R.] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA; [Storey, John D.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Storey, John D.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Texas A&M University System; Texas A&M University College Station; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dabney, AR (corresponding author), Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA.	adabney@stat.tamu.edu; jstorey@u.washington.edu	Storey, John/B-5282-2011; Dabney, Alan/C-1171-2011	Storey, John/0000-0001-5992-402X	Cancer-Epidemiology and Biostatistics Training [5T32CA009168-29]; NIH [1 U54 GM2119]; NATIONAL CANCER INSTITUTE [T32CA009168] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002913] Funding Source: NIH RePORTER	Cancer-Epidemiology and Biostatistics Training; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported in part by the Cancer-Epidemiology and Biostatistics Training Grant 5T32CA009168-29 and NIH grant 1 U54 GM2119.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Bickel PJ, 2004, BERNOULLI, V10, P989, DOI 10.3150/bj/1106314847; Bo TH, 2002, GENOME BIOL, V3; Dabney AR, 2005, BIOINFORMATICS, V21, P4148, DOI 10.1093/bioinformatics/bti681; DABNEY AR, 2005, UW BIOSTATISTICS WOR; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guo YQ, 2007, BIOSTATISTICS, V8, P86, DOI 10.1093/biostatistics/kxj035; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Lee JW, 2005, COMPUT STAT DATA AN, V48, P869, DOI 10.1016/j.csda.2004.03.017; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; MCKAY RJ, 1982, BRIT J MATH STAT PSY, V35, P1, DOI 10.1111/j.2044-8317.1982.tb00638.x; MCKAY RJ, 1982, BRIT J MATH STAT PSY, V35, P30, DOI 10.1111/j.2044-8317.1982.tb00639.x; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Shen RL, 2006, BIOINFORMATICS, V22, P2635, DOI 10.1093/bioinformatics/btl442; Stein C., 1956, INADMISSIBILITY USUA, DOI DOI 10.1525/9780520313880-018; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299	21	26	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e1002	10.1371/journal.pone.0001002	http://dx.doi.org/10.1371/journal.pone.0001002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912341	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455900038
J	Azevedo, JL; Tietz, E; Two-Feathers, T; Paull, J; Chapman, K				Azevedo, John L., Jr.; Tietz, Emily; Two-Feathers, Tashena; Paull, Jeff; Chapman, Kenneth			Lactate, Fructose and Glucose Oxidation Profiles in Sports Drinks and the Effect on Exercise Performance	PLOS ONE			English	Article							EXOGENOUS CARBOHYDRATE OXIDATION; MODERATE-INTENSITY EXERCISE; COMBINED INGESTION; OXYGEN-UPTAKE; RAT; MUSCLE; EXPRESSION; TRANSPORT; HUMANS; METABOLISM	Exogenous carbohydrate oxidation was assessed in 6 male Category 1 and 2 cyclists who consumed CytoMax (TM) (C) or a leading sports drink (G) before and during continuous exercise (CE). C contained lactate-polymer, fructose, glucose and glucose polymer, while G contained fructose and glucose. Peak power output and VO2 on a cycle ergometer were 408+/-13 W and 67.4+/-3.2 mlO(2).kg(-1).min(-1). Subjects performed 3 bouts of CE with C, and 2 with G at 62% VO(2)peak for 90 min, followed by high intensity (HI) exercise (86% VO(2)peak) to volitional fatigue. Subjects consumed 250 ml fluid immediately before (-2 min) and every 15 min of cycling. Drinks at -2 and 45 min contained 100 mg of [U-C-13]-lactate, -glucose or -fructose. Blood, pulmonary gas samples and (CO2)-C-13 excretion were taken prior to fluid ingestion and at 5,10,15,30,45,60,75, and 90 min of CE, at the end of HI, and 15 min of recovery. HI after CE was 25% longer with C than G (6.5+/-0.8 vs. 5.2+/-1.0 min, P<0.05). (CO2)-C-13 from the -2 min lactate tracer was significantly elevated above rest at 5 min of exercise, and peaked at 15 min. (CO2)-C-13 from the -2 min glucose tracer peaked at 45 min for C and G. (CO2)-C-13 increased rapidly from the 45 min lactate dose, and by 60 min of exercise was 33% greater than glucose in C or G, and 36% greater than fructose in G. (CO2)-C-13 production following tracer fructose ingestion was greater than glucose in the first 45 minutes in C and G. Cumulative recoveries of tracer during exercise were: 92%+/-5.3% for lactate in C and 25+/-4.0% for glucose in C or G. Recoveries for fructose in C and G were 75+/-5.9% and 26+/-6.6%, respectively. Lactate was used more rapidly and to a greater extent than fructose or glucose. CytoMax significantly enhanced HI.	[Azevedo, John L., Jr.; Tietz, Emily; Two-Feathers, Tashena; Paull, Jeff; Chapman, Kenneth] Calif State Univ Chico, Dept Kinesiol, Exercise Biol Lab, Chico, CA 95929 USA	California State University System; California State University Chico	Azevedo, JL (corresponding author), Calif State Univ Chico, Dept Kinesiol, Exercise Biol Lab, Chico, CA 95929 USA.	JLAzevedo@csuchico.edu			CytoSport, Inc	CytoSport, Inc	JLA received a grant from CytoSport, Inc.	BALDWIN KM, 1978, BIOCHEM BIOPH RES CO, V83, P151, DOI 10.1016/0006-291X(78)90410-2; Bergman BC, 1999, J APPL PHYSIOL, V87, P1684, DOI 10.1152/jappl.1999.87.5.1684; Bertocci LA, 1997, J APPL PHYSIOL, V83, P32, DOI 10.1152/jappl.1997.83.1.32; Bonen A, 1997, CAN J APPL PHYSIOL, V22, P531, DOI 10.1139/h97-034; Brooks G. A., 1984, CIRCULATION RESPIRAT, P208, DOI DOI 10.1007/978-3-642-70610-3_15; Brooks GA, 1998, COMP BIOCHEM PHYS B, V120, P89, DOI 10.1016/S0305-0491(98)00025-X; Brooks GA, 2002, BIOCHEM SOC T, V30, P258, DOI 10.1042/bst0300258; Brooks GA, 1999, P NATL ACAD SCI USA, V96, P1129, DOI 10.1073/pnas.96.3.1129; BROOKS GA, 1991, J APPL PHYSIOL, V71, P333, DOI 10.1152/jappl.1991.71.1.333; Brooks GA, 1999, J APPL PHYSIOL, V87, P1713, DOI 10.1152/jappl.1999.87.5.1713; BROZEK J, 1963, ANN NY ACAD SCI, V110, P113, DOI 10.1111/j.1749-6632.1963.tb17079.x; BURANT CF, 1992, J BIOL CHEM, V267; DAVIDSON NO, 1992, AM J PHYSIOL, V262, pC795, DOI 10.1152/ajpcell.1992.262.3.C795; DONOVAN CM, 1983, AM J PHYSIOL, V244, pE83, DOI 10.1152/ajpendo.1983.244.1.E83; Fahey T D, 1991, Int J Sport Nutr, V1, P249; Fattor JA, 2005, AM J PHYSIOL-ENDOC M, V288, pE143, DOI 10.1152/ajpendo.00117.2004; GERTZ EW, 1988, J CLIN INVEST, V82, P2017, DOI 10.1172/JCI113822; Gutmann I., 1974, METHODS ENZYMATIC AN, P1464; Hashimoto T, 2005, J PHYSIOL-LONDON, V567, P121, DOI 10.1113/jphysiol.2005.087411; Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005; Iwanaga T, 2006, BIOMED RES-TOKYO, V27, P243, DOI 10.2220/biomedres.27.243; Jentjens RLPG, 2005, BRIT J NUTR, V93, P485, DOI 10.1079/BJN20041368; Jentjens RLPG, 2005, METABOLISM, V54, P610, DOI 10.1016/j.metabol.2004.12.004; Jentjens RLPG, 2004, MED SCI SPORT EXER, V36, P1551, DOI 10.1249/01.MSS.0000139796.07843.1D; Jentjens RLPG, 2004, J APPL PHYSIOL, V96, P1277, DOI 10.1152/japplphysiol.00974.2003; Jeukendrup AE, 2006, J APPL PHYSIOL, V100, P1134, DOI 10.1152/japplphysiol.00981.2004; Jeukendrup AE, 2004, NUTRITION, V20, P669, DOI 10.1016/j.nut.2004.04.017; KAYANO T, 1990, J BIOL CHEM, V265, P13276; MAZZEO RS, 1986, J APPL PHYSIOL, V60, P232, DOI 10.1152/jappl.1986.60.1.232; Miller BF, 2005, J APPL PHYSIOL, V98, P856, DOI 10.1152/japplphysiol.00753.2004; Miller BF, 2002, J PHYSIOL-LONDON, V544, P963, DOI 10.1113/jphysiol.2002.027128; Miller BF, 2002, AM J PHYSIOL-ENDOC M, V283, pE889, DOI 10.1152/ajpendo.00266.2002; MITCHELL JB, 1989, J APPL PHYSIOL, V67, P1843, DOI 10.1152/jappl.1989.67.5.1843; Murray R, 1998, INT J SPORTS MED, V19, pS133, DOI 10.1055/s-2007-971978; Paroder V, 2006, P NATL ACAD SCI USA, V103, P7270, DOI 10.1073/pnas.0602365103; Peronnet F, 1997, J APPL PHYSIOL, V82, P440, DOI 10.1152/jappl.1997.82.2.440; ROTH DA, 1990, ARCH BIOCHEM BIOPHYS, V279, P386, DOI 10.1016/0003-9861(90)90506-T; ROTH DA, 1990, ARCH BIOCHEM BIOPHYS, V279, P377, DOI 10.1016/0003-9861(90)90505-S; Scheepers A, 2004, JPEN-PARENTER ENTER, V28, P364, DOI 10.1177/0148607104028005364; SHERRATT HS, 1968, COMP BIOCHEM PHYSIOL, V24, P745, DOI 10.1016/0010-406X(68)90787-1; STANLEY WC, 1986, J APPL PHYSIOL, V60, P1116, DOI 10.1152/jappl.1986.60.4.1116; STANLEY WC, 1988, METABOLISM, V37, P850, DOI 10.1016/0026-0495(88)90119-9; STANLEY WC, 1985, AM J PHYSIOL, V249, pE595, DOI 10.1152/ajpendo.1985.249.6.E595; SWENSEN T, 1994, INT J SPORTS MED, V15, P430, DOI 10.1055/s-2007-1021083; Trimmer JK, 2002, J APPL PHYSIOL, V93, P233, DOI 10.1152/japplphysiol.01050.2001; WAHLE KWJ, 1972, COMP BIOCHEM PHYSIOL, V41, P759, DOI 10.1016/0305-0491(72)90088-0; Wallis GA, 2005, MED SCI SPORT EXER, V37, P426, DOI 10.1249/01.MSS.0000155399.23358.82; ZIERATH JR, 1995, BIOCHEM J, V311, P517, DOI 10.1042/bj3110517	48	25	32	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e927	10.1371/journal.pone.0000927	http://dx.doi.org/10.1371/journal.pone.0000927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895968	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455800006
J	Nitta, RT; Smith, CL; Kennedy, BK				Nitta, Ryan T.; Smith, Catherine L.; Kennedy, Brian K.			Evidence that Proteasome-Dependent Degradation of the Retinoblastoma Protein in Cells Lacking A-Type Lamins Occurs Independently of Gankyrin and MDM2	PLOS ONE			English	Article							GENE-PRODUCT; TUMOR SUPPRESSORS; FAMILY PROTEINS; NUCLEAR LAMINA; RB FAMILY; ONCOPROTEIN; INHIBITION; P53; IDENTIFICATION; PHOSPHORYLATION	Background. A-type lamins, predominantly lamins A and C, are nuclear intermediate filaments believed to act as scaffolds for assembly of transcription factors. Lamin A/C is necessary for the retinoblastoma protein (pRB) stabilization through unknown mechanism(s). Two oncoproteins, gankyrin and MDM2, are known to promote pRB degradation in other contexts. Consequently, we tested the hypothesis that gankyrin and/or MDM2 are required for enhanced pRB degradation in Lmna(-/-) fibroblasts. Principal Findings. To determine if gankyrin promotes pRB destabilization in the absence of lamin A/C, we first analyzed its protein levels in Lmna(-/-) fibroblasts. Both gankyrin mRNA levels and protein levels are increased in these cells, leading us to further investigate its role in pRB degradation. Consistent with prior reports, overexpression of gankyrin in Lmna(+/+) cells destabilizes pRB. This decrease is functionally significant, since gankyrin overexpressing cells are resistant to p16(ink4a)-mediated cell cycle arrest. These findings suggest that lamin A-mediated degradation of pRB would be gankyrin-dependent. However, effective RNAi-enforced reduction of gankyrin expression in Lmna(-/-) cells was insufficient to restore pRB stability. To test the importance of MDM2, we disrupted the MDM2-pRB interaction by transfecting Lmna(-/-) cells with p14(arf). p14(arf) expression was also insufficient to stabilize pRB or confer cell cycle arrest, suggesting that MDM2 also does not mediate pRB degradation in Lmna(-/-) cells. Conclusions/Significance. Our findings suggest that pRB degradation in Lmna(-/-) cells occurs by gankyrin and MDM2-independent mechanisms, leading us to propose the existence of a third proteasome-dependent pathway for pRB degradation. Two findings from this study also increase the likelihood that lamin A/C functions as a tumor suppressor. First, protein levels of the oncoprotein gankyrin are elevated in Lmna(-/-) fibroblasts. Second, Lmna(-/-) cells are refractory to p14(arf)-mediated cell cycle arrest, as was previously shown with p16(ink4a). Potential roles of lamin A/C in the suppression of tumorigenesis are discussed.	[Nitta, Ryan T.; Smith, Catherine L.; Kennedy, Brian K.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kennedy, BK (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	bkenn@u.washington.edu		Kennedy, Brian/0000-0002-5754-1874	National Institutes of Health [R01AG024287, AG013280]; NATIONAL INSTITUTE ON AGING [P30AG013280, R01AG024287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institutes of Health grant R01AG024287 to BKK. RTN. was supported by the NIH training grant AG013280.	Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Barbie DA, 2005, TRENDS CELL BIOL, V15, P378, DOI 10.1016/j.tcb.2005.05.005; Berezutskaya E, 1997, CELL GROWTH DIFFER, V8, P1277; Berezutskaya E, 1997, J BIOL CHEM, V272, P30135, DOI 10.1074/jbc.272.48.30135; Boyer SN, 1996, CANCER RES, V56, P4620; BRIDGER JM, 1993, J CELL SCI, V104, P297; Bridger JM, 2007, FEBS J, V274, P1354, DOI 10.1111/j.1742-4658.2007.05694.x; Bruce JL, 2000, MOL CELL, V6, P737, DOI 10.1016/S1097-2765(00)00072-1; Chang DLF, 2007, ONCOGENE, V26, P4627, DOI 10.1038/sj.onc.1210254; Chen TLL, 2001, EXP CELL RES, V263, P224, DOI 10.1006/excr.2000.5093; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; Dawson S, 2006, TRENDS CELL BIOL, V16, P229, DOI 10.1016/j.tcb.2006.03.001; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dimri GP, 1996, MOL CELL BIOL, V16, P2987; Dreuillet C, 2002, NUCLEIC ACIDS RES, V30, P4634, DOI 10.1093/nar/gkf587; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; GERACE L, 1978, J CELL BIOL, V79, P546, DOI 10.1083/jcb.79.2.546; Goldman Robert D., 2005, V264, P3, DOI 10.1002/0470093765.ch2; Goldman Robert D., 2005, V264, P1, DOI 10.1002/0470093765.ch1; Goldman Robert D., 2005, V264, P279, DOI 10.1002/0470093765.ch19; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; Higashitsuji H, 2005, CANCER CELL, V8, P75, DOI 10.1016/j.ccr.2005.06.006; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Higashitsuji H, 2005, CELL CYCLE, V4, P1335, DOI 10.4161/cc.4.10.2107; Hori T, 1998, GENE, V216, P113, DOI 10.1016/S0378-1119(98)00309-6; Horton LE, 1997, ONCOGENE, V14, P491, DOI 10.1038/sj.onc.1200851; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Jones DL, 1997, VIROLOGY, V239, P97, DOI 10.1006/viro.1997.8851; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Knight JS, 2005, P NATL ACAD SCI USA, V102, P18562, DOI 10.1073/pnas.0503886102; Kudlow BA, 2005, AIDS, V19, P1565, DOI 10.1097/01.aids.0000186827.91408.90; Leduc C, 2006, ONCOGENE, V25, P4147, DOI 10.1038/sj.onc.1209446; Li JN, 2002, BIOCHEMISTRY-US, V41, P3977, DOI 10.1021/bi011550s; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; MALLER JL, 1989, J CELL SCI, P53; MANCINI MA, 1994, P NATL ACAD SCI USA, V91, P418, DOI 10.1073/pnas.91.1.418; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; MITTNACHT S, 1991, COLD SPRING HARB SYM, V56, P197; Naetar N, 2007, J CELL SCI, V120, P737, DOI 10.1242/jcs.03390; Nishiyama R, 1998, CELL STRUCT FUNCT, V23, P291, DOI 10.1247/csf.23.291; Nitta RT, 2006, MOL CELL BIOL, V26, P5360, DOI 10.1128/MCB.02464-05; OZAKI T, 1994, ONCOGENE, V9, P2649; Park TJ, 2001, MOL CARCINOGEN, V30, P138, DOI 10.1002/mc.1022; Pekovic V, 2007, J CELL BIOL, V176, P163, DOI 10.1083/jcb.200606139; Prokocimer M, 2006, J STRUCT BIOL, V155, P351, DOI 10.1016/j.jsb.2006.02.016; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; RABINOVITCH PS, 1989, LAB INVEST, V60, P65; RABINOVITCH PS, 1994, METHOD CELL BIOL, V41, P263; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; SHAN B, 1992, MOL CELL BIOL, V12, P5620, DOI 10.1128/MCB.12.12.5620; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Takano M, 2002, EUR J BIOCHEM, V269, P943, DOI 10.1046/j.0014-2956.2001.02730.x; Van Berlo JH, 2005, HUM MOL GENET, V14, P2839, DOI 10.1093/hmg/ddi316; Yang YL, 2004, ONCOGENE, V23, P2096, DOI 10.1038/sj.onc.1207411; Ying HQ, 2006, CELL CYCLE, V5, P506, DOI 10.4161/cc.5.5.2515	59	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e963	10.1371/journal.pone.0000963	http://dx.doi.org/10.1371/journal.pone.0000963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17896003	gold, Green Submitted, Green Published			2022-12-27	WOS:000207455800041
J	Miralves, J; Magdeleine, E; Kaddoum, L; Brun, H; Peries, S; Joly, E				Miralves, Julie; Magdeleine, Eddy; Kaddoum, Lara; Brun, Helene; Peries, Sophie; Joly, Etienne			High Levels of MeCP2 Depress MHC Class I Expression in Neuronal Cells	PLOS ONE			English	Article							CPG-BINDING-PROTEIN; SEVERE MENTAL-RETARDATION; RETT-SYNDROME BRAIN; DNA METHYLATION; MOUSE MODEL; TRANSCRIPTIONAL REPRESSOR; CELLULAR-DIFFERENTIATION; NEUROLOGICAL SYMPTOMS; CHROMOSOMAL-PROTEIN; GENE-EXPRESSION	Background. The expression of MHC class I genes is repressed in mature neurons. The molecular basis of this regulation is poorly understood, but the genes are particularly rich in CpG islands. MeCP2 is a transcriptional repressor that binds to methylated CpG dinucleotides; mutations in this protein also cause the neurodevelopmental disease called Rett syndrome. Because MHC class I molecules play a role in neuronal connectivity, we hypothesised that MeCP2 might repress MHC class I expression in the CNS and that this might play a role in the pathology of Rett syndrome. Methodology. We show here that transiently transfected cells expressing high levels of MeCP2 specifically downregulate cell-surface expression of MHC class I molecules in the neuronal cell line N2A and they prevent the induction of MHC class I expression in response to interferon in these cells, supporting our first hypothesis. Surprisingly, however, overexpression of the mutated forms of MeCP2 that cause Rett syndrome had a similar effect on MHC class I expression as the wild-type protein. Immunohistological analyses of brain slices from MECP2 knockout mice (the MeCP2(tm1.1Bird) strain) demonstrated a small but reproducible increase in MHC class I when compared to their wild type littermates, but we found no difference in MHC class I expression in primary cultures of mixed glial cells (mainly neurons and astrocytes) from the knockout and wild-type mice. Conclusion. These data suggest that high levels of MeCP2, such as those found in mature neurons, may contribute to the repression of MHC expression, but we find no evidence that MeCP2 regulation of MHC class I is important for the pathogenesis of Rett syndrome.	[Miralves, Julie; Magdeleine, Eddy; Kaddoum, Lara; Peries, Sophie; Joly, Etienne] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Brun, Helene] Fac Med Toulouse, INSERM, Ctr Physiopathol Toulouse Purpan, F-31073 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Joly, E (corresponding author), CNRS, Inst Pharmacol & Biol Struct, Toulouse, France.	atn@cict.fr	Joly, Etienne/A-5644-2009	Joly, Etienne/0000-0002-7264-2681	Association Francaise du Syndrome de Rett (AFSR); CNRS	Association Francaise du Syndrome de Rett (AFSR); CNRS(Centre National de la Recherche Scientifique (CNRS))	Funding: This work was funded mostly by Association Francaise du Syndrome de Rett (AFSR), as well as core funds from CNRS, salaries were from MRT and FRM for JM, ITAV for EM and INSERM for EJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ariani F, 2004, HUM MUTAT, V24, P172, DOI 10.1002/humu.20065; Balmer D, 2003, J MOL MED-JMM, V81, P61, DOI 10.1007/s00109-002-0396-5; Beyer KS, 2002, HUM GENET, V111, P305, DOI 10.1007/s00439-002-0786-3; Bienvenu T, 2000, HUM MOL GENET, V9, P1377, DOI 10.1093/hmg/9.9.1377; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Clayton-Smith J, 2000, LANCET, V356, P830, DOI 10.1016/S0140-6736(00)02661-1; Cohen DRS, 2003, MOL CELL NEUROSCI, V22, P417, DOI 10.1016/S1044-7431(03)00026-5; Colantuoni C, 2001, NEUROBIOL DIS, V8, P847, DOI 10.1006/nbdi.2001.0428; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Couvert P, 2001, HUM MOL GENET, V10, P941, DOI 10.1093/hmg/10.9.941; DEsposito M, 1996, MAMM GENOME, V7, P533, DOI 10.1007/s003359900157; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Gobin SJP, 1999, J IMMUNOL, V163, P1428; GODDARD CA, 2007, P NATL ACAD SCI US; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; Jeffery L, 2004, J BIOL CHEM, V279, P49479, DOI 10.1074/jbc.M409070200; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jung BP, 2003, J NEUROBIOL, V55, P86, DOI 10.1002/neu.10201; Kaludov NK, 2000, NUCLEIC ACIDS RES, V28, P1921, DOI 10.1093/nar/28.9.1921; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; Lam C W, 2000, J Med Genet, V37, pE41, DOI 10.1136/jmg.37.12.e41; LaSalle JM, 2001, HUM MOL GENET, V10, P1729, DOI 10.1093/hmg/10.17.1729; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Lugtenberg D, 2006, J MED GENET, V43, P362, DOI 10.1136/jmg.2005.036178; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McLaren FH, 2001, J NEUROIMMUNOL, V112, P35, DOI 10.1016/S0165-5728(00)00410-0; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Miralves J, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-16; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Mullaney BC, 2004, NEUROSCIENCE, V123, P939, DOI 10.1016/j.neuroscience.2003.11.025; Nan XS, 1996, MOL CELL BIOL, V16, P414; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Neul JL, 2004, NEUROSCIENTIST, V10, P118, DOI 10.1177/1073858403260995; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; NIKITINA T, 2007, J BIOL CHEM; Nikitina T, 2007, MOL CELL BIOL, V27, P864, DOI 10.1128/MCB.01593-06; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; Peddada S, 2006, HUM MOL GENET, V15, P2003, DOI 10.1093/hmg/ddl124; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Percy AK, 2002, NEUROL CLIN, V20, P1125, DOI 10.1016/S0733-8619(02)00022-1; QUADERI NA, 1994, GENOMICS, V22, P648, DOI 10.1006/geno.1994.1442; Ritz U, 2001, MOL MED, V7, P149, DOI 10.1007/BF03401948; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Shahbazian MD, 2001, CURR OPIN NEUROL, V14, P171, DOI 10.1097/00019052-200104000-00006; Sirianni N, 1998, AM J HUM GENET, V63, P1552, DOI 10.1086/302105; Syken J, 2003, P NATL ACAD SCI USA, V100, P13048, DOI 10.1073/pnas.1735415100; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; TYKOCINSKI ML, 1984, NUCLEIC ACIDS RES, V12, P4385, DOI 10.1093/nar/12.10.4385; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Villard L, 2000, NEUROLOGY, V55, P1188, DOI 10.1212/WNL.55.8.1188; Watson P, 2001, J MED GENET, V38, P224, DOI 10.1136/jmg.38.4.224; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Zoghbi HY, 2005, J CHILD NEUROL, V20, P736, DOI 10.1177/08830738050200090701	80	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1354	10.1371/journal.pone.0001354	http://dx.doi.org/10.1371/journal.pone.0001354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159237	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459700011
J	Cangiano, L; Gargini, C; Della Santina, L; Demontis, GC; Cervetto, L				Cangiano, Lorenzo; Gargini, Claudia; Della Santina, Luca; Demontis, Gian Carlo; Cervetto, Luigi			High-Pass Filtering of Input Signals by the I(h) Current in a Non-Spiking Neuron, the Retinal Rod Bipolar Cell	PLOS ONE			English	Article								Hyperpolarization-activated cyclic nucleotide-sensitive (HCN) channels mediate the I(f) current in heart and I(h) throughout the nervous system. In spiking neurons I(h) participates primarily in different forms of rhythmic activity. Little is known, however, about its role in neurons operating with graded potentials as in the retina, where all four channel isoforms are expressed. Intriguing evidence for an involvement of I(h) in early visual processing are the side effects reported, in dim light or darkness, by cardiac patients treated with HCN inhibitors. Moreover, electroretinographic recordings indicate that these drugs affect temporal processing in the outer retina. Here we analyzed the functional role of HCN channels in rod bipolar cells (RBCs) of the mouse. Perforated-patch recordings in the dark-adapted slice found that RBCs exhibit I(h), and that this is sensitive to the specific blocker ZD7288. RBC input impedance, explored by sinusoidal frequency-modulated current stimuli (0.1-30 Hz), displays band-pass behavior in the range of I(h) activation. Theoretical modeling and pharmacological blockade demonstrate that high-pass filtering of input signals by I(h), in combination with low-pass filtering by passive properties, fully accounts for this frequency-tuning. Correcting for the depolarization introduced by shunting through the pipette-membrane seal, leads to predict that in darkness I(h) is tonically active in RBCs and quickens their responses to dim light stimuli. Immunohistochemistry targeting candidate subunit isoforms HCN1-2, in combination with markers of RBCs (PKC) and rod-RBC synaptic contacts (bassoon, mGluR6, Kv1.3), suggests that RBCs express HCN2 on the tip of their dendrites. The functional properties conferred by I(h) onto RBCs may contribute to shape the retina's light response and explain the visual side effects of HCN inhibitors.	[Cangiano, Lorenzo; Gargini, Claudia; Demontis, Gian Carlo] Univ Pisa, Dipartimento Psichiat & Neurobiol, Pisa, Italy; [Della Santina, Luca; Cervetto, Luigi] Univ Pisa, Dipartimento Fisiol Umana G Moruzzi, Pisa, Italy	University of Pisa; University of Pisa	Cangiano, L (corresponding author), Univ Pisa, Dipartimento Psichiat & Neurobiol, Pisa, Italy.	lorenzo.cangiano@farm.unipi.it	Cangiano, Lorenzo/F-1482-2019; Demontis, Gian Carlo A.G./K-6963-2016; Della Santina, Luca/J-9795-2016	Cangiano, Lorenzo/0000-0001-7145-1288; Demontis, Gian Carlo A.G./0000-0001-7641-0426; Della Santina, Luca/0000-0001-6036-1295; GARGINI, MARIA CLAUDIA/0000-0002-4992-9086	Italian Ministry of Research (PRIN-Cofin, MiUR)	Italian Ministry of Research (PRIN-Cofin, MiUR)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	support was provided by the Italian Ministry of Research (PRIN-Cofin, MiUR).	BADER CR, 1979, J PHYSIOL-LONDON, V296, P1; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; BEECH DJ, 1989, NEURON, V3, P573, DOI 10.1016/0896-6273(89)90267-5; Berntson A, 2004, VISUAL NEUROSCI, V21, P693, DOI 10.1017/S0952523804215048; BIALEK W, 1990, BIOPHYS J, V58, P1227, DOI 10.1016/S0006-3495(90)82463-2; Brandstatter JH, 1999, EUR J NEUROSCI, V11, P3683, DOI 10.1046/j.1460-9568.1999.00793.x; Cervetto L, 2007, BRIT J PHARMACOL, V150, P383, DOI 10.1038/sj.bjp.0706998; Chavas J, 2003, J NEUROSCI, V23, P2019; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Demontis GC, 2002, J PHYSIOL-LONDON, V542, P89, DOI 10.1113/jphysiol.2002.017640; Demontis GC, 2002, NEWS PHYSIOL SCI, V17, P110, DOI 10.1152/nips.01364.2001; Demontis GC, 1999, J PHYSIOL-LONDON, V515, P813, DOI 10.1111/j.1469-7793.1999.813ab.x; DETWILER PB, 1980, J PHYSIOL-LONDON, V300, P213, DOI 10.1113/jphysiol.1980.sp013159; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Dong CJ, 2003, J NEUROPHYSIOL, V89, P2159, DOI 10.1152/jn.01008.2002; Dunn FA, 2006, J NEUROSCI, V26, P3959, DOI 10.1523/JNEUROSCI.5148-05.2006; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; FISCHMEISTER R, 1986, PFLUG ARCH EUR J PHY, V406, P73, DOI 10.1007/BF00582957; Fyk-Kolodziej B, 2007, J COMP NEUROL, V501, P891, DOI 10.1002/cne.21287; Gargini C, 1999, VISION RES, V39, P1767, DOI 10.1016/S0042-6989(98)00282-X; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; GOLD CEA, 2003, J NEUROSCI, V23, P3796; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; HUTCHEON B, 1994, J NEUROPHYSIOL, V71, P583, DOI 10.1152/jn.1994.71.2.583; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P698, DOI 10.1152/jn.1996.76.2.698; Ivanova E, 2006, VISUAL NEUROSCI, V23, P143, DOI 10.1017/S0952523806232048; Jackson HA, 2007, PHYSIOL GENOMICS, V29, P231, DOI 10.1152/physiolgenomics.00142.2006; Kim IB, 2003, J COMP NEUROL, V467, P389, DOI 10.1002/cne.10957; KLUMPP DJ, 1995, J NEUROSCI, V15, P5004; Koizumi A, 2004, MOL VIS, V10, P328; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Ma YP, 2003, J NEUROPHYSIOL, V90, P3479, DOI 10.1152/jn.00426.2003; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1998, J NEUROSCI, V18, P7613; Mao BQ, 2003, BIOPHYS J, V84, P2756, DOI 10.1016/S0006-3495(03)75080-2; Maric D, 1998, EUR J NEUROSCI, V10, P2532, DOI 10.1046/j.1460-9568.1998.00284.x; Meuth SG, 2006, J NEUROPHYSIOL, V96, P1517, DOI 10.1152/jn.01212.2005; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Muller F, 2003, EUR J NEUROSCI, V17, P2084, DOI 10.1046/j.1460-9568.2003.02634.x; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Pan ZH, 2000, J NEUROPHYSIOL, V83, P513, DOI 10.1152/jn.2000.83.1.513; Pan ZH, 2001, NEURON, V32, P89, DOI 10.1016/S0896-6273(01)00454-8; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; PUIL E, 1986, J NEUROPHYSIOL, V55, P995, DOI 10.1152/jn.1986.55.5.995; Qu JH, 2004, J BIOL CHEM, V279, P43497, DOI 10.1074/jbc.M405018200; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Satoh TO, 2000, NEUROPHARMACOLOGY, V39, P1284, DOI 10.1016/S0028-3908(99)00207-5; Singer JH, 2003, J NEUROSCI, V23, P10923; Tabata T, 1996, J NEUROPHYSIOL, V75, P1932, DOI 10.1152/jn.1996.75.5.1932; TESSIERLAVIGNE M, 1988, J GEN PHYSIOL, V91, P49, DOI 10.1085/jgp.91.1.49; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Ulrich D, 2002, J NEUROPHYSIOL, V87, P2753, DOI 10.1152/jn.2002.87.6.2753; Williams SR, 2003, J NEUROSCI, V23, P7358; Williams SR, 2002, J PHYSIOL-LONDON, V539, P469, DOI 10.1113/jphysiol.2001.013136; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; WOLLMUTH LP, 1992, J GEN PHYSIOL, V100, P749, DOI 10.1085/jgp.100.5.749; Wu SM, 2004, VISION RES, V44, P3277, DOI 10.1016/j.visres.2004.07.045; Xue T, 2002, CIRC RES, V90, P1267, DOI 10.1161/01.RES.0000024390.97889.C6; Ying SW, 2007, J NEUROSCI, V27, P8719, DOI 10.1523/JNEUROSCI.1630-07.2007; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; Zhou ZY, 2006, J NEUROPHYSIOL, V96, P2539, DOI 10.1152/jn.00688.2006; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	73	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1327	10.1371/journal.pone.0001327	http://dx.doi.org/10.1371/journal.pone.0001327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091997	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459600015
J	Sayer, EJ; Powers, JS; Tanner, EVJ				Sayer, Emma J.; Powers, Jennifer S.; Tanner, Edmund V. J.			Increased Litterfall in Tropical Forests Boosts the Transfer of Soil CO2 to the Atmosphere	PLOS ONE			English	Article							GROUND CARBON ALLOCATION; MICROBIAL BIOMASS; ROOT RESPIRATION; ORGANIC-CARBON; RAIN-FORESTS; DECOMPOSITION; NITROGEN; ECOSYSTEMS; CLIMATE; MANIPULATION	Aboveground litter production in forests is likely to increase as a consequence of elevated atmospheric carbon dioxide (CO2) concentrations, rising temperatures, and shifting rainfall patterns. As litterfall represents a major flux of carbon from vegetation to soil, changes in litter inputs are likely to have wide-reaching consequences for soil carbon dynamics. Such disturbances to the carbon balance may be particularly important in the tropics because tropical forests store almost 30% of the global soil carbon, making them a critical component of the global carbon cycle; nevertheless, the effects of increasing aboveground litter production on belowground carbon dynamics are poorly understood. We used long-term, large-scale monthly litter removal and addition treatments in a lowland tropical forest to assess the consequences of increased litterfall on belowground CO2 production. Over the second to the fifth year of treatments, litter addition increased soil respiration more than litter removal decreased it; soil respiration was on average 20% lower in the litter removal and 43% higher in the litter addition treatment compared to the controls but litter addition did not change microbial biomass. We predicted a 9% increase in soil respiration in the litter addition plots, based on the 20% decrease in the litter removal plots and an 11% reduction due to lower fine root biomass in the litter addition plots. The 43% measured increase in soil respiration was therefore 34% higher than predicted and it is possible that this 'extra' CO2 was a result of priming effects, i.e. stimulation of the decomposition of older soil organic matter by the addition of fresh organic matter. Our results show that increases in aboveground litter production as a result of global change have the potential to cause considerable losses of soil carbon to the atmosphere in tropical forests.	[Sayer, Emma J.; Tanner, Edmund V. J.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Sayer, Emma J.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Powers, Jennifer S.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Powers, Jennifer S.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Powers, Jennifer S.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA	University of Cambridge; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sayer, EJ (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	ejs44@cam.ac.uk	Sayer, Emma/B-2514-2010	Sayer, Emma/0000-0002-3322-4487	Mellon Foundation; Smithsonian Tropical Research Institute; Cambridge Philosophical Society; Drummond Fund; Gonville and Caius College, Cambridge; Gates Cambridge Scholarship; European Union Marie Curie Outgoing International Fellowship; NSF ADVANCE Fellowship [DBI0338143]	Mellon Foundation; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Cambridge Philosophical Society; Drummond Fund; Gonville and Caius College, Cambridge; Gates Cambridge Scholarship; European Union Marie Curie Outgoing International Fellowship(European Commission); NSF ADVANCE Fellowship	This study was funded by the Mellon Foundation, the Smithsonian Tropical Research Institute, the Cambridge Philosophical Society, and the Drummond Fund, Gonville and Caius College, Cambridge. EJS was supported by a Gates Cambridge Scholarship and a European Union Marie Curie Outgoing International Fellowship; JSP was supported by an NSF ADVANCE Fellowship ( DBI0338143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AS, 2000, ECOL APPL, V10, P437, DOI 10.1890/1051-0761(2000)010[0437:EOFACE]2.0.CO;2; ANDERSON JM, 1983, J ECOL, V71, P503, DOI 10.2307/2259731; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Beck T, 1997, SOIL BIOL BIOCHEM, V29, P1023, DOI 10.1016/S0038-0717(97)00030-8; Bernoux M, 2002, SOIL SCI SOC AM J, V66, P888, DOI 10.2136/sssaj2002.0888; BINGEMAN C. W., 1953, Proceedings. Soil Science Society of America, V17, P34; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; CAVELIER J, 1992, PLANT SOIL, V142, P187, DOI 10.1007/BF00010965; Clark DA, 2004, PHILOS T R SOC B, V359, P477, DOI 10.1098/rstb.2003.1426; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; CORNEJO FH, 1994, OIKOS, V70, P183, DOI 10.2307/3545629; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2002, AGR FOREST METEOROL, V113, P39, DOI 10.1016/S0168-1923(02)00101-6; De Nobili M, 2001, SOIL BIOL BIOCHEM, V33, P1163, DOI 10.1016/S0038-0717(01)00020-7; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; Desrochers A, 2002, TREE PHYSIOL, V22, P725, DOI 10.1093/treephys/22.10.725; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Finzi AC, 2001, ECOLOGY, V82, P470, DOI 10.1890/0012-9658(2001)082[0470:FLPCAD]2.0.CO;2; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Hamer U, 2005, GEODERMA, V128, P38, DOI 10.1016/j.geoderma.2004.12.014; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Leigh E.G., 1999, TROPICAL FOREST ECOL, P245; Leigh E.G. Jr, 1990, P28; Li YQ, 2004, SOIL BIOL BIOCHEM, V36, P2111, DOI 10.1016/j.soilbio.2004.06.003; Metcalfe DB, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000443; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Palmroth S, 2006, P NATL ACAD SCI USA, V103, P19362, DOI 10.1073/pnas.0609492103; Powers JS, 2005, NEW PHYTOL, V165, P913, DOI 10.1111/j.1469-8137.2004.01279.x; Pregitzer KS, 1998, TREE PHYSIOL, V18, P665; Priess JA, 2001, SOIL BIOL BIOCHEM, V33, P503, DOI 10.1016/S0038-0717(00)00191-7; Raich JW, 2006, ECOLOGY, V87, P76, DOI 10.1890/05-0023; RAICH JW, 1989, ECOLOGY, V70, P1346, DOI 10.2307/1938194; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; ROUT SK, 1989, ACTA OECOL-OEC PLANT, V10, P229; Sayer EJ, 2006, FOREST ECOL MANAG, V229, P285, DOI 10.1016/j.foreco.2006.04.007; Sayer EJ, 2006, PLANT SOIL, V281, P5, DOI 10.1007/s11104-005-6334-x; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; SINGH JS, 1977, BOT REV, V43, P499, DOI 10.1007/BF02860844; Vasconcelos SS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002210; Zak DR, 2003, ECOL APPL, V13, P1508, DOI 10.1890/03-5055; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025	45	103	125	6	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1299	10.1371/journal.pone.0001299	http://dx.doi.org/10.1371/journal.pone.0001299			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074023	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000207459500018
J	Tatem, AJ; Noor, AM; von Hagen, C; Di Gregorio, A; Hay, SI				Tatem, Andrew J.; Noor, Abdisalan M.; von Hagen, Craig; Di Gregorio, Antonio; Hay, Simon I.			High Resolution Population Maps for Low Income Nations: Combining Land Cover and Census in East Africa	PLOS ONE			English	Article							GLOBAL DISTRIBUTION; SPATIAL-RESOLUTION; PUBLIC-HEALTH; MALARIA; KENYA; URBANIZATION; COUNTRIES; RISK	Background. Between 2005 and 2050, the human population is forecast to grow by 2.7 billion, with the vast majority of this growth occurring in low income countries. This growth is likely to have significant social, economic and environmental impacts, and make the achievement of international development goals more difficult. The measurement, monitoring and potential mitigation of these impacts require high resolution, contemporary data on human population distributions. In low income countries, however, where the changes will be concentrated, the least information on the distribution of population exists. In this paper we investigate whether satellite imagery in combination with land cover information and census data can be used to create inexpensive, high resolution and easily-updatable settlement and population distribution maps over large areas. Methodology/Principal Findings. We examine various approaches for the production of maps of the East African region (Kenya, Uganda, Burundi, Rwanda and Tanzania) and where fine resolution census data exists, test the accuracies of map production approaches and existing population distribution products. The results show that combining high resolution census, settlement and land cover information is important in producing accurate population distribution maps. Conclusions. We find that this semi-automated population distribution mapping at unprecedented spatial resolution produces more accurate results than existing products and can be undertaken for as little as $0.01 per km(2). The resulting population maps are a product of the Malaria Atlas Project (MAP: http://www.map.ox.ac.uk) and are freely available.	[Tatem, Andrew J.; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Tatem, Andrew J.; Noor, Abdisalan M.; Hay, Simon I.] Univ Oxford, Wellcome Trust Collaborat Programme, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med,Kenya Med Res Inst KEMRI, Nairobi, Kenya; [von Hagen, Craig] Food & Agr Org United Nations, Somali Water & Land Informat Management Project, Nairobi, Kenya; [Di Gregorio, Antonio] Food & Agr Org United Nations, Global Land Cover Network, Rome, Italy	University of Oxford; Kenya Medical Research Institute; Food & Agriculture Organization of the United Nations (FAO); Food & Agriculture Organization of the United Nations (FAO)	Tatem, AJ (corresponding author), Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, S Parks Rd, Oxford OX1 3PS, England.	andy.tatem@zoo.ox.ac.uk	Hay, Simon Iain/F-8967-2015	Hay, Simon Iain/0000-0002-0611-7272; Tatem, Andrew/0000-0002-7270-941X	Wellcome Trust [079091]; Wellcome Trust, UK	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust, UK(Wellcome Trust)	SIH and AJT are supported by a Senior Research Fellowship from the Wellcome Trust (# 079091, to SIH). This work also forms part of the output of the Malaria Atlas Project ( MAP, http://www.map.ox.ac.uk), principally funded by the Wellcome Trust, UK. We thank Jack Rogers and Anjali Nayar for their help with Landsat data acquisition, and Gordana Vujanic for her help with the provision of Radarsat imagery. We also thank John Owour and Thomas Emanwu for provision of the Tanzania and Uganda census data respectively, and Priscilla Warimu for her substantial help in correcting the Kenya EA boundaries.	[Anonymous], 2005, WORLD URB PROSP 2005; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Bhaduri B., 2002, GEOINFORMATICS, V5, P34; Campbell James, 2006, INTRO REMOTE SENSING; Campbell M, 2007, SCIENCE, V315, P1501, DOI 10.1126/science.1140057; Chavez PS, 1996, PHOTOGRAMM ENG REM S, V62, P1025; DEICHMANN U, 1998, AFRICA MEDIUM RESOLU; Dobson JE, 2000, PHOTOGRAMM ENG REM S, V66, P849; ERDAS, 2005, ERDAS FIELD GUID; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; HAY SI, 2005, TROP MED INT HEALTH, V10, P1; Mahiny AS, 2007, PHOTOGRAMM ENG REM S, V73, P361, DOI 10.14358/PERS.73.4.361; McMichael AJ, 2000, B WORLD HEALTH ORGAN, V78, P1117; Nelson A., 2006, DATA SCI J, V5, P223; Noor AM, 2004, ACTA TROP, V91, P239, DOI 10.1016/j.actatropica.2004.05.003; Omumbo JA, 2005, TROP MED INT HEALTH, V10, P557, DOI 10.1111/j.1365-3156.2005.01424.x; Riley S. J., 1999, INTERMOUNTAIN J SCI, V5, P1; Salvatore M., 2005, MAPPING GLOBAL URBAN; Small C, 2004, CURR ANTHROPOL, V45, P269, DOI 10.1086/382255; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Tatem AJ, 2004, J URBAN HEALTH, V81, P363, DOI 10.1093/jurban/jth124; Tatem AJ, 2004, REMOTE SENS ENVIRON, V93, P42, DOI 10.1016/j.rse.2004.06.014; Tatem AJ, 2005, REMOTE SENS ENVIRON, V96, P87, DOI 10.1016/j.rse.2005.02.001; Tatem AJ, 2006, INT J REMOTE SENS, V27, P3073, DOI 10.1080/01431160600589195; Tatem Andrew J, 2004, Int J Appl Earth Obs Geoinf, V6, P33, DOI 10.1016/j.jag.2004.07.001; United Nations Population Division, 2006, WORLD POP PROSP 2006	26	133	135	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1298	10.1371/journal.pone.0001298	http://dx.doi.org/10.1371/journal.pone.0001298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074022	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000207459500017
J	Felberbaum-Corti, M; Morel, E; Cavalli, V; Vilbois, F; Gruenberg, J				Felberbaum-Corti, Michela; Morel, Etienne; Cavalli, Valeria; Vilbois, Francis; Gruenberg, Jean			The Redox Sensor TXNL1 Plays a Regulatory Role in Fluid Phase Endocytosis	PLOS ONE			English	Article								Background. Small GTPases of the Rab family can cycle between a GTP- and a GDP-bound state and also between membrane and cytosol. The latter cycle is mediated by the Guanine Nucleotide Dissociation Inhibitor GDI, which can selectively extract GDP-bound Rab proteins from donor membranes, and then reload them on target membranes. In previous studies, we found that capture of the small GTPase Rab5, a key regulator of endocytic membrane traffic, by GDI is stimulated by oxidative stress via p38MAPK, resulting in increased fluid phase endocytosis. Methodology/Principal Findings. When purifying the GDI stimulating activity we found that that it copurified with a high MW protein complex, which included p38MAPK. Here we report the identification and characterization of another component of this complex as the thioredoxin-like protein TXNL1. Our observations indicate that TXNL1 play a selective role in the regulation of fluid phase endocytosis, by controlling GDI capacity to capture Rab5. Conclusions/Significance. Oxidants, which are known to cause cellular damage, can also trigger signaling pathways, in particular via members of the thioredoxin family. We propose that TXNL1 acts as an effector of oxidants or a redox sensor by converting redox changes into changes of GDI capacity to capture Rab5, which in turn modulates fluid phase endocytosis.	[Felberbaum-Corti, Michela; Morel, Etienne; Cavalli, Valeria; Gruenberg, Jean] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Vilbois, Francis] Serono Pharmaceut Res Inst, Geneva, Switzerland	University of Geneva	Gruenberg, J (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland.	jean.gruenberg@biochem.unige.ch	MOREL, Etienne L/F-4765-2010; MOREL, Etienne/N-2194-2014	MOREL, Etienne L/0000-0001-7340-1313; MOREL, Etienne/0000-0002-4763-4954	Swiss National Science Foundation; Swiss Telethon Foundation; Fondation pour la Recherche Medicale (FRM); Roche Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Telethon Foundation; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Roche Research Foundation	Support was from the Swiss National Science Foundation and the Swiss Telethon Foundation (to JG) and Fondation pour la Recherche Medicale (FRM) and Roche Research Foundation (to EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI S, 1990, J BIOL CHEM, V265, P13007; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chinni SR, 1998, EXP CELL RES, V242, P373, DOI 10.1006/excr.1998.4105; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Felberbaum-Corti M, 2005, METHOD ENZYMOL, V403, P367, DOI 10.1016/S0076-6879(05)03032-6; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Gonzalez-Gaitan Marcos, 2003, Cell, V115, P513, DOI 10.1016/S0092-8674(03)00932-2; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Huang Qizhi, 2004, Cell and Tissue Banking, V5, P3, DOI 10.1023/B:CATB.0000022234.02322.13; Jimenez A, 2006, FEBS LETT, V580, P960, DOI 10.1016/j.febslet.2006.01.025; Jin J, 2002, EUR J BIOCHEM, V269, P2060, DOI 10.1046/j.1432-1033.2002.02844.x; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Lee KK, 1998, J BIOL CHEM, V273, P19160, DOI 10.1074/jbc.273.30.19160; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Miranda-Vizuete A, 1998, BIOCHEM BIOPH RES CO, V243, P284, DOI 10.1006/bbrc.1997.8003; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Slusarewicz P, 1997, P NATL ACAD SCI USA, V94, P5582, DOI 10.1073/pnas.94.11.5582; STEELEMORTIMER O, 1993, FEBS LETT, V329, P313, DOI 10.1016/0014-5793(93)80244-O; Vergarajauregui S, 2006, TRAFFIC, V7, P686, DOI 10.1111/j.1600-0854.2006.00420.x; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001; Witte S, 2000, J BIOL CHEM, V275, P1902, DOI 10.1074/jbc.275.3.1902; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Xu ZY, 1996, J CELL BIOL, V132, P787, DOI 10.1083/jcb.132.5.787; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	41	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1144	10.1371/journal.pone.0001144	http://dx.doi.org/10.1371/journal.pone.0001144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987124	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459000027
J	Wolf, LE; Donoghoe, A; Lane, T				Wolf, Leslie E.; Donoghoe, Alexis; Lane, Tim			Implementing Routine HIV Testing: The Role of State Law	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PACIFIC ISLANDER MEN; UNITED-STATES; HEALTH; BARRIERS; SEX; DISCRIMINATION; SAMPLE; ADULTS; RISK	In September 2006, the Centers for Disease Control and Prevention (CDC) recommended routine HIV testing for all Americans aged 13-64, which would eliminate requirements for written consent and pretest counseling as previously required. However, this approach may conflict with state requirements concerning pretest counseling and informed consent for HIV testing. Our survey of state HIV testing laws demonstrates that the majority of states have HIV testing requirements that are inconsistent with the CDC's recommendations. Moreover, states that have recently amended their laws have not eased the requirements for pretest counseling and informed consent. The reasons for the persistence of these legal requirements must be understood to effect policy changes to increase HIV testing.	[Wolf, Leslie E.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, Program Med Eth, San Francisco, CA 94143 USA; [Donoghoe, Alexis] Univ San Francisco, Sch Law, San Francisco, CA 94117 USA	University of California System; University of California San Francisco; University of San Francisco	Wolf, LE (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, Program Med Eth, San Francisco, CA 94143 USA.	lwolf@gsu.edu		Wolf, Leslie/0000-0002-4660-8383	Greenwall Foundation; NIMH Center	Greenwall Foundation; NIMH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding: This work was supported in part by the Greenwall Foundation and a NIMH Center Grant. The work is entirely that of the authors.	*AIDS ED TRAIN CTR, 2007, AETC RESP 2006 CDC H; *AM CIV LIB UN, 2006, HIV ACT TELL NEW YOR; [Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], 1999, Pediatrics, V104, P128; Bayer R, 2006, NEW ENGL J MED, V355, P647, DOI 10.1056/NEJMp068153; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Bolu OO, 2004, SEX TRANSM DIS, V31, P469, DOI 10.1097/01.olq.0000135987.12346.f2; Bond L, 2005, AIDS CARE, V17, P125, DOI 10.1080/09541020512331325653; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brooks RA, 2005, AIDS PATIENT CARE ST, V19, P737, DOI 10.1089/apc.2005.19.737; *CDCP, 1999, COUNS PROT STAND TES; *CDCP, 2001, MMWR RECOMM REP, V50, P63; *CDCP, 1999, COUNS PROT RAP TEST; CHAN S, 2006, NY TIMES NEW YORK CI, pB1; CHASE M, 2006, WALL STREET J NEW YO, pA1; Conyers Liza, 2005, Work, V25, P37; Do TD, 2006, AIDS EDUC PREV, V18, P44, DOI 10.1521/aeap.2006.18.1.44; Do TD, 2005, AIDS EDUC PREV, V17, P540, DOI 10.1521/aeap.2005.17.6.540; Fernandez MI, 2002, AIDS CARE, V14, P375, DOI 10.1080/09540120220123757; Freedberg KA, 1999, ARCH INTERN MED, V159, P1994, DOI 10.1001/archinte.159.17.1994; FREYER FJ, 2006, PROVIDENCE J PROVIDE, pB1; Gallant JE, 2004, AM FAM PHYSICIAN, V70, P295; Gostin LO, 2006, JAMA-J AM MED ASSOC, V296, P2023, DOI 10.1001/jama.296.16.2023; GRAHAM J, 2006, CHICAGO TRIBUNE CHIC; Herndon B, 2003, PUBLIC HEALTH REP, V118, P261, DOI 10.1093/phr/118.3.261; Huebner DM, 2004, AM J PUBLIC HEALTH, V94, P1200, DOI 10.2105/AJPH.94.7.1200; Inungu JN, 2002, AIDS PATIENT CARE ST, V16, P293, DOI 10.1089/10872910260066723; Johnson DF, 2003, AIDS PATIENT CARE ST, V17, P277, DOI 10.1089/108729103322108157; *KAIS FAM FDN, 2006, KAIS FAM FDN SURV AM; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; LEVINE S, 2006, WALL ST J       0227, pA1; Lopez-Quintero C, 2005, AIDS PATIENT CARE ST, V19, P672, DOI 10.1089/apc.2005.19.672; MacKellar DA, 2006, SEX TRANSM DIS, V33, P183, DOI 10.1097/01.olq.0000204507.21902.b3; Mimiaga MJ, 2007, SEX TRANSM DIS, V34, P113, DOI 10.1097/01.olq.0000225327.13214.bf; NIELSEN N, 2006, AMA WELCOMES NEW CTR; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; *SAN FRANC AIDS FD, 2006, COMM CDCS REV REC HI; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schuster MA, 2005, J GEN INTERN MED, V20, P807, DOI 10.1111/j.1525-1497.2005.05049.x; STOTO MA, 1999, REDUCING ODDS PREVEN; SZYMANSKI Z, 2006, BAY AREA REPORTER SA; Tobin KE, 2004, AIDS BEHAV, V8, P303, DOI 10.1023/B:AIBE.0000044077.66072.14; Weinhardt LS, 2000, ARCH INTERN MED, V160, P1538, DOI 10.1001/archinte.160.10.1538; Wolf LE, 2004, J LAW MED ETHICS, V32, P137, DOI 10.1111/j.1748-720X.2004.tb00459.x; ZELOTA NM, 2007, JAMA-J AM MED ASSOC, V297, P1061; FEDERAL HIV TESTING; 2006, ADV PAN M IMPL 2006; ACLU SAYS NEW CDC HI	48	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1005	10.1371/journal.pone.0001005	http://dx.doi.org/10.1371/journal.pone.0001005			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925853	Green Published, gold, Green Submitted			2022-12-27	WOS:000207456000004
J	Langer, M; Sniderhan, LF; Grossniklaus, U; Ray, A				Langer, Marybeth; Sniderhan, Lynn F.; Grossniklaus, Ueli; Ray, Animesh			Transposon Excision from an Atypical Site: A Mechanism of Evolution of Novel Transposable Elements	PLOS ONE			English	Article							ACTIVATOR TRANSPOSASE; MEIOTIC RECOMBINATION; MAIZE; GENE; REPAIR; ARABIDOPSIS; FREQUENCY; SEQUENCES; PATTERNS; HOMOLOG	The role of transposable elements in sculpting the genome is well appreciated but remains poorly understood. Some organisms, such as humans, do not have active transposons; however, transposable elements were presumably active in their ancestral genomes. Of specific interest is whether the DNA surrounding the sites of transposon excision become recombinogenic, thus bringing about homologous recombination. Previous studies in maize and Drosophila have provided conflicting evidence on whether transposon excision is correlated with homologous recombination. Here we take advantage of an atypical Dissociation (Ds) element, a maize transposon that can be mobilized by the Ac transposase gene in Arabidopsis thaliana, to address questions on the mechanism of Ds excision. This atypical Ds element contains an adjacent 598 base pairs (bp) inverted repeat; the element was allowed to excise by the introduction of an unlinked Ac transposase source through mating. Footprints at the excision site suggest a micro-homology mediated non-homologous end joining reminiscent of V(D)J recombination involving the formation of intra-helix 3' to 5' trans-esterification as an intermediate, a mechanism consistent with previous observations in maize, Antirrhinum and in certain insects. The proposed mechanism suggests that the broken chromosome at the excision site should not allow recombinational interaction with the homologous chromosome, and that the linked inverted repeat should also be mobilizable. To test the first prediction, we measured recombination of flanking chromosomal arms selected for the excision of Ds. In congruence with the model, Ds excision did not influence crossover recombination. Furthermore, evidence for correlated movement of the adjacent inverted repeat sequence is presented; its origin and movement suggest a novel mechanism for the evolution of repeated elements. Taken together these results suggest that the movement of transposable elements themselves may not directly influence linkage. Possibility remains, however, for novel repeated DNA sequences produced as a consequence of transposon movement to influence crossover in subsequent generations.	[Langer, Marybeth; Sniderhan, Lynn F.; Ray, Animesh] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Grossniklaus, Ueli] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Ray, Animesh] Keck Grad Inst, Claremont, CA USA	University of Rochester; Cold Spring Harbor Laboratory; Claremont Colleges; Keck Graduate Institute	Ray, A (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	aray@kgi.edu	Grossniklaus, Ueli/A-2736-2012; Grossniklaus, Ueli/E-9995-2016	Grossniklaus, Ueli/0000-0002-0522-8974; Ray, Animesh/0000-0002-0120-5820	National Science Foundation [IBN-9982414, EIA-0130059, EIA-0205061]; Cold Spring Harbor Laboratory President's Council; European Molecular Biology Organization	National Science Foundation(National Science Foundation (NSF)); Cold Spring Harbor Laboratory President's Council; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	Work in AR's laboratory was supported by National Science Foundation grants IBN-9982414, EIA-0130059, and EIA-0205061 to AR. Work in UG's laboratory was supported by the Cold Spring Harbor Laboratory President's Council and the European Molecular Biology Organization grants to UG.	Bai L, 2007, GENETICS, V175, P981, DOI 10.1534/genetics.106.066837; Becker HA, 1997, MOL GEN GENET, V254, P219, DOI 10.1007/s004380050410; COEN ES, 1986, CELL, V47, P285, DOI 10.1016/0092-8674(86)90451-4; Conrad LJ, 2005, GENETICS, V171, P1999, DOI 10.1534/genetics.105.046623; Dooner HK, 1997, PLANT CELL, V9, P1633, DOI 10.1105/tpc.9.9.1633; Dooner HK, 1997, GENETICS, V147, P1923; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; ENGELS WR, 1990, CELL, V62, P515, DOI 10.1016/0092-8674(90)90016-8; FEDOROFF NV, 1993, PLANT J, V3, P273, DOI 10.1046/j.1365-313X.1993.t01-15-00999.x; Fischer SEJ, 2003, GENETICS, V164, P127; FRADKIN CMW, 1956, GENETICS, V41, P901; Fu HH, 2002, P NATL ACAD SCI USA, V99, P1082, DOI 10.1073/pnas.022635499; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Golden TA, 2002, PLANT PHYSIOL, V130, P808, DOI 10.1104/pp.003491; Gorbunova V, 2000, GENETICS, V155, P349; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; McClintock B, 1953, CARNEGIE I WASH YB, V52, P227; Page DR, 2004, P NATL ACAD SCI USA, V101, P2969, DOI 10.1073/pnas.0400089101; Ray A, 1996, DEVELOPMENT, V122, P2631; Rinehart TA, 1997, PLANT J, V12, P1419, DOI 10.1046/j.1365-313x.1997.12061419.x; ROMMENS CMT, 1991, MOL GEN GENET, V228, P453, DOI 10.1007/BF00260639; Ros F, 2001, GENETICS, V157, P1723; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; SAEDLER H, 1985, EMBO J, V4, P585, DOI 10.1002/j.1460-2075.1985.tb03670.x; Scott L, 1996, GENETICS, V142, P237; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; vanderBiezen EA, 1996, MOL GEN GENET, V251, P267, DOI 10.1007/BF02172517; Weil CF, 2000, NAT GENET, V26, P187, DOI 10.1038/82827; Wright SI, 2003, GENOME RES, V13, P1897, DOI 10.1101/gr.1281503; Xiao YL, 2002, MOL GENET GENOMICS, V266, P720, DOI 10.1007/s00438-001-0600-2; Xiao YL, 2000, GENETICS, V156, P2007; Yan XH, 1999, GENETICS, V152, P1733; Yao H, 2002, P NATL ACAD SCI USA, V99, P6157, DOI 10.1073/pnas.082562199; Yu JH, 2004, MOL CELL BIOL, V24, P1351, DOI 10.1128/MCB.24.3.1351-1364.2004; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e965	10.1371/journal.pone.0000965	http://dx.doi.org/10.1371/journal.pone.0000965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912344	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455900003
J	Goldman, B; Bhat, S; Shimkets, LJ				Goldman, Barry; Bhat, Swapna; Shimkets, Lawrence J.			Genome Evolution and the Emergence of Fruiting Body Development in Myxococcus xanthus	PLOS ONE			English	Article								Background. Lateral gene transfer (LGT) is thought to promote speciation in bacteria, though well-defined examples have not been put forward. Methodology/Principle Findings. We examined the evolutionary history of the genes essential for a trait that defines a phylogenetic order, namely fruiting body development of the Myxococcales. Seventy-eight genes that are essential for Myxococcus xanthus development were examined for LGT. About 73% of the genes exhibit a phylogeny similar to that of the 16S rDNA gene and a codon bias consistent with other M. xanthus genes suggesting vertical transmission. About 22% have an altered codon bias and/or phylogeny suggestive of LGT. The remaining 5% are unique. Genes encoding signal production and sensory transduction were more likely to be transmitted vertically with clear examples of duplication and divergence into multigene families. Genes encoding metabolic enzymes were frequently acquired by LGT. Myxobacteria exhibit aerobic respiration unlike most of the delta Proteobacteria. M. xanthus contains a unique electron transport pathway shaped by LGT of genes for succinate dehydrogenase and three cytochrome oxidase complexes. Conclusions/Significance. Fruiting body development depends on genes acquired by LGT, particularly those involved in polysaccharide production. We suggest that aerobic growth fostered innovation necessary for development by allowing myxobacteria access to a different gene pool from anaerobic members of the delta Proteobacteria. Habitat destruction and loss of species diversity could restrict the evolution of new bacterial groups by limiting the size of the prospective gene pool.	[Bhat, Swapna; Shimkets, Lawrence J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Goldman, Barry] Monsanto Co, Appl Bioinformat, St Louis, MO USA	University System of Georgia; University of Georgia; Monsanto	Shimkets, LJ (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	shimkets@uga.edu			National Science Foundation [0343874]	National Science Foundation(National Science Foundation (NSF))	Funding: This work was supported by National Science Foundation grant 0343874.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; BRETON AM, 1985, J BACTERIOL, V161, P523, DOI 10.1128/JB.161.2.523-528.1985; Bull AT, 2000, MICROBIOL MOL BIOL R, V64, P573, DOI 10.1128/MMBR.64.3.573-606.2000; CAMPOS JM, 1978, J MOL BIOL, V119, P167, DOI 10.1016/0022-2836(78)90431-X; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; CHENG Y, 1989, J BACTERIOL, V171, P3727, DOI 10.1128/jb.171.7.3727-3731.1989; CHENG YL, 1994, J BACTERIOL, V176, P1427, DOI 10.1128/jb.176.5.1427-1433.1994; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Dolla A, 2006, J BIOTECHNOL, V126, P87, DOI 10.1016/j.jbiotec.2006.03.041; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Gevers D, 2004, TRENDS MICROBIOL, V12, P148, DOI 10.1016/j.tim.2004.02.007; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Gophna U, 2006, TRENDS MICROBIOL, V14, P64, DOI 10.1016/j.tim.2005.12.008; KALMAN LV, 1994, J BACTERIOL, V176, P1434, DOI 10.1128/jb.176.5.1434-1442.1994; Karlin S, 2000, J BACTERIOL, V182, P5238, DOI 10.1128/JB.182.18.5238-5250.2000; KASHEFI K, 1995, MOL MICROBIOL, V15, P483, DOI 10.1111/j.1365-2958.1995.tb02262.x; KLEINIG H, 1974, ARCH MICROBIOL, V101, P91, DOI 10.1007/BF00455928; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Lueders T, 2006, APPL ENVIRON MICROB, V72, P5342, DOI 10.1128/AEM.00400-06; Medrano-Soto A, 2004, MOL BIOL EVOL, V21, P1884, DOI 10.1093/molbev/msh202; Mrazek J, 1999, ANN NY ACAD SCI, V870, P314, DOI 10.1111/j.1749-6632.1999.tb08893.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Quaiser A, 2003, MOL MICROBIOL, V50, P563, DOI 10.1046/j.1365-2958.2003.03707.x; Rubin EJ, 1999, P NATL ACAD SCI USA, V96, P1645, DOI 10.1073/pnas.96.4.1645; SHIMKETS LJ, 1983, P NATL ACAD SCI-BIOL, V80, P1406, DOI 10.1073/pnas.80.5.1406; SHIMKETS LJ, 2007, HDB BIOL BACTERIA, V7, P31; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Vlamakis HC, 2004, MOL MICROBIOL, V52, P1799, DOI 10.1111/j.1365-2958.2004.04098.x; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; YAMANAKA S, 1987, J GEN APPL MICROBIOL, V33, P247, DOI 10.2323/jgam.33.247; Yanyushin MF, 2005, BIOCHEMISTRY-US, V44, P10037, DOI 10.1021/bi047267l; Youderian P, 2006, GENETICS, V172, P1397, DOI 10.1534/genetics.105.050542; Youderian P, 2003, MOL MICROBIOL, V49, P555, DOI 10.1046/j.1365-2958.2003.03582.x; Yu R, 2007, MOL MICROBIOL, V63, P454, DOI 10.1111/j.1365-2958.2006.05536.x	41	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1329	10.1371/journal.pone.0001329	http://dx.doi.org/10.1371/journal.pone.0001329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159227	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459700001
J	Sonderby, IE; Hansen, BG; Bjarnholt, N; Ticconi, C; Halkier, BA; Kliebenstein, DJ				Sonderby, Ida Elken; Hansen, Bjarne Gram; Bjarnholt, Nanna; Ticconi, Carla; Halkier, Barbara Ann; Kliebenstein, Daniel J.			A Systems Biology Approach Identifies a R2R3 MYB Gene Subfamily with Distinct and Overlapping Functions in Regulation of Aliphatic Glucosinolates	PLOS ONE			English	Article								Background. Glucosinolates are natural metabolites in the order Brassicales that defend plants against both herbivores and pathogens and can attract specialized insects. Knowledge about the genes controlling glucosinolate regulation is limited. Here, we identify three R2R3 MYB transcription factors regulating aliphatic glucosinolate biosynthesis in Arabidopsis by combining several systems biology tools. Methodology/Principal Findings. MYB28 was identified as a candidate regulator of aliphatic glucosinolates based on its co-localization within a genomic region controlling variation both in aliphatic glucosinolate content (metabolite QTL) and in transcript level for genes involved in the biosynthesis of aliphatic glucosinolates (expression QTL), as well as its co-expression with genes in aliphatic glucosinolate biosynthesis. A phylogenetic analysis with the R2R3 motif of MYB28 showed that it and two homologues, MYB29 and MYB76, were members of an Arabidopsis-specific clade that included three characterized regulators of indole glucosinolates. Over-expression of the individual MYB genes showed that they all had the capacity to increase the production of aliphatic glucosinolates in leaves and seeds and induce gene expression of aliphatic biosynthetic genes within leaves. Analysis of leaves and seeds of single knockout mutants showed that mutants of MYB29 and MYB76 have reductions in only short-chained aliphatic glucosinolates whereas a mutant in MYB28 has reductions in both short- and long-chained aliphatic glucosinolates. Furthermore, analysis of a double knockout in MYB28 and MYB29 identified an emergent property of the system since the absence of aliphatic glucosinolates in these plants could not be predicted by the chemotype of the single knockouts. Conclusions/Significance. It seems that these cruciferous-specific MYB regulatory genes have evolved both overlapping and specific regulatory capacities. This provides a unique system within which to study the evolution of MYB regulatory factors and their downstream targets.	[Ticconi, Carla; Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Sonderby, Ida Elken; Hansen, Bjarne Gram; Bjarnholt, Nanna; Halkier, Barbara Ann] Univ Copenhagen, Plant Biochem Lab, Dept Plant Biol, Ctr Mol Plant Physiol PlaCe,Fac Life Sci, Copenhagen, Denmark	University of California System; University of California Davis; University of Copenhagen	Kliebenstein, DJ (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	kliebenstein@ucdavis.edu	Bjarnholt, Nanna/F-5137-2017; Halkier, Barbara A/H-3196-2014	Bjarnholt, Nanna/0000-0002-5301-5885; Halkier, Barbara A/0000-0002-3742-702X; Kliebenstein, Daniel/0000-0001-5759-3175	The Danish National Research Foundation; PlaCe (Center for Molecular Plant Physiology); NSF [DBI 0642481]; FOBI (Graduate School in Biotechnology); Faculty of Life Sciences (Copenhagen University)	The Danish National Research Foundation(Danmarks Grundforskningsfond); PlaCe (Center for Molecular Plant Physiology); NSF(National Science Foundation (NSF)); FOBI (Graduate School in Biotechnology); Faculty of Life Sciences (Copenhagen University)	The presented work was supported by The Danish National Research Foundation through its support to PlaCe (Center for Molecular Plant Physiology) (Barbara Ann Halkier) and by NSF grants DBI# 0642481 to Dan J. Kliebenstein. The PhD stipends of Bjarne Gram Hansen and Ida Elken Sonderby were funded by FOBI (Graduate School in Biotechnology) and Faculty of Life Sciences (Copenhagen University), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Basten CJ, 1999, QTL CARTOGRAPHER VER; Bender J, 1998, P NATL ACAD SCI USA, V95, P5655, DOI 10.1073/pnas.95.10.5655; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett RN, 2005, PLANT BIOLOGY, V7, P348, DOI 10.1055/s-2005-837634; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Celenza JL, 2005, PLANT PHYSIOL, V137, P253, DOI 10.1104/pp.104.054395; CHURCHILL GA, 1994, GENETICS, V138, P963; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Doerge RW, 1996, GENETICS, V142, P285; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Field B, 2004, PLANT PHYSIOL, V135, P828, DOI 10.1104/pp.104.039347; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Gigolashvili T, 2007, PLANT J, V50, P886, DOI 10.1111/j.1365-313X.2007.03099.x; Gray J, 2005, CURR BIOL, V15, pR593, DOI 10.1016/j.cub.2005.07.039; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen BG, 2007, PLANT J, V50, P902, DOI 10.1111/j.1365-313X.2007.03101.x; Hemm MR, 2003, PLANT CELL, V15, P179, DOI 10.1105/tpc.006544; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jansen RC, 2004, TRENDS GENET, V20, P223, DOI 10.1016/j.tig.2004.03.002; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Kim JH, 2004, PLANT MOL BIOL, V54, P671, DOI 10.1023/B:PLAN.0000040897.49151.98; Kliebenstein D, 2002, GENETICS, V161, P325; Kliebenstein DJ, 2007, PLANT J, V51, P1062, DOI 10.1111/j.1365-313X.2007.03205.x; Kliebenstein DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-308; Kliebenstein DJ, 2005, CURR OPIN PLANT BIOL, V8, P264, DOI 10.1016/j.pbi.2005.03.002; Kliebenstein DJ, 2006, GENETICS, V172, P1179, DOI 10.1534/genetics.105.049353; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kliebenstein DJ, 2001, GENETICS, V159, P359; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Lehfeldt C, 2000, PLANT CELL, V12, P1295, DOI 10.1105/tpc.12.8.1295; Levy M, 2005, PLANT J, V43, P79, DOI 10.1111/j.1365-313X.2005.02435.x; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Martin C, 2002, PHILOS T ROY SOC B, V357, P809, DOI 10.1098/rstb.2002.1089; Mewis I, 2005, PLANT PHYSIOL, V138, P1149, DOI 10.1104/pp.104.053389; Mikkelsen MD, 2003, PLANT PHYSIOL, V131, P298, DOI 10.1104/pp.011015; Mithen R, 2003, THEOR APPL GENET, V106, P727, DOI 10.1007/s00122-002-1123-x; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sinlapadech T, 2007, PLANT J, V49, P655, DOI 10.1111/j.1365-313X.2006.02984.x; Skirycz A, 2006, PLANT J, V47, P10, DOI 10.1111/j.1365-313X.2006.02767.x; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Textor S, 2004, PLANTA, V218, P1026, DOI 10.1007/s00425-003-1184-3; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Tissier AF, 1999, PLANT CELL, V11, P1841, DOI 10.1105/tpc.11.10.1841; Wang S, 2012, WINDOWS QTL CARTOGRA; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; West MAL, 2006, GENOME RES, V16, P787, DOI 10.1101/gr.5011206; ZAMBRYSKI P, 1983, EMBO J, V2, P2143, DOI 10.1002/j.1460-2075.1983.tb01715.x; Zeng ZB, 1999, GENET RES, V74, P279, DOI 10.1017/S0016672399004255; Zhu JH, 2005, P NATL ACAD SCI USA, V102, P9966, DOI 10.1073/pnas.0503960102	63	253	263	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1322	10.1371/journal.pone.0001322	http://dx.doi.org/10.1371/journal.pone.0001322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18094747	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459600010
J	Iwamoto, K; Bundo, M; Ueda, J; Nakano, Y; Ukai, W; Hashimoto, E; Saito, T; Kato, T				Iwamoto, Kazuya; Bundo, Miki; Ueda, Junko; Nakano, Yoko; Ukai, Wataru; Hashimoto, Eri; Saito, Toshikazu; Kato, Tadafumi			Detection of Chromosomal Structural Alterations in Single Cells by SNP Arrays: A Systematic Survey of Amplification Bias and Optimized Workflow	PLOS ONE			English	Article								Background. In single-cell human genome analysis using whole-genome amplified product, a strong amplification bias involving allele dropout and preferential amplification hampers the quality of results. Using an oligonucleotide single nucleotide polymorphism (SNP) array, we systematically examined the nature of this amplification bias, including frequency, degree, and preference for genomic location, and we assessed the effects of this amplification bias on subsequent genotype and chromosomal copy number analyses. Methodology/Principal Findings. We found a large variability in amplification bias among the amplified products obtained by multiple displacement amplification (MDA), and this bias had a severe effect on the genotype and chromosomal copy number analyses. We established optimal experimental conditions for pre-screening for high-quality amplified products, processing array data, and analyzing chromosomal structural alterations. Using this optimized protocol, we successfully detected previously unidentified chromosomal structural alterations in single cells from a lymphoblastoid cell line. These alterations were subsequently confirmed by karyotype analysis. In addition, we successfully obtained reproducible chromosomal copy number profiles of single cells from the cell line with a complex karyotype, indicating the applicability and potential of our optimized workflow. Conclusions/Significance. Our results suggest that the quality of amplification products should be critically assessed before using them for genomic analyses. The method of MDA-based whole-genome amplification followed by SNP array analysis described here will be useful for exploring chromosomal alterations in single cells.	[Iwamoto, Kazuya; Bundo, Miki; Ueda, Junko; Nakano, Yoko; Kato, Tadafumi] RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, Saitama, Japan; [Ukai, Wataru; Hashimoto, Eri; Saito, Toshikazu] Sapporo Med Univ, Dept Neuropsychiat, Chuo Ku, Sapporo, Hokkaido, Japan	RIKEN; Sapporo Medical University	Iwamoto, K (corresponding author), RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, Saitama, Japan.	kaziwamoto@brain.riken.jp	Kato, Tadafumi/J-3583-2014	Kato, Tadafumi/0000-0001-7856-3952	Japanese Ministry of Health, Welfare, and Labor	Japanese Ministry of Health, Welfare, and Labor(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid from the Japanese Ministry of Health, Welfare, and Labor.	Arriola E, 2007, LAB INVEST, V87, P75, DOI 10.1038/labinvest.3700495; Cardoso J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh142; Cheung VG, 1996, P NATL ACAD SCI USA, V93, P14676, DOI 10.1073/pnas.93.25.14676; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dietmaier W, 1999, AM J PATHOL, V154, P83, DOI 10.1016/S0002-9440(10)65254-6; Fiegler H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1030; Grant SFA, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf125; Handyside AH, 2004, MOL HUM REPROD, V10, P767, DOI 10.1093/molehr/gah101; Harada T, 2002, ONCOLOGY-BASEL, V62, P251, DOI 10.1159/000059573; Hellani A, 2004, MOL HUM REPROD, V10, P847, DOI 10.1093/molehr/gah114; Hu DG, 2004, MOL HUM REPROD, V10, P283, DOI 10.1093/humrep/gah038; Hughes S, 2005, PROG BIOPHYS MOL BIO, V88, P173, DOI 10.1016/j.pbiomolbio.2004.01.007; Hughes S, 2004, CYTOGENET GENOME RES, V105, P18, DOI 10.1159/000078004; Iourov IY, 2006, INT REV CYTOL, V249, P143, DOI 10.1016/S0074-7696(06)49003-3; Iwamoto K, 2007, J NEUROSCI METH, V165, P104, DOI 10.1016/j.jneumeth.2007.05.029; Johnson NA, 2006, LAB INVEST, V86, P968, DOI 10.1038/labinvest.3700441; Kato T, 2002, LIFE SCI, V71, P581, DOI 10.1016/S0024-3205(02)01725-3; Kingsbury MA, 2006, CELL MOL LIFE SCI, V63, P2626, DOI 10.1007/s00018-006-6169-5; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Langmore JP, 2002, PHARMACOGENOMICS, V3, P557, DOI 10.1517/14622416.3.4.557; Lasken RS, 2003, TRENDS BIOTECHNOL, V21, P531, DOI 10.1016/j.tibtech.2003.09.010; Le Caignec C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl336; Lovmar L, 2006, HUM MUTAT, V27, P603, DOI 10.1002/humu.20341; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Rook MS, 2004, AM J PATHOL, V164, P23, DOI 10.1016/S0002-9440(10)63092-1; SATO T, 1989, BRIT J HAEMATOL, V72, P184, DOI 10.1111/j.1365-2141.1989.tb07681.x; Sermon K, 1996, MOL HUM REPROD, V2, P209, DOI 10.1093/molehr/2.3.209; Spits C, 2006, HUM MUTAT, V27, P496, DOI 10.1002/humu.20324; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Stoecklein NH, 2002, AM J PATHOL, V161, P43, DOI 10.1016/S0002-9440(10)64155-7; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Wang VW, 2001, CANCER RES, V61, P4169; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	35	32	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1306	10.1371/journal.pone.0001306	http://dx.doi.org/10.1371/journal.pone.0001306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074030	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459500025
J	McClintock, D; Ratner, D; Lokuge, M; Owens, DM; Gordon, LB; Collins, FS; Djabali, K				McClintock, Dayle; Ratner, Desiree; Lokuge, Meepa; Owens, David M.; Gordon, Leslie B.; Collins, Francis S.; Djabali, Karima			The Mutant Form of Lamin A that Causes Hutchinson-Gilford Progeria Is a Biomarker of Cellular Aging in Human Skin	PLOS ONE			English	Article								Hutchinson-Gilford progeria syndrome (HGPS, OMIM 176670) is a rare disorder characterized by accelerated aging and early death, frequently from stroke or coronary artery disease. 90% of HGPS cases carry the LMNA G608G (GGC>GGT) mutation within exon 11 of LMNA, activating a splice donor site that results in production of a dominant negative form of lamin A protein, denoted progerin. Screening 150 skin biopsies from unaffected individuals ( newborn to 97 years) showed that a similar splicing event occurs in vivo at a low level in the skin at all ages. While progerin mRNA remains low, the protein accumulates in the skin with age in a subset of dermal fibroblasts and in a few terminally differentiated keratinocytes. Progerin-positive fibroblasts localize near the basement membrane and in the papillary dermis of young adult skin; however, their numbers increase and their distribution reaches the deep reticular dermis in elderly skin. Our findings demonstrate that progerin expression is a biomarker of normal cellular aging and may potentially be linked to terminal differentiation and senescence in elderly individuals.	[McClintock, Dayle; Ratner, Desiree; Lokuge, Meepa; Owens, David M.; Djabali, Karima] Columbia Univ, Coll Phys & Surg, Dept Dermatol, New York, NY 10027 USA; [Owens, David M.] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA; [Gordon, Leslie B.] Brown Univ, Dept BioMed Pediat, Providence, RI 02912 USA; [Collins, Francis S.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA	Columbia University; Columbia University; Brown University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Djabali, K (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Dermatol, New York, NY 10027 USA.	kd206@columbia.edu	Gordon, Leslie B./AAJ-5793-2021	Ratner, Desiree/0000-0002-1217-1929	Progeria Research Foundation; Irving Foundation; NIH [K01AR048594, RO1AG025302, NCI R01CA114010]; National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR048594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025302] Funding Source: NIH RePORTER	Progeria Research Foundation; Irving Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by The Progeria Research Foundation, The Irving Foundation, and NIH Grants K01AR048594 and RO1AG025302 (to KD), NCI R01CA114010 (to DMO), and from the intramural program of the National Human Genome Research Institute (to FSC).	AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; BENAVENTE R, 1985, CELL, V41, P177, DOI 10.1016/0092-8674(85)90072-8; BRIDGER JM, 1993, J CELL SCI, V104, P297; BROWN WT, 1992, AM J CLIN NUTR, V55, P1222; BROWN WT, 1985, ADV EXP MED BIOL, V190, P229; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cao HN, 2003, J HUM GENET, V48, P271, DOI 10.1007/s10038-003-0025-3; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Csoka AB, 2004, J MED GENET, V41, P304, DOI 10.1136/jmg.2003.015651; CURRIGAN DP, 2005, BIOCHEM J, P129; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Delbarre E, 2006, HUM MOL GENET, V15, P1113, DOI 10.1093/hmg/ddl026; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; FERNANDEZPALAZZI F, 1992, EUR J PEDIATR SURG, V2, P378, DOI 10.1055/s-2008-1063486; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; FUNAYAMA R, 2007, CHROMOSOMA; FURUKAWA K, 1993, EMBO J, V12, P97, DOI 10.1002/j.1460-2075.1993.tb05635.x; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; HOZAK P, 1995, J CELL SCI, V108, P635; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; LENHER CF, 1987, J CELL BIOL, V105; LIN F, 1995, GENOMICS, V27, P230, DOI 10.1006/geno.1995.1036; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Machiels BM, 1996, J BIOL CHEM, V271, P9249, DOI 10.1074/jbc.271.16.9249; McClintock D, 2006, P NATL ACAD SCI USA, V103, P2154, DOI 10.1073/pnas.0511133103; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Paradisi M, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-27; Plasilova M, 2004, J MED GENET, V41, P609, DOI 10.1136/jmg.2004.019661; Rankin J, 2006, CLIN GENET, V70, P261, DOI 10.1111/j.1399-0004.2006.00677.x; ROBER RA, 1989, DEVELOPMENT, V105, P365; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Shumaker DK, 2003, CURR OPIN CELL BIOL, V15, P358, DOI 10.1016/S0955-0674(03)00050-4; SINENSKY M, 1994, J CELL SCI, V107, P61; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; STICK R, 1985, CELL, V41, P191, DOI 10.1016/0092-8674(85)90073-X; SWEENEY KJ, 1992, GERONTOLOGY, V38, P139; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; VOLZ A, 1993, GENOMICS, V18, P92, DOI 10.1006/geno.1993.1430; Wang HJ, 2004, IN VITRO CELL DEV-AN, V40, P268; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Wydner KL, 1996, GENOMICS, V32, P474, DOI 10.1006/geno.1996.0146; Young SG, 2006, J BIOL CHEM, V281, P39741, DOI 10.1074/jbc.R600033200; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	51	244	250	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1269	10.1371/journal.pone.0001269	http://dx.doi.org/10.1371/journal.pone.0001269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060063	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459400016
J	Hoshida, Y; Brunet, JP; Tamayo, P; Golub, TR; Mesirov, JP				Hoshida, Yujin; Brunet, Jean-Philippe; Tamayo, Pablo; Golub, Todd R.; Mesirov, Jill P.			Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets	PLOS ONE			English	Article								Whole genome expression profiles are widely used to discover molecular subtypes of diseases. A remaining challenge is to identify the correspondence or commonality of subtypes found in multiple, independent data sets generated on various platforms. While model-based supervised learning is often used to make these connections, the models can be biased to the training data set and thus miss inherent, relevant substructure in the test data. Here we describe an unsupervised subclass mapping method (SubMap), which reveals common subtypes between independent data sets. The subtypes within a data set can be determined by unsupervised clustering or given by predetermined phenotypes before applying SubMap. We define a measure of correspondence for subtypes and evaluate its significance building on our previous work on gene set enrichment analysis. The strength of the SubMap method is that it does not impose the structure of one data set upon another, but rather uses a bi-directional approach to highlight the common substructures in both. We show how this method can reveal the correspondence between several cancer-related data sets. Notably, it identifies common subtypes of breast cancer associated with estrogen receptor status, and a subgroup of lymphoma patients who share similar survival patterns, thus improving the accuracy of a clinical outcome predictor.	[Hoshida, Yujin; Brunet, Jean-Philippe; Tamayo, Pablo; Golub, Todd R.; Mesirov, Jill P.] MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02139 USA; [Hoshida, Yujin; Brunet, Jean-Philippe; Tamayo, Pablo; Golub, Todd R.; Mesirov, Jill P.] Harvard Univ, Cambridge, MA 02138 USA; [Hoshida, Yujin; Golub, Todd R.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute	Hoshida, Y (corresponding author), MIT, Eli & Edythe L Broad Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hoshida@broad.mit.edu	Mesirov, Jill/AGF-7626-2022; Hoshida, Yujin/R-7513-2019		Charles A King Trust Fellowship	Charles A King Trust Fellowship	Yujin Hoshida is supported by Charles A King Trust Fellowship. There was no contribution from the funder in any aspects of the current study including the design, analysis, interpretation, and preparation of the manuscript.	[Anonymous], 1932, STAT METHODS RES WOR; Becker B.J., 1994, HDB RES SYNTHESIS, P215; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Kapp AV, 2007, BIOSTATISTICS, V8, P9, DOI 10.1093/biostatistics/kxj029; Lakhani SR, 1998, JNCI-J NATL CANCER I, V90, P1138, DOI 10.1093/jnci/90.15.1138; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998	20	291	294	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1195	10.1371/journal.pone.0001195	http://dx.doi.org/10.1371/journal.pone.0001195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030330	Green Published, gold			2022-12-27	WOS:000207459200009
J	Jin, GX; Zhang, SH; Zhang, XS; Chen, LN				Jin, Guangxu; Zhang, Shihua; Zhang, Xiang-Sun; Chen, Luonan			Hubs with Network Motifs Organize Modularity Dynamically in the Protein-Protein Interaction Network of Yeast	PLOS ONE			English	Article								Background. It has been recognized that modular organization pervades biological complexity. Based on network analysis, 'party hubs' and 'date hubs' were proposed to understand the basic principle of module organization of biomolecular networks. However, recent study on hubs has suggested that there is no clear evidence for coexistence of 'party hubs' and 'date hubs'. Thus, an open question has been raised as to whether or not 'party hubs' and 'date hubs' truly exist in yeast interactome. Methodology. In contrast to previous studies focusing on the partners of a hub or the individual proteins around the hub, our work aims to study the network motifs of a hub or interactions among individual proteins including the hub and its neighbors. Depending on the relationship between a hub's network motifs and protein complexes, we define two new types of hubs, 'motif party hubs' and 'motif date hubs', which have the same characteristics as the original 'party hubs' and 'date hubs' respectively. The network motifs of these two types of hubs display significantly different features in spatial distribution (or cellular localizations), co-expression in microarray data, controlling topological structure of network, and organizing modularity. Conclusion. By virtue of network motifs, we basically solved the open question about 'party hubs' and 'date hubs' which was raised by previous studies. Specifically, at the level of network motifs instead of individual proteins, we found two types of hubs, motif party hubs (mPHs) and motif date hubs (mDHs), whose network motifs display distinct characteristics on biological functions. In addition, in this paper we studied network motifs from a different viewpoint. That is, we show that a network motif should not be merely considered as an interaction pattern but be considered as an essential function unit in organizing modules of networks.	[Jin, Guangxu; Zhang, Shihua; Zhang, Xiang-Sun] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China; [Jin, Guangxu; Zhang, Shihua] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Chen, Luonan] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Chen, Luonan] Osaka Sangyo Univ, Dept Elect Engn & Elect, Osaka, Japan; [Chen, Luonan] Japan Sci & Technol Corp JST, Aihara Complex Modelling Project, Exploratory Res Adv Technol, Tokyo, Japan; [Chen, Luonan] Univ Tokyo, Inst Ind Sci, Tokyo, Japan	Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai University; Japan Science & Technology Agency (JST); University of Tokyo	Zhang, XS (corresponding author), Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China.	zxs@amt.ac.cn; chen@eic.osaka-sandai.ac.jp	Zhang, Shihua/A-6764-2010; Jin, Guangxu/B-4627-2012	Jin, Guangxu/0000-0002-6616-6981; Jin, Guangxu/0000-0001-9451-4886	National Natural Science Foundation of China [10631070]; Ministry of Science and Technology, China [2006CB503905]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This work was partially supported by the National Natural Science Foundation of China under grant No. 10631070, and the Ministry of Science and Technology, China, under grant No. 2006CB503905.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Barabasi A. L., 2002, FORMULA UNIVERSAL LA; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Batada NN, 2006, PLOS BIOL, V4, P1720, DOI 10.1371/journal.pbio.0040317; Bernard R, 1986, FUNDAMENTALS BIOSTAT; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Enright AJ, 2001, BIOINFORMATICS, V17, P853, DOI 10.1093/bioinformatics/17.9.853; Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HE X, 2006, PLOS GENET, V2; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ideker T, 2003, TRENDS BIOTECHNOL, V21, P255, DOI 10.1016/S0167-7799(03)00115-X; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kemmeren P, 2002, MOL CELL, V9, P1133, DOI 10.1016/S1097-2765(02)00531-2; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Li CG, 2007, IEEE SIGNAL PROC MAG, V24, P136, DOI 10.1109/MSP.2007.323279; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sole RV, 2006, TRENDS ECOL EVOL, V21, P419, DOI 10.1016/j.tree.2006.05.013; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Thomas JA, 2003, ASTM STAND NEWS, V31, P6; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	54	43	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1207	10.1371/journal.pone.0001207	http://dx.doi.org/10.1371/journal.pone.0001207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030341	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459200020
J	Lin, W; Zhou, GF; Cheng, XY; Xu, RM				Lin, Wen; Zhou, Guofa; Cheng, Xinyue; Xu, Rumei			Fast Economic Development Accelerates Biological Invasions in China	PLOS ONE			English	Article								Increasing levels of global trade and intercontinental travel have been cited as the major causes of biological invasion. However, indirect factors such as economic development that affect the intensity of invasion have not been quantitatively explored. Herein, using principal factor analysis, we investigated the relationship between biological invasion and economic development together with climatic information for China from the 1970s to present. We demonstrate that the increase in biological invasion is coincident with the rapid economic development that has occurred in China over the past three decades. The results indicate that the geographic prevalence of invasive species varies substantially on the provincial scale, but can be surprisingly well predicted using the combination of economic development (R-2 = 0.378) and climatic factors (R-2 = 0.347). Economic factors are proven to be at least equal to if not more determinant of the occurrence of invasive species than climatic factors. International travel and trade are shown to have played a less significant role in accounting for the intensity of biological invasion in China. Our results demonstrate that more attention should be paid to economic factors to improve the understanding, prediction and management of biological invasions.	[Lin, Wen; Cheng, Xinyue; Xu, Rumei] Beijing Normal Univ, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Beijing 100875, Peoples R China; [Zhou, Guofa] Univ Calif Irvine, Coll Hlth Sci, Irvine, CA USA	Beijing Normal University; University of California System; University of California Irvine	Xu, RM (corresponding author), Beijing Normal Univ, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Beijing 100875, Peoples R China.	xurumei@bnu.edu.cn			The Nature Conservancy and also by the National Basic Research Program of China [2002CB111400]; National Natural Science Foundation of China [30370207]	The Nature Conservancy and also by the National Basic Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by The Nature Conservancy and also by the National Basic Research Program of China ( No. 2002CB111400) and the National Natural Science Foundation of China ( No. 30370207).	[Anonymous], 2007, XINHUA NEWS AGENCY; Baker H. G., 1965, The genetics of colonizing species., P147; Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Elton C. S., 1958, ECOLOGY INVASIONS AN; Enserink M, 1999, SCIENCE, V285, P1834, DOI 10.1126/science.285.5435.1834; Joshi J, 2005, ECOL LETT, V8, P704, DOI 10.1111/j.1461-0248.2005.00769.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Lavoie C, 2005, ECOSCIENCE, V12, P366, DOI 10.2980/i1195-6860-12-3-366.1; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McKinney ML, 2002, DIVERS DISTRIB, V8, P311, DOI 10.1046/j.1472-4642.2002.00153.x; McNeely JA, 2006, EUPHYTICA, V148, P5, DOI 10.1007/s10681-006-5937-5; Melbourne BA, 2007, ECOL LETT, V10, P77, DOI 10.1111/j.1461-0248.2006.00987.x; Muller JC, 2002, P ROY SOC B-BIOL SCI, V269, P1139, DOI 10.1098/rspb.2002.1994; *NAT BUR STAT CHIN, 1986, CHIN NAT STAT YB; National Research Council, 2002, PRED INV NON PLANTS; Perrings C, 2002, CONSERV ECOL, V6; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; REJMANEK M, 1995, PLANT INVASIONS, P3; Rixon CAM, 2005, BIODIVERS CONSERV, V14, P1365, DOI 10.1007/s10531-004-9663-9; Schreiber ESG, 2003, FRESHWATER BIOL, V48, P951, DOI 10.1046/j.1365-2427.2003.01070.x; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Strong D., 1984, INSECTS PLANTS COMMU; Sutherst RW, 1999, CLIMEX PREDICTING EF; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; WAN FH, 2002, INT WORKSH BIOD MAN, P77; Williamson M., 1996, BIOL INVASIONS; Xie Y, 2001, BIODIVERS CONSERV, V10, P1317, DOI 10.1023/A:1016695609745; Xu R., 2003, BIOL INVASION THEORY; XU RM, 2003, BIOL INVASION DATA A	35	77	95	13	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1208	10.1371/journal.pone.0001208	http://dx.doi.org/10.1371/journal.pone.0001208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030342	gold, Green Published			2022-12-27	WOS:000207459200021
J	Palacios, R; Goni, J; Martinez-Forero, I; Iranzo, J; Sepulcre, J; Melero, I; Villoslada, P				Palacios, Ricardo; Goni, Joaquin; Martinez-Forero, Ivan; Iranzo, Jaime; Sepulcre, Jorge; Melero, Ignacio; Villoslada, Pablo			A Network Analysis of the Human T-Cell Activation Gene Network Identifies Jagged1 as a Therapeutic Target for Autoimmune Diseases	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; NOTCH LIGANDS; EXPRESSION; MECHANISMS; PROTEIN; MOLECULES; CYTOKINES	Understanding complex diseases will benefit the recognition of the properties of the gene networks that control biological functions. Here, we set out to model the gene network that controls T-cell activation in humans, which is critical for the development of autoimmune diseases such as Multiple Sclerosis (MS). The network was established on the basis of the quantitative expression from 104 individuals of 20 genes of the immune system, as well as on biological information from the Ingenuity database and Bayesian inference. Of the 31 links (gene interactions) identified in the network, 18 were identified in the Ingenuity database and 13 were new and we validated 7 of 8 interactions experimentally. In the MS patients network, we found an increase in the weight of gene interactions related to Th1 function and a decrease in those related to Treg and Th2 function. Indeed, we found that IFN-beta therapy induces changes in gene interactions related to T cell proliferation and adhesion, although these gene interactions were not restored to levels similar to controls. Finally, we identify JAG1 as a new therapeutic target whose differential behaviour in the MS network was not modified by immunomodulatory therapy. In vitro treatment with a Jagged1 agonist peptide modulated the T-cell activation network in PBMCs from patients with MS. Moreover, treatment of mice with experimental autoimmune encephalomyelitis with the Jagged1 agonist ameliorated the disease course, and modulated Th2, Th1 and Treg function. This study illustrates how network analysis can predict therapeutic targets for immune intervention and identified the immunomodulatory properties of Jagged1 making it a new therapeutic target for MS and other autoimmune diseases.	[Palacios, Ricardo; Goni, Joaquin; Martinez-Forero, Ivan; Iranzo, Jaime; Sepulcre, Jorge; Villoslada, Pablo] Univ Navarra, Dept Neurol, Univ Navarra Clin, E-31080 Pamplona, Spain; [Palacios, Ricardo; Goni, Joaquin; Martinez-Forero, Ivan; Iranzo, Jaime; Sepulcre, Jorge; Melero, Ignacio; Villoslada, Pablo] Univ Navarra, Ctr Appl Med Res, E-31080 Pamplona, Spain; [Goni, Joaquin; Martinez-Forero, Ivan] Univ Navarra, Dept Appl Math & Phys, E-31080 Pamplona, Spain	University of Navarra; University of Navarra; University of Navarra	Villoslada, P (corresponding author), Univ Navarra, Dept Neurol, Univ Navarra Clin, E-31080 Pamplona, Spain.	pvilloslada@unav.es	Iranzo, Jaime/H-5197-2011; Melero, Ignacio/T-7600-2019; Sepulcre, Jorge/ABE-6375-2020; Villoslada, Pablo/AAF-9547-2019	Iranzo, Jaime/0000-0002-4538-7726; Melero, Ignacio/0000-0002-1360-348X; Villoslada, Pablo/0000-0002-8735-6119; Sepulcre, Jorge/0000-0002-4199-2304	Begona Fernandez-Diez; Spanish Ministry of Health [FIS PI051201, FIS PI060117]	Begona Fernandez-Diez; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants from the Spanish Ministry of Health (FIS PI051201, FIS PI060117) and from the Fundacion Uriach to PV.	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Baecher-Allan C, 2006, IMMUNOL REV, V212, P203, DOI 10.1111/j.0105-2896.2006.00417.x; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; de la Fuente A, 2002, TRENDS GENET, V18, P395, DOI 10.1016/S0168-9525(02)02692-6; Feldmann M, 1998, Int Rev Immunol, V17, P217, DOI 10.3109/08830189809084493; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Galimberti Daniela, 2004, Expert Rev Neurother, V4, P439, DOI 10.1586/14737175.4.3.439; *GAM COLL G, 2006, J NEUROIMMUNOL, V23, P23; Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946; Glover F., 1997, TABU SEARCH; GOH KI, 2007, P NATL ACAD SCI US; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hayes AL, 1999, J BIOL CHEM, V274, P33455, DOI 10.1074/jbc.274.47.33455; Hill N, 2002, CURR OPIN IMMUNOL, V14, P791, DOI 10.1016/S0952-7915(02)00403-X; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Kang BY, 2006, CURR MED CHEM, V13, P1149, DOI 10.2174/092986706776360879; Kang BY, 2005, CELL SIGNAL, V17, P665, DOI 10.1016/j.cellsig.2004.12.010; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Kitano H, 2004, DIABETES, V53, pS6, DOI 10.2337/diabetes.53.suppl_3.S6; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Klamt S, 2006, BIOSYSTEMS, V83, P233, DOI 10.1016/j.biosystems.2005.04.009; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Le YY, 2005, INT IMMUNOPHARMACOL, V5, P1771, DOI 10.1016/j.intimp.2005.07.006; Leon K, 2004, J AUTOIMMUN, V22, P31, DOI 10.1016/j.jaut.2003.10.002; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Liu ZG, 2005, CELL RES, V15, P24, DOI 10.1038/sj.cr.7290259; Melero I, 2005, IMMUNOL RES, V33, P135, DOI 10.1385/IR:33:2:135; MONTALBAN X, 2007, J NEUROL SCI; Moreno B, 2006, ANN NEUROL, V60, P323, DOI 10.1002/ana.20895; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Neuhaus O, 2003, TRENDS PHARMACOL SCI, V24, P131, DOI 10.1016/S0165-6147(03)00028-2; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Peter HH, 2005, EXPERT OPIN BIOL TH, V5, pS61, DOI 10.1517/14712598.5.1.S61; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; QUELLE FW, 1995, MOL CELL BIOL, V15, P3336; Rice GPA, 2005, NEUROLOGY, V64, P1336, DOI 10.1212/01.WNL.0000158329.30470.D0; Roncarolo MG, 2003, J AUTOIMMUN, V20, P269, DOI 10.1016/S0896-8411(03)00047-7; Rutz S, 2005, EUR J IMMUNOL, V35, P2443, DOI 10.1002/eji.200526294; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Segel LA, 1999, J IMMUNOL, V163, P1342; Sontag E, 2004, BIOINFORMATICS, V20, P1877, DOI 10.1093/bioinformatics/bth173; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stallwood Y, 2006, J IMMUNOL, V177, P885, DOI 10.4049/jimmunol.177.2.885; Steinman L, 2003, NAT REV IMMUNOL, V3, P483, DOI 10.1038/nri1108; Styczynski MP, 2005, COMPUT CHEM ENG, V29, P519, DOI 10.1016/j.compchemeng.2004.08.029; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	56	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1222	10.1371/journal.pone.0001222	http://dx.doi.org/10.1371/journal.pone.0001222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030350	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459200029
J	Siva, K; Venu, P; Mahadevan, A; Shankar, SK; Inamdar, MS				Siva, Kavitha; Venu, Parvathy; Mahadevan, Anita; Shankar, S. K.; Inamdar, Maneesha S.			Human BCAS3 Expression in Embryonic Stem Cells and Vascular Precursors Suggests a Role in Human Embryogenesis and Tumor Angiogenesis	PLOS ONE			English	Article								Cancer is often associated with multiple and progressive genetic alterations in genes that are important for normal development. BCAS3 (Breast Cancer Amplified Sequence 3) is a gene of unknown function on human chromosome 17q23, a region associated with breakpoints of several neoplasms. The normal expression pattern of BCAS3 has not been studied, though it is implicated in breast cancer progression. Rudhira, a murine WD40 domain protein that is 98% identical to BCAS3 is expressed in embryonic stem (ES) cells, erythropoiesis and angiogenesis. This suggests that BCAS3 expression also may not be restricted to mammary tissue and may have important roles in other normal as well as malignant tissues. We show that BCAS3 is also expressed in human ES cells and during their differentiation into blood vascular precursors. We find that BCAS3 is aberrantly expressed in malignant human brain lesions. In glioblastoma, hemangiopericytoma and brain abscess we note high levels of BCAS3 expression in tumor cells and some blood vessels. BCAS3 may be associated with multiple cancerous and rapidly proliferating cells and hence the expression, function and regulation of this gene merits further investigation. We suggest that BCAS3 is mis-expressed in brain tumors and could serve as a human ES cell and tumor marker.	[Siva, Kavitha; Venu, Parvathy; Inamdar, Maneesha S.] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560012, Karnataka, India; [Mahadevan, Anita; Shankar, S. K.] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India	Inamdar, MS (corresponding author), Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560012, Karnataka, India.	inamdar@jncasr.ac.in		Siva, Kavitha/0000-0001-9480-4496	Jawaharlal Nehru Centre for Advanced Scientific Research; Department of Biotechnology, Government of India; University Grants Commission	Jawaharlal Nehru Centre for Advanced Scientific Research(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grants Commission(University Grants Commission, India)	This work was supported by the Jawaharlal Nehru Centre for Advanced Scientific Research, and Department of Biotechnology, Government of India. KS was supported by a fellowship from University Grants Commission.	Barbouti A, 2004, AM J HUM GENET, V74, P1, DOI 10.1086/380648; Barlund M, 2000, CANCER RES, V60, P5340; Bautch VL, 2000, BLOOD, V95, P1979, DOI 10.1182/blood.V95.6.1979; Bergwerff M, 1998, CIRC RES, V82, P221; Brinkschmidt C, 1997, J PATHOL, V181, P394; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Courjal F, 1997, CANCER RES, V57, P4368; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; Etchevers HC, 2002, TRENDS CARDIOVAS MED, V12, P299, DOI 10.1016/S1050-1738(02)00178-0; Gerecht-Nir S, 2005, DEV DYNAM, V232, P487, DOI 10.1002/dvdy.20247; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Gururaj AE, 2006, CELL CYCLE, V5, P1407, DOI 10.4161/cc.5.13.2924; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Kielian T, 2000, AM J PATHOL, V157, P647, DOI 10.1016/S0002-9440(10)64575-0; Lane D., 1995, COMPLEXITY, V1, P9; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; MULERIS M, 1994, GENE CHROMOSOME CANC, V10, P160, DOI 10.1002/gcc.2870100303; Nishizaki T, 1997, INT J CANCER, V74, P513, DOI 10.1002/(SICI)1097-0215(19971021)74:5<513::AID-IJC6>3.3.CO;2-X; Park SS, 2002, GENOME RES, V12, P729, DOI 10.1101/gr.82802; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Siva K, 2006, GENE EXPR PATTERNS, V6, P225, DOI 10.1016/j.modgep.2005.06.002; Tirkkonen M, 1998, GENE CHROMOSOME CANC, V21, P177, DOI 10.1002/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.3.CO;2-C; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Zhang XY, 2005, P NATL ACAD SCI USA, V102, P13968, DOI 10.1073/pnas.0502330102	32	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1202	10.1371/journal.pone.0001202	http://dx.doi.org/10.1371/journal.pone.0001202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030336	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459200015
J	Rodriguez-Campos, A; Azorin, F				Rodriguez-Campos, Antonio; Azorin, Fernando			RNA Is an Integral Component of Chromatin that Contributes to Its Structural Organization	PLOS ONE			English	Article								Chromatin structure is influenced by multiples factors, such as pH, temperature, nature and concentration of counterions, post-translational modifications of histones and binding of structural non-histone proteins. RNA is also known to contribute to the regulation of chromatin structure as chromatin-induced gene silencing was shown to depend on the RNAi machinery in S. pombe, plants and Drosophila. Moreover, both in Drosophila and mammals, dosage compensation requires the contribution of specific non-coding RNAs. However, whether RNA itself plays a direct structural role in chromatin is not known. Here, we report results that indicate a general structural role for RNA in eukaryotic chromatin. RNA is found associated to purified chromatin prepared from chicken liver, or cultured Drosophila S2 cells, and treatment with RNase A alters the structural properties of chromatin. Our results indicate that chromatin-associated RNAs, which account for 2%-5% of total chromatin-associated nucleic acids, are polyA(-) and show a size similar to that of the DNA contained in the corresponding chromatin fragments. Chromatin-associated RNA(s) are not likely to correspond to nascent transcripts as they are also found bound to chromatin when cells are treated with alpha-amanitin. After treatment with RNase A, chromatin fragments of molecular weight >3.000 bp of DNA showed reduced sedimentation through sucrose gradients and increased sensitivity to micrococcal nuclease digestion. This structural transition, which is observed both at euchromatic and heterochromatic regions, proceeds without loss of histone H1 or any significant change in core-histone composition and integrity.	[Rodriguez-Campos, Antonio] CSIC, Inst Mol Biol Barcelona IBMB, Barcelona, Spain; IRB, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Rodriguez-Campos, A (corresponding author), CSIC, Inst Mol Biol Barcelona IBMB, Barcelona, Spain.	arobmc@gmail.com	Azorin, Fernando/N-4388-2014	Azorin, Fernando/0000-0002-8426-7858	MCyT [BMC2003-243]; CIRIT [2001SGR00344, 2005SGR00678]; EU [LSHB-CT-2004-511965]; CSIC	MCyT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIRIT; EU(European Commission); CSIC	This work was financed by grants from the MCyT (BMC2003-243), the CIRIT (2001SGR00344 and 2005SGR00678), and the EU (LSHB-CT-2004-511965). A.R.-C. acknowledges receipt of an I3P postdoctoral contract from CSIC.	AUGENLICHT LH, 1976, BIOCHEMISTRY-US, V15, P3818, DOI 10.1021/bi00662a026; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; CLARK DJ, 1990, J MOL BIOL, V211, P883, DOI 10.1016/0022-2836(90)90081-V; FINCH JT, 1977, NATURE, V269, P29, DOI 10.1038/269029a0; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; FURUNO M, 2006, PLOS GENETICS, V2; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; Ghirlando R, 2004, J MOL BIOL, V336, P597, DOI 10.1016/j.jmb.2003.12.049; Gilbert N, 2001, P NATL ACAD SCI USA, V98, P11949, DOI 10.1073/pnas.211322798; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; KEDINGER C, 1970, BIOCHEM BIOPH RES CO, V38, P165, DOI 10.1016/0006-291X(70)91099-5; Kelley RL, 2000, CELL, V103, P9, DOI 10.1016/S0092-8674(00)00099-4; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; MATZKE MA, 1990, CHROMOSOMA, V99, P131, DOI 10.1007/BF01735329; MCGHEE JD, 1980, ANNU REV BIOCHEM, V49, P1115, DOI 10.1146/annurev.bi.49.070180.005343; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; NOHNO T, 1993, DEV BIOL, V158, P254, DOI 10.1006/dbio.1993.1184; NOLL H, 1989, METHOD ENZYMOL, V170, P55; NOLL M, 1974, NATURE, V251, P249, DOI 10.1038/251249a0; NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SHIMAMURA A, 1989, MOL CELL BIOL, V9, P5573, DOI 10.1128/MCB.9.12.5573; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; van Holde K.E., 1988, CHROMATIN; WARNER JR, 1963, P NATL ACAD SCI USA, V49, P122, DOI 10.1073/pnas.49.1.122; WETTSTEIN FO, 1963, NATURE, V197, P430, DOI 10.1038/197430a0; WIDOM J, 1989, ANNU REV BIOPHYS BIO, V18, P365, DOI 10.1146/annurev.biophys.18.1.365; WUTZ A, 2003, NONCODING RNAS MOL B	38	73	78	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1182	10.1371/journal.pone.0001182	http://dx.doi.org/10.1371/journal.pone.0001182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000552	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459100023
J	Schymeinsky, J; Then, C; Sindrilaru, A; Gerstl, R; Jakus, Z; Tybulewicz, VLJ; Scharffetter-Kochanek, K; Walzog, B				Schymeinsky, Juergen; Then, Cornelia; Sindrilaru, Anca; Gerstl, Ronald; Jakus, Zoltan; Tybulewicz, Victor L. J.; Scharffetter-Kochanek, Karin; Walzog, Barbara			Syk-Mediated Translocation of PI3K delta to the Leading Edge Controls Lamellipodium Formation and Migration of Leukocytes	PLOS ONE			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; PROTEIN-TYROSINE KINASE; PHOSPHOINOSITIDE 3-KINASE; HUMAN NEUTROPHILS; PHOSPHATIDYLINOSITOL 3-KINASE; PROTOONCOGENE PRODUCT; PHOSPHOLIPASE-C; CELL ACTIVATION; LINKER REGION; T-CELLS	The non-receptor tyrosine kinase Syk is mainly expressed in the hematopoietic system and plays an essential role in beta(2) integrin-mediated leukocyte activation. To elucidate the signaling pathway downstream of Syk during beta(2) integrin (CD11/CD18)-mediated migration and extravasation of polymorphonuclear neutrophils (PMN), we generated neutrophil-like differentiated HL-60 (dHL-60) cells expressing a fluorescently tagged Syk mutant lacking the tyrosine residue at the position 323 (Syk-Tyr(323)) that is known to be required for the binding of the regulatory subunit p85 of the phosphatidylinositol 3-kinase (PI3K) class I-A. Syk-Tyr(323) was found to be critical for the enrichment of the catalytic subunit p110 delta of PI3K class I-A as well as for the generation of PI3K products at the leading edge of the majority of polarized cells. In accordance, the translocation of PI3K p110 delta to the leading edge was diminished in Syk deficient murine PMN. Moreover, the expression of EGFP-Syk Y323F interfered with proper cell polarization and it impaired efficient migration of dHL-60 cells. In agreement with a major role of beta(2) integrins in the recruitment of phagocytic cells to sites of lesion, mice with a Syk-deficient hematopoietic system demonstrated impaired PMN infiltration into the wounded tissue that was associated with prolonged cutaneous wound healing. These data imply a novel role of Syk via PI3K p110 delta signaling for beta(2) integrin-mediated migration which is a prerequisite for efficient PMN recruitment in vivo.	[Schymeinsky, Juergen; Then, Cornelia; Gerstl, Ronald; Walzog, Barbara] Univ Munich, Dept Physiol, D-8000 Munich, Germany; [Sindrilaru, Anca; Scharffetter-Kochanek, Karin] Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany; [Jakus, Zoltan] Semmelweis Univ, Sch Med, Dept Physiol, Budapest, Hungary; [Tybulewicz, Victor L. J.] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England	University of Munich; Ulm University; Semmelweis University; MRC National Institute for Medical Research	Walzog, B (corresponding author), Univ Munich, Dept Physiol, Pettenkoferstr 12, D-8000 Munich, Germany.	walzog@lrz.uni-muenchen.de	Sindrilaru, Anca/G-1203-2014; Jakus, Zoltán/O-1762-2015	Jakus, Zoltán/0000-0002-6304-2369; Tybulewicz, Victor/0000-0003-2439-0798; Scharffetter-Kochanek, Karin/0000-0002-9655-685X	Deutsche Forschungsgemeinschaft [Wa 1048/2-3, SFB 497-C7]; Medical Research Council [MC_U117527252] Funding Source: researchfish; MRC [MC_U117527252] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work has been funded by grants of the Deutsche Forschungsgemeinschaft; Wa 1048/2-3 (to B. Walzog) and SFB 497-C7 (to K. ScharffetterKochanek).	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Abtahian F, 2006, MOL CELL BIOL, V26, P6936, DOI 10.1128/MCB.01040-06; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; Axelsson L, 2000, EXP CELL RES, V256, P257, DOI 10.1006/excr.2000.4816; Beitz LO, 1999, J BIOL CHEM, V274, P32662, DOI 10.1074/jbc.274.46.32662; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Boulven I, 2006, J IMMUNOL, V176, P7621, DOI 10.4049/jimmunol.176.12.7621; Caveggion E, 2003, J CELL PHYSIOL, V195, P276, DOI 10.1002/jcp.10236; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Groesch TD, 2006, J MOL BIOL, V356, P1222, DOI 10.1016/j.jmb.2005.11.095; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hong JJ, 2002, J BIOL CHEM, V277, P31703, DOI 10.1074/jbc.M201362200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Lee KS, 2006, FASEB J, V20, P455, DOI 10.1096/fj.05-5045com; Liu LX, 2007, BLOOD, V110, P1191, DOI 10.1182/blood-2006-11-060103; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Moon KD, 2005, J BIOL CHEM, V280, P1543, DOI 10.1074/jbc.M407805200; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Peters T, 2005, EMBO J, V24, P3400, DOI 10.1038/sj.emboj.7600809; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Popa-Nita O, 2007, J LEUKOCYTE BIOL, V82, P763, DOI 10.1189/jlb.0307174; Puri KD, 2004, BLOOD, V103, P3448, DOI 10.1182/blood-2003-05-1667; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Sada K, 2000, J IMMUNOL, V164, P338, DOI 10.4049/jimmunol.164.1.338; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Schruefer R, 2006, J VASC RES, V43, P1, DOI 10.1159/000088975; Schymeinsky J, 2007, THROMB HAEMOSTASIS, V98, P262, DOI 10.1160/TH07-02-0156; Schymeinsky J, 2006, BLOOD, V108, P3919, DOI 10.1182/blood-2005-12-030387; Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Theilgaard-Monch K, 2004, J IMMUNOL, V172, P7684, DOI 10.4049/jimmunol.172.12.7684; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; von Willebrand M, 1998, CELL SIGNAL, V10, P407, DOI 10.1016/S0898-6568(97)00139-3; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Willeke T, 2000, J LEUKOCYTE BIOL, V68, P284; Yankee TM, 1999, J IMMUNOL, V163, P5827	56	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1132	10.1371/journal.pone.0001132	http://dx.doi.org/10.1371/journal.pone.0001132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987119	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459000016
J	Wang, X; Green, DS; Roberts, SP; de Belle, JS				Wang, Xia; Green, David S.; Roberts, Stephen P.; de Belle, J. Steven			Thermal Disruption of Mushroom Body Development and Odor Learning in Drosophila	PLOS ONE			English	Article								Environmental stress (nutritive, chemical, electromagnetic and thermal) has been shown to disrupt central nervous system (CNS) development in every model system studied to date. However, empirical linkages between stress, specific targets in the brain, and consequences for behavior have rarely been established. The present study experimentally demonstrates one such linkage by examining the effects of ecologically-relevant thermal stress on development of the Drosophila melanogaster mushroom body (MB), a conserved sensory integration and associative center in the insect brain. We show that a daily hyperthermic episode throughout larval and pupal development (1) severely disrupts MB anatomy by reducing intrinsic Kenyon cell (KC) neuron numbers but has little effect on other brain structures or general anatomy, and (2) greatly impairs associative odor learning in adults, despite having little effect on memory or sensory acuity. Hence, heat stress of ecologically relevant duration and intensity can impair brain development and learning potential.	[Wang, Xia; Green, David S.; Roberts, Stephen P.; de Belle, J. Steven] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Green, David S.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of California System; University of California San Diego	de Belle, JS (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	steven.debelle@unlv.edu			National Science Foundation [0213921]; National Center for Research Resources, a component of the National Institutes of Health [2 P20 RR016464]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources, a component of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by grants to JSdB and SPR from the National Science Foundation (0213921) and the National Center for Research Resources, a component of the National Institutes of Health (2 P20 RR016464).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahmad K, 2001, CELL, V104, P839, DOI 10.1016/S0092-8674(01)00281-1; Akalal DBG, 2006, LEARN MEMORY, V13, P659, DOI 10.1101/lm.221206; Armstrong JD, 1998, LEARN MEMORY, V5, P102; BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; Barth M, 1997, LEARN MEMORY, V4, P219, DOI 10.1101/lm.4.2.219; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campos-Ortega Jose A., 1993, P1091; de Belle J. Steven, 1999, P243; deBelle JS, 1996, P NATL ACAD SCI USA, V93, P9875, DOI 10.1073/pnas.93.18.9875; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Feder ME, 1997, J THERM BIOL, V22, P1, DOI 10.1016/S0306-4565(96)00028-9; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Groh C, 2006, BRAIN BEHAV EVOLUT, V68, P1, DOI 10.1159/000092309; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HEISENBERG M, 1979, Z NATURFORSCH C, V34, P143; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Ito K, 1997, CELL TISSUE RES, V290, P1, DOI 10.1007/s004410050901; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Lee T, 1999, DEVELOPMENT, V126, P4065; MADER MT, 2004, THESIS U WURZBURG; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; Mattson SN, 1998, ALCOHOL CLIN EXP RES, V22, P279, DOI 10.1111/j.1530-0277.1998.tb03651.x; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; MILUNSKY A, 1992, JAMA-J AM MED ASSOC, V268, P882, DOI 10.1001/jama.268.7.882; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pinto S, 1999, NEURON, V23, P45, DOI 10.1016/S0896-6273(00)80752-7; Rhees RW, 1999, BRAIN RES BULL, V50, P193, DOI 10.1016/S0361-9230(99)00191-4; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Roberts SP, 1999, OECOLOGIA, V121, P323, DOI 10.1007/s004420050935; Robertson K, 2003, DEV BIOL, V260, P124, DOI 10.1016/S0012-1606(03)00220-3; Roebuck TM, 1998, ALCOHOL CLIN EXP RES, V22, P339, DOI 10.1111/j.1530-0277.1998.tb03658.x; Schulz RA, 1996, ONCOGENE, V12, P1827; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Suarez L, 2004, BIRTH DEFECTS RES A, V70, P815, DOI 10.1002/bdra.20077; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; Technau GM, 1984, J NEUROGENET, V1, P113, DOI 10.3109/01677068409107077; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; YANG MY, 1995, NEURON, V15, P45; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zars T, 2000, CURR OPIN NEUROBIOL, V10, P790, DOI 10.1016/S0959-4388(00)00147-1; Zars T., 2000, Science (Washington D C), V288, P672, DOI 10.1126/science.288.5466.672	55	29	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1125	10.1371/journal.pone.0001125	http://dx.doi.org/10.1371/journal.pone.0001125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17992254	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459000009
J	Cartwright, P; Halgedahl, SL; Hendricks, JR; Jarrard, RD; Marques, AC; Collins, AG; Lieberman, BS				Cartwright, Paulyn; Halgedahl, Susan L.; Hendricks, Jonathan R.; Jarrard, Richard D.; Marques, Antonio C.; Collins, Allen G.; Lieberman, Bruce S.			Exceptionally Preserved Jellyfishes from the Middle Cambrian	PLOS ONE			English	Article								Cnidarians represent an early diverging animal group and thus insight into their origin and diversification is key to understanding metazoan evolution. Further, cnidarian jellyfish comprise an important component of modern marine planktonic ecosystems. Here we report on exceptionally preserved cnidarian jellyfish fossils from the Middle Cambrian (similar to 505 million years old) Marjum Formation of Utah. These are the first described Cambrian jellyfish fossils to display exquisite preservation of soft part anatomy including detailed features of structures interpreted as trailing tentacles and subumbrellar and exumbrellar surfaces. If the interpretation of these preserved characters is correct, their presence is diagnostic of modern jellyfish taxa. These new discoveries may provide insight into the scope of cnidarian diversity shortly after the Cambrian radiation, and would reinforce the notion that important taxonomic components of the modern planktonic realm were in place by the Cambrian period.	[Hendricks, Jonathan R.; Lieberman, Bruce S.] Univ Kansas, Dept Geol, Nat Hist Museum, Lawrence, KS 66045 USA; [Hendricks, Jonathan R.; Lieberman, Bruce S.] Univ Kansas, Div Invertebrate Paleontol, Nat Hist Museum, Lawrence, KS 66045 USA; [Cartwright, Paulyn] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Halgedahl, Susan L.; Jarrard, Richard D.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Marques, Antonio C.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Collins, Allen G.] Fisheries Serv, Natl Systemat Lab, NOAA, Natl Museum Nat Hist,Smithsonian Inst, Washington, DC USA	University of Kansas; University of Kansas; University of Kansas; Utah System of Higher Education; University of Utah; Universidade de Sao Paulo; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History	Lieberman, BS (corresponding author), Univ Kansas, Dept Geol, Nat Hist Museum, Lawrence, KS 66045 USA.	blieber@ku.edu	Marques, Antonio Carlos/E-8049-2011; Collins, Allen G/A-7944-2008	Marques, Antonio Carlos/0000-0002-2884-0541; Collins, Allen G/0000-0002-3664-9691; Cartwright, Paulyn/0000-0002-8174-6933	NSF [AToL EF-0531779, EAR-0518976]; FAPESP; CNPq	NSF(National Science Foundation (NSF)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding: This work was supported by grants from NSF AToL EF-0531779 (to PC and AGC), NSF EAR-0518976 (to BSL) and FAPESP and CNPq (Brazil, to ACM).	ALLISON PA, 1993, GEOLOGY, V21, P527, DOI 10.1130/0091-7613(1993)021<0527:EFRDOS>2.3.CO;2; ALLISON PA, 1995, GEOLOGY, V23, P1079, DOI 10.1130/0091-7613(1995)023<1079:ISBAPO>2.3.CO;2; BRIGGS DEG, 1984, U KANSAS PALEONTOLOG, V111, P1; Butterfield NJ, 1997, PALEOBIOLOGY, V23, P247, DOI 10.1017/S009483730001681X; CAMPBELL RD, 1987, CELL TISSUE RES, V249, P647; Conway Morris S., 1986, PALEONTOLOGICAL CONT, V117, P1; CONWAY MS, 1993, PALAEONTOLOGY, V36, P593; Fedonkin M.A., 1992, P389; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Gaines RR, 2005, PALAEOGEOGR PALAEOCL, V220, P193, DOI 10.1016/j.palaeo.2004.07.034; Garm A, 2006, CELL TISSUE RES, V325, P333, DOI 10.1007/s00441-005-0134-8; Gehling JG, 2000, PALAEONTOLOGY, V43, P427, DOI 10.1111/j.0031-0239.2000.00134.x; Gershwin Lisa-Ann, 2005, Beagle, V21, P27; Glaessner M. F., 1966, Palaeontology, V9, P599; Hagadorn JW, 2002, GEOLOGY, V30, P147, DOI 10.1130/0091-7613(2002)030<0147:SOALCS>2.0.CO;2; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Hou XG, 2005, LETHAIA, V38, P193, DOI 10.1080/00241160510013295; Hughes NC, 2000, J PALEONTOL, V74, P828, DOI 10.1666/0022-3360(2000)074<0828:LCCFWA>2.0.CO;2; JOHNSON R G, 1968, Fieldiana Geology, V12, P109; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lewis C, 2005, MAR BIOL, V147, P477, DOI 10.1007/s00227-005-1602-0; Marques AC, 2004, INVERTEBR BIOL, V123, P23; Morris SC, 1996, PHILOS T ROY SOC B, V351, P279, DOI 10.1098/rstb.1996.0024; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; NARBONNE GM, 1991, J PALEONTOL, V65, P186, DOI 10.1017/S0022336000020412; Nielsen C, 1996, BIOL J LINN SOC, V57, P385; NORRIS RD, 1989, LETHAIA, V22, P381, DOI 10.1111/j.1502-3931.1989.tb01439.x; OSSIAN CR, 1973, J PALEONTOL, V47, P990; PEARSE JS, 1978, SCIENCE, V199, P458, DOI 10.1126/science.22934; PLUMMER P S, 1980, Transactions of the Royal Society of South Australia, V104, P13; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Robison R.A., 1991, P77; ROSS MI, 2000, PALEOGIS ARCVIEW 3 5; Russell F. S., 1970, MEDUSAE BRIT ISLES, V2; STANLEY GD, 1986, PROBLEMATIC FOSSIL T, P68; Van Iten H, 2006, J SYST PALAEONTOL, V4, P109, DOI 10.1017/S1477201905001793; WADE M, 1971, Proceedings of the Royal Society of Victoria, V84, P183; Waggoner Benjamin M., 1995, Palaeontologische Zeitschrift, V69, P7; Walcott Charles Doolittle, 1911, Smithsonian Institution Miscellaneous Collection, V57; WILLOUGHBY RH, 1979, J PALEONTOL, V53, P494; Yanagihara AA, 2002, CELL TISSUE RES, V308, P307, DOI 10.1007/s00441-002-0545-8	41	98	101	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1121	10.1371/journal.pone.0001121	http://dx.doi.org/10.1371/journal.pone.0001121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YE	17971881	Green Published, gold			2022-12-27	WOS:000207566100001
J	Morel, E; Gruenberg, J				Morel, Etienne; Gruenberg, Jean			The p11/S100A10 Light Chain of Annexin A2 Is Dispensable for Annexin A2 Association to Endosomes and Functions in Endosomal Transport	PLOS ONE			English	Article								Background. Annexin A2 is a peripheral membrane protein that belongs to the annexin family of Ca2+ and phospholipid-binding proteins. This protein, which plays a role in membrane organization and dynamics in particular along the endocytic pathway, exists as a heterotetrameric complex, consisting of two annexin A2 molecules bound via their N-termini to a dimer of p11/S100A10 light chains. The light chain, and thus presumably formation of the heterotetramer, was reported to control annexin A2 association to the plasma membrane and to cortical actin, as well as the distribution of recycling endosomes. However, the specific role of the light chain and the functions of monomeric versus heterotetrameric annexin A2 have remained elusive in the endocytic pathway. Methodology/Principal Findings. Here, we have investigated whether p11 plays a role in the endosomal functions of annexin A2. Using morphological and biochemical approaches, we found that p11, unlike annexin A2, was not present on early endosomes. Neither was the heterotetramer detected on purified early endosomes, while it was clearly present in total cell lysates. Moreover, knockdown of p11 with siRNAs did not affect annexin A2 targeting to early endosomes, and, conversely, binding of annexin A2 to purified endosomes or liposomes occurred without p11 in vitro. Finally, while we could confirm that annexin A2 knockdown inhibits transport beyond early endosomes, p11 knockdown had no such effects on early-to-late endosome transport. Conclusions/Significance. Our data show that the binding of annexin A2 to endosomal membranes and its role in endosomal trafficking are independent of the p11/S100A10 light chain. We thus conclude that annexin A2 functions are fully supported by the monomeric form of the protein, at least the endocytic pathway leading to lysosomes.	[Morel, Etienne; Gruenberg, Jean] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland	University of Geneva	Gruenberg, J (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland.	jean.gruenberg@biochem.unige.ch	MOREL, Etienne L/F-4765-2010; MOREL, Etienne/N-2194-2014	MOREL, Etienne L/0000-0001-7340-1313; MOREL, Etienne/0000-0002-4763-4954	Swiss National Science Foundation; Swiss Telethon Foundation; Fondation pour la Recherche Medicale (FRM); Roche Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Telethon Foundation; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Roche Research Foundation	Support was from the Swiss National Science Foundation and the Swiss Telethon Foundation (to JG), the Fondation pour la Recherche Medicale (FRM) and the Roche Research Foundation (to EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; BECKER T, 1990, EMBO J, V9, P4207, DOI 10.1002/j.1460-2075.1990.tb07868.x; BECKER T, 1992, EUR J BIOCHEM, V207, P541, DOI 10.1111/j.1432-1033.1992.tb17080.x; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; BORTHWICK LA, 2007, MOL BIOL CELL; CREUTZ CE, 1992, SCIENCE, V258, P924, DOI 10.1126/science.1439804; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; FUTTER CE, 2007, TRAFFIC; GERKE V, 1984, EMBO J, V3, P227, DOI 10.1002/j.1460-2075.1984.tb01789.x; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GLENNEY JR, 1985, FEBS LETT, V192, P79, DOI 10.1016/0014-5793(85)80047-8; GOULD KL, 1986, MOL CELL BIOL, V6, P2738, DOI 10.1128/MCB.6.7.2738; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Hayes MJ, 2004, J BIOL CHEM, V279, P14157, DOI 10.1074/jbc.M313025200; Huber LA, 2000, TRAFFIC, V1, P494, DOI 10.1034/j.1600-0854.2000.010607.x; JOHNSSON N, 1988, FEBS LETT, V236, P201, DOI 10.1016/0014-5793(88)80314-4; JOHNSSON N, 1988, EMBO J, V7, P2435, DOI 10.1002/j.1460-2075.1988.tb03089.x; Jost M, 1997, J CELL SCI, V110, P221; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Merrifield CJ, 2001, CURR BIOL, V11, P1136, DOI 10.1016/S0960-9822(01)00321-9; OSBORN M, 1988, EXP CELL RES, V175, P81, DOI 10.1016/0014-4827(88)90257-1; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rescher U, 2000, J CELL SCI, V113, P3931; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; RESCHER U, 2007, S100A10 P11 FAMILY F; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Seemann J, 1997, FEBS LETT, V413, P185, DOI 10.1016/S0014-5793(97)00911-3; THIEL C, 1992, J CELL SCI, V103, P733; THIEL C, 1991, FEBS LETT, V285, P59, DOI 10.1016/0014-5793(91)80724-H; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387	36	50	52	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1118	10.1371/journal.pone.0001118	http://dx.doi.org/10.1371/journal.pone.0001118			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971878	Green Submitted, Green Published, gold			2022-12-27	WOS:000207458700032
J	Fall, S; Mercier, A; Bertolla, F; Calteau, A; Gueguen, L; Perriere, G; Vogel, TM; Simonet, P				Fall, Saliou; Mercier, Anne; Bertolla, Franck; Calteau, Alexandra; Gueguen, Laurent; Perriere, Guy; Vogel, Timothy M.; Simonet, Pascal			Horizontal Gene Transfer Regulation in Bacteria as a "Spandrel'' of DNA Repair Mechanisms	PLOS ONE			English	Article								Horizontal gene transfer (HGT) is recognized as the major force for bacterial genome evolution. Yet, numerous questions remain about the transferred genes, their function, quantity and frequency. The extent to which genetic transformation by exogenous DNA has occurred over evolutionary time was initially addressed by an in silico approach using the complete genome sequence of the Ralstonia solanacearum GMI1000 strain. Methods based on phylogenetic reconstruction of prokaryote homologous genes families detected 151 genes (13.3%) of foreign origin in the R. solanacearum genome and tentatively identified their bacterial origin. These putative transfers were analyzed in comparison to experimental transformation tests involving 18 different genomic DNA positions in the genome as sites for homologous or homeologous recombination. Significant transformation frequency differences were observed among these positions tested regardless of the overall genomic divergence of the R. solanacearum strains tested as recipients. The genomic positions containing the putative exogenous DNA were not systematically transformed at the highest frequencies. The two genomic "hot spots'', which contain recA and mutS genes, exhibited transformation frequencies from 2 to more than 4 orders of magnitude higher than positions associated with other genes depending on the recipient strain. These results support the notion that the bacterial cell is equipped with active mechanisms to modulate acquisition of new DNA in different genomic positions. Bio-informatics study correlated recombination "hot-spots'' to the presence of Chi-like signature sequences with which recombination might be preferentially initiated. The fundamental role of HGT is certainly not limited to the critical impact that the very rare foreign genes acquired mainly by chance can have on the bacterial adaptation potential. The frequency to which HGT with homologous and homeologous DNA happens in the environment might have led the bacteria to hijack DNA repair mechanisms in order to generate genetic diversity without losing too much genomic stability.	[Fall, Saliou; Vogel, Timothy M.; Simonet, Pascal] Univ Lyon, Environm Microbial Genom Grp, Lab AMPERE UMR CNRS 5005, Ecole Cent Lyon, Ecully, France; [Mercier, Anne; Bertolla, Franck] Univ Lyon 1, UMR CNRS 5557, F-69622 Villeurbanne, France; [Calteau, Alexandra; Gueguen, Laurent; Perriere, Guy] Univ Lyon 1, Lab Biometrie & Biol Evolut, UMR CNRS 5558, F-69622 Villeurbanne, France	Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Simonet, P (corresponding author), Univ Lyon, Environm Microbial Genom Grp, Lab AMPERE UMR CNRS 5005, Ecole Cent Lyon, Ecully, France.	pascal.simonet@ec-lyon.fr		CALTEAU, Alexandra/0000-0002-5871-9347; Vogel, Timothy/0000-0002-9542-3246	EU project TRANSBAC [QLK3-CT2001-02242]; ANR project PLOBEN [ANR-05-POGM-004-01]	EU project TRANSBAC; ANR project PLOBEN(French National Research Agency (ANR))	This work was funded in part by the EU project TRANSBAC (QLK3-CT2001-02242, 5th RTD Program) and in part by the ANR project PLOBEN (ANR-05-POGM-004-01).	BAKKALI M, 2007, PLOS ONE E, V741, P1; Bertolla F, 1997, APPL ENVIRON MICROB, V63, P4965, DOI 10.1128/AEM.63.12.4965-4968.1997; Bertolla F, 1999, MOL PLANT MICROBE IN, V12, P467, DOI 10.1094/MPMI.1999.12.5.467; BOUCHER C, 1986, MOL GEN GENET, V205, P270, DOI 10.1007/BF00430438; BRAU B, 1984, MOL GEN GENET, V193, P179, DOI 10.1007/BF00327434; Brown EW, 2001, J BACTERIOL, V183, P1631, DOI 10.1128/JB.183.5.1631-1644.2001; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Daubin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r57; Daubin V, 2003, MOL BIOL EVOL, V20, P471, DOI 10.1093/molbev/msg022; Delmas S, 2005, DNA REPAIR, V4, P221, DOI 10.1016/j.dnarep.2004.09.008; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; DIXON DA, 1995, J BIOL CHEM, V270, P16360, DOI 10.1074/jbc.270.27.16360; Doolittle WF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-116; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; El Karoui M, 1999, RES MICROBIOL, V150, P579, DOI 10.1016/S0923-2508(99)00132-1; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gonin M, 2000, J BACTERIOL, V182, P337, DOI 10.1128/JB.182.2.337-347.2000; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Guidot A, 2007, J BACTERIOL, V189, P377, DOI 10.1128/JB.00999-06; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAYWARD AC, 1994, DIS ITS CAUSATIVE AG, P9; HENNECKE F, 1991, NATURE, V353, P776, DOI 10.1038/353776a0; HUMBERT O, 1995, P NATL ACAD SCI USA, V92, P9052, DOI 10.1073/pnas.92.20.9052; Kay E, 2002, MICROBIAL ECOL, V43, P291, DOI 10.1007/s00248-002-2007-y; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lawrence JG, 2002, TRENDS MICROBIOL, V10, P1, DOI 10.1016/S0966-842X(01)02282-X; Li XZ, 1998, J BACTERIOL, V180, P2987, DOI 10.1128/JB.180.11.2987-2991.1998; Lieb M, 1996, MOL MICROBIOL, V20, P467, DOI 10.1046/j.1365-2958.1996.5291066.x; Matic I, 1996, TRENDS MICROBIOL, V4, P69, DOI 10.1016/0966-842X(96)81514-9; Metzgar D, 2000, CELL, V101, P581, DOI 10.1016/S0092-8674(00)80869-7; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; PAGET E, 1994, FEMS MICROBIOL ECOL, V15, P109, DOI 10.1111/j.1574-6941.1994.tb00235.x; PALLERONI NJ, 1971, J BACTERIOL, V107, P690, DOI 10.1128/JB.107.3.690-696.1971; Ragan MA, 2001, CURR OPIN GENET DEV, V11, P620, DOI 10.1016/S0959-437X(00)00244-6; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Taha MK, 1996, MOL MICROBIOL, V19, P1073, DOI 10.1046/j.1365-2958.1996.448979.x; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; WATSON GS, 1961, BIOMETRIKA, V48, P109, DOI 10.2307/2333135; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851	49	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1055	10.1371/journal.pone.0001055	http://dx.doi.org/10.1371/journal.pone.0001055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957239	Green Published, gold, Green Submitted			2022-12-27	WOS:000207458500002
J	Sarndahl, E; Bergstrom, I; Brodin, VP; Nijm, J; Setterud, HL; Jonasson, L				Sarndahl, Eva; Bergstrom, Ida; Brodin, Veronika Patcha; Nijm, Johnny; Setterud, Helen Lundqvist; Jonasson, Lena			Neutrophil Activation Status in Stable Coronary Artery Disease	PLOS ONE			English	Article								Background. During the last years, neutrophils have emerged as important players in atherogenesis. They are highly activated in peripheral blood of patients with unstable angina. Moreover, a primed state of circulating neutrophils has been proposed in patients with stable angina. Our aim was to investigate the neutrophil activation status in patients with stable coronary artery disease ( CAD) at conventional drug treatment. Methodology and Principal Findings. Thirty patients with stable CAD and 30 healthy controls were included using a paired design. The neutrophil expression of CD18 and high-affinity state of CD11b was analysed by flow cytometry before and after stimulation with chemoattractants. Also, the production of reactive oxygen species (ROS) was determined by chemiluminescence. During basal conditions, the neutrophil expression of CD18 or high-affinity state of CD11b did not differ between patients and controls. Chemoattractants (Interleukin-8 and Leukotriene B(4)) did not increase either the expression or the amount of high-affinity CD11b/CD18-integrins in CAD patients compared to controls, and had no effect on the production of ROS. On the other hand, the ROS production in response to C3bi-opsonised yeast particles and the neutrophils' inherent capacity to produce ROS were both significantly decreased in patients. Conclusion/Significance. We could not find any evidence that neutrophils in patients with stable CAD were primed, i.e. more prone to activation, compared to cells from healthy controls. According to our data, the circulating neutrophils in CAD patients rather showed an impaired activation status. It remains to be elucidated whether the neutrophil dysfunction in CAD is mainly a marker of chronic disease, an atherogenic factor or a consequence of the drug treatment.	[Sarndahl, Eva; Bergstrom, Ida; Setterud, Helen Lundqvist] Linkoping Univ, Fac Hlth Sci, Div Med Microbiol, Dept Clin & Expt Med, Linkoping, Sweden; [Brodin, Veronika Patcha] Linkoping Univ, Fac Hlth Sci, Div Cell Biol, Dept Clin & Expt Med, Linkoping, Sweden; [Nijm, Johnny; Jonasson, Lena] Linkoping Univ, Fac Hlth Sci, Div Cardiol, Dept Med & Hlth, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University	Sarndahl, E (corresponding author), Univ Orebro, Dept Clin Med, Orebro, Sweden.	eva.sarndahl@ikm.oru.se			Medical Research Council of Southeast Sweden; County Council of ystergotland; Foundation of "Gamla Tjanarinnor''; Biomedical Research School; Cardiovascular Inflammation Research Centre (CIRC) at the Faculty of Health Sciences at Linkoping University; Swedish Heart & Lung Foundation	Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); County Council of ystergotland; Foundation of "Gamla Tjanarinnor''; Biomedical Research School; Cardiovascular Inflammation Research Centre (CIRC) at the Faculty of Health Sciences at Linkoping University; Swedish Heart & Lung Foundation(Swedish Heart-Lung Foundation)	This work was supported by grants from the Medical Research Council of Southeast Sweden, the County Council of ystergotland, the Foundation of "Gamla Tjanarinnor'', the Biomedical Research School and the Cardiovascular Inflammation Research Centre (CIRC) at the Faculty of Health Sciences at Linkoping University. Veronika Patcha Brodin was supported by a fellowship from the Swedish Heart & Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 1999, J BIOL CHEM, V274, P6027, DOI 10.1074/jbc.274.10.6027; BELLER DI, 1982, J EXP MED, V156, P1000, DOI 10.1084/jem.156.4.1000; Boekholdt SM, 2004, ARTERIOSCL THROM VAS, V24, P1503, DOI 10.1161/01.ATV.0000134294.54422.2e; Buffon A, 2002, NEW ENGL J MED, V347, P5, DOI 10.1056/NEJMoa012295; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Cougoule C, 2004, SEMIN CELL DEV BIOL, V15, P679, DOI 10.1016/j.semcdb.2004.09.001; DIAMOND MS, 1993, J CELL BIOL, V120, P545, DOI 10.1083/jcb.120.2.545; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; Egger G, 2001, INFLAMMATION, V25, P129, DOI 10.1023/A:1007174723608; Fiorucci S, 2003, BRIT J PHARMACOL, V139, P1351, DOI 10.1038/sj.bjp.0705356; Gahmberg CG, 2002, VOX SANG, V83, P355, DOI 10.1111/j.1423-0410.2002.tb05333.x; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Guasti L, 2006, J HYPERTENS, V24, P2423, DOI 10.1097/01.hjh.0000251903.62804.77; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HED J, 1982, IMMUNOLOGY, V45, P727; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Lindmark E, 2001, THROMB RES, V103, P249, DOI 10.1016/S0049-3848(01)00313-9; Lundqvist H, 1995, INFLAMM RES, V44, P510, DOI 10.1007/BF01757354; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; MEHTA J, 1989, CIRCULATION, V79, P549, DOI 10.1161/01.CIR.79.3.549; Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20; Nijm J, 2005, AM J CARDIOL, V95, P452, DOI 10.1016/j.amjcard.2004.10.009; Ott I, 1996, CIRCULATION, V94, P1239, DOI 10.1161/01.CIR.94.6.1239; Papayianni A, 1996, J IMMUNOL, V156, P2264; Patcha V, 2004, EXP CELL RES, V300, P308, DOI 10.1016/j.yexcr.2004.07.015; Patel PB, 2004, AM J CARDIOL, V93, P410, DOI 10.1016/j.amjcard.2003.10.033; Paulsson J, 2007, ATHEROSCLEROSIS, V192, P328, DOI 10.1016/j.atherosclerosis.2006.08.003; Prasad K, 2006, CARDIOVASC DRUG REV, V24, P33, DOI 10.1111/j.1527-3466.2006.00033.x; Price DT, 1999, AM J MED, V107, P85, DOI 10.1016/S0002-9343(99)00153-9; Rothenbacher D, 2006, ARTERIOSCL THROM VAS, V26, P194, DOI 10.1161/01.ATV.0000191633.52585.14; Sarndahl E, 1996, J BIOL CHEM, V271, P15267; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Wilsson A, 1996, J LEUKOCYTE BIOL, V59, P902, DOI 10.1002/jlb.59.6.902; Yang YY, 2004, ATHEROSCLEROSIS, V174, P207, DOI 10.1016/j.atherosclerosis.2004.01.024	35	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1056	10.1371/journal.pone.0001056	http://dx.doi.org/10.1371/journal.pone.0001056			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957240	Green Published, gold			2022-12-27	WOS:000207458500003
J	Twellmeyer, J; Wende, A; Wolfertz, J; Pfeiffer, F; Panhuysen, M; Zaigler, A; Soppa, J; Welzl, G; Oesterhelt, D				Twellmeyer, Jens; Wende, Andy; Wolfertz, Jan; Pfeiffer, Friedhelm; Panhuysen, Markus; Zaigler, Alexander; Soppa, Joerg; Welzl, Gerhard; Oesterhelt, Dieter			Microarray Analysis in the Archaeon Halobacterium salinarum Strain R1	PLOS ONE			English	Article							MEMBRANE PROTEOME; PURPLE MEMBRANE; DNA-MICROARRAY; GENE; HALOBIUM; TRANSDUCER; CHEMOTAXIS; EXPRESSION; DESIGN; GROWTH	Background. Phototrophy of the extremely halophilic archaeon Halobacterium salinarum was explored for decades. The research was mainly focused on the expression of bacteriorhodopsin and its functional properties. In contrast, less is known about genome wide transcriptional changes and their impact on the physiological adaptation to phototrophy. The tool of choice to record transcriptional profiles is the DNA microarray technique. However, the technique is still rarely used for transcriptome analysis in archaea. Methodology/Principal Findings. We developed a whole-genome DNA microarray based on our sequence data of the Hbt. salinarum strain R1 genome. The potential of our tool is exemplified by the comparison of cells growing under aerobic and phototrophic conditions, respectively. We processed the raw fluorescence data by several stringent filtering steps and a subsequent MAANOVA analysis. The study revealed a lot of transcriptional differences between the two cell states. We found that the transcriptional changes were relatively weak, though significant. Finally, the DNA microarray data were independently verified by a real-time PCR analysis. Conclusion/Significance. This is the first DNA microarray analysis of Hbt. salinarum cells that were actually grown under phototrophic conditions. By comparing the transcriptomics data with current knowledge we could show that our DNA microarray tool is well applicable for transcriptome analysis in the extremely halophilic archaeon Hbt. salinarum. The reliability of our tool is based on both the high-quality array of DNA probes and the stringent data handling including MAANOVA analysis. Among the regulated genes more than 50% had unknown functions. This underlines the fact that haloarchaeal phototrophy is still far away from being completely understood. Hence, the data recorded in this study will be subject to future systems biology analysis.	[Twellmeyer, Jens; Wende, Andy; Wolfertz, Jan; Pfeiffer, Friedhelm; Oesterhelt, Dieter] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Panhuysen, Markus] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Zaigler, Alexander; Soppa, Joerg] Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany; [Welzl, Gerhard] GSF Forschungszentrum Umwelt & Gesundheit, Natl Res Ctr Environm & Hlth, Inst Biomath & Biometry, Neuherberg, Germany	Max Planck Society; Max Planck Society; Goethe University Frankfurt; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Oesterhelt, D (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	oesterhe@biochem.mpg.de	Pfeiffer, Friedhelm/K-1757-2019	Pfeiffer, Friedhelm/0000-0003-4691-3246; Soppa, Jorg/0000-0002-6132-5840	Deutsche Forschungsgesellschaft (DFG) [OE 52/18-1]	Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgesellschaft (DFG) by the funds OE 52/18-1. The DFG was not involved in the design or conduct of the study nor in any other part of the work.	AREGGER M, 2003, THESIS LUDWIGMAXIMIL; Baliga NS, 2002, P NATL ACAD SCI USA, V99, P14913, DOI 10.1073/pnas.192558999; Baliga NS, 2001, P NATL ACAD SCI USA, V98, P2521, DOI 10.1073/pnas.051632498; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bisle B, 2006, MOL CELL PROTEOMICS, V5, P1543, DOI 10.1074/mcp.M600106-MCP200; Brooun A, 1998, J BACTERIOL, V180, P1642, DOI 10.1128/JB.180.7.1642-1646.1998; DASSARMA S, 1988, P NATL ACAD SCI USA, V85, P6861, DOI 10.1073/pnas.85.18.6861; Dharmadi Y, 2004, BIOTECHNOL PROGR, V20, P1309, DOI 10.1021/bp0400240; Diehl F, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e38; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; GROPP F, 1994, P NATL ACAD SCI USA, V91, P5475, DOI 10.1073/pnas.91.12.5475; Klein C, 2005, PROTEOMICS, V5, P180, DOI 10.1002/pmic.200400943; Kokoeva MV, 2000, MOL MICROBIOL, V35, P647, DOI 10.1046/j.1365-2958.2000.01735.x; Lee MLT, 2000, P NATL ACAD SCI USA, V97, P9834, DOI 10.1073/pnas.97.18.9834; Mary-Huard T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-63; Muller JA, 2005, J BACTERIOL, V187, P1659, DOI 10.1128/JB.187.5.1659-1667.2005; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; OESTERHELT D, 1982, METHOD ENZYMOL, V88, P417; OESTERHELT D, 1983, ANN INST PASTEUR MIC, VB134, P137, DOI 10.1016/S0769-2609(83)80101-X; Peck RF, 2001, J BIOL CHEM, V276, P5739, DOI 10.1074/jbc.M009492200; Raddatz G, 2001, BIOINFORMATICS, V17, P98, DOI 10.1093/bioinformatics/17.1.98; Rousseeuw P. J., 1987, ROBUST REGRESSION OU; RUDOLPH J, 1995, EMBO J, V14, P667, DOI 10.1002/j.1460-2075.1995.tb07045.x; Ruepp A, 1996, J BACTERIOL, V178, P4942, DOI 10.1128/jb.178.16.4942-4947.1996; SHAND RF, 1991, J BACTERIOL, V173, P4692, DOI 10.1128/jb.173.15.4692-4699.1991; STOECKENIUS W, 1968, J CELL BIOL, V38, P337, DOI 10.1083/jcb.38.2.337; SUMPER M, 1976, FEBS LETT, V69, P149, DOI 10.1016/0014-5793(76)80673-4; SUMPER M, 1976, ANGEW CHEM INT EDIT, V15, P187, DOI 10.1002/anie.197601871; Tebbe A, 2005, PROTEOMICS, V5, P168, DOI 10.1002/pmic.200400910; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Whitehead K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100091; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; YAO VJ, 1992, P NATL ACAD SCI USA, V89, P11915, DOI 10.1073/pnas.89.24.11915; Zaigler A, 2003, MOL MICROBIOL, V48, P1089, DOI 10.1046/j.1365-2958.2003.03497.x	35	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1064	10.1371/journal.pone.0001064	http://dx.doi.org/10.1371/journal.pone.0001064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957248	Green Submitted, Green Published, gold			2022-12-27	WOS:000207458500011
J	Zhao, JS; Punj, V; Matta, H; Mazzacurati, L; Schamus, S; Yang, YQ; Yang, TB; Hong, Y; Chaudhary, PM				Zhao, Jinshun; Punj, Vasu; Matta, Hittu; Mazzacurati, Lucia; Schamus, Sandra; Yang, Yanqiang; Yang, Tianbing; Hong, Yan; Chaudhary, Preet M.			K13 Blocks KSHV Lytic Replication and Deregulates vIL6 and hIL6 Expression: A Model of Lytic Replication Induced Clonal Selection in Viral Oncogenesis	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; NF-KAPPA-B; PRIMARY-EFFUSION LYMPHOMA; KAPOSIS-SARCOMA; DNA-SEQUENCES; GROWTH-FACTOR; HUMAN INTERLEUKIN-6; ENDOTHELIAL-CELLS; SIGNAL TRANSDUCER; INDUCED APOPTOSIS	Background. Accumulating evidence suggests that dysregulated expression of lytic genes plays an important role in KSHV ( Kaposi's sarcoma associated herpesvirus) tumorigenesis. However, the molecular events leading to the dysregulation of KSHV lytic gene expression program are incompletely understood. Methodology/Principal Findings. We have studied the effect of KSHV-encoded latent protein vFLIP K13, a potent activator of the NF-kappa B pathway, on lytic reactivation of the virus. We demonstrate that K13 antagonizes RTA, the KSHV lytic-regulator, and effectively blocks the expression of lytic proteins, production of infectious virions and death of the infected cells. Induction of lytic replication selects for clones with increased K13 expression and NF-kappa B activity, while siRNA-mediated silencing of K13 induces the expression of lytic genes. However, the suppressive effect of K13 on RTA-induced lytic genes is not uniform and it fails to block RTA-induced viral IL6 secretion and cooperates with RTA to enhance cellular IL-6 production, thereby dysregulating the lytic gene expression program. Conclusions/Significance. Our results support a model in which ongoing KSHV lytic replication selects for clones with progressively higher levels of K13 expression and NF-kappa B activity, which in turn drive KSHV tumorigenesis by not only directly stimulating cellular survival and proliferation, but also indirectly by dysregulating the viral lytic gene program and allowing non-lytic production of growth-promoting viral and cellular genes. Lytic Replication-Induced Clonal Selection (LyRICS) may represent a general mechanism in viral oncogenesis.	[Zhao, Jinshun; Punj, Vasu; Matta, Hittu; Mazzacurati, Lucia; Schamus, Sandra; Yang, Yanqiang; Hong, Yan; Chaudhary, Preet M.] Univ Pittsburgh, Dept Med, Div Hematol Oncol, Hillman Canc Ctr, Pittsburgh, PA 15260 USA; [Yang, Tianbing] Univ Pittsburgh, Spang Translat Res Core Facil, Hillman Canc Ctr, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chaudhary, PM (corresponding author), Univ Pittsburgh, Dept Med, Div Hematol Oncol, Hillman Canc Ctr, Pittsburgh, PA 15260 USA.	chaudharypm@upmc.edu	Chaudhary, Preet/E-1970-2018	mazzacurati, lucia/0000-0002-8336-8032	National Institutes of Health [CA85177, CA124621]; Leukemia & Lymphoma Society; Mario Lemieux Foundation; NATIONAL CANCER INSTITUTE [R01CA085177, R01CA124621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Mario Lemieux Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (CA85177 and CA124621), the Leukemia & Lymphoma Society, and the Mario Lemieux Foundation.	An JB, 2003, ONCOGENE, V22, P3371, DOI 10.1038/sj.onc.1206407; Andreoni M, 2001, J INFECTION, V43, P195, DOI 10.1053/jinf.2001.0899; Aoki Y, 1999, BLOOD, V93, P4034, DOI 10.1182/blood.V93.12.4034.412k38_4034_4043; Aoki Y, 2000, J HEMATOTH STEM CELL, V9, P137, DOI 10.1089/152581600319351; Babcock GJ, 1999, J EXP MED, V190, P567, DOI 10.1084/jem.190.4.567; Brousset P, 2001, HUM PATHOL, V32, P95, DOI 10.1053/hupa.2001.21131; Brown HJ, 2003, J VIROL, V77, P8532, DOI 10.1128/JVI.77.15.8532-8540.2003; BURGER R, 1994, ANN HEMATOL, V69, P25, DOI 10.1007/BF01757344; Cannon JS, 1999, J INFECT DIS, V180, P824, DOI 10.1086/314956; Cannon M, 2006, BLOOD, V107, P277, DOI 10.1182/blood-2005-06-2350; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chang PJ, 2002, J VIROL, V76, P3168, DOI 10.1128/JVI.76.7.3168-3178.2002; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chatterjee M, 2002, SCIENCE, V298, P1432, DOI 10.1126/science.1074883; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Chugh P, 2005, P NATL ACAD SCI USA, V102, P12885, DOI 10.1073/pnas.0408577102; COHEN T, 1996, INTERLEUKIN 6 INDUCE, P736; Deng HY, 2000, J GEN VIROL, V81, P3043, DOI 10.1099/0022-1317-81-12-3043; Deng HY, 2002, BLOOD, V100, P1919, DOI 10.1182/blood-2002-01-0015; Deng HY, 2002, J VIROL, V76, P8252, DOI 10.1128/JVI.76.16.8252-8264.2002; ENSOLI B, 1995, P ASSOC AM PHYSICIAN, V107, P8; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Foussat A, 1999, EUR CYTOKINE NETW, V10, P501; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Godfrey A, 2005, BLOOD, V105, P2510, DOI 10.1182/blood-2004-08-3052; Grisotto MG, 2006, J CLIN INVEST, V116, P1264, DOI 10.1172/JCI26666; Grossmann C, 2006, J VIROL, V80, P7179, DOI 10.1128/JVI.01603-05; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Grundhoff A, 2001, J VIROL, V75, P1857, DOI 10.1128/JVI.75.4.1857-1863.2001; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Hayward GS, 2003, CANCER CELL, V3, P1, DOI 10.1016/S1535-6108(03)00002-3; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Inoue N, 2003, J VIROL, V77, P8147, DOI 10.1128/JVI.77.14.8147-8152.2003; Jenkins FJ, 2002, J INFECT DIS, V185, P1238, DOI 10.1086/340237; Jenner RG, 2001, J VIROL, V75, P891, DOI 10.1128/JVI.75.2.891-902.2001; Jones KD, 1999, BLOOD, V94, P2871; KAAYA EE, 1992, EUR J CANCER, V28A, P1890, DOI 10.1016/0959-8049(92)90030-6; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; LAM KMC, 1991, LANCET, V337, P876, DOI 10.1016/0140-6736(91)90203-2; Lan K, 2004, J VIROL, V78, P6585, DOI 10.1128/JVI.78.12.6585-6594.2004; Lee BS, 2002, J VIROL, V76, P12185, DOI 10.1128/JVI.76.23.12185-12199.2002; Li H, 2002, J VIROL, V76, P5627, DOI 10.1128/JVI.76.11.5627-5636.2002; Liu CQ, 2001, J VIROL, V75, P10933, DOI 10.1128/JVI.75.22.10933-10940.2001; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukac DM, 2001, J VIROL, V75, P6786, DOI 10.1128/JVI.75.15.6786-6799.2001; Matta H, 2007, ONCOGENE, V26, P1656, DOI 10.1038/sj.onc.1209931; MILES SA, 1990, P NATL ACAD SCI USA, V87, P4068, DOI 10.1073/pnas.87.11.4068; Molden J, 1997, J BIOL CHEM, V272, P19625, DOI 10.1074/jbc.272.31.19625; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535-6108(02)00237-4; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Nicholas J, 1997, NAT MED, V3, P287, DOI 10.1038/nm0397-287; Nicholas J, 2007, FRONT BIOSCI-LANDMRK, V12, P265, DOI 10.2741/2063; Parravicini C, 2000, AM J PATHOL, V156, P743, DOI 10.1016/S0002-9440(10)64940-1; Paulose-Murphy M, 2001, J VIROL, V75, P4843, DOI 10.1128/JVI.75.10.4843-4853.2001; Picard D, 2000, METHOD ENZYMOL, V327, P385, DOI 10.1016/S0076-6879(00)27291-1; Qunibi W, 1998, TRANSPLANTATION, V65, P583, DOI 10.1097/00007890-199802270-00024; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Sarid R, 1998, J VIROL, V72, P1005, DOI 10.1128/JVI.72.2.1005-1012.1998; Schulz TF, 2006, J PATHOL, V208, P187, DOI 10.1002/path.1904; Sirianni MC, 2002, EUR J IMMUNOL, V32, P2711, DOI 10.1002/1521-4141(2002010)32:10<2711::AID-IMMU2711>3.0.CO;2-3; Sodhi A, 2004, FASEB J, V18, P422, DOI 10.1096/fj.03-1035hyp; Song MJ, 2003, J VIROL, V77, P9451, DOI 10.1128/JVI.77.17.9451-9462.2003; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Staskus KA, 1999, J VIROL, V73, P4181, DOI 10.1128/JVI.73.5.4181-4187.1999; Sturzl M, 1999, J NATL CANCER I, V91, P1725, DOI 10.1093/jnci/91.20.1725; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Sun Q, 2003, BLOOD, V101, P1956, DOI 10.1182/blood-2002-07-2072; Sun QM, 2003, J BIOL CHEM, V278, P52437, DOI 10.1074/jbc.M304199200; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; WABINGA HR, 1993, INT J CANCER, V54, P26, DOI 10.1002/ijc.2910540106	75	40	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1067	10.1371/journal.pone.0001067	http://dx.doi.org/10.1371/journal.pone.0001067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957251	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000207458500014
J	Strier, DE; Dawson, SP				Strier, Damian E.; Dawson, Silvina Ponce			Turing Patterns Inside Cells	PLOS ONE			English	Article								Concentration gradients inside cells are involved in key processes such as cell division and morphogenesis. Here we show that a model of the enzymatic step catalized by phosphofructokinase (PFK), a step which is responsible for the appearance of homogeneous oscillations in the glycolytic pathway, displays Turing patterns with an intrinsic length-scale that is smaller than a typical cell size. All the parameter values are fully consistent with classic experiments on glycolytic oscillations and equal diffusion coefficients are assumed for ATP and ADP. We identify the enzyme concentration and the glycolytic flux as the possible regulators of the pattern. To the best of our knowledge, this is the first closed example of Turing pattern formation in a model of a vital step of the cell metabolism, with a built-in mechanism for changing the diffusion length of the reactants, and with parameter values that are compatible with experiments. Turing patterns inside cells could provide a check-point that combines mechanical and biochemical information to trigger events during the cell division process.	[Dawson, Silvina Ponce] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, DF, Argentina; [Strier, Damian E.] Univ Libre Bruxelles, Serv Chim Phys, Brussels, Belgium; [Strier, Damian E.] Univ Libre Bruxelles, Ctr Nonlinear Phenomena & Complex Syst, Brussels, Belgium	University of Buenos Aires; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Dawson, SP (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, Ciudad Univ,Pabellon 1, RA-1428 Buenos Aires, DF, Argentina.	silvina@df.uba.ar		Ponce Dawson, Silvina/0000-0001-6550-4267	UBACyT [X099]; CONICET [PIP 5131]; ANPCyT (Argentina) [PICT 1721001]; Santa Fe Institute	UBACyT; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT (Argentina)(ANPCyT); Santa Fe Institute	This research is supported by UBACyT X099, CONICET PIP 5131, PICT 1721001 of ANPCyT (Argentina) and Santa Fe Institute. Sponsors played no role in the design and conduct of this study.	Bagyan S, 2005, BIOPHYS CHEM, V116, P67, DOI 10.1016/j.bpc.2005.02.002; BEZRUKOV SM, 1994, NATURE, V370, P279, DOI 10.1038/370279a0; BOITEUX A, 1975, P NATL ACAD SCI USA, V72, P3829, DOI 10.1073/pnas.72.10.3829; CASTETS V, 1990, PHYS REV LETT, V64, P2953, DOI 10.1103/PhysRevLett.64.2953; CHANCE B, 1974, BIOL BIOCH OSCILLATO; CLAPHAM DE, 1995, NATURE, V375, P634, DOI 10.1038/375634a0; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; Goldbeter A, 1997, BIOCH OSCILLATIONS C; Hasslacher B, 1993, CHAOS, V3, P7, DOI 10.1063/1.165967; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; HESS B, 1971, ANNU REV BIOCHEM, V40, P237, DOI 10.1146/annurev.bi.40.070171.001321; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Lawrence Peter A, 1993, MAKING FLY GENETICS, V6; LENGYEL I, 1991, SCIENCE, V251, P650, DOI 10.1126/science.251.4994.650; Mair T, 1996, J BIOL CHEM, V271, P627, DOI 10.1074/jbc.271.2.627; Meinhardt Hans, 1999, P129; Murray J. D., 1989, MATH BIOL, DOI DOI 10.1007/978-3-662-08539-4; OUYANG Q, 1991, NATURE, V352, P610, DOI 10.1038/352610a0; Pearson John E., 1992, Chaos, V2, P513, DOI 10.1063/1.165893; PRIGOGIN.I, 1969, NATURE, V223, P913, DOI 10.1038/223913a0; PYE EK, 1966, P NATL ACAD SCI USA, V55, P888; RICHTER PH, 1981, PROG THEOR PHYS, V66, P385, DOI 10.1143/PTP.66.385; SELKOV EE, 1968, EUR J BIOCHEM, V4, P79, DOI 10.1111/j.1432-1033.1968.tb00175.x; SELKOV EE, 1968, MOL BIOL, V2, P252; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Strier DE, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066207; Strier DE, 2000, J CHEM PHYS, V112, P825, DOI 10.1063/1.480650; STRIER DE, 2002, THESIS U BUENOS AIRE; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Xu HT, 2004, P NATL ACAD SCI USA, V101, P4296, DOI 10.1073/pnas.0303893101	31	27	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1053	10.1371/journal.pone.0001053	http://dx.doi.org/10.1371/journal.pone.0001053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940616	Green Published, Green Submitted, gold			2022-12-27	WOS:000207456100020
J	Castelletti, E; Lo Caputo, S; Kuhn, L; Borelli, M; Gajardo, J; Sinkala, M; Trabattoni, D; Kankasa, C; Lauri, E; Clivio, A; Piacentini, L; Bray, DH; Aldrovandi, GM; Thea, DM; Veas, F; Nebuloni, M; Mazzotta, F; Clerici, M				Castelletti, Eleonora; Lo Caputo, Sergio; Kuhn, Louise; Borelli, Manuela; Gajardo, Johanna; Sinkala, Moses; Trabattoni, Daria; Kankasa, Chipepo; Lauri, Eleonora; Clivio, Alberto; Piacentini, Luca; Bray, Dorothy H.; Aldrovandi, Grace M.; Thea, Donald M.; Veas, Francisco; Nebuloni, Manuela; Mazzotta, Francesco; Clerici, Mario			The Mucosae-Associated Epithelial Chemokine (MEC/CCL28) Modulates Immunity in HIV Infection	PLOS ONE			English	Article								Background. CCL28 (MEC) binds to CCR3 and CCR10 and recruits IgA-secreting plasma cells (IgA-ASC) in the mucosal lamina propria (MLP). Mucosal HIV-specific IgA are detected in HIV-infection and exposure. The CCL28 circuit was analyzed in HIV-infected and-exposed individuals and in HIV-unexposed controls; the effect of CCL28 administration on gastrointestinal MLP IgA-ASC was verified in a mouse model. Methodology/Findings. CCL28 was augmented in breast milk (BM) plasma and saliva of HIV-infected and -exposed individuals; CCR3+ and CCR10+ B lymphocytes were increased in these same individuals. Additionally: 1) CCL28 concentration in BM was associated with longer survival in HIV vertically-infected children; and 2) gastro-intestinal mucosal IgA-ASC were significantly increased in VSV-immunized mice receiving CCL28. Conclusions. CCL28 mediates mucosal immunity in HIV exposure and infection. CCL28-including constructs should be considered in mucosal vaccines to prevent HIV infection of the gastro-intestinal MLP via modulation of IgA-ASC.	[Castelletti, Eleonora; Borelli, Manuela; Trabattoni, Daria; Clivio, Alberto; Piacentini, Luca; Thea, Donald M.; Clerici, Mario] Univ Milan, Dept Preclin Sci, Lab Interdisciplinare Technol Avanzate LITA Vialb, Milan, Italy; [Lo Caputo, Sergio; Mazzotta, Francesco] SS Annunziata Hosp, Infect Dis Clin, Florence, Italy; [Kuhn, Louise] Columbia Univ, Gertrude H Sergievsky Ctr, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Gajardo, Johanna; Veas, Francisco] IRD UR178, Inst Dev Res, Lab Retroviral & Mol Immunol, Montpellier, France; [Sinkala, Moses] Lusaka Dist Hlth Management Team, Lusaka, Zambia; [Kankasa, Chipepo] Univ Zambia, Univ Teaching Hosp, Lusaka, Zambia; [Lauri, Eleonora; Nebuloni, Manuela] Univ Milan, Pathol Unit, Dept Clin Sci, Milan, Italy; [Bray, Dorothy H.] ImmunoClin, London, England; [Aldrovandi, Grace M.] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA USA; Univ Milan, Dept Biomed Sci & Technol, I-20133 Milan, Italy	University of Milan; Columbia University; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Zambia; University of Milan; University of Southern California; Boston University; University of Milan	Clerici, M (corresponding author), Univ Milan, Dept Preclin Sci, Lab Interdisciplinare Technol Avanzate LITA Vialb, Milan, Italy.	mario.clerici@unimi.it	Trabattoni, Daria/G-7424-2012; Piacentini, Luca/K-8908-2016; CLIVIO, ALBERTO/S-9320-2017; NEBULONI, MANUELA/L-3969-2017	Trabattoni, Daria/0000-0001-9535-3359; Piacentini, Luca/0000-0003-1022-4481; Clerici, Mario/0000-0001-5920-6191; Lo Caputo, Sergio/0000-0002-4729-7548; Thea, Donald/0000-0002-6933-1030; CLIVIO, ALBERTO/0000-0002-1423-046X; NEBULONI, MANUELA/0000-0002-2773-734X	Istituto Superiore di Sanita; Tuscany Region; EMPRO; AVIP EC [WP6]; Japan Health Science Foundation; National Institutes of Child Health and Human Development [HD 39611, HD 40777]	Istituto Superiore di Sanita; Tuscany Region(Regione Toscana); EMPRO; AVIP EC; Japan Health Science Foundation; National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by grants from the Istituto Superiore di Sanita' "Programma Nazionale di Ricerca sull' AIDS''; Tuscany Region, DG Right to Health and Solidarity Policy; the EMPRO and AVIP EC WP6 Projects; the Japan Health Science Foundation; and from the National Institutes of Child Health and Human Development HD 39611 and HD 40777.	Belec L, 2001, J INFECT DIS, V184, P1412, DOI 10.1086/324375; Beyrer C, 1999, J INFECT DIS, V179, P59, DOI 10.1086/314556; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Bomsel M, 2007, AIDS, V21, P13, DOI 10.1097/QAD.0b013e328011049b; Bourges D, 2004, SCAND J IMMUNOL, V60, P338, DOI 10.1111/j.0300-9475.2004.01479.x; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cartry O, 1997, CLIN EXP IMMUNOL, V109, P47, DOI 10.1046/j.1365-2249.1997.4261320.x; Clerici M, 2002, AIDS, V16, P1731, DOI 10.1097/00002030-200209060-00004; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Devito C, 2000, AIDS, V14, P1917, DOI 10.1097/00002030-200009080-00006; Devito C, 2002, J ACQ IMMUN DEF SYND, V30, P413, DOI [10.1097/00042560-200208010-00007, 10.1097/01.QAI.0000021664.20213.5A]; Dorrell L, 2000, AIDS, V14, P1117, DOI 10.1097/00002030-200006160-00008; Eksteen B, 2006, J IMMUNOL, V177, P593, DOI 10.4049/jimmunol.177.1.593; Feng NG, 2006, J IMMUNOL, V176, P5749, DOI 10.4049/jimmunol.176.10.5749; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hieshima K, 2004, J IMMUNOL, V173, P3668, DOI 10.4049/jimmunol.173.6.3668; Hieshima K, 2003, J IMMUNOL, V170, P1452, DOI 10.4049/jimmunol.170.3.1452; Hocini H, 1997, AIDS RES HUM RETROV, V13, P1179, DOI 10.1089/aid.1997.13.1179; JANOFF EN, 1995, J INFECT DIS, V172, P855, DOI 10.1093/infdis/172.3.855; John AE, 2005, AM J PATHOL, V166, P345, DOI 10.1016/S0002-9440(10)62258-4; Kaul R, 1999, AIDS, V13, P23, DOI 10.1097/00002030-199901140-00004; Kozlowski PA, 2003, CURR MOL MED, V3, P217, DOI 10.2174/1566524033479852; Kuhn L, 2005, JAIDS-J ACQ IMM DEF, V39, P138; Kunkel EJ, 2003, MICROCIRCULATION, V10, P313, DOI 10.1038/sj.mn.7800196; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Lazarus NH, 2003, J IMMUNOL, V170, P3799, DOI 10.4049/jimmunol.170.7.3799; Lehner T, 2005, VACCINE, V23, P5551, DOI 10.1016/j.vaccine.2005.07.009; Lehner T, 2002, AIDS, V16, pS125, DOI 10.1097/00002030-200216004-00017; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; Nakayama T, 2003, J IMMUNOL, V170, P1136, DOI 10.4049/jimmunol.170.3.1136; Ogawa H, 2004, AM J PHYSIOL-GASTR L, V287, pG1062, DOI 10.1152/ajpgi.00162.2004; Oswald J, 2005, TISSUE ANTIGENS, V66, P373; Qin LZ, 2004, J VIROL, V78, P7016, DOI 10.1128/JVI.78.13.7016-7022.2004; Qin LZ, 2003, VIROLOGY, V308, P225, DOI [10.1016/S0042-6822(02)00088-0, 10.1016/S0042-3822(02)00088-0]; Schnell MJ, 1996, J VIROL, V70, P2318, DOI 10.1128/JVI.70.4.2318-2323.1996; Soderlund J, 2004, SCAND J INFECT DIS, V36, P663, DOI 10.1080/00365540410020857; Vincent N, 2004, AIDS, V18, P37, DOI 10.1097/00002030-200401020-00004; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; Williams IR, 2004, IMMUNOL RES, V29, P283, DOI 10.1385/IR:29:1-3:283; Wu XL, 2003, AIDS RES HUM RETROV, V19, P275, DOI 10.1089/088922203764969474; Wu XL, 2002, J CLIN IMMUNOL, V22, P106, DOI 10.1023/A:1014435920321	46	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e969	10.1371/journal.pone.0000969	http://dx.doi.org/10.1371/journal.pone.0000969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912348	Green Published, gold			2022-12-27	WOS:000207455900007
J	Enqvist, S; Sletten, K; Stevens, FJ; Hellman, U; Westermark, P				Enqvist, Stina; Sletten, Knut; Stevens, Fred J.; Hellman, Ulf; Westermark, Per			Germ Line Origin and Somatic Mutations Determine the Target Tissues in Systemic AL-Amyloidosis	PLOS ONE			English	Article								Background. Amyloid is insoluble aggregated proteins deposited in the extra cellular space. About 25 different proteins are known to form amyloid in vivo and are associated with severe diseases such as Alzheimers disease, prion diseases and type-2 diabetes. Light chain (AL) -amyloidosis is unique among amyloid diseases in that the fibril protein, a monoclonal immunoglobulin light chain, varies between individuals and that no two AL-proteins with identical primary structures have been described to date. The variability in tissue distribution of amyloid deposits is considerably larger in systemic AL-amyloidosis than in any other form of amyloidosis. The reason for this variation is believed to be based on the differences in properties of the amyloidogenic immunoglobulin light chain. However, there is presently no known relationship between the structure of an AL-protein and tissue distribution. Methodology/Principal Findings. We compared the pattern of amyloid deposition in four individuals with amyloid protein derived from variable light chain gene O18-O8, the source of a high proportion of amyloidogenic light chains, and in whom all or most of the fibril protein had been determined by amino acid sequencing. In spite of great similarities between the structures of the proteins, there was a pronounced variability in deposition pattern. We also compared the tissue distribution in these four individuals with that of four other patients with AL-amyloid derived from the L2-L16 gene. Although the interindividual variations were pronounced, liver and kidney involvement was much more evident in the latter four. Conclusions/Significance. We conclude that although the use of a specific gene influences the tissue distribution of amyloid, each light chain exhibits one or more determinants of organ-specificity, which originate from somatic mutations and post-translational modifications. Eventual identification of such determinants could lead to improved treatment of patients with AL amyloidosis.	[Enqvist, Stina; Westermark, Per] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; [Sletten, Knut] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway; [Stevens, Fred J.] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA; [Hellman, Ulf] Ludwig Inst Canc Res, S-75124 Uppsala, Sweden	Uppsala University; University of Oslo; United States Department of Energy (DOE); Argonne National Laboratory; Ludwig Institute for Cancer Research	Westermark, P (corresponding author), Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden.	Per.Westermark@genpat.uu.se			Research Council of Norway; Swedish Research Council [5941]; European Union	Research Council of Norway(Research Council of Norway); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission)	The work was supported by the Research Council of Norway, the Swedish Research Council (Project No. 5941) and the European Union FP6 Program.	Abraham RS, 2003, BLOOD, V101, P3801, DOI 10.1182/blood-2002-09-2707; Bergstrom J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759; Comenzo RL, 2001, BLOOD, V98, P714, DOI 10.1182/blood.V98.3.714; Decourt C, 1996, CLIN EXP IMMUNOL, V106, P357; Engvig JP, 1998, SCAND J IMMUNOL, V48, P92; EULITZ M, 1985, BIOL CHEM H-S, V366, P907, DOI 10.1515/bchm3.1985.366.2.907; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; Galea HR, 2002, CLIN EXP IMMUNOL, V129, P113, DOI 10.1046/j.1365-2249.2002.01896.x; Hamill SJ, 2000, J MOL BIOL, V295, P641, DOI 10.1006/jmbi.1999.3360; Hellman U, 2002, MASS SPECTROMETRY AND HYPHENATED TECHNIQUES IN NEUROPEPTIDE RESEARCH, P259; Hellman U, 2002, RAPID COMMUN MASS SP, V16, P1851, DOI 10.1002/rcm.805; ISOBE T, 1974, NEW ENGL J MED, V290, P473, DOI 10.1056/NEJM197402282900902; Karimi M, 2003, SCAND J IMMUNOL, V57, P319, DOI 10.1046/j.1365-3083.2003.01230.x; KLEIN R, 1993, EUR J IMMUNOL, V23, P3248, DOI 10.1002/eji.1830231231; KYLE RA, 1983, MAYO CLIN PROC, V58, P665; KYLE RA, 1992, BLOOD, V79, P1817; MERLINI G, 1995, SEMIN HEMATOL, V32, P60; NYQUIST J, 1993, AMYLOID AMYLOIDOSIS, P247; Olsen KE, 1998, BIOCHEM BIOPH RES CO, V251, P642, DOI 10.1006/bbrc.1998.9508; Olsen KE, 1998, BIOCHEM BIOPH RES CO, V245, P713, DOI 10.1006/bbrc.1998.8515; Pokkuluri PR, 2002, PROTEIN SCI, V11, P1687, DOI 10.1110/ps.4920102; Prado MJBA, 1997, BRAZ J MED BIOL RES, V30, P865, DOI 10.1590/S0100-879X1997000700008; PRAS M, 1982, ISRAEL J MED SCI, V18, P866; Samdal I, 1999, AMYLOID AND AMYLOIDOSIS 1998, P62; Samdal IA, 2001, AMYLOID, V8, P111, DOI 10.3109/13506120109007353; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHINODA T, 1986, AMYLOIDOSIS, P151; SLETTEN K, 1986, AMYLOIDOSIS, P463; Solomon A, 1998, P NATL ACAD SCI USA, V95, P9547, DOI 10.1073/pnas.95.16.9547; SOLOMON A, 1982, J CLIN INVEST, V70, P453, DOI 10.1172/JCI110635; Stevens FJ, 2000, AMYLOID, V7, P200, DOI 10.3109/13506120009146835; Stevens FJ, 1999, PROTEIN STRUCTURE ST; Stevens FJ, 1999, ANTIBODIES, V5, P175; SYMMERS WSC, 1956, J CLIN PATHOL, V9, P187, DOI 10.1136/jcp.9.3.187; SYMMERS WSC, 1956, J CLIN PATHOL, V9, P212, DOI 10.1136/jcp.9.3.212; TERRY WD, 1973, J CLIN INVEST, V52, P1276, DOI 10.1172/JCI107295; TOFT KG, 1990, AMYLOID AMYLOIDOSIS, P169; Vidal R, 1999, AM J PATHOL, V155, P2009, DOI 10.1016/S0002-9440(10)65520-4; Wally J, 1999, BBA-MOL BASIS DIS, V1454, P49, DOI 10.1016/S0925-4439(99)00019-8; WESTERMARK GT, 1990, AM J PATHOL, V137, P377; Westermark P, 2005, AMYLOID, V12, P1, DOI 10.1080/13506120500032196	41	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e981	10.1371/journal.pone.0000981	http://dx.doi.org/10.1371/journal.pone.0000981			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912358	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455900017
J	Fayard, E; Gill, J; Paolino, M; Hynx, D; Hollander, GA; Hemmings, BA				Fayard, Elisabeth; Gill, Jason; Paolino, Magdalena; Hynx, Debby; Hollaender, Georg A.; Hemmings, Brian A.			Deletion of PKB alpha/Akt1 Affects Thymic Development	PLOS ONE			English	Article								Background. The thymus constitutes the primary lymphoid organ for the majority of T cells. The phosphatidyl-inositol 3 kinase (PI3K) signaling pathway is involved in lymphoid development. Defects in single components of this pathway prevent thymocytes from progressing beyond early T cell developmental stages. Protein kinase B (PKB) is the main effector of the PI3K pathway. Methodology/Principal Findings. To determine whether PKB mediates PI3K signaling in the thymus, we characterized PKB knockout thymi. Our results reveal a significant thymic hypocellularity in PKB alpha(-/-) neonates and an accumulation of early thymocyte subsets in PKB alpha(-/-) adult mice. Using thymic grafting and fetal liver cell transfer experiments, the latter finding was specifically attributed to the lack of PKB alpha within the lymphoid component of the thymus. Microarray analyses show that the absence of PKB alpha in early thymocyte subsets modifies the expression of genes known to be involved in pre-TCR signaling, in T cell activation, and in the transduction of interferon-mediated signals. Conclusions/Significance. This report highlights the specific requirements of PKB alpha for thymic development and opens up new prospects as to the mechanism downstream of PKB alpha in early thymocytes.	[Fayard, Elisabeth; Paolino, Magdalena; Hynx, Debby; Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Gill, Jason; Hollaender, Georg A.] Univ Basel, Univ Childrens Hosp, Ctr Biomed, Dept Clin Biol Sci, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Hemmings, BA (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	brian.hemmings@fmi.ch	Paolino, Magdalena/AAN-9417-2020	Hollander, Georg/0000-0002-8790-0874; Gill, Jason/0000-0003-0955-6470; Paolino, Magdalena/0000-0001-9724-9029	European Molecular Biology Organization (EMBO) [ALTF 506-2005]; Marie Curie Fellowship [MEIF-CT-2006-025075]; NHMRC of Australia [237036]; Swiss National Science Foundation [3100-68310.02]; European Community; National Institute of Health [RO1-A1057477]	European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Marie Curie Fellowship(European Commission); NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community(European Commission); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	EF is supported by the European Molecular Biology Organization (EMBO) Long Term Fellowship ALTF 506-2005 and the Marie Curie Fellowship MEIF-CT-2006-025075. JG is supported by NHMRC of Australia, CJ Martin Fellowship 237036. This work has been in part supported by Swiss National Science Foundation (3100-68310.02), the European Community 6th Framework Program Euro-Thymaide Integrated Project and the National Institute of Health (RO1-A1057477). The Friedrich Miescher Institute for Biomedical Research is part of the Novartis Research Foundation.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bellavia D, 2003, SEMIN IMMUNOL, V15, P107, DOI 10.1016/S1044-5323(03)00007-1; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Ceredig R, 2002, NAT REV IMMUNOL, V2, P888, DOI 10.1038/nri937; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gill J, 2003, IMMUNOL REV, V195, P28, DOI 10.1034/j.1600-065X.2003.00077.x; Hagenbeek TJ, 2004, J EXP MED, V200, P883, DOI 10.1084/jem.20040495; Hinton HJ, 2006, FEBS LETT, V580, P5845, DOI 10.1016/j.febslet.2006.09.045; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; Juntilla MM, 2007, P NATL ACAD SCI USA, V104, P12105, DOI 10.1073/pnas.0705285104; Kaur S, 2005, J INTERF CYTOK RES, V25, P780, DOI 10.1089/jir.2005.25.780; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Kurimasa A, 1999, P NATL ACAD SCI USA, V96, P1403, DOI 10.1073/pnas.96.4.1403; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Malstrom S, 2001, P NATL ACAD SCI USA, V98, P14967, DOI 10.1073/pnas.231467698; Mao CC, 2007, J IMMUNOL, V178, P5443, DOI 10.4049/jimmunol.178.9.5443; Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200; Norment AM, 2000, J IMMUNOL, V164, P639, DOI 10.4049/jimmunol.164.2.639; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Parsons MJ, 2001, J IMMUNOL, V167, P42, DOI 10.4049/jimmunol.167.1.42; Patra AK, 2006, J IMMUNOL, V177, P4567, DOI 10.4049/jimmunol.177.7.4567; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; PETERSON SR, 1995, P NATL ACAD SCI USA, V92, P3171, DOI 10.1073/pnas.92.8.3171; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shiroki F, 2007, J IMMUNOL, V178, P1349, DOI 10.4049/jimmunol.178.3.1349; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wagner DH, 2007, CLIN IMMUNOL, V123, P1, DOI 10.1016/j.clim.2006.08.006; WILSON A, 1995, INT IMMUNOL, V7, P1659, DOI 10.1093/intimm/7.10.1659; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	53	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e992	10.1371/journal.pone.0000992	http://dx.doi.org/10.1371/journal.pone.0000992			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912369	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455900028
J	Verra, F; Simpore, J; Warimwe, GM; Tetteh, KK; Howard, T; Osier, FHA; Bancone, G; Avellino, P; Blot, I; Fegan, G; Bull, PC; Williams, TN; Conway, DJ; Marsh, K; Modiano, D				Verra, Federica; Simpore, Jacques; Warimwe, George M.; Tetteh, Kevin K.; Howard, Tevis; Osier, Faith H. A.; Bancone, Germana; Avellino, Pamela; Blot, Isa; Fegan, Greg; Bull, Peter C.; Williams, Thomas N.; Conway, David J.; Marsh, Kevin; Modiano, David			Haemoglobin C and S Role in Acquired Immunity against Plasmodium falciparum Malaria	PLOS ONE			English	Article							ANTIBODY-RESPONSES; SURFACE-ANTIGENS; PROTECTION; ERYTHROCYTES; TRAIT	A recently proposed mechanism of protection for haemoglobin C (HbC; beta 6Glu -> Lys) links an abnormal display of PfEMP1, an antigen involved in malaria pathogenesis, on the surface of HbC infected erythrocytes together with the observation of reduced cytoadhesion of parasitized erythrocytes and impaired rosetting in vitro. We investigated the impact of this hypothesis on the development of acquired immunity against Plasmodium falciparum variant surface antigens (VSA) encoding PfEMP1 in HbC in comparison with HbA and HbS carriers of Burkina Faso. We measured: i) total IgG against a single VSA, A4U, and against a panel of VSA from severe malaria cases in human sera from urban and rural areas of Burkina Faso of different haemoglobin genotypes (CC, AC, AS, SC, SS); ii) total IgG against recombinant proteins of P. falciparum asexual sporozoite, blood stage antigens, and parasite schizont extract; iii) total IgG against tetanus toxoid. Results showed that the reported abnormal cell-surface display of PfEMP1 on HbC infected erythrocytes observed in vitro is not associated to lower anti-PfEMP1 response in vivo. Higher immune response against the VSA panel and malaria antigens were observed in all adaptive genotypes containing at least one allelic variant HbC or HbS in the low transmission urban area whereas no differences were detected in the high transmission rural area. In both contexts the response against tetanus toxoid was not influenced by the beta-globin genotype. These findings suggest that both HbC and HbS affect the early development of naturally acquired immunity against malaria. The enhanced immune reactivity in both HbC and HbS carriers supports the hypothesis that the protection against malaria of these adaptive genotypes might be at least partially mediated by acquired immunity against malaria.	[Verra, Federica; Bancone, Germana; Avellino, Pamela; Modiano, David] Univ Roma La Sapienza, Dipartimento Sci Sanita Pubbl, Sez Parassitol, Rome, Italy; [Verra, Federica; Tetteh, Kevin K.; Osier, Faith H. A.; Fegan, Greg; Conway, David J.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Simpore, Jacques] Ctr Med St Camille, Ouagadougou, Burkina Faso; [Warimwe, George M.; Howard, Tevis; Osier, Faith H. A.; Fegan, Greg; Bull, Peter C.; Williams, Thomas N.; Marsh, Kevin] Kilifi Dist Hosp, Ctr Geog Med Res, Wellcome Trust Programme, Kenya Med Res Inst, Kilifi, Kenya; [Blot, Isa] Ctr Natl Transfus Sanguine, Ouagadougou, Burkina Faso; [Conway, David J.] MRC Labs, Banjul, Gambia	Sapienza University Rome; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; MRC Laboratory Molecular Biology	Verra, F (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Sanita Pubbl, Sez Parassitol, Rome, Italy.	federica.verra@uniroma1.it	Tetteh, Kevin/GYQ-9704-2022; Fegan, Greg W/O-8079-2018; SIMPORE, Jacques/ABA-4873-2020	Tetteh, Kevin/0000-0003-2733-0037; Fegan, Greg W/0000-0002-2663-2765; SIMPORE, Jacques/0000-0002-0415-9161; Bull, Peter/0000-0002-7674-6752; Osier, Faith/0000-0001-7133-5375; Bancone, Germana/0000-0003-4550-0431; Conway, David/0000-0002-8711-3037	Wellcome Trust [071626]; European, Priority 1 Life Sciences, Genomics and Biotechnology for Health [LSH-CT-2004-503578]; malaria Network; Compagnia di San Paolo, Turin, Italy; MRC [MC_U190081993] Funding Source: UKRI; Medical Research Council [MC_U190081993] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European, Priority 1 Life Sciences, Genomics and Biotechnology for Health; malaria Network; Compagnia di San Paolo, Turin, Italy(Compagnia di San Paolo); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was supported by the Wellcome Trust grant no 071626 (Advanced Training Fellowship in Tropical Medicine to FV). This work is also part of the activities of the BioMalPar European Network of Excellence supported by a European grant (LSH-CT-2004-503578) from the Priority 1 Life Sciences, Genomics and Biotechnology for Health in the 6th Framework Programme. FV is currently funded by the malaria Network sponsored by the Compagnia di San Paolo, Turin, Italy. The above mentioned funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation, review, or approval of the manuscript.	Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; ALLISON AC, 1954, T ROY SOC TROP MED H, V48, P312, DOI 10.1016/0035-9203(54)90101-7; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; Bull PC, 2002, J INFECT DIS, V185, P1688, DOI 10.1086/340420; Cabrera G, 2005, J INFECT DIS, V191, P1631, DOI 10.1086/429832; Cavanagh DR, 1997, MOL BIOCHEM PARASIT, V85, P197, DOI 10.1016/S0166-6851(96)02826-5; Cavanagh DR, 1998, J IMMUNOL, V161, P347; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Fairhurst RM, 2003, BLOOD, V101, P3309, DOI 10.1182/blood-2002-10-3105; Giha HA, 1999, INFECT IMMUN, V67, P4092, DOI 10.1128/IAI.67.8.4092-4098.1999; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Kinyanjui SM, 2004, J INFECT DIS, V190, P1527, DOI 10.1086/424675; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; Mockenhaupt FP, 2004, J INFECT DIS, V190, P1006, DOI 10.1086/422847; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; VIRIYAKOSOL S, 1995, B WORLD HEALTH ORGAN, V73, P85; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2003, CYTOM PART A, V56A, P96, DOI 10.1002/cyto.a.10088	20	50	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e978	10.1371/journal.pone.0000978	http://dx.doi.org/10.1371/journal.pone.0000978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912355	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000207455900014
J	Lodes, MJ; Suciu, D; Wilmoth, JL; Ross, M; Munro, S; Dix, K; Bernards, K; Stover, AG; Quintana, M; Iihoshi, N; Lyon, WJ; Danley, DL; McShea, A				Lodes, Michael J.; Suciu, Dominic; Wilmoth, Jodi L.; Ross, Marty; Munro, Sandra; Dix, Kim; Bernards, Karen; Stoever, Axel G.; Quintana, Miguel; Iihoshi, Naomi; Lyon, Wanda J.; Danley, David L.; McShea, Andrew			Identification of Upper Respiratory Tract Pathogens Using Electrochemical Detection on an Oligonucleotide Microarray	PLOS ONE			English	Article								Bacterial and viral upper respiratory infections (URI) produce highly variable clinical symptoms that cannot be used to identify the etiologic agent. Proper treatment, however, depends on correct identification of the pathogen involved as antibiotics provide little or no benefit with viral infections. Here we describe a rapid and sensitive genotyping assay and microarray for URI identification using standard amplification and hybridization techniques, with electrochemical detection (ECD) on a semiconductor-based oligonucleotide microarray. The assay was developed to detect four bacterial pathogens (Bordetella pertussis, Streptococcus pyogenes, Chlamydia pneumoniae and Mycoplasma pneumoniae) and 9 viral pathogens (adenovirus 4, coronavirus OC43, 229E and HK, influenza A and B, parainfluinza types 1, 2, and 3 and respiratory syncytial virus. This new platform forms the basis for a fully automated diagnostics system that is very flexible and can be customized to suit different or additional pathogens. Multiple probes on a flexible platform allow one to test probes empirically and then select highly reactive probes for further iterative evaluation. Because ECD uses an enzymatic reaction to create electrical signals that can be read directly from the array, there is no need for image analysis or for expensive and delicate optical scanning equipment. We show assay sensitivity and specificity that are excellent for a multiplexed format.	[Lodes, Michael J.; Suciu, Dominic; Wilmoth, Jodi L.; Ross, Marty; Munro, Sandra; Dix, Kim; Bernards, Karen; Stoever, Axel G.; Danley, David L.; McShea, Andrew] CombiMatrix Corp, Mukilteo, WA USA; [Quintana, Miguel; Iihoshi, Naomi] USA, Ctr Hlth Promot & Prevent Med W, Ft Lewis, WA USA; [Lyon, Wanda J.] USAF, Res Lab, Human Effectiveness Directorate, Appl Biotechnol Branch, Wright Patterson AFB, OH 45433 USA	United States Department of Defense; United States Air Force; US Air Force Research Laboratory	Lodes, MJ (corresponding author), CombiMatrix Corp, Mukilteo, WA USA.	mlodes@combimatrix.com	Munro, Sandra B/S-2611-2019	Munro, Sandra B/0000-0002-9643-0528	CombiMatrix Corporation	CombiMatrix Corporation	This is a research and development project funded by CombiMatrix Corporation (MJL, DS, JLW, AGS, MR, SM, KD, KB, DLD, and AM). MQ and NI are employees of CHPPM-West at Fort Lewis, Washington and WJL is an employee of the US Air Force Research Laboratory, Wright-Patterson AFB, OH.	Allwinn R, 2002, MED MICROBIOL IMMUN, V191, P157, DOI 10.1007/s00430-002-0137-y; Amano Y, 2005, ANAL BIOANAL CHEM, V381, P156, DOI 10.1007/s00216-004-2927-0; Baxi MK, 2006, VET J, V172, P473, DOI 10.1016/j.tvjl.2005.07.007; Bodrossy L, 2004, CURR OPIN MICROBIOL, V7, P245, DOI 10.1016/j.mib.2004.04.005; Boivin G, 2004, J CLIN MICROBIOL, V42, P45, DOI 10.1128/JCM.42.1.45-51.2004; Briese T, 2005, EMERG INFECT DIS, V11, P310, DOI 10.3201/eid1102.040492; Brook I, 2005, CHEST, V127, P2072, DOI 10.1378/chest.127.6.2072; Costa LF, 2006, MEM I OSWALDO CRUZ, V101, P301, DOI 10.1590/S0074-02762006000300014; Cram P, 1999, AM J MANAG CARE, V5, P1555; Dill K, 2004, BIOSENS BIOELECTRON, V20, P736, DOI 10.1016/j.bios.2004.06.049; Dosh SA, 2000, J FAM PRACTICE, V49, P407; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Ellis JS, 2002, REV MED VIROL, V12, P375, DOI 10.1002/rmv.370; Ghindilis AL, 2007, BIOSENS BIOELECTRON, V22, P1853, DOI 10.1016/j.bios.2006.06.024; Grondahl B, 1999, J CLIN MICROBIOL, V37, P1; Ivshina AV, 2004, J CLIN MICROBIOL, V42, P5793, DOI 10.1128/JCM.42.12.5793-5801.2004; Kessler N, 2004, J CLIN MICROBIOL, V42, P2173, DOI 10.1128/JCM.42.5.2173-2185.2004; Konno Masatoshi, 2006, Journal of Infection and Chemotherapy, V12, P83, DOI 10.1007/s10156-006-0433-3; Korimbocus J, 2005, J CLIN MICROBIOL, V43, P3779, DOI 10.1128/JCM.43.8.3779-3787.2005; Li JP, 2001, J CLIN MICROBIOL, V39, P696, DOI 10.1128/JCM.39.2.696-704.2001; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Lin BC, 2004, J CLIN MICROBIOL, V42, P3232, DOI 10.1128/JCM.42.7.3232-3239.2004; Liu HH, 1999, PHARMACOTHERAPY, V19, P371, DOI 10.1592/phco.19.6.371.31051; Liu RH, 2006, ANAL CHEM, V78, P4184, DOI 10.1021/ac060450v; Lodes MJ, 2006, J CLIN MICROBIOL, V44, P1209, DOI 10.1128/JCM.44.4.1209-1218.2006; Louie JK, 2005, CLIN INFECT DIS, V41, P822, DOI 10.1086/432800; Mainous AG, 1999, PHARMACOTHERAPY, V19, P388, DOI 10.1592/phco.19.6.388.31036; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; McDonough EA, 2005, MOL CELL PROBE, V19, P314, DOI 10.1016/j.mcp.2005.05.002; Mentel R, 2003, J MED MICROBIOL, V52, P893, DOI 10.1099/jmm.0.05290-0; Metzgar D, 2005, J CLIN MICROBIOL, V43, P5743, DOI 10.1128/JCM.43.11.5743-5752.2005; Mitterer G, 2004, J CLIN MICROBIOL, V42, P1048, DOI 10.1128/JCM.42.3.1048-1057.2004; Perkins SM, 2005, J CLIN MICROBIOL, V43, P2356, DOI 10.1128/JCM.43.5.2356-2362.2005; Roth SB, 2004, J CLIN MICROBIOL, V42, P4268, DOI 10.1128/JCM.42.9.4268-4274.2004; Schweiger B, 2000, J CLIN MICROBIOL, V38, P1552, DOI 10.1128/JCM.38.4.1552-1558.2000; Sengupta S, 2003, J CLIN MICROBIOL, V41, P4542, DOI 10.1128/JCM.41.10.4542-4550.2003; Stralin K, 2006, J CLIN MICROBIOL, V44, P643, DOI 10.1128/JCM.44.2.643-645.2006; Syrmis MW, 2004, J MOL DIAGN, V6, P125, DOI 10.1016/S1525-1578(10)60500-4; Taubenberger JK, 2001, MOL DIAGN, V6, P291, DOI 10.1054/modi.2001.28063; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Westin L, 2000, NAT BIOTECHNOL, V18, P199, DOI 10.1038/72658; Zou SM, 1997, J CLIN MICROBIOL, V35, P2623, DOI 10.1128/JCM.35.10.2623-2627.1997	44	49	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e924	10.1371/journal.pone.0000924	http://dx.doi.org/10.1371/journal.pone.0000924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895966	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455800004
J	Lamm, C; Nusbaum, HC; Meltzoff, AN; Decety, J				Lamm, Claus; Nusbaum, Howard C.; Meltzoff, Andrew N.; Decety, Jean			What Are You Feeling? Using Functional Magnetic Resonance Imaging to Assess the Modulation of Sensory and Affective Responses during Empathy for Pain	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; NEURAL RESPONSES; OTHERS PAIN; EXPERIENCE; SELF; REPRESENTATIONS; PERCEPTION; MECHANISMS; SIMULATION; COMPONENTS	Background. Recent neuroscientific evidence suggests that empathy for pain activates similar neural representations as the first-hand experience of pain. However, empathy is not an all-or-none phenomenon but it is strongly malleable by interpersonal, intrapersonal and situational factors. This study investigated how two different top-down mechanisms attention and cognitive appraisal - affect the perception of pain in others and its neural underpinnings. Methodology/Principal Findings. We performed one behavioral (N = 23) and two functional magnetic resonance imaging (fMRI) experiments (N = 18). In the first fMRI experiment, participants watched photographs displaying painful needle injections, and were asked to evaluate either the sensory or the affective consequences of these injections. The role of cognitive appraisal was examined in a second fMRI experiment in which participants watched injections that only appeared to be painful as they were performed on an anesthetized hand. Perceiving pain in others activated the affective-motivational and sensory-discriminative aspects of the pain matrix. Activity in the somatosensory areas was specifically enhanced when participants evaluated the sensory consequences of pain. Perceiving non-painful injections into the anesthetized hand also led to signal increase in large parts of the pain matrix, suggesting an automatic affective response to the putatively harmful stimulus. This automatic response was modulated by areas involved in self/other distinction and valence attribution - including the temporo-parietal junction and medial orbitofrontal cortex. Conclusions/Significance. Our findings elucidate how top-down control mechanisms and automatic bottom-up processes interact to generate and modulate other-oriented responses. They stress the role of cognitive processing in empathy, and shed light on how emotional and bodily awareness enable us to evaluate the sensory and affective states of others.	[Lamm, Claus; Nusbaum, Howard C.; Decety, Jean] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Lamm, Claus; Nusbaum, Howard C.; Decety, Jean] Univ Chicago, Ctr Cognit & Social Neurosci, Chicago, IL 60637 USA; [Meltzoff, Andrew N.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA	University of Chicago; University of Chicago; University of Washington; University of Washington Seattle	Decety, J (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	decety@uchicago.edu	Meltzoff, Andrew N/GPC-8807-2022; Lamm, Claus/B-3357-2014	Meltzoff, Andrew N/0000-0001-8683-0547; Lamm, Claus/0000-0002-5422-0653	NSF [BCS 0718480, SBE-0354453]	NSF(National Science Foundation (NSF))	NSF grants ( BCS 0718480 and SBE-0354453)	Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Avenanti A, 2006, NEUROIMAGE, V32, P316, DOI 10.1016/j.neuroimage.2006.03.010; Bingel U, 2002, PAIN, V99, P313, DOI 10.1016/S0304-3959(02)00157-4; Blanke O, 2005, NEUROSCIENTIST, V11, P16, DOI 10.1177/1073858404270885; BLUM JS, 1950, J COMP NEUROL, V93, P53, DOI 10.1002/cne.900930105; BOIK RJ, 1981, PSYCHOMETRIKA, V46, P241, DOI 10.1007/BF02293733; Botvinick M, 2005, NEUROIMAGE, V25, P312, DOI 10.1016/j.neuroimage.2004.11.043; Buchel C, 2002, J NEUROSCI, V22, P970, DOI 10.1523/JNEUROSCI.22-03-00970.2002; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; BUFALARI I, 2007, CEREB CORTEX; Carlsson K, 2006, NEUROIMAGE, V32, P1804, DOI 10.1016/j.neuroimage.2006.05.027; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CHENG Y, 2007, 13 ANN M ORG HUM BRA; CLARKE FJJ, 1983, LIGHTING RES TECHNOL, V15, P25; Cooke DF, 2003, J NEUROPHYSIOL, V90, P3317, DOI 10.1152/jn.00513.2003; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Danziger N, 2006, BRAIN, V129, P2494, DOI 10.1093/brain/awl155; Davis M. H., 1994, EMPATHY SOCIAL PSYCH; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; DECETY J, 2007, NEUROSCIENT IN PRESS; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Derbyshire S W, 2000, Curr Rev Pain, V4, P467; DERRYBERRY D, 1988, J PERS SOC PSYCHOL, V55, P958, DOI 10.1037/0022-3514.55.6.958; Doherty RW, 1997, J NONVERBAL BEHAV, V21, P131, DOI 10.1023/A:1024956003661; Donaldson D., 2001, FUNCTIONAL MRI INTRO, P177; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eisenberg N, 2006, HANDBOOK OF MORAL DEVELOPMENT, P517; FAN Y, 2007, NEUROPSYCHO IN PRESS; FERNANDEZ E, 1992, PSYCHOL BULL, V112, P205, DOI 10.1037/0033-2909.112.2.205; Field DT, 2005, CURR BIOL, V15, P453, DOI 10.1016/j.cub.2004.12.081; Fischer A.H., 2001, APPRAISAL PROCESSES, P221; Gallagher S, 2007, SOC NEUROSCI-UK, V2, P353, DOI 10.1080/17470910601183549; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; Goubert L, 2005, PAIN, V118, P285, DOI 10.1016/j.pain.2005.10.025; Gu XS, 2007, NEUROIMAGE, V36, P256, DOI 10.1016/j.neuroimage.2007.02.025; Jackson PL, 2006, PAIN, V125, P5, DOI 10.1016/j.pain.2006.09.013; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; JACKSON PL, 2007, 13 ANN M ORG HUM BRA; Kalisch R, 2005, J COGNITIVE NEUROSCI, V17, P874, DOI 10.1162/0898929054021184; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kulkarni B, 2005, EUR J NEUROSCI, V21, P3133, DOI 10.1111/j.1460-9568.2005.04098.x; Lamm C, 2007, NEUROPSYCHOLOGIA, V45, P2480, DOI 10.1016/j.neuropsychologia.2007.03.024; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Lloyd D, 2006, J NEUROPHYSIOL, V95, P205, DOI 10.1152/jn.00614.2005; Morrison I, 2007, CEREB CORTEX, V17, P2214, DOI 10.1093/cercor/bhl129; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2007, HDB EMOTION REGULATI, P135; Ogino Y, 2007, CEREB CORTEX, V17, P1139, DOI 10.1093/cercor/bhl023; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Ostrowsky K, 2002, CEREB CORTEX, V12, P376, DOI 10.1093/cercor/12.4.376; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Porro CA, 2003, NEUROSCIENTIST, V9, P354, DOI 10.1177/1073858403253660; Porro CA, 2002, J NEUROSCI, V22, P3206, DOI 10.1523/JNEUROSCI.22-08-03206.2002; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Prinz, 2004, GUT REACTIONS PERCEP; Prinz W., 2003, AGENCY SELF AWARENES, P165; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rainville P, 1999, PAIN, V82, P159, DOI 10.1016/S0304-3959(99)00048-2; Rainville P, 2002, CURR OPIN NEUROBIOL, V12, P195, DOI 10.1016/S0959-4388(02)00313-6; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Schubotz RI, 2003, NEUROIMAGE, V20, pS120, DOI 10.1016/j.neuroimage.2003.09.014; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wager TD, 2004, AFFECT CONTROL FUNCT	75	248	253	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1292	10.1371/journal.pone.0001292	http://dx.doi.org/10.1371/journal.pone.0001292			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18091986	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459500011
J	Lu, M; Miller, DR; Sun, JH				Lu, Min; Miller, Daniel R.; Sun, Jiang-Hua			Cross-Attraction between an Exotic and a Native Pine Bark Beetle: A Novel Invasion Mechanism?	PLOS ONE			English	Article							RED TURPENTINE BEETLE; DENDROCTONUS-VALENS; COLEOPTERA; SCOLYTIDAE; COLONIZATION; BEHAVIOR; FUNGI	Background. Aside from the ecological impacts, invasive species fascinate ecologists because of the unique opportunities that invasives offer in the study of community ecology. Some hypotheses have been proposed to illustrate the mechanisms that allow exotics to become invasive. However, positive interactions between exotic and native insects are rarely utilized to explain invasiveness of pests. Methodology/Principal Findings. Here, we present information on a recently formed association between a native and an exotic bark beetle on their shared host, Pinus tabuliformis, in China. In field examinations, we found that 35-40% of P. tabuliformis attacked by an exotic bark beetle, Dendroctonus valens, were also attacked by a native pine bark beetle, Hylastes parallelus. In the laboratory, we found that the antennal and walking responses of H. parallelus to host- and beetle-produced compounds were similar to those of the exotic D. valens in China. In addition, D. valens was attracted to volatiles produced by the native H. parallelus. Conclusions/Significance. We report, for the first time, facilitation between an exotic and a native bark beetle seems to involve overlap in the use of host attractants and pheromones, which is cross-attraction. The concept of this interspecific facilitation could be explored as a novel invasive mechanism which helps explain invasiveness of not only exotic bark beetles but also other introduced pests in principle. The results reported here also have particularly important implications for risk assessments and management strategies for invasive species.	[Lu, Min; Sun, Jiang-Hua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Miller, Daniel R.] US Forest Serv, So Res Stn, USDA, Athens, GA USA; [Lu, Min] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; United States Department of Agriculture (USDA); United States Forest Service; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, JH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	sunjh@ioz.ac.cn		sun, jianghua/0000-0002-9465-3672	National Nature Science Foundation of China [30525009, 30621003]; National Key RD Program [2006BAD08A17]; USDA Forest Service	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key RD Program; USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	The research was supported by the National Nature Science Foundation of China ( 30525009 and 30621003), National Key R&D Program ( 2006BAD08A17), and the USDA Forest Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARN H, 1975, Z NATURFORSCH C, V30, P722; ATKINS MD, 1966, CAN ENTOMOL, V98, P285, DOI 10.4039/Ent98285-3; BIRCH MC, 1980, J CHEM ECOL, V6, P395, DOI 10.1007/BF01402917; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Blum MS, 1996, ANNU REV ENTOMOL, V41, P353, DOI 10.1146/annurev.en.41.010196.002033; Borden J.H., 1982, P74; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; BYERS JA, 1989, HOLARCTIC ECOL, V12, P466; Carolin V.M., 1977, MISCELLANEOUS PUBLIC, P1; Cognato AI, 2005, AGR FOREST ENTOMOL, V7, P87, DOI 10.1111/j.1461-9555.2005.00243.x; DeBach P., 1991, BIOL CONTROL NATURAL, V2nd Edn; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; FRAEDRICH SW, 2008, PLANT DIS IN PRESS; HUFBAUER RA, 2007, BIOL INVASIONS, P79; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; KLEPZIG KD, 1991, FOREST SCI, V37, P1119; KO J-H, 1985, Esakia, P151; Li J.S., 2001, FOREST PEST DIS, V4, P41; Lieutier F, 2002, MECHANISMS AND DEPLOYMENT OF RESISTANCE IN TREES TO INSECTS, P31, DOI 10.1007/0-306-47596-0_2; MACARTHUR R, 1970, Theoretical Population Biology, V1, P1, DOI 10.1016/0040-5809(70)90039-0; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Miao Z.W., 2001, SHANXI FOR SCI TECH, V1, P34; Mondor EB, 2007, BIOL INVASIONS, V9, P623, DOI 10.1007/s10530-006-9062-0; OWEN DR, 1987, PHYTOPATHOLOGY, V77, P631, DOI 10.1094/Phyto-77-631; PAINE TD, 1981, OECOLOGIA, V48, P1, DOI 10.1007/BF00346980; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; PARMETER JR, 1989, PHYTOPATHOLOGY, V79, P768, DOI 10.1094/Phyto-79-768; Redmer JS, 2001, J ECON ENTOMOL, V94, P844, DOI 10.1603/0022-0493-94.4.844; Rejmanek M, 2001, TRENDS ECOL EVOL, V16, P545, DOI 10.1016/S0169-5347(01)02273-X; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; SMITH MT, 1990, J CHEM ECOL, V16, P3317, DOI 10.1007/BF00982101; SPSS Inc, 2001, SPSS 11 WIND; Sun JH, 2004, ENVIRON ENTOMOL, V33, P206, DOI 10.1603/0046-225X-33.2.206; SVIHRA P, 1980, NATURWISSENSCHAFTEN, V67, P518, DOI 10.1007/BF01047641; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; Wood S. L., 1982, Great Basin Naturalist Memoirs; WU JG, 2002, FOR PEST DIS, V3, P38; Yan ZL, 2005, BIODIVERS CONSERV, V14, P1735, DOI 10.1007/s10531-004-0697-9; YIN HF, 1984, EDITORIAL COMMITTEE; Zhang Liyan, 2002, Scientia Silvae Sinicae, V38, P95; Zhang LW, 2006, ENVIRON ENTOMOL, V35, P1232, DOI 10.1603/0046-225X(2006)35[1232:EABROD]2.0.CO;2	42	12	14	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1302	10.1371/journal.pone.0001302	http://dx.doi.org/10.1371/journal.pone.0001302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074026	Green Published, gold			2022-12-27	WOS:000207459500021
J	Pariyadath, V; Eagleman, D				Pariyadath, Vani; Eagleman, David			The Effect of Predictability on Subjective Duration	PLOS ONE			English	Article							NEURAL RESPONSE SUPPRESSION; TIME-SHRINKING; PERCEIVED DURATION; MECHANISMS; CHRONOSTASIS; REPETITION; MEMORY; FAMILIARITY; PERCEPTION; ANTERIOR	Events can sometimes appear longer or shorter in duration than other events of equal length. For example, in a repeated presentation of auditory or visual stimuli, an unexpected object of equivalent duration appears to last longer. Illusions of duration distortion beg an important question of time representation: when durations dilate or contract, does time in general slow down or speed up during that moment? In other words, what entailments do duration distortions have with respect to other timing judgments? We here show that when a sound or visual flicker is presented in conjunction with an unexpected visual stimulus, neither the pitch of the sound nor the frequency of the flicker is affected by the apparent duration dilation. This demonstrates that subjective time in general is not slowed; instead, duration judgments can be manipulated with no concurrent impact on other temporal judgments. Like spatial vision, time perception appears to be underpinned by a collaboration of separate neural mechanisms that usually work in concert but are separable. We further show that the duration dilation of an unexpected stimulus is not enhanced by increasing its saliency, suggesting that the effect is more closely related to prediction violation than enhanced attention. Finally, duration distortions induced by violations of progressive number sequences implicate the involvement of high-level predictability, suggesting the involvement of areas higher than primary visual cortex. We suggest that duration distortions can be understood in terms of repetition suppression, in which neural responses to repeated stimuli are diminished.	[Pariyadath, Vani; Eagleman, David] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Eagleman, David] Baylor Coll Med, Dept Psychiat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Eagleman, D (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	eagleman@bcm.edu	Pariyadath, Vani/B-7904-2009	Pariyadath, Vani/0000-0001-6340-0771	RO1 NIH [NS053960]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053960] Funding Source: NIH RePORTER	RO1 NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: RO1 NIH NS053960 (DME)	Alexander I, 2005, EXP BRAIN RES, V161, P125, DOI 10.1007/s00221-004-2054-3; Arao H, 2000, PERCEPTION, V29, P819, DOI 10.1068/p2853; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Eagleman DM, 2005, J NEUROSCI, V25, P10369, DOI 10.1523/JNEUROSCI.3487-05.2005; Eagleman DM, 2005, NAT NEUROSCI, V8, P850, DOI 10.1038/nn0705-850; EAGLEMAN DM, 2007, CURRENT DIR IN PRESS; FAHY FL, 1993, EXP BRAIN RES, V96, P457; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Hodinott-Hill I, 2002, CURR BIOL, V12, P1779, DOI 10.1016/S0960-9822(02)01219-8; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Kanai R, 2006, PERCEPT PSYCHOPHYS, V68, P1113, DOI 10.3758/BF03193714; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Lang P. J., 2005, INT AFFECTIVE PICTUR; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; NAKAJIMA Y, 1992, PERCEPT PSYCHOPHYS, V51, P504, DOI 10.3758/BF03211646; Nakajima Y, 2004, PERCEPTION, V33, P1061, DOI 10.1068/p5061; Orfanidou E, 2006, J COGNITIVE NEUROSCI, V18, P1237, DOI 10.1162/jocn.2006.18.8.1237; Park J, 2003, EXP BRAIN RES, V149, P527, DOI 10.1007/s00221-003-1376-x; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; ROSE D, 1995, PERCEPTION, V24, P1177, DOI 10.1068/p241177; Ross J, 1996, BEHAV BRAIN RES, V80, P1, DOI 10.1016/0166-4328(96)00012-5; Sasaki T, 2002, PERCEPT PSYCHOPHYS, V64, P919, DOI 10.3758/BF03196796; STETSON C, 2007, PLOS ONE IN PRESS; TENHOOPEN G, 1995, PERCEPTION, V24, P577, DOI 10.1068/p240577; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; Ulrich R, 2006, PSYCHOL RES-PSYCH FO, V70, P77, DOI 10.1007/S00426-004-0195-4; VANWASSENHOVE V, 2006, SOC NEUROSCIENCE; Wearden JH, 2002, Q J EXP PSYCHOL-B, V55, P1, DOI 10.1080/02724990143000108; WEARDEN JH, 1993, Q J EXP PSYCHOL-B, V46, P163; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2; Yarrow K, 2003, CURR BIOL, V13, P1134, DOI 10.1016/S0960-9822(03)00413-5; Yarrow K, 2001, NATURE, V414, P302, DOI 10.1038/35104551	41	173	180	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1264	10.1371/journal.pone.0001264	http://dx.doi.org/10.1371/journal.pone.0001264			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043760	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459300034
J	Yamamoto, H; Takematsu, H; Fujinawa, R; Naito, Y; Okuno, Y; Tsujimoto, G; Suzuki, A; Kozutsumi, Y				Yamamoto, Harumi; Takematsu, Hiromu; Fujinawa, Reiko; Naito, Yuko; Okuno, Yasushi; Tsujimoto, Gozoh; Suzuki, Akemi; Kozutsumi, Yasunori			Correlation Index-Based Responsible-Enzyme Gene Screening (CIRES), a Novel DNA Microarray-Based Method for Enzyme Gene Involved in Glycan Biosynthesis	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-III; COMPLEX-TYPE OLIGOSACCHARIDES; MOLECULAR-CLONING; MAACKIA-AMURENSIS; HUMAN BREAST; EXPRESSION; LECTIN; CDNA; ACID; GLYCOPROTEINS	Background. Glycan biosynthesis occurs though a multi-step process that requires a variety of enzymes ranging from glycosyltransferases to those involved in cytosolic sugar metabolism. In many cases, glycan biosynthesis follows a glycan-specific, linear pathway. As glycosyltransferases are generally regulated at the level of transcription, assessing the overall transcriptional profile for glycan biosynthesis genes seems warranted. However, a systematic approach for assessing the correlation between glycan expression and glycan-related gene expression has not been reported previously. Methodology. To facilitate genetic analysis of glycan biosynthesis, we sought to correlate the expression of genes involved in cell-surface glycan formation with the expression of the glycans, as detected by glycan-recognizing probes. We performed cross-sample comparisons of gene expression profiles using a newly developed, glycan-focused cDNA microarray. Cell-surface glycan expression profiles were obtained using flow cytometry of cells stained with plant lectins. Pearson's correlation coefficients were calculated for these profiles and were used to identify enzyme genes correlated with glycan biosynthesis. Conclusions. This method, designated correlation index-based responsible-enzyme gene screening (CIRES), successfully identified genes already known to be involved in the biosynthesis of certain glycans. Our evaluation of CIRES indicates that it is useful for identifying genes involved in the biosynthesis of glycan chains that can be probed with lectins using flow cytometry.	[Yamamoto, Harumi; Takematsu, Hiromu; Naito, Yuko; Kozutsumi, Yasunori] Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Sakyo Ku, Kyoto, Japan; [Okuno, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept PharmacoInformat, Sakyo Ku, Kyoto, Japan; [Tsujimoto, Gozoh] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery, Sakyo Ku, Kyoto, Japan; [Yamamoto, Harumi; Fujinawa, Reiko; Suzuki, Akemi; Kozutsumi, Yasunori] RIKEN, RIKEN Frontier Res Syst, Supra Biomol Syst Res Grp, Wako, Saitama, Japan; [Takematsu, Hiromu; Naito, Yuko; Kozutsumi, Yasunori] Japan Sci & Technol Corp JST, CREST, Kawaguchi, Saitama, Japan	Kyoto University; Kyoto University; Kyoto University; RIKEN; Japan Science & Technology Agency (JST)	Takematsu, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Sakyo Ku, Kyoto, Japan.	htakema@pharm.kyoto-u.ac.jp			CREST; JST; Ministry of Education, Culture, Sports, Science and Technology of Japan; RIKEN	CREST(Core Research for Evolutional Science and Technology (CREST)); JST(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN	This work was supported by CREST, JST, a grant- in-aid program from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by RIKEN.	ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; BIERHUIZEN MFA, 1993, GENE DEV, V7, P468, DOI 10.1101/gad.7.3.468; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; CHEN YX, 1995, GLYCOCONJUGATE J, V12, P55, DOI 10.1007/BF00731869; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; CROWLEY JF, 1984, ARCH BIOCHEM BIOPHYS, V231, P524, DOI 10.1016/0003-9861(84)90417-X; Edwards D, 2003, BIOINFORMATICS, V19, P825, DOI 10.1093/bioinformatics/btg083; FERNANDES B, 1991, CANCER RES, V51, P718; Freeze H. H., 1999, ESSENTIALS GLYCOBIOL, P69; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Furukawa K, 1999, BBA-GEN SUBJECTS, V1473, P54, DOI 10.1016/S0304-4165(99)00169-5; GILLESPIE W, 1993, J BIOL CHEM, V268, P3801; Granovsky M, 2000, NAT MED, V6, P306; Hakomori S, 2004, ARCH BIOCHEM BIOPHYS, V426, P173, DOI 10.1016/j.abb.2004.02.032; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; IHARA Y, 1995, GLYCOCONJUGATE J, V12, P787, DOI 10.1007/BF00731240; Ito N, 1996, HISTOCHEM CELL BIOL, V106, P331, DOI 10.1007/BF02473243; KAIFU R, 1975, CARBOHYD RES, V40, P111, DOI 10.1016/S0008-6215(00)82673-7; Kamekawa N, 2006, J BIOCHEM, V140, P337, DOI 10.1093/jb/mvj154; Kawano S, 2005, BIOINFORMATICS, V21, P3976, DOI 10.1093/bioinformatics/bti666; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; KNIBBS RN, 1991, J BIOL CHEM, V266, P83; KONAMI Y, 1994, FEBS LETT, V342, P334, DOI 10.1016/0014-5793(94)80527-X; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; LARSEN RD, 1989, P NATL ACAD SCI USA, V86, P8227, DOI 10.1073/pnas.86.21.8227; MATSUMOT.I, 1969, BIOCHIM BIOPHYS ACTA, V194, P180, DOI 10.1016/0005-2795(69)90193-7; MIYOSHI E, 1994, CANCER RES, V54, P1854; Moremen KW, 2002, BBA-GEN SUBJECTS, V1573, P225, DOI 10.1016/S0304-4165(02)00388-4; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Nakamura-Tsuruta S, 2006, BIOCHEM BIOPH RES CO, V347, P215, DOI 10.1016/j.bbrc.2006.06.073; Narimatsu H, 2004, GLYCOCONJUGATE J, V21, P17, DOI 10.1023/B:GLYC.0000043742.99482.01; Okajima T, 1999, J BIOL CHEM, V274, P11479, DOI 10.1074/jbc.274.17.11479; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Sasai K, 2002, FEBS LETT, V522, P151, DOI 10.1016/S0014-5793(02)02916-2; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Sultan AS, 1997, J BIOL CHEM, V272, P2866, DOI 10.1074/jbc.272.5.2866; TAKEMATSU H, 2007, COMPREHENSIVE GLYCOS, V2, P428; Team RDC, 2004, R LANG ENV STAT COMP; Varki A, 1999, ESSENTIALS GLYCOBIOL, P455; WANG WC, 1988, J BIOL CHEM, V263, P4576; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Yamamoto H, 2000, CANCER RES, V60, P134; YAMASHITA K, 1987, J BIOL CHEM, V262, P1602	51	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1232	10.1371/journal.pone.0001232	http://dx.doi.org/10.1371/journal.pone.0001232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043739	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459300013
J	Haller, C; Rauch, S; Fackler, OT				Haller, Claudia; Rauch, Susanne; Fackler, Oliver T.			HIV-1 Nef Employs Two Distinct Mechanisms to Modulate Lck Subcellular Localization and TCR Induced Actin Remodeling	PLOS ONE			English	Article								The Nef protein acts as critical factor during HIV pathogenesis by increasing HIV replication in vivo via the modulation of host cell vesicle transport and signal transduction processes. Recent studies suggested that Nef alters formation and function of immunological synapses (IS), thereby modulating exogenous T-cell receptor (TCR) stimulation to balance between partial T cell activation required for HIV-1 spread and prevention of activation induced cell death. Alterations of IS function by Nef include interference with cell spreading and actin polymerization upon TCR engagement, a pronounced intracellular accumulation of the Src kinase Lck and its reduced IS recruitment. Here we use a combination of Nef mutagenesis and pharmacological inhibition to analyze the relative contribution of these effects to Nef mediated alterations of IS organization and function on TCR stimulatory surfaces. Inhibition of actin polymerization and IS recruitment of Lck were governed by identical Nef determinants and correlated well with Nef's association with Pak2 kinase activity. In contrast, Nef mediated Lck endosomal accumulation was separable from these effects, occurred independently of Pak2, required integrity of the microtubule rather than the actin filament system and thus represents a distinct Nef activity. Finally, reduction of TCR signal transmission by Nef was linked to altered actin remodeling and Lck IS recruitment but did not require endosomal Lck rerouting. Thus, Nef affects IS function via multiple independent mechanisms to optimize virus replication in the infected host.	[Haller, Claudia; Rauch, Susanne; Fackler, Oliver T.] Univ Klinikum Heidelberg, Abt Virol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Fackler, OT (corresponding author), Univ Klinikum Heidelberg, Abt Virol, Heidelberg, Germany.	oliver_fackler@med.uni-heidelberg.de		Fackler, Oliver Till/0000-0003-2982-4209	Deutsche Forschungsgemeinschaft [SFB 638]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft ( SFB 638, project A11).	Agopian K, 2006, J VIROL, V80, P3050, DOI 10.1128/JVI.80.6.3050-3061.2006; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Casartelli N, 2006, J GEN VIROL, V87, P2291, DOI 10.1099/vir.0.81775-0; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dohner K, 2002, MOL BIOL CELL, V13, P2795, DOI 10.1091/mbc.01-07-0348; Fackler OT, 2007, NAT REV IMMUNOL, V7, P310, DOI 10.1038/nri2041; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Giese SI, 2006, VIROLOGY, V355, P175, DOI 10.1016/j.virol.2006.07.003; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Harder T, 2007, CURR OPIN IMMUNOL, V19, P470, DOI 10.1016/j.coi.2007.05.002; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Jordan S, 2003, J IMMUNOL, V171, P78, DOI 10.4049/jimmunol.171.1.78; Keppler OT, 2006, J LEUKOCYTE BIOL, V79, P616, DOI 10.1189/jlb.0805461; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Krautkramer E, 2004, J VIROL, V78, P4085, DOI 10.1128/JVI.78.8.4085-4097.2004; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; Madrid R, 2005, FEBS LETT, V579, P441, DOI 10.1016/j.febslet.2004.12.009; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Manninen A, 2000, J BIOL CHEM, V275, P16513, DOI 10.1074/jbc.M910032199; Manninen A, 1998, VIROLOGY, V250, P273, DOI 10.1006/viro.1998.9381; Matarrese P, 2005, CELL DEATH DIFFER, V12, P932, DOI 10.1038/sj.cdd.4401582; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Michel N, 2006, MOL BIOL CELL, V17, P3578, DOI 10.1091/mbc.E06-02-0117; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Saito T, 2006, CURR OPIN IMMUNOL, V18, P305, DOI 10.1016/j.coi.2006.03.014; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; SAWAI ET, 1995, J BIOL CHEM, V270, P15307, DOI 10.1074/jbc.270.25.15307; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Tavano R, 2004, J IMMUNOL, V173, P5392, DOI 10.4049/jimmunol.173.9.5392; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Tskvitaria-Fuller I, 2003, J IMMUNOL, V171, P2287, DOI 10.4049/jimmunol.171.5.2287; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394	47	60	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1212	10.1371/journal.pone.0001212	http://dx.doi.org/10.1371/journal.pone.0001212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030346	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459200025
J	Pontes, O; Lawrence, RJ; Silva, M; Preuss, S; Costa-Nunes, P; Earley, K; Neves, N; Viegas, W; Pikaard, CS				Pontes, Olga; Lawrence, Richard J.; Silva, Manuela; Preuss, Sasha; Costa-Nunes, Pedro; Earley, Keith; Neves, Nuno; Viegas, Wanda; Pikaard, Craig S.			Postembryonic Establishment of Megabase-Scale Gene Silencing in Nucleolar Dominance	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; EPIGENETIC ON/OFF SWITCH; RIBOSOMAL-RNA GENES; DNA METHYLATION; RDNA CHROMATIN; DOSAGE CONTROL; ARABIDOPSIS; PLANTS; HETEROCHROMATIN; EXPRESSION	Nucleolar dominance is an epigenetic phenomenon in plant and animal genetic hybrids that describes the expression of 45S ribosomal RNA genes (rRNA genes) inherited from only one progenitor due to the silencing of the other progenitor's rRNA genes. rRNA genes are tandemly arrayed at nucleolus organizer regions (NORs) that span millions of basepairs, thus gene silencing in nucleolar dominance occurs on a scale second only to X-chromosome inactivation in female mammals. In Arabidopsis suecica, the allotetraploid hybrid of A. thaliana and A. arenosa, the A. thaliana-derived rRNA genes are subjected to nucleolar dominance and are silenced via repressive chromatin modifications. However, the developmental stage at which nucleolar dominance is established in A. suecica is currently unknown. We show that nucleolar dominance is not apparent in seedling cotyledons formed during embryogenesis but becomes progressively established during early postembryonic development in tissues derived from both the shoot and root apical meristems. The progressive silencing of A. thaliana rRNA genes correlates with the transition of A. thaliana NORs from a decondensed euchromatic state associated with histone H3 that is trimethylated on lysine 4 (H3K4me3) to a highly condensed heterochromatic state in which the NORs are associated with H3K9me2 and 5-methylcytosine-enriched chromocenters. In RNAi-lines in which the histone deacetylases HDA6 and HDT1 are knocked down, the developmentally regulated condensation and inactivation of A. thaliana NORs is disrupted. Collectively, these data demonstrate that HDA6 and HDT1 function in the postembryonic establishment of nucleolar dominance, a process which recurs in each generation.	[Pontes, Olga; Silva, Manuela; Costa-Nunes, Pedro; Neves, Nuno; Viegas, Wanda] Univ Tecn Lisboa, Inst Super Agron, Ctr Bot Aplicada & Agr, P-1100 Lisbon, Portugal; [Pontes, Olga; Lawrence, Richard J.; Preuss, Sasha; Costa-Nunes, Pedro; Earley, Keith; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Neves, Nuno] Univ Nova Lisboa, Fac Ciencias & Tecnol, Secc Autonoma Biotecnol, Caparica, Portugal	Universidade de Lisboa; Washington University (WUSTL); Universidade Nova de Lisboa	Viegas, W (corresponding author), Univ Tecn Lisboa, Inst Super Agron, Ctr Bot Aplicada & Agr, P-1100 Lisbon, Portugal.	wandaviegas@isa.utl.pt; pikaard@biology.wustl.edu	Silva, Manuela/GSN-4031-2022; Pontes, Olga MF/F-9768-2011; Silva, Manuela/ABF-7085-2020; Pikaard, Craig S/K-8772-2012	Pontes, Olga MF/0000-0003-3316-1145; Silva, Manuela/0000-0003-4677-870X; Pikaard, Craig S/0000-0001-8204-7459; Viegas, Wanda/0000-0003-4660-1226	National Institutes of Health [2RO1-GM60380]; National Science Foundation [9975930]; Fundacao de Ciencia e Tecnologia (Portugal) [SFRH/BPD/17508/2004, SFRH/BPD/20320/2004, POCI/BIA-BDE/57575/2004]; Fundacao para a Ciencia e Tecnologia [POCI/BIA-BCM/59389/2004]; Fundo Comunitario Europeu FEDER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Fundacao de Ciencia e Tecnologia (Portugal); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Comunitario Europeu FEDER(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Pikaard lab was supported by National Institutes of Health grant 2RO1-GM60380. RNAi vector development was supported by the National Science Foundation under grant number 9975930. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Institutes of Health or National Science Foundation. O.P. and M. S were supported by fellowships SFRH/BPD/17508/2004 and SFRH/BPD/20320/2004 and M. S. was additionally supported under project POCI/BIA-BDE/57575/2004 from the Fundacao de Ciencia e Tecnologia (Portugal). Research in the Viegas lab was supported by the Fundacao para a Ciencia e Tecnologia (project POCI/BIA-BCM/59389/2004 to N.N.) and Fundo Comunitario Europeu FEDER.	Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; CASTILHO A, 1995, CHROMOSOME RES, V3, P169, DOI 10.1007/BF00710710; Chen ZJ, 1997, P NATL ACAD SCI USA, V94, P3442, DOI 10.1073/pnas.94.7.3442; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Chen ZJ, 1998, P NATL ACAD SCI USA, V95, P14891, DOI 10.1073/pnas.95.25.14891; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fransz P, 2003, CHROMOSOME RES, V11, P227, DOI 10.1023/A:1022835825899; Fransz PF, 2002, CURR OPIN PLANT BIOL, V5, P560, DOI 10.1016/S1369-5266(02)00298-4; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; GUERCHE P, 1990, PLANT CELL, V2, P469, DOI 10.1105/tpc.2.5.469; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; LAWSON EJR, 1995, TRENDS GENET, V11, P263, DOI 10.1016/S0168-9525(00)89072-1; Lewis MS, 2001, P NATL ACAD SCI USA, V98, P14536, DOI 10.1073/pnas.251424098; Masui Y, 1998, BIOL CELL, V90, P537, DOI 10.1016/S0248-4900(99)80011-2; Mathieu O, 2003, PLANT CELL, V15, P2929, DOI 10.1105/tpc.017467; McStay B, 2006, GENE DEV, V20, P1207, DOI 10.1101/gad.1436906; NAVASHIN M., 1934, CYTOLOGIA, V5, P169, DOI 10.1508/cytologia.5.169; NEVES N, 1995, THEOR APPL GENET, V91, P529, DOI 10.1007/BF00222984; Neves N, 2005, ANNU PLANT REV, V19, P201, DOI 10.1002/9780470988626.ch7; Pikaard CS, 2000, TRENDS GENET, V16, P495, DOI 10.1016/S0168-9525(00)02113-2; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Pontes O, 2003, P NATL ACAD SCI USA, V100, P11418, DOI 10.1073/pnas.1932522100; PREUSS S, 2007, BIOCH BIOPHYS ACTA; Preuss S, 2007, BBA-GENE STRUCT EXPR, V1769, P383, DOI 10.1016/j.bbaexp.2007.02.005; REEDER RH, 1985, J CELL BIOL, V101, P2013, DOI 10.1083/jcb.101.5.2013; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; SILVA M, 1995, CHROMOSOME RES, V3, P492, DOI 10.1007/BF00713964; Spring H, 1996, INT J DEV BIOL, V40, P263; WALLACE H, 1971, HEREDITY, V27, P1, DOI 10.1038/hdy.1971.66; WOLFFE AP, 1994, J CELL SCI, V107, P2055	33	52	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1157	10.1371/journal.pone.0001157	http://dx.doi.org/10.1371/journal.pone.0001157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987131	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459000039
J	Fabene, PF; Merigo, F; Galie, M; Benati, D; Bernardi, P; Farace, P; Nicolato, E; Marzola, P; Sbarbati, A				Fabene, Paolo Francesco; Merigo, Flavia; Galie, Mirco; Benati, Donatella; Bernardi, Paolo; Farace, Paolo; Nicolato, Elena; Marzola, Pasquina; Sbarbati, Andrea			Pilocarpine-Induced Status Epilepticus in Rats Involves Ischemic and Excitotoxic Mechanisms	PLOS ONE			English	Article								The neuron loss characteristic of hippocampal sclerosis in temporal lobe epilepsy patients is thought to be the result of excitotoxic, rather than ischemic, injury. In this study, we assessed changes in vascular structure, gene expression, and the time course of neuronal degeneration in the cerebral cortex during the acute period after onset of pilocarpine-induced status epilepticus (SE). Immediately after 2 hr SE, the subgranular layers of somatosensory cortex exhibited a reduced vascular perfusion indicative of ischemia, whereas the immediately adjacent supragranular layers exhibited increased perfusion. Subgranular layers exhibited necrotic pathology, whereas the supergranular layers were characterized by a delayed (24 h after SE) degeneration apparently via programmed cell death. These results indicate that both excitotoxic and ischemic injuries occur during pilocarpine-induced SE. Both of these degenerative pathways, as well as the widespread and severe brain damage observed, should be considered when animal model-based data are compared to human pathology.	[Fabene, Paolo Francesco; Merigo, Flavia; Galie, Mirco; Benati, Donatella; Bernardi, Paolo; Farace, Paolo; Nicolato, Elena; Sbarbati, Andrea] Univ Verona, Dept Morphol & Biomed Sci, Sect Anat & Histol, I-37100 Verona, Italy; [Marzola, Pasquina] Univ Verona, Ctr Expt Magnet Resonance Imaging, I-37100 Verona, Italy	University of Verona; University of Verona	Fabene, PF (corresponding author), Univ Verona, Dept Morphol & Biomed Sci, Sect Anat & Histol, I-37100 Verona, Italy.	paolo@anatomy.univr.it	Farace, Paolo/AAK-4072-2020	Farace, Paolo/0000-0002-6051-2345; GALIE', Mirco/0000-0002-6441-8313; Fabene, Paolo/0000-0002-9644-4399; MARZOLA, Pasquina/0000-0001-6936-8901	MIUR; EC [LSHM-CT-2006-037315]	MIUR(Ministry of Education, Universities and Research (MIUR)); EC(European CommissionEuropean Commission Joint Research Centre)	Funding: This study was supported by grants of MIUR (MIUR 60% and FIRB) and by the EC grant LSHM-CT-2006-037315.	Anguelova E, 2000, NEUROSCI LETT, V280, P99, DOI 10.1016/S0304-3940(00)00762-X; Barber AJ, 1997, DEV DYNAM, V208, P62, DOI 10.1002/(SICI)1097-0177(199701)208:1<62::AID-AJA6>3.0.CO;2-#; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dousset V, 1999, AM J NEURORADIOL, V20, P223; Fabene PF, 2006, NEUROBIOL DIS, V21, P80, DOI 10.1016/j.nbd.2005.06.013; Fabene PF, 2004, CURR DRUG TARGETS, V5, P629, DOI 10.2174/1389450043345218; Fabene PF, 2003, NEUROIMAGE, V18, P375, DOI 10.1016/S1053-8119(02)00025-3; GALLYAS F, 1990, ACTA NEUROPATHOL, V79, P620, DOI 10.1007/BF00294239; Gillardon F, 1996, BRAIN RES, V739, P244, DOI 10.1016/S0006-8993(96)00829-3; Hirase H, 2004, NEUROSCIENCE, V128, P209, DOI 10.1016/j.neuroscience.2004.07.002; KANE DJ, 1995, J NEUROSCI RES, V40, P269, DOI 10.1002/jnr.490400216; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Leroy C, 2003, EXP NEUROL, V182, P361, DOI 10.1016/S0014-4886(03)00122-5; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; MCINTYRE DC, 1982, BRAIN RES, V250, P53, DOI 10.1016/0006-8993(82)90952-0; MELDRUM B.S., 1992, GREENFIELDS NEUROPAT, P1246; MELDRUM BS, 1976, BRAIN, V99, P523, DOI 10.1093/brain/99.3.523; MELDRUM BS, 1973, ARCH NEUROL-CHICAGO, V28, P10, DOI 10.1001/archneur.1973.00490190028002; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; NADLER JV, 1978, J NEUROCHEM, V31, P147, DOI 10.1111/j.1471-4159.1978.tb12442.x; Nersesyan H, 2004, J CEREBR BLOOD F MET, V24, P1057, DOI 10.1097/01.WCB.0000131669.02027.3E; OLTVAI ZN, 1993, CELL, V74, P619; Plumier JCL, 1996, NEUROSCIENCE, V75, P849, DOI 10.1016/0306-4522(96)00317-X; Poirier JL, 2000, NEUROSCIENCE, V97, P59, DOI 10.1016/S0306-4522(00)00026-9; Quach N, 2005, BRAIN RES, V1042, P236, DOI 10.1016/j.brainres.2005.02.053; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; SATOH JI, 1995, J NEUROSCI RES, V41, P805, DOI 10.1002/jnr.490410611; Sbarbati A, 1996, ACTA NEUROPATHOL, V92, P56, DOI 10.1007/s004010050489; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; Sloviter RS, 2005, CR BIOL, V328, P143, DOI 10.1016/j.crvi.2004.10.010; SLOVITER RS, 1981, NEUROPHARMACOLOGY, V20, P1003, DOI 10.1016/0028-3908(81)90088-5; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Valentim LM, 2001, NEUROSCIENCE, V107, P43, DOI 10.1016/S0306-4522(01)00325-6; VANDENPOL AN, 1990, J COMP NEUROL, V296, P654, DOI 10.1002/cne.902960410; Villoslada P, 2004, PROG BRAIN RES, V146, P403; Yamada K, 2002, STROKE, V33, P87, DOI 10.1161/hs0102.101893; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0	37	56	58	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1105	10.1371/journal.pone.0001105	http://dx.doi.org/10.1371/journal.pone.0001105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971868	Green Published, gold, Green Submitted			2022-12-27	WOS:000207458700022
J	Cornelisse, LN; van Elburg, RAJ; Meredith, RM; Yuste, R; Mansvelder, HD				Cornelisse, L. Niels; van Elburg, Ronald A. J.; Meredith, Rhiannon M.; Yuste, Rafael; Mansvelder, Huibert D.			High Speed Two-Photon Imaging of Calcium Dynamics in Dendritic Spines: Consequences for Spine Calcium Kinetics and Buffer Capacity	PLOS ONE			English	Article								Rapid calcium concentration changes in postsynaptic structures are crucial for synaptic plasticity. Thus far, the determinants of postsynaptic calcium dynamics have been studied predominantly based on the decay kinetics of calcium transients. Calcium rise times in spines in response to single action potentials (AP) are almost never measured due to technical limitations, but they could be crucial for synaptic plasticity. With high-speed, precisely-targeted, two-photon point imaging we measured both calcium rise and decay kinetics in spines and secondary dendrites in neocortical pyramidal neurons. We found that both rise and decay kinetics of changes in calcium-indicator fluorescence are about twice as fast in spines. During AP trains, spine calcium changes follow each AP, but not in dendrites. Apart from the higher surface-to-volume ratio (SVR), we observed that neocortical dendritic spines have a markedly smaller endogenous buffer capacity with respect to their parental dendrites. Calcium influx time course and calcium extrusion rate were both in the same range for spines and dendrites when fitted with a dynamic multi-compartment model that included calcium binding kinetics and diffusion. In a subsequent analysis we used this model to investigate which parameters are critical determinants in spine calcium dynamics. The model confirmed the experimental findings: a higher SVR is not sufficient by itself to explain the faster rise time kinetics in spines, but only when paired with a lower buffer capacity in spines. Simulations at zero calcium-dye conditions show that calmodulin is more efficiently activated in spines, which indicates that spine morphology and buffering conditions in neocortical spines favor synaptic plasticity.	[Cornelisse, L. Niels; van Elburg, Ronald A. J.; Meredith, Rhiannon M.; Mansvelder, Huibert D.] Vrije Univ Amsterdam, Dept Expt Neurophysiol, CNCR, Amsterdam, Netherlands; [Cornelisse, L. Niels] Vrije Univ Amsterdam, Dept Funct Genom, CNCR, Amsterdam, Netherlands; [Yuste, Rafael] Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10032 USA	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Columbia University; Howard Hughes Medical Institute	Cornelisse, LN (corresponding author), Vrije Univ Amsterdam, Dept Expt Neurophysiol, CNCR, Amsterdam, Netherlands.	niels.cornelisse@cncr.vu.nl; huib.mansvelder@cncr.vu.nl	Meredith, Rhiannon/A-4657-2010; van Elburg, Ronald/A-5463-2010; Mansvelder, Huibert/N-6138-2018	van Elburg, Ronald/0000-0001-9508-1461; Mansvelder, Huibert/0000-0003-1365-5340; Meredith, Rhiannon/0000-0003-0228-4169; Cornelisse, Lennart Niels/0000-0001-9425-2935	National Eye Institute; New York STAR Center for High Resolution Imaging of Functional Neural Circuits and HHMI; Netherlands Royal Academy of Sciences; Netherlands Organization for Scientific Research (NWO) [911-03-014]; Medical Research Council (ZonMW) [917-76-360, 912-04-022]; Center for Medical Systems Biology	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); New York STAR Center for High Resolution Imaging of Functional Neural Circuits and HHMI; Netherlands Royal Academy of Sciences; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Medical Research Council (ZonMW)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Health Research and Development); Center for Medical Systems Biology	RY is supported by grants from the National Eye Institute, the New York STAR Center for High Resolution Imaging of Functional Neural Circuits and HHMI. HDM is supported by grants from the Netherlands Royal Academy of Sciences and the Netherlands Organization for Scientific Research (NWO, 911-03-014), and the Medical Research Council (ZonMW, 917-76-360, 912-04-022). LNC was supported by the Center for Medical Systems Biology.	ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Antic SD, 2003, J PHYSIOL-LONDON, V550, P35, DOI 10.1113/jphysiol.2002.033746; Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Franks KM, 2002, BIOESSAYS, V24, P1130, DOI 10.1002/bies.10193; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Holmes WR, 2000, J COMPUT NEUROSCI, V8, P65, DOI 10.1023/A:1008969032563; Holthoff K, 2002, NEURON, V33, P425, DOI 10.1016/S0896-6273(02)00576-7; KAKIUCHI S, 1982, J BIOCHEM-TOKYO, V92, P1041, DOI 10.1093/oxfordjournals.jbchem.a134019; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kits KS, 1999, BIOPHYS J, V76, P1693, DOI 10.1016/S0006-3495(99)77328-5; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Lee SH, 2000, J PHYSIOL-LONDON, V525, P419, DOI 10.1111/j.1469-7793.2000.t01-2-00419.x; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LLINAS R, 1982, P NATL ACAD SCI-BIOL, V79, P2415, DOI 10.1073/pnas.79.7.2415; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Majewska A, 2000, J NEUROSCI, V20, P1722; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Markram H, 1998, J COMPUT NEUROSCI, V5, P331, DOI 10.1023/A:1008891229546; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matveev V, 2002, BIOPHYS J, V83, P1368, DOI 10.1016/S0006-3495(02)73907-6; Nagerl UV, 2000, BIOPHYS J, V79, P3009, DOI 10.1016/S0006-3495(00)76537-4; Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Nikolenko V, 2003, METHODS, V30, P3, DOI 10.1016/S1046-2023(03)00003-3; NOWYCKY MC, 1993, BIOPHYS J, V64, P77, DOI 10.1016/S0006-3495(93)81342-0; Nuriya M, 2006, P NATL ACAD SCI USA, V103, P786, DOI 10.1073/pnas.0510092103; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Sabatini BL, 1998, BIOPHYS J, V74, P1549, DOI 10.1016/S0006-3495(98)77867-1; Saggau P, 2006, CURR OPIN NEUROBIOL, V16, P543, DOI 10.1016/j.conb.2006.08.011; Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824; Schmidt H, 2003, BIOPHYS J, V84, P2599, DOI 10.1016/S0006-3495(03)75065-6; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Tank DW, 1995, J NEUROSCI, V15, P7940; TIMMERMAN MP, 1986, FEBS LETT, V209, P1, DOI 10.1016/0014-5793(86)81073-0; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; WAGNER J, 1994, BIOPHYS J, V67, P447, DOI 10.1016/S0006-3495(94)80500-4; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	50	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1073	10.1371/journal.pone.0001073	http://dx.doi.org/10.1371/journal.pone.0001073			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957255	Green Published, gold, Green Submitted			2022-12-27	WOS:000207458500018
J	von der Haar, T				von der Haar, Tobias			Optimized Protein Extraction for Quantitative Proteomics of Yeasts	PLOS ONE			English	Article								Background. The absolute quantification of intracellular protein levels is technically demanding, but has recently become more prominent because novel approaches like systems biology and metabolic control analysis require knowledge of these parameters. Current protocols for the extraction of proteins from yeast cells are likely to introduce artifacts into quantification procedures because of incomplete or selective extraction. Principal Findings. We have developed a novel procedure for protein extraction from S. cerevisiae based on chemical lysis and simultaneous solubilization in SDS and urea, which can extract the great majority of proteins to apparent completeness. The procedure can be used for different Saccharomycetes yeast species and varying growth conditions, is suitable for high-throughput extraction in a 96-well format, and the resulting extracts can easily be post-processed for use in non-SDS compatible procedures like 2D gel electrophoresis. Conclusions. An improved method for quantitative protein extraction has been developed that removes some of the sources of artefacts in quantitative proteomics experiments, while at the same time allowing novel types of applications.	Univ Kent, Prot Sci Grp, Dept Biosci, Canterbury, Kent, England	University of Kent	von der Haar, T (corresponding author), Univ Kent, Prot Sci Grp, Dept Biosci, Canterbury, Kent, England.	T.von-der-Haar@kent.ac.uk		von der Haar, Tobias/0000-0002-6031-9254	Wellcome Trust (UK) Research Career Development Fellowship [075438/Z/04/Z]	Wellcome Trust (UK) Research Career Development Fellowship(Wellcome Trust)	This work was funded by a Wellcome Trust (UK) Research Career Development Fellowship (Ref. 075438/Z/04/Z). The funders had no role in the design or conduct of this study, nor in the preparation of the manuscript.	Brachmann CB, 1998, YEAST, V14, P115; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; ELBARADI TTAL, 1984, EUR J BIOCHEM, V144, P393, DOI 10.1111/j.1432-1033.1984.tb08477.x; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Remacha M, 1995, BIOCHEM CELL BIOL, V73, P959, DOI 10.1139/o95-103; STARK GR, 1960, J BIOL CHEM, V235, P3177; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tuite MF, 2006, METHODS, V39, P9, DOI 10.1016/j.ymeth.2006.04.001; von der Haar T, 2007, TRENDS MICROBIOL, V15, P78, DOI 10.1016/j.tim.2006.12.002; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	17	111	113	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1078	10.1371/journal.pone.0001078	http://dx.doi.org/10.1371/journal.pone.0001078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957260	Green Accepted, Green Published, gold			2022-12-27	WOS:000207458500023
J	Mohler, PJ; Healy, JA; Xue, H; Puca, AA; Kline, CF; Allingham, RR; Kranias, EG; Rockman, HA; Bennett, V				Mohler, Peter J.; Healy, Jane A.; Xue, Hui; Puca, Annibale A.; Kline, Crystal F.; Allingham, R. Rand; Kranias, Evangelia G.; Rockman, Howard A.; Bennett, Vann			Ankyrin-B Syndrome: Enhanced Cardiac Function Balanced by Risk of Cardiac Death and Premature Senescence	PLOS ONE			English	Article							MEMBRANE ATTACHMENT SITE; LONG-QT SYNDROME; LATERAL MEMBRANE; RECEPTOR; ATPASE; EXPRESSION; SPECTRIN; MICE; CELL; PURIFICATION	Here we report the unexpected finding that specific human ANK2 variants represent a new example of balanced human variants. The prevalence of certain ANK2 (encodes ankyrin-B) variants range from 2 percent of European individuals to 8 percent in individuals from West Africa. Ankyrin-B variants associated with severe human arrhythmia phenotypes (eg E1425G, V1516D, R1788W) were rare in the general population. Variants associated with less severe clinical and in vitro phenotypes were unexpectedly common. Studies with the ankyrin-B+/- mouse reveal both benefits of enhanced cardiac contractility, as well as costs in earlier senescence and reduced lifespan. Together these findings suggest a constellation of traits that we term "ankyrin-B syndrome'', which may contribute to both aging-related disorders and enhanced cardiac function.	[Mohler, Peter J.; Kline, Crystal F.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Mohler, Peter J.; Kline, Crystal F.] Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA; [Rockman, Howard A.; Bennett, Vann] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Healy, Jane A.; Bennett, Vann] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Xue, Hui; Rockman, Howard A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Allingham, R. Rand] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Puca, Annibale A.] Policlin MultiMed, IRCCS, Milan, Italy; [Kranias, Evangelia G.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Healy, Jane A.; Xue, Hui; Bennett, Vann] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	University of Iowa; University of Iowa; Duke University; Duke University; Duke University; Duke University; University System of Ohio; University of Cincinnati; Duke University; Howard Hughes Medical Institute	Mohler, PJ (corresponding author), Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA.	peter-mohler@uiowa.edu; v.bennett@cellbio.duke.edu	Puca, Annibale Alessandro/K-2099-2018		NIH [HL084583, HL083422, HL-26057, HL-64018, HL-77101, HL056687]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083422, P50HL077101, R01HL056687, R01HL026057, R37HL026057, R01HL084583, R01HL064018] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge financial support from the NIH (HL084583 and HL083422 to PJM; HL-26057, HL-64018 and HL-77101 to EGK, HL056687 to HR). PJM is also supported by the Pew Charitable Trusts. VB acknowledges support from the Muscular Dystrophy Association.	AGRE P, 1982, NEW ENGL J MED, V306, P1155, DOI 10.1056/NEJM198205133061906; AGRE P, 1985, NATURE, V314, P380, DOI 10.1038/314380a0; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; BENNETT V, 1979, J BIOL CHEM, V254, P2533; BENNETT V, 1978, J BIOL CHEM, V253, P2292; BENNETT V, 1979, NATURE, V281, P597, DOI 10.1038/281597a0; Bhasin N, 2007, AM J PHYSIOL-HEART C, V293, pH109, DOI 10.1152/ajpheart.00059.2007; Cho MC, 1999, J BIOL CHEM, V274, P22251, DOI 10.1074/jbc.274.32.22251; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; Esposito G, 2000, AM J PHYSIOL-HEART C, V279, pH3101, DOI 10.1152/ajpheart.2000.279.6.H3101; Glitsch HG, 2001, PHYSIOL REV, V81, P1791, DOI 10.1152/physrev.2001.81.4.1791; Hauptman PJ, 1999, CIRCULATION, V99, P1265, DOI 10.1161/01.CIR.99.9.1265; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; Muller-Ehmsen J, 2001, AM J PHYSIOL-CELL PH, V281, pC1355, DOI 10.1152/ajpcell.2001.281.4.C1355; Nicholls DG, 2002, INT J BIOCHEM CELL B, V34, P1372, DOI 10.1016/S1357-2725(02)00077-8; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; Priori SG, 1999, CIRCULATION, V99, P529, DOI 10.1161/01.CIR.99.4.529; Rockman HA, 1998, P NATL ACAD SCI USA, V95, P7000, DOI 10.1073/pnas.95.12.7000; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Roden DM, 2004, TRENDS CARDIOVAS MED, V14, P112, DOI 10.1016/j.tcm.2004.01.001; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Sherman J, 2005, HEART RHYTHM, V2, P1218, DOI 10.1016/j.hrthm.2005.07.026; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Wang JN, 2001, AM J PHYSIOL-CELL PH, V281, pC1336, DOI 10.1152/ajpcell.2001.281.4.C1336; Wolska BM, 1996, AM J PHYSIOL-CELL PH, V271, pC391, DOI 10.1152/ajpcell.1996.271.1.C391; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	36	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1051	10.1371/journal.pone.0001051	http://dx.doi.org/10.1371/journal.pone.0001051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940615	Green Published, gold, Green Submitted			2022-12-27	WOS:000207456100019
J	Semple, MG; Dankert, HM; Ebrahimi, B; Correia, JB; Booth, JA; Stewart, JP; Smyth, RL; Hart, CA				Semple, Malcolm G.; Dankert, Hinke M.; Ebrahimi, Bahram; Correia, Jailson B.; Booth, J. Angela; Stewart, James P.; Smyth, Rosalind L.; Hart, C. Anthony			Severe Respiratory Syncytial Virus Bronchiolitis in Infants Is Associated with Reduced Airway Interferon Gamma and Substance P	PLOS ONE			English	Article								Background. Severe human respiratory syncytial virus (hRSV) bronchiolitis in previously well infants may be due to differences in the innate immune response to hRSV infection. Aim: to determine if factors mediating proposed mechanisms for severe bronchiolitis differ with severity of disease. Methodology/Principle Findings. 197 infants admitted to hospital with hRSV bronchiolitis were recruited and grouped according to no oxygen requirement (n = 27), oxygen dependence (n = 114) or mechanical ventilation (n = 56). We collected clinical data, nasopharyngeal aspirate (NPA) and if ventilated bronchoalveolar lavage (BAL). Interferon-gamma (IFN-gamma), substance P (SP), interleukin 9 (IL-9), urea and hRSV load, were measured in cell free supernatant from NPA and BAL. Multivariate analysis compared independent effects of clinical, virological and immunological variables upon disease severity. IFN-gamma and SP concentrations were lower in NPA from infants who required oxygen or mechanical ventilation. Viral load and IL-9 concentrations were high but did not vary with severity of disease. Independent predictors of severe disease (in diminishing size of effect) were low weight on admission, low gestation at birth, low NPA IFN-gamma and NPA SP. Nasal airway sampling appears to be a useful surrogate for distal airway sampling since concentrations of IFN-gamma, SP, IL-9 and viral load in NPA correlate with the same in BAL. Conclusions. Our data support two proposed mechanisms for severe hRSV disease; reduced local IFN-gamma response and SP mediated inflammation. We found large amounts of hRSV and IL-9 in airways secretions from the upper and lower respiratory tract but could not associate these with disease severity.	[Semple, Malcolm G.; Dankert, Hinke M.; Booth, J. Angela; Smyth, Rosalind L.] Univ Liverpool, Div Child Hlth, Sch Reprod & Dev Med, Liverpool L69 3BX, Merseyside, England; [Semple, Malcolm G.; Ebrahimi, Bahram; Correia, Jailson B.; Stewart, James P.; Hart, C. Anthony] Univ Liverpool, Div Med Microbiol & Genito Urinary Med, Sch Infect & Host Def, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Semple, MG (corresponding author), Univ Liverpool, Div Child Hlth, Sch Reprod & Dev Med, Liverpool L69 3BX, Merseyside, England.	m.g.semple@liver-pool.ac.uk	Semple, Malcolm Gracie/A-8790-2008; Correia, Jailson B./J-4331-2015; Stewart, James/A-6034-2012	Semple, Malcolm Gracie/0000-0001-9700-0418; Stewart, James/0000-0002-8928-2037; de Barros Correia, Jailson/0000-0002-0927-2219; Ebrahimi, Bahram/0000-0002-8758-4592	National Clinician Scientist; Royal Liverpool Children's Hospital; American Thoracic Society	National Clinician Scientist; Royal Liverpool Children's Hospital; American Thoracic Society	This study was funded by a National Clinician Scientist Award to Dr MG Semple by the Department of Health, HMG United Kingdom. This study was supported by an equipment grant from the Royal Liverpool Children's Hospital (Alder Hey) Endowment Fund. Oral presentation of this data at The 2006 American Thoracic Society International Conference San Diego USA was supported by an International Trainee Travel Award to MGS from the American Thoracic Society. None of the sponsors had any role in the study design, execution or writing of this paper.	Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Bont L, 2000, Paediatr Respir Rev, V1, P221, DOI 10.1053/prrv.2000.0052; Bont L, 2001, J INFECT DIS, V184, P355, DOI 10.1086/322035; BRAUNSTEIN G, 1991, AM REV RESPIR DIS, V144, P630, DOI 10.1164/ajrccm/144.3_Pt_1.630; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; de Blic J, 2000, EUR RESPIR J, V15, P217; DeVincenzo JP, 2005, J INFECT DIS, V191, P1861, DOI 10.1086/430008; Dong Q, 1999, EUR J IMMUNOL, V29, P2130, DOI 10.1002/(SICI)1521-4141(199907)29:07<2130::AID-IMMU2130>3.0.CO;2-S; EVERARD ML, 1994, ARCH DIS CHILD, V71, P428, DOI 10.1136/adc.71.5.428; EXCLER JL, 2005, STATE ART NEW VACCIN, P14; Friedrich L, 2006, AM J RESP CRIT CARE, V173, P442, DOI 10.1164/rccm.200503-444OC; Greensill J, 2003, EMERG INFECT DIS, V9, P372, DOI 10.3201/eid0903.020289; HALL CB, 1975, J INFECT DIS, V132, P151, DOI 10.1093/infdis/132.2.151; Heaney LG, 1996, CLIN EXP ALLERGY, V26, P799, DOI 10.1111/j.1365-2222.1996.tb00611.x; Hjalmarson O, 2002, AM J RESP CRIT CARE, V165, P83, DOI 10.1164/ajrccm.165.1.2107093; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; HOSMER DW, 1978, COMPUT PROG BIOMED, V8, P121, DOI 10.1016/0010-468X(78)90047-8; Jartti T, 2004, EMERG INFECT DIS, V10, P1095, DOI 10.3201/eid1006.030629; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; Kaltreider HB, 1997, AM J RESP CELL MOL, V16, P133, DOI 10.1165/ajrcmb.16.2.9032120; King KA, 2001, AM J RESP CELL MOL, V24, P101, DOI 10.1165/ajrcmb.24.2.4264; Leader S, 2002, PEDIATR INFECT DIS J, V21, P629, DOI 10.1097/00006454-200207000-00005; Legg JP, 2003, AM J RESP CRIT CARE, V168, P633, DOI 10.1164/rccm.200210-1148OC; Lo MS, 2005, J VIROL, V79, P9315, DOI 10.1128/JVI.79.14.9315-9319.2005; LOCKITCH G, 1988, CLIN CHEM, V34, P1622; McNamara PS, 2004, LANCET, V363, P1031, DOI 10.1016/S0140-6736(04)15838-8; McNamara PS, 2004, EUR RESPIR J, V23, P106, DOI 10.1183/09031936.03.00048103; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; Mills PC, 2006, J FELINE MED SURG, V8, P105, DOI 10.1016/j.jfms.2005.11.001; Mills PC, 2005, NEW ZEAL VET J, V53, P423, DOI 10.1080/00480169.2005.36587; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; Perkins SM, 2005, J CLIN MICROBIOL, V43, P2356, DOI 10.1128/JCM.43.5.2356-2362.2005; Piedimonte G, 1999, AM J PHYSIOL-LUNG C, V277, pL831, DOI 10.1152/ajplung.1999.277.4.L831; Pierson RN, 2000, ANN NY ACAD SCI, V904, P1; Ratjen F, 1996, PEDIATR PULM, V21, P184, DOI 10.1002/(SICI)1099-0496(199603)21:3<184::AID-PPUL6>3.0.CO;2-Q; Reader JR, 2003, AM J RESP CELL MOL, V28, P664, DOI 10.1165/rcmb.2002-0207OC; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; Sabogal C, 2005, PEDIATR RES, V57, P819, DOI 10.1203/01.PDR.0000157679.67227.11; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Smyth RL, 2002, PEDIATR PULM, V33, P339, DOI 10.1002/ppul.10080; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; TALKE H, 1965, KLIN WOCHENSCHR, V43, P174, DOI 10.1007/BF01484513; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Tortorolo L, 2005, AM J RESP CRIT CARE, V172, P233, DOI 10.1164/rccm.200412-1693OC; Tripp RA, 2003, J VIROL, V77, P6580, DOI 10.1128/JVI.77.11.6580-6584.2003; Wright PF, 2002, J INFECT DIS, V185, P1011, DOI 10.1086/339822; WRIGHT PF, 2000, WHOVB0008; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373	48	45	49	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1038	10.1371/journal.pone.0001038	http://dx.doi.org/10.1371/journal.pone.0001038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940602	Green Published, Green Submitted, gold			2022-12-27	WOS:000207456100006
J	Yamagishi, S; Koyama, Y; Katayama, T; Taniguchi, M; Hitomi, J; Kato, M; Aoki, M; Itoyama, Y; Kato, S; Tohyama, M				Yamagishi, Satoru; Koyama, Yoshihisa; Katayama, Taiichi; Taniguchi, Manabu; Hitomi, Junichi; Kato, Masaaki; Aoki, Masashi; Itoyama, Yasuto; Kato, Shinsuke; Tohyama, Masaya			An In Vitro Model for Lewy Body-Like Hyaline Inclusion/Astrocytic Hyaline Inclusion: Induction by ER Stress with an ALS-Linked SOD1 Mutation	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED-PROTEIN RESPONSE; EXPRESSING HUMAN SOD1; SUPEROXIDE-DISMUTASE; TRANSGENIC MICE; MUTANT SOD1; NEURODEGENERATIVE DISEASE; GENE-MUTATIONS; SPINAL-CORD	Neuronal Lewy body-like hyaline inclusions (LBHI) and astrocytic hyaline inclusions (Ast-HI) containing mutant Cu/Zn superoxide dismutase 1 (SOD1) are morphological hallmarks of familial amyotrophic lateral sclerosis (FALS) associated with mutant SOD1. However, the mechanisms by which mutant SOD1 contributes to formation of LBHI/Ast-HI in FALS remain poorly defined. Here, we report induction of LBHI/Ast-HI-like hyaline inclusions (LHIs) in vitro by ER stress in neuroblastoma cells. These LHI closely resemble LBHI/Ast-HI in patients with SOD1-linked FALS. LHI and LBHI/Ast-HI share the following features: 1) eosinophilic staining with a pale core, 2) SOD1, ubiquitin and ER resident protein (KDEL) positivity and 3) the presence of approximately 15-25 nm granule-coated fibrils, which are morphological hallmark of mutant SOD1-linked FALS. Moreover, in spinal cord neurons of L84V SOD1 transgenic mice at presymptomatic stage, we observed aberrant aggregation of ER and numerous free ribosomes associated with abnormal inclusion-like structures, presumably early stage neuronal LBHI. We conclude that the LBHI/Ast-HI seen in human patients with mutant SOD1-linked FALS may arise from ER dysfunction.	[Yamagishi, Satoru; Koyama, Yoshihisa; Katayama, Taiichi; Taniguchi, Manabu; Hitomi, Junichi; Tohyama, Masaya] Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, Osaka, Japan; [Yamagishi, Satoru; Koyama, Yoshihisa; Katayama, Taiichi; Taniguchi, Manabu; Hitomi, Junichi; Tohyama, Masaya] Osaka Univ, 21st Century Ctr Excellence Program, Grad Sch Med, Osaka, Japan; [Kato, Masaaki; Aoki, Masashi; Itoyama, Yasuto] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Kato, Shinsuke] Tottori Univ, Sch Med, Inst Neurol Sci, Dept Neuropathol, Yonago, Tottori 683, Japan	Osaka University; Osaka University; Tohoku University; Tottori University	Yamagishi, S (corresponding author), Max Planck Inst Neurobiol, Munich, Germany.	yamagishi@neuro.mpg.de; kato@grape.med.tottori-u.ac.jp			Japan Society for the Promotion of Science [102-8471]; Ministry of Education, Culture, Sports, Science and Technology of Japan [17500229]; Research on Psychiatric and Neurological Disease and Mental Health; Ministry of Health, Labour and Welfare of Japan; European Molecular Biology Organization (EMBO)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research on Psychiatric and Neurological Disease and Mental Health; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This work was supported in part by a grant from the 21st Century COE Program, Japan Society for the Promotion of Science, 6 Ichibancho, Chiyoda-ku, Tokyo 102-8471, Japan, a Grant-in-Aid for Scientific Research (c) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S. K.: 17500229), a Grant from Research on Psychiatric and Neurological Disease and Mental Health (SK, MA, YI) and a Research Grant on Measures for Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan (SK, YI). SY is supported by a longterm fellowship by European Molecular Biology Organization (EMBO) and Japan Society for the Promotion of Science (JSPS).	AOKI M, 1995, ANN NEUROL, V37, P676, DOI 10.1002/ana.410370518; Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Brown RH, 2001, SEMIN NEUROL, V21, P131; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Gurney ME, 2000, BIOESSAYS, V22, P297, DOI 10.1002/(SICI)1521-1878(200003)22:3<297::AID-BIES12>3.0.CO;2-I; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; HIRANO A, 1967, ARCH NEUROL-CHICAGO, V16, P232, DOI 10.1001/archneur.1967.00470210008002; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hyun DH, 2003, J NEUROCHEM, V86, P363, DOI 10.1046/j.1471-4159.2003.01841.x; Ishihara N, 1998, J BIOCHEM-TOKYO, V123, P722; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Katayama T, 2001, J BIOL CHEM, V276, P43446, DOI 10.1074/jbc.M104096200; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kato H, 2006, J CELL SCI, V119, P2342, DOI 10.1242/jcs.02951; Kato S, 1999, ACTA NEUROPATHOL, V97, P260, DOI 10.1007/s004010050983; Kato S, 2004, ACTA NEUROPATHOL, V107, P149, DOI 10.1007/s00401-003-0791-1; Kato S, 2001, NEUROPATHOLOGY, V21, P67, DOI 10.1046/j.1440-1789.2001.00359.x; Kato S, 2001, ACTA NEUROPATHOL, V102, P233; Kato S, 1999, HISTOL HISTOPATHOL, V14, P973, DOI 10.14670/HH-14.973; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Kato S, 2000, ACTA NEUROPATHOL, V100, P490, DOI 10.1007/s004010000226; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Niwa J, 2002, J BIOL CHEM, V277, P36793, DOI 10.1074/jbc.M206559200; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sasaki S, 2005, ACTA NEUROPATHOL, V110, P48, DOI 10.1007/s00401-005-1021-9; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Takahashi R, 2003, J NEUROL, V250, P25, DOI 10.1007/s00415-003-1305-8; Takahashi R, 2003, ANN NY ACAD SCI, V991, P101; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Tobisawa S, 2003, BIOCHEM BIOPH RES CO, V303, P496, DOI 10.1016/S0006-291X(03)00353-X; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Wang B, 2003, J BIOL CHEM, V278, P14461, DOI 10.1074/jbc.M209684200; Wate R, 2005, ACTA NEUROPATHOL, V110, P557, DOI 10.1007/s00401-005-1080-y; Wootz H, 2004, BIOCHEM BIOPH RES CO, V322, P281, DOI 10.1016/j.bbrc.2004.07.118; Wootz H, 2006, EXP CELL RES, V312, P1890, DOI 10.1016/j.yexcr.2006.02.021	49	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1030	10.1371/journal.pone.0001030	http://dx.doi.org/10.1371/journal.pone.0001030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925878	gold, Green Published, Green Submitted			2022-12-27	WOS:000207456000029
J	Ahmed, N; Saini, V; Raghuvanshi, S; Khurana, JP; Tyagi, AK; Tyagi, AK; Hasnain, SE				Ahmed, Niyaz; Saini, Vikram; Raghuvanshi, Saurabh; Khurana, Jitendra P.; Tyagi, Akhilesh K.; Tyagi, Anil K.; Hasnain, Seyed E.			Molecular Analysis of a Leprosy Immunotherapeutic Bacillus Provides Insights into Mycobacterium Evolution	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; TUBERCULOSIS COMPLEX; GENETIC-ANALYSIS; GYRB GENES; VACCINE; IDENTIFICATION; POLYMORPHISM; MULTIDRUG; SEQUENCES; BCG	Background. Evolutionary dynamics plays a central role in facilitating the mechanisms of species divergence among pathogenic and saprophytic mycobacteria. The ability of mycobacteria to colonize hosts, to proliferate and to cause diseases has evolved due to its predisposition to various evolutionary forces acting over a period of time. Mycobacterium indicus pranii (MIP), a taxonomically unknown 'generalist' mycobacterium, acts as an immunotherapeutic against leprosy and is approved for use as a vaccine against it. The large-scale field trials of this MIP based leprosy vaccine coupled with its demonstrated immunomodulatory and adjuvant property has led to human clinical evaluations of MIP in interventions against HIV-AIDS, psoriasis and bladder cancer. MIP, commercially available as 'Immuvac', is currently the focus of advanced phase III clinical trials for its antituberculosis efficacy. Thus a comprehensive analysis of MIP vis-a-vis evolutionary path, underpinning its immanent immunomodulating properties is of the highest desiderata. Principal Findings. Genome wide comparisons together with molecular phylogenetic analyses by fluorescent amplified fragment length polymorphism (FAFLP), enterobacterial repetitive intergenic consensus (ERIC) based genotyping and candidate orthologues sequencing revealed that MIP has been the predecessor of highly pathogenic Mycobacterium avium intracellulare complex (MAIC) that did not resort to parasitic adaptation by reductional gene evolution and therefore, preferred a free living life-style. Further analysis suggested a shared aquatic phase of MAIC bacilli with the early pathogenic forms of Mycobacterium, well before the latter diverged as 'specialists'. Conclusions/Significance. This evolutionary paradigm possibly affirms to marshal our understanding about the acquisition and optimization of virulence in mycobacteria and determinants of boundaries therein.	[Hasnain, Seyed E.] Univ Hyderabad, Hyderabad 500134, Andhra Pradesh, India; [Ahmed, Niyaz] Ctr DNA Fingerprinting & Diagnost CDFD, Pathogen Evolut Lab, Hyderabad, Andhra Pradesh, India; [Saini, Vikram; Raghuvanshi, Saurabh; Khurana, Jitendra P.; Tyagi, Akhilesh K.] Univ Delhi, Interdisciplinary Ctr Plant Gen, Dept Plant Mol Biol, New Delhi, India; [Saini, Vikram; Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India; [Hasnain, Seyed E.] Univ Hyderabad, Inst Life Sci, Hyderabad 500134, Andhra Pradesh, India; [Hasnain, Seyed E.] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	University of Hyderabad; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); University of Delhi; University of Delhi; University of Hyderabad; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Hasnain, SE (corresponding author), Univ Hyderabad, Hyderabad 500134, Andhra Pradesh, India.	vc@uohyd.ernet.in	Saini, Vikram/B-4547-2009; Ahmed, Niyaz/D-2589-2010	Saini, Vikram/0000-0002-0258-2871; Ahmed, Niyaz/0000-0001-6425-7583; Hasnain, Seyed/0000-0002-2967-0791	Department of Biotechnology of the Indian Ministry of Science and Technology [BT/PR4127/MED/12/165/2003]; CSIR, India	Department of Biotechnology of the Indian Ministry of Science and Technology(Department of Biotechnology (DBT) India); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a research grant (BT/PR4127/MED/12/165/2003) to NA, JPK, AKT, AKT and SEH from the Department of Biotechnology of the Indian Ministry of Science and Technology. VS acknowledges CSIR, India for research studentship (CSIR JRF/SRF).	Ahmed N, 2003, INFECT GENET EVOL, V2, P193, DOI 10.1016/S1567-1348(02)00100-4; Akbar S, 1997, MOL MICROBIOL, V24, P567, DOI 10.1046/j.1365-2958.1997.3631732.x; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Chaudhuri Prabir, 2003, J Indian Med Assoc, V101, P559; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cousins DV, 2003, INT J SYST EVOL MICR, V53, P1305, DOI 10.1099/ijs.0.02401-0; Dagan T, 2006, MOL BIOL EVOL, V23, P310, DOI 10.1093/molbev/msj036; Danelishvili L, 2007, P NATL ACAD SCI USA, V104, P11038, DOI 10.1073/pnas.0610746104; de Bruyn G, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001166; Devulder G, 2005, INT J SYST EVOL MICR, V55, P293, DOI 10.1099/ijs.0.63222-0; Flint JL, 2004, P NATL ACAD SCI USA, V101, P12598, DOI 10.1073/pnas.0404892101; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Kharkar Rajendra, 2002, J Indian Med Assoc, V100, P578; Kong Y, 2006, J CLIN MICROBIOL, V44, P3940, DOI 10.1128/JCM.01146-06; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Marri PR, 2006, CAN J MICROBIOL, V52, P560, DOI 10.1139/W06-001; Matte-Tailliez O, 2002, MOL BIOL EVOL, V19, P631, DOI 10.1093/oxfordjournals.molbev.a004122; Patel Naresh, 2002, J Indian Med Assoc, V100, P191; Rao KR, 2005, J CLIN MICROBIOL, V43, P5978, DOI 10.1128/JCM.43.12.5978-5982.2005; Rath N, 2003, INT J DERMATOL, V42, P756; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; REDDI PP, 1994, INT J LEPROSY, V62, P229; Rook GAW, 2007, IMMUNOBIOLOGY, V212, P461, DOI 10.1016/j.imbio.2007.03.003; Rosas-Magallanes V, 2006, MOL BIOL EVOL, V23, P1129, DOI 10.1093/molbev/msj120; Sechi LA, 1998, J CLIN MICROBIOL, V36, P128, DOI 10.1128/JCM.36.1.128-132.1998; Sharma P, 2005, LEPROSY REV, V76, P127; Siddiqi N, 1998, MEM I OSWALDO CRUZ, V93, P589, DOI 10.1590/S0074-02761998000500006; SINGH IG, 1992, INFECT IMMUN, V60, P257, DOI 10.1128/IAI.60.1.257-263.1992; SOINI H, 1994, J CLIN MICROBIOL, V32, P2944, DOI 10.1128/JCM.32.12.2944-2947.1994; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Stinear TP, 2000, J BACTERIOL, V182, P6322, DOI 10.1128/JB.182.22.6322-6330.2000; Talwar G P, 1999, Int Rev Immunol, V18, P229, DOI 10.3109/08830189909043027; TALWAR GP, 1990, VACCINE, V8, P121, DOI 10.1016/0264-410X(90)90134-8; Talwar GP, 2008, INFECT GENET EVOL, V8, P100, DOI 10.1016/j.meegid.2007.07.009; YADAVA A, 1991, SCAND J IMMUNOL, V34, P23, DOI 10.1111/j.1365-3083.1991.tb01517.x; Yamamoto S, 1996, INT J SYST BACTERIOL, V46, P506, DOI 10.1099/00207713-46-2-506; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P1104, DOI 10.1128/AEM.61.3.1104-1109.1995; ZAHEER SA, 1993, J INFECT DIS, V167, P401, DOI 10.1093/infdis/167.2.401	42	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e968	10.1371/journal.pone.0000968	http://dx.doi.org/10.1371/journal.pone.0000968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912347	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455900006
J	Hougardy, JM; Schepers, K; Place, S; Drowart, A; Lechevin, V; Verscheure, V; Debrie, AS; Doherty, TM; Van Vooren, JP; Locht, C; Mascart, F				Hougardy, Jean-Michel; Schepers, Kinda; Place, Sammy; Drowart, Annie; Lechevin, Veronique; Verscheure, Virginie; Debrie, Anne-Sophie; Doherty, T. Mark; Van Vooren, Jean-Paul; Locht, Camille; Mascart, Francoise			Heparin-Binding-Hemagglutinin-Induced IFN-gamma Release as a Diagnostic Tool for Latent Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; T-CELL; IMMUNE-RESPONSES; INFECTION; TESTS; ASSAY; METAANALYSIS	Background. The detection of latent tuberculosis infection (LTBI) is a major component of tuberculosis (TB) control strategies. In addition to the tuberculosis skin test (TST), novel blood tests, based on in vitro release of IFN-gamma in response to Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 (IGRAs), are used for TB diagnosis. However, neither IGRAs nor the TST can separate acute TB from LTBI, and there is concern that responses in IGRAs may decline with time after infection. We have therefore evaluated the potential of the novel antigen heparin-binding hemagglutinin (HBHA) for in vitro detection of LTBI. Methodology and Principal Findings. HBHA was compared to purified protein derivative (PPD) and ESAT-6 in IGRAs on lymphocytes drawn from 205 individuals living in Belgium, a country with low TB prevalence, where BCG vaccination is not routinely used. Among these subjects, 89 had active TB, 65 had LTBI, based on well-standardized TST reactions and 51 were negative controls. HBHA was significantly more sensitive than ESAT-6 and more specific than PPD for the detection of LTBI. PPD-based tests yielded 90.00% sensitivity and 70.00% specificity for the detection of LTBI, whereas the sensitivity and specificity for the ESAT-6-based tests were 40.74% and 90.91%, and those for the HBHA-based tests were 92.06% and 93.88%, respectively. The QuantiFERON-TB Gold In-Tube (QFT-IT) test applied on 20 LTBI subjects yielded 50% sensitivity. The HBHA IGRA was not influenced by prior BCG vaccination, and, in contrast to the QFT-IT test, remote (. 2 years) infections were detected as well as recent (< 2 years) infections by the HBHA-specific test. Conclusions. The use of ESAT-6- and CFP-10-based IGRAs may underestimate the incidence of LTBI, whereas the use of HBHA may combine the operational advantages of IGRAs with high sensitivity and specificity for latent infection.	[Hougardy, Jean-Michel; Schepers, Kinda; Place, Sammy; Verscheure, Virginie; Mascart, Francoise] Univ Libre Bruxelles, Hop Erasme, Lab Vaccinol & Mucosal Immun, Brussels, Belgium; [Drowart, Annie] Univ Libre Bruxelles, Hop Brugmann, Dept Pneumol, Brussels, Belgium; [Drowart, Annie] Univ Libre Bruxelles, Hop Erasme, Dept Pneumol, Brussels, Belgium; [Lechevin, Veronique; Van Vooren, Jean-Paul] Univ Libre Bruxelles, Hop Erasme, Dept Immunodeficiency, Brussels, Belgium; [Lechevin, Veronique] Univ Libre Bruxelles, Hop Erasme, Dept Occupat Med, Brussels, Belgium; [Debrie, Anne-Sophie; Locht, Camille] INSERM, U629, F-59045 Lille, France; [Debrie, Anne-Sophie; Locht, Camille] Inst Pasteur, F-59019 Lille, France; [Doherty, T. Mark] Statens Serum Inst, Dept TB Immunol, DK-2300 Copenhagen, Denmark; [Mascart, Francoise] Free Univ Brussels, Hop Erasme, Immunobiol Clin, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Statens Serum Institut; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Mascart, F (corresponding author), Univ Libre Bruxelles, Hop Erasme, Lab Vaccinol & Mucosal Immun, Brussels, Belgium.	fmascart@ulb.ac.be	Locht, Camille/L-3516-2018	Debrie, Anne-Sophie/0000-0003-0570-4413; Locht, Camille/0000-0001-7295-7336; Hougardy, Jean-Michel/0000-0002-7769-5360	Fond de la Recherche Scientifique Medicale; European Commission [LSHP-CT-2003-503367]; Fond pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA); Fondation Erasme	Fond de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); European Commission(European CommissionEuropean Commission Joint Research Centre); Fond pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); Fondation Erasme	This work was supported by a grant from the Fond de la Recherche Scientifique Medicale, by the European Commission, within the 6th Framework Program, contract Nu LSHP-CT-2003-503367, and by the "Region de Bruxelles-Capitale''. JMH was supported by a fellowship from the Fond pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA). KS and SP were supported by a fellowship from the Fondation Erasme. None of the organizations supporting the authors with grants had any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in preparation, review or approval of the manuscript.	*AM THOR SOC CDC, 2000, J RESP CRIT CARE M 1, V161, P1376; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; LOCHT C, 2007, MYCOBACTERI IN PRESS; Masungi C, 2002, J INFECT DIS, V185, P513, DOI 10.1086/338833; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; MENZIES R, 2006, TB COMPREHENSIVE INT, P251; Porsa E, 2006, CLIN VACCINE IMMUNOL, V13, P53, DOI 10.1128/CVI.13.1.53-58.2006; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; Sterling TR, 2006, NEW ENGL J MED, V355, P118, DOI 10.1056/NEJMp068015; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201; *WHO, 2007, 104 WHO	30	94	98	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e926	10.1371/journal.pone.0000926	http://dx.doi.org/10.1371/journal.pone.0000926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912342	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455900001
J	Komarova, NL; Wodarz, D				Komarova, Natalia L.; Wodarz, Dominik			Effect of Cellular Quiescence on the Success of Targeted CML Therapy	PLOS ONE			English	Article								Background. Similar to tissue stem cells, primitive tumor cells in chronic myelogenous leukemia have been observed to undergo quiescence; that is, the cells can temporarily stop dividing. Using mathematical models, we investigate the effect of cellular quiescence on the outcome of therapy with targeted small molecule inhibitors. Methods and Results. According to the models, the initiation of treatment can result in different patterns of tumor cell decline: a biphasic decline, a one-phase decline, and a reverse biphasic decline. A biphasic decline involves a fast initial phase (which roughly corresponds to the eradication of cycling cells by the drug), followed by a second and slower phase of exponential decline (corresponding to awakening and death of quiescent cells), which helps explain clinical data. We define the time when the switch to the second phase occurs, and identify parameters that determine whether therapy can drive the tumor extinct in a reasonable period of time or not. We further ask how cellular quiescence affects the evolution of drug resistance. We find that it has no effect on the probability that resistant mutants exist before therapy if treatment occurs with a single drug, but that quiescence increases the probability of having resistant mutants if patients are treated with a combination of two or more drugs with different targets. Interestingly, while quiescence prolongs the time until therapy reduces the number of cells to low levels or extinction, the therapy phase is irrelevant for the evolution of drug resistant mutants. If treatment fails as a result of resistance, the mutants will have evolved during the tumor growth phase, before the start of therapy. Thus, prevention of resistance is not promoted by reducing the quiescent cell population during therapy (e. g., by a combination of cell activation and drug-mediated killing). Conclusions. The mathematical models provide insights into the effect of quiescence on the basic kinetics of the response to targeted treatment of CML. They identify determinants of success in the absence of drug resistant mutants, and elucidate how quiescence influences the emergence of drug resistant mutants.	[Komarova, Natalia L.; Wodarz, Dominik] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA; [Komarova, Natalia L.; Wodarz, Dominik] Univ Calif Irvine, Dept Ecol & Evolut, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Wodarz, D (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA.	dwodarz@uci.edu			NIH [1R01AI058153-01A2]; Sloan Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058153] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Fellowship(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grant 1R01AI058153-01A2 (DW & NK), and a Sloan Fellowship (NK).	Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; ARAI F, 2007, ANN N Y ACAD SCI; Barnes DJ, 2006, CELL CYCLE, V5, P2862, DOI 10.4161/cc.5.24.3573; Burkert J, 2006, J PATHOL, V209, P287, DOI 10.1002/path.2016; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; COLDMAN AJ, 1986, B MATH BIOL, V48, P279, DOI 10.1016/S0092-8240(86)90028-5; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; Daley GQ, 2003, SEMIN HEMATOL, V40, P11, DOI 10.1053/shem.2003.50035; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Druker BJ, 2003, MOL CANCER THER, V2, P225; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gambacorti-Passerini CB, 2003, LANCET ONCOL, V4, P75, DOI 10.1016/S1470-2045(03)00979-3; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; GYLLENBERG M, 1990, J MATH BIOL, V28, P671, DOI 10.1007/BF00160231; GYLLENBERG M, 1989, GROWTH DEVELOP AGING, V53, P25; GYLLENBERG M, 1987, MATH BIOSCI, V86, P67, DOI 10.1016/0025-5564(87)90064-2; Higashi T, 2004, AM J HEMATOL, V76, P275, DOI 10.1002/ajh.20096; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Holyoake TL, 2001, BLOOD, V97, P720, DOI 10.1182/blood.V97.3.720; HOUGHTON J, 2006, SEMIN CANC BIOL; Jabbour E, 2007, SEMIN HEMATOL, V44, pS25, DOI 10.1053/seminhematol.2006.12.003; John AM, 2004, SEMIN CANCER BIOL, V14, P41, DOI 10.1016/j.semcancer.2003.11.006; Jones RJ, 2004, JNCI-J NATL CANCER I, V96, P583, DOI 10.1093/jnci/djh095; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Melo Junia V, 2003, Hematology Am Soc Hematol Educ Program, P132; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nardi V, 2004, CURR OPIN HEMATOL, V11, P35, DOI 10.1097/00062752-200401000-00006; O'Dwyer ME, 2002, ANNU REV MED, V53, P369, DOI 10.1146/annurev.med.53.082901.103853; Pelayo R, 2006, STEM CELLS, V24, P2703, DOI 10.1634/stemcells.2006-0217; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roeder I, 2006, NAT MED, V12, P1181, DOI 10.1038/nm1487; ROUSSELOT P, 2006, BLOOD; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shannon KM, 2002, CANCER CELL, V2, P99, DOI 10.1016/S1535-6108(02)00101-0; Shet AS, 2002, LEUKEMIA, V16, P1402, DOI 10.1038/sj.leu.2402577; Tauchi T, 2004, LEUKEMIA RES, V28, pS39, DOI 10.1016/j.leukres.2003.10.007; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Yee Karen W L, 2003, Expert Rev Anticancer Ther, V3, P295, DOI 10.1586/14737140.3.3.295; Yoshida C, 2004, INT J HEMATOL, V79, P420, DOI 10.1532/IJH97.04032	46	65	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e990	10.1371/journal.pone.0000990	http://dx.doi.org/10.1371/journal.pone.0000990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912367	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455900026
J	Letourneau, S; Im, EJ; Mashishi, T; Brereton, C; Bridgeman, A; Yang, HB; Dorrell, L; Dong, T; Korber, B; McMichael, AJ; Hanke, T				Letourneau, Sven; Im, Eung-Jun; Mashishi, Tumelo; Brereton, Choechoe; Bridgeman, Anne; Yang, Hongbing; Dorrell, Lucy; Dong, Tao; Korber, Bette; McMichael, Andrew J.; Hanke, Tomas			Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CYTOTOXIC T-LYMPHOCYTES; HIGHLY CONSERVED REGION; CELL RESPONSES; CROSS-CLADE; IMMUNE-RESPONSES; CTL EPITOPE; IMMUNOGENICITY EVALUATION; ENVELOPE GLYCOPROTEIN; PROTECTIVE IMMUNITY	Background. One of the big roadblocks in development of HIV-1/AIDS vaccines is the enormous diversity of HIV-1, which could limit the value of any HIV-1 vaccine candidate currently under test. Methodology and Findings. To address the HIV-1 variation, we designed a novel T cell immunogen, designated HIVCONSV, by assembling the 14 most conserved regions of the HIV-1 proteome into one chimaeric protein. Each segment is a consensus sequence from one of the four major HIV-1 clades A, B, C and D, which alternate to ensure equal clade coverage. The gene coding for the HIVCONSV protein was inserted into the three most studied vaccine vectors, plasmid DNA, human adenovirus serotype 5 and modified vaccine virus Ankara (MVA), and induced HIV-1-specific T cell responses in mice. We also demonstrated that these conserved regions prime CD8(+) and CD4(+) T cell to highly conserved epitopes in humans and that these epitopes, although usually subdominant, generate memory T cells in patients during natural HIV-1 infection. Significance. Therefore, this vaccine approach provides an attractive and testable alternative for overcoming the HIV-1 variability, while focusing T cell responses on regions of the virus that are less likely to mutate and escape. Furthermore, this approach has merit in the simplicity of design and delivery, requiring only a single immunogen to provide extensive coverage of global HIV-1 population diversity.	[Letourneau, Sven; Im, Eung-Jun; Mashishi, Tumelo; Brereton, Choechoe; Bridgeman, Anne; Yang, Hongbing; Dorrell, Lucy; Dong, Tao; McMichael, Andrew J.; Hanke, Tomas] Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England; [Korber, Bette] Los Alamo Natl Lab, Los Alamos, NM USA; [Korber, Bette] Santa Fe Inst, Santa Fe, NM USA	University of Oxford; The Santa Fe Institute	Hanke, T (corresponding author), Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England.	tomas.hanke@imm.ox.ac.uk		Korber, Bette/0000-0002-2026-5757; Dong, Tao/0000-0003-3545-3758; Bridgeman, Anne/0000-0002-9478-6125	MRC UK; Medical Research Council [G0502048, MC_U137884179, MC_U137884177, G0600520] Funding Source: researchfish; MRC [MC_U137884177, G0502048, MC_U137884179, G0600520] Funding Source: UKRI	MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TH is the Jenner Institute Investigator. The work was supported by MRC UK.	Allen TM, 1998, J IMMUNOL, V160, P6062; Altfeld M, 2003, J VIROL, V77, P7330, DOI 10.1128/JVI.77.13.7330-7340.2003; Amara RR, 2005, VIROLOGY, V334, P124; Andre S, 1998, J VIROL, V72, P1497; Basu D, 1998, P NATL ACAD SCI USA, V95, P14332, DOI 10.1073/pnas.95.24.14332; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; Betts MR, 1997, J VIROL, V71, P8908, DOI 10.1128/JVI.71.11.8908-8911.1997; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Blay WM, 2006, J VIROL, V80, P999, DOI 10.1128/JVI.80.2.999-1014.2006; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Buseyne F, 1998, VIROLOGY, V250, P316, DOI 10.1006/viro.1998.9373; Cao HY, 1997, J VIROL, V71, P8615, DOI 10.1128/JVI.71.11.8615-8623.1997; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Dorrell L, 1999, J VIROL, V73, P1708, DOI 10.1128/JVI.73.2.1708-1714.1999; Dorrell L, 2001, EUR J IMMUNOL, V31, P1747, DOI 10.1002/1521-4141(200106)31:6<1747::AID-IMMU1747>3.3.CO;2-C; Dorrell L, 2006, J VIROL, V80, P4705, DOI 10.1128/JVI.80.10.4705-4716.2006; Duerr A, 2006, CLIN INFECT DIS, V43, P500, DOI 10.1086/505979; Ferrari G, 2000, AIDS RES HUM RETROV, V16, P1433, DOI 10.1089/08892220050140982; Ferrari G, 1997, P NATL ACAD SCI USA, V94, P1396, DOI 10.1073/pnas.94.4.1396; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Gallimore A, 1998, J EXP MED, V187, P1647; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Gao Feng, 2004, Expert Rev Vaccines, V3, pS161, DOI 10.1586/14760584.3.4.S161; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gilbert SC, 2002, VACCINE, V20, P1039, DOI 10.1016/S0264-410X(01)00450-9; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; GOTCH F, 1988, J EXP MED, V168, P2045, DOI 10.1084/jem.168.6.2045; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Hanke T, 2000, NAT MED, V6, P951, DOI 10.1038/79626; Hanke T, 1998, VACCINE, V16, P426, DOI 10.1016/S0264-410X(97)00296-X; HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653; Hanke T, 1998, J GEN VIROL, V79, P83, DOI 10.1099/0022-1317-79-1-83; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; Harrer E, 1996, J INFECT DIS, V173, P476, DOI 10.1093/infdis/173.2.476; Hausmann S, 1999, J IMMUNOL, V162, P5389; Im EJ, 2007, AIDS RES HUM RETROV, V23, P857, DOI 10.1089/aid.2007.0009; JOHNSON RP, 1993, J VIROL, V67, P438, DOI 10.1128/JVI.67.1.438-445.1993; JOHNSON RP, 1992, J EXP MED, V175, P961, DOI 10.1084/jem.175.4.961; JOHNSON RP, 1991, J IMMUNOL, V147, P1512; JOHNSON RP, 1994, J VIROL, V68, P3145, DOI 10.1128/JVI.68.5.3145-3153.1994; Klenerman P, 2002, CURR OPIN MICROBIOL, V5, P408, DOI 10.1016/S1369-5274(02)00339-9; KLENERMAN P, 1994, NATURE, V369, P403, DOI 10.1038/369403a0; Kmieciak D, 1998, INT IMMUNOL, V10, P1789, DOI 10.1093/intimm/10.12.1789; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Kothe DL, 2007, VIROLOGY, V360, P218, DOI 10.1016/j.virol.2006.10.017; Kothe DL, 2006, VIROLOGY, V352, P438, DOI 10.1016/j.virol.2006.05.011; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Larke N, 2007, EUR J IMMUNOL, V37, P566, DOI 10.1002/eji.200636711; Lau LL, 2005, J IMMUNOL, V174, P7970, DOI 10.4049/jimmunol.174.12.7970; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Makki Amira, 2002, Cancer Immun, V2, P4; McMichael A, 2002, VACCINE, V20, P1918, DOI 10.1016/S0264-410X(02)00067-1; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nkolola JP, 2004, GENE THER, V11, P1068, DOI 10.1038/sj.gt.3302241; Plebanski M, 1999, NAT MED, V5, P565, DOI 10.1038/8444; ROLLAND M, 2007, PROTEINS J VIROL; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; Seaman MS, 2005, J VIROL, V79, P2956, DOI 10.1128/JVI.79.5.2956-2963.2005; Slyker JA, 2005, VACCINE, V23, P4711, DOI 10.1016/j.vaccine.2005.01.145; STREECK H, 2007, J VIROL; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; Walker BD, 2000, NATURE, V407, P313, DOI 10.1038/35030283; Weaver EA, 2006, J VIROL, V80, P6745, DOI 10.1128/JVI.02484-05; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649; Wilson CC, 2003, J IMMUNOL, V171, P5611, DOI 10.4049/jimmunol.171.10.5611; Wilson CC, 2001, J VIROL, V75, P4195, DOI 10.1128/JVI.75.9.4195-4207.2001	72	225	235	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e984	10.1371/journal.pone.0000984	http://dx.doi.org/10.1371/journal.pone.0000984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912361	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455900020
J	Rogers, KL; Picaud, S; Roncali, E; Boisgard, R; Colasante, C; Stinnakre, J; Tavitian, B; Brulet, P				Rogers, Kelly L.; Picaud, Sandrine; Roncali, Emilie; Boisgard, Raphael; Colasante, Cesare; Stinnakre, Jacques; Tavitian, Bertrand; Brulet, Philippe			Non-Invasive In Vivo Imaging of Calcium Signaling in Mice	PLOS ONE			English	Article								Rapid and transient elevations of Ca2+ within cellular microdomains play a critical role in the regulation of many signal transduction pathways. Described here is a genetic approach for non-invasive detection of localized Ca2+ concentration ([Ca2+]) rises in live animals using bioluminescence imaging (BLI). Transgenic mice conditionally expressing the Ca2+-sensitive bioluminescent reporter GFP-aequorin targeted to the mitochondrial matrix were studied in several experimental paradigms. Rapid [Ca2+] rises inside the mitochondrial matrix could be readily detected during single-twitch muscle contractions. Whole body patterns of [Ca2+] were monitored in freely moving mice and during epileptic seizures. Furthermore, variations in mitochondrial [Ca2+] correlated to behavioral components of the sleep/wake cycle were observed during prolonged whole body recordings of newborn mice. This non-invasive imaging technique opens new avenues for the analysis of Ca2+ signaling whenever whole body information in freely moving animals is desired, in particular during behavioral and developmental studies.	[Rogers, Kelly L.; Picaud, Sandrine; Colasante, Cesare; Stinnakre, Jacques; Brulet, Philippe] Inst Pasteur, Unite Embryol Mol, CNRS, URA 2578, Paris, France; [Rogers, Kelly L.; Roncali, Emilie; Boisgard, Raphael; Tavitian, Bertrand] CEA, Serv Hosp Frederic Joliot, INSERM, U803, F-91406 Orsay, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Brulet, P (corresponding author), Inst Pasteur, Unite Embryol Mol, CNRS, URA 2578, Paris, France.	pbrulet@pasteur.fr	Roncali, Emilie/AAP-9701-2020; roncali, emilie/C-2130-2016; Tavitian, Bertrand M/P-6578-2018	Roncali, Emilie/0000-0002-2439-1064; Tavitian, Bertrand M/0000-0002-5349-8194; Rogers, Kelly L./0000-0002-6755-0221	Institut Pasteur; CNRS; AFM; E.U.; INSERM	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); AFM(Association Francaise contre les Myopathies); E.U.(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	The work was funded by Institut Pasteur, CNRS and AFM to PB and by E.U. support through the EMIL and DIMI European Networks to BT. KR received support from Institut Pasteur, CNRS and INSERM. Biospace Lab provided a PhD scholarship to ER. CC was supported by CNRS.	Abraham U, 2005, J NEUROSCI, V25, P8620, DOI 10.1523/JNEUROSCI.2225-05.2005; Adelsberger H, 2005, NAT NEUROSCI, V8, P988, DOI 10.1038/nn1502; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Bell CJ, 2006, J BIOL CHEM, V281, P28058, DOI 10.1074/jbc.M604540200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Bizeau ME, 1998, J APPL PHYSIOL, V85, P1279, DOI 10.1152/jappl.1998.85.4.1279; Blumberg MS, 1996, DEV PSYCHOBIOL, V29, P1, DOI 10.1002/(SICI)1098-2302(199601)29:1<1::AID-DEV1>3.0.CO;2-Y; Blumberg MS, 2005, J SLEEP RES, V14, P91, DOI 10.1111/j.1365-2869.2004.00430_1.x; Blumberg MS, 2005, P NATL ACAD SCI USA, V102, P14860, DOI 10.1073/pnas.0506340102; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Bruton J, 2003, J PHYSIOL-LONDON, V551, P179, DOI 10.1113/jphysiol.2003.043927; CLARK JB, 1970, J BIOL CHEM, V245, P4724; Curie T, 2007, MOL IMAGING, V6, P30, DOI 10.2310/7290.2006.00033; De A, 2005, FASEB J, V19, P2017, DOI 10.1096/fj.05-4628fje; De Sarro G, 2004, NEUROSCI RES, V50, P37, DOI 10.1016/j.neures.2004.05.007; Durand E, 2005, AM J RESP CRIT CARE, V172, P238, DOI 10.1164/rccm.200411-1528OC; Frank MG, 1997, AM J PHYSIOL-REG I, V272, pR1792, DOI 10.1152/ajpregu.1997.272.6.R1792; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Gorokhovatsky AY, 2004, BIOCHEM BIOPH RES CO, V320, P703, DOI 10.1016/j.bbrc.2004.06.014; GRAMSBERGEN A, 1970, Developmental Psychobiology, V3, P267, DOI 10.1002/dev.420030407; Hardy J, 2004, SCIENCE, V303, P851, DOI 10.1126/science.1092712; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Hayashi M, 2003, J HISTOCHEM CYTOCHEM, V51, P1375, DOI 10.1177/002215540305101014; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Karlsson KAE, 2005, PLOS BIOL, V3, P891, DOI 10.1371/journal.pbio.0030143; Karlsson KAE, 2004, NEUROSCIENCE, V123, P575, DOI 10.1016/j.neuroscience.2003.09.025; Karlsson KAE, 2002, BEHAV NEUROSCI, V116, P912, DOI 10.1037//0735-7044.116.5.912; KENDALL JM, 1992, BIOCHEM BIOPH RES CO, V187, P1091, DOI 10.1016/0006-291X(92)91309-E; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Kovacs R, 2005, J NEUROSCI, V25, P4260, DOI 10.1523/JNEUROSCI.4000-04.2005; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lannergren J, 2001, J MUSCLE RES CELL M, V22, P265, DOI 10.1023/A:1012227009544; LOEW LM, 1994, P NATL ACAD SCI USA, V91, P12579, DOI 10.1073/pnas.91.26.12579; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pichler A, 2004, P NATL ACAD SCI USA, V101, P1702, DOI 10.1073/pnas.0304326101; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Robert V, 2001, EMBO J, V20, P4998, DOI 10.1093/emboj/20.17.4998; Rogers KL, 2005, EUR J NEUROSCI, V21, P597, DOI 10.1111/j.1460-9568.2005.03871.x; Roux S, 2005, MOL CELL NEUROSCI, V30, P572, DOI 10.1016/j.mcn.2005.05.009; Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102; Schiavetta AM, 2003, CONTEMP TOP LAB ANIM, V42, P12; SHIMOMURA O, 1989, BIOCHEM J, V261, P913, DOI 10.1042/bj2610913; So MK, 2006, NAT BIOTECHNOL, V24, P339, DOI 10.1038/nbt1188; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388; Zhao Hui, 2004, Mol Imaging, V3, P43, DOI 10.1162/153535004773861714	52	65	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e974	10.1371/journal.pone.0000974	http://dx.doi.org/10.1371/journal.pone.0000974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912353	Green Published, gold			2022-12-27	WOS:000207455900012
J	Makarova, KS; Omelchenko, MV; Gaidamakova, EK; Matrosova, VY; Vasilenko, A; Zhai, M; Lapidus, A; Copeland, A; Kim, E; Land, M; Mavromatis, K; Pitluck, S; Richardson, PM; Detter, C; Brettin, T; Saunders, E; Lai, B; Ravel, B; Kemner, KM; Wolf, YI; Sorokin, A; Gerasimova, AV; Gelfand, MS; Fredrickson, JK; Koonin, EV; Daly, MJ				Makarova, Kira S.; Omelchenko, Marina V.; Gaidamakova, Elena K.; Matrosova, Vera Y.; Vasilenko, Alexander; Zhai, Min; Lapidus, Alla; Copeland, Alex; Kim, Edwin; Land, Miriam; Mavromatis, Konstantinos; Pitluck, Samuel; Richardson, Paul M.; Detter, Chris; Brettin, Thomas; Saunders, Elizabeth; Lai, Barry; Ravel, Bruce; Kemner, Kenneth M.; Wolf, Yuri I.; Sorokin, Alexander; Gerasimova, Anna V.; Gelfand, Mikhail S.; Fredrickson, James K.; Koonin, Eugene V.; Daly, Michael J.			Deinococcus geothermalis: The Pool of Extreme Radiation Resistance Genes Shrinks	PLOS ONE			English	Article							ESCHERICHIA-COLI; IONIZING-RADIATION; DNA-POLYMERASE; TARGETED MUTAGENESIS; COMPARATIVE GENOMICS; CRYOELECTRON MICROSCOPY; SHEWANELLA-ONEIDENSIS; AROMATIC-COMPOUNDS; CRYSTAL-STRUCTURE; PROTEIN FAMILIES	Bacteria of the genus Deinococcus are extremely resistant to ionizing radiation (IR), ultraviolet light (UV) and desiccation. The mesophile Deinococcus radiodurans was the first member of this group whose genome was completely sequenced. Analysis of the genome sequence of D. radiodurans, however, failed to identify unique DNA repair systems. To further delineate the genes underlying the resistance phenotypes, we report the whole-genome sequence of a second Deinococcus species, the thermophile Deinococcus geothermalis, which at its optimal growth temperature is as resistant to IR, UV and desiccation as D. radiodurans, and a comparative analysis of the two Deinococcus genomes. Many D. radiodurans genes previously implicated in resistance, but for which no sensitive phenotype was observed upon disruption, are absent in D. geothermalis. In contrast, most D. radiodurans genes whose mutants displayed a radiation-sensitive phenotype in D. radiodurans are conserved in D. geothermalis. Supporting the existence of a Deinococcus radiation response regulon, a common palindromic DNA motif was identified in a conserved set of genes associated with resistance, and a dedicated transcriptional regulator was predicted. We present the case that these two species evolved essentially the same diverse set of gene families, and that the extreme stress-resistance phenotypes of the Deinococcus lineage emerged progressively by amassing cell-cleaning systems from different sources, but not by acquisition of novel DNA repair systems. Our reconstruction of the genomic evolution of the Deinococcus-Thermus phylum indicates that the corresponding set of enzymes proliferated mainly in the common ancestor of Deinococcus. Results of the comparative analysis weaken the arguments for a role of higher-order chromosome alignment structures in resistance; more clearly define and substantially revise downward the number of uncharacterized genes that might participate in DNA repair and contribute to resistance; and strengthen the case for a role in survival of systems involved in manganese and iron homeostasis.	[Makarova, Kira S.; Omelchenko, Marina V.; Wolf, Yuri I.; Sorokin, Alexander; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Gaidamakova, Elena K.; Matrosova, Vera Y.; Vasilenko, Alexander; Zhai, Min; Daly, Michael J.] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA; [Lapidus, Alla; Copeland, Alex; Kim, Edwin; Land, Miriam; Mavromatis, Konstantinos; Pitluck, Samuel; Richardson, Paul M.] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Detter, Chris; Brettin, Thomas; Saunders, Elizabeth] Los Alamos Natl Lab, US Dept Energy, Joint Genome Inst, Los Alamos, NM USA; [Lai, Barry; Ravel, Bruce; Kemner, Kenneth M.] Argonne Natl Lab, Div Environm Res, Argonne, IL 60439 USA; [Lai, Barry; Ravel, Bruce; Kemner, Kenneth M.] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Gerasimova, Anna V.] Res Inst Genet & Select Ind Microorganisms, Moscow, Russia; [Gelfand, Mikhail S.] RAS, Inst Informat Transmiss Problems, Moscow 117901, Russia; [Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Fredrickson, James K.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Uniformed Services University of the Health Sciences - USA; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Makarova, KS (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	makarova@ncbi.nlm.nih.gov; mdaly@usuhs.mil	Matrosova, Vera/AAX-4125-2020; Lapidus, Alla L/I-4348-2013; Gelfand, Mikhail S/F-3425-2012; Land, Miriam L/A-6200-2011	Lapidus, Alla L/0000-0003-0427-8731; Land, Miriam L/0000-0001-7102-0031; Gelfand, Mikhail/0000-0003-4181-0846; Wolf, Yuri/0000-0002-0247-8708	National Institutes of Health; National Library of Medicine; USUHS [DE-FG02-04ER63918]; U.S. Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research; Environmental Remediation Sciences Program (ERSP); Air Force Office of Scientific Research [FA9550-07-1-0218]; DOE Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Howard Hughes Medical Institute [55005610]; INTAS [05-8028]; Molecular and Cellular Virology program of the Russian Academy of Sciences; NATIONAL LIBRARY OF MEDICINE [Z01LM000073, ZIALM000061, Z01LM000061, ZIALM000073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); USUHS; U.S. Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Environmental Remediation Sciences Program (ERSP); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); DOE Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); INTAS(INTASEuropean Commission); Molecular and Cellular Virology program of the Russian Academy of Sciences; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The work of KSM, MVO, YIW, AS, and EVK was supported by the Intramural Research Program of the National Institutes of Health, National Library of Medicine. The work at USUHS was supported by grant DE-FG02-04ER63918 to MJD from the U.S. Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research (BER), Environmental Remediation Sciences Program (ERSP); and by grant FA9550-07-1-0218 to MJD from the Air Force Office of Scientific Research. The work at the DOE-Joint Genome Institute was supported by the DOE Office of Science. Work at the Advanced Photon Source was supported by the DOE Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The work of MSG and AVG was supported by grants from the Howard Hughes Medical Institute (55005610), INTAS (05-8028), and the Molecular and Cellular Virology program of the Russian Academy of Sciences. D. geothermalis was selected for genome sequencing by BER (http://www.science. doe.gov/ober/RFS-2.pdf) with MJD as the Principal Investigator.	Agostini HJ, 1996, J BACTERIOL, V178, P6759, DOI 10.1128/jb.178.23.6759-6765.1996; Albuquerque L, 2005, FEMS MICROBIOL LETT, V247, P161, DOI 10.1016/j.femsle.2005.05.002; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; AZEDDOUG H, 1994, CURR MICROBIOL, V29, P229, DOI 10.1007/BF01570159; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Battista JR, 2001, CRYOBIOLOGY, V43, P133, DOI 10.1006/cryo.2001.2357; Bearson SMD, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-13; Belyakov OV, 2005, P NATL ACAD SCI USA, V102, P14203, DOI 10.1073/pnas.0505020102; Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Blasius M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-69; BORDO D, 1994, J MOL BIOL, V238, P366, DOI 10.1006/jmbi.1994.1298; Bouchard JD, 2004, J BACTERIOL, V186, P3649, DOI 10.1128/JB.186.11.3649-3652.2004; Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; BOYD A, 1995, J IND MICROBIOL, V15, P162, DOI 10.1007/BF01569821; Brim H, 2000, NAT BIOTECHNOL, V18, P85, DOI 10.1038/71986; Brim H, 2003, APPL ENVIRON MICROB, V69, P4575, DOI 10.1128/AEM.69.8.4575-4582.2003; Brim H, 2006, MICROBIOL-SGM, V152, P2469, DOI 10.1099/mic.0.29009-0; Brinkrolf K, 2006, GENET MOL RES, V5, P773; BRUCE AK, 1976, CAN J MICROBIOL, V22, P1336, DOI 10.1139/m76-197; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Cabello P, 2004, J BIOL CHEM, V279, P45485, DOI 10.1074/jbc.M404417200; Carroll JD, 1996, J BACTERIOL, V178, P130, DOI 10.1128/jb.178.1.130-135.1996; CHASIN LA, 1968, J BIOL CHEM, V243, P5165; CHEO DL, 1991, J BACTERIOL, V173, P1696, DOI 10.1128/jb.173.5.1696-1703.1991; Courcelle J, 2001, GENETICS, V158, P41; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2006, CLIN LAB MED, V26, P491, DOI 10.1016/j.cll.2006.03.009; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; DALY MJ, 1995, J BACTERIOL, V177, P5495, DOI 10.1128/jb.177.19.5495-5505.1995; Daly MJ, 1997, GENE, V187, P225, DOI 10.1016/S0378-1119(96)00755-X; DALY MJ, 1995, SCIENCE, V270, P1318, DOI 10.1126/science.270.5240.1318; Daly MJ, 2000, CURR OPIN BIOTECH, V11, P280, DOI 10.1016/S0958-1669(00)00096-3; DALY MJ, 1994, J BACTERIOL, V176, P3508, DOI 10.1128/JB.176.12.3508-3517.1994; DALY MJ, 1994, J BACTERIOL, V176, P7506, DOI 10.1128/JB.176.24.7506-7515.1994; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Detter JC, 2002, GENOMICS, V80, P691, DOI 10.1006/geno.2002.7020; Du J, 2004, INT J BIOCHEM CELL B, V36, P2334, DOI 10.1016/j.biocel.2004.05.012; Earl AM, 2002, J BACTERIOL, V184, P6216, DOI 10.1128/JB.184.22.6216-6224.2002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 2000, GENOME BIOL, V1; Eltsov M, 2005, J BACTERIOL, V187, P8047, DOI 10.1128/JB.187.23.8047-8054.2005; ELTSOV M, 2006, J BACTERIOL, V188, P6059; Eltsov M, 2006, J BACTERIOL, V188, P6053, DOI 10.1128/JB.00230-06; Englander J, 2004, J BACTERIOL, V186, P5973, DOI 10.1128/jb.186.18.5973-5977.2004; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Ferreira AC, 1997, INT J SYST BACTERIOL, V47, P939, DOI 10.1099/00207713-47-4-939; Fisher DI, 2006, ARCH MICROBIOL, V186, P415, DOI 10.1007/s00203-006-0155-z; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Frankenberg N, 2003, APPL MICROBIOL BIOT, V63, P115, DOI 10.1007/s00253-003-1432-2; Fredrickson JK, 2000, APPL ENVIRON MICROB, V66, P2006, DOI 10.1128/AEM.66.5.2006-2011.2000; Funayama T, 1999, MUTAT RES-DNA REPAIR, V435, P151, DOI 10.1016/S0921-8777(99)00044-0; Gacesa P, 1998, MICROBIOL-SGM, V144, P1133, DOI 10.1099/00221287-144-5-1133; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Gao GJ, 2006, FEMS MICROBIOL LETT, V257, P195, DOI 10.1111/j.1574-6968.2006.00169.x; Gao GJ, 2007, SCI CHINA SER C, V50, P525, DOI 10.1007/s11427-007-0061-x; Gerard E, 2001, MOL GENET GENOMICS, V266, P72, DOI 10.1007/s004380100520; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerischer U, 2002, J MOL MICROB BIOTECH, V4, P111; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; Gury J, 2004, APPL ENVIRON MICROB, V70, P2146, DOI 10.1128/AEM.70.4.2146-2153.2004; GUTMAN PD, 1994, GENE, V141, P31, DOI 10.1016/0378-1119(94)90124-4; GUTMAN PD, 1991, MUTAT RES, V254, P207, DOI 10.1016/0921-8777(91)90058-W; GUTMAN PD, 1993, J BACTERIOL, V175, P3581, DOI 10.1128/jb.175.11.3581-3590.1993; GUTMAN PD, 1994, MUTAT RES, V314, P87, DOI 10.1016/0921-8777(94)90064-7; HARBORNE NR, 1992, MOL MICROBIOL, V6, P2805, DOI 10.1111/j.1365-2958.1992.tb01460.x; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; Heinz K, 2007, J BIOL CHEM, V282, P10908, DOI 10.1074/jbc.M611404200; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; Hobman JL, 2005, BIOMETALS, V18, P429, DOI 10.1007/s10534-005-3717-7; Holland AD, 2006, APPL MICROBIOL BIOT, V72, P1074, DOI 10.1007/s00253-006-0399-1; Hou B, 2007, J RADIAT RES, V48, P57, DOI 10.1269/jrr.06067; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Huang Li-fen, 2006, Weishengwu Xuebao, V46, P205; Huang LF, 2007, DNA REPAIR, V6, P167, DOI 10.1016/j.dnarep.2006.09.006; Huillet E, 2006, FEMS MICROBIOL LETT, V254, P87, DOI 10.1111/j.1574-6968.2005.00014.x; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; JOBLING MG, 1988, GENE, V66, P245, DOI 10.1016/0378-1119(88)90361-7; Junemann S, 1997, BBA-BIOENERGETICS, V1321, P107, DOI 10.1016/S0005-2728(97)00046-7; Kannan K, 1998, FEMS MICROBIOL LETT, V161, P7, DOI 10.1016/S0378-1097(98)00043-3; Kemner KM, 2004, SCIENCE, V306, P686, DOI 10.1126/science.1103524; Kim JI, 2002, J BACTERIOL, V184, P1649, DOI 10.1128/JB.184.6.1649-1660.2002; Kimura H, 2003, APPL ENVIRON MICROB, V69, P644, DOI 10.1128/AEM.69.1.644-648.2003; Kitajima S, 1999, J BIOCHEM, V125, P1, DOI 10.1093/oxfordjournals.jbchem.a022244; Kitayama S, 1997, MUTAT RES-DNA REPAIR, V385, P151, DOI 10.1016/S0921-8777(97)00048-7; Kitayama S, 2000, MUTAT RES-DNA REPAIR, V461, P179, DOI 10.1016/S0921-8777(00)00044-6; Knofel T, 1999, NAT STRUCT BIOL, V6, P448; Kobayashi I, 2006, J BIOSCI BIOENG, V101, P315, DOI 10.1263/jbb.101.315; Kobayashi Yasuhiko, 2004, Biol Sci Space, V18, P134; Kolari M, 2003, J IND MICROBIOL BIOT, V30, P225, DOI 10.1007/s10295-003-0047-z; KOONIN EV, 2007, MOL SYST BI IN PRESS; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LABIE C, 1989, J BACTERIOL, V171, P4315, DOI 10.1128/JB.171.8.4315-4319.1989; Lai WA, 2006, INT J SYST EVOL MICR, V56, P787, DOI 10.1099/ijs.0.64007-0; Lecointe F, 2004, MOL MICROBIOL, V53, P1721, DOI 10.1111/j.1365-2958.2004.04233.x; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; Lin JY, 1999, SCIENCE, V285, P1558, DOI 10.1126/science.285.5433.1558; Lipton MS, 2002, P NATL ACAD SCI USA, V99, P11049, DOI 10.1073/pnas.172170199; LITTLE JW, 1981, P NATL ACAD SCI-BIOL, V78, P4199, DOI 10.1073/pnas.78.7.4199; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2000, GENETICA, V108, P25, DOI 10.1023/A:1004035424657; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; Makarova KS, 1999, GENOME RES, V9, P608; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Makarova KS, 1999, RES MICROBIOL, V150, P711, DOI 10.1016/S0923-2508(99)00121-7; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Markillie LM, 1999, J BACTERIOL, V181, P666, DOI 10.1128/JB.181.2.666-669.1999; Marteinsson VT, 2001, APPL ENVIRON MICROB, V67, P4242, DOI 10.1128/AEM.67.9.4242-4248.2001; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; Minton KW, 1996, MUTAT RES-DNA REPAIR, V363, P1, DOI 10.1016/0921-8777(95)00014-3; Mironov A. A., 2000, Molekulyarnaya Biologiya (Moscow), V34, P253; Mironov AA, 1999, NUCLEIC ACIDS RES, V27, P2981, DOI 10.1093/nar/27.14.2981; Miura S, 2000, APPL ENVIRON MICROB, V66, P4883, DOI 10.1128/AEM.66.11.4883-4889.2000; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; MOSELEY BEB, 1971, J BACTERIOL, V105, P976, DOI 10.1128/JB.105.3.976-983.1971; Nakamura K, 2003, FEBS LETT, V553, P239, DOI 10.1016/S0014-5793(03)01000-7; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Narumi I, 2001, J BACTERIOL, V183, P6951, DOI 10.1128/JB.183.23.6951-6956.2001; Narumi I, 1999, MUTAT RES-DNA REPAIR, V435, P233, DOI 10.1016/S0921-8777(99)00048-8; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Omelchenko MV, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-57; Pavlov AK, 2006, ASTROBIOLOGY, V6, P911, DOI 10.1089/ast.2006.6.911; Pennella MA, 2005, BIOMETALS, V18, P413, DOI 10.1007/s10534-005-3716-8; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Qiu XY, 2006, J BACTERIOL, V188, P1199, DOI 10.1128/JB.188.3.1199-1204.2006; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Saarimaa C, 2006, J BACTERIOL, V188, P7016, DOI 10.1128/JB.00608-06; Sandrini MPB, 2006, NUCLEOS NUCLEOT NUCL, V25, P1153, DOI 10.1080/15257770600894469; Satoh K, 2006, MICROBIOL-SGM, V152, P3217, DOI 10.1099/mic.0.29139-0; Schlesinger DJ, 2007, FEMS MICROBIOL LETT, V274, P342, DOI 10.1111/j.1574-6968.2007.00862.x; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SETLOW JK, 1964, BIOCHIM BIOPHYS ACTA, V87, P664, DOI 10.1016/0926-6550(64)90284-1; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; Sheng DH, 2004, J BIOCHEM, V136, P787, DOI 10.1093/jb/mvh188; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Sorensen KI, 1996, J BACTERIOL, V178, P1003, DOI 10.1128/jb.178.4.1003-1011.1996; STERN S, 2007, MOL SYST BI IN PRESS; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Touati E, 1996, MUTAT RES-FUND MOL M, V349, P193, DOI 10.1016/0027-5107(95)00178-6; UDUPA KS, 1994, J BACTERIOL, V176, P7439, DOI 10.1128/JB.176.24.7439-7446.1994; Vaisanen OM, 1998, J APPL MICROBIOL, V84, P1069; Venkateswaran A, 2000, APPL ENVIRON MICROB, V66, P2620, DOI 10.1128/AEM.66.6.2620-2626.2000; Von Sonntag C, 1987, CHEM BASIS RAD BIOL; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8; Wright EG, 2006, MUTAT RES-FUND MOL M, V597, P119, DOI 10.1016/j.mrfmmm.2005.03.035; Xi HL, 2000, J BACTERIOL, V182, P5332, DOI 10.1128/JB.182.19.5332-5341.2000; YASBIN RE, 1991, RES MICROBIOL, V142, P885, DOI 10.1016/0923-2508(91)90069-M; Yokoyama K, 2006, FEMS MICROBIOL REV, V30, P89, DOI 10.1111/j.1574-6976.2005.00005.x; Yun EJ, 2000, FEMS MICROBIOL LETT, V184, P155; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zhang YM, 2003, MOL MICROBIOL, V48, P1317, DOI 10.1046/j.1365-2958.2003.03486.x; Zimmerman JM, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-17; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	171	174	182	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e955	10.1371/journal.pone.0000955	http://dx.doi.org/10.1371/journal.pone.0000955			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895995	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455800033
J	Girao, LC; Lopes, AV; Tabarelli, M; Bruna, EM				Girao, Luciana Coe; Lopes, Ariadna Valentina; Tabarelli, Marcelo; Bruna, Emilio M.			Changes in Tree Reproductive Traits Reduce Functional Diversity in a Fragmented Atlantic Forest Landscape	PLOS ONE			English	Article							RAIN-FOREST; HABITAT FRAGMENTATION; SEED DISPERSAL; POLLINATION; COMMUNITY; PATTERNS; EDGE; CONSERVATION; BIODIVERSITY; RECRUITMENT	Functional diversity has been postulated to be critical for the maintenance of ecosystem functioning, but the way it can be disrupted by human-related disturbances remains poorly investigated. Here we test the hypothesis that habitat fragmentation changes the relative contribution of tree species within categories of reproductive traits (frequency of traits) and reduces the functional diversity of tree assemblages. The study was carried out in an old and severely fragmented landscape of the Brazilian Atlantic forest. We used published information and field observations to obtain the frequency of tree species and individuals within 50 categories of reproductive traits (distributed in four major classes: pollination systems, floral biology, sexual systems, and reproductive systems) in 10 fragments and 10 tracts of forest interior (control plots). As hypothesized, populations in fragments and control plots differed substantially in the representation of the four major classes of reproductive traits (more than 50% of the categories investigated). The most conspicuous differences were the lack of three pollination systems in fragments-pollination by birds, flies and non-flying mammals-and that fragments had a higher frequency of both species and individuals pollinated by generalist vectors. Hermaphroditic species predominate in both habitats, although their relative abundances were higher in fragments. On the contrary, self-incompatible species were underrepresented in fragments. Moreover, fragments showed lower functional diversity (H' scores) for pollination systems (-30.3%), floral types (-23.6%), and floral sizes (-20.8%) in comparison to control plots. In contrast to the overwhelming effect of fragmentation, patch and landscape metrics such as patch size and forest cover played a minor role on the frequency of traits. Our results suggest that habitat fragmentation promotes a marked shift in the relative abundance of tree reproductive traits and greatly reduces the functional diversity of tree assemblages in fragmented landscapes.	[Girao, Luciana Coe] Univ Fed Pernambuco, Dept Bot, Programa Posgrad Biol Vegetal, Recife, PE, Brazil; [Bruna, Emilio M.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA	Universidade Federal de Pernambuco; State University System of Florida; University of Florida	Lopes, AV (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA.	avflopes@ufpe.br	Bruna, Emilio M/H-2769-2012; Lopes, Ariadna V/E-8432-2010; Tabarelli, Marcelo/F-1088-2010	Bruna, Emilio M/0000-0003-3381-8477; Lopes, Ariadna V/0000-0001-5750-5913; Tabarelli, Marcelo/0000-0001-7573-7216	CAPES; CNPq; Fundacao O Boticario de Protecao a Natureza; Conservation International-Brazil	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao O Boticario de Protecao a Natureza; Conservation International-Brazil	Financial support was provided by CAPES (a Master's Thesis scholarship to L. Girao and a Research Grant to A. Lopes), CNPq ( Research Grants to A. Lopes and M. Tabarelli; and Research Funding via "Edital Universal''), Fundacao O Boticario de Protecao a Natureza, and Conservation International-Brazil.	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; AIZEN MA, 1994, ECOLOGY, V75, P330, DOI 10.2307/1939538; [Anonymous], 2004, MATA ATLANTICA ARVOR; BAWA KS, 1985, AM J BOT, V72, P346, DOI 10.2307/2443527; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; Bruna EM, 2002, CONSERV BIOL, V16, P1256, DOI 10.1046/j.1523-1739.2002.99494.x; Buchmann SL, 1996, FORGOTTEN POLLINATOR; Chambers JQ, 1998, NATURE, V391, P135, DOI 10.1038/34325; Chazdon RL, 2003, ECOL MONOGR, V73, P331, DOI 10.1890/02-4037; Chiarello AG, 1999, BIOL CONSERV, V89, P71, DOI 10.1016/S0006-3207(98)00130-X; Clark DB, 1998, J ECOL, V86, P101, DOI 10.1046/j.1365-2745.1998.00238.x; Clarke K.R., 2001, PRIMER V5 PLYMOUTH R, P91; COIMBRA F, 1996, LIMITES ORIGINAIS BI; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Cordeiro NJ, 2001, CONSERV BIOL, V15, P1733, DOI 10.1046/j.1523-1739.2001.99579.x; COSTA JBP, 2007, THESIS U FEDERAL PER; de Melo FPL, 2006, BIOL CONSERV, V132, P50, DOI 10.1016/j.biocon.2006.03.015; Endress P. K., 1994, DIVERSITY EVOLUTIONA; FAEGRI K, 1979, P244; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Galetti M, 2006, BOT J LINN SOC, V151, P141, DOI 10.1111/j.1095-8339.2006.00529.x; Galindo-Leal C., 2005, MATA ATLANTICA BIOD, P3; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Gorresen PM, 2004, J MAMMAL, V85, P688, DOI 10.1644/BWG-125; Grillo A, 2006, DIVERSIDADE BIOL CON, P191; GRILLO AS, 2005, THESIS U FEDERAL PER; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Harris L. Fabienne, 2004, International Journal of Tropical Insect Science, V24, P29; Hobbs RJ, 2003, AUST J BOT, V51, P471, DOI 10.1071/BT03037; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; IBGE, 1985, ATL NAC BRAS REG NOR; Jones MM, 2006, J ECOL, V94, P181, DOI 10.1111/j.1365-2745.2005.01071.x; Kang H, 2003, AM J BOT, V90, P865, DOI 10.3732/ajb.90.6.865; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kevan PG, 1999, AGR ECOSYST ENVIRON, V74, P373, DOI 10.1016/S0167-8809(99)00044-4; Krebs C.J., 1989, ECOLOGICAL METODOLOG; Laurance W. F., 2001, LESSONS AMAZONIA ECO, P158; Laurance WF, 1998, CONSERV BIOL, V12, P460, DOI 10.1046/j.1523-1739.1998.97175.x; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; LAURANCE WF, 2006, EMERGING THREATS TRO; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; LOPES AV, 2006, DIVERSIDADE BIOL CON, P229; Melo FPL, 2007, ECOSCIENCE, V14, P124, DOI 10.2980/1195-6860(2007)14[124:EOLSFT]2.0.CO;2; Lorenzi H., 2002, ARVORES BRASILEIRAS, V1; Lorenzi H, 2002, ARVORES BRASILEIRAS, V2; Machado IC, 2004, ANN BOT-LONDON, V94, P365, DOI 10.1093/aob/mch152; MACHADO IC, 2002, DIAGNOSTICO BIODIVER, P583; Mason NWH, 2003, J VEG SCI, V14, P571, DOI 10.1111/j.1654-1103.2003.tb02184.x; Mayfield MM, 2005, ECOLOGY, V86, P2365, DOI 10.1890/05-0141; McCune B., 1999, MULTIVARIATE ANAL EC; Metzger JP, 2000, ECOL APPL, V10, P1147, DOI 10.1890/1051-0761(2000)010[1147:TFGRAL]2.0.CO;2; Michalski F, 2007, BIOTROPICA, V39, P691, DOI 10.1111/j.1744-7429.2007.00318.x; Murcia Carolina, 1996, P19; Oliveira MA, 2004, ORYX, V38, P389, DOI 10.1017/S0030605304000754; Oliveira PE, 2000, FLORA, V195, P311; Petchey OL, 2002, P ROY SOC B-BIOL SCI, V269, P1721, DOI 10.1098/rspb.2002.2073; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Pimentel DS, 2004, BIOTROPICA, V36, P74, DOI 10.1111/j.1744-7429.2004.tb00298.x; PORTO K, 2006, DIVERSIDADE BIOL CON; Prance G.T., 1982, BIOL DIVERSIFICATION, P137; Prieur-Richard AH, 2000, AUSTRAL ECOL, V25, P1; PRIMERS for Windows, 2001, PRIMER 5 WINDOWS; Proctor M., 1996, NATURAL HIST POLLINA; Ranta P, 1998, BIODIVERS CONSERV, V7, P385, DOI 10.1023/A:1008885813543; RATHCKE BJ, 1993, CURR SCI INDIA, V65, P273; Renner S.S., 1998, P339; Ribeiro J.E.L. da S., 1999, FLORA RESERVA DUCKE; Richards A. J., 1997; RICHARDS P. W., 1952, The tropical rain forest. An ecological study.; Ricotta C, 2005, BASIC APPL ECOL, V6, P479, DOI 10.1016/j.baae.2005.02.008; SANETO RJ, 2003, THESIS U FEDERAL PER, P29; SILVA JMC, 2000, NATURE, V404, P72, DOI DOI 10.1038/35003563; Sokal R.R., 2012, BIOMETRY; Tabarelli M, 1999, BIOL CONSERV, V91, P119, DOI 10.1016/S0006-3207(99)00085-3; Tabarelli M, 2004, BIODIVERS CONSERV, V13, P1419, DOI 10.1023/B:BIOC.0000019398.36045.1b; Tabarelli M, 2002, BIOL CONSERV, V106, P165, DOI 10.1016/S0006-3207(01)00243-9; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; The Angiosperm Phylogeny Group II, 2003, BOT J LINN SOC, V141, P399, DOI [DOI 10.1046/J.1095-8339.2003.T01-1-00158.X, 10.1046/j.1095-8339.2003.t01-1-00158.x]; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Turner I.M., 2001, CAM TROP B, DOI 10.1017/CBO9780511542206; Vamosi JC, 2006, P NATL ACAD SCI USA, V103, P956, DOI 10.1073/pnas.0507165103; Veloso H. M. P., 1991, CLASSIFICACAO VEGETA; Whitmore T.C, 1990, INTRO TROPICAL RAIN; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6; Wilkinson L, 1996, SYSTAT VERSION 6 0; WIRTH R, 2007, PROGR BOT, V69, P423	90	127	132	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e908	10.1371/journal.pone.0000908	http://dx.doi.org/10.1371/journal.pone.0000908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878943	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455700016
J	Weng, ZM; Barthelson, R; Gowda, S; Hilf, ME; Dawson, WO; Galbraith, DW; Xiong, ZG				Weng, Ziming; Barthelson, Roger; Gowda, Siddarame; Hilf, Mark E.; Dawson, William O.; Galbraith, David W.; Xiong, Zhongguo			Persistent Infection and Promiscuous Recombination of Multiple Genotypes of an RNA Virus within a Single Host Generate Extensive Diversity	PLOS ONE			English	Article								Recombination and reassortment of viral genomes are major processes contributing to the creation of new, emerging viruses. These processes are especially significant in long-term persistent infections where multiple viral genotypes co-replicate in a single host, generating abundant genotypic variants, some of which may possess novel host-colonizing and pathogenicity traits. In some plants, successive vegetative propagation of infected tissues and introduction of new genotypes of a virus by vector transmission allows for viral populations to increase in complexity for hundreds of years allowing co-replication and subsequent recombination of the multiple viral genotypes. Using a resequencing microarray, we examined a persistent infection by a Citrus tristeza virus (CTV) complex in citrus, a vegetatively propagated, globally important fruit crop, and found that the complex comprised three major and a number of minor genotypes. Subsequent deep sequencing analysis of the viral population confirmed the presence of the three major CTV genotypes and, in addition, revealed that the minor genotypes consisted of an extraordinarily large number of genetic variants generated by promiscuous recombination between the major genotypes. Further analysis provided evidence that some of the recombinants underwent subsequent divergence, further increasing the genotypic complexity. These data demonstrate that persistent infection of multiple viral genotypes within a host organism is sufficient to drive the large-scale production of viral genetic variants that may evolve into new and emerging viruses.	[Weng, Ziming; Barthelson, Roger; Galbraith, David W.; Xiong, Zhongguo] Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; [Gowda, Siddarame; Dawson, William O.] Univ Florida, Ctr Citrus Res & Educ, Lake Alfred, FL USA; [Hilf, Mark E.] ARS, USDA, US Hort Res Lab, Ft Pierce, FL USA	University of Arizona; State University System of Florida; University of Florida; United States Department of Agriculture (USDA)	Xiong, ZG (corresponding author), Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA.	zxiong@email.arizona.edu	Galbraith, David/AAG-8891-2021	Xiong, Zhongguo/0000-0002-2999-0840	USDA [2003-34399-13764, 2005-34399-16070]	USDA(United States Department of Agriculture (USDA))	This work was supported by funding from USDA grants 2003-34399-13764 and 2005-34399-16070 to ZX and DWG.	Albiach-Marti MR, 2000, J VIROL, V74, P6856, DOI 10.1128/JVI.74.15.6856-6865.2000; BARJOSEPH M, 1989, ANNU REV PHYTOPATHOL, V27, P291, DOI 10.1146/annurev.py.27.090189.001451; Chare ER, 2006, ARCH VIROL, V151, P933, DOI 10.1007/s00705-005-0675-x; Cheng CP, 2005, VIROLOGY, V341, P107, DOI 10.1016/j.virol.2005.06.042; Cheng CP, 2003, J VIROL, V77, P12033, DOI 10.1128/JVI.77.22.12033-12047.2003; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Dzianott A, 2001, VIROLOGY, V289, P137, DOI 10.1006/viro.2001.1118; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gibbs MJ, 1999, P NATL ACAD SCI USA, V96, P8022, DOI 10.1073/pnas.96.14.8022; Gibbs MJ, 2001, SCIENCE, V293, P1842, DOI 10.1126/science.1061662; Gowda S, 2000, VIROLOGY, V274, P246, DOI 10.1006/viro.2000.0413; Hilf ME, 2005, PHYTOPATHOLOGY, V95, P909, DOI 10.1094/PHYTO-95-0909; HILF ME, 1995, VIROLOGY, V208, P576, DOI 10.1006/viro.1995.1188; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; KARASEV AV, 1995, VIROLOGY, V208, P511, DOI 10.1006/viro.1995.1182; Karasev AV, 1997, J VIROL, V71, P6233, DOI 10.1128/JVI.71.8.6233-6236.1997; Karasev AV, 2000, ANNU REV PHYTOPATHOL, V38, P293, DOI 10.1146/annurev.phyto.38.1.293; Kim MJ, 2001, P NATL ACAD SCI USA, V98, P4972, DOI 10.1073/pnas.081077198; Kong P, 2000, VIRUS GENES, V21, P139, DOI 10.1023/A:1008198311398; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Lin BC, 2007, J CLIN MICROBIOL, V45, P443, DOI 10.1128/JCM.01870-06; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Lopez C, 1998, PHYTOPATHOLOGY, V88, P685, DOI 10.1094/PHYTO.1998.88.7.685; Lu R, 2004, P NATL ACAD SCI USA, V101, P15742, DOI 10.1073/pnas.0404940101; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Mawassi M, 1996, J GEN VIROL, V77, P2359, DOI 10.1099/0022-1317-77-9-2359; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pernas M, 2006, JAIDS-J ACQ IMM DEF, V42, P12, DOI 10.1097/01.qai.0000214810.65292.73; ROCHAPENA MA, 1995, PLANT DIS, V79, P437, DOI 10.1094/PD-79-0437; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roy A, 2004, ARCH VIROL, V149, P1911, DOI 10.1007/s00705-004-0355-2; Rubio L, 2001, J VIROL, V75, P8054, DOI 10.1128/JVI.75.17.8054-8062.2001; Ruiz-Ruiz S, 2006, ARCH VIROL, V151, P387, DOI 10.1007/s00705-005-0618-6; Satyanarayana T, 2004, P NATL ACAD SCI USA, V101, P799, DOI 10.1073/pnas.0307747100; Satyanarayana T, 2002, J VIROL, V76, P473, DOI 10.1128/JVI.76.2.473-483.2002; Satyanarayana T, 1999, P NATL ACAD SCI USA, V96, P7433, DOI 10.1073/pnas.96.13.7433; Shapka N, 2004, J VIROL, V78, P2288, DOI 10.1128/JVI.78.5.2288-2300.2004; Sulaiman IM, 2007, J CLIN MICROBIOL, V45, P358, DOI 10.1128/JCM.01848-06; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vives MC, 2005, VIROLOGY, V331, P232, DOI 10.1016/j.virol.2004.10.037; Vives MC, 1999, J GEN VIROL, V80, P811, DOI 10.1099/0022-1317-80-3-811; Wang Z, 2006, EMERG INFECT DIS, V12, P638, DOI 10.3201/eid1204.051441; Wong CW, 2004, GENOME RES, V14, P398, DOI 10.1101/gr.2141004; XIONG Z, 2006, P INT ORG CITRUS VIR, V16, P11; Yang GA, 1999, VIRUS GENES, V19, P5, DOI 10.1023/A:1008105004407; Yang ZN, 1999, VIRUS GENES, V19, P131, DOI 10.1023/A:1008127224147; Yu W, 2006, BIOTECHNIQUES, V40, P499, DOI 10.2144/000112124; Zwick ME, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r10	49	46	51	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e917	10.1371/journal.pone.0000917	http://dx.doi.org/10.1371/journal.pone.0000917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878952	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455700025
J	Ciarrocchi, A; Jankovic, V; Shaked, Y; Nolan, DJ; Mittal, V; Kerbel, RS; Nimer, SD; Benezra, R				Ciarrocchi, Alessia; Jankovic, Vladimir; Shaked, Yuval; Nolan, Daniel J.; Mittal, Vivek; Kerbel, Robert S.; Nimer, Stephen D.; Benezra, Robert			Id1 Restrains p21 Expression to Control Endothelial Progenitor Cell Formation	PLOS ONE			English	Article								Loss of Id1 in the bone marrow (BM) severely impairs tumor angiogenesis resulting in significant inhibition of tumor growth. This phenotype has been associated with the absence of circulating endothelial progenitor cells (EPCs) in the peripheral blood of Id1 mutant mice. However, the manner in which Id1 loss in the BM controls EPC generation or mobilization is largely unknown. Using genetically modified mouse models we demonstrate here that the generation of EPCs in the BM depends on the ability of Id1 to restrain the expression of its target gene p21. Through a series of cellular and functional studies we show that the increased myeloid commitment of BM stem cells and the absence of EPCs in Id1 knockout mice are associated with elevated p21 expression. Genetic ablation of p21 rescues the EPC population in the Id1 null animals, re-establishing functional BM-derived angiogenesis and restoring normal tumor growth. These results demonstrate that the restraint of p21 expression by Id1 is one key element of its activity in facilitating the generation of EPCs in the BM and highlight the critical role these cells play in tumor angiogenesis.	[Jankovic, Vladimir; Nimer, Stephen D.] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10021 USA; [Ciarrocchi, Alessia; Benezra, Robert] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA; [Shaked, Yuval; Kerbel, Robert S.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Nolan, Daniel J.; Mittal, Vivek] Cold Spring Harbor Lab, Canc Genome Res Ctr, Woodbury, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Cold Spring Harbor Laboratory	Nimer, SD (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, 1275 York Ave, New York, NY 10021 USA.	nimers@mskcc.org; r-benezra@ski.mskcc.org	Ciarrocchi, Alessia/AAA-1130-2019	Ciarrocchi, Alessia/0000-0002-5541-2075	National Institute of Health; Breast Cancer Research Foundation (RB); Leukemia Lymphoma Society (SDN); American-Italian Cancer Foundation	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation (RB); Leukemia Lymphoma Society (SDN)(Leukemia and Lymphoma Society); American-Italian Cancer Foundation	This work was supported by grants from National Institute of Health to RB and SDN, by the Breast Cancer Research Foundation (RB) and by the Leukemia Lymphoma Society (SDN). AC was supported by a postdoctoral fellowship from the American-Italian Cancer Foundation.	Bailey AS, 2004, BLOOD, V103, P13, DOI 10.1182/blood-2003-05-1684; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bertolini F, 2003, CANCER RES, V63, P4342; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Braun SE, 1998, BLOOD CELL MOL DIS, V24, P138, DOI 10.1006/bcmd.1998.0181; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Coukos G, 2005, BRIT J CANCER, V92, P1182, DOI 10.1038/sj.bjc.6602476; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Dong Y, 2004, CELL SIGNAL, V16, P263, DOI 10.1016/S0898-6568(03)00136-0; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; HIRSCH S, 1983, IMMUNOGENETICS, V18, P229, DOI 10.1007/BF00952962; Jaggi JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000267; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Yaroslavskiy B, 1999, BLOOD, V93, P2907; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	43	65	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1338	10.1371/journal.pone.0001338	http://dx.doi.org/10.1371/journal.pone.0001338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18092003	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000207459600021
J	Dubois, V; Debreyer, C; Litvak, S; Quentin, C; Parissi, V				Dubois, Veronique; Debreyer, Carole; Litvak, Simon; Quentin, Claudine; Parissi, Vincent			A New In Vitro Strand Transfer Assay for Monitoring Bacterial Class 1 Integron Recombinase Intl1 Activity	PLOS ONE			English	Article								Intl1 integrase is a tyrosine recombinase involved in the mobility of antibiotic resistance gene cassettes within bacterial class 1 integrons. Recent data have shown that its recombination specifically involves the bottom strand of the attC site, but the exact mechanism of the reaction is still unclear. An efficient in vitro assay is still required to better characterize the biochemical properties of the enzyme. In this report we describe for the first time an in vitro system partially reproducing the activity of a recombinant pure Intl1. This new assay, which constitutes the only available in vitro model of recombination by Intl1, was used to determine whether this enzyme might be the sole bacterial protein required for the recombination process. Results show that Intl1 possesses all the features needed for performing recombination between attl and attC sites. However, differences in the in vitro intermolecular recombination efficiencies were found according to the target sites and were correlated with DNA affinities of the enzyme but not with in vivo data. The differential affinity of the enzyme for each site, its capacity to bind to a single-stranded structure at the attC site and the recombination observed with single-stranded substrates unambiguously confirm that it constitutes an important intermediary in the reaction. Our data strongly suggest that the enzyme possesses all the functions for generating and/or recognizing this structure even in the absence of other cellular factors. Furthermore, the in vitro assay reported here constitutes a powerful tool for the analysis of the recombination steps catalyzed by Intl1, its structure-function studies and the search for specific inhibitors.	[Dubois, Veronique; Debreyer, Carole; Litvak, Simon; Quentin, Claudine; Parissi, Vincent] Univ Bordeaux 2, Lab Cellular & Mol Microbiol & Pathogen, CNRS, UMR 5097, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Parissi, V (corresponding author), Univ Bordeaux 2, Lab Cellular & Mol Microbiol & Pathogen, CNRS, UMR 5097, F-33076 Bordeaux, France.	vincent.parissi@reger.u-bordeaux2.fr	QUENTIN, Claudine/A-9701-2012; Dubois, Veronique/F-9378-2011		CNRS; University of Bordeaux 2	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Bordeaux 2	This work was supported by the CNRS and the University of Bordeaux 2.	BABINEAU D, 1985, J BIOL CHEM, V260, P2313; BALL CA, 1991, J BACTERIOL, V173, P4027, DOI 10.1128/jb.173.13.4027-4031.1991; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; Bouvier M, 2005, EMBO J, V24, P4356, DOI 10.1038/sj.emboj.7600898; Collis CM, 1998, MOL MICROBIOL, V29, P477, DOI 10.1046/j.1365-2958.1998.00936.x; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; Collis CM, 2002, MOL MICROBIOL, V46, P1415, DOI 10.1046/j.1365-2958.2002.03260.x; Collis CM, 2001, J BACTERIOL, V183, P2535, DOI 10.1128/JB.183.8.2535-2542.2001; Dubois W, 2002, ANTIMICROB AGENTS CH, V46, P638, DOI 10.1128/AAC.46.3.638-645.2002; FRANCIA MV, 1993, MOL MICROBIOL, V10, P823, DOI 10.1111/j.1365-2958.1993.tb00952.x; Francia MV, 1999, J BACTERIOL, V181, P6844, DOI 10.1128/JB.181.21.6844-6849.1999; Grainge I, 1999, MOL MICROBIOL, V33, P449, DOI 10.1046/j.1365-2958.1999.01493.x; Gravel A, 1998, J BACTERIOL, V180, P5437, DOI 10.1128/JB.180.20.5437-5442.1998; Gravel A, 1998, NUCLEIC ACIDS RES, V26, P4347, DOI 10.1093/nar/26.19.4347; GRONOSTAJSKI RM, 1985, J BIOL CHEM, V260, P2328; HALL RM, 1991, MOL MICROBIOL, V5, P1941, DOI 10.1111/j.1365-2958.1991.tb00817.x; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; HALL RM, 1999, ANN N Y ACAD SCI, V870; Hansson K, 1997, MOL MICROBIOL, V26, P441, DOI 10.1046/j.1365-2958.1997.5401964.x; Jahnz M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni060; Johansson C, 2004, NUCLEIC ACIDS RES, V32, P4033, DOI 10.1093/nar/gkh730; Klemm M, 2000, J MOL BIOL, V299, P1203, DOI 10.1006/jmbi.2000.3829; MacDonald D, 2006, NATURE, V440, P1157, DOI 10.1038/nature04643; Partridge SR, 2000, MICROBIOL-UK, V146, P2855, DOI 10.1099/00221287-146-11-2855; RECCHIA GD, 1994, NUCLEIC ACIDS RES, V22, P2071, DOI 10.1093/nar/22.11.2071; Ringrose L, 1998, J MOL BIOL, V284, P363, DOI 10.1006/jmbi.1998.2149; Segall AM, 1998, J BIOL CHEM, V273, P24258, DOI 10.1074/jbc.273.37.24258; Stokes HW, 1997, MOL MICROBIOL, V26, P731, DOI 10.1046/j.1365-2958.1997.6091980.x	28	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1315	10.1371/journal.pone.0001315	http://dx.doi.org/10.1371/journal.pone.0001315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091989	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459600003
J	Carmeli, C; Lopez-Aguado, L; Schmidt, KE; De Feo, O; Innocenti, GM				Carmeli, Cristian; Lopez-Aguado, Laura; Schmidt, Kerstin E.; De Feo, Oscar; Innocenti, Giorgio M.			A Novel Interhemispheric Interaction: Modulation of Neuronal Cooperativity in the Visual Areas	PLOS ONE			English	Article							STIMULUS-DEPENDENT CHANGES; CORPUS-CALLOSUM; EEG COHERENCE; SYNCHRONIZATION; CORTEX; CONNECTIONS; SPECIFICITY; RESPONSES	Background. The cortical representation of the visual field is split along the vertical midline, with the left and the right hemi-fields projecting to separate hemispheres. Connections between the visual areas of the two hemispheres are abundant near the representation of the visual midline. It was suggested that they re-establish the functional continuity of the visual field by controlling the dynamics of the responses in the two hemispheres. Methods/Principal Findings. To understand if and how the interactions between the two hemispheres participate in processing visual stimuli, the synchronization of responses to identical or different moving gratings in the two hemi-fields were studied in anesthetized ferrets. The responses were recorded by multiple electrodes in the primary visual areas and the synchronization of local field potentials across the electrodes were analyzed with a recent method derived from dynamical system theory. Inactivating the visual areas of one hemisphere modulated the synchronization of the stimulus-driven activity in the other hemisphere. The modulation was stimulus-specific and was consistent with the fine morphology of callosal axons in particular with the spatio-temporal pattern of activity that axonal geometry can generate. Conclusions/Significance. These findings describe a new kind of interaction between the cerebral hemispheres and highlight the role of axonal geometry in modulating aspects of cortical dynamics responsible for stimulus detection and/or categorization.	[Innocenti, Giorgio M.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Carmeli, Cristian; De Feo, Oscar] Swiss Fed Inst Technol Lausanne EPFL, Lab Nonlinear Syst LANOS, I&C Schools Comp & Commun Sci, CH-1015 Lausanne, Switzerland; [Lopez-Aguado, Laura] Univ Complutense Madrid, Dept Appl Math, Sch Opt, Madrid, Spain; [Schmidt, Kerstin E.] Max Planck Inst Brain Res, D-60496 Frankfurt, Germany; [De Feo, Oscar] Univ Coll Cork, Dept Microelect, Cork, Ireland	Karolinska Institutet; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Complutense University of Madrid; Max Planck Society; University College Cork	Innocenti, GM (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	giorgio.innocenti@ki.se		Carmeli, Cristian/0000-0002-1463-4587	European Community [IST-2001-34893]	European Community(European Commission)	Supported by European Community grant IST-2001-34893 ( APEREST).	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; BERBEL P, 1988, J COMP NEUROL, V276, P132, DOI 10.1002/cne.902760109; BERLUCCHI G, 1968, SCIENCE, V159, P308, DOI 10.1126/science.159.3812.308; Boccaletti S, 2002, PHYS REP, V366, P1, DOI 10.1016/S0370-1573(02)00137-0; Brown R, 2000, CHAOS, V10, P344, DOI 10.1063/1.166500; Carmeli C, 2005, NEUROIMAGE, V25, P339, DOI 10.1016/j.neuroimage.2004.11.049; DESIMONE R, 1993, VISUAL NEUROSCI, V10, P159, DOI 10.1017/S095252380000328X; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Innocenti GM, 2005, NAT REV NEUROSCI, V6, P955, DOI 10.1038/nrn1790; INNOCENTI GM, 1995, NEUROPSYCHOLOGIA, V33, P961, DOI 10.1016/0028-3932(95)00033-Y; INNOCENTI GM, 1994, EUR J NEUROSCI, V6, P918, DOI 10.1111/j.1460-9568.1994.tb00586.x; Innocenti GM., 1986, GEN ORG CALLOSAL CON, P291, DOI [10.1007/978-1-4613-2149-1_9, DOI 10.1007/978-1-4613-2149-1_9]; Kiper DC, 1999, J NEUROPHYSIOL, V82, P3082, DOI 10.1152/jn.1999.82.6.3082; Knyazeva MG, 1999, J NEUROPHYSIOL, V82, P3095, DOI 10.1152/jn.1999.82.6.3095; LAMANTIA AS, 1990, J COMP NEUROL, V291, P520, DOI 10.1002/cne.902910404; Li L, 2006, EXP BRAIN RES, V172, P397, DOI 10.1007/s00221-005-0337-y; Lomber SG, 1999, J NEUROSCI METH, V86, P179, DOI 10.1016/S0165-0270(98)00165-4; MAKAROV VA, 2007, CEREBRAL CO IN PRESS, P18; Manger PR, 2002, CEREB CORTEX, V12, P423, DOI 10.1093/cercor/12.4.423; MARZI CA, 1982, BEHAV BRAIN RES, V4, P155, DOI 10.1016/0166-4328(82)90070-5; Nowak LG, 1995, J NEUROPHYSIOL, V74, P2379, DOI 10.1152/jn.1995.74.6.2379; PAYNE BR, 1991, VISUAL NEUROSCI, V6, P283, DOI 10.1017/S0952523800006283; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Ptito D, 2002, IS CL CO NE, P139; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Schmidt KE, 1997, J NEUROSCI, V17, P5480; SPERRY R, 1982, SCIENCE, V217, P1223, DOI 10.1126/science.7112125; Strang G, 1988, LINEAR ALGEBRA ITS A; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Tettoni L, 1998, CEREB CORTEX, V8, P543, DOI 10.1093/cercor/8.6.543; WAXMAN SG, 1976, EXP NEUROL, V53, P115, DOI 10.1016/0014-4886(76)90287-9; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258	36	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1287	10.1371/journal.pone.0001287	http://dx.doi.org/10.1371/journal.pone.0001287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074012	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459500006
J	Lopez-Fernandez, H; Bolnick, DI				Lopez-Fernandez, Hernan; Bolnick, Daniel I.			What Causes Partial F1 Hybrid Viability? Incomplete Penetrance versus Genetic Variation	PLOS ONE			English	Article								Background. Interspecific hybrid crosses often produce offspring with reduced but non-zero survivorship. In this paper we ask why such partial inviability occurs. This partial inviability could arise from incomplete penetrance of lethal Dobzhansky-Muller incompatibilities (DMIs) shared by all members of a hybrid cross. Alternatively, siblings may differ with respect to the presence or number of DMIs, leading to genotype-dependent variation in viability and hence non-Mendelian segregation of parental alleles in surviving F1 hybrids. Methodology/Principal Findings. We used amplified fragment length polymorphisms (AFLPs) to test for segregation distortion in one hybrid cross between green and longear sunfish (Lepomis cyanellus and L. megalotis). Hybrids showed partial viability, and twice as much segregation distortion (36.8%) of AFLPs as an intraspecific control cross (18.8%). Incomplete penetrance of DMIs, which should cause genotype-independent mortality, is insufficient to explain the observed segregation distortion. Conclusions/Significance. We conclude that F1 hybrid sunfish are polymorphic for DMIs, either due to sex-linked DMI loci (causing Haldane's Rule), or polymorphic autosomal DMI loci. Because few AFLP markers were sex-linked (2%), the most parsimonious conclusion is that parents may have been heterozygous for loci causing hybrid inviability.	[Bolnick, Daniel I.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Lopez-Fernandez, Hernan] Texas A&M Univ, Dept Wildlife & Fisheries Sci, Sect Ecol Evolutionary Biol & Systemat, College Stn, TX 77843 USA	University of Texas System; University of Texas Austin; Texas A&M University System; Texas A&M University College Station	Bolnick, DI (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	danbolnick@mail.utexas.edu	Bolnick, Daniel I./G-4440-2015	Bolnick, Daniel I./0000-0003-3148-6296; Lopez-Fernandez, Hernan/0000-0003-0270-1671	The University of Texas at Austin; National Science Foundation [DEB 0516831]; Texas AM University	The University of Texas at Austin; National Science Foundation(National Science Foundation (NSF)); Texas AM University	The University of Texas at Austin funded DIB as assistant professor, HLF as a postdoctoral researcher at DIB's lab, and all experimental work. The National Science Foundation grant DEB 0516831 supported HLF as a postdoctoral researcher at Texas A&M University during the writing phase of this project.	Bailey R. M., 2004, MISCELLANEOUS PUBLIC, V192; Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Bolnick DI, 2006, EVOL ECOL RES, V8, P903; Bolnick DI, 2005, EVOLUTION, V59, P1754, DOI 10.1111/j.0014-3820.2005.tb01824.x; Bordenstein SR, 2000, EVOLUTION, V54, P567, DOI 10.1111/j.0014-3820.2000.tb00059.x; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Burton RS, 2006, AM NAT, V168, pS14, DOI 10.1086/509046; CHILDERS WILLIAM F., 1967, ILL NAT HIST SURV BULL, V29, P159; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; Coyne J.A., 1989, P180; Coyne J.A., 2004, SPECIATION; COYNE JA, 1989, EVOLUTION, V43, P362, DOI [10.2307/2409213, 10.1111/j.1558-5646.1989.tb04233.x]; Coyne JA, 1997, EVOLUTION, V51, P295, DOI [10.1111/j.1558-5646.1997.tb02412.x, 10.2307/2410984]; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Fishman L, 2001, GENETICS, V159, P1701; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Gadau J, 1999, GENETICS, V153, P1731; Garrity DM, 2002, DEVELOPMENT, V129, P4635; Gomelsky B, 2002, N AM J AQUACULT, V64, P66, DOI 10.1577/1548-8454(2002)064&lt;0066:HSRAEO&gt;2.0.CO;2; Hall MC, 2005, GENETICS, V170, P375, DOI 10.1534/genetics.104.038653; Harushima Y, 2001, GENETICS, V159, P883; HOLLINGSHEAD L, 1930, GENETICS, V15, P116; Jenczewski E, 1997, THEOR APPL GENET, V94, P682, DOI 10.1007/s001220050466; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Laurie CC, 1997, GENETICS, V147, P937; Lerceteau E, 1999, HEREDITY, V82, P252, DOI 10.1038/sj.hdy.6884720; Masly JP, 2007, PLOS BIOL, V5, P1890, DOI 10.1371/journal.pbio.0050243; Moyle LC, 2005, GENETICS, V169, P355, DOI 10.1534/genetics.104.029546; Myburg AA, 2004, GENETICS, V166, P1405, DOI 10.1534/genetics.166.3.1405; Near TJ, 2005, EVOLUTION, V59, P1768, DOI 10.1111/j.0014-3820.2005.tb01825.x; ORR HA, 1995, GENETICS, V139, P1805; Orr HA, 2001, EVOLUTION, V55, P1085; Orr HA, 2001, TRENDS ECOL EVOL, V16, P343; Orr HA, 1997, ANNU REV ECOL SYST, V28, P195, DOI 10.1146/annurev.ecolsys.28.1.195; PAABO S, 1990, J BIOL CHEM, V265, P4718; PARKER HR, 1985, J EXP ZOOL, V233, P451, DOI 10.1002/jez.1402330314; Patterson JT, 1952, EVOLUTION GENUS DROS, P610; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Presgraves DC, 2002, EVOLUTION, V56, P1168, DOI 10.1111/j.0014-3820.2002.tb01430.x; Price TD, 2002, EVOLUTION, V56, P2083; Reed LK, 2004, P NATL ACAD SCI USA, V101, P9009, DOI 10.1073/pnas.0403106101; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; ROBERTS FL, 1964, J MORPHOL, V115, P401, DOI 10.1002/jmor.1051150305; Sasa MM, 1998, EVOLUTION, V52, P1811, DOI 10.1111/j.1558-5646.1998.tb02258.x; Shuker DM, 2005, P ROY SOC B-BIOL SCI, V272, P2491, DOI 10.1098/rspb.2005.3242; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Ting CT, 2001, P NATL ACAD SCI USA, V98, P6709, DOI 10.1073/pnas.121418898; Turelli M, 2000, GENETICS, V154, P1663; Turelli M, 1997, GENETICS, V147, P1799; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wade MJ, 1997, GENETICS, V147, P1235; WADE MJ, 1994, GENETICS, V138, P791; WITTBRODT J, 1989, NATURE, V341, P415, DOI 10.1038/341415a0; Zar J.H., 1996, BIOSTAT ANAL	54	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1294	10.1371/journal.pone.0001294	http://dx.doi.org/10.1371/journal.pone.0001294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074018	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459500013
J	Sereno, PC; Wilson, JA; Witmer, LM; Whitlock, JA; Maga, A; Ide, O; Rowe, TA				Sereno, Paul C.; Wilson, Jeffrey A.; Witmer, Lawrence M.; Whitlock, John A.; Maga, Abdoulaye; Ide, Oumarou; Rowe, Timothy A.			Structural Extremes in a Cretaceous Dinosaur	PLOS ONE			English	Article							SAUROPOD DINOSAUR; EARLY EVOLUTION; PHYLOGENY; POSTURE; NECK	Fossils of the Early Cretaceous dinosaur, Nigersaurus taqueti, document for the first time the cranial anatomy of a rebbachisaurid sauropod. Its extreme adaptations for herbivory at ground-level challenge current hypotheses regarding feeding function and feeding strategy among diplodocoids, the larger clade of sauropods that includes Nigersaurus. We used high resolution computed tomography, stereolithography, and standard molding and casting techniques to reassemble the extremely fragile skull. Computed tomography also allowed us to render the first endocast for a sauropod preserving portions of the olfactory bulbs, cerebrum and inner ear, the latter permitting us to establish habitual head posture. To elucidate evidence of tooth wear and tooth replacement rate, we used photographic-casting techniques and crown thin sections, respectively. To reconstruct its 9-meter postcranial skeleton, we combined and size-adjusted multiple partial skeletons. Finally, we used maximum parsimony algorithms on character data to obtain the best estimate of phylogenetic relationships among diplodocoid sauropods. Nigersaurus taqueti shows extreme adaptations for a dinosaurian herbivore including a skull of extremely light construction, tooth batteries located at the distal end of the jaws, tooth replacement as fast as one per month, an expanded muzzle that faces directly toward the ground, and hollow presacral vertebral centra with more air sac space than bone by volume. A cranial endocast provides the first reasonably complete view of a sauropod brain including its small olfactory bulbs and cerebrum. Skeletal and dental evidence suggests that Nigersaurus was a ground-level herbivore that gathered and sliced relatively soft vegetation, the culmination of a low-browsing feeding strategy first established among diplodocoids during the Jurassic.	[Sereno, Paul C.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Wilson, Jeffrey A.; Whitlock, John A.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; [Wilson, Jeffrey A.; Whitlock, John A.] Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; [Witmer, Lawrence M.] Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Maga, Abdoulaye; Ide, Oumarou] Univ Niamey, Inst Human Sci, Niamey, Niger; [Rowe, Timothy A.] Univ Texas Austin, Jackson Sch Geol Sci, Austin, TX 78712 USA	University of Chicago; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Ohio; Ohio University; University of Texas System; University of Texas Austin	Sereno, PC (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	dinosaur@uchicago.edu	Whitlock, John/A-3079-2009; Wilson, Jeffrey/C-2737-2008; Whitlock, John/G-5814-2018	Whitlock, John/0000-0002-1118-2925; Whitlock, John/0000-0002-1118-2925; Maga, Abdoulaye/0000-0002-4684-217X	David and Lucile Packard Foundation; National Geographic Society; Island Fund; Women's Board of the University of Chicago (to PCS); National Science Foundation [IOB-0343744, IOB-0517257]; Ohio University College of Osteopathic Medicine; Scott Turner Award of the University of Michigan and Geological Society of America [8689-07]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Geographic Society(National Geographic Society); Island Fund; Women's Board of the University of Chicago (to PCS); National Science Foundation(National Science Foundation (NSF)); Ohio University College of Osteopathic Medicine; Scott Turner Award of the University of Michigan and Geological Society of America	Supported by the David and Lucile Packard Foundation, National Geographic Society, Island Fund, and Women's Board of the University of Chicago (to PCS); National Science Foundation (IOB-0343744, IOB-0517257) and the Ohio University College of Osteopathic Medicine (to LMW); Scott Turner Award of the University of Michigan and Geological Society of America (8689-07) (to JAW-2).	BAKKER RT, 1978, NATURE, V274, P661, DOI 10.1038/274661a0; Bakker RT., 1986, DINOSAUR HERESIES; Barrett Paul M., 1995, P107; Barrett Paul M., 1994, Gaia, V10, P195; Barrett PM, 2001, BIOL REV, V76, P411, DOI 10.1017/S1464793101005735; Calvo Jorge O., 1994, Gaia, V10, P183; Calvo Jorge O., 1995, Gaia, V11, P13; Coe M.J., 1987, P225; Dalla Vecchia Fabio Marco, 1998, Geologia Croatica, V51, P105; Dalla Vecchia FM, 2005, LIFE O PAST, P395; Dodson P., 1990, P402; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; Gallina Pablo A., 2005, Revista del Museo Argentino de Ciencias Naturales, V7, P153; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; Holland W. J., 1924, Memoirs of the Carnegie Museum, V9, P379; HOLLAND WJ, 1906, MEM CARNEGIE MUS, V2, P225; Hopson J.A., 1979, P39; JANENSCH W, 1929, PALAEONTOGRAPHICA, V2, P39; JANIS CM, 1988, ZOOL J LINN SOC-LOND, V92, P267, DOI 10.1111/j.1096-3642.1988.tb01513.x; Kellner Alexander W. A., 1996, Memoirs of the Queensland Museum, V39, P611; KRASSILOV VA, 1981, PALAEOGEOGR PALAEOCL, V34, P207, DOI 10.1016/0031-0182(81)90065-1; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; LAVOCAT R, 1954, COMPTES RENDUS DIX N, V21, P65; MARSH OC, 1896, ANN REPORT US GEOLOG, V16, P133; MARTIN J, 1987, 4 S MES TERR EC SHOR, P150; NAISH D, 2001, DINOSAURS ISLE WIGHT, P185; Pereda Suberbiola Xabier, 2003, Bulletin de la Societe Geologique de France, V174, P471; Prasad V, 2005, SCIENCE, V310, P1177, DOI 10.1126/science.1118806; Rauhut OWM, 2005, NATURE, V435, P670, DOI 10.1038/nature03623; ROSS C, 2005, ANAT REC PART A, V238, P391; Salgado L, 2004, J VERTEBR PALEONTOL, V24, P903, DOI 10.1671/0272-4634(2004)024[0903:LCRSFC]2.0.CO;2; SALGADO L, 1991, Ameghiniana, V28, P333; Schwarz D, 2007, ACTA PALAEONTOL POL, V52, P167; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Sereno PC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P157; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; SOLOUNIAS N, 1993, J MAMMAL, V74, P1059, DOI 10.2307/1382445; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Stevens KA, 2005, LIFE O PAST, P212; Stevens KA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P178; Taquet Philippe, 1999, Annales de Paleontologie, V85, P85, DOI 10.1016/S0753-3969(99)80009-3; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; WEAVER JC, 1983, PALEOBIOLOGY, V9, P173, DOI 10.1017/S0094837300007557; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; WITMER LM, ANATOMICAL IN PRESS; Witzel U, 2005, ANAT REC PART A, V283A, P391, DOI 10.1002/ar.a.20174	52	239	244	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1230	10.1371/journal.pone.0001230	http://dx.doi.org/10.1371/journal.pone.0001230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030355	Green Published, gold			2022-12-27	WOS:000207459200034
J	Thedieck, K; Polak, P; Kim, ML; Molle, KD; Cohen, A; Jeno, P; Arrieumerlou, C; Hall, MN				Thedieck, Kathrin; Polak, Pazit; Kim, Man Lyang; Molle, Klaus D.; Cohen, Adiel; Jenoe, Paul; Arrieumerlou, Cecile; Hall, Michael N.			PRAS40 and PRR5-Like Protein Are New mTOR Interactors that Regulate Apoptosis	PLOS ONE			English	Article								TOR (Target of Rapamycin) is a highly conserved protein kinase and a central controller of cell growth. TOR is found in two functionally and structurally distinct multiprotein complexes termed TOR complex 1 (TORC1) and TOR complex 2 (TORC2). In the present study, we developed a two-dimensional liquid chromatography tandem mass spectrometry (2D LC-MS/MS) based proteomic strategy to identify new mammalian TOR ( mTOR) binding proteins. We report the identification of Proline-rich Akt substrate (PRAS40) and the hypothetical protein Q6MZQ0/FLJ14213/CAE45978 as new mTOR binding proteins. PRAS40 binds mTORC1 via Raptor, and is an mTOR phosphorylation substrate. PRAS40 inhibits mTORC1 autophosphorylation and mTORC1 kinase activity toward eIF-4E binding protein (4E-BP) and PRAS40 itself. HeLa cells in which PRAS40 was knocked down were protected against induction of apoptosis by TNF alpha and cycloheximide. Rapamycin failed to mimic the pro-apoptotic effect of PRAS40, suggesting that PRAS40 mediates apoptosis independently of its inhibitory effect on mTORC1. Q6MZQ0 is structurally similar to proline rich protein 5 (PRR5) and was therefore named PRR5-Like (PRR5L). PRR5L binds specifically to mTORC2, via Rictor and/or SIN1. Unlike other mTORC2 members, PRR5L is not required for mTORC2 integrity or kinase activity, but dissociates from mTORC2 upon knock down of tuberous sclerosis complex 1 (TSC1) and TSC2. Hyperactivation of mTOR by TSC1/2 knock down enhanced apoptosis whereas PRR5L knock down reduced apoptosis. PRR5L knock down reduced apoptosis also in mTORC2 deficient cells. The above suggests that mTORC2-dissociated PRR5L may promote apoptosis when mTOR is hyperactive. Thus, PRAS40 and PRR5L are novel mTOR-associated proteins that control the balance between cell growth and cell death.	[Thedieck, Kathrin; Polak, Pazit; Kim, Man Lyang; Molle, Klaus D.; Cohen, Adiel; Jenoe, Paul; Arrieumerlou, Cecile; Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland	University of Basel	Hall, MN (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	m.hall@unibas.ch		Polak, Pazit/0000-0001-8363-0734; Hall, Michael N/0000-0002-2998-0757; Thedieck, Kathrin/0000-0002-9069-2930; ARRIEUMERLOU, Cecile/0000-0002-6463-2897	Peter und Traudl Engelhorn Stiftung zur Forderung der Biotechnologie und Gentechnik; Roche Research Foundation; Swiss National Science Foundation; Canton of Basel (MNH)	Peter und Traudl Engelhorn Stiftung zur Forderung der Biotechnologie und Gentechnik; Roche Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton of Basel (MNH)	We acknowledge support from the Peter und Traudl Engelhorn Stiftung zur Forderung der Biotechnologie und Gentechnik (KT), the Roche Research Foundation (PP), and the Swiss National Science Foundation and the Canton of Basel (MNH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avellino R, 2005, BLOOD, V106, P1400, DOI 10.1182/blood-2005-03-0929; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Brunn GJ, 1997, J BIOL CHEM, V272, P32547, DOI 10.1074/jbc.272.51.32547; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Edinger AL, 2004, ONCOGENE, V23, P5654, DOI 10.1038/sj.onc.1207738; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hahn M, 2005, MOL CANCER THER, V4, P457; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huang B, 2005, ACTA PHARMACOL SIN, V26, P1253, DOI 10.1111/j.1745-7254.2005.00184.x; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Johnstone CN, 2005, GENOMICS, V85, P338, DOI 10.1016/j.ygeno.2004.11.002; Kettritz R, 2002, KIDNEY INT, V61, P502, DOI 10.1046/j.1523-1755.2002.00161.x; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Saito A, 2004, J NEUROSCI, V24, P1584, DOI 10.1523/JNEUROSCI.5209-03.2004; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Teachey DT, 2006, BLOOD, V107, P1149, DOI 10.1182/blood-2005-05-1935; Thimmaiah KN, 2003, CANCER RES, V63, P364; Treeck O, 2006, GYNECOL ONCOL, V102, P292, DOI 10.1016/j.ygyno.2005.12.019; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	56	221	228	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1217	10.1371/journal.pone.0001217	http://dx.doi.org/10.1371/journal.pone.0001217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030348	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459200027
J	Chigurupati, S; Arumugam, TV; Son, TG; Lathia, JD; Jameel, S; Mughal, MR; Tang, SC; Jo, DG; Camandola, S; Giunta, M; Rakova, I; McDonnell, N; Miele, L; Mattson, MP; Poosala, S				Chigurupati, Srinivasulu; Arumugam, Thiruma V.; Son, Tae Gen; Lathia, Justin D.; Jameel, Shafaq; Mughal, Mohamed R.; Tang, Sung-Chun; Jo, Dong-Gyu; Camandola, Simonetta; Giunta, Marialuisa; Rakova, Irina; McDonnell, Nazli; Miele, Lucio; Mattson, Mark P.; Poosala, Suresh			Involvement of Notch Signaling in Wound Healing	PLOS ONE			English	Article								The Notch signaling pathway is critically involved in cell fate decisions during development of many tissues and organs. In the present study we employed in vivo and cell culture models to elucidate the role of Notch signaling in wound healing. The healing of full-thickness dermal wounds was significantly delayed in Notch antisense transgenic mice and in normal mice treated with gamma-secretase inhibitors that block proteolytic cleavage and activation of Notch. In contrast, mice treated with a Notch ligand Jagged peptide showed significantly enhanced wound healing compared to controls. Activation or inhibition of Notch signaling altered the behaviors of cultured vascular endothelial cells, keratinocytes and fibroblasts in a scratch wound healing model in ways consistent with roles for Notch signaling in wound healing functions all three cell types. These results suggest that Notch signaling plays important roles in wound healing and tissue repair, and that targeting the Notch pathway might provide a novel strategy for treatment of wounds and for modulation of angiogenesis in other pathological conditions.	[Chigurupati, Srinivasulu; Arumugam, Thiruma V.; Son, Tae Gen; Lathia, Justin D.; Jameel, Shafaq; Mughal, Mohamed R.; Tang, Sung-Chun; Jo, Dong-Gyu; Camandola, Simonetta; Giunta, Marialuisa; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA; [Rakova, Irina; McDonnell, Nazli] NIA, Clin Invest Lab, Intramural Res Program, Baltimore, MD 21224 USA; [Chigurupati, Srinivasulu; Poosala, Suresh] NIA, Res Resources Branch, Intramural Res Program, Baltimore, MD 21224 USA; [Arumugam, Thiruma V.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Sch Pharm, Amarillo, TX USA; [Jo, Dong-Gyu] Sungkyunkwan Univ, Coll Pharm, Suwon, South Korea; [Miele, Lucio] Loyola Univ, Dept Pathol, Breast Canc Program, Hlth Sci Ctr, Maywood, IL 60153 USA; [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Sungkyunkwan University (SKKU); Loyola University Chicago; Johns Hopkins University	Mattson, MP (corresponding author), NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Jo, Dong-Gyu/AAN-9278-2021; Lathia, Justin/AHB-8296-2022; Mattson, Mark P/F-6038-2012; Arumugam, Thiruma/AAG-6958-2019; Arumugam, Thiruma Valavan/B-4898-2011	Jo, Dong-Gyu/0000-0003-2271-1076; Arumugam, Thiruma/0000-0002-3377-0939; Miele, Lucio/0000-0002-5853-7287; Tang, Sung-Chun/0000-0003-3731-5973	National Institute on Aging, NIH; NATIONAL INSTITUTE ON AGING [Z01AG000893, ZIAAG000893] Funding Source: NIH RePORTER	National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the Intramural Research Program of the National Institute on Aging, NIH.	Aho S, 2004, J CELL BIOCHEM, V92, P1271, DOI 10.1002/jcb.20125; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cereseto A, 2000, J CELL PHYSIOL, V185, P425, DOI 10.1002/1097-4652(200012)185:3<425::AID-JCP13>3.0.CO;2-U; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dorsch M, 2002, BLOOD, V100, P2046, DOI 10.1182/blood.V100.6.2046.h81802002046_2046_2055; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Hunt T K, 2000, Adv Skin Wound Care, V13, P6; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Kared H, 2006, IMMUNITY, V25, P823, DOI 10.1016/j.immuni.2006.09.008; Krebs LT, 2000, GENE DEV, V14, P1343; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Nakajima M, 2003, MECH DEVELOP, V120, P657, DOI 10.1016/S0925-4773(03)00064-9; Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Ostroukhova M, 2006, J CLIN INVEST, V116, P996, DOI 10.1172/JCI26490; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Paris D, 2005, EUR J PHARMACOL, V514, P1, DOI 10.1016/j.ejphar.2005.02.050; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; SARMA V, 1992, J IMMUNOL, V148, P3302; Savill NJ, 2003, DEV BIOL, V258, P141, DOI 10.1016/S0012-1606(03)00107-6; Shi SL, 2006, CELL CYCLE, V5, P274, DOI 10.4161/cc.5.3.2396; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Uyttendaele H, 2000, MICROVASC RES, V60, P91, DOI 10.1006/mvre.2000.2254; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9; Zheng Y, 2007, ARTERIOSCL THROM VAS, V27, P503, DOI 10.1161/01.ATV.0000256459.06671.3c; Zimrin AB, 1996, J BIOL CHEM, V271, P32499, DOI 10.1074/jbc.271.51.32499	45	100	101	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1167	10.1371/journal.pone.0001167	http://dx.doi.org/10.1371/journal.pone.0001167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000539	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459100009
J	Wang, L; Dutta, SK; Kojima, T; Xu, XL; Khosravi-Far, R; Ekker, SC; Mukhopadhyay, D				Wang, Ling; Dutta, Shamit K.; Kojima, Tatsuyoshi; Xu, Xiaolei; Khosravi-Far, Roya; Ekker, Stephen C.; Mukhopadhyay, Debabrata			Neuropilin-1 Modulates p53/Caspases Axis to Promote Endothelial Cell Survival	PLOS ONE			English	Article								Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF), one of the crucial pro-angiogenic factors, functions as a potent inhibitor of endothelial cell (EC) apoptosis. Previous progress has been made towards delineating the VPF/VEGF survival signaling downstream of the activation of VEGFR-2. Here, we seek to define the function of NRP-1 in VPF/VEGF-induced survival signaling in EC and to elucidate the concomitant molecular signaling events that are pivotal for our understanding of the signaling of VPF/VEGF. Utilizing two different in vitro cell culture systems and an in vivo zebrafish model, we demonstrate that NRP-1 mediates VPF/VEGF-induced EC survival independent of VEGFR-2. Furthermore, we show here a novel mechanism for NRP-1-specific control of the anti-apoptotic pathway in EC through involvement of the NRP-1-interacting protein (NIP/GIPC) in the activation of PI-3K/Akt and subsequent inactivation of p53 pathways and FoxOs, as well as activation of p21. This study, by elucidating the mechanisms that govern VPF/VEGF-induced EC survival signaling via NRP-1, contributes to a better understanding of molecular mechanisms of cardiovascular development and disease and widens the possibilities for better therapeutic targets.	[Wang, Ling; Dutta, Shamit K.; Kojima, Tatsuyoshi; Xu, Xiaolei; Mukhopadhyay, Debabrata] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Ekker, Stephen C.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Khosravi-Far, Roya] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School	Mukhopadhyay, D (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	Mukhopadhyay.debabrata@mayo.edu		Ekker, Stephen/0000-0003-0726-4212	NIH [CA78383, HL072178, HL70567]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA078383, R29CA078383] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072178, R01HL070567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is partly supported by NIH grants CA78383, HL072178, HL70567 to DM. LW is a fellow of the American Heart Association.	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Bachelder RE, 2001, CANCER RES, V61, P5736; Bachelder RE, 2003, CANCER RES, V63, P5230; Barboule N, 1997, ONCOGENE, V15, P2867, DOI 10.1038/sj.onc.1201469; Barr MP, 2005, BRIT J CANCER, V92, P328, DOI 10.1038/sj.bjc.6602308; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Brusselmans K, 2005, J BIOL CHEM, V280, P3493, DOI 10.1074/jbc.M406613200; Cailhier JF, 2006, AM J TRANSPLANT, V6, P247, DOI 10.1111/j.1600-6143.2005.01165.x; Chang DW, 2003, J BIOL CHEM, V278, P16466, DOI 10.1074/jbc.C300089200; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Dimmeler S, 1998, EUR CYTOKINE NETW, V9, P697; DOWNWARD J, 1995, NATURE, V376, P553, DOI 10.1038/376553a0; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Erber R, 1997, INT J CANCER, V74, P383, DOI 10.1002/(SICI)1097-0215(19970822)74:4<383::AID-IJC4>3.0.CO;2-R; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fukuchi K, 2000, BBA-MOL CELL RES, V1496, P207, DOI 10.1016/S0167-4889(00)00018-5; Gagnon ML, 2000, P NATL ACAD SCI USA, V97, P2573, DOI 10.1073/pnas.040337597; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gobe G, 1997, J STRUCT BIOL, V118, P63, DOI 10.1006/jsbi.1996.3835; Gorospe M, 1999, GENE EXPRESSION, V7, P377; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Haffter P, 1996, DEVELOPMENT, V123, P1; HANSSON GK, 1994, BASIC RES CARDIOL, V89, P41; HARPER JW, 1993, CELL, V75, P805; Jain RK, 1998, P NATL ACAD SCI USA, V95, P10820, DOI 10.1073/pnas.95.18.10820; Johannessen LE, 1999, BIOCHEM J, V337, P599, DOI 10.1042/0264-6021:3370599; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Khosravi-Far R, 2004, CANCER BIOL THER, V3, P1051, DOI 10.4161/cbt.3.11.1173; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KLIPPEL A, 1994, MOL CELL BIOL, V14, P2675, DOI 10.1128/MCB.14.4.2675; KOHN AD, 1995, EMBO J, V4288, P4295; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lawlor MA, 2000, MOL CELL BIOL, V20, P8983, DOI 10.1128/MCB.20.23.8983-8995.2000; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Liedtke C, 2003, J BIOL CHEM, V278, P27593, DOI 10.1074/jbc.M304077200; Littlewood TD, 2003, CURR OPIN LIPIDOL, V14, P469, DOI 10.1097/00041433-200310000-00007; Liu JW, 2005, ONCOGENE, V24, P2020, DOI 10.1038/sj.onc.1208385; MICHIELI P, 1994, CANCER RES, V54, P3391; Mitsuuchi Y, 2000, CANCER RES, V60, P5390; Murga M, 2005, BLOOD, V105, P1992, DOI 10.1182/blood-2004-07-2598; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakamura Y, 2004, CANCER SCI, V95, P7, DOI 10.1111/j.1349-7006.2004.tb03163.x; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Parrizas M, 1997, J BIOL CHEM, V272, P154; Pauli SA, 2005, ENDOCRINOLOGY, V146, P1301, DOI 10.1210/en.2004-0765; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Potente M, 2003, J BIOL CHEM, V278, P29619, DOI 10.1074/jbc.M305385200; Raj K, 2001, NATURE, V412, P914, DOI 10.1038/35091082; ROSS R, 1977, AM J PATHOL, V86, P675; Rossig L, 2001, BASIC RES CARDIOL, V96, P11, DOI 10.1007/s003950170073; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Sohn D, 2006, CANCER RES, V66, P11254, DOI 10.1158/0008-5472.CAN-06-1569; Soker S, 1997, J BIOL CHEM, V272, P31582, DOI 10.1074/jbc.272.50.31582; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; STEMERMAN MB, 1972, J EXP MED, V136, P769, DOI 10.1084/jem.136.4.769; Suhara T, 2002, MOL CELL BIOL, V22, P680, DOI 10.1128/MCB.22.2.680-691.2002; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Tricot O, 2000, CIRCULATION, V101, P2450, DOI 10.1161/01.CIR.101.21.2450; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Waltenberger J, 1997, CIRCULATION, V96, P4083; Wang L, 2003, J BIOL CHEM, V278, P48848, DOI 10.1074/jbc.M310047200; Wang L, 2006, FASEB J, V20, P1513, DOI 10.1096/fj.05-5504fje; Weiss RH, 2000, J BIOL CHEM, V275, P10285, DOI 10.1074/jbc.275.14.10285; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Yilmaz A, 2003, BIOCHEM BIOPH RES CO, V306, P730, DOI 10.1016/S0006-291X(03)01064-7; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101; Zeng YX, 1996, ONCOGENE, V12, P1557; Zhang W, 1995, CLIN CANCER RES, V1, P1051; Zhang YK, 1999, ONCOGENE, V18, P1131, DOI 10.1038/sj.onc.1202426	83	59	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1161	10.1371/journal.pone.0001161	http://dx.doi.org/10.1371/journal.pone.0001161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000534	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459100004
J	Behonick, DJ; Xing, ZQ; Lieu, S; Buckley, JM; Lotz, JC; Marcucio, RS; Werb, Z; Miclau, T; Colnot, C				Behonick, Danielle J.; Xing, Zhiqing; Lieu, Shirley; Buckley, Jenni M.; Lotz, Jeffrey C.; Marcucio, Ralph S.; Werb, Zena; Miclau, Theodore; Colnot, Celine			Role of Matrix Metalloproteinase 13 in Both Endochondral and Intramembranous Ossification during Skeletal Regeneration	PLOS ONE			English	Article								Extracellular matrix (ECM) remodeling is important during bone development and repair. Because matrix metalloproteinase 13 (MMP13, collagenase-3) plays a role in long bone development, we have examined its role during adult skeletal repair. In this study we find that MMP13 is expressed by hypertrophic chondrocytes and osteoblasts in the fracture callus. We demonstrate that MMP13 is required for proper resorption of hypertrophic cartilage and for normal bone remodeling during non-stabilized fracture healing, which occurs via endochondral ossification. However, no difference in callus strength was detected in the absence of MMP13. Transplant of wild- type bone marrow, which reconstitutes cells only of the hematopoietic lineage, did not rescue the endochondral repair defect, indicating that impaired healing in Mmp13(-/-) mice is intrinsic to cartilage and bone. Mmp13(-/-) mice also exhibited altered bone remodeling during healing of stabilized fractures and cortical defects via intramembranous ossification. This indicates that the bone phenotype occurs independently from the cartilage phenotype. Taken together, our findings demonstrate that MMP13 is involved in normal remodeling of bone and cartilage during adult skeletal repair, and that MMP13 may act directly in the initial stages of ECM degradation in these tissues prior to invasion of blood vessels and osteoclasts.	[Xing, Zhiqing; Lieu, Shirley; Marcucio, Ralph S.; Miclau, Theodore; Colnot, Celine] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco Gen Hosp, Cellular & Mol Biol Lab, San Francisco, CA 94143 USA; [Behonick, Danielle J.; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Behonick, Danielle J.; Werb, Zena] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Buckley, Jenni M.; Lotz, Jeffrey C.] Univ Calif San Francisco, Dept Orthopaed Surg, Orthopaed Bioengn Lab, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Colnot, C (corresponding author), Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco Gen Hosp, Cellular & Mol Biol Lab, San Francisco, CA 94143 USA.	colnotc@orthosurg.ucsf.edu	Colnot, Celine/D-4997-2017	Colnot, Celine/0000-0001-8423-8718; Marcucio, Ralph/0000-0002-0537-818X; Behonick, Dani/0000-0003-1149-0597	National Institutes of Health [AG023218, AR046238, AR053645, DE016701]; Musculoskeletal Transplant Foundation; UCSF Research Evaluation and Allocation Committee; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046238, R01AR053645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE016701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Musculoskeletal Transplant Foundation; UCSF Research Evaluation and Allocation Committee; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by grants from the National Institutes of Health (AG023218 and AR046238 to ZW, AR053645 to TM, RM and CC, DE016701 to CC), the Musculoskeletal Transplant Foundation and the UCSF Research Evaluation and Allocation Committee (CC).	ALBRECHT U, 1997, VISUALIZATION GENE E; BLAVIER L, 1995, J CELL SCI, V108, P3649; Buckley JM, 2007, BONE, V40, P767, DOI 10.1016/j.bone.2006.10.025; Colnot C, 2006, BIOCHEM BIOPH RES CO, V350, P557, DOI 10.1016/j.bbrc.2006.09.079; Colnot C, 2005, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000167251.26164.37; Colnot C, 2003, DEVELOPMENT, V130, P4123, DOI 10.1242/dev.00559; Colnot CI, 2001, MECH DEVELOP, V100, P245, DOI 10.1016/S0925-4773(00)00532-3; CRAWFORD NR, 1995, SPINE, V20, P2097, DOI 10.1097/00007632-199510000-00005; DOEGE KJ, 1999, GUIDEBOOK EXTRACELLU, P359; Egeblad M, 2007, DEV DYNAM, V236, P1683, DOI 10.1002/dvdy.21159; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8; GOLDRING MB, 1990, CLIN ORTHOP RELAT R, P245; Henle P, 2005, BONE, V37, P791, DOI 10.1016/j.bone.2005.06.015; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Karsdal MA, 2001, J BIOL CHEM, V276, P39350, DOI 10.1074/jbc.M008738200; Kasper G, 2007, STEM CELLS, V25, P1985, DOI 10.1634/stemcells.2006-0676; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Lee ER, 1999, DEV DYNAM, V215, P190, DOI 10.1002/(SICI)1097-0177(199907)215:3<190::AID-AJA2>3.0.CO;2-B; Lehmann W, 2005, BONE, V36, P300, DOI 10.1016/j.bone.2004.10.010; Lu CY, 2004, HISTOCHEM CELL BIOL, V121, P493, DOI 10.1007/s00418-004-0653-5; Lu CY, 2005, J ORTHOP RES, V23, P1300, DOI 10.1016/j.orthres.2005.04.003; Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100; Ortega N, 2005, MOL BIOL CELL, V16, P3028, DOI 10.1091/mbc.E04-12-1119; Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003; Parikka V, 2005, MATRIX BIOL, V24, P438, DOI 10.1016/j.matbio.2005.06.009; Roberts W E, 1988, J Dent Educ, V52, P804; Sato T, 1998, J BONE MINER RES, V13, P59, DOI 10.1359/jbmr.1998.13.1.59; SCOTT DK, 1992, MOL ENDOCRINOL, V6, P2153, DOI 10.1210/me.6.12.2153; Selvamurugan N, 2006, J CELL BIOCHEM, V99, P545, DOI 10.1002/jcb.20878; SINGER H, 1995, J CLIN INVEST, V95, P2178; STEELE DG, 1988, BONE BIOL ANATOMY BI, P10; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Thompson Z, 2002, J ORTHOPAED RES, V20, P1091, DOI 10.1016/S0736-0266(02)00017-7; Uusitalo M, 2000, ACTA OPHTHALMOL SCAN, V78, P536, DOI 10.1034/j.1600-0420.2000.078005536.x; Varghese S, 1996, ENDOCRINOLOGY, V137, P431, DOI 10.1210/en.137.2.431; VARGHESE S, 1995, ENDOCRINOLOGY, V136, P2156, DOI 10.1210/en.136.5.2156; Varghese S, 2000, ENDOCRINOLOGY, V141, P2185, DOI 10.1210/en.141.6.2185; Vortkamp A, 1998, MECH DEVELOP, V71, P65, DOI 10.1016/S0925-4773(97)00203-7; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Weizmann S, 2005, MATRIX BIOL, V24, P520, DOI 10.1016/j.matbio.2005.07.003; Yamagiwa H, 1999, BONE, V25, P197, DOI 10.1016/S8756-3282(99)00157-X	46	115	118	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1150	10.1371/journal.pone.0001150	http://dx.doi.org/10.1371/journal.pone.0001150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987127	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459000033
J	Reddy, BM; Langstieh, BT; Kumar, V; Nagaraja, T; Reddy, ANS; Meka, A; Reddy, AG; Thangaraj, K; Singh, L				Reddy, B. Mohan; Langstieh, B. T.; Kumar, Vikrant; Nagaraja, T.; Reddy, A. N. S.; Meka, Aruna; Reddy, A. G.; Thangaraj, K.; Singh, Lalji			Austro-Asiatic Tribes of Northeast India Provide Hitherto Missing Genetic Link between South and Southeast Asia	PLOS ONE			English	Article								Northeast India, the only region which currently forms a land bridge between the Indian subcontinent and Southeast Asia, has been proposed as an important corridor for the initial peopling of East Asia. Given that the Austro-Asiatic linguistic family is considered to be the oldest and spoken by certain tribes in India, Northeast India and entire Southeast Asia, we expect that populations of this family from Northeast India should provide the signatures of genetic link between Indian and Southeast Asian populations. In order to test this hypothesis, we analyzed mtDNA and Y-Chromosome SNP and STR data of the eight groups of the Austro-Asiatic Khasi from Northeast India and the neighboring Garo and compared with that of other relevant Asian populations. The results suggest that the Austro-Asiatic Khasi tribes of Northeast India represent a genetic continuity between the populations of South and Southeast Asia, thereby advocating that northeast India could have been a major corridor for the movement of populations from India to East/Southeast Asia.	[Reddy, B. Mohan; Langstieh, B. T.; Kumar, Vikrant; Nagaraja, T.; Reddy, A. N. S.; Meka, Aruna] Indian Stat Inst, Biol Anthropol Unit, Hyderabad, Andhra Pradesh, India; [Kumar, Vikrant] Genome Inst Singapore, Singapore, Singapore; [Reddy, A. G.; Thangaraj, K.; Singh, Lalji] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Langstieh, B. T.] NE Hill Univ, Dept Anthropol, Shillong 793014, Meghalaya, India	Indian Statistical Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); North Eastern Hill University	Reddy, BM (corresponding author), Indian Stat Inst, Biol Anthropol Unit, Hyderabad, Andhra Pradesh, India.	bmr@isical.ac.in	Thangaraj, Kumarasamy/G-5596-2010	Thangaraj, Kumarasamy/0000-0002-0075-0106	Indian Statistical Institute	Indian Statistical Institute	This project was funded by Indian Statistical Institute.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Butler JM, 2002, FORENSIC SCI INT, V129, P10, DOI 10.1016/S0379-0738(02)00195-0; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cordaux R, 2004, MOL BIOL EVOL, V21, P1525, DOI 10.1093/molbev/msh151; Diffloth G., 2005, PEOPLING E ASIA PUTT, P77; Ellis N, 2002, GENOME RES, V12, P339; Endicott P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000081; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fucharoen G, 2001, J HUM GENET, V46, P115, DOI 10.1007/s100380170098; HUSSAIN Z, 1991, ARCHAEOLOGY N E INDI, P74; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Krithika S, 2006, ANN HUM BIOL, V33, P26, DOI 10.1080/03014460500424043; Kumar V, 2003, J BIOSCIENCES, V28, P507, DOI 10.1007/BF02705125; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Nei M., 1987, MOL EVOLUTIONARY GEN; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Palanichamy MG, 2006, SCIENCE, V311, DOI 10.1126/science.1120176; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Prasad BVR, 2001, HUM BIOL, V73, P715; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Roychoudhury S, 2001, HUM GENET, V109, P339, DOI 10.1007/s004390100577; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; SHARMA TC, 1984, TRIBES N E INDIA, P1; SHARMA TC, 1966, JR ASSAM SC SOC, V9, P1; SHARMA TC, 1980, E HIMALAYAS, P102; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Thangaraj K, 2003, CURR BIOL, V13, P86, DOI 10.1016/S0960-9822(02)01336-2; Thanseem I, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-42; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999	43	56	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1141	10.1371/journal.pone.0001141	http://dx.doi.org/10.1371/journal.pone.0001141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17989774	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459000024
J	Sheu, ML; Liu, SH; Lan, KH				Sheu, Meei Ling; Liu, Shing Hwa; Lan, Keng Hsin			Honokiol Induces Calpain-Mediated Glucose-Regulated Protein-94 Cleavage and Apoptosis in Human Gastric Cancer Cells and Reduces Tumor Growth	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; WEIGHT NATURAL-PRODUCT; DRUG-RESISTANCE; DEATH PROGRAM; IN-VITRO; CASPASE; GRP94; EXPRESSION; INDUCTION; MAGNOLOL	Background. Honokiol, a small molecular weight natural product, has been shown to possess potent anti-neoplastic and anti-angiogenic properties. Its molecular mechanisms and the ability of anti-gastric cancer remain unknown. It has been shown that the anti-apoptotic function of the glucose-regulated proteins (GRPs) predicts that their induction in neoplastic cells can lead to cancer progression and drug resistance. We explored the effects of honokiol on the regulation of GRPs and apoptosis in human gastric cancer cells and tumor growth. Methodology and Principal Findings. Treatment of various human gastric cancer cells with honokiol led to the induction of GRP94 cleavage, but did not affect GRP78. Silencing of GRP94 by small interfering RNA (siRNA) could induce cell apoptosis. Treatment of cells with honokiol or chemotherapeutics agent etoposide enhanced the increase in apoptosis and GRP94 degradation. The calpain activity and calpain-II (m-calpain) protein (but not calpain-I (mu-calpain)) level could also be increased by honokiol. Honokiol-induced GRP94 down-regulation and apoptosis in gastric cancer cells could be reversed by siRNA targeting calpain-II and calpain inhibitors. Furthermore, the results of immunofluorescence staining and immunoprecipitation revealed a specific interaction of GRP94 with calpain-II in cells following honokiol treatment. We next observed that tumor GRP94 over-expression and tumor growth in BALB/c nude mice, which were inoculated with human gastric cancer cells MKN45, are markedly decreased by honokiol treatment. Conclusions and Significance. These results provide the first evidence that honokiol-induced calpain-II-mediated GRP94 cleavage causes human gastric cancer cell apoptosis. We further suggest that honokiol may be a possible therapeutic agent to improve clinical outcome of gastric cancer.	[Sheu, Meei Ling] Natl Chung Hsing Univ, Inst Med Technol, Taichung 40227, Taiwan; [Sheu, Meei Ling] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Liu, Shing Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan; [Liu, Shing Hwa] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Lan, Keng Hsin] Natl Yang Ming Univ, Dept Med, Div Gastroenterol, Taipei 112, Taiwan	National Chung Hsing University; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University	Sheu, ML (corresponding author), Natl Chung Hsing Univ, Inst Med Technol, Taichung 40227, Taiwan.	mlsheu@nchu.edu.tw; shliu@ha.mc.ntu.edu.tw	Sheu, Meei-Ling/AAT-3401-2020	Sheu, Meei-Ling/0000-0002-0431-1282; LIU, SHING-HWA/0000-0002-9976-1197	National Science Council of Taiwan [NSC95-2320-B040-005]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	Funding: This work was supported by research grants from National Science Council of Taiwan (NSC95-2320-B040-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XH, 2003, J BIOL CHEM, V278, P35501, DOI 10.1074/jbc.M302967200; Battle TE, 2005, BLOOD, V106, P690, DOI 10.1182/blood-2004-11-4273; Beliakoff J, 2004, ANTI-CANCER DRUG, V15, P651, DOI 10.1097/01.cad.0000136876.11928.be; Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702; Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chavany C, 1996, J BIOL CHEM, V271, P4974; Chen XX, 2002, CARCINOGENESIS, V23, P123, DOI 10.1093/carcin/23.1.123; Chiang CK, 2006, KIDNEY INT, V70, P682, DOI 10.1038/sj.ki.5001617; Fettucciari K, 2006, J IMMUNOL, V176, P7542, DOI 10.4049/jimmunol.176.12.7542; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Gazit G, 1999, BREAST CANCER RES TR, V54, P135, DOI 10.1023/A:1006102411439; HUGHES CS, 1989, CANCER RES, V49, P4452; Ishitsuka K, 2005, BLOOD, V106, P1794, DOI 10.1182/blood-2005-01-0346; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kato M, 2000, J BIOCHEM, V127, P297, DOI 10.1093/oxfordjournals.jbchem.a022607; KOONG AC, 1994, INT J RADIAT ONCOL, V28, P661, DOI 10.1016/0360-3016(94)90191-0; Kubota H, 2005, INT J RADIAT BIOL, V81, P701, DOI 10.1080/09553000500434727; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lin WC, 2000, ONCOGENE, V19, P5680, DOI 10.1038/sj.onc.1203924; Liou KT, 2003, BRAIN RES, V992, P159, DOI 10.1016/j.brainres.2003.08.026; LITTLE E, 1995, J BIOL CHEM, V270, P9526, DOI 10.1074/jbc.270.16.9526; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Liu SL, 2005, CANCER RES, V65, P9126, DOI 10.1158/0008-5472.CAN-05-0945; LO YC, 1994, BIOCHEM PHARMACOL, V47, P549, DOI 10.1016/0006-2952(94)90187-2; MENORET A, 1994, INT J CANCER, V56, P400, DOI 10.1002/ijc.2910560319; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Ohtsu A, 2006, J CLIN ONCOL, V24, P2188, DOI 10.1200/JCO.2006.05.9758; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Park J, 2004, EUR J PHARMACOL, V496, P189, DOI 10.1016/j.ejphar.2004.05.047; Pezzuto JM, 1997, BIOCHEM PHARMACOL, V53, P121, DOI 10.1016/S0006-2952(96)00654-5; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Reddy RK, 1999, J BIOL CHEM, V274, P28476, DOI 10.1074/jbc.274.40.28476; SAREEN D, 2007, MOL PHARM IN PRESS; SHEN J, 1987, P NATL ACAD SCI USA, V84, P3278, DOI 10.1073/pnas.84.10.3278; Sheu ML, 2005, ARTERIOSCL THROM VAS, V25, P539, DOI 10.1161/01.ATV.0000155462.24263.e4; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Tomida A, 1996, INT J CANCER, V68, P391, DOI 10.1002/(SICI)1097-0215(19961104)68:3<391::AID-IJC19>3.0.CO;2-B; Utz PJ, 2000, CELL DEATH DIFFER, V7, P589, DOI 10.1038/sj.cdd.4400696; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Witkowski JM, 2002, BLOOD, V100, P1802, DOI 10.1182/blood-2001-11-0073; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Zhai H, 2003, EUR J PHARMACOL, V474, P199, DOI 10.1016/S0014-2999(03)02075-2	44	63	65	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1096	10.1371/journal.pone.0001096	http://dx.doi.org/10.1371/journal.pone.0001096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971859	gold, Green Published, Green Submitted			2022-12-27	WOS:000207458700013
J	Ziv, E; Nemenman, I; Wiggins, CH				Ziv, Etay; Nemenman, Ilya; Wiggins, Chris H.			Optimal Signal Processing in Small Stochastic Biochemical Networks	PLOS ONE			English	Article							MAP KINASE; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; NOISE; INFORMATION; SPECIFICITY; FLUCTUATIONS; DIFFERENTIATION; TRANSDUCTION; PROBABILITY	We quantify the influence of the topology of a transcriptional regulatory network on its ability to process environmental signals. By posing the problem in terms of information theory, we do this without specifying the function performed by the network. Specifically, we study the maximum mutual information between the input ( chemical) signal and the output ( genetic) response attainable by the network in the context of an analytic model of particle number fluctuations. We perform this analysis for all biochemical circuits, including various feedback loops, that can be built out of 3 chemical species, each under the control of one regulator. We find that a generic network, constrained to low molecule numbers and reasonable response times, can transduce more information than a simple binary switch and, in fact, manages to achieve close to the optimal information transmission fidelity. These high-information solutions are robust to tenfold changes in most of the networks' biochemical parameters; moreover they are easier to achieve in networks containing cycles with an odd number of negative regulators ( overall negative feedback) due to their decreased molecular noise ( a result which we derive analytically). Finally, we demonstrate that a single circuit can support multiple high-information solutions. These findings suggest a potential resolution of the "cross-talk'' phenomenon as well as the previously unexplained observation that transcription factors that undergo proteolysis are more likely to be auto-repressive.	[Ziv, Etay] Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA; [Ziv, Etay] Columbia Univ, Dept Biomed Engn, New York, NY USA; [Wiggins, Chris H.] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY USA; [Wiggins, Chris H.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA; [Nemenman, Ilya] Los Alamos Natl Lab, Comp Computat & Stat Sci Div, Los Alamos, NM USA; [Nemenman, Ilya] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA	Columbia University; Columbia University; Columbia University; Columbia University; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Ziv, E (corresponding author), Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA.	ez87@columbia.edu		Nemenman, Ilya/0000-0003-3024-4244	NSF [ECS-0425850]; DOE [DE-AC52-06NA25396]; NIH [1U54CA121852]; Krell Institute's DOE CSGF; DOD NDSEGF; NIH-MSTP; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Krell Institute's DOE CSGF(United States Department of Energy (DOE)); DOD NDSEGF; NIH-MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by NSF Grant No. ECS-0425850 to CW and IN. IN was further supported by DOE under Contract No. DE-AC52-06NA25396. CW was further funded by NIH Grant No. 1U54CA121852. EZ was funded by the Krell Institute's DOE CSGF grant, DOD NDSEGF grant, and the NIH-MSTP grant.	ALBERT R, 2004, COMPLEX NETWORKS; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; BALL K, 2005, ARXIVMATHPR0508015; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Bundschuh R, 2003, BIOPHYS J, V84, P1606, DOI 10.1016/S0006-3495(03)74970-4; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Davidson EH, 2006, REG GEN GEN REG; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; El-Samad H, 2006, BIOPHYS J, V90, P3749, DOI 10.1529/biophysj.105.060491; Elf J, 2003, GENOME RES, V13, P2475, DOI 10.1101/gr.1196503; Elf J, 2003, BIOPHYS J, V84, P154, DOI 10.1016/S0006-3495(03)74839-5; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fodde R, 2002, SCIENCE, V298, P761, DOI 10.1126/science.1077707; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; GARCIA JA, 2006, SCI STKE, V337, P25; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ghosh B, 2006, PHYS BIOL, V3, P29, DOI 10.1088/1478-3975/3/1/003; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GLEISS PM, 2000, ARXIVCONDMAT0009124; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Hohenstein P, 2004, PLOS BIOL, V2, P165, DOI 10.1371/journal.pbio.0020040; HUANG CYF, 2004, J CELL BIOL, V164, P354; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Levin MD, 2003, FEBS LETT, V550, P135, DOI 10.1016/S0014-5793(03)00857-3; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; LIU EW, 2005, J CHEM PHYS, V123, DOI DOI 10.1063/1.2109987; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; MARKEVICH NI, 1996, P NATL ACAD SCI USA, V93, P10078; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Min W, 2006, J PHYS CHEM B, V110, P20093, DOI 10.1021/jp065187g; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; ROSS IL, 1994, IMMUNOL CELL BIOL, V72, P177, DOI 10.1038/icb.1994.26; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Salgado H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-5; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; SCHLESSINGER J, 1994, COLD SPRING HARB SYM, V59, P173, DOI 10.1101/SQB.1994.059.01.021; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sinitsyn NA, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/58001; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; TKACIK G, 2000, ARXIV07050313QBIOMN; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Voigt CA, 2005, GENETICS, V169, P1187, DOI 10.1534/genetics.104.031955; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Wall ME, 2005, J MOL BIOL, V349, P501, DOI 10.1016/j.jmb.2005.04.022; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; Wigler M, 2002, SCIENCE, V296, P1407, DOI 10.1126/science.1072445; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	81	90	90	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1077	10.1371/journal.pone.0001077	http://dx.doi.org/10.1371/journal.pone.0001077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957259	Green Submitted, Green Published, gold			2022-12-27	WOS:000207458500022
J	Abraham, JM; Sato, F; Cheng, YL; Paun, B; Kan, T; Olaru, A; Jin, Z; Yang, J; Agarwal, R; David, S; Hamilton, JP; Ito, T; Mori, Y; Meltzer, SJ				Abraham, John M.; Sato, Fumiaki; Cheng, Yulan; Paun, Bogdan; Kan, Takatsugu; Olaru, Alexandru; Jin, Zhe; Yang, Jian; Agarwal, Rachana; David, Stefan; Hamilton, James P.; Ito, Tetsuo; Mori, Yuriko; Meltzer, Stephen J.			Novel Decapeptides that Bind Avidly and Deliver Radioisotope to Colon Cancer Cells	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; BREAST-CANCER; LOW-GRADE; THERAPY; CHEMOTHERAPY; TRASTUZUMAB; TRIAL; PLUS; RADIOIMMUNOTHERAPY; PEPTIDES	Background. The rapidly growing field of targeted tumor therapy often utilizes an antibody, sometimes tagged with a tumor-ablating material such as radioisotope, directed against a specific molecule. Methodology/Principal Findings. This report describes the discovery of nine novel decapeptides which can be radioactively labeled, bind to, and deliver P-32 to colon cancer cells. The decapeptides vary from one another by one to three amino acids and demonstrate vastly different binding abilities. The most avidly binding decapeptide can permanently deliver very high levels of radioisotope to the adenocarcinoma cancer cell lines at an efficiency 35 to 150 times greater than to a variety of other cell types, including cell lines derived from other types of cancer or from normal tissue. Conclusions/Significance. This experimental approach represents a new example of a strategy, termed peptide binding therapy, for the potential treatment of colorectal and other adenocarcinomas.	[Abraham, John M.; Sato, Fumiaki; Cheng, Yulan; Paun, Bogdan; Kan, Takatsugu; Olaru, Alexandru; Jin, Zhe; Yang, Jian; Agarwal, Rachana; David, Stefan; Hamilton, James P.; Ito, Tetsuo; Mori, Yuriko; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Abraham, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	jabrah14@jhmi.edu			National Cancer Institute [2RO1CA095323-14, 2RO1CA07705709, 1R01CA001808-05, 7R21/R33CA106763]; NATIONAL CANCER INSTITUTE [R01CA077057, R01CA001808, R01CA095323, R21CA106763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK067872] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants 2RO1CA095323-14, 2RO1CA07705709, 1R01CA001808-05 and 7R21/ R33CA106763 from the National Cancer Institute.	Aina OH, 2005, MOL CANCER THER, V4, P806, DOI 10.1158/1535-7163.MCT-05-0029; Aina OH, 2002, BIOPOLYMERS, V66, P184, DOI 10.1002/bip.10257; Boerman OC, 2007, ANTI-CANCER AGENT ME, V7, P335, DOI 10.2174/187152007780618126; Cilley JC, 2007, EXPERT OPIN BIOL TH, V7, P739, DOI 10.1517/14712598.7.5.739; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Davis TA, 2000, J CLIN ONCOL, V18, P3135, DOI 10.1200/JCO.2000.18.17.3135; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kreitman RJ, 2003, CURR OPIN MOL THER, V5, P44; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; Kreitman RJ, 2006, CURR DRUG TARGETS, V7, P1301, DOI 10.2174/138945006778559139; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Okarvi SM, 2004, MED RES REV, V24, P357, DOI 10.1002/med.20002; Presta LG, 1997, CANCER RES, V57, P4593; Rini BI, 2007, CLIN CANCER RES, V13, p741S, DOI 10.1158/1078-0432.CCR-06-2110; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Siberil S, 2007, CRIT REV ONCOL HEMAT, V62, P26, DOI 10.1016/j.critrevonc.2006.12.003; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tan-Chiu E, 2005, J CLIN ONCOL, V23, P7811, DOI 10.1200/JCO.2005.02.4091; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Vose JM, 2004, ONCOLOGIST, V9, P160, DOI 10.1634/theoncologist.9-2-160; Wangler C, 2007, PROTEIN PEPTIDE LETT, V14, P273, DOI 10.2174/092986607780090874; Wiseman GA, 2001, CRIT REV ONCOL HEMAT, V39, P181, DOI 10.1016/S1040-8428(01)00107-X; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Zafir-Lavie I, 2007, ONCOGENE, V26, P3714, DOI 10.1038/sj.onc.1210372	25	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e964	10.1371/journal.pone.0000964	http://dx.doi.org/10.1371/journal.pone.0000964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912343	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455900002
J	Linksvayer, TA				Linksvayer, Timothy A.			Ant Species Differences Determined by Epistasis between Brood and Worker Genomes	PLOS ONE			English	Article							GENUS LEPTOTHORAX HYMENOPTERA; APIS-MELLIFERA; INTERACTING PHENOTYPES; MULTILEVEL SELECTION; GENETIC ARCHITECTURE; EVOLUTIONARY PROCESS; SOCIAL EVOLUTION; BEHAVIOR; CONFLICT; ENVIRONMENT	Epistasis arising from physiological interactions between gene products often contributes to species differences, particularly those involved in reproductive isolation. In social organisms, phenotypes are influenced by the genotypes of multiple interacting individuals. In theory, social interactions can give rise to an additional type of epistasis between the genomes of social partners that can contribute to species differences. Using a full-factorial cross-fostering design with three species of closely related Temnothorax ants, I found that adult worker size was determined by an interaction between the genotypes of developing brood and care-giving workers, i.e. intergenomic epistasis. Such intergenomic social epistasis provides a strong signature of coevolution between social partners. These results demonstrate that just as physiologically interacting genes coevolve, diverge, and contribute to species differences, so do socially interacting genes. Coevolution and conflict between social partners, especially relatives such as parents and offspring, has long been recognized as having widespread evolutionary effects. This coevolutionary process may often result in coevolved socially-interacting gene complexes that contribute to species differences.	[Linksvayer, Timothy A.] Indiana Univ, Dept Biol, Bloomington, IN USA	Indiana University System; Indiana University Bloomington	Linksvayer, TA (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	tlinksvayer@gmail.com		Linksvayer, Timothy/0000-0001-7034-1546	NSF; Indiana Academy of Sciences	NSF(National Science Foundation (NSF)); Indiana Academy of Sciences	This research was supported by an NSF Graduate Research Fellowship and a grant from the Indiana Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, AM NAT, V158, P308, DOI 10.1086/321324; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Alloway T.M., 1982, Psyche (Cambridge), V89, P249, DOI 10.1155/1982/64124; Bijma P, 2007, GENETICS, V175, P277, DOI 10.1534/genetics.106.062711; Blows MW, 2003, AM NAT, V161, P240, DOI 10.1086/345783; Bourke AFG, 1999, BEHAV ECOL SOCIOBIOL, V46, P287, DOI 10.1007/s002650050622; Brillet C, 2002, ETHOLOGY, V108, P115, DOI 10.1046/j.1439-0310.2002.00760.x; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Buschinger A., 1973, EFFECTS TEMPERATURE, P229; CALDERONE NW, 1992, BEHAV ECOL SOCIOBIOL, V30, P219, DOI 10.1007/BF00166706; Calis JNM, 2002, APIDOLOGIE, V33, P193, DOI 10.1051/apido:2002009; Cheverud James M., 1994, P67; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; DASILVA DLN, 1977, BOLM ZOOL U S PAULO, V2, P7; Dobzhansky T, 1936, GENETICS, V21, P113; Foitzik S, 1999, ENTOMOL GEN, V24, P065; Gardner A, 2007, AM NAT, V169, P207, DOI 10.1086/510602; Goodnight CJ, 2005, POPUL ECOL, V47, P3, DOI 10.1007/s10144-005-0207-2; Goodnight CJ, 1997, AM NAT, V150, pS59, DOI 10.1086/286050; Griffing B., 1977, Proceedings of the International Conference on Quantitative Genetics, August 16-21, 1976., P413; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Herbers J.M., 1983, Psyche (Cambridge), V90, P361, DOI 10.1155/1983/52489; Holldobler B., 1990, pi; Hunt J, 2002, P NATL ACAD SCI USA, V99, P6828, DOI 10.1073/pnas.092676199; Kang MS, 2004, GENETIC ANAL COMPLEX; Kaptein N, 2005, ANIM BEHAV, V69, P293, DOI 10.1016/j.anbehav.2004.04.012; KELLER L, 1995, FUNCT ECOL, V9, P667, DOI 10.2307/2390159; Kolliker M, 2005, AM NAT, V166, P506, DOI 10.1086/491687; LE CONTE Y, 1995, J ECON ENTOMOL, V88, P798, DOI 10.1093/jee/88.4.798; Linksvayer TA, 2005, Q REV BIOL, V80, P317, DOI 10.1086/432266; LINKSVAYER TA, 2007, BEHAV ECOL IN PRESS; Linksvayer TA, 2006, EVOLUTION, V60, P2552, DOI 10.1111/j.0014-3820.2006.tb01889.x; LUMSDEN CJ, 1982, J THEOR BIOL, V95, P749, DOI 10.1016/0022-5193(82)90352-6; LYNCH M, 1987, P NATL ACAD SCI USA, V84, P8507, DOI 10.1073/pnas.84.23.8507; Lynch M., 1998, GENETICS ANAL QUANTI; Mackay WP, 2000, SOCIOBIOLOGY, V36, P265; MCCAULEY DE, 1980, EVOLUTION, V34, P813, DOI 10.1111/j.1558-5646.1980.tb04020.x; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Moore AJ, 2005, AM NAT, V165, pS88, DOI 10.1086/429354; Moore AJ, 2002, AM NAT, V160, pS186, DOI 10.1086/342899; MORITZ RFA, 1987, BEHAV ECOL SOCIOBIOL, V21, P53, DOI 10.1007/BF00324435; Muller HJ, 1942, BIOL S, V6, P71; NONACS P, 1992, EVOLUTION, V46, P1605, DOI [10.2307/2410019, 10.1111/j.1558-5646.1992.tb01157.x]; Oldroyd BP, 2001, BEHAV ECOL SOCIOBIOL, V50, P366, DOI 10.1007/s002650100376; Orr HA, 2001, TRENDS ECOL EVOL, V16, P343; Pankiw T, 2002, ANIM BEHAV, V64, P663, DOI 10.1006/anbe.2002.3096; Plateaux L., 1985, Actes des Colloques Insectes Sociaux, V2, P203; QUELLER DC, 1985, NATURE, V318, P366, DOI 10.1038/318366a0; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; Ross KG, 2002, BEHAV ECOL SOCIOBIOL, V51, P287, DOI [10.1007/s00265-001-0431-5, 10.1007/S00265-001-0431-5]; Ruppell O, 2001, HEREDITY, V87, P33, DOI 10.1046/j.1365-2540.2001.00904.x; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRIVERS RL, 1976, SCIENCE, V191, P249, DOI 10.1126/science.1108197; WADE MJ, 1980, SCIENCE, V210, P665, DOI 10.1126/science.210.4470.665; WADE MJ, 1979, AM NAT, V113, P399, DOI 10.1086/283398; Wade MJ, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P5; Wenseleers T, 2006, J EVOLUTION BIOL, V19, P1419, DOI 10.1111/j.1420-9101.2006.01144.x; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; WHITE JM, 1968, GENETICS, V60, P395; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; WILLHAM RL, 1963, BIOMETRICS, V19, P18, DOI 10.2307/2527570; WILSON EO, 1985, FORTS ZOOL, V31, P307; Wolf JB, 2003, P NATL ACAD SCI USA, V100, P4655, DOI 10.1073/pnas.0635741100; Wolf JB, 2000, EVOLUTION, V54, P1882, DOI 10.1111/j.0014-3820.2000.tb01235.x; Wolf JB, 1998, EVOLUTION, V52, P299, DOI [10.1111/j.1558-5646.1998.tb01632.x, 10.2307/2411068]; Wolf JB, 1999, AM NAT, V153, P254, DOI 10.1086/303168; Wolf JB, 2002, HEREDITY, V89, P300, DOI 10.1038/sj.hdy.6800140; Wolf JB., 2000, EPISTASIS EVOLUTIONA, P158; WOLF JB, EPISTASIS EVOLUTIONA; Wright S, 1931, GENETICS, V16, P0097	71	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e994	10.1371/journal.pone.0000994	http://dx.doi.org/10.1371/journal.pone.0000994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912371	gold, Green Submitted, Green Published			2022-12-27	WOS:000207455900030
J	Postma, E				Postma, Erik			Inflated Impact Factors? The True Impact of Evolutionary Papers in Non-Evolutionary Journals	PLOS ONE			English	Article								Amongst the numerous problems associated with the use of impact factors as a measure of quality are the systematic differences in impact factors that exist among scientific fields. While in theory this can be circumvented by limiting comparisons to journals within the same field, for a diverse and multidisciplinary field like evolutionary biology, in which the majority of papers are published in journals that publish both evolutionary and non-evolutionary papers, this is impossible. However, a journal's overall impact factor may well be a poor predictor for the impact of its evolutionary papers. The extremely high impact factors of some multidisciplinary journals, for example, are by many believed to be driven mostly by publications from other fields. Despite plenty of speculation, however, we know as yet very little about the true impact of evolutionary papers in journals not specifically classified as evolutionary. Here I present, for a wide range of journals, an analysis of the number of evolutionary papers they publish and their average impact. I show that there are large differences in impact among evolutionary and non-evolutionary papers within journals; while the impact of evolutionary papers published in multidisciplinary journals is substantially overestimated by their overall impact factor, the impact of evolutionary papers in many of the more specialized, non-evolutionary journals is significantly underestimated. This suggests that, for evolutionary biologists, publishing in high-impact multidisciplinary journals should not receive as much weight as it does now, while evolutionary papers in more narrowly defined journals are currently undervalued. Importantly, however, their ranking remains largely unaffected. While journal impact factors may thus indeed provide a meaningful qualitative measure of impact, a fair quantitative comparison requires a more sophisticated journal classification system, together with multiple field-specific impact statistics per journal.	Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Postma, E (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	e.postma@unsw.edu.au	Postma, Erik/B-7258-2008	Postma, Erik/0000-0003-0856-1294	University of New South Wales	University of New South Wales	University of New South Wales Vice-Chancellor's post-doctoral fellowship	[Anonymous], 2005, NATURE, V435, P1003, DOI 10.1038/4351003a; [Anonymous], 2006, PLOS MED, V3, P707, DOI 10.1371/journal.pmed.0030291; Garfield E, 1996, BRIT MED J, V313, P411, DOI 10.1136/bmj.313.7054.411; Kokko H, 1999, TRENDS ECOL EVOL, V14, P382, DOI 10.1016/S0169-5347(99)01711-5; METCALFE NB, 1995, NATURE, V376, P720, DOI 10.1038/376720b0; Seglen PO, 1997, BRIT MED J, V314, P498; STATZNER B, 1995, OIKOS, V72, P440, DOI 10.2307/3546130	7	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e999	10.1371/journal.pone.0000999	http://dx.doi.org/10.1371/journal.pone.0000999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912376	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455900035
J	Nettle, D; Grace, JB; Choisy, M; Cornell, HV; Guegan, JF; Hochberg, ME				Nettle, Daniel; Grace, James B.; Choisy, Marc; Cornell, Howard V.; Guegan, Jean-Francois; Hochberg, Michael E.			Cultural Diversity, Economic Development and Societal Instability	PLOS ONE			English	Article								Background. Social scientists have suggested that cultural diversity in a nation leads to societal instability. However, societal instability may be affected not only by within-nation or alpha diversity, but also diversity between a nation and its neighbours or beta diversity. It is also necessary to distinguish different domains of diversity, namely linguistic, ethnic and religious, and to distinguish between the direct effects of diversity on societal instability, and effects that are mediated by economic conditions. Methodology/Principal Findings. We assembled a large cross-national dataset with information on alpha and beta cultural diversity, economic conditions, and indices of societal instability. Structural equation modeling was used to evaluate the direct and indirect effects of cultural diversity on economics and societal stability. Results show that different types and domains of diversity have interacting effects. As previously documented, linguistic alpha diversity has a negative effect on economic performance, and we show that it is largely through this economic mechanism that it affects societal instability. For beta diversity, the higher the linguistic diversity among nations in a region, the less stable the nation. But, religious beta diversity has the opposite effect, reducing instability, particularly in the presence of high linguistic diversity. Conclusions. Within-nation linguistic diversity is associated with reduced economic performance, which, in turn, increases societal instability. Nations which differ linguistically from their neighbors are also less stable. However, religious diversity between neighboring nations has the opposite effect, decreasing societal instability.	[Nettle, Daniel] Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England; [Grace, James B.] US Geol Survey, Lafayette, LA USA; [Choisy, Marc] Univ Georgia, Inst Ecol, Athens, GA 30602 USA; [Choisy, Marc; Guegan, Jean-Francois] IRD CNRS, UMR 2724, Montpellier, France; [Cornell, Howard V.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Hochberg, Michael E.] Univ Montpellier 2, UMR 5554, Inst Sci Evolut, Montpellier, France; [Hochberg, Michael E.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Hochberg, Michael E.] Santa Fe Inst, Santa Fe, NM 87501 USA	Newcastle University - UK; United States Department of the Interior; United States Geological Survey; University System of Georgia; University of Georgia; Institut de Recherche pour le Developpement (IRD); University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; National Center for Ecological Analysis & Synthesis; The Santa Fe Institute	Nettle, D (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England.	daniel.nettle@ncl.ac.uk	Guegan, Jean-Francois/F-4346-2012; Choisy, Marc/J-7131-2016; Nettle, Daniel/B-2259-2008; Choisy, Marc/AAE-2557-2020; Grace, James/B-8472-2009	Guegan, Jean-Francois/0000-0002-7218-107X; Choisy, Marc/0000-0002-5187-6390; Nettle, Daniel/0000-0001-9089-2599; Choisy, Marc/0000-0002-5187-6390; Grace, James/0000-0001-6374-4726	National Center for Ecological Analysis and Synthesis, Santa Barbara, California, USA	National Center for Ecological Analysis and Synthesis, Santa Barbara, California, USA	This research was supported by the National Center for Ecological Analysis and Synthesis, Santa Barbara, California, USA.	Alesina A, 2003, J ECON GROWTH, V8, P155, DOI 10.1023/A:1024471506938; Alexander R., 2008, ESSAYS PEDAGOGY; Arbuckle J.L., 2006, AMOS 7 0 USERS GUIDE; Arbuckle JL., 1996, ADV STRUCTURAL EQUAT, P243, DOI DOI 10.4324/9781315827414; Barro R.J., 1994, DATA SET PANEL 138 C; Bollen KA, 1989, STRUCTURAL EQUATIONS; *CIA, 2005, CIA WORLD FACT BOOK; Easterly W, 2001, ECON DEV CULT CHANGE, V49, P687, DOI 10.1086/452521; Easterly W, 1997, Q J ECON, V112, P1203, DOI 10.1162/003355300555466; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; Grace J.B., 2006, STRUCT EQ MOD NAT; GRACE JB, ENV ECOLOGI IN PRESS; GRAFTON RQ, 2001, SOCIAL DIVERGENCE EC; Hall RE, 1997, AM ECON REV, V87, P173; LIAM B, 1997, EC DEV CULTURAL CHAN, V46, P61; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Nettle D, 2000, ECON DEV CULT CHANGE, V48, P335, DOI 10.1086/452461; Pool J., 1972, ADV SOCIOLOGY LANGUA, P213; Zak PJ, 2001, ECON J, V111, P295, DOI 10.1111/1468-0297.00609	19	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e929	10.1371/journal.pone.0000929	http://dx.doi.org/10.1371/journal.pone.0000929			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895970	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455800008
J	Lesueur, F; Oudot, T; Heath, S; Foglio, M; Lathrop, M; Prud'homme, JF; Fischer, J				Lesueur, Fabienne; Oudot, Tiphaine; Heath, Simon; Foglio, Mario; Lathrop, Mark; Prud'homme, Jean-Francois; Fischer, Judith			ADAM33, a New Candidate for Psoriasis Susceptibility	PLOS ONE			English	Article							GENOME-WIDE SEARCH; LINKAGE DISEQUILIBRIUM; ATOPIC-DERMATITIS; CHROMOSOME 6P; HLA-C; GENE; IDENTIFICATION; ASTHMA; PSORS1; POLYMORPHISMS	Psoriasis is a chronic skin disorder with multifactorial etiology. In a recent study, we reported results of a genome-wide scan on 46 French extended families presenting with plaque psoriasis. In addition to unambiguous linkage to the major susceptibility locus PSORS1 on Chromosome 6p21, we provided evidence for a susceptibility locus on Chromosome 20p13. To follow up this novel psoriasis susceptibility locus we used a family-based association test (FBAT) for an association scan over the 17 Mb candidate region. A total of 85 uncorrelated SNP markers located in 65 genes of the region were initially investigated in the same set of large families used for the genome wide search, which consisted of 295 nuclear families. When positive association was obtained for a SNP, candidate genes nearby were explored more in detail using a denser set of SNPs. Thus, the gene ADAM33 was found to be significantly associated with psoriasis in this family set (The best association was on a 3-SNP haplotype P = 0.00004, based on 1,000,000 permutations). This association was independent of PSORS1. ADAM33 has been previously associated with asthma, which demonstrates that immune system diseases may be controlled by common susceptibility genes with general effects on dermal inflammation and immunity. The identification of ADAM33 as a psoriasis susceptibility gene identified by positional cloning in an outbred population should provide insights into the pathogenesis and natural history of this common disease.	[Lesueur, Fabienne; Oudot, Tiphaine; Heath, Simon; Foglio, Mario; Lathrop, Mark; Fischer, Judith] Ctr Natl Genotypage, Evry, France; [Prud'homme, Jean-Francois] Genethon, Evry, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Lesueur, F (corresponding author), Ctr Natl Genotypage, Evry, France.	lesueurf@iarc.fr; fischer@cng.fr	Foglio, mary A./B-9149-2012; Fischer, Judith/E-6327-2016; Heath, Simon C/J-4138-2012; Lesueur, Fabienne/R-2178-2017	Foglio, mary A./0000-0001-7715-4452; Fischer, Judith/0000-0002-8580-8118; Heath, Simon C/0000-0002-9550-0897; Lesueur, Fabienne/0000-0001-7404-4549	Centre National de GeNotypage (CNG); Association Francaise contre les Myopathies (AFM); Genethon; GenopA'le	Centre National de GeNotypage (CNG); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Genethon; GenopA'le	This study was supported by the Centre National de GeNotypage (CNG), the Association Francaise contre les Myopathies (AFM), and Genethon. FL was recipient of a fellowship from GenopA'le.	Allen M, 2003, AM J HUM GENET, V73, P430; Asumalahti K, 2002, HUM MOL GENET, V11, P589, DOI 10.1093/hmg/11.5.589; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Bowcock AM, 2004, HUM MOL GENET, V13, pR43, DOI 10.1093/hmg/ddh094; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Cebrian A, 2005, J CLIN ENDOCR METAB, V90, P6268, DOI 10.1210/jc.2004-2449; Chae SC, 2003, J HUM GENET, V48, P278, DOI 10.1007/s10038-003-0019-1; Cheng L, 2004, CLIN EXP ALLERGY, V34, P1192, DOI 10.1111/j.1365-2222.2004.02008.x; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; Cox NJ, 2004, DIABETES, V53, pS19, DOI 10.2337/diabetes.53.2007.S19; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Elder JT, 2006, J INVEST DERMATOL, V126, P1205, DOI 10.1038/sj.jid.5700357; Enlund F, 1999, HUM HERED, V49, P2, DOI 10.1159/000022832; Giardina E, 2006, HUM HERED, V61, P229, DOI 10.1159/000095059; Helms C, 2005, HUM GENET, V118, P466, DOI 10.1007/s00439-005-0048-2; Hewett D, 2002, GENOMICS, V79, P305, DOI 10.1006/geno.2002.6720; Holgate ST, 2003, THORAX, V58, P466, DOI 10.1136/thorax.58.6.466; Howard TD, 2003, J ALLERGY CLIN IMMUN, V112, P717, DOI 10.1016/S0091-6749(03)01939-0; Jannot AS, 2003, GENET EPIDEMIOL, V25, P158, DOI 10.1002/gepi.10256; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Lench N, 2005, J INVEST DERMATOL, V124, P545, DOI 10.1111/j.0022-202X.2005.23604.x; LESUEUR F, 2007, J INVESTIGATIVE 0308; Mahe E, 2002, EUR J DERMATOL, V12, P66; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; Nevitt GJ, 1996, BRIT J DERMATOL, V135, P533, DOI 10.1046/j.1365-2133.1996.d01-1035.x; Powell RM, 2004, AM J RESP CELL MOL, V31, P13, DOI 10.1165/rcmb.2003-0330OC; Sagoo GS, 2004, J INVEST DERMATOL, V122, P1401, DOI 10.1111/j.0022-202X.2004.22607.x; Samuelsson L, 1999, HUM GENET, V105, P523, DOI 10.1007/s004390051141; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stram DO, 2004, GENET EPIDEMIOL, V27, P365, DOI 10.1002/gepi.20028; Tagami H, 1997, CLIN DERMATOL, V15, P677, DOI 10.1016/S0738-081X(97)00024-2; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Umland SP, 2003, AM J RESP CELL MOL, V29, P571, DOI 10.1165/rcmb.2003-0028OC; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Veal CD, 2002, AM J HUM GENET, V71, P554, DOI 10.1086/342289; Veal CD, 2001, J MED GENET, V38, P7, DOI 10.1136/jmg.38.1.7; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Werner M, 2004, CLIN EXP ALLERGY, V34, P26, DOI 10.1111/j.1365-2222.2004.01846.x; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Wjst M, 2007, ALLERGY, V62, P444, DOI 10.1111/j.1398-9995.2006.01298.x; Yoshinaka T, 2002, GENE, V282, P227, DOI 10.1016/S0378-1119(01)00818-6; Zhang XJ, 2002, J INVEST DERMATOL, V119, P1361, DOI 10.1046/j.1523-1747.2002.19612.x	45	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e906	10.1371/journal.pone.0000906	http://dx.doi.org/10.1371/journal.pone.0000906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878941	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455700014
J	Roussarie, JP; Ruffie, C; Edgar, JM; Griffiths, I; Brahic, M				Roussarie, Jean-Pierre; Ruffie, Claude; Edgar, Julia M.; Griffiths, Ian; Brahic, Michel			Axon Myelin Transfer of a Non-Enveloped Virus	PLOS ONE			English	Article								We showed previously that Theiler's virus, a neurotropic non-enveloped picornavirus of mouse, traffics from the axon of infected neurons into the surrounding myelin. When this traffic is interrupted, as in the shiverer mouse which bears a mutation in the myelin basic protein gene, the virus is unable to persist in the central nervous system. In the present work, we used the Wld(5) mutant mouse, a strain in which axonal degeneration is considerably slowed down, to show that axon to myelin traffic takes place in the absence of axon degeneration. Our results suggest the existence of a mechanism of transfer of axonal cytoplasm into the myelin which Theiler's virus might exploit to ensure its persistence.	[Roussarie, Jean-Pierre; Ruffie, Claude; Brahic, Michel] Inst Pasteur, CNRS, URA3015, Dept Virol, Paris, France; [Edgar, Julia M.; Griffiths, Ian] Univ Glasgow, Inst Comparat Med, Appl Neurobiol Grp, Glasgow, Lanark, Scotland	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Glasgow	Brahic, M (corresponding author), Stanford Univ, Sch Med, Dept Microbiol Immunol, Stanford, CA 94305 USA.	mbrahic@stanford.edu	Edgar, Julia M/U-8456-2019	Edgar, Julia M/0000-0002-3869-0962; roussarie, jean-pierre/0000-0003-2644-6046	Institut Pasteur; CNRS; ARSEP; FRM; MSS (Scotland)	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ARSEP; FRM(Fondation pour la Recherche Medicale); MSS (Scotland)	Funding: The work was funded by the Institut Pasteur, the CNRS, the ARSEP, the FRM, the MSS (Scotland). These funders did not play any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Bihl F, 1997, J VIROL, V71, P5025, DOI 10.1128/JVI.71.7.5025-5030.1997; Brahic M, 2005, ANNU REV MICROBIOL, V59, P279, DOI 10.1146/annurev.micro.59.030804.121242; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Edgar JM, 2004, J NEUROSCI RES, V76, P593, DOI 10.1002/jnr.20063; Gatzinsky KP, 1997, GLIA, V20, P115, DOI 10.1002/(SICI)1098-1136(199706)20:2<115::AID-GLIA3>3.0.CO;2-8; GRIFFITHS IR, 1981, J NEUROCYTOL, V10, P847, DOI 10.1007/BF01262657; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kirkegaard K, 2005, AUTOPHAGY, V1, P182, DOI 10.4161/auto.1.3.2065; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Li YC, 2005, NEUROSCI RES, V53, P298, DOI 10.1016/j.neures.2005.07.006; NOVOTNY GEK, 1984, ACTA ANAT, V119, P106; Roussarie JP, 2007, PLOS PATHOG, V3, P212, DOI 10.1371/journal.ppat.0030023; SPENCER PS, 1974, J NEUROCYTOL, V3, P763, DOI 10.1007/BF01097197	13	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1331	10.1371/journal.pone.0001331	http://dx.doi.org/10.1371/journal.pone.0001331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159229	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459700003
J	Vitale, I; Galluzzi, L; Vivet, S; Nanty, L; Dessen, P; Senovilla, L; Olaussen, KA; Lazar, V; Prudhomme, M; Golsteyn, RM; Castedo, M; Kroemer, G				Vitale, Ilio; Galluzzi, Lorenzo; Vivet, Sonia; Nanty, Lisa; Dessen, Philippe; Senovilla, Laura; Olaussen, Ken A.; Lazar, Vladimir; Prudhomme, Michelle; Golsteyn, Roy M.; Castedo, Maria; Kroemer, Guido			Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway	PLOS ONE			English	Article								Tetraploidy constitutes an adaptation to stress and an intermediate step between euploidy and aneuploidy in oncogenesis. Tetraploid cells are particularly resistant against genotoxic stress including radiotherapy and chemotherapy. Here, we designed a strategy to preferentially kill tetraploid tumor cells. Depletion of checkpoint kinase-1 (Chk1) by siRNAs, transfection with dominant-negative Chk1 mutants or pharmacological Chk1 inhibition killed tetraploid colon cancer cells yet had minor effects on their diploid counterparts. Chk1 inhibition abolished the spindle assembly checkpoint and caused premature and abnormal mitoses that led to p53 activation and cell death at a higher frequency in tetraploid than in diploid cells. Similarly, abolition of the spindle checkpoint by knockdown of Bub1, BubR1 or Mad2 induced p53- dependent apoptosis of tetraploid cells. Chk1 inhibition reversed the cisplatin resistance of tetraploid cells in vitro and in vivo, in xenografted human cancers. Chk1 inhibition activated p53-regulated transcripts including Puma/BBC3 in tetraploid but not in diploid tumor cells. Altogether, our results demonstrate that, in tetraploid tumor cells, the inhibition of Chk1 sequentially triggers aberrant mitosis, p53 activation and Puma/BBC3-dependent mitochondrial apoptosis.	[Vitale, Ilio; Galluzzi, Lorenzo; Vivet, Sonia; Nanty, Lisa; Senovilla, Laura; Olaussen, Ken A.; Castedo, Maria; Kroemer, Guido] INSERM, U848, Villejuif, France; [Dessen, Philippe; Lazar, Vladimir] Inst Gustave Roussy, Unite Genom Fonct, Villejuif, France; [Vitale, Ilio; Galluzzi, Lorenzo; Vivet, Sonia; Dessen, Philippe; Senovilla, Laura; Olaussen, Ken A.; Lazar, Vladimir; Castedo, Maria; Kroemer, Guido] Univ Paris Sud, Villejuif, France; [Dessen, Philippe; Lazar, Vladimir] CNRS, FRE2939, Villejuif, France; [Prudhomme, Michelle] Univ Clermont Ferrand, CNRS, UMR 6504, Aubiere, France; [Golsteyn, Roy M.] Inst Rech Servier, Croissy Sur Seine, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Servier; Institut de Recherches Internationales Servier	Kroemer, G (corresponding author), INSERM, U848, Villejuif, France.	kroemer@igr.fr	Lazar, Vladimir/AAQ-2086-2020; Galluzzi, Lorenzo/AAG-6294-2019; Galluzzi, Lorenzo/AAH-3286-2021; Galluzzi, Lorenzo/K-2709-2012; Vitale, Ilio/M-3960-2017; Lazar, Vladimir/AAV-2087-2020; Kroemer, Guido/AAY-9859-2020; Senovilla, Laura/AAX-5599-2021; Galluzzi, Lorenzo/AAG-6432-2019; KROEMER, Guido/B-4263-2013	Galluzzi, Lorenzo/0000-0003-2257-8500; Vitale, Ilio/0000-0002-5918-1841; KROEMER, Guido/0000-0002-9334-4405; Senovilla, Laura/0000-0001-6887-2436; Olaussen, Ken/0000-0002-3115-8914	Association pour la Recherche sur le Cancer; Ligue Nationale contre le cancer, Institut National du Cancer [PL06_086]; European Community; Institut Gustave Roussy	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale contre le cancer, Institut National du Cancer(Institut National du Cancer (INCA) France); European Community(European Commission); Institut Gustave Roussy	Funding: MC is supported by Association pour la Recherche sur le Cancer. GK is supported by Ligue Nationale contre le cancer, Institut National du Cancer (N degrees PL06_086), European Community (Active p53 EC FP6 funding, RIGHT, TransDeath, Death-Train, CHEMORES), and Institut Gustave Roussy.	Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Asher G, 2003, P NATL ACAD SCI USA, V100, P15065, DOI 10.1073/pnas.2436329100; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; BARRES DR, 1985, ANAL QUANT CYTOL, V7, P320; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BJELKENKRANTZ K, 1983, ANAL QUANT CYTOL, V5, P184; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Buhmeida A, 2002, ANTICANCER RES, V22, P2397; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Castedo M, 2002, EMBO J, V21, P4070, DOI 10.1093/emboj/cdf391; Castedo M, 2006, ANN NY ACAD SCI, V1090, P35, DOI 10.1196/annals.1378.004; Castedo M, 2006, EMBO J, V25, P2584, DOI 10.1038/sj.emboj.7601127; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Criollo A, 2007, APOPTOSIS, V12, P3, DOI 10.1007/s10495-006-0328-x; CUVELIER CA, 1987, HISTOPATHOLOGY, V11, P927, DOI 10.1111/j.1365-2559.1987.tb01899.x; Damia G, 2001, NEOPLASIA, V3, P10, DOI 10.1038/sj.neo.7900122; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4; Duelli DM, 2005, J CELL BIOL, V171, P493, DOI 10.1083/jcb.200507069; Durkin SG, 2006, ONCOGENE, V25, P4381, DOI 10.1038/sj.onc.1209466; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Furuta T, 2006, ONCOGENE, V25, P2839, DOI 10.1038/sj.onc.1209313; GALLUZZI L, 2007, APOPTOSIS; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guerra S, 2006, J BIOL CHEM, V281, P18734, DOI 10.1074/jbc.M511983200; Heselmeyer K, 1996, P NATL ACAD SCI USA, V93, P479, DOI 10.1073/pnas.93.1.479; Incassati A, 2006, ONCOGENE, V25, P2444, DOI 10.1038/sj.onc.1209276; Lara PN, 2005, CLIN CANCER RES, V11, P4444, DOI 10.1158/1078-0432.CCR-04-2602; Levesque AA, 2005, ONCOGENE, V24, P3786, DOI 10.1038/sj.onc.1208451; Maley CC, 2004, CANCER RES, V64, P7629, DOI 10.1158/0008-5472.CAN-04-1738; Margolis RL, 2005, CANCER CELL, V8, P353, DOI 10.1016/j.ccr.2005.10.017; Nelson DA, 2004, GENE DEV, V18, P2095, DOI 10.1101/gad.1204904; Nevanlinna H, 2006, ONCOGENE, V25, P5912, DOI 10.1038/sj.onc.1209877; Niida H, 2005, J BIOL CHEM, V280, P39246, DOI 10.1074/jbc.M505009200; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Pawelek JM, 2005, LANCET ONCOL, V6, P988, DOI 10.1016/S1470-2045(05)70466-6; Perfettini JL, 2005, CELL DEATH DIFFER, V12, P916, DOI 10.1038/sj.cdd.4401584; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Sampath D, 2006, BLOOD, V107, P2517, DOI 10.1182/blood-2005-08-3351; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Shieh SY, 2000, GENE DEV, V14, P289; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Sugimoto M, 2006, MOL CELL BIOL, V26, P502, DOI 10.1128/MCB.26.2.502-512.2006; Syljuasen RG, 2004, CANCER RES, V64, P9035, DOI 10.1158/0008-5472.CAN-04-2434; Tang JB, 2006, P NATL ACAD SCI USA, V103, P11964, DOI 10.1073/pnas.0604987103; Tao Zhi-Fu, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P377, DOI 10.2174/187152006777698132; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Tse AN, 2004, CANCER RES, V64, P6635, DOI 10.1158/0008-5472.CAN-04-0841; Tsuchihara K, 2005, CANCER RES, V65, P6685, DOI 10.1158/0008-5472.CAN-04-4223; VANDYKE DL, 1994, GENE CHROMOSOME CANC, V9, P192, DOI 10.1002/gcc.2870090308; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; ZERMATI Y, 2007, MOL CELL IN PRESS; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou Bin-Bing S, 2003, Prog Cell Cycle Res, V5, P413	60	66	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1337	10.1371/journal.pone.0001337	http://dx.doi.org/10.1371/journal.pone.0001337			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159231	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459700005
J	Camargo, A; Azuaje, F				Camargo, Anyela; Azuaje, Francisco			Linking Gene Expression and Functional Network Data in Human Heart Failure	PLOS ONE			English	Article								Background. Gene expression profiling and the analysis of protein-protein interaction (PPI) networks may support the identification of disease bio-markers and potential drug targets. Thus, a step forward in the development of systems approaches to medicine is the integrative analysis of these data sources in specific pathological conditions. We report such an integrative bioinformatics analysis in human heart failure (HF). A global PPI network in HF was assembled, which by itself represents a useful compendium of the current status of human HF-relevant interactions. This provided the basis for the analysis of interaction connectivity patterns in relation to a HF gene expression data set. Results. Relationships between the significance of the differentiation of gene expression and connectivity degrees in the PPI network were established. In addition, relationships between gene co-expression and PPI network connectivity were analysed. Highly-connected proteins are not necessarily encoded by genes significantly differentially expressed. Genes that are not significantly differentially expressed may encode proteins that exhibit diverse network connectivity patterns. Furthermore, genes that were not defined as significantly differentially expressed may encode proteins with many interacting partners. Genes encoding network hubs may exhibit weak co-expression with the genes encoding their interacting protein partners. We also found that hubs and superhubs display a significant diversity of co-expression patterns in comparison to peripheral nodes. Gene Ontology ( GO) analysis established that highly-connected proteins are likely to be engaged in higher level GO biological process terms, while low-connectivity proteins tend to be engaged in more specific disease-related processes. Conclusion. This investigation supports the hypothesis that the integrative analysis of differential gene expression and PPI network analysis may facilitate a better understanding of functional roles and the identification of potential drug targets in human heart failure.	[Camargo, Anyela; Azuaje, Francisco] Univ Ulster, Sch Comp & Math, Jordanstown, Newtownabbey, North Ireland	Ulster University	Azuaje, F (corresponding author), Univ Ulster, Sch Comp & Math, Jordanstown, Newtownabbey, North Ireland.	fj.azuaje@ieee.org			European Union	European Union(European Commission)	This work was supported in part by a grant from the European Union (FP6), CARDIOWORKBENCH project, to FA. Public data and methodologies were used. Funders did not have any role in the design and conduct of this study.	*AHA, 2007, HEART DIS STROK STAT; Barth AS, 2006, J AM COLL CARDIOL, V48, P1610, DOI 10.1016/j.jacc.2006.07.026; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Deo RC, 2002, CELL, V108, P71, DOI 10.1016/S0092-8674(01)00632-8; Fischer P, 2007, BASIC RES CARDIOL, V102, P393, DOI 10.1007/s00395-007-0674-z; Kang PM, 2000, CIRC RES, V86, P1107; KANN MG, 2007, BRIEF BIOINFORM; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; KITTLESON MM, 2005, PHYSIOL GENOMICS, V3, P99; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mathivanan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S19; Niu J, 2006, CARDIOVASC RES, V71, P139, DOI 10.1016/j.cardiores.2006.03.008; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tan FL, 2002, P NATL ACAD SCI USA, V99, P11387, DOI 10.1073/pnas.162370099; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang MJ, 2007, AM J PHYSIOL-HEART C, V292, pH1694, DOI 10.1152/ajpheart.01063.2006; Watanabe Tetsuya, 2004, Nihon Rinsho, V62, P2337; Wittchen F, 2007, J MOL MED, V85, P253, DOI 10.1007/s00109-006-0122-9; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467	22	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1347	10.1371/journal.pone.0001347	http://dx.doi.org/10.1371/journal.pone.0001347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18094754	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459600029
J	Varma, H; Skildum, AJ; Conrad, SE				Varma, Hemant; Skildum, Andrew J.; Conrad, Susan E.			Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells	PLOS ONE			English	Article								Estrogens are required for the proliferation of hormone dependent breast cancer cells, making estrogen receptor ( ER) positive tumors amenable to endocrine therapies such as antiestrogens. However, resistance to these agents remains a significant cause of treatment failure. We previously demonstrated that inactivation of the retinoblastoma protein (pRb) family tumor suppressors causes antiestrogen resistance in MCF-7 cells, a widely studied model of estrogen responsive human breast cancers. In this study, we investigate the mechanism by which pRb inactivation leads to antiestrogen resistance. Cdk4 and cdk2 are two key cell cycle regulators that can phosphorylate and inactivate pRb, therefore we tested whether these kinases are required in cells lacking pRb function. pRb family members were inactivated in MCF-7 cells by expressing polyomavirus large tumor antigen (PyLT), and cdk activity was inhibited using the cdk inhibitors p16(INK4A) and p21(Waf1/Cip1). Cdk4 activity was no longer required in cells lacking functional pRb, while cdk2 activity was required for proliferation in both the presence and absence of pRb function. Using inducible PyLT cell lines, we further demonstrated that pRb inactivation leads to increased cyclin A expression, cdk2 activation and proliferation in antiestrogen arrested cells. These results demonstrate that antiestrogens do not inhibit cdk2 activity or proliferation of MCF-7 cells in the absence of pRb family function, and suggest that antiestrogen resistant breast cancer cells resulting from pRb pathway inactivation would be susceptible to therapies that target cdk2.	[Varma, Hemant] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Skildum, Andrew J.; Conrad, Susan E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Varma, H (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	hv2108@columbia.edu			NIH [CA76647]; Jean P. Schultz Endowed Oncology Fund for Cancer Research, Michigan State University; NATIONAL CANCER INSTITUTE [R01CA076647] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jean P. Schultz Endowed Oncology Fund for Cancer Research, Michigan State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH Grant CA76647 and Jean P. Schultz Endowed Oncology Fund for Cancer Research, Michigan State University	Alevizopoulos K, 1998, EMBO J, V17, P5987, DOI 10.1093/emboj/17.20.5987; Bosco EE, 2007, CELL CYCLE, V6, P667, DOI 10.4161/cc.6.6.3988; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Brodsky JL, 1998, J VIROL, V72, P5329, DOI 10.1128/JVI.72.7.5329-5334.1998; BRUNNER N, 1989, CANCER RES, V49, P1515; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chu I, 2005, CANCER RES, V65, P18; Cigler T, 2007, CANCER J, V13, P148, DOI 10.1097/PPO.0b013e318074d363; DARBRE P, 1983, CANCER RES, V43, P349; Dublin EA, 1998, INT J CANCER, V79, P71, DOI 10.1002/(SICI)1097-0215(19980220)79:1<71::AID-IJC14>3.0.CO;2-K; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Fischer PM, 2005, EXPERT OPIN INV DRUG, V14, P457, DOI 10.1517/13543784.14.4.457; Foster JS, 2001, MOL CELL BIOL, V21, P794, DOI 10.1128/MCB.21.3.794-810.2001; Howes SH, 1996, J VIROL, V70, P3581, DOI 10.1128/JVI.70.6.3581-3588.1996; Jares P, 1997, J PATHOL, V182, P160; Levenson AS, 1997, CANCER RES, V57, P3071; LIPPMAN M, 1976, CANCER RES, V36, P4595; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Mann DJ, 1996, CURR BIOL, V6, P474, DOI 10.1016/S0960-9822(02)00515-8; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; MELORA DB, 1998, PRINCIPLES MOL MED, P625; Mukherjee S, 2005, J BIOL CHEM, V280, P17617, DOI 10.1074/jbc.M502278200; OSBORNE CK, 1984, CANCER RES, V44, P1433; PlanasSilva MD, 1997, MOL CELL BIOL, V17, P4059, DOI 10.1128/MCB.17.7.4059; Prall OWJ, 1998, MOL CELL BIOL, V18, P4499, DOI 10.1128/MCB.18.8.4499; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; SCHULZE A, 1995, P NATL ACAD SCI USA, V92, P11264, DOI 10.1073/pnas.92.24.11264; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Skildum AJ, 2002, J BIOL CHEM, V277, P5145, DOI 10.1074/jbc.M109179200; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; VARLEY JM, 1989, ONCOGENE, V4, P725; Varma H, 2000, ONCOGENE, V19, P4746, DOI 10.1038/sj.onc.1203827; Varma H, 2002, CANCER RES, V62, P3985; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Zhang XH, 2000, MOL BIOL CELL, V11, P2117, DOI 10.1091/mbc.11.6.2117	40	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1256	10.1371/journal.pone.0001256	http://dx.doi.org/10.1371/journal.pone.0001256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060053	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459400005
J	Ruiz, MF; Milano, A; Salvemini, M; Eirin-Lopez, JM; Perondini, ALP; Selivon, D; Polito, C; Saccone, G; Sanchez, L				Fernanda Ruiz, Maria; Milano, Andreina; Salvemini, Marco; Maria Eirin-Lopez, Jose; Perondini, Andre L. P.; Selivon, Denise; Polito, Catello; Saccone, Giuseppe; Sanchez, Lucas			The Gene Transformer of Anastrepha Fruit Flies (Diptera, Tephritidae) and Its Evolution in Insects	PLOS ONE			English	Article							SEX-DETERMINING GENE; DROSOPHILA-MELANOGASTER; DOUBLESEX; RNA; DIFFERENTIATION; SEQUENCE; LETHAL; CONSERVATION; MAINTAINS; ENCODES	In the tephritids Ceratitis capitata and Bactrocera oleae, the gene transformer acts as the memory device for sex determination, via an auto-regulatory function; and functional Tra protein is produced only in females. This paper investigates the evolution of the gene tra, which was characterised in twelve tephritid species belonging to the less extensively analysed genus Anastrepha. Our study provided the following major conclusions. Firstly, the memory device mechanism used by this gene in sex determination in tephritids likely existed in the common ancestor of the Ceratitis, Bactrocera and Anastrepha phylogenetic lineages. This mechanism would represent the ancestral state with respect to the extant cascade seen in the more evolved Drosophila lineage. Secondly, Transformer2-specific binding intronic splicing silencer sites were found in the splicing regulatory region of transformer but not in doublesex pre-mRNAs in these tephritids. Thus, these sites probably provide the discriminating feature for the putative dual splicing activity of the Tra-Tra2 complex in tephritids. It acts as a splicing activator in dsx pre-mRNA splicing (its binding to the female-specific exon promotes the inclusion of this exon into the mature mRNA), and as a splicing inhibitor in tra pre-mRNA splicing (its binding to the male-specific exons prevents the inclusion of these exons into the mature mRNA). Further, a highly conserved region was found in the specific amino-terminal region of the tephritid Tra protein that might be involved in Tra auto-regulatory function and hence in its repressive splicing behaviour. Finally, the Tra proteins conserved the SR dipeptides, which are essential for Tra functionality.	[Fernanda Ruiz, Maria; Sanchez, Lucas] CSIC, Ctr Invest Biol, Madrid, Spain; [Milano, Andreina; Salvemini, Marco; Polito, Catello; Saccone, Giuseppe] Univ Naples Federico II, Sez Genet & Biol Mol, Dipartimento Sci Biol, Naples, Italy; [Polito, Catello] CNR, Inst Genet & Biofis Adriano Buzzati Traverso ABT, I-80125 Naples, Italy; [Maria Eirin-Lopez, Jose] Univ A Coruna, Dept Biol Celular & Mol, Coruna, Spain; [Perondini, Andre L. P.; Selivon, Denise] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Universidade da Coruna; Universidade de Sao Paulo	Sanchez, L (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	lsanchez@cib.csic.es	Eirin-Lopez, Jose Maria/A-5618-2008; Ruiz, Maria Fernanda/F-3290-2016; saccone, giuseppe/F-8627-2013; Sánchez, Lucas/K-4238-2015; Perondini, André/B-2393-2014; Salvemini, Marco/AAJ-5560-2021	Eirin-Lopez, Jose Maria/0000-0002-8041-9770; saccone, giuseppe/0000-0002-9835-3693; Sánchez, Lucas/0000-0002-7725-8961; SALVEMINI, Marco/0000-0003-2297-9267; Ruiz, Maria Fernanda/0000-0002-1649-2105	D.G.I.C.Y.T. [BFU2005-03000]; PRIN; Insect Biotechnology PhD Programme; CSIC [20004BR0005, 20004IT0017]; CNPq [690088/02-7]; FAPESP [03/02698-3]; Fondo PRIN 2006 (Ministero dell'Istruzione, dell'Universita e della Ricerca); ASTF [168-05]; European Community	D.G.I.C.Y.T.(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Insect Biotechnology PhD Programme; CSIC; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fondo PRIN 2006 (Ministero dell'Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); ASTF; European Community(European Commission)	This work was financed by grants BFU2005-03000 awarded to L. Sanchez by the D.G.I.C.Y.T., by grant PRIN 2004 to C. Polito, by the Insect Biotechnology PhD Programme for A. Milano; by grants from a Joint Programme of the CSIC (20004BR0005 to L. Sanchez, Spain) and CNPq (690088/02-7 to ALP Perondini, Brazil), and a grant to D. Selivon (FAPESP, 03/02698-3, Brazil), and grant from a Joint Programme of the CSIC (20004IT0017) to L. Sanchez (Spain) and C. Polito (Italy). The work was partially supported by Fondo PRIN 2006 (Ministero dell'Istruzione, dell'Universita e della Ricerca) to C. Polito. M. F. Ruiz was recipient of a Short-term EMBO fellowship (ASTF Nu 168-05). J. M. Eirin-Lopez was awarded a Postdoctoral Marie Curie International Fellowship within the 6th European Community Framework Programme.	AMREIN H, 1990, EMBO J, V9, P3619, DOI 10.1002/j.1460-2075.1990.tb07573.x; Barr NB, 2005, ANN ENTOMOL SOC AM, V98, P173, DOI 10.1603/0013-8746(2005)098[0173:MSONGP]2.0.CO;2; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; BELOTE JM, 1989, DEV GENET, V10, P143, DOI 10.1002/dvg.1020100304; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BOGGS RT, 1987, CELL, V50, P739, DOI 10.1016/0092-8674(87)90332-1; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; CLINE TW, 1984, GENETICS, V107, P231; Ruiz MF, 2007, DEV GENES EVOL, V217, P725, DOI 10.1007/s00427-007-0178-8; GORALSKI TJ, 1989, CELL, V56, P1011, DOI 10.1016/0092-8674(89)90634-X; HEDLEY ML, 1991, CELL, V65, P579, DOI 10.1016/0092-8674(91)90090-L; HEINRICHS V, 1995, EMBO J, V14, P3987, DOI 10.1002/j.1460-2075.1995.tb00070.x; Hertel KJ, 1996, RNA, V2, P969; HOSHIJIMA K, 1991, SCIENCE, V252, P833, DOI 10.1126/science.1902987; INOUE K, 1990, NATURE, V344, P461, DOI 10.1038/344461a0; IRMINGERFINGER I, 1995, GENE, V163, P203, DOI 10.1016/0378-1119(95)00326-2; Kulathinal RJ, 2003, MOL BIOL EVOL, V20, P441, DOI 10.1093/molbev/msg053; Lagos D, 2007, INSECT MOL BIOL, V16, P221, DOI 10.1111/j.1365-2583.2006.00717.x; Maniatis T., 1982, MOL CLONING; McAllister BF, 2000, GENETICS, V154, P1711; MCKEOWN M, 1987, CELL, V48, P489, DOI 10.1016/0092-8674(87)90199-1; NAGOSHI RN, 1988, CELL, V53, P229, DOI 10.1016/0092-8674(88)90384-4; Norrbom AL, 2002, P ENTOMOL SOC WASH, V104, P390; Norrbom AL, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P299; ONEIL MT, 1992, GENETICS, V131, P113; Pane A, 2005, GENETICS, V171, P615, DOI 10.1534/genetics.105.041004; Pane A, 2002, DEVELOPMENT, V129, P3715; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pomiankowski A, 2004, GENETICS, V166, P1761, DOI 10.1534/genetics.166.4.1761; Qi JL, 2007, MOL CELL BIOL, V27, P699, DOI 10.1128/MCB.01572-06; Ruiz MF, 2005, GENETICS, V171, P849, DOI 10.1534/genetics.105.044925; RYNER LC, 1991, GENE DEV, V5, P2071, DOI 10.1101/gad.5.11.2071; SANCHEZ L, 2005, COMPREHENSIVE MOL IN, V1, P1; Selivon D., 2004, Proceedings of the 6th International Symposium on fruit flies of economic importance, Stellenbosch, South Africa, 6-10 May 2002, P253; Selivon D, 2005, ANN ENTOMOL SOC AM, V98, P367, DOI 10.1603/0013-8746(2005)098[0367:AGCOTC]2.0.CO;2; Serna E, 2004, GENETICS, V168, P907, DOI 10.1534/genetics.104.031278; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TIAN M, 1993, CELL, V74, P105, DOI 10.1016/0092-8674(93)90298-5; WILKINS AS, 1995, BIOESSAYS, V17, P71, DOI 10.1002/bies.950170113; Willhoeft U, 1996, GENETICS, V144, P737	40	72	77	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1239	10.1371/journal.pone.0001239	http://dx.doi.org/10.1371/journal.pone.0001239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043746	Green Published, gold			2022-12-27	WOS:000207459300020
J	Stoddart, CA; Joshi, P; Sloan, B; Bare, JC; Smith, PC; Allaway, GP; Wild, CT; Martin, DE				Stoddart, Cheryl A.; Joshi, Pheroze; Sloan, Barbara; Bare, Jennifer C.; Smith, Philip C.; Allaway, Graham P.; Wild, Carl T.; Martin, David E.			Potent Activity of the HIV-1 Maturation Inhibitor Bevirimat in SCID-hu Thy/Liv Mice	PLOS ONE			English	Article								Background. The HIV-1 maturation inhibitor, 3-O-(39,39-dimethylsuccinyl) betulinic acid (bevirimat, PA-457) is a promising drug candidate with 10 nM in vitro antiviral activity against multiple wild-type (WT) and drug-resistant HIV-1 isolates. Bevirimat has a novel mechanism of action, specifically inhibiting cleavage of spacer peptide 1 (SP1) from the C-terminus of capsid which results in defective core condensation. Methods and Findings. Oral administration of bevirimat to HIV-1-infected SCID-hu Thy/Liv mice reduced viral RNA by >2 log(10) and protected immature and mature T cells from virus-mediated depletion. This activity was observed at plasma concentrations that are achievable in humans after oral dosing, and bevirimat was active up to 3 days after inoculation with both WT HIV-1 and an AZT-resistant HIV-1 clinical isolate. Consistent with its mechanism of action, bevirimat caused a dose-dependent inhibition of capsid-SP1 cleavage in HIV-1-infected human thymocytes obtained from these mice. HIV-1 NL4-3 with an alanine-to-valine substitution at the N-terminus of SP1 (SP1/A1V), which is resistant to bevirimat in vitro, was also resistant to bevirimat treatment in the mice, and SP1/AIV had replication and thymocyte kinetics similar to that of WT NL4-3 with no evidence of fitness impairment in in vivo competition assays. Interestingly, protease inhibitor-resistant HIV-1 with impaired capsid-SP1 cleavage was hypersensitive to bevirimat in vitro with a 50% inhibitory concentration 140 times lower than for WT HIV-1. Conclusions. These results support further clinical development of this first-in-class maturation inhibitor and confirm the usefulness of the SCID-hu Thy/Liv model for evaluation of in vivo antiretroviral efficacy, drug resistance, and viral fitness.	[Stoddart, Cheryl A.; Joshi, Pheroze; Sloan, Barbara; Bare, Jennifer C.] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA; [Smith, Philip C.] Univ N Carolina, Sch Pharm, Chapel Hill, NC USA; [Allaway, Graham P.; Wild, Carl T.; Martin, David E.] Panacos Pharmaceut, Gaithersburg, MD USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of North Carolina; University of North Carolina Chapel Hill	Stoddart, CA (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Expt Med, San Francisco, CA 94143 USA.	cheryl.stoddart@ucsf.edu		Martin, David/0000-0003-2820-5983	NIAID; NIH [N01-AI-05418, N01-AI-70002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005418] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This project has been funded in whole or in part with Federal funds from NIAID, NIH, under contract no. N01-AI-05418 and N01-AI-70002.	Accola MA, 1998, J VIROL, V72, P2072, DOI 10.1128/JVI.72.3.2072-2078.1998; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Adamson CS, 2006, J VIROL, V80, P10957, DOI 10.1128/JVI.01369-06; BAST RC, 2000, CANC MED E 5 ONLINE; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Hashimoto F, 1997, BIOORGAN MED CHEM, V5, P2133, DOI 10.1016/S0968-0896(97)00158-2; Kanamoto T, 2001, ANTIMICROB AGENTS CH, V45, P1225, DOI 10.1128/AAC.45.4.1225-1230.2001; Kashiwada Y, 1996, J MED CHEM, V39, P1016, DOI 10.1021/jm950922q; Li F, 2003, P NATL ACAD SCI USA, V100, P13555, DOI 10.1073/pnas.2234683100; Li F, 2006, VIROLOGY, V356, P217, DOI 10.1016/j.virol.2006.07.023; Liang C, 2002, J VIROL, V76, P11729, DOI 10.1128/JVI.76.22.11729-11737.2002; Mammano F, 1998, J VIROL, V72, P7632, DOI 10.1128/JVI.72.9.7632-7637.1998; Martin DE, 2007, ANTIMICROB AGENTS CH, V51, P3063, DOI 10.1128/AAC.01391-06; Martin DE, 2007, CLIN PHARMACOKINET, V46, P589, DOI 10.2165/00003088-200746070-00004; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; Pillay D, 2005, J INFECT DIS, V192, P967, DOI 10.1086/432763; Rabin L, 1996, ANTIMICROB AGENTS CH, V40, P755, DOI 10.1128/AAC.40.3.755; Sakalian M, 2006, J VIROL, V80, P5716, DOI 10.1128/JVI.02743-05; Smith PF, 2007, ANTIMICROB AGENTS CH, V51, P3574, DOI 10.1128/AAC.00152-07; Stoddart CA, 2000, ANTIMICROB AGENTS CH, V44, P783, DOI 10.1128/AAC.44.3.783-786.2000; Stoddart CA, 2001, NAT MED, V7, P712, DOI 10.1038/89090; Stoddart CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000655; Vogt VM, 1996, CURR TOP MICROBIOL, V214, P95; Wen ZM, 2006, DRUG METAB DISPOS, V34, P1436, DOI 10.1124/dmd.106.009233; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; Yu DG, 2005, EXPERT OPIN INV DRUG, V14, P681, DOI 10.1517/13543784.14.6.681; Zennou V, 1998, J VIROL, V72, P3300, DOI 10.1128/JVI.72.4.3300-3306.1998; Zhou J, 2005, J BIOL CHEM, V280, P42149, DOI 10.1074/jbc.M508951200; Zhou J, 2004, J VIROL, V78, P922, DOI 10.1128/JVI.78.2.922-929.2004; Zhou J, 2006, J VIROL, V80, P12095, DOI 10.1128/JVI.01626-06; Zhou Jing, 2004, Retrovirology, V1, P15, DOI 10.1186/1742-4690-1-15	33	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1251	10.1371/journal.pone.0001251	http://dx.doi.org/10.1371/journal.pone.0001251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043758	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459300032
J	Balas, B; Cox, D; Conwell, E				Balas, Benjamin; Cox, David; Conwell, Erin			The Effect of Real-World Personal Familiarity on the Speed of Face Information Processing	PLOS ONE			English	Article								Background. Previous studies have explored the effects of familiarity on various kinds of visual face judgments, yet the role of familiarity in face processing is not fully understood. Across different face judgments and stimulus sets, the data is equivocal as to whether or not familiarity impacts recognition processes. Methodology/Principal Findings. Here, we examine the effect of real-world personal familiarity in three simple delayed-match-to-sample tasks in which subjects were required to match faces on the basis of orientation (upright v. inverted), gender and identity. We find that subjects had a significant speed advantage with familiar faces in all three tasks, with large effects for the gender and identity matching tasks. Conclusion/Significance. Our data indicates that real-world experience with a face exerts a powerful influence on face processing in tasks where identity information is irrelevant, even in tasks that could in principle be solved via low-level cues. These results underscore the importance of experience in shaping visual recognition processes.	[Balas, Benjamin; Cox, David] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Conwell, Erin] Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA	Massachusetts Institute of Technology (MIT); Brown University	Balas, B (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	bjbalas@gmail.com	Balas, Ben/R-4003-2019; Cox, David/C-4888-2008	Cox, David/0000-0002-2189-9743	NDSEG	NDSEG	This research was supported by NDSEG fellowships to BJB and DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRUCE V, 1983, PHILOS T ROY SOC B, V302, P423, DOI 10.1098/rstb.1983.0065; BRUCE V, 1986, PERCEPTION, V15, P387, DOI 10.1068/p150387; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Bruce V, 2001, J EXP PSYCHOL-APPL, V7, P207, DOI 10.1037/1076-898X.7.3.207; Bruyer R, 2004, PERCEPTION, V33, P169, DOI 10.1068/p5094; Clutterbuck R, 2002, PERCEPTION, V31, P985, DOI 10.1068/p3335; Cox DD, 2005, NAT NEUROSCI, V8, P1145, DOI 10.1038/nn1519; Gallegos DR, 2005, BRAIN LANG, V93, P338, DOI 10.1016/j.bandl.2004.11.001; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Ge LZ, 2003, PERCEPTION, V32, P601, DOI 10.1068/p5022; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Hancock PJB, 2000, TRENDS COGN SCI, V4, P330, DOI 10.1016/S1364-6613(00)01519-9; Hill H, 1996, J EXP PSYCHOL HUMAN, V22, P986, DOI 10.1037/0096-1523.22.4.986; Kaufmann JM, 2004, PERCEPTION, V33, P399, DOI 10.1068/p5083; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; O'Donnell C, 2001, PERCEPTION, V30, P755, DOI 10.1068/p3027; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rossion B, 2002, VIS COGN, V9, P1003, DOI 10.1080/13506280143000485; Schyns PG, 2002, PSYCHOL SCI, V13, P402, DOI 10.1111/1467-9280.00472; Sporer SL, 2001, PSYCHOL PUBLIC POL L, V7, P36, DOI 10.1038//1076-8971.7.1.36; Troje NF, 1999, PERCEPTION, V28, P483, DOI 10.1068/p2901; Troje NF, 1996, VISION RES, V36, P1761, DOI 10.1016/0042-6989(95)00230-8; VALENTINE T, 1991, Q J EXPT PSYCHOL A, V43, P89; WALKER S, 1995, PERCEPT PSYCHOPHYS, V57, P1124, DOI 10.3758/BF03208369; Wallis G, 2001, P NATL ACAD SCI USA, V98, P4800, DOI 10.1073/pnas.071028598; YOUNG AW, 1986, PSYCHOL RES-PSYCH FO, V48, P63, DOI 10.1007/BF00309318; YOUNG AW, 1985, PERCEPTION, V14, P737, DOI 10.1068/p140737	28	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1223	10.1371/journal.pone.0001223	http://dx.doi.org/10.1371/journal.pone.0001223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030351	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459200030
J	Rechavi, O; Goldstein, I; Vernitsky, H; Rotblat, B; Kloog, Y				Rechavi, Oded; Goldstein, Itamar; Vernitsky, Helly; Rotblat, Barak; Kloog, Yoel			Intercellular Transfer of Oncogenic H-Ras at the Immunological Synapse	PLOS ONE			English	Article								Immune cells establish dynamic adhesive cell-cell interactions at a specific contact region, termed the immunological synapse (IS). Intriguing features of the IS are the formation of regions of plasma membrane fusion and the intercellular exchange of membrane fragments between the conjugated cells. It is not known whether upon IS formation, intact intracellular proteins can transfer from target cells to lymphocytes to allow the transmission of signals across cell boundaries. Here we show by both FACS and confocal microscopy that human lymphocytes acquire from the cells they scan the inner-membrane protein H-Ras, a G-protein vital for common lymphocyte functions and a prominent participant in human cancer. The transfer was cell contact-dependent and occurred in the context of cell-conjugate formation. Moreover, the acquisition of oncogenic H-RasG12V by natural killer (NK) and T lymphocytes had important biological functions in the adopting lymphocytes: the transferred H-RasG12V induced ERK phosphorylation, increased interferon-gamma and tumor necrosis factor-alpha secretion, enhanced lymphocyte proliferation, and augmented NK-mediated target cell killing. Our findings reveal a novel mode of cell-to-cell communication-allowing lymphocytes to extend the confines of their own proteome-which may moreover play an important role in natural tumor immunity.	[Goldstein, Itamar; Vernitsky, Helly] Chaim Sheba Med Ctr, Canc Res Ctr, Program Immunol, IL-52621 Tel Hashomer, Israel; [Goldstein, Itamar; Vernitsky, Helly] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Rechavi, Oded; Rotblat, Barak; Kloog, Yoel] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Goldstein, I (corresponding author), Chaim Sheba Med Ctr, Canc Res Ctr, Program Immunol, IL-52621 Tel Hashomer, Israel.	Itamar.Goldstein@sheba.health.gov.il; kloog@post.tau.ac.il	Rotblat, Barak/H-5970-2019	Rotblat, Barak/0000-0003-2985-7115; Goldstein, Itamar/0000-0001-5393-186X; Rechavi, Oded/0000-0001-6172-3024	Wolfson Foundation; Israel Science Foundation [912/06]	Wolfson Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported in part by grants to YK from the Wolfson Foundation and the Israel Science Foundation grant 912/06.	Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Caumartin J, 2007, EMBO J, V26, P1423, DOI 10.1038/sj.emboj.7601570; Chen X, 2006, P NATL ACAD SCI USA, V103, P10346, DOI 10.1073/pnas.0604236103; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Goldstein I, 2003, J CLIN INVEST, V112, P1444, DOI 10.1172/JCI200319607; Goldstein I, 2007, J IMMUNOL, V178, P201, DOI 10.4049/jimmunol.178.1.201; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hudrisier D, 2007, J IMMUNOL, V178, P3637, DOI 10.4049/jimmunol.178.6.3637; Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; JOHNSON PW, 1987, J IMMUNOL, V138, P3996; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Kienzle N, 2002, J IMMUNOL METHODS, V267, P99, DOI 10.1016/S0022-1759(02)00150-3; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mainiero F, 1998, J EXP MED, V188, P1267, DOI 10.1084/jem.188.7.1267; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; MARRACK P, 1988, NATURE, V332, P840, DOI 10.1038/332840a0; McCann FE, 2007, J IMMUNOL, V178, P3418, DOI 10.4049/jimmunol.178.6.3418; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Poupot M, 2005, J IMMUNOL, V174, P1717, DOI 10.4049/jimmunol.174.3.1717; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Rotblat B, 2006, CANCER RES, V66, P1974, DOI 10.1158/0008-5472.CAN-05-3791; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Saha K, 1996, J IMMUNOL, V157, P3876; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; SPRENT J, 2005, SCI STKE, pPE8; Wei S, 1998, J EXP MED, V187, P1753, DOI 10.1084/jem.187.11.1753; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394	35	34	34	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1204	10.1371/journal.pone.0001204	http://dx.doi.org/10.1371/journal.pone.0001204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030338	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459200017
J	Gonzalez, RD; Pertejo, YP; Ordonez, D; Balana-Fouce, R; Reguera, RM				Diaz Gonzalez, Rosario; Perez Pertejo, Yolanda; Ordonez, David; Balana-Fouce, Rafael; Reguera, Rosa M.			Deletion Study of DNA Topoisomerase IB from Leishmania donovani: Searching for a Minimal Functional Heterodimer	PLOS ONE			English	Article							CAMPTOTHECIN; RESISTANCE; INHIBITOR; PROTEIN; LINKER	The substantial differences between trypanosomal and leishmanial DNA topoisomerase IB concerning to their homologues in mammals have provided a new lead in the study of the structural determinants that can be effectively targeted. Leishmania donovani, the causative agent of visceral leishmaniasis, contains an unusual heterodimeric DNA topoisomerase IB. The catalytically active enzyme consists of a large subunit (LdTopIL), which contains the non-conserved N-terminal end and the phylogenetically conserved "core'' domain, and of a small subunit (LdTopIS) which harbors the C-terminal region with the characteristic tyrosine residue in the active site. Heterologous co-expression of LdTopIL and LdTopIS genes in a topoisomerase I deficient yeast strain, reconstitutes a fully functional enzyme LdTopIL/S which can be used for structural studies. An approach by combinatorial cloning of deleted genes encoding for truncated versions of both subunits was used in order to find out structural insights involved in enzyme activity or protein-protein interaction. The role played by the non-conserved N-terminal extension of LdTopIL in both relaxation activity and CPT sensitivity has been examined co-expressing the full-length LdTopIS and a fully active LdTopI Delta S deletion with several deletions of LdTopIL lacking growing sequences of the N-terminal end. The sequential deletion study shows that the first 26 amino acids placed at the N-terminal end and a variable region comprised between Ala548 to end of the C-terminal extension of LdTopIL were enzymatically dispensable. Altogether this combinatorial approach provides important structural insights of the regions involved in relaxation activity and for understanding the atypical structure of this heterodimeric enzyme.	[Diaz Gonzalez, Rosario; Perez Pertejo, Yolanda; Ordonez, David; Balana-Fouce, Rafael; Reguera, Rosa M.] Univ Leon, Dept Farmacol & Toxicol INTOXCAL, E-24071 Leon, Spain	Universidad de Leon	Balana-Fouce, R (corresponding author), Univ Leon, Dept Farmacol & Toxicol INTOXCAL, E-24071 Leon, Spain.	rbalf@unileon.es	Díaz, Rosario/GPW-5555-2022; Pérez-Pertejo, Yolanda/K-6609-2017; Balana-Fouce, Rafael/AAK-9485-2021; Balana-Fouce, Rafael/K-4890-2014; Reguera, Rosa M/K-6027-2017	Pérez-Pertejo, Yolanda/0000-0003-2361-3785; Balana-Fouce, Rafael/0000-0003-0418-6116; Balana-Fouce, Rafael/0000-0003-0418-6116; Reguera, Rosa M/0000-0001-9148-2997; Diaz Gonzalez, Rosario/0000-0002-3187-2704	Ministerio de Ciencia y Tecnologia [BMC2002-04107-C02-02, AGL2003 06976/GAN, GL2006-07420/GAN]; Instituto de Salud Carlos III [PI06302]; "Ministerio de Sanidad y Consumo'' from Spain	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); "Ministerio de Sanidad y Consumo'' from Spain	This research was supported by Ministerio de Ciencia y Tecnologia (grants BMC2002-04107-C02-02, AGL2003 06976/GAN and AGL2006-07420/GAN) and Instituto de Salud Carlos III (grant PI06302) from "Ministerio de Sanidad y Consumo'' from Spain.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bakshi RP, 2004, MOL BIOCHEM PARASIT, V136, P249, DOI 10.1016/j.molbiopara.2004.04.006; Balana-Fouce R, 1998, GEN PHARMACOL-VASC S, V30, P435, DOI 10.1016/S0306-3623(97)00268-1; Balana-Fouce R, 2006, DRUG DISCOV TODAY, V11, P733, DOI 10.1016/j.drudis.2006.06.014; Bodley AL, 2003, P NATL ACAD SCI USA, V100, P7539, DOI 10.1073/pnas.1330762100; BODLEY AL, 1995, P NATL ACAD SCI USA, V92, P3726, DOI 10.1073/pnas.92.9.3726; Bodley AL, 1998, BIOCHEM PHARMACOL, V55, P709, DOI 10.1016/S0006-2952(97)00556-X; Bosedasgupta S, 2008, BIOCHEM J, V409, P481, DOI 10.1042/BJ20071358; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broccoli S, 1999, NUCLEIC ACIDS RES, V27, P2745, DOI 10.1093/nar/27.13.2745; Cheesman SJ, 2000, PARASITOL TODAY, V16, P277, DOI 10.1016/S0169-4758(00)01697-5; Das A, 2004, TRENDS PARASITOL, V20, P381, DOI 10.1016/j.pt.2004.06.005; Das A, 2002, NUCLEIC ACIDS RES, V30, P794, DOI 10.1093/nar/30.3.794; Davies DR, 2006, J MOL BIOL, V357, P1202, DOI 10.1016/j.jmb.2006.01.022; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Gonzalez RD, 2007, BIOCHIMIE, V89, P1517, DOI 10.1016/j.biochi.2007.07.015; Hann CL, 1998, J BIOL CHEM, V273, P31519, DOI 10.1074/jbc.273.47.31519; Ireton GC, 2000, J BIOL CHEM, V275, P25820, DOI 10.1074/jbc.M002144200; JAZWINSKI SM, 1990, METHOD ENZYMOL, V182, P154; Marquis JF, 2005, ANTIMICROB AGENTS CH, V49, P1441, DOI 10.1128/AAC.49.4.1441-1446.2005; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Park H, 1998, CHROMOSOMA, V107, P211, DOI 10.1007/s004120050299; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Yves, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P429, DOI 10.2174/1568011043352777; PORTER SE, 1989, NUCLEIC ACIDS RES, V17, P8521, DOI 10.1093/nar/17.21.8521; Proulx ME, 2001, ANTIMICROB AGENTS CH, V45, P2623, DOI 10.1128/AAC.45.9.2623-2627.2001; Reguera RM, 2006, BBA-GENE STRUCT EXPR, V1759, P117, DOI 10.1016/j.bbaexp.2006.03.006; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Stewart L, 1999, J BIOL CHEM, V274, P32950, DOI 10.1074/jbc.274.46.32950; Stewart L, 1997, J MOL BIOL, V269, P355, DOI 10.1006/jmbi.1997.1056; THRASH C, 1984, J BIOL CHEM, V259, P1375; Villa H, 2003, J BIOL CHEM, V278, P3521, DOI 10.1074/jbc.M203991200	35	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1177	10.1371/journal.pone.0001177	http://dx.doi.org/10.1371/journal.pone.0001177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000548	Green Submitted, gold, Green Published			2022-12-27	WOS:000207459100019
J	Mash, DC; Ffrench-Mullen, J; Adi, N; Qin, YJ; Buck, A; Pablo, J				Mash, Deborah C.; Ffrench-Mullen, Jarlath; Adi, Nikhil; Qin, Yujing; Buck, Andrew; Pablo, John			Gene Expression in Human Hippocampus from Cocaine Abusers Identifies Genes which Regulate Extracellular Matrix Remodeling	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ADDICTION; MATRIX-METALLOPROTEINASE-9; ASSOCIATION; CHANNELS; METALLOPROTEINASES; PLASTICITY; DOPAMINE; TISSUE; BRAIN	The chronic effects of cocaine abuse on brain structure and function are blamed for the inability of most addicts to remain abstinent. Part of the difficulty in preventing relapse is the persisting memory of the intense euphoria or cocaine "rush''. Most abused drugs and alcohol induce neuroplastic changes in brain pathways subserving emotion and cognition. Such changes may account for the consolidation and structural reconfiguration of synaptic connections with exposure to cocaine. Adaptive hippocampal plasticity could be related to specific patterns of gene expression with chronic cocaine abuse. Here, we compare gene expression profiles in the human hippocampus from cocaine addicts and age-matched drug-free control subjects. Cocaine abusers had 151 gene transcripts upregulated, while 91 gene transcripts were downregulated. Topping the list of cocaine-regulated transcripts was RECK in the human hippocampus (FC = 2.0; p<0.05). RECK is a membrane-anchored MMP inhibitor that is implicated in the coordinated regulation of extracellular matrix integrity and angiogenesis. In keeping with elevated RECK expression, active MMP9 protein levels were decreased in the hippocampus from cocaine abusers. Pathway analysis identified other genes regulated by cocaine that code for proteins involved in the remodeling of the cytomatrix and synaptic connections and the inhibition of blood vessel proliferation (PCDH8, LAMB1, ITGB6, CTGF and EphB4). The observed microarray phenotype in the human hippocampus identified RECK and other region-specific genes that may promote long-lasting structural changes with repeated cocaine abuse. Extracellular matrix remodeling in the hippocampus may be a persisting effect of chronic abuse that contributes to the compulsive and relapsing nature of cocaine addiction.	[Mash, Deborah C.; Adi, Nikhil; Qin, Yujing; Buck, Andrew; Pablo, John] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Mash, Deborah C.] Univ Miami, Miller Sch Med, Dept Cellular & Mol Pharmacol, Miami, FL 33136 USA; [Ffrench-Mullen, Jarlath] GeneLogic Inc, Gaithersburg, MD USA	University of Miami; University of Miami	Mash, DC (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.	dmash@med.miami.edu			PHS [DA06227]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006227] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by PHS grant DA06227 (DCM).	Bozdagi O, 2007, J NEUROPHYSIOL, V98, P334, DOI 10.1152/jn.00202.2007; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Corrado D, 2001, CARDIOVASC RES, V50, P399, DOI 10.1016/S0008-6363(01)00254-1; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Erber R, 2006, EMBO J, V25, P628, DOI 10.1038/sj.emboj.7600949; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; Goto Y, 2001, J NEUROSCI, V21; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Hernandez PJ, 2005, NEURON, V47, P772, DOI 10.1016/j.neuron.2005.09.001; Huntley GW, 2002, CELL, V108, P1, DOI 10.1016/S0092-8674(01)00631-6; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; ISHIGURO H, 2007, ADDICTION IN PRESS; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Kramar EA, 2003, J BIOL CHEM, V278, P10722, DOI 10.1074/jbc.M210225200; Krasnova IN, 2008, GENES BRAIN BEHAV, V7, P193, DOI 10.1111/j.1601-183X.2007.00338.x; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Lehrmann E, 2003, PHARMACOGENOMICS J, V3, P27, DOI 10.1038/sj.tpj.6500146; Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Liu QR, 2006, AM J MED GENET B, V141B, P918, DOI 10.1002/ajmg.b.30436; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Mellor J, 2002, SCIENCE, V295, P143, DOI 10.1126/science.1064285; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Muraguchi T, 2007, NAT NEUROSCI, V10, P838, DOI 10.1038/nn1922; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Nakagami Y, 2000, J NEUROSCI, V20, P2003; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Noble EP, 2000, EUR PSYCHIAT, V15, P79, DOI 10.1016/S0924-9338(00)00208-X; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Papapetropoulos S, 2006, GENE EXPRESSION, V13, P205, DOI 10.3727/000000006783991827; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Post RM, 2004, EPILEPSIA, V45, P5, DOI 10.1111/j.0013-9580.2004.452001.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Sasahara RM, 2002, CANCER DETECT PREV, V26, P435, DOI 10.1016/S0361-090X(02)00123-X; Sequeira A, 2007, MOL PSYCHIATR, V12, P640, DOI 10.1038/sj.mp.4001969; Sequeira A, 2006, ARCH GEN PSYCHIAT, V63, P35, DOI 10.1001/archpsyc.63.1.35; SETLERSTEVENSON WG, 1996, AM J PATHOL, V148, P1345; Shapiro ML, 1999, HIPPOCAMPUS, V9, P365, DOI 10.1002/(SICI)1098-1063(1999)9:4<365::AID-HIPO4>3.3.CO;2-K; Smolen P, 2006, BIOPHYS J, V90, P2760, DOI 10.1529/biophysj.105.072470; Staubli U, 1998, J NEUROSCI, V18, P3460; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Stephens BG, 2004, AM J FOREN MED PATH, V25, P11, DOI 10.1097/01.paf.0000114041.70865.24; Stephens BG, 2004, AM J FOREN MED PATH, V25, P1, DOI 10.1097/01.paf.0000118960.58334.a9; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Thompson AM, 2002, NEUROPHARMACOLOGY, V42, P1039, DOI 10.1016/S0028-3908(02)00059-X; UHL G, 1993, TRENDS NEUROSCI, V16, P83, DOI 10.1016/0166-2236(93)90128-9; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043; Wang XQ, 2003, J BIOL CHEM, V278, P25591, DOI 10.1074/jbc.M302211200; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WOESSNER JF, 1994, ANN NY ACAD SCI, V732, P11; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang JW, 1997, J NEUROSCI METH, V76, P15, DOI 10.1016/S0165-0270(97)00065-4	64	83	86	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1187	10.1371/journal.pone.0001187	http://dx.doi.org/10.1371/journal.pone.0001187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000554	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459100025
J	van Orsouw, NJ; Hogers, RCJ; Janssen, A; Yalcin, F; Snoeijers, S; Verstege, E; Schneiders, H; van der Poel, H; van Oeveren, J; Verstegen, H; van Eijk, MJT				van Orsouw, Nathalie J.; Hogers, Rene C. J.; Janssen, Antoine; Yalcin, Feyruz; Snoeijers, Sandor; Verstege, Esther; Schneiders, Harrie; van der Poel, Hein; van Oeveren, Jan; Verstegen, Harold; van Eijk, Michiel J. T.			Complexity Reduction of Polymorphic Sequences (CRoPS (TM)): A Novel Approach for Large-Scale Polymorphism Discovery in Complex Genomes	PLOS ONE			English	Article							MAIZE; RETROTRANSPOSONS; TRANSCRIPTOME; TECHNOLOGY; ENRICHMENT; GENES; AFLP	Application of single nucleotide polymorphisms (SNPs) is revolutionizing human bio-medical research. However, discovery of polymorphisms in low polymorphic species is still a challenging and costly endeavor, despite widespread availability of Sanger sequencing technology. We present CRoPS (TM) as a novel approach for polymorphism discovery by combining the power of reproducible genome complexity reduction of AFLP (R) with Genome Sequencer (GS) 20/GS FLX next-generation sequencing technology. With CRoPS, hundreds-of-thousands of sequence reads derived from complexity-reduced genome sequences of two or more samples are processed and mined for SNPs using a fully-automated bioinformatics pipeline. We show that over 75% of putative maize SNPs discovered using CRoPS are successfully converted to SNPWave (R) assays, confirming them to be true SNPs derived from unique (single-copy) genome sequences. By using CRoPS, polymorphism discovery will become affordable in organisms with high levels of repetitive DNA in the genome and/or low levels of polymorphism in the (breeding) germplasm without the need for prior sequence information.	[van Orsouw, Nathalie J.; Hogers, Rene C. J.; Janssen, Antoine; Yalcin, Feyruz; Snoeijers, Sandor; Verstege, Esther; Schneiders, Harrie; van der Poel, Hein; van Oeveren, Jan; Verstegen, Harold; van Eijk, Michiel J. T.] Keygene NV, Wageningen, Netherlands	Keygene N.V.	van Orsouw, NJ (corresponding author), Keygene NV, Wageningen, Netherlands.	nathalie.van-orsouw@keygene.com			Keygene N. V	Keygene N. V(Keygene N.V.)	This work was funded by Keygene N. V.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; An Chung Sun, 1996, Journal of Plant Biology, V39, P57; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; BENNETZEN JL, 1994, GENOME, V37, P565, DOI 10.1139/g94-081; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Emberton J, 2005, GENOME RES, V15, P1441, DOI 10.1101/gr.3362105; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Li WL, 2004, PLANT J, V40, P500, DOI 10.1111/j.1365-313X.2004.02228.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsuda T, 2004, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2004/10/014; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Oliphant A, 2002, BIOTECHNIQUES, P56; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Peterson DG, 2002, TRENDS GENET, V18, P547, DOI 10.1016/S0168-9525(02)02764-6; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Swaminathan K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-132; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; van Eijk MJT, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh045; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vuylsteke M, 2007, NAT PROTOC, V2, P1387, DOI 10.1038/nprot.2007.175; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Whitelaw CA, 2003, SCIENCE, V302, P2118, DOI 10.1126/science.1090047; ZABEAU M, 1993, Patent No. 6045994; Zabeau M, 1993, European Patent Application, Patent No. [0-534-858-A1, 0534858]	30	159	197	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1172	10.1371/journal.pone.0001172	http://dx.doi.org/10.1371/journal.pone.0001172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000544	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459100014
J	Miraucourt, LS; Dallel, R; Voisin, DL				Miraucourt, Lois S.; Dallel, Radhouane; Voisin, Daniel L.			Glycine Inhibitory Dysfunction Turns Touch into Pain through PKCgamma Interneurons	PLOS ONE			English	Article							PROTEIN-KINASE-C; SUPERFICIAL DORSAL-HORN; TRIGEMINAL NUCLEUS ORALIS; SUBSTANTIA-GELATINOSA NEURONS; SPINAL-CORD; NEUROPATHIC PAIN; NMDA RECEPTOR; SOMATOSENSORY THALAMUS; CENTRAL SENSITIZATION; CONVERGENT NEURONS	Dynamic mechanical allodynia is a widespread and intractable symptom of neuropathic pain for which there is a lack of effective therapy. During tactile allodynia, activation of the sensory fibers which normally detect touch elicits pain. Here we provide a new behavioral investigation into the dynamic component of tactile allodynia that developed in rats after segmental removal of glycine inhibition. Using in vivo electrophysiological recordings, we show that in this condition innocuous mechanical stimuli could activate superficial dorsal horn nociceptive specific neurons. These neurons do not normally respond to touch. We anatomically show that the activation was mediated through a local circuit involving neurons expressing the gamma isoform of protein kinase C (PKC gamma). Selective inhibition of PKC gamma as well as selective blockade of glutamate NMDA receptors in the superficial dorsal horn prevented both activation of the circuit and allodynia. Thus, our data demonstrates that a normally inactive circuit in the dorsal horn can be recruited to convert touch into pain. It also provides evidence that glycine inhibitory dysfunction gates tactile input to nociceptive specific neurons through PKC gamma-dependent activation of a local, excitatory, NMDA receptor-dependent, circuit. As a consequence of these findings, we suggest that pharmacological inhibition of PKC gamma might provide a new tool for alleviating allodynia in the clinical setting.	[Miraucourt, Lois S.; Dallel, Radhouane; Voisin, Daniel L.] INSERM, E216, F-63000 Clermont Ferrand, France; [Miraucourt, Lois S.; Dallel, Radhouane; Voisin, Daniel L.] CHU Clermont Ferrand, F-63000 Clermont Ferrand, France; [Miraucourt, Lois S.; Dallel, Radhouane; Voisin, Daniel L.] Univ Auvergne Clermont1, F-63000 Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand	Dallel, R (corresponding author), INSERM, E216, F-63000 Clermont Ferrand, France.	radhouane.dallel@u-clermont1.fr; daniel.voisin@bordeaux.inserm.fr	Dallel, Radhouane/W-4599-2017	Dallel, Radhouane/0000-0001-7494-116X	INSERM; MENESR; Universite d'Auvergne-Clermont1 (France)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); MENESR; Universite d'Auvergne-Clermont1 (France)	This work was supported by funding from INSERM, MENESR, and Universite d'Auvergne-Clermont1 (France).	Ahmadi S, 2002, NAT NEUROSCI, V5, P34, DOI 10.1038/nn778; AZERAD J, 1982, BRAIN RES, V246, P7, DOI 10.1016/0006-8993(82)90137-8; Baron R, 2006, NAT CLIN PRACT NEURO, V2, P95, DOI 10.1038/ncpneuro0113; Bester H, 2000, J COMP NEUROL, V428, P45, DOI 10.1002/1096-9861(20001204)428:1<45::AID-CNE5>3.0.CO;2-A; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; CAMPBELL JN, 1988, PAIN, V32, P89, DOI 10.1016/0304-3959(88)90027-9; CASTROLOPES JM, 1993, BRAIN RES, V620, P287, DOI 10.1016/0006-8993(93)90167-L; Catheline G, 1999, PAIN, V80, P347, DOI 10.1016/S0304-3959(98)00234-6; Chen L, 2001, CHEM BIOL, V8, P1123, DOI 10.1016/S1074-5521(01)00076-X; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Dahlhaus A, 2005, J PHYSIOL-LONDON, V566, P355, DOI 10.1113/jphysiol.2005.088567; Dallel R, 1996, EUR J PHARMACOL, V314, P19, DOI 10.1016/S0014-2999(96)00480-3; Dallel R, 1998, J NEUROSCI, V18, P3529; Dallel R, 2004, J COMP NEUROL, V470, P181, DOI 10.1002/cne.11043; DALLEL R, 1990, BRAIN RES, V521, P95, DOI 10.1016/0006-8993(90)91529-P; Dallel R, 1999, EUR J NEUROSCI, V11, P31, DOI 10.1046/j.1460-9568.1999.00404.x; DAVIES J, 1981, NEUROSCI LETT, V21, P77, DOI 10.1016/0304-3940(81)90061-6; De Chazeron I, 2004, NEUROSCIENCE, V127, P921, DOI 10.1016/j.neuroscience.2004.06.005; Dorn GW, 2002, ANNU REV PHYSIOL, V64, P407, DOI 10.1146/annurev.physiol.64.081501.155903; DUBNER R, 1983, ANNU REV NEUROSCI, V6, P381, DOI 10.1146/annurev.ne.06.030183.002121; FEIL K, 1995, J COMP NEUROL, V353, P506, DOI 10.1002/cne.903530404; FROMM GH, 1993, APS J, V2, P1; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; Guy N, 2005, EUR J NEUROSCI, V21, P741, DOI 10.1111/j.1460-9568.2005.03918.x; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; HU JW, 1992, PAIN, V48, P53, DOI 10.1016/0304-3959(92)90131-T; Hu JW, 1999, ARCH ORAL BIOL, V44, P287, DOI 10.1016/S0003-9969(98)00111-3; Hughes DI, 2003, J NEUROSCI, V23, P9491; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Jensen TS, 2003, PAIN, V102, P1, DOI 10.1016/S0304-3959(03)00006-X; KOLTZENBURG M, 1994, BRAIN, V117, P579, DOI 10.1093/brain/117.3.579; KUMAZAWA T, 1978, J COMP NEUROL, V177, P417, DOI 10.1002/cne.901770305; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Li HF, 2005, BRIT J PHARMACOL, V144, P301, DOI 10.1038/sj.bjp.0706033; LIGHT AR, 1979, J COMP NEUROL, V186, P133, DOI 10.1002/cne.901860203; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Lu Y, 2005, J NEUROSCI, V25, P3900, DOI 10.1523/JNEUROSCI.0102-05.2005; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Ma WY, 2001, PAIN, V93, P295, DOI 10.1016/S0304-3959(01)00335-9; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; MAO JR, 1995, NEUROSCI LETT, V198, P75, DOI 10.1016/0304-3940(95)11975-3; Martin WJ, 2001, J NEUROSCI, V21, P5321, DOI 10.1523/JNEUROSCI.21-14-05321.2001; Meyer RA, 2006, WALL MELZACKS TXB PA, V5, P3; MITCHELL K, 1993, J NEUROSCI, V13, P2371, DOI 10.1523/JNEUROSCI.13-06-02371.1993; Mochly-Rosen D, 1998, FASEB J, V12, P35; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Narikawa K, 2000, J NEUROPHYSIOL, V84, P2171, DOI 10.1152/jn.2000.84.4.2171; OCHOA JL, 1993, ANN NEUROL, V33, P465, DOI 10.1002/ana.410330509; Onaka M, 1996, ANESTHESIOLOGY, V84, P1215, DOI 10.1097/00000542-199605000-00024; Park SJ, 2001, J NEUROPHYSIOL, V85, P1836, DOI 10.1152/jn.2001.85.5.1836; PAXINOS G, 1997, RAT BRAIN STEREOTAXI, P266; PERPER JA, 1985, J FORENSIC SCI, V30, P1248; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; Polgar E, 1999, BRAIN RES, V833, P71, DOI 10.1016/S0006-8993(99)01500-0; RABOISSON P, 1995, J NEUROPHYSIOL, V73, P496, DOI 10.1152/jn.1995.73.2.496; Sakai N, 2004, GENES CELLS, V9, P945, DOI 10.1111/j.1365-2443.2004.00779.x; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Seagrove LC, 2004, PAIN, V108, P76, DOI 10.1016/j.pain.2003.12.004; Sessle BJ, 2000, CRIT REV ORAL BIOL M, V11, P57, DOI 10.1177/10454411000110010401; SHERMAN SE, 1994, PAIN, V56, P17, DOI 10.1016/0304-3959(94)90146-5; Shumilla JA, 2005, J PAIN, V6, P535, DOI 10.1016/j.jpain.2005.03.005; Simpson RK, 1998, NEUROL RES, V20, P161; Sorkin LS, 1996, PAIN, V68, P283, DOI 10.1016/S0304-3959(96)03130-2; South SM, 2003, J NEUROSCI, V23, P5031; SUGIURA Y, 1986, SCIENCE, V234, P358, DOI 10.1126/science.3764416; Sweitzer SM, 2004, PAIN, V110, P281, DOI 10.1016/j.pain.2004.04.004; Sweitzer SM, 2004, J PHARMACOL EXP THER, V309, P616, DOI 10.1124/jpet.103.060350; Todd A. J., 2006, WALL MELZACKS TXB PA, P73; Torsney C, 2006, J NEUROSCI, V26, P1833, DOI 10.1523/JNEUROSCI.4584-05.2006; Vanegas H, 2004, BRAIN RES REV, V46, P295, DOI 10.1016/j.brainresrev.2004.07.004; Voisin DL, 2005, J PHYSIOL-LONDON, V566, P929, DOI 10.1113/jphysiol.2005.086520; VOS BP, 1994, J NEUROSCI, V14, P2708; Weng HR, 2002, EXP NEUROL, V175, P209, DOI 10.1006/exnr.2002.7886; Wiesenfeld-Hallin Z, 1997, BEHAV BRAIN SCI, V20, P420, DOI 10.1017/S0140525X97261480; WILLIS WD, 1993, APS J, V2, P23; Woda A, 2004, EUR J NEUROSCI, V19, P2009, DOI 10.1111/j.0953-816X.2004.03328.x; Woda A, 2001, NEUROSCIENCE, V107, P317, DOI 10.1016/S0306-4522(01)00359-1; Woolf CJ, 1998, PAIN, V77, P227, DOI 10.1016/S0304-3959(98)00099-2; WOOLF CJ, 1987, J COMP NEUROL, V261, P105, DOI 10.1002/cne.902610109; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; WOOLF CJ, 2006, WALL MELZACKS TXB PA, P91; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Yamamura H, 1999, J NEUROPHYSIOL, V81, P479, DOI 10.1152/jn.1999.81.2.479; ZAKRZEWSKA JM, 2006, CLIN EVID, V15, P1827; Zheng X, 1999, P NATL ACAD SCI USA, V96, P15262, DOI 10.1073/pnas.96.26.15262; Zou XJ, 2004, BRAIN RES, V1020, P95, DOI 10.1016/j.brainres.2004.06.017	89	134	135	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1116	10.1371/journal.pone.0001116	http://dx.doi.org/10.1371/journal.pone.0001116			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987109	Green Submitted, gold, Green Published			2022-12-27	WOS:000207459000004
J	Peckham, SH; Diaz, DM; Walli, A; Ruiz, G; Crowder, LB; Nichols, WJ				Peckham, S. Hoyt; Maldonado Diaz, David; Walli, Andreas; Ruiz, Georgita; Crowder, Larry B.; Nichols, Wallace J.			Small-Scale Fisheries Bycatch Jeopardizes Endangered Pacific Loggerhead Turtles	PLOS ONE			English	Article							SEA-TURTLES; CARETTA-CARETTA; MIGRATION; STRANDINGS; INCENTIVES; MORTALITY; IMPACTS; HABITAT	Background. Although bycatch of industrial-scale fisheries can cause declines in migratory megafauna including seabirds, marine mammals, and sea turtles, the impacts of small-scale fisheries have been largely overlooked. Small-scale fisheries occur in coastal waters worldwide, employing over 99% of the world's 51 million fishers. New telemetry data reveal that migratory megafauna frequent coastal habitats well within the range of small-scale fisheries, potentially producing high bycatch. These fisheries occur primarily in developing nations, and their documentation and management are limited or non-existent, precluding evaluation of their impacts on non-target megafauna. Principal Findings/Methodology. 30 North Pacific loggerhead turtles that we satellite-tracked from 1996-2005 ranged oceanwide, but juveniles spent 70% of their time at a high use area coincident with small-scale fisheries in Baja California Sur, Mexico (BCS). We assessed loggerhead bycatch mortality in this area by partnering with local fishers to 1) observe two small-scale fleets that operated closest to the high use area and 2) through shoreline surveys for discarded carcasses. Minimum annual bycatch mortality in just these two fleets at the high use area exceeded 1000 loggerheads year(-1), rivaling that of oceanwide industrial-scale fisheries, and threatening the persistence of this critically endangered population. As a result of fisher participation in this study and a bycatch awareness campaign, a consortium of local fishers and other citizens are working to eliminate their bycatch and to establish a national loggerhead refuge. Conclusions/Significance.. Because of the overlap of ubiquitous small-scale fisheries with newly documented high-use areas in coastal waters worldwide, our case study suggests that small-scale fisheries may be among the greatest current threats to non-target megafauna. Future research is urgently needed to quantify small-scale fisheries bycatch worldwide. Localizing coastal high use areas and mitigating bycatch in partnership with small-scale fishers may provide a crucial solution toward ensuring the persistence of vulnerable megafauna.	[Peckham, S. Hoyt] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Peckham, S. Hoyt; Maldonado Diaz, David] Grp Tortuguero AC, La Paz, Baja Calif Sur, Mexico; [Walli, Andreas] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Crowder, Larry B.] Duke Univ, Ctr Marine Conservat, Nicholas Sch Environm & Earth Sci, Beaufort, NC USA; [Nichols, Wallace J.] Calif Acad Sci, San Francisco, CA 94118 USA; [Nichols, Wallace J.] Ocean Conservancy, Davenport, CA USA	University of California System; University of California Santa Cruz; Stanford University; Duke University; California Academy of Sciences	Peckham, SH (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	hoyt@biology.ucsc.edu			David and Lucile Packard Foundation; USFWS; NMFS-SWFSC; Western Pacific Fisheries Management Council; Project GLOBAL; Gordon and Betty Moore Foundation; PADI Foundation; TE Foundation; Wallace Research Foundation; School for Field Studies; Earthwatch Institute; ONR/National Oceanographic Partnership Program; Ocean Conservancy; ProPeninsula; Fulbright and Marshall Fellowships; CILS-NSF; UCMEXUS	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); USFWS(US Fish & Wildlife Service); NMFS-SWFSC; Western Pacific Fisheries Management Council; Project GLOBAL; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); PADI Foundation; TE Foundation; Wallace Research Foundation; School for Field Studies; Earthwatch Institute; ONR/National Oceanographic Partnership Program(Office of Naval Research); Ocean Conservancy; ProPeninsula; Fulbright and Marshall Fellowships; CILS-NSF; UCMEXUS	This work was supported by the David and Lucile Packard Foundation, USFWS, NMFS-SWFSC, Western Pacific Fisheries Management Council, Project GLOBAL, Gordon and Betty Moore Foundation, PADI Foundation, T&E Foundation, Wallace Research Foundation, School for Field Studies, Earthwatch Institute, ONR/National Oceanographic Partnership Program, Ocean Conservancy and ProPeninsula. WJN was supported by Fulbright and Marshall Fellowships. SHP was supported with CILS-NSF, Project Global and UCMEXUS graduate fellowships and awards.	Berkes F., 2001, MANAGING SMALL SCALE; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; BOWEN BW, 1995, P NATL ACAD SCI USA, V92, P3731, DOI 10.1073/pnas.92.9.3731; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; CROWDER LB, 1994, ECOL APPL, V4, P437, DOI 10.2307/1941948; DELGADO SG, 2004, MARITIME STUDIES, V4, P89; Epperly SP, 1996, B MAR SCI, V59, P289; Hart KM, 2006, BIOL CONSERV, V129, P283, DOI 10.1016/j.biocon.2005.10.047; Heppell Selina S., 2005, P211; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 2007, ECOL RES, V22, P16, DOI 10.1007/s11284-006-0075-z; Jacobson S.K., 1999, COMMUNICATION SKILLS; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; KAMEZAKI N., 2003, LOGGERHEAD SEA TURTL, P210; Koch V, 2006, BIOL CONSERV, V128, P327, DOI 10.1016/j.biocon.2005.09.038; Lewison RL, 2007, CONSERV BIOL, V21, P79, DOI 10.1111/j.1523-1739.2006.00592.x; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; MACKENZIEMOHR J, 1999, FOSTERING SUSTAINABL; MANGEL M, 1993, ECOL APPL, V3, P221, DOI 10.2307/1941825; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Nichols WJ, 2000, B MAR SCI, V67, P937; NICHOLS WJ, 2004, CONSERVATION PRACTIC, V5, P30; NICHOLS WJ, 2003, BIOL CONSERVATION SE, P1; Panayotou T, 1982, MANAGEMENT CONCEPTS; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; PECKHAM SH, BY CATCH RE IN PRESS; Polovina J, 2006, DEEP-SEA RES PT II, V53, P326, DOI 10.1016/j.dsr2.2006.01.006; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Sala E, 2004, FISHERIES, V29, P19, DOI 10.1577/1548-8446(2004)29[19:FDCFWI]2.0.CO;2; SERVICE NMF, 2004, ENDANGERED SPECIES A; SILVERMAN BW, 1986, DENSITY ANAL STAT DE; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Tasker ML, 2000, ICES J MAR SCI, V57, P531, DOI 10.1006/jmsc.2000.0714; WETHERALL JA, 1993, INPFC S BIOL DISTR S, P519; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	40	161	185	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1041	10.1371/journal.pone.0001041	http://dx.doi.org/10.1371/journal.pone.0001041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940605	gold, Green Published			2022-12-27	WOS:000207456100009
J	Filler, AG				Filler, Aaron G.			Homeotic Evolution in the Mammalia: Diversification of Therian Axial Seriation and the Morphogenetic Basis of Human Origins	PLOS ONE			English	Article							MIDDLE MIOCENE; HOX GENES; SKELETON; HOMINID; BODY; APE; SAHELANTHROPUS; MORPHOLOGY; OREOPITHECUS; SEGMENTATION	Background. Despite the rising interest in homeotic genes, little has been known about the course and pattern of evolution of homeotic traits across the mammalian radiation. An array of emerging and diversifying homeotic gradients revealed by this study appear to generate new body plans and drive evolution at a large scale. Methodology/Principal Findings. This study identifies and evaluates a set of homeotic gradients across 250 extant and fossil mammalian species and their antecedents over a period of 220 million years. These traits are generally expressed as co-linear gradients along the body axis rather than as distinct segmental identities. Relative position or occurrence sequence vary independently and are subject to polarity reversal and mirroring. Five major gradient modification sets are identified: (1)-quantitative changes of primary segmental identity pattern that appeared at the origin of the tetrapods; (2)-frame shift relation of costal and vertebral identity which diversifies from the time of amniote origins; (3)-duplication, mirroring, splitting and diversification of the neomorphic laminar process first commencing at the dawn of mammals; (4)-emergence of homologically variable lumbar lateral processes upon commencement of the radiation of therian mammals and; (5)-inflexions and transpositions of the relative position of the horizontal septum of the body and the neuraxis at the emergence of various orders of therian mammals. Convergent functional changes under homeotic control include laminar articular engagement with septo-neural transposition and ventrally arrayed lumbar transverse process support systems. Conclusion/Significance. Clusters of homeotic transformations mark the emergence point of mammals in the Triassic and the radiation of therians in the Cretaceous. A cluster of homeotic changes in the Miocene hominoid Morotopithecus that are still seen in humans supports establishment of a new "hominiform'' clade and suggests a homeotic origin for the human upright body plan.	[Filler, Aaron G.] Harvard Univ, Museum Comparat Zool, Dept Anthropol, Cambridge, MA 02138 USA; [Filler, Aaron G.] Cedars Sinai Med Ctr, Inst Spinal Disorders, Dept Neurosurg, Los Angeles, CA 90048 USA	Harvard University; Cedars Sinai Medical Center	Filler, AG (corresponding author), Harvard Univ, Museum Comparat Zool, Dept Anthropol, Cambridge, MA 02138 USA.	afiller@earthlink.net			NIH PHS Musculoskeletal Biology Training [5 T32 GM07117-09 0011]	NIH PHS Musculoskeletal Biology Training	Funding: Portions of this work were supported by NIH PHS Musculoskeletal Biology Training Grant # 5 T32 GM07117-09 0011.	Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; Appel Toby A., 1987, CUVIER GEOFFROY DEBA; Argot C, 2003, J MORPHOL, V255, P279, DOI 10.1002/jmor.10062; Bateson W., 1894, MAT STUDY VARIATION; Bezuidenhout AJ, 1996, ONDERSTEPOORT J VET, V63, P131; Boszczyk BM, 2001, ANAT RECORD, V264, P157, DOI 10.1002/ar.1156; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Buchholtz EA, 2007, EVOL DEV, V9, P278, DOI 10.1111/j.1525-142X.2007.00160.x; Budd GE, 2006, BIOL REV, V81, P609, DOI 10.1017/S1464793106007135; BURKE AC, 1995, DEVELOPMENT, V121, P333; Burke AC, 2000, CURR TOP DEV BIOL, V47, P155; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Douady CJ, 2003, P NATL ACAD SCI USA, V100, P8325, DOI 10.1073/pnas.0832467100; Filler Aaron G., 1993, P13; FILLER AG, 1979, THESIS U CHICAGO CHI; Filler AG, 2007, NEUROSURG FOCUS, V23, P1, DOI [10.3171/FOC-07/07/E4, DOI 10.3171/FOC-07/07/E4]; FILLER AG, 2007, UPRIGHT APE NEW ORIG; FILLER AG, 2007, THESIS HARVARD U CAM; Fischer MS, 2002, J EXP BIOL, V205, P1315; Flower WH, 1885, INTRO OSTEOLOGY MAMM, pxi; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; Galik K, 2004, SCIENCE, V305, P1450, DOI 10.1126/science.1098807; Geisler R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-11; Geoffroy Saint-Hilaire E., 1830, TRADUCTIONS IMITATIO; Geoffroy Saint-Hilaire E., 1822, MEMOIRES DU MUSEUM D, V9, P89; GOULD SJ, 2002, STRUCTURE EVOLUTIONA, pR21; Gregory William K., 1947, BULL AMER MUS NAT HIST, V88, P1; Guy F, 2005, P NATL ACAD SCI USA, V102, P18836, DOI 10.1073/pnas.0509564102; Haeusler M, 2002, J HUM EVOL, V43, P621, DOI 10.1006/jhev.2002.0595; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; Hoffstetter R., 1969, P201; Ishida H, 2004, J HUM EVOL, V46, P69, DOI 10.1016/j.jhevol.2003.10.001; Jacobs DK, 2005, EVOL DEV, V7, P498, DOI 10.1111/j.1525-142X.2005.05055.x; JENKINS FA, 1971, POSTCRANIAL SKELETON, pR10; Keith A, 1923, BMJ-BRIT MED J, V1923, P669, DOI 10.1136/bmj.1.3251.669; Keith A, 1923, BRIT MED J, V1923, P624; Keith A, 1923, BRIT MED J, V1923, P587; Keith A, 1923, BRIT MED J, V1923, P545; Keith A, 1923, BRIT MED J, V1923, P499; Keith A, 1923, BMJ-BRIT MED J, V1923, P451, DOI 10.1136/bmj.1.3246.451; Keith A, 1902, J ANAT PHYSIOL, V37, P18; KEMP TS, 2005, ORIGIN EVOLUTION MAM, pR10; Kielan-Jaworowska Zofia, 1994, Fossils and Strata, V36, P1; KIELANJAWOROWSK.Z, 2004, MAMMALS AGE DINOSAUR, pR15; Kohler M, 1997, P NATL ACAD SCI USA, V94, P11747, DOI 10.1073/pnas.94.21.11747; Kuratani S, 2005, ZOOL SCI, V22, P1, DOI 10.2108/zsj.22.1; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li G, 2006, NATURE, V439, P195, DOI 10.1038/nature04168; Lovejoy CO, 2003, ANNU REV ANTHROPOL, V32, P85, DOI 10.1146/annurev.anthro.32.061002.093223; MACLATCHY I, 2004, EVOL ANTHROPOL, P90; MacLatchy L, 2000, J HUM EVOL, V39, P159, DOI 10.1006/jhev.2000.0407; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Minelli A, 2005, J EXP ZOOL PART B, V304B, P520, DOI 10.1002/jez.b.21044; Minelli A, 2004, TRENDS ECOL EVOL, V19, P423, DOI 10.1016/j.tree.2004.06.007; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; Nakatsukasa M, 2004, J HUM EVOL, V46, P777, DOI 10.1016/j.jhevol.2004.04.005; Narita Y, 2005, J EXP ZOOL PART B, V304B, P91, DOI 10.1002/jez.b.21029; Nilsson MA, 2004, GENE, V340, P189, DOI 10.1016/j.gene.2004.07.040; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; NUSSLEINVOLHARD C, 1994, SCIENCE, V266, P572, DOI 10.1126/science.7939708; NussleinVolhard C, 1996, SCI AM, V275, P54; NUSSLEINVOLHARD C, 1979, S SOC DEV BIOL, V37, P185; Ohman JC, 2005, SCIENCE, V307, P845; Owen R., 1848, ARCHETYPE HOMOLOGIES, DOI [10.5962/bhl.title.118611, DOI 10.5962/BHL.TITLE.118611]; OWEN R, 1862, T ZOOL SOC LONDON, V4, P89; Pilbeam D, 2004, J EXP ZOOL PART B, V302B, P241, DOI 10.1002/jez.b.22; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; RICHARDS RJ, 2002, ROMANTIC CONCEPTION, pR19; ROBERTSON JT, 1972, EARLY HOMINID POSTUR; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Rook L, 1999, P NATL ACAD SCI USA, V96, P8795, DOI 10.1073/pnas.96.15.8795; Schilling N, 2006, J EXP BIOL, V209, P3925, DOI 10.1242/jeb.02400; SCHLOSSER G, 2004, MODULARITY DEV EVOLU, pR10; Slijper E. J., 1946, Verh K nod Akad Wet Amsterdam (2), V42, P1; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Stollewerk A, 2003, NATURE, V423, P863, DOI 10.1038/nature01682; Stoltzfus A, 2006, EVOL DEV, V8, P304, DOI 10.1111/j.1525-142X.2006.00101.x; Theissen G, 2006, THEOR BIOSCI, V124, P349, DOI 10.1016/j.thbio.2005.11.002; Theissen G, 2004, NATURE, V428, P813, DOI 10.1038/428813b; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; TUTTLE R, 1974, CURR ANTHROPOL, V15, P389, DOI 10.1086/201494; Tuttle RH, 2006, DEV PRIMATOL-PROG PR, P249, DOI 10.1007/0-387-29798-7_19; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; VONGOETHE JW, 1817, NATURWISSENSCHAFT UB; WALKER A, 1968, NATURE, V217, P980, DOI 10.1038/217980a0; WARD CV, 1993, AM J PHYS ANTHROPOL, V90, P77, DOI 10.1002/ajpa.1330900106; WARD CV, 1993, AM J PHYS ANTHROPOL, V92, P291, DOI 10.1002/ajpa.1330920306; WILLISTON SW, 1925, OSTEOLOGY REPTILES, pR13; Wolpoff MH, 2002, NATURE, V419, P581, DOI 10.1038/419581a; Young NM, 2004, J HUM EVOL, V46, P163, DOI 10.1016/j.jhevol.2003.11.002; YU JK, 2007, NATURE; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	98	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1019	10.1371/journal.pone.0001019	http://dx.doi.org/10.1371/journal.pone.0001019			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925867	Green Submitted, gold, Green Published			2022-12-27	WOS:000207456000018
J	Ding, C; Liu, Y; Wang, Y; Park, BK; Wang, CY; Zheng, P; Liu, Y				Ding, Cheng; Liu, Yan; Wang, Yin; Park, Bae Keun; Wang, Cun-Yu; Zheng, Pan; Liu, Yang			Siglecg Limits the Size of B1a B Cell Lineage by Down-Regulating NF kappa B Activation	PLOS ONE			English	Article								Background. B1 B cells are believed to be a unique lineage with a distinct developmental pathway, function and activation requirement. How this lineage is genetically determined remained largely obscure. Methods and Principal Findings. Using the Siglecg-deficient mice with a knockin of green-fluorescent protein encoding sequence, we show here that, although the Siglecg gene is broadly expressed at high levels in all stages and/or lineages of B cells tested and at lower levels in other lineages, its deletion selectively expanded the B1a B cell lineages, including the frequency of the B1 cell progenitor in the bone marrow and the number of B1a cells in the peritoneal cavity, by postnatal expansion. The expansion of B1a B cells in the peritoneal correlated with enhanced activation of NF kappa B and was ablated by an IKK inhibitor. Conclusion and Significance. Our data revealed a critical role for Siglec G-NF kappa B pathway in regulating B1a B cell lineage. These data lead to a novel model of B1a lineage development that explains a large array of genetic data in this field.	[Ding, Cheng; Liu, Yan; Wang, Yin; Zheng, Pan; Liu, Yang] Univ Michigan, Sch Med, Dept Surg, Div Immunotherapy,Sect Gen Surg, Ann Arbor, MI 48109 USA; [Liu, Yang] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI USA; [Zheng, Pan; Liu, Yang] Univ Michigan, Sch Med, Program Mol Mech Dis, Ann Arbor, MI USA; [Zheng, Pan; Liu, Yang] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Zheng, Pan] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Park, Bae Keun; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Lab Mol Signaling & Apoptosis, Los Angeles, CA 90024 USA; [Ding, Cheng] Ohio State Univ, Integrated Biomed Grad Program, Columbus, OH 43210 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University System of Ohio; Ohio State University	Zheng, P (corresponding author), Univ Michigan, Sch Med, Dept Surg, Div Immunotherapy,Sect Gen Surg, Ann Arbor, MI 48109 USA.	panz@umich.edu; yangl@umich.edu	Zheng, Pan/E-8691-2011	Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X	National Institutes of Health, USA; State of Ohio	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Ohio	This work is supported by National Institutes of Health, USA and Biomedical Research Technology Transfer fund of the State of Ohio. Neither has any role of any sponsors or funders in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; HARDY RR, 1984, J EXP MED, V159, P1169, DOI 10.1084/jem.159.4.1169; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hayakawa K, 2003, J EXP MED, V197, P87, DOI 10.1084/jem.20021459; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hoffmann A, 2007, NAT IMMUNOL, V8, P694, DOI 10.1038/ni1480; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501; Kitzig F, 2002, BIOCHEM BIOPH RES CO, V296, P355, DOI 10.1016/S0006-291X(02)00885-9; Li N, 2001, J BIOL CHEM, V276, P28106, DOI 10.1074/jbc.M100467200; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Munday J, 2001, BIOCHEM J, V355, P489, DOI 10.1042/0264-6021:3550489; Oetke C, 2006, MOL CELL BIOL, V26, P1549, DOI 10.1128/MCB.26.4.1549-1557.2006; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; PAO LI, 2007, IMMUNITY IN PRESS; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; PAUL WE, 2006, FUNDAMENTAL IMMUNOLO; Pohl T, 2002, P NATL ACAD SCI USA, V99, P4514, DOI 10.1073/pnas.072071599; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115; Tung JW, 2006, P NATL ACAD SCI USA, V103, P6293, DOI 10.1073/pnas.0511305103; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Whitney G, 2001, EUR J BIOCHEM, V268, P6083, DOI 10.1046/j.0014-2956.2001.02543.x	27	47	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e997	10.1371/journal.pone.0000997	http://dx.doi.org/10.1371/journal.pone.0000997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912374	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455900033
J	Paul, C; Povey, JE; Lawrence, NJ; Selfridge, J; Melton, DW; Saunders, PTK				Paul, Catriona; Povey, Joanne E.; Lawrence, Nicola J.; Selfridge, Jim; Melton, David W.; Saunders, Philippa T. K.			Deletion of Genes Implicated in Protecting the Integrity of Male Germ Cells Has Differential Effects on the Incidence of DNA Breaks and Germ Cell Loss	PLOS ONE			English	Article								Background. Infertility affects similar to 20% of couples in Europe and in 50% of cases the problem lies with the male partner. The impact of damaged DNA originating in the male germ line on infertility is poorly understood but may increase miscarriage. Mouse models allow us to investigate how deficiencies in DNA repair/damage response pathways impact on formation and function of male germ cells. We have investigated mice with deletions of ERCC1 (excision repair cross-complementing gene 1), MSH2 (MutS homolog 2, involved in mismatch repair pathway), and p53 (tumour suppressor gene implicated in elimination of germ cells with DNA damage). Principal Findings. We demonstrate for the first time that depletion of ERCC1 or p53 from germ cells results in an increased incidence of unrepaired DNA breaks in pachytene spermatocytes and increased numbers of caspase-3 positive (apoptotic) germ cells. Sertoli cell-only tubules were detected in testes from mice lacking expression of ERCC1 or MSH2 but not p53. The number of sperm recovered from epididymes was significantly reduced in mice lacking testicular ERCC1 and 40% of sperm contained DNA breaks whereas the numbers of sperm were not different to controls in adult Msh2 -/- or p53 -/- mice nor did they have significantly compromised DNA. Conclusions. These data have demonstrated that deletion of Ercc1, Msh2 and p53 can have differential but overlapping affects on germ cell function and sperm production. These findings increase our understanding of the ways in which gene mutations can have an impact on male fertility.	[Paul, Catriona; Saunders, Philippa T. K.] Queens Med Res Inst, MRC, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland; [Povey, Joanne E.; Lawrence, Nicola J.; Selfridge, Jim; Melton, David W.] Univ Edinburgh, Western Gen Hosp, Sir Alastair Currie Canc Res United Kingdom Labs, Mol Med Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Saunders, PTK (corresponding author), Queens Med Res Inst, MRC, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland.	p.saunders@ed.ac.uk	Saunders, Philippa TK/C-7489-2013	Saunders, Philippa TK/0000-0001-9051-9380; SELFRIDGE, JIM/0000-0003-2473-4386	MRC; Cancer Research UK [C376/A1570]; MRC [MC_U127685841, MC_U127685844] Funding Source: UKRI; Medical Research Council [MC_U127685841, MC_U127685844] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	CP was funded by an MRC studentship. This work was also supported by programme grant C376/A1570 from Cancer Research UK to DM and core MRC Unit funding to PTKS.	Baarends WM, 2001, REPRODUCTION, V121, P31, DOI 10.1530/rep.0.1210031; BAKALKIN GY, 1993, MOL BRAIN RES, V20, P137, DOI 10.1016/0169-328X(93)90119-A; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow AL, 1997, EMBO J, V16, P5207, DOI 10.1093/emboj/16.17.5207; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Biggers J. D., 1971, CULTURE MOUSE EMBRYO, P86; Campbell AJ, 2000, BRIT MED BULL, V56, P616, DOI 10.1258/0007142001903427; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chohan KR, 2004, ANDROLOGIA, V36, P321, DOI 10.1111/j.1439-0272.2004.00626.x; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; CLERMONT Y, 1963, AM J ANAT, V112, P35, DOI 10.1002/aja.1001120103; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; DAVIES AA, 1995, J BIOL CHEM, V270, P24638, DOI 10.1074/jbc.270.42.24638; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Dunson DB, 2004, OBSTET GYNECOL, V103, P51, DOI 10.1097/01.AOG.0000100153.24061.45; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Embree-Ku M, 2002, EXP BIOL MED, V227, P545, DOI 10.1177/153537020222700720; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; GORCZYCA W, 1993, EXP CELL RES, V207, P202, DOI 10.1006/excr.1993.1182; GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211; Hamer G, 2003, BIOL REPROD, V68, P628, DOI 10.1095/biolreprod.102.008672; Hsia KT, 2003, DEVELOPMENT, V130, P369, DOI 10.1242/dev.00221; Jansen HT, 2001, BIOL REPROD, V65, P866, DOI 10.1095/biolreprod65.3.866; Jaroudi S, 2007, MUTAT RES-REV MUTAT, V635, P53, DOI 10.1016/j.mrrev.2006.09.002; Kirkpatrick DT, 1999, CELL MOL LIFE SCI, V55, P437, DOI 10.1007/s000180050300; Kneitz B, 2000, GENE DEV, V14, P1085; Kolas NK, 2005, J CELL BIOL, V171, P447, DOI 10.1083/jcb.200506170; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; KRZANOWSKA H, 1989, GAMETE RES, V23, P357, DOI 10.1002/mrd.1120230312; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; Li L, 1996, NUCLEIC ACIDS RES, V24, P1026, DOI 10.1093/nar/24.6.1026; Linke SP, 2003, CANCER RES, V63, P2596; Marcon E, 2005, BIOESSAYS, V27, P795, DOI 10.1002/bies.20264; Marty MS, 1999, MUTAT RES-FUND MOL M, V427, P39, DOI 10.1016/S0027-5107(99)00083-4; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Meira LB, 2002, DNA REPAIR, V1, P929, DOI 10.1016/S1568-7864(02)00143-X; Modrich P, 1997, J BIOL CHEM, V272, P24727, DOI 10.1074/jbc.272.40.24727; Moens PB, 2002, J CELL SCI, V115, P1611; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NAKANE H, 1995, NATURE, V377, P165, DOI 10.1038/377165a0; Ng JMY, 2002, MOL CELL BIOL, V22, P1233, DOI 10.1128/MCB.22.4.1233-1245.2002; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Polanski Z, 2000, J REPROD FERTIL, V119, P165, DOI 10.1530/reprod/119.1.165; Richardson LL, 2000, BIOL REPROD, V62, P789, DOI 10.1095/biolreprod62.3.789; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; Saunders PTK, 2001, MOL HUM REPROD, V7, P227, DOI 10.1093/molehr/7.3.227; SCHIESTL RH, 1990, MOL CELL BIOL, V10, P2485, DOI 10.1128/MCB.10.6.2485; SCHWARTZ D, 1993, ONCOGENE, V8, P1487; Schwartz D, 1999, CELL GROWTH DIFFER, V10, P665; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Selfridge J, 2001, NUCLEIC ACIDS RES, V29, P4541, DOI 10.1093/nar/29.22.4541; Seo YR, 2004, EXP MOL MED, V36, P505, DOI 10.1038/emm.2004.64; Shannon M, 1999, GENOMICS, V62, P427, DOI 10.1006/geno.1999.6016; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sjoblom T, 1996, ONCOGENE, V12, P2499; Sorahan T, 1997, BRIT J CANCER, V76, P1525, DOI 10.1038/bjc.1997.589; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Svetlanov A, 2004, EXP CELL RES, V296, P71, DOI 10.1016/j.yexcr.2004.03.020; Tang W, 1999, CANCER RES, V59, P2562; Twigg JP, 1998, HUM REPROD, V13, P1864, DOI 10.1093/humrep/13.7.1864; VanZelst SJ, 1995, REPROD FERT DEVELOP, V7, P1117, DOI 10.1071/RD9951117; WALDBIESER GC, 1986, GAMETE RES, V15, P153, DOI 10.1002/mrd.1120150206; WEEDA G, 1991, CARCINOGENESIS, V12, P2361, DOI 10.1093/carcin/12.12.2361; WIND N, 1995, CELL, V82, P321; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031; Xu GG, 2005, BIOL REPROD, V73, P123, DOI 10.1095/biolreprod.104.039123; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yin YZ, 1998, DEV BIOL, V204, P165, DOI 10.1006/dbio.1998.9074; Yin YZ, 2002, J ANDROL, V23, P64, DOI 10.1002/jand.2002.23.1.64; Yoshino M, 2002, DNA REPAIR, V1, P935, DOI 10.1016/S1568-7864(02)00144-1; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zenzes MT, 2000, HUM REPROD UPDATE, V6, P122, DOI 10.1093/humupd/6.2.122; Zenzes MT, 1999, MOL HUM REPROD, V5, P125, DOI 10.1093/molehr/5.2.125; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	86	46	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e989	10.1371/journal.pone.0000989	http://dx.doi.org/10.1371/journal.pone.0000989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912366	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455900025
J	Mutch, DM; Temanni, MR; Henegar, C; Combes, F; Pelloux, V; Holst, C; Sorensen, TIA; Astrup, A; Martinez, JA; Saris, WHM; Viguerie, N; Langin, D; Zucker, JD; Clement, K				Mutch, David M.; Temanni, M. Ramzi; Henegar, Corneliu; Combes, Florence; Pelloux, Veronique; Holst, Claus; Sorensen, Thorkild I. A.; Astrup, Arne; Alfredo Martinez, J.; Saris, Wim H. M.; Viguerie, Nathalie; Langin, Dominique; Zucker, Jean-Daniel; Clement, Karine			Adipose Gene Expression Prior to Weight Loss Can Differentiate and Weakly Predict Dietary Responders	PLOS ONE			English	Article							LOW-FAT; OBESE SUBJECTS; CANCER; CLASSIFICATION; TISSUE; MICROARRAYS; DISCOVERY; TRIAL	Background. The ability to identify obese individuals who will successfully lose weight in response to dietary intervention will revolutionize disease management. Therefore, we asked whether it is possible to identify subjects who will lose weight during dietary intervention using only a single gene expression snapshot. Methodology/Principal Findings. The present study involved 54 female subjects from the Nutrient-Gene Interactions in Human Obesity-Implications for Dietary Guidelines (NUGENOB) trial to determine whether subcutaneous adipose tissue gene expression could be used to predict weight loss prior to the 10-week consumption of a low-fat hypocaloric diet. Using several statistical tests revealed that the gene expression profiles of responders (8-12 kgs weight loss) could always be differentiated from non-responders (<4 kgs weight loss). We also assessed whether this differentiation was sufficient for prediction. Using a bottom-up (i.e. black-box) approach, standard class prediction algorithms were able to predict dietary responders with up to 61.1%+/- 68.1% accuracy. Using a top-down approach (i.e. using differentially expressed genes to build a classifier) improved prediction accuracy to 80.9%+/- 62.2%. Conclusion. Adipose gene expression profiling prior to the consumption of a low-fat diet is able to differentiate responders from non-responders as well as serve as a weak predictor of subjects destined to lose weight. While the degree of prediction accuracy currently achieved with a gene expression snapshot is perhaps insufficient for clinical use, this work reveals that the comprehensive molecular signature of adipose tissue paves the way for the future of personalized nutrition.	[Mutch, David M.; Temanni, M. Ramzi; Henegar, Corneliu; Combes, Florence; Pelloux, Veronique; Zucker, Jean-Daniel; Clement, Karine] INSERM, Nutriom U872, Paris, France; [Mutch, David M.; Temanni, M. Ramzi; Henegar, Corneliu; Combes, Florence; Pelloux, Veronique; Zucker, Jean-Daniel; Clement, Karine] Univ Paris 06, Ctr Rech Cordeliers, UMR S 872, Paris, France; [Mutch, David M.; Henegar, Corneliu; Combes, Florence; Pelloux, Veronique; Zucker, Jean-Daniel; Clement, Karine] Univ Paris 05, UMR S 872, Paris, France; [Temanni, M. Ramzi] Univ Paris 13, EA3969, LIM&BIO, Bobigny, France; [Holst, Claus; Sorensen, Thorkild I. A.] Univ Copenhagen Hosp, Inst Prevent Med, Ctr Hlth & Soc, DK-2100 Copenhagen, Denmark; [Astrup, Arne] Univ Copenhagen, Fac Life Sci, Dept Human Nutr, Copenhagen, Denmark; [Alfredo Martinez, J.] Univ Navarra, Dept Physiol & Nutr, E-31080 Pamplona, Spain; [Saris, Wim H. M.] Maastricht Univ, NUTRIM, Dept Human Biol, Maastricht, Netherlands; [Viguerie, Nathalie; Langin, Dominique] Fac Med Toulouse, INSERM, Inst Med Mol Rangueil, Lab Rech Obesites,U858, F-31073 Toulouse, France; [Viguerie, Nathalie; Langin, Dominique] Univ Toulouse 3, Inst Louis Bugnard, IFR31, F-31062 Toulouse, France; [Langin, Dominique] CHU Toulouse, Biochim Lab, Inst Federatif Biol Purpan, Toulouse, France; [Clement, Karine] Hop La Pitie Salpetriere, AP HP, Dept Nutr & Endocrinol, Ctr Rech Nutr Humaine Ile France, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; University of Copenhagen; University of Copenhagen; University of Navarra; Maastricht University; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Clement, K (corresponding author), INSERM, Nutriom U872, Paris, France.	karine.clement@psl.aphp.fr	Combes, Francoise/F-6046-2011; Martínez, J. Alfredo/K-8709-2014; ZUCKER, Jean-Daniel/K-3008-2016; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Clément, karine/R-1120-2017; Henegar, Corneliu R/K-9166-2013; TEMANNI, Mohamed Ramzi/AAQ-6936-2020; Astrup, Arne/B-1407-2015; Viguerie, Nathalie/M-2422-2017	Combes, Francoise/0000-0003-2658-7893; Martínez, J. Alfredo/0000-0001-5218-6941; ZUCKER, Jean-Daniel/0000-0002-5597-7922; Henegar, Corneliu R/0000-0002-8486-5591; TEMANNI, Mohamed Ramzi/0000-0001-9125-1136; Astrup, Arne/0000-0001-8968-8996; Viguerie, Nathalie/0000-0002-1730-9915; Combes, Florence/0000-0001-7384-4587; Langin, Dominique/0000-0002-2669-7825; Mutch, David/0000-0002-0908-7259	European Community [QLK1-CT 2000-00618, FP6-513946]; INSERM; Programme National de Recherche en Nutrition Humaine (PNRH); Paris 6 University	European Community(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Programme National de Recherche en Nutrition Humaine (PNRH); Paris 6 University	This work was supported by the European Community NUGENOB-Nutrient Gene Interaction in Human Obesity contract QLK1-CT 2000-00618: www.nugenob.com/, and DIOGENES-Diet, genes and obesity (Contract FP6-513946: http://www.diogenes-eu.org), INSERM, the Programme National de Recherche en Nutrition Humaine (PNRH), and Paris 6 University. M Ramzi Temanni received thesis support from the Teaching and Research ministry (MRT grant).	Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Clement K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dudoit S, 2003, INTERDISC STAT, P93; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Finer N, 2006, DIABETES OBES METAB, V8, P206, DOI 10.1111/j.1463-1326.2005.00481.x; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hastie T, 2004, J MACH LEARN RES, V5, P1391; Heidecker B, 2007, HEART FAIL REV, V12, P1, DOI 10.1007/s10741-007-9004-7; Jain KK, 2006, CURR OPIN MOL THER, V8, P487; Kaput J, 2005, BRIT J NUTR, V94, P623, DOI 10.1079/BJN20051585; Klaus S, 2004, NUTRITION, V20, P115, DOI 10.1016/j.nut.2003.09.020; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lee Y, 2003, BIOINFORMATICS, V19, P1132, DOI 10.1093/bioinformatics/btg102; Lin SM, 2006, PHARMACOGENOMICS, V7, P495, DOI 10.2217/14622416.7.3.495; Loos RJF, 2005, J AM DIET ASSOC, V105, pS29, DOI 10.1016/j.jada.2005.02.015; MARYHUARD T, 2006, MATH COMPUTATIONAL M; Moreno-Aliaga MJ, 2005, OBES REV, V6, P155, DOI 10.1111/j.1467-789X.2005.00180.x; Mutch DM, 2006, PLOS GENET, V2, P1956, DOI 10.1371/journal.pgen.0020188; Mutch DM, 2005, FASEB J, V19, P1602, DOI 10.1096/fj.05-3911rev; MUTCH DM, 2006, CURR OPIN ENDOCRINOL, V13, P431; Perez-Diez A, 2007, ADV EXP MED BIOL, V593, P74; Perusse L, 2000, AM J CLIN NUTR, V72, p1285S, DOI 10.1093/ajcn/72.5.1285s; Petersen M, 2006, INT J OBESITY, V30, P552, DOI 10.1038/sj.ijo.0803186; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Rissanen A, 2003, INT J OBESITY, V27, P103, DOI 10.1038/sj.ijo.0802165; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Sorensen TIA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010012; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Viguerie N, 2005, BIOCHIMIE, V87, P117, DOI 10.1016/j.biochi.2004.12.011; Viguerie N, 2005, DIABETOLOGIA, V48, P123, DOI 10.1007/s00125-004-1618-x	38	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1344	10.1371/journal.pone.0001344	http://dx.doi.org/10.1371/journal.pone.0001344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18094752	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459600027
J	McGovern, G; Jeffrey, M				McGovern, Gillian; Jeffrey, Martin			Scrapie-Specific Pathology of Sheep Lymphoid Tissues	PLOS ONE			English	Article								Transmissible spongiform encephalopathies (TSEs) or prion diseases often result in accumulation of disease-associated PrP (PrP(d)) in the lymphoreticular system (LRS), specifically in association with follicular dendritic cells (FDCs) and tingible body macrophages (TBMs) of secondary follicles. We studied the effects of sheep scrapie on lymphoid tissue in tonsils and lymph nodes by light and electron microscopy. FDCs of sheep were grouped according to morphology as immature, mature or regressing. Scrapie was associated with FDC dendrite hypertrophy and electron dense deposit or vesicles. PrP(d) was located using immunogold labelling at the plasmalemma of FDC dendrites and, infrequently, mature B cells. Abnormal electron dense deposits surrounding FDC dendrites were identified as immunoglobulins suggesting that excess immune complexes are retained and are indicative of an FDC dysfunction. Within scrapie-affected lymph nodes, macrophages outside the follicle and a proportion of germinal centre TBMs accumulated PrP(d) within endosomes and lysosomes. In addition, TBMs showed PrP(d) in association with the cell membrane, non-coated pits and vesicles, and also with discrete, large and random endoplasmic reticulum networks, which co-localised with ubiquitin. These observations suggest that PrP(d) is internalised via the caveolin-mediated pathway, and causes an abnormal disease-related alteration in endoplasmic reticulum structure. In contrast to current dogma, this study shows that sheep scrapie is associated with cytopathology of germinal centres, which we attribute to abnormal antigen complex trapping by FDCs and abnormal endocytic events in TBMs. The nature of the sub-cellular changes in FDCs and TBMs differs from those of scrapie infected neurones and glial cells suggesting that different PrP(d)/cell membrane interactions occur in different cell types.	[McGovern, Gillian; Jeffrey, Martin] Vet Labs Agcy Lasswade, Penicuik, Midlothian, Scotland		McGovern, G (corresponding author), Vet Labs Agcy Lasswade, Pentlands Sci Pk, Penicuik, Midlothian, Scotland.	g.mcgovern@vla.defra.gsi.gov.uk	Jeffrey, Martin/D-2251-2009; McGOVERN, GILLIAN/C-3441-2011	McGOVERN, GILLIAN/0000-0001-5344-5909	Department for Environment, Food and Rural Affairs [Se1940, Se1955]	Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported by funding from Department for Environment, Food and Rural Affairs projects Se1940 and Se1955.	BENLIMAME N, 1995, J CELL BIOL, V129, P459, DOI 10.1083/jcb.129.2.459; BOSSELOIR A, 1995, FOLLICULAR DENDRITIC, P53; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; CARP RI, 1994, ARCH VIROL, V136, P255, DOI 10.1007/BF01321056; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Denzer K, 2000, J CELL SCI, V113, P3365; Ersdal C, 2003, ACTA NEUROPATHOL, V106, P17, DOI 10.1007/s00401-003-0690-5; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gonzalez L, 2006, VET REC, V158, P325, DOI 10.1136/vr.158.10.325; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; Gonzalez L, 2001, J COMP PATHOL, V125, P41, DOI 10.1053/jcpa.2001.0475; GONZALEZ L, 2007, VET REC IN PRESS; Heggebo R, 2002, J GEN VIROL, V83, P479, DOI 10.1099/0022-1317-83-2-479; Heinen E, 1995, CURR TOP MICROBIOL, V201, P15; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Jeffrey M, 2000, J PATHOL, V191, P323, DOI 10.1002/1096-9896(200007)191:3&lt;323::AID-PATH629&gt;3.0.CO;2-Z; Jeffrey M, 2004, ANN NEUROL, V55, P781, DOI 10.1002/ana.20093; Jeffrey M, 2003, J GEN VIROL, V84, P1033, DOI 10.1099/vir.0.18825-0; JEFFREY M, 1994, NEUROSCI LETT, V174, P39, DOI 10.1016/0304-3940(94)90113-9; Jeffrey M, 2001, J COMP PATHOL, V125, P271, DOI 10.1053/jcpa.2001.0499; Jeffrey M, 2001, J COMP PATHOL, V125, P48, DOI 10.1053/jcpa.2001.0476; Jeffrey M, 1996, PRION DIS, P301; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; MAUL GG, 1978, J VIROL, V28, P936, DOI 10.1128/JVI.28.3.936-944.1978; McGovern G, 2004, J COMP PATHOL, V130, P181, DOI 10.1016/j.jcpa.2003.11.001; Nielsen CH, 2000, IMMUNOLOGY, V100, P4, DOI 10.1046/j.1365-2567.2000.00009.x; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Press CM, 2004, ADV DRUG DELIVER REV, V56, P885, DOI 10.1016/j.addr.2003.09.008; RADEMAKERS LHPM, 1992, CELL TISSUE RES, V269, P359, DOI 10.1007/BF00319629; RADOUX D, 1985, ADV EXP MED BIOL, V186, P185; REYNOLDS JD, 1983, EUR J IMMUNOL, V13, P627, DOI 10.1002/eji.1830130805; SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Smith J P, 1998, Dev Immunol, V6, P285, DOI 10.1155/1998/38923; Sprocati T, 2006, J CELL SCI, V119, P3249, DOI 10.1242/jcs.03058; St Rose SG, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-5; SZAKAL AK, 1990, ANAT REC, V227, P475, DOI 10.1002/ar.1092270411; Szakal AK, 2002, SEMIN IMMUNOL, V14, P267, DOI 10.1016/S1044-5323(02)00059-3; THORBECKE GJ, 1994, FASEB J, V8, P832, DOI 10.1096/fasebj.8.11.8070632; vanKeulen LJM, 1996, J CLIN MICROBIOL, V34, P1228, DOI 10.1128/JCM.34.5.1228-1231.1996	42	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1304	10.1371/journal.pone.0001304	http://dx.doi.org/10.1371/journal.pone.0001304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074028	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459500023
J	Levesque, M; Gatien, S; Finnson, K; Desmeules, S; Villiard, E; Pilote, M; Philip, A; Roy, S				Levesque, Mathieu; Gatien, Samuel; Finnson, Kenneth; Desmeules, Sophie; Villiard, Eric; Pilote, Mireille; Philip, Anie; Roy, Stephane			Transforming Growth Factor: beta Signaling Is Essential for Limb Regeneration in Axolotls 2	PLOS ONE			English	Article								Axolotls (urodele amphibians) have the unique ability, among vertebrates, to perfectly regenerate many parts of their body including limbs, tail, jaw and spinal cord following injury or amputation. The axolotl limb is the most widely used structure as an experimental model to study tissue regeneration. The process is well characterized, requiring multiple cellular and molecular mechanisms. The preparation phase represents the first part of the regeneration process which includes wound healing, cellular migration, dedifferentiation and proliferation. The redevelopment phase represents the second part when dedifferentiated cells stop proliferating and redifferentiate to give rise to all missing structures. In the axolotl, when a limb is amputated, the missing or wounded part is regenerated perfectly without scar formation between the stump and the regenerated structure. Multiple authors have recently highlighted the similarities between the early phases of mammalian wound healing and urodele limb regeneration. In mammals, one very important family of growth factors implicated in the control of almost all aspects of wound healing is the transforming growth factor-beta family (TGF-beta). In the present study, the full length sequence of the axolotl TGF-beta 1 cDNA was isolated. The spatio-temporal expression pattern of TGF-beta 1 in regenerating limbs shows that this gene is up-regulated during the preparation phase of regeneration. Our results also demonstrate the presence of multiple components of the TGF-beta signaling machinery in axolotl cells. By using a specific pharmacological inhibitor of TGF-beta type I receptor, SB-431542, we show that TGF-beta signaling is required for axolotl limb regeneration. Treatment of regenerating limbs with SB-431542 reveals that cellular proliferation during limb regeneration as well as the expression of genes directly dependent on TGF-beta signaling are down-regulated. These data directly implicate TGF-beta signaling in the initiation and control of the regeneration process in axolotls.	[Levesque, Mathieu; Gatien, Samuel; Pilote, Mireille; Roy, Stephane] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Desmeules, Sophie; Villiard, Eric; Roy, Stephane] Univ Montreal, Fac Dent, Montreal, PQ H3C 3J7, Canada; [Finnson, Kenneth; Philip, Anie] McGill Univ, Fac Med, Dept Surg, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University	Roy, S (corresponding author), Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada.	stephane.roy@umontreal.ca		Finnson, Kenneth/0000-0003-2930-0595	CIHR; FRSQ; Network for oral and bone health research	CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); Network for oral and bone health research	Research funded by the CIHR, FRSQ and the Network for oral and bone health research.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Burt David W., 1994, Progress in Growth Factor Research, V5, P99; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Carlson MRJ, 1998, J EXP ZOOL, V282, P715, DOI 10.1002/(SICI)1097-010X(19981215)282:6<715::AID-JEZ7>3.0.CO;2-F; Cash DE, 1998, GENE, V222, P119, DOI 10.1016/S0378-1119(98)00478-8; CHALKLEY DT, 1954, J MORPHOL, V94, P21, DOI 10.1002/jmor.1050940103; Chang J, 2000, PLAST RECONSTR SURG, V105, P148, DOI 10.1097/00006534-200001000-00025; Chodorowska Grazyna, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P403; Christensen RN, 2000, DEV DYNAM, V217, P216, DOI 10.1002/(SICI)1097-0177(200002)217:2<216::AID-DVDY8>3.0.CO;2-8; CLARK RAF, 1985, J AM ACAD DERMATOL, V13, P701, DOI 10.1016/S0190-9622(85)70213-7; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Finnson KW, 2006, FASEB J, V20, P1525, DOI 10.1096/fj.05-5229fje; Frank S, 1996, J BIOL CHEM, V271, P10188, DOI 10.1074/jbc.271.17.10188; GAILIT J, 1994, J INVEST DERMATOL, V103, P221, DOI 10.1111/1523-1747.ep12393176; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; Gardiner DM, 1999, SEMIN CELL DEV BIOL, V10, P385, DOI 10.1006/scdb.1999.0325; GOSS RJ, 1980, CLIN ORTHOP RELAT R, P270; Grose R, 1999, SEMIN CELL DEV BIOL, V10, P395, DOI 10.1006/scdb.1999.0326; Han Manjong, 2005, Anatomical Record Part B:The New Anatomist, V287, P14, DOI 10.1002/ar.b.20082; Harty M, 2003, DEV DYNAM, V226, P268, DOI 10.1002/dvdy.10239; Ho DM, 2006, DEV BIOL, V295, P730, DOI 10.1016/j.ydbio.2006.03.050; Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558; Hutchison C, 2007, BONE, V40, P45, DOI 10.1016/j.bone.2006.07.005; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; ITEN LE, 1973, ROUX ARCH DEV BIOL, V173, P263, DOI 10.1007/BF00575834; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jazwinska A, 2007, CURR BIOL, V17, P1390, DOI 10.1016/j.cub.2007.07.019; Jester JV, 1997, CORNEA, V16, P177; Kahari VM, 1997, EXP DERMATOL, V6, P199, DOI 10.1111/j.1600-0625.1997.tb00164.x; KANE CJM, 1991, J CELL PHYSIOL, V148, P157, DOI 10.1002/jcp.1041480119; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; KESKIOJA J, 1988, J BIOL CHEM, V263, P3111; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Letterio JJ, 1996, J LEUKOCYTE BIOL, V59, P769, DOI 10.1002/jlb.59.6.769; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Levesque M, 2005, DEV DYNAM, V233, P1525, DOI 10.1002/dvdy.20458; Liu XJ, 2005, BIOTECHNOL LETT, V27, P1609, DOI 10.1007/s10529-005-2516-0; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; Lu L, 2005, J AM COLL SURGEONS, V201, P391, DOI 10.1016/j.jamcollsurg.2005.03.032; LUNA LG, 1968, MANUAL HISTOLOGIC ST, pR12; Madlener M, 1998, ARCH DERMATOL RES, V290, pS24, DOI 10.1007/PL00007450; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MARTIN P, 1993, DEV GENET, V14, P225, DOI 10.1002/dvg.1020140309; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mescher AL, 2006, THESCIENTIFICWORLDJO, V6, P1, DOI 10.1100/tsw.2006.323; Montesano R, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-7; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Mullen LM, 1996, DEVELOPMENT, V122, P3487; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Nath RK, 1998, PLAST RECONSTR SURG, V102, P1100, DOI 10.1097/00006534-199809040-00027; Ninomiya K, 2006, HYPERTENS RES, V29, P269, DOI 10.1291/hypres.29.269; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Piek E, 1997, J CELL PHYSIOL, V173, P447, DOI 10.1002/(SICI)1097-4652(199712)173:3<447::AID-JCP17>3.0.CO;2-8; Pierce G F, 1988, Prog Clin Biol Res, V266, P93; POSTLETHWAITE AE, 1987, J EXP MED, V165, P251, DOI 10.1084/jem.165.1.251; Prud'homme GJ, 2000, J AUTOIMMUN, V14, P23, DOI 10.1006/jaut.1999.0339; Putta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-54; Quan G, 2005, ARCH DERMATOL RES, V297, P84, DOI 10.1007/s00403-005-0582-8; Quan TH, 2004, AM J PATHOL, V165, P741, DOI 10.1016/S0002-9440(10)63337-8; Quan TH, 2001, J BIOL CHEM, V276, P26349, DOI 10.1074/jbc.M010835200; Roberts Anita B., 1995, Wound Repair and Regeneration, V3, P408, DOI 10.1046/j.1524-475X.1995.30405.x; ROY S, 1994, ENDOCRINOLOGY, V134, P1761, DOI 10.1210/en.134.4.1761; Roy S, 2000, DEV BIOL, V218, P199, DOI 10.1006/dbio.1999.9556; Roy S, 2006, THESCIENTIFICWORLDJO, V6, P12, DOI 10.1100/tsw.2006.324; Schultze-Mosgau S, 2004, BRIT J ORAL MAX SURG, V42, P112, DOI 10.1016/S0266-4356(03)00257-2; SHAH M, 1995, J CELL SCI, V108, P985; SHAH M, 1994, J CELL SCI, V107, P1137; SHAH M, 1992, LANCET, V339, P213, DOI 10.1016/0140-6736(92)90009-R; SICARD RE, 1985, REGULATION VERTEBRAT, pR9; Singer M., 1961, GROWTH LIVING SYSTEM, P277; Sun ZH, 2006, BIOCHEM BIOPH RES CO, V345, P694, DOI 10.1016/j.bbrc.2006.04.148; Tam BYY, 2003, J BIOL CHEM, V278, P49610, DOI 10.1074/jbc.M308492200; TANK PW, 1976, J MORPHOL, V150, P117, DOI 10.1002/jmor.1051500106; Tournefier A, 1998, IMMUNOL REV, V166, P259, DOI 10.1111/j.1600-065X.1998.tb01268.x; TSONIS PA, 1996, LIMB REGENERATION, pR12; Vinarsky V, 2005, DEV BIOL, V279, P86, DOI 10.1016/j.ydbio.2004.12.003; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; WALLACE H, 1981, VERTEBRATE LIMB REGE, pR12; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; Wang XJ, 2006, J INVEST DERM SYMP P, V11, P112, DOI 10.1038/sj.jidsymp.5650004; Wu S, 2007, AM J RESP CELL MOL, V36, P552, DOI 10.1165/rcmb.2006-0320OC; YANG EV, 1994, DEV BIOL, V166, P696, DOI 10.1006/dbio.1994.1348; Yang EV, 1999, DEV DYNAM, V216, P2, DOI 10.1002/(SICI)1097-0177(199909)216:1<2::AID-DVDY2>3.3.CO;2-G	95	104	105	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1227	10.1371/journal.pone.0001227	http://dx.doi.org/10.1371/journal.pone.0001227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043735	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459300009
J	Scott, KC; White, CV; Willard, HF				Scott, Kristin C.; White, Caroline V.; Willard, Huntington F.			An RNA Polymerase III-Dependent Heterochromatin Barrier at Fission Yeast Centromere 1	PLOS ONE			English	Article								Heterochromatin formation involves the nucleation and spreading of structural and epigenetic features along the chromatin fiber. Chromatin barriers and associated proteins counteract the spreading of heterochromatin, thereby restricting it to specific regions of the genome. We have performed gene expression studies and chromatin immunoprecipitation on strains in which native centromere sequences have been mutated to study the mechanism by which a tRNA(Alanine) gene barrier (cen1 tDNA(Ala)) blocks the spread of pericentromeric heterochromatin at the centromere of chromosome 1 (cen1) in the fission yeast, Schizosaccharomyces pombe. Within the centromere, barrier activity is a general property of tDNAs and, unlike previously characterized barriers, requires the association of both transcription factor IIIC and RNA Polymerase III. Although the cen1 tDNA Ala gene is actively transcribed, barrier activity is independent of transcriptional orientation. These findings provide experimental evidence for the involvement of a fully assembled RNA polymerase III transcription complex in defining independent structural and functional domains at a eukaryotic centromere.	[Scott, Kristin C.; White, Caroline V.; Willard, Huntington F.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA	Duke University	Scott, KC (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA.	kristin.scott@duke.edu			March of Dimes Birth Defects Foundation; Program in Genome Biology of the Duke Institute for Genome Sciences and Policy	March of Dimes Birth Defects Foundation(March of Dimes); Program in Genome Biology of the Duke Institute for Genome Sciences and Policy	Funding: This work was supported by a grant from the March of Dimes Birth Defects Foundation and funds from the Program in Genome Biology of the Duke Institute for Genome Sciences and Policy.	Avramova Z, 1999, TRENDS GENET, V15, P138, DOI 10.1016/S0168-9525(99)01712-6; Bolton EC, 2003, GENOME RES, V13, P254, DOI 10.1101/gr.612203; Braglia P, 2007, MOL CELL BIOL, V27, P1545, DOI 10.1128/MCB.00773-06; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chedin S, 1998, COLD SPRING HARB SYM, V63, P381, DOI 10.1101/sqb.1998.63.381; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Chiu YH, 2003, GENETICS, V165, P115; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Conesa C, 2005, MOL CELL BIOL, V25, P8631, DOI 10.1128/MCB.25.19.8631-8642.2005; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Donze D, 2002, BIOESSAYS, V24, P344, DOI 10.1002/bies.10072; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1996, J CELL SCI, V109, P2637; Fourel G, 2001, EMBO REP, V2, P124, DOI 10.1093/embo-reports/kve024; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; GERLACH VL, 1995, MOL CELL BIOL, V15, P1455; GORDON M, 2007, MOL CELL BIOL; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamada M, 2001, MOL CELL BIOL, V21, P6870, DOI 10.1128/MCB.21.20.6870-6881.2001; Huang Y, 2001, NUCLEIC ACIDS RES, V29, P2675, DOI 10.1093/nar/29.13.2675; Huisinga KL, 2006, CHROMOSOMA, V115, P110, DOI 10.1007/s00412-006-0052-x; HULL MW, 1994, MOL CELL BIOL, V14, P1266, DOI 10.1128/MCB.14.2.1266; Jia ST, 2004, CELL, V119, P469, DOI 10.1016/j.cell.2004.10.020; Kassavetis GA, 1998, P NATL ACAD SCI USA, V95, P9196, DOI 10.1073/pnas.95.16.9196; Kimura A, 2004, GENES CELLS, V9, P499, DOI 10.1111/j.1356-9597.2004.00740.x; KINSEY PT, 1991, NUCLEIC ACIDS RES, V19, P1317, DOI 10.1093/nar/19.6.1317; Lan F, 2007, MOL CELL, V26, P89, DOI 10.1016/j.molcel.2007.02.023; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MORSE RH, 1992, MOL CELL BIOL, V12, P4015, DOI 10.1128/MCB.12.9.4015; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma KI, 2006, CELL, V125, P859, DOI 10.1016/j.cell.2006.04.028; Oki M, 2005, MOL CELL, V19, P707, DOI 10.1016/j.molcel.2005.07.022; Oki M, 2004, MOL CELL BIOL, V24, P1956, DOI 10.1128/MCB.24.5.1956-1967.2004; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Simms TA, 2004, NUCLEIC ACIDS RES, V32, P5206, DOI 10.1093/nar/gkh858; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Sun FL, 1999, CELL, V99, P459, DOI 10.1016/S0092-8674(00)81534-2; TAKAHASHI K, 1991, J MOL BIOL, V218, P13, DOI 10.1016/0022-2836(91)90867-6; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Valenzuela L, 2006, ANNU REV GENET, V40, P107, DOI 10.1146/annurev.genet.39.073003.113546; Wang L, 2005, J BIOL CHEM, V280, P8637, DOI 10.1074/jbc.C500017200; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; WITTIG S, 1982, NATURE, V297, P31, DOI 10.1038/297031a0	52	52	53	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1099	10.1371/journal.pone.0001099	http://dx.doi.org/10.1371/journal.pone.0001099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971862	Green Published, Green Submitted, gold			2022-12-27	WOS:000207458700016
J	Naderi, S; Rezaei, HR; Taberlet, P; Zundel, S; Rafat, SA; Naghash, HR; El-Barody, MAA; Ertugrul, O; Pompanon, F				Naderi, Saeid; Rezaei, Hamid-Reza; Taberlet, Pierre; Zundel, Stephanie; Rafat, Seyed-Abbas; Naghash, Hamid-Reza; El-Barody, Mohamed A. A.; Ertugrul, Okan; Pompanon, Francois		Econogene Consortium	Large-Scale Mitochondrial DNA Analysis of the Domestic Goat Reveals Six Haplogroups with High Diversity	PLOS ONE			English	Article							CAPRA-HIRCUS; PHYLOGEOGRAPHIC STRUCTURE; INITIAL DOMESTICATION; PHYLOGENETIC ANALYSIS; INTEGRATED SOFTWARE; SEQUENCE; BREEDS; LINEAGES; GENETICS; ORIGINS	Background. From the beginning of domestication, the transportation of domestic animals resulted in genetic and demographic processes that explain their present distribution and genetic structure. Thus studying the present genetic diversity helps to better understand the history of domestic species. Methodology/Principal Findings. The genetic diversity of domestic goats has been characterized with 2430 individuals from all over the old world, including 946 new individuals from regions poorly studied until now (mainly the Fertile Crescent). These individuals represented 1540 haplotypes for the HVI segment of the mitochondrial DNA (mtDNA) control region. This large-scale study allowed the establishment of a clear nomenclature of the goat maternal haplogroups. Only five of the six previously defined groups of haplotypes were divergent enough to be considered as different haplogroups. Moreover a new mitochondrial group has been localized around the Fertile Crescent. All groups showed very high haplotype diversity. Most of this diversity was distributed among groups and within geographic regions. The weak geographic structure may result from the worldwide distribution of the dominant A haplogroup (more than 90% of the individuals). The large-scale distribution of other haplogroups (except one), may be related to human migration. The recent fragmentation of local goat populations into discrete breeds is not detectable with mitochondrial markers. The estimation of demographic parameters from mismatch analyses showed that all groups had a recent demographic expansion corresponding roughly to the period when domestication took place. But even with a large data set it remains difficult to give relative dates of expansion for different haplogroups because of large confidence intervals. Conclusions/Significance. We propose standard criteria for the definition of the different haplogroups based on the result of mismatch analysis and on the use of sequences of reference. Such a method could be also applied for clarifying the nomenclature of mitochondrial haplogroups in other domestic species.	[Naderi, Saeid; Rezaei, Hamid-Reza; Taberlet, Pierre; Zundel, Stephanie; Naghash, Hamid-Reza; Pompanon, Francois] Univ Grenoble 1, CNRS, Lab Ecol Alpine, UMR 5553, Grenoble, France; [Naderi, Saeid] Univ Guilan, Nat Resources Fac, Guilan, Iran; [Rezaei, Hamid-Reza] Gorgan Univ Agr & Nat Resources, Dept Environm Sci, Gorgan, Iran; [Rafat, Seyed-Abbas] Univ Tabriz, Fac Agr, Dept Anim Sci, Tabriz, Iran; [El-Barody, Mohamed A. A.] Minia Univ, Fac Agr, Dept Anim Prod, Al Minya, Egypt; [Ertugrul, Okan] Ankara Univ, Fac Vet Med, Dept Genet, TR-06100 Ankara, Turkey	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; University of Guilan; University of Tabriz; Egyptian Knowledge Bank (EKB); Minia University; Ankara University	Pompanon, F (corresponding author), Univ Grenoble 1, CNRS, Lab Ecol Alpine, UMR 5553, Grenoble, France.	francois.pompanon@ujf-grenoble.fr	Crepaldi, Paola/L-4681-2017; Pérez, Trinidad/AAC-6729-2019; rafat, seyed abbas/GRX-3016-2022; Naderi, Saeid/ABG-3450-2021; Joost, Stéphane/B-4152-2010; Angiolillo, Antonella/F-4941-2012; Pompanon, François/D-3459-2009; rafat, seyed abbas/AAU-2025-2020; Bruford, Michael/Y-7463-2019; Hoda, Anila/GRY-7191-2022; Beja-Pereira, Albano/B-3681-2008; AJMONE MARSAN, Paolo/M-2466-2018; valentini, alessio/L-3970-2013; Canon Ferreras, Francisco Javier/M-5704-2018	Crepaldi, Paola/0000-0002-6526-2162; Pérez, Trinidad/0000-0003-1216-5593; rafat, seyed abbas/0000-0003-0231-1331; Naderi, Saeid/0000-0003-4918-208X; Joost, Stéphane/0000-0002-1184-7501; Angiolillo, Antonella/0000-0002-0158-3039; Pompanon, François/0000-0003-4600-0172; rafat, seyed abbas/0000-0003-0231-1331; Bruford, Michael/0000-0001-6357-6080; Hoda, Anila/0000-0003-0906-2550; Beja-Pereira, Albano/0000-0002-1607-7382; Roosen, Jutta/0000-0002-3032-399X; Ibeagha-Awemu, Eveline/0000-0001-8810-9294; Luikart, Gordon/0000-0001-8697-0582; Nijman, Isaac/0000-0002-1840-1158; Carta, Antonello/0000-0003-0534-4876; Lenstra, Johannes A./0000-0003-1745-7739; PILLA, Fabio/0000-0002-1781-994X; LIGDA, CHRISTINA/0000-0003-4980-3026; Rezaei, HamidReza/0000-0002-9422-5600; AJMONE MARSAN, Paolo/0000-0003-3165-4579; Niznikowski, Roman/0000-0002-8401-106X; CANALI, Gabriele/0000-0001-9244-8184; Marletta, Donata/0000-0002-8408-7443; valentini, alessio/0000-0003-4733-7519; Canon Ferreras, Francisco Javier/0000-0003-1137-0958; Dobi, Petrit/0000-0002-6101-0101; Baret, Philippe/0000-0002-6189-666X	Ministry of Science, Research, and Technology [800125, 791135]; Institut National de la Recherche Agronomique; Chronobos project [ANR 05-GANI-004-02]; EU [QLK5-CT-2001-02461]	Ministry of Science, Research, and Technology; Institut National de la Recherche Agronomique; Chronobos project; EU(European Commission)	Funding: S. Naderi and HR. Rezaei were supported by PhD scholarships from the Iranian Ministry of Science, Research, and Technology (number 800125 and, 791135 respectively). F. Pompanon was supported by the Institut National de la Recherche Agronomique. This work has been partially supported by the Chronobos project (ANR 05-GANI-004-02) and by the EU ECONOGENE contract QLK5-CT-2001-02461. The content of the publication does not represent necessarily the views of the European Commission or its services.	Amills M, 2004, J DAIRY RES, V71, P257, DOI 10.1017/S0022029904000342; Azor PJ, 2005, ANIM GENET, V36, P423, DOI 10.1111/j.1365-2052.2005.01327.x; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Canon J, 2006, ANIM GENET, V37, P327, DOI 10.1111/j.1365-2052.2006.01461.x; Chen SY, 2005, MOL PHYLOGENET EVOL, V37, P804, DOI 10.1016/j.ympev.2005.06.014; CLUTTONBROCK J, 1999, DOMESTICATED ANIMALS; Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandez H, 2006, P NATL ACAD SCI USA, V103, P15375, DOI 10.1073/pnas.0602753103; Freeman AR, 2004, MOL ECOL, V13, P3477, DOI 10.1111/j.1365-294X.2004.02311.x; Fumagalli L, 1996, MOL BIOL EVOL, V13, P31, DOI 10.1093/oxfordjournals.molbev.a025568; Hiendleder S, 1998, J MOL EVOL, V47, P441, DOI 10.1007/PL00006401; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Joshi MB, 2004, MOL BIOL EVOL, V21, P454, DOI 10.1093/molbev/msh038; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; MacHugh DE, 2001, P NATL ACAD SCI USA, V98, P5382, DOI 10.1073/pnas.111163198; Manceau V, 1999, MOL PHYLOGENET EVOL, V13, P504, DOI 10.1006/mpev.1999.0688; Mannen H, 2004, MOL PHYLOGENET EVOL, V32, P539, DOI 10.1016/j.ympev.2004.01.010; Meadow R. H., 1996, ORIGINS SPREAD AGR P, P390; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Meadows JRS, 2005, J HERED, V96, P494, DOI 10.1093/jhered/esi100; NADERI S, GENETIC EVIDEN UNPUB; Odahara S, 2006, ASIAN AUSTRAL J ANIM, V19, P482, DOI 10.5713/ajas.2006.482; PARISET L, 2006, J CHROMATOGRAPHY B; Pereira F, 2005, MOL ECOL, V14, P2313, DOI 10.1111/j.1365-294X.2005.02594.x; Pidancier N, 2006, MOL PHYLOGENET EVOL, V40, P739, DOI 10.1016/j.ympev.2006.04.002; Pietro P, 2003, DNA SEQUENCE, V14, P199, DOI 10.1080/1042517031000089487; PORTER V, 1996, GOATS WORLD; Pringle H, 1998, SCIENCE, V282, P1448, DOI 10.1126/science.282.5393.1448; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sardina MT, 2006, ANIM GENET, V37, P376, DOI 10.1111/j.1365-2052.2006.01451.x; Schneider S, 1999, GENETICS, V152, P1079; Shackleton DM, 1997, WILD SHEEP GOATS THE; Sultana S, 2003, ANIM GENET, V34, P417, DOI 10.1046/j.0268-9146.2003.01040.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TABERLET P, MOL ECOL; Takada T, 1997, BIOCHEM GENET, V35, P315, DOI 10.1023/A:1021869704889; TUNON MJ, 1989, ANIM GENET, V20, P205; VIGNE JD, 2000, ARCHAEOZOOLOGY NEAR, V4, P52; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zeder MA, 2006, TRENDS GENET, V22, P139, DOI 10.1016/j.tig.2006.01.007; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; Zeder Melinda A., 2005, P125	48	156	165	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1012	10.1371/journal.pone.0001012	http://dx.doi.org/10.1371/journal.pone.0001012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925860	gold, Green Submitted, Green Published			2022-12-27	WOS:000207456000011
J	Miranda, I; Rocha, R; Santos, MC; Mateus, DD; Moura, GR; Carreto, L; Santos, MAS				Miranda, Isabel; Rocha, Rita; Santos, Maria C.; Mateus, Denisa D.; Moura, Gabriela R.; Carreto, Laura; Santos, Manuel A. S.			A Genetic Code Alteration Is a Phenotype Diversity Generator in the Human Pathogen Candida albicans	PLOS ONE			English	Article								Background. The discovery of genetic code alterations and expansions in both prokaryotes and eukaryotes abolished the hypothesis of a frozen and universal genetic code and exposed unanticipated flexibility in codon and amino acid assignments. It is now clear that codon identity alterations involve sense and non-sense codons and can occur in organisms with complex genomes and proteomes. However, the biological functions, the molecular mechanisms of evolution and the diversity of genetic code alterations remain largely unknown. In various species of the genus Candida, the leucine CUG codon is decoded as serine by a unique serine tRNA that contains a leucine 5'-CAG-3' anticodon (tRNA(CAG)(Ser)). We are using this codon identity redefinition as a model system to elucidate the evolution of genetic code alterations. Methodology/Principal Findings. We have reconstructed the early stages of the Candida genetic code alteration by engineering tRNAs that partially reverted the identity of serine CUG codons back to their standard leucine meaning. Such genetic code manipulation had profound cellular consequences as it exposed important morphological variation, altered gene expression, re-arranged the karyotype, increased cell-cell adhesion and secretion of hydrolytic enzymes. Conclusion/Significance. Our study provides the first experimental evidence for an important role of genetic code alterations as generators of phenotypic diversity of high selective potential and supports the hypothesis that they speed up evolution of new phenotypes.	[Miranda, Isabel; Rocha, Rita; Santos, Maria C.; Mateus, Denisa D.; Moura, Gabriela R.; Carreto, Laura; Santos, Manuel A. S.] Univ Aveiro, Dept Biol, CESAM, P-3800 Aveiro, Portugal	Universidade de Aveiro	Santos, MAS (corresponding author), Univ Aveiro, Dept Biol, CESAM, P-3800 Aveiro, Portugal.	msantos@bio.ua.pt	Mateus, Denisa D/J-8827-2014; Santos, Conceição/ABE-6172-2020; Moura, Gabriela R/E-6717-2010; Moura, Gabriela/GPF-9079-2022; Miranda, Isabel M./B-2017-2009; Rocha, Rita/M-9564-2013; dos Santos, Maria/B-7426-2012; Santos, Manuel/E-6704-2010	Mateus, Denisa D/0000-0002-8665-5176; Santos, Conceição/0000-0003-4129-6381; Moura, Gabriela R/0000-0003-2243-6123; Moura, Gabriela/0000-0003-2243-6123; Miranda, Isabel M./0000-0003-4839-1613; Rocha, Rita/0000-0003-1193-8320; Santos, Manuel/0000-0002-0437-1146	FCT/FEDER [POCI/BIA-MIC/55466/04, POCI/BIA-PRO/55472/2004, POCI/SAU-MMO/55476/2004, BD/19807/99, BD/8296/2002]; EMBO [RGP45/2005]; Fundação para a Ciência e a Tecnologia [POCI/SAU-MMO/55476/2004, POCI/BIA-PRO/55472/2004] Funding Source: FCT	FCT/FEDER(Portuguese Foundation for Science and TechnologyEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); Fundação para a Ciência e a Tecnologia	This study was supported by FCT/FEDER projects POCI/BIA-MIC/55466/04, POCI/BIA-PRO/55472/2004 and POCI/SAU-MMO/55476/2004. IM, RR are supported by FCT/FEDER, BD/19807/99 and BD/8296/2002 PhD grants, respectively. MASS was supported by an EMBO YIP and a Human Frontier Science Programme Grant (REF: RGP45/2005).	Bacher JM, 2005, P NATL ACAD SCI USA, V102, P1697, DOI 10.1073/pnas.0409064102; Bacher JM, 2001, J BACTERIOL, V183, P5414, DOI 10.1128/JB.183.18.5414-5425.2001; Bennett RJ, 2003, EMBO J, V22, P2505, DOI 10.1093/emboj/cdg235; BREITSCHOPF K, 1994, EMBO J, V13, P3166, DOI 10.1002/j.1460-2075.1994.tb06615.x; CARON F, 1985, NATURE, V314, P185, DOI 10.1038/314185a0; Castresana J, 1998, P NATL ACAD SCI USA, V95, P3703, DOI 10.1073/pnas.95.7.3703; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; CHU WS, 1993, J BACTERIOL, V175, P6637, DOI 10.1128/jb.175.20.6637-6651.1993; Dorazi R, 2002, MOL MICROBIOL, V44, P131, DOI 10.1046/j.1365-2958.2002.02847.x; FORTUNA M, 2000, CURRENT PROTOCOLS CY; Fu Y, 1998, INFECT IMMUN, V66, P1783, DOI 10.1128/IAI.66.4.1783-1786.1998; Gaur NK, 2002, CELL COMMUN ADHES, V9, P45, DOI 10.1080/15419060212187; Gaur NK, 1997, INFECT IMMUN, V65, P5289, DOI 10.1128/IAI.65.12.5289-5294.1997; Gaur NK, 1999, INFECT IMMUN, V67, P6040, DOI 10.1128/IAI.67.11.6040-6047.1999; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; HANYU N, 1986, EMBO J, V5, P1307, DOI 10.1002/j.1460-2075.1986.tb04360.x; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; HARPER DS, 1989, P NATL ACAD SCI USA, V86, P3252, DOI 10.1073/pnas.86.9.3252; HEITZLER J, 1992, BIOCHIM BIOPHYS ACTA, V1129, P273, DOI 10.1016/0167-4781(92)90503-R; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Huang GH, 2006, P NATL ACAD SCI USA, V103, P12813, DOI 10.1073/pnas.0605270103; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; IBRAHIM AS, 1995, INFECT IMMUN, V63, P1993, DOI 10.1128/IAI.63.5.1993-1998.1995; Innis MA, 1990, PCR PROTOCOLS GUIDE; Iwaguchi S, 2000, YEAST, V16, P411, DOI 10.1002/(SICI)1097-0061(20000330)16:5&lt;411::AID-YEA532&gt;3.0.CO;2-N; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Jukes TH, 1996, J MOL EVOL, V42, P321, DOI 10.1007/BF02198859; Knight RD, 2001, NAT REV GENET, V2, P49, DOI 10.1038/35047500; Knight RD, 2001, J MOL EVOL, V53, P299, DOI 10.1007/s002390010220; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; LASKER BA, 1989, NUCLEIC ACIDS RES, V17, P3783, DOI 10.1093/nar/17.10.3783; Le Mouel A, 2003, EUKARYOT CELL, V2, P1076, DOI 10.1128/EC.2.5.1076-1090.2003; LEE BJ, 1989, J BIOL CHEM, V264, P9724; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Legrand M, 2004, MOL MICROBIOL, V52, P1451, DOI 10.1111/j.1365-2958.2004.04068.x; Li F, 2003, EUKARYOT CELL, V2, P1266, DOI 10.1128/EC.2.6.1266-1273.2003; LOVETT PS, 1991, J BACTERIOL, V173, P1810, DOI 10.1128/jb.173.5.1810-1812.1991; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; MAGEE BB, 1987, J GEN MICROBIOL, V133, P425; Massey SE, 2003, GENOME RES, V13, P544, DOI 10.1101/gr.811003; Miller MG, 2002, CELL, V110, P293, DOI 10.1016/S0092-8674(02)00837-1; Miranda I, 2006, YEAST, V23, P203, DOI 10.1002/yea.1350; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; O'Sullivan JM, 2001, TRENDS GENET, V17, P20, DOI 10.1016/S0168-9525(00)02144-2; O'Sullivan JM, 2001, YEAST, V18, P313, DOI 10.1002/1097-0061(20010315)18:4&lt;313::AID-YEA673&gt;3.0.CO;2-7; OHAMA T, 1993, NUCLEIC ACIDS RES, V21, P4039, DOI 10.1093/nar/21.17.4039; OSULLIVAN JM, 2002, STANDARD NONSTANDARD, P279; Perepnikhatka V, 1999, J BACTERIOL, V181, P4041, DOI 10.1128/JB.181.13.4041-4049.1999; Perreau VM, 1999, J MOL BIOL, V293, P1039, DOI 10.1006/jmbi.1999.3209; Pla J, 1996, YEAST, V12, P1677; Rauceo JM, 2004, INFECT IMMUN, V72, P4948, DOI 10.1128/IAI.72.9.4948-4955.2004; RORABACHER DB, 1991, ANAL CHEM, V63, P139, DOI 10.1021/ac00002a010; Rottmann M, 2003, MOL MICROBIOL, V47, P943, DOI 10.1046/j.1365-2958.2003.03358.x; Rustchenko EP, 1997, MICROBIOL-UK, V143, P1765, DOI 10.1099/00221287-143-5-1765; RUSTCHENKOBULGAC EP, 1990, J BACTERIOL, V172, P1276, DOI 10.1128/jb.172.3.1276-1283.1990; RUSTCHENKOBULGAC EP, 1993, J GEN MICROBIOL, V139, P1195, DOI 10.1099/00221287-139-6-1195; SAMARANAYAKE LP, 1984, SABOURAUDIA, V22, P201; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez-Silva R, 2003, CURR BIOL, V13, P442, DOI 10.1016/S0960-9822(03)00126-X; Santos MAS, 2004, TRENDS GENET, V20, P95, DOI 10.1016/j.tig.2003.12.009; Santos MAS, 1996, EMBO J, V15, P5060, DOI 10.1002/j.1460-2075.1996.tb00886.x; SANTOS MAS, 1993, EMBO J, V12, P607, DOI 10.1002/j.1460-2075.1993.tb05693.x; Santos MAS, 1999, MOL MICROBIOL, V31, P937, DOI 10.1046/j.1365-2958.1999.01233.x; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; Santos MAS, 1997, MOL MICROBIOL, V26, P423, DOI 10.1046/j.1365-2958.1997.5891961.x; Schultz DW, 1996, J MOL EVOL, V42, P597, DOI 10.1007/BF02352290; SCHULTZ DW, 1994, J MOL BIOL, V235, P1377, DOI 10.1006/jmbi.1994.1094; Selmecki A, 2005, MOL MICROBIOL, V55, P1553, DOI 10.1111/j.1365-2958.2005.04492.x; SOLL DR, 2002, PHENOTYPIC SWITCHING, P123; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Sugita T, 1999, SYST APPL MICROBIOL, V22, P79, DOI 10.1016/S0723-2020(99)80030-7; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; SUZUKI T, 1994, J BACTERIOL, V176, P3345, DOI 10.1128/jb.176.11.3345-3353.1994; SUZUKI T, 1989, J GEN MICROBIOL, V135, P425; Suzuki T, 1997, EMBO J, V16, P1122, DOI 10.1093/emboj/16.5.1122; Tuite MF, 1996, BIOCHIMIE, V78, P993, DOI 10.1016/S0300-9084(97)86722-3; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; WEYGANDDURASEVIC I, 1994, J BACTERIOL, V176, P232; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195; Zordan RE, 2006, P NATL ACAD SCI USA, V103, P12807, DOI 10.1073/pnas.0605138103	84	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e996	10.1371/journal.pone.0000996	http://dx.doi.org/10.1371/journal.pone.0000996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912373	Green Published, gold			2022-12-27	WOS:000207455900032
J	Dirnberger, D; Seuwen, K				Dirnberger, Dietmar; Seuwen, Klaus			Signaling of Human Frizzled Receptors to the Mating Pathway in Yeast	PLOS ONE			English	Article								Frizzled receptors have seven membrane-spanning helices and are considered as atypical G protein-coupled receptors (GPCRs). The mating response of the yeast Saccharomyces cerevisiae is mediated by a GPCR signaling system and this model organism has been used extensively in the past to study mammalian GPCR function. We show here that human Frizzled receptors (Fz1 and Fz2) can be properly targeted to the yeast plasma membrane, and that they stimulate the yeast mating pathway in the absence of added Wnt ligands, as evidenced by cell cycle arrest in G1 and reporter gene expression dependent on the mating pathway-activated FUS1 gene. Introducing intracellular portions of Frizzled receptors into the Ste2p backbone resulted in the generation of constitutively active receptor chimeras that retained mating factor responsiveness. Introducing intracellular portions of Ste2p into the Frizzled receptor backbone was found to strongly enhance mating pathway activation as compared to the native Frizzleds, likely by facilitating interaction with the yeast Ga protein Gpa1p. Furthermore, we show reversibility of the highly penetrant G1-phase arrests exerted by the receptor chimeras by deletion of the mating pathway effector FAR1. Our data demonstrate that Frizzled receptors can functionally replace mating factor receptors in yeast and offer an experimental system to study modulators of Frizzled receptors.	[Dirnberger, Dietmar; Seuwen, Klaus] Novartis Inst Biomed Res, Basel, Switzerland	Novartis	Dirnberger, D (corresponding author), Novartis Inst Biomed Res, Basel, Switzerland.	Dietmar.Dirnberger@Novartis.com			NIBR	NIBR	This work was sponsored by a "NIBR-Presidential Postdoctoral Fellowship'' granted to D. D.	Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776; [Anonymous], 1991, Methods Enzymol, V194, P1; Baranski TJ, 1999, J BIOL CHEM, V274, P15757, DOI 10.1074/jbc.274.22.15757; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Crowe ML, 2000, J RECEPT SIGNAL TR R, V20, P61, DOI 10.3109/10799890009150037; DENOBEL JG, 1991, YEAST, V7, P313, DOI 10.1002/yea.320070402; Dirnberger D, 2006, CHEMBIOCHEM, V7, P936, DOI 10.1002/cbic.200500544; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Dowell SJ, 2002, RECEPTOR CHANNEL, V8, P343, DOI 10.1080/10606820214647; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Erickson JP, 1998, J BIOL CHEM, V273, P1506, DOI 10.1074/jbc.273.3.1506; Gazit A, 1999, ONCOGENE, V18, P5959, DOI 10.1038/sj.onc.1202985; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Goo JH, 1999, DNA CELL BIOL, V18, P429, DOI 10.1089/104454999315312; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; KING K, 1990, SCIENCE, V250, P121, DOI 10.1126/science.2171146; Konopka JB, 1996, P NATL ACAD SCI USA, V93, P6764, DOI 10.1073/pnas.93.13.6764; KONOPKA JB, 1993, MOL CELL BIOL, V13, P6876, DOI 10.1128/MCB.13.11.6876; KONOPKA JB, 1995, MOL CELL BIOL, V15, P723; Ladds G, 2005, TRENDS BIOTECHNOL, V23, P367, DOI 10.1016/j.tibtech.2005.05.007; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Liu XX, 1999, P NATL ACAD SCI USA, V96, P14383, DOI 10.1073/pnas.96.25.14383; Martin NP, 1999, BIOCHEMISTRY-US, V38, P682, DOI 10.1021/bi982062w; Minic J, 2005, FEBS J, V272, P524, DOI 10.1111/j.1742-4658.2004.04494.x; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Overton MC, 2005, EUKARYOT CELL, V4, P1963, DOI 10.1128/EC.4.12.1963-1970.2005; Pajot-Augy E, 2003, J RECEPT SIG TRANSD, V23, P155, DOI 10.1081/RRS-120025196; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; SIKORSKI RS, 1989, GENETICS, V122, P19; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Sommers CM, 2000, BIOCHEMISTRY-US, V39, P6898, DOI 10.1021/bi992616a; Stefan CJ, 1999, J BIOL CHEM, V274, P1835, DOI 10.1074/jbc.274.3.1835; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang HY, 2004, CELL MOL LIFE SCI, V61, P69, DOI 10.1007/s00018-003-3165-x; Wittke S, 1999, MOL BIOL CELL, V10, P2519, DOI 10.1091/mbc.10.8.2519; Zilberberg A, 2004, J BIOL CHEM, V279, P17535, DOI 10.1074/jbc.M311292200	48	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e954	10.1371/journal.pone.0000954	http://dx.doi.org/10.1371/journal.pone.0000954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895994	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455800032
J	Read, MA; Grigg, GC; Irwin, SR; Shanahan, D; Franklin, CE				Read, Mark A.; Grigg, Gordon C.; Irwin, Steve R.; Shanahan, Danielle; Franklin, Craig E.			Satellite Tracking Reveals Long Distance Coastal Travel and Homing by Translocated Estuarine Crocodiles, Crocodylus porosus	PLOS ONE			English	Article								Crocodilians have a wide distribution, often in remote areas, are cryptic, secretive and are easily disturbed by human presence. Their capacity for large scale movements is poorly known. Here, we report the first study of post-release movement patterns in translocated adult crocodiles, and the first application of satellite telemetry to a crocodilian. Three large male Crocodylus porosus (3.1-4.5 m) were captured in northern Australia and translocated by helicopter for 56, 99 and 411 km of coastline, the last across Cape York Peninsula from the west coast to the east coast. All crocodiles spent time around their release site before returning rapidly and apparently purposefully to their capture locations. The animal that circumnavigated Cape York Peninsula to return to its capture site, travelled more than 400 km in 20 days, which is the longest homeward travel yet reported for a crocodilian. Such impressive homing ability is significant because translocation has sometimes been used to manage potentially dangerous C. porosus close to human settlement. It is clear that large male estuarine crocodiles can exhibit strong site fidelity, have remarkable navigational skills, and may move long distances following a coastline. These long journeys included impressive daily movements of 10-30 km, often consecutively.	[Grigg, Gordon C.; Shanahan, Danielle; Franklin, Craig E.] Univ Queensland, Sch Integrat Biol, St Lucia, Qld, Australia; [Read, Mark A.] Queensland Pk & Wildlife Serv, Cairns, Qld, Australia; [Irwin, Steve R.] Australia Zoo, Beerwah, Qld, Australia	University of Queensland	Franklin, CE (corresponding author), Univ Queensland, Sch Integrat Biol, St Lucia, Qld, Australia.	c.franklin@uq.edu.au	Franklin, Craig/G-7343-2012; Shanahan, Danielle/F-8437-2013	Franklin, Craig/0000-0003-1315-3797; 	Charles Tanner Bequest; Wildlife Warriors Worldwide; Australian Research Council	Charles Tanner Bequest; Wildlife Warriors Worldwide; Australian Research Council(Australian Research Council)	This work was supported by the Charles Tanner Bequest, Wildlife Warriors Worldwide and an Australian Research Council Grant to CEF, MAR and SRI.	Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Chabreck RH, 1965, P SE ASS GAME FISH C, V19, P102; Ferraroli S, 2004, NATURE, V429, P521, DOI 10.1038/429521a; GORZULA SJ, 1978, OECOLOGIA, V35, P21, DOI 10.1007/BF00345539; Hays GC, 2004, NATURE, V429, P522, DOI 10.1038/429522a; JOUVENTIN P, 1990, NATURE, V343, P746, DOI 10.1038/343746a0; Kay WR, 2004, WILDLIFE RES, V31, P495, DOI 10.1071/WR04037; Lang J.W., 1987, P273; Read MA, 2004, WILDLIFE RES, V31, P527, DOI 10.1071/WR02025; RODDA GH, 1984, BEHAV ECOL SOCIOBIOL, V14, P241, DOI 10.1007/BF00299494; Ross J. P., 1998, CROCODILES STATUS SU; Seymour R.S., 1987, P253; TAPLIN LE, 1981, SCIENCE, V212, P1045, DOI 10.1126/science.212.4498.1045; Walsh B., 1987, P249; WALSH B, 1993, WILDLIFE RES, V20, P127, DOI 10.1071/WR9930127; WEBB GJW, 1983, AUST WILDLIFE RES, V10, P403; WEBB GJW, 1978, AUST WILDLIFE RES, V5, P263, DOI 10.1071/WR9780263; 2000, ARGOS USERS MANUAL	19	59	66	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e949	10.1371/journal.pone.0000949	http://dx.doi.org/10.1371/journal.pone.0000949			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895990	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455800028
J	Roizen, J; Luedke, CE; Herzog, ED; Muglia, LJ				Roizen, Jeffrey; Luedke, Christina E.; Herzog, Erik D.; Muglia, Louis J.			Oxytocin in the Circadian Timing of Birth	PLOS ONE			English	Article								Background. The molecular components determining the timing for birth remain an incompletely characterized aspect of reproduction, with important conceptual and therapeutic ramifications for management of preterm, post-term and arrested labor. Methodology/Principal Findings. To test the hypothesis that oxytocin mediates circadian regulation of birth, we evaluated parturition timing following shifts in light cycles in oxytocin (OT)-deficient mice. We find that, in contrast to wild type mice that do not shift the timing of birth following a 6-h advance or delay in the light cycle, OT-deficient mice delivered at random times of day. Moreover, shifts in the light-dark cycle of gravid wild type mice have little impact on the pattern of circadian oxytocin release. Conclusions/Significance. Our results demonstrate oxytocin plays a critical role in minimizing labor disruption due to circadian clock resetting.	[Roizen, Jeffrey; Muglia, Louis J.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Roizen, Jeffrey; Muglia, Louis J.] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; [Roizen, Jeffrey; Muglia, Louis J.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Luedke, Christina E.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Herzog, Erik D.] Washington Univ, Dept Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Boston Children's Hospital; Washington University (WUSTL)	Muglia, LJ (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	Muglia_L@kids.wustl.edu	Roizen, Jeffrey D/J-5050-2012	Roizen, Jeffrey D/0000-0002-3384-6200; Herzog, Erik/0000-0001-7209-5174	March of Dimes	March of Dimes(March of Dimes)	March of Dimes	Caba M, 1996, BRAIN RES, V720, P7, DOI 10.1016/0006-8993(96)00036-4; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Egli M, 2004, ENDOCRINOLOGY, V145, P3386, DOI 10.1210/en.2003-1710; Forsling ML, 2000, EXP PHYSIOL, V85, p179S, DOI 10.1111/j.1469-445X.2000.tb00022.x; Forsling ML, 1995, ADV EXP MED BIOL, V395, P92; GOTO M, 1994, MOL BRAIN RES, V21, P349, DOI 10.1016/0169-328X(94)90266-6; Imamura T, 2000, AM J PHYSIOL-REG I, V279, pR1061, DOI 10.1152/ajpregu.2000.279.3.R1061; LINCOLN DW, 1976, NATURE, V260, P780, DOI 10.1038/260780a0; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; REFINETTI R, 1992, BEHAV NEURAL BIOL, V58, P27, DOI 10.1016/0163-1047(92)90862-X; REPPERT SM, 1987, BRAIN RES, V403, P398, DOI 10.1016/0006-8993(87)90084-9; Saeb-Parsy K, 2000, J NEUROENDOCRINOL, V12, P635; VISWANATHAN N, 1992, BIOL REPROD, V47, P6, DOI 10.1095/biolreprod47.1.6; Young WS, 1996, J NEUROENDOCRINOL, V8, P847, DOI 10.1046/j.1365-2826.1996.05266.x	15	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e922	10.1371/journal.pone.0000922	http://dx.doi.org/10.1371/journal.pone.0000922			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895964	Green Published, gold			2022-12-27	WOS:000207455800002
J	Lenka, N; Ramasamy, SK				Lenka, Nibedita; Ramasamy, Saravana Kumar			Neural Induction from ES Cells Portrays Default Commitment but Instructive Maturation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; IN-VITRO; NESTIN ENHANCER; PRECURSOR CELLS; FATE; HEDGEHOG; NEURONS; PROTEIN; DIFFERENTIATION	The neural induction has remained a debatable issue pertaining to whether it is a mere default process or it involves precise instructive cues. We have chosen the embryonic stem (ES) cell model to address this issue. In a devised monoculture strategy, the cell-cell interaction availed through optimum cell plating density could define the niche for the attainment of efficient in vitro neurogenesis from the ES cells. The medium plating density was found ideal in generating optimum number of progenitors and also yielded about 80% mature neurons in a serum free culture set up barring any exogenous inducers. We could also demarcate and quantify the neural stem cells/progenitors among the heterogeneous cell population of differentiating ES cells using nestin intron II driven EGFP expression as a tool. The one week post-plating was determined to be the critical time window for optimum neural progenitor generation from ES cells that helped us further in purifying these cells and in demonstrating their proliferation and multipotent differentiation potential. Seeding cells at varying densities, we could decipher an interesting paradoxical scenario that interlinked both commitment and maturation with the initial plating density having a vital influence on neuronal maturation but not specification and the secretory factors were apparently playing a key role during this process. Thus it was comprehended that, the neural specification was a default process independent of exogenous factors and cellular interaction. Conversely, a defined number of cells at the specification stage itself seemed critical to provide an auto-/paracrine means of signaling threshold for the maturation process to materialize.	[Lenka, Nibedita; Ramasamy, Saravana Kumar] Natl Ctr Cell Sci, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Lenka, N (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	nibedita@nccs.res.in	Lenka, Nibedita/ABX-3824-2022	Ramasamy, Saravana/0000-0003-2658-2945	Department of Biotechnology (DBT); Govt. of India [BT/PR2993/MED/14/399/2002]; Council of Scientific and Industrial Research (CSIR), India	Department of Biotechnology (DBT); Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	Part of this work was supported by a project grant from Department of Biotechnology (DBT); Govt. of India (BT/PR2993/MED/14/399/2002) to NL. SKR is a Senior Research fellow, Council of Scientific and Industrial Research (CSIR), India pursuing his Ph. D. The funding agencies have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andressen C, 2001, STEM CELLS, V19, P419, DOI 10.1634/stemcells.19-5-419; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Bainter JJ, 2001, DEV DYNAM, V222, P315, DOI 10.1002/dvdy.1210; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Cayuso J, 2006, DEVELOPMENT, V133, P517, DOI 10.1242/dev.02228; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Irioka T, 2005, DEV BRAIN RES, V154, P63, DOI 10.1016/j.devbrainres.2004.10.004; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim T, 2007, IET ELECTR POWER APP, V1, P557, DOI 10.1049/iet-epa:20060358; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; LAMB TM, 1995, DEVELOPMENT, V121, P3627; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lenka N, 2002, J CELL SCI, V115, P1471; Lenka Nibedita, 2006, V330, P33; Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445; Lothian C, 1997, EUR J NEUROSCI, V9, P452, DOI 10.1111/j.1460-9568.1997.tb01622.x; Lothian C, 1999, EXP CELL RES, V248, P509, DOI 10.1006/excr.1999.4417; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moreau M, 2004, INT J DEV BIOL, V48, P75, DOI 10.1387/ijdb.15272372; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Ribes V, 2006, DEVELOPMENT, V133, P351, DOI 10.1242/dev.02204; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Streit A, 1999, TRENDS GENET, V15, P20, DOI 10.1016/S0168-9525(98)01620-5; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027; Wilson PA, 1997, NEURON, V18, P699, DOI 10.1016/S0896-6273(00)80311-6; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Yamazoe H, 2006, CELL TRANSPLANT, V15, P135, DOI 10.3727/000000006783982061; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	48	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1349	10.1371/journal.pone.0001349	http://dx.doi.org/10.1371/journal.pone.0001349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18092007	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459600030
J	Rischitor, PE; May, KM; Hardwick, KG				Rischitor, Patricia E.; May, Karen M.; Hardwick, Kevin G.			Bub1 Is a Fission Yeast Kinetochore Scaffold Protein, and Is Sufficient to Recruit other Spindle Checkpoint Proteins to Ectopic Sites on Chromosomes	PLOS ONE			English	Article								The spindle checkpoint delays anaphase onset until all chromosomes have attached in a bi-polar manner to the mitotic spindle. Mad and Bub proteins are recruited to unattached kinetochores, and generate diffusible anaphase inhibitors. Checkpoint models propose that Mad1 and Bub1 act as stable kinetochore-bound scaffolds, to enhance recruitment of Mad2 and Mad3/BubR1, but this remains untested for Bub1. Here, fission yeast FRAP experiments confirm that Bub1 stably binds kinetochores, and by tethering Bub1 to telomeres we demonstrate that it is sufficient to recruit anaphase inhibitors in a kinase-independent manner. We propose that the major checkpoint role for Bub1 is as a signalling scaffold.	[Rischitor, Patricia E.; May, Karen M.; Hardwick, Kevin G.] Univ Edinburgh, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Hardwick, KG (corresponding author), Univ Edinburgh, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	Kevin.Hardwick@ed.ac.uk	Pillay, Nischalan/F-9536-2012	Hardwick, Kevin/0000-0002-6462-1047	HFSP Programme; Wellcome Trust Senior Research Fellowship	HFSP Programme; Wellcome Trust Senior Research Fellowship(Wellcome Trust)	This work was supported by an HFSP Programme Grant (PR and KM) and a Wellcome Trust Senior Research Fellowship (KGH). The sponsors had no role in design or conduct of these studies, or in preparation or approval of the manuscript.	Acquaviva C, 2004, NAT CELL BIOL, V6, P892, DOI 10.1038/ncb1167; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kadura S, 2005, MOL BIOL CELL, V16, P385, DOI 10.1091/mbc.E04-07-0558; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; KEENEY JB, 1994, GENETICS, V136, P849; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; King EMJ, 2007, GENE DEV, V21, P1163, DOI 10.1101/gad.431507; Kitazono AA, 2003, MOL GENET GENOMICS, V269, P672, DOI 10.1007/s00438-003-0870-y; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; Molk JN, 2004, MOL BIOL CELL, V15, P1519, DOI 10.1091/mbc.E03-09-0708; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Snaith HA, 2005, EMBO J, V24, P3690, DOI 10.1038/sj.emboj.7600838; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Vanoosthuyse V, 2004, MOL CELL BIOL, V24, P9786, DOI 10.1128/MCB.24.22.9786-9801.2004; Vink M, 2006, CURR BIOL, V16, P755, DOI 10.1016/j.cub.2006.03.057; Yamaguchi S, 2003, EMBO J, V22, P1075, DOI 10.1093/emboj/cdg100; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	38	37	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1342	10.1371/journal.pone.0001342	http://dx.doi.org/10.1371/journal.pone.0001342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18094750	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459600025
J	El-Sayed, B; El-Zaki, SE; Babiker, H; Gadalla, N; Ageep, T; Mansour, F; Baraka, O; Milligan, P; Babiker, A				El-Sayed, Badria; El-Zaki, Salah-Eldin; Babiker, Hamza; Gadalla, Nahla; Ageep, Tellal; Mansour, Fathi; Baraka, Omer; Milligan, Paul; Babiker, Ahmed			A Randomized Open-Label Trial of Artesunate-Sulfadoxine-Pyrimethamine with or without Primaquine for Elimination of Sub-Microscopic P-falciparum Parasitaemia and Gametocyte Carriage in Eastern Sudan	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; SEXUAL DEVELOPMENT; UNSTABLE MALARIA; TRANSMISSION; STAGE; INFECTIVITY; DYNAMICS; SURVIVAL; EFFICACY; SEASON	Background. In areas of seasonal malaria transmission, treatment of asymptomatic carriers of malaria parasites, whose parasitaemia persists at low densities throughout the dry season, could be a useful strategy for malaria control. We carried out a randomized trial to compare two drug regimens for clearance of parasitaemia in order to identify the optimum regimen for use in mass drug administration in the dry season. Methodology and Principal Findings. A two-arm open-label randomized controlled trial was conducted during the dry season in an area of distinct seasonal malaria in two villages in Gedarif State in eastern Sudan. Participants were asymptomatic adults and children aged over 6 months, with low-density P. falciparum infection detected by PCR. Participants were randomized to receive artesunate/sulfadoxine-pyrimethamine (AS+SP) combination for three days with or without a dose of primaquine (PQ) on the fourth day. Parasitaemia detected by PCR on days 3, 7 and 14 after the start of treatment and gametocytes detected by RT-PCR on days 7 and 14 were then recorded. 104 individuals who had low density parasitaemia at screening were randomized and treated during the dry season. On day 7, 8.3% were positive by PCR in the AS+SP+PQ group and 6.5% in the AS+SP group (risk difference 1.8%, 95% CI 210.3% to + 13.8%). At enrolment, 12% (12/100) were carrying gametocytes. This was reduced to 6.4% and 4.4% by day 14 (Risk difference 1.9% (95% CI 29.3% to +13.2%) in AS+SP+PQ and AS+SP groups, respectively. Conclusion. Addition of primaquine to artemisinin combination treatment did not improve elimination of parasitaemia and prevention of gametocyte carriage in carriers with low-density parasitaemia in the dry season. Trial Registration. ClinicalTrials. gov NCT00330902	[El-Sayed, Badria; El-Zaki, Salah-Eldin; Gadalla, Nahla; Ageep, Tellal; Mansour, Fathi; Babiker, Ahmed] Natl Res Ctr, Res Inst Trop Med, Dept Epidemiol, Khartoum, Sudan; [Babiker, Hamza] Sultan Qaboos Univ, Fac Med, Muscat, Oman; [Baraka, Omer] Univ Khartoum, Fac Med, Khartoum, Sudan; [Milligan, Paul] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England	Sultan Qaboos University; University of Khartoum; University of London; London School of Hygiene & Tropical Medicine	El-Sayed, B (corresponding author), Natl Res Ctr, Res Inst Trop Med, Dept Epidemiol, Khartoum, Sudan.	badriab2@yahoo.com	Milligan, Paul/D-8985-2017; GADALLA, NAHLA/F-3464-2013	Milligan, Paul/0000-0003-3430-3395; GADALLA, NAHLA/0000-0002-6177-6705	WHO Eastern Mediterranean Regional Office (EMRO), Division of Communicable Diseases (DCD); WHO Special Programme for Research and Training in Tropical Diseases (TDR): The EMRO/TDR Small Grants Scheme for Operational Research in Tropical and other Communicable Diseases [SGS 04/64]; International Atomic Energy Agency (IAEA) [SUD 06/21]; National Centre for Research and Ministry of Science and Technology, Sudan	WHO Eastern Mediterranean Regional Office (EMRO), Division of Communicable Diseases (DCD); WHO Special Programme for Research and Training in Tropical Diseases (TDR): The EMRO/TDR Small Grants Scheme for Operational Research in Tropical and other Communicable Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); National Centre for Research and Ministry of Science and Technology, Sudan	Funding: This work received technical and financial support from the joint WHO Eastern Mediterranean Regional Office (EMRO), Division of Communicable Diseases (DCD), and the WHO Special Programme for Research and Training in Tropical Diseases (TDR): The EMRO/TDR Small Grants Scheme for Operational Research in Tropical and other Communicable Diseases (grant no. SGS 04/64, to B. B. El Sayed), TC grant SUD 06/21 from the International Atomic Energy Agency (IAEA) and the National Centre for Research and Ministry of Science and Technology, Sudan to TMRI. The sponsors did not contribute to the design of the study or interpretation of the data.	Abdel-Wahab A, 2002, J INFECT DIS, V185, P1838, DOI 10.1086/340638; Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Babiker HA, 2000, PARASITOLOGY, V120, P105, DOI 10.1017/S0031182099005387; Babiker HA, 1998, AM J TROP MED HYG, V59, P582, DOI 10.4269/ajtmh.1998.59.582; Babiker HA, 1999, MOL BIOCHEM PARASIT, V99, P143, DOI 10.1016/S0166-6851(98)00175-3; BAYOUMI RA, 1989, ACTA TROP, V46, P157, DOI 10.1016/0001-706X(89)90032-6; BUNNAG D, 1980, LANCET, V2, P91; CARTER R, 1980, INFECT GAMETE IMMUNI, P263; CARTER R, 1989, MALARIA PRINCIPLES P, P1; DEARSLY AL, 1990, PARASITOLOGY, V100, P359, DOI 10.1017/S0031182000078628; DOWLING MAC, 1966, B WORLD HEALTH ORGAN, V34, P249; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010020; Dyer M, 2003, AM J TROP MED HYG, V68, P403, DOI 10.4269/ajtmh.2003.68.403; Eichner M, 2001, T ROY SOC TROP MED H, V95, P497, DOI 10.1016/S0035-9203(01)90016-1; GRAVES PM, 1984, AM J TROP MED HYG, V33, P1045, DOI 10.4269/ajtmh.1984.33.1045; GREWAL RS, 1981, B WORLD HEALTH ORGAN, V59, P397; Hamad AA, 2002, ACTA TROP, V83, P71, DOI 10.1016/S0001-706X(02)00059-1; KASLOW DC, 1989, MOL BIOCHEM PARASIT, V32, P101, DOI 10.1016/0166-6851(89)90134-5; KITCHEN SF, 1942, AM J TROP MED, V22, P381; Menegon M, 2000, MOL BIOCHEM PARASIT, V111, P153, DOI 10.1016/S0166-6851(00)00314-5; MUIRHEADTHOMSON RC, 1954, T ROY SOC TROP MED H, V48, P208, DOI 10.1016/0035-9203(54)90067-X; Nassir E, 2005, INT J PARASITOL, V35, P49, DOI 10.1016/j.ijpara.2004.10.014; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Pukrittayakamee S, 2004, ANTIMICROB AGENTS CH, V48, P1329, DOI 10.1128/AAC.48.4.1329-1334.2004; Robert V, 1996, AM J TROP MED HYG, V55, P350, DOI 10.4269/ajtmh.1996.55.350; Roper C, 1996, AM J TROP MED HYG, V54, P325, DOI 10.4269/ajtmh.1996.54.325; SATTABONGKOT J, 1991, PARASITOLOGY, V102, P27, DOI 10.1017/S0031182000060303; Sauerwein RW, 2002, CHEM IMMUNOL, V80, P188; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Suputramongkol Y, 2003, AM J TROP MED HYG, V68, P620, DOI 10.4269/ajtmh.2003.68.620; Talman AM, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-24; Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689; Taylor LH, 1997, PARASITOL TODAY, V13, P135, DOI 10.1016/S0169-4758(97)89810-9; von Seidlein L, 2000, LANCET, V355, P352, DOI 10.1016/S0140-6736(99)10237-X; *WHO, 1994, WHOMAL941070	37	34	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1311	10.1371/journal.pone.0001311	http://dx.doi.org/10.1371/journal.pone.0001311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074034	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000207459500029
J	Okitsu, SL; Silvie, O; Westerfeld, N; Curcic, M; Kammer, AR; Mueller, MS; Sauerwein, RW; Robinson, JA; Genton, B; Mazier, D; Zurbriggen, R; Pluschke, G				Okitsu, Shinji L.; Silvie, Olivier; Westerfeld, Nicole; Curcic, Marija; Kammer, Andreas R.; Mueller, Markus S.; Sauerwein, Robert W.; Robinson, John A.; Genton, Blaise; Mazier, Dominique; Zurbriggen, Rinaldo; Pluschke, Gerd			A Virosomal Malaria Peptide Vaccine Elicits a Long-Lasting Sporozoite-Inhibitory Antibody Response in a Phase 1a Clinical Trial	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE PROTEIN; INFLUENZA VIROSOMES; DELIVERY-SYSTEM; CHILDREN; INDUCTION; IMMUNITY; DISEASE; DESIGN; MEMORY	Objectives. Peptides delivered on the surface of influenza virosomes have been shown to induce solid humoral immune responses in experimental animals. High titers of peptide-specific antibodies were also induced in a phase 1a clinical trial in volunteers immunized with virosomal formulations of two peptides derived from the circumsporozoite protein (CSP) and the apical membrane antigen 1 (AMA-1) of Plasmodium falciparum. The main objective of this study was to perform a detailed immunological and functional analysis of the CSP-specific antibodies elicited in this phase 1a trial. Methodology/Principal Findings. 46 healthy malaria-naive adults were immunized with virosomal formulations of two peptide-phosphatidylethanolamine conjugates, one derived from the NANP repeat region of P. falciparum CSP ( designated UK-39) the other from P. falciparum AMA-1 ( designated AMA49-C1). The two antigens were delivered in two different concentrations, alone and in combination. One group was immunized with empty virosomes as control. In this report we show a detailed analysis of the antibody response against UK-39. Three vaccinations with a 10 mg dose of UK-39 induced high titers of sporozoite-binding antibodies in all volunteers. This IgG response was affinity maturated and long-lived. Co-administration of UK-39 and AMA49-C1 loaded virosomes did not interfere with the immunogenicity of UK-39. Purified total IgG from UK-39 immunized volunteers inhibited sporozoite migration and invasion of hepatocytes in vitro. Sporozoite inhibition closely correlated with titers measured in immunogenicity assays. Conclusions. Virosomal delivery of a short, conformationally constrained peptide derived from P. falciparum CSP induced a long-lived parasite-inhibitory antibody response in humans. Combination with a second virosomally-formulated peptide derived from P. falciparum AMA-1 did not interfere with the immunogenicity of either peptide, demonstrating the potential of influenza virosomes as a versatile, human-compatible antigen delivery platform for the development of multivalent subunit vaccines.	[Okitsu, Shinji L.; Curcic, Marija; Mueller, Markus S.; Genton, Blaise; Pluschke, Gerd] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Silvie, Olivier; Mazier, Dominique] CHU Pitie Salpetriere, Fac Med Pierre & Marie Curie, UPMC, INSERM,UMR S Immunobiol Cellulaire & Mol Infect P, Paris, France; [Westerfeld, Nicole; Kammer, Andreas R.; Zurbriggen, Rinaldo] Pevion Biotech, Basel, Switzerland; [Sauerwein, Robert W.] Radboud Univ Nijmegen Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; [Robinson, John A.] Univ Zurich, Inst Organ Chem, Zurich, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Radboud University Nijmegen; University of Zurich	Pluschke, G (corresponding author), Swiss Trop Inst, CH-4002 Basel, Switzerland.	Gerd.Pluschke@unibas.ch	Silvie, Olivier/AAF-5437-2021; Sauerwein, Robert/C-8519-2013; Silvie, Olivier/K-7290-2017	Silvie, Olivier/0000-0002-0525-6940; Silvie, Olivier/0000-0002-0525-6940	Pevion Biotech, Switzerland	Pevion Biotech, Switzerland	This study was supported by Pevion Biotech, Switzerland.	Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Amacker M, 2005, INT IMMUNOL, V17, P695, DOI 10.1093/intimm/dxh249; Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Bisang C, 1998, J AM CHEM SOC, V120, P7439, DOI 10.1021/ja980444j; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; FERREIRA MU, 1995, J IMMUNOL METHODS, V187, P297, DOI 10.1016/0022-1759(95)00186-4; Genton B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001018; Ghasparian A, 2006, CHEM COMMUN, P174, DOI 10.1039/b510812h; Good MF, 2005, TRENDS PARASITOL, V21, P29, DOI 10.1016/j.pt.2004.10.006; Greenwood B, 2005, ACTA TROP, V95, P298, DOI 10.1016/j.actatropica.2005.04.017; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Huckriede A, 2003, VACCINE, V21, P925, DOI 10.1016/S0264-410X(02)00542-X; James WPT, 2006, INT J PEDIATR OBES, V1, P7, DOI 10.1080/17477160600630404; Kappe SHI, 2004, TRENDS PARASITOL, V20, P13, DOI 10.1016/j.pt.2003.10.011; MAZIER D, 1986, SCIENCE, V231, P156, DOI 10.1126/science.3510455; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; MOORTHY VS, 2005, PROGR DEV VACCINE AI; Moreno R, 2001, CHEMBIOCHEM, V2, P838, DOI 10.1002/1439-7633(20011105)2:11<838::AID-CBIC838>3.0.CO;2-4; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Mueller MS, 2003, INFECT IMMUN, V71, P4749, DOI 10.1128/IAI.71.8.4749-4758.2003; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; Okitsu SL, 2007, CHEM BIOL, V14, P577, DOI 10.1016/j.chembiol.2007.04.008; OKITSU SL, 2007, PEPTIDES; Pfeiffer B, 2003, ANGEW CHEM INT EDIT, V42, P2368, DOI 10.1002/anie.200250348; Poltl-Frank F, 1999, CLIN EXP IMMUNOL, V117, P496; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Targett GA, 2005, TRENDS PARASITOL, V21, P499, DOI 10.1016/j.pt.2005.08.018; Tongren JE, 2004, TRENDS PARASITOL, V20, P604, DOI 10.1016/j.pt.2004.09.005; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; Waters A, 2006, CELL, V124, P689, DOI 10.1016/j.cell.2006.02.011; Zurbriggen R, 2003, VACCINE, V21, P921, DOI 10.1016/S0264-410X(02)00541-8	34	44	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1278	10.1371/journal.pone.0001278	http://dx.doi.org/10.1371/journal.pone.0001278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060072	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459400025
J	Weng, W; Sukowati, EW; Sheng, GJ				Weng, Wei; Sukowati, Erike W.; Sheng, Guojun			On Hemangioblasts in Chicken	PLOS ONE			English	Article								Hemangioblasts are bi-potential precursors for blood and endothelial cells (BCs and ECs). Existence of the hemangioblast in vivo by its strict definition, i.e. a clonal precursor giving rise to these two cell types after division, is still debated. Using a combination of mitotic figure analysis, cell labeling and long-term cell tracing, we show that, in chicken, cell division does not play a major role during the entire ventral mesoderm differentiation process after gastrulation. One eighth of cells do undergo at least one round of division, but mainly give rise to daughter cells contributing to the same lineage. Approximately 7% of the dividing cells that contribute to either the BC or EC lineage meet the criteria of true hemangioblasts, with one daughter cell becoming a BC and the other an EC. Our data suggest that hemangioblast-type generation of BC/EC occurs, but is not used as a major mechanism during early chicken development. It remains unclear, however, whether hemangioblast-like progenitor cells play a more prominent role in later development.	[Weng, Wei; Sukowati, Erike W.; Sheng, Guojun] RIKEN, Ctr Dev Biol, Lab Early Embryogenesis, Kobe, Hyogo, Japan	RIKEN	Sheng, GJ (corresponding author), RIKEN, Ctr Dev Biol, Lab Early Embryogenesis, Kobe, Hyogo, Japan.	sheng@cdb.riken.jp	Sheng, Guojun/I-4900-2015; Sheng, Guojun/G-4116-2014; Sheng, Guojun/G-8746-2013		RIKEN	RIKEN	This work is supported by RIKEN.	Choi K, 1998, DEVELOPMENT, V125, P725; Darnell DK, 2000, METH MOL B, V135, P31; Derrick GE, 1937, J MORPHOL, V61, P257, DOI 10.1002/jmor.1050610203; DONDUA AK, 1966, ACTA BIOL ACAD SCI H, V17, P127; Duval M. M., 1889, ATLAS DEMBRYOLOGIE; EMANUELSSON H, 1961, ACTA PHYSIOL SCAND, V52, P211, DOI 10.1111/j.1748-1716.1961.tb02220.x; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jaffredo T, 2005, INT J DEV BIOL, V49, P269, DOI 10.1387/ijdb.041948tj; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Lillie FR., 1908, DEV CHICK; MURRAY PDF, 1932, P R SOC LOND, V11, P497; Nakazawa F, 2006, BLOOD, V108, P3335, DOI 10.1182/blood-2006-05-021386; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; OZATO K, 1969, EMBRYOLOGIA, V10, P297, DOI 10.1111/j.1440-169X.1969.tb00242.x; Park C, 2005, EXP HEMATOL, V33, P965, DOI 10.1016/j.exphem.2005.06.003; PATTEN BM, 1951, EARLY EMBRYOLOGY CHI, pR13; PRIMMETT DRN, 1989, DEVELOPMENT, V105, P119; ROMANOFF AL, 1960, AVIAN EMBRYO STRUCTU, pR15; ROSENQUIST GC, 1982, ANAT REC, V202, P95, DOI 10.1002/ar.1092020111; Sabin F, 1920, CONTRIB EMBRYOL, V9, P213; Sabin FR, 1917, ANAT REC, V13, P199, DOI 10.1002/ar.1090130403; SABIN FR, 1917, CARNEGIE I WASH PUBL, V61, P124; SANDERS EJ, 1993, DEVELOPMENT, V118, P389; SCHULTZ AF, 1922, P OKLA ACAD SCI, V52, P45; SOLOMON JB, 1957, BIOCHIM BIOPHYS ACTA, V23, P24, DOI 10.1016/0006-3002(57)90280-9; STERN CD, 1984, ANAT EMBRYOL, V169, P97, DOI 10.1007/BF00300591; STERN CD, 1979, ANAT EMBRYOL, V156, P319, DOI 10.1007/BF00299630; STERN CD, 1981, ANAT EMBRYOL, V163, P245, DOI 10.1007/BF00315703; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; WILT FH, 1974, ANN NY ACAD SCI, V241, P99, DOI 10.1111/j.1749-6632.1974.tb21870.x; WOODARD TM, 1948, AM NAT, V82, P129, DOI 10.1086/281573; Yokomizo T, 2007, EMBO J, V26, P184, DOI 10.1038/sj.emboj.7601480	34	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1228	10.1371/journal.pone.0001228	http://dx.doi.org/10.1371/journal.pone.0001228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043736	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459300010
J	Llagostera, E; Catalucci, D; Marti, L; Liesa, M; Camps, M; Ciaraldi, TP; Kondo, R; Reddy, S; Dillmann, WH; Palacin, M; Zorzano, A; Ruiz-Lozano, P; Gomis, R; Kaliman, P				Llagostera, Esther; Catalucci, Daniele; Marti, Luc; Liesa, Marc; Camps, Marta; Ciaraldi, Theodore P.; Kondo, Richard; Reddy, Sita; Dillmann, Wolfgang H.; Palacin, Manuel; Zorzano, Antonio; Ruiz-Lozano, Pilar; Gomis, Ramon; Kaliman, Perla			Role of Myotonic Dystrophy Protein Kinase (DMPK) in Glucose Homeostasis and Muscle Insulin Action	PLOS ONE			English	Article								Myotonic dystrophy 1 (DM1) is caused by a CTG expansion in the 3'-unstranslated region of the DMPK gene, which encodes a serine/threonine protein kinase. One of the common clinical features of DM1 patients is insulin resistance, which has been associated with a pathogenic effect of the repeat expansions. Here we show that DMPK itself is a positive modulator of insulin action. DMPK-deficient (dmpk(-/-)) mice exhibit impaired insulin signaling in muscle tissues but not in adipocytes and liver, tissues in which DMPK is not expressed. Dmpk(-/-) mice display metabolic derangements such as abnormal glucose tolerance, reduced glucose uptake and impaired insulin-dependent GLUT4 trafficking in muscle. Using DMPK mutants, we show that DMPK is required for a correct intracellular trafficking of insulin and IGF-1 receptors, providing a mechanism to explain the molecular and metabolic phenotype of dmpk(-/-) mice. Taken together, these findings indicate that reduced DMPK expression may directly influence the onset of insulin-resistance in DM1 patients and point to dmpk as a new candidate gene for susceptibility to type 2-diabetes.	[Gomis, Ramon; Kaliman, Perla] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Endocrinol & Diabet Unit, Barcelona, Spain; [Ruiz-Lozano, Pilar] Burnham Inst Med Res, La Jolla, CA USA; [Reddy, Sita] Univ So Calif, Inst Med Genet, Los Angeles, CA USA; [Llagostera, Esther; Camps, Marta; Palacin, Manuel; Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Catalucci, Daniele; Ciaraldi, Theodore P.; Kondo, Richard; Dillmann, Wolfgang H.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Catalucci, Daniele] Ist Ric & Cura Cancro IRCC Multimed, Milan, Italy; [Marti, Luc; Liesa, Marc; Palacin, Manuel; Zorzano, Antonio] Inst Res Biomed, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Sanford Burnham Prebys Medical Discovery Institute; University of Southern California; University of Barcelona; University of California System; University of California San Diego; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Kaliman, P (corresponding author), Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Endocrinol & Diabet Unit, Barcelona, Spain.	pkaliman@clinic.ub.es	Camps, Marta/F-6557-2016; Liesa, Marc/K-8590-2019; Catalucci, Daniele/B-6745-2015; Catalucci, Daniele/AAA-6056-2022; Zorzano, Antonio/R-5479-2018	Camps, Marta/0000-0001-5392-1792; Liesa, Marc/0000-0002-5909-8570; Catalucci, Daniele/0000-0001-7041-6114; Catalucci, Daniele/0000-0001-7041-6114; Palacin, Manuel/0000-0002-8670-293X	Ministerio de Ciencia y Tecnologia, Spain [SAF2004-01281]; National Institutes of Health [HL065484]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL065484, R01HL065484] Funding Source: NIH RePORTER	Ministerio de Ciencia y Tecnologia, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by SAF2004-01281 from the Ministerio de Ciencia y Tecnologia, Spain and the "Ramon y Cajal Research Program'' (to PK), and National Institutes of Health Grant HL065484 (to PR-L).	ACCILI D, 1989, EMBO J, V8, P2509, DOI 10.1002/j.1460-2075.1989.tb08388.x; An P, 2005, DIABETES, V54, P909, DOI 10.2337/diabetes.54.3.909; Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Buckley DA, 2002, J CLIN PATHOL-MOL PA, V55, P46, DOI 10.1136/mp.55.1.46; Bush EW, 2000, BIOCHEMISTRY-US, V39, P8480, DOI 10.1021/bi992142f; Ciaraldi TP, 2001, J CLIN ENDOCR METAB, V86, P5838, DOI 10.1210/jc.86.12.5838; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Fecchi K, 2006, FASEB J, V20, P705, DOI 10.1096/fj.05-4661fje; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Foti M, 2007, P NATL ACAD SCI USA, V104, P1242, DOI 10.1073/pnas.0610523104; Fuller W, 2001, ANAL BIOCHEM, V293, P216, DOI 10.1006/abio.2001.5127; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Harper P.S., 1989, MYOTONIC DYSTROPHY; Issad T, 2005, BIOCHIMIE, V87, P111, DOI 10.1016/j.biochi.2004.12.008; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Jin S, 2000, CELL MOTIL CYTOSKEL, V45, P133, DOI 10.1002/(SICI)1097-0169(200002)45:2<133::AID-CM5>3.0.CO;2-S; Kaliman P, 2005, J BIOL CHEM, V280, P8016, DOI 10.1074/jbc.M412845200; KNUTSON VP, 1991, FASEB J, V5, P2130, DOI 10.1096/fasebj.5.8.2022311; Kondo RP, 2006, J PHYSIOL-LONDON, V571, P131, DOI 10.1113/jphysiol.2005.101428; KRENTZ AJ, 1992, DIABETOLOGIA, V35, P1170, DOI 10.1007/BF00401372; Lam LT, 2000, HUM MOL GENET, V9, P2167, DOI 10.1093/hmg/9.14.2167; Leung T, 1996, MOL CELL BIOL, V16, P5313; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Morin N, 2002, J PHARMACOL EXP THER, V303, P1238, DOI 10.1124/jpet.102.040592; MOXLEY RT, 1978, J CLIN INVEST, V62, P857, DOI 10.1172/JCI109198; MOXLEY RT, 1984, ANN NEUROL, V15, P157, DOI 10.1002/ana.410150208; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Salvatori S, 2005, NEUROL SCI, V26, P235, DOI 10.1007/s10072-005-0466-x; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Shimizu M, 2000, FEBS LETT, V475, P273, DOI 10.1016/S0014-5793(00)01692-6; van Tilburg JHO, 2003, J CLIN ENDOCR METAB, V88, P2223, DOI 10.1210/jc.2002-021252; VIALETTES B, 1986, HORM METAB RES, V18, P395, DOI 10.1055/s-2007-1012325; Woodman SE, 2004, NEUROLOGY, V62, P538, DOI 10.1212/WNL.62.4.538; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	40	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1134	10.1371/journal.pone.0001134	http://dx.doi.org/10.1371/journal.pone.0001134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987120	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459000018
J	Volkmann, N; Lui, HJ; Hazelwood, L; Trybus, KM; Lowey, S; Hanein, D				Volkmann, Niels; Lui, HongJun; Hazelwood, Larnele; Trybus, Kathleen M.; Lowey, Susan; Hanein, Dorit			The R403Q Myosin Mutation Implicated in Familial Hypertrophic Cardiomyopathy Causes Disorder at the Actomyosin Interface	PLOS ONE			English	Article							BETA-CARDIAC MYOSIN; SMOOTH-MUSCLE MYOSIN; ESSENTIAL LIGHT-CHAIN; HEAVY-CHAIN; 3-DIMENSIONAL STRUCTURE; MOTOR DOMAIN; HETEROLOGOUS EXPRESSION; ELECTRON CRYOMICROSCOPY; CRYSTAL-STRUCTURE; GENE MUTATION	Background. Mutations in virtually all of the proteins comprising the cardiac muscle sarcomere have been implicated in causing Familial Hypertrophic Cardiomyopathy (FHC). Mutations in the beta-myosin heavy chain (MHC) remain among the most common causes of FHC, with the widely studied R403Q mutation resulting in an especially severe clinical prognosis. In vitro functional studies of cardiac myosin containing the R403Q mutation have revealed significant changes in enzymatic and mechanical properties compared to wild-type myosin. It has been proposed that these molecular changes must trigger events that ultimately lead to the clinical phenotype. Principal Findings. Here we examine the structural consequences of the R403Q mutation in a recombinant smooth muscle myosin subfragment (S1), whose kinetic features have much in common with slow beta-MHC. We obtained three-dimensional reconstructions of wild-type and R403Q smooth muscle S1 bound to actin filaments in the presence (ADP) and absence (apo) of nucleotide by electron cryomicroscopy and image analysis. We observed that the mutant S1 was attached to actin at highly variable angles compared to wild-type reconstructions, suggesting a severe disruption of the actin-myosin interaction at the interface. Significance. These results provide structural evidence that disarray at the molecular level may be linked to the histopathological myocyte disarray characteristic of the diseased state.	[Trybus, Kathleen M.; Lowey, Susan] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Volkmann, Niels; Lui, HongJun; Hazelwood, Larnele; Hanein, Dorit] Burnham Inst Med Res, La Jolla, CA USA	University of Vermont; Sanford Burnham Prebys Medical Discovery Institute	Lowey, S (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	Susan.Lowey@uvm.edu; dorit@burnham.org			NIH [AR47199, GM076503, HL059408, AR47906]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR047906, R01AR047199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076503] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants AR47199 for electron microscopy and image analysis to DH, GM076503 for software development to NV, HL059408 to KMT, and AR47906 to SL.	Bonne G, 1998, CIRC RES, V83, P580, DOI 10.1161/01.RES.83.6.580; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Cuda G, 1997, J MUSCLE RES CELL M, V18, P275, DOI 10.1023/A:1018613907574; DEROSIER DJ, 1970, J MOL BIOL, V52, P355, DOI 10.1016/0022-2836(70)90036-7; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; FERRANS VJ, 1972, CIRCULATION, V45, P769, DOI 10.1161/01.CIR.45.4.769; Fujita H, 1997, J CLIN INVEST, V99, P1010, DOI 10.1172/JCI119228; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Hanein D, 1999, ULTRAMICROSCOPY, V76, P233, DOI 10.1016/S0304-3991(98)00086-2; Hanein D, 1997, J CELL BIOL, V139, P387, DOI 10.1083/jcb.139.2.387; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Iorga B, 2007, J BIOL CHEM, V282, P3559, DOI 10.1074/jbc.M608191200; Jontes JD, 1998, J CELL BIOL, V141, P155, DOI 10.1083/jcb.141.1.155; Kim SJ, 1999, AM J PHYSIOL-HEART C, V276, pH1780, DOI 10.1152/ajpheart.1999.276.5.H1780; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maass AH, 2000, CURR OPIN CARDIOL, V15, P189, DOI 10.1097/00001573-200005000-00012; MARGOSSIAN SS, 1985, J BIOL CHEM, V260, P3747; Marian AJ, 1999, J CLIN INVEST, V104, P1683, DOI 10.1172/JCI7956; Miller G, 2003, J PHYSIOL-LONDON, V548, P167, DOI 10.1113/jphysiol.2002.031922; Owen CH, 1996, J STRUCT BIOL, V116, P167, DOI 10.1006/jsbi.1996.0027; Palmiter KA, 2000, J MUSCLE RES CELL M, V21, P609, DOI 10.1023/A:1005678905119; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rost LE, 1998, ULTRAMICROSCOPY, V72, P187, DOI 10.1016/S0304-3991(98)00017-5; Sata M, 1996, J CLIN INVEST, V98, P2866, DOI 10.1172/JCI119115; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; SWEENEY HL, 1994, J BIOL CHEM, V269, P1603; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; TRACHTENBERG S, 1987, J MOL BIOL, V195, P581, DOI 10.1016/0022-2836(87)90184-7; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; Tyska MJ, 2000, CIRC RES, V86, P737, DOI 10.1161/01.RES.86.7.737; VANBUREN P, 1995, CIRC RES, V77, P439, DOI 10.1161/01.RES.77.2.439; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Volkmann N, 2003, P NATL ACAD SCI USA, V100, P3227, DOI 10.1073/pnas.0536510100; Volkmann N, 2000, NAT STRUCT BIOL, V7, P1147; Volkmann N, 1999, J STRUCT BIOL, V125, P176, DOI 10.1006/jsbi.1998.4074; Volkmann N, 2002, J STRUCT BIOL, V138, P123, DOI 10.1016/S1047-8477(02)00009-6; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Yamashita H, 2000, J BIOL CHEM, V275, P28045	46	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1123	10.1371/journal.pone.0001123	http://dx.doi.org/10.1371/journal.pone.0001123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987111	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459000007
J	Begliomini, C; Caria, A; Grodd, W; Castiello, U				Begliomini, Chiara; Caria, Andrea; Grodd, Wolfgang; Castiello, Umberto			Comparing Natural and Constrained Movements: New Insights into the Visuomotor Control of Grasping	PLOS ONE			English	Article								Background. Neurophysiological studies showed that in macaques, grasp-related sensorimotor transformations are accomplished in a circuit connecting the anterior intraparietal sulcus (area AIP) with premotor area F5. Single unit recordings of macaque indicate that activity of neurons in this circuit is not simply linked to any particular object. Instead, responses correspond to the final hand configuration used to grasp the object. Although a human homologue of such a circuit has been identified, its role in planning and controlling different grasp configurations has not been decisively shown. We used functional magnetic resonance imaging to explicitly test whether activity within this network varies depending on the congruency between the adopted grasp and the grasp called by the stimulus. Methodology/Principal Findings. Subjects were requested to reach towards and grasp a small or a large stimulus naturally (i.e., precision grip, involving the opposition of index finger and thumb, for a small size stimulus and a whole hand grasp for a larger stimulus) or with an constrained grasp (i.e., a precision grip for a large stimulus and a whole hand grasp for a small stimulus). The human anterior intraparietal sulcus (hAIPS) was more active for precise grasping than for whole hand grasp independently of stimulus size. Conversely, both the dorsal premotor cortex (dPMC) and the primary motor cortex (M1) were modulated by the relationship between the type of grasp that was adopted and the size of the stimulus. Conclusions/Significance. The demonstration that activity within the hAIPS is modulated according to different types of grasp, together with the evidence in humans that the dorsal premotor cortex is involved in grasp planning and execution offers a substantial contribution to the current debate about the neural substrates of visuomotor grasp in humans.	[Castiello, Umberto] Univ Padua, Dept Gen Psychol, Padua, Italy; [Begliomini, Chiara] Univ Trento, Ctr Mind & Brain Sci, Rovereto, Italy; [Caria, Andrea] Univ Tubingen, Inst Med Psychol, Tubingen, Germany; [Grodd, Wolfgang] Univ Tubingen Hosp, Dept Neuroradiol, CNS, Sect Expt MRI, Tubingen, Germany; [Castiello, Umberto] Univ London, Dept Psychol, Egham, Surrey, England	University of Padua; University of Trento; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of London; Royal Holloway University London	Castiello, U (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	umberto.castiello@unipd.it	BEGLIOMINI, CHIARA/D-1516-2014	BEGLIOMINI, CHIARA/0000-0001-7433-0414; Caria, Andrea/0000-0003-2017-7084; Castiello, Umberto/0000-0003-0629-1286	Ministero dell'Universita e della Ricerca (MUR)	Ministero dell'Universita e della Ricerca (MUR)(Ministry of Education, Universities and Research (MIUR))	Funding: This work was supported by a grant from the Ministero dell'Universita e della Ricerca (MUR) to Prof. Umberto Castiello.	Begliomini C, 2007, EUR J NEUROSCI, V25, P1245, DOI 10.1111/j.1460-9568.2007.05365.x; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; CAMINITI R, 1991, J NEUROSCI, V11, P1182; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Castiello U, 1996, NEUROREPORT, V7, P825, DOI 10.1097/00001756-199602290-00034; CASTIELLO U, 1993, EXP BRAIN RES, V94, P163; Cavina-Pratesi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000424; Culham J.C., 2004, ATTENTION PERFORM, P417; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; DUVERNOY P, 1991, HUMAN BRAIN STRUCTUR; Ehrsson HH, 2000, EUR J NEUROSCI, V12, P3385, DOI 10.1046/j.1460-9568.2000.00209.x; Ehrsson HH, 2001, J NEUROPHYSIOL, V85, P2613, DOI 10.1152/jn.2001.85.6.2613; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Frey SH, 2005, COGNITIVE BRAIN RES, V23, P397, DOI 10.1016/j.cogbrainres.2004.11.010; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FU QG, 1993, J NEUROPHYSIOL, V70, P2097, DOI 10.1152/jn.1993.70.5.2097; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; GENTILUCCI M, 1991, NEUROPSYCHOLOGIA, V29, P361, DOI 10.1016/0028-3932(91)90025-4; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Glaser DE, 2001, NEUROIMAGE, V13, pS127; Gomez JE, 2000, EUR J NEUROSCI, V12, P3748, DOI 10.1046/j.1460-9568.2000.00232.x; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Hagberg GE, 2001, NEUROIMAGE, V14, P1193, DOI 10.1006/nimg.2001.0880; Hazeltine E, 2003, NEUROPSYCHOLOGIA, V41, P1208, DOI 10.1016/S0028-3932(03)00040-X; HEPPREYMOND MC, 1998, COMP PRIMATE BIOL; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Kuhtz-Buschbeck JP, 2001, EUR J NEUROSCI, V14, P382, DOI 10.1046/j.0953-816x.2001.01639.x; LEMON RN, 1981, J PHYSIOL-LONDON, V311, P521, DOI 10.1113/jphysiol.1981.sp013602; LEMON RN, 1993, EXP PHYSIOL, V78, P263, DOI 10.1113/expphysiol.1993.sp003686; LEMON RN, 1976, PROC R SOC SER B-BIO, V194, P341, DOI 10.1098/rspb.1976.0083; LEMON RN, 1986, J PHYSL, V38, P497; Manthey S, 2003, COGNITIVE BRAIN RES, V15, P296, DOI 10.1016/S0926-6410(02)00201-X; Mason CR, 2002, ARCH ITAL BIOL, V140, P229; Morrow MM, 2003, J NEUROPHYSIOL, V89, P2279, DOI 10.1152/jn.00632.2002; MUIR RB, 1983, BRAIN RES, V261, P312, DOI 10.1016/0006-8993(83)90635-2; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Napier J. R., 1993, HANDS; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Raos V, 2006, J NEUROPHYSIOL, V95, P709, DOI 10.1152/jn.00463.2005; Raos V, 2004, J NEUROPHYSIOL, V92, P1990, DOI 10.1152/jn.00154.2004; Raos V, 2003, J NEUROPHYSIOL, V89, P1503, DOI 10.1152/jn.00661.2002; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; SAKATA H, 1992, CONTROL ARM MOVEMENT, P185; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Talairach J., 1988, COPLANAR STEREOTAXIC; TALLIS R, 2004, HAND PHILOS ENQUIRY; Umilta MA, 2007, J NEUROPHYSIOL, V98, P488, DOI 10.1152/jn.01094.2006; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25	56	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1108	10.1371/journal.pone.0001108	http://dx.doi.org/10.1371/journal.pone.0001108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971871	gold, Green Published, Green Submitted			2022-12-27	WOS:000207458700025
J	Peirce, JL; Broman, KW; Lu, L; Williams, RW				Peirce, Jeremy L.; Broman, Karl W.; Lu, Lu; Williams, Robert W.			A Simple Method for Combining Genetic Mapping Data from Multiple Crosses and Experimental Designs	PLOS ONE			English	Article								Background. Over the past decade many linkage studies have defined chromosomal intervals containing polymorphisms that modulate a variety of traits. Many phenotypes are now associated with enough mapping data that meta-analysis could help refine locations of known QTLs and detect many novel QTLs. Methodology/Principal Findings. We describe a simple approach to combining QTL mapping results for multiple studies and demonstrate its utility using two hippocampus weight loci. Using data taken from two populations, a recombinant inbred strain set and an advanced intercross population we demonstrate considerable improvements in significance and resolution for both loci. 1-LOD support intervals were improved 51% for Hipp1a and 37% for Hipp9a. We first generate locus-wise permuted P-values for association with the phenotype from multiple maps, which can be done using a permutation method appropriate to each population. These results are then assigned to defined physical positions by interpolation between markers with known physical and genetic positions. We then use Fisher's combination test to combine position-by-position probabilities among experiments. Finally, we calculate genome-wide combined P-values by generating locus-specific P-values for each permuted map for each experiment. These permuted maps are then sampled with replacement and combined. The distribution of best locus-specific P-values for each combined map is the null distribution of genome-wide adjusted P-values. Conclusions/Significance. Our approach is applicable to a wide variety of segregating and non-segregating mapping populations, facilitates rapid refinement of physical QTL position, is complementary to other QTL fine mapping methods, and provides an appropriate genome-wide criterion of significance for combined mapping results.	[Peirce, Jeremy L.; Lu, Lu; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Ctr Neurosci, Memphis, TN USA; [Peirce, Jeremy L.; Lu, Lu; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Ctr Genom & Bioinformat, Memphis, TN USA; [Broman, Karl W.] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Johns Hopkins University	Peirce, JL (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Ctr Neurosci, Memphis, TN USA.	jpeirce@utmem.edu	Williams, Robert W./H-8789-2016	Williams, Robert W./0000-0001-8924-4447; Broman, Karl/0000-0002-4914-6671	NIMH [P20-MH62009]; NIDA; NSF; NIAAA [U01AA13499, U24AA135B, U01AA01442501]; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH062009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013499] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NSF(National Science Foundation (NSF)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Our thanks for financial support from (1) P20-MH62009 from NIMH, NIDA, and NSF. (2) INIA grants U01AA13499 and U24AA135B from NIAAA, and INIA grant U01AA01442501 from NIAAA. The funding agencies had no role in design, conduct, analysis, and interpretation of data or preparation of the manuscript.	Belknap JK, 2001, MAMM GENOME, V12, P893, DOI 10.1007/s00335-001-2074-2; Bolivar VJ, 2001, GENOME RES, V11, P1549, DOI 10.1101/gr.194001; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chesler EJ, 2004, NAT NEUROSCI, V7, P485, DOI 10.1038/nn0504-485; CHURCHILL GA, 1994, GENETICS, V138, P963; DARVASI A, 1995, GENETICS, V141, P1199; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Haldane JBS, 1931, GENETICS, V16, P0357; Hitzemann R, 2003, MAMM GENOME, V14, P733, DOI 10.1007/s00335-003-2277-9; Hitzemann R, 2002, GENES BRAIN BEHAV, V1, P214, DOI 10.1034/j.1601-183X.2002.10403.x; Iakoubova OA, 2001, GENOMICS, V74, P89, DOI 10.1006/geno.2000.6497; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; Li RH, 2005, GENETICS, V169, P1699, DOI 10.1534/genetics.104.033993; Lu L, 2001, J NEUROSCI, V21, P3503, DOI 10.1523/JNEUROSCI.21-10-03503.2001; Lyon ML, 1989, GENETIC VARIANTS STR, P773; Park YG, 2003, GENOME RES, V13, P118, DOI 10.1101/gr.786403; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; PEIRCE JL, GENOME RESHUFF UNPUB; Province MA, 2001, AM J HUM GENET, V69, P660, DOI 10.1086/323316; Sen S, 2001, GENETICS, V159, P371; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Walling GA, 2000, GENETICS, V155, P1369; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Williams RW, 1998, J NEUROSCI, V18, P138; ZOU F, 2005, GENETICS	28	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1036	10.1371/journal.pone.0001036	http://dx.doi.org/10.1371/journal.pone.0001036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940600	gold, Green Submitted, Green Published			2022-12-27	WOS:000207456100004
J	Meier, R; Muhlethaler-Mottet, A; Flahaut, M; Coulon, A; Fusco, C; Louache, F; Auderset, K; Bourloud, KB; Daudigeos, E; Ruegg, C; Vassal, G; Gross, N; Joseph, JM				Meier, Roland; Muehlethaler-Mottet, Annick; Flahaut, Marjorie; Coulon, Aurelie; Fusco, Carlo; Louache, Fawzia; Auderset, Katya; Bourloud, Katia Balmas; Daudigeos, Estelle; Ruegg, Curzio; Vassal, Gilles; Gross, Nicole; Joseph, Jean-Marc			The Chemokine Receptor CXCR4 Strongly Promotes Neuroblastoma Primary Tumour and Metastatic Growth, but not Invasion	PLOS ONE			English	Article								Neuroblastoma (NB) is a heterogeneous, and particularly malignant childhood neoplasm in its higher stages, with a propensity to form metastasis in selected organs, in particular liver and bone marrow, and for which there is still no efficient treatment available beyond surgery. Recent evidence indicates that the CXCR4/CXCL12 chemokine/receptor axis may be involved in promoting NB invasion and metastasis. In this study, we explored the potential role of CXCR4 in the malignant behaviour of NB, using a combination of in vitro functional analyses and in vivo growth and metastasis assessment in an orthotopic NB mouse model. We show here that CXCR4 overexpression in non-metastatic CXCR4-negative NB cells IGR-NB8 and in moderately metastatic, CXCR4 expressing NB cells IGR-N91, strongly increased tumour growth of primary tumours and liver metastases, without altering the frequency or the pattern of metastasis. Moreover shRNA-mediated knock-down experiments confirmed our observations by showing that silencing CXCR4 in NB cells impairs in vitro and almost abrogates in vivo growth. High levels of CXCL12 were detected in the mouse adrenal gland (the primary tumour site), and in the liver suggesting a paracrine effect of host-derived CXCL12 on NB growth. In conclusion, this study reveals a yet unreported NB-specific predominant growth and survival-promoting role of CXCR4, which warrants a critical reconsideration of the role of CXCR4 in the malignant behaviour of NB and other cancers.	[Gross, Nicole; Joseph, Jean-Marc] Univ Lausanne Hosp, CHUV, Dept Paediat, Surg Unit, Lausanne, Switzerland; [Fusco, Carlo] Univ Inst Pathol, Div Expt Pathol, Lausanne, Switzerland; [Louache, Fawzia] Inst Gustave Roussy, INSERM, U362, F-94805 Villejuif, France; [Daudigeos, Estelle; Vassal, Gilles] Inst Gustave Roussy, Unite Propre Rech Enseignement Super EA3535, F-94805 Villejuif, France; [Ruegg, Curzio] Lausanne Canc Ctr, Multidisciplinary Oncol Ctr CePO, Div Expt Oncol, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy	Gross, N (corresponding author), Univ Lausanne Hosp, CHUV, Dept Paediat, Surg Unit, Lausanne, Switzerland.	nicole.gross@chuv.ch	Fusco, Carlo/AAC-7332-2022; Mühlethaler-Mottet, Annick/H-2848-2019; Meier, Roland/ABI-4322-2020; Louache, Fawzia/M-4901-2017	Mühlethaler-Mottet, Annick/0000-0001-8274-0907; Louache, Fawzia/0000-0002-4247-5421	Swiss National Scientific Foundation; FORCE foundation; UICC; Yamagiwa- Yoshida Memorial International Cancer Study; Oncosuisse	Swiss National Scientific Foundation(Swiss National Science Foundation (SNSF)); FORCE foundation; UICC; Yamagiwa- Yoshida Memorial International Cancer Study; Oncosuisse	Funding: This work has been supported by grants from the Swiss National Scientific Foundation (JMJ and NG), FORCE foundation, (NG, RM and JMJ), a UICC (Union Internationale Contre le Cancer) Yamagiwa- Yoshida Memorial International Cancer Study Grant (RM), and an Oncosuisse grant (to RM).	Airoldi I, 2006, CLIN CANCER RES, V12, P77, DOI 10.1158/1078-0432.CCR-05-1376; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill F, 2003, SEMIN IMMUNOL, V15, P49, DOI 10.1016/S1044-5323(02)00127-6; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Calvet L, 2006, ONCOGENE, V25, P3150, DOI 10.1038/sj.onc.1209348; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Cui NH, 2005, CLIN CANCER RES, V11, P2713, DOI 10.1158/1078-0432.CCR-04-1767; Ehtesham M, 2006, ONCOGENE; FERRANDIS E, 1994, CANCER RES, V54, P2256; Flahaut M, 2006, APOPTOSIS, V11, P255, DOI 10.1007/s10495-006-3435-9; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hasmim M, 2005, THROMB HAEMOSTASIS, V94, P1060, DOI 10.1160/TH05-02-0108; Hatse S, 2003, Cell Mol Biol (Noisy-le-grand), V49 Online Pub, pOL443; Joseph JM, 2005, INT J CANCER, V113, P881, DOI 10.1002/ijc.20681; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Khanna C, 2002, IN VIVO, V16, P77; Killion JJ, 1998, CANCER METAST REV, V17, P279, DOI 10.1023/A:1006140513233; Kim J, 2006, ANN SURG, V244, P113, DOI 10.1097/01.sla.0000217690.65909.9c; Kubetzko FBB, 2004, CARCINOGENESIS, V25, P1839, DOI 10.1093/carcin/bgh190; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; MANZOTTI C, 1993, CLIN EXP METASTAS, V11, P5, DOI 10.1007/BF00880061; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Mashino K, 2002, CANCER RES, V62, P2937; Mori T, 2004, MOL CANCER THER, V3, P29; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nevo I, 2004, IMMUNOL LETT, V92, P163, DOI 10.1016/j.imlet.2003.10.019; RASHYAHANA M, 2004, FASEB J, V18, P1240; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Scotton CJ, 2002, CANCER RES, V62, P5930; Taichman RS, 2002, CANCER RES, V62, P1832; Tamamura H, 2004, FEBS LETT, V569, P99, DOI 10.1016/j.febslet.2004.05.056; Uhm JH, 1996, CLIN EXP METASTAS, V14, P421, DOI 10.1007/BF00128958; Valteau D, 1996, CANCER RES, V56, P362; Wang JH, 2005, CELL SIGNAL, V17, P1578, DOI 10.1016/j.cellsig.2005.03.022; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zhang LB, 2007, NEOPLASIA, V9, P36, DOI 10.1593/neo.06670; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	44	49	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1016	10.1371/journal.pone.0001016	http://dx.doi.org/10.1371/journal.pone.0001016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925864	Green Submitted, Green Published, gold			2022-12-27	WOS:000207456000015
J	Shekalaghe, S; Drakeley, C; Gosling, R; Ndaro, A; van Meegeren, M; Enevold, A; Alifrangis, M; Mosha, F; Sauerwein, R; Bousema, T				Shekalaghe, Seif; Drakeley, Chris; Gosling, Roly; Ndaro, Arnold; van Meegeren, Monique; Enevold, Anders; Alifrangis, Michael; Mosha, Frank; Sauerwein, Robert; Bousema, Teun			Primaquine Clears Submicroscopic Plasmodium falciparum Gametocytes that Persist after Treatment with Sulphadoxine-Pyrimethamine and Artesunate	PLOS ONE			English	Article								Background. P. falciparum gametocytes may persist after treatment with sulphadoxine-pyrimethamine (SP) plus artesunate (AS) and contribute considerably to malaria transmission. We determined the efficacy of SP+AS plus a single dose of primaquine (PQ, 0.75 mg/kg) on clearing gametocytaemia measured by molecular methods. Methodology. The study was conducted in Mnyuzi, an area of hyperendemic malaria in north-eastern Tanzania. Children aged 3-15 years with uncomplicated P. falciparum malaria with an asexual parasite density between 500-100,000 parasites/mu L were randomized to receive treatment with either SP+AS or SP+AS+PQ. P. falciparum gametocyte prevalence and density during the 42-day follow-up period were determined by real-time nucleic acid sequence-based amplification (QT-NASBA). Haemoglobin levels (Hb) were determined to address concerns about haemolysis in G6PD-deficient individuals. Results. 108 individuals were randomized. Pfs25 QT-NASBA gametocyte prevalence was 88-91% at enrolment and decreased afterwards for both treatment arms. Gametocyte prevalence and density were significantly lower in children treated with SP+AS+PQ. On day 14 after treatment 3.9% (2/51) of the SP+AS+PQ treated children harboured gametocytes compared to 62.7% (32/51) of those treated with SP+AS (p < 0.001). Hb levels were reduced in the week following treatment with SP+AS+PQ and this reduction was related to G6PD deficiency. The Hb levels of all patients recovered to pre-treatment levels or greater within one month after treatment. Conclusions. PQ clears submicroscopic gametocytes after treatment with SP+AS and the persisting gametocytes circulated at densities that are unlikely to contribute to malaria transmission. For individuals without severe anaemia, addition of a single dose of PQ to an efficacious antimalarial drug combination is a safe approach to reduce malaria transmission following treatment.	[Shekalaghe, Seif; van Meegeren, Monique; Sauerwein, Robert; Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Shekalaghe, Seif; Ndaro, Arnold; Mosha, Frank] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Drakeley, Chris; Gosling, Roly] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Drakeley, Chris; Gosling, Roly; Enevold, Anders; Alifrangis, Michael; Mosha, Frank] KCMC, Joint Malaria Programme, Moshi, Tanzania; [Enevold, Anders; Alifrangis, Michael] Univ Copenhagen, Ctr Med Parasitol, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark	Radboud University Nijmegen; Kilimanjaro Christian Medical Centre; University of London; London School of Hygiene & Tropical Medicine; University of Copenhagen	Bousema, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands.	t.bousema@ncmls.ru.nl	van Meegeren, Monique ER/H-7876-2014; Ndaro, Arnold/ABH-2102-2021; Sauerwein, Robert/C-8519-2013; Bousema, Teun/N-3574-2014	van Meegeren, Monique ER/0000-0001-8612-9945; Bousema, Teun/0000-0003-2666-094X; Alifrangis, Michael/0000-0002-3835-3333	NWO-WOTRO [WIZ93-465, W 07.05.203.00]; Wellcome Trust [063516]	NWO-WOTRO(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust(Wellcome TrustEuropean Commission)	Funding: Seif Shekalaghe is supported by NWO-WOTRO (WIZ93-465) through PRIOR, Teun Bousema by NWO-WOTRO (W 07.05.203.00) through APRIORI, and Chris Drakeley by a research fellowship in tropical medicine (# 063516) from the Wellcome Trust. The study sponsors had no role in the study design, data collection, analysis, interpretation or publication.	Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Babiker HA, 1998, AM J TROP MED HYG, V59, P582, DOI 10.4269/ajtmh.1998.59.582; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051; Butcher GA, 1997, INT J PARASITOL, V27, P975, DOI 10.1016/S0020-7519(97)00079-9; Cattamanchi A, 2003, AM J TROP MED HYG, V68, P133, DOI 10.4269/ajtmh.2003.68.133; CHEN PQ, 1994, CHINESE MED J-PEKING, V107, P709; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; Drakeley CJ, 2004, TROP MED INT HEALTH, V9, P53, DOI 10.1046/j.1365-3156.2003.01169.x; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010020; Enevold A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-61; Gogtay NJ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-16; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lederman ER, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-108; Lusingu JPA, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-26; Mendez F, 2006, AM J TROP MED HYG, V75, P640, DOI 10.4269/ajtmh.2006.75.640; Menge DM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-44; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Ofosu-Okyere A, 2001, PARASITOLOGY, V123, P113, DOI 10.1017/S0031182001008162; Pearce RJ, 2003, ANTIMICROB AGENTS CH, V47, P1347, DOI 10.1128/AAC.47.4.1347-1354.2003; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P812, DOI 10.1016/0035-9203(82)90116-X; Pukrittayakamee S, 2004, ANTIMICROB AGENTS CH, V48, P1329, DOI 10.1128/AAC.48.4.1329-1334.2004; Schellenberg D, 2003, B WORLD HEALTH ORGAN, V81, P581; Schneider P, 2005, J CLIN MICROBIOL, V43, P402, DOI 10.1128/JCM.43.1.402-405.2005; Schneider P, 2004, MOL BIOCHEM PARASIT, V137, P35, DOI 10.1016/j.molbiopara.2004.03.018; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Schneider P, 2006, INT J PARASITOL, V36, P403, DOI 10.1016/j.ijpara.2006.01.002; Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Suputramongkol Y, 2003, AM J TROP MED HYG, V68, P620, DOI 10.4269/ajtmh.2003.68.620; Sutherland CJ, 2005, PLOS MED, V2, P338, DOI 10.1371/journal.pmed.0020092; Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689; Taylor WRJ, 2004, DRUG SAFETY, V27, P25, DOI 10.2165/00002018-200427010-00003; von Seidlein L, 2003, TRENDS PARASITOL, V19, P452, DOI 10.1016/j.pt.2003.08.003; Weerasinghe K. L., 2002, Ceylon Medical Journal, V47, P83; *WHO, 2008, WHOHTMMAL20061108; *WHO, 2002, WHOCDSCSREPH200217; WOODEN J, 1993, PARASITOL TODAY, V9, P303, DOI 10.1016/0169-4758(93)90131-X	38	100	101	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1023	10.1371/journal.pone.0001023	http://dx.doi.org/10.1371/journal.pone.0001023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925871	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000207456000022
J	Decker, EH; Kerkhoff, AJ; Moses, ME				Decker, Ethan H.; Kerkhoff, Andrew J.; Moses, Melanie E.			Global Patterns of City Size Distributions and Their Fundamental Drivers	PLOS ONE			English	Article							BODY-SIZE; ZIPFS LAW; POPULATION-DENSITY; MODEL; INTERMITTENCY; ENERGETICS; SYSTEMS; GROWTH; ENERGY	Urban areas and their voracious appetites are increasingly dominating the flows of energy and materials around the globe. Understanding the size distribution and dynamics of urban areas is vital if we are to manage their growth and mitigate their negative impacts on global ecosystems. For over 50 years, city size distributions have been assumed to universally follow a power function, and many theories have been put forth to explain what has become known as Zipf's law (the instance where the exponent of the power function equals unity). Most previous studies, however, only include the largest cities that comprise the tail of the distribution. Here we show that national, regional and continental city size distributions, whether based on census data or inferred from cluster areas of remotely-sensed nighttime lights, are in fact lognormally distributed through the majority of cities and only approach power functions for the largest cities in the distribution tails. To explore generating processes, we use a simple model incorporating only two basic human dynamics, migration and reproduction, that nonetheless generates distributions very similar to those found empirically. Our results suggest that macroscopic patterns of human settlements may be far more constrained by fundamental ecological principles than more fine-scale socioeconomic factors.	[Decker, Ethan H.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Kerkhoff, Andrew J.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA; [Kerkhoff, Andrew J.] Kenyon Coll, Dept Math, Gambier, OH 43022 USA; [Moses, Melanie E.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA	University of New Mexico; Kenyon College; Kenyon College; University of New Mexico	Decker, EH (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	ehd@ehdecker.com		Kerkhoff, Andrew/0000-0001-9617-8687	NASA; National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF))	This research was supported in part by NASA and a National Science Foundation Doctoral Research Fellowship. Both groups funded the research but were not involved in conducting or analyzing the research.	Andersson C, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026204; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Brown J. H., 1995, MACROECOLOGY; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CARROLL GR, 1982, PROG HUM GEOG, V6, P1; Collins JP, 2000, AM SCI, V88, P416; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Decker EH, 2000, ANNU REV ENERG ENV, V25, P685, DOI 10.1146/annurev.energy.25.1.685; Decker Ethan H, 2002, ScientificWorldJournal, V2, P374; Eeckhout J, 2004, AM ECON REV, V94, P1429, DOI 10.1257/0002828043052303; Elvidge CD, 1997, PHOTOGRAMM ENG REM S, V63, P727; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Gabaix X, 1999, AM ECON REV, V89, P129, DOI 10.1257/aer.89.2.129; GABAIX X, 2003, HDB URBAN REGIONAL E, V4; Gibrat R, 1931, INEGALITIES EC; HILL BM, 1970, J AM STAT ASSOC, V65, P1220, DOI 10.2307/2284288; LEWIN R, 1985, SCIENCE, V229, P151, DOI 10.1126/science.229.4709.151; Loehle C, 2006, ECOLOGY, V87, P2221, DOI 10.1890/0012-9658(2006)87[2221:SADRFB]2.0.CO;2; Mandelbrot B. B., 1977, FRACTAL GEOMETRY NAT; Manrubia SC, 1998, PHYS REV E, V58, P295, DOI 10.1103/PhysRevE.58.295; MAURER BA, 1992, EVOLUTION, V46, P939, DOI 10.1111/j.1558-5646.1992.tb00611.x; Maurer BA, 1998, SCIENCE, V279, P502, DOI 10.1126/science.279.5350.502; MONTROLL EW, 1982, P NATL ACAD SCI USA, V79, P3380, DOI 10.1073/pnas.79.10.3380; Moses ME, 2003, ECOL LETT, V6, P295, DOI 10.1046/j.1461-0248.2003.00446.x; Nekola JC, 2007, ECOL LETT, V10, P188, DOI 10.1111/j.1461-0248.2006.01003.x; Odum Eugene, 1997, ECOLOGY BRIDGE SCI S; Perline R, 1996, PHYS REV E, V54, P220, DOI 10.1103/PhysRevE.54.220; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; Pumain D., 1982, DYNAMIQUE VILLES; Robson B.T., 1973, URBAN GROWTH APPROAC; Rodriguez-Iturbe I., 1997, FRACTAL RIVER BASINS; SIMON HA, 1955, BIOMETRIKA, V42, P425; Stanley HE, 1996, PHYSICA A, V231, P20, DOI 10.1016/0378-4371(96)00086-6; Stauffer D., 1992, INTRO PERCOLATION TH; Sutton P, 1997, PHOTOGRAMM ENG REM S, V63, P1303; *SWISS FED STAT OF, 1997, ANN POP STAT; Tobler W., 1995, GLOBAL DEMOGRAPHY PR; Turco R.P., 1997, EARTH SIEGE AIR POLL; *UN POP DIV, 2001, WORLD POP PROSP 2000; *UN POP DIV, 1996, WORLD URB PROSP 1996; *US BUR CENS, 1999, EST POP METR AR; *US GEOL SURV, 1995, GEOGR NAM INF SYST; WATT AS, 1947, J ECOL, V35, P1, DOI 10.2307/2256497; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WHO/UNEP, 1994, ANN REPORT; *WORLD RES I, 1998, WORLD RES 1998 99; WYLLYS RE, 1981, LIBR TRENDS, V30, P53; Zanette DH, 1997, PHYS REV LETT, V79, P523, DOI 10.1103/PhysRevLett.79.523; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	50	50	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e934	10.1371/journal.pone.0000934	http://dx.doi.org/10.1371/journal.pone.0000934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895975	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455800013
J	Grzmil, M; Whiting, D; Maule, J; Anastasaki, C; Amatruda, JF; Kelsh, RN; Norbury, CJ; Patton, EE				Grzmil, Michal; Whiting, Danny; Maule, John; Anastasaki, Corina; Amatruda, James F.; Kelsh, Robert N.; Norbury, Chris J.; Patton, E. Elizabeth			The INT6 Cancer Gene and MEK Signaling Pathways Converge during Zebrafish Development	PLOS ONE			English	Article							CELL-CYCLE; EXPRESSION; PROGRESSION; PATTERNS; P53	Background. Int-6 (integration site 6) was identified as an oncogene in a screen of tumorigenic mouse mammary tumor virus (MMTV) insertions. INT6 expression is altered in human cancers, but the precise role of disrupted INT6 in tumorigenesis remains unclear, and an animal model to study Int-6 physiological function has been lacking. Principal Findings. Here, we create an in vivo model of Int6 function in zebrafish, and through genetic and chemical-genetic approaches implicate Int6 as a tissue-specific modulator of MEK-ERK signaling. We find that Int6 is required for normal expression of MEK1 protein in human cells, and for Erk signaling in zebrafish embryos. Loss of either Int6 or Mek signaling causes defects in craniofacial development, and Int6 and Erk-signaling have overlapping domains of tissue expression. Significance. Our results provide new insight into the physiological role of vertebrate Int6, and have implications for the treatment of human tumors displaying altered INT6 expression.	[Grzmil, Michal; Whiting, Danny; Norbury, Chris J.; Patton, E. Elizabeth] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Maule, John; Anastasaki, Corina; Patton, E. Elizabeth] Univ Edinburgh, Western Gen Hosp, Canc Res Ctr, Edinburgh, Midlothian, Scotland; [Maule, John; Anastasaki, Corina; Patton, E. Elizabeth] MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Kelsh, Robert N.] Univ Bath, Ctr Regenerat Med, Dev Biol Programme, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Oxford; University of Edinburgh; University of Edinburgh; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Bath	Patton, EE (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	epatton@staffmail.ed.ac.uk	Kelsh, Robert/B-6445-2008	Kelsh, Robert/0000-0002-9381-0066; Grzmil, Michal/0000-0002-7866-8145	MRC; CRUK; AICR; Medical Research Council [G120/875, MC_U127585840] Funding Source: researchfish; MRC [MC_U127585840, G120/875] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); AICR; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a MRC grant to EEP, and by grants from CRUK and the AICR to CJN. Funders had no role in the design or conduct of the study, in the collection, analysis, or interpretation of the data, or in the preparation, review, or approval of the manuscript.	Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; BUCHSBAUM S, 2007, HUMAN INT6 INTERACTS, P1; Buttitta F, 2005, CLIN CANCER RES, V11, P3198, DOI 10.1158/1078-0432.CCR-04-2308; Callahan R, 2000, ONCOGENE, V19, P992, DOI 10.1038/sj.onc.1203276; Chen L, 2007, J BIOL CHEM, V282, P12707, DOI 10.1074/jbc.M700423200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Crane R, 2000, MOL BIOL CELL, V11, P3993, DOI 10.1091/mbc.11.11.3993; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Graham A, 2005, J ANAT, V207, P479, DOI 10.1111/j.1469-7580.2005.00472.x; Javidan Y, 2004, METHOD CELL BIOL, V76, P415; Jenkins CCL, 2005, EUKARYOT CELL, V4, P1840, DOI 10.1128/EC.4.11.1840-1850.2005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krens SFG, 2006, GENE EXPR PATTERNS, V6, P1019, DOI 10.1016/j.modgep.2006.04.008; MACK DL, 2007, BR CAN RES, V4, P42; Marchetti A, 2001, INT J ONCOL, V18, P175; Mayeur GL, 2002, FEBS LETT, V514, P49, DOI 10.1016/S0014-5793(02)02307-4; Morris C, 2005, ONCOGENE, V24, P1203, DOI 10.1038/sj.onc.1208268; Morris C, 2007, EMBO REP, V8, P596, DOI 10.1038/sj.embor.7400955; MURAKAMI S, 2000, PNAS, V97, P113; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Rasmussen SB, 2001, ONCOGENE, V20, P5291, DOI 10.1038/sj.onc.1204624; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shepard JL, 2004, METHOD CELL BIOL, V76, P109; TEKMAL RR, 1997, FRONT BIOSCI, V379, P519; Traicoff JL, 2007, J BIOMED SCI, V14, P395, DOI 10.1007/s11373-007-9149-3; Watkins SJ, 2004, CELL PROLIFERAT, V37, P149, DOI 10.1111/j.1365-2184.2004.00305.x; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; Yen HCS, 2003, CELL CYCLE, V2, P81, DOI 10.4161/cc.2.2.340; Zebrafish Nusslein-Volhard C., 2002, PRACTICAL APPROACH; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	37	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e959	10.1371/journal.pone.0000959	http://dx.doi.org/10.1371/journal.pone.0000959			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895999	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455800037
J	Russell, TV; Do, AN; Setik, E; Sullivan, PS; Rayle, VD; Fridlund, CA; Quan, VM; Voetsch, AC; Fleming, PL				Russell, Toya V.; Do, Ann N.; Setik, Eleanor; Sullivan, Patrick S.; Rayle, Victoria D.; Fridlund, Carol A.; Quan, Vu M.; Voetsch, Andrew C.; Fleming, Patricia L.			Sexual Risk Behaviors for HIV/AIDS in Chuuk State, Micronesia: The Case for HIV Prevention in Vulnerable Remote Populations	PLOS ONE			English	Article								Background. After the first two cases of locally-acquired HIV infection were recognized in Chuuk State, Federated States of Micronesia (FSM), a public health response was initiated. The purpose of the response was to assess the need for HIV education and prevention services, to develop recommendations for controlling further spread of HIV in Chuuk, and to initiate some of the prevention measures. Methodology/Principal Findings. A public health team conducted a survey and rapid HIV testing among a sample of residents on the outer islands in Chuuk. Local public health officials conducted contact tracing and testing of sex partners of the two locally-acquired cases of HIV infection. A total of 333 persons completed the survey. The majority knew that HIV is transmitted through unprotected sexual contact (81%), injection drug use (61%), or blood transfusion (64%). Sexual activity in the past 12 months was reported among 159 participants, including 90 females and 69 males. Compared to women, men were more likely to have had multiple sex partners, to have been drunk during sex, but less likely to have used a condom in the past 12 months. The two men with locally acquired HIV infection had unprotected anal sex with a third Chuukese man who likely contracted HIV while outside of Chuuk. All 370 persons who received voluntary, confidential HIV counseling and testing had HIV negative test results. Conclusions/Significance. Despite the low HIV seroprevalence, risky sexual behaviors in this small isolated population raise concerns about the potential for rapid spread of HIV. The lack of knowledge about risks, along with stigmatizing attitudes towards persons infected with HIV and high risk sexual behaviors indicate the need for resources to be directed toward HIV prevention in Chuuk and on other Pacific Islands.	[Do, Ann N.; Sullivan, Patrick S.; Rayle, Victoria D.; Voetsch, Andrew C.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; [Russell, Toya V.] Uniformed Serv Univ Hlth Sci, Res Off, Rockville, MD USA; [Setik, Eleanor] Chuuk State Dept Hlth & Hosp, Chuuk, Micronesia; [Fridlund, Carol A.] Ctr Dis Control & Prevent, Global AIDS Program, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA; [Quan, Vu M.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Fleming, Patricia L.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Prevent Med & Community Hlth, Newark, NJ 07103 USA	Centers for Disease Control & Prevention - USA; Uniformed Services University of the Health Sciences - USA; Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rutgers State University New Brunswick; Rutgers State University Medical Center	Do, AN (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA.	aad9@cdc.gov	Voetsch, Andrew/CAF-1978-2022	Sullivan, Patrick Sean/0000-0002-7728-0587; Voetsch, Andrew/0000-0002-0783-1312	National Center for STD, TB, and HIV Prevention	National Center for STD, TB, and HIV Prevention	This project was funded by the National Center for STD, TB, and HIV Prevention, CDC. The CDC was the employer of 8 of the 9 co-authors at the time of this project, and has no other specific role in the project, besides providing the funding, material support, personnel and technical support for the project, which was essentially a public health response to the first cases of locally-acquired HIV infection in Chuuk.	*CDCP, 2003, MMWR-MORBID MORTAL W, V52, P329; *CDCP, 2001, HIV AIDS SURVEILLANC, V13, P7; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P211; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P434; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1051; Holtgrave DR, 2000, AIDS PUBLIC POLICY J, V15, P75; Michael RT, 1998, AM J PUBLIC HEALTH, V88, P749, DOI 10.2105/AJPH.88.5.749; *POP REF BUR, 2006, 2006 WORLD POP DAT S; Stetler HC, 1997, AIDS, V11, P369, DOI 10.1097/00002030-199703110-00015; Sullivan EA, 2003, SEX TRANSM DIS, V30, P362, DOI 10.1097/00007435-200304000-00017; *UNAIDS WHO, 2001, GUID US HIV TEST TEC	11	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1283	10.1371/journal.pone.0001283	http://dx.doi.org/10.1371/journal.pone.0001283			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074009	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459500002
J	Yates, A; Graw, F; Barber, DL; Ahmed, R; Regoes, RR; Antia, R				Yates, Andrew; Graw, Frederik; Barber, Daniel L.; Ahmed, Rafi; Regoes, Roland R.; Antia, Rustom			Revisiting Estimates of CTL Killing Rates In Vivo	PLOS ONE			English	Article								Recent experimental advances have allowed the estimation of the in vivo rates of killing of infected target cells by cytotoxic T lymphocytes (CTL). We present several refinements to a method applied previously to quantify killing of targets in the spleen using a dynamical model. We reanalyse data previously used to estimate killing rates of CTL specific for two epitopes of lymphocytic choriomeningitis virus (LCMV) in mice and show that, contrary to previous estimates the "killing rate'' of effector CTL is approximately twice that of memory CTL. Further, our method allows the fits to be visualized, and reveals one potentially interesting discrepancy between fits and data. We discuss extensions to the basic CTL killing model to explain this discrepancy and propose experimental tests to distinguish between them.	[Yates, Andrew; Antia, Rustom] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Graw, Frederik; Regoes, Roland R.] ETH, Inst Integrat Biol, Zurich, Switzerland; [Barber, Daniel L.] NIAID, Bethesda, MD 20892 USA; [Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA	Emory University; Swiss Federal Institutes of Technology Domain; ETH Zurich; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University	Yates, A (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	ayates2@emory.edu	Regoes, Roland R/A-6538-2008; Barber, Daniel L./V-1190-2019	Regoes, Roland R/0000-0001-8319-5293; 	Swiss National Science Foundation; NIH [RO1 AI 49334]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049334] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RRR and FG gratefully acknowledge the financial support of the Swiss National Science Foundation. AY and Rustom Antia were supported by NIH grant RO1 AI 49334 to Rustom Antia. The funders played no other role in the study.	Asquith B, 2006, PLOS BIOL, V4, P583, DOI 10.1371/journal.pbio.0040090; Asquith B, 2007, P NATL ACAD SCI USA, V104, P6365, DOI 10.1073/pnas.0700666104; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Barchet W, 2000, EUR J IMMUNOL, V30, P1356, DOI 10.1002/(SICI)1521-4141(200005)30:5<1356::AID-IMMU1356>3.0.CO;2-K; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Fernandez CS, 2005, J VIROL, V79, P5721, DOI 10.1128/JVI.79.9.5721-5731.2005; GRIMM EA, 1979, J IMMUNOL, V123, P2870; LEBOW LT, 1986, NAT IMMUN CELL GROW, V5, P221; Ludewig B, 2001, EUR J IMMUNOL, V31, P1772, DOI 10.1002/1521-4141(200106)31:6<1772::AID-IMMU1772>3.3.CO;2-#; MACKEN CA, 1984, J IMMUNOL, V132, P1614; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; PERELSON AS, 1985, ADV EXP MED BIOL, V184, P551; PERELSON AS, 1982, J IMMUNOL, V129, P2796; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; PERELSON AS, 1984, J IMMUNOL, V132, P2190; R Development Core Team, 2007, R LANG ENV STAT COMP; Regoes RR, 2007, P NATL ACAD SCI USA, V104, P1599, DOI 10.1073/pnas.0508830104; Regoes RR, 2007, IMMUNOL CELL BIOL, V85, P274, DOI 10.1038/sj.icb.7100053; Regoes RR, 2004, J VIROL, V78, P4866, DOI 10.1128/JVI.78.9.4866-4875.2004; ROTHSTEIN TL, 1978, J IMMUNOL, V121, P1652; SLATE EH, 1994, J AM STAT ASSOC, V89, P1471, DOI 10.2307/2291009; van der Most RG, 1998, VIROLOGY, V240, P158, DOI 10.1006/viro.1997.8934; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wick WD, 2005, J VIROL, V79, P13579, DOI 10.1128/JVI.79.21.13579-13586.2005; ZAGURY D, 1979, J IMMUNOL, V123, P1604	25	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1301	10.1371/journal.pone.0001301	http://dx.doi.org/10.1371/journal.pone.0001301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074025	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000207459500020
J	Corradi, N; Akiyoshi, DE; Morrison, HG; Feng, XC; Weiss, LM; Tzipori, S; Keeling, PJ				Corradi, Nicolas; Akiyoshi, Donna E.; Morrison, Hilary G.; Feng, Xiaochuan; Weiss, Louis M.; Tzipori, Saul; Keeling, Patrick J.			Patterns of Genome Evolution among the Microsporidian Parasites Encephalitozoon cuniculi, Antonospora locustae and Enterocytozoon bieneusi	PLOS ONE			English	Article							GENE ORDER; NOSEMA-LOCUSTAE; HIGH-FREQUENCY; ALPHA-TUBULIN; REARRANGEMENT; SEQUENCE; IDENTIFICATION; INVERSIONS; COMPACTION; PHYLOGENY	Background. Microsporidia are intracellular parasites that are highly-derived relatives of fungi. They have compacted genomes and, despite a high rate of sequence evolution, distantly related species can share high levels of gene order conservation. To date, only two species have been analysed in detail, and data from one of these largely consists of short genomic fragments. It is therefore difficult to determine how conservation has been maintained through microsporidian evolution, and impossible to identify whether certain regions are more prone to genomic stasis. Principal Findings. Here, we analyse three large fragments of the Enterocytozoon bieneusi genome ( in total 429 kbp), a species of medical significance. A total of 296 ORFs were identified, annotated and their context compared with Encephalitozoon cuniculi and Antonospora locustae. Overall, a high degree of conservation was found between all three species, and interestingly the level of conservation was similar in all three pairwise comparisons, despite the fact that A. locustae is more distantly related to E. cuniculi and E. bieneusi than either are to each other. Conclusions/Significance. Any two genes that are found together in any pair of genomes are more likely to be conserved in the third genome as well, suggesting that a core of genes tends to be conserved across the entire group. The mechanisms of rearrangments identified among microsporidian genomes were consistent with a very slow evolution of their architecture, as opposed to the very rapid sequence evolution reported for these parasites.	[Corradi, Nicolas; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Canadian Inst Adv Res, Vancouver, BC, Canada; [Akiyoshi, Donna E.; Feng, Xiaochuan; Tzipori, Saul] Tufts Cummings Sch Vet Med, Div Infect Dis, North Grafton, MA USA; [Morrison, Hilary G.] Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Marine Biol Lab, Woods Hole, MA USA; [Weiss, Louis M.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; Marine Biological Laboratory - Woods Hole; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Keeling, PJ (corresponding author), Univ British Columbia, Dept Bot, Canadian Inst Adv Res, Vancouver, BC, Canada.	pkeeling@interchange.ubc.ca		Keeling, Patrick/0000-0002-7644-0745; Morrison, Hilary/0000-0003-0281-326X; Corradi, Nicolas/0000-0002-7932-7932	National Institutes of Health [R21 AI52792, R21 AI064118]; Canadian Institutes for Heath Research [MOP-84265]; NSF [0135272]; Swiss National Science Foundation [PBLAA-114238]; Canadian Institute for Advanced Research; Michael Smith Foundation for Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064118, R01AI031788, R21AI052792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Heath Research(Canadian Institutes of Health Research (CIHR)); NSF(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Enterocytozoon bieneusi genome sequence survey was supported by National Institutes of Health grants R21 AI52792 and R21 AI064118 and analysis was supported by a grant from the Canadian Institutes for Heath Research (MOP-84265). We acknowledge the Josephine Bay Paul Center for Comparative Molecular Biology and Evolution for the use of data included in the Antonospora locustae Genome Project funded by NSF award number 0135272. NC is supported by a fellowship from the Swiss National Science Foundation (PBLAA-114238). PJK is a fellow of the Canadian Institute for Advanced Research and the Michael Smith Foundation for Health Research. None of these institutions played a role in the design and conduct of the study, in the collection, analysis and interpretation of the data and in the preparation, review or approval of this manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bennetzen JL, 2002, PLANT MOL BIOL, V48, P821, DOI 10.1023/A:1014841515249; Burt DW, 1999, NATURE, V402, P411, DOI 10.1038/46555; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; DESPORTES I, 1985, J PROTOZOOL, V32, P250; Fast NM, 2003, EUKARYOT CELL, V2, P1069, DOI 10.1128/EC.2.5.1069-1075.2003; Franzen C, 2001, MICROBES INFECT, V3, P389, DOI 10.1016/S1286-4579(01)01395-8; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Hinkle G, 1997, BIOL BULL, V193, P250, DOI 10.1086/BBLv193n2p250; Hurst LD, 2002, TRENDS GENET, V18, P604, DOI 10.1016/S0168-9525(02)02813-5; Huynen MA, 2001, TRENDS GENET, V17, P304, DOI 10.1016/S0168-9525(01)02302-2; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2003, FUNGAL GENET BIOL, V38, P298, DOI 10.1016/S1087-1845(02)00537-6; Keeling PJ, 2005, CURR OPIN GENET DEV, V15, P601, DOI 10.1016/j.gde.2005.09.003; Keeling PJ, 1996, MOL BIOL EVOL, V13, P1297, DOI 10.1093/oxfordjournals.molbev.a025576; Keeling PJ, 2000, MOL BIOL EVOL, V17, P23, DOI 10.1093/oxfordjournals.molbev.a026235; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Keogh RS, 1998, YEAST, V14, P443, DOI 10.1002/(SICI)1097-0061(19980330)14:5<443::AID-YEA243>3.0.CO;2-L; Larsson JIR, 1999, ACTA PROTOZOOL, V38, P161; Mittleider D, 2002, J EUKARYOT MICROBIOL, V49, P393, DOI 10.1111/j.1550-7408.2002.tb00218.x; Nilsen F, 1998, J EUKARYOT MICROBIOL, V45, P535, DOI 10.1111/j.1550-7408.1998.tb05113.x; Notermans DW, 2005, J CLIN MICROBIOL, V43, P610, DOI 10.1128/JCM.43.2.610-614.2005; Pal C, 2003, NAT GENET, V33, P392, DOI 10.1038/ng1111; Peyretaillade E, 1998, NUCLEIC ACIDS RES, V26, P3513, DOI 10.1093/nar/26.15.3513; Ranz JM, 2001, GENOME RES, V11, P230, DOI 10.1101/gr.162901; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Seoighe C, 2000, P NATL ACAD SCI USA, V97, P14433, DOI 10.1073/pnas.240462997; Slamovits CH, 2004, J EUKARYOT MICROBIOL, V51, P207, DOI 10.1111/j.1550-7408.2004.tb00547.x; Slamovits CH, 2004, CURR BIOL, V14, P891, DOI 10.1016/j.cub.2004.04.041; Slamovits CH, 2006, J MOL BIOL, V359, P1196, DOI 10.1016/j.jmb.2006.04.028; Suyama M, 2001, TRENDS GENET, V17, P10, DOI 10.1016/S0168-9525(00)02159-4; Tamames J, 2001, GENOME BIOL, V2; Thomarat F, 2004, J MOL EVOL, V59, P780, DOI 10.1007/s00239-004-2673-0; Van de Peer Y, 2000, GENE, V246, P1, DOI 10.1016/S0378-1119(00)00063-9; Vivares CP, 2000, CURR OPIN MICROBIOL, V3, P463, DOI 10.1016/S1369-5274(00)00123-5; Williams BAP, 2005, P NATL ACAD SCI USA, V102, P10936, DOI 10.1073/pnas.0501321102; Xu JS, 2006, INT J PARASITOL, V36, P1049, DOI [10.1016/j.ijpara.2006.04.010, 10.1016/j.ijpara.2006.09.010]; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhang QS, 2005, INFECT IMMUN, V73, P5166, DOI 10.1128/IAI.73.8.5166-5172.2005	41	41	71	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1277	10.1371/journal.pone.0001277	http://dx.doi.org/10.1371/journal.pone.0001277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060071	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459400024
J	Srividhya, KV; Alaguraj, V; Poornima, G; Kumar, D; Singh, GP; Raghavenderan, L; Katta, AVSKM; Mehta, P; Krishnaswamy, S				Srividhya, K. V.; Alaguraj, V.; Poornima, G.; Kumar, Dinesh; Singh, G. P.; Raghavenderan, L.; Katta, A. V. S. K. Mohan; Mehta, Preeti; Krishnaswamy, S.			Identification of Prophages in Bacterial Genomes by Dinucleotide Relative Abundance Difference	PLOS ONE			English	Article								Background. Prophages are integrated viral forms in bacterial genomes that have been found to contribute to interstrain genetic variability. Many virulence-associated genes are reported to be prophage encoded. Present computational methods to detect prophages are either by identifying possible essential proteins such as integrases or by an extension of this technique, which involves identifying a region containing proteins similar to those occurring in prophages. These methods suffer due to the problem of low sequence similarity at the protein level, which suggests that a nucleotide based approach could be useful. Methodology. Earlier dinucleotide relative abundance (DRA) have been used to identify regions, which deviate from the neighborhood areas, in genomes. We have used the difference in the dinucleotide relative abundance (DRAD) between the bacterial and prophage DNA to aid location of DNA stretches that could be of prophage origin in bacterial genomes. Prophage sequences which deviate from bacterial regions in their dinucleotide frequencies are detected by scanning bacterial genome sequences. The method was validated using a subset of genomes with prophage data from literature reports. A web interface for prophage scan based on this method is available at http://bicmku.in:8082/prophagedb/dra.html. Two hundred bacterial genomes which do not have annotated prophages have been scanned for prophage regions using this method. Conclusions. The relative dinucleotide distribution difference helps detect prophage regions in genome sequences. The usefulness of this method is seen in the identification of 461 highly probable loci pertaining to prophages which have not been annotated so earlier. This work emphasizes the need to extend the efforts to detect and annotate prophage elements in genome sequences.	[Srividhya, K. V.; Alaguraj, V.; Poornima, G.; Kumar, Dinesh; Singh, G. P.; Raghavenderan, L.; Katta, A. V. S. K. Mohan; Mehta, Preeti; Krishnaswamy, S.] Madurai Kamaraj Univ, Sch Biotechnol, Ctr Excellence Bioinformat, Madurai 625021, Tamil Nadu, India	Madurai Kamaraj University	Krishnaswamy, S (corresponding author), Madurai Kamaraj Univ, Sch Biotechnol, Ctr Excellence Bioinformat, Madurai 625021, Tamil Nadu, India.	krishna@mrna.tn.nic.in	Veluchamy, Alaguraj/AAW-1680-2020; Kalra, D/H-6661-2019; Singh, Gajinder/I-6062-2015	Veluchamy, Alaguraj/0000-0002-5349-5794; Kalra, D/0000-0001-5254-4067; Singh, Gajinder/0000-0002-3972-3324; Krishnaswamy, Sankaran/0000-0002-6797-4614	Dept of Biotechnology, Govt of India under CoE; CSIR	Dept of Biotechnology, Govt of India under CoE; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Bioinformatics facilities provided by Dept of Biotechnology, Govt of India under CoE. CSIR for fellowship to PM, KVS, AVSKKM, UGC for fellowship to VA. The funding organisation had no role in the design and conduct of the study; collection, analysis, interpretation of data; and in the preparation, review or approval of the manuscript.	Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Blaisdell BE, 1996, P NATL ACAD SCI USA, V93, P5854, DOI 10.1073/pnas.93.12.5854; Bose M., 2006, In Silico Biology, V6, P223; Boyd EF, 2001, TRENDS MICROBIOL, V9, P137, DOI 10.1016/S0966-842X(01)01960-6; Boyd EF, 2000, INFECT IMMUN, V68, P1507, DOI 10.1128/IAI.68.3.1507-1513.2000; Boyd EF, 2000, J BACTERIOL, V182, P5530, DOI 10.1128/JB.182.19.5530-5538.2000; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; CAMPBELL A, 2001, LYSOGENY ENCY LIFE S, P1; Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; CHITRA D, 2002, J BIOSCIENCE, V27, P27; Chiu CH, 2005, NUCLEIC ACIDS RES, V33, P1690, DOI 10.1093/nar/gki297; Covacci A, 1997, TRENDS MICROBIOL, V5, P205, DOI 10.1016/S0966-842X(97)01035-4; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; Garcia-Vallve S, 2003, NUCLEIC ACIDS RES, V31, P187, DOI 10.1093/nar/gkg004; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; KARLIN S, 1994, P NATL ACAD SCI USA, V91, P12837, DOI 10.1073/pnas.91.26.12837; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; KOEN AL, 1999, MICROBIOLOGY, V145, P3177; Lan RT, 1996, MOL BIOL EVOL, V13, P47, DOI 10.1093/oxfordjournals.molbev.a025569; Lerat E, 2002, MOL BIOL EVOL, V19, P964, DOI 10.1093/oxfordjournals.molbev.a004154; Li MR, 2003, APPL ENVIRON MICROB, V69, P1728, DOI 10.1128/AEM.69.3.1728-1738.2003; Makarov Vladimir, 2002, Brief Bioinform, V3, P195, DOI 10.1093/bib/3.2.195; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; RAO GV, 2005, GENOME BIOL, V6, P11; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Smith J, 2001, P ROY SOC B-BIOL SCI, V268, P61, DOI 10.1098/rspb.2000.1330; Sozhamannan S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-34; Srividhya KV, 2006, LECT NOTES CONTR INF, V344, P863; Tinsley CR, 2006, MICROBES INFECT, V8, P1365, DOI 10.1016/j.micinf.2005.12.013; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Wilson JW, 2002, POSTGRAD MED J, V78, P216, DOI 10.1136/pmj.78.918.216; Yoon SH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-184	47	38	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1193	10.1371/journal.pone.0001193	http://dx.doi.org/10.1371/journal.pone.0001193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030328	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459200007
J	Ayyar, S; Pistillo, D; Calleja, M; Brookfield, A; Gittins, K; Goldstone, C; Simpson, P				Ayyar, Savita; Pistillo, Daniela; Calleja, Manuel; Brookfield, Anna; Gittins, Kelly; Goldstone, Claire; Simpson, Pat			NF-kappa B/Rel-Mediated Regulation of the Neural Fate in Drosophila	PLOS ONE			English	Article								Two distinct roles are described for Dorsal, Dif and Relish, the three NF-kappa B/Rel proteins of Drosophila, in the development of the peripheral nervous system. First, these factors regulate transcription of scute during the singling out of sensory organ precursors from clusters of cells expressing the proneural genes achaete and scute. This effect is possibly mediated through binding sites for NF-kappa B/Rel proteins in a regulatory module of the scute gene required for maintenance of scute expression in precursors as well as repression in cells surrounding precursors. Second, genetic evidence suggests that the receptor Toll-8, Relish, Dif and Dorsal, and the caspase Dredd pathway are active over the entire imaginal disc epithelium, but Toll-8 expression is excluded from sensory organ precursors. Relish promotes rapid turnover of transcripts of the target genes scute and asense through an indirect, post-transcriptional mechanism. We propose that this buffering of gene expression levels serves to keep the neuro-epithelium constantly poised for neurogenesis.	[Ayyar, Savita; Pistillo, Daniela; Calleja, Manuel; Brookfield, Anna; Gittins, Kelly; Goldstone, Claire; Simpson, Pat] Univ Cambridge, Dept Zool, Cambridge, England; [Calleja, Manuel] Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain	University of Cambridge; Autonomous University of Madrid	Simpson, P (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	pas49@cam.ac.uk	Pistillo, Daniela/AAC-2367-2020	Pistillo, Daniela/0000-0002-7665-3783; Ayyar, Savita/0000-0002-6323-7211	The Wellcome Trust [29156]	The Wellcome Trust(Wellcome TrustEuropean Commission)	The Wellcome Trust [29156]	Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BRAND M, 1993, DEVELOPMENT, V119, P1; Calleja M, 2002, GENE, V292, P1, DOI 10.1016/S0378-1119(02)00628-5; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; CAMPUZANO S, 1986, CELL, V44, P303, DOI 10.1016/0092-8674(86)90764-6; Cantera R, 1999, J NEUROBIOL, V38, P16, DOI 10.1002/(SICI)1097-4695(199901)38:1<16::AID-NEU2>3.0.CO;2-0; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Culi J, 1998, GENE DEV, V12, P2036, DOI 10.1101/gad.12.13.2036; DELIDAKIS C, 1991, GENETICS, V129, P803; DOMINGUEZ M, 1993, EMBO J, V12, P2049, DOI 10.1002/j.1460-2075.1993.tb05854.x; Dubnicoff T, 1997, GENE DEV, V11, P2952, DOI 10.1101/gad.11.22.2952; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; GONZALEZ F, 1989, EMBO J, V8, P3553, DOI 10.1002/j.1460-2075.1989.tb08527.x; GONZALEZCRESPO S, 1993, GENE DEV, V7, P1703, DOI 10.1101/gad.7.9.1703; Han ZS, 1999, J BIOL CHEM, V274, P21355, DOI 10.1074/jbc.274.30.21355; Heitzler P, 1996, DEVELOPMENT, V122, P161; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Jafar-Nejad H, 2003, GENE DEV, V17, P2966, DOI 10.1101/gad.1122403; JARMAN AP, 1993, DEVELOPMENT, V119, P19; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Jimenez G, 1997, MOL CELL BIOL, V17, P4355, DOI 10.1128/MCB.17.8.4355; Kambris Zakaria, 2002, Gene Expression Patterns, V2, P311, DOI 10.1016/S1567-133X(02)00020-0; Kim S, 2006, GENESIS, V44, P541, DOI 10.1002/dvg.20245; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Lai EC, 2003, GENETICS, V163, P1413; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Loercher A, 2004, CANCER RES, V64, P6511, DOI 10.1158/0008-5472.CAN-04-0852; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Ratnaparkhi GS, 2006, DEVELOPMENT, V133, P4409, DOI 10.1242/dev.02643; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; Seppo A, 2003, DEVELOPMENT, V130, P1439, DOI 10.1242/dev.00347; Sitcheran R, 2003, GENE DEV, V17, P2368, DOI 10.1101/gad.1114503; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; Stein D, 1998, DEVELOPMENT, V125, P2159; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Valentine SA, 1998, MOL CELL BIOL, V18, P6584, DOI 10.1128/MCB.18.11.6584; Wu LP, 1998, NATURE, V392, P93, DOI 10.1038/32195	42	24	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1178	10.1371/journal.pone.0001178	http://dx.doi.org/10.1371/journal.pone.0001178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000549	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459100020
J	Loffredo, JT; Friedrich, TC; Leon, EJ; Stephany, JJ; Rodrigues, DS; Spencer, SP; Bean, AT; Beal, DR; Burwitz, BJ; Rudersdorf, RA; Wallace, LT; Piaskowski, SM; May, GE; Sidney, J; Gostick, E; Wilson, NA; Price, DA; Kallas, EG; Piontkivska, H; Hughes, AL; Sette, A; Watkins, DI				Loffredo, John T.; Friedrich, Thomas C.; Leon, Enrique J.; Stephany, Jason J.; Rodrigues, Denise S.; Spencer, Sean P.; Bean, Alex T.; Beal, Dominic R.; Burwitz, Benjamin J.; Rudersdorf, Richard A.; Wallace, Lyle T.; Piaskowski, Shari M.; May, Gemma E.; Sidney, John; Gostick, Emma; Wilson, Nancy A.; Price, David A.; Kallas, Esper G.; Piontkivska, Helen; Hughes, Austin L.; Sette, Alessandro; Watkins, David I.			CD8(+) T Cells from SIV Elite Controller Macaques Recognize Mamu-B*08-Bound Epitopes and Select for Widespread Viral Variation	PLOS ONE			English	Article								Background. It is generally accepted that CD8(+) T cell responses play an important role in control of immunodeficiency virus replication. The association of HLA-B27 and -B57 with control of viremia supports this conclusion. However, specific correlates of viral control in individuals expressing these alleles have been difficult to define. We recently reported that transient in vivo CD8(+) cell depletion in simian immunodeficiency virus (SIV)-infected elite controller (EC) macaques resulted in a brief period of viral recrudescence. SIV replication was rapidly controlled with the reappearance of CD8(+) cells, implicating that these cells actively suppress viral replication in ECs. Methods and Findings. Here we show that three ECs in that study made at least seven robust CD8(+) T cell responses directed against novel epitopes in Vif, Rev, and Nef restricted by the MHC class I molecule Mamu-B*08. Two of these Mamu-B*08-positive animals subsequently lost control of SIV replication. Their breakthrough virus harbored substitutions in multiple Mamu-B*08-restricted epitopes. Indeed, we found evidence for selection pressure mediated by Mamu-B*08-restricted CD8(+) T cells in all of the newly identified epitopes in a cohort of chronically infected macaques. Conclusions. Together, our data suggest that Mamu-B*08-restricted CD8(+) T cell responses effectively control replication of pathogenic SIV(mac)239. All seven regions encoding Mamu-B*08-restricted CD8(+) T cell epitopes also exhibit amino acid replacements typically seen only in the presence of Mamu-B*08, suggesting that the variation we observe is indeed selected by CD8(+) T cell responses. SIVmac239 infection of Indian rhesus macaques expressing Mamu-B*08 may therefore provide an animal model for understanding CD8(+) T cell-mediated control of HIV replication in humans.	[Loffredo, John T.; Friedrich, Thomas C.; Leon, Enrique J.; Stephany, Jason J.; Rodrigues, Denise S.; Spencer, Sean P.; Bean, Alex T.; Beal, Dominic R.; Burwitz, Benjamin J.; Rudersdorf, Richard A.; Wallace, Lyle T.; May, Gemma E.; Wilson, Nancy A.; Watkins, David I.] Univ Wisconsin, WNPRC, Madison, WI 53706 USA; [Rodrigues, Denise S.; Kallas, Esper G.] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil; [Piaskowski, Shari M.; Watkins, David I.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Sidney, John; Sette, Alessandro] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Gostick, Emma; Price, David A.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Piontkivska, Helen] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Hughes, Austin L.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of Wisconsin System; University of Wisconsin Madison; Universidade Federal de Sao Paulo (UNIFESP); University of Wisconsin System; University of Wisconsin Madison; La Jolla Institute for Immunology; University of Oxford; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Loffredo, JT (corresponding author), Univ Wisconsin, WNPRC, Madison, WI 53706 USA.	loffredo@primate.wisc.edu	Sette, Alessandro/AFO-8916-2022; Kallas, Esper G/C-9539-2012; Price, David A/C-7876-2013	Price, David A/0000-0001-9416-2737; Friedrich, Thomas/0000-0001-9831-6895; Wallace, Lyle/0000-0002-6985-5854; Kallas, Esper/0000-0003-2026-6925; Spencer, Sean/0000-0002-7328-5399; Wilson, Nancy/0000-0002-9472-6026	National Institutes of Health (NIH) [HHSN266200400088C, R01 AI049120, R01 AI052056, R24 RR015371, R24 RR016038, R21 AI068586]; National Center for Research Resources (NCRR) [P51 RR000167]; Japan Health Sciences Foundation [GM43940]; Kent State University Research Council; Ohio Board of Regents Research Challenge; Research Facilities Improvement [RR15459-01, RR020141-01]; MRC [G0501963] Funding Source: UKRI; Medical Research Council [G0501963] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR015371, C06RR020141, R24RR016038, P51RR000167, C06RR015459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI068586, R01AI049120, R01AI052056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043940] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Japan Health Sciences Foundation; Kent State University Research Council; Ohio Board of Regents Research Challenge; Research Facilities Improvement(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (NIH) contract HHSN266200400088C, NIH grants R01 AI049120, R01 AI052056, R24 RR015371, and R24 RR016038 to D. I. W. as well as R21 AI068586 to T. C. F. Additionally, this publication was made possible in part by grant number P51 RR000167 from the National Center for Research Resources (NCRR), a component of the NIH, awarded to the WNPRC. This project has also been funded in part by a grant from the Japan Health Sciences Foundation to D. I. W., NIH grant GM43940 to A. L. H., and support to H. P. through the Kent State University Research Council and Ohio Board of Regents Research Challenge Grant. D. A. P. is a Medical Research Council (UK) Senior Clinical Fellow. This work was conducted in part at a facility constructed with support from Research Facilities Improvement grant numbers RR15459-01 and RR020141-01 (WNPRC). This publication's contents are solely the responsibility of the authors and do not necessarily represent the official views of NCRR or NIH.	Alexander L, 2000, J VIROL, V74, P4361, DOI 10.1128/JVI.74.9.4361-4376.2000; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001; Barassi C, 2004, BLOOD, V104, P2205, DOI 10.1182/blood-2004-06-2134; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Boyson JE, 1996, J IMMUNOL, V156, P4656; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Cline AN, 2005, J MED PRIMATOL, V34, P303; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Dzuris JL, 2000, J IMMUNOL, V164, P283, DOI 10.4049/jimmunol.164.1.283; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; Evans DT, 2000, J VIROL, V74, P7400, DOI 10.1128/JVI.74.16.7400-7410.2000; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Friedrich TC, 2004, J VIROL, V78, P10064, DOI 10.1128/JVI.78.18.10064-10073.2004; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Harrer T, 1996, AIDS RES HUM RETROV, V12, P585, DOI 10.1089/aid.1996.12.585; Harrer T, 1996, J IMMUNOL, V156, P2616; Hendel H, 1999, J IMMUNOL, V162, P6942; Herberts CA, 2006, J IMMUNOL, V176, P2697, DOI 10.4049/jimmunol.176.5.2697; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Hughes AL, 2005, BIOINFORMATICS, V21, P39, DOI 10.1093/bioinformatics/bti1203; Hughes AL, 2006, CURR GENOMICS, V7, P227, DOI 10.2174/138920206778426942; Hutchinson SL, 2003, J BIOL CHEM, V278, P24285, DOI 10.1074/jbc.M300633200; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaizu M, 2007, IMMUNOGENETICS, V59, P693, DOI 10.1007/s00251-007-0233-7; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Keet IPM, 1999, J INFECT DIS, V180, P299, DOI 10.1086/314862; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; KOENIG WJ, 1995, PLAST RECONSTR SURG, V95, P1; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Liu HL, 2004, J INFECT DIS, V190, P1055, DOI 10.1086/423209; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Loffredo JT, 2007, J VIROL, V81, P2624, DOI 10.1128/JVI.01912-06; Loffredo JT, 2005, J IMMUNOL, V175, P5986, DOI 10.4049/jimmunol.175.9.5986; Loffredo JT, 2004, J IMMUNOL, V173, P5064, DOI 10.4049/jimmunol.173.8.5064; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Mao HW, 2005, J VIROL, V79, P14887, DOI 10.1128/JVI.79.23.14887-14898.2005; Marsh SG, 2000, HLA FACTS BOOK; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2003, J VIROL, V77, P6889, DOI 10.1128/JVI.77.12.6889-6898.2003; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Mothe BR, 2002, J IMMUNOL, V169, P210, DOI 10.4049/jimmunol.169.1.210; Muhl T, 2002, J IMMUNOL, V169, P3438, DOI 10.4049/jimmunol.169.6.3438; NEI M, 1986, MOL BIOL EVOL, V3, P418; O'Connor DH, 2003, J VIROL, V77, P9029, DOI 10.1128/JVI.77.16.9029-9040.2003; O'Connor DH, 2002, NAT MED, V8, P493, DOI 10.1038/nm0502-493; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Pastori C, 2006, BLOOD, V107, P4825, DOI 10.1182/blood-2005-06-2463; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; REIMANN KA, 1994, J VIROL, V68, P2362, DOI 10.1128/JVI.68.4.2362-2370.1994; Rhodes DI, 2000, J VIROL, V74, P10581, DOI 10.1128/JVI.74.22.10581-10588.2000; Robinson S, 2001, J VIROL, V75, P10179, DOI 10.1128/JVI.75.21.10179-10186.2001; Salvi R, 1998, J VIROL, V72, P3646, DOI 10.1128/JVI.72.5.3646-3657.1998; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SHIMIZU Y, 1986, MOL CELL BIOL, V6, P1074, DOI 10.1128/MCB.6.4.1074; Soriano A, 2002, J INFECT DIS, V186, P922, DOI 10.1086/343741; Vogel TU, 2002, J VIROL, V76, P11623, DOI 10.1128/JVI.76.22.11623-11636.2002; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; Zhang ZQ, 2002, J VIROL, V76, P12845, DOI 10.1128/JVI.76.24.12845-12854.2002	82	69	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1152	10.1371/journal.pone.0001152	http://dx.doi.org/10.1371/journal.pone.0001152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000532	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000207459100001
J	Aerts, S; van Helden, J; Sand, O; Hassan, BA				Aerts, Stein; van Helden, Jacques; Sand, Olivier; Hassan, Bassem A.			Fine-Tuning Enhancer Models to Predict Transcriptional Targets across Multiple Genomes	PLOS ONE			English	Article							CIS-REGULATORY MODULES; FACTOR-BINDING SITES; PRONEURAL GENE; DROSOPHILA; DISCOVERY; MOTIFS; IDENTIFICATION; BROWSER; CLUSTERS; ELEMENTS	Networks of regulatory relations between transcription factors (TF) and their target genes (TG)-implemented through TF binding sites (TFBS)- are key features of biology. An idealized approach to solving such networks consists of starting from a consensus TFBS or a position weight matrix (PWM) to generate a high accuracy list of candidate TGs for biological validation. Developing and evaluating such approaches remains a formidable challenge in regulatory bioinformatics. We perform a benchmark study on 34 Drosophila TFs to assess existing TFBS and cis-regulatory module (CRM) detection methods, with a strong focus on the use of multiple genomes. Particularly, for CRM-modelling we investigate the addition of orthologous sites to a known PWM to construct phyloPWMs and we assess the added value of phylogenentic footprinting to predict contextual motifs around known TFBSs. For CRM-prediction, we compare motif conservation with network-level conservation approaches across multiple genomes. Choosing the optimal training and scoring strategies strongly enhances the performance of TG prediction for more than half of the tested TFs. Finally, we analyse a 35(th) TF, namely Eyeless, and find a significant overlap between predicted TGs and candidate TGs identified by microarray expression studies. In summary we identify several ways to optimize TF-specific TG predictions, some of which can be applied to all TFs, and others that can be applied only to particular TFs. The ability to model known TF-TG relations, together with the use of multiple genomes, results in a significant step forward in solving the architecture of gene regulatory networks.	[Aerts, Stein; Hassan, Bassem A.] Vlaams Inst Biotechnol VIB, Dept Mol & Dev Genet, Neurogenet Lab, Leuven, Belgium; [Aerts, Stein; Hassan, Bassem A.] KU Leuven Sch Med, Dept Human Genet, Leuven, Belgium; [van Helden, Jacques; Sand, Olivier] Univ Libre Bruxelles, Dept Mol Biol, Serv Conformat Macromol Biol & Bioinformat, Brussels, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Universite Libre de Bruxelles	Aerts, S (corresponding author), Vlaams Inst Biotechnol VIB, Dept Mol & Dev Genet, Neurogenet Lab, Leuven, Belgium.	stein.aerts@med.kuleuven.be; bassem.hassan@med.kuleuven.be	van Helden, Jacques/D-8590-2013; Aerts, Stein/A-1100-2009; Hassan, Bassem A/D-5221-2012	van Helden, Jacques/0000-0002-8799-8584; Aerts, Stein/0000-0002-8006-0315; Hassan, Bassem A/0000-0001-9533-4908; Sand, Olivier/0000-0003-1465-1640	FWO; VIB; University of Leuven; European Communities [LSHG-CT-2003-503265]; Belgian Fonds de la Recherche Fondamentale Collective; Fonds d'Encouragement a la Recherche	FWO(FWO); VIB; University of Leuven(KU Leuven); European Communities(European Commission); Belgian Fonds de la Recherche Fondamentale Collective(Fonds de la Recherche Scientifique - FNRS); Fonds d'Encouragement a la Recherche	This research was funded by an FWO (Fund for Scientific Research, Flanders) postdoctoral fellowship (to SA) as well as VIB, a Concerted Research Action (GOA) grant and an Impuls grant from University of Leuven (to BAH). BioSapiens Network of excellence funded under the sixth Framework program of the European Communities (LSHG-CT-2003-503265 to JvH). Linux clusters were used from KUL and SMBCC, the latter funded by the Belgian Fonds de la Recherche Fondamentale Collective and the Fonds d'Encouragement a la Recherche.	Adryan B, 2006, BIOINFORMATICS, V22, P1532, DOI 10.1093/bioinformatics/btl143; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Aerts S, 2003, NUCLEIC ACIDS RES, V31, P1753, DOI 10.1093/nar/gkg268; Bailey TL, 2003, BIOINFORMATICS, V19, pII16, DOI 10.1093/bioinformatics/btg1054; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Chan BY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-262; Chang LW, 2006, GENOME RES, V16, P405, DOI 10.1101/gr.4303406; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; DAVIDSON EH, 2001, GENOMIC REGULATORY S, P261; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1315, DOI 10.1038/nbt1004-1315; Emberly E, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-57; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Gallo SM, 2006, BIOINFORMATICS, V22, P381, DOI 10.1093/bioinformatics/bti794; Halfon MS, 2002, GENOME RES, V12, P1019, DOI 10.1101/gr.228902; Hassan BA, 2000, NEURON, V25, P549, DOI 10.1016/S0896-6273(00)81059-4; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Johansson O, 2003, BIOINFORMATICS, V19, pi169, DOI 10.1093/bioinformatics/btg1021; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; King DC, 2007, GENOME RES, V17, P775, DOI 10.1101/gr.5592107; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Ochoa-Espinosa A, 2005, P NATL ACAD SCI USA, V102, P4960, DOI 10.1073/pnas.0500373102; Ostrin EJ, 2006, GENOME RES, V16, P466, DOI 10.1101/gr.4673006; Philippakis AA, 2006, PLOS COMPUT BIOL, V2, P439, DOI 10.1371/journal.pcbi.0020053; Pritsker M, 2004, GENOME RES, V14, P99; Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30; Rebeiz M, 2002, P NATL ACAD SCI USA, V99, P9888, DOI 10.1073/pnas.152320899; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Segal E, 2005, J COMPUT BIOL, V12, P822, DOI 10.1089/cmb.2005.12.822; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Siepel A., 2005, STAT METHODS MOL EVO; Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-129; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sun Y, 1998, DEVELOPMENT, V125, P3731; Taverner NV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-210; Thijs G, 2002, J COMPUT BIOL, V9, P447, DOI 10.1089/10665270252935566; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Zhang TY, 2006, DEVELOPMENT, V133, P4881, DOI 10.1242/dev.02669; zur Lage PI, 2004, DEV CELL, V7, P687, DOI 10.1016/j.devcel.2004.09.015	51	24	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1115	10.1371/journal.pone.0001115	http://dx.doi.org/10.1371/journal.pone.0001115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17973026	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459000003
J	Acquisti, C; Poste, G; Curtiss, D; Kumar, S				Acquisti, Claudia; Poste, George; Curtiss, David; Kumar, Sudhir			Nullomers: Really a Matter of Natural Selection?	PLOS ONE			English	Article								Background. Nullomers are short DNA sequences that are absent from the genomes of humans and other species. Assuming that nullomers are the signatures of natural selection against deleterious sequences in humans, the use of nullomers in drug target identification, pesticide development, environmental monitoring, and forensic applications has been envisioned. Results. Here, we show that the hypermutability of CpG dinucleotides, rather than the natural selection against the nullomer sequences, is likely the reason for the phenomenal event of short sequence motifs becoming nullomers. Furthermore, many reported human nullomers differ by only one nucleotide, which reinforces the role of mutation in the evolution of the constellation of nullomers in populations and species. The known nullomers in chimpanzee, cow, dog, and mouse genomes show patterns that are consistent with those seen in humans. Conclusions. The role of mutations, instead of selection, in generating nullomers cast doubt on the utility of nullomers in many envisioned applications, because of their dependence on the role of lethal selection on the origin of nullomers.	[Acquisti, Claudia; Curtiss, David; Kumar, Sudhir] Arizona State Univ, Ctr Evolutionary Funct Gen, Tempe, AZ 85287 USA; [Acquisti, Claudia; Poste, George; Kumar, Sudhir] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Acquisti, Claudia; Poste, George; Kumar, Sudhir] Arizona State Univ, Biodesign Inst, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Kumar, S (corresponding author), Arizona State Univ, Ctr Evolutionary Funct Gen, Tempe, AZ 85287 USA.	s.kumar@asu.edu	Kumar, Sudhir/F-1411-2011	Kumar, Sudhir/0000-0002-9918-8212	National Institutes of Health and National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002096] Funding Source: NIH RePORTER	National Institutes of Health and National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding: This work was supported in part by research grants from National Institutes of Health and National Science Foundation (SK).	Fofanov Y, 2004, BIOINFORMATICS, V20, P2421, DOI 10.1093/bioinformatics/bth266; GEDDES L, 2007, NEW SCI, V2585, P12; Gentles AJ, 2001, GENOME RES, V11, P540, DOI 10.1101/gr.163101; Hampikian G, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P355; Haubold B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-123; JOSSE J, 1961, J BIOL CHEM, V236, P864; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Subramanian S, 2003, GENOME RES, V13, P838, DOI 10.1101/gr.1152803; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692	9	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1022	10.1371/journal.pone.0001022	http://dx.doi.org/10.1371/journal.pone.0001022			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925870	Green Published, gold			2022-12-27	WOS:000207456000021
J	Bielaszewska, M; Kock, R; Friedrich, AW; von Eiff, C; Zimmerhackl, LB; Karch, H; Mellmann, A				Bielaszewska, Martina; Koeck, Robin; Friedrich, Alexander W.; von Eiff, Christof; Zimmerhackl, Lothar B.; Karch, Helge; Mellmann, Alexander			Shiga Toxin-Mediated Hemolytic Uremic Syndrome: Time to Change the Diagnostic Paradigm?	PLOS ONE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; ENCODING BACTERIOPHAGES; BACTERIAL GENOTYPES; UNITED-STATES; IN-VITRO; O157-H7; GENE; INFECTION; STRAINS; SEROPATHOTYPES	Background. Hemolytic uremic syndrome (HUS) is caused by enterohemorrhagic Escherichia coli (EHEC) which possess genes encoding Shiga toxin (stx), the major virulence factor, and adhesin intimin (eae). However, the frequency of stx-negative/eae-positive E. coli in stools of HUS patients and the clinical significance of such strains are unknown. Methodology/Principal Findings. Between 1996 and 2006, we sought stx-negative/eae-positive E. coli in stools of HUS patients using colony blot hybridization with the eae probe and compared the isolates to EHEC causing HUS. stx-negative/eae-positive E. coli were isolated as the only pathogens from stools of 43 (5.5%) of 787 HUS patients; additional 440 (55.9%) patients excreted EHEC. The majority (90.7%) of the stx-negative/eae-positive isolates belonged to serotypes O26: H11/NM (nonmotile), O103:H2/NM, O145:H28/NM, and O157:H7/NM, which were also the most frequent serotypes identified among EHEC. The stx-negative isolates shared non-stx virulence and fitness genes with EHEC of the corresponding serotypes and clustered with them into the same clonal complexes in multilocus sequence typing, demonstrating their close relatedness to EHEC. Conclusions/Significance. At the time of microbiological analysis, similar to 5% of HUS patients shed no longer the causative EHEC, but do excrete stx-negative derivatives of EHEC that lost stx during infection. In such patients, the EHEC etiology of HUS is missed using current methods detecting solely stx or Shiga toxin; this can hamper epidemiological investigations and lead to inappropriate clinical management. While maintaining the paradigm that HUS is triggered by Shiga toxin, our data demonstrate the necessity of considering genetic changes of the pathogen during infection to adapt appropriately diagnostic strategies.	[Bielaszewska, Martina; Koeck, Robin; Friedrich, Alexander W.; Karch, Helge; Mellmann, Alexander] Univ Munster, Inst Hyg, Munster, Germany; [Bielaszewska, Martina; Koeck, Robin; Friedrich, Alexander W.; Karch, Helge; Mellmann, Alexander] Univ Munster, Natl Consulting Lab Hemolyt Urem Syndrome, Munster, Germany; [von Eiff, Christof] Univ Munster, Inst Med Microbiol, Munster, Germany; [Zimmerhackl, Lothar B.] Univ Innsbruck Hosp, Dept Pediat, A-6020 Innsbruck, Austria	University of Munster; University of Munster; University of Munster; Medical University of Innsbruck	Bielaszewska, M (corresponding author), Univ Munster, Inst Hyg, Munster, Germany.	mbiela@uni-muenster.de	Friedrich, Alex/ABG-9823-2020; Köck, Robin/AAC-1552-2019; Bielaszewska, Martina/AAC-9812-2022	Mellmann, Alexander/0000-0002-0649-5185	Interdisciplinary Center of Clinical Research (IZKF) Munster [Ka2/061/04]; EU [LSHB-CT-2005-512061, 0313937C]	Interdisciplinary Center of Clinical Research (IZKF) Munster; EU(European Commission)	Funding: This study was supported by a grant from the Interdisciplinary Center of Clinical Research (IZKF) Munster (project no. Ka2/061/04), by a grant from the EU Network of Excellence EuroPathoGenomic (number LSHB-CT-2005-512061), and by a grant from the EU Network ERA-NET PathoGenoMics (project number 0313937C). The funders had no role in study design, data collection, analysis, and interpretation, decision to publish, or preparation, review or approval of the manuscript.	Ake JA, 2005, PEDIATRICS, V115, pE673, DOI 10.1542/peds.2004-2236; Banatvala N, 2001, J INFECT DIS, V183, P1063, DOI 10.1086/319269; Beutin L, 2003, INFECT IMMUN, V71, P3995, DOI 10.1128/IAI.71.7.3995-4002.2003; Bielaszewska M, 2006, APPL ENVIRON MICROB, V72, P1900, DOI 10.1128/AEM.72.3.1900-1909.2006; Bielaszewska M, 2005, J CLIN MICROBIOL, V43, P4225, DOI 10.1128/JCM.43.8.4225-4228.2005; Bielaszewska M, 2005, J CLIN MICROBIOL, V43, P452, DOI 10.1128/JCM.43.1.452-454.2005; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Bielaszewska M, 2006, CLIN INFECT DIS, V43, P1160, DOI 10.1086/508195; Bockemuhl J., 2003, MANUAL CLIN MICROBIO, P672; Bokete TN, 1997, J INFECT DIS, V175, P1382, DOI 10.1086/516470; Bopp CA, 2003, MANUAL CLIN MICROBIO, P654; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; CIMOLAI N, 1994, CLIN NEPHROL, V42, P85; Creuzburg K, 2005, MICROBIOL-SGM, V151, P941, DOI 10.1099/mic.0.27632-0; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1418, DOI 10.1172/JCI116718; Elliott EJ, 2001, ARCH DIS CHILD, V85, P125, DOI 10.1136/adc.85.2.125; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Friedrich AW, 2007, CLIN INFECT DIS, V45, P39, DOI 10.1086/518573; Friedrich AW, 2004, J CLIN MICROBIOL, V42, P4697, DOI 10.1128/JCM.42.10.4697-4701.2004; Gerber A, 2002, J INFECT DIS, V186, P493, DOI 10.1086/341940; Janka A, 2003, INFECT IMMUN, V71, P3634, DOI 10.1128/IAI.71.6.3634-3638.2003; Janka A, 2002, INT J MED MICROBIOL, V292, P207, DOI 10.1078/1438-4221-00206; Jelacic JK, 2003, J INFECT DIS, V188, P719, DOI 10.1086/376999; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; Karch H, 1999, INFECT IMMUN, V67, P5994, DOI 10.1128/IAI.67.11.5994-6001.1999; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Klein EJ, 2002, J PEDIATR-US, V141, P172, DOI 10.1067/mpd.2002.125908; Lynn RM, 2005, EMERG INFECT DIS, V11, P590, DOI 10.3201/eid1104.040833; Mellmann A, 2005, CLIN INFECT DIS, V41, P785, DOI 10.1086/432722; Nachamkin I., 2003, MANUAL CLIN MICROBIO, P902; Park CH, 2002, J CLIN MICROBIOL, V40, P3542, DOI 10.1128/JCM.40.9.3542-3543.2002; Paton AW, 2001, INFECT IMMUN, V69, P6999, DOI 10.1128/IAI.69.11.6999-7009.2001; Prager R, 2003, INT J MED MICROBIOL, V292, P477, DOI 10.1078/1438-4221-00226; RICHARDSON SE, 1988, HUM PATHOL, V19, P1102, DOI 10.1016/S0046-8177(88)80093-5; Sandvig K, 2001, TOXICON, V39, P1629, DOI 10.1016/S0041-0101(01)00150-7; Shaikh N, 2003, J BACTERIOL, V185, P3596, DOI 10.1128/JB.185.12.3596-3605.2003; Siegler RL, 2003, JAMA-J AM MED ASSOC, V290, P1379, DOI 10.1001/jama.290.10.1379; Sonntag AK, 2004, J CLIN MICROBIOL, V42, P954, DOI 10.1128/JCM.42.3.954-962.2004; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; TARR PI, 1990, J INFECT DIS, V162, P553, DOI 10.1093/infdis/162.2.553; Toma C, 2004, J CLIN MICROBIOL, V42, P4937, DOI 10.1128/JCM.42.11.4937-4946.2004; Tozzi AE, 2003, EMERG INFECT DIS, V9, P106, DOI 10.3201/eid0901.020266; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Zhang WL, 2007, INT J MED MICROBIOL, V297, P17, DOI 10.1016/j.ijmm.2006.10.004; Zhang WL, 2002, J CLIN MICROBIOL, V40, P4486, DOI 10.1128/JCM.40.12.4486-4492.2002; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239; Zimmerhackl LB, 2000, NEW ENGL J MED, V342, P1990, DOI 10.1056/NEJM200006293422611	49	112	118	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1024	10.1371/journal.pone.0001024	http://dx.doi.org/10.1371/journal.pone.0001024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925872	Green Submitted, Green Published, gold			2022-12-27	WOS:000207456000023
J	Little, TJ; Nelson, L; Hupp, T				Little, Tom J.; Nelson, Lenny; Hupp, Ted			Adaptive Evolution of a Stress Response Protein	PLOS ONE			English	Article								Background. Some cancers are mediated by an interplay between tissue damage, pathogens and localised innate immune responses, but the mechanisms that underlie these linkages are only beginning to be unravelled. Methods and Principal Findings. Here we identify a strong signature of adaptive evolution on the DNA sequence of the mammalian stress response gene SEP53, a member of the epidermal differentiation complex fused-gene family known for its role in suppressing cancers. The SEP53 gene appears to have been subject to adaptive evolution of a type that is commonly (though not exclusively) associated with coevolutionary arms races. A similar pattern of molecular evolution was not evident in the p53 cancer-suppressing gene. Conclusions. Our data thus raises the possibility that SEP53 is a component of the mucosal/epithelial innate immune response engaged in an ongoing interaction with a pathogen. Although the pathogenic stress mediating adaptive evolution of SEP53 is not known, there are a number of well-known candidates, in particular viruses with established links to carcinoma.	[Little, Tom J.] Univ Edinburgh, Sch Biol, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Nelson, Lenny; Hupp, Ted] Univ Edinburgh, CRUK Signal Transduct Grp P53, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Little, TJ (corresponding author), Univ Edinburgh, Sch Biol, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	tlittle1@staffmail.ed.ac.uk	Little, Tom J/B-7890-2009	Little, Tom J/0000-0002-8945-0416	Cancer Research UK; International Association for Cancer Research; Wellcome Trust; MRC Human Genetics Unit, Edinburgh	Cancer Research UK(Cancer Research UK); International Association for Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); MRC Human Genetics Unit, Edinburgh(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank John Maule of the MRC Human Genetics Unit, Edinburgh for technical advice and support. Andrew Rambaut, Phillipe Lemey, Darren Obbard and Brian Charlesworth provided advice on analysis and discussion.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BLAKE MJ, 1990, J BIOL CHEM, V265, P15275; BLAKE MJ, 1991, AM J PHYSIOL, V260, pR663, DOI 10.1152/ajpregu.1991.260.4.R663; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P141, DOI 10.1016/S0167-5699(98)01413-3; Chae SW, 2004, GASTROENTEROLOGY, V126, pA33; CLARK NL, 2005, PLOS BIOL, V1; Contzler R, 2005, J INVEST DERMATOL, V124, P990, DOI 10.1111/j.0022-202X.2005.23694.x; Cox JT, 2006, CURR OPIN OBSTET GYN, V18, pS5, DOI 10.1097/01.gco.0000216315.72572.fb; Darragh J, 2006, FEBS J, V273, P1930, DOI 10.1111/j.1742-4658.2006.05206.x; Eckmann L, 2005, SPRINGER SEMIN IMMUN, V27, P181, DOI 10.1007/s00281-005-0207-5; Ford MJ, 2002, MOL ECOL, V11, P1245, DOI 10.1046/j.1365-294X.2002.01536.x; Hopwood D, 1997, GUT, V41, P156, DOI 10.1136/gut.41.2.156; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Iimura M, 2005, J IMMUNOL, V174, P4901, DOI 10.4049/jimmunol.174.8.4901; Imai FL, 2005, INT J BIOCHEM CELL B, V37, P1641, DOI 10.1016/j.biocel.2005.02.005; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; KOSAKOVSKYPOND SL, 2005, BIOINFORMATICS, V21, P675; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Lakhotia SC, 1996, EXPERIENTIA, V52, P751, DOI 10.1007/BF01923984; Li WH, 2005, NATURE, V437, P50, DOI 10.1038/437050a; Little TJ, 2005, INSECT MOL BIOL, V14, P599, DOI 10.1111/j.1365-2583.2005.00588.x; Little TJ, 2004, J MOL EVOL, V59, P498, DOI 10.1007/s00239-004-2641-8; MACDONALD JH, 1991, NATURE, V351, P652; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Obbard DJ, 2007, MOL ECOL, V16, P3497, DOI 10.1111/j.1365-294X.2007.03395.x; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schlenke TA, 2003, GENETICS, V164, P1471; Snijders PJF, 2006, J PATHOL, V208, P152, DOI 10.1002/path.1866; Wyckoff GJ, 2005, TRENDS GENET, V21, P381, DOI 10.1016/j.tig.2005.05.005; Yagui-Beltran A, 2001, EUR J BIOCHEM, V268, P5343, DOI 10.1046/j.0014-2956.2001.02468.x; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	39	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1003	10.1371/journal.pone.0001003	http://dx.doi.org/10.1371/journal.pone.0001003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925851	Green Published, gold			2022-12-27	WOS:000207456000002
J	Lee, I; Li, ZH; Marcotte, EM				Lee, Insuk; Li, Zhihua; Marcotte, Edward M.			An Improved, Bias-Reduced Probabilistic Functional Gene Network of Baker's Yeast, Saccharomyces cerevisiae	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; GENOME-WIDE PREDICTION; 60S RIBOSOMAL-SUBUNITS; GLOBAL ANALYSIS; DATABASE; EXPRESSION; COMPLEXES; RNA; TRANSLATION; DISCOVERY	Background. Probabilistic functional gene networks are powerful theoretical frameworks for integrating heterogeneous functional genomics and proteomics data into objective models of cellular systems. Such networks provide syntheses of millions of discrete experimental observations, spanning DNA microarray experiments, physical protein interactions, genetic interactions, and comparative genomics; the resulting networks can then be easily applied to generate testable hypotheses regarding specific gene functions and associations. Methodology/Principal Findings. We report a significantly improved version (v. 2) of a probabilistic functional gene network [1] of the baker's yeast, Saccharomyces cerevisiae. We describe our optimization methods and illustrate their effects in three major areas: the reduction of functional bias in network training reference sets, the application of a probabilistic model for calculating confidences in pair-wise protein physical or genetic interactions, and the introduction of simple thresholds that eliminate many false positive mRNA co-expression relationships. Using the network, we predict and experimentally verify the function of the yeast RNA binding protein Puf6 in 60S ribosomal subunit biogenesis. Conclusions/Significance. YeastNet v. 2, constructed using these optimizations together with additional data, shows significant reduction in bias and improvements in precision and recall, in total covering 102,803 linkages among 5,483 yeast proteins (95% of the validated proteome). YeastNet is available from http://www.yeastnet.org.	[Lee, Insuk; Li, Zhihua; Marcotte, Edward M.] Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Mol & Cellular Biol, Austin, TX 78712 USA; [Marcotte, Edward M.] Univ Texas Austin, Dept Chem & Biochem, Inst Mol & Cellular Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Marcotte, EM (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Mol & Cellular Biol, Austin, TX 78712 USA.	marcotte@icmb.utexas.edu	Li, ZhiHua/GYU-9914-2022; Lee, Insuk/F-7722-2010; li, zh/HII-5698-2022	Marcotte, Edward/0000-0001-8808-180X	N.S.F [IIS-0325116, EIA0219061]; N.I.H. [GM06779-01, GM076536-01]; Welch [F-1515]; Packard Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076536] Funding Source: NIH RePORTER	N.S.F(National Science Foundation (NSF)); N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch(The Welch Foundation); Packard Fellowship(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the N.S.F. (IIS-0325116, EIA0219061), N.I.H. (GM06779-01, GM076536-01), Welch (F-1515), and a Packard Fellowship (EMM). These agencies were not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Adams CC, 2002, RNA, V8, P150, DOI 10.1017/S1355838202010026; Aloy P, 2003, BIOINFORMATICS, V19, P161, DOI 10.1093/bioinformatics/19.1.161; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; BAIM SB, 1985, MOL CELL BIOL, V5, P1839, DOI 10.1128/MCB.5.8.1839; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; CARLSON MW, 2002, THESIS U TEXAS; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; EFRON B, 1983, J AM STAT ASSOC, V78, P316, DOI 10.2307/2288636; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Fraser AG, 2004, NAT GENET, V36, P559, DOI 10.1038/ng1370; Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gollub J, 2003, NUCLEIC ACIDS RES, V31, P94, DOI 10.1093/nar/gkg078; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hart GT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-236; Ho JHN, 1999, MOL CELL BIOL, V19, P2389; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoang T, 2005, MOL CELL BIOL, V25, P5523, DOI 10.1128/MCB.25.13.5523-5534.2005; Horsey EW, 2004, RNA, V10, P813, DOI 10.1261/rna.5255804; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huttenhower C, 2006, BIOINFORMATICS, V22, P2890, DOI 10.1093/bioinformatics/btl492; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; LEE I, 2007, METHODS MOL BIOL COM; Lee I, 2007, METHOD MICROBIOL, V36, P597, DOI 10.1016/S0580-9517(06)36024-2; Marcotte Cynthia J Verjovsky, 2002, Appl Bioinformatics, V1, P93; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Mellor JC, 2002, NUCLEIC ACIDS RES, V30, P306, DOI 10.1093/nar/30.1.306; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Myers CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r114; Nariai N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000337; Newman JRS, 2000, P NATL ACAD SCI USA, V97, P13203, DOI 10.1073/pnas.97.24.13203; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; ROTENBERG MO, 1988, GENE DEV, V2, P160, DOI 10.1101/gad.2.2.160; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Shapira M, 2004, MOL BIOL CELL, V15, P5659, DOI 10.1091/mbc.E04-04-0340; Sima C, 2005, BIOINFORMATICS, V21, P1046, DOI 10.1093/bioinformatics/bti081; Stapley B J, 2000, Pac Symp Biocomput, P529; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wade CH, 2006, YEAST, V23, P293, DOI 10.1002/yea.1353; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Witten I. H., 2005, DATA MINING PRACTICA; Wolf YI, 2001, GENOME RES, V11, P356, DOI 10.1101/gr.GR-1619R; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Yanai I, 2001, P NATL ACAD SCI USA, V98, P7940, DOI 10.1073/pnas.141236298; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287	77	146	149	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e988	10.1371/journal.pone.0000988	http://dx.doi.org/10.1371/journal.pone.0000988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912365	Green Published, gold			2022-12-27	WOS:000207455900024
J	Ashiabi, GS; O'Neal, KK				Ashiabi, Godwin S.; O'Neal, Keri K.			Children's Health Status: Examining the Associations among Income Poverty, Material Hardship, and Parental Factors	PLOS ONE			English	Article							FOOD INSUFFICIENCY; RESPIRATORY ILLNESS; ECONOMIC HARDSHIP; DEPRESSED MOTHER; MENTAL-HEALTH; FAMILY INCOME; CARE; INSECURITY; PRESCHOOL; ADJUSTMENT	Background. We examined a model of multiple mediating pathways of income poverty, material hardship, parenting factors, and child health status to understand how material hardship and parental factors mediate the effects of poverty on child health. We hypothesized that: (a) poverty will be directly associated with material hardship, parental depression, and health status, and indirectly with parenting behaviors through its effects on parental depression and material hardship; (b) material hardship will be associated with parental depression, parenting behaviors, and health status; and (c) parental depression will be correlated with parenting behaviors, and that both parental depression and parenting behaviors will predict child health. Methods and Results. We used data from the 2002 National Survey of American Families for a sample of 9,645 6-to-11 year-olds to examine a 4-step structural equation model. The baseline model included covariates and income poverty. In the hardship model, food insufficiency and medical need were added to the baseline model. The parental model included parental depression and parenting behavior and baseline model. In the full model, all the constructs were included. First, income poverty had a direct effect on health status, and an indirect effect through its association with material hardship, parental depressive affect, and parenting behaviors. Medical need and food insufficiency had negative effects on child health, and indirect effects on health through their association with parental depression and parenting behaviors. Finally, parental depression and parenting behaviors were associated with child health, and part of the effect of parental depression on health was explained by its association with parenting behaviors. Conclusions. Poverty has an independent effect on health, however, its effects are partially explained by material hardship, parental depression and parental behaviors. To improve children's health would require a multi-pronged approach involving income transfers, health insurance coverage, food and nutrition assistance, and parenting interventions.	[Ashiabi, Godwin S.; O'Neal, Keri K.] Calif State Univ E Bay, Dept Human Dev, Hayward, CA USA	California State University System; California State University East Bay	Ashiabi, GS (corresponding author), Calif State Univ E Bay, Dept Human Dev, Hayward, CA USA.	godwin.ashiabi@csueastbay.edu						Aber JL, 1997, ANNU REV PUBL HEALTH, V18, P463, DOI 10.1146/annurev.publhealth.18.1.463; ABIHABIB N, 2003, NSAF METHODOLOGY REP, V6; Alaimo K, 2001, AM J PUBLIC HEALTH, V91, P781, DOI 10.2105/AJPH.91.5.781; ARBUCKLE JL, 2005, AMOS 6 0 USERS GUIDE; Arbuckle JL., 1996, ADV STRUCTURAL EQUAT, P243, DOI DOI 10.4324/9781315827414; Ashiabi G., 2005, J CHILD POVERTY, V11, P3, DOI [10.1080/1079612042000333027, DOI 10.1080/1079612042000333027]; ASHIABI GS, J CHILDREN IN PRESS; Ashman S. B., 2002, CHILDREN DEPRESSED P, DOI DOI 10.1037/10449-000; Beverly SG, 2001, SOC WORK RES, V25, P143, DOI 10.1093/swr/25.3.143; Boushey H., 2001, HARDSHIPS AM REAL ST; CASE A, 2001, 8344 NBER; CASEY PH, 2001, ARCH PEDIAT ADOL MED, V155, P232; CONGER RD, 1992, CHILD DEV, V63, P526, DOI 10.1111/j.1467-8624.1992.tb01644.x; Cook JT, 2004, J NUTR, V134, P1432; Dunifon R, 2003, SOC SERV REV, V77, P72, DOI 10.1086/345705; Edhborg M, 2000, J REPROD INFANT PSYC, V18, P225, DOI 10.1080/713683036; Ettner SL, 1996, AM J PUBLIC HEALTH, V86, P1748, DOI 10.2105/AJPH.86.12.1748; GERONIMUS AT, 1993, AM J EPIDEMIOL, V137, P213, DOI 10.1093/oxfordjournals.aje.a116662; Gershoff ET, 2007, CHILD DEV, V78, P70, DOI 10.1111/j.1467-8624.2007.00986.x; GOODMAN SH, 1993, COMMUNITY MENT HLT J, V29, P119, DOI 10.1007/BF00756338; Hamelin AM, 1999, J NUTR, V129, p525S, DOI 10.1093/jn/129.2.525S; Hauser RM, 1997, INDICATORS OF CHILDREN'S WELL-BEING, P152; HILL MA, 1997, SPSS MISSING VALUE A; HOLL JL, 1995, ARCH PEDIAT ADOL MED, V149, P398, DOI 10.1001/archpedi.1995.02170160052008; Holmbeck GN, 1997, J CONSULT CLIN PSYCH, V65, P599, DOI 10.1037/0022-006X.65.4.599; HU LT, 1999, STRUCTURAL EQUATION, V1, P55; Hughes DC, 2003, FUTURE CHILD, V13, P153; Iceland J., 2007, J SOCIO-ECON, V36, P376, DOI [10.1016/j.socec.2006.12.003, DOI 10.1016/J.SOCEC.2006.12.003]; Iceland J, 2005, MEAS-INTERDISCIP RES, V3, P199, DOI 10.1207/s15366359mea0304_1; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; KOCHANSKA G, 1987, AM J ORTHOPSYCHIAT, V57, P345, DOI 10.1111/j.1939-0025.1987.tb03543.x; Leiferman J, 2002, HEALTH EDUC BEHAV, V29, P596, DOI 10.1177/109019802237027; Linver MR, 2002, DEV PSYCHOL, V38, P719, DOI 10.1037//0012-1649.38.5.719; LIVINGOOD AB, 1983, J CLIN PSYCHOL, V39, P369, DOI 10.1002/1097-4679(198305)39:3<369::AID-JCLP2270390310>3.0.CO;2-8; Loehlin JC, 1998, LATENT VARIABLE MODE; MCLOYD VC, 1990, CHILD DEV, V61, P311, DOI 10.1111/j.1467-8624.1990.tb02781.x; MCLOYD VC, 1994, CHILD DEV, V65, P562, DOI 10.1111/j.1467-8624.1994.tb00769.x; Minkovitz CS, 2005, PEDIATRICS, V115, P306, DOI 10.1542/peds.2004-0341; Mistry RS, 2004, DEV PSYCHOL, V40, P727, DOI 10.1037/0012-1649.40.5.727; Montgomery LE, 1996, AM J PUBLIC HEALTH, V86, P1401, DOI 10.2105/AJPH.86.10.1401; NEWACHECK PW, 1992, MED CARE, V30, P30, DOI 10.1097/00005650-199201000-00003; Newacheck PW, 1998, NEW ENGL J MED, V338, P513, DOI 10.1056/NEJM199802193380806; Oakley A, 1993, EUR J PUBLIC HEALTH, V3, P18, DOI [DOI 10.1093/EURPUB/3.1.18, 10.1093/eurpub/3.1.18]; OGSTON SA, 1987, J EPIDEMIOL COMMUN H, V41, P21, DOI 10.1136/jech.41.1.21; OULLETTE T, 2004, MEASURES MAT HARDSHI; PARCEL TL, 1994, AM J SOCIOL, V99, P972, DOI 10.1086/230369; Patel V, 2004, BMJ-BRIT MED J, V328, P820, DOI 10.1136/bmj.328.7443.820; PAUL W, 1998, NEW ENGL J MED, V338, P513; PERRIN JM, 1989, NEW ENGL J MED, V320, P1183, DOI 10.1056/NEJM198905043201805; Reading R, 1997, ARCH DIS CHILD, V76, P463, DOI 10.1136/adc.76.5.463; Rector RE, 1999, REV SOC ECON, V57, P351, DOI 10.1080/00346769900000007; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Robila M, 2006, J CHILD FAM STUD, V15, P435, DOI DOI 10.1007/S10826-006-9053-X; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Seccombe K, 2000, J MARRIAGE FAM, V62, P1094, DOI 10.1111/j.1741-3737.2000.01094.x; Short KS, 2005, J SOC POLICY, V34, P21, DOI 10.1017/S0047279404008244; Siefert K, 2001, WOMEN HEALTH, V32, P159, DOI 10.1300/J013v32n01_08; Smith JP, 1998, AM ECON REV, V88, P192; STODDARD JJ, 1994, NEW ENGL J MED, V330, P1421, DOI 10.1056/NEJM199405193302006; TAYLOR B, 1982, LANCET, V1, P1227; Vozoris NT, 2003, J NUTR, V133, P120, DOI 10.1093/jn/133.1.120; Weinreb L, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e41; Weinreb L, 1998, PEDIATRICS, V102, P554, DOI 10.1542/peds.102.3.554; Whitaker RC, 2006, PEDIATRICS, V118, pE859, DOI 10.1542/peds.2006-0239; WOOD DL, 1990, PEDIATRICS, V86, P666; Wu Z, 2005, SOCIOL PERSPECT, V48, P481, DOI 10.1525/sop.2005.48.4.481; Yeung WJ, 2002, CHILD DEV, V73, P1861, DOI 10.1111/1467-8624.t01-1-00511	67	56	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e940	10.1371/journal.pone.0000940	http://dx.doi.org/10.1371/journal.pone.0000940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895981	Green Published, gold			2022-12-27	WOS:000207455800019
J	Cane, G; Lievin-Le Moal, V; Pages, G; Servin, AL; Hofman, P; Vouret-Craviari, V				Cane, Gaelle; Lievin-Le Moal, Vanessa; Pages, Gilles; Servin, Alain L.; Hofman, Paul; Vouret-Craviari, Valerie			Up-Regulation of Intestinal Vascular Endothelial Growth Factor by Afa/Dr Diffusely Adhering Escherichia coli	PLOS ONE			English	Article								Background. Angiogenesis has been recently described as a novel component of inflammatory bowel disease pathogenesis. The level of vascular endothelial growth factor (VEGF) has been found increased in Crohn's disease and ulcerative colitis mucosa. To question whether a pro-inflammatory Escherichia coli could regulate the expression of VEGF in human intestinal epithelial cells, we examine the response of cultured human colonic T84 cells to infection by E. coli strain C1845 that belongs to the typical Afa/Dr diffusely adhering E. coli family (Afa/Dr DAEC). Methodology. VEGF mRNA expression was examined by Northern blotting and q-PCR. VEGF protein levels were assayed by ELISA and its bioactivity was analysed in endothelial cells. The bacterial factor involved in VEGF induction was identified using recombinant E. coli expressing Dr adhesin, purified Dr adhesin and lipopolysaccharide. The signaling pathway activated for the up-regulation of VEGF was identified using a blocking monoclonal anti-DAF antibody, Western blot analysis and specific pharmacological inhibitors. Principal Findings. C1845 bacteria induce the production of VEGF protein which is bioactive. VEGF is induced by adhering C1845 in both a time-and bacteria concentration-dependent manner. This phenomenon is not cell line dependent since we reproduced this observation in intestinal LS174, Caco2/TC7 and INT407 cells. Up-regulation of VEGF production requires: (1) the interaction of the bacterial F1845 adhesin with the brush border-associated decay accelerating factor (DAF, CD55) acting as a bacterial receptor, and (2) the activation of a Src protein kinase upstream of the activation of the Erk and Akt signaling pathways. Conclusions. Results demonstrate that a Afa/Dr DAEC strain induces an adhesin-dependent activation of DAF signaling that leads to the up-regulation of bioactive VEGF in cultured human intestinal cells. Thus, these results suggest a link between an entero-adherent, pro-inflammatory E. coli strain and angiogenesis which appeared recently as a novel component of IBD pathogenesis.	[Cane, Gaelle; Pages, Gilles; Vouret-Craviari, Valerie] Univ Nice Sophia Antipolis, CNRS, UMR 6543, Nice, France; [Hofman, Paul] Fac Med Nice, INSERM, ERI 21, F-06034 Nice, France; [Lievin-Le Moal, Vanessa; Servin, Alain L.] INSERM, U756, Chatenay Malabry, France; [Lievin-Le Moal, Vanessa; Servin, Alain L.] Univ Paris 11, Fac Pharm, F-92290 Chatenay Malabry, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Vouret-Craviari, V (corresponding author), Univ Nice Sophia Antipolis, CNRS, UMR 6543, Nice, France.	vouret@unice.fr	Pages, Gilles/N-7135-2017; Hofman, Paul/P-7654-2018	Hofman, Paul/0000-0003-0431-9353	"Centre National de la Recherche Scientifique'' (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); "Association pour la Recherche sur le Cancer (ARC)"; Universities of Nice Sophia Antipolis" [UMR6543]; Paris-Sud 11 [UMR756]	"Centre National de la Recherche Scientifique'' (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); "Association pour la Recherche sur le Cancer (ARC)"(Fondation ARC pour la Recherche sur le Cancer); Universities of Nice Sophia Antipolis"; Paris-Sud 11	Funding: This work was supported by the "Centre National de la Recherche Scientifique'' (CNRS), the Institut National de la Sante et de la Recherche Medicale (Inserm), the "Association pour la Recherche sur le Cancer (ARC)", and the Universities of Nice Sophia Antipolis" (UMR6543) and Paris-Sud 11 (UMR756).	Alatas F, 2004, CHEST, V125, P2156, DOI 10.1378/chest.125.6.2156; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; BARBIERI B, 1981, P SOC EXP BIOL MED, V168, P204; Barnich N, 2003, MOL MICROBIOL, V48, P781, DOI 10.1046/j.1365-2958.2003.03468.x; Barnich N, 2007, CURR OPIN GASTROEN, V23, P16, DOI 10.1097/MOG.0b013e3280105a38; Beddy D, 2004, BRIT J SURG, V91, P72, DOI 10.1002/bjs.4453; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Berstad AE, 1998, GUT, V42, P522, DOI 10.1136/gut.42.4.522; Betis F, 2003, INFECT IMMUN, V71, P1774, DOI 10.1128/IAI.71.4.1774-1783.2003; Betis F, 2003, INFECT IMMUN, V71, P1068, DOI 10.1128/IAI.71.3.1068-1074.2003; BILGE SS, 1989, J BACTERIOL, V171, P4281, DOI 10.1128/JB.171.8.4281-4289.1989; Blomfield IC, 2001, ADV MICROB PHYSIOL, V45, P1, DOI 10.1016/S0065-2911(01)45001-6; Botero TM, 2006, J ENDODONT, V32, P951, DOI 10.1016/j.joen.2006.03.018; Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Bringer MA, 2006, CELL MICROBIOL, V8, P471, DOI 10.1111/j.1462-5822.2005.00639.x; Campieri M, 2001, GUT, V48, P132, DOI 10.1136/gut.48.1.132; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carratelli CR, 2007, INT IMMUNOPHARMACOL, V7, P287, DOI 10.1016/j.intimp.2006.10.007; CHANG HR, 1994, ANN SURG ONCOL, V1, P213, DOI 10.1007/BF02303526; COYNE KE, 1992, J IMMUNOL, V149, P2906; DANESE S, 2006, GUT; Danese S, 2006, GASTROENTEROLOGY, V130, P2060, DOI 10.1053/j.gastro.2006.03.054; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Desreumaux P., 2003, Annales Pharmaceutiques Francaises, V61, P276; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; Ferrante M, 2006, INFLAMM BOWEL DIS, V12, P870, DOI 10.1097/01.mib.0000235095.01608.10; Ferrara N, 2005, ONCOLOGY-BASEL, V69, P11, DOI 10.1159/000088479; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Goebel S, 2006, AM J PHYSIOL-GASTR L, V290, pG648, DOI 10.1152/ajpgi.00466.2005; Goluszko P, 1999, INFECT IMMUN, V67, P3989, DOI 10.1128/IAI.67.8.3989-3997.1999; Griga T, 1999, DIGEST DIS SCI, V44, P1196, DOI 10.1023/A:1026640610621; Griga T, 2002, HEPATO-GASTROENTEROL, V49, P116; Guignot J, 2000, INFECT IMMUN, V68, P3554, DOI 10.1128/IAI.68.6.3554-3563.2000; Guignot J, 2007, CELL MICROBIOL, V9, P204, DOI 10.1111/j.1462-5822.2006.00782.x; Harmey JH, 2002, INT J CANCER, V101, P415, DOI 10.1002/ijc.10632; Hasan RJ, 2002, INFECT IMMUN, V70, P4485, DOI 10.1128/IAI.70.8.4485-4493.2002; Heine H, 2003, EUR J IMMUNOL, V33, P1399, DOI 10.1002/eji.200323381; Hudault S, 2004, INFECT IMMUN, V72, P4859, DOI 10.1128/IAI.72.8.4859-4863.2004; Inaba T, 1998, CLIN EXP IMMUNOL, V112, P237; Kanazawa S, 2001, AM J GASTROENTEROL, V96, P822; Kansau I, 2004, INFECT IMMUN, V72, P3733, DOI 10.1128/IAI.72.7.3733-3742.2004; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x; Kirby JE, 2004, INFECT IMMUN, V72, P7315, DOI 10.1128/IAI.72.12.7315-7317.2004; Kitadai Y, 2003, BIOCHEM BIOPH RES CO, V311, P809, DOI 10.1016/j.bbrc.2003.10.077; Konno S, 2004, J GASTROENTEROL, V39, P931, DOI 10.1007/s00535-004-1423-9; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Koutroubakis IE, 2006, INFLAMM BOWEL DIS, V12, P515, DOI 10.1097/00054725-200606000-00012; MADARA JL, 1987, GASTROENTEROLOGY, V92, P1133, DOI 10.1016/S0016-5085(87)91069-9; Mangia A, 2006, WORLD J GASTROENTERO, V12, P5465, DOI 10.3748/wjg.v12.i34.5465; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Masseret E, 2001, GUT, V48, P320, DOI 10.1136/gut.48.3.320; Mazure NM, 2003, CURR PHARM DESIGN, V9, P531, DOI 10.2174/1381612033391469; Meconi S, 2007, CELL MICROBIOL, V9, P1252, DOI 10.1111/j.1462-5822.2006.00868.x; MORAN AP, 1992, J BACTERIOL, V174, P1370, DOI 10.1128/jb.174.4.1370-1377.1992; Neut C, 2002, AM J GASTROENTEROL, V97, P939, DOI 10.1111/j.1572-0241.2002.05613.x; NOWICKI B, 1993, J EXP MED, V178, P2115, DOI 10.1084/jem.178.6.2115; NOWICKI B, 1990, INFECT IMMUN, V58, P279, DOI 10.1128/IAI.58.1.279-281.1990; O'Brien DP, 2006, J BIOL CHEM, V281, P13317, DOI 10.1074/jbc.M601805200; Ohm JE, 2003, BLOOD, V101, P4878, DOI 10.1182/blood-2002-07-1956; Pages G, 2000, ANN NY ACAD SCI, V902, P187; Peeters H, 2007, INT J IMMUNOGENET, V34, P181, DOI 10.1111/j.1744-313X.2007.00670.x; Peiffer I, 1998, INFECT IMMUN, V66, P4036; Rodriguez-Martinez S, 2006, EXP EYE RES, V83, P1373, DOI 10.1016/j.exer.2006.07.015; Sato F, 2007, BIOCHEM BIOPH RES CO, V354, P608, DOI 10.1016/j.bbrc.2007.01.027; Schulte B, 2006, INFECT IMMUN, V74, P5003, DOI 10.1128/IAI.00663-06; SCHULZ R, 1994, PORTL PR P, V8, P81; Sepehri S, 2007, INFLAMM BOWEL DIS, V13, P675, DOI 10.1002/ibd.20101; Servin AL, 2005, CLIN MICROBIOL REV, V18, P264, DOI 10.1128/CMR.18.2.264-292.2005; SHENOYSCARIA AM, 1992, J IMMUNOL, V149, P3535; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Telles PDS, 2003, J DENT RES, V82, P466, DOI 10.1177/154405910308200612; Tieng V, 2002, P NATL ACAD SCI USA, V99, P2977, DOI 10.1073/pnas.032668099; Tiveljung A, 1999, J MED MICROBIOL, V48, P263, DOI 10.1099/00222615-48-3-263; Trisciuoglio D, 2005, MOL BIOL CELL, V16, P4153, DOI 10.1091/mbc.E04-12-1087; Tuccillo C, 2005, J PATHOL, V207, P277, DOI 10.1002/path.1844; UESU T, 1995, LAB INVEST, V72, P587; van der Flier M, 2000, INFECT IMMUN, V68, P4792, DOI 10.1128/IAI.68.8.4792-4794.2000; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	82	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1359	10.1371/journal.pone.0001359	http://dx.doi.org/10.1371/journal.pone.0001359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159242	gold, Green Submitted, Green Published			2022-12-27	WOS:000207459700016
J	Tillmann, RL; Simon, A; Muller, A; Schildgen, O				Tillmann, Ramona Liza; Simon, Arne; Mueller, Andreas; Schildgen, Oliver			Sensitive Commercial NASBA Assay for the Detection of Respiratory Syncytial Virus in Clinical Specimen	PLOS ONE			English	Article							TRACT INFECTIONS; YOUNG-CHILDREN; RAPID DETECTION; INCREASED RISK; BD DIRECTIGEN; RSV; HOSPITALIZATION; OUTBREAK; IMPACT; BINAX	The aim of the study was to evaluate the usability of three diagnostic procedures for the detection of respiratory syncytial virus in clinical samples. Therefore, the FDA cleared CE marked NOW (R) RSV ELISA, the NucliSENS (R) EasyQ RSV A+B NASBA, and a literature based inhouse RT-PCR protocol were compared for their relative sensitivities. Thereby, NASBA turned out to be the most sensitive method with a total number of 80 RSV positive samples out of a cohort of 251 nasopharyngeal washings from patients suffering from clinical symptoms, followed by the inhouse RT-PCR (62/251) and ELISA (52/251). Thus, NASBA may serve as a rapid and highly sensitive alternative for RSV diagnostics.	[Tillmann, Ramona Liza; Schildgen, Oliver] Univ Bonn, Inst Virol, D-5300 Bonn, Germany; [Simon, Arne; Mueller, Andreas] Univ Bonn, Childrens Hosp, D-5300 Bonn, Germany	University of Bonn; University of Bonn	Schildgen, O (corresponding author), Univ Bonn, Inst Virol, D-5300 Bonn, Germany.	schildgen@mibi03.meb.uni-bonn.de	Schildgen, Oliver/D-5327-2014	Schildgen, Oliver/0000-0003-4297-9627	bioMerieux, Nurtingen, Germany	bioMerieux, Nurtingen, Germany	Funding: The authors thank bioMerieux, Nurtingen, Germany for technical support and providing resources for this study.	Black Craig Patrick, 2003, Respir Care, V48, P209; Buckingham S C, 2001, Pediatr Crit Care Med, V2, P318, DOI 10.1097/00130478-200110000-00006; Cox RA, 2001, J HOSP INFECT, V48, P186, DOI 10.1053/jhin.2001.1002; Cruz AT, 2007, J CLIN MICROBIOL, V45, P1993, DOI 10.1128/JCM.00279-07; Ehlken B, 2005, EUR J PEDIATR, V164, P607, DOI 10.1007/s00431-005-1705-0; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Fitzgerald DA, 2004, MED J AUSTRALIA, V180, P399, DOI 10.5694/j.1326-5377.2004.tb05993.x; Forster J, 2004, EUR J PEDIATR, V163, P709, DOI 10.1007/s00431-004-1523-9; Grondahl B, 2005, CLIN MICROBIOL INFEC, V11, P848, DOI 10.1111/j.1469-0691.2005.01223.x; Jennings LC, 2004, PEDIATR INFECT DIS J, V23, P1003, DOI 10.1097/01.inf.0000143648.04673.6c; MANJI R, 2006, NUCL ACID SEQUENCE B; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Meissner HC, 2003, PEDIATR INFECT DIS J, V22, pS40, DOI 10.1097/00006454-200302001-00006; Mentel R, 2003, J MED MICROBIOL, V52, P893, DOI 10.1099/jmm.0.05290-0; Moore C, 2006, EUR J CLIN MICROBIOL, V25, P167, DOI 10.1007/S10096-006-0112-4; Ohm-Smith MJ, 2004, J CLIN MICROBIOL, V42, P2996, DOI 10.1128/JCM.42.7.2996-2999.2004; Reina J, 2004, CLIN MICROBIOL INFEC, V10, P967, DOI 10.1111/j.1469-0691.2004.00986.x; Rietveld E, 2004, PEDIATR INFECT DIS J, V23, P523, DOI 10.1097/01.inf.0000129690.35341.8d; Simon A, 2006, INT J HYG ENVIR HEAL, V209, P317, DOI 10.1016/j.ijheh.2006.02.003; Terletskaia-Ladwig E, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-20; Thorburn K, 2004, J HOSP INFECT, V57, P194, DOI 10.1016/j.jhin.2004.03.013; Wilkesmann A, 2006, EUR J PEDIATR, V165, P467, DOI 10.1007/s00431-006-0105-4; Wilkesmann A, 2007, PEDIATR INFECT DIS J, V26, P485, DOI 10.1097/INF.0b013e31805d01e3	23	16	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1357	10.1371/journal.pone.0001357	http://dx.doi.org/10.1371/journal.pone.0001357			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159240	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459700014
J	Alahari, A; Trivelli, X; Guerardel, Y; Dover, LG; Besra, GS; Sacchettini, JC; Reynolds, RC; Coxon, GD; Kremer, L				Alahari, Anuradha; Trivelli, Xavier; Guerardel, Yann; Dover, Lynn G.; Besra, Gurdyal S.; Sacchettini, James C.; Reynolds, Robert C.; Coxon, Geoffrey D.; Kremer, Laurent			Thiacetazone, an Antitubercular Drug that Inhibits Cyclopropanation of Cell Wall Mycolic Acids in Mycobacteria	PLOS ONE			English	Article								Background. Mycolic acids are a complex mixture of branched, long-chain fatty acids, representing key components of the highly hydrophobic mycobacterial cell wall. Pathogenic mycobacteria carry mycolic acid sub-types that contain cyclopropane rings. Double bonds at specific sites on mycolic acid precursors are modified by the action of cyclopropane mycolic acid synthases (CMASs). The latter belong to a family of S-adenosyl-methionine-dependent methyl transferases, of which several have been well studied in Mycobacterium tuberculosis, namely, MmaA1 through A4, PcaA and CmaA2. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence of M. tuberculosis. While several antitubercular agents inhibit mycolic acid synthesis, to date, the CMASs have not been shown to be drug targets. Methodology/Principle Findings. We have employed various complementary approaches to show that the antitubercular drug, thiacetazone (TAC), and its chemical analogues, inhibit mycolic acid cyclopropanation. Dramatic changes in the content and ratio of mycolic acids in the vaccine strain Mycobacterium bovis BCG, as well as in the related pathogenic species Mycobacterium marinum were observed after treatment with the drugs. Combination of thin layer chromatography, mass spectrometry and Nuclear Magnetic Resonance (NMR) analyses of mycolic acids purified from drug-treated mycobacteria showed a significant loss of cyclopropanation in both the alpha- and oxygenated mycolate sub-types. Additionally, High-Resolution Magic Angle Spinning (HR-MAS) NMR analyses on whole cells was used to detect cell wall-associated mycolates and to quantify the cyclopropanation status of the cell envelope. Further, overexpression of cmaA2, mmaA2 or pcaA in mycobacteria partially reversed the effects of TAC and its analogue on mycolic acid cyclopropanation, suggesting that the drugs act directly on CMASs. Conclusions/Significance. This is a first report on the mechanism of action of TAC, demonstrating the CMASs as its cellular targets in mycobacteria. The implications of this study may be important for the design of alternative strategies for tuberculosis treatment.	[Alahari, Anuradha; Kremer, Laurent] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, Montpellier, France; [Alahari, Anuradha; Kremer, Laurent] Univ Montpellier 1, CNRS, UMR 5235, Montpellier, France; [Kremer, Laurent] INSERM, Montpellier, France; [Trivelli, Xavier; Guerardel, Yann] Univ Sci & Technol Lille, CNRS, UMR 8576, Unite Glycobiol Struct & Fonct, Villeneuve Dascq, France; [Dover, Lynn G.] Northumbria Univ, Sch Appl Sci, Biomol & Biomed Res Ctr, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Reynolds, Robert C.] So Res Inst, Drug Discovery Div, Birmingham, AL 35255 USA; [Coxon, Geoffrey D.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Div Pharmaceut Sci, Glasgow, Lanark, Scotland	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Northumbria University; University of Birmingham; Texas A&M University System; Texas A&M University College Station; University of Strathclyde	Kremer, L (corresponding author), Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, Montpellier, France.	laurent.kremer@univ-montp2.fr	Kremer, Laurent/M-4935-2017; Dover, Lynn G/F-3021-2010; Dover, Lynn George/Q-6778-2019	Kremer, Laurent/0000-0002-6604-4458; Dover, Lynn G/0000-0002-4776-2665; Dover, Lynn George/0000-0002-4776-2665; Besra, Gurdyal/0000-0002-5605-0395; Guerardel, Yann/0000-0003-4967-9512; Trivelli, Xavier/0000-0001-6775-9650	Royal Society Wolfson Research Merit Award; Lister Institute; Medical Research Council (UK); Wellcome Trust; Centre National de la Recherche Scientifique (CNRS); European Union (FEDER); Ministere Francais de l'Enseignement Superieur et de la Recherche; region Nord-Pas de Calais; Universite des Sciences et Technologies de Lille; CNRS; MRC [G0400789] Funding Source: UKRI; Medical Research Council [G0400789] Funding Source: researchfish	Royal Society Wolfson Research Merit Award(Royal Society of London); Lister Institute; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); European Union (FEDER)(European Commission); Ministere Francais de l'Enseignement Superieur et de la Recherche; region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); Universite des Sciences et Technologies de Lille; CNRS(Centre National de la Recherche Scientifique (CNRS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GSB acknowledges support from Mr. James Bardrick in the form of a Personal Chair, a Royal Society Wolfson Research Merit Award, the Lister Institute as a former Jenner Research Fellow, the Medical Research Council (UK) and the Wellcome Trust. LK is supported by a Grant from the Centre National de la Recherche Scientifique (CNRS) (Action Thematique Incitative sur Programme "Microbiologie Fondamentale''). The 800 MHz spectrometer was funded by European Union (FEDER), Ministere Francais de l'Enseignement Superieur et de la Recherche, region Nord-Pas de Calais, Universite des Sciences et Technologies de Lille and CNRS.	BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Behr MA, 2000, J BACTERIOL, V182, P3394, DOI 10.1128/JB.182.12.3394-3399.2000; Bermudez LE, 2004, ANTIMICROB AGENTS CH, V48, P3556, DOI 10.1128/AAC.48.9.3556-3558.2004; Bermudez LE, 2003, ANTIMICROB AGENTS CH, V47, P2685, DOI 10.1128/AAC.47.8.2685-2687.2003; BHATT A, 2007, P NATL ACAD IN PRESS; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; DAFFE M, 1991, RES MICROBIOL, V142, P397, DOI 10.1016/0923-2508(91)90109-N; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; DAVIDSON PT, 1992, DRUGS, V43, P651, DOI 10.2165/00003495-199243050-00003; DeBarber AE, 2000, P NATL ACAD SCI USA, V97, P9677, DOI 10.1073/pnas.97.17.9677; Dinadayala P, 2003, J BIOL CHEM, V278, P7310, DOI 10.1074/jbc.M210501200; Dorman SE, 2007, NAT MED, V13, P295, DOI 10.1038/nm0307-295; Dover LG, 2007, ANTIMICROB AGENTS CH, V51, P1055, DOI 10.1128/AAC.01063-06; Dubnau E, 1997, MOL MICROBIOL, V23, P313, DOI 10.1046/j.1365-2958.1997.2301589.x; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; GEORGE KM, 1995, J BIOL CHEM, V270, P27292, DOI 10.1074/jbc.270.45.27292; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2003, J BIOL CHEM, V278, P7844, DOI 10.1074/jbc.M212458200; Glickman MS, 2001, J BIOL CHEM, V276, P2228, DOI 10.1074/jbc.C000652200; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; HOUSTON S, 1994, DRUGS, V48, P689, DOI 10.2165/00003495-199448050-00004; Huang CC, 2002, J BIOL CHEM, V277, P11559, DOI 10.1074/jbc.M111698200; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; Lee REB, 2005, GLYCOBIOLOGY, V15, P139, DOI 10.1093/glycob/cwh150; MINNIKIN DE, 1982, J GEN MICROBIOL, V128, P817; Mitchison DA, 2004, FRONT BIOSCI-LANDMRK, V9, P1059, DOI 10.2741/1293; NUNN P, 1993, T ROY SOC TROP MED H, V87, P578, DOI 10.1016/0035-9203(93)90096-9; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; *PREV CFDCA, 2006, MMWR-MORBID MORTAL W, V55, P301; Qian L, 2006, CHEM RES TOXICOL, V19, P443, DOI 10.1021/tx050328b; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Vilcheze C, 2006, NAT MED; Wang F, 2007, J EXP MED, V204, P73, DOI 10.1084/jem.20062100; Watanabe M, 1999, J BACTERIOL, V181, P2293, DOI 10.1128/JB.181.7.2293-2297.1999; Watkins WM, 1996, BRIT J CLIN PHARMACO, V41, P160, DOI 10.1111/j.1365-2125.1996.tb00175.x; Wieruszeski JM, 2006, J MAGN RESON, V181, P199, DOI 10.1016/j.jmr.2006.04.007; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x; YUAN Y, 1995, P NATL ACAD SCI USA, V92, P6630, DOI 10.1073/pnas.92.14.6630; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828; Yuan Y, 1997, J BIOL CHEM, V272, P10041; Zhang Y, 2006, DRUG DISCOV TODAY, V11, P21, DOI 10.1016/S1359-6446(05)03626-3	50	100	104	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1343	10.1371/journal.pone.0001343	http://dx.doi.org/10.1371/journal.pone.0001343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18094751	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000207459600026
J	Doolan, K; Ehrlich, R; Myer, L				Doolan, Katherine; Ehrlich, Rodney; Myer, Landon			Experience of Violence and Socioeconomic Position in South Africa: A National Study	PLOS ONE			English	Article							HEALTH	Background. Violence is a leading cause of morbidity and mortality in South Africa and needs to be researched from a public health perspective. Typically in violence research, socioeconomic position is used in the analysis to control for confounding. Social epidemiology approaches this variable as a primary determinant of interest and is used in this research to better understand the aetiology of violence in South Africa. We hypothesised that measures of socioeconomic position (employment, education and household wealth) would be inversely related to violence at the individual and household levels. Methodology/Principal Findings. Data came from the 1998 South African Demographic and Health Survey (SADHS). Measures of socioeconomic position used were employment, education and household wealth. Eighty-eight people (0.2%) received treatment for a violent injury in the previous 30 days and 103 households (0.9%) experienced a violent death in the previous year. Risk factors for violence at the individual level included employment (41% of those who experienced violence were employed vs. 27% of those who did not, p = 0.02), and education (those who experienced violence had on average, one year more education than those who did not, p = 0.04). Belonging to a household in the wealthiest quintile was protective against violence (OR: 0.32; 95% CI: 0.12-0.89). In contrast, at the household level all three measures of socioeconomic position were protective against the experience of a violent death. The only association to persist in the multivariate analysis was that between the wealth of the household and violence at the individual level. Conclusions/Significance. Our hypothesis was supported if household wealth was used as the measure of socioeconomic position at the individual level. While more research is needed to inform the conflicting results observed between the individual and household levels, this analysis has begun to identify the disparities across the socioeconomic structure with respect to violent outcomes.	[Doolan, Katherine; Ehrlich, Rodney; Myer, Landon] Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Doolan, Katherine] Univ Calif San Francisco, Ctr Int Data Evaluat & Anal, Womens Global Hlth Imperat, San Francisco, CA 94143 USA; [Ehrlich, Rodney; Myer, Landon] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	University of Cape Town; University of California System; University of California San Francisco; Columbia University	Myer, L (corresponding author), Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa.	landon.myer@uct.ac.za	Ehrlich, Rodney/M-5654-2014	Ehrlich, Rodney/0000-0001-5736-9237				BLAU JR, 1982, AM SOCIOL REV, V47, P114, DOI 10.2307/2095046; Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Braveman P, 2003, AM J PUBLIC HEALTH, V93, P12, DOI 10.2105/AJPH.93.1.12-a; Cubbin C, 2000, AM J PUBLIC HEALTH, V90, P70, DOI 10.2105/AJPH.90.1.70; Engels F., 1993, CONDITION WORKING CL; Gilbert L, 1996, SOC SCI MED, V43, P873, DOI 10.1016/0277-9536(96)00131-1; Hox JJ, 2010, MULTILEVEL ANAL TECH, V2nd; Hsieh C.-C., 1993, CRIMINAL JUSTICE REV, V18, P182, DOI [10.1177/073401689301800203, DOI 10.1177/073401689301800203]; Jewkes R, 2002, SOC SCI MED, V55, P1603, DOI 10.1016/S0277-9536(01)00294-5; LEGGETT T, 2004, S AFR CRIME Q, V7, P15; MATZOPOULOS R, 2004, VIOLENCE INJURY PREV, P9; MATZOPOULOS R, 2003, 4 MED RES COUNC NAT, P1; MERTON RK, 1957, SOCIAL THEORY SOCIAL, P185; Myer L, 2004, EPIDEMIOL REV, V26, P112, DOI 10.1093/epirev/mxh004; Pick WM, 2002, SOC SCI MED, V54, P193, DOI 10.1016/S0277-9536(01)00288-X; PRINSLOO M, 2004, INJURY SAFETY MONITO, V3, P5; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Rothman K., 1998, MODERN EPIDEMIOLOGY; *S AFR DEM HLTH SU, 1998, FULL REP; *STAT S AFR, 2007, PEOPLE S AFR POP CEN; Stein DJ, 2002, SAMJ S AFR MED J, V92, P789; THOMSON JDS, 2004, S AFR CRIME Q, V7, P9	22	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1290	10.1371/journal.pone.0001290	http://dx.doi.org/10.1371/journal.pone.0001290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074015	Green Published, gold			2022-12-27	WOS:000207459500009
J	Hsu, R; Woodroffe, A; Lai, WS; Cook, MN; Mukai, J; Dunning, JP; Swanson, DJ; Roos, JL; Abecasis, GR; Karayiorgou, M; Gogos, JA				Hsu, Ruby; Woodroffe, Abigail; Lai, Wen-Sung; Cook, Melloni N.; Mukai, Jun; Dunning, Jonathan P.; Swanson, Douglas J.; Roos, J. Louw; Abecasis, Goncalo R.; Karayiorgou, Maria; Gogos, Joseph A.			Nogo Receptor 1 (RTN4R) as a Candidate Gene for Schizophrenia: Analysis Using Human and Mouse Genetic Approaches	PLOS ONE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; 22Q11.2 DELETION SYNDROME; PREPULSE INHIBITION; SEQUENCE VARIANTS; NMDA RECEPTORS; WORKING-MEMORY; ANIMAL-MODELS; FAMILY-MEMBER; BINDS NOGO-66; CHILDREN	Background. NOGO Receptor 1 (RTN4R) regulates axonal growth, as well as axon regeneration after injury. The gene maps to the 22q11.2 schizophrenia susceptibility locus and is thus a strong functional and positional candidate gene. Methodology/Principal Findings. We evaluate evidence for genetic association between common RTN4R polymorphisms and schizophrenia in a large family sample of Afrikaner origin and screen the exonic sequence of RTN4R for rare variants in an independent sample from the U. S. We also employ animal model studies to assay a panel of schizophrenia-related behavioral tasks in an Rtn4r-deficient mouse model. We found weak sex-specific evidence for association between common RTN4R polymorphisms and schizophrenia in the Afrikaner patients. In the U. S. sample, we identified two novel non-conservative RTN4R coding variants in two patients with schizophrenia that were absent in 600 control chromosomes. In our complementary mouse model studies, we identified a haploinsufficient effect of Rtn4r on locomotor activity, but normal performance in schizophrenia-related behavioral tasks. We also provide evidence that Rtn4r deficiency can modulate the long-term behavioral effects of transient postnatal N-methyl-D-aspartate (NMDA) receptor hypofunction. Conclusions. Our results do not support a major role of RTN4R in susceptibility to schizophrenia or the cognitive and behavioral deficits observed in individuals with 22q11 microdeletions. However, they suggest that RTN4R may modulate the genetic risk or clinical expression of schizophrenia in a subset of patients and identify additional studies that will be necessary to clarify the role of RTN4R in psychiatric phenotypes. In addition, our results raise interesting issues about evaluating the significance of rare genetic variants in disease and their role in causation.	[Karayiorgou, Maria] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA; [Hsu, Ruby; Gogos, Joseph A.] Columbia Univ, Dept Neurosci, New York, NY USA; [Woodroffe, Abigail] Univ Michigan, Dept Epidemiol, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Lai, Wen-Sung; Mukai, Jun; Gogos, Joseph A.] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY USA; [Cook, Melloni N.; Dunning, Jonathan P.] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA; [Swanson, Douglas J.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Roos, J. Louw] Univ Pretoria, Dept Psychiat, ZA-0002 Pretoria, South Africa; [Abecasis, Goncalo R.] Weskoppies Hosp, Pretoria, South Africa; [Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA	Columbia University; Columbia University; University of Michigan System; University of Michigan; Columbia University; University of Memphis; University of Tennessee System; University of Tennessee Health Science Center; University of Pretoria; University of Michigan System; University of Michigan	Karayiorgou, M (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA.	mk2758@columbia.edu; jag90@columbia.edu	Abecasis, Goncalo R/B-7840-2010	Roos, Johannes/0000-0002-0572-1072; Mukai, Jun/0000-0003-2065-4784; Lai, Wen-Sung/0000-0001-6918-5531; Abecasis, Goncalo/0000-0003-1509-1825	National Institutes of Health [MH67068, MH61399, U01-MH61971]; New York Academy of Sciences; HHMI; NARSAD Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061399, U01MH061971, R01MH067068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Academy of Sciences; HHMI(Howard Hughes Medical Institute); NARSAD Young Investigator Award(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported in part by the National Institutes of Health (grant MH67068 to MK and JAG, MH61399 to MK, and U01-MH61971 to Tennessee Mouse Genome Consortium) and by the New York Academy of Sciences (JAG). RH is supported by an HHMI pre-doctoral fellowship. JM is supported by a NARSAD Young Investigator Award. JAG is also the recipient of a McKnight Brain Disorders Award, and a NARSAD Award.	Abecasis GR, 2004, AM J HUM GENET, V74, P403, DOI 10.1086/381713; Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Altshuler D, 2005, J CLIN INVEST, V115, P831, DOI 10.1172/JCI200524715; American Psychiatric Association, 1994, DSM IV DIAGN STAT MA; Antshel KM, 2005, CHILD NEUROPSYCHOL, V11, P5, DOI 10.1080/09297040590911185; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Bearden CE, 2001, J CLIN EXP NEUROPSYC, V23, P447, DOI 10.1076/jcen.23.4.447.1228; Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Cannon TD, 2000, AM J HUM GENET, V67, P369, DOI 10.1086/303006; Chow EWC, 2006, SCHIZOPHR RES, V87, P270, DOI 10.1016/j.schres.2006.04.007; CLONINGER CR, 1989, COMPREHENSIVE TXB PS; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Colonnese MT, 2006, J COMP NEUROL, V494, P738, DOI 10.1002/cne.20841; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Ellenbroek BA, 2000, BEHAV PHARMACOL, V11, P223, DOI 10.1097/00008877-200006000-00006; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; FALLIN MD, 2006, 2076 ASHG M; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Franks KM, 2005, NEURON, V47, P101, DOI 10.1016/j.neuron.2005.05.024; Gogos JA, 1999, NAT GENET, V21, P434, DOI 10.1038/7777; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Harris LW, 2003, EUR J NEUROSCI, V18, P1706, DOI 10.1046/j.1460-9568.2003.02902.x; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Karayiorgou M, 2004, AM J MED GENET B, V124B, P20, DOI 10.1002/ajmg.b.20090; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Keen-Kim D, 2006, HUM MOL GENET, V15, P3324, DOI 10.1093/hmg/ddl408; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lee LJ, 2005, J COMP NEUROL, V485, P280, DOI 10.1002/cne.20481; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; MANSCHRECK TC, 1984, BIOL PSYCHIAT, V19, P703; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Meng J, 2007, J NEURAL TRANSM, V114, P249, DOI 10.1007/s00702-006-0538-y; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mitchell AA, 2005, GENOME RES, V15, P960, DOI 10.1101/gr.3761405; MORROW B, 1995, AM J HUM GENET, V56, P1391; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Novak G, 2002, MOL BRAIN RES, V107, P183, DOI 10.1016/S0169-328X(02)00492-8; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PIERCE T, 2006, 14 WORLD C PSYCH GEN, P179; Porsolt RD, 2000, REV NEUROSCIENCE, V11, P53; Puech A, 1997, P NATL ACAD SCI USA, V94, P14608, DOI 10.1073/pnas.94.26.14608; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Putzhammer Albert, 2006, Dialogues Clin Neurosci, V8, P123; Raux G, 2007, HUM MOL GENET, V16, P83, DOI 10.1093/hmg/ddl443; Seeger T, 2004, J NEUROSCI, V24, P10117, DOI 10.1523/JNEUROSCI.3581-04.2004; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Shprintzen RJ, 2000, MENT RETARD DEV D R, V6, P142, DOI 10.1002/1098-2779(2000)6:2<142::AID-MRDD9>3.0.CO;2-H; Simon TJ, 2005, NEUROIMAGE, V25, P169, DOI 10.1016/j.neuroimage.2004.11.018; Sinibaldi Lorenzo, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9292; Sobin C, 2005, CHILD NEUROPSYCHOL, V11, P39, DOI 10.1080/09297040590911167; Sobin C, 2005, AM J PSYCHIAT, V162, P1090, DOI 10.1176/appi.ajp.162.6.1090; Sobin C, 2006, MOVEMENT DISORD, V21, P2082, DOI 10.1002/mds.21103; Stefani MR, 2005, BIOL PSYCHIAT, V57, P433, DOI 10.1016/j.biopsych.2004.11.031; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Van Amelsvoort T, 2001, BRIT J PSYCHIAT, V178, P412; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Woodin M, 2001, GENET MED, V3, P34, DOI 10.1097/00125817-200101000-00008	78	49	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1234	10.1371/journal.pone.0001234	http://dx.doi.org/10.1371/journal.pone.0001234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043741	Green Published, gold			2022-12-27	WOS:000207459300015
J	Medina, DC; Findley, SE; Guindo, B; Doumbia, S				Medina, Daniel C.; Findley, Sally E.; Guindo, Boubacar; Doumbia, Seydou			Forecasting Non-Stationary Diarrhea, Acute Respiratory Infection, and Malaria Time-Series in Niono, Mali	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; WEATHER-BASED PREDICTION; EPIDEMIC-PRONE REGIONS; SYNCYTIAL VIRUS; SEASONAL-VARIATION; CLIMATE-CHANGE; PATTERNS; ETHIOPIA; IMPACT; RISK	Background. Much of the developing world, particularly sub-Saharan Africa, exhibits high levels of morbidity and mortality associated with diarrhea, acute respiratory infection, and malaria. With the increasing awareness that the aforementioned infectious diseases impose an enormous burden on developing countries, public health programs therein could benefit from parsimonious general-purpose forecasting methods to enhance infectious disease intervention. Unfortunately, these disease time-series often i) suffer from non-stationarity; ii) exhibit large inter-annual plus seasonal fluctuations; and, iii) require disease-specific tailoring of forecasting methods. Methodology/Principal Findings. In this longitudinal retrospective (01/1996-06/2004) investigation, diarrhea, acute respiratory infection of the lower tract, and malaria consultation time-series are fitted with a general-purpose econometric method, namely the multiplicative Holt-Winters, to produce contemporaneous on-line forecasts for the district of Niono, Mali. This method accommodates seasonal, as well as inter-annual, fluctuations and produces reasonably accurate median 2- and 3-month horizon forecasts for these non-stationary time-series, i.e., 92% of the 24 time-series forecasts generated (2 forecast horizons, 3 diseases, and 4 age categories = 24 time-series forecasts) have mean absolute percentage errors circa 25%. Conclusions/Significance. The multiplicative Holt-Winters forecasting method: i) performs well across diseases with dramatically distinct transmission modes and hence it is a strong general-purpose forecasting method candidate for non-stationary epidemiological time-series; ii) obliquely captures prior non-linear interactions between climate and the aforementioned disease dynamics thus, obviating the need for more complex disease-specific climate-based parametric forecasting methods in the district of Niono; furthermore, iii) readily decomposes time-series into seasonal components thereby potentially assisting with programming of public health interventions, as well as monitoring of disease dynamics modification. Therefore, these forecasts could improve infectious diseases management in the district of Niono, Mali, and elsewhere in the Sahel.	[Findley, Sally E.] Columbia Univ, Mailman Sch Publ Hlth, Dept Populat & Family Hlth, New York, NY 10027 USA; [Medina, Daniel C.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Medina, Daniel C.; Guindo, Boubacar; Doumbia, Seydou] Univ Bamako, FMPOS, Malaria Res & Training Ctr, Bamako, Mali	Columbia University; Columbia University; University of Bamako	Findley, SE (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Populat & Family Hlth, New York, NY 10027 USA.	sef5@columbia.edu			The Climate and Society Program ( Earth Institute, Columbia University, New York, NY, USA)	The Climate and Society Program ( Earth Institute, Columbia University, New York, NY, USA)	The Climate and Society Program ( Earth Institute, Columbia University, New York, NY, USA) partially funded data collection and analyses.	Abeku TA, 2002, TROP MED INT HEALTH, V7, P851, DOI 10.1046/j.1365-3156.2002.00924.x; ADAMS AM, 1994, ECOL FOOD NUTR, V33, P93, DOI 10.1080/03670244.1994.9991418; Baird JK, 2002, AM J TROP MED HYG, V66, P280, DOI 10.4269/ajtmh.2002.66.280; Bloland PB, 2002, MALARIA CONTROL MASS; Breman JG, 2001, AM J TROP MED HYG, V64, P1; BREWSTER DR, 1993, ANN TROP PAEDIATR, V13, P133, DOI 10.1080/02724936.1993.11747637; Burkom HS, 2007, STAT MED, V26, P4202, DOI 10.1002/sim.2835; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Callejas D, 1999, Invest Clin, V40, P81; Chambers Robert., 1981, SEASONAL DIMENSIONS; Chatfield C, 2001, J ROY STAT SOC D-STA, V50, P147, DOI 10.1111/1467-9884.00267; Chaves LF, 2006, PLOS MED, V3, P1320, DOI 10.1371/journal.pmed.0030295; Checon RE, 2002, AM J TROP MED HYG, V67, P490, DOI 10.4269/ajtmh.2002.67.490; Cleveland R.B., 1990, J OFF STAT, V6, P3; Connor SJ, 1998, DISASTERS, V22, P39, DOI 10.1111/1467-7717.00074; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; *DIV SERV SOC, 2005, DIS STAT DISTR GAO M; *DIV SERV SOC, 1996, DIS STAT DISTR NION; Duffy PE, 2005, CURR TOP MICROBIOL, V295, P169; Gemperli A, 2004, AM J EPIDEMIOL, V159, P64, DOI 10.1093/aje/kwh001; Gijbels I, 1999, J ROY STAT SOC B, V61, P39, DOI 10.1111/1467-9868.00161; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Hay SI, 2003, LANCET, V361, P1705, DOI 10.1016/S0140-6736(03)13366-1; HOLT CC, 1957, ONR RES MEMORANDUM, V52; Hyndman RJ, 2002, INT J FORECASTING, V18, P439, DOI 10.1016/S0169-2070(01)00110-8; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P779, DOI 10.1046/j.1365-3156.2001.00790.x; LAMB PJ, 1978, TELLUS, V30, P240, DOI 10.1111/j.2153-3490.1978.tb00839.x; Makridakis S, 2000, INT J FORECASTING, V16, P451, DOI 10.1016/S0169-2070(00)00057-1; Musa HA, 1999, J APPL MICROBIOL, V87, P676, DOI 10.1046/j.1365-2672.1999.00907.x; National Research Council, 2001, WEATH CLIM EC INF DI; Ord JK, 1997, J AM STAT ASSOC, V92, P1621, DOI 10.2307/2965433; ORD JK, 1990, P DEC SCI I, P555; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Phillips-Howard PA, 1999, ANN TROP MED PARASIT, V93, pS11, DOI 10.1080/00034989957691; Politis DN, 2003, STAT SCI, V18, P219, DOI 10.1214/ss/1063994977; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Singh RBK, 2001, ENVIRON HEALTH PERSP, V109, P155, DOI 10.2307/3434769; Siritantikorn Sontana, 2002, Journal of the Medical Association of Thailand, V85, pS1167; Small J, 2003, P NATL ACAD SCI USA, V100, P15341, DOI 10.1073/pnas.2236969100; Sugaya N, 2000, J MED VIROL, V60, P102, DOI 10.1002/(SICI)1096-9071(200001)60:1&lt;102::AID-JMV17&gt;3.0.CO;2-D; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-44; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-41; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; *USAID, 2004, COUNTR HLTH REP MAL; van der Sande MAB, 2004, PEDIATR INFECT DIS J, V23, P73, DOI 10.1097/01.inf.0000105183.12781.06; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; Weber MW, 2002, B WORLD HEALTH ORGAN, V80, P562; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; WINTERS PR, 1960, MANAGE SCI, V6, P324, DOI 10.1287/mnsc.6.3.324	55	34	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1181	10.1371/journal.pone.0001181	http://dx.doi.org/10.1371/journal.pone.0001181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030322	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459200001
J	Stevenson, B; Choy, HA; Pinne, M; Rotondi, ML; Miller, MC; DeMoll, E; Kraiczy, P; Cooley, AE; Creamer, TP; Suchard, MA; Brissette, CA; Verma, A; Haake, DA				Stevenson, Brian; Choy, Henry A.; Pinne, Marija; Rotondi, Matthew L.; Miller, M. Clarke; DeMoll, Edward; Kraiczy, Peter; Cooley, Anne E.; Creamer, Trevor P.; Suchard, Marc A.; Brissette, Catherine A.; Verma, Ashutosh; Haake, David A.			Leptospira interrogans Endostatin-Like Outer Membrane Proteins Bind Host Fibronectin, Laminin and Regulators of Complement	PLOS ONE			English	Article							SURFACE-EXPOSED LIPOPROTEIN; H-RELATED PROTEINS; SECONDARY STRUCTURE; ANTILEPTOSPIRAL ACTIVITY; MOLECULAR-CLONING; SEQUENCE-ANALYSIS; EXPRESSION; SERUM; IDENTIFICATION; TEMPERATURE	The pathogenic spirochete Leptospira interrogans disseminates throughout its hosts via the bloodstream, then invades and colonizes a variety of host tissues. Infectious leptospires are resistant to killing by their hosts' alternative pathway of complement-mediated killing, and interact with various host extracellular matrix (ECM) components. The LenA outer surface protein (formerly called LfhA and Lsa24) was previously shown to bind the host ECM component laminin and the complement regulators factor H and factor H-related protein-1. We now demonstrate that infectious L. interrogans contain five additional paralogs of lenA, which we designated lenB, lenC, lenD, lenE and lenF. All six genes encode domains predicted to bear structural and functional similarities with mammalian endostatins. Sequence analyses of genes from seven infectious L. interrogans serovars indicated development of sequence diversity through recombination and intragenic duplication. LenB was found to bind human factor H, and all of the newly-described Len proteins bound laminin. In addition, LenB, LenC, LenD, LenE and LenF all exhibited affinities for fibronectin, a distinct host extracellular matrix protein. These characteristics suggest that Len proteins together facilitate invasion and colonization of host tissues, and protect against host immune responses during mammalian infection.	[Stevenson, Brian; Cooley, Anne E.; Brissette, Catherine A.; Verma, Ashutosh] Univ Kentucky, Coll Med, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40506 USA; [Choy, Henry A.; Pinne, Marija; Haake, David A.] Vet Affairs Greater Los Angeles Hlth Care Syst, Div Infect Dis, Los Angeles, CA USA; [Choy, Henry A.; Pinne, Marija; Haake, David A.] Univ Calif Los Angeles, Dept Med, Sch Med, Los Angeles, CA 90024 USA; [Rotondi, Matthew L.; Miller, M. Clarke; DeMoll, Edward] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; [Kraiczy, Peter] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Creamer, Trevor P.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA; [Suchard, Marc A.] Univ Calif Los Angeles, Sch Med, Dept Biomath, Los Angeles, CA 90024 USA; [Verma, Ashutosh] Univ Kentucky, Dept Vet Sci, Lexington, KY 40546 USA	University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Kentucky; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Kentucky; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Kentucky	Stevenson, B (corresponding author), Univ Kentucky, Coll Med, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40506 USA.	brian.stevenson@uky.edu	Miller, M. Clarke/C-9483-2011; Creamer, Trevor P/A-5252-2008	Miller, M. Clarke/0000-0002-9877-6581; Brissette, Catherine/0000-0003-0792-1403	VA Medical Research funds; National 10 Institute of Allergy and Infectious Diseases [AI-34431]; Paul Mellon Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI034431, R01AI034431, R29AI034431] Funding Source: NIH RePORTER	VA Medical Research funds(US Department of Veterans Affairs); National 10 Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Paul Mellon Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by VA Medical Research funds and National 10 Institute of Allergy and Infectious Diseases grant AI-34431 to D. Haake. M. Suchard is an Alfred P. Sloan Research Fellow. A. Verma was supported by a Paul Mellon Fellowship in Equine Studies.	ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222; Artiushin S, 2004, INFECT IMMUN, V72, P742, DOI 10.1128/IAI.72.2.742-749.2004; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; BRANDTS JF, 1973, BIOCHEMISTRY-US, V12, P2011, DOI 10.1021/bi00734a027; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Cinco M, 2002, MICROB PATHOGENESIS, V33, P299, DOI 10.1006/mpat.2002.0537; CINCO M, 1983, ZBL BAKT-INT J MED M, V254, P261; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; DiScipio RG, 1998, J IMMUNOL, V160, P4057; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; Force A, 1999, GENETICS, V151, P1531; Gogarten JP, 1999, CURR OPIN GENET DEV, V9, P630, DOI 10.1016/S0959-437X(99)00029-5; Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491; Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004; Haake DA, 1998, INFECT IMMUN, V66, P1579, DOI 10.1128/IAI.66.4.1579-1587.1998; HAAKE DA, 1993, J BACTERIOL, V175, P4225, DOI 10.1128/JB.175.13.4225-4234.1993; Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942; Haake DA, 2002, INFECT IMMUN, V70, P4936, DOI 10.1128/IAI.70.9.4936-4945.2002; HAAKE DA, 1991, INFECT IMMUN, V59, P1131, DOI 10.1128/IAI.59.3.1131-1140.1991; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hellwage J, 1999, FEBS LETT, V462, P345, DOI 10.1016/S0014-5793(99)01554-9; Hellwage J, 2006, IMMUNOGENETICS, V58, P883, DOI 10.1007/s00251-006-0153-y; Hohenester E, 1998, EMBO J, V17, P1656, DOI 10.1093/emboj/17.6.1656; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; ITO T, 1987, JPN J VET SCI, V49, P875; JOHNSON RC, 1965, J BACTERIOL, V89, P1625, DOI 10.1128/JB.89.6.1625-1626.1965; JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967; JOHNSON RC, 1966, J BACTERIOL, V91, P1403, DOI 10.1128/JB.91.4.1403-1409.1966; JOHNSON RC, 1967, J BACTERIOL, V93, P513, DOI 10.1128/JB.93.2.513-519.1967; Jokiranta TS, 2005, AM J PATHOL, V167, P1173, DOI 10.1016/S0002-9440(10)61205-9; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Lo M, 2006, INFECT IMMUN, V74, P5848, DOI 10.1128/IAI.00755-06; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Malhotra R, 1999, BIOCHEM J, V341, P61, DOI 10.1042/0264-6021:3410061; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Marneros AG, 2005, FASEB J, V19, P716, DOI 10.1096/fj.04-2134rev; Matsunaga J, 2007, MICROBIOL-SGM, V153, P3390, DOI 10.1099/mic.0.2007/007948-0; Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06; Matsunaga J, 2006, MICROBIOL-SGM, V152, P3777, DOI 10.1099/mic.0.29162-0; McRae JL, 2005, J IMMUNOL, V174, P6250, DOI 10.4049/jimmunol.174.10.6250; Meri T, 2005, MICROB PATHOGENESIS, V39, P139, DOI 10.1016/j.micpath.2005.07.003; Merien F, 2000, FEMS MICROBIOL LETT, V185, P17, DOI 10.1111/j.1574-6968.2000.tb09034.x; Nally JE, 2005, INFECT IMMUN, V73, P3251, DOI 10.1128/IAI.73.6.3251-3260.2005; Nally JE, 2001, INFECT IMMUN, V69, P400, DOI 10.1128/IAI.69.1.400-404.2001; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Park CT, 1996, J BIOL CHEM, V271, P18054, DOI 10.1074/jbc.271.30.18054; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Saito A, 2007, BBA-GEN SUBJECTS, V1770, P241, DOI 10.1016/j.bbagen.2006.10.015; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; Shang ES, 1996, INFECT IMMUN, V64, P2322, DOI 10.1128/IAI.64.6.2322-2330.1996; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stevenson B, 2002, INFECT IMMUN, V70, P491, DOI 10.1128/IAI.70.2.491-497.2002; Suchard MA, 2005, GENETICS, V170, P419, DOI 10.1534/genetics.103.025692; Suchard MA, 2002, SYST BIOL, V51, P715, DOI 10.1080/10635150290102384; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Putten JPM, 1998, MOL MICROBIOL, V29, P369, DOI 10.1046/j.1365-2958.1998.00951.x; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vaziri-Sani F, 2005, J THROMB HAEMOST, V3, P154, DOI 10.1111/j.1538-7836.2004.01010.x; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	71	154	159	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1188	10.1371/journal.pone.0001188	http://dx.doi.org/10.1371/journal.pone.0001188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000555	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459100026
J	Paaijmans, KP; Wandago, MO; Githeko, AK; Takken, W				Paaijmans, Krijn P.; Wandago, Moses O.; Githeko, Andrew K.; Takken, Willem			Unexpected High Losses of Anopheles gambiae Larvae Due to Rainfall	PLOS ONE			English	Article							SENSU-STRICTO DIPTERA; AQUATIC STAGES; CULICIDAE LARVAE; CLIMATE-CHANGE; GILES COMPLEX; SURVIVORSHIP; TEMPERATURE; ARABIENSIS; HABITATS; SURVIVAL	Background. Immature stages of the malaria mosquito Anopheles gambiae experience high mortality, but its cause is poorly understood. Here we study the impact of rainfall, one of the abiotic factors to which the immatures are frequently exposed, on their mortality. Methodology/Principal Findings. We show that rainfall significantly affected larval mosquitoes by flushing them out of their aquatic habitat and killing them. Outdoor experiments under natural conditions in Kenya revealed that the additional nightly loss of larvae caused by rainfall was on average 17.5% for the youngest (L1) larvae and 4.8% for the oldest (L4) larvae; an additional 10.5% (increase from 0.9 to 11.4%) of the L1 larvae and 3.3% (from 0.1 to 3.4%) of the L4 larvae were flushed away and larval mortality increased by 6.9% (from 4.6 to 11.5%) and 1.5% (from 4.1 to 5.6%) for L1 and L4 larvae, respectively, compared to nights without rain. On rainy nights, 1.3% and 0.7% of L1 and L4 larvae, respectively, were lost due to ejection from the breeding site. Conclusions/Significance. This study demonstrates that immature populations of malaria mosquitoes suffer high losses during rainfall events. As these populations are likely to experience several rain showers during their lifespan, rainfall will have a profound effect on the productivity of mosquito breeding sites and, as a result, on the transmission of malaria. These findings are discussed in the light of malaria risk and changing rainfall patterns in response to climate change.	[Paaijmans, Krijn P.; Wandago, Moses O.; Takken, Willem] Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands; [Githeko, Andrew K.] Kenya Govt Med Res Ctr, Climate & Human Hlth Res Unit, Kisumu, Kenya	Wageningen University & Research; Kenya Medical Research Institute	Paaijmans, KP (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands.	krijn@paaijmans.nl	Paaijmans, Krijn/ABC-9928-2020		Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO) [WB93-409]	Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO; WB93-409).	ANIEDU I, 1993, INSECT SCI APPL, V14, P39, DOI 10.1017/S1742758400013370; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; BAYOH MN, 2001, STUDIES DEV SURVIVAL, P134; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Charlwood JD, 1996, J MED ENTOMOL, V33, P202, DOI 10.1093/jmedent/33.2.202; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Edillo FE, 2004, J MED ENTOMOL, V41, P333, DOI 10.1603/0022-2585-41.3.333; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; Gillies M, 1987, PUBL S AFRI CAN I ME, V55, P1; Gillies M. T., 1968, PUBL S AFR I MED RES, V54, P343; Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162; Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; JEPSON WF, 1947, B ENTOMOL RES, V38, P177, DOI 10.1017/S0007485300030273; Koenraadt CJM, 2004, ACTA TROP, V90, P141, DOI 10.1016/j.actatropica.2003.11.007; Koenraadt CJM, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-20; Koenraadt CJM, 2003, MED VET ENTOMOL, V17, P61, DOI 10.1046/j.1365-2915.2003.00409.x; Lines J., 1995, INSECTS CHANGING ENV, P157; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; MARTENS WJM, 1995, GLOBAL ENVIRON CHANG, V5, P195, DOI 10.1016/0959-3780(95)00051-O; McMichael A J., 1996, CLIMATE CHANGE HUMAN, P297; Miller JR, 2007, NATURWISSENSCHAFTEN, V94, P195, DOI 10.1007/s00114-006-0178-y; Mutuku FM, 2006, AM J TROP MED HYG, V74, P54, DOI 10.4269/ajtmh.2006.74.54; Okogun Godwin R. A., 2005, Journal of Vector Borne Diseases, V42, P1; Robert V, 1999, PARASITE, V6, P195; Romoser WS, 1999, J AM MOSQUITO CONTR, V15, P194; ROMOSER WS, 1994, J AM MOSQUITO CONTR, V10, P10; RUSSELL PF, 1946, PRACTICAL MALARIOLOG, P555; Schneider P, 2000, MED VET ENTOMOL, V14, P165, DOI 10.1046/j.1365-2915.2000.00204.x; SERVICE MW, 1971, B WORLD HEALTH ORGAN, V45, P169; SERVICE MW, 1977, J MED ENTOMOL, V13, P535, DOI 10.1093/jmedent/13.4-5.535; SERVICE MW, 1973, B ENTOMOL RES, V62, P359, DOI 10.1017/S0007485300003862; SERVICE MW, 1993, MOSQUITO ECOLOGY FIE, P988; Shaman J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000331; Timmermann S. E., 1993, Bulletin of the Society for Vector Ecology, V18, P174; Tuno N, 2005, J MED ENTOMOL, V42, P270, DOI 10.1603/0022-2585(2005)042[0270:SOAGSS]2.0.CO;2; Tuno N, 2004, J MED ENTOMOL, V41, P810, DOI 10.1603/0022-2585-41.4.810; Tuno N, 2007, J VECTOR ECOL, V32, P112, DOI 10.3376/1081-1710(2007)32[112:IVIDAA]2.0.CO;2; *WHO, 2005, WHOHTMMAL20051102, P293	40	154	159	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1146	10.1371/journal.pone.0001146	http://dx.doi.org/10.1371/journal.pone.0001146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987125	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459000029
J	Margineantu, DH; Emerson, CB; Diaz, D; Hockenbery, DM				Margineantu, Daciana H.; Emerson, Christine B.; Diaz, Dolores; Hockenbery, David M.			Hsp90 Inhibition Decreases Mitochondrial Protein Turnover	PLOS ONE			English	Article								Background. Cells treated with hsp90 inhibitors exhibit pleiotropic changes, including an expansion of the mitochondrial compartment, accompanied by mitochondrial fragmentation and condensed mitochondrial morphology, with ultimate compromise of mitochondrial integrity and apoptosis. Findings. We identified several mitochondrial oxidative phosphorylation complex subunits, including several encoded by mtDNA, that are upregulated by hsp90 inhibitors, without corresponding changes in mRNA abundance. Post-transcriptional accumulation of mitochondrial proteins observed with hsp90 inhibitors is also seen in cells treated with proteasome inhibitors. Detailed studies of the OSCP subunit of mitochondrial F1F0-ATPase revealed the presence of mono- and polyubiquitinated OSCP in mitochondrial fractions. We demonstrate that processed OSCP undergoes retrotranslocation to a trypsin-sensitive form associated with the outer mitochondrial membrane. Inhibition of proteasome or hsp90 function results in accumulation of both correctly targeted and retrotranslocated mitochondrial OSCP. Conclusions. Cytosolic turnover of mitochondrial proteins demonstrates a novel connection between mitochondrial and cytosolic compartments through the ubiquitin-proteasome system. Analogous to defective protein folding in the endoplasmic reticulum, a mitochondrial unfolded protein response may play a role in the apoptotic effects of hsp90 and proteasome inhibitors.	[Margineantu, Daciana H.; Emerson, Christine B.; Diaz, Dolores; Hockenbery, David M.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Margineantu, Daciana H.; Emerson, Christine B.; Diaz, Dolores; Hockenbery, David M.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Hockenbery, DM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	dhockenb@fhcrc.org			NIH [104402]; Amgen Interdisciplinary Fellowship Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056761] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen Interdisciplinary Fellowship Fund(Amgen); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH (RO1 grant # 104402) and Amgen Interdisciplinary Fellowship Fund.	Abu-Farha M, 2005, BIOCHEM CELL BIOL, V83, P620, DOI 10.1139/o05-045; Blagosklonny MV, 2001, LEUKEMIA, V15, P1537, DOI 10.1038/sj.leu.2402257; Chillaron J, 2000, MOL BIOL CELL, V11, P217, DOI 10.1091/mbc.11.1.217; Chiosis G, 2001, CHEM BIOL, V8, P289, DOI 10.1016/S1074-5521(01)00015-1; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hanson BJ, 2001, J BIOL CHEM, V276, P16296, DOI 10.1074/jbc.M011162200; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Jarosch E, 2003, INT REV CYTOL, V223, P39; Jeon HB, 2007, BIOCHEM BIOPH RES CO, V357, P731, DOI 10.1016/j.bbrc.2007.04.015; Kawai A, 2006, BIOCHEM BIOPH RES CO, V351, P71, DOI 10.1016/j.bbrc.2006.09.168; Liao W, 2006, J CELL BIOCHEM, V99, P1085, DOI 10.1002/jcb.20996; Lopez-Maderuelo MD, 2001, FEBS LETT, V490, P23, DOI 10.1016/S0014-5793(01)02130-5; Mancini M, 1997, J CELL BIOL, V138, P449, DOI 10.1083/jcb.138.2.449; Mancini M, 1998, ANN SURG ONCOL, V5, P287, DOI 10.1007/BF02303787; Mancini R, 2000, FASEB J, V14, P769, DOI 10.1096/fasebj.14.5.769; Maor R, 2007, MOL CELL PROTEOMICS, V6, P601, DOI 10.1074/mcp.M600408-MCP200; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Minnnaugh EG, 2004, MOL CANCER THER, V3, P551; Morrish F, 2003, GENE DEV, V17, P240, DOI 10.1101/gad.1032503; Munster PN, 2002, CANCER RES, V62, P3132; Nimmanapalli R, 2003, BLOOD, V102, P269, DOI 10.1182/blood-2002-12-3718; PAVLICA RJ, 1990, BIOCHIM BIOPHYS ACTA, V1022, P115, DOI 10.1016/0005-2736(90)90407-F; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prescott M, 1997, FEBS LETT, V411, P97, DOI 10.1016/S0014-5793(97)00670-4; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; SCALETTAR BA, 1991, P NATL ACAD SCI USA, V88, P8057, DOI 10.1073/pnas.88.18.8057; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Sirk DP, 2003, CYTOM PART A, V56A, P15, DOI 10.1002/cyto.a.10084; Smith V, 2002, ANTICANCER RES, V22, P1993; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Tateishi Y, 2006, MOL CELL BIOL, V26, P7966, DOI 10.1128/MCB.00713-06; Thompson WE, 2003, BIOL REPROD, V69, P254, DOI 10.1095/biolreprod.102.010975; Weekes J, 2003, PROTEOMICS, V3, P208, DOI 10.1002/pmic.200390029; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9; Zhao M, 2000, LEUKEMIA, V14, P374, DOI 10.1038/sj.leu.2401680	42	118	119	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1066	10.1371/journal.pone.0001066	http://dx.doi.org/10.1371/journal.pone.0001066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957250	Green Submitted, Green Published, gold			2022-12-27	WOS:000207458500013
J	Abboud, S; Karhunen, PJ; Lutjohann, D; Goebeler, S; Luoto, T; Friedrichs, S; Lehtimaki, T; Pandolfo, M; Laaksonen, R				Abboud, Sherine; Karhunen, Pekka J.; Luetjohann, Dieter; Goebeler, Sirkka; Luoto, Teemu; Friedrichs, Silvia; Lehtimaki, Terho; Pandolfo, Massimo; Laaksonen, Reijo			Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gene Is a Risk Factor of Large-Vessel Atherosclerosis Stroke	PLOS ONE			English	Article								Background/Purpose. Genetic variation in proprotein convertase subtilisin/kexin type 9 (PCSK9) gene has been recently identified as an important determinant of plasma LDL-cholesterol and severity of coronary heart disease. We studied whether the PCSK9 gene is linked to the risk of ischemic stroke (IS) and with the development of intracranial atherosclerosis. Methods/Results. The pivotal E670G polymorphism, tagging an important haplotype of the PCSK9 gene, was genotyped in two independent studies. The Belgium Stroke Study included 237 middle aged (45-60) Belgian patients, with small-vessel occlusion (SVO) and large-vessel atherosclerosis stroke (LVA), and 326 gender and ethnicity matched controls (>60 yrs) without a history of stroke. In multivariate analysis the minor allele (G) carriers appeared as a significant predictor of LVA (OR = 3.52, 95% CI 1.25-9.85; p = 0.017). In a Finnish crossectional population based consecutive autopsy series of 604 males and females (mean age 62.5 years), G-allele carriers tended to have more severe allele copy number-dependent (p = 0.095) atherosclerosis in the circle of Willis and in its branches. Conclusion. Our findings in this unique combination of clinical and autopsy data, provide evidence that PCSK9 gene associates with the risk of LVA stroke subtype, and suggest that the risk is mediated by the severity of intracranial atherosclerosis.	[Abboud, Sherine; Pandolfo, Massimo; Laaksonen, Reijo] Univ Libre Bruxelles, Erasme Hosp, Dept Neurol, Lab Expt Neurol, Brussels, Belgium; [Karhunen, Pekka J.; Goebeler, Sirkka; Luoto, Teemu] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Karhunen, Pekka J.; Goebeler, Sirkka; Luoto, Teemu] Tampere Univ Hosp, Res Unit Lab Ctr, Tampere, Finland; [Luetjohann, Dieter; Friedrichs, Silvia] Univ Bonn, Dept Clin Pharmacol, D-5300 Bonn, Germany; [Abboud, Sherine; Lehtimaki, Terho; Laaksonen, Reijo] Tampere Univ Hosp, Dept Clin Chem, Lab Atherosclerosis Genet, Tampere, Finland; [Abboud, Sherine; Lehtimaki, Terho; Laaksonen, Reijo] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland	Universite Libre de Bruxelles; Tampere University; Tampere University; Tampere University Hospital; University of Bonn; Tampere University; Tampere University Hospital; Tampere University	Abboud, S (corresponding author), Univ Libre Bruxelles, Erasme Hosp, Dept Neurol, Lab Expt Neurol, Brussels, Belgium.	shabboud@ulb.ac.be	Lehtimäki, Terho/AAD-1094-2022; Luoto, Teemu/W-6468-2018; Laaksonen, Reijo/D-6323-2014; Pandolfo, Massimo/B-2853-2010	Lehtimäki, Terho/0000-0002-2555-4427; Luoto, Teemu/0000-0002-7329-3284; 	Erasme Funds; FNRS; Emil Aaltonen Foundation; Tampere University Hospital; Finnish Cultural Foundation; Finnish Foundation for Cardiovascular Research; Yrjo Jahnsson Foundation	Erasme Funds; FNRS(Fonds de la Recherche Scientifique - FNRS); Emil Aaltonen Foundation; Tampere University Hospital; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Foundation for Cardiovascular Research; Yrjo Jahnsson Foundation	Erasme Funds, FNRS, Emil Aaltonen Foundation, Medical Research Fund of Tampere University Hospital, the Pirkanmaa Regional Fund of the Finnish Cultural Foundation, the Finnish Foundation for Cardiovascular Research, and the Yrjo Jahnsson Foundation	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Chen SN, 2005, J AM COLL CARDIOL, V45, P1611, DOI 10.1016/j.jacc.2005.01.051; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Evans D, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-66; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; HUMPHRIES SE, 2006, J MED GENET; Jerrard-Dunne P, 2003, STROKE, V34, P1364, DOI 10.1161/01.STR.0000069723.17984.FD; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Polychronopoulos P, 2002, J NEUROL SCI, V195, P117, DOI 10.1016/S0022-510X(01)00691-8; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Schulz UGR, 2004, STROKE, V35, P819, DOI 10.1161/01.STR.0000121646.23955.0f; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Wardlaw JM, 2005, J NEUROL NEUROSUR PS, V76, P617, DOI 10.1136/jnnp.2004.039982; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	22	53	81	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1043	10.1371/journal.pone.0001043	http://dx.doi.org/10.1371/journal.pone.0001043			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940607	Green Published, gold, Green Submitted			2022-12-27	WOS:000207456100011
J	Seizova-Cajic, T; Smith, JL; Taylor, JL; Gandevia, SC				Seizova-Cajic, Tatjana; Smith, Janette L.; Taylor, Janet L.; Gandevia, Simon C.			Proprioceptive Movement Illusions Due to Prolonged Stimulation: Reversals and Aftereffects	PLOS ONE			English	Article								Background. Adaptation to constant stimulation has often been used to investigate the mechanisms of perceptual coding, but the adaptive processes within the proprioceptive channels that encode body movement have not been well described. We investigated them using vibration as a stimulus because vibration of muscle tendons results in a powerful illusion of movement. Methodology/Principal Findings. We applied sustained 90 Hz vibratory stimulation to biceps brachii, an elbow flexor and induced the expected illusion of elbow extension (in 12 participants). There was clear evidence of adaptation to the movement signal both during the 6-min long vibration and on its cessation. During vibration, the strong initial illusion of extension waxed and waned, with diminishing duration of periods of illusory movement and occasional reversals in the direction of the illusion. After vibration there was an aftereffect in which the stationary elbow seemed to move into flexion. Muscle activity shows no consistent relationship with the variations in perceived movement. Conclusion. We interpret the observed effects as adaptive changes in the central mechanisms that code movement in direction-selective opponent channels.	[Seizova-Cajic, Tatjana] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Smith, Janette L.; Taylor, Janet L.; Gandevia, Simon C.] Prince Wales Med Res Inst, Sydney, NSW, Australia	University of Sydney; Prince Wales Medical Research Institute	Seizova-Cajic, T (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	tseizova-cajic@psy.unsw.edu.au	Taylor, Janet L/C-9667-2011; Seizova-Cajic, Tatjana/A-5916-2016; Gandevia, Simon C/D-5009-2011; Smith, Janette L/C-2833-2008; Seizova-Cajic, Tatjana/E-9946-2010	Taylor, Janet L/0000-0001-8976-5162; Seizova-Cajic, Tatjana/0000-0002-8319-4095; Gandevia, Simon C/0000-0002-1345-3821; Smith, Janette L/0000-0001-8896-1188; 	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the National Health and Medical Research Council of Australia (SCG, JLT, JLS).	BARLOW HB, 1963, NATURE, V200, P1345, DOI 10.1038/2001345a0; Bergenheim M, 2000, EXP BRAIN RES, V134, P301, DOI 10.1007/s002210000471; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; Clifford C.W.G., 2005, FITTING MIND WORLD A; Clifford CWG, 2005, FITTING MIND WORLD A, P47; Desmurget M, 2000, EXP BRAIN RES, V134, P363, DOI 10.1007/s002210000473; DiZio P, 2002, HUM FAC ER, P751; FELDMAN AG, 1982, NEUROSCI LETT, V31, P147, DOI 10.1016/0304-3940(82)90107-0; GANDEVIA SC, 1985, BRAIN, V108, P965, DOI 10.1093/brain/108.4.965; GANDEVIA SC, 1996, HDB PHYSIOL 12, P128; GILHODES JC, 1986, EXP BRAIN RES, V61, P395; GOLDSTEIN A, 1959, J EXP PSYCHOL, V54, P457; GOODWIN GM, 1972, BRAIN, V95, P705, DOI 10.1093/brain/95.4.705; HELSON H, 1948, PSYCHOL REV, V55, P297, DOI 10.1037/h0056721; Kito T, 2006, BRAIN RES, V1114, P75, DOI 10.1016/j.brainres.2006.07.062; Kline K, 2004, VISION RES, V44, P2653, DOI 10.1016/j.visres.2004.05.030; Koffka K, 1935, PRINCIPLES GESTALT P; LACKNER JR, 1979, AVIAT SPACE ENVIR MD, V50, P346; MATHER G, 1980, PERCEPTION, V9, P379, DOI 10.1068/p090379; Mather G, 1998, MOTION AFTEREFFECT, P157; MATHER G, 1998, MOTION AFTEREFFECT; MATTHEWS PBC, 1982, ANNU REV NEUROSCI, V5, P189, DOI 10.1146/annurev.ne.05.030182.001201; Purves D, 1996, P NATL ACAD SCI USA, V93, P3693, DOI 10.1073/pnas.93.8.3693; Ribot-Ciscar E, 1998, BRAIN RES, V791, P167, DOI 10.1016/S0006-8993(98)00092-4; Ribot-Ciscar E, 1998, NEUROSCI LETT, V258, P147, DOI 10.1016/S0304-3940(98)00732-0; ROLL JP, 1982, EXP BRAIN RES, V47, P177; ROLL JP, 1980, ARCH ITAL BIOL, V118, P51; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Wade NJ., 1998, NATURAL HIST VISION; Wierzbicka MM, 1998, J NEUROPHYSIOL, V79, P143, DOI 10.1152/jn.1998.79.1.143; Wohlgemuth A., 1911, AFTER EFFECT SEEN MO, V1; [No title captured]	32	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1037	10.1371/journal.pone.0001037	http://dx.doi.org/10.1371/journal.pone.0001037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940601	gold, Green Published			2022-12-27	WOS:000207456100005
J	Rich, T; Varadaraj, A				Rich, Tina; Varadaraj, Archana			Ataxin-1 Fusion Partners Alter PolyQ Lethality and Aggregation	PLOS ONE			English	Article								Intranuclear inclusion bodies (IBs) are the histopathologic markers of multiple protein folding diseases. IB formation has been extensively studied using fluorescent fusion products of pathogenic polyglutamine (polyQ) expressing proteins. These studies have been informative in determining the cellular targets of expanded polyQ protein as well as the methods by which cells rid themselves of IBs. The experimental thrust has been to intervene in the process of polyQ aggregation in an attempt to alleviate cytotoxicity. However new data argues against the notion that polyQ aggregation and cytotoxicity are inextricably linked processes. We reasoned that changing the protein context of a disease causing polyQ protein could accelerate its precipitation as an IB, potentially reducing its cytotoxicity. Our experimental strategy simply exploited the fact that conjoined proteins influence each others folding and aggregation properties. We fused a full-length pathogenic ataxin-1 construct to fluorescent tags (GFP and DsRed1-E5) that exist at different oligomeric states. The spectral properties of the DsRed1-E5-ataxin-1 transfectants had the additional advantage of allowing us to correlate fluorochrome maturation with cytotoxicity. Each fusion protein expressed a distinct cytotoxicity and IB morphology. Flow cytometric analyses of transfectants expressing the greatest fluorescent signals revealed that the DsRed1-E5-ataxin-1 fusion was more toxic than GFP fused ataxin-1 (31.8+/-4.5% cell death versus 12.85+/-3%), although co-transfection with the GFP fusion inhibited maturation of the DsRed1-E5 fluorochrome and diminished the toxicity of the DsRed1-E5-ataxin-1 fusion. These data show that polyQ driven aggregation can be influenced by fusion partners to generate species with different toxic properties and provide new opportunities to study IB aggregation, maturation and lethality.	[Rich, Tina; Varadaraj, Archana] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Cambridge	Rich, T (corresponding author), Univ Glasgow, Fac Vet Sci, Inst Comparat Med, Glasgow, Lanark, Scotland.	T.Rich@vet.gla.ac.uk		Varadaraj, Archana/0000-0002-1868-1268				Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; BULONE D, 2007, PLOS ONE E, V111, P1; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cowan KJ, 2003, HUM MOL GENET, V12, P1377, DOI 10.1093/hmg/ddg151; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dovey CL, 2004, J PATHOL, V203, P877, DOI 10.1002/path.1604; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Fu LW, 2005, NEUROBIOL DIS, V20, P656, DOI 10.1016/j.nbd.2005.05.015; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Hoshino M, 2006, J CELL BIOL, V172, P589, DOI 10.1083/jcb.200509132; Janer A, 2006, J CELL BIOL, V174, P65, DOI 10.1083/jcb.200511045; Kumada S, 2002, J NEUROPATH EXP NEUR, V61, P984, DOI 10.1093/jnen/61.11.984; Menon RP, 2006, CELL MOL LIFE SCI, V63, P1677, DOI 10.1007/s00018-006-6097-4; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nozaki K, 2001, NEUROREPORT, V12, P3357, DOI 10.1097/00001756-200110290-00042; Nye AC, 2002, MOL CELL BIOL, V22, P3437, DOI 10.1128/MCB.22.10.3437-3449.2002; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Rich T, 1999, HUM MOL GENET, V8, P2451, DOI 10.1093/hmg/8.13.2451; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Sebastian Sarah, 2007, Curr Infect Dis Rep, V9, P167, DOI 10.1007/s11908-007-0013-4; Sheffield LG, 2006, J NEUROPATH EXP NEUR, V65, P45, DOI 10.1097/01.jnen.0000195939.40410.08; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Takahashi J, 2003, NEUROBIOL DIS, V13, P230, DOI 10.1016/S0969-9961(03)00080-9; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Terskikh AV, 2002, J BIOL CHEM, V277, P7633, DOI 10.1074/jbc.C100694200; Varadaraj A, 2007, J PATHOL, V211, P471, DOI 10.1002/path.2126; Villagra NT, 2006, NEUROBIOL DIS, V21, P181, DOI 10.1016/j.nbd.2005.07.003; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; Zoghbi HY, 2000, CURR OPIN NEUROBIOL, V10, P655, DOI 10.1016/S0959-4388(00)00135-5	33	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1014	10.1371/journal.pone.0001014	http://dx.doi.org/10.1371/journal.pone.0001014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925862	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000207456000013
J	Peretz, A; Degani-Katzav, N; Talmon, M; Danieli, E; Gopin, A; Malka, E; Nachman, R; Raz, A; Shabat, D; Attali, B				Peretz, Asher; Degani-Katzav, Nurit; Talmon, Maya; Danieli, Eyal; Gopin, Anna; Malka, Eti; Nachman, Rachel; Raz, Amiram; Shabat, Doron; Attali, Bernard			A Tale of Switched Functions: From Cyclooxygenase Inhibition to M-Channel Modulation in New Diphenylamine Derivatives	PLOS ONE			English	Article								Cyclooxygenase (COX) enzymes are molecular targets of nonsteroidal anti-inflammatory drugs (NSAIDs), the most used medication worldwide. However, the COX enzymes are not the sole molecular targets of NSAIDs. Recently, we showed that two NSAIDs, diclofenac and meclofenamate, also act as openers of Kv7.2/3 K+ channels underlying the neuronal M-current. Here we designed new derivatives of diphenylamine carboxylate to dissociate the M-channel opener property from COX inhibition. The carboxylate moiety was derivatized into amides or esters and linked to various alkyl and ether chains. Powerful M-channel openers were generated, provided that the diphenylamine moiety and a terminal hydroxyl group are preserved. In transfected CHO cells, they activated recombinant Kv7.2/3 K+ channels, causing a hyperpolarizing shift of current activation as measured by whole-cell patch-clamp recording. In sensory dorsal root ganglion and hippocampal neurons, the openers hyperpolarized the membrane potential and robustly depressed evoked spike discharges. They also decreased hippocampal glutamate and GABA release by reducing the frequency of spontaneous excitatory and inhibitory post-synaptic currents. In vivo, the openers exhibited anti-convulsant activity, as measured in mice by the maximal electroshock seizure model. Conversion of the carboxylate function into amide abolished COX inhibition but preserved M-channel modulation. Remarkably, the very same template let us generating potent M-channel blockers. Our results reveal a new and crucial determinant of NSAID-mediated COX inhibition. They also provide a structural framework for designing novel M-channel modulators, including openers and blockers.	[Peretz, Asher; Degani-Katzav, Nurit; Malka, Eti; Nachman, Rachel; Attali, Bernard] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Talmon, Maya; Raz, Amiram] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; [Danieli, Eyal; Gopin, Anna; Shabat, Doron] Tel Aviv Univ, Sch Chem, Fac Exact Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University	Attali, B (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	battali@post.tau.ac.il			Israel Science Foundation [ISF 672/05]; Keren Wolfson	Israel Science Foundation(Israel Science Foundation); Keren Wolfson	Funding: This work is supported by the Israel Science Foundation (ISF 672/05) and the Keren Wolfson funds to BA.	BARLOW RB, 1978, BRIT J PHARMACOL, V62, P39, DOI 10.1111/j.1476-5381.1978.tb07004.x; Brown D A, 1988, Ion Channels, V1, P55; Camerino DC, 2007, NEUROTHERAPEUTICS, V4, P184; Diaz A, 1998, EXP CELL RES, V241, P222, DOI 10.1006/excr.1998.4050; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; Galanakis D, 2004, BIOORG MED CHEM LETT, V14, P3639, DOI 10.1016/j.bmcl.2004.05.025; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; Hoozemans JJM, 2005, CNS NEUROL DISORD-DR, V4, P307, DOI 10.2174/1568007054038201; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kalgutkar AS, 2000, P NATL ACAD SCI USA, V97, P925, DOI 10.1073/pnas.97.2.925; Kalgutkar AS, 2002, BIOORG MED CHEM LETT, V12, P521, DOI 10.1016/S0960-894X(01)00792-2; Kalgutkar AS, 2000, J MED CHEM, V43, P2860, DOI 10.1021/jm000004e; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Levin G, 2002, BIOCHEM J, V365, P489, DOI 10.1042/BJ20011798; Llorens O, 2002, J MOL GRAPH MODEL, V20, P359, DOI 10.1016/S1093-3263(01)00135-8; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; MACDONALD RL, 1995, EPILEPSIA, V36, P2; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Passmore GM, 2003, J NEUROSCI, V23, P7227, DOI 10.1523/JNEUROSCI.23-18-07227.2003; Peretz A, 2005, MOL PHARMACOL, V67, P1053, DOI 10.1124/mol.104.007112; Peretz A, 2007, J NEUROPHYSIOL, V97, P283, DOI 10.1152/jn.00634.2006; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Pouplana R, 2002, J MOL GRAPH MODEL, V20, P329, DOI 10.1016/S1093-3263(01)00133-4; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Selinsky BS, 2001, BIOCHEMISTRY-US, V40, P5172, DOI 10.1021/bi010045s; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Solomon DH, 2005, ARTHRITIS RHEUM, V52, P1968, DOI 10.1002/art.21132; Solomon DH, 2002, ARCH INTERN MED, V162, P1099, DOI 10.1001/archinte.162.10.1099; Sriram D, 2006, BIOORGAN MED CHEM, V14, P3113, DOI 10.1016/j.bmc.2005.12.042; Takahashi T, 2006, CANCER LETT, V231, P319, DOI 10.1016/j.canlet.2005.02.025; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004	38	34	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1332	10.1371/journal.pone.0001332	http://dx.doi.org/10.1371/journal.pone.0001332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159230	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459700004
J	Webb, BS; Roach, NW; McGraw, PV				Webb, Ben S.; Roach, Neil W.; McGraw, Paul V.			Perceptual Learning in the Absence of Task or Stimulus Specificity	PLOS ONE			English	Article								Performance on most sensory tasks improves with practice. When making particularly challenging sensory judgments, perceptual improvements in performance are tightly coupled to the trained task and stimulus configuration. The form of this specificity is believed to provide a strong indication of which neurons are solving the task or encoding the learned stimulus. Here we systematically decouple task-and stimulus-mediated components of trained improvements in perceptual performance and show that neither provides an adequate description of the learning process. Twenty-four human subjects trained on a unique combination of task (three-element alignment or bisection) and stimulus configuration (vertical or horizontal orientation). Before and after training, we measured subjects' performance on all four task-configuration combinations. What we demonstrate for the first time is that learning does actually transfer across both task and configuration provided there is a common spatial axis to the judgment. The critical factor underlying the transfer of learning effects is not the task or stimulus arrangements themselves, but rather the recruitment of commons sets of neurons most informative for making each perceptual judgment.	[Webb, Ben S.; Roach, Neil W.; McGraw, Paul V.] Univ Nottingham, Sch Psychol, Visual Neurosci Grp, Nottingham NG7 2RD, England	University of Nottingham	Webb, BS (corresponding author), Univ Nottingham, Sch Psychol, Visual Neurosci Grp, Nottingham NG7 2RD, England.	bsw@psychology.nottingham.ac.uk	Webb, Ben/O-2386-2014	Webb, Ben/0000-0003-4344-8369; McGraw, Paul/0000-0001-9484-8560; Roach, Neil/0000-0002-4155-745X	Leverhulme Trust	Leverhulme Trust(Leverhulme Trust)	The work was funded by the Leverhulme Trust. BSW is a Levehulme Trust Research Fellow and PVM is a Wellcome Trust Research Fellow.	AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; Ahissar M, 1996, VISION RES, V36, P3487, DOI 10.1016/0042-6989(96)00036-3; Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; BEARD BL, 1995, VISION RES, V35, P1679, DOI 10.1016/0042-6989(94)00267-P; BERARDI N, 1987, J PHYSIOL-LONDON, V384, P633, DOI 10.1113/jphysiol.1987.sp016474; BURBECK CA, 1990, VISION RES, V30, P739, DOI 10.1016/0042-6989(90)90099-7; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; Fahle M, 2005, CURR OPIN NEUROBIOL, V15, P154, DOI 10.1016/j.conb.2005.03.010; Fahle M, 2004, J VISION, V4, P879, DOI 10.1167/4.10.4; Fahle M, 1997, VISION RES, V37, P1885, DOI 10.1016/S0042-6989(96)00308-2; FAHLE M, 1993, VISION RES, V33, P397, DOI 10.1016/0042-6989(93)90094-D; Fahle M, 1996, INVEST OPHTH VIS SCI, V37, P869; Fahle M, 1996, CURR BIOL, V6, P292, DOI 10.1016/S0960-9822(02)00479-7; Fahle M, 2002, PERCEPTUAL LEARNING; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Fiorentini A, 1997, ARCH ITAL BIOL, V135, P157; Folta K, 2003, VISION RES, V43, P1177, DOI 10.1016/S0042-6989(03)00041-5; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; GIBSON EJ, 1963, ANNU REV PSYCHOL, V14, P29, DOI 10.1146/annurev.ps.14.020163.000333; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; GILBERT CD, 1994, P NATL ACAD SCI USA, V91, P1195, DOI 10.1073/pnas.91.4.1195; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Herzog MH, 1997, VISION RES, V37, P2133, DOI 10.1016/S0042-6989(97)00043-6; Herzog MH, 1999, VISION RES, V39, P4232, DOI 10.1016/S0042-6989(99)00138-8; HESS RF, 1993, VISION RES, V33, P1673, DOI 10.1016/0042-6989(93)90033-S; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KLEIN SA, 1987, J OPT SOC AM A, V4, P1543, DOI 10.1364/JOSAA.4.001543; LEVI DM, 1985, VISION RES, V25, P979, DOI 10.1016/0042-6989(85)90208-1; LEVI DM, 1988, VISION RES, V28, P597, DOI 10.1016/0042-6989(88)90109-5; Li RW, 2004, NAT NEUROSCI, V7, P178, DOI 10.1038/nn1183; Lu ZL, 2004, J VISION, V4, P44, DOI 10.1167/4.1.5; Morgan M. J., 1991, SPATIAL VISION, P87, DOI DOI 10.1167/14.10.392; MORGAN MJ, 1990, J OPT SOC AM A, V7, P297, DOI 10.1364/JOSAA.7.000297; OTOOLE AJ, 1992, PERCEPTION, V21, P227, DOI 10.1068/p210227; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; RAMACHANDRAN VS, 1973, PERCEPTION, V2, P371, DOI 10.1068/p020371; SAARINEN J, 1995, VISION RES, V35, P519, DOI 10.1016/0042-6989(94)00141-8; Saffell T, 2003, VISION RES, V43, P1365, DOI 10.1016/S0042-6989(03)00137-8; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; SULLIVAN GD, 1972, PERCEPT PSYCHOPHYS, V12, P438, DOI 10.3758/BF03205858; Tsodyks M, 2004, NATURE, V431, P775, DOI 10.1038/nature03013; WATT RJ, 1984, VISION RES, V24, P1377, DOI 10.1016/0042-6989(84)90193-7; WAUGH SJ, 1993, VISION RES, V33, P539, DOI 10.1016/0042-6989(93)90257-W; Whitaker D, 2002, VISION RES, V42, P1137, DOI 10.1016/S0042-6989(02)00030-5; WHITE JM, 1992, VISION RES, V32, P513, DOI 10.1016/0042-6989(92)90243-C; Wilson DA, 2004, LEARN MEMORY, V11, P28, DOI 10.1101/lm.66404; Wright BA, 2006, INT J AUDIOL, V45, pS92, DOI 10.1080/14992020600783004	64	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1323	10.1371/journal.pone.0001323	http://dx.doi.org/10.1371/journal.pone.0001323			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18094748	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459600011
J	Altermatt, F; Ebert, D				Altermatt, Florian; Ebert, Dieter			The Genotype Specific Competitive Ability Does Not Correlate with Infection in Natural Daphnia magna Populations	PLOS ONE			English	Article								Background. Different evolutionary hypotheses predict a correlation between the fitness of a genotype in the absence of infection and the likelihood to become infected. The cost of resistance hypothesis predicts that resistant genotypes pay a cost of being resistant and are less fit in the absence of parasites. The inbreeding-infection hypothesis predicts that the susceptible individuals are less fit due to inbreeding depression. Methods and Results. Here we tested if a host's natural infection status was associated with its fitness. First, we experimentally confirmed that cured but formerly infected Daphnia magna are genetically more susceptible to reinfections with Octosporea bayeri than naturally uninfected D. magna. We then collected from each of 22 populations both uninfected and infected D. magna genotypes. All were treated against parasites and kept in their asexual phase. We estimated their relative fitness in an experiment against a tester genotype and in another experiment in direct competition. Consistently, we found no difference in competitive abilities between uninfected and cured but formerly infected genotypes. This was the case both in the presence as well as in the absence of sympatric parasites during the competition trials. Conclusions. Our data do not support the inbreeding-infection hypothesis. They also do not support a cost of resistance, however ignoring other parasite strains or parasite species. We suggest as a possible explanation for our results that resistance genes might segregate largely independently of other fitness associated genes in this system.	[Altermatt, Florian; Ebert, Dieter] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Altermatt, Florian; Ebert, Dieter] Tvarminne Zool Stn, SF-10900 Hango, Finland	University of Basel	Altermatt, F (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.	florian.altermatt@unibas.ch	Ebert, Dieter/B-5502-2009; Ebert, Dieter/P-6134-2019	Ebert, Dieter/0000-0003-2653-3772; Ebert, Dieter/0000-0003-2653-3772; Altermatt, Florian/0000-0002-4831-6958	Swiss National Science Foundation; Tomcsik Foundation; Swiss Academy of Natural Sciences	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Tomcsik Foundation; Swiss Academy of Natural Sciences	The study was supported by the Swiss National Science Foundation. F. Altermatt was also supported by the Tomcsik Foundation and the Swiss Academy of Natural Sciences during the field work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2007, EVOL ECOL, V21, P561, DOI 10.1007/s10682-006-9136-6; Baganz F, 1998, YEAST, V14, P1417, DOI 10.1002/(SICI)1097-0061(199811)14:15<1417::AID-YEA334>3.0.CO;2-N; Bandi C, 2001, TRENDS PARASITOL, V17, P88, DOI 10.1016/S1471-4922(00)01812-2; Bengtsson J, 1998, OECOLOGIA, V115, P213, DOI 10.1007/s004420050510; BENGTSSON J, 1993, OIKOS, V67, P451, DOI 10.2307/3545357; BENGTSSON J, 1989, NATURE, V340, P713, DOI 10.1038/340713a0; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; Capaul M, 2003, EVOLUTION, V57, P249, DOI 10.1111/j.0014-3820.2003.tb00260.x; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; Carton Y, 2005, DEV COMP IMMUNOL, V29, P9, DOI 10.1016/j.dci.2004.05.004; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Crawley M. J, 2002, STAT COMPUTING INTRO; Duncan AB, 2006, J EVOLUTION BIOL, V19, P1183, DOI 10.1111/j.1420-9101.2006.01085.x; Ebert D, 2001, ECOLOGY, V82, P3417; Ebert D, 2002, SCIENCE, V295, P485, DOI 10.1126/science.1067485; Ebert D., 2005, ECOLOGY EPIDEMIOLOGY; Ebert D, 2007, J R SOC INTERFACE, V4, P777, DOI 10.1098/rsif.2007.0232; Fellowes MDE, 1998, P ROY SOC B-BIOL SCI, V265, P1553, DOI 10.1098/rspb.1998.0471; GROETERS FR, 1994, EVOLUTION, V48, P197, DOI 10.2307/2410015; Haag CR, 2007, J EVOLUTION BIOL, V20, P881, DOI 10.1111/j.1420-9101.2007.01313.x; Haag CR, 2006, HEREDITY, V96, P150, DOI 10.1038/sj.hdy.6800774; Haag CR, 2005, GENETICS, V170, P1809, DOI 10.1534/genetics.104.036814; Haag CR, 2003, EVOLUTION, V57, P777, DOI 10.1111/j.0014-3820.2003.tb00289.x; Haag CR, 2002, EVOLUTION, V56, P518; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hebert P.D.N, 1993, ZOOLOGY, V32; Hudson P, 1998, TRENDS ECOL EVOL, V13, P387, DOI 10.1016/S0169-5347(98)01475-X; Jensen KH, 2006, PLOS BIOL, V4, P1265, DOI 10.1371/journal.pbio.0040197; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Little TJ, 2000, P ROY SOC B-BIOL SCI, V267, P2037, DOI 10.1098/rspb.2000.1246; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Little TJ, 2002, J EVOLUTION BIOL, V15, P796, DOI 10.1046/j.1420-9101.2002.00436.x; LIVELY CM, 1989, EVOLUTION, V43, P1663, DOI [10.2307/2409382, 10.1111/j.1558-5646.1989.tb02616.x]; Luong LT, 2007, J EVOLUTION BIOL, V20, P79, DOI 10.1111/j.1420-9101.2006.01226.x; MINCHELLA DJ, 1991, TRENDS ECOL EVOL, V6, P250, DOI 10.1016/0169-5347(91)90071-5; Mitchell SE, 2005, EVOLUTION, V59, P70, DOI 10.1111/j.0014-3820.2005.tb00895.x; NEE S, 1989, J THEOR BIOL, V140, P499, DOI 10.1016/S0022-5193(89)80111-0; Pajunen VI, 2007, HYDROBIOLOGIA, V592, P291, DOI 10.1007/s10750-007-0769-4; Pajunen VI, 2003, ECOGRAPHY, V26, P731; POULIN R, 1998, EVOLUTIONARY ECOLOGY; R Development Core Team, 2007, R LANG ENV STAT COMP; RANTA E, 1979, ARCH HYDROBIOL, V87, P205; Rauch G, 2007, BASIC APPL ECOL, V8, P89, DOI 10.1016/j.baae.2006.03.007; REID JM, 2003, P ROYAL SOC B, V270; Salathe P, 2003, J EVOLUTION BIOL, V16, P976, DOI 10.1046/j.1420-9101.2003.00582.x; Sasaki A, 2000, P ROY SOC B-BIOL SCI, V267, P2183, DOI 10.1098/rspb.2000.1267; Vizoso DB, 2005, OECOLOGIA, V143, P157, DOI 10.1007/s00442-004-1771-4; Vizoso DB, 2004, PARASITOLOGY, V128, P31, DOI 10.1017/S0031182003004293; Zbinden M, 2005, EXP PARASITOL, V109, P58, DOI 10.1016/j.exppara.2004.11.002; ZBINDEN M, 2008, RAPID HOST ADAPTATIO	52	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1280	10.1371/journal.pone.0001280	http://dx.doi.org/10.1371/journal.pone.0001280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060074	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459400027
J	Potti, J; Blanco, G; Lemus, JA; Canal, D				Potti, Jaime; Blanco, Guillermo; Lemus, Jesus A.; Canal, David			Infectious Offspring: How Birds Acquire and Transmit an Avian Polyomavirus in the Wild	PLOS ONE			English	Article							MEDITERRANEAN POPULATION; VERTICAL TRANSMISSION; VIRUS; CALLIPHORIDAE; MECHANISMS; VIRULENCE; EVOLUTION; DIPTERA; SUCCESS	Detailed patterns of primary virus acquisition and subsequent dispersal in wild vertebrate populations are virtually absent. We show that nestlings of a songbird acquire polyomavirus infections from larval blowflies, common nest ectoparasites of cavity-nesting birds, while breeding adults acquire and renew the same viral infections via cloacal shedding from their offspring. Infections by these DNA viruses, known potential pathogens producing disease in some bird species, therefore follow an 'upwards vertical' route of an environmental nature mimicking horizontal transmission within families, as evidenced by patterns of viral infection in adults and young of experimental, cross-fostered offspring. This previously undescribed route of viral transmission from ectoparasites to offspring to parent hosts may be a common mechanism of virus dispersal in many taxa that display parental care.	[Potti, Jaime; Canal, David] CSIC, Estac Biol Donana, Dept Evolutionary Ecol, E-41080 Seville, Spain; [Blanco, Guillermo] Univ Castilla La Mancha, CSIC, IREC, E-13071 Ciudad Real, Spain; [Lemus, Jesus A.] CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Potti, J (corresponding author), CSIC, Estac Biol Donana, Dept Evolutionary Ecol, E-41080 Seville, Spain.	jpotti@ebd.csic.es	Canal, David/E-4401-2013; Potti, Jaime/A-3077-2009; Potti, Jaime/H-3113-2019; Blanco, Guillermo/L-3170-2014	Canal, David/0000-0003-2875-2987; Potti, Jaime/0000-0002-2284-0022; Blanco, Guillermo/0000-0001-5742-4929	Spanish Ministry of Education [CGL2004-04479/BOS, CGL2006-07481/BOS]; Universidad de Castilla-La Mancha [PAC05-006-1]; Junta de Comunidad de Castilla-La Mancha [PAI-05-051]	Spanish Ministry of Education(Spanish Government); Universidad de Castilla-La Mancha; Junta de Comunidad de Castilla-La Mancha	J. Potti and D. Canal were partially supported by projects from the Spanish Ministry of Education (CGL2004-04479/BOS, to J. A. Fargallo and CGL2006-07481/BOS, to J. C. Senar) and Universidad de Castilla-La Mancha (PAC05-006-1, to J. A. Davila). G. Blanco and J. A .Lemus were supported by Junta de Comunidad de Castilla-La Mancha Project (PAI-05-051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT GF, 1991, CAN J ZOOL, V69, P2048, DOI 10.1139/z91-286; Carn VM, 1996, BRIT VET J, V152, P377, DOI 10.1016/S0007-1935(96)80033-9; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Cramp S., 1993, HDB BIRDS EUROPE MID, V7; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Essbauer S, 2001, J VET MED B, V48, P403, DOI 10.1046/j.1439-0450.2001.00473.x; Ewald PW, 1994, EVOLUTION INFECT DIS; Gray SM, 1999, MICROBIOL MOL BIOL R, V63, P128, DOI 10.1128/MMBR.63.1.128-148.1999; Hurd PL, 1991, BEHAV ECOL, V2, P69, DOI 10.1093/beheco/2.1.69; Hurtrez-Bousses S, 1998, ECOL LETT, V1, P17, DOI 10.1046/j.1461-0248.1998.00017.x; HurtrezBousses S, 1997, OECOLOGIA, V112, P514, DOI 10.1007/s004420050339; HurtrezBousses S, 1997, J AVIAN BIOL, V28, P267, DOI 10.2307/3676980; Johne R, 1998, ARCH VIROL, V143, P1501, DOI 10.1007/s007050050393; Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lednicky JA, 1999, FRONT BIOSCI, V4, P153; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; Lipsitch M, 1996, EVOLUTION, V50, P1729, DOI [10.2307/2410731, 10.1111/j.1558-5646.1996.tb03560.x]; Lundberg A, 1992, PIED FLYCATCHER; MCCANCE DJ, 1979, INFECT IMMUN, V25, P998, DOI 10.1128/IAI.25.3.998-1002.1979; MCCANCE DJ, 1977, INFECT IMMUN, V18, P196, DOI 10.1128/IAI.18.1.196-202.1977; MERINO S, 1995, OIKOS, V73, P95, DOI 10.2307/3545730; MIMS CA, 1981, MICROBIOL REV, V45, P267, DOI 10.1128/MMBR.45.2.267-286.1981; Murphy F.A., 1999, VET VIROLOGY; Perez-Losada M, 2006, J VIROL, V80, P5663, DOI 10.1128/JVI.00056-06; Phalen David N., 2000, P111; Phalen DN, 2000, J AM VET MED ASSOC, V217, P32, DOI 10.2460/javma.2000.217.32; PHALEN DN, 1991, J CLIN MICROBIOL, V29, P1030, DOI 10.1128/JCM.29.5.1030-1037.1991; Potti J, 2002, MOL ECOL, V11, P1317, DOI 10.1046/j.1365-294X.2002.01545.x; Ritchie B. W., 1991, Journal of the Association of Avian Veterinarians, V5, P202, DOI 10.2307/27671072; Rognes K, 1997, CLADISTICS, V13, P27, DOI 10.1111/j.1096-0031.1997.tb00240.x; Shadan FF, 1995, VIRUS GENES, V11, P239, DOI 10.1007/BF01728663; Stevens J, 2001, FORENSIC SCI INT, V120, P116, DOI 10.1016/S0379-0738(01)00417-0; Villarreal LP, 2000, VIROLOGY, V272, P1, DOI 10.1006/viro.2000.0381; VILLARREAL LP, 2006, VIRUSES EVOLUTION LI; Zhang SJ, 2005, J GEN VIROL, V86, P2721, DOI 10.1099/vir.0.81168-0	36	15	15	77	1423	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1276	10.1371/journal.pone.0001276	http://dx.doi.org/10.1371/journal.pone.0001276			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060070	gold, Green Published			2022-12-27	WOS:000207459400023
J	Rusyn, I; Fry, RC; Begley, TJ; Klapacz, J; Svensson, JP; Ambrose, M; Samson, LD				Rusyn, Ivan; Fry, Rebecca C.; Begley, Thomas J.; Klapacz, Joanna; Svensson, J. Peter; Ambrose, Mark; Samson, Leona D.			Transcriptional Networks in S-cerevisiae Linked to an Accumulation of Base Excision Repair Intermediates	PLOS ONE			English	Article								Upon exposure to DNA damaging agents, Saccharomyces cerevisiae respond by activating a massive transcriptional program that reflects the fact that "DNA damaging" agents also damage other cellular macromolecules. To identify the transcriptional response that is specific to DNA damage, we have modulated the first two enzymes in the base excision repair (BER) pathway generating yeast strains with varied levels of the repair intermediates, abasic sites or strand breaks. We show that the number of abasic sites is significantly increased when the 3-methyladenine DNA glycosylase (Mag): AP endonuclease (Apn1) ratio is increased and that spontaneous frame shift mutation is considerably elevated when either Mag, or Mag plus Apn1, expression is elevated. Expression profiling identified 633 ORFs with differential expression associated with BER modulation. Analysis of transcriptional networks associated with the accumulation of DNA repair intermediates identifies an enrichment for numerous biological processes. Moreover, most of the BER-activated transcriptional response was independent of the classical yeast environmental stress response (ESR). This study highlights that DNA damage in the form of abasic sites or strand breaks resulting from BER modulation is a trigger for substantial genome-wide change and that this response is largely ESR-independent. Taken together, these results suggest that a branch point exists in the current model for DNA damage-signaled transcription in S. cerevisiae.	[Samson, Leona D.] MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Samson, LD (corresponding author), MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA.	lsamson@mit.edu	Svensson, J Peter/B-4276-2008; Rusyn, Ivan/S-2426-2016	Svensson, J Peter/0000-0002-5863-6250; Ambrose, Mark/0000-0002-8031-8240; Rusyn, Ivan/0000-0001-9340-7384; Fry, Rebecca/0000-0003-0899-9018	National Institute of Environmental Health Sciences [ES11399, ES002109]; National Cancer Institute [CA055042]; NATIONAL CANCER INSTITUTE [R01CA055042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109, U19ES011399] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding: This work was supported by the National Institute of Environmental Health Sciences (ES11399 and ES002109), and the National Cancer Institute(CA055042). LDS is an American Cancer Society Research Professor.	Aguilaniu H, 2001, J BIOL CHEM, V276, P35396, DOI 10.1074/jbc.M101796200; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; COOPER DP, 1982, CANCER RES, V42, P4203; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Glassner BJ, 1998, P NATL ACAD SCI USA, V95, P9997, DOI 10.1073/pnas.95.17.9997; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; LAKE RS, 1980, MUTAT RES, V74, P357, DOI 10.1016/0165-1161(80)90194-6; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Memisoglu A, 2000, MUTAT RES-FUND MOL M, V451, P39, DOI 10.1016/S0027-5107(00)00039-7; MONTESANO R, 1980, CANCER RES, V40, P452; Nakamura J, 2000, J BIOL CHEM, V275, P5323, DOI 10.1074/jbc.275.8.5323; Nakamura J, 1999, CANCER RES, V59, P2522; OCONNOR PJ, 1982, BIOCHIMIE, V64, P769, DOI 10.1016/S0300-9084(82)80127-2; Posnick LM, 1999, J BACTERIOL, V181, P6756, DOI 10.1128/JB.181.21.6756-6762.1999; Posnick LM, 1999, J BACTERIOL, V181, P6763, DOI 10.1128/JB.181.21.6763-6771.1999; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; SAMSON L, 1988, EMBO J, V7, P2261, DOI 10.1002/j.1460-2075.1988.tb03066.x; SAMSON L, 1977, NATURE, V267, P281, DOI 10.1038/267281a0; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; WEI X, 1993, P NATL ACAD SCI USA, V90, P2117, DOI 10.1073/pnas.90.6.2117; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4	26	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1252	10.1371/journal.pone.0001252	http://dx.doi.org/10.1371/journal.pone.0001252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043759	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459300033
J	Pavard, S; Metcalf, CJE				Pavard, Samuel; Metcalf, C. Jessica E.			Negative Selection on BRCA1 Susceptibility Alleles Sheds Light on the Population Genetics of Late-Onset Diseases and Aging Theory	PLOS ONE			English	Article							OVARIAN-CANCER; BREAST-CANCER; MUTATIONS; SENESCENCE; FREQUENCY; PENETRANCE; EVOLUTION; PATTERNS; FAMILIES; SERIES	The magnitude of negative selection on alleles involved in age-specific mortality decreases with age. This is the foundation of the evolutionary theory of senescence. Because of this decrease in negative selection with age, and because of the absence of reproduction after menopause, alleles involved in women's late-onset diseases are generally considered evolutionarily neutral. Recently, genetic and epidemiological data on alleles involved in late onset-diseases have become available. It is therefore timely to estimate selection on these alleles. Here, we estimate selection on BRCA1 alleles leading to susceptibility to late-onset breast and ovarian cancer. For this, we integrate estimates of the risk of developing a cancer for BRCA1-carriers into population genetics frameworks, and calculate selection coefficients on BRCA1 alleles for different demographic scenarios varying across the extent of human demography. We then explore the magnitude of negative selection on alleles leading to a diverse range of risk patterns, to capture a variety of late-onset diseases. We show that BRCA1 alleles may have been under significant negative selection during human history. Although the mean age of onset of the disease is long after menopause, variance in age of onset means that there are always enough cases occurring before the end of reproductive life to compromise the selective value of women carrying a susceptibility allele in BRCA1. This seems to be the case for an extended range of risk of onset functions varying both in mean and variance. This finding may explain the distribution of BRCA1 alleles' frequency, and also why alleles for many late-onset diseases, like certain familial forms of cancer, coronary artery diseases and Alzheimer dementia, are typically recent and rare. Finally, we discuss why the two most popular evolutionary theories of aging, mutation accumulation and antagonistic pleiotropy, may underestimate the effect of selection on survival at old ages.	[Pavard, Samuel; Metcalf, C. Jessica E.] Max Planck Inst Demog Res, Lab Survival & Longev, Rostock, Germany; [Pavard, Samuel] Museum Natl Hist Nat, Grp Ecoanthropol, F-75231 Paris, France; [Metcalf, C. Jessica E.] Duke Univ, Duke Populat Res Inst, Durham, NC USA	Max Planck Society; Museum National d'Histoire Naturelle (MNHN); Duke University	Pavard, S (corresponding author), Max Planck Inst Demog Res, Lab Survival & Longev, Rostock, Germany.	pavard@demogr.mpg.de		Pavard, Samuel/0000-0002-6803-8123	Fondation de France; Association pour la Recherche sur le Cancer; Max Planck Institute for Demographic Research	Fondation de France(Fondation de France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Max Planck Institute for Demographic Research	We acknowledge funding from the Fondation de France, the Association pour la Recherche sur le Cancer and the Max Planck Institute for Demographic Research.	ABRAMS PA, 1993, EVOLUTION, V47, P877, DOI 10.1111/j.1558-5646.1993.tb01241.x; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Austerlitz F, 1998, P NATL ACAD SCI USA, V95, P15140, DOI 10.1073/pnas.95.25.15140; CHARBONNEAU H, 1987, NAISSANCE POPULATION; Charlesworth B, 2001, J THEOR BIOL, V210, P47, DOI 10.1006/jtbi.2001.2296; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Charmantier A, 2006, P NATL ACAD SCI USA, V103, P6587, DOI 10.1073/pnas.0511123103; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; CLAUS EB, 1991, AM J HUM GENET, V48, P232; Demeny Coale AJ., 1966, REGIONAL MODEL LIFE; EATON SB, 1994, Q REV BIOL, V69, P353, DOI 10.1086/418650; Goldstein AM, 1997, GENET EPIDEMIOL, V14, P1085, DOI 10.1002/(SICI)1098-2272(1997)14:6<1085::AID-GEPI87>3.0.CO;2-D; Hadwiger H, 1940, SKAND AKTUARIETIDSKR, V23, P101; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; HOEM JM, 1981, DEMOGRAPHY, V18, P231, DOI 10.2307/2061095; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KOVACS BW, 1990, BIOL MAMMALIAN GERM, P351; Lee RD, 2003, P NATL ACAD SCI USA, V100, P9637, DOI 10.1073/pnas.1530303100; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; Morton N. E., 1982, OUTLINE GENETIC EPID; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Pavard S, 2007, EVOLUTION, V61, P1153, DOI 10.1111/j.1558-5646.2007.00086.x; Rahman N, 1998, ANNU REV GENET, V32, P95, DOI 10.1146/annurev.genet.32.1.95; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Steinsaltz D, 2005, ADV APPL MATH, V35, P16, DOI 10.1016/j.aam.2004.09.003; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Tuljapurkar SD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000785; Whitlock Michael C., 2004, P155, DOI 10.1017/CBO9780511542022.013; Wright A, 2003, TRENDS GENET, V19, P97, DOI 10.1016/S0168-9525(02)00033-1; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	32	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1206	10.1371/journal.pone.0001206	http://dx.doi.org/10.1371/journal.pone.0001206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030340	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459200019
J	Delacourt, C; Benoist, MR; Le Bourgeois, M; Waernessyckle, S; Rufin, P; Brouard, JJ; de Blic, J; Scheinmann, P				Delacourt, Christophe; Benoist, Marie-Rose; Le Bourgeois, Muriel; Waernessyckle, Serge; Rufin, Patrick; Brouard, Jean-Jacques; de Blic, Jacques; Scheinmann, Pierre			Relationship between Bronchial Hyperresponsiveness and Impaired Lung Function after Infantile Asthma	PLOS ONE			English	Article								Wheezing during infancy has been linked to early loss of pulmonary function. We prospectively investigated the relation between bronchial hyperresponsiveness (BHR) and progressive impairment of pulmonary function in a cohort of asthmatic infants followed until age 9 years. We studied 129 infants who had had at least three episodes of wheezing. Physical examinations, baseline lung function tests and methacholine challenge tests were scheduled at ages 16 months and 5, 7 and 9 years. Eighty-three children completed follow-up. Twenty-four (29%) infants had wheezing that persisted at 9 years of age. Clinical outcome at age 9 years was significantly predicted by symptoms at 5 years of age and by parental atopy. Specific airway resistance (sRaw) was altered in persistent wheezers as early as 5 years of age, and did not change thereafter. Ninety-five per cent of the children still responded to methacholine at the end of follow-up. The degree of BHR at 9 years was significantly related to current clinical status, baseline lung function, and parental atopy. BHR at 16 months and 5 years of age did not predict persistent wheezing between 5 and 9 years of age, or the final degree of BHR, but it did predict altered lung function. Wheezing that persists from infancy to 9 years of age is associated with BHR and to impaired lung function. BHR itself is predictive of impaired lung function in children, strongly pointing to early airway remodeling in infantile asthma.	[Delacourt, Christophe; Benoist, Marie-Rose; Le Bourgeois, Muriel; Waernessyckle, Serge; Rufin, Patrick; Brouard, Jean-Jacques; de Blic, Jacques; Scheinmann, Pierre] Hop Enfants Malad, Serv Pneumol & Allergol Pediat, Lab Explorat Fonct Resp, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP	Delacourt, C (corresponding author), Ctr Hosp Intercommunal, Serv Pediat, Creteil, France.	christophe.delacourt@chicreteil.fr	Delacourt, Christophe/K-6161-2019					BROOKE AM, 1995, AM J RESP CRIT CARE, V152, P1872, DOI 10.1164/ajrccm.152.6.8520749; Brussee JE, 2004, AM J RESP CRIT CARE, V169, P209, DOI 10.1164/rccm.200306-800OC; Brutsche MH, 2006, THORAX, V61, P671, DOI 10.1136/thx.2005.052241; Cockcroft DW, 2006, J ALLERGY CLIN IMMUN, V118, P551, DOI 10.1016/j.jaci.2006.07.012; Delacourt C, 2001, AM J RESP CRIT CARE, V164, P1382, DOI 10.1164/ajrccm.164.8.2007066; Dezateux C, 1999, AM J RESP CRIT CARE, V159, P403, DOI 10.1164/ajrccm.159.2.9712029; Grol MH, 1999, AM J RESP CRIT CARE, V160, P1830, DOI 10.1164/ajrccm.160.6.9812100; Host A, 2003, ALLERGY, V58, P559, DOI 10.1034/j.1398-9995.2003.00238.x; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Lowe L, 2002, LANCET, V359, P1904, DOI 10.1016/S0140-6736(02)08781-0; Lowe LA, 2005, AM J RESP CRIT CARE, V171, P231, DOI 10.1164/rccm.200406-695OC; Marchal Francois, 2005, Paediatr Respir Rev, V6, P278, DOI 10.1016/j.prrv.2005.09.007; MARTINEZ FD, 1995, THORAX, V50, P1067, DOI 10.1136/thx.50.10.1067; Martinez FD, 2007, J ALLERGY CLIN IMMUN, V119, P30, DOI 10.1016/j.jaci.2006.10.020; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; MULLER BA, 1994, J ALLERGY CLIN IMMUN, V94, P77, DOI 10.1016/0091-6749(94)90074-4; OCONNOR GT, 1995, AM J RESP CRIT CARE, V152, P87, DOI 10.1164/ajrccm.152.1.7599868; Palmer LJ, 2001, AM J RESP CRIT CARE, V163, P37, DOI 10.1164/ajrccm.163.1.2005013; PARK ES, 1986, ARCH DIS CHILD, V61, P642, DOI 10.1136/adc.61.7.642; Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011; Porsbjerg C, 2006, CHEST, V129, P309, DOI 10.1378/chest.129.2.309; Rasmussen F, 2002, AM J RESP CRIT CARE, V165, P1480, DOI 10.1164/rccm.2108009; Saglani S, 2005, AM J RESP CRIT CARE, V171, P722, DOI 10.1164/rccm.200410-1404OC; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; TABACHNIK E, 1981, J ALLERGY CLIN IMMUN, V67, P339, DOI 10.1016/0091-6749(81)90077-4; Ulrik CS, 1996, RESP MED, V90, P623, DOI 10.1016/S0954-6111(96)90021-9; Yang E, 2006, LUNG, V184, P73, DOI 10.1007/s00408-005-2565-0	27	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1180	10.1371/journal.pone.0001180	http://dx.doi.org/10.1371/journal.pone.0001180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000551	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459100022
J	Hammerle, B; Tejedor, FJ				Haemmerle, Barbara; Tejedor, Francisco J.			A Novel Function of DELTA-NOTCH Signalling Mediates the Transition from Proliferation to Neurogenesis in Neural Progenitor Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; STEM-CELLS; NEURONAL DIFFERENTIATION; NEUROEPITHELIAL CELLS; INTRACELLULAR DOMAIN; CHICK HINDBRAIN; GAMMA-SECRETASE; LIGAND DELTA1; GENE-DELTA	A complete account of the whole developmental process of neurogenesis involves understanding a number of complex underlying molecular processes. Among them, those that govern the crucial transition from proliferative (self-replicating) to neurogenic neural progenitor (NP) cells remain largely unknown. Due to its sequential rostro-caudal gradients of proliferation and neurogenesis, the prospective spinal cord of the chick embryo is a good experimental system to study this issue. We report that the NOTCH ligand DELTA-1 is expressed in scattered cycling NP cells in the prospective chick spinal cord preceding the onset of neurogenesis. These Delta-1-expressing progenitors are placed in between the proliferating caudal neural plate (stem zone) and the rostral neurogenic zone (NZ) where neurons are born. Thus, these Delta-1-expressing progenitors define a proliferation to neurogenesis transition zone (PNTZ). Gain and loss of function experiments carried by electroporation demonstrate that the expression of Delta-1 in individual progenitors of the PNTZ is necessary and sufficient to induce neuronal generation. The activation of NOTCH signalling by DELTA-1 in the adjacent progenitors inhibits neurogenesis and is required to maintain proliferation. However, rather than inducing cell cycle exit and neuronal differentiation by a typical lateral inhibition mechanism as in the NZ, DELTA-1/NOTCH signalling functions in a distinct manner in the PNTZ. Thus, the inhibition of NOTCH signalling arrests proliferation but it is not sufficient to elicit neuronal differentiation. Moreover, after the expression of Delta-1 PNTZ NP continue cycling and induce the expression of Tis21, a gene that is upregulated in neurogenic progenitors, before generating neurons. Together, these experiments unravel a novel function of DELTA-NOTCH signalling that regulates the transition from proliferation to neurogenesis in NP cells. We hypothesize that this novel function is evolutionary conserved.	[Tejedor, Francisco J.] CSIC, Inst Neurociencias, Alicante, Spain; Univ Miguel Hernandez, Alicante, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche	Tejedor, FJ (corresponding author), CSIC, Inst Neurociencias, Alicante, Spain.	f.tejedor@umh.es		Tejedor, Francisco J/0000-0003-1942-2580	Spanish Ministry of Education and Science; Generalitat Valenciana	Spanish Ministry of Education and Science(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by grants from the Spanish Ministry of Education and Science, and the Generalitat Valenciana to FJT.	Akai J, 2005, GENE DEV, V19, P2877, DOI 10.1101/gad.357705; Alexiades MR, 1997, DEVELOPMENT, V124, P1119; Appel B, 2001, BMC Dev Biol, V1, P13, DOI 10.1186/1471-213X-1-13; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Bel-Vialar S, 2007, DEV BIOL, V305, P659, DOI 10.1016/j.ydbio.2007.02.012; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; CAMPOSORTEGA JA, 1993, J NEUROBIOL, V24, P1305, DOI 10.1002/neu.480241005; Canzoniere D, 2004, J NEUROSCI, V24, P3355, DOI 10.1523/JNEUROSCI.3860-03.2004; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Chitnis AB, 1999, CURR OPIN NEUROBIOL, V9, P18, DOI 10.1016/S0959-4388(99)80003-8; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Doe CQ, 1996, CURR OPIN NEUROBIOL, V6, P18, DOI 10.1016/S0959-4388(96)80004-3; Dornseifer P, 1997, MECH DEVELOP, V63, P159, DOI 10.1016/S0925-4773(97)00037-3; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Fior R, 2005, DEV BIOL, V281, P318, DOI 10.1016/j.ydbio.2005.03.017; FUJITA S, 1962, EXP CELL RES, V28, P52, DOI 10.1016/0014-4827(62)90311-7; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; Haddon C, 1998, DEVELOPMENT, V125, P359; Hagting A, 1999, CURR BIOL, V9, P680, DOI 10.1016/S0960-9822(99)80308-X; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hammerle B, 2002, J NEUROSCI METH, V122, P59, DOI 10.1016/S0165-0270(02)00278-9; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; HEMOND SG, 1993, J NEUROSCI, V13, P1387; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Hiratochi M, 2007, NUCLEIC ACIDS RES, V35, P912, DOI 10.1093/nar/gkl1128; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kolev V, 2005, FEBS LETT, V579, P5798, DOI 10.1016/j.febslet.2005.09.042; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Kos R, 2003, DEV DYNAM, V226, P470, DOI 10.1002/dvdy.10254; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; LANGMAN J, 1966, J COMP NEUROL, V127, P399, DOI 10.1002/cne.901270308; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Le Roux I, 2003, INT J DEV BIOL, V47, P263; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; MATTHIAS P, 1989, NUCLEIC ACIDS RES, V17, P6418, DOI 10.1093/nar/17.15.6418; Megason SG, 2002, DEVELOPMENT, V129, P2087; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Nakada Y, 2004, DEVELOPMENT, V131, P1319, DOI 10.1242/dev.01008; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; PRESTIGE MC, 1973, BRAIN RES, V59, P400, DOI 10.1016/0006-8993(73)90280-1; Sakamoto K, 2002, DEV BIOL, V241, P313, DOI 10.1006/dbio.2001.0517; SECHRIST J, 1991, NEURON, V7, P947, DOI 10.1016/0896-6273(91)90340-6; Shen Q, 2002, DEVELOPMENT, V129, P4843; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; SIDMAN RL, 1959, EXP NEUROL, V1, P322, DOI 10.1016/0014-4886(59)90024-X; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; SMART IHM, 1972, J ANAT, V111, P365; Sun X, 1996, DEVELOPMENT, V122, P2465; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Temple S, 1996, CURR OPIN NEUROBIOL, V6, P11, DOI 10.1016/S0959-4388(96)80003-1; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Torii MA, 1999, DEVELOPMENT, V126, P443; Wilcock AC, 2007, DEVELOPMENT, V134, P1943, DOI 10.1242/dev.002519; Wildner H, 2006, DEVELOPMENT, V133, P2105, DOI 10.1242/dev.02345; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	82	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1169	10.1371/journal.pone.0001169	http://dx.doi.org/10.1371/journal.pone.0001169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000541	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459100011
J	Vazeille, M; Moutailler, S; Coudrier, D; Rousseaux, C; Khun, H; Huerre, M; Thiria, J; Dehecq, JS; Fontenille, D; Schuffenecker, I; Despres, P; Failloux, AB				Vazeille, Marie; Moutailler, Sara; Coudrier, Daniel; Rousseaux, Claudine; Khun, Huot; Huerre, Michel; Thiria, Julien; Dehecq, Jean-Sebastien; Fontenille, Didier; Schuffenecker, Isabelle; Despres, Philippe; Failloux, Anna-Bella			Two Chikungunya Isolates from the Outbreak of La Reunion (Indian Ocean) Exhibit Different Patterns of Infection in the Mosquito, Aedes albopictus	PLOS ONE			English	Article							VALLEY FEVER VIRUS; AEGYPTI; DENGUE; SUSCEPTIBILITY; DIPTERA; TRANSMISSION; REEMERGENCE; MEMBRANE; STRAINS; ISLAND	Background. A Chikungunya (CHIK) outbreak hit La Reunion Island in 2005-2006. The implicated vector was Aedes albopictus. Here, we present the first study on the susceptibility of Ae. albopictus populations to sympatric CHIKV isolates from La Reunion Island and compare it to other virus/vector combinations. Methodology and Findings. We orally infected 8 Ae. albopictus collections from La Reunion and 3 from Mayotte collected in March 2006 with two Chikungunya virus (CHIKV) from La Reunion: (i) strain 05.115 collected in June 2005 with an Alanine at the position 226 of the glycoprotein E1 and (ii) strain 06.21 collected in November 2005 with a substitution A226V. Two other CHIKV isolates and four additional mosquito strains/species were also tested. The viral titer of the infectious blood-meal was 10 7 plaque forming units (pfu)/mL. Dissemination rates were assessed by immunofluorescent staining on head squashes of surviving females 14 days after infection. Rates were at least two times higher with CHIKV 06.21 compared to CHIKV 05.115. In addition, 10 individuals were analyzed every day by quantitative RTPCR. Viral RNA was quantified on (i) whole females and (ii) midguts and salivary glands of infected females. When comparing profiles, CHIKV 06.21 produced nearly 2 log more viral RNA copies than CHIKV 05.115. Furthermore, females infected with CHIKV 05.115 could be divided in two categories: weakly susceptible or strongly susceptible, comparable to those infected by CHIKV 06.21. Histological analysis detected the presence of CHIKV in salivary glands two days after infection. In addition, Ae. albopictus from La Reunion was as efficient vector as Ae. aegypti and Ae. albopictus from Vietnam when infected with the CHIKV 06.21. Conclusions. Our findings support the hypothesis that the CHIK outbreak in La Reunion Island was due to a highly competent vector Ae. albopictus which allowed an efficient replication and dissemination of CHIKV 06.21.	[Vazeille, Marie; Failloux, Anna-Bella] Inst Pasteur, Dept Virol, Chikungunya Program, Paris, France; [Thiria, Julien; Dehecq, Jean-Sebastien] Direct Reg Affaires Sanit & Sociales Reunion, St Denis, France; [Fontenille, Didier] Inst Rech Dev, UR Caracterisat & Controle Populat Vecteurs 016, Montpellier, France; [Schuffenecker, Isabelle] Ctr Natl Reference Arbovirus & Virus Fievres Hemo, Lyon, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut de Recherche pour le Developpement (IRD)	Failloux, AB (corresponding author), Inst Pasteur, Dept Virol, Chikungunya Program, Paris, France.	afaillou@pasteur.fr	FONTENILLE, didier/G-4091-2013; Sara, Moutailler/J-9633-2019	Sara, Moutailler/0000-0003-3010-6968; FONTENILLE, didier/0000-0002-0544-3885	Pasteur Institute [PTR nu 201]; Foundation "Jean et Odette Duranton de Magny''; "Mutuelle du Personnel du Groupe Credit Lyonnais	Pasteur Institute; Foundation "Jean et Odette Duranton de Magny''; "Mutuelle du Personnel du Groupe Credit Lyonnais	This work was funded by the Pasteur Institute (PTR nu 201), the Foundation "Jean et Odette Duranton de Magny'' and the "Mutuelle du Personnel du Groupe Credit Lyonnais.	Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; Anishchenko M, 2006, P NATL ACAD SCI USA, V103, P4994, DOI 10.1073/pnas.0509961103; Bancroft J. D., 1994, MANUAL HISTOLOGICAL; Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000; BRIEGEL H, 1979, J MED ENTOMOL, V15, P235, DOI 10.1093/jmedent/15.3.235; COULANGES P, 1979, B SOC PATHOL EXOT, V72, P205; Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281; FARAN ME, 1988, AM J TROP MED HYG, V39, P206, DOI 10.4269/ajtmh.1988.39.206; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; HAMON J., 1953, MEM INST SCI MADAGASCAR SER E, V4, P521; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Jupp PG, 1996, S AFR MED J, V86, P35; KARCH S, 1993, B SOC PATHOL EXOT, V86, P68; Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075; KLES V, 1994, B SOC PATHOL EXOT, V87, P71; KONISHI E, 1986, J MED ENTOMOL, V23, P92, DOI 10.1093/jmedent/23.1.92; Lam S K, 2001, Southeast Asian J Trop Med Public Health, V32, P447; Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013; MANGIAFICO JA, 1971, AM J TROP MED HYG, V20, P642, DOI 10.4269/ajtmh.1971.20.642; Mourya DT, 1998, INDIAN J MED RES, V107, P10; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROSS R. W., 1956, JOUR HYG, V54, P177; SALVAN M, 1994, ANN SOC BELG MED TR, V74, P323; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; SMITH C E G, 1956, J Trop Med Hyg, V59, P243; TESH RB, 1976, AM J TROP MED HYG, V25, P326, DOI 10.4269/ajtmh.1976.25.326; TURELL MJ, 1984, AM J TROP MED HYG, V33, P176, DOI 10.4269/ajtmh.1984.33.176; TURELL MJ, 1992, J MED ENTOMOL, V29, P49, DOI 10.1093/jmedent/29.1.49; Vashishtha M, 1998, J CELL BIOL, V140, P91, DOI 10.1083/jcb.140.1.91; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292	34	445	462	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1168	10.1371/journal.pone.0001168	http://dx.doi.org/10.1371/journal.pone.0001168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000540	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459100010
J	Morris, SA; Almeida, AD; Tanaka, H; Ohta, K; Ohnuma, S				Morris, Samantha A.; Almeida, Alexandra D.; Tanaka, Hideaki; Ohta, Kunimasa; Ohnuma, Shin-ichi			Tsukushi Modulates Xnr2, FGF and BMP Signaling: Regulation of Xenopus Germ Layer Formation	PLOS ONE			English	Article								Background. Cell-cell communication is essential in tissue patterning. In early amphibian development, mesoderm is formed in the blastula-stage embryo through inductive interactions in which vegetal cells act on overlying equatorial cells. Members of the TGF-beta family such as activin B, Vg1, derriere and Xenopus nodal-related proteins (Xnrs) are candidate mesoderm inducing factors, with further activity to induce endoderm of the vegetal region. TGF-beta-like ligands, including BMP, are also responsible for patterning of germ layers. In addition, FGF signaling is essential for mesoderm formation whereas FGF signal inhibition has been implicated in endoderm induction. Clearly, several signaling pathways are coordinated to produce an appropriate developmental output; although intracellular crosstalk is known to integrate multiple pathways, relatively little is known about extracellular coordination. Methodology/Principal Findings. Here, we show that Xenopus Tsukushi (X-TSK), a member of the secreted small leucine rich repeat proteoglycan (SLRP) family, is expressed in ectoderm, endoderm, and the organizer during early development. We have previously reported that X-TSK binds to and inhibits BMP signaling in cooperation with chordin. We now demonstrate two novel interactions: X-TSK binds to and inhibits signaling by FGF8b, in addition to binding to and enhancement of Xnr2 signaling. This signal integration by X-TSK at the extracellular level has an important role in germ layer formation and patterning. Vegetally localized X-TSK potentiates endoderm formation through coordination of BMP, FGF and Xnr2 signaling. In contrast, X-TSK inhibition of FGF-MAPK signaling blocks ventrolateral mesoderm formation, while BMP inhibition enhances organizer formation. These actions of X-TSK are reliant upon its expression in endoderm and dorsal mesoderm, with relative exclusion from ventrolateral mesoderm, in a pattern shaped by FGF signals. Conclusions/Significance. Based on our observations, we propose a novel mechanism by which X-TSK refines the field of positional information by integration of multiple pathways in the extracellular space.	[Morris, Samantha A.; Almeida, Alexandra D.; Ohnuma, Shin-ichi] Univ Cambridge, Res Ctr, Hutchison Med Res Council, Dept Oncol, Cambridge, England; [Tanaka, Hideaki; Ohta, Kunimasa] Kumamoto Univ, Grad Sch Med Sci, Dept Dev Neurobiol, Kumamoto, Japan	University of Cambridge; Kumamoto University	Morris, SA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Henry Wellcome Bldg Canc & Dev Biol, Cambridge, England.	s.morris@gurdon.cam.ac.uk; so218@cam.ac.uk	Ohta, Kunimasa/AAW-6993-2020	Ohta, Kunimasa/0000-0002-4564-9757; D. ALMEIDA, ALEXANDRA/0000-0002-2708-2072; Ohnuma, Shin-ichi/0000-0002-3305-5126	Cancer Research UK; Medical Research Council; FCT Portugal; PRESTO Japan	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FCT Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); PRESTO Japan	Funding: Cancer Research UK, Medical Research Council, FCT Portugal, PRESTO Japan	Abe T, 2005, MECH DEVELOP, V122, P671, DOI 10.1016/j.mod.2004.12.006; Afouda BA, 2005, DEVELOPMENT, V132, P763, DOI 10.1242/dev.01647; Agius E, 2000, DEVELOPMENT, V127, P1173; AMAYA E, 1993, DEVELOPMENT, V118, P477; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Baker JC, 1996, GENE DEV, V10, P1880, DOI 10.1101/gad.10.15.1880; Bell E, 2003, DEVELOPMENT, V130, P1381, DOI 10.1242/dev.00344; Birsoy B, 2005, DEVELOPMENT, V132, P591, DOI 10.1242/dev.01599; Butler K, 2001, METHODS, V23, P303, DOI 10.1006/meth.2000.1142; Cha SW, 2004, BIOCHEM BIOPH RES CO, V315, P100, DOI 10.1016/j.bbrc.2004.01.019; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; Clements D, 2003, DEV BIOL, V258, P454, DOI 10.1016/S0012-1606(03)00124-6; Clements D, 1999, DEVELOPMENT, V126, P4903; Contakos SP, 2005, DEV BIOL, V288, P294, DOI 10.1016/j.ydbio.2005.09.015; Darras S, 1997, DEVELOPMENT, V124, P4275; Dorey K, 2006, DEV BIOL, V292, P303, DOI 10.1016/j.ydbio.2006.01.006; Dyson S, 1998, CELL, V93, P557, DOI 10.1016/S0092-8674(00)81185-X; Ecochard V, 1995, DEV BIOL, V172, P699, DOI 10.1006/dbio.1995.8052; Engleka MJ, 2001, DEV BIOL, V237, P159, DOI 10.1006/dbio.2001.0366; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Fletcher RB, 2006, DEVELOPMENT, V133, P1703, DOI 10.1242/dev.02342; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Green J, 2002, DEV DYNAM, V225, P392, DOI 10.1002/dvdy.10170; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; GURDON JB, 1995, NATURE, V376, P520, DOI 10.1038/376520a0; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Heasman J, 1997, DEVELOPMENT, V124, P4179; Henry GL, 1998, SCIENCE, V281, P91, DOI 10.1126/science.281.5373.91; Hocking AM, 1998, MATRIX BIOL, V17, P1; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; JONES CM, 1995, DEVELOPMENT, V121, P3651; Joseph EM, 1997, DEV BIOL, V184, P367, DOI 10.1006/dbio.1997.8510; Kofron M, 1999, DEVELOPMENT, V126, P5759; Kuriyama S, 2006, DEVELOPMENT, V133, P75, DOI 10.1242/dev.02178; LABONNE C, 1995, DEVELOPMENT, V121, P1475; Larrain J, 2000, DEVELOPMENT, V127, P821; Lemaire P, 1998, DEVELOPMENT, V125, P2371; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Loose M, 2004, DEV BIOL, V271, P467, DOI 10.1016/j.ydbio.2004.04.014; Moreno M, 2005, EMBO J, V24, P1397, DOI 10.1038/sj.emboj.7600615; Nieuwkoop P D, 1967, Acta Biotheor, V17, P151, DOI 10.1007/BF01601986; Ohta K, 2004, DEV CELL, V7, P347, DOI 10.1016/j.devcel.2004.08.014; OHTA K, 2006, DEVELOPMENT; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Poulain M, 2006, DEVELOPMENT, V133, P2189, DOI 10.1242/dev.02387; Pownall ME, 2003, DEV BIOL, V256, P89, DOI 10.1016/S0012-1606(02)00120-3; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schohl A, 2002, DEVELOPMENT, V129, P37; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Steinbach OC, 1998, DEV BIOL, V202, P280, DOI 10.1006/dbio.1998.8993; STERN CD, 2004, GASTRULATION CELLS E, P219; Sun BI, 1999, DEVELOPMENT, V126, P1467; Takahashi S, 2000, DEVELOPMENT, V127, P5319; Weber H, 2000, DEVELOPMENT, V127, P4345; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7; WHITMAN M, 1992, NATURE, V357, P252, DOI 10.1038/357252a0; Williams PH, 2004, CURR BIOL, V14, P1916, DOI 10.1016/j.cub.2004.10.020; Xanthos JB, 2002, DEVELOPMENT, V129, P4027; Xanthos JB, 2001, DEVELOPMENT, V128, P167; Zetser A, 2001, DEV BIOL, V240, P168, DOI 10.1006/dbio.2001.0465; Zhang C, 2005, DEV BIOL, V278, P526, DOI 10.1016/j.ydbio.2004.11.008; Zhang Y, 1999, TRENDS CELL BIOL, V9, P274, DOI 10.1016/S0962-8924(99)01579-2	71	34	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1004	10.1371/journal.pone.0001004	http://dx.doi.org/10.1371/journal.pone.0001004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925852	Green Submitted, Green Published, gold			2022-12-27	WOS:000207456000003
J	Gioia, J; Yerrapragada, S; Qin, X; Jiang, HY; Igboeli, OC; Muzny, D; Dugan-Rocha, S; Ding, Y; Hawes, A; Liu, W; Perez, L; Kovar, C; Dinh, H; Lee, S; Nazareth, L; Blyth, P; Holder, M; Buhay, C; Tirumalai, MR; Liu, YM; Dasgupta, I; Bokhetache, L; Fujita, M; Karouia, F; Moorthy, PE; Siefert, J; Uzman, A; Buzumbo, P; Verma, A; Zwiya, H; McWilliams, BD; Olowu, A; Clinkenbeard, KD; Newcombe, D; Golebiewski, L; Petrosino, JF; Nicholson, WL; Fox, GE; Venkateswaran, K; Highlander, SK; Weinstock, GM				Gioia, Jason; Yerrapragada, Shailaja; Qin, Xiang; Jiang, Huaiyang; Igboeli, Okezie C.; Muzny, Donna; Dugan-Rocha, Shannon; Ding, Yan; Hawes, Alicia; Liu, Wen; Perez, Lesette; Kovar, Christie; Dinh, Huyen; Lee, Sandra; Nazareth, Lynne; Blyth, Peter; Holder, Michael; Buhay, Christian; Tirumalai, Madhan R.; Liu, Yamei; Dasgupta, Indrani; Bokhetache, Lina; Fujita, Masaya; Karouia, Fathi; Moorthy, Prahathees Eswara; Siefert, Johnathan; Uzman, Akif; Buzumbo, Prince; Verma, Avani; Zwiya, Hiba; McWilliams, Brian D.; Olowu, Adeola; Clinkenbeard, Kenneth D.; Newcombe, David; Golebiewski, Lisa; Petrosino, Joseph F.; Nicholson, Wayne L.; Fox, George E.; Venkateswaran, Kasthuri; Highlander, Sarah K.; Weinstock, George M.			Paradoxical DNA Repair and Peroxide Resistance Gene Conservation in Bacillus pumilus SAFR-032	PLOS ONE			English	Article							SOLUBLE SPORE PROTEINS; ESCHERICHIA-COLI; OXIDATIVE STRESS; SUBTILIS SPORES; SIGMA-FACTOR; GENOME; IDENTIFICATION; HELICASE; EXPRESSION; SEQUENCE	Background. Bacillus spores are notoriously resistant to unfavorable conditions such as UV radiation, gamma-radiation, H2O2, desiccation, chemical disinfection, or starvation. Bacillus pumilus SAFR-032 survives standard decontamination procedures of the Jet Propulsion Lab spacecraft assembly facility, and both spores and vegetative cells of this strain exhibit elevated resistance to UV radiation and H2O2 compared to other Bacillus species. Principal Findings. The genome of B. pumilus SAFR-032 was sequenced and annotated. Lists of genes relevant to DNA repair and the oxidative stress response were generated and compared to B. subtilis and B. licheniformis. Differences in conservation of genes, gene order, and protein sequences are highlighted because they potentially explain the extreme resistance phenotype of B. pumilus. The B. pumilus genome includes genes not found in B. subtilis or B. licheniformis and conserved genes with sequence divergence, but paradoxically lacks several genes that function in UV or H2O2 resistance in other Bacillus species. Significance. This study identifies several candidate genes for further research into UV and H2O2 resistance. These findings will help explain the resistance of B. pumilus and are applicable to understanding sterilization survival strategies of microbes.	[Gioia, Jason; Yerrapragada, Shailaja; Qin, Xiang; Jiang, Huaiyang; Igboeli, Okezie C.; Muzny, Donna; Dugan-Rocha, Shannon; Ding, Yan; Hawes, Alicia; Liu, Wen; Perez, Lesette; Kovar, Christie; Dinh, Huyen; Lee, Sandra; Nazareth, Lynne; Blyth, Peter; Holder, Michael; Buhay, Christian; Highlander, Sarah K.; Weinstock, George M.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Weinstock, George M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [McWilliams, Brian D.; Golebiewski, Lisa; Petrosino, Joseph F.; Highlander, Sarah K.; Weinstock, George M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Tirumalai, Madhan R.; Liu, Yamei; Dasgupta, Indrani; Bokhetache, Lina; Fujita, Masaya; Karouia, Fathi; Moorthy, Prahathees Eswara; Siefert, Johnathan; Fox, George E.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Uzman, Akif; Buzumbo, Prince; Verma, Avani; Zwiya, Hiba] Univ Houston Downtown, Dept Nat Sci, Houston, TX USA; [Olowu, Adeola] St Thomas Univ, Houston, TX USA; [Clinkenbeard, Kenneth D.] Oklahoma State Univ, Dept Vet Pathobiol, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA; [Newcombe, David] Univ Idaho Coeur dAlene, Coeur Dalene, ID USA; [Newcombe, David; Venkateswaran, Kasthuri] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Nicholson, Wayne L.] Univ Florida, Space Life Sci Lab, Dept Microbiol & Cell Sci, Kennedy Space Ctr, FL USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston; University of Houston System; University of Houston; University of Houston Downtown; University of Saint Thomas; Oklahoma State University System; Oklahoma State University - Stillwater; Idaho; Idaho State University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); State University System of Florida; University of Florida	Weinstock, GM (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	gwstock@bcm.tmc.edu	Eswara, Prahathees/J-2353-2019; Weinstock, George M/C-6314-2013; Tirumalai, Madhan R/J-4988-2017; Petrosino, Joseph F./AAF-1621-2019; Willson, richard/AAD-4832-2019	Eswara, Prahathees/0000-0003-4430-261X; Weinstock, George M/0000-0002-2997-4592; Tirumalai, Madhan R/0000-0002-5999-333X; Fujita, Masaya/0000-0003-0060-5328; Karouia, Fathi/0000-0002-1142-9684	NSF [414410]; NASA [NNG05GN75G]; NRA ROSS	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NRA ROSS	This research was supported in part by grants to GMW (NSF-414410), GEF (NASA-Exobiology #NNG05GN75G) and KV (contract to JPL/Caltech from NASA and funded by NRA ROSS 2005). The sponsors had no role in the conduct of this study.	Aamodt RM, 2004, J BIOL CHEM, V279, P13601, DOI 10.1074/jbc.M314277200; Andersson B, 1996, ANAL BIOCHEM, V236, P107, DOI 10.1006/abio.1996.0138; Au N, 2005, J BACTERIOL, V187, P7655, DOI 10.1128/JB.187.22.7655-7666.2005; Bagyan I, 1998, J BACTERIOL, V180, P6704, DOI 10.1128/JB.180.24.6704-6712.1998; Bagyan I, 1998, J BACTERIOL, V180, P2057, DOI 10.1128/JB.180.8.2057-2062.1998; Benardini JN, 2003, ASTROBIOLOGY, V3, P709, DOI 10.1089/153110703322736033; Brosh RM, 1997, J BIOL CHEM, V272, P572; Cabrera-Hernandez A, 1999, GENE, V232, P1, DOI 10.1016/S0378-1119(99)00124-9; Cao M, 2005, J BACTERIOL, V187, P2948, DOI 10.1128/JB.187.9.2948-2956.2005; CARRILLOMARTINEZ Y, 1994, J BACTERIOL, V176, P5357, DOI 10.1128/JB.176.17.5357-5363.1994; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; CasillasMartinez L, 1997, J BACTERIOL, V179, P7420, DOI 10.1128/jb.179.23.7420-7425.1997; Cortezzo DE, 2005, J APPL MICROBIOL, V98, P606, DOI 10.1111/j.1365-2672.2004.02495.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DODD IB, 1988, PROTEIN ENG, V2, P174, DOI 10.1093/protein/2.3.174; Duigou S, 2004, MOL MICROBIOL, V54, P439, DOI 10.1111/j.1365-2958.2004.04259.x; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Essen LO, 2006, CELL MOL LIFE SCI, V63, P1266, DOI 10.1007/s00018-005-5447-y; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Groban ES, 2005, NUCLEIC ACIDS RES, V33, P6287, DOI 10.1093/nar/gki939; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Hawkins T, 2006, PROTEIN SCI, V15, P1550, DOI 10.1110/ps.062153506; Jedrzejas MJ, 2003, CRIT REV BIOCHEM MOL, V38, P173, DOI 10.1080/713609234; Kanno S, 1999, NUCLEIC ACIDS RES, V27, P3096, DOI 10.1093/nar/27.15.3096; Keijser BJF, 2007, J BACTERIOL, V189, P3624, DOI 10.1128/JB.01736-06; Kempf MJ, 2005, ASTROBIOLOGY, V5, P391, DOI 10.1089/ast.2005.5.391; KOOISTRA J, 1993, MOL MICROBIOL, V7, P915, DOI 10.1111/j.1365-2958.1993.tb01182.x; Lin J, 2007, GENE, V387, P15, DOI 10.1016/j.gene.2006.07.031; Liu XF, 2006, J BIOL CHEM, V281, P27827, DOI 10.1074/jbc.M601398200; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martins-Pinheiro M, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-17; Matsumoto T, 2005, GENES GENET SYST, V80, P385, DOI 10.1266/ggs.80.385; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; MOELLER R, 2007, ARCH MICROBIOLOGY; MOELLER R, 2007, J BACTERIOLOGY; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; MOROHOSHI F, 1990, NUCLEIC ACIDS RES, V18, P5473, DOI 10.1093/nar/18.18.5473; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; Newcombe DA, 2005, APPL ENVIRON MICROB, V71, P8147, DOI 10.1128/AEM.71.12.8147-8156.2005; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Pedraza-Reyes M, 2004, J BACTERIOL, V186, P6485, DOI 10.1128/JB.186.19.6485-6491.2004; Petit MA, 1998, MOL MICROBIOL, V29, P261, DOI 10.1046/j.1365-2958.1998.00927.x; Priest Fergus G., 1993, P3; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rohankhedkar MS, 2006, J BACTERIOL, V188, P223, DOI 10.1128/JB.188.1.223-230.2006; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Salas-Pacheco JA, 2005, J BACTERIOL, V187, P7374, DOI 10.1128/JB.187.21.7374-7381.2005; Sambrook J., 2001, MOL CLONING LAB MANU; SASSANFAR M, 1991, J BIOL CHEM, V266, P2767; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Setlow P, 2001, ENVIRON MOL MUTAGEN, V38, P97, DOI 10.1002/em.1058; SETLOW P, 1995, ANNU REV MICROBIOL, V49, P29, DOI 10.1146/annurev.mi.49.100195.000333; Smith BT, 2001, MOL CELL, V8, P1197, DOI 10.1016/S1097-2765(01)00402-6; Smits WK, 2005, J BACTERIOL, V187, P3921, DOI 10.1128/JB.187.12.3921-3930.2005; TOVARROJO F, 1991, J BACTERIOL, V173, P4827, DOI 10.1128/jb.173.15.4827-4835.1991; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Voloshin ON, 2003, J BIOL CHEM, V278, P28284, DOI 10.1074/jbc.M301188200; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584; Wheeler DL, 2005, NUCLEIC ACIDS RES, V33, pD39, DOI 10.1093/nar/gki062; YASBIN RE, 1992, MOL MICROBIOL, V6, P1263, DOI 10.1111/j.1365-2958.1992.tb00847.x; Yasuda T, 1998, EMBO J, V17, P3207, DOI 10.1093/emboj/17.11.3207; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1	70	98	530	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e928	10.1371/journal.pone.0000928	http://dx.doi.org/10.1371/journal.pone.0000928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895969	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455800007
J	Kelley, DJ; Davidson, RJ; Elliott, JL; Lahvis, GP; Yin, JCP; Bhattacharyya, A				Kelley, Daniel J.; Davidson, Richard J.; Elliott, Jamie L.; Lahvis, Garet P.; Yin, Jerry C. P.; Bhattacharyya, Anita			The Cyclic AMP Cascade Is Altered in the Fragile X Nervous System	PLOS ONE			English	Article								Fragile X syndrome (FX), the most common heritable cause of mental retardation and autism, is a developmental disorder characterized by physical, cognitive, and behavioral deficits. FX results from a trinucleotide expansion mutation in the fmr1 gene that reduces levels of fragile X mental retardation protein (FMRP). Although research efforts have focused on FMRP's impact on mGluR signaling, how the loss of FMRP leads to the individual symptoms of FX is not known. Previous studies on human FX blood cells revealed alterations in the cyclic adenosine 3', 5'-monophosphate (cAMP) cascade. We tested the hypothesis that cAMP signaling is altered in the FX nervous system using three different model systems. Induced levels of cAMP in platelets and in brains of fmr1 knockout mice are substantially reduced. Cyclic AMP induction is also significantly reduced in human FX neural cells. Furthermore, cAMP production is decreased in the heads of FX Drosophila and this defect can be rescued by reintroduction of the dfmr gene. Our results indicate that a robust defect in cAMP production in FX is conserved across species and suggest that cAMP metabolism may serve as a useful biomarker in the human disease population. Reduced cAMP induction has implications for the underlying causes of FX and autism spectrum disorders. Pharmacological agents known to modulate the cAMP cascade may be therapeutic in FX patients and can be tested in these models, thus supplementing current efforts centered on mGluR signaling.	[Bhattacharyya, Anita] Univ Wisconsin, Waisman Ctr, Stem Cells & Dev Disorders Lab, Madison, WI 53705 USA; [Kelley, Daniel J.; Davidson, Richard J.] Univ Wisconsin, Waisman Ctr, Waisman Lab Brain Imaging & Behav, Madison, WI 53705 USA; [Kelley, Daniel J.] Univ Wisconsin, Sch Med & Publ Hlth, Neurosci Training Program, Madison, WI 53705 USA; [Kelley, Daniel J.; Elliott, Jamie L.] Univ Wisconsin, Sch Med & Publ Hlth, Med Scientist Training Program, Madison, WI 53705 USA; [Lahvis, Garet P.] Univ Wisconsin, Dept Surg, Madison, WI 53705 USA; [Elliott, Jamie L.; Yin, Jerry C. P.] Univ Wisconsin, Dept Genet, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bhattacharyya, A (corresponding author), Univ Wisconsin, Waisman Ctr, Stem Cells & Dev Disorders Lab, Madison, WI 53705 USA.	bhattacharyy@waisman.wisc.edu		Lahvis, Garet/0000-0002-1986-8251; Davidson, Richard/0000-0002-8506-4964; Bhattacharyya, Anita/0000-0002-0360-7145	FRAXA Foundation Research; National Institute of Child Health and Human Development [P30 HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067774] Funding Source: NIH RePORTER	FRAXA Foundation Research; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a FRAXA Foundation Research Grant (AB) and in part by a core grant from the National Institute of Child Health and Human Development (P30 HD03352).	Azad SC, 2004, J NEUROSCI, V24, P9953, DOI 10.1523/JNEUROSCI.2134-04.2004; Bacchelli E, 2003, MOL PSYCHIATR, V8, P916, DOI 10.1038/sj.mp.4001340; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Balazs R, 1998, J NEUROCHEM, V70, P2446; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Berry-Kravis E, 1998, J NEUROSCI RES, V51, P41, DOI 10.1002/(SICI)1097-4547(19980101)51:1<41::AID-JNR4>3.0.CO;2-L; BERRYKRAVIS E, 1992, ANN NEUROL, V31, P22, DOI 10.1002/ana.410310105; BERRYKRAVIS E, 1995, PEDIATR RES, V38, P638, DOI 10.1203/00006450-199511000-00002; BERRYKRAVIS E, 1993, AM J MED GENET, V45, P81, DOI 10.1002/ajmg.1320450120; BHATTACHARYYA A, STEM CELLS IN PRESS; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Cartmell J, 1997, BRIT J PHARMACOL, V121, P1263, DOI 10.1038/sj.bjp.0701266; DEER JLR, 1995, J BIOL CHEM, V270, P12623, DOI 10.1074/jbc.270.21.12623; GILMAN AG, 1995, BIOSCIENCE REP, V15, P65, DOI 10.1007/BF01200143; Hagerman RJ, 2002, FRAGILE X SYNDROME D, P3; Heyduk E, 2003, COMB CHEM HIGH T SCR, V6, P347; Hines LM, 2005, BIOL PSYCHIAT, V58, P955, DOI 10.1016/j.biopsych.2005.05.040; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Kaytor MD, 2001, CELL, V107, P555, DOI 10.1016/S0092-8674(01)00590-6; Kooy RF, 2003, TRENDS GENET, V19, P148; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; MOOS M, 1988, SEC MESS PHOSPHOPROT, V12, P163; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; Ortinau S, 2005, ANN NY ACAD SCI, V1041, P211, DOI 10.1196/annals.1282.032; OTTE AP, 1989, CELL, V58, P641, DOI 10.1016/0092-8674(89)90099-8; Pacheco R, 2004, J BIOL CHEM, V279, P33352, DOI 10.1074/jbc.M401761200; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Pilc A, 1996, PROG NEURO-PSYCHOPH, V20, P673, DOI 10.1016/0278-5846(96)00040-1; Serajee FJ, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e42; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Warwick HK, 2005, J NEUROCHEM, V93, P232, DOI 10.1111/j.1471-4159.2005.03012.x; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Zhang YQ, 2005, MOL CELL PROTEOMICS, V4, P278, DOI 10.1074/mcp.M400174-MCP200; Zhang YQ, 2005, TRENDS GENET, V21, P37, DOI 10.1016/j.tig.2004.11.003	40	62	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e931	10.1371/journal.pone.0000931	http://dx.doi.org/10.1371/journal.pone.0000931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895972	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455800010
J	Okvist, A; Johansson, S; Kuzmin, A; Bazov, I; Merino-Martinez, R; Ponomarev, I; Mayfield, RD; Harris, RA; Sheedy, D; Garrick, T; Harper, C; Hurd, YL; Terenius, L; Ekstrom, TJ; Bakalkin, G; Yakovleva, T				Okvist, Anna; Johansson, Sofia; Kuzmin, Alexander; Bazov, Igor; Merino-Martinez, Roxana; Ponomarev, Igor; Mayfield, R. Dayne; Harris, R. Adron; Sheedy, Donna; Garrick, Therese; Harper, Clive; Hurd, Yasmin L.; Terenius, Lars; Ekstrom, Tomas J.; Bakalkin, Georgy; Yakovleva, Tatjana			Neuroadaptations in Human Chronic Alcoholics: Dysregulation of the NF-kappa B System	PLOS ONE			English	Article							DNA-BINDING ACTIVITY; GENE-EXPRESSION; FRONTAL-CORTEX; RAT-BRAIN; LONG-TERM; TRANSCRIPTION; ETHANOL; PROTEIN; ACTIVATION; PHOSPHORYLATION	Background. Alcohol dependence and associated cognitive impairments apparently result from neuroadaptations to chronic alcohol consumption involving changes in expression of multiple genes. Here we investigated whether transcription factors of Nuclear Factor-kappaB (NF-kappa B) family, controlling neuronal plasticity and neurodegeneration, are involved in these adaptations in human chronic alcoholics. Methods and Findings. Analysis of DNA-binding of NF-kappa B (p65/p50 heterodimer) and the p50 homodimer as well as NF-kappa B proteins and mRNAs was performed in postmortem human brain samples from 15 chronic alcoholics and 15 control subjects. The prefrontal cortex involved in alcohol dependence and cognition was analyzed and the motor cortex was studied for comparison. The p50 homodimer was identified as dominant kappa B binding factor in analyzed tissues. NF-kappa B and p50 homodimer DNA-binding was downregulated, levels of p65 (RELA) mRNA were attenuated, and the stoichiometry of p65/p50 proteins and respective mRNAs was altered in the prefrontal cortex of alcoholics. Comparison of a number of p50 homodimer/NF-kappa B target DNA sites, kappa B elements in 479 genes, down-or upregulated in alcoholics demonstrated that genes with kappa B elements were generally upregulated in alcoholics. No significant differences between alcoholics and controls were observed in the motor cortex. Conclusions. We suggest that cycles of alcohol intoxication/withdrawal, which may initially activate NF-kappa B, when repeated over years downregulate RELA expression and NF-kappa B and p50 homodimer DNA-binding. Downregulation of the dominant p50 homodimer, a potent inhibitor of gene transcription apparently resulted in derepression of kappa B regulated genes. Alterations in expression of p50 homodimer/NF-kappa B regulated genes may contribute to neuroplastic adaptation underlying alcoholism.	[Okvist, Anna; Johansson, Sofia; Kuzmin, Alexander; Bazov, Igor; Terenius, Lars; Ekstrom, Tomas J.; Bakalkin, Georgy; Yakovleva, Tatjana] Karolinska Inst, Dept Clin Neurosci, Sect Alcohol & Drug Dependence Res, Stockholm, Sweden; [Merino-Martinez, Roxana] Karolinska Inst, Dept Mol Med, Stockholm, Sweden; [Ponomarev, Igor; Mayfield, R. Dayne; Harris, R. Adron] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Sheedy, Donna; Garrick, Therese; Harper, Clive] Univ Sydney, Discipline Pathol, Sydney, NSW 2006, Australia; [Hurd, Yasmin L.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Hurd, Yasmin L.] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY USA; [Bakalkin, Georgy; Yakovleva, Tatjana] Uppsala Univ, Dept Pharmaceut Biosci, Div Biol Res Drug Dependence, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; University of Texas System; University of Texas Austin; University of Sydney; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Uppsala University	Bakalkin, G (corresponding author), Karolinska Inst, Dept Clin Neurosci, Sect Alcohol & Drug Dependence Res, Stockholm, Sweden.	Georgy.Bakalkin@ki.se	Ekström, Tomas/B-7764-2013	Merino Martinez, Roxana/0000-0002-8939-0003; Bakalkin, Georgy/0000-0002-8074-9833; Bazov, Igor/0000-0003-4388-1656	AFA Forsakring; Research Foundation of the Swedish Alcohol Retail Monopoly (SRA); Karolinska Institutet; Swedish Science Research Council; Swedish National Drug Policy Coordinator; University of Sydney; National Health and Medical Research Council of Australia; Neuroscience Institute of Schizophrenia and Allied Disorders; National Institute of Alcohol Abuse and Alcoholism; NSW Department of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012725, R28AA012725] Funding Source: NIH RePORTER	AFA Forsakring; Research Foundation of the Swedish Alcohol Retail Monopoly (SRA); Karolinska Institutet(Karolinska Institutet); Swedish Science Research Council; Swedish National Drug Policy Coordinator; University of Sydney(University of Sydney); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Neuroscience Institute of Schizophrenia and Allied Disorders; National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NSW Department of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the AFA Forsakring to AK, YLH, TJE and GB, the Research Foundation of the Swedish Alcohol Retail Monopoly (SRA) and Karolinska Institutet to AK, TJE and GB, and the Swedish Science Research Council and the Swedish National Drug Policy Coordinator to GB. The Australian Brain Donor Programs NSW Tissue Resource Centre was supported by The University of Sydney, National Health and Medical Research Council of Australia, Neuroscience Institute of Schizophrenia and Allied Disorders, National Institute of Alcohol Abuse and Alcoholism and NSW Department of Health.	Agartz I, 1999, ARCH GEN PSYCHIAT, V56, P356, DOI 10.1001/archpsyc.56.4.356; Alexander-Kaufman K, 2006, MOL PSYCHIATR, V11, P56, DOI 10.1038/sj.mp.4001741; Altura BM, 2002, EUR J PHARMACOL, V448, P89, DOI 10.1016/S0014-2999(02)01899-X; Association AP, 1994, DIAGN STAT MAN MENT, V4th; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAKALKIN G, 1994, MOL BRAIN RES, V24, P301, DOI 10.1016/0169-328X(94)90143-0; Bakalkin G, 1997, NEUROREPORT, V8, P2143; Bakalkin G, 1998, NEUROREPORT, V9, P2147, DOI 10.1097/00001756-199806220-00044; BAKALKIN GY, 1993, MOL BRAIN RES, V20, P137, DOI 10.1016/0169-328X(93)90119-A; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; BOURS V, 1990, NATURE, V348, P76, DOI 10.1038/348076a0; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen-Park FE, 2002, J BIOL CHEM, V277, P24701, DOI 10.1074/jbc.M200007200; Crews FT, 2006, ALCOHOL CLIN EXP RES, V30, P720, DOI 10.1111/j.1530-0277.2006.00084.x; Crews FT, 2005, ALCOHOL CLIN EXP RES, V29, P1504, DOI 10.1097/01.alc.0000175013.50644.61; Davis RL, 2004, NEUROSCI LETT, V371, P128, DOI 10.1016/j.neulet.2004.08.051; Ehrlich ME, 2002, J NEUROSCI, V22, P9155; Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X; Flatscher-Bader T, 2005, J NEUROCHEM, V93, P359, DOI 10.1111/j.1471-4159.2004.03021.x; GEIGER A, 2004, PARALLEL COMPUTING L, V14, P301; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GRANT KA, 1995, CLIN NEUROSCI, V3, P155; GRANT KA, 1990, EUR J PHARMACOL, V176, P289, DOI 10.1016/0014-2999(90)90022-X; Grundstrom S, 2004, J BIOL CHEM, V279, P8460, DOI 10.1074/jbc.M312398200; Guan HC, 2005, J BIOL CHEM, V280, P9957, DOI 10.1074/jbc.M412180200; GUERRINI L, 1995, P NATL ACAD SCI USA, V92, P9077, DOI 10.1073/pnas.92.20.9077; Hajishengallis G, 2004, INFECT IMMUN, V72, P1188, DOI 10.1128/IAI.72.2.1188-1191.2004; HARPER CG, 1985, LANCET, V2, P327; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Huang CJ, 2002, INT J DEV NEUROSCI, V20, P289, DOI 10.1016/S0736-5748(02)00022-9; Huang R, 2006, GENOMICS, V87, P315, DOI 10.1016/j.ygeno.2005.11.011; JENSEN GB, 1993, LANCET, V342, P1201; Johansson S, 2007, BRAIN RES, V1132, P20, DOI 10.1016/j.brainres.2006.11.026; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; KORNER M, 1989, NEURON, V3, P563, DOI 10.1016/0896-6273(89)90266-3; Kril JJ, 1997, NEUROSCIENCE, V79, P983, DOI 10.1016/S0306-4522(97)00083-3; KRIL JJ, 1989, ACTA NEUROPATHOL, V79, P200, DOI 10.1007/BF00294379; LI CCH, 1994, J BIOL CHEM, V269, P30089; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Mazzeo A, 2004, ARCH NEUROL-CHICAGO, V61, P1097, DOI 10.1001/archneur.61.7.1097; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; MERINOMARTINEZ R, PROMETHEUS SYS UNPUB; Michaelson JS, 2003, J CELL SCI, V116, P345, DOI 10.1242/jcs.00234; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Nickols JC, 2003, NAT NEUROSCI, V6, P161, DOI 10.1038/nn995; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; O'Mahony A, 2006, MOL CELL BIOL, V26, P7283, DOI 10.1128/MCB.00510-06; O'Riordan KJ, 2006, J NEUROSCI, V26, P4870, DOI 10.1523/JNEUROSCI.4527-05.2006; PARSONS OA, 1993, NEUROL CLIN, V11, P205, DOI 10.1016/S0733-8619(18)30178-6; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Rulten SL, 2006, GENES BRAIN BEHAV, V5, P257, DOI 10.1111/j.1601-183X.2005.00157.x; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Schmidt KS, 2005, DEMENT GERIATR COGN, V20, P286, DOI 10.1159/000088306; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Teferedegne B, 2006, MOL CELL BIOL, V26, P5759, DOI 10.1128/MCB.00271-06; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Ward RJ, 1996, FEBS LETT, V389, P119, DOI 10.1016/0014-5793(96)00545-5; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; YAKOVLEVA T, 2006, NEUROBIOLOGY AGING; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; JASPAR DATABASE	77	57	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e930	10.1371/journal.pone.0000930	http://dx.doi.org/10.1371/journal.pone.0000930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895971	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455800009
J	Poulsen, M; Erhardt, DP; Molinaro, DJ; Lin, TL; Currie, CR				Poulsen, Michael; Erhardt, Daniel P.; Molinaro, Daniel J.; Lin, Ting-Li; Currie, Cameron R.			Antagonistic Bacterial Interactions Help Shape Host-Symbiont Dynamics within the Fungus-Growing Ant-Microbe Mutualism	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; EVOLUTION; CONFLICT; HYMENOPTERA; PLANT; AGRICULTURE; RECOGNITION; COEVOLUTION; SPECIFICITY; PERSPECTIVE	Conflict within mutually beneficial associations is predicted to destabilize relationships, and theoretical and empirical work exploring this has provided significant insight into the dynamics of cooperative interactions. Within mutualistic associations, the expression and regulation of conflict is likely more complex than in intraspecific cooperative relationship, because of the potential presence of: i) multiple genotypes of microbial species associated with individual hosts, ii) multiple species of symbiotic lineages forming cooperative partner pairings, and iii) additional symbiont lineages. Here we explore complexity of conflict expression within the ancient and coevolved mutualistic association between attine ants, their fungal cultivar, and actinomycetous bacteria (Pseudonocardia). Specifically, we examine conflict between the ants and their Pseudonocardia symbionts maintained to derive antibiotics against parasitic microfungi (Escovopsis) infecting the ants' fungus garden. Symbiont assays pairing isolates of Pseudonocardia spp. associated with fungus-growing ants spanning the phylogenetic diversity of the mutualism revealed that antagonism between strains is common. In contrast, antagonism was substantially less common between more closely related bacteria associated with Acromyrmex leaf-cutting ants. In both experiments, the observed variation in antagonism across pairings was primarily due to the inhibitory capabilities and susceptibility of individual strains, but also the phylogenetic relationships between the ant host of the symbionts, as well as the pair-wise genetic distances between strains. The presence of antagonism throughout the phylogenetic diversity of Pseudonocardia symbionts indicates that these reactions likely have shaped the symbiosis from its origin. Antagonism is expected to prevent novel strains from invading colonies, enforcing single-strain rearing within individual ant colonies. While this may align ant-actinomycete interests in the bipartite association, the presence of single strains of Pseudonocardia within colonies may not be in the best interest of the ants, because increasing the diversity of bacteria, and thereby antibiotic diversity, would help the ant-fungus mutualism deal with the specialized parasites.	[Poulsen, Michael; Erhardt, Daniel P.; Molinaro, Daniel J.; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Lin, Ting-Li] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Poulsen, M (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	poulsen@wisc.edu	Poulsen, Michael/C-6276-2012	Poulsen, Michael/0000-0002-2839-1715	Lundbeckfonden; National Science Foundation [DEB-0110073]	Lundbeckfonden(Lundbeckfonden); National Science Foundation(National Science Foundation (NSF))	Funded by Lundbeckfonden to MP and National Science Foundation (Integrative Research Challenges in Environmental Biology DEB-0110073) to CRC.	Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; AUTUORI M, 1956, INSTINCT COMPORTEMEN; BASS M, 1994, ECOL ENTOMOL, V19, P215, DOI 10.1111/j.1365-2311.1994.tb00412.x; Bot ANM, 2001, EVOLUTION, V55, P1980, DOI 10.1111/j.0014-3820.2001.tb01315.x; Bronstein JL, 2003, AM NAT, V162, pS24, DOI 10.1086/378645; BROOK I, 2004, CRITIC REV MICR, V25, P155; Cafaro MJ, 2005, CAN J MICROBIOL, V51, P441, DOI 10.1139/W05-023; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Clark MA, 2000, EVOLUTION, V54, P517, DOI 10.1111/j.0014-3820.2000.tb00054.x; Clay K, 2005, P NATL ACAD SCI USA, V102, P12465, DOI 10.1073/pnas.0503059102; Currie CR, 2006, SCIENCE, V311, P81, DOI 10.1126/science.1119744; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 2003, SCIENCE, V299, P386, DOI 10.1126/science.1078155; Currie CR, 2003, NATURE, V423, P461, DOI 10.1038/nature01563; Currie CR, 2003, OIKOS, V101, P91, DOI 10.1034/j.1600-0706.2003.12036.x; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Currie CR, 2001, OECOLOGIA, V128, P99, DOI 10.1007/s004420100630; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; Davelos AL, 2004, APPL ENVIRON MICROB, V70, P1051, DOI 10.1128/AEM.70.2.1051-1058.2004; Davelos AL, 2004, CAN J MICROBIOL, V50, P79, DOI 10.1139/W03-107; Denison RF, 2000, AM NAT, V156, P567, DOI 10.1086/316994; Frank SA, 1996, P ROY SOC B-BIOL SCI, V263, P339, DOI 10.1098/rspb.1996.0052; Frank SA, 2003, EVOLUTION, V57, P693; Gerardo NM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-88; Gerardo NM, 2006, PLOS BIOL, V4, P1358, DOI 10.1371/journal.pbio.0040235; Gerardo NM, 2004, P ROY SOC B-BIOL SCI, V271, P1791, DOI 10.1098/rspb.2004.2792; Green AM, 2002, MOL ECOL, V11, P191, DOI 10.1046/j.1365-294X.2002.01433.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Huth CJ, 2000, ECOLOGY, V81, P1100, DOI 10.2307/177181; IKEDA H, 1992, SEARCH BIOACTIVE COM, P327; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; LAW R, 1992, P ROY SOC B-BIOL SCI, V248, P69, DOI 10.1098/rspb.1992.0044; Leigh EG, 1999, MG BEH ECOL, P15; Maddison D.R., 2005, MACCLADE 4 07 OS X; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Mehdiabadi NJ, 2006, NATURE, V442, P881, DOI 10.1038/442881a; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Mueller UG, 2004, BEHAV ECOL, V15, P357, DOI 10.1093/beheco/arh020; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poulsen M, 2005, SCIENCE, V307, P741, DOI 10.1126/science.1106688; Poulsen M, 2005, MOL ECOL, V14, P3597, DOI 10.1111/j.1365-294X.2005.02695.x; Poulsen M, 2002, INSECT SOC, V49, P15, DOI 10.1007/s00040-002-8271-5; POULSEN M, 2006, INSECT SYMBIOSIS, V2, P57; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Riley MA, 1996, J IND MICROBIOL, V17, P151, DOI 10.1007/BF01574688; Riley MA, 2003, J EVOLUTION BIOL, V16, P690, DOI 10.1046/j.1420-9101.2003.00575.x; Rudgers JA, 2004, P ROY SOC B-BIOL SCI, V271, P2481, DOI 10.1098/rspb.2004.2900; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Schneider S., 2000, ARLEQUIN VER 2 000 S; Schultz TR, 1995, SYST ENTOMOL, V20, P337, DOI 10.1111/j.1365-3113.1995.tb00100.x; Stahl DA, 2006, NATURE, V443, P925, DOI 10.1038/nature05208; Stanton ML, 2003, AM NAT, V162, pS10, DOI 10.1086/378646; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tintjer T, 2006, NEW PHYTOL, V170, P513, DOI 10.1111/j.1469-8137.2006.01720.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Viana AMM, 2001, CHEMOECOLOGY, V11, P29, DOI 10.1007/PL00001829; Visick KL, 2000, J BACTERIOL, V182, P4578, DOI 10.1128/JB.182.16.4578-4586.2000; von Ihering H., 1898, ZOOL ANZ, V21, P238; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Yahr R, 2004, MOL ECOL, V13, P3367, DOI 10.1111/j.1365-294X.2004.02350.x; Zhang MM, 2007, ISME J, V1, P313, DOI 10.1038/ismej.2007.41	68	41	41	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e960	10.1371/journal.pone.0000960	http://dx.doi.org/10.1371/journal.pone.0000960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17896000	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455800038
J	Trombone, APF; Silva, CL; Lima, KM; Oliver, C; Jamur, MC; Prescott, AR; Coelho-Castelo, AAM				Trombone, Ana Paula F.; Silva, Celio L.; Lima, Karla M.; Oliver, Constance; Jamur, Maria Celia; Prescott, Alan R.; Coelho-Castelo, Arlete A. M.			Endocytosis of DNA-Hsp65 Alters the pH of the Late Endosome/Lysosome and Interferes with Antigen Presentation	PLOS ONE			English	Article							DIRECT GENE-TRANSFER; BACTERIAL CPG-DNA; PLASMID DNA; NUCLEAR IMPORT; IN-VIVO; EXPRESSION; CELLS; TUBERCULOSIS; MECHANISM; DELIVERY	Background. Experimental models using DNA vaccine has shown that this vaccine is efficient in generating humoral and cellular immune responses to a wide variety of DNA-derived antigens. Despite the progress in DNA vaccine development, the intracellular transport and fate of naked plasmid DNA in eukaryotic cells is poorly understood, and need to be clarified in order to facilitate the development of novel vectors and vaccine strategies. Methodology and Principal Findings. Using confocal microscopy, we have demonstrated for the first time that after plasmid DNA uptake an inhibition of the acidification of the lysosomal compartment occurs. This lack of acidification impaired antigen presentation to CD4 T cells, but did not alter the recruitment of MyD88. The recruitment of Rab 5 and Lamp I were also altered since we were not able to co-localize plasmid DNA with Rab 5 and Lamp I in early endosomes and late endosomes/lysosomes, respectively. Furthermore, we observed that the DNA capture process in macrophages was by clathrin-mediated endocytosis. In addition, we observed that plasmid DNA remains in vesicles until it is in a juxtanuclear location, suggesting that the plasmid does not escape into the cytoplasmic compartment. Conclusions and Significance. Taken together our data suggests a novel mechanism involved in the intracellular trafficking of plasmid DNA, and opens new possibilities for the use of lower doses of plasmid DNA to regulate the immune response.	[Trombone, Ana Paula F.; Silva, Celio L.; Lima, Karla M.; Coelho-Castelo, Arlete A. M.] Univ Sao Paulo, Dept Biochem & Immunol, Sch Med Ribeirao Preto, Sao Paulo, Brazil; [Trombone, Ana Paula F.; Silva, Celio L.; Coelho-Castelo, Arlete A. M.] Univ Sao Paulo, Brazilian TB Res Network, Sch Med Ribeirao Preto, Sao Paulo, Brazil; [Oliver, Constance; Jamur, Maria Celia] Univ Sao Paulo, Dept Cellular & Mol Biol, Sch Med Ribeirao Preto, Sao Paulo, Brazil; [Prescott, Alan R.] Univ Dundee, Sch Life Sci, Div Cell Biol & Immunol, Dundee, Scotland	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Dundee	Coelho-Castelo, AAM (corresponding author), Univ Sao Paulo, Dept Biochem & Immunol, Sch Med Ribeirao Preto, Sao Paulo, Brazil.	arlete@fmrp.usp.br	Castelo, Arlete AM Coelho/C-8530-2012; Prescott, Alan/Y-5956-2018; Silva, Celio/C-4639-2012; Garlet, Ana Paula Trombone/N-9346-2013	Prescott, Alan/0000-0002-0747-7317; Silva, Celio/0000-0002-0043-4568; Garlet, Ana Paula Trombone/0000-0002-8102-6098; Coelho-Castelo, Arlete A. M./0000-0001-5737-2671	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Pesquisa (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Pesquisa (CNPq).	ABBAS AK, 2003, CELLULAR MOL IMMUNOL, P81; Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; ACSADI G, 1991, NEW BIOL, V3, P71; Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Basner-Tschakarjan E, 2004, GENE THER, V11, P765, DOI 10.1038/sj.gt.3302221; BENVENISTY N, 1986, P NATL ACAD SCI USA, V83, P9551, DOI 10.1073/pnas.83.24.9551; Budker V, 2000, J GENE MED, V2, P76, DOI 10.1002/(SICI)1521-2254(200003/04)2:2<76::AID-JGM97>3.0.CO;2-4; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Ciftci K, 2001, INT J PHARM, V218, P81, DOI 10.1016/S0378-5173(01)00623-8; Clark PR, 1999, CURR OPIN MOL THER, V1, P158; Coelho-Castelo AAM, 2003, HUM GENE THER, V14, P1279, DOI 10.1089/104303403767740812; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Foster KA, 2001, J PHARM PHARMACOL, V53, P57, DOI 10.1211/0022357011775190; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hagstrom JE, 1997, J CELL SCI, V110, P2323; Hengge UR, 1996, J CLIN INVEST, V97, P2911, DOI 10.1172/JCI118750; Jilek S, 2005, ADV DRUG DELIVER REV, V57, P377, DOI 10.1016/j.addr.2004.09.010; Klemm AR, 1998, BIOCHEM PHARMACOL, V56, P41, DOI 10.1016/S0006-2952(98)00098-7; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lechardeur D, 2005, ADV DRUG DELIVER REV, V57, P755, DOI 10.1016/j.addr.2004.12.008; Li K, 1997, J MOL CELL CARDIOL, V29, P1499, DOI 10.1006/jmcc.1997.0389; LOWRIE DB, 1994, VACCINE, V12, P1537, DOI 10.1016/0264-410X(94)90080-9; Lowrie DB, 1999, NATURE, V400, P269, DOI 10.1038/22326; Lowrie DB, 2000, VACCINE, V18, P1712, DOI 10.1016/S0264-410X(99)00512-5; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; Mui B, 2000, BBA-BIOMEMBRANES, V1467, P281, DOI 10.1016/S0005-2736(00)00226-1; Newman SL, 2006, J IMMUNOL, V176, P1806, DOI 10.4049/jimmunol.176.3.1806; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; SIKES ML, 1994, HUM GENE THER, V5, P837, DOI 10.1089/hum.1994.5.7-837; Simoes S, 1999, CURR OPIN MOL THER, V1, P147; Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; STENMARK H, 1994, EMBO J, V13, P575, DOI 10.1002/j.1460-2075.1994.tb06295.x; Suh HR, 1998, J BIOMED MATER RES, V42, P331, DOI 10.1002/(SICI)1097-4636(199811)42:2<331::AID-JBM19>3.0.CO;2-L; Tascon RE, 1996, NAT MED, V2, P888, DOI 10.1038/nm0896-888; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Wattiaux R, 2000, ADV DRUG DELIVER REV, V41, P201, DOI 10.1016/S0169-409X(99)00066-6; West MA, 1999, EUR J IMMUNOL, V29, P3450, DOI 10.1002/(SICI)1521-4141(199911)29:11<3450::AID-IMMU3450>3.0.CO;2-A; Wiethoff CM, 2003, J PHARM SCI-US, V92, P203, DOI 10.1002/jps.10286; Wilson GL, 1999, J BIOL CHEM, V274, P22025, DOI 10.1074/jbc.274.31.22025; WOLFF JA, 1992, J CELL SCI, V103, P1249; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Zelphati O, 1996, PHARMACEUT RES, V13, P1367, DOI 10.1023/A:1016026101195; Zelphati O, 1996, P NATL ACAD SCI USA, V93, P11493, DOI 10.1073/pnas.93.21.11493; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	50	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e923	10.1371/journal.pone.0000923	http://dx.doi.org/10.1371/journal.pone.0000923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895965	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455800003
J	Wani, AA; Ahanger, SH; Bapat, SA; Rangrez, AY; Hingankar, N; Suresh, CG; Barnabas, S; Patole, MS; Shouche, YS				Wani, Aijaz A.; Ahanger, Sajad H.; Bapat, Sharmila A.; Rangrez, Ashraf Y.; Hingankar, Nitin; Suresh, C. G.; Barnabas, Shama; Patole, Milind S.; Shouche, Yogesh S.			Analysis of Mitochondrial DNA Sequences in Childhood Encephalomyopathies Reveals New Disease-Associated Variants	PLOS ONE			English	Article								Background. Mitochondrial encephalomyopathies are a heterogeneous group of clinical disorders generally caused due to mutations in either mitochondrial DNA (mtDNA) or nuclear genes encoding oxidative phosphorylation (OXPHOS). We analyzed the mtDNA sequences from a group of 23 pediatric patients with clinical and morphological features of mitochondrial encephalopathies and tried to establish a relationship of identified variants with the disease. Methodology/Principle Findings. Complete mitochondrial genomes were amplified by PCR and sequenced by automated DNA sequencing. Sequencing data was analyzed by SeqScape software and also confirmed by BLASTn program. Nucleotide sequences were compared with the revised Cambridge reference sequence (CRS) and sequences present in mitochondrial databases. The data obtained shows that a number of known and novel mtDNA variants were associated with the disease. Most of the non-synonymous variants were heteroplasmic (A4136G, A9194G and T11916A) suggesting their possibility of being pathogenic in nature. Some of the missense variants although homoplasmic were showing changes in highly conserved amino acids (T3394C, T3866C, and G9804A) and were previously identified with diseased conditions. Similarly, two other variants found in tRNA genes (G5783A and C8309T) could alter the secondary structure of Cys-tRNA and Lys-tRNA. Most of the variants occurred in single cases; however, a few occurred in more than one case (e. g. G5783A and A10149T). Conclusions and Significance. The mtDNA variants identified in this study could be the possible cause of mitochondrial encephalomyopathies with childhood onset in the patient group. Our study further strengthens the pathogenic score of known variants previously reported as provisionally pathogenic in mitochondrial diseases. The novel variants found in the present study can be potential candidates for further investigations to establish the relationship between their incidence and role in expressing the disease phenotype. This study will be useful in genetic diagnosis and counseling of mitochondrial diseases in India as well as worldwide.	[Wani, Aijaz A.; Ahanger, Sajad H.; Bapat, Sharmila A.; Rangrez, Ashraf Y.; Patole, Milind S.; Shouche, Yogesh S.] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Hingankar, Nitin; Suresh, C. G.; Barnabas, Shama] Natl Chem Lab, Div Biochem Sci, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Shouche, YS (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	yogesh@nccs.res.in	Rangrez, Ashraf/H-4988-2016; Bapat, Sharmila/AGU-4130-2022	Rangrez, Ashraf/0000-0003-2630-9754; Bapat, Sharmila/0000-0002-9557-2233	Department of Biotechnology, India; Council of Scientific and Industrial Research (CSIR), India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by a grant from Department of Biotechnology, India. Wani A. A. is Senior Research fellow of Council of Scientific and Industrial Research (CSIR), India.	Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; BROWN MD, 1992, GENETICS, V130, P163; BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405; Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6; Da Pozzo P, 2004, BIOCHEM BIOPH RES CO, V324, P360, DOI 10.1016/j.bbrc.2004.09.058; DiMauro S, 2000, BRAIN PATHOL, V10, P431; DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008; Fauser S, 2002, BIOCHEM BIOPH RES CO, V295, P342, DOI 10.1016/S0006-291X(02)00672-1; Feigenbaum A, 2006, AM J MED GENET A, V140A, P2216, DOI 10.1002/ajmg.a.31436; HOWELL N, 1991, AM J HUM GENET, V48, P935; Hutchin TP, 2000, CELL MOL LIFE SCI, V57, P1927, DOI 10.1007/PL00000673; Janssen RJRJ, 2004, EXPERT REV MOL DIAGN, V4, P143, DOI 10.1586/14737159.4.2.143; Kovalenko SA, 1996, BIOCHEM BIOPH RES CO, V222, P201, DOI 10.1006/bbrc.1996.0722; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M; Marchington DR, 1996, HUM MOL GENET, V5, P473, DOI 10.1093/hmg/5.4.473; Martorell L, 2006, EUR J HUM GENET, V14, P520, DOI 10.1038/sj.ejhg.5201606; Matsumoto M, 1999, Ophthalmic Genet, V20, P153, DOI 10.1076/opge.20.3.153.2281; McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Parfait B, 1998, BIOCHEM BIOPH RES CO, V247, P57, DOI 10.1006/bbrc.1998.8666; Pereira C, 2007, BIOCHEM BIOPH RES CO, V354, P937, DOI 10.1016/j.bbrc.2007.01.068; Rajkumar R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-26; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565; SHOFFNER JM, 1995, NEUROLOGY, V45, P286, DOI 10.1212/WNL.45.2.286; Simon DK, 1999, ANNU REV MED, V50, P111; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443; Zhadanov SI, 2005, BIOCHEM BIOPH RES CO, V332, P1115, DOI 10.1016/j.bbrc.2005.05.059	34	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e942	10.1371/journal.pone.0000942	http://dx.doi.org/10.1371/journal.pone.0000942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895983	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455800021
J	Byrd, A; Hoffmann, SC; Jarahian, M; Momburg, F; Watzl, C				Byrd, Andreina; Hoffmann, Sabrina C.; Jarahian, Mostafa; Momburg, Frank; Watzl, Carsten			Expression Analysis of the Ligands for the Natural Killer Cell Receptors NKp30 and NKp44	PLOS ONE			English	Article								Background. The natural cytotoxicity receptors (NCR) are important to stimulate the activity of Natural Killer (NK) cells against transformed cells. Identification of NCR ligands and their level of expression on normal and neoplastic cells has important implications for the rational design of immunotherapy strategies for cancer. Methodology/Principal Findings. Here we analyze the expression of NKp30 ligand and NKp44 ligand on 30 transformed or non-transformed cell lines of different origin. We find intracellular and surface expression of these two ligands on almost all cell lines tested. Expression of NKp30 and NKp44 ligands was variable and did not correlate with the origin of the cell line. Expression of NKp30 and NKp44 ligand correlated with NKp30 and NKp44-mediated NK cell lysis of tumor cells, respectively. The surface expression of NKp30 ligand and NKp44 ligand was sensitive to trypsin treatment and was reduced in cells arrested in G2/M phase. Conclusion/Significance. These data demonstrate the ubiquitous expression of the ligands for NKp30 and NKp44 and give an important insight into the regulation of these ligands.	[Byrd, Andreina; Hoffmann, Sabrina C.; Watzl, Carsten] Univ Heidelberg, Inst Immunol, D-6900 Heidelberg, Germany; [Jarahian, Mostafa; Momburg, Frank] German Canc Res Ctr, Dept Mol Immunol, D-6900 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Watzl, C (corresponding author), Univ Heidelberg, Inst Immunol, Neuenheimer Feld 305, D-6900 Heidelberg, Germany.	Carsten.watzl@urz.uni-heidelberg.de	Watzl, Carsten/B-4911-2013	Watzl, Carsten/0000-0001-5195-0995	Deutsche Krebshilfe [106174]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Deutsche Krebshilfe (grant 106174).	Arnon TI, 2006, SEMIN CANCER BIOL, V16, P348, DOI 10.1016/j.semcancer.2006.07.005; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Bhat R, 2006, J LEUKOCYTE BIOL, V79, P417, DOI 10.1189/jlb.0905537; Bloushtain N, 2004, J IMMUNOL, V173, P2392, DOI 10.4049/jimmunol.173.4.2392; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Chisholm SE, 2006, J VIROL, V80, P2225, DOI 10.1128/JVI.80.5.2225-2233.2006; Chisholm SE, 2007, J INFECT DIS, V195, P1160, DOI 10.1086/512862; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; Hayakawa Y, 2006, ADV CANCER RES, V95, P293, DOI 10.1016/S0065-230X(06)95008-8; Hershkovitz O, 2007, BIOCHEMISTRY-US, V46, P7426, DOI 10.1021/bi7000455; Jarahian M, 2007, INT J CANCER, V120, P2625, DOI 10.1002/ijc.22579; Kumar V, 2005, NAT REV IMMUNOL, V5, P363, DOI 10.1038/nri1603; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee SH, 2007, TRENDS IMMUNOL, V28, P252, DOI 10.1016/j.it.2007.04.001; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mavoungou E, 2007, J INFECT DIS, V195, P1521, DOI 10.1086/515579; Messmer B, 2006, J IMMUNOL, V176, P4646, DOI 10.4049/jimmunol.176.8.4646; Moretta L, 2004, CURR OPIN IMMUNOL, V16, P626, DOI 10.1016/j.coi.2004.07.010; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Newman KC, 2007, NAT REV IMMUNOL, V7, P279, DOI 10.1038/nri2057; Nolte-'t Hoen ENM, 2007, BLOOD, V109, P670, DOI 10.1182/blood-2006-07-036509; Nowbakht P, 2005, BLOOD, V105, P3615, DOI 10.1182/blood-2004-07-2585; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Ruggeri L, 2007, CURR OPIN ONCOL, V19, P142, DOI 10.1097/CCO.0b013e3280148a1a; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Sivori S, 2000, EUR J IMMUNOL, V30, P787, DOI 10.1002/1521-4141(200003)30:3<787::AID-IMMU787>3.0.CO;2-I; Stark S, 2005, J IMMUNOL METHODS, V296, P149, DOI 10.1016/j.jim.2004.11.010; Vieillard V, 2005, P NATL ACAD SCI USA, V102, P10981, DOI 10.1073/pnas.0504315102; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Warren HS, 2005, J IMMUNOL, V175, P207, DOI 10.4049/jimmunol.175.1.207; Watzl C, 2003, J EXP MED, V197, P77, DOI 10.1084/jem.20020427; Wu J, 2003, ADV CANCER RES, V90, P127, DOI 10.1016/S0065-230X(03)90004-2; Zamai L, 2007, J IMMUNOL, V178, P4011, DOI 10.4049/jimmunol.178.7.4011	39	76	77	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1339	10.1371/journal.pone.0001339	http://dx.doi.org/10.1371/journal.pone.0001339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18092004	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459600022
J	Diaz, JA; Jaramillo, NA; Murillo, MF				Diaz, Jairo A.; Jaramillo, Natalia A.; Murillo, Mauricio F.			Geometric Triangular Chiral Hexagon Crystal-Like Complexes Organization in Pathological Tissues Biological Collision Order	PLOS ONE			English	Article							STELLATE	The present study describes and documents self-assembly of geometric triangular chiral hexagon crystal like complex organizations (GTCHC) in human pathological tissues. The authors have found this architectural geometric expression at macroscopic and microscopic levels mainly in cancer processes. This study is based essentially on macroscopic and histopathologic analyses of 3000 surgical specimens: 2600 inflammatory lesions and 400 malignant tumours. Geometric complexes identified photographically at macroscopic level were located in the gross surgical specimen, and these areas were carefully dissected. Samples were taken to carry out histologic analysis. Based on the hypothesis of a collision genesis mechanism and because it is difficult to carry out an appropriate methodological observation in biological systems, the authors designed a model base on other dynamic systems to obtain indirect information in which a strong white flash wave light discharge, generated by an electronic device, hits over the lines of electrical conductance structured in helicoidal pattern. In their experimental model, the authors were able to reproduce and to predict polarity, chirality, helicoid geometry, triangular and hexagonal clusters through electromagnetic sequential collisions. They determined that similar events among constituents of extracelular matrix which drive and produce piezoelectric activity are responsible for the genesis of GTCHC complexes in pathological tissues. This research suggests that molecular crystals represented by triangular chiral hexagons derived from a collision-attraction event against collagen type I fibrils emerge at microscopic and macroscopic scales presenting a lateral assembly of each side of hypertrophy helicoid fibers, that represent energy flow in cooperative hierarchically chiral electromagnetic interaction in pathological tissues and arises as a geometry of the equilibrium in perturbed biological systems. Further interdisciplinary studies must be carried out to reproduce, manipulate and amplify their activity and probably use them as a base to develop new therapeutic strategies in cancer.	[Diaz, Jairo A.; Jaramillo, Natalia A.; Murillo, Mauricio F.] Univ Cooperativa Colombia, Sch Med, Pathol Lab, Dept Pathol,Clin Hlth Social Ent Policarpa Salava, Villavicencio, Meta, Colombia	Universidad Cooperativa de Colombia	Diaz, JA (corresponding author), Univ Cooperativa Colombia, Sch Med, Pathol Lab, Dept Pathol,Clin Hlth Social Ent Policarpa Salava, Villavicencio, Meta, Colombia.	jaditod@hotmail.com		Jaramillo Gomez, Natalia/0000-0002-0939-171X	Medicine School, Pathology Department, Cooperative University of Colombia; Clinical Carlos Hugo Estrada, State social company Policarpa Salavarrieta, Villavicencio, Colombia	Medicine School, Pathology Department, Cooperative University of Colombia; Clinical Carlos Hugo Estrada, State social company Policarpa Salavarrieta, Villavicencio, Colombia	This investigation was possible thanks to the logistical and economic support of the Medicine School, Pathology Department, Cooperative University of Colombia and the Clinical Carlos Hugo Estrada, State social company Policarpa Salavarrieta, Villavicencio, Colombia.	ADDADI L, 2007, TOPICS STEREOCHEMIST, V17; Barron LD, 2000, NATURE, V405, P895, DOI 10.1038/35016183; Brizard A, 2005, TOP CURR CHEM, V256, P167, DOI 10.1007/b107174; Cherel P, 2005, EUR J RADIOL, V54, P37, DOI 10.1016/j.ejrad.2004.11.018; Dong LF, 2006, PLASMA SOURCES SCI T, V15, P840, DOI 10.1088/0963-0252/15/4/029; He HJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.101803; Hulliger J, 2002, CHEM MATER, V14, P1523, DOI 10.1021/cm010405y; HULMES DJS, 1979, NATURE, V282, P878, DOI 10.1038/282878a0; LANYI M, 1982, FORTSCHR RONTG NEUEN, V136, P182, DOI 10.1055/s-2008-1056023; Oda R, 1996, J PHYS II, V6, P1429, DOI 10.1051/jp2:1996140; Pokorna E, 2003, FOLIA BIOL-PRAGUE, V49, P33; Prockop DJ, 1998, J STRUCT BIOL, V122, P111, DOI 10.1006/jsbi.1998.3976; Prosser RS, 1998, BIOPHYS J, V75, P2163, DOI 10.1016/S0006-3495(98)77659-3; SHAMOS MH, 1967, NATURE, V213, P267, DOI 10.1038/213267a0; Tadokoro T, 2004, J GASTROENTEROL, V39, P635, DOI 10.1007/s00535-004-1358-1; Tamura S, 2002, J GASTROENTEROL, V37, P798, DOI 10.1007/s005350200133	16	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1282	10.1371/journal.pone.0001282	http://dx.doi.org/10.1371/journal.pone.0001282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074008	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459500001
J	Estep, AL; Palmer, C; McCormick, F; Rauen, KA				Estep, Anne L.; Palmer, Chana; McCormick, Frank; Rauen, Katherine A.			Mutation Analysis of BRAF, MEK1 and MEK2 in 15 Ovarian Cancer Cell Lines: Implications for Therapy	PLOS ONE			English	Article							KINASE GENE FAMILY; PROTEIN MAP KINASE; LOW-GRADE; SOMATIC MUTATIONS; SIGNALING PATHWAY; PIK3CA MUTATIONS; PTEN GENE; KRAS; ACTIVATION; NEOPLASMS	Background. Among gynecologic cancers, ovarian cancer is the second most common and has the highest death rate. Cancer is a genetic disorder and arises due to the accumulation of somatic mutations in critical genes. An understanding of the genetic basis of ovarian cancer has implications both for early detection and for therapeutic intervention in this population of patients. Methodology/Principal Findings. Fifteen ovarian cancer cell lines, commonly used for in vitro experiments, were screened for mutations using bidirectional direct sequencing in all coding regions of BRAF, MEK1 and MEK2. BRAF mutations were identified in four of the fifteen ovarian cancer cell lines studied. Together, these four cell lines contained four different BRAF mutations, two of which were novel. ES-2 had the common B-Raf p. V600E mutation in exon 15 and Hey contained an exon 11 missense mutation, p.G464E. The two novel B-Raf mutants identified were a 5 amino acid heterozygous deletion p.N486-P490del in OV90, and an exon 4 missense substitution p.Q201H in OVCAR 10. One of the cell lines, ES-2, contained a mutation in MEK1, specifically, a novel heterozygous missense substitution, p. D67N which resulted from a nt 199 G -> A transition. None of the cell lines contained coding region mutations in MEK2. Functional characterization of the MEK1 mutant p. D67N by transient transfection with subsequent Western blot analysis demonstrated increased ERK phosphorylation as compared to controls. Conclusions/Significance. In this study, we report novel BRAF mutations in exon 4 and exon 12 and also report the first mutation in MEK1 associated with human cancer. Functional data indicate the MEK1 mutation may confer alteration of activation through the MAPK pathway. The significance of these findings is that BRAF and MEK1/2 mutations may be more common than anticipated in ovarian cancer which could have important implications for treatment of patients with this disease and suggests potential new therapeutic avenues.	[Estep, Anne L.; McCormick, Frank; Rauen, Katherine A.] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [Estep, Anne L.; McCormick, Frank; Rauen, Katherine A.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Palmer, Chana] Canary Fdn, San Jose, CA USA; [McCormick, Frank] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Rauen, Katherine A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rauen, KA (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA.	rauen@cc.ucsf.edu			NIH [HD048502]; Canary Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD048502] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canary Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	NIH grant HD048502 (K.A.R.) provided partial funding. Canary Foundation provided partial funding. The Canary Foundation did not have a role in the collection, analysis, and interpretation of data.	Bansal A, 1997, ONCOGENE, V14, P1231, DOI 10.1038/sj.onc.1200947; Bignell G, 2006, GENE CHROMOSOME CANC, V45, P42, DOI 10.1002/gcc.20265; BUICK RN, 1985, CANCER RES, V45, P3668; Campbell IG, 2005, CLIN CANCER RES, V11, P7042, DOI 10.1158/1078-0432.CCR-05-1024; ChenevixTrench G, 1997, GENE CHROMOSOME CANC, V18, P75, DOI 10.1002/(SICI)1098-2264(199702)18:2<75::AID-GCC1>3.0.CO;2-Y; Cruz F, 2003, CANCER RES, V63, P5761; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Delaney AM, 2002, MOL CELL BIOL, V22, P7593, DOI 10.1128/MCB.22.21.7593-7602.2002; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; Gemignani ML, 2003, GYNECOL ONCOL, V90, P378, DOI 10.1016/S0090-8258(03)00264-6; Ho CL, 2004, CANCER RES, V64, P6915, DOI 10.1158/0008-5472.CAN-04-2067; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; LAU DHM, 1991, CANCER RES, V51, P5181; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; MANSOUR SJ, 1994, J BIOCHEM-TOKYO, V116, P304, DOI 10.1093/oxfordjournals.jbchem.a124524; Morita K, 2000, PATHOL INT, V50, P219, DOI 10.1046/j.1440-1827.2000.01028.x; Nakayama K, 2006, CANCER BIOL THER, V5, P779, DOI 10.4161/cbt.5.7.2751; Narumi Y, 2007, AM J MED GENET A, V143A, P799, DOI 10.1002/ajmg.a.31658; NAVA C, 2007, J MED GENET; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Russell SEH, 2004, J PATHOL, V203, P617, DOI 10.1002/path.1563; Saito M, 2000, INT J CANCER, V85, P160, DOI 10.1002/(SICI)1097-0215(20000115)85:2<160::AID-IJC2>3.0.CO;2-5; Schondorf T, 2000, J SOC GYNECOL INVEST, V7, P313, DOI 10.1016/S1071-5576(00)00076-9; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Sieben NLG, 2004, J PATHOL, V202, P336, DOI 10.1002/path.1521; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Trovisco V, 2005, HUM PATHOL, V36, P694, DOI 10.1016/j.humpath.2005.04.011; Tworek H, 1999, CANCER GENET CYTOGEN, V112, P105, DOI 10.1016/S0165-4608(98)00267-2; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang Y, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9316; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	44	65	75	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1279	10.1371/journal.pone.0001279	http://dx.doi.org/10.1371/journal.pone.0001279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060073	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459400026
J	Hornshoj, H; Conley, LN; Hedegaard, J; Sorensen, P; Panitz, F; Bendixen, C				Hornshoj, Henrik; Conley, Lene Nagstrup; Hedegaard, Jakob; Sorensen, Peter; Panitz, Frank; Bendixen, Christian			Microarray Expression Profiles of 20.000 Genes across 23 Healthy Porcine Tissues	PLOS ONE			English	Article							MOUSE; CDNA; ONTOLOGY; DATABASE	Background. Gene expression microarrays have been intensively applied to screen for genes involved in specific biological processes of interest such as diseases or responses to environmental stimuli. For mammalian species, cataloging of the global gene expression profiles in large tissue collections under normal conditions have been focusing on human and mouse genomes but is lacking for the pig genome. Methodology/Principal Findings. Here we present the results from a large-scale porcine study establishing microarray cDNA expression profiles of approximately 20.000 genes across 23 healthy tissues. As expected, a large portion of the genes show tissue specific expression in agreement with mappings to gene descriptions, Gene Ontology terms and KEGG pathways. Two-way hierarchical clustering identified expected tissue clusters in accordance with tissue type and a number of cDNA clusters having similar gene expression patterns across tissues. For one of these cDNA clusters, we demonstrate that possible tissue associated gene function can be inferred for previously uncharacterized genes based on their shared expression patterns with functionally annotated genes. We show that gene expression in common porcine tissues is similar to the expression in homologous tissues of human. Conclusions/Significance. The results from this study constitute a valuable and publicly available resource of basic gene expression profiles in normal porcine tissues and will contribute to the identification and functional annotation of porcine genes.	[Hornshoj, Henrik; Conley, Lene Nagstrup; Hedegaard, Jakob; Sorensen, Peter; Panitz, Frank; Bendixen, Christian] Univ Aarhus, Fac Agr Sci, Dept Genet & Biotechnol, Tjele, Denmark	Aarhus University	Bendixen, C (corresponding author), Univ Aarhus, Fac Agr Sci, Dept Genet & Biotechnol, Tjele, Denmark.	christian.bendixen@agrsci.dk	Panitz, Frank/A-3281-2017	Panitz, Frank/0000-0002-6909-5162				Agrawal D, 2002, J NATL CANCER I, V94, P513; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Chen HM, 1996, AM J HUM GENET, V59, P66; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Gorodkin J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r45; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Saito-Hisaminato A, 2002, DNA RES, V9, P35, DOI 10.1093/dnares/9.2.35; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Vencio RZN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-86; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang JH, 2003, BIOINFORMATICS, V19, P155, DOI 10.1093/bioinformatics/19.1.155; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	25	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1203	10.1371/journal.pone.0001203	http://dx.doi.org/10.1371/journal.pone.0001203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030337	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459200016
J	Kelley, DJ; Farhoud, M; Meyerand, ME; Nelson, DL; Ramirez, LF; Dempsey, RJ; Wolf, AJ; Alexander, AL; Davidson, RJ				Kelley, Daniel J.; Farhoud, Mohammed; Meyerand, M. Elizabeth; Nelson, David L.; Ramirez, Lincoln F.; Dempsey, Robert J.; Wolf, Alan J.; Alexander, Andrew L.; Davidson, Richard J.			Creating Physical 3D Stereolithograph Models of Brain and Skull	PLOS ONE			English	Article								The human brain and skull are three dimensional (3D) anatomical structures with complex surfaces. However, medical images are often two dimensional (2D) and provide incomplete visualization of structural morphology. To overcome this loss in dimension, we developed and validated a freely available, semi-automated pathway to build 3D virtual reality (VR) and hand-held, stereolithograph models. To evaluate whether surface visualization in 3D was more informative than in 2D, undergraduate students (n = 50) used the Gillespie scale to rate 3D VR and physical models of both a living patient-volunteer's brain and the skull of Phineas Gage, a historically famous railroad worker whose misfortune with a projectile tamping iron provided the first evidence of a structure-function relationship in brain. Using our processing pathway, we successfully fabricated human brain and skull replicas and validated that the stereolithograph model preserved the scale of the VR model. Based on the Gillespie ratings, students indicated that the biological utility and quality of visual information at the surface of VR and stereolithograph models were greater than the 2D images from which they were derived. The method we developed is useful to create VR and stereolithograph 3D models from medical images and can be used to model hard or soft tissue in living or preserved specimens. Compared to 2D images, VR and stereolithograph models provide an extra dimension that enhances both the quality of visual information and utility of surface visualization in neuroscience and medicine.	[Kelley, Daniel J.; Alexander, Andrew L.; Davidson, Richard J.] Waisman Ctr Mental Retardat & Human Dev, Waisman Lab Brain Imaging & Behav, Madison, WI USA; [Kelley, Daniel J.] Univ Wisconsin, Sch Med & Publ Hlth, Med Scientist Training Program, Madison, WI USA; [Kelley, Daniel J.] Univ Wisconsin, Neurosci Training Program, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Kelley, Daniel J.] Univ Wisconsin, Howard Hughes Med Inst, Teaching Fellows Program, Wisconsin Program Sci Teaching,Dept Bacteriol, Madison, WI 53706 USA; [Farhoud, Mohammed] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Madison, WI USA; [Farhoud, Mohammed; Wolf, Alan J.] Univ Wisconsin, Ctr Biotechnol, Biol New Media Ctr, Madison, WI 53705 USA; [Meyerand, M. Elizabeth; Alexander, Andrew L.] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA; [Nelson, David L.] Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI USA; [Ramirez, Lincoln F.; Dempsey, Robert J.] Univ Wisconsin, Dept Neurol Surg, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kelley, DJ (corresponding author), Waisman Ctr Mental Retardat & Human Dev, Waisman Lab Brain Imaging & Behav, Madison, WI USA.	djkelley@wisc.edu	Wolf, Alan J/G-9822-2011	Wolf, Alan J/0000-0002-9576-477X; Davidson, Richard/0000-0002-8506-4964	Studies to Advance Autism Research and Treatment [U54MH066398]; National Institute of Mental Health [P50-MH069315]; National Institutes of Health [P30 HD03352]; National Science Foundation [0411278]; Howard Hughes Medical Institute Professors Program [2006-0516]; National Science Foundation for Course, Curriculum, and Lab Improvement; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH066398, P50MH069315] Funding Source: NIH RePORTER	Studies to Advance Autism Research and Treatment; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute Professors Program(Howard Hughes Medical Institute); National Science Foundation for Course, Curriculum, and Lab Improvement; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a Studies to Advance Autism Research and Treatment grant U54MH066398 Project IV (RJD), a center grant P50-MH069315 to RJD from the US National Institute of Mental Health, a core grant P30 HD03352 (MM Seltzer) from the National Institutes of Health, and National Science Foundation award 0411278 (DLN and AJW). The survey work was exempt from review with IRB protocol #2006-0516 (November 2006) of the Wisconsin Program for Scientific Teaching, which is supported by the Howard Hughes Medical Institute Professors Program awarded to Dr. Jo Handelsman, and by a grant from the National Science Foundation for Course, Curriculum, and Lab Improvement, awarded to JH and Sarah M. Miller.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Chen JCT, 1999, NEUROSURGERY, V45, P883, DOI 10.1097/00006123-199910000-00031; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; D'Urso PS, 1999, NEUROSURGERY, V44, P1084, DOI 10.1097/00006123-199905000-00080; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Eftekhar Behzad, 2005, BMC Med Educ, V5, P15, DOI 10.1186/1472-6920-5-15; Gering DT, 2001, J MAGN RESON IMAGING, V13, P967, DOI 10.1002/jmri.1139; Lukic IK, 2003, LANCET, V362, P2110, DOI 10.1016/S0140-6736(03)15114-8; McGurk M, 1997, ANN ROY COLL SURG, V79, P169; Meakin JR, 2004, BRIT J RADIOL, V77, P504, DOI 10.1259/bjr/50012454; Muller A, 2003, J CRANIOFAC SURG, V14, P899; NOORANI R, 2006, RAPID PROTOTYPING PR, pR21; Panchaphongsaphak B, 2005, ST HEAL T, V111, P378; Pevsner J, 2002, TRENDS NEUROSCI, V25, P217, DOI 10.1016/S0166-2236(00)02121-4; RAMACHANDRAN P, 2001, FREE TOOL CFD DATA V; Ratiu PF, 2004, NEW ENGL J MED, V351, pE21, DOI 10.1056/NEJMicm031024; Wurm G, 2004, SURG NEUROL, V62, P510, DOI 10.1016/j.surneu.2004.01.025; Wurm G, 2004, J NEUROSURG, V100, P139, DOI 10.3171/jns.2004.100.1.0139	18	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1119	10.1371/journal.pone.0001119	http://dx.doi.org/10.1371/journal.pone.0001119			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971879	Green Submitted, Green Published, gold			2022-12-27	WOS:000207458700033
J	Nathavitharana, R; Coronel, J; Moore, DAJ				Nathavitharana, Ruvandhi; Coronel, Jorge; Moore, David A. J.			Solar Disinfection of MODS Mycobacterial Cultures in Resource-Poor Settings	PLOS ONE			English	Article								Introduction. Safe disposal of TB culture material in which the infectious burden of clinical samples has been greatly amplified is an important challenge in resource-limited settings. The bactericidal capacity of solar cookers has been demonstrated previously for conventional bacteria and contaminated clinical waste. We investigated the use of a simple solar cooker for the sterilization of mycobacterial broth cultures from the microscopic observation drug susceptibility assay (MODS). Methods. Simulated TB culture materials were prepared by inoculating 24-well MODS plates with 500 mu L of a known concentration of Mycobacterium bovis BCG. In a series of experiments, samples were simultaneously placed inside a box-type solar cooker and control box and removed at timepoints between 15 minutes and 6 hours. Quantitative cultures were performed using retrieved samples to determine sterilization effect. Results. All cultures from the control box were positive at or within 1-4 logs of inoculation concentration. Simulated culture plates at concentrations from 10(3) colony-forming-units (CFU)/ml to 10(7) CFU/ml were completely sterilized after only one hour of cooker exposure, at temperatures between 50-102 degrees C. At 10(9) CFU/ml (far in excess of diagnostic cultures), it was only possible to recover mycobacterial growth in plates removed after 15 minutes. By 30 minutes all plates were effectively sterilized. Discussion. Solar disinfection provides a very effective, safe and low-cost alternative to conventional equipment used for disposal of mycobacterial culture material. Effect of climatic conditions and optimal operating procedure remain to be defined.	[Nathavitharana, Ruvandhi; Moore, David A. J.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis & Immun, London, England; [Nathavitharana, Ruvandhi; Moore, David A. J.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Wellcome Ctr Clin Trop Med, London, England; [Coronel, Jorge; Moore, David A. J.] Univ Peruana Cayetano Heredia, Lab Invest Enfermedades Infecciosas, Lima, Peru; [Moore, David A. J.] Asociac Benef PRISMA, Lima, Peru	Imperial College London; Imperial College London; Universidad Peruana Cayetano Heredia	Nathavitharana, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis & Immun, London, England.	rrn01@imperial.ac.uk		Coronel, Jorge/0000-0002-4580-6716	Wellcome Trust [078067]	Wellcome Trust(Wellcome TrustEuropean Commission)	Funding: This study was supported by a Student Elective Prize from the Wellcome Trust. DAJM is supported by the Wellcome Trust (grant number 078067).	Chitnis V, 2003, LANCET, V362, P1285, DOI 10.1016/S0140-6736(03)14610-7; Conroy RM, 1996, LANCET, V348, P1695, DOI 10.1016/S0140-6736(96)02309-4; Doig C, 2002, J CLIN PATHOL, V55, P778, DOI 10.1136/jcp.55.10.778; Moore DAJ, 2004, J CLIN MICROBIOL, V42, P4432, DOI 10.1128/JCM.42.10.4432-4437.2004; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; RILEY RL, 1976, AM REV RESPIR DIS, V113, P413; RILEY RL, 1989, AM REV RESPIR DIS, V139, P1286, DOI 10.1164/ajrccm/139.5.1286; WHO (World Health Organization), 2006, WHO TUB FACT SHEET	8	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1100	10.1371/journal.pone.0001100	http://dx.doi.org/10.1371/journal.pone.0001100			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971863	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000207458700017
J	Witt, MJ; Godley, BJ				Witt, Matthew J.; Godley, Brendan J.			A Step Towards Seascape Scale Conservation: Using Vessel Monitoring Systems (VMS) to Map Fishing Activity	PLOS ONE			English	Article								Background. Conservation of marine ecosystems will require a holistic understanding of fisheries with concurrent spatial patterns of biodiversity. Methodology/Principal Findings. Using data from the UK Government Vessel Monitoring System (VMS) deployed on UK-registered large fishing vessels we investigate patterns of fisheries activity on annual and seasonal scales. Analysis of VMS data shows that regions of the UK European continental shelf (i.e. Western Channel and Celtic Sea, Northern North Sea and the Goban Spur) receive consistently greater fisheries pressure than the rest of the UK continental shelf fishing zone. Conclusions/Significance. VMS provides a unique and independent method from which to derive patterns of spatially and temporally explicit fisheries activity. Such information may feed into ecosystem management plans seeking to achieve sustainable fisheries while minimising putative risk to non-target species (e.g. cetaceans, seabirds and elasmobranchs) and habitats of conservation concern. With multilateral collaboration VMS technologies may offer an important solution to quantifying and managing ecosystem disturbance, particularly on the high-seas.	[Witt, Matthew J.; Godley, Brendan J.] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England	University of Exeter	Godley, BJ (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England.	b.j.godley@ex.ac.uk	Witt, Matthew J/C-2279-2008; Witt, Matthew/V-3318-2018; godley, brendan j/A-6139-2009; godley, brendan/O-1959-2019	Witt, Matthew/0000-0002-9498-5378; godley, brendan j/0000-0003-3845-0034; godley, brendan/0000-0003-3845-0034	Natural Environment Research Council [NER/S/A/2004/12980]; European Social Fund	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Social Fund(European Social Fund (ESF))	MJW is supported by a Natural Environment Research Council PhD studentship (NER/S/A/2004/12980) at the University of Exeter (Cornwall Campus). BJG receives funding from the European Social Fund.	Bearhop S, 2001, CONDOR, V103, P802, DOI 10.1650/0010-5422(2001)103[0802:AVIGSD]2.0.CO;2; Bowen BW, 2005, MOL ECOL, V14, P2389, DOI 10.1111/j.1365-294X.2005.02598.x; Carranza A, 2006, BIOL CONSERV, V131, P52, DOI 10.1016/j.biocon.2006.02.003; *COMM EUR COMM, 2004, 7242004 COMM EUR COM; Connor D.W., 2006, UKSEAMAP MAPPING SEA, V3rd ed.; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Deng R, 2005, CAN J FISH AQUAT SCI, V62, P611, DOI 10.1139/F04-219; *DEP ENV FOOD RUR, 2004, EXPL MEM S W TERR WA; *DEP ENV FOOD RUR, 2005, SAT MON UK FISH BOAT; *DEP ENV FOOD RUR, 2005, SAT MON NOT GUID; *DEP ENV FOOD RUR, 2005, CHART PROGR INT ASS; Gallaway BJ, 2003, N AM J FISH MANAGE, V23, P581, DOI 10.1577/1548-8675(2003)023<0581:DOASEL>2.0.CO;2; Gilkinson KD, 2005, ICES J MAR SCI, V62, P925, DOI 10.1016/j.icesjms.2005.03.009; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; HAMMOND PS, 1995, 922UK27 LIFE EUR COM; HAMMOND PS, 2007, FINAL REPORT SMALL C; Huthnance JM, 2001, DEEP-SEA RES PT II, V48, P2979, DOI 10.1016/S0967-0645(01)00030-3; LEFEVRE J, 1986, ADV MAR BIOL, V23, P163; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lewison RL, 2003, ECOL APPL, V13, P743, DOI 10.1890/1051-0761(2003)013[0743:EFBAEO]2.0.CO;2; *MAR FISH AG, 2005, UK SEA FISH STAT 200; Mills CM, 2007, ICES J MAR SCI, V64, P248, DOI 10.1093/icesjms/fsl026; MOLENARR EJ, 2000, ORG FAA; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; NORTHRIDGE S, 2006, 1735R07D M ELL PARTN; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Phillips RA, 2006, BIOL CONSERV, V129, P336, DOI 10.1016/j.biocon.2005.10.046; Reid J.B., 2003, ATLAS CETACEAN DISTR; Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187; Stone C.J., 1995, ATLAS SEABIRD DISTRI; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Zeller D, 2005, FISH FISH, V6, P156, DOI 10.1111/j.1467-2979.2005.00177.x	34	117	123	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1111	10.1371/journal.pone.0001111	http://dx.doi.org/10.1371/journal.pone.0001111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971874	gold, Green Published, Green Submitted			2022-12-27	WOS:000207458700028
J	Beniac, DR; Devarennes, SL; Andonov, A; He, R; Booth, TF				Beniac, Daniel R.; deVarennes, Shauna L.; Andonov, Anton; He, Runtao; Booth, Tim F.			Conformational Reorganization of the SARS Coronavirus Spike Following Receptor Binding: Implications for Membrane Fusion	PLOS ONE			English	Article								The SARS coronavirus (SARS-CoV) spike is the largest known viral spike molecule, and shares a similar function with all class 1 viral fusion proteins. Previous structural studies of membrane fusion proteins have largely used crystallography of static molecular fragments, in isolation of their transmembrane domains. In this study we have produced purified, irradiated SARS-CoV virions that retain their morphology, and are fusogenic in cell culture. We used cryo-electron microscopy and image processing to investigate conformational changes that occur in the entire spike of intact virions when they bind to the viral receptor, angiotensin-converting enzyme 2 (ACE2). We have shown that ACE2 binding results in structural changes that appear to be the initial step in viral membrane fusion, and precisely localized the receptor-binding and fusion core domains within the entire spike. Furthermore, our results show that receptor binding and subsequent membrane fusion are distinct steps, and that each spike can bind up to three ACE2 molecules. The SARS-CoV spike provides an ideal model system to study receptor binding and membrane fusion in the native state, employing cryo-electron microscopy and single-particle image analysis.	[Beniac, Daniel R.; deVarennes, Shauna L.; Andonov, Anton; He, Runtao; Booth, Tim F.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Div Viral Dis, Winnipeg, MB, Canada; [Andonov, Anton; He, Runtao; Booth, Tim F.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba	Booth, TF (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Div Viral Dis, Winnipeg, MB, Canada.	tim_booth@phac-aspc.gc.ca	Andonov, Anton/AAJ-6955-2021		Public Health Agency of Canada; Chief Scientist, Health Canada	Public Health Agency of Canada; Chief Scientist, Health Canada	Funding was provided by the Public Health Agency of Canada and in part by a grant from the office of the Chief Scientist, Health Canada.	Baker KA, 1999, MOL CELL, V3, P309, DOI 10.1016/S1097-2765(00)80458-X; Beniac DR, 2006, NAT STRUCT MOL BIOL, V13, P751, DOI 10.1038/nsmb1123; Booth TF, 2005, J INFECT DIS, V191, P1472, DOI 10.1086/429634; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chen L, 2001, STRUCTURE, V9, P255, DOI 10.1016/S0969-2126(01)00581-0; COLLINS AR, 1982, VIROLOGY, V119, P358, DOI 10.1016/0042-6822(82)90095-2; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Damico RL, 1998, P NATL ACAD SCI USA, V95, P2580, DOI 10.1073/pnas.95.5.2580; Dimitrov DS, 2003, CELL, V115, P652, DOI 10.1016/S0092-8674(03)00976-0; Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817; Duquerroy S, 2005, VIROLOGY, V335, P276, DOI 10.1016/j.virol.2005.02.022; Dutch RE, 2000, BIOSCIENCE REP, V20, P597; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Hakansson-McReynolds S, 2006, J BIOL CHEM, V281, P11965, DOI 10.1074/jbc.M601174200; Hernandez LD, 1997, J CELL BIOL, V139, P1455, DOI 10.1083/jcb.139.6.1455; Hofmann H, 2004, TRENDS MICROBIOL, V12, P466, DOI 10.1016/j.tim.2004.08.008; Hwang WC, 2006, J BIOL CHEM, V281, P34610, DOI 10.1074/jbc.M603275200; KEMBLE GW, 1992, J VIROL, V66, P4940, DOI 10.1128/JVI.66.8.4940-4950.1992; Kobe B, 1999, P NATL ACAD SCI USA, V96, P4319, DOI 10.1073/pnas.96.8.4319; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Petit CM, 2007, VIROLOGY, V360, P264, DOI 10.1016/j.virol.2006.10.034; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prabakaran P, 2006, J BIOL CHEM, V281, P15829, DOI 10.1074/jbc.M600697200; Rao PV, 1998, J VIROL, V72, P3278, DOI 10.1128/JVI.72.4.3278-3288.1998; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Supekar VM, 2004, P NATL ACAD SCI USA, V101, P17958, DOI 10.1073/pnas.0406128102; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; Wentworth DE, 2001, J VIROL, V75, P9741, DOI 10.1128/JVI.75.20.9741-9752.2001; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Xiao XD, 2003, BIOCHEM BIOPH RES CO, V312, P1159, DOI 10.1016/j.bbrc.2003.11.054; Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; Zhao X, 2000, P NATL ACAD SCI USA, V97, P14172, DOI 10.1073/pnas.260499197	46	35	36	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1082	10.1371/journal.pone.0001082	http://dx.doi.org/10.1371/journal.pone.0001082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957264	gold, Green Published, Green Submitted			2022-12-27	WOS:000207458500027
J	Oxman, AD; Flottorp, S; Havelsrud, K; Fretheim, A; Odgaard-Jensen, J; Austvoll-Dahlgren, A; Carling, C; Pallesen, S; Bjorvatn, B				Oxman, Andrew D.; Flottorp, Signe; Havelsrud, Kari; Fretheim, Atle; Odgaard-Jensen, Jan; Austvoll-Dahlgren, Astrid; Carling, Cheryl; Pallesen, Stale; Bjorvatn, Bjorn			A Televised, Web-Based Randomised Trial of an Herbal Remedy (Valerian) for Insomnia	PLOS ONE			English	Article							DOUBLE-BLIND; SLEEP; DIPHENHYDRAMINE; EXTRACT	Background. This trial was conducted as part of a project that aims to enhance public understanding and use of research in decisions about healthcare by enabling viewers to participate in research and to follow the process, through television reports and on the web. Valerian is an herbal over-the-counter drug that is widely used for insomnia. Systematic reviews have found inconsistent and inconclusive results about its effects. Methods. Participants were recruited through a weekly nationally televised health program in Norway. Enrolment and data collection were over the Internet. 405 participants who were 18 to 75 years old and had insomnia completed a two week diary-keeping run-in period without treatment and were randomised and mailed valerian or placebo tablets for two weeks. All participants and investigators were blind to treatment until after the analysis was completed. Findings. For the primary outcome of a minimally important improvement in self-reported sleep quality (>= 0.5 units on a 7 point scale), the difference between the valerian group (29%) and the placebo group (21%) was not statistically significant (difference 7.5%; 95% CI-0.9 to 15.9; p = 0.08). On the global self-assessment question at the end of the treatment period 5.5% (95% CI 0.2 to 10.8) more participants in the valerian group perceived their sleep as better or much better (p = 0.04). There were similar trends favouring the valerian group for night awakenings (difference = 6.0%, 95% CI-0.5 to 12.5) and sleep duration (difference = 7.5%, 95% CI-1.0 to 16.1). There were no serious adverse events and no important or statistically significant differences in minor adverse events. Interpretation. Based on this and previous studies, valerian appears to be safe, but with modest beneficial effects at most on insomnia compared to placebo. The combined use of television and the Internet in randomised trials offers opportunities to answer questions about the effects of health care interventions and to improve public understanding and use of randomised trials. Trial Registration. Controlled-Trials.com ISRCTN72748991	[Oxman, Andrew D.; Flottorp, Signe; Havelsrud, Kari; Fretheim, Atle; Odgaard-Jensen, Jan; Austvoll-Dahlgren, Astrid; Carling, Cheryl] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Pallesen, Stale; Bjorvatn, Bjorn] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway; [Pallesen, Stale] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway; [Bjorvatn, Bjorn] Univ Bergen, Sect Gen Practice, Bergen, Norway	Norwegian Knowledge Centre for Health Services; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen	Oxman, AD (corresponding author), Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway.	oxman@online.no	Oxman, Andrew/Y-3004-2019	Oxman, Andrew/0000-0002-5608-5061; Fretheim, Atle/0000-0002-6268-7966; Flottorp, Signe/0000-0003-2961-7461	Norwegian Knowledge Centre for the Health Services (NOKC)	Norwegian Knowledge Centre for the Health Services (NOKC)	The trial was funded by the Norwegian Knowledge Centre for the Health Services (NOKC) as part of "ForskningsPuls" (Research Pulse), a collaboration between NOKC and the Norwegian Broadcasting Corporation (NRK). ForskningsPuls aims to enhance public understanding and use of research in decisions about healthcare by enabling viewers to participate in research and to follow the process, both through reports on Puls (Pulse), a weekly television health program, and on the web pages of Puls and NOKC. Seven of the authors are employed by NOKC. Otherwise neither NOKC or NRK had any role in the design or conduct of the study; the collection, analysis or interpretation of the data; or the preparation, review or approval of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Babkoff H, 1996, J CLIN EPIDEMIOL, V49, P455, DOI 10.1016/0895-4356(95)00529-3; Bent S, 2006, AM J MED, V119, P1005, DOI 10.1016/j.amjmed.2006.02.026; BUSCEMI N, 2005, AHRQ PUBLICATION; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Coxeter PD, 2003, COMPLEMENT THER MED, V11, P215, DOI 10.1016/S0965-2299(03)00122-5; Diaper A, 2004, PHYTOTHER RES, V18, P831, DOI 10.1002/ptr.1574; Glass JR, 2003, J CLIN PSYCHOPHARM, V23, P260, DOI 10.1097/00004714-200306000-00007; Gutierrez S, 2004, PHARMACOL BIOCHEM BE, V78, P57, DOI 10.1016/j.pbb.2004.02.011; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; Hallam KT, 2003, HUM PSYCHOPHARM CLIN, V18, P619, DOI 10.1002/hup.542; Herrera-Arellano A, 2001, PLANTA MED, V67, P695, DOI 10.1055/s-2001-18344; Holbrook AM, 2000, CAN MED ASSOC J, V162, P225; Jacobs BP, 2005, MEDICINE, V84, P197, DOI 10.1097/01.md.0000172299.72364.95; Morin CM, 2005, SLEEP, V28, P1465, DOI 10.1093/sleep/28.11.1465; Morris CA, 2003, JAMA-J AM MED ASSOC, V290, P1505, DOI 10.1001/jama.290.11.1505; Moul DE, 2004, SLEEP MED REV, V8, P177, DOI 10.1016/S1087-0792(03)00060-1; MURTAGH DRR, 1995, J CONSULT CLIN PSYCH, V63, P79, DOI 10.1037/0022-006X.63.1.79; Pallesen S, 2001, SLEEP, V24, P771; Pallesen Stale, 2002, Tidsskr Nor Laegeforen, V122, P2857; Poyares DR, 2002, PROG NEURO-PSYCHOPH, V26, P539, DOI 10.1016/S0278-5846(01)00305-0; RICHMAN A, 1999, WHOLE FOODS, V22, P49; Roth T, 2002, SLEEP MED, V3, P99, DOI 10.1016/S1389-9457(01)00131-9; Sackett DL, 2007, INT J EPIDEMIOL, V36, P664, DOI 10.1093/ije/dym088; SANDERS TAB, 1990, LANCET, V336, P918, DOI 10.1016/0140-6736(90)92280-U; Sateia MJ, 2004, LANCET, V364, P1959, DOI 10.1016/S0140-6736(04)17480-1; Sateia MJ, 2000, SLEEP, V23, P243; SCHENK CH, 2003, JAMA-J AM MED ASSOC, V289, P2476; Stevinson C, 2000, SLEEP MED, V1, P91, DOI 10.1016/S1389-9457(99)00015-5; Ziegler G, 2002, EUR J MED RES, V7, P480	30	19	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1040	10.1371/journal.pone.0001040	http://dx.doi.org/10.1371/journal.pone.0001040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940604	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000207456100008
J	Plachetzki, DC; Degnan, BM; Oakley, TH				Plachetzki, David C.; Degnan, Bernard M.; Oakley, Todd H.			The Origins of Novel Protein Interactions during Animal Opsin Evolution	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; MAXIMUM-LIKELIHOOD; MOLECULAR PHYLOGENY; ADAPTIVE EVOLUTION; SEQUENCE ALIGNMENT; GENE DUPLICATION; TREE SELECTION; VISUAL CELLS; PHOTORECEPTORS; RHODOPSIN	Background. Biologists are gaining an increased understanding of the genetic bases of phenotypic change during evolution. Nevertheless, the origins of phenotypes mediated by novel protein-protein interactions remain largely undocumented. Methodology/Principle Findings. Here we analyze the evolution of opsin visual pigment proteins from the genomes of early branching animals, including a new class of opsins from Cnidaria. We combine these data with existing knowledge of the molecular basis of opsin function in a rigorous phylogenetic framework. We identify adaptive amino acid substitutions in duplicated opsin genes that correlate with a diversification of physiological pathways mediated by different protein-protein interactions. Conclusions/Significance. This study documents how gene duplication events early in the history of animals followed by adaptive structural mutations increased organismal complexity by adding novel protein-protein interactions that underlie different physiological pathways. These pathways are central to vision and other photo-reactive phenotypes in most extant animals. Similar evolutionary processes may have been at work in generating other metazoan sensory systems and other physiological processes mediated by signal transduction.	[Plachetzki, David C.; Oakley, Todd H.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Degnan, Bernard M.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld, Australia	University of California System; University of California Santa Barbara; University of Queensland	Oakley, TH (corresponding author), Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA.	oakley@lifesci.ucsb.edu	Oakley, Todd/A-5419-2008	Oakley, Todd/0000-0002-4478-915X; Degnan, Bernard/0000-0001-7573-8518	US National Science Foundation [DEB-0710406, DEB-0643840]; Australian Research Council	US National Science Foundation(National Science Foundation (NSF)); Australian Research Council(Australian Research Council)	This work was supported by US National Science Foundation grants DEB-0710406 to DCP and THO and DEB-0643840 to THO, and Australian Research Council grants to BMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Arendt D, 2003, INT J DEV BIOL, V47, P563; ARENDT D, 2001, T ROYAL SOC LONDON B, P1545; Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Dunlap JC, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P371, DOI 10.1002/352760510X.ch18; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; EAKIN RM, 1962, P NATL ACAD SCI USA, V48, P826, DOI 10.1073/pnas.48.5.826; EAKIN RM, 1979, AM ZOOL, V19, P647; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gehring W, 2003, J MOL EVOL, V57, pS286, DOI 10.1007/s00239-003-0038-8; Gomez MD, 2000, J NEUROSCI, V20, P5254, DOI 10.1523/JNEUROSCI.20-14-05254.2000; Grens A, 1996, DEV BIOL, V180, P473, DOI 10.1006/dbio.1996.0321; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Huelsenbeck JP, 1997, SYST BIOL, V46, P69, DOI 10.2307/2413636; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kojima D, 1997, J BIOL CHEM, V272, P22979, DOI 10.1074/jbc.272.37.22979; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Leys SP, 2002, J COMP PHYSIOL A, V188, P199, DOI 10.1007/s00359-002-0293-y; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Lynch VJ, 2004, P ROY SOC B-BIOL SCI, V271, P2201, DOI 10.1098/rspb.2004.2848; Marin EP, 2000, J BIOL CHEM, V275, P1930, DOI 10.1074/jbc.275.3.1930; NIELSEN R, 2001, PACIFIC S BIOCOMPUTI, P576; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Halloran DM, 2006, J MOL EVOL, V63, P87, DOI 10.1007/s00239-005-0215-z; Ohno S., 1970, EVOLUTION GENE DUPLI; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Raible F, 2006, DEV BIOL, V300, P461, DOI 10.1016/j.ydbio.2006.08.070; RAMBAUT A, 1997, COMPUTER AP IN PRESS; Rambaut A., 2003, TRACER MCMC TRACE AN; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Spaethe J, 2005, J EXP BIOL, V208, P2347, DOI 10.1242/jeb.01634; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Su CY, 2006, SCIENCE, V311, P1617, DOI 10.1126/science.1123802; Suga H, 1999, J MOL EVOL, V48, P646, DOI 10.1007/PL00006508; SWOFFORD DL, 2002, PAUP; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Telford MJ, 2006, CURR BIOL, V16, pR981, DOI 10.1016/j.cub.2006.10.048; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Thornton JW, 2000, ANNU REV GENOM HUM G, V1, P41, DOI 10.1146/annurev.genom.1.1.41; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Velarde RA, 2005, INSECT BIOCHEM MOLEC, V35, P1367, DOI 10.1016/j.ibmb.2005.09.001; Wilkinson M, 2007, TRENDS ECOL EVOL, V22, P114, DOI 10.1016/j.tree.2007.01.002; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zheng Y, 2007, J EXP ZOOL PART B, V308B, P85, DOI 10.1002/jez.b.21140	68	84	84	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1054	10.1371/journal.pone.0001054	http://dx.doi.org/10.1371/journal.pone.0001054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940617	gold, Green Published, Green Submitted			2022-12-27	WOS:000207456100021
J	Frank, SA				Frank, Steven A.			Maladaptation and the Paradox of Robustness in Evolution	PLOS ONE			English	Article								Background. Organisms use a variety of mechanisms to protect themselves against perturbations. For example, repair mechanisms fix damage, feedback loops keep homeostatic systems at their setpoints, and biochemical filters distinguish signal from noise. Such buffering mechanisms are often discussed in terms of robustness, which may be measured by reduced sensitivity of performance to perturbations. Methodology/Principal Findings. I use a mathematical model to analyze the evolutionary dynamics of robustness in order to understand aspects of organismal design by natural selection. I focus on two characters: one character performs an adaptive task; the other character buffers the performance of the first character against perturbations. Increased perturbations favor enhanced buffering and robustness, which in turn decreases sensitivity and reduces the intensity of natural selection on the adaptive character. Reduced selective pressure on the adaptive character often leads to a less costly, lower performance trait. Conclusions/Significance. The paradox of robustness arises from evolutionary dynamics: enhanced robustness causes an evolutionary reduction in the adaptive performance of the target character, leading to a degree of maladaptation compared to what could be achieved by natural selection in the absence of robustness mechanisms. Over evolutionary time, buffering traits may become layered on top of each other, while the underlying adaptive traits become replaced by cheaper, lower performance components. The paradox of robustness has widespread implications for understanding organismal design.	Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Frank, SA (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	safrank@uci.edu		Frank, Steven/0000-0001-7348-7794	National Science Foundation [DEB-0089741]; National Institute of General Medical Sciences [U01-GM-76499]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM076499] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: National Science Foundation grant DEB-0089741 and National Institute of General Medical Sciences MIDAS Program grant support the research of this author.	ALEXANDER RM, 1981, SCI PROGRESS-UK, V67, P109; Alon U, 2007, INTRO SYSTEMS BIOL D; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Diamond J, 2002, J PHYSIOL-LONDON, V542, P337, DOI 10.1113/jphysiol.2002.018366; Frank SA, 2004, P NATL ACAD SCI USA, V101, P8061, DOI 10.1073/pnas.0400561101; Goldstein B, 2004, NAT REV IMMUNOL, V4, P445, DOI 10.1038/nri1374; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Rice SH, 1998, EVOLUTION, V52, P647, DOI 10.1111/j.1558-5646.1998.tb03690.x; Wagner A., 2005, ROBUSTNESS EVOLVABIL; WEIBEL ER, 1998, PRINCIPLES ANIMAL DE	12	27	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1021	10.1371/journal.pone.0001021	http://dx.doi.org/10.1371/journal.pone.0001021			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925869	Green Published, Green Submitted, gold			2022-12-27	WOS:000207456000020
J	Edwards, RJ; Davey, NE; Shields, DC				Edwards, Richard J.; Davey, Norman E.; Shields, Denis C.			SLiMFinder: A Probabilistic Method for Identifying Over-Represented, Convergently Evolved, Short Linear Motifs in Proteins	PLOS ONE			English	Article								Background. Short linear motifs (SLiMs) in proteins are functional microdomains of fundamental importance in many biological systems. SLiMs typically consist of a 3 to 10 amino acid stretch of the primary protein sequence, of which as few as two sites may be important for activity, making identification of novel SLiMs extremely difficult. In particular, it can be very difficult to distinguish a randomly recurring "motif'' from a truly over-represented one. Incorporating ambiguous amino acid positions and/or variable-length wildcard spacers between defined residues further complicates the matter. Methodology/Principal Findings. In this paper we present two algorithms. SLiMBuild identifies convergently evolved, short motifs in a dataset of proteins. Motifs are built by combining dimers into longer patterns, retaining only those motifs occurring in a sufficient number of unrelated proteins. Motifs with fixed amino acid positions are identified and then combined to incorporate amino acid ambiguity and variable-length wildcard spacers. The algorithm is computationally efficient compared to alternatives, particularly when datasets include homologous proteins, and provides great flexibility in the nature of motifs returned. The SLiMChance algorithm estimates the probability of returned motifs arising by chance, correcting for the size and composition of the dataset, and assigns a significance value to each motif. These algorithms are implemented in a software package, SLiMFinder. SLiMFinder default settings identify known SLiMs with 100% specificity, and have a low false discovery rate on random test data. Conclusions/Significance. The efficiency of SLiMBuild and low false discovery rate of SLiMChance make SLiMFinder highly suited to high throughput motif discovery and individual high quality analyses alike. Examples of such analyses on real biological data, and how SLiMFinder results can help direct future discoveries, are provided. SLiMFinder is freely available for download under a GNU license from http://bioinformatics.ucd.ie/shields/software/slimfinder/.	[Edwards, Richard J.; Davey, Norman E.; Shields, Denis C.] Univ Coll Dublin, Univ Coll Dublin Complex & Adapt Syst Lab, Univ Coll Dublin Conway Inst Biomol & Biomed Sci, Dublin 2, Ireland; [Edwards, Richard J.] Univ Southampton, Sch Biol Sci, Southampton, Hants, England	University College Dublin; University of Southampton	Edwards, RJ (corresponding author), Univ Coll Dublin, Univ Coll Dublin Complex & Adapt Syst Lab, Univ Coll Dublin Conway Inst Biomol & Biomed Sci, Dublin 2, Ireland.	r.edwards@soton.ac.uk	Edwards, Richard/C-8755-2011; Davey, Norman/D-5362-2013	Edwards, Richard/0000-0002-3645-5539; Shields, Denis/0000-0003-4015-2474; Davey, Norman/0000-0002-4151-3510; Davey, Norman/0000-0001-6988-4850	Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was funded by Science Foundation Ireland. The funders had no role in the manuscript or the work presented therein.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; CEOL A, 2006, NUCLEIC ACIDS RES, V29, P29; Davey NE, 2006, NUCLEIC ACIDS RES, V34, P3546, DOI 10.1093/nar/gkl486; De Falco S, 2001, J BIOL CHEM, V276, P36613, DOI 10.1074/jbc.M102377200; Deng Q, 2007, J VIROL, V81, P4244, DOI 10.1128/JVI.01270-06; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; NEURATH AR, 1992, J EXP MED, V175, P461, DOI 10.1084/jem.175.2.461; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; ZHOU SY, 1995, METHOD ENZYMOL, V254, P523	18	114	116	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e967	10.1371/journal.pone.0000967	http://dx.doi.org/10.1371/journal.pone.0000967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912346	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455900005
J	Sheng, Y; Engstrom, PG; Lenhard, B				Sheng, Ying; Engstrom, Par G.; Lenhard, Boris			Mammalian MicroRNA Prediction through a Support Vector Machine Model of Sequence and Structure	PLOS ONE			English	Article							NONCODING RNAS; IDENTIFICATION; MOUSE; EXPRESSION; GENES; PRECURSORS; VERTEBRATE; TRANSCRIPTS; THOUSANDS; ELEMENTS	Background. MicroRNAs (miRNAs) are endogenous small noncoding RNA gene products, on average 22 nt long, found in a wide variety of organisms. They play important regulatory roles by targeting mRNAs for degradation or translational repression. There are 377 known mouse miRNAs and 475 known human miRNAs in the May 2007 release of the miRBase database, the majority of which are conserved between the two species. A number of recent reports imply that it is likely that many mammalian miRNAs remain to be discovered. The possibility that there are more of them expressed at lower levels or in more specialized expression contexts calls for the exploitation of genome sequence information to accelerate their discovery. Methodology/Principal Findings. In this article, we describe a computational method-mirCoS-that uses three support vector machine models sequentially to discover new miRNA candidates in mammalian genomes based on sequence, secondary structure, and conservation. mirCoS can efficiently detect the majority of known miRNAs and predicts an extensive set of hairpin structures based on human-mouse comparisons. In total, 3476 mouse candidates and 3441 human candidates were found. These hairpins are more similar to known miRNAs than to negative controls in several aspects not considered by the prediction algorithm. A significant fraction of predictions is supported by existing expression evidence. Conclusions/Significance. Using a novel approach, mirCoS performs comparably to or better than existing miRNA prediction methods, and contributes a significant number of new candidate miRNAs for experimental verification.	[Sheng, Ying; Engstrom, Par G.; Lenhard, Boris] Univ Bergen, Bergen Ctr Computat Sci, Computat Biol Unit, Bergen, Norway; [Sheng, Ying; Engstrom, Par G.; Lenhard, Boris] Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Sheng, Ying; Engstrom, Par G.] Karolinska Inst, Dept Cell & Mol Biol, Programme Genom & Bioinformat, Stockholm, Sweden	University of Bergen; University of Bergen; Karolinska Institutet	Lenhard, B (corresponding author), Univ Bergen, Bergen Ctr Computat Sci, Computat Biol Unit, Bergen, Norway.	Boris.Lenhard@bccs.uib.no		Lenhard, Boris/0000-0002-1114-1509; Engstrom, Par/0000-0001-5265-2121	Functional Genomics Programme (FUGE) of the Research Council of Norway; Sars Centre for Marine Molecular Biology	Functional Genomics Programme (FUGE) of the Research Council of Norway(Research Council of Norway); Sars Centre for Marine Molecular Biology	This work was supported by the Functional Genomics Programme (FUGE) of the Research Council of Norway and a core grant from the Sars Centre for Marine Molecular Biology.	Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Bailey PJ, 2006, EXP CELL RES, V312, P3108, DOI 10.1016/j.yexcr.2006.06.017; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barutcuoglu Z, 2006, BIOINFORMATICS, V22, P830, DOI 10.1093/bioinformatics/btk048; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Bhardwaj N, 2005, NUCLEIC ACIDS RES, V33, P6486, DOI 10.1093/nar/gki949; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen Y-W, 2003, COMBINING SVMS VARIO; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Duan Ranhui, 2006, V342, P267, DOI 10.1385/1-59745-123-1:267; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Gomez-Skarmeta JL, 2006, DEV DYNAM, V235, P870, DOI 10.1002/dvdy.20659; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gu J, 2006, MAMM GENOME, V17, P1033, DOI 10.1007/s00335-006-0007-9; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; Hertel J, 2006, BIOINFORMATICS, V22, pE197, DOI 10.1093/bioinformatics/btl257; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Chung-Tien, 2006, Birth Defects Research, V78, P129, DOI 10.1002/bdrc.20072; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; LOONG SNK, 2007, NOVO SVM CLASSIFICAT; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lunter G, 2006, PLOS COMPUT BIOL, V2, P2, DOI 10.1371/journal.pcbi.0020005; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; O'Rourke Jason R., 2006, Birth Defects Research, V78, P172, DOI 10.1002/bdrc.20071; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Takada S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl653; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Watanabe T, 2005, FEBS LETT, V579, P318, DOI 10.1016/j.febslet.2004.11.067; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yousef M, 2006, BIOINFORMATICS, V22, P1325, DOI 10.1093/bioinformatics/btl094; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998	72	40	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e946	10.1371/journal.pone.0000946	http://dx.doi.org/10.1371/journal.pone.0000946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895987	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455800025
J	Budde, BS; Binner, P; Waldmuller, S; Hohne, W; Blankenfeldt, W; Hassfeld, S; Bromsen, J; Dermintzoglou, A; Wieczorek, M; May, E; Kirst, E; Selignow, C; Rackebrandt, K; Muller, M; Goody, RS; Vosberg, HP; Nurnberg, P; Scheffold, T				Budde, Birgit S.; Binner, Priska; Waldmueller, Stephan; Hoehne, Wolfgang; Blankenfeldt, Wulf; Hassfeld, Sabine; Broemsen, Juergen; Dermintzoglou, Anastassia; Wieczorek, Marcus; May, Erik; Kirst, Elisabeth; Selignow, Carmen; Rackebrandt, Kirsten; Mueller, Melanie; Goody, Roger S.; Vosberg, Hans-Peter; Nuernberg, Peter; Scheffold, Thomas			Noncompaction of the Ventricular Myocardium Is Associated with a De Novo Mutation in the beta-Myosin Heavy Chain Gene	PLOS ONE			English	Article							HYPERTROPHIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; CARDIAC MYOSIN; CLASSIFICATION; CARDIOLOGY	Noncompaction of the ventricular myocardium (NVM) is the morphological hallmark of a rare familial or sporadic unclassified heart disease of heterogeneous origin. NVM results presumably from a congenital developmental error and has been traced back to single point mutations in various genes. The objective of this study was to determine the underlying genetic defect in a large German family suffering from NVM. Twenty four family members were clinically assessed using advanced imaging techniques. For molecular characterization, a genome-wide linkage analysis was undertaken and the disease locus was mapped to chromosome 14ptel-14q12. Subsequently, two genes of the disease interval, MYH6 and MYH7 (encoding the alpha- and beta-myosin heavy chain, respectively) were sequenced, leading to the identification of a previously unknown de novo missense mutation, c. 842G>C, in the gene MYH7. The mutation affects a highly conserved amino acid in the myosin subfragment-1 (R281T). In silico simulations suggest that the mutation R281T prevents the formation of a salt bridge between residues R281 and D325, thereby destabilizing the myosin head. The mutation was exclusively present in morphologically affected family members. A few members of the family displayed NVM in combination with other heart defects, such as dislocation of the tricuspid valve (Ebstein's anomaly, EA) and atrial septal defect (ASD). A high degree of clinical variability was observed, ranging from the absence of symptoms in childhood to cardiac death in the third decade of life. The data presented in this report provide first evidence that a mutation in a sarcomeric protein can cause noncompaction of the ventricular myocardium.	[Binner, Priska; Waldmueller, Stephan; Rackebrandt, Kirsten; Mueller, Melanie; Vosberg, Hans-Peter; Scheffold, Thomas] Univ Witten Herdecke, Inst Herz Kreislaufforsch, Dortmund, Germany; [Budde, Birgit S.; Kirst, Elisabeth; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Budde, Birgit S.; Kirst, Elisabeth; Nuernberg, Peter] Univ Cologne, Genet Inst, Cologne, Germany; [Hoehne, Wolfgang] Charite, Inst Biochem, D-13353 Berlin, Germany; [Blankenfeldt, Wulf; Goody, Roger S.] Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44139 Dortmund, Germany; [Hassfeld, Sabine] Franz Volhard Klin, Charite, Berlin, Germany; [Broemsen, Juergen; Dermintzoglou, Anastassia; Wieczorek, Marcus; May, Erik] Herzzentrum Duisburg, Duisburg, Germany; [Broemsen, Juergen] Herzklin Augustinum, Munich, Germany; [Vosberg, Hans-Peter] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	Witten Herdecke University; University of Cologne; University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Heart Center Duisburg pediatric hospital; Max Planck Society	Scheffold, T (corresponding author), Univ Witten Herdecke, Inst Herz Kreislaufforsch, Dortmund, Germany.	scheffold@herz-kreislaufforschung.de	Goody, Roger S/J-8845-2014; Blankenfeldt, Wulf/F-8877-2010	Goody, Roger S/0000-0002-0772-0444; Blankenfeldt, Wulf/0000-0001-9886-9668; Budde, Birgit/0000-0001-9385-4168	German Federal Ministry of Science and Education (BMBF) through the National Genome Research Network [01GR0416]; Competence Network of Heart Failure [FKZ 01GI0205]	German Federal Ministry of Science and Education (BMBF) through the National Genome Research Network(Federal Ministry of Education & Research (BMBF)); Competence Network of Heart Failure	Funding: This study was supported by the German Federal Ministry of Science and Education (BMBF) through the National Genome Research Network (grant 01GR0416 to P.N.) and through the Competence Network of Heart Failure, FKZ 01GI0205.	Bleyl SB, 1997, AM J HUM GENET, V61, P868, DOI 10.1086/514879; CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; EDWARDS D, 1993, FOSS REC, V2, P15; ENGBERDING R, 1984, AM J CARDIOL, V53, P1733, DOI 10.1016/0002-9149(84)90618-0; Ichida F, 1999, J AM COLL CARDIOL, V34, P233, DOI 10.1016/S0735-1097(99)00170-9; Ichida F, 2001, CIRCULATION, V103, P1256; JAENICKE T, 1990, GENOMICS, V8, P194, DOI 10.1016/0888-7543(90)90272-V; Jenni R, 2001, HEART, V86, P666, DOI 10.1136/heart.86.6.666; Karkkainen S, 2007, ANN MED, V39, P91, DOI 10.1080/07853890601145821; KURABAYASHI M, 1988, J CLIN INVEST, V82, P524, DOI 10.1172/JCI113627; Lind Joanne M, 2006, Expert Rev Cardiovasc Ther, V4, P927, DOI 10.1586/14779072.4.6.927; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Murphy RT, 2005, EUR HEART J, V26, P187, DOI 10.1093/eurheartj/ehi025; Pauli RM, 1999, AM J MED GENET, V85, P419, DOI 10.1002/(SICI)1096-8628(19990806)85:4<419::AID-AJMG21>3.0.CO;2-S; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4019, DOI 10.1093/nar/19.14.4019-a; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; RAYMENT I, 1995, P NATL ACAD SCI USA, V92, P3864, DOI 10.1073/pnas.92.9.3864; Reiser PJ, 2001, AM J PHYSIOL-HEART C, V280, pH1814, DOI 10.1152/ajpheart.2001.280.4.H1814; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Rigopoulos A, 2002, CARDIOLOGY, V98, P25, DOI 10.1159/000064677; Sasse-Klaassen S, 2004, CIRCULATION, V109, P2720, DOI 10.1161/01.CIR.0000131865.21260.56; SCHWARTZ K, 1992, CIRC RES, V71, P3, DOI 10.1161/01.RES.71.1.3; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Sen-Chowdhry S, 2005, J CARDIOVASC ELECTR, V16, P927, DOI 10.1111/j.1540-8167.2005.40842.x; Sobel E, 1996, AM J HUM GENET, V58, P1323; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Villard E, 2005, EUR HEART J, V26, P794, DOI 10.1093/eurheartj/ehi193; Waldmuller S, 2003, J MOL CELL CARDIOL, V35, P623, DOI 10.1016/S0022-2828(03)00050-6; Woo A, 2003, HEART, V89, P1179, DOI 10.1136/heart.89.10.1179; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	33	77	80	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1362	10.1371/journal.pone.0001362	http://dx.doi.org/10.1371/journal.pone.0001362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159245	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459700019
J	Yang, H; Fung, SY; Pritzker, M; Chen, P				Yang, Hong; Fung, Shan-Yu; Pritzker, Mark; Chen, P.			Modification of Hydrophilic and Hydrophobic Surfaces Using an Ionic-Complementary Peptide	PLOS ONE			English	Article								Ionic-complementary peptides are novel nano-biomaterials with a variety of biomedical applications including potential biosurface engineering. This study presents evidence that a model ionic-complementary peptide EAK16-II is capable of assembling/coating on hydrophilic mica as well as hydrophobic highly ordered pyrolytic graphite (HOPG) surfaces with different nano-patterns. EAK16-II forms randomly oriented nanofibers or nanofiber networks on mica, while ordered nanofibers parallel or oriented 60 degrees or 120 degrees to each other on HOPG, reflecting the crystallographic symmetry of graphite (0001). The density of coated nanofibers on both surfaces can be controlled by adjusting the peptide concentration and the contact time of the peptide solution with the surface. The coated EAK16-II nanofibers alter the wettability of the two surfaces differently: the water contact angle of bare mica surface is measured to be <10 degrees, while it increases to 20.3 +/- 62.9 degrees upon 2 h modification of the surface using a 29 mu M EAK16-II solution. In contrast, the water contact angle decreases significantly from 71.2 +/- 11.1 degrees to 39.4 +/- 4.3 degrees after the HOPG surface is coated with a 29 mM peptide solution for 2 h. The stability of the EAK16-II nanofibers on both surfaces is further evaluated by immersing the surface into acidic and basic solutions and analyzing the changes in the nanofiber surface coverage. The EAK16-II nanofibers on mica remain stable in acidic solution but not in alkaline solution, while they are stable on the HOPG surface regardless of the solution pH. This work demonstrates the possibility of using self-assembling peptides for surface modification applications.	[Yang, Hong; Fung, Shan-Yu; Pritzker, Mark; Chen, P.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Pritzker, M (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.	pritzker@uwaterloo.ca; p4chen@cape.uwaterloo.ca	Fung, Shan-Yu/E-3477-2014; Yang, Hong/E-3478-2014; Yang, Hong/AAZ-1061-2020	Fung, Shan-Yu/0000-0002-4547-8740; Yang, Hong/0000-0002-6707-8481; 	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Canada Research Chairs Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs Program(Canada Research Chairs)	Funding from the following agencies supported the work presented in this manuscript: Natural Sciences and Engineering Research Council of Canada, Canada Foundation for Innovation, Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown CL, 2002, J AM CHEM SOC, V124, P6846, DOI 10.1021/ja0261271; Chinn JA, 1998, J BIOMED MATER RES, V39, P130, DOI 10.1002/(SICI)1097-4636(19980101)39:1<130::AID-JBM15>3.0.CO;2-J; Clare TL, 2005, LANGMUIR, V21, P6344, DOI 10.1021/la050362q; Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Falini G, 2002, ACTA CRYSTALLOGR D, V58, P1649, DOI 10.1107/S0907444902012763; Fung SY, 2007, COLLOID SURFACE B, V55, P200, DOI 10.1016/j.colsurfb.2006.12.002; Fung SY, 2003, BIOPHYS J, V85, P537, DOI 10.1016/S0006-3495(03)74498-1; Gettens RTT, 2005, J BIOMED MATER RES A, V72A, P246, DOI 10.1002/jbm.a.30218; He H., 2004, ENCY NANOSCIENCE NAN, V2, P755; Heller DA, 2005, BIOMATERIALS, V26, P883, DOI 10.1016/j.biomaterials.2004.03.029; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374; Jun S, 2004, BIOPHYS J, V87, P1249, DOI 10.1529/biophysj.103.038166; Keyes-Baig C, 2004, J AM CHEM SOC, V126, P7522, DOI 10.1021/ja0381297; Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Lahann J, 2001, BIOMATERIALS, V22, P817, DOI 10.1016/S0142-9612(00)00244-1; Larsen CC, 2006, BIOMATERIALS, V27, P4846, DOI 10.1016/j.biomaterials.2006.05.009; Long J, 2001, LANGMUIR, V17, P2965, DOI 10.1021/la001547u; Mansur HS, 2005, J MATER SCI-MATER M, V16, P333, DOI 10.1007/s10856-005-0632-y; Moulton SE, 2003, J COLLOID INTERF SCI, V261, P312, DOI 10.1016/S0021-9797(03)00073-0; NISHIMURA S, 1995, LANGMUIR, V11, P291, DOI 10.1021/la00001a049; Pallandre A, 2006, ELECTROPHORESIS, V27, P584, DOI 10.1002/elps.200500761; Patel S, 2006, BIOMATERIALS, V27, P2890, DOI 10.1016/j.biomaterials.2005.12.009; Sawant RM, 2006, BIOCONJUGATE CHEM, V17, P943, DOI 10.1021/bc060080h; SCHAMBERGER PC, 1994, COLLOID SURFACE B, V2, P209, DOI 10.1016/0927-7765(94)80036-7; Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x; Shervedani RK, 2006, BIOELECTROCHEMISTRY, V69, P201, DOI 10.1016/j.bioelechem.2006.01.003; Toublan FJJ, 2006, J AM CHEM SOC, V128, P3472, DOI 10.1021/ja0544455; Voet D., 2005, BIOCHEMISTRY-US; Walter EC, 2002, MICROELECTRON ENG, V61-2, P555, DOI 10.1016/S0167-9317(02)00582-8; Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4; Yang GC, 2002, J AM CHEM SOC, V124, P10648, DOI 10.1021/ja027302g; Yang H, 2007, J AM CHEM SOC, V129, P12200, DOI 10.1021/ja073168u; YE Y, 2002, SENSORS, V3, P128; Yemini M, 2005, NANO LETT, V5, P183, DOI 10.1021/nl0484189; Yemini M, 2005, ANAL CHEM, V77, P5155, DOI 10.1021/ac050414g; Ying PQ, 2004, J COLLOID INTERF SCI, V279, P95, DOI 10.1016/j.jcis.2004.06.048; ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y; Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5; Zhang SX, 2005, BIOELECTROCHEMISTRY, V67, P15, DOI 10.1016/j.bioelechem.2004.12.002; Zhang Y, 2005, J COLLOID INTERF SCI, V283, P352, DOI 10.1016/j.jcis.2004.09.042	46	70	71	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1325	10.1371/journal.pone.0001325	http://dx.doi.org/10.1371/journal.pone.0001325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091996	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459600013
J	Houshdaran, S; Cortessis, VK; Siegmund, K; Yang, A; Laird, PW; Sokol, RZ				Houshdaran, Sahar; Cortessis, Victoria K.; Siegmund, Kimberly; Yang, Allen; Laird, Peter W.; Sokol, Rebecca Z.			Widespread Epigenetic Abnormalities Suggest a Broad DNA Methylation Erasure Defect in Abnormal Human Sperm	PLOS ONE			English	Article							IMPRINTED GENES; CPG ISLAND; SNURF-SNRPN; PATTERNS; ESTABLISHMENT; INHERITANCE; H19; SPECIFICATION; EXPRESSION; GERMLINE	Background. Male-factor infertility is a common condition, and etiology is unknown for a high proportion of cases. Abnormal epigenetic programming of the germline is proposed as a possible mechanism compromising spermatogenesis of some men currently diagnosed with idiopathic infertility. During germ cell maturation and gametogenesis, cells of the germ line undergo extensive epigenetic reprogramming. This process involves widespread erasure of somatic-like patterns of DNA methylation followed by establishment of sex-specific patterns by de novo DNA methylation. Incomplete reprogramming of the male germ line could, in theory, result in both altered sperm DNA methylation and compromised spermatogenesis. Methodology/Principal Finding. We determined concentration, motility and morphology of sperm in semen samples collected by male members of couples attending an infertility clinic. Using MethyLight and Illumina assays we measured methylation of DNA isolated from purified sperm from the same samples. Methylation at numerous sequences was elevated in DNA from poor quality sperm. Conclusions. This is the first report of a broad epigenetic defect associated with abnormal semen parameters. Our results suggest that the underlying mechanism for these epigenetic changes may be improper erasure of DNA methylation during epigenetic reprogramming of the male germ line.	[Cortessis, Victoria K.; Siegmund, Kimberly] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Houshdaran, Sahar; Laird, Peter W.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Laird, Peter W.] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Sokol, Rebecca Z.] Univ So Calif, Keck Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA; [Yang, Allen; Sokol, Rebecca Z.] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Cortessis, VK (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	cortessis_v@ccnt.hsc.usc.edu	Laird, Peter W/G-8683-2012	Laird, Peter W/0000-0001-9117-3641; Cortessis, Victoria/0000-0002-2339-1089	National Institute of Environmental Health Sciences [5P30ES007048]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Southern California Environmental Health Sciences Center ( grant # 5P30ES007048) funded by the National Institute of Environmental Health Sciences. The funders of this study had no role in the design or conduct of this study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Abma J C, 1997, Vital Health Stat 23, P1; Acacio BD, 2000, FERTIL STERIL, V73, P595, DOI 10.1016/S0015-0282(99)00591-9; ARIEL M, 1994, NAT GENET, V7, P59, DOI 10.1038/ng0594-59; Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bastepe M, 2003, J CLIN INVEST, V112, P1255, DOI 10.1172/JCI200319159; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Benchaib M, 2005, HUM REPROD, V20, P768, DOI 10.1093/humrep/deh684; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bestor TH, 2004, COLD SPRING HARB SYM, V69, P381, DOI 10.1101/sqb.2004.69.381; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; BIERMANN K, 2007, J ANDROL; Chandra A, 1998, FAM PLANN PERSPECT, V30, P34, DOI 10.2307/2991524; Chang HS, 2006, ENDOCRINOLOGY, V147, P5524, DOI 10.1210/en.2006-0987; Cui HM, 2002, CANCER RES, V62, P6442; Cupp AS, 2003, J ANDROL, V24, P736; Dale, 1997, IN VITRO FERTILIZATI; de la Puente A, 2002, GENE, V291, P287, DOI 10.1016/S0378-1119(02)00601-7; Emery BR, 2006, ASIAN J ANDROL, V8, P131, DOI 10.1111/j.1745-7262.2006.00127.x; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Gaston V, 2001, EUR J HUM GENET, V9, P409, DOI 10.1038/sj.ejhg.5200649; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hancock AL, 2007, HUM MOL GENET, V16, P343, DOI 10.1093/hmg/ddl478; Hartmann S, 2006, MOL HUM REPROD, V12, P407, DOI 10.1093/molehr/gal040; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Higashimoto K, 2006, CYTOGENET GENOME RES, V113, P306, DOI 10.1159/000090846; JIE X, 2007, ONCOGENE; Kaufman L., 1990, FINDING GROUPS DATA; Kearns M, 2000, NUCLEIC ACIDS RES, V28, P3301, DOI 10.1093/nar/28.17.3301; Kerjean A, 2000, HUM MOL GENET, V9, P2183, DOI 10.1093/hmg/9.14.2183; Kim JD, 2007, GENOMICS, V89, P262, DOI 10.1016/j.ygeno.2006.09.009; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lee J, 2002, DEVELOPMENT, V129, P1807; Lees-Murdock DJ, 2003, GENOMICS, V82, P230, DOI 10.1016/S0888-7543(03)00105-8; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li JY, 2004, GENOMICS, V84, P952, DOI 10.1016/j.ygeno.2004.08.012; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Liu J, 2005, HUM MOL GENET, V14, P95, DOI 10.1093/hmg/ddi009; Maduro MR, 2003, J ANDROL, V24, P485; Manning M, 2001, INT J ANDROL, V24, P87, DOI 10.1046/j.1365-2605.2001.00274.x; Marques CJ, 2004, LANCET, V363, P1700, DOI 10.1016/S0140-6736(04)16256-9; McElreavey K, 2000, Results Probl Cell Differ, V28, P211; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Murphy SK, 2001, GENOMICS, V71, P110, DOI 10.1006/geno.2000.6419; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Oakes CC, 2007, P NATL ACAD SCI USA, V104, P228, DOI 10.1073/pnas.0607521104; Ono R, 2001, GENOMICS, V73, P232, DOI 10.1006/geno.2001.6494; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rousseaux S, 2005, GENE, V345, P139, DOI 10.1016/j.gene.2004.12.004; Runte M, 2004, HUM GENET, V114, P553, DOI 10.1007/s00439-004-1104-z; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Santos F, 2004, REPRODUCTION, V127, P643, DOI 10.1530/rep.1.00221; Schaefer CB, 2007, SCIENCE, V316, P398, DOI 10.1126/science.1137544; Sharlip ID, 2002, FERTIL STERIL, V77, P873, DOI 10.1016/S0015-0282(02)03105-9; SOKOL RZ, 1997, INFERTILITY CONTRACE, P547; Sullivan MJ, 1999, ONCOGENE, V18, P7527, DOI 10.1038/sj.onc.1203096; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Suzuki S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030055; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; THONNEAU P, 1991, HUM REPROD, V6, P811, DOI 10.1093/oxfordjournals.humrep.a137433; Trasler JM, 2006, REPROD FERT DEVELOP, V18, P63, DOI 10.1071/RD05118; Trasler JM, 1998, SEMIN CELL DEV BIOL, V9, P467, DOI 10.1006/scdb.1998.0225; Varrault A, 2001, J BIOL CHEM, V276, P18653, DOI 10.1074/jbc.C100095200; Ventura S J, 1999, Natl Vital Stat Rep, V47, P1; Vu TH, 2000, GENOMICS, V64, P132, DOI 10.1006/geno.1999.6094; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; *WHO, 1999, WHO LAB MAN HUM SEM; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamazaki Y, 2003, P NATL ACAD SCI USA, V100, P12207, DOI 10.1073/pnas.2035119100; Yun J, 2003, MAMM GENOME, V14, P376, DOI 10.1007/s00335-002-2252-x	74	201	216	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1289	10.1371/journal.pone.0001289	http://dx.doi.org/10.1371/journal.pone.0001289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074014	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459500008
J	Santhi, N; Horowitz, TS; Duffy, JF; Czeisler, CA				Santhi, Nayantara; Horowitz, Todd S.; Duffy, Jeanne F.; Czeisler, Charles A.			Acute Sleep Deprivation and Circadian Misalignment Associated with Transition onto the First Night of Work Impairs Visual Selective Attention	PLOS ONE			English	Article							RESPONSE-TIME DISTRIBUTIONS; SHIFT WORK; PSYCHOMOTOR VIGILANCE; SUBJECTIVE ALERTNESS; BRIGHT LIGHT; PERFORMANCE DEGRADATION; EXTENDED WAKEFULNESS; DOSE-RESPONSE; PHASE; CAFFEINE	Background. Overnight operations pose a challenge because our circadian biology promotes sleepiness and dissipates wakefulness at night. Since the circadian effect on cognitive functions magnifies with increasing sleep pressure, cognitive deficits associated with night work are likely to be most acute with extended wakefulness, such as during the transition from a day shift to night shift. Methodology/Principal Findings. To test this hypothesis we measured selective attention (with visual search), vigilance (with Psychomotor Vigilance Task [PVT]) and alertness (with a visual analog scale) in a shift work simulation protocol, which included four day shifts followed by three night shifts. There was a nocturnal decline in cognitive processes, some of which were most pronounced on the first night shift. The nighttime decrease in visual search sensitivity was most pronounced on the first night compared with subsequent nights (p=.04), and this was accompanied by a trend towards selective attention becoming 'fast and sloppy'. The nighttime increase in attentional lapses on the PVT was significantly greater on the first night compared to subsequent nights (p <.05) indicating an impaired ability to sustain focus. The nighttime decrease in subjective alertness was also greatest on the first night compared with subsequent nights (p <.05). Conclusions/Significance. These nocturnal deficits in attention and alertness offer some insight into why occupational errors, accidents, and injuries are pronounced during night work compared to day work. Examination of the nighttime vulnerabilities underlying the deployment of attention can be informative for the design of optimal work schedules and the implementation of effective countermeasures for performance deficits during night work.	[Santhi, Nayantara; Duffy, Jeanne F.; Czeisler, Charles A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Sleep Med, Boston, MA 02115 USA; [Horowitz, Todd S.] Brigham & Womens Hosp, Visual Attent Lab, Cambridge, MA USA; [Horowitz, Todd S.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Santhi, N (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Sleep Med, Boston, MA 02115 USA.	nsanthi@rics.bwh.harvard.edu	Duffy, Jeanne F./AAJ-4845-2020; Horowitz, Todd S/J-3376-2013	Duffy, Jeanne F./0000-0003-4177-4179; Santhi, Nayantara/0000-0003-4568-1447; Horowitz, Todd/0000-0001-5571-6266	National Heart Lung and Blood Institute [R01 HL52992]; National Heart, Lung and Blood Institute to the Division of Sleep Medicine (NHLBI) [T32 HL079010]; National Center for Research Resources [M01 RR02635]; National Space Biomedical Research Institute through the National Aeronautics and Space Administration [NCC 98-58]; Air Force Office of Scientific Research (AFOSR) [FA9550-06-0080/O5NL132]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052992] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung and Blood Institute to the Division of Sleep Medicine (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Space Biomedical Research Institute through the National Aeronautics and Space Administration; Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by a grant from the National Heart Lung and Blood Institute (R01 HL52992) to CAC; NS was supported by an Institutional NRSA in Sleep, Circadian and Respiratory Neurobiology from the National Heart, Lung and Blood Institute to the Division of Sleep Medicine (NHLBI; T32 HL079010); the studies were carried out on the BWH GCRC supported by the General Clinical Research Center Program of the National Center for Research Resources (M01 RR02635). CAC is supported in part by the National Space Biomedical Research Institute through the National Aeronautics and Space Administration (NCC 98-58) and by the Air Force Office of Scientific Research (AFOSR FA9550-06-0080/O5NL132).	Akerstedt T., 1994, Journal of Sleep Research, V3, P195; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Bartel P, 2004, OCCUP ENVIRON MED, V61, P167, DOI 10.1136/oem.2002.006197; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; BUDNICK LD, 1994, J OCCUP ENVIRON MED, V36, P1295, DOI 10.1097/00043764-199412000-00010; Bureau of Labor Statistics, 2005, WORK FLEX SHIFT SCHE; Caputo G, 1998, VISION RES, V38, P669, DOI 10.1016/S0042-6989(97)00189-2; Crowley SJ, 2003, J BIOL RHYTHM, V18, P513, DOI 10.1177/0748730403258422; Czeisler CA, 1995, J SLEEP RES, V4, P70, DOI 10.1111/j.1365-2869.1995.tb00231.x; De Gennaro L, 2001, PHYSIOL BEHAV, V74, P197, DOI 10.1016/S0031-9384(01)00551-0; DECOSTRE P, 1971, METABOLISM, V20, P782, DOI 10.1016/S0026-0495(71)80008-2; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; Dinges D, 1988, SLEEP RES, V17, P84; DINGES DF, 1987, SLEEP, V10, P313; DINGES DF, 1988, WORK STRESS, V2, P139, DOI 10.1080/02678378808259158; DINGES DF, 1994, SLEEP, V23, P129; Dorrian J., 2005, THESIS, P39; Drake CL, 2004, SLEEP, V27, P1453, DOI 10.1093/sleep/27.8.1453; Dula DJ, 2001, ANN EMERG MED, V38, P152, DOI 10.1067/mem.2001.116024; EASTMAN CI, 1995, PHYSIOL BEHAV, V58, P1287, DOI 10.1016/0031-9384(95)02031-4; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; FOLKARD S, 1992, ERGONOMICS, V35, P1453, DOI 10.1080/00140139208967414; Folkard S, 2003, OCCUP MED-OXFORD, V53, P95, DOI 10.1093/occmed/kqg047; FOLKARD S, 2006, AM J IND MED; FOLKARD S, 1975, P 3 INT S NIGHT SHIF, P113; Graw P, 2004, PHYSIOL BEHAV, V80, P695, DOI 10.1016/j.physbeh.2003.12.004; Horowitz TS, 2003, PSYCHOL SCI, V14, P549, DOI 10.1046/j.0956-7976.2003.psci_1464.x; Horowitz TS, 2001, AM J PHYSIOL-ENDOC M, V281, pE384, DOI 10.1152/ajpendo.2001.281.2.E384; Horrocks N, 2006, WORKING NIGHT SHIFT; Jewett ME, 1999, SLEEP, V22, P171, DOI 10.1093/sleep/22.2.171; Jewett ME, 1999, J BIOL RHYTHM, V14, P588, DOI 10.1177/074873099129000920; Lamond N, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.11.e13; Lamond N, 1999, J SLEEP RES, V8, P255, DOI 10.1046/j.1365-2869.1999.00167.x; Landolt HP, 2004, NEUROPSYCHOPHARMACOL, V29, P1933, DOI 10.1038/sj.npp.1300526; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Macmillan N. A., 2004, DETECTION THEORY USE; MIKULINCER M, 1989, BRIT J PSYCHOL, V80, P145, DOI 10.1111/j.2044-8295.1989.tb02309.x; Monk TH, 1997, J SLEEP RES, V6, P9, DOI 10.1046/j.1365-2869.1997.00023.x; NERI DF, 1996, SLEEP RES, V25, P144; Parasuraman, 1998, ATTENTIVE BRAIN; PTERNITIS C, 1981, NIGHT SHIFT WORK BIO, P171; Purnell MT, 2002, J SLEEP RES, V11, P219, DOI 10.1046/j.1365-2869.2002.00309.x; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Rouder JN, 2004, PSYCHON B REV, V11, P419, DOI 10.3758/BF03196589; Santhi N, 2005, NEUROSCI LETT, V384, P316, DOI 10.1016/j.neulet.2005.04.094; Scheffers MK, 1999, PSYCHOPHYSIOLOGY, V36, P149, DOI 10.1111/1469-8986.3620149; Schweitzer PK, 2006, SLEEP, V29, P39, DOI 10.1093/sleep/29.1.39; Smith PL, 2004, VISION RES, V44, P1297, DOI 10.1016/j.visres.2004.01.002; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Suzuki K, 2004, J OCCUP HEALTH, V46, P448, DOI 10.1539/joh.46.448; TREISMAN A, 1990, J EXP PSYCHOL HUMAN, V16, P459, DOI 10.1037/0096-1523.16.3.459; Van Dongen HPA, 2005, CLIN SPORT MED, V24, P237, DOI 10.1016/j.csm.2004.12.007; Van Dongen HPA, 2003, J SLEEP RES, V12, P181, DOI 10.1046/j.1365-2869.2003.00357.x; Wiener E., 1984, SUSTAINED ATTENTION, P207; WILLIAMS HL, 1959, PSYCHOL MONOGR, V73, P1; Williamson AM, 2001, ACCIDENT ANAL PREV, V33, P313, DOI 10.1016/S0001-4575(00)00045-2; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wyatt JK, 2004, SLEEP, V27, P374, DOI 10.1093/sleep/27.3.374	60	97	99	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1233	10.1371/journal.pone.0001233	http://dx.doi.org/10.1371/journal.pone.0001233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043740	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459300014
J	Di Dio, C; Macaluso, E; Rizzolatti, G				Di Dio, Cinzia; Macaluso, Emiliano; Rizzolatti, Giacomo			The Golden Beauty: Brain Response to Classical and Renaissance Sculptures	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; AMYGDALA; EMOTION; ACTIVATION; RETRIEVAL; STIMULI; INSULA; IMAGES	Is there an objective, biological basis for the experience of beauty in art? Or is aesthetic experience entirely subjective? Using fMRI technique, we addressed this question by presenting viewers, naive to art criticism, with images of masterpieces of Classical and Renaissance sculpture. Employing proportion as the independent variable, we produced two sets of stimuli: one composed of images of original sculptures; the other of a modified version of the same images. The stimuli were presented in three conditions: observation, aesthetic judgment, and proportion judgment. In the observation condition, the viewers were required to observe the images with the same mind-set as if they were in a museum. In the other two conditions they were required to give an aesthetic or proportion judgment on the same images. Two types of analyses were carried out: one which contrasted brain response to the canonical and the modified sculptures, and one which contrasted beautiful vs. ugly sculptures as judged by each volunteer. The most striking result was that the observation of original sculptures, relative to the modified ones, produced activation of the right insula as well as of some lateral and medial cortical areas (lateral occipital gyrus, precuneus and prefrontal areas). The activation of the insula was particularly strong during the observation condition. Most interestingly, when volunteers were required to give an overt aesthetic judgment, the images judged as beautiful selectively activated the right amygdala, relative to those judged as ugly. We conclude that, in observers naive to art criticism, the sense of beauty is mediated by two non-mutually exclusive processes: one based on a joint activation of sets of cortical neurons, triggered by parameters intrinsic to the stimuli, and the insula (objective beauty); the other based on the activation of the amygdala, driven by one's own emotional experiences (subjective beauty).	[Di Dio, Cinzia; Rizzolatti, Giacomo] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Di Dio, Cinzia; Macaluso, Emiliano] Fdn Santa Lucia, Neuroimaging Lab, Rome, Italy	University of Parma; IRCCS Santa Lucia	Rizzolatti, G (corresponding author), Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy.	giacomo.rizzolatti@unipr.it	Macaluso, Emiliano/AAE-9185-2019; Di Dio, Cinzia/HGB-3168-2022; Macaluso, Emiliano/H-3139-2017	Macaluso, Emiliano/0000-0002-1919-5288; Macaluso, Emiliano/0000-0002-1919-5288	Italian Ministero Universita Ricerca	Italian Ministero Universita Ricerca(Ministry of Education, Universities and Research (MIUR))	This study was supported by a grant from Italian Ministero Universita Ricerca to G Rizzolatti. Funders had no role in the design and conduct of the study, in the collection, analysis, or interpretation of the data, and in the preparation, review, or approval of the manuscript.	Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; ASTAFIEV SV, 2005, NAT NEUROSCI, V7, P542; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; BAYLES D, 2007, ART FEAR OBSERVATION; BOLLER F, 2001, HDB NEUROPSYCHOLOGY; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cela-Conde CJ, 2004, P NATL ACAD SCI USA, V101, P6321, DOI 10.1073/pnas.0401427101; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2005, NEUROIMAGE, V24, P751, DOI 10.1016/j.neuroimage.2004.10.013; Damasio A.R., 2000, FEELING WHAT HAPPENS; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Dougherty DD, 2004, ARCH GEN PSYCHIAT, V61, P795, DOI 10.1001/archpsyc.61.8.795; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; DUPONT P, 1994, J NEUROPHYSIOL, V72, P1420, DOI 10.1152/jn.1994.72.3.1420; Dupont S, 2003, SURG RADIOL ANAT, V25, P113, DOI 10.1007/s00276-003-0103-4; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; Friston KJ, 2002, NEUROIMAGE, V16, P513, DOI 10.1006/nimg.2001.1044; Gombrich EH, 1984, TRIBUTES INTERPRETER; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Henson R.N.A., 1999, NEUROIMAGE, V9, P125, DOI DOI 10.1016/J.NEUROIMAGE.2011.06.078; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Huntley H.E., 1970, DIVINE PROPORTION ST; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kleist K, 1937, Z GESAMTE NEUROL PSY, V158, P159, DOI 10.1007/BF02870728; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; LeDoux, 1996, EMOTIONAL BRAIN MYST, P384; Livio M., 2008, GOLDEN RATIO STORY P; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Mesulam M-M., 1985, CEREB CORTEX, P179, DOI DOI 10.1007/978-1-4757-9619-3_5; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; ORBAN GA, 1995, P NATL ACAD SCI USA, V92, P993, DOI 10.1073/pnas.92.4.993; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Ramachandran VS, 2004, BRIEF TOUR HUMAN CON; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rotshtein P, 2001, NEURON, V32, P747, DOI 10.1016/S0896-6273(01)00513-X; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Tatarkiewicz W., 1970, HIST AESTHETICS; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2012, DOI 10.1073/pnas.91.6.2012; Valentine C.W., 1962, INTRO EXPT PSYCHOL B, V1st ed., DOI [10.4324/9781315707617, DOI 10.4324/9781315707617]; Vartanian O, 2004, NEUROREPORT, V15, P893, DOI 10.1097/00001756-200404090-00032; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	52	193	195	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1201	10.1371/journal.pone.0001201	http://dx.doi.org/10.1371/journal.pone.0001201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030335	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459200014
J	Eisenberg, DTA; Campbell, B; MacKillop, J; Lum, JK; Wilson, DS				Eisenberg, Dan T. A.; Campbell, Benjamin; MacKillop, James; Lum, J. Koji; Wilson, David S.			Season of Birth and Dopamine Receptor Gene Associations with Impulsivity, Sensation Seeking and Reproductive Behaviors	PLOS ONE			English	Article							MORNINGNESS-EVENINGNESS; ENVIRONMENT INTERACTION; VNTR POLYMORPHISM; ANOREXIA-NERVOSA; NOVELTY SEEKING; PRENATAL STRESS; FETAL ORIGINS; DRD4; VARIANTS; PERSONALITY	Season of birth (SOB) has been associated with many physiological and psychological traits including novelty seeking and sensation seeking. Similar traits have been associated with genetic polymorphisms in the dopamine system. SOB and dopamine receptor genetic polymorphisms may independently and interactively influence similar behaviors through their common effects on the dopaminergic system. Methodology/Principal Findings. Based on a sample of 195 subjects, we examined whether SOB was associated with impulsivity, sensation seeking and reproductive behaviors. Additionally we examined potential interactions of dopamine receptor genes with SOB for the same set of traits. Phenotypes were evaluated using the Sociosexual Orientation Inventory, the Barratt Impulsivity Scale, the Eysenck Impulsivity Questionnaire, the Sensation Seeking Scale, and the Delay Discounting Task. Subjects were also asked about their age at first sex as well as their desired age at the birth of their first child. The dopamine gene polymorphisms examined were Dopamine Receptor D2 (DRD2) TaqI A and D4 (DRD4) 48 bp VNTR. Primary analyses included factorial genderxSOB ANOVAs or binary logistic regression models for each dependent trait. Secondary analysis extended the factorial models by also including DRD2 and DRD4 genotypes as independent variables. Winter-born males were more sensation seeking than non-winter born males. In factorial models including both genotype and season of birth as variables, two previously unobserved effects were discovered: (1) a SOB x DRD4 interaction effect on venturesomeness and (2) a DRD2 x DRD4 interaction effect on sensation seeking. Conclusion. These results are consistent with past findings that SOB is related to sensation seeking. Additionally, these results provide tentative support for the hypothesis that SOB modifies the behavioral expression of dopaminergic genetic polymorphism. These findings suggest that SOB should be included in future studies of risky behaviors and behavioral genetic studies of the dopamine system.	[Eisenberg, Dan T. A.] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA; [Eisenberg, Dan T. A.; Lum, J. Koji; Wilson, David S.] SUNY Binghamton, Dept Anthropol, Binghamton, NY USA; [Eisenberg, Dan T. A.; Lum, J. Koji; Wilson, David S.] SUNY Binghamton, Dept Biol, Binghamton, NY USA; [Eisenberg, Dan T. A.; Lum, J. Koji] SUNY Binghamton, Lab Evolutionary Anthropol & Hlth, Binghamton, NY USA; [Campbell, Benjamin] Univ Wisconsin, Dept Anthropol, Milwaukee, WI 53201 USA; [MacKillop, James] SUNY Binghamton, Dept Psychol, Binghamton, NY USA; [MacKillop, James] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA	Northwestern University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Wisconsin System; University of Wisconsin Milwaukee; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Brown University	Eisenberg, DTA (corresponding author), Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA.	dtae@dtae.net	Eisenberg, Dan T.A./D-7691-2011; , James/ABI-3641-2020	Eisenberg, Dan T.A./0000-0003-0812-1862; , James/0000-0002-8695-1071	Harpur College Awards Committee of the State University of New York at Binghamton to DTAE; Research Foundation of Binghamton University to JKL [T32 AA007459-20]; National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007459] Funding Source: NIH RePORTER	Harpur College Awards Committee of the State University of New York at Binghamton to DTAE; Research Foundation of Binghamton University to JKL; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported in part by Undergraduate Research Awards from the Harpur College Awards Committee of the State University of New York at Binghamton to DTAE; by a start up grant from the Research Foundation of Binghamton University to JKL; and by grant T32 AA007459-20 from the National Institute on Alcohol Abuse and Alcoholism. Study sponsors had no influence on the study design, collection, analysis, interpretation, writing or submission.	Adams J, 1999, PROG PHYS GEOG, V23, P1, DOI 10.1177/030913339902300101; ASGHARI V, 1994, MOL PHARMACOL, V46, P364; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Banegas JR, 2000, J HYPERTENS, V18, P1763, DOI 10.1097/00004872-200018120-00009; Bergen AW, 2005, NEUROPSYCHOPHARMACOL, V30, P1703, DOI 10.1038/sj.npp.1300719; Bland M, 2000, MULTIPLE SIGNIFICANC, P148; Blum K, 2000, J PSYCHOACTIVE DRUGS, V32; BOLTON P, 1992, J CHILD PSYCHOL PSYC, V33, P509, DOI 10.1111/j.1469-7610.1992.tb00888.x; Boor K, 2002, CURR MED CHEM, V9, P793, DOI 10.2174/0929867024606821; Brody AL, 2006, ARCH GEN PSYCHIAT, V63, P808, DOI 10.1001/archpsyc.63.7.808; Bronson EH, 2004, J BIOL RHYTHM, V19, P180, DOI 10.1177/0748730404264658; BRZUSTOWSKI J, HARDYWEINBERG EQUILI; Caci H, 2005, ENCEPHALE, V31, P56; Callier S, 2003, BIOL CELL, V95, P489, DOI 10.1016/S0248-4900(03)00089-3; Castrogiovanni P, 1999, NEUROPSYCHOBIOLOGY, V40, P177, DOI 10.1159/000026616; Cho DI, 2006, BIOCHEM BIOPH RES CO, V350, P634, DOI 10.1016/j.bbrc.2006.09.090; Chotai J, 1999, ARCH SUICIDE RES, V5, P245, DOI 10.1080/13811119908258335; Chotai J, 2003, PERS INDIV DIFFER, V35, P897, DOI 10.1016/S0191-8869(02)00306-9; Chotai J, 2003, PSYCHIAT RES, V119, P99, DOI 10.1016/S0165-1781(03)00112-4; Chotai J, 2002, EUR ARCH PSY CLIN N, V252, P130, DOI 10.1007/s00406-002-0372-7; Chotai J, 2002, PSYCHIAT RES, V111, P45, DOI 10.1016/S0165-1781(02)00107-5; Chotai J, 2002, J AFFECT DISORDERS, V69, P69, DOI 10.1016/S0165-0327(00)00379-7; Chotai J, 1999, NEUROPSYCHOBIOLOGY, V39, P57, DOI 10.1159/000026561; Chotai J, 2001, NEUROPSYCHOBIOLOGY, V44, P19, DOI 10.1159/000054909; Clarke AS, 1996, BIOL PSYCHIAT, V40, P338, DOI 10.1016/0006-3223(95)00663-X; Comings DE, 2000, GENETIC INFLUENCES ON HUMAN FERTILITY AND SEXUALITY, P271; Czermak C, 2006, EUR J PHARMACOL, V531, P20, DOI 10.1016/j.ejphar.2005.11.063; Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587, DOI 10.1093/oxfordjournals.schbul.a007030; DEVONA J, 2005, DELAY DISCOUNTING TA; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Doblhammer G, 2001, P NATL ACAD SCI USA, V98, P2934, DOI 10.1073/pnas.041431898; Dubertret C, 2004, SCHIZOPHR RES, V67, P75, DOI 10.1016/S0920-9964(03)00220-2; Eisenberg DTA, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-2; EISENBERG DTA, 2007, EVOLUTIONARY PSYCHOL, V5, P696; EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P613, DOI 10.1016/0191-8869(85)90011-X; EYSENCK SBG, 1978, PSYCHOL REP, V43, P1247, DOI 10.2466/pr0.1978.43.3f.1247; Fieder M, 2006, AM J HUM BIOL, V18, P714, DOI 10.1002/ajhb.20539; Frisch A, 2001, MOL PSYCHIATR, V6, P243, DOI 10.1038/sj.mp.4000830; Gerardin DCC, 2005, PHYSIOL BEHAV, V84, P97, DOI 10.1016/j.physbeh.2004.10.014; Goldman BD, 1999, STEROIDS, V64, P679, DOI 10.1016/S0039-128X(99)00052-5; *GSFL RES GROUP, 2003, GSFL GEN PROT DRD2 D; Guo GA, 2006, HUM MUTAT, V27, P236, DOI 10.1002/humu.20282; Hamarman S, 2004, J CHILD ADOL PSYCHOP, V14, P564, DOI 10.1089/cap.2004.14.564; Hartman DS, 1997, POL J PHARMACOL, V49, P191; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Hur YM, 1997, BEHAV GENET, V27, P455, DOI 10.1023/A:1025674417078; Hutchison KE, 2003, NEUROPSYCHOPHARMACOL, V28, P1882, DOI 10.1038/sj.npp.1300264; Hutchison KE, 2006, NEUROPSYCHOPHARMACOL, V31, P1310, DOI 10.1038/sj.npp.1300917; Joinson C, 2005, PERS INDIV DIFFER, V38, P859, DOI 10.1016/j.paid.2004.06.010; Jongbloet PH, 2005, INT J EAT DISORDER, V38, P236, DOI 10.1002/eat.20173; JONGBLOET PH, 1994, ANN HUM BIOL, V21, P511, DOI 10.1080/03014469400003522; Jovanovic V, 1999, PHARMACOGENETICS, V9, P561, DOI 10.1097/00008571-199910000-00003; Kluger AN, 2002, MOL PSYCHIATR, V7, P712, DOI 10.1038/sj.mp.4001082; Kuzawa CW, 2005, AM J HUM BIOL, V17, P5, DOI 10.1002/ajhb.20091; Kuzawa CW, 2005, AM J HUM BIOL, V17, P1, DOI 10.1002/ajhb.20090; LEGRO RS, 1994, HUM REPROD, V9, P1271, DOI 10.1093/oxfordjournals.humrep.a138693; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Levitan RD, 2004, NEUROPSYCHOPHARMACOL, V29, P179, DOI 10.1038/sj.npp.1300314; LEVITAN RD, 2006, NEUROPSYCHOPHARMACOL; Limosin F, 2003, PSYCHIAT GENET, V13, P127, DOI 10.1097/01.ypg.0000066963.66429.00; MacMurray J, 2003, BIODEMOGRAPHY OF HUMAN REPRODUCTION AND FERTILITY, P187; MACMURRAY J, 2006, COMMUNICATION; Martin M, 1999, CORTEX, V35, P123, DOI 10.1016/S0010-9452(08)70790-1; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; McClure WO, 2004, DEV BRAIN RES, V149, P21, DOI 10.1016/j.devbrainres.2003.11.015; McGough J, 2006, J AM ACAD CHILD PSY, V45, P1314, DOI 10.1097/01.chi.0000235083.40285.08; McGrath JJ, 2006, SCHIZOPHR RES, V81, P91, DOI 10.1016/j.schres.2005.07.017; McGrath JJ, 2005, EARLY HUM DEV, V81, P609, DOI 10.1016/j.earlhumdev.2005.03.013; Meek LR, 2006, PHYSIOL BEHAV, V89, P133, DOI 10.1016/j.physbeh.2006.05.006; MIURA T, 1983, ARCH GYNECOL, V233, P263, DOI 10.1007/BF02133800; Mongrain V, 2006, NEUROSCI LETT, V406, P113, DOI 10.1016/j.neulet.2006.07.002; Natale V, 2002, NEUROPSYCHOBIOLOGY, V46, P209, DOI 10.1159/000067803; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Nir I, 2002, J NEUROSCI, V22, P2063, DOI 10.1523/JNEUROSCI.22-06-02063.2002; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; Oak JN, 2001, MOL PHARMACOL, V60, P92, DOI 10.1124/mol.60.1.92; Patin V, 2005, DEV BRAIN RES, V160, P265, DOI 10.1016/j.devbrainres.2005.09.010; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Phillips DIW, 2000, INT J OBESITY, V24, P281, DOI 10.1038/sj.ijo.0801125; Pijl H, 2003, EUR J PHARMACOL, V480, P125, DOI 10.1016/j.ejphar.2003.08.100; Ratsma JE, 2001, ALCOHOL CLIN EXP RES, V25, P960, DOI 10.1097/00000374-200107000-00003; Retz W, 2003, J NEURAL TRANSM, V110, P561, DOI 10.1007/s00702-002-0805-5; Reynolds B, 2004, BEHAV PROCESS, V67, P343, DOI 10.1016/j.beproc.2004.06.003; Roberti JW, 2004, J RES PERS, V38, P256, DOI 10.1016/S0092-6566(03)00067-9; Rock D, 2006, EUR ARCH PSY CLIN N, V256, P98, DOI 10.1007/s00406-005-0614-6; Salib E, 2006, BRIT J PSYCHIAT, V188, P416, DOI 10.1192/bjp.bp.105.009118; Savitz JB, 2004, AM J MED GENET B, V131B, P20, DOI 10.1002/ajmg.b.20155; Schinka JA, 2002, AM J MED GENET, V114, P643, DOI 10.1002/ajmg.10649; Schmitt DP, 2005, BEHAV BRAIN SCI, V28, P247, DOI 10.1017/S0140525X05000051; Schoots O, 2003, PHARMACOGENOMICS J, V3, P343, DOI 10.1038/sj.tpj.6500208; Seeger G, 2004, NEUROSCI LETT, V366, P282, DOI 10.1016/j.neulet.2004.05.049; Sen S, 2005, AM J HYPERTENS, V18, P1206, DOI 10.1016/j.amjhyper.2005.04.010; Shinohara M, 2004, J PSYCHIATR NEUROSCI, V29, P134; SIMPSON JA, 1991, J PERS SOC PSYCHOL, V60, P870, DOI 10.1037/0022-3514.60.6.870; Smits LJ, 1997, HUM REPROD, V12, P2572, DOI 10.1093/humrep/12.11.2572; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Tochigi M, 2004, NEUROSCI RES, V48, P1, DOI 10.1016/j.neures.2003.09.002; Torrey EF, 1997, SCHIZOPHR RES, V28, P1, DOI 10.1016/S0920-9964(97)00092-3; Tosini G, 2000, NEUROSCI LETT, V286, P119, DOI 10.1016/S0304-3940(00)01117-4; Van Craenenbroeck K, 2005, J BIOL CHEM, V280, P19350, DOI 10.1074/jbc.M414043200; VANTOL HHM, 1992, NATURE, V358, P149; Waldie KE, 2000, EARLY HUM DEV, V60, P35, DOI 10.1016/S0378-3782(00)00102-X; Watts VJ, 1999, PSYCHOPHARMACOLOGY, V141, P83, DOI 10.1007/s002130050810; Zawilska JB, 1997, POL J PHARMACOL, V49, P201; Zhang DD, 2006, CLIMATIC CHANGE, V76, P459, DOI 10.1007/s10584-005-9024-z; Zuckerman M., 2014, SENSATION SEEKING OP	107	58	59	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1216	10.1371/journal.pone.0001216	http://dx.doi.org/10.1371/journal.pone.0001216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030347	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459200026
J	Wu, D; Townsley, E; Tartakoff, AM				Wu, Di; Townsley, Elizabeth; Tartakoff, Alan Michael			Covert Genetic Selections to Optimize Phenotypes	PLOS ONE			English	Article								In many high complexity systems (cells, organisms, institutions, societies, economies, etc.), it is unclear which components should be regulated to affect overall performance. To identify and prioritize molecular targets which impact cellular phenotypes, we have developed a selection procedure ("SPI''-single promoting/inhibiting target identification) which monitors the abundance of ectopic cDNAs. We have used this approach to identify growth regulators. For this purpose, complex pools of S. cerevisiae cDNA transformants were established and we quantitated the evolution of the spectrum of cDNAs which was initially present. These data emphasized the importance of translation initiation and ER-Golgi traffic for growth. SPI provides functional insight into the stability of cellular phenotypes under circumstances in which established genetic approaches cannot be implemented. It provides a functional "synthetic genetic signature'' for each state of the cell (i.e. genotype and environment) by surveying complex genetic libraries, and does not require specialized arrays of cDNAs/shRNAs, deletion strains, direct assessment of clonal growth or even a conditional phenotype. Moreover, it establishes a hierarchy of importance of those targets which can contribute, either positively or negatively, to modify the prevailing phenotype. Extensions of these proof-of-principle experiments to other cell types should provide a novel and powerful approach to analyze multiple aspects of the basic biology of yeast and animal cells as well as clinically-relevant issues.	[Townsley, Elizabeth; Tartakoff, Alan Michael] Case Western Reserve Univ, Sch Med, Dept Pathol, Cell Biol Program, Cleveland, OH 44106 USA; [Wu, Di] Monash Univ, Monash Med Ctr, Monash Inst Med Res, Melbourne, Vic 3004, Australia	Case Western Reserve University; Monash University	Tartakoff, AM (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Cell Biol Program, Cleveland, OH 44106 USA.	amt10@case.edu	Wu, Di/AAB-7566-2021	Wu, Di/0000-0001-8331-2357	NSF [MCB04311496]; NIH [P30CA43703]; Case Western Presidential Research Initiative Grant; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Presidential Research Initiative Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NSF MCB04311496; NIH P30CA43703, Case Western Presidential Research Initiative Grant. None of the above played any active role in the design, review, or approval of this manuscript.	Abruzzi K, 2007, MOL CELL BIOL, V27, P1044, DOI 10.1128/MCB.01299-06; Akada R, 1997, MOL GEN GENET, V254, P267, DOI 10.1007/s004380050415; Beggs JD, 2005, BIOCHEM SOC T, V33, P433, DOI 10.1042/BST0330433; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyer J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r72; Butcher RA, 2006, NAT PROTOC, V1, P569, DOI 10.1038/nprot.2006.80; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; DESHMUKH M, 1995, J BIOL CHEM, V270, P30148; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; ESPINET C, 1995, YEAST, V11, P25, DOI 10.1002/yea.320110104; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Guillon L, 2005, BIOCHEMISTRY-US, V44, P15594, DOI 10.1021/bi051514j; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Lim TS, 2000, MACH LEARN, V40, P203, DOI 10.1023/A:1007608224229; LIU HP, 1992, GENETICS, V132, P665; Luo JY, 2004, J CELL BIOL, V165, P843, DOI 10.1083/jcb.200401040; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Meunier JR, 1999, YEAST, V15, P1159, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1159::AID-YEA441>3.0.CO;2-D; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; OGUR M, 1960, GENETICS, V45, P189; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Peng RW, 2000, J BIOL CHEM, V275, P11521, DOI 10.1074/jbc.275.15.11521; PESTOV DG, 1994, P NATL ACAD SCI USA, V91, P12549, DOI 10.1073/pnas.91.26.12549; RAMER SW, 1992, P NATL ACAD SCI USA, V89, P11589, DOI 10.1073/pnas.89.23.11589; Reimann B, 1999, YEAST, V15, P397, DOI 10.1002/(SICI)1097-0061(19990330)15:5<397::AID-YEA384>3.3.CO;2-L; ROSSI G, 1991, NATURE, V351, P158, DOI 10.1038/351158a0; Simons JF, 1998, EMBO J, V17, P396, DOI 10.1093/emboj/17.2.396; Singhi AD, 2004, P NATL ACAD SCI USA, V101, P9327, DOI 10.1073/pnas.0403080101; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Speed TP, 2003, STAT ANAL GENE EXPRE, Vxiii; Stansfield I, 1998, J MOL BIOL, V282, P13, DOI 10.1006/jmbi.1998.1976; Stevenson LF, 2001, P NATL ACAD SCI USA, V98, P3946, DOI 10.1073/pnas.051013498; Tomishige N, 2003, MOL GENET GENOMICS, V269, P562, DOI 10.1007/s00438-003-0864-9; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1200	10.1371/journal.pone.0001200	http://dx.doi.org/10.1371/journal.pone.0001200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030334	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459200013
J	Jeong, YH; Kim, MC; Ahn, EK; Seol, SY; Do, EJ; Choi, HJ; Chu, IS; Kim, WJ; Kim, WJ; Sunwoo, Y; Leem, SH				Jeong, Yun Hee; Kim, Min Chan; Ahn, Eun-Kyung; Seol, So-Young; Do, Eun-Ju; Choi, Hong-Jo; Chu, In-Sun; Kim, Wun-Jae; Kim, Woo Jin; Sunwoo, Yangil; Leem, Sun-Hee			Rare Exonic Minisatellite Alleles in MUC2 Influence Susceptibility to Gastric Carcinoma	PLOS ONE			English	Article							HUMAN TELOMERASE GENE; TANDEM REPEATS; MICROSATELLITE INSTABILITY; VARIABLE NUMBER; EXPRESSION; POLYMORPHISM; ASSOCIATION; IDENTIFICATION; SEQUENCE; CANCER	Background. Mucins are the major components of mucus and their genes share a common, centrally-located region of sequence that encodes tandem repeats. Mucins are well known genes with respect to their specific expression levels; however, their genomic levels are unclear because of complex genomic properties. In this study, we identified eight novel minisatellites from the entire MUC2 region and investigated how allelic variation in these minisatellites may affect susceptibility to gastrointestinal cancer. Methodology/Principle Findings. We analyzed genomic DNA from the blood of normal healthy individuals and multi-generational family groups. Six of the eight minisatellites exhibited polymorphism and were transmitted meiotically in seven families, following Mendelian inheritance. Furthermore, a case-control study was performed that compared genomic DNA from 457 cancer-free controls with DNA from individuals with gastric (455), colon (192) and rectal (271) cancers. A statistically significant association was identified between rare exonic MUC2-MS6 alleles and the occurrence of gastric cancer: odds ratio (OR), 2.56; 95% confidence interval (CI), 1.31-5.04; and p = 0.0047. We focused on an association between rare alleles and gastric cancer. Rare alleles were divided into short (40, 43 and 44) and long (47, 50 and 54), according to their TR (tandem repeats) lengths. Interestingly, short rare alleles were associated with gastric cancer (OR = 5.6, 95% CI: 1.93-16.42; p=0.00036). Moreover, hypervariable MUC2 minisatellites were analyzed in matched blood and cancer tissue from 28 patients with gastric cancer and in 4 cases of MUC2-MS2, minisatellites were found to have undergone rearrangement. Conclusions/Significance. Our observations suggest that the short rare MUC2-MS6 alleles could function as identifiers for risk of gastric cancer. Additionally, we suggest that minisatellite instability might be associated with MUC2 function in cancer cells.	[Jeong, Yun Hee; Ahn, Eun-Kyung; Seol, So-Young; Do, Eun-Ju; Sunwoo, Yangil; Leem, Sun-Hee] Dong A Univ, Dept Biol Sci, Pusan, South Korea; [Kim, Min Chan; Choi, Hong-Jo] Dong A Univ, Dept Surg, Coll Med, Pusan, South Korea; [Chu, In-Sun] KRIBB, Med Genom Res Ctr, Taejon, South Korea; [Kim, Wun-Jae] Chungbuk Natl Univ, Dept Urol, Coll Med, Cheongju, South Korea; [Kim, Woo Jin] Kangwon Natl Univ, Dept Internal Med, Coll Med, Chunchon, Kangwon Do, South Korea	Dong A University; Dong A University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University; Kangwon National University	Leem, SH (corresponding author), Dong A Univ, Dept Biol Sci, Pusan, South Korea.	shleem@dau.ac.kr			Ministry of Science & Technology, Korea [FG06-11-06]	Ministry of Science & Technology, Korea(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported by a grant (FG06-11-06) from the 21C Frontier Functional Human Genome Project, Ministry of Science & Technology, Korea.	Bailly S, 1996, MOL IMMUNOL, V33, P999, DOI 10.1016/S0161-5890(96)00042-9; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Biemer-Huttmann AE, 2000, CLIN CANCER RES, V6, P1909; BLANK M, 1994, INT J CANCER, V59, P301, DOI 10.1002/ijc.2910590302; BRAGA VMM, 1992, DEVELOPMENT, V115, P427; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; Carvalho F, 1997, GLYCOCONJUGATE J, V14, P107, DOI 10.1023/A:1018573201347; CHAKRAVARTI A, 2004, GENOME ANAL LAB MANU, V4; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; CIMERMAN M, 1994, INT SURG, V79, P27; Debailleul V, 1998, J BIOL CHEM, V273, P881, DOI 10.1074/jbc.273.2.881; Desseyn JL, 1999, ELECTROPHORESIS, V20, P493, DOI 10.1002/(SICI)1522-2683(19990301)20:3<493::AID-ELPS493>3.0.CO;2-7; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; GUM JR, 1994, J BIOL CHEM, V269, P2440; Guzman K, 1996, AM J PHYSIOL-LUNG C, V270, pL846, DOI 10.1152/ajplung.1996.270.5.L846; Herrmann A, 1999, J BIOL CHEM, V274, P15828, DOI 10.1074/jbc.274.22.15828; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; Kirkbride HJ, 2001, EUR J HUM GENET, V9, P347, DOI 10.1038/sj.ejhg.5200642; KRONTIRIS TG, 1993, NEW ENGL J MED, V329, P517, DOI 10.1056/NEJM199308193290801; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; Kyo K, 1999, HUM MOL GENET, V8, P307, DOI 10.1093/hmg/8.2.307; Lee HS, 2001, CANCER, V92, P1427, DOI 10.1002/1097-0142(20010915)92:6<1427::AID-CNCR1466>3.0.CO;2-L; Leem SH, 2002, ONCOGENE, V21, P769, DOI 10.1038/sj.onc.1205122; LENGAUER C, NATURE, V8396, P643; Paquette J, 1998, J BIOL CHEM, V273, P14158, DOI 10.1074/jbc.273.23.14158; Pigny P, 1996, GENOMICS, V38, P340, DOI 10.1006/geno.1996.0637; Rousseau K, 2004, GENOMICS, V83, P936, DOI 10.1016/j.ygeno.2003.11.003; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; Rozen S, 2000, Methods Mol Biol, V132, P365; Sternberg LR, 2004, ARCH BIOCHEM BIOPHYS, V421, P21, DOI 10.1016/j.abb.2003.10.002; Szutorisz H, 2001, ONCOGENE, V20, P2600, DOI 10.1038/sj.onc.1204346; The Information Committee of the Korean Gastric Cancer Association, 2007, J KOREAN GASTRIC CAN, V7, P47; TREPICCHIO WL, 1992, NUCLEIC ACIDS RES, V20, P2427, DOI 10.1093/nar/20.10.2427; Utsunomiya T, 1998, CLIN CANCER RES, V4, P2605; Vinall LE, 1998, HUM GENET, V102, P357, DOI 10.1007/s004390050705; Vinall LE, 2000, AM J RESP CELL MOL, V23, P678, DOI 10.1165/ajrcmb.23.5.4176; Wang L, 2003, ONCOGENE, V22, P7123, DOI 10.1038/sj.onc.1206852; Weitzel JN, 2000, CANCER RES, V60, P259; YEE CJ, 1994, CANCER RES, V54, P1641; Yi XM, 2000, NEOPLASIA, V2, P433, DOI 10.1038/sj.neo.7900113	41	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1163	10.1371/journal.pone.0001163	http://dx.doi.org/10.1371/journal.pone.0001163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000536	Green Submitted, gold, Green Published			2022-12-27	WOS:000207459100006
J	Kalilani, L; Mofolo, I; Chaponda, M; Rogerson, SJ; Alker, AP; Kwiek, JJ; Meshnick, SR				Kalilani, Linda; Mofolo, Innocent; Chaponda, Marjorie; Rogerson, Stephen J.; Alker, Alisa P.; Kwiek, Jesse J.; Meshnick, Steven R.			A Randomized Controlled Pilot Trial of Azithromycin or Artesunate Added to Sulfadoxine-Pyrimethamine as Treatment for Malaria in Pregnant Women	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; INTERMITTENT PREVENTIVE TREATMENT; 1ST LINE TREATMENT; ARTEMETHER-LUMEFANTRINE; HIGH PREVALENCE; EFFICACY; UGANDA; EPIDEMIOLOGY; COMBINATION; RESISTANCE	Objective. New anti-malarial regimens are urgently needed in sub-Saharan Africa because of the increase in drug resistance. We investigated the safety and efficacy of azithromycin or artesunate combined with sulfadoxine-pyrimethamine used for treatment of malaria in pregnant women in Blantyre, Malawi. Methods/Findings. This was a randomized open-label clinical trial, conducted at two rural health centers in Blantyre district, Malawi. A total of 141 pregnant women with uncomplicated Plasmodium falciparum malaria were recruited and randomly allocated to 3 treatment groups: sulfadoxine-pyrimethamine (SP; 3 tablets, 500 mg sulfadoxine and 25 mg pyrimethamine per tablet); SP plus azithromycin (1 g/day x 2 days); or SP plus artesunate (200 mg/day x 3 days). Women received two doses administered at least 4 weeks apart. Heteroduplex tracking assays were performed to distinguish recrudescence from new infections. Main outcome measures were incidence of adverse outcomes, parasite and fever clearance times and recrudescence rates. All treatment regimens were well tolerated. Two women vomited soon after ingesting azithromycin. The parasite clearance time was significantly faster in the SP-artesunate group. Recrudescent episodes of malaria were less frequent with SP-azithromycin [Hazard Ratio 0.19 (95% confidence interval 0.06 to 0.63)] and SP-artesunate [Hazard Ratio 0.25 ( 95% confidence interval 0.10 to 0.65)] compared with SP monotherapy. With one exception (an abortion in the SP-azithromycin group), all adverse pregnancy outcomes could be attributed to known infectious or obstetrical causes. Because of the small sample size, the effect on birth outcomes, maternal malaria or maternal anemia could not be evaluated. Conclusions. Both SP-artesunate and SP-azithromycin appeared to be safe, well tolerated and efficacious for the treatment of malaria during pregnancy. A larger study is needed to determine their safety and efficacy in preventing poor birth outcomes. Trial Registration. ClinialTrials.gov NCT00287300	[Kalilani, Linda; Alker, Alisa P.; Kwiek, Jesse J.; Meshnick, Steven R.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Mofolo, Innocent; Chaponda, Marjorie] Univ Malawi, Coll Med, Blantyre, Malawi; [Rogerson, Stephen J.] Univ Melbourne, Parkville, Vic 3052, Australia	University of North Carolina; University of North Carolina Chapel Hill; University of Malawi; University of Melbourne	Kalilani, L (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.	lkalilani@rsc.medcol.mw	Kwiek, Jesse/E-3449-2011	Kwiek, Jesse/0000-0003-4277-8315; Rogerson, Stephen/0000-0003-4287-1982	CDC [CDC/ASPH/ASTDR S1935-21/21]; Wellcome Trust	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Wellcome Trust(Wellcome Trust)	This study was funded by CDC grant CDC/ASPH/ASTDR S1935-21/21. Dr Steve Rogerson is supported by a Wellcome Trust Senior Research Fellowship. The CDC had no role in the design and conduct of the study, data collection, analysis and interpretation of the data, in the preparation, review, or approval of the manuscript.	Adair CD, 1998, OBSTET GYNECOL, V91, P165, DOI 10.1016/S0029-7844(97)00586-3; ADAM I, 2006, T ROY SOC TROP MED H, P632; Alker AP, 2005, ANTIMICROB AGENTS CH, V49, P3919, DOI 10.1128/AAC.49.9.3919-3921.2005; Alker AP, 2004, ANTIMICROB AGENTS CH, V48, P2924, DOI 10.1128/AAC.48.8.2924-2929.2004; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Andersen SL, 1998, CLIN INFECT DIS, V26, P146, DOI 10.1086/516281; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Brentlinger PE, 2006, LANCET INFECT DIS, V6, P100, DOI 10.1016/S1473-3099(06)70383-8; Bwijo B, 2003, ACTA TROP, V85, P363, DOI 10.1016/S0001-706X(02)00264-4; Clark RL, 2004, BIRTH DEFECTS RES B, V71, P380, DOI 10.1002/bdrb.20027; Deen JL, 2001, T ROY SOC TROP MED H, V95, P424, DOI 10.1016/S0035-9203(01)90204-4; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; Filler SJ, 2006, J INFECT DIS, V194, P286, DOI 10.1086/505080; Gray RH, 2001, AM J OBSTET GYNECOL, V185, P1209, DOI 10.1067/mob.2001.118158; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Hastings IM, 2005, J INFECT DIS, V192, P1303, DOI 10.1086/432554; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Kwiek JJ, 2007, ANTIMICROB AGENTS CH, V51, P521, DOI 10.1128/AAC.00902-06; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lin H, 2002, MODELING SURVIVAL DA, V44, P85; *MAL NAT STAT OFF, 1998, MAL POP HOUS CENS SU, V1, P123; McGready R, 2005, J INFECT DIS, V192, P846, DOI 10.1086/432551; McGready R, 2001, T ROY SOC TROP MED H, V95, P651, DOI 10.1016/S0035-9203(01)90106-3; McGready R, 1998, T ROY SOC TROP MED H, V92, P430, DOI 10.1016/S0035-9203(98)91081-1; McGready R, 2001, CLIN INFECT DIS, V33, P2009, DOI 10.1086/324349; Ngrenngarmlert W, 2005, AM J TROP MED HYG, V72, P694, DOI 10.4269/ajtmh.2005.72.694; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; PhillipsHoward PA, 1996, DRUG SAFETY, V14, P131, DOI 10.2165/00002018-199614030-00001; Piola P, 2005, LANCET, V365, P1467, DOI 10.1016/S0140-6736(05)66416-1; Plowe CV, 2004, BRIT MED J, V328, P545, DOI 10.1136/bmj.37977.653750.EE; Priotto G, 2003, T ROY SOC TROP MED H, V97, P325, DOI 10.1016/S0035-9203(03)90161-1; Rogerson SJ, 2000, T ROY SOC TROP MED H, V94, P549, DOI 10.1016/S0035-9203(00)90083-X; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Sarkar Moumita, 2006, BMC Pregnancy Childbirth, V6, P18, DOI 10.1186/1471-2393-6-18; SCHULTZ LJ, 1994, AM J TROP MED HYG, V51, P515, DOI 10.4269/ajtmh.1994.51.515; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Shulman CE, 1999, ANN TROP MED PARASIT, V93, pS59, DOI 10.1080/00034989957745; Steketee RW, 1996, AM J TROP MED HYG, V55, P33, DOI 10.4269/ajtmh.1996.55.33; Ter Kuile FO, 2004, AM J TROP MED HYG, V71, P41, DOI 10.4269/ajtmh.2004.71.41; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P351, DOI 10.1111/j.1365-3156.2004.01196.x; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; WHO, 2005, SUSC PLASM FALC ANT; *WHO, 2006, WORLD MAL REP 2005; *WHO, 2004, STRAT FRAM MAL CONTR; *WHO, 1996, ASS THER EFF ANT DRU; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; Yeramian P, 2005, J INFECT DIS, V192, P319, DOI 10.1086/430928	49	56	57	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1166	10.1371/journal.pone.0001166	http://dx.doi.org/10.1371/journal.pone.0001166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000538	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459100008
J	Sale, A; Cenni, MC; Ciucci, F; Putignano, E; Chierzi, S; Maffei, L				Sale, Alessandro; Cenni, Maria Cristina; Ciucci, Francesca; Putignano, Elena; Chierzi, Sabrina; Maffei, Lamberto			Maternal Enrichment during Pregnancy Accelerates Retinal Development of the Fetus	PLOS ONE			English	Article								The influence of maternal environment on fetal development is largely unexplored, the available evidence concerns only the deleterious effects elicited by prenatal stress. Here we investigated the influence of prenatal enrichment on the early development of the visual system in the fetus. We studied the anatomical development of the rat retina, by analyzing the migration of neural progenitors and the process of retinal ganglion cell death, which exerts a key role in sculpturing the developing retinal system at perinatal ages. The number of apoptotic cells in the retinal ganglion cell layer was analyzed using two distinct methods: the presence of pyknotic nuclei stained for cresyl violet and the appearance of DNA fragmentation (Tunel method). We report that environmental enrichment of the mother during pregnancy affects the structural maturation of the retina, accelerating the migration of neural progenitors and the dynamics of natural cell death. These effects seem to be under the control of insulin-like growth factor-I: its levels, higher in enriched pregnant rats and in their milk, are increased also in their offspring, its neutralization abolishes the action of maternal enrichment on retinal development and chronic insulin-like growth factor-I injection to standard-reared females mimics the effects of enrichment in the fetuses. Thus, the development of the visual system is sensitive to environmental stimulation during prenatal life. These findings could have a bearing in orienting clinical research in the field of prenatal therapy.	[Sale, Alessandro; Ciucci, Francesca; Putignano, Elena; Chierzi, Sabrina; Maffei, Lamberto] Scuola Normale Super Pisa, Pisa, Italy; [Cenni, Maria Cristina; Maffei, Lamberto] CNR, Inst Neurosci, I-56100 Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Sale, A (corresponding author), Scuola Normale Super Pisa, Pisa, Italy.	sale@sns.it	Sale, Alessandro/K-7760-2016	Putignano, Elena/0000-0002-4313-408X; Sale, Alessandro/0000-0001-7608-4456	PRIN 04; FISR CNR/MIUR	PRIN 04; FISR CNR/MIUR(Ministry of Education, Universities and Research (MIUR))	This research was supported by PRIN 04, FISR CNR/MIUR.	BARLOW SM, 1978, TERATOLOGY, V18, P211, DOI 10.1002/tera.1420180206; Bartoletti A, 2004, NAT NEUROSCI, V7, P215, DOI 10.1038/nn1201; BENESOVA O, 1989, NEUROPHARMACOLOGY, V28, P89, DOI 10.1016/0028-3908(89)90073-7; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Carro E, 2000, J NEUROSCI, V20, P2926; Ciucci F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000475; Fowden AL, 2003, PLACENTA, V24, P803, DOI 10.1016/S0143-4004(03)00080-8; Frade JN, 1996, DEVELOPMENT, V122, P2497; Gramsbergen A, 1998, PEDIATR RES, V44, P105, DOI 10.1203/00006450-199807000-00017; HERNANDEZSANCHEZ C, 1995, P NATL ACAD SCI USA, V92, P9834, DOI 10.1073/pnas.92.21.9834; HORSBURGH GM, 1987, J COMP NEUROL, V263, P553, DOI 10.1002/cne.902630407; Imai Y, 1999, ENDOCRINOLOGY, V140, P4228, DOI 10.1210/en.140.9.4228; Javaid MK, 2004, J BONE MINER RES, V19, P56, DOI 10.1359/JBMR.0301211; Kofman O, 2002, NEUROSCI BIOBEHAV R, V26, P457, DOI 10.1016/S0149-7634(02)00015-5; Landi S, 2007, FASEB J, V21, P130, DOI 10.1096/fj.06-6083com; Lee EJ, 2003, EUR J NEUROSCI, V17, P1542, DOI 10.1046/j.1460-9568.2003.02583.x; LEE WH, 1992, J NEUROSCI, V12, P4737; Lordi B, 1997, PHYSIOL BEHAV, V62, P1087, DOI 10.1016/S0031-9384(97)00261-8; MILLER NM, 1981, J COMP NEUROL, V202, P493, DOI 10.1002/cne.902020404; Mulder EJH, 2002, EARLY HUM DEV, V70, P3, DOI 10.1016/S0378-3782(02)00075-0; OWENS JA, 1991, REPROD FERT DEVELOP, V3, P501, DOI 10.1071/RD9910501; PERRY VH, 1981, NEUROSCIENCE, V6, P931, DOI 10.1016/0306-4522(81)90174-3; PERRY VH, 1983, J COMP NEUROL, V219, P356, DOI 10.1002/cne.902190309; Poltyrev T, 1996, DEV PSYCHOBIOL, V29, P453, DOI 10.1002/(SICI)1098-2302(199607)29:5<453::AID-DEV4>3.0.CO;2-N; REESE BE, 1992, NEUROSCIENCE, V46, P419, DOI 10.1016/0306-4522(92)90062-7; RODRIGUES M, 1988, BRAIN RES, V443, P389, DOI 10.1016/0006-8993(88)91639-3; Sale A, 2004, NEUROPHARMACOLOGY, V47, P649, DOI 10.1016/j.neuropharm.2004.07.008; SCHNEIDER ML, 1992, DEV PSYCHOBIOL, V25, P529, DOI 10.1002/dev.420250706; Shigematsu Satoshi, 1999, Endocrine Journal, V46, pS59, DOI 10.1507/endocrj.46.Suppl_S59; SHIOTA K, 1989, BIOL NEONATE, V56, P6; Szuran TF, 2000, PHYSIOL BEHAV, V71, P353, DOI 10.1016/S0031-9384(00)00351-6; TORRESALEMAN I, 1994, J NEUROSCI RES, V39, P117, DOI 10.1002/jnr.490390202; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; WALDBILLIG RJ, 1988, EXP EYE RES, V47, P587, DOI 10.1016/0014-4835(88)90097-8; Weinstock M, 1997, NEUROSCI BIOBEHAV R, V21, P1, DOI 10.1016/S0149-7634(96)00014-0; WILLIAMS MA, 1990, EXP BRAIN RES, V82, P393	37	56	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1160	10.1371/journal.pone.0001160	http://dx.doi.org/10.1371/journal.pone.0001160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000533	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459100003
J	Khodosevich, K; Inta, D; Seeburg, PH; Monyer, H				Khodosevich, Konstantin; Inta, Dragos; Seeburg, Peter H.; Monyer, Hannah			Gene Expression Analysis of In Vivo Fluorescent Cells	PLOS ONE			English	Article								Background. The analysis of gene expression for tissue homogenates is of limited value because of the considerable cell heterogeneity in tissues. However, several methods are available to isolate a cell type of interest from a complex tissue, the most reliable one being Laser Microdissection (LMD). Cells may be distinguished by their morphology or by specific antigens, but the obligatory staining often results in RNA degradation. Alternatively, particular cell types can be detected in vivo by expression of fluorescent proteins from cell type-specific promoters. Methodology/Principal Findings. We developed a technique for fixing in vivo fluorescence in brain cells and isolating them by LMD followed by an optimized RNA isolation procedure. RNA isolated from these cells was of equal quality as from unfixed frozen tissue, with clear 28S and 18S rRNA bands of a mass ratio of similar to 2:1. We confirmed the specificity of the amplified RNA from the microdissected fluorescent cells as well as its usefulness and reproducibility for microarray hybridization and quantitative real-time PCR (qRT-PCR). Conclusions/Significance. Our technique guarantees the isolation of sufficient high quality RNA obtained from specific cell populations of the brain expressing soluble fluorescent marker, which is a critical prerequisite for subsequent gene expression studies by microarray analysis or qRT-PCR.	[Khodosevich, Konstantin; Inta, Dragos; Monyer, Hannah] Univ Heidelberg, Dept Clin Neurobiol, Interdisciplinary Ctr Neurosci, Heidelberg, Germany; [Seeburg, Peter H.] Max Planck Inst Med Res, Dept Mol Neurosci, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Max Planck Society	Monyer, H (corresponding author), Univ Heidelberg, Dept Clin Neurobiol, Interdisciplinary Ctr Neurosci, Heidelberg, Germany.	monyer@urz.uni-hd.de		Monyer, Hannah/0000-0002-9332-5749; Khodosevich, Konstantin/0000-0001-7232-5558	Schilling Foundation; SFB484; BMBF [01GS0117, 01GS0498]	Schilling Foundation; SFB484; BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported in part by the Schilling Foundation, the SFB484 and the BMBF grants 01GS0117 and 01GS0498.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Bhattacherjee V, 2004, GENESIS, V39, P58, DOI 10.1002/gene.20026; Cox ML, 2006, EXP MOL PATHOL, V80, P183, DOI 10.1016/j.yexmp.2005.10.002; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fink L, 2000, LAB INVEST, V80, P327, DOI 10.1038/labinvest.3780037; Fink Ludger, 2005, Methods Mol Biol, V293, P167; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gjerdrum LM, 2004, DIAGN MOL PATHOL, V13, P224, DOI 10.1097/01.pdm.0000134779.45353.d6; Goldsworthy SM, 1999, MOL CARCINOGEN, V25, P86, DOI 10.1002/(SICI)1098-2744(199906)25:2<86::AID-MC2>3.3.CO;2-W; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Herzenberg LA, 2002, CLIN CHEM, V48, P1819; Jackson V, 1999, METHODS, V17, P125, DOI 10.1006/meth.1998.0724; Jalabi W, 2003, J HISTOCHEM CYTOCHEM, V51, P913, DOI 10.1177/002215540305100706; Jin L, 1999, LAB INVEST, V79, P511; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kihara AH, 2005, J NEUROSCI METH, V148, P103, DOI 10.1016/j.jneumeth.2005.04.019; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luzzi Veronica I, 2005, Methods Mol Biol, V293, P187; Marks KM, 2006, NAT METHODS, V3, P591, DOI 10.1038/NMETH906; MASON CA, 1986, NEUROSCIENCE, V19, P1319, DOI 10.1016/0306-4522(86)90146-6; Morris R, 2004, J NEUROCHEM, V90, P1445, DOI 10.1111/j.1471-4159.2004.02612.x; Murakami H, 2000, KIDNEY INT, V58, P1346, DOI 10.1046/j.1523-1755.2000.00295.x; Murase S, 2002, HISTOCHEM J, V34, P85, DOI 10.1023/A:1021308328278; Okuducu AF, 2003, INT J MOL MED, V11, P449; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Qin Y, 2003, J NEUROSCI METH, V131, P205, DOI 10.1016/j.jneumeth.2003.08.010; Rossner MJ, 2006, J NEUROSCI, V26, P9956, DOI 10.1523/JNEUROSCI.0468-06.2006; Wang HY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-97; Yu TT, 2005, J COMP NEUROL, V483, P251, DOI 10.1002/cne.20429	32	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1151	10.1371/journal.pone.0001151	http://dx.doi.org/10.1371/journal.pone.0001151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987128	Green Submitted, gold, Green Published			2022-12-27	WOS:000207459000034
J	Gonzalez-Rey, E; Martinez-Romero, R; O'Valle, F; Aguilar-Quesada, R; Conde, C; Delgado, M; Oliver, FJ				Gonzalez-Rey, Elena; Martinez-Romero, Ruben; O'Valle, Francisco; Aguilar-Quesada, Rocio; Conde, Carmen; Delgado, Mario; Javier Oliver, F.			Therapeutic Effect of a Poly(ADP-Ribose) Polymerase-1 Inhibitor on Experimental Arthritis by Downregulating Inflammation and Th1 Response	PLOS ONE			English	Article								Poly(ADP-ribose) polymerase-1 (PARP-1) synthesizes and transfers ADP ribose polymers to target proteins, and regulates DNA repair and genomic integrity maintenance. PARP-1 also plays a crucial role in the progression of the inflammatory response, and its inhibition confers protection in several models of inflammatory disorders. Here, we investigate the impact of a selective PARP-1 inhibitor in experimental arthritis. PARP-1 inhibition with 5-aminoisoquinolinone (AIQ) significantly reduces incidence and severity of established collagen-induced arthritis, completely abrogating joint swelling and destruction of cartilage and bone. The therapeutic effect of AIQ is associated with a striking reduction of the two deleterious components of the disease, i.e. the Th1-driven autoimmune and inflammatory responses. AIQ downregulates the production of various inflammatory cytokines and chemokines, decreases the antigen-specific Th1-cell expansion, and induces the production of the antiinflammatory cytokine IL-10. Our results provide evidence of the contribution of PARP-1 to the progression of arthritis and identify this protein as a potential therapeutic target for the treatment of rheumatoid arthritis.	[Gonzalez-Rey, Elena; Martinez-Romero, Ruben; Aguilar-Quesada, Rocio; Delgado, Mario; Javier Oliver, F.] CSIC, Inst Parasitol & Biomed, Granada, Spain; [O'Valle, Francisco] Univ Granada, Dept Pathol, Sch Med, Granada, Spain; [Conde, Carmen] Hosp Clin Univ, Res Lab, Santiago De Compostela, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Granada; Complexo Hospitalario Universitario de Santiago de Compostela	Oliver, FJ (corresponding author), CSIC, Inst Parasitol & Biomed, Granada, Spain.	joliver@ipb.csic.es	OValle, Francisco/AAA-9151-2019; Oliver, Javier/S-1725-2018; Conde, Carmen/ABA-2396-2021; Delgado, Mario/P-1524-2016; GONZALEZ-REY, ELENA/L-3296-2014	Oliver, Javier/0000-0001-8468-1998; Delgado, Mario/0000-0003-1893-5982; GONZALEZ-REY, ELENA/0000-0003-3917-9020; Conde, Carmen/0000-0001-5717-5483; Aguilar-Quesada, Rocio/0000-0003-3125-6634	Junta de Andalucia [CTS870];  [SAF 2003-01217];  [RNIHG c03/02];  [PI050972];  [SAF2006-01089];  [FIS G03/152]	Junta de Andalucia(Junta de Andalucia); ; ; ; ; 	Funding: This work has been supported by grants CTS870 from Junta de Andalucia to MD, SAF 2003-01217, RNIHG c03/02, PI050972, SAF2006-01089 and FIS G03/152 to FJO.	Andreone TL, 2003, J IMMUNOL, V170, P2113, DOI 10.4049/jimmunol.170.4.2113; Anthony DD, 1999, CLIN EXP RHEUMATOL, V17, P240; Brand DD, 2003, SPRINGER SEMIN IMMUN, V25, P3, DOI 10.1007/s00281-003-0127-1; Chiarugi A, 2002, BRIT J PHARMACOL, V137, P761, DOI 10.1038/sj.bjp.0704934; Cuzzocrea S, 2002, BIOCHEM PHARMACOL, V63, P293, DOI 10.1016/S0006-2952(01)00864-4; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Delgado M, 2001, NAT MED, V7, P563, DOI 10.1038/87887; Di Paola R, 2004, EUR J PHARMACOL, V492, P203, DOI 10.1016/j.ejphar.2004.03.033; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Garcia-Vicuna R, 2004, ARTHRITIS RHEUM-US, V50, P3866, DOI 10.1002/art.20615; Goronzy JJ, 2005, CURR OPIN IMMUNOL, V17, P468, DOI 10.1016/j.coi.2005.07.020; Goronzy JJ, 2005, IMMUNOL REV, V204, P55, DOI 10.1111/j.0105-2896.2005.00245.x; Ha HC, 2004, P NATL ACAD SCI USA, V101, P5087, DOI 10.1073/pnas.0306895101; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hur JW, 2006, RHEUMATOLOGY, V45, P711, DOI 10.1093/rheumatology/kei262; KASAMA T, 1995, J CLIN INVEST, V95, P2868, DOI 10.1172/JCI117993; Koch AE, 2005, ARTHRITIS RHEUM, V52, P710, DOI 10.1002/art.20932; Mabley JG, 2001, INFLAMM RES, V50, P561, DOI 10.1007/PL00000234; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Pascual M, 2003, ARTHRITIS RHEUM, V48, P638, DOI 10.1002/art.10864; Scott DL, 2006, NEW ENGL J MED, V355, P704, DOI 10.1056/NEJMct055183; Scott GS, 2004, J PHARMACOL EXP THER, V310, P1053, DOI 10.1124/jpet.103.063214; SEKI N, 1988, J IMMUNOL, V140, P1477; Suarez-Pinzon WL, 2003, DIABETES, V52, P1683, DOI 10.2337/diabetes.52.7.1683; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Szabo C, 2006, NITRIC OXIDE-BIOL CH, V14, P169, DOI 10.1016/j.niox.2005.06.008; Tremoulet AH, 2006, EXPERT OPIN INV DRUG, V15, P1427, DOI 10.1517/13543784.15.11.1427; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Walmsley M, 1996, ARTHRITIS RHEUM-US, V39, P495, DOI 10.1002/art.1780390318	29	32	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1071	10.1371/journal.pone.0001071	http://dx.doi.org/10.1371/journal.pone.0001071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971849	gold, Green Published, Green Submitted			2022-12-27	WOS:000207458700002
J	Parker, JDK; Bradley, BA; Mooers, AO; Quarmby, LM				Parker, Jeremy D. K.; Bradley, Brian A.; Mooers, Arne O.; Quarmby, Lynne M.			Phylogenetic Analysis of the Neks Reveals Early Diversification of Ciliary-Cell Cycle Kinases	PLOS ONE			English	Article								Background. NIMA-related kinases (Neks) have been studied in diverse eukaryotes, including the fungus Aspergillus and the ciliate Tetrahymena. In the former, a single Nek plays an essential role in cell cycle regulation; in the latter, which has more than 30 Neks in its genome, multiple Neks regulate ciliary length. Mammalian genomes encode an intermediate number of Neks, several of which are reported to play roles in cell cycle regulation and/or localize to centrosomes. Previously, we reported that organisms with cilia typically have more Neks than organisms without cilia, but were unable to establish the evolutionary history of the gene family. Methodology/Principle Findings. We have performed a large-scale analysis of the Nek family using Bayesian techniques, including tests of alternate topologies. We find that the Nek family had already expanded in the last common ancestor of eukaryotes, a ciliated cell which likely expressed at least five Neks. We suggest that Neks played an important role in the common ancestor in regulating cilia, centrioles, and centrosomes with respect to mitotic entry, and that this role continues today in organisms with cilia. Organisms that lack cilia generally show a reduction in the number of Nek clades represented, sometimes associated with lineage specific expansion of a single clade, as has occurred in the plants. Conclusion/Significance. This is the first rigorous phylogenetic analysis of a kinase family across a broad array of phyla. Our findings provide a coherent framework for the study of Neks and their roles in coordinating cilia and cell cycle progression.	[Parker, Jeremy D. K.; Bradley, Brian A.; Quarmby, Lynne M.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Mooers, Arne O.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Quarmby, LM (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	quarmby@sfu.ca		Parker, Jeremy/0000-0001-8319-5891; Quarmby, Lynne/0000-0001-6661-680X	Natural Sciences and Engineering Research Council of Canada (NSERC); Michael Smith Foundation for Health Research	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to LMQ. BAB was supported by fellowships from NSERC and the Michael Smith Foundation for Health Research. Neither of these agencies had any role in any aspect of this study or the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Bingham J, 2000, BIOINFORMATICS, V16, P660, DOI 10.1093/bioinformatics/16.7.660; Bradley BA, 2005, J CELL SCI, V118, P3317, DOI 10.1242/jcs.02455; Bradley BA, 2004, J EUKARYOT MICROBIOL, V51, P66, DOI 10.1111/j.1550-7408.2004.tb00164.x; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Chepurnov VA, 2004, INT REV CYTOL, V237, P91; Cloutier M, 2005, FEBS LETT, V579, P4659, DOI 10.1016/j.febslet.2005.07.036; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Feige E, 2006, BBA-MOL CELL RES, V1763, P272, DOI 10.1016/j.bbamcr.2006.01.009; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Liu SM, 2002, DEVELOPMENT, V129, P5839, DOI 10.1242/dev.00173; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Mahjoub MR, 2005, J AM SOC NEPHROL, V16, P3485, DOI 10.1681/ASN.2005080824; Mahjoub MR, 2004, MOL BIOL CELL, V15, P5172, DOI 10.1091/mbc.E04-07-0571; Mahjoub MR, 2002, J CELL SCI, V115, P1759; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; Mayor T, 2002, J CELL SCI, V115, P3275; Miller SL, 2005, MOL ENDOCRINOL, V19, P939, DOI 10.1210/me.2004-0443; MILLER SL, 2007, ONCOGENE; Noguchi K, 2004, J BIOL CHEM, V279, P32716, DOI 10.1074/jbc.M404104200; Nohynkova E, 2006, EUKARYOT CELL, V5, P753, DOI 10.1128/EC.5.4.753-761.2006; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; OSMANI AH, 1991, CELL, V67, P283, DOI 10.1016/0092-8674(91)90180-7; OTTO EA, 2007, J AM SOC NE IN PRESS; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pazour GJ, 2004, J AM SOC NEPHROL, V15, P2528, DOI 10.1097/01.ASN.0000141055.57643.E0; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Quarmby LM, 2005, J CELL BIOL, V169, P707, DOI 10.1083/jcb.200503053; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Tan BCM, 2004, J BIOL CHEM, V279, P9321, DOI 10.1074/jbc.M311477200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TUCKER RW, 1979, CELL, V17, P527, DOI 10.1016/0092-8674(79)90261-7; Upadhya P, 2000, P NATL ACAD SCI USA, V97, P217, DOI 10.1073/pnas.97.1.217; Wloga D, 2006, MOL BIOL CELL, V17, P2799, DOI 10.1091/mbc.E05-05-0450; Yin MJ, 2003, J BIOL CHEM, V278, P52454, DOI 10.1074/jbc.M308080200; Yissachar N, 2006, FEBS LETT, V580, P6489, DOI 10.1016/j.febslet.2006.10.069; Zhang H, 1996, J MICROSC-OXFORD, V181, P186, DOI 10.1046/j.1365-2818.1996.110390.x	55	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1076	10.1371/journal.pone.0001076	http://dx.doi.org/10.1371/journal.pone.0001076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957258	Green Published, gold			2022-12-27	WOS:000207458500021
J	Goedhart, J; Vermeer, JEM; Adjobo-Hermans, MJW; van Weeren, L; Gadella, TWJ				Goedhart, Joachim; Vermeer, Joop E. M.; Adjobo-Hermans, Merel J. W.; van Weeren, Laura; Gadella, Theodorus W. J., Jr.			Sensitive Detection of p65 Homodimers Using Red-Shifted and Fluorescent Protein-Based FRET Couples	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; LIVING CELLS; MONOMERIC RED; RHODAMINE 6G; CYAN; DYNAMICS; CA2+; INDICATORS; MICROSCOPY; STANDARDS	Background. Fluorescence Resonance Energy Transfer (FRET) between the green fluorescent protein (GFP) variants CFP and YFP is widely used for the detection of protein-protein interactions. Nowadays, several monomeric red-shifted fluorescent proteins are available that potentially improve the efficiency of FRET. Methodology/Principal Findings. To allow side-by-side comparison of several fluorescent protein combinations for detection of FRET, yellow or orange fluorescent proteins were directly fused to red fluorescent proteins. FRET from yellow fluorescent proteins to red fluorescent proteins was detected by both FLIM and donor dequenching upon acceptor photobleaching, showing that mCherry and mStrawberry were more efficient acceptors than mRFP1. Circular permutated yellow fluorescent protein variants revealed that in the tandem constructs the orientation of the transition dipole moment influences the FRET efficiency. In addition, it was demonstrated that the orange fluorescent proteins mKO and mOrange are both suitable as donor for FRET studies. The most favorable orange-red FRET pair was mKO-mCherry, which was used to detect homodimerization of the NF-kappa B subunit p65 in single living cells, with a threefold higher lifetime contrast and a twofold higher FRET efficiency than for CFP-YFP. Conclusions/Significance. The observed high FRET efficiency of red-shifted couples is in accordance with increased Forster radii of up to 64 angstrom, being significantly higher than the Forster radius of the commonly used CFP-YFP pair. Thus, red-shifted FRET pairs are preferable for detecting protein-protein interactions by donor-based FRET methods in single living cells.	[Goedhart, Joachim; Vermeer, Joop E. M.; Adjobo-Hermans, Merel J. W.; van Weeren, Laura; Gadella, Theodorus W. J., Jr.] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Adv Microscopy, Sect Mol Cytol, Amsterdam, Netherlands	University of Amsterdam	Goedhart, J (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Adv Microscopy, Sect Mol Cytol, Amsterdam, Netherlands.	j.goedhart@science.uva.nl	Adjobo-Hermans, Merel/AAN-5989-2020; Adjobo-Hermans, M.J.W./L-4170-2015; Vermeer, Joop E.M./J-2232-2014	Adjobo-Hermans, Merel/0000-0002-5947-2876; Adjobo-Hermans, M.J.W./0000-0002-5947-2876; Vermeer, Joop E.M./0000-0001-8876-5873; Goedhart, Joachim/0000-0002-0630-3825; Gadella, Theodorus/0000-0002-7639-219X	EU [LSHG-CT-2003-503259]	EU(European Commission)	Funding: Part of this work is supported by the EU integrated project on "Molecular Imaging'' LSHG-CT-2003-503259. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjobo-Hermans MJW, 2006, J CELL SCI, V119, P5087, DOI 10.1242/jcs.03284; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; BASTIAENS PIH, 1992, BIOCHEMISTRY-US, V31, P7050, DOI 10.1021/bi00146a005; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; DOMINGO B, 2007, MICROSC RES TECH; Fischer M, 1996, CHEM PHYS LETT, V260, P115, DOI 10.1016/0009-2614(96)00838-X; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Galperin E, 2004, NAT METHODS, V1, P209, DOI 10.1038/NMETH720; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Harpur AG, 2001, NAT BIOTECHNOL, V19, P167, DOI 10.1038/84443; He LS, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni057; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Immink RGH, 2002, P NATL ACAD SCI USA, V99, P2416, DOI 10.1073/pnas.042677699; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Jares-Erijman EA, 2006, CURR OPIN CHEM BIOL, V10, P409, DOI 10.1016/j.cbpa.2006.08.021; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Magde D, 2002, PHOTOCHEM PHOTOBIOL, V75, P327, DOI 10.1562/0031-8655(2002)075<0327:FQYATR>2.0.CO;2; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Ohashi T, 2007, PROTEIN SCI, V16, P1429, DOI 10.1110/ps.072845607; Peyker A, 2005, CHEMBIOCHEM, V6, P78, DOI 10.1002/cbic.200400280; Pfeifer D, 2006, J FLUORESC, V16, P581, DOI 10.1007/s10895-006-0086-8; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Schultz C, 2005, CHEMBIOCHEM, V6, P1323, DOI 10.1002/cbic.200500012; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shimozono S, 2006, BIOCHEMISTRY-US, V45, P6267, DOI 10.1021/bi060093i; Sinnecker D, 2005, BIOCHEMISTRY-US, V44, P7085, DOI 10.1021/bi047881x; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; van Munster EB, 2005, ADV BIOCHEM ENG BIOT, V95, P143; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; Van Munster EB, 2004, J MICROSC-OXFORD, V213, P29, DOI 10.1111/j.1365-2818.2004.01249.x; van Munster EB, 2004, CYTOM PART A, V58A, P185, DOI 10.1002/cyto.a.20013; Vermeer JEM, 2004, J MICROSC-OXFORD, V214, P190, DOI 10.1111/j.0022-2720.2004.01318.x; Wu XL, 2006, CYTOM PART A, V69A, P477, DOI 10.1002/cyto.a.20300; Yasuda R, 2006, CURR OPIN NEUROBIOL, V16, P551, DOI 10.1016/j.conb.2006.08.012; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	50	69	71	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1011	10.1371/journal.pone.0001011	http://dx.doi.org/10.1371/journal.pone.0001011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925859	Green Published, gold, Green Submitted			2022-12-27	WOS:000207456000010
J	Laurance, WF; Nascimento, HEM; Laurance, SG; Andrade, A; Ewers, RM; Harms, KE; Luizao, RCC; Ribeiro, JE				Laurance, William F.; Nascimento, Henrique E. M.; Laurance, Susan G.; Andrade, Ana; Ewers, Robert M.; Harms, Kyle E.; Luizao, Regina C. C.; Ribeiro, Jose E.			Habitat Fragmentation, Variable Edge Effects, and the Landscape-Divergence Hypothesis	PLOS ONE			English	Article							RAIN-FOREST FRAGMENTATION; POSITIVE FEEDBACKS; SPECIES RESPONSES; TREE MORTALITY; VEGETATION; MATRIX; ENVIRONMENT; MICROCLIMATE; COMMUNITIES; RECRUITMENT	Edge effects are major drivers of change in many fragmented landscapes, but are often highly variable in space and time. Here we assess variability in edge effects altering Amazon forest dynamics, plant community composition, invading species, and carbon storage, in the world's largest and longest-running experimental study of habitat fragmentation. Despite detailed knowledge of local landscape conditions, spatial variability in edge effects was only partially foreseeable: relatively predictable effects were caused by the differing proximity of plots to forest edge and varying matrix vegetation, but windstorms generated much random variability. Temporal variability in edge phenomena was also only partially predictable: forest dynamics varied somewhat with fragment age, but also fluctuated markedly over time, evidently because of sporadic droughts and windstorms. Given the acute sensitivity of habitat fragments to local landscape and weather dynamics, we predict that fragments within the same landscape will tend to converge in species composition, whereas those in different landscapes will diverge in composition. This 'landscape-divergence hypothesis', if generally valid, will have key implications for biodiversity-conservation strategies and for understanding the dynamics of fragmented ecosystems.	[Laurance, William F.; Laurance, Susan G.] Smithsonian Trop Res Inst, Balboa, Panama; [Nascimento, Henrique E. M.; Andrade, Ana; Luizao, Regina C. C.] Smithsonian Trop Res Inst, Natl Inst Amazonian Res INPA, Biol Dynam Forest Fragments Project, Manaus, Amazonas, Brazil; [Ewers, Robert M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Harms, Kyle E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Ribeiro, Jose E.] Natl Inst Amazonian Res INPA, Dept Bot, Manaus, Amazonas, Brazil	Smithsonian Institution; Smithsonian Tropical Research Institute; Institute Nacional de Pesquisas da Amazonia; Smithsonian Institution; Smithsonian Tropical Research Institute; Zoological Society of London; Louisiana State University System; Louisiana State University; Institute Nacional de Pesquisas da Amazonia	Laurance, WF (corresponding author), Smithsonian Trop Res Inst, Balboa, Panama.	laurancew@si.edu	Nascimento, Henrique E/F-8612-2012; Laurance, Susan/G-6021-2011; Ribeiro, Jose Eduardo L. S./A-8574-2013; Laurance, William F/B-2709-2012	Laurance, Susan/0000-0002-2831-2933; Ribeiro, Jose Eduardo L. S./0000-0002-2389-5631; Laurance, William F/0000-0003-4430-9408	U. S. National Science Foundation; NASA-LBA Program; A. W. Mellon Foundation; Conservation, Food and Health Foundation; World Wildlife Fund-U.S.; MacArthur Foundation; National Institute for Amazonian Research; Smithsonian Institution	U. S. National Science Foundation(National Science Foundation (NSF)); NASA-LBA Program(National Aeronautics & Space Administration (NASA)); A. W. Mellon Foundation; Conservation, Food and Health Foundation; World Wildlife Fund-U.S.; MacArthur Foundation; National Institute for Amazonian Research; Smithsonian Institution(Smithsonian Institution)	Funding: Support was provided by the U. S. National Science Foundation, NASA-LBA Program, A. W. Mellon Foundation, Conservation, Food and Health Foundation, World Wildlife Fund-U.S., MacArthur Foundation, National Institute for Amazonian Research, and Smithsonian Institution.	ASIER GP, 2005, SCIENCE, V310, P480; Benedick S, 2006, J APPL ECOL, V43, P967, DOI 10.1111/j.1365-2664.2006.01209.x; Benitez-Malvido J, 1998, CONSERV BIOL, V12, P380, DOI 10.1046/j.1523-1739.1998.96295.x; Bierregaard Richard O. Jr., 1997, P138; BOOSE ER, 1994, ECOL MONOGR, V64, P369, DOI 10.2307/2937142; BROADBENT EN, CONSERV BIO IN PRESS; Bruna EM, 1999, NATURE, V402, P139, DOI 10.1038/45963; Cadenasso ML, 2003, BIOSCIENCE, V53, P750, DOI 10.1641/0006-3568(2003)053[0750:AFFATO]2.0.CO;2; CHEN JQ, 1992, ECOL APPL, V2, P387, DOI 10.2307/1941873; CHEN JQ, 1995, ECOL APPL, V5, P74, DOI 10.2307/1942053; Cochrane MA, 2002, J TROP ECOL, V18, P311, DOI 10.1017/S0266467402002237; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Cronin JT, 2003, ECOLOGY, V84, P1506, DOI 10.1890/0012-9658(2003)084[1506:MHAHII]2.0.CO;2; D'Angelo SA, 2004, J TROP ECOL, V20, P243, DOI 10.1017/S0266467403001032; Didham Raphael K., 1997, P55; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; Didham RK, 1999, BIOTROPICA, V31, P17, DOI 10.1111/j.1744-7429.1999.tb00113.x; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Ewers RM, 2007, ECOLOGY, V88, P96, DOI 10.1890/0012-9658(2007)88[96:SIBEAA]2.0.CO;2; Fearnside PM, 2001, ENVIRON CONSERV, V28, P23, DOI 10.1017/S0376892901000030; Ferreira LV, 1997, CONSERV BIOL, V11, P797, DOI 10.1046/j.1523-1739.1997.96167.x; Foster MS, 1998, BIOTROPICA, V30, P470, DOI 10.1111/j.1744-7429.1998.tb00081.x; Gascon C, 2000, SCIENCE, V288, P1356, DOI 10.1126/science.288.5470.1356; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; GATES JE, 1978, ECOLOGY, V59, P871, DOI 10.2307/1938540; Gilbert B, 2006, AM NAT, V168, P304, DOI 10.1086/506969; Grau HR, 2004, BIOTROPICA, V36, P52, DOI 10.1111/j.1744-7429.2004.tb00295.x; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; JANZEN DH, 1983, OIKOS, V41, P402, DOI 10.2307/3544100; KAPOS V, 1993, J ECOL, V81, P425, DOI 10.2307/2261521; KAPOS V, 1989, J TROP ECOL, V5, P173, DOI 10.1017/S0266467400003448; Kapos Valerie, 1997, P33; Kupfer JA, 2006, GLOBAL ECOL BIOGEOGR, V15, P8, DOI 10.1111/j.1466-822x.2006.00204.x; Laurance W. F., 1997, P71; Laurance W.F., 1997, TROPICAL FOREST REMN, P616; LAURANCE WF, 1991, BIOL CONSERV, V57, P205, DOI 10.1016/0006-3207(91)90139-Z; Laurance WF, 2001, ECOLOGY, V82, P105, DOI 10.1890/0012-9658(2001)082[0105:RFFATS]2.0.CO;2; Laurance WF, 1998, ECOLOGY, V79, P2032, DOI 10.1890/0012-9658(1998)079[2032:RFFATD]2.0.CO;2; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Laurance WF, 2004, SCIENCE, V304, P1109, DOI 10.1126/science.304.5674.1109b; Laurance WF, 1998, CONSERV BIOL, V12, P460, DOI 10.1046/j.1523-1739.1998.97175.x; Laurance WF, 1998, FOREST ECOL MANAG, V110, P173, DOI 10.1016/S0378-1127(98)00291-6; Laurance WF, 2002, J VEG SCI, V13, P595, DOI 10.1111/j.1654-1103.2002.tb02086.x; Laurance WF, 2001, CONSERV BIOL, V15, P1488, DOI 10.1046/j.1523-1739.2001.01088.x; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2004, PHILOS T R SOC B, V359, P345, DOI 10.1098/rstb.2003.1430; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Laurance WF, 2001, J TROP ECOL, V17, P771, DOI 10.1017/S0266467401001596; Laurance WF, 2001, CONSERV BIOL, V15, P1529, DOI 10.1046/j.1523-1739.2001.01093.x; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; LAURANCE WF, 2006, EMERGING THREATS TRO, P534; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; Lovejoy T.E., 1986, P257; MALCOLM JR, 1994, ECOLOGY, V75, P2438, DOI 10.2307/1940897; MATLACK GR, 1993, BIOL CONSERV, V66, P185, DOI 10.1016/0006-3207(93)90004-K; Mesquita RCG, 2001, J ECOL, V89, P528, DOI 10.1046/j.1365-2745.2001.00583.x; Mesquita RCG, 1999, BIOL CONSERV, V91, P129, DOI 10.1016/S0006-3207(99)00086-5; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Nascimento HEM, 2004, ECOL APPL, V14, pS127; Nascimento HEM, 2006, CONSERV BIOL, V20, P853, DOI 10.1111/j.1523-1739.2006.00344.x; NELSON BW, 1994, ECOLOGY, V75, P853, DOI 10.2307/1941742; PATTERSON B D, 1987, Conservation Biology, V1, P323, DOI 10.1111/j.1523-1739.1987.tb00052.x; Pohlman CL, 2007, BIOTROPICA, V39, P62, DOI 10.1111/j.1744-7429.2006.00238.x; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Savill P. S., 1983, Forestry Abstracts Review Article, V44, P473; Sizer N, 1999, BIOL CONSERV, V91, P135, DOI 10.1016/S0006-3207(99)00076-2; SOMERVILLE A, 1980, NEW ZEAL J FOR SCI, V10, P476; Suarez AV, 1998, ECOLOGY, V79, P2041, DOI 10.1890/0012-9658(1998)079[2041:EOFAIO]2.0.CO;2; Turton Stephen M., 1997, P45; Vasconcelos HL, 2005, OECOLOGIA, V144, P456, DOI 10.1007/s00442-005-0117-1; Vasconcelos HL, 2004, ECOL APPL, V14, P884, DOI 10.1890/03-5093; Wright DH, 1998, OECOLOGIA, V113, P1, DOI 10.1007/s004420050348; YOUNG A, 1994, BIOL CONSERV, V67, P63, DOI 10.1016/0006-3207(94)90010-8	76	271	280	2	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1017	10.1371/journal.pone.0001017	http://dx.doi.org/10.1371/journal.pone.0001017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925865	Green Submitted, gold, Green Published			2022-12-27	WOS:000207456000016
J	Audhya, A; McLeod, IX; Yates, JR; Oegema, K				Audhya, Anjon; McLeod, Ian X.; Yates, John R., III; Oegema, Karen			MVB-12, a Fourth Subunit of Metazoan ESCRT-I, Functions in Receptor Downregulation	PLOS ONE			English	Article								After ligand binding and endocytosis, cell surface receptors can continue to signal from endosomal compartments until sequestered from the cytoplasm. An important mechanism for receptor downregulation in vivo is via the inward budding of receptors into intralumenal vesicles to form specialized endosomes called multivesicular bodies (MVBs) that subsequently fuse with lysosomes, degrading their cargo. This process requires four heterooligomeric protein complexes collectively termed the ESCRT machinery. In yeast, ESCRT-I is a heterotetrameric complex comprised of three conserved subunits and a fourth subunit for which identifiable metazoan homologs were lacking. Using C. elegans, we identify MVB-12, a fourth metazoan ESCRT-I subunit. Depletion of MVB-12 slows the kinetics of receptor downregulation in vivo, but to a lesser extent than inhibition of other ESCRT-I subunits. Consistent with these findings, targeting of MVB-12 to membranes requires the other ESCRT-I subunits, but MVB-12 is not required to target the remaining ESCRT-I components. Both endogenous and recombinant ESCRT-I are stable complexes with a 1:1:1:1 subunit stoichiometry. MVB-12 has two human homologs that co-localize and co-immunoprecipitate with the ESCRT-I component TSG101. Thus, MVB-12 is a conserved core component of metazoan ESCRT-I that regulates its activity during MVB biogenesis.	[Audhya, Anjon; Oegema, Karen] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [McLeod, Ian X.; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Scripps Research Institute	Audhya, A (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	aaudhya@ucsd.edu; koegema@ucsd.edu			NIH [RR11823]; Ludwig Institute for Cancer Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	AA is a Fellow of the Helen Hay Whitney Foundation; JY receives support from grant NIH RR11823 that funds the YRC; KO is a Pew Scholar in the Biomedical Sciences and receives salary and additional support from the Ludwig Institute for Cancer Research.	Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Audhya A, 2007, J CELL BIOL, V178, P43, DOI 10.1083/jcb.200701139; Bache KG, 2004, MOL BIOL CELL, V15, P4337, DOI 10.1091/mbc.E04-03-0250; Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chu T, 2006, J CELL BIOL, V175, P815, DOI 10.1083/jcb.200608053; Curtiss M, 2007, MOL BIOL CELL, V18, P636, DOI 10.1091/mbc.E06-07-0588; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Eastman SW, 2005, J BIOL CHEM, V280, P628, DOI 10.1074/jbc.M410384200; Gonzalez-Gaitan Marcos, 2003, Cell, V115, P513, DOI 10.1016/S0092-8674(03)00932-2; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; GREENSTEIN D, 2005, C ELEGANS; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kadandale P, 2005, CURR BIOL, V15, P2222, DOI 10.1016/j.cub.2005.10.043; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Konishi H, 2006, J BIOL CHEM, V281, P28919, DOI 10.1074/jbc.M605693200; Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Oestreich AJ, 2007, MOL BIOL CELL, V18, P646, DOI 10.1091/mbc.E06-07-0601; Porter AC, 1998, ONCOGENE, V17, P1343, DOI 10.1038/sj.onc.1202171; Praitis V, 2001, GENETICS, V157, P1217; Sato K, 2006, MOL BIOL CELL, V17, P3085, DOI 10.1091/mbc.E06-03-0211; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Vivekanand P, 2006, ANNU REV GENET, V40, P139, DOI 10.1146/annurev.genet.40.110405.090555; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Zhong Q, 1997, CANCER RES, V57, P4225	37	39	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e956	10.1371/journal.pone.0000956	http://dx.doi.org/10.1371/journal.pone.0000956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895996	gold, Green Submitted, Green Published			2022-12-27	WOS:000207455800034
J	Kitajima, S; Kudo, Y; Ogawa, I; Tatsuka, M; Kawai, H; Pagano, M; Takata, T				Kitajima, Shojiro; Kudo, Yasusei; Ogawa, Ikuko; Tatsuka, Masaaki; Kawai, Hidehiko; Pagano, Michele; Takata, Takashi			Constitutive Phosphorylation of Aurora-A on Ser51 Induces Its Stabilization and Consequent Overexpression in Cancer	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; CENTROSOME AMPLIFICATION; DESTRUCTION BOX; PROTEIN-KINASE; CELL-CYCLE; DEGRADATION; IDENTIFICATION; RECOGNITION; TRANSFORMATION; PROTEOLYSIS	Background. The serine/threonine kinase Aurora-A (Aur-A) is a proto-oncoprotein overexpressed in a wide range of human cancers. Overexpression of Aur-A is thought to be caused by gene amplification or mRNA overexpression. However, recent evidence revealed that the discrepancies between amplification of Aur-A and overexpression rates of Aur-A mRNA were observed in breast cancer, gastric cancer, hepatocellular carcinoma, and ovarian cancer. We found that aggressive head and neck cancers exhibited overexpression and stabilization of Aur-A protein without gene amplification or mRNA overexpression. Here we tested the hypothesis that aberration of the protein destruction system induces accumulation and consequently overexpression of Aur-A in cancer. Principal Findings. Aur-A protein was ubiquitinylated by APC(Cdh1) and consequently degraded when cells exited mitosis, and phosphorylation of Aur-A on Ser51 was observed during mitosis. Phosphorylation of Aur-A on Ser51 inhibited its APC(Cdh1)-mediated ubiquitylation and consequent degradation. Interestingly, constitutive phosphorylation on Ser51 was observed in head and neck cancer cells with protein overexpression and stabilization. Indeed, phosphorylation on Ser51 was observed in head and neck cancer tissues with Aur-A protein overexpression. Moreover, an Aur-A Ser51 phospho-mimetic mutant displayed stabilization of protein during cell cycle progression and enhanced ability to cell transformation. Conclusions/Significance. Broadly, this study identifies a new mode of Aur-A overexpression in cancer through phosphorylation-dependent inhibition of its proteolysis in addition to gene amplification and mRNA overexpression. We suggest that the inhibition of Aur-A phosphorylation can represent a novel way to decrease Aur-A levels in cancer therapy.	[Kitajima, Shojiro; Kudo, Yasusei; Takata, Takashi] Hiroshima Univ, Grad Sch Biomed Sci, Div Frontier Med Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan; [Ogawa, Ikuko] Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima, Japan; [Tatsuka, Masaaki; Kawai, Hidehiko] Hiroshima Univ, Dept Regulatory Radiobiol, Res Inst Radiat Biol & Med, Hiroshima, Japan; [Pagano, Michele] NYU, Sch Med, Dept Pathol, Inst Canc, New York, NY USA	Hiroshima University; Hiroshima University; Hiroshima University; New York University	Kudo, Y (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Div Frontier Med Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan.	ykudo@hiroshima-u.ac.jp; ttakata@hiroshima-u.ac.jp		Kawai, Hidehiko/0000-0003-2213-7166; Kitajima, Shojiro/0000-0002-4000-0473; pagano, michele/0000-0003-3210-2442; Kudo, Yasusei/0000-0002-0392-7720	Ministry of Education, Science and Culture of Japan; Uehara memorial foundation; National Institutes of Health [R37-CA76584, R01-GM57587, R21-CA125173]; NATIONAL CANCER INSTITUTE [R21CA125173, R37CA076584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara memorial foundation(Uehara Memorial Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported by grants-in-aid from the Ministry of Education, Science and Culture of Japan (YK and TT); grants from Uehara memorial foundation (YK) and grants from the National Institutes of Health (R37-CA76584, R01-GM57587 and R21-CA125173) (MP).	Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Arlot-Bonnemains Y, 2001, FEBS LETT, V508, P149, DOI 10.1016/S0014-5793(01)03048-4; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carrano AC, 2001, J CELL BIOL, V153, P1381, DOI 10.1083/jcb.153.7.1381; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Castro A, 2002, EMBO REP, V3, P457, DOI 10.1093/embo-reports/kvf095; Castro A, 2002, EMBO REP, V3, P1209, DOI 10.1093/embo-reports/kvf241; Crane R, 2004, J CELL SCI, V117, P5975, DOI 10.1242/jcs.01418; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Fukuda T, 2005, MOL CELL BIOL, V25, P5270, DOI 10.1128/MCB.25.12.5270-5281.2005; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Goepfert TM, 2000, CURR TOP DEV BIOL, V49, P331; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Honda K, 2000, ONCOGENE, V19, P2812, DOI 10.1038/sj.onc.1203609; Horn V, 2007, MOL BIOL CELL, V18, P1233, DOI 10.1091/mbc.E06-12-1152; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Jeng YM, 2004, CLIN CANCER RES, V10, P2065, DOI 10.1158/1078-0432.CCR-1057-03; Kitajima S, 2004, AM J PATHOL, V165, P2147, DOI 10.1016/S0002-9440(10)63264-6; Li DH, 2003, CLIN CANCER RES, V9, P991; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Miyoshi Y, 2001, INT J CANCER, V92, P370, DOI 10.1002/ijc.1200; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Ota T, 2002, CANCER RES, V62, P5168; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Reiter R, 2006, CLIN CANCER RES, V12, P5136, DOI 10.1158/1078-0432.CCR-05-1650; Rojanala S, 2004, MOL CANCER THER, V3, P451; Sakakura C, 2001, BRIT J CANCER, V84, P824, DOI 10.1054/bjoc.2000.1684; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Taguchi S, 2002, FEBS LETT, V519, P59, DOI 10.1016/S0014-5793(02)02711-4; Takahashi T, 2000, JPN J CANCER RES, V91, P1007, DOI 10.1111/j.1349-7006.2000.tb00878.x; Tanaka T, 1999, CANCER RES, V59, P2041; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Tatsuka M, 2005, ONCOGENE, V24, P1122, DOI 10.1038/sj.onc.1208293; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Watanabe T, 2002, JPN J CANCER RES, V93, P1114, DOI 10.1111/j.1349-7006.2002.tb01213.x; YAGI T, 1989, MOL CARCINOGEN, V1, P222, DOI 10.1002/mc.2940010404; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Zhang DW, 2004, ONCOGENE, V23, P8720, DOI 10.1038/sj.onc.1208153; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	49	42	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e944	10.1371/journal.pone.0000944	http://dx.doi.org/10.1371/journal.pone.0000944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895985	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455800023
J	Bourvis, N; Boelle, PY; Cesbron, JY; Valleron, AJ				Bourvis, Nadege; Boelle, Pierre-Yves; Cesbron, Jean-Yves; Valleron, Alain-Jacques			Risk Assessment of Transmission of Sporadic Creutzfeldt-Jakob Disease in Endodontic Practice in Absence of Adequate Prion Inactivation	PLOS ONE			English	Article								Background. Experimental results evidenced the infectious potential of the dental pulp of animals infected with transmissible spongiform encephalopathies (TSE). This route of iatrogenic transmission of sporadic Creutzfeldt- Jakob disease (sCJD) may exist in humans via reused endodontic instruments if inadequate prion decontamination procedures are used. Methodology/Principal Findings. To assess this risk, 10 critical parameters in the transmission process were identified, starting with contamination of an endodontic file during treatment of an infectious sCJD patient and ending with possible infection of a subsequent susceptible patient. It was assumed that a dose-risk response existed, with no-risk below threshold values. Plausible ranges of those parameters were obtained through literature search and expert opinions, and a sensitivity analysis was conducted. Without effective prion-deactivation procedures, the risk of being infected during endodontic treatment ranged between 3.4 and 13 per million procedures. The probability that more than one case was infected secondary to endodontic treatment of an infected sCJD patient ranged from 47% to 77% depending on the assumed quantity of infective material necessary for disease transmission. If current official recommendations on endodontic instrument decontamination were strictly followed, the risk of secondary infection would become quasi-null. Conclusion. The risk of sCJD transmission through endodontic procedure compares with other health care risks of current concern such as death after liver biopsy or during general anaesthesia. These results show that single instrument use or adequate prion-decontamination procedures like those recently implemented in dental practice must be rigorously enforced.	[Bourvis, Nadege; Boelle, Pierre-Yves; Valleron, Alain-Jacques] Univ Paris 06, Unite Rech Epidemiol Syst Informat Modelisat, UMR S 707, Paris, France; [Bourvis, Nadege; Boelle, Pierre-Yves; Valleron, Alain-Jacques] INSERM, U707, Paris, France; [Boelle, Pierre-Yves; Valleron, Alain-Jacques] Hop St Antoine, AP HP, Unite Sante Publ, F-75571 Paris, France; [Cesbron, Jean-Yves] Univ Grenoble 1, UMR 5163, Lab Adaptat & Pathogenie Microorgansimes, Grenoble, France; [Cesbron, Jean-Yves] CNRS, UMR 5163, Grenoble, France; [Cesbron, Jean-Yves] Ctr Hosp Univ Grenoble, Immunol Lab, Grenoble, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Valleron, AJ (corresponding author), Univ Paris 06, Unite Rech Epidemiol Syst Informat Modelisat, UMR S 707, Paris, France.	alain-jacques.valleron@upmc.fr		Boelle, Pierre-Yves/0000-0002-5367-8232	EU	EU(European Commission)	Funding: EU contract INFTRANS	*ASS MAL SAL DEP D, 2003, FREQ ACT BUCC DENT S; Bagg J, 2001, BRIT DENT J, V191, P87, DOI 10.1038/sj.bdj.4801104a; Barash PG, 2006, CLIN ANESTHESIA; BERNOULLI C, 1977, LANCET, V1, P478; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Blanquet-Grossard F, 2000, J DENT RES, V79, P700, DOI 10.1177/00220345000790020101; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; *CCLIN SUD OUEST, 2004, AUT PRAT PREV RISQ I; *CJD INC PAN, 2005, MAN POSS EXP CJD MED; Collins S, 1999, LANCET, V353, P693, DOI 10.1016/S0140-6736(98)08138-0; CREUTZFELDT HG, 1920, NEUROL PSYCHIAT, V57, P1; CUNNIGHAM F, 2005, WILLIAMS OBSTET; d'Aignaux JH, 1999, NEUROLOGY, V53, P1197, DOI 10.1212/WNL.53.6.1197; *DEP HLTH, 2007, PREC ADV GIV DENT RE; *DEP HLTH EC RES D, 2003, RISK ASS VCJD DENT; *DEP HLTH EC RES D, 2001, RISK ASS TRANSM VCJD; *EUR ALL COUNTR CO, 2007, EUROCJD REP; Fichet G, 2004, LANCET, V364, P521, DOI 10.1016/S0140-6736(04)16810-4; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Gurevich I, 1996, J HOSP INFECT, V32, P295, DOI 10.1016/S0195-6701(96)90040-7; Herzog C, 2005, J VIROL, V79, P14339, DOI 10.1128/JVI.79.22.14339-14345.2005; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Ingle J.I., 2002, ENDODONTICS; Ingrosso L, 1999, J GEN VIROL, V80, P3043, DOI 10.1099/0022-1317-80-11-3043; Lewis V, 2002, LANCET NEUROL, V1, P470, DOI 10.1016/S1474-4422(02)00233-8; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641; SANCHEZJUAN P, 2004, BR J OPHTHALMOL, V88, P446; *SEAC, 2007, 97 M SPONG ENC ADV C; Smith A, 2005, J HOSP INFECT, V61, P237, DOI 10.1016/j.jhin.2005.01.021; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Thackray AM, 2002, J VIROL, V76, P2510, DOI 10.1128/JVI.76.5.2510-2517.2002; Ward HJT, 2002, NEUROLOGY, V59, P543, DOI 10.1212/WNL.59.4.543; WILL RG, 1996, LANCET, V347, P925; Yan ZX, 2004, INFECT CONT HOSP EP, V25, P280, DOI 10.1086/502392; Zanusso G, 2003, NEW ENGL J MED, V348, P711, DOI 10.1056/NEJMoa022043; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	38	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1330	10.1371/journal.pone.0001330	http://dx.doi.org/10.1371/journal.pone.0001330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159228	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459700002
J	Ma, X; Liu, YH; Gowen, BB; Graviss, EA; Clark, AG; Musser, JM				Ma, Xin; Liu, Yuhua; Gowen, Brian B.; Graviss, Edward A.; Clark, Andrew G.; Musser, James M.			Full-Exon Resequencing Reveals Toll-Like Receptor Variants Contribute to Human Susceptibility to Tuberculosis Disease	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; PATHOGEN RECOGNITION; CELLULAR ACTIVATION; IMMUNE-SYSTEM; CUTTING EDGE; POLYMORPHISM; GENE; PROTEIN; INFECTIONS; MUTATIONS	Tuberculosis (TB) is the leading cause of death worldwide due to an infectious agent. Data have accumulated over decades suggesting that variability in human susceptibility to TB disease has a genetic component. Toll-like receptors (TLRs) play a critical role in initiating the innate immune response to many pathogens in mouse models, but little is known about their role in human infections. Human TLRs have been reported to recognize mycobacterial antigens and initiate an immune response. We tested the hypothesis that amino acid-altering polymorphisms in five TLRs were associated with susceptibility to TB disease using a population-based case-control study with 1,312 adult TB patients and controls. Full-coding region sequencing of the five TLR genes in all 1,312 subjects yielded a data set in excess of 16 Mb. Rare nonsynonymous polymorphisms in TLR6-TLR1-TLR10 were significantly overrepresented among African-American TB cases compared with ethnically-matched control subjects. Common nonsynonymous polymorphisms in TLR6-TLR1-TLR10 also were significantly associated with TB disease in certain ethnic groups. Among African Americans, homozygotes for the common-variant haplotype TLR1-248S, TLR1-6021, and TLR6-249S had a significantly increased TB disease risk. A transmission/disequilibrium test on an independent sample found that the TLR1-248S variant was preferentially transmitted to diseased children, thereby confirming disease association. These results are consistent with recent reports implicating TLR1 variants, including TLR1-602, in significantly altered innate immune responses. Also consistent with disease association, rare TLR6 variants were defective in their ability to mediate NF-kappa B signal transduction in transfected human cells. Taken together, the data suggest that variant TLRs contribute to human susceptibility to TB disease. Extensive full-exon resequencing was critical for revealing new information about the role of TLRs in human-pathogen interactions and the genetic basis of innate immune function.	[Liu, Yuhua; Gowen, Brian B.; Musser, James M.] NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Ma, Xin; Graviss, Edward A.] Baylor Coll Med, Dept Pathol, Ctr Human Bacterial Pathogenesis, Houston, TX 77030 USA; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; [Musser, James M.] Methodist Hosp, Res Inst, Ctr Human Mol & Translat Infect Dis Res, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Baylor College of Medicine; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Musser, JM (corresponding author), NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	jmmusser@tmhs.org		Clark, Andrew/0000-0001-7159-8511	The Division of Intramural Research; National Institute of Allergy and Infectious Diseases; National Institute of Health	The Division of Intramural Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institute of Health	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Akahoshi M, 2003, HUM GENET, V112, P237, DOI 10.1007/s00439-002-0873-5; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Barreiro LB, 2006, PLOS MED, V3, P230, DOI 10.1371/journal.pmed.0030020; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Ben-Ali M, 2004, CLIN DIAGN LAB IMMUN, V11, P625, DOI 10.1128/CDLI.11.3.625-626.2004; Branger J, 2004, INT IMMUNOL, V16, P509, DOI 10.1093/intimm/dxh052; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chang JS, 2006, J IMMUNOL, V176, P3010, DOI 10.4049/jimmunol.176.5.3010; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Fieschi C, 2003, J EXP MED, V197, P527, DOI 10.1084/jem.20021769; Filliol I, 2002, EMERG INFECT DIS, V8, P1347, DOI 10.3201/eid0811.020125; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Heyworth PG, 2001, BLOOD CELL MOL DIS, V27, P16, DOI 10.1006/bcmd.2000.0347; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; KALLMANN F. J., 1943, American Review of Tuberculosis and Pulmonary Diseases, V47, P549; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kramnik I, 2002, CURR OPIN MICROBIOL, V5, P111, DOI 10.1016/S1369-5274(02)00295-3; Lichtenauer-Kaligis EGR, 2003, EUR J IMMUNOL, V33, P59, DOI 10.1002/immu.200390008; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Ma X, 2003, J INFECT DIS, V188, P349, DOI 10.1086/376559; Ma X, 2002, INT J TUBERC LUNG D, V6, P818; Malik S, 2005, P NATL ACAD SCI USA, V102, P12183, DOI 10.1073/pnas.0503368102; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Means TK, 1999, J IMMUNOL, V163, P3920; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Musser JM, 2000, GENETICS, V155, P7; Newport MJ, 2004, TUBERCULOSIS, V84, P347, DOI 10.1016/j.tube.2004.02.001; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Omueti KO, 2007, J IMMUNOL, V178, P6387, DOI 10.4049/jimmunol.178.10.6387; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pritchard JK, 2000, GENETICS, V155, P945; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Remus N, 2003, IMMUNOL RES, V28, P109, DOI 10.1385/IR:28:2:109; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Roura-Mir C, 2005, J IMMUNOL, V175, P1758, DOI 10.4049/jimmunol.175.3.1758; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Schumann RR, 2007, EUR J IMMUNOL, V37, P2059, DOI 10.1002/eji.200737604; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tapping RI, 2000, J IMMUNOL, V165, P5780, DOI 10.4049/jimmunol.165.10.5780; Thuong NTT, 2007, GENES IMMUN, V8, P422, DOI 10.1038/sj.gene.6364405; Topol EJ, 2007, NAT GENET, V39, P439, DOI 10.1038/ng0407-439; Tosh K, 2006, P NATL ACAD SCI USA, V103, P10364, DOI 10.1073/pnas.0603340103; Uehori J, 2005, J IMMUNOL, V174, P7096, DOI 10.4049/jimmunol.174.11.7096; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; *WHO, 2001, WHOCDSTB200128; Wright FA, 2001, GENOME BIOL, V2; Yu N, 2001, MOL BIOL EVOL, V18, P214, DOI 10.1093/oxfordjournals.molbev.a003795	65	158	167	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1318	10.1371/journal.pone.0001318	http://dx.doi.org/10.1371/journal.pone.0001318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091991	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459600006
J	Shultzaberger, RK; Chiang, DY; Moses, AM; Eisen, MB				Shultzaberger, Ryan K.; Chiang, Derek Y.; Moses, Alan M.; Eisen, Michael B.			Determining Physical Constraints in Transcriptional Initiation Complexes Using DNA Sequence Analysis	PLOS ONE			English	Article								Eukaryotic gene expression is often under the control of cooperatively acting transcription factors whose binding is limited by structural constraints. By determining these structural constraints, we can understand the "rules'' that define functional cooperativity. Conversely, by understanding the rules of binding, we can infer structural characteristics. We have developed an information theory based method for approximating the physical limitations of cooperative interactions by comparing sequence analysis to microarray expression data. When applied to the coordinated binding of the sulfur amino acid regulatory protein Met4 by Cbf1 and Met31, we were able to create a combinatorial model that can correctly identify Met4 regulated genes. Interestingly, we found that the major determinant of Met4 regulation was the sum of the strength of the Cbf1 and Met31 binding sites and that the energetic costs associated with spacing appeared to be minimal.	[Shultzaberger, Ryan K.; Chiang, Derek Y.; Eisen, Michael B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Moses, Alan M.] Univ Calif Berkeley, Grad Grp Biophys, Berkeley, CA 94720 USA; [Eisen, Michael B.] Ernest Orlando Lawrence Berkeley Natl Lab, Genom Div, Dept Genome Sci, Berkeley, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Eisen, MB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mbeisen@lbl.gov	Chiang, Derek/L-6452-2019	Eisen, Michael/0000-0002-7528-738X	U.S. Department of Energy [DE-AC02-05CH11231]; NIH [RHG002779A]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002779] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Director, Office of Science, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231 and NIH grant # RHG002779A.	Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Blaiseau PL, 1998, EMBO J, V17, P6327, DOI 10.1093/emboj/17.21.6327; Blaiseau PL, 1997, MOL CELL BIOL, V17, P3640, DOI 10.1128/MCB.17.7.3640; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Chiang DY, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-16; Chiang DY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r43; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GuhaThakurta D, 2001, BIOINFORMATICS, V17, P608, DOI 10.1093/bioinformatics/17.7.608; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Kent NA, 2004, J BIOL CHEM, V279, P27116, DOI 10.1074/jbc.M403818200; Kuras L, 1997, EMBO J, V16, P2441, DOI 10.1093/emboj/16.9.2441; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Lehman AM, 1998, J BIOL CHEM, V273, P932, DOI 10.1074/jbc.273.2.932; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; NIEDENTHAL RK, 1993, NUCLEIC ACIDS RES, V21, P4726, DOI 10.1093/nar/21.20.4726; RINKEAPPEL J, 1994, NUCLEIC ACIDS RES, V22, P3018, DOI 10.1093/nar/22.15.3018; Schneider TD, 1997, J THEOR BIOL, V189, P427, DOI 10.1006/jtbi.1997.0540; Schneider TD, 1996, METHOD ENZYMOL, V274, P445; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schneider TD, 2001, NUCLEIC ACIDS RES, V29, P4881, DOI 10.1093/nar/29.23.4881; SCHNEIDER TD, 1991, J THEOR BIOL, V148, P125, DOI 10.1016/S0022-5193(05)80467-9; Schneider TD, 2000, NUCLEIC ACIDS RES, V28, P2794, DOI 10.1093/nar/28.14.2794; Shultzaberger RK, 2001, J MOL BIOL, V313, P215, DOI 10.1006/jmbi.2001.5040; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P5275, DOI 10.1093/nar/gkm471; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1992, MOL CELL BIOL, V12, P1719, DOI 10.1128/MCB.12.4.1719; Tribus M., 1961, THERMOSTATICS THERMO; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Wieland G, 2001, NUCLEIC ACIDS RES, V29, P1054, DOI 10.1093/nar/29.5.1054	36	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1199	10.1371/journal.pone.0001199	http://dx.doi.org/10.1371/journal.pone.0001199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030333	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459200012
J	Colzato, LS; van den Wildenberg, WPM; Hommel, B				Colzato, Lorenza S.; van den Wildenberg, Wery P. M.; Hommel, Bernhard			Impaired Inhibitory Control in Recreational Cocaine Users	PLOS ONE			English	Article								Chronic use of cocaine is associated with impairment in response inhibition but it is an open question whether and to which degree findings from chronic users generalize to the upcoming type of recreational users. This study compared the ability to inhibit and execute behavioral responses in adult recreational users and in a cocaine-free-matched sample controlled for age, race, gender distribution, level of intelligence, and alcohol consumption. Response inhibition and response execution were measured by a stop-signal paradigm. Results show that users and non users are comparable in terms of response execution but users need significantly more time to inhibit responses to stop-signals than non users. Interestingly, the magnitude of the inhibitory deficit was positively correlated with the individuals lifetime cocaine exposure suggesting that the magnitude of the impairment is proportional to the degree of cocaine consumed.	[Colzato, Lorenza S.; Hommel, Bernhard] Leiden Univ, Inst Psychol Res, Leiden, Netherlands; [Colzato, Lorenza S.; Hommel, Bernhard] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [van den Wildenberg, Wery P. M.] Univ Amsterdam, Amsterdam Ctr Study Adapt Control Brain & Behav A, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam	Colzato, LS (corresponding author), Leiden Univ, Inst Psychol Res, Leiden, Netherlands.	colzato@fsw.leidenuniv.nl	Colzato, Lorenza S/H-6296-2013; Hommel, Bernhard/F-8173-2010	Hommel, Bernhard/0000-0003-4731-5125; Colzato, Lorenza/0000-0003-1735-1280	NWO	NWO(Netherlands Organization for Scientific Research (NWO))	The research of WVDW is supported by NWO (Netherlands Organisation for Scientific Research).	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ARDILA A, 1991, INT J NEUROSCI, V57, P73, DOI 10.3109/00207459109150348; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Biggins CA, 1997, BIOL PSYCHIAT, V42, P472, DOI 10.1016/S0006-3223(96)00425-8; Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; Bolla KI, 1998, J NEUROPSYCH CLIN N, V10, P280, DOI 10.1176/jnp.10.3.280; Colzato LS, 2005, EUR J NEUROSCI, V21, P591, DOI 10.1111/j.1460-9568.2005.03868.x; Colzato LS, 2004, NEUROSCI LETT, V360, P103, DOI 10.1016/j.neulet.2004.01.054; European Monitoring Centre for Drugs and Drug Addiction, 2003, STAT DRUGS PROBL EUR; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; Hershey T, 2004, COGNITIVE BRAIN RES, V20, P438, DOI 10.1016/j.cogbrainres.2004.03.018; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Jovanovski D, 2005, J CLIN EXP NEUROPSYC, V27, P189, DOI 10.1080/13803390490515694; Kubler A, 2005, EUR J NEUROSCI, V21, P1984, DOI 10.1111/j.1460-9568.2005.04027.x; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li CSR, 2006, DRUG ALCOHOL DEPEN, V85, P205, DOI 10.1016/j.drugalcdep.2006.04.008; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan Gordon D., 1994, P189; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monterosso J, 2001, ADDICTION, V96, P1825, DOI 10.1046/j.1360-0443.2001.9612182512.x; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Raven JC, 1988, MANUAL RAVENS PROGR; Rosenberg DR, 1997, J PSYCHIATR NEUROSCI, V22, P29; SCHACHAR R, 1990, DEV PSYCHOL, V26, P710, DOI 10.1037/0012-1649.26.5.710; Thoma P, 2007, SCHIZOPHR RES, V92, P168, DOI 10.1016/j.schres.2007.02.004; van den Wildenberg WPM, 2006, J COGNITIVE NEUROSCI, V18, P626, DOI 10.1162/jocn.2006.18.4.626; Verdejo-Garcia AJ, 2005, ADDICT BEHAV, V30, P89, DOI 10.1016/j.addbeh.2004.04.015; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Volkow ND, 1999, J PSYCHOPHARMACOL, V13, P337, DOI 10.1177/026988119901300406; von Geusau NA, 2004, PSYCHOPHARMACOLOGY, V175, P331, DOI 10.1007/s00213-004-1832-8	36	113	113	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1143	10.1371/journal.pone.0001143	http://dx.doi.org/10.1371/journal.pone.0001143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17989775	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459000026
J	Yang, GH; Gao, P; Zhang, H; Huang, SJ; Zheng, ZL				Yang, Guohua; Gao, Peng; Zhang, Hua; Huang, Shanjin; Zheng, Zhi-Liang			A Mutation in MRH2 Kinesin Enhances the Root Hair Tip Growth Defect Caused by Constitutively Activated ROP2 Small GTPase in Arabidopsis	PLOS ONE			English	Article							DYNAMIC ACTIN CYTOSKELETON; F-ACTIN; CELL EXPANSION; CORTICAL MICROTUBULES; PROTEIN; MORPHOGENESIS; FUSION; SWITCH; GENE; POLYMERIZATION	Root hair tip growth provides a unique model system for the study of plant cell polarity. Transgenic plants expressing constitutively active (CA) forms of ROP (Rho-of-plants) GTPases have been shown to cause the disruption of root hair polarity likely as a result of the alteration of actin filaments (AF) and microtubules (MT) organization. Towards understanding the mechanism by which ROP controls the cytoskeletal organization during root hair tip growth, we have screened for CA-rop2 suppressors or enhancers using CA1-1, a transgenic line that expresses CA-rop2 and shows only mild disruption of tip growth. Here, we report the characterization of a CA-rop2 enhancer (cae1-1 CA1-1) that exhibits bulbous root hairs. The cae1-1 mutation on its own caused a waving and branching root hair phenotype. CAE1 encodes the root hair growth-related, ARM domain-containing kinesin-like protein MRH2 (and thus cae1-1 was renamed to mrh2-3). Cortical MT displayed fragmentation and random orientation in mrh2 root hairs. Consistently, the MT-stabilizing drug taxol could partially rescue the wavy root hair phenotype of mrh2-3, and the MT-depolymerizing drug Oryzalin slightly enhanced the root hair tip growth defect in CA1-1. Interestingly, the addition of the actin-depolymerizing drug Latrunculin B further enhanced the Oryzalin effect. This indicates that the cross-talk of MT and AF organization is important for the mrh2-3 CA1-1 phenotype. Although we did not observe an apparent effect of the MRH2 mutation in AF organization, we found that mrh2-3 root hair growth was more sensitive to Latrunculin B. Moreover, an ARM domain-containing MRH2 fragment could bind to the polymerized actin in vitro. Therefore, our genetic analyses, together with cell biological and pharmacological evidence, suggest that the plant-specific kinesin-related protein MRH2 is an important component that controls MT organization and is likely involved in the ROP2 GTPase-controlled coordination of AF and MT during polarized growth of root hairs.	[Yang, Guohua; Gao, Peng; Zheng, Zhi-Liang] CUNY, Lehman Coll, Dept Biol Sci, Bronx, NY USA; [Zhang, Hua; Huang, Shanjin] Chinese Acad Sci, Key Lab Photosynth & Environm Mol Physiol, Ctr Signal Transduct & Metabol, Inst Bot, Beijing, Peoples R China; [Zheng, Zhi-Liang] CUNY Grad Sch & Univ Ctr, Plant Sci PhD Subprogram, New York, NY USA	City University of New York (CUNY) System; Lehman College (CUNY); Chinese Academy of Sciences; Institute of Botany, CAS; City University of New York (CUNY) System; City University of New York (CUNY) Graduate School	Zheng, ZL (corresponding author), CUNY, Lehman Coll, Dept Biol Sci, Bronx, NY USA.	zhiliang.zheng@lehman.cuny.edu	Huang, Shanjin/M-4112-2017	Huang, Shanjin/0000-0001-9517-2515	NIH-SCORE [S06GM008225, 12]; Chinese Academy of Sciences through its Hundred Talent Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008225] Funding Source: NIH RePORTER	NIH-SCORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences through its Hundred Talent Program(Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from NIH-SCORE (S06GM008225, Project Number 12, to Z-LZ) and the Chinese Academy of Sciences through its Hundred Talent Program ( to SH).	Baluska F, 2000, DEV BIOL, V227, P618, DOI 10.1006/dbio.2000.9908; Bao YQ, 2001, PLANT J, V28, P145, DOI 10.1046/j.1365-313X.2001.01142.x; Bibikova TN, 1999, PLANT J, V17, P657, DOI 10.1046/j.1365-313X.1999.00415.x; Bisgrove SR, 2004, PLANT PHYSIOL, V136, P3855, DOI 10.1104/pp.104.051037; Bloch D, 2005, MOL BIOL CELL, V16, P1913, DOI 10.1091/mbc.E04-07-0562; Carol RJ, 2005, NATURE, V438, P1013, DOI 10.1038/nature04198; Carol RJ, 2002, PHILOS T ROY SOC B, V357, P815, DOI 10.1098/rstb.2002.1092; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chen CB, 2002, DEVELOPMENT, V129, P2401; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Dong CH, 2001, PLANT CELL, V13, P1333, DOI 10.1105/tpc.13.6.1333; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Fu Y, 2002, PLANT CELL, V14, P777, DOI 10.1105/tpc.001537; Grierson Claire, 2002, Arabidopsis Book, V1, pe0060, DOI 10.1199/tab.0060; Gu Y, 2005, J CELL BIOL, V169, P127, DOI 10.1083/jcb.200409140; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Huang S, 2005, PLANT CELL, V17, P486, DOI 10.1105/tpc.104.028555; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Jones MA, 2006, PLANT J, V45, P83, DOI 10.1111/j.1365-313X.2005.02609.x; Jones MA, 2007, J EXP BOT, V58, P1261, DOI 10.1093/jxb/erl279; Ketelaar T, 2003, PLANT CELL, V15, P285, DOI 10.1105/tpc.007039; Kovar DR, 2000, PLANT J, V24, P625, DOI 10.1046/j.1365-313x.2000.00907.x; Lee YRJ, 2004, PLANT PHYSIOL, V136, P3877, DOI 10.1104/pp.104.052621; Lee YRJ, 2001, PLANT CELL, V13, P2427, DOI 10.1105/tpc.13.11.2427; Li H, 2001, PLANT PHYSIOL, V126, P670, DOI 10.1104/pp.126.2.670; LLOYD CW, 1987, CELL MOTIL CYTOSKEL, V8, P27, DOI 10.1002/cm.970080105; Lu L, 2005, MOL BIOL CELL, V16, P811, DOI 10.1091/mbc.E04-05-0400; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Mao TL, 2005, PLANT PHYSIOL, V138, P654, DOI 10.1104/pp.104.052456; Marc J, 1998, PLANT CELL, V10, P1927, DOI 10.1105/tpc.10.11.1927; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Molendijk AJ, 2001, EMBO J, V20, P2779, DOI 10.1093/emboj/20.11.2779; Motes CM, 2005, PROTOPLASMA, V226, P109, DOI 10.1007/s00709-005-0124-4; Muller S, 2006, CURR BIOL, V16, P888, DOI 10.1016/j.cub.2006.03.034; Nibau C, 2006, TRENDS PLANT SCI, V11, P309, DOI 10.1016/j.tplants.2006.04.003; Oppenheimer DG, 1997, P NATL ACAD SCI USA, V94, P6261, DOI 10.1073/pnas.94.12.6261; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Preuss ML, 2004, PLANT PHYSIOL, V136, P3945, DOI 10.1104/pp.104.052340; Ramachandran S, 2000, PLANT PHYSIOL, V124, P1637, DOI 10.1104/pp.124.4.1637; Ren HY, 1997, PLANT CELL, V9, P1445, DOI 10.1105/tpc.9.8.1445; Richardson DN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-18; Ringli C, 2002, PLANT PHYSIOL, V129, P1464, DOI 10.1104/pp.005777; Samaj J, 2006, TRENDS PLANT SCI, V11, P594, DOI 10.1016/j.tplants.2006.10.002; Sheahan MB, 2004, PLANT PHYSIOL, V136, P3968, DOI 10.1104/pp.104.049411; Sieberer BJ, 2005, NEW PHYTOL, V167, P711, DOI 10.1111/j.1469-8137.2005.01506.x; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Van Bruaene N, 2004, PLANT PHYSIOL, V136, P3905, DOI 10.1104/pp.103.031591; Voigt B, 2005, EUR J CELL BIOL, V84, P595, DOI 10.1016/j.ejcb.2004.11.011; Wang QM, 2004, LETT ORG CHEM, V1, P93, DOI 10.2174/1570178043488770; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; Xin ZY, 2005, PLANT PHYSIOL, V139, P1350, DOI 10.1104/pp.105.068064; Xu J, 2005, CURR OPIN PLANT BIOL, V8, P613, DOI 10.1016/j.pbi.2005.09.003; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yang ZB, 2002, PLANT CELL, V14, pS375, DOI 10.1105/tpc.001065; Yi KX, 2005, PLANT PHYSIOL, V138, P1071, DOI 10.1104/pp.104.055665; Ying G, 2004, CURR OPIN PLANT BIOL, V7, P527, DOI 10.1016/j.pbi.2004.07.006; Zheng ZL, 2000, TRENDS PLANT SCI, V5, P298, DOI 10.1016/S1360-1385(00)01654-X; Zheng ZL, 2000, PLANT MOL BIOL, V44, P1, DOI 10.1023/A:1006402628948; Zhong RQ, 2002, PLANT CELL, V14, P3101, DOI 10.1105/tpc.005801	63	54	60	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1074	10.1371/journal.pone.0001074	http://dx.doi.org/10.1371/journal.pone.0001074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957256	Green Published, gold			2022-12-27	WOS:000207458500019
J	Knight, JDR; Qian, B; Baker, D; Kothary, R				Knight, James D. R.; Qian, Bin; Baker, David; Kothary, Rashmi			Conservation, Variability and the Modeling of Active Protein Kinases	PLOS ONE			English	Article								The human proteome is rich with protein kinases, and this richness has made the kinase of crucial importance in initiating and maintaining cell behavior. Elucidating cell signaling networks and manipulating their components to understand and alter behavior require well designed inhibitors. These inhibitors are needed in culture to cause and study network perturbations, and the same compounds can be used as drugs to treat disease. Understanding the structural biology of protein kinases in detail, including their commonalities, differences and modes of substrate interaction, is necessary for designing high quality inhibitors that will be of true use for cell biology and disease therapy. To this end, we here report on a structural analysis of all available active-conformation protein kinases, discussing residue conservation, the novel features of such conservation, unique properties of atypical kinases and variability in the context of substrate binding. We also demonstrate how this information can be used for structure prediction. Our findings will be of use not only in understanding protein kinase function and evolution, but they highlight the flaws inherent in kinase drug design as commonly practiced and dictate an appropriate strategy for the sophisticated design of specific inhibitors for use in the laboratory and disease therapy.	[Knight, James D. R.; Kothary, Rashmi] Ottawa Hlth Res Inst, Program Mol Med, Ottawa, ON, Canada; [Knight, James D. R.; Kothary, Rashmi] Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada; [Knight, James D. R.; Kothary, Rashmi] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Qian, Bin; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Kothary, Rashmi] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Washington; University of Washington Seattle; University of Ottawa	Kothary, R (corresponding author), Ottawa Hlth Res Inst, Program Mol Med, Ottawa, ON, Canada.	rkothary@ohri.ca	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Kothary, Rashmi/0000-0002-9239-7310	Canadian Institutes of Health Research Canadian Graduate Scholarship; Multiple Sclerosis Society of Canada (MSSC); American Leukemia and Lymphoma Society Fellowship; Howard Hughes Medical Institute	Canadian Institutes of Health Research Canadian Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada (MSSC); American Leukemia and Lymphoma Society Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by a Canadian Institutes of Health Research Canadian Graduate Scholarship and a Multiple Sclerosis Society of Canada (MSSC) Studentship (JDRK), by an American Leukemia and Lymphoma Society Fellowship (BQ), the Howard Hughes Medical Institute (DB) and an MSSC grant (RK).	Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; Bogoyevitch MA, 2005, BBA-PROTEINS PROTEOM, V1754, P79, DOI 10.1016/j.bbapap.2005.07.025; CARRERA AC, 1993, P NATL ACAD SCI USA, V90, P442, DOI 10.1073/pnas.90.2.442; Claude J, 2004, SYST BIOL, V53, P933, DOI 10.1080/10635150490889498; DAS R, PROTEINS IN PRESS; Dedhar S, 1999, TRENDS CELL BIOL, V9, P319, DOI 10.1016/S0962-8924(99)01612-8; Drennan D, 2004, PROG BIOPHYS MOL BIO, V85, P1, DOI 10.1016/S0079-6107(03)00060-9; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Felberg J, 2004, J BIOL CHEM, V279, P3455, DOI 10.1074/jbc.M309537200; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; Hawkins J, 2000, ARCH BIOCHEM BIOPHYS, V382, P310, DOI 10.1006/abbi.2000.2005; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Huang JH, 2003, BIOCHEM BIOPH RES CO, V303, P532, DOI 10.1016/S0006-291X(03)00387-5; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Iyer GH, 2005, J MOL BIOL, V351, P1110, DOI 10.1016/j.jmb.2005.06.011; Kent J.T., 1992, ART STAT SCI, P115; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; LaRonde-LeBlanc N, 2005, J BIOL CHEM, V280, P37297, DOI 10.1074/jbc.R500013200; LaRonde-LeBlanc N, 2005, FEBS J, V272, P2800, DOI 10.1111/j.1742-4658.2005.04702.x; LaRonde-LeBlanc N, 2004, STRUCTURE, V12, P1585, DOI 10.1016/j.str.2004.06.016; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Lougheed JC, 2004, J BIOL CHEM, V279, P44039, DOI 10.1074/jbc.M406703200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Nolen B, 2003, BIOCHEMISTRY-US, V42, P9575, DOI 10.1021/bi0344331; Nolen B, 2001, NAT STRUCT BIOL, V8, P176, DOI 10.1038/84178; Ono-Saito N, 1999, PHARMACOL THERAPEUT, V82, P123, DOI 10.1016/S0163-7258(98)00070-9; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; Perea SE, 2004, CANCER RES, V64, P7127, DOI 10.1158/0008-5472.CAN-04-2086; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Robinson MJ, 1996, BIOCHEMISTRY-US, V35, P5641, DOI 10.1021/bi952723e; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Shah Kavita, 2003, Methods Mol Biol, V233, P253; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tereshko V, 2001, NAT STRUCT BIOL, V8, P899, DOI 10.1038/nsb1001-899; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd AE, 2002, TRENDS BIOCHEM SCI, V27, P419, DOI 10.1016/S0968-0004(02)02158-8; Tu Z, 2003, CELL SIGNAL, V15, P65, DOI 10.1016/S0898-6568(02)00056-6; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yde CW, 2005, J MOL BIOL, V347, P399, DOI 10.1016/j.jmb.2005.01.003; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; Zhou TJ, 2004, STRUCTURE, V12, P1891, DOI 10.1016/j.str.2004.07.021	59	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e982	10.1371/journal.pone.0000982	http://dx.doi.org/10.1371/journal.pone.0000982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912359	gold, Green Published			2022-12-27	WOS:000207455900018
J	Liu, CL; Xie, LX; Li, M; Durairajan, SSK; Goto, S; Huang, JD				Liu, Chen-Li; Xie, Li-Xia; Li, Min; Durairajan, Siva Sundara Kumar; Goto, Shinya; Huang, Jian-Dong			Salvianolic Acid B Inhibits Hydrogen Peroxide-Induced Endothelial Cell Apoptosis through Regulating PI3K/Akt Signaling	PLOS ONE			English	Article								Background. Salvianolic acid B (Sal B) is one of the most bioactive components of Salvia miltiorrhiza, a traditional Chinese herbal medicine that has been commonly used for prevention and treatment of cerebrovascular disorders. However, the mechanism responsible for such protective effects remains largely unknown. It has been considered that cerebral endothelium apoptosis caused by reactive oxygen species including hydrogen peroxide (H2O2) is implicated in the pathogenesis of cerebrovascular disorders. Methodology and Principal Findings. By examining the effect of Sal B on H2O2-induced apoptosis in rat cerebral microvascular endothelial cells (rCMECs), we found that Sal B pretreatment significantly attenuated H2O2-induced apoptosis in rCMECs. We next examined the signaling cascade(s) involved in Sal B-mediated anti-apoptotic effects. We showed that H2O2 induces rCMECs apoptosis mainly through the PI3K/ERK pathway, since a PI3K inhibitor (LY294002) blocked ERK activation caused by H2O2 and a specific inhibitor of MEK (U0126) protected cells from apoptosis. On the other hand, blockage of the PI3K/Akt pathway abrogated the protective effect conferred by Sal B and potentated H2O2-induced apoptosis, suggesting that Sal B prevents H2O2-induced apoptosis predominantly through the PI3K/Akt (upstream of ERK) pathway. Significance. Our findings provide the first evidence that H2O2 induces rCMECs apoptosis via the PI3K/MEK/ERK pathway and that Sal B protects rCMECs against H2O2-induced apoptosis through the PI3K/Akt/Raf/MEK/ ERK pathway.	[Liu, Chen-Li; Xie, Li-Xia; Li, Min; Durairajan, Siva Sundara Kumar] Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Liu, Chen-Li; Huang, Jian-Dong] Univ Hong Kong, Dept Biochem, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Goto, Shinya] Tokai Univ, Sch Med, Dept Med, Hiratsuka, Kanagawa 25912, Japan	Hong Kong Baptist University; University of Hong Kong; Tokai University	Li, M (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China.	limin@hkbu.edu.hk; jdhuang@hkucc.hku.hk	Xie, li/HGE-6052-2022; Durairajan, Siva Sundara Kumar/AAW-4617-2020; Goto, Shinya/AAU-6045-2020; /C-4277-2009	Durairajan, Siva Sundara Kumar/0000-0001-7376-7163; Goto, Shinya/0000-0002-6821-1504; /0000-0001-7531-2816; Li, Min/0000-0002-7113-2700	Research Grant Council of Hong Kong [HKU 7636/05M]; Hong Kong Baptist University [FRG/06-07/I-07, FRG/06-07/II-43]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council); Hong Kong Baptist University	This work was supported by a grant (HKU 7636/05M) from the Research Grant Council of Hong Kong awarded to Dr. J.D. Huang, and was also supported by grants (FRG/06-07/I-07 and FRG/06-07/II-43) from Hong Kong Baptist University awarded to Dr. M. Li. The funders had no roles in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Abe J, 1998, TRENDS CARDIOVAS MED, V8, P59, DOI 10.1016/S1050-1738(97)00133-3; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Blanc A, 2003, INT J MOL MED, V11, P229; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bresgen N, 2003, J NEUROSCI RES, V72, P327, DOI 10.1002/jnr.10582; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen YH, 2000, ACTA PHARMACOL SIN, V21, P463; Chen YL, 2006, J CELL BIOCHEM, V98, P618, DOI 10.1002/jcb.20793; Cheng Yang, 2006, Chin J Integr Med, V12, P207; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Ding M, 2005, INT IMMUNOPHARMACOL, V5, P1641, DOI 10.1016/j.intimp.2005.05.005; Du GH, 2000, J ASIAN NAT PROD RES, V2, P145, DOI 10.1080/10286020008039903; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fischer S, 2005, EUR J CELL BIOL, V84, P687, DOI 10.1016/j.ejcb.2005.03.002; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; HASHIMOTO Y, 1994, J SURG RES, V57, P693, DOI 10.1006/jsre.1994.1203; Jiang RW, 2005, CURR MED CHEM, V12, P237, DOI 10.2174/0929867053363397; Kontos CD, 2002, MOL CELL BIOL, V22, P1704, DOI 10.1128/MCB.22.6.1704-1713.2002; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lee JS, 2006, ARCH TOXICOL, V80, P337, DOI 10.1007/s00204-005-0052-2; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lin SJ, 2007, J CELL BIOCHEM, V100, P372, DOI 10.1002/jcb.21042; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Nohl H, 2003, BIOCHEM SOC T, V31, P1308; Ohashi H, 2004, CIRC RES, V94, P785, DOI 10.1161/01.RES.0000121103.03275.EC; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; SAMBROOK J, 1993, MOL CLONING LAB MANU, P888; Schmidt EK, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-7; Shi LG, 2006, CHINESE MED J-PEKING, V119, P725, DOI 10.1097/00029330-200605010-00004; Sinha D, 2004, J BIOL CHEM, V279, P10962, DOI 10.1074/jbc.M312048200; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Stein RC, 2000, MOL MED TODAY, V6, P347, DOI 10.1016/S1357-4310(00)01770-6; Tang MK, 2006, BEHAV PHARMACOL, V17, P493, DOI 10.1097/00008877-200609000-00015; Tang MK, 2002, PHYTOMEDICINE, V9, P405, DOI 10.1078/09447110260571634; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang J, 2006, FEBS LETT, V580, P2779, DOI 10.1016/j.febslet.2006.04.041; Warner TD, 1999, CLIN EXP PHARMACOL P, V26, P247, DOI 10.1046/j.1440-1681.1999.03025.x; Watanabe N, 2006, AM J PATHOL, V168, P1737, DOI 10.2353/ajpath.2006.050648; Watzke A, 2006, J NAT PROD, V69, P1231, DOI 10.1021/np060136w; Xiao XQ, 2000, NEUROSCI LETT, V290, P197, DOI 10.1016/S0304-3940(00)01357-4; Yang BH, 2006, FASEB J, V20, P1501, DOI 10.1096/fj.05-5359fje; Yang JY, 2004, BIOCHEM PHARMACOL, V68, P1027, DOI 10.1016/j.bcp.2004.03.043; Zhang JJ, 2000, BRAIN RES, V877, P134, DOI 10.1016/S0006-8993(00)02666-4; Zhang YH, 2007, AM J PHYSIOL-HEART C, V292, pH2573, DOI 10.1152/ajpheart.01098.2006; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zhuang SG, 2007, AM J PHYSIOL-RENAL, V292, pF440, DOI 10.1152/ajprenal.00170.2006; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741; Zipser BD, 2007, NEUROBIOL AGING, V28, P977, DOI 10.1016/j.neurobiolaging.2006.05.016	51	77	87	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1321	10.1371/journal.pone.0001321	http://dx.doi.org/10.1371/journal.pone.0001321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091994	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459600009
J	Ordway, JM; Budiman, MA; Korshunova, Y; Maloney, RK; Bedell, JA; Citek, RW; Bacher, B; Peterson, S; Rohlfing, T; Hall, J; Brown, R; Lakey, N; Doerge, RW; Martienssen, RA; Leon, J; McPherson, JD; Jeddeloh, JA				Ordway, Jared M.; Budiman, Muhammad A.; Korshunova, Yulia; Maloney, Rebecca K.; Bedell, Joseph A.; Citek, Robert W.; Bacher, Blaire; Peterson, Seth; Rohlfing, Tracy; Hall, Jacqueline; Brown, Robert; Lakey, Nathan; Doerge, Rebecca W.; Martienssen, Robert A.; Leon, Jorge; McPherson, John D.; Jeddeloh, Jeffrey A.			Identification of Novel High-Frequency DNA Methylation Changes in Breast Cancer	PLOS ONE			English	Article								Recent data have revealed that epigenetic alterations, including DNA methylation and chromatin structure changes, are among the earliest molecular abnormalities to occur during tumorigenesis. The inherent thermodynamic stability of cytosine methylation and the apparent high specificity of the alterations for disease may accelerate the development of powerful molecular diagnostics for cancer. We report a genome-wide analysis of DNA methylation alterations in breast cancer. The approach efficiently identified a large collection of novel differentially DNA methylated loci (, 200), a subset of which was independently validated across a panel of over 230 clinical samples. The differential cytosine methylation events were independent of patient age, tumor stage, estrogen receptor status or family history of breast cancer. The power of the global approach for discovery is underscored by the identification of a single differentially methylated locus, associated with the GHSR gene, capable of distinguishing infiltrating ductal breast carcinoma from normal and benign breast tissues with a sensitivity and specificity of 90% and 96%, respectively. Notably, the frequency of these molecular abnormalities in breast tumors substantially exceeds the frequency of any other single genetic or epigenetic change reported to date. The discovery of over 50 novel DNA methylation-based biomarkers of breast cancer may provide new routes for development of DNA methylation-based diagnostics and prognostics, as well as reveal epigenetically regulated mechanism involved in breast tumorigenesis.	[Ordway, Jared M.; Budiman, Muhammad A.; Korshunova, Yulia; Maloney, Rebecca K.; Bedell, Joseph A.; Citek, Robert W.; Bacher, Blaire; Peterson, Seth; Rohlfing, Tracy; Lakey, Nathan; Leon, Jorge; Jeddeloh, Jeffrey A.] Orion Genom, St Louis, MO USA; [Hall, Jacqueline] McGill Univ, Ctr Bioinformat, Montreal, PQ, Canada; [Brown, Robert] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London, England; [Doerge, Rebecca W.] Purdue Univ, Dept Agron, Lafayette, IN USA; [Doerge, Rebecca W.] Purdue Univ, Dept Stat, Lafayette, IN USA; [Martienssen, Robert A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [McPherson, John D.] Ontario Inst Canc Res, Toronto, ON, Canada	McGill University; Imperial College London; Purdue University System; Purdue University; Purdue University System; Purdue University; Cold Spring Harbor Laboratory; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Ordway, JM (corresponding author), Orion Genom, St Louis, MO USA.	jordway@oriongenomics.com	McPherson, John D/D-2633-2017	McPherson, John D/0000-0001-8049-9347; Hall, Jacqueline/0000-0003-0708-1360; Brown, Robert/0000-0001-7960-5755				Akashi M, 1998, CLIN OBSTET GYNECOL, V41, P172, DOI 10.1097/00003081-199803000-00024; Barzon L, 2005, ONCOLOGY-BASEL, V68, P414, DOI 10.1159/000086983; CHOI YC, 1991, J BIOL CHEM, V266, P20504; Chrzan P, 2001, CLIN BIOCHEM, V34, P557, DOI 10.1016/S0009-9120(01)00260-0; COLDITZ GA, 1993, JAMA-J AM MED ASSOC, V270, P338, DOI 10.1001/jama.270.3.338; COLES C, 1992, CANCER RES, V52, P5291; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Fackler MJ, 2004, CANCER RES, V64, P4442, DOI 10.1158/0008-5472.CAN-03-3341; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hoque MO, 2006, J CLIN ONCOL, V24, P4262, DOI 10.1200/JCO.2005.01.3516; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hurlin PJ, 2006, SEMIN CANCER BIOL, V16, P265, DOI 10.1016/j.semcancer.2006.07.009; Jeffery PL, 2005, ENDOCR-RELAT CANCER, V12, P839, DOI 10.1677/erc.1.00984; Jeffery PL, 2003, CYTOKINE GROWTH F R, V14, P113, DOI 10.1016/S1359-6101(02)00089-8; JOHNSON N, 1995, FAM PRACT, V12, P287, DOI 10.1093/fampra/12.3.287; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P39, DOI 10.1001/jama.276.1.39; KORSHUNOVA K, GENOME RES IN PRESS; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Linke SP, 2006, CLIN CANCER RES, V12, P1175, DOI 10.1158/1078-0432.CCR-05-1562; Lippman Z, 2005, NAT METHODS, V2, P219, DOI 10.1038/nmeth0305-219; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; McKee KK, 1997, MOL ENDOCRINOL, V11, P415, DOI 10.1210/me.11.4.415; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Miyamoto K, 2005, JPN J CLIN ONCOL, V35, P293, DOI 10.1093/jjco/hyi088; Naidu R, 2002, INT J MOL MED, V9, P189; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ordway JM, 2006, CARCINOGENESIS, V27, P2409, DOI 10.1093/carcin/bgl161; Ordway JM, 2005, BIOTECHNIQUES, V39, P464, DOI 10.2144/000112035; Petersenn S, 2001, ENDOCRINOLOGY, V142, P2649, DOI 10.1210/en.142.6.2649; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Rosenberg RD, 1998, RADIOLOGY, V209, P511, DOI 10.1148/radiology.209.2.9807581; Scorilas A, 1999, BRIT J CANCER, V81, P1385, DOI 10.1038/sj.bjc.6693404; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; SLATTERY ML, 1993, JAMA-J AM MED ASSOC, V270, P1563, DOI 10.1001/jama.270.13.1563; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Weischer M, 2007, J CLIN ONCOL, V25, P57, DOI 10.1200/JCO.2005.05.5160; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	49	84	90	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1314	10.1371/journal.pone.0001314	http://dx.doi.org/10.1371/journal.pone.0001314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091988	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000207459600002
J	Morrison, D; Roy, S; Rayner, C; Amer, A; Howard, D; Smith, JR; Evans, TG				Morrison, Dennis; Roy, Sandip; Rayner, Craig; Amer, Ahmed; Howard, Dan; Smith, James R.; Evans, Thomas G.			A Randomized, Crossover Study to Evaluate the Pharmacokinetics of Amantadine and Oseltamivir Administered Alone and in Combination	PLOS ONE			English	Article								The threat of potential pandemic influenza requires a reevaluation of licensed therapies for the prophylaxis or treatment of avian H5N1 infection that may adapt to man. Among the therapies considered for use in pandemic influenza is the co-administration of ion channel and neuraminidase inhibitors, both to potentially increase efficacy as well as to decrease the emergence of resistant isolates. To better understand the potential for drug interactions, a cross-over, randomized, open-label trial was conducted with amantadine, 100 mg po bid, and oseltamivir, 75 mg po bid, given alone or in combination for 5 days. Each subject (N = 17) served as their own control and was administered each drug alone or in combination, with appropriate wash-out. Co-administration with oseltamivir had no clinically significant effect on the pharmacokinetics (PK) of amantadine [mean ratios (90% CI) for AUC(0-12) 0.93 (0.89, 0.98) and C(max) 0.96 (0.90, 1.02). Similarly, amantadine co-administration did not affect oseltamivir PK [AUC(0-12) 0.92 (0.86, 0.99) and C(max) 0.85 (0.73, 0.99)] or the PK of the metabolite, oseltamivir carboxylate [AUC(0-12) 0.98 (0.95, 1.02) and C(max) 0.95 (0.89, 1.01)]. In this small trial there was no evidence of an increase in adverse events. Although many more subjects would need to be studied to rule out a synergistic increase in adverse events, the combination in this small human drug-drug interaction trial appears safe and without pharmacokinetic consequences. Trial Registration. ClinicalTrials.gov NCT00416962	[Roy, Sandip; Amer, Ahmed; Howard, Dan; Evans, Thomas G.] Novartis Exploratory Clin Dev, Cambridge, MA USA; [Roy, Sandip; Amer, Ahmed; Howard, Dan; Evans, Thomas G.] Novartis Exploratory Clin Dev, E Hanover, NJ USA; [Rayner, Craig; Smith, James R.] F Hoffmann La Roche Ltd, Div Pharmaceut, Basel, Switzerland	Novartis; Novartis; Roche Holding	Evans, TG (corresponding author), Novartis Exploratory Clin Dev, Cambridge, MA USA.	thomasg.evans@novartis.com		Smith, James/0000-0001-8985-208X	Roche; Novartis	Roche(Roche Holding); Novartis(Novartis)	All of the authors except D. Morrison are employees of the two companies, Roche and Novartis, that jointly financed this study.	AOKI FY, 1988, CLIN PHARMACOKINET, V14, P35, DOI 10.2165/00003088-198814010-00003; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Doucette K E, 2001, Expert Opin Pharmacother, V2, P1671; Govorkova EA, 2004, ANTIMICROB AGENTS CH, V48, P4855, DOI 10.1128/AAC.48.12.4855-4863.2004; Hayden F, 2005, ANTIVIR THER, V10, P873; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V18, P536, DOI 10.1128/AAC.18.4.536; Hayden FG, 2006, ANTIVIR RES, V71, P372, DOI 10.1016/j.antiviral.2006.05.016; Ilyushina NA, 2005, VIROLOGY, V341, P102, DOI 10.1016/j.virol.2005.07.003; Ilyushina NA, 2006, ANTIVIR RES, V70, P121, DOI 10.1016/j.antiviral.2006.01.012; Ison MG, 2003, ANTIVIR THER, V8, P183; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Schentag JJ, 2007, J CLIN PHARMACOL, V47, P689, DOI 10.1177/0091270007299761; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; WILSON SZ, 1980, ANTIMICROB AGENTS CH, V17, P642, DOI 10.1128/AAC.17.4.642; Wiltshire H, 2000, J CHROMATOGR B, V745, P373, DOI 10.1016/S0378-4347(00)00300-5	18	45	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1305	10.1371/journal.pone.0001305	http://dx.doi.org/10.1371/journal.pone.0001305			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074029	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459500024
J	Valor, LM; Grant, SGN				Valor, Luis M.; Grant, Seth G. N.			Clustered Gene Expression Changes Flank Targeted Gene Loci in Knockout Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; POSTSYNAPTIC DENSITY-95; NMDA RECEPTOR; LATE-PHASE; PLASTICITY; TRANSCRIPTION; PSD-95; ORGANIZATION; INDUCTION	Background. Gene expression profiling using microarrays is a powerful technology widely used to study regulatory networks. Profiling of mRNA levels in mutant organisms has the potential to identify genes regulated by the mutated protein. Methodology/Principle Findings. Using tissues from multiple lines of knockout mice we have examined genome-wide changes in gene expression. We report that a significant proportion of changed genes were found near the targeted gene. Conclusions/Significance. The apparent clustering of these genes was explained by the presence of flanking DNA from the parental ES cell. We provide recommendations for the analysis and reporting of microarray data from knockout mice	[Valor, Luis M.; Grant, Seth G. N.] Wellcome Trust Sanger Inst, Genes Cognit Programme, Cambridge, England	Wellcome Trust Sanger Institute	Grant, SGN (corresponding author), Wellcome Trust Sanger Inst, Genes Cognit Programme, Cambridge, England.	sg3@sanger.ac.uk	Valor, Luis/ABG-1754-2020	Valor, Luis M./0000-0002-1229-0565; Grant, Seth/0000-0001-8732-8735	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by the Wellcome Trust. They supported the research and played no specific role in the details of the research.	Alberini CM, 1999, J EXP BIOL, V202, P2887; Bading H, 2000, EUR J BIOCHEM, V267, P5280, DOI 10.1046/j.1432-1327.2000.01565.x; BEHR R, 2007, DEV BIOL IN PRESS; Cecchi C, 1996, GENOMICS, V37, P96, DOI 10.1006/geno.1996.0525; COLLINS MO, 2005, J NEUROCHEM; Crusio WE, 2004, BIOL PSYCHIAT, V56, P381, DOI 10.1016/j.biopsych.2003.12.026; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Garry EM, 2003, CURR BIOL, V13, P321, DOI 10.1016/S0960-9822(03)00084-8; Hanada K, 2007, CIRC RES, V100, P738, DOI 10.1161/01.RES.0000260181.19449.95; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Husi H, 2001, TRENDS NEUROSCI, V24, P259, DOI 10.1016/S0166-2236(00)01792-6; Husi H, 2001, J NEUROCHEM, V77, P281, DOI 10.1046/j.1471-4159.2001.t01-1-00248.x; Komiyama NH, 2002, J NEUROSCI, V22, P9721; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; Linden DJ, 1996, NEURON, V17, P483, DOI 10.1016/S0896-6273(00)80180-4; McEwan C, 2003, TRANSGENIC RES, V12, P519, DOI 10.1023/A:1024273324890; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MOORE RC, 1995, BIO-TECHNOL, V13, P999, DOI 10.1038/nbt0995-999; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Opazo P, 2003, J NEUROSCI, V23, P3679; Pocklington A. J., 2006, Briefings in Functional Genomics & Proteomics, V5, P66, DOI 10.1093/bfgp/ell013; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Schalkwyk LC, 2007, GENES BRAIN BEHAV, V6, P299, DOI 10.1111/j.1601-183X.2007.00304.x; Selbert S, 1998, TRANSGENIC RES, V7, P387, DOI 10.1023/A:1008848304391; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Threadgill DW, 1997, MAMM GENOME, V8, P390, DOI 10.1007/s003359900453; Tsuda H, 1997, GENOMICS, V42, P413, DOI 10.1006/geno.1997.4771; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; TYMMS M, 1999, METHOD MOL BIOL, P431; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Witt CC, 2006, EMBO J, V25, P3843, DOI 10.1038/sj.emboj.7601242; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yang S, 2007, ACTA BIOMATER, V3, P77, DOI 10.1016/j.actbio.2006.07.005; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	41	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1303	10.1371/journal.pone.0001303	http://dx.doi.org/10.1371/journal.pone.0001303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074027	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459500022
J	Kanai, R; Sheth, BR; Verstraten, FAJ; Shimojo, S				Kanai, Ryota; Sheth, Bhavin R.; Verstraten, Frans A. J.; Shimojo, Shinsuke			Dynamic Perceptual Changes in Audiovisual Simultaneity	PLOS ONE			English	Article							TEMPORAL-ORDER; COMPLICATION EXPERIMENT; ATTENTION; RECALIBRATION; DISTANCE; CAPTURE; VISION; TIME	Background. The timing at which sensory input reaches the level of conscious perception is an intriguing question still awaiting an answer. It is often assumed that both visual and auditory percepts have a modality specific processing delay and their difference determines perceptual temporal offset. Methodology/Principal Findings. Here, we show that the perception of audiovisual simultaneity can change flexibly and fluctuates over a short period of time while subjects observe a constant stimulus. We investigated the mechanisms underlying the spontaneous alternations in this audiovisual illusion and found that attention plays a crucial role. When attention was distracted from the stimulus, the perceptual transitions disappeared. When attention was directed to a visual event, the perceived timing of an auditory event was attracted towards that event. Conclusions/Significance. This multistable display illustrates how flexible perceived timing can be, and at the same time offers a paradigm to dissociate perceptual from stimulus-driven factors in crossmodal feature binding. Our findings suggest that the perception of crossmodal synchrony depends on perceptual binding of audiovisual stimuli as a common event.	[Kanai, Ryota; Shimojo, Shinsuke] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Sheth, Bhavin R.] Univ Houston, Dept Elect & Comp Engn, Houston, TX USA; [Sheth, Bhavin R.] Univ Houston, Ctr NeuroEngn & Cognit Sci, Houston, TX USA; [Verstraten, Frans A. J.] Univ Utrecht, Helmholtz Inst, Dept Expt Psychol, Utrecht, Netherlands	California Institute of Technology; University of Houston System; University of Houston; University of Houston System; University of Houston; Utrecht University	Kanai, R (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	kanair@gmail.com		Kanai, Ryota/0000-0002-0186-2687	Della Martin Fellowship; JST.ERATO; NWO Pionier	Della Martin Fellowship; JST.ERATO(Japan Science & Technology Agency (JST)); NWO Pionier	This work was supported by Della Martin Fellowship (RK), by JST.ERATO (SS) and by NWO Pionier (FV).	Alais D, 2005, P NATL ACAD SCI USA, V102, P2244, DOI 10.1073/pnas.0407034102; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Burrow NT, 1909, PSYCHOL MONOGR, V11, P1; CAIRNEY PT, 1975, PERCEPTION, V4, P255, DOI 10.1068/p040255; Cinel C, 2002, J EXP PSYCHOL HUMAN, V28, P1243, DOI 10.1037/0096-1523.28.5.1243; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; DUNCAN J, 1989, PERCEPTION, V18, P457, DOI 10.1068/p180457; Dunlap K, 1910, PSYCHOL REV, V17, P157, DOI 10.1037/h0073064; ENGEL GR, 1971, NATURE, V234, P308, DOI 10.1038/234308a0; Farroni T, 2000, VIS COGN, V7, P705, DOI 10.1080/13506280050144399; Fendrich R, 2001, PERCEPT PSYCHOPHYS, V63, P719, DOI 10.3758/BF03194432; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; Fraisse P, 1964, PSYCHOL TIME; Fujisaki W, 2005, EXP BRAIN RES, V166, P455, DOI 10.1007/s00221-005-2385-8; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; HIKOSAKA O, 1993, VISION RES, V33, P1219, DOI 10.1016/0042-6989(93)90210-N; Hupe JM, 2003, VISION RES, V43, P531, DOI 10.1016/S0042-6989(02)00593-X; JASKOWSKI P, 1990, PSYCHOL RES-PSYCH FO, V52, P35, DOI 10.1007/BF00867209; Kopinska A, 2004, PERCEPTION, V33, P1049, DOI 10.1068/p5169; Lewald J, 2004, NEUROSCI LETT, V357, P119, DOI 10.1016/j.neulet.2003.12.045; Miyazaki M, 2006, NAT NEUROSCI, V9, P875, DOI 10.1038/nn1712; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Navarra J, 2005, COGNITIVE BRAIN RES, V25, P499, DOI 10.1016/j.cogbrainres.2005.07.009; Pieron H, 1952, SENSATIONS THEIR FUN; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Pressnitzer D, 2006, CURR BIOL, V16, P1351, DOI 10.1016/j.cub.2006.05.054; RUTSCHMANN JACQUES, 1964, PERCEPT MOT SKILLS, V18, P345; Smith WF, 1933, J EXP PSYCHOL, V16, P239, DOI 10.1037/h0071379; Spence C, 2003, CURR BIOL, V13, pR519, DOI 10.1016/S0960-9822(03)00445-7; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; STONE JV, P BIOL SCI, V268, P31; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; Titchener E. B, 1909, LECT ELEMENTARY PSYC; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; Visser TAW, 2001, PERCEPTION, V30, P135, DOI 10.1068/p3089; Vroomen J, 2004, J EXP PSYCHOL HUMAN, V30, P513, DOI 10.1037/0096-1523.30.3.513; WUNDT WM, 1833, PHILOS STUDIEN; Yeshurun Y, 2003, PSYCHOL SCI, V14, P225, DOI 10.1111/1467-9280.02436; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329; Zampini M, 2003, EXP BRAIN RES, V152, P198, DOI 10.1007/s00221-003-1536-z	41	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1253	10.1371/journal.pone.0001253	http://dx.doi.org/10.1371/journal.pone.0001253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060050	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000207459400002
J	Lighton, JRB; Schilman, PE				Lighton, John R. B.; Schilman, Pablo E.			Oxygen Reperfusion Damage in an Insect	PLOS ONE			English	Article								The deleterious effects of anoxia followed by reperfusion with oxygen in higher animals including mammals are well known. A convenient and genetically well characterized small-animal model that exhibits reproducible, quantifiable oxygen reperfusion damage is currently lacking. Here we describe the dynamics of whole-organism metabolic recovery from anoxia in an insect, Drosophila melanogaster, and report that damage caused by oxygen reperfusion can be quantified in a novel but straightforward way. We monitored CO(2) emission ( an index of mitochondrial activity) and water vapor output ( an index of neuromuscular control of the spiracles, which are valves between the outside air and the insect's tracheal system) during entry into, and recovery from, rapid-onset anoxia exposure with durations ranging from 7.5 to 120 minutes. Anoxia caused a brief peak of CO(2) output followed by knock-out. Mitochondrial respiration ceased and the spiracle constrictor muscles relaxed, but then re-contracted, presumably powered by anaerobic processes. Reperfusion to sustained normoxia caused a bimodal reactivation of mitochondrial respiration, and in the case of the spiracle constrictor muscles, slow inactivation followed by reactivation. After long anoxia durations, both the bimodality of mitochondrial reactivation and the recovery of spiracular control were impaired. Repeated reperfusion followed by episodes of anoxia depressed mitochondrial respiratory flux rates and damaged the integrity of the spiracular control system in a dose-dependent fashion. This is the first time that physiological evidence of oxygen reperfusion damage has been described in an insect or any invertebrate. We suggest that some of the traditional approaches of insect respiratory biology, such as quantifying respiratory water loss, may facilitate using D. melanogaster as a convenient, well-characterized experimental model for studying the underlying biology and mechanisms of ischemia and reperfusion damage and its possible mitigation.	[Lighton, John R. B.] Univ Nevada, Dept Biol Sci, Las Vegas, NV 89154 USA; [Lighton, John R. B.] Sable Syst Int, Las Vegas, NV USA; [Schilman, Pablo E.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of California System; University of California San Diego	Lighton, JRB (corresponding author), Univ Nevada, Dept Biol Sci, Las Vegas, NV 89154 USA.	john.lighton@unlv.edu	Schilman, Pablo/GLR-8952-2022; Lighton, John R B/A-9691-2009	Lighton, John/0000-0002-9264-924X; Schilman, Pablo/0000-0003-1485-1650	Sable Systems International	Sable Systems International	We received funding from Sable Systems International.	Chown SL, 2006, PHYSIOL BIOCHEM ZOOL, V79, P333, DOI 10.1086/499992; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; Harrison J, 2006, RESP PHYSIOL NEUROBI, V154, P4, DOI 10.1016/j.resp.2006.02.008; Hermes-Lima M, 2002, COMP BIOCHEM PHYS C, V133, P537, DOI 10.1016/S1532-0456(02)00080-7; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; Idris AH, 2005, CRIT CARE MED, V33, P2043, DOI 10.1097/01.CCM.0000174104.50799.BD; Joanisse DR, 1996, J EXP BIOL, V199, P1483; Joos B, 1997, PHYSIOL ZOOL, V70, P167, DOI 10.1086/639570; Kestler P., 1985, P137; Krishnan SN, 1997, J INSECT PHYSIOL, V43, P203, DOI 10.1016/S0022-1910(96)00084-4; Krogh A, 1920, PFLUG ARCH GES PHYS, V179, P95, DOI 10.1007/BF01722125; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; Lehmann FA, 2001, SCIENCE, V294, P1926, DOI 10.1126/science.1064821; Lighton JRB, 2007, J THERM BIOL, V32, P134, DOI 10.1016/j.jtherbio.2007.01.009; Lighton JRB, 2005, J EXP BIOL, V208, P4671, DOI 10.1242/jeb.01934; LIGHTON JRB, 1989, PHYSIOL ZOOL, V62, P1232, DOI 10.1086/physzool.62.6.30156211; LIGHTON JRB, 1995, J EXP BIOL, V198, P1613; Lighton JRB, 2004, J EXP BIOL, V207, P4463, DOI 10.1242/jeb.01284; Lighton JRB, 1998, AM ZOOL, V38, P483; Lighton JRB, 1996, J INSECT PHYSIOL, V42, P347, DOI 10.1016/0022-1910(95)00112-3; LIGHTON JRB, 1991, CONCISE ENCY BIOL BI, P201; Liu GW, 2006, PHYSIOL GENOMICS, V25, P134, DOI 10.1152/physiolgenomics.00262.2005; Mellanby K, 1935, BIOL REV CAMB PHILOS, V10, P317, DOI 10.1111/j.1469-185X.1935.tb00487.x; Storey KB., 2004, FUNCTIONAL METABOLIS, DOI [10.1002/047167558X, DOI 10.1002/047167558X]; Wigglesworth V.B., 1983, Advances in Insect Physiology, V17, P85, DOI 10.1016/S0065-2806(08)60217-9; Williams AE, 1998, J EXP BIOL, V201, P2953; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490	27	53	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1267	10.1371/journal.pone.0001267	http://dx.doi.org/10.1371/journal.pone.0001267			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060061	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459400014
J	Ninomiya, Y; Ichinose, S				Ninomiya, Youichirou; Ichinose, Shizuko			Subcellular Distribution of Mitochondrial Ribosomal RNA in the Mouse Oocyte and Zygote	PLOS ONE			English	Article							GERM PLASM; DROSOPHILA EMBRYOS; LOCALIZATION; PROTEINS; POLARITY; CLEAVAGE; SPERM; STAGE; EGGS; ACQUISITION	Mitochondrial ribosomal RNAs (mtrRNAs) have been reported to translocate extra-mitochondrially and localize to the germ cell determinant of oocytes and zygotes in some metazoa except mammals. To address whether the mtrRNAs also localize in the mammals, expression and distribution of mitochondrion-encoded RNAs in the mouse oocytes and zygotes was examined by whole-mount in situ hybridization (ISH). Both 12S and 16S rRNAs were predominantly distributed in the animal hemisphere of the mature oocyte. This distribution pattern was rearranged toward the second polar body in zygotes after fertilization. The amount of mtrRNAs decreased around first cleavage, remained low during second cleavage and increased after third cleavage. Staining intensity of the 12S rRNA was weaker than that of the 16S rRNA throughout the examined stages. Similar distribution dynamics of the 16S rRNA was observed in strontium-activated haploid parthenotes, suggesting the distribution rearrangement does not require a component from sperm. The distribution of 16S rRNAs did not coincide with that of mitochondrion-specific heat shock protein 70, suggesting that the mtrRNA is translocated from mitochondria. The ISH-scanning electron microscopy confirms the extra-mitochondrial mtrRNA in the mouse oocyte. Chloramphenicol (CP) treatment of late pronuclear stage zygotes perturbed first cleavage as judged by the greater than normal disparity in size of blastomeres of 2-cell conceptuses. Two-third of the CP-treated zygotes arrested at either 2-cell or 3-cell stage even after the CP was washed out. These findings indicate that the extra-mitochondrial mtrRNAs are localized in the mouse oocyte and implicated in correct cytoplasmic segregation into blastomeres through cleavages of the zygote.	[Ninomiya, Youichirou] Univ Oxford, Dept Zool, Mammalian Dev Lab, Oxford OX1 3PS, England; [Ichinose, Shizuko] Tokyo Med & Dent Univ, Instrumental Anal Res Ctr, Bunkyo Ku, Tokyo, Japan	University of Oxford; Tokyo Medical & Dental University (TMDU)	Ninomiya, Y (corresponding author), Univ Oxford, Dept Zool, Mammalian Dev Lab, S Parks Rd, Oxford OX1 3PS, England.	yo.ninomy@zoo.ox.ac.uk		Ninomiya, Youichirou/0000-0003-3572-2532	Biotechnology and Biological Sciences Research Council, UK (BBSRC) [43/G17886]; March of Dimes Foundation, USA; Grant-in-Aid for Scientific Research; Japan Society for the Promotion of Science, Japan [19500403]	Biotechnology and Biological Sciences Research Council, UK (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); March of Dimes Foundation, USA(March of Dimes); Grant-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Biotechnology and Biological Sciences Research Council, UK (BBSRC, Grant Reference Number 43/G17886), the March of Dimes Foundation, USA to YN and the Grant-in-Aid for Scientific Research, the Japan Society for the Promotion of Science, Japan (Project Number 19500403) to SI.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Amikura R, 2005, MECH DEVELOP, V122, P1087, DOI 10.1016/j.mod.2005.06.003; Amikura R, 2001, P NATL ACAD SCI USA, V98, P9133, DOI 10.1073/pnas.171286998; Antczak M, 1997, MOL HUM REPROD, V3, P1067, DOI 10.1093/molehr/3.12.1067; Aoki F, 2003, MOL REPROD DEV, V64, P270, DOI 10.1002/mrd.10227; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; CALARCO PG, 1995, DEV GENET, V16, P36, DOI 10.1002/dvg.1020160108; CASCIO SM, 1981, DEV BIOL, V83, P166, DOI 10.1016/S0012-1606(81)80019-X; Davies TJ, 2002, HUM REPROD, V17, P2368, DOI 10.1093/humrep/17.9.2368; DING D, 1994, DEV BIOL, V163, P503, DOI 10.1006/dbio.1994.1166; DING D, 1993, BIOESSAYS, V15, P651, DOI 10.1002/bies.950151004; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; EVSIKOV SV, 1994, ROUX ARCH DEV BIOL, V203, P199, DOI 10.1007/BF00636335; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Gardner R L, 2003, Reprod Biomed Online, V6, P157; Gardner RL, 2006, HUM REPROD, V21, P492, DOI 10.1093/humrep/dei318; Gardner RL, 2002, HUM REPROD, V17, P3178, DOI 10.1093/humrep/17.12.3178; Gardner RL, 1999, BIOESSAYS, V21, P271, DOI 10.1002/(SICI)1521-1878(199904)21:4<271::AID-BIES2>3.0.CO;2-C; Gardner RL, 2006, REPROD BIOMED ONLINE, V12, P144, DOI 10.1016/S1472-6483(10)60853-X; Gardner RL, 2003, PHILOS T ROY SOC B, V358, P1331, DOI 10.1098/rstb.2003.1322; GREEN JM, 1995, HYBRIDOMA, V14, P347, DOI 10.1089/hyb.1995.14.347; Gur Y, 2006, GENE DEV, V20, P411, DOI 10.1101/gad.367606; HAY B, 1988, DEVELOPMENT, V103, P625; Hiiragi T, 2004, NATURE, V430, P360, DOI 10.1038/nature02595; Hiiragi T, 2006, NATURE, V442, pE3, DOI 10.1038/nature04907; Hiiragi T, 2006, REPROD BIOMED ONLINE, V12, P150, DOI 10.1016/S1472-6483(10)60854-1; Hiiragi T, 2006, INT J DEV BIOL, V50, P581, DOI 10.1387/ijdb.062181th; Ichinose S, 2005, CLIN EXP PHARMACOL P, V32, P561, DOI 10.1111/j.1440-1681.2005.04231.x; Iida T, 1998, P NATL ACAD SCI USA, V95, P11274, DOI 10.1073/pnas.95.19.11274; INGLIS JD, 1993, MAMM GENOME, V4, P401, DOI 10.1007/BF00360595; JOHNSON MH, 1981, BIOL REV, V56, P463, DOI 10.1111/j.1469-185X.1981.tb00356.x; King ML, 1999, BIOESSAYS, V21, P546, DOI 10.1002/(SICI)1521-1878(199907)21:7<546::AID-BIES3>3.0.CO;2-Z; Kloc M, 2001, INT REV CYTOL, V203, P63; Ko MSH, 2000, DEVELOPMENT, V127, P1737; Kobayashi S, 1998, CURR BIOL, V8, P1117, DOI 10.1016/S0960-9822(98)70466-X; KOBAYASHI S, 1989, DEVELOPMENT, V107, P733; KOBAYASHI S, 1995, DEV BIOL, V169, P384, DOI 10.1006/dbio.1995.1153; KOBAYASHI S, 1993, SCIENCE, V260, P1521, DOI 10.1126/science.7684857; LATHAM KE, 1992, DEV BIOL, V149, P457, DOI 10.1016/0012-1606(92)90300-6; Mahowald AP, 2001, INT REV CYTOL, V203, P187; Matova N, 2001, DEV BIOL, V231, P291, DOI 10.1006/dbio.2000.0120; Motosugi N, 2005, GENE DEV, V19, P1081, DOI 10.1101/gad.1304805; Motosugi N, 2006, PLOS BIOL, V4, P799, DOI 10.1371/journal.pbio.0040135; Mowry KL, 1999, FASEB J, V13, P435, DOI 10.1096/fasebj.13.3.435; MULNARD J, 1984, ARCH BIOL, V95, P461; Ninomiya Y, 2005, DEV DYNAM, V233, P837, DOI 10.1002/dvdy.20405; Ogawa M, 1999, ZOOL SCI, V16, P445, DOI 10.2108/zsj.16.445; OKADA M, 1974, DEV BIOL, V37, P43, DOI 10.1016/0012-1606(74)90168-7; Perkins GA, 2000, MICRON, V31, P97, DOI 10.1016/S0968-4328(99)00065-7; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; PIKO L, 1973, J CELL BIOL, V58, P357, DOI 10.1083/jcb.58.2.357; Piotrowska K, 2001, NATURE, V409, P517, DOI 10.1038/35054069; Plusa B, 2002, NAT CELL BIOL, V4, P811, DOI 10.1038/ncb860; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Rand K, 2001, Results Probl Cell Differ, V34, P157; Rasband W., 2006, IMAGEJ; Reunov A, 2004, ZYGOTE, V12, P329, DOI 10.1017/S0967199404002916; Reunov A, 2006, ZYGOTE, V14, P231, DOI 10.1017/S0967199406003789; Rushlow C, 1990, Semin Cell Biol, V1, P137; SCHUPBACH T, 1994, CURR OPIN GENET DEV, V4, P502, DOI 10.1016/0959-437X(94)90064-A; Tokura Takashi, 1993, Journal of Assisted Reproduction and Genetics, V10, P417, DOI 10.1007/BF01228092; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; VANBLERKOM J, 1984, AM J ANAT, V171, P335, DOI 10.1002/aja.1001710309; VANBLERKOM J, 1981, P NATL ACAD SCI-BIOL, V78, P7629; Villegas J, 2002, MOL HUM REPROD, V8, P977, DOI 10.1093/molehr/8.11.977; Vinot S, 2005, DEV BIOL, V282, P307, DOI 10.1016/j.ydbio.2005.03.001; Vinot S, 2004, CURR BIOL, V14, P520, DOI 10.1016/j.cub.2004.02.061; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Zernicka-Goetz M, 1998, DEVELOPMENT, V125, P4803; Zernicka-Goetz M, 2006, CURR OPIN GENET DEV, V16, P406, DOI 10.1016/j.gde.2006.06.011; Zernicka-Goetz MZ, 2005, NAT REV MOL CELL BIO, V6, P919, DOI 10.1038/nrm1782	72	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1241	10.1371/journal.pone.0001241	http://dx.doi.org/10.1371/journal.pone.0001241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043748	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459300022
J	Chan, LY; Cross, HF; She, JK; Cavalli, G; Martins, HFP; Neylon, C				Chan, Lilyan; Cross, Hannah F.; She, Joseph K.; Cavalli, Gabriel; Martins, Hugo F. P.; Neylon, Cameron			Covalent Attachment of Proteins to Solid Supports and Surfaces via Sortase-Mediated Ligation	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; IMMOBILIZATION; MUTANT; CHIP; TUS	Background. There is growing interest in the attachment of proteins to solid supports for the development of supported catalysts, affinity matrices, and micro devices as well as for the development of planar and bead based protein arrays for multiplexed assays of protein concentration, interactions, and activity. A critical requirement for these applications is the generation of a stable linkage between the solid support and the immobilized, but still functional, protein. Methodology. Solid supports including crosslinked polymer beads, beaded agarose, and planar glass surfaces, were modified to present an oligoglycine motif to solution. A range of proteins were ligated to the various surfaces using the Sortase A enzyme of S. aureus. Reactions were carried out in aqueous buffer conditions at room temperature for times between one and twelve hours. Conclusions. The Sortase A transpeptidase of S. aureus provides a general, robust, and gentle approach to the selective covalent immobilization of proteins on three very different solid supports. The proteins remain functional and accessible to solution. Sortase mediated ligation is therefore a straightforward methodology for the preparation of solid supported enzymes and bead based assays, as well as the modification of planar surfaces for microanalytical devices and protein arrays.	[Chan, Lilyan; Cross, Hannah F.; She, Joseph K.; Cavalli, Gabriel; Martins, Hugo F. P.; Neylon, Cameron] Univ Southampton, Sch Chem, Southampton, Hants, England; [Cavalli, Gabriel] Univ Surrey, Sch Biomed & Mol Sci, Guildford GU2 5XH, Surrey, England; [Neylon, Cameron] Rutherford Appleton Lab, Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England	University of Southampton; University of Surrey; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Neylon, C (corresponding author), Univ Southampton, Sch Chem, Southampton, Hants, England.	C.Neylon@rl.ac.uk	Cavalli, Gabriel/B-7207-2009; Cavalli, Gabriel/ABE-2401-2020	Cavalli, Gabriel/0000-0002-2856-1956; Cavalli, Gabriel/0000-0002-2856-1956; Neylon, Cameron/0000-0002-0068-716X	Research Councils UK through the Basic Technology Programme	Research Councils UK through the Basic Technology Programme	This work was supported in part by Research Councils UK through the Basic Technology Programme.	Camarero JA, 2004, J AM CHEM SOC, V126, P14730, DOI 10.1021/ja0456611; Cazalis CS, 2004, BIOCONJUGATE CHEM, V15, P1005, DOI 10.1021/bc049903y; Cha T, 2005, PROTEOMICS, V5, P416, DOI 10.1002/pmic.200400948; Choi JW, 2002, LAB CHIP, V2, P27, DOI 10.1039/b107540n; Decreau RA, 2007, J ORG CHEM, V72, P2794, DOI 10.1021/jo062349w; Girish A, 2005, BIOORG MED CHEM LETT, V15, P2447, DOI 10.1016/j.bmcl.2005.03.079; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Ichihara T, 2006, J PROTEOME RES, V5, P2144, DOI 10.1021/pr0504889; JEONG WJ, 2005, CONTINUOUS FABRICATI, P3738; KALIA J, BIOCONJUG CHEM; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Neylon C, 2000, BIOCHEMISTRY-US, V39, P11989, DOI 10.1021/bi001174w; Neylon C, 2005, MICROBIOL MOL BIOL R, V69, P501, DOI 10.1128/MMBR.69.3.501-526.2005; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; POPP MW, 2007, NAT CHEM BIOL; PRITZ S, 2007, J ORG CHEM; SCHWENK JM, 2006, MOL CELL PROTEOMICS; Soellner MB, 2003, J AM CHEM SOC, V125, P11790, DOI 10.1021/ja036712h; Sun XL, 2006, BIOCONJUGATE CHEM, V17, P52, DOI 10.1021/bc0502311; Tan LP, 2004, BIOORG MED CHEM LETT, V14, P6067, DOI 10.1016/j.bmcl.2004.09.083; Terrettaz S, 2002, PROTEIN SCI, V11, P1917, DOI 10.1110/ps.0206102; Tomizaki KY, 2005, CHEMBIOCHEM, V6, P783, DOI 10.1002/cbic.200400232; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Watzke A, 2006, ANGEW CHEM INT EDIT, V45, P1408, DOI 10.1002/anie.200502057; Zhang ZL, 2005, MICROELECTRON ENG, V78-79, P556, DOI 10.1016/j.mee.2004.12.071	26	82	92	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1164	10.1371/journal.pone.0001164	http://dx.doi.org/10.1371/journal.pone.0001164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000537	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459100007
J	Lu, Y; Yi, YJ; Liu, PY; Wen, WD; James, M; Wang, DL; You, M				Lu, Yan; Yi, Yijun; Liu, Pengyuan; Wen, Weidong; James, Michael; Wang, Daolong; You, Ming			Common Human Cancer Genes Discovered by Integrated Gene-Expression Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MICROARRAY DATA; ANALYSIS REVEALS; DOWN-REGULATION; HIGH-GRADE; IN-VITRO; TUMOR; CLUSTERIN; PROFILES; PATTERNS	Background. Microarray technology enables a standardized, objective assessment of oncological diagnosis and prognosis. However, such studies are typically specific to certain cancer types, and the results have limited use due to inadequate validation in large patient cohorts. Discovery of genes commonly regulated in cancer may have an important implication in understanding the common molecular mechanism of cancer. Methods and Findings. We described an integrated gene-expression analysis of 2,186 samples from 39 studies to identify and validate a cancer type-independent gene signature that can identify cancer patients for a wide variety of human malignancies. The commonness of gene expression in 20 types of common cancer was assessed in 20 training datasets. The discriminative power of a signature defined by these common cancer genes was evaluated in the other 19 independent datasets including novel cancer types. QRT-PCR and tissue microarray were used to validate commonly regulated genes in multiple cancer types. We identified 187 genes dysregulated in nearly all cancerous tissue samples. The 187-gene signature can robustly predict cancer versus normal status for a wide variety of human malignancies with an overall accuracy of 92.6%. We further refined our signature to 28 genes confirmed by QRT-PCR. The refined signature still achieved 80% accuracy of classifying samples from mixed cancer types. This signature performs well in the prediction of novel cancer types that were not represented in training datasets. We also identified three biological pathways including glycolysis, cell cycle checkpoint II and plk3 pathways in which most genes are systematically up-regulated in many types of cancer. Conclusions. The identified signature has captured essential transcriptional features of neoplastic transformation and progression in general. These findings will help to elucidate the common molecular mechanism of cancer, and provide new insights into cancer diagnostics, prognostics and therapy.	[You, Ming] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	You, M (corresponding author), Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA.	youm@wudosis.wustl.edu		James, Michael/0000-0002-8112-1108	NIH [R01CA58554]; NATIONAL CANCER INSTITUTE [R01CA058554] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant R01CA58554 (MY).	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; ANDERSEN CL, 2007, CLUSTERIN EXPRESSION; Behrens P, 2001, PATHOBIOLOGY, V69, P19, DOI 10.1159/000048753; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Bredel M, 2006, J CLIN ONCOL, V24, P274, DOI 10.1200/JCO.2005.02.9405; Chaparro J, 2005, METABOLISM, V54, P561, DOI 10.1016/j.metabol.2004.08.022; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Cromer A, 2004, ONCOGENE, V23, P2484, DOI 10.1038/sj.onc.1207345; De Vos J, 2002, ONCOGENE, V21, P6848, DOI 10.1038/sj.onc.1205868; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Geschickter C.F., 1930, J CHEM EDUC, DOI [10.1021/ed007p179, DOI 10.1021/ED007P179]; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Gordon GJ, 2005, AM J PATHOL, V166, P1827, DOI 10.1016/S0002-9440(10)62492-3; Graudens E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r19; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; Hippo Y, 2002, CANCER RES, V62, P233; Hoffman PJ, 2004, FERTIL STERIL, V82, P639, DOI 10.1016/j.fertnstert.2004.01.047; Huang Y, 2001, P NATL ACAD SCI USA, V98, P15044, DOI 10.1073/pnas.251547398; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Kimchi ET, 2005, CANCER RES, V65, P3146, DOI 10.1158/0008-5472.CAN-04-2490; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Krajewska M, 2002, NEOPLASIA, V4, P129, DOI 10.1038/sj.neo.7900222; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lenburg ME, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-31; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazumder A, 2006, PHARMACOGENOMICS, V7, P1167, DOI 10.2217/14622416.7.8.1167; Nakamura E, 2006, AM J PATHOL, V168, P574, DOI 10.2353/ajpath.2006.050867; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rickman DS, 2001, CANCER RES, V61, P6885; Risinger JI, 2003, CANCER RES, V63, P6; Rittling SR, 2004, BRIT J CANCER, V90, P1877, DOI 10.1038/sj.bjc.6601839; Scaltriti M, 2004, INT J CANCER, V108, P23, DOI 10.1002/ijc.11496; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Skotheim RI, 2005, CANCER RES, V65, P5588, DOI 10.1158/0008-5472.CAN-05-0153; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Stearman RS, 2005, AM J PATHOL, V167, P1763, DOI 10.1016/S0002-9440(10)61257-6; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Storz MN, 2003, J INVEST DERMATOL, V120, P865, DOI 10.1046/j.1523-1747.2003.12142.x; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Thomas-Tikhonenko A, 2004, CANCER RES, V64, P3126, DOI 10.1158/0008-5472.CAN-03-1953; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Welsh JB, 2001, P NATL ACAD SCI USA, V98, P1176, DOI 10.1073/pnas.98.3.1176; Wong YF, 2003, CLIN CANCER RES, V9, P5486; Wu Y, 2000, BRIT J CANCER, V83, P156; Xie MJ, 2002, PANCREAS, V25, P234, DOI 10.1097/00006676-200210000-00004; Xu L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-275; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; Yoon SS, 2006, J SURG RES, V135, P282, DOI 10.1016/j.jss.2006.01.023; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745; Zhang DH, 2005, MOL CELL PROTEOMICS, V4, P1686, DOI 10.1074/mcp.M400221-MCP200; Zhang LY, 2003, WORLD J GASTROENTERO, V9, P650, DOI 10.3748/wjg.v9.i4.650	57	62	65	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1149	10.1371/journal.pone.0001149	http://dx.doi.org/10.1371/journal.pone.0001149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17989776	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459000032
J	Schroger, E; Bendixen, A; Trujillo-Barreto, NJ; Roeber, U				Schroeger, Erich; Bendixen, Alexandra; Trujillo-Barreto, Nelson J.; Roeber, Urte			Processing of Abstract Rule Violations in Audition	PLOS ONE			English	Article								The ability to encode rules and to detect rule-violating events outside the focus of attention is vital for adaptive behavior. Our brain recordings reveal that violations of abstract auditory rules are processed even when the sounds are unattended. When subjects performed a task related to the sounds but not to the rule, rule violations impaired task performance and activated a network involving supratemporal, parietal and frontal areas although none of the subjects acquired explicit knowledge of the rule or became aware of rule violations. When subjects tried to behaviorally detect rule violations, the brain's automatic violation detection facilitated intentional detection. This shows the brain's capacity for abstraction - an important cognitive function necessary to model the world. Our study provides the first evidence for the task-independence (i.e. automaticity) of this ability to encode abstract rules and for its immediate consequences for subsequent mental processes.	[Schroeger, Erich; Bendixen, Alexandra; Roeber, Urte] Univ Leipzig, Inst Psychol 1, Leipzig, Germany; [Trujillo-Barreto, Nelson J.] Cuban Neurosci Ctr, Havana, Cuba	Leipzig University	Schroger, E (corresponding author), Univ Leipzig, Inst Psychol 1, Leipzig, Germany.	schroger@uni-leipzig.de	Schröger, Erich/C-3079-2009; Bendixen, Alexandra/B-3922-2010; Trujillo-Barreto, Nelson J/G-3764-2013; Roeber, Urte/A-1880-2010	Schröger, Erich/0000-0002-8321-6629; Trujillo-Barreto, Nelson J/0000-0001-6581-7503; Roeber, Urte/0000-0002-6631-5828; Bendixen, Alexandra/0000-0001-8211-9619	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) graduate program "function of attention in cognition''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; Allen J, 2000, PERCEPT PSYCHOPHYS, V62, P1383, DOI 10.3758/BF03212140; Bosch-Bayard J, 2001, CLIN ELECTROENCEPHAL, V32, P47, DOI 10.1177/155005940103200203; Bunge SA, 2005, J NEUROSCI, V25, P10347, DOI 10.1523/JNEUROSCI.2937-05.2005; Carral V, 2005, NEUROREPORT, V16, P301, DOI 10.1097/00001756-200502280-00020; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deouell LY, 1998, PSYCHOPHYSIOLOGY, V35, P355, DOI 10.1017/S0048577298970287; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Evans A.C., 1993, NUCL SCI S MED IM C, P1813, DOI DOI 10.1109/NSSMIC.1993.373602; Gottselig JM, 2004, LEARN MEMORY, V11, P162, DOI 10.1101/lm.63304; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; Kahneman D., 1984, VARIETIES ATTENTION, P29; Korzyukov OA, 2003, NEUROIMAGE, V20, P2245, DOI 10.1016/j.neuroimage.2003.08.014; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; LANG H, 1990, PSYCHOPHYSIOLOGICAL, P294; Maess B, 2007, NEUROIMAGE, V37, P561, DOI 10.1016/j.neuroimage.2007.05.040; Marco-Pallares J, 2005, NEUROIMAGE, V25, P471, DOI 10.1016/j.neuroimage.2004.11.028; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Muller BW, 2002, NEUROIMAGE, V17, P231, DOI 10.1006/nimg.2002.1176; NAATANEN R, 2002, STEVENS HDB EXPT PSY, P601; Naatanen R., 2018, ATTENTION BRAIN FUNC; Opitz B, 2005, EUR J NEUROSCI, V21, P531, DOI 10.1111/j.1460-9568.2005.03839.x; Paavilainen P, 2003, NEUROREPORT, V14, P715, DOI 10.1097/00001756-200304150-00011; Paavilainen P, 2007, NEUROREPORT, V18, P159, DOI 10.1097/WNR.0b013e328010e2ac; PERRIN F, 1990, ELECTROEN CLIN NEURO, V76, P565; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Picton TW, 1999, AUDIOL NEURO-OTOL, V4, P64, DOI 10.1159/000013823; REBER AS, 1989, J EXP PSYCHOL GEN, V118, P219, DOI 10.1037/0096-3445.118.3.219; Rinne T, 2005, NEUROIMAGE, V26, P66, DOI 10.1016/j.neuroimage.2005.01.017; Rinne T, 2000, NEUROIMAGE, V12, P14, DOI 10.1006/nimg.2000.0591; Rinne T, 2007, NEUROSCI LETT, V416, P247, DOI 10.1016/j.neulet.2007.01.077; Rosburg T, 2005, BRAIN, V128, P819, DOI 10.1093/brain/awh442; SAARINEN J, 1992, NEUROREPORT, V3, P1149, DOI 10.1097/00001756-199212000-00030; Schroger E, 2000, CLIN NEUROPHYSIOL, V111, P1450, DOI 10.1016/S1388-2457(00)00337-0; Schubotz RI, 2007, TRENDS COGN SCI, V11, P211, DOI 10.1016/j.tics.2007.02.006; SQUIRES KC, 1976, SCIENCE, V193, P1142, DOI 10.1126/science.959831; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; Trujillo-Barreto NJ, 2004, NEUROIMAGE, V21, P1300, DOI 10.1016/j.neuroimage.2003.11.008; Tse CY, 2006, NEUROIMAGE, V29, P314, DOI 10.1016/j.neuroimage.2005.07.013; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; ULANOVSKY N, 2004, NEURONAL ADAPTATION; van Zuijen TL, 2006, J COGNITIVE NEUROSCI, V18, P1292, DOI 10.1162/jocn.2006.18.8.1292; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P74, DOI 10.1002/(SICI)1097-0193(1996)4:1<74::AID-HBM5>3.0.CO;2-M; Yucel G, 2005, J COGNITIVE NEUROSCI, V17, P1819, DOI 10.1162/089892905775008698; Zachau S, 2005, NEUROREPORT, V16, P2015, DOI 10.1097/00001756-200512190-00009; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	50	73	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1131	10.1371/journal.pone.0001131	http://dx.doi.org/10.1371/journal.pone.0001131			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987118	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459000015
J	Grande, T; Bernasconi, A; Erhart, A; Gamboa, D; Casapia, M; Delgado, C; Torres, K; Fanello, C; Llanos-Cuentas, A; D'Alessandro, U				Grande, Tanilu; Bernasconi, Andrea; Erhart, Annette; Gamboa, Dioni; Casapia, Martin; Delgado, Christopher; Torres, Kathy; Fanello, Caterina; Llanos-Cuentas, Alejandro; D'Alessandro, Umberto			A Randomised Controlled Trial to Assess the Efficacy of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Falciparum Malaria in Peru	PLOS ONE			English	Article								Background. Multi-drug resistant falciparum malaria is an important health problem in the Peruvian Amazon region. We carried out a randomised open label clinical trial comparing mefloquine-artesunate, the current first line treatment in this region, with dihydroartemisinin-piperaquine. Methods and Findings. Between July 2003 and July 2005, 522 patients with P. falciparum uncomplicated malaria were recruited, randomized (260 with mefloquine-artesunate and 262 with dihydroartemisinin-piperaquine), treated and followed up for 63 days. PCR-adjusted adequate clinical and parasitological response, estimated by Kaplan Meier survival and Per Protocol analysis, was extremely high for both drugs (99.6% for mefloquine-artesunate and 98.4% and for dihydroartemisinin-piperaquine) (RR: 0.99, 95% CI [0.9721.01], Fisher Exact p = 0.21). All recrudescences were late parasitological failures. Overall, gametocytes were cleared faster in the mefloquine-artesunate group (28 vs 35 days) and new gametocytes tended to appear more frequently in patients treated with dihydroartemisinin-piperaquine (day 7: 8 (3.6%) vs 2 (0.9%), RR: 3.84, 95% CI [0.82-17.87]). Adverse events such as anxiety and insomnia were significantly more frequent in the mefloquine-artesunate group, both in adults and children. Conclusion. Dihydroartemisinin-piperaquine is as effective as mefloquine-artesunate in treating uncomplicated P. falciparum malaria but it is better tolerated and more affordable than mefloquine-artesunate (US$1.0 versus US$18.65 on the local market). Therefore, it should be considered as a potential candidate for the first line treatment of P. falciparum malaria in Peru. Trial Registration. ClinicalTrials.gov NCT00373607 [http://www.clinicaltrials.gov/ct/show/NCT00373607]	[Bernasconi, Andrea; Erhart, Annette; D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Grande, Tanilu; Gamboa, Dioni; Delgado, Christopher; Torres, Kathy; Llanos-Cuentas, Alejandro] Univ Peruana Cayetano Heredia, ITM AvH, Lima, Peru; [Casapia, Martin] Minist Salud Peru, Direcc Reg Salud Loreto, Lima, Peru; [Fanello, Caterina] London Sch Hyg & Trop Med, London WC1, England	Institute of Tropical Medicine (ITM); Universidad Peruana Cayetano Heredia; University of London; London School of Hygiene & Tropical Medicine	Erhart, A (corresponding author), Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium.	aerhart@itg.be	Delgado Ratto, Christopher/D-3838-2013; Gamboa, Dionicia/CAF-2097-2022; D'Alessandro, Umberto/D-3457-2015; Fanello, Caterina/AAT-9679-2021	Gamboa, Dionicia/0000-0002-1420-7729; D'Alessandro, Umberto/0000-0001-6341-5009; Fanello, Caterina/0000-0003-1932-9562; Llanos-Cuentas, Alejandro/0000-0002-7567-5534; Torres, Katherine/0000-0003-0414-7547; Delgado-Ratto, Christopher/0000-0003-2300-5181; Casapia Morales, Wilfredo Martin/0000-0002-5972-0948	Directorate-General for Development and Cooperation (DGDC) of the Belgian Government [95501]	Directorate-General for Development and Cooperation (DGDC) of the Belgian Government	Funding: Financial support was provided by the Directorate-General for Development and Cooperation (DGDC) of the Belgian Government (framework agreement 02, project 95501).	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; [Anonymous], 2003, ASS MON ANT DRUG EFF; Ashley EA, 2004, J INFECT DIS, V190, P1773, DOI 10.1086/425015; Cattamanchi A, 2003, AM J TROP MED HYG, V68, P133, DOI 10.4269/ajtmh.2003.68.133; Chauca H, 1993, REV PERUANA EPIDEMIO, V6, P34; Davis TME, 2005, DRUGS, V65, P75, DOI 10.2165/00003495-200565010-00004; Denis MB, 2002, CLIN INFECT DIS, V35, P1469, DOI 10.1086/344647; Guarda JA, 1999, EMERG INFECT DIS, V5, P209; Hien TT, 2004, LANCET, V363, P18, DOI 10.1016/S0140-6736(03)15163-X; Janssens B, 2007, TROP MED INT HEALTH, V12, P251, DOI [10.1111/j.1365-3165.2006.01786.x, 10.1111/j.1365-3156.2006.01786.x]; KAREMA C, 2006, T R SOC TROP MED HYG, V438, P1; KARUNAJEEWA H, 2003, BR J CLIN PHARM, V57, P193; Marquino W, 2003, AM J TROP MED HYG, V68, P608, DOI 10.4269/ajtmh.2003.68.608; Mayxay M, 2006, TROP MED INT HEALTH, V11, P1157, DOI 10.1111/j.1365-3156.2006.01671.x; *MIN HLTH PER, 2004, RES INT SURV ADV EV; Mugittu K, 2006, TROP MED INT HEALTH, V11, P1350, DOI 10.1111/j.1365-3156.2006.01688.x; NAVITSKY RC, 1997, AM J TROP MED HYG  S, V57, P229; *OF GEN EP PER, 2006, WEEKL EP B; Olliaro P L, 2004, J Postgrad Med, V50, P40; Roshanravan B, 2003, AM J TROP MED HYG, V69, P45, DOI 10.4269/ajtmh.2003.69.45; RUEBUSH T, 2003, REV PERU MED EXP SAL, V20, P162; Smithuis F, 2006, LANCET, V367, P2075, DOI 10.1016/S0140-6736(06)68931-9; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; *WHO, 1980, MAN BAS TECHN HLTH L, P379	24	38	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1101	10.1371/journal.pone.0001101	http://dx.doi.org/10.1371/journal.pone.0001101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971864	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000207458700018
J	Petrella, JR; Prince, SE; Wang, LH; Hellegers, C; Doraiswamy, PM				Petrella, Jeffrey R.; Prince, Steven E.; Wang, Lihong; Hellegers, Caroline; Doraiswamy, P. Murali			Prognostic Value of Posteromedial Cortex Deactivation in Mild Cognitive Impairment	PLOS ONE			English	Article								Background. Normal subjects deactivate specific brain regions, notably the posteromedial cortex (PMC), during many tasks. Recent cross-sectional functional magnetic resonance imaging (fMRI) data suggests that deactivation during memory tasks is impaired in Alzheimer's disease (AD). The goal of this study was to prospectively determine the prognostic significance of PMC deactivation in mild cognitive impairment (MCI). Methodology/Principal Findings. 75 subjects (34 MCI, 13 AD subjects and 28 controls) underwent baseline fMRI scanning during encoding of novel and familiar face-name pairs. MCI subjects were followed longitudinally to determine conversion to AD. Regression and analysis of covariance models were used to assess the effect of PMC activation/deactivation on conversion to dementia as well as in the longitudinal change in dementia measures. At longitudinal follow up of up to 3.5 years (mean 2.5 +/- 0.79 years), 11 MCI subjects converted to AD. The proportion of deactivators was significantly different across all groups: controls (79%), MCI-Nonconverters (73%), MCI-converters (45%), and AD (23%) (p<0.05). Mean PMC activation magnitude parameter estimates, at baseline, were negative in the control (-0.57 +/- 0.12) and MCI-Nonconverter (-0.33 +/- 0.14) groups, and positive in the MCI-Converter (0.37 +/- 0.40) and AD (0.92 +/- 0.30) groups. The effect of diagnosis on PMC deactivation remained significant after adjusting for age, education and baseline Mini-Mental State Exam (p<0.05). Baseline PMC activation magnitude was correlated with change in dementia ratings from baseline. Conclusion. Loss of physiological functional deactivation in the PMC may have prognostic value in preclinical AD, and could aid in profiling subgroups of MCI subjects at greatest risk for progressive cognitive decline.	[Petrella, Jeffrey R.; Prince, Steven E.; Wang, Lihong] Duke Univ, Med Ctr, Alzheimer Imaging Res Lab, Durham, NC 27710 USA; [Petrella, Jeffrey R.; Prince, Steven E.; Wang, Lihong] Duke Univ, Med Ctr, Dept Radiol, Brain Imaging & Anal Ctr, Durham, NC 27710 USA; [Hellegers, Caroline; Doraiswamy, P. Murali] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; [Hellegers, Caroline; Doraiswamy, P. Murali] Duke Univ, Med Ctr, Dept Geriatr Med, Durham, NC 27710 USA; [Doraiswamy, P. Murali] Duke Univ, Med Ctr, Ctr Study Aging, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Petrella, JR (corresponding author), Duke Univ, Med Ctr, Alzheimer Imaging Res Lab, Durham, NC 27710 USA.	petre001@mc.duke.edu	Wang, Lihong/D-8960-2011; Prince, Steven E./Z-1175-2019; Prince, Steven/C-4104-2009	Prince, Steven/0000-0002-6606-7481	NIA [R01AG019728]; NATIONAL INSTITUTE ON AGING [R01AG019728] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: Supported by NIA R01AG019728. The funding agency did not have any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Aupee AM, 2001, NEUROIMAGE, V13, P1164, DOI 10.1006/nimg.2001.0762; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; DELIS D, 1987, CALIFORNIA VERBAL LE; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Frackowiak RS., 1997, HUMAN BRAIN FUNCTION; Golby A, 2005, BRAIN, V128, P773, DOI 10.1093/brain/awh400; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; HACHINSKI VC, 1974, LANCET, V2, P207; Huettel SA, 2001, NEUROIMAGE, V13, P161, DOI 10.1006/nimg.2000.0675; Jack CR, 2002, NEUROLOGY, V58, P750, DOI 10.1212/WNL.58.5.750; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Johnson SC, 2006, NEUROBIOL AGING, V27, P1604, DOI 10.1016/j.neurobiolaging.2005.09.017; Kaye JA, 1997, NEUROLOGY, V48, P1297, DOI 10.1212/WNL.48.5.1297; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; LEUCHTER AF, 1992, BRAIN, V115, P1543, DOI 10.1093/brain/115.5.1543; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Machulda MM, 2003, NEUROLOGY, V61, P500, DOI 10.1212/01.WNL.0000079052.01016.78; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meguro K, 1999, BRAIN, V122, P1519, DOI 10.1093/brain/122.8.1519; Millien I, 2002, J CEREBR BLOOD F MET, V22, P1248, DOI 10.1097/01.WCB.0000037997.34930.67; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Pariente J, 2005, ANN NEUROL, V58, P870, DOI 10.1002/ana.20653; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Petrella JR, 2007, RADIOLOGY, V245, P224, DOI 10.1148/radiol.2451061847; Petrella JR, 2006, RADIOLOGY, V240, P177, DOI 10.1148/radiol.2401050739; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reed LJ, 1999, MEMORY, V7, P599, DOI 10.1080/096582199387779; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rombouts SARB, 2000, AM J NEURORADIOL, V21, P1869; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Small SA, 1999, ANN NEUROL, V45, P466, DOI 10.1002/1531-8249(199904)45:4<466::AID-ANA8>3.0.CO;2-Q; Sperling RA, 2003, J NEUROL NEUROSUR PS, V74, P44, DOI 10.1136/jnnp.74.1.44; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Tanzi RE, 2005, NAT NEUROSCI, V8, P977, DOI 10.1038/nn0805-977; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; 1998, AM J PSYCHIAT, V155, P1649	48	74	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1104	10.1371/journal.pone.0001104	http://dx.doi.org/10.1371/journal.pone.0001104			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971867	Green Submitted, gold, Green Published			2022-12-27	WOS:000207458700021
J	Thakur, AS; Robin, G; Guncar, G; Saunders, NFW; Newman, J; Martin, JL; Kobe, B				Thakur, Anil S.; Robin, Gautier; Guncar, Gregor; Saunders, Neil F. W.; Newman, Janet; Martin, Jennifer L.; Kobe, Bostjan			Improved Success of Sparse Matrix Protein Crystallization Screening with Heterogeneous Nucleating Agents	PLOS ONE			English	Article								Background. Crystallization is a major bottleneck in the process of macromolecular structure determination by X-ray crystallography. Successful crystallization requires the formation of nuclei and their subsequent growth to crystals of suitable size. Crystal growth generally occurs spontaneously in a supersaturated solution as a result of homogenous nucleation. However, in a typical sparse matrix screening experiment, precipitant and protein concentration are not sampled extensively, and supersaturation conditions suitable for nucleation are often missed. Methodology/Principal Findings. We tested the effect of nine potential heterogenous nucleating agents on crystallization of ten test proteins in a sparse matrix screen. Several nucleating agents induced crystal formation under conditions where no crystallization occurred in the absence of the nucleating agent. Four nucleating agents: dried seaweed; horse hair; cellulose and hydroxyapatite, had a considerable overall positive effect on crystallization success. This effect was further enhanced when these nucleating agents were used in combination with each other. Conclusions/Significance. Our results suggest that the addition of heterogeneous nucleating agents increases the chances of crystal formation when using sparse matrix screens.	[Thakur, Anil S.; Guncar, Gregor; Saunders, Neil F. W.; Martin, Jennifer L.; Kobe, Bostjan] Univ Queensland, Sch Mol & Microbial Sci, Brisbane, Qld, Australia; [Robin, Gautier; Martin, Jennifer L.; Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Robin, Gautier; Martin, Jennifer L.; Kobe, Bostjan] Univ Queensland, Australian Res Council ARC, Special Res Ctr Funct & Appl Genom, Brisbane, Qld, Australia; [Newman, Janet] Commonwealth Sci & Ind Res Org, Mol & Hlth Technol, Parkville, Vic, Australia	University of Queensland; University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Kobe, B (corresponding author), Univ Queensland, Sch Mol & Microbial Sci, Brisbane, Qld, Australia.	b.kobe@uq.edu.au	Kobe, Bostjan/D-1292-2009; Newman, Janet M/D-1857-2011; Saunders, Neil/B-5325-2010; Martin, Jennifer L./A-6039-2010	Kobe, Bostjan/0000-0001-9413-9166; Newman, Janet M/0000-0003-2666-3219; Saunders, Neil/0000-0003-2139-6107; Guncar, Gregor/0000-0003-4500-6951; Martin, Jennifer L./0000-0002-9225-8863	Australian Research Council (ARC)	Australian Research Council (ARC)(Australian Research Council)	Funding: This work was supported by an Australian Research Council (ARC) grant to JLM and BK. BK is an ARC Federation Fellow and a National Health and Medical Research Council (NHMRC) Honorary Research Fellow. JLM is an NHMRC Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asherie N, 2004, METHODS, V34, P266, DOI 10.1016/j.ymeth.2004.03.028; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; Bodenstaff ER, 2002, ACTA CRYSTALLOGR D, V58, P1901, DOI 10.1107/S0907444902016608; Cacciuto A, 2004, NATURE, V428, P404, DOI 10.1038/nature02397; Chayen NE, 2006, P NATL ACAD SCI USA, V103, P597, DOI 10.1073/pnas.0504860102; CHAYEN NE, 1990, J APPL CRYSTALLOGR, V23, P297, DOI 10.1107/S0021889890003260; Chayen NE, 2001, J MOL BIOL, V312, P591, DOI 10.1006/jmbi.2001.4995; D'Arcy A, 2003, ACTA CRYSTALLOGR D, V59, P1343, DOI 10.1107/S0907444903009430; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; Dale GE, 2003, J STRUCT BIOL, V142, P88, DOI 10.1016/S1047-8477(03)00041-8; EDWARDS AM, 1994, NAT STRUCT BIOL, V1, P195, DOI 10.1038/nsb0394-195; Fermani S, 2001, J CRYST GROWTH, V224, P327, DOI 10.1016/S0022-0248(01)00797-7; Georgieva DG, 2007, ACTA CRYSTALLOGR D, V63, P564, DOI 10.1107/S0907444907007810; Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001; HEMMING SA, 1995, J MOL BIOL, V246, P308, DOI 10.1006/jmbi.1994.0086; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; MCPHERSON A, 1988, SCIENCE, V239, P385, DOI 10.1126/science.239.4838.385; McPherson A, 2004, METHODS, V34, P254, DOI 10.1016/j.ymeth.2004.03.019; MCPHERSON A, 1987, J CRYST GROWTH, V85, P206, DOI 10.1016/0022-0248(87)90224-7; McPherson A., 1999, CRYSTALLIZATION BIOL; Pechkova E, 2002, J CELL BIOCHEM, V85, P243, DOI 10.1002/jcb.10123; PUNZI JS, 1991, J APPL CRYSTALLOGR, V24, P406, DOI 10.1107/S0021889891001644; Rong L, 2004, J SYNCHROTRON RADIAT, V11, P27, DOI 10.1107/S0909049503023525; Sanjoh A, 2001, J CRYST GROWTH, V232, P618, DOI 10.1016/S0022-0248(01)01057-0; Yoshizaki I, 2001, ACTA CRYSTALLOGR D, V57, P1621, DOI 10.1107/S0907444901013610	25	47	50	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1091	10.1371/journal.pone.0001091	http://dx.doi.org/10.1371/journal.pone.0001091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971854	Green Submitted, gold, Green Published			2022-12-27	WOS:000207458700008
J	Cojoc, D; Difato, F; Ferrari, E; Shahapure, RB; Laishram, J; Righi, M; Di Fabrizio, EM; Torre, V				Cojoc, Dan; Difato, Francesco; Ferrari, Enrico; Shahapure, Rajesh B.; Laishram, Jummi; Righi, Massimo; Di Fabrizio, Enzo M.; Torre, Vincent			Properties of the Force Exerted by Filopodia and Lamellipodia and the Involvement of Cytoskeletal Components	PLOS ONE			English	Article								During neuronal differentiation, lamellipodia and filopodia explore the environment in search for the correct path to the axon's final destination. Although the motion of lamellipodia and filopodia has been characterized to an extent, little is known about the force they exert. In this study, we used optical tweezers to measure the force exerted by filopodia and lamellipodia with a millisecond temporal resolution. We found that a single filopodium exerts a force not exceeding 3 pN, whereas lamellipodia can exert a force up to 20 pN. Using metabolic inhibitors, we showed that no force is produced in the absence of actin polymerization and that development of forces larger than 3 pN requires microtubule polymerization. These results show that actin polymerization is necessary for force production and demonstrate that not only do neurons process information, but they also act on their environment exerting forces varying from tenths pN to tens of pN.	[Cojoc, Dan; Ferrari, Enrico; Di Fabrizio, Enzo M.] Ist Nazl Fis Mat, Lab Nazl Tecnol Avanzate & Nanosci TASC, CNR, Trieste, Italy; [Difato, Francesco; Shahapure, Rajesh B.; Laishram, Jummi; Righi, Massimo; Torre, Vincent] Int Sch Adv Studies SISSA ISAS, Trieste, Italy; [Di Fabrizio, Enzo M.] Magna Graecia Univ Catanzaro, Catanzaro, Italy; [Cojoc, Dan] CBM, LANADA Lab, Trieste, Italy; [Torre, Vincent] Int Sch Adv Studies, Italian Inst Technol, Unit, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Padua; International School for Advanced Studies (SISSA); Magna Graecia University of Catanzaro; International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT	Cojoc, D (corresponding author), Ist Nazl Fis Mat, Lab Nazl Tecnol Avanzate & Nanosci TASC, CNR, Area Sci Pk Basovizza, Trieste, Italy.	cojoc@tasc.infm.it; torre@sissa.it	Ferrari, Enrico/N-2400-2019	Ferrari, Enrico/0000-0002-9102-7422; difato, francesco/0000-0001-6404-588X	EU [NEURO, BINASP]; Italian Government [FIRB]; CIPE/FVG [GRAND]	EU(European Commission); Italian Government; CIPE/FVG	This work was partially supported by the EU grants NEURO and BINASP, by a FIRB grant from the Italian Government and by the GRAND grant from CIPE/FVG.	ALETTA JM, 1988, J NEUROSCI, V8, P1425; Ashkin A, 1997, P NATL ACAD SCI USA, V94, P4853, DOI 10.1073/pnas.94.10.4853; Atilgan E, 2006, BIOPHYS J, V90, P65, DOI 10.1529/biophysj.105.071480; Bayer MW, 2007, J COMP NEUROL, V500, P850, DOI 10.1002/cne.21228; BOVOLENTA P, 1987, J NEUROSCI, V7, P1447; BRAY D, 1978, P NATL ACAD SCI USA, V75, P5226, DOI 10.1073/pnas.75.10.5226; Bustamante C, 2000, NAT REV MOL CELL BIO, V1, P130, DOI 10.1038/35040072; Cojoc D, 2004, JPN J APPL PHYS 1, V43, P3910, DOI 10.1143/JJAP.43.3910; DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Dufresne ER, 2001, REV SCI INSTRUM, V72, P1810, DOI 10.1063/1.1344176; Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Gallo G, 2000, J NEUROBIOL, V44, P159, DOI 10.1002/1097-4695(200008)44:2<159::AID-NEU6>3.0.CO;2-H; Ghashghaei HT, 2007, NAT REV NEUROSCI, V8, P141, DOI 10.1038/nrn2074; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gittes F, 1998, OPT LETT, V23, P7, DOI 10.1364/OL.23.000007; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; GOMEZ TM, 1994, J NEUROSCI, V14, P5959; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Grunwald IC, 2002, CURR OPIN NEUROBIOL, V12, P250, DOI 10.1016/S0959-4388(02)00323-9; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Howard J., 2001, MECH MOTOR PROTEINS; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Marcy Y, 2004, P NATL ACAD SCI USA, V101, P5992, DOI 10.1073/pnas.0307704101; Mogilner A, 2006, CURR OPIN CELL BIOL, V18, P32, DOI 10.1016/j.ceb.2005.11.001; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mongiu AK, 2007, J CELL SCI, V120, P1113, DOI 10.1242/jcs.03384; Myers KA, 2006, NEUROSCIENTIST, V12, P107, DOI 10.1177/1073858405283428; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Solecki DJ, 2006, J NEUROSCI, V26, P10624, DOI 10.1523/JNEUROSCI.4060-06.2006; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164	43	107	108	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1072	10.1371/journal.pone.0001072	http://dx.doi.org/10.1371/journal.pone.0001072			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957254	Green Published, gold, Green Submitted			2022-12-27	WOS:000207458500017
J	Wang, Y; Barbacioru, CC; Shiffman, D; Balasubramanian, S; Iakoubova, O; Tranquilli, M; Albornoz, G; Blake, J; Mehmet, NN; Ngadimo, D; Poulter, K; Chan, F; Samaha, RR; Elefteriades, JA				Wang, Yulei; Barbacioru, Catalin C.; Shiffman, Dov; Balasubramanian, Sriram; Iakoubova, Olga; Tranquilli, Maryann; Albornoz, Gonzalo; Blake, Julie; Mehmet, Necip N.; Ngadimo, Dewi; Poulter, Karen; Chan, Frances; Samaha, Raymond R.; Elefteriades, John A.			Gene Expression Signature in Peripheral Blood Detects Thoracic Aortic Aneurysm	PLOS ONE			English	Article								Background. Thoracic aortic aneurysm (TAA) is usually asymptomatic and associated with high mortality. Adverse clinical outcome of TAA is preventable by elective surgical repair; however, identifying at-risk individuals is difficult. We hypothesized that gene expression patterns in peripheral blood cells may correlate with TAA disease status. Our goal was to identify a distinct gene expression signature in peripheral blood that may identify individuals at risk for TAA. Methods and Findings. Whole genome gene expression profiles from 94 peripheral blood samples (collected from 58 individuals with TAA and 36 controls) were analyzed. Significance Analysis of Microarray (SAM) identified potential signature genes characterizing TAA vs. normal, ascending vs. descending TAA, and sporadic vs. familial TAA. Using a training set containing 36 TAA patients and 25 controls, a 41-gene classification model was constructed for detecting TAA status and an overall accuracy of 78+/-66% was achieved. Testing this classifier on an independent validation set containing 22 TAA samples and 11 controls yielded an overall classification accuracy of 78%. These 41 classifier genes were further validated by TaqMan (R) real-time PCR assays. Classification based on the TaqMan (R) data replicated the microarray results and achieved 80% classification accuracy on the testing set. Conclusions. This study identified informative gene expression signatures in peripheral blood cells that can characterize TAA status and subtypes of TAA. Moreover, a 41-gene classifier based on expression signature can identify TAA patients with high accuracy. The transcriptional programs in peripheral blood leading to the identification of these markers also provide insights into the mechanism of development of aortic aneurysms and highlight potential targets for therapeutic intervention. The classifier genes identified in this study, and validated by TaqMan (R) real-time PCR, define a set of promising potential diagnostic markers, setting the stage for a blood-based gene expression test to facilitate early detection of TAA.	[Wang, Yulei; Barbacioru, Catalin C.; Blake, Julie; Mehmet, Necip N.; Poulter, Karen; Chan, Frances; Samaha, Raymond R.] Appl Biosyst Inc, Foster City, CA 94404 USA; [Shiffman, Dov; Iakoubova, Olga] Celera, Alameda, CA USA; [Balasubramanian, Sriram; Ngadimo, Dewi] Celera Genom, San Francisco, CA USA; [Tranquilli, Maryann; Albornoz, Gonzalo; Elefteriades, John A.] Yale Univ, Sch Med, Sect Cardiothorac Surg, New Haven, CT USA	Thermo Fisher Scientific; Applied Biosystems; Yale University	Samaha, RR (corresponding author), Appl Biosyst Inc, 850 Lincoln Ctr Dr, Foster City, CA 94404 USA.	Raymond.Samaha@appliedbiosystems.com; john.elefteriades@yale.edu		Wang, Yulei/0000-0002-9057-9786	Yale University School of Medicine; Applied Biosystems; Celera	Yale University School of Medicine; Applied Biosystems; Celera	This work was supported by Yale University School of Medicine, Applied Biosystems and Celera.	Achiron A, 2004, Clin Dev Immunol, V11, P299, DOI 10.1080/17402520400001603; Achiron A, 2004, ANN NEUROL, V55, P410, DOI 10.1002/ana.20008; Albornoz G, 2006, ANN THORAC SURG, V82, P1400, DOI 10.1016/j.athoracsur.2006.04.098; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baranzini SE, 2005, PLOS BIOL, V3, P166, DOI 10.1371/journal.pbio.0030002; Batliwalla FM, 2005, GENES IMMUN, V6, P388, DOI 10.1038/sj.gene.6364209; Bomprezzi R, 2003, HUM MOL GENET, V12, P2191, DOI 10.1093/hmg/ddg221; Chittenden TW, 2006, CIRCULATION, V114, P1811, DOI 10.1161/CIRCULATIONAHA.106.628396; Cho RJ, 2000, TRENDS GENET, V16, P409, DOI 10.1016/S0168-9525(00)02065-5; Coady MA, 1997, J THORAC CARDIOV SUR, V113, P476, DOI 10.1016/S0022-5223(97)70360-X; Coady MA, 1999, ARCH SURG-CHICAGO, V134, P361, DOI 10.1001/archsurg.134.4.361; Curci JA, 2004, J CLIN INVEST, V114, P168, DOI 10.1172/JCI200422309; DAPUNT OE, 1994, ANN THORAC SURG, V58, P689, DOI 10.1016/0003-4975(94)90729-3; Davis VA, 2001, J SURG RES, V101, P152, DOI 10.1006/jsre.2001.6281; Dawson J, 2007, J VASC SURG, V45, P350, DOI 10.1016/j.jvs.2006.09.049; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Guo DC, 2001, CIRCULATION, V103, P2461; Hasham SN, 2004, ANN EMERG MED, V43, P79, DOI 10.1016/S0196-0644(03)00818-7; Hasham SN, 2003, CIRCULATION, V107, P3184, DOI 10.1161/01.CIR.0000078634.33124.95; Henderson EL, 1999, CIRCULATION, V99, P96, DOI 10.1161/01.CIR.99.1.96; Huber TS, 2000, SHOCK, V13, P425, DOI 10.1097/00024382-200006000-00002; Ivanov VN, 2002, J BIOL CHEM, V277, P4932, DOI 10.1074/jbc.M108233200; Kakko S, 2003, J THORAC CARDIOV SUR, V126, P106, DOI 10.1016/S0022-5223(03)00037-0; Koullias G, 2005, J THORAC CARDIOV SUR, V130, P677, DOI 10.1016/j.jtcvs.2005.02.052; Koullias GJ, 2004, ANN THORAC SURG, V78, P2106, DOI 10.1016/j.athoracsur.2004.05.088; Lin CL, 2006, NEUROL RES, V28, P721, DOI 10.1179/016164106X152007; Ma J, 2003, J MOL CELL CARDIOL, V35, P993, DOI 10.1016/S0022-2828(03)00179-2; Mandel M, 2004, CLIN EXP IMMUNOL, V138, P164, DOI 10.1111/j.1365-2249.2004.02587.x; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Middleton RK, 2007, J VASC SURG, V45, P574, DOI 10.1016/j.jvs.2006.11.020; Ocana E, 2003, ATHEROSCLEROSIS, V170, P39, DOI 10.1016/S0021-9150(03)00282-X; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; Pan JH, 2003, J VASC SURG, V37, P628, DOI 10.1067/mva.2003.74; Patino WD, 2005, P NATL ACAD SCI USA, V102, P3423, DOI 10.1073/pnas.0408032102; Schonbeck U, 2002, AM J PATHOL, V161, P499, DOI 10.1016/S0002-9440(10)64206-X; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Suhara T, 2002, MOL CELL BIOL, V22, P680, DOI 10.1128/MCB.22.2.680-691.2002; Tang PCY, 2005, FASEB J, V19, P1528, DOI 10.1096/fj.05-3671fje; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Timofeeva AV, 2006, ANN NY ACAD SCI, V1091, P319, DOI 10.1196/annals.1378.077; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uyemura K, 1996, J CLIN INVEST, V97, P2130, DOI 10.1172/JCI118650; Van Kien PK, 2005, CIRCULATION, V112, P200, DOI 10.1161/CIRCULATIONAHA.104.506345; Verschuren L, 2005, ANTIOXID REDOX SIGN, V7, P1195, DOI 10.1089/ars.2005.7.1195; Walton LJ, 1999, CIRCULATION, V100, P48, DOI 10.1161/01.CIR.100.1.48; Wung Shu-Fen, 2004, J Cardiovasc Nurs, V19, P409; Xiong WF, 2006, J VASC SURG, V44, P1061, DOI 10.1016/j.jvs.2006.06.036	49	69	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1050	10.1371/journal.pone.0001050	http://dx.doi.org/10.1371/journal.pone.0001050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940614	Green Published, gold, Green Submitted			2022-12-27	WOS:000207456100018
J	Fick, J; Lindberg, RH; Tysklind, M; Haemig, PD; Waldenstrom, J; Wallensten, A; Olsen, B				Fick, Jerker; Lindberg, Richard H.; Tysklind, Mats; Haemig, Paul D.; Waldenstrom, Jonas; Wallensten, Anders; Olsen, Bjorn			Antiviral Oseltamivir Is not Removed or Degraded in Normal Sewage Water Treatment: Implications for Development of Resistance by Influenza A Virus	PLOS ONE			English	Article								Oseltamivir is the main antiviral for treatment and prevention of pandemic influenza. The increase in oseltamivir resistance reported recently has therefore sparked a debate on how to use oseltamivir in non pandemic influenza and the risks associated with wide spread use during a pandemic. Several questions have been asked about the fate of oseltamivir in the sewage treatment plants and in the environment. We have assessed the fate of oseltamivir and discuss the implications of environmental residues of oseltamivir regarding the occurrence of resistance. A series of batch experiments that simulated normal sewage treatment with oseltamivir present was conducted and the UV-spectra of oseltamivir were recorded. Findings: Our experiments show that the active moiety of oseltamivir is not removed in normal sewage water treatments and is not degraded substantially by UV light radiation, and that the active substance is released in waste water leaving the plant. Our conclusion is that a ubiquitous use of oseltamivir may result in selection pressures in the environment that favor development of drug-resistance.	[Fick, Jerker; Lindberg, Richard H.; Tysklind, Mats] Umea Univ, Dept Chem, Umea, Sweden; [Haemig, Paul D.; Waldenstrom, Jonas; Olsen, Bjorn] Kalmar Univ, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Waldenstrom, Jonas] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; [Wallensten, Anders] Kalmar Cty Council, Smedby Hlth Ctr, Kalmar, Sweden; [Wallensten, Anders] Linkoping Univ, Fac Hlth Sci, Div Virol, Dept Mol & Clin Med IMK, Linkoping, Sweden; [Olsen, Bjorn] Univ Uppsala Hosp, Infect Dis Sect, Dept Clin Sci, Uppsala, Sweden	Umea University; Linnaeus University; University of Kalmar; Lund University; Linkoping University; Uppsala University; Uppsala University Hospital	Fick, J (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	jerker.fick@chem.umu.se	Berglund Fick, Jerker/HDO-5788-2022; Waldenström, Jonas/E-4460-2013; Lindberg, Richard/C-8882-2013	Waldenström, Jonas/0000-0002-1152-4235; Fick, Jerker/0000-0002-3949-7371; Tysklind, Mats/0000-0001-8709-6970; Olsen, Bjorn/0000-0002-4646-691X	Umea University; The Swedish Research Council; The Swedish Research Council FORMAS	Umea University; The Swedish Research Council(Swedish Research Council); The Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	Umea University, The Swedish Research Council and The Swedish Research Council FORMAS which were the major funders, had no role in the experiments, the analysis of the data or the preparation of the publication. All authors had full access to all the data; the corresponding author had the final responsibility to submit to publication.	Boreen AL, 2003, AQUAT SCI, V65, P320, DOI 10.1007/s00027-003-0672-7; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; Chutinimitkul S, 2007, J VIROL METHODS, V139, P44, DOI 10.1016/j.jviromet.2006.09.007; *F HOFFM LTD, 2005, FURTH EXP TAM MAN CA; *FAO OIE WHO, 2005, CONS AV INFL HUM HLT; Gubareva LV, 2001, ANTIMICROB AGENTS CH, V45, P3403, DOI 10.1128/AAC.45.12.3403-3408.2001; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Lindberg RH, 2006, ENVIRON SCI TECHNOL, V40, P1042, DOI 10.1021/es0516211; Lindberg RH, 2005, ENVIRON SCI TECHNOL, V39, P3421, DOI 10.1021/es048143z; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Moscona A, 2007, JAMA-J AM MED ASSOC, V297, P1492, DOI 10.1001/jama.297.13.1492; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Oxford JS, 2000, REV MED VIROL, V10, P119, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;119::AID-RMV272&gt;3.0.CO;2-O; Singer AC, 2007, ENVIRON HEALTH PERSP, V115, P102, DOI 10.1289/ehp.9574; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Sweetman S. C., 2007, MARTINDALE COMPLETE; Ternes TA, 2004, WATER RES, V38, P4075, DOI 10.1016/j.watres.2004.07.015; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, 2005, WHO DRUG INFORM, V19, P273; Wiltshire H, 2000, J CHROMATOGR B, V745, P373, DOI 10.1016/S0378-4347(00)00300-5	28	76	79	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e986	10.1371/journal.pone.0000986	http://dx.doi.org/10.1371/journal.pone.0000986			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912363	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455900022
J	Forstmeier, W				Forstmeier, Wolfgang			Do Individual Females Differ Intrinsically in Their Propensity to Engage in Extra-Pair Copulations?	PLOS ONE			English	Article								Background. While many studies have investigated the occurrence of extra-pair paternity in wild populations of birds, we still know surprisingly little about whether individual females differ intrinsically in their principal readiness to copulate, and to what extent this readiness is affected by male attractiveness. Methodology/Findings. To address this question I used captive zebra finches (Taeniopygia guttata) as a model system. I first measured female readiness to copulate when courted by a male for the first time in life. Second, I conducted choice-chamber experiments to assess the mating preferences of individual females prior to pair formation. I then paired females socially with a non-desired mate and once they had formed a stable pair bond, I observed the inclination of these females to engage in extra-pair copulations with various males. Females showing a high readiness to copulate when courted by a male for the first time in life were much more likely to engage in extra-pair copulations later in life than others. Male attractiveness, as measured in choice tests, was a useful predictor of whether females engaged in extra-pair copulations with these males, but, surprisingly, the attractiveness of a female's social partner had no effect on her fidelity. However, it remained unclear what made some males more attractive than others. Contrary to a widespread but rarely tested hypothesis, females did not preferentially copulate with males having a redder beak or singing at a higher rate. Rather it seemed that song rate was a confounding factor in choice-chamber experiments: song attracted the female's attention but did not increase the male's attractiveness as a copulation partner. Conclusions/Significance. Intrinsic variation in female readiness to copulate as well as variation in the attractiveness of the extra-pair male but not the social partner decided the outcome of extra-pair encounters.	[Forstmeier, Wolfgang] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Forstmeier, Wolfgang] Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, Seewiesen, Germany	University of Sheffield; Max Planck Society	Forstmeier, W (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	forstmeier@orn.mpg.de			DFG [FO 340/1]; EU [HPMF-CT-2002-01871]	DFG(German Research Foundation (DFG)); EU(European Commission)	This project was funded by an Emmy-Noether Fellowship (DFG: FO 340/1) and a Marie-Curie Fellowship (EU: HPMF-CT-2002-01871).	BIRKHEAD TR, 1990, BEHAV ECOL SOCIOBIOL, V27, P315, DOI 10.1007/BF00164002; BIRKHEAD TR, 1988, ANIM BEHAV, V36, P1853, DOI 10.1016/S0003-3472(88)80133-7; Birkhead TR, 1992, SPERM COMPETITION BI; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; BURLEY N, 1987, ETHOLOGY, V76, P133; BURLEY NT, 1994, ANIM BEHAV, V48, P1031, DOI 10.1006/anbe.1994.1336; Burley NT, 1996, BEHAV ECOL, V7, P218, DOI 10.1093/beheco/7.2.218; COLLINS SA, 1994, BEHAV ECOL SOCIOBIOL, V35, P21, DOI 10.1007/s002650050065; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dietrich V, 2004, BEHAVIOUR, V141, P817, DOI 10.1163/1568539042265644; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Forstmeier W, 2004, ANIM BEHAV, V68, P1005, DOI 10.1016/j.anbehav.2004.02.003; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; HOUTMAN AM, 1992, P ROY SOC B-BIOL SCI, V249, P3, DOI 10.1098/rspb.1992.0075; Immelmann K., 1959, Zool Jb (Abt Syst), V86, P437; JOHNSON K, 1998, ORNITHOLOGICAL MONOG, V49, P1; Ligon JD, 1999, EVOLUTION AVIAN BREE; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; SILCOX AP, 1982, ANIM BEHAV, V30, P1237, DOI 10.1016/S0003-3472(82)80216-9; Weatherhead PJ, 1999, P ROY SOC B-BIOL SCI, V266, P1027, DOI 10.1098/rspb.1999.0739; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Witte K, 2006, ETHOL ECOL EVOL, V18, P195, DOI 10.1080/08927014.2006.9522707; ZANN R, 1996, ZEBRA FINCH	26	49	50	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e952	10.1371/journal.pone.0000952	http://dx.doi.org/10.1371/journal.pone.0000952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895992	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455800030
J	Heyers, D; Manns, M; Luksch, H; Gunturkun, O; Mouritsen, H				Heyers, Dominik; Manns, Martina; Luksch, Harald; Guentuerkuen, Onur; Mouritsen, Henrik			A Visual Pathway Links Brain Structures Active during Magnetic Compass Orientation in Migratory Birds	PLOS ONE			English	Article								The magnetic compass of migratory birds has been suggested to be light-dependent. Retinal cryptochrome-expressing neurons and a forebrain region, "Cluster N", show high neuronal activity when night-migratory songbirds perform magnetic compass orientation. By combining neuronal tracing with behavioral experiments leading to sensory-driven gene expression of the neuronal activity marker ZENK during magnetic compass orientation, we demonstrate a functional neuronal connection between the retinal neurons and Cluster N via the visual thalamus. Thus, the two areas of the central nervous system being most active during magnetic compass orientation are part of an ascending visual processing stream, the thalamofugal pathway. Furthermore, Cluster N seems to be a specialized part of the visual wulst. These findings strongly support the hypothesis that migratory birds use their visual system to perceive the reference compass direction of the geomagnetic field and that migratory birds "see" the reference compass direction provided by the geomagnetic field.	[Heyers, Dominik; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Inst Biol, AG Neurosensor, D-2900 Oldenburg, Germany; [Manns, Martina; Guentuerkuen, Onur] Ruhr Univ Bochum, Inst Cognit Neurosci, Dept Biophychol, Bochum, Germany; [Luksch, Harald] Tech Univ Munich, Dept Zool, D-8050 Freising Weihenstephan, Germany	Carl von Ossietzky Universitat Oldenburg; Ruhr University Bochum; Technical University of Munich	Heyers, D (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol, AG Neurosensor, D-2900 Oldenburg, Germany.	dominik.heyers@uni-oldenburg.de	Manns, Martina/AAX-1421-2021; Mouritsen, Henrik/A-5401-2010; Heyers, Dominik/D-3885-2015	Mouritsen, Henrik/0000-0001-7082-4839; Heyers, Dominik/0000-0002-2831-6985; Gunturkun, Onur/0000-0003-4173-5233; Luksch, Harald/0000-0002-9835-7715; Manns, Martina/0000-0001-8860-9504	VolkswagenStiftung; Deutsche Forschungsgemeinschaft [FOR 701, MO 1408/1-2, Lu 622/8, SFB 509]	VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	VolkswagenStiftung ("Dynamics and adaptivity of neuronal systems" grant given to D. Heyers and "Nachwuchsgruppe/Lichtenberg" grant given to H. Mouritsen), Deutsche Forschungsgemeinschaft (FOR 701 and MO 1408/1-2 grants to H. Mouritsen; Lu 622/8 grant to H. Luksch; SFB 509 to M. Manns and O. Gunturkun).	Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Fleissner G, 2003, J COMP NEUROL, V458, P350, DOI 10.1002/cne.10579; GUNTURKUN O, 1991, J COMP NEUROL, V314, P721, DOI 10.1002/cne.903140407; Gunturkun Onur, 2000, P1, DOI 10.1016/B978-012747605-6/50002-X; Gunturkun Onur, 1993, P115; Hellmann B, 2001, J COMP NEUROL, V429, P94, DOI 10.1002/1096-9861(20000101)429:1<94::AID-CNE8>3.0.CO;2-5; Hellmann B, 2004, J COMP NEUROL, V472, P395, DOI 10.1002/cne.20056; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; KARTEN H, 1968, ANAT REC, V160, P373; KARTEN HJ, 1973, STEREOTACTIC ATLAS B; Kirschvink JL, 2001, CURR OPIN NEUROBIOL, V11, P462, DOI 10.1016/S0959-4388(00)00235-X; Koshiba M, 2005, NEUROSCI RES, V52, P235, DOI 10.1016/j.neures.2005.03.017; Kuenzel W.J., 1988, STEREOTAXIC ATLAS BR; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; Marin G, 2003, J COMP NEUROL, V458, P361, DOI 10.1002/cne.10591; MICELI D, 1990, BRAIN RES, V518, P317, DOI 10.1016/0006-8993(90)90990-S; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Mouritsen H, 2004, CURR BIOL, V14, P1946, DOI 10.1016/j.cub.2004.10.025; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Mouritsen H, 2001, J EXP BIOL, V204, P3855; Muheim R, 2002, J EXP BIOL, V205, P3845; REMY M, 1991, J COMP NEUROL, V305, P57, DOI 10.1002/cne.903050107; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; SCHULTEN K, 1978, BIOPHYS J, V24, P295, DOI 10.1016/S0006-3495(78)85378-8; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R., 1995, TIEROSYCHOL; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; Wiltschko W, 2002, NATURWISSENSCHAFTEN, V89, P445, DOI 10.1007/s00114-002-0356-5	35	134	139	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e937	10.1371/journal.pone.0000937	http://dx.doi.org/10.1371/journal.pone.0000937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895978	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455800016
J	Klapholz-Brown, Z; Walmsley, GG; Nusse, YM; Nusse, R; Brown, PO				Klapholz-Brown, Zach; Walmsley, Graham G.; Nusse, Ysbrand M.; Nusse, Roel; Brown, Patrick O.			Transcriptional Program Induced by Wnt Protein in Human Fibroblasts Suggests Mechanisms for Cell Cooperativity in Defining Tissue Microenvironments	PLOS ONE			English	Article								Background. The Wnt signaling system plays key roles in development, regulation of stem cell self-renewal and differentiation, cell polarity, morphogenesis and cancer. Given the multifaceted roles of Wnt signaling in these processes, its transcriptional effects on the stromal cells that make up the scaffold and infrastructure of epithelial tissues are of great interest. Methods and Results. To begin to investigate these effects, we used DNA microarrays to identify transcriptional targets of the Wnt pathway in human lung fibroblasts. Cells were treated with active Wnt3a protein in culture, and RNA was harvested at 4 hours and 24 hours. Nuclear accumulation of beta-Catenin, as shown by immunofluorescence, and induction of AXIN2 demonstrate that fibroblasts are programmed to respond to extracellular Wnt signals. In addition to several known Wnt targets, we found many new Wnt induced genes, including many transcripts encoding regulatory proteins. Transcription factors with important developmental roles, including HOX genes, dominated the early transcriptional response. Furthermore, we found differential expression of several genes that play direct roles in the Wnt signaling pathway, as well as genes involved in other cell signaling pathways including fibroblast growth factor (FGF) and bone morphogenetic protein (BMP) signaling. The gene most highly induced by Wnt3a was GREMLIN2, which encodes a secreted BMP antagonist. Conclusions. Elevated expression of GREMLIN2 suggests a new role for Wnt signals in the maintenance of stem cell niches, whereby Wnt signals induce nearby fibroblasts to produce a BMP antagonist, inhibiting differentiation and promoting expansion of stem cells in their microenvironment. We suggest that Wnt-induced changes in the gene expression program of local stromal cells may play an important role in the establishment of specialized niches hospitable to the self-renewal of normal or malignant epithelial stem cells in vivo.	[Klapholz-Brown, Zach; Walmsley, Graham G.; Brown, Patrick O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Nusse, Ysbrand M.; Nusse, Roel] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Nusse, Roel; Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Klapholz-Brown, Z (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	zklapholzbrown@umail.ucsb.edu		Nusse, Ysbrand/0000-0001-6437-1490	Howard Hughes Medical Institute; NIH [CA77097]; NATIONAL CANCER INSTITUTE [R01CA077097] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Howard Hughes Medical Institute and NIH grant CA77097 funded the work. The funders had no role in the design or conduct of the study or preparation or approval of the manuscript.	Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Deimling J, 2007, AM J PHYSIOL-LUNG C, V292, pL725, DOI 10.1152/ajplung.00221.2006; Eblaghie MC, 2006, DEV BIOL, V291, P67, DOI 10.1016/j.ydbio.2005.12.006; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Im J, 2007, BIOCHEM BIOPH RES CO, V354, P296, DOI 10.1016/j.bbrc.2006.12.205; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Olumi AF, 1999, CANCER RES, V59, P5002; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; Sakiyama J, 2000, DEV BIOL, V227, P12, DOI 10.1006/dbio.2000.9880; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shats I, 2007, CELL CYCLE, V6, P1141, DOI 10.4161/cc.6.10.4251; Shimokawa T, 2003, CANCER RES, V63, P6116; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8	28	66	71	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e945	10.1371/journal.pone.0000945	http://dx.doi.org/10.1371/journal.pone.0000945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895986	gold, Green Submitted, Green Published			2022-12-27	WOS:000207455800024
J	Boyd, WA; McBride, SJ; Freedman, JH				Boyd, Windy A.; McBride, Sandra J.; Freedman, Jonathan H.			Effects of Genetic Mutations and Chemical Exposures on Caenorhabditis elegans Feeding: Evaluation of a Novel, High-Throughput Screening Assay	PLOS ONE			English	Article							C-ELEGANS; END-POINTS; TOXICITY; CADMIUM; PHARYNX; STARVATION; LONGEVITY; SEROTONIN; BEHAVIOR; MUTANTS	Background. Government agencies have defined a need to reduce, refine or replace current mammalian-based bioassays with testing methods that use alternative species. Invertebrate species, such as Caenorhabditis elegans, provide an attractive option because of their short life cycles, inexpensive maintenance, and high degree of evolutionary conservation with higher eukaryotes. The C. elegans pharynx is a favorable model for studying neuromuscular function, and the effects of chemicals on neuromuscular activity, i.e., feeding. Current feeding methodologies, however, are labor intensive and only semi-quantitative. Methodology/Principal Findings. Here a high-throughput assay is described that uses flow cytometry to measure C. elegans feeding by determining the size and intestinal fluorescence of hundreds of nematodes after exposure to fluorescent-labeled microspheres. This assay was validated by quantifying fluorescence in feeding-defective C. elegans ( eat mutants), and by exposing wild-type nematodes to the neuroactive compounds, serotonin and arecoline. The eat mutations previously determined to cause slow pumping rates exhibited the lowest feeding levels with our assay. Concentration-dependent increases in feeding levels after serotonin exposures were dependent on food availability, while feeding levels decreased in arecoline-exposed nematodes regardless of the presence of food. The effects of the environmental contaminants, cadmium chloride and chlorpyrifos, on wild-type C. elegans feeding were then used to demonstrate an application of the feeding assay. Cadmium exposures above 200 mu M led to a sharp drop in feeding levels. Feeding of chlorpyrifos-exposed nematodes decreased in a concentration-dependent fashion with an EC50 of 2 mu M. Conclusions/Significance. The C. elegans fluorescence microsphere feeding assay is a rapid, reliable method for the assessment of neurotoxic effects of pharmaceutical drugs, industrial chemicals or environmental agents. This assay may also be applicable to large scale genetic or RNAi screens used to identify genes that are necessary for the development or function of the pharynx or other neuromuscular systems.	[Boyd, Windy A.; Freedman, Jonathan H.] NIEHS, Mol Toxicol Lab, Natl Toxicol Program, NIH, Res Triangle Pk, NC 27709 USA; [McBride, Sandra J.; Freedman, Jonathan H.] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University	Freedman, JH (corresponding author), NIEHS, Mol Toxicol Lab, Natl Toxicol Program, NIH, Res Triangle Pk, NC 27709 USA.	freedma1@niehs.nih.gov		Boyd, Windy/0000-0003-3803-3716; McBride, Sandra/0000-0003-3730-9864	National Toxicology Program; Intramural Research Program of the NIH; NIEHS; NIH National Center for Research Resources (NCRR).; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES102046, ZIAES102046] Funding Source: NIH RePORTER	National Toxicology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH National Center for Research Resources (NCRR).(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported ( in part) by the National Toxicology Program, and by the Intramural Research Program of the NIH, and NIEHS. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Anderson GL, 2004, ENVIRON TOXICOL CHEM, V23, P1235, DOI 10.1897/03-264; Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; AVERY L, 1993, GENETICS, V134, P454; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; AVERY L, 1997, C ELEGANS, V2, P679, DOI [10.1101/087969532.33.679, DOI 10.1101/087969532.33.679]; Bargmann CI, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews1005; Barron MG, 1995, REV ENVIRON CONTAM T, V144, P1; Becker RA, 2006, REGUL TOXICOL PHARM, V46, P18, DOI 10.1016/j.yrtph.2006.06.001; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P3049, DOI 10.1897/02-565; BRENNER S, 1974, GENETICS, V77, P71; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Cole RD, 2004, TOXICOL APPL PHARM, V194, P248, DOI 10.1016/j.taap.2003.09.013; Combes D, 2001, INT REV CYTOL, V209, P207; Copeland RA, 2000, ENZYMES PRACTICAL IN, P109; Corsi AK, 2006, ANAL BIOCHEM, V359, P1, DOI 10.1016/j.ab.2006.07.033; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; CROLL NA, 1975, CAN J ZOOL, V53, P894, DOI 10.1139/z75-103; Culetto E, 2000, HUM MOL GENET, V9, P869, DOI 10.1093/hmg/9.6.869; Davis MW, 1995, J NEUROSCI, V15, P8408; Franks DM, 2006, DEV BIOL, V296, P409, DOI 10.1016/j.ydbio.2006.06.008; Furlong EEM, 2001, NAT BIOTECHNOL, V19, P153, DOI 10.1038/84422; Gill MS, 2003, FREE RADICAL BIO MED, V35, P558, DOI 10.1016/S0891-5849(03)00328-9; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Jones D, 1999, J EXP ZOOL, V284, P147, DOI 10.1002/(SICI)1097-010X(19990701)284:2&lt;147::AID-JEZ4&gt;3.0.CO;2-Z; Kaganman I, 2006, NAT METHODS, V3, P662, DOI 10.1038/nmeth0906-662a; KAUFMAN L, 2005, FINDING GROUPS DATA, P126; Khanna N, 1997, ARCH ENVIRON CON TOX, V32, P110, DOI 10.1007/s002449900162; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; KOTSONIS FN, 1977, TOXICOL APPL PHARM, V41, P667, DOI 10.1016/S0041-008X(77)80020-3; Morck C, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-39; NETER J, 1996, APPL LINEAR STAT MOD, P959; Niacaris T, 2003, J EXP BIOL, V206, P223, DOI 10.1242/jeb.00101; Petersen CI, 2004, P NATL ACAD SCI USA, V101, P11773, DOI 10.1073/pnas.0306005101; Pulak Rock, 2006, V351, P275; RAIZEN DM, 1995, GENETICS, V141, P1365; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; RATKOWSKY DA, 1983, NONLINEAR REGRESSION, P75; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Shibata Y, 2000, GENETICS, V154, P635; Thompson G, 2005, J BIOCHEM MOL TOXIC, V19, P87, DOI 10.1002/jbt.20060; Waalkes MP, 2000, J INORG BIOCHEM, V79, P241, DOI 10.1016/S0162-0134(00)00009-X; WILLIAMS PL, 1988, TOXICOL IND HEALTH, V4, P469, DOI 10.1177/074823378800400406; WONG KL, 1982, TOXICOL APPL PHARM, V63, P330, DOI 10.1016/0041-008X(82)90261-7; You YJ, 2006, CELL METAB, V3, P237, DOI 10.1016/j.cmet.2006.02.012	47	51	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1259	10.1371/journal.pone.0001259	http://dx.doi.org/10.1371/journal.pone.0001259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060055	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459400008
J	Smith, TJ; Hill, KK; Foley, BT; Detter, JC; Munk, AC; Bruce, DC; Doggett, NA; Smith, LA; Marks, JD; Xie, G; Brettin, TS				Smith, Theresa J.; Hill, Karen K.; Foley, Brian T.; Detter, John C.; Munk, A. Christine; Bruce, David C.; Doggett, Norman A.; Smith, Leonard A.; Marks, James D.; Xie, Gary; Brettin, Thomas S.			Analysis of the Neurotoxin Complex Genes in Clostridium botulinum A1-A4 and B1 Strains: BoNT/A3, BoNT/Ba4 and BoNT/B1 Clusters Are Located within Plasmids	PLOS ONE			English	Article							GENOME SEQUENCE; INFANT BOTULISM; TOXIN COMPLEX; C-NEUROTOXIN; ORGANIZATION; DATABASE; BINDING; MECHANISMS; DIVERSITY; ALIGNMENT	Background. Clostridium botulinum and related clostridial species express extremely potent neurotoxins known as botulinum neurotoxins (BoNTs) that cause long-lasting, potentially fatal intoxications in humans and other mammals. The amino acid variation within the BoNT is used to categorize the species into seven immunologically distinct BoNT serotypes (A-G) which are further divided into subtypes. The BoNTs are located within two generally conserved gene arrangements known as botulinum progenitor complexes which encode toxin-associated proteins involved in toxin stability and expression. Methodology/Principal Findings. Because serotype A and B strains are responsible for the vast majority of human botulism cases worldwide, the location, arrangement and sequences of genes from eight different toxin complexes representing four different BoNT/A subtypes (BoNT/A1-Ba4) and one BoNT/B1 strain were examined. The bivalent Ba4 strain contained both the BoNT/A4 and BoNT/bvB toxin clusters. The arrangements of the BoNT/A3 and BoNT/A4 subtypes differed from the BoNT/A1 strains and were similar to those of BoNT/A2. However, unlike the BoNT/A2 subtype, the toxin complex genes of BoNT/A3 and BoNT/A4 were found within large plasmids and not within the chromosome. In the Ba4 strain, both BoNT toxin clusters (A4 and bivalent B) were located within the same 270 kb plasmid, separated by 97 kb. Complete genomic sequencing of the BoNT/B1 strain also revealed that its toxin complex genes were located within a 149 kb plasmid and the BoNT/A3 complex is within a 267 kb plasmid. Conclusions/Significance. Despite their size differences and the BoNT genes they contain, the three plasmids containing these toxin cluster genes share significant sequence identity. The presence of partial insertion sequence ( IS) elements, evidence of recombination/gene duplication events, and the discovery of the BoNT/A3, BoNT/Ba4 and BoNT/B1 toxin complex genes within plasmids illustrate the different mechanisms by which these genes move among diverse genetic backgrounds of C. botulinum.	[Hill, Karen K.; Detter, John C.; Munk, A. Christine; Bruce, David C.; Doggett, Norman A.; Xie, Gary; Brettin, Thomas S.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Smith, Theresa J.; Smith, Leonard A.] USA, Med Inst Infect Dis, Integrated Toxicol Div, Ft Detrick, MD USA; [Foley, Brian T.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Marks, James D.] Univ Calif San Francisco, Dept Anesthesia & Pharmaceut Chem, San Francisco, CA 94143 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California San Francisco	Hill, KK (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA.	Khill@lanl.gov	Foley, Brian T/N-4527-2018	Foley, Brian T/0000-0002-1086-0296; xie, gary/0000-0002-9176-924X	U.S. Department of Energy; NIAID [UO1 AI056493, U01 AI056493]; Intelligence Technology Innovation Center (ITIC); DoD [DAMD17-03-C-0076]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI056493] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intelligence Technology Innovation Center (ITIC); DoD(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this project was provided by the U.S. Department of Energy, and NIAID grant UO1 AI056493. The DOE Joint Genome Institute (JGI) at Los Alamos National Laboratory acknowledges the support of the Intelligence Technology Innovation Center (ITIC) for this research. This work was partially supported by DoD contract DAMD17-03-C-0076 and by NIAID cooperative agreement U01 AI056493.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoki KR, 2004, CURR MED CHEM, V11, P3085, DOI 10.2174/0929867043363802; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bhandari M, 1997, CURR MICROBIOL, V35, P207, DOI 10.1007/s002849900240; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bruggemann H, 2004, ANAEROBE, V10, P53, DOI 10.1016/j.anaerobe.2003.08.001; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; *CDC, 1998, BOT US 1899 1998 HDB; Collins MD, 1998, J APPL MICROBIOL, V84, P5, DOI 10.1046/j.1365-2672.1997.00313.x; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Dineen SS, 2004, FEMS MICROBIOL LETT, V235, P9, DOI 10.1016/j.femsle.2004.04.002; Dineen SS, 2003, CURR MICROBIOL, V46, P345, DOI 10.1007/s00284-002-3851-1; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; East AK, 1998, CURR MICROBIOL, V37, P262, DOI 10.1007/s002849900376; East AK, 1996, INT J SYST BACTERIOL, V46, P1105, DOI 10.1099/00207713-46-4-1105; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDMOND BJ, 1977, TEX MED, V73, P85; Franciosa G, 2006, FEMS MICROBIOL LETT, V261, P88, DOI 10.1111/j.1574-6968.2006.00331.x; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; GIMENEZ DF, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P421; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Han C., 2006, P 2006 INT C BIOINF, P141; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; HAUSER D, 1994, MOL GEN GENET, V243, P631, DOI 10.1007/BF00279572; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Jovita MR, 1998, CURR MICROBIOL, V36, P226, DOI 10.1007/s002849900299; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kubota T, 1998, FEMS MICROBIOL LETT, V158, P215, DOI 10.1016/S0378-1097(97)00525-9; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LAMANNA C, 1947, J BACTERIOL, V54, P575, DOI 10.1128/JB.54.5.575-584.1947; Lee JC, 2005, MICROBIOL-SGM, V151, P3739, DOI 10.1099/mic.0.28421-0; Leighton Gerald, 1923, BOTULISM FOOD PRESER; Lindstrom M, 2006, CLIN MICROBIOL REV, V19, P298, DOI 10.1128/CMR.19.2.298-314.2006; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MACDONALD TE, 2007, APPL ENV MICROBIOL; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Maksymowych AB, 1999, INFECT IMMUN, V67, P4708, DOI 10.1128/IAI.67.9.4708-4712.1999; Marshall KM, 2007, BIOCHEM BIOPH RES CO, V361, P49, DOI 10.1016/j.bbrc.2007.06.166; McHardy AC, 2004, BIOINFORMATICS, V20, P1622, DOI 10.1093/bioinformatics/bth137; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Miyamoto K, 2006, J BACTERIOL, V188, P1585, DOI 10.1128/JB.188.4.1585-1598.2006; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Nakajima H, 1998, MICROBIOL IMMUNOL, V42, P599, DOI 10.1111/j.1348-0421.1998.tb02330.x; NIELSEN H, 1998, P 6 INT C INT SYST M, P122; Popoff MR, 1999, COMPREHENSIVE SOURCE, P202; Raffestin S, 2004, ANAEROBE, V10, P93, DOI 10.1016/j.anaerobe.2004.01.001; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Sakaguchi Y, 2005, P NATL ACAD SCI USA, V102, P17472, DOI 10.1073/pnas.0505503102; Santos-Buelga JA, 1998, CURR MICROBIOL, V37, P312, DOI 10.1007/s002849900384; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; STROM MS, 1984, APPL ENVIRON MICROB, V48, P956, DOI 10.1128/AEM.48.5.956-963.1984; Suzek BE, 2001, BIOINFORMATICS, V17, P1123, DOI 10.1093/bioinformatics/17.12.1123; TAKAHASHI M, 1988, JPN J MED SCI BIOL, V41, P21, DOI 10.7883/yoken1952.41.21; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Webb RP, 2007, VACCINE, V25, P4273, DOI 10.1016/j.vaccine.2007.02.081; ZHOU YT, 1995, INFECT IMMUN, V63, P2087, DOI 10.1128/IAI.63.5.2087-2091.1995	62	126	1289	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1271	10.1371/journal.pone.0001271	http://dx.doi.org/10.1371/journal.pone.0001271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060065	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459400018
J	Bar-Yehuda, D; Korngreen, A				Bar-Yehuda, Dan; Korngreen, Alon			Cellular and Network Contributions to Excitability of Layer 5 Neocortical Pyramidal Neurons in the Rat	PLOS ONE			English	Article								There is a considerable gap between investigating the dynamics of single neurons and the computational aspects of neural networks. A growing number of studies have attempted to overcome this gap using the excitation in brain slices elicited by various chemical manipulations of the bath solution. However, there has been no quantitative study on the effects of these manipulations on the cellular and network factors controlling excitability. Using the whole-cell configuration of the patch-clamp technique we recorded the membrane potential from the soma of layer 5 pyramidal neurons in acute brain slices from the somatosensory cortex of young rats at 22 degrees C and 35 degrees C. Using blockers of synaptic transmission, we show distinct changes in cellular properties following modification of the ionic composition of the artificial cerebrospinal fluid (ACSF). Thus both cellular and network changes may contribute to the observed effects of slice excitation solutions on the physiology of single neurons. Furthermore, our data suggest that the difference in the ionic composition of current standard ACSF from that of CSF measured in vivo cause ACSF to depress network activity in acute brain slices. This may affect outcomes of experiments investigating biophysical and physiological properties of neurons in such preparations. Our results strongly advocate the necessity of redesigning experiments routinely carried out in the quiescent acute brain slice preparation.	[Korngreen, Alon] Bar Ilan Univ, Mina & Everard Fac Life Sci, Ramat Gan, Israel; [Bar-Yehuda, Dan; Korngreen, Alon] Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Korngreen, A (corresponding author), Bar Ilan Univ, Mina & Everard Fac Life Sci, Ramat Gan, Israel.	korngra@mail.biu.ac.il		Korngreen, Alon/0000-0002-2036-6160	German Israeli Foundation [748158.1/2002]	German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	This research was supported by the German Israeli Foundation (# 748158.1/2002).	Andrew RD, 1996, J NEUROPHYSIOL, V76, P2707, DOI 10.1152/jn.1996.76.4.2707; Antic SD, 2003, J PHYSIOL-LONDON, V550, P35, DOI 10.1113/jphysiol.2002.033746; Ariav G, 2003, J NEUROSCI, V23, P7750; Arvanov VL, 1997, BRAIN RES, V768, P361, DOI 10.1016/S0006-8993(97)00842-1; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chen WR, 2002, J NEUROPHYSIOL, V88, P2755, DOI 10.1152/jn.00057.2002; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; De Schutter E, 1999, REV NEUROSCIENCE, V10, P233; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Harsch A, 2000, J NEUROSCI, V20, P6181, DOI 10.1523/JNEUROSCI.20-16-06181.2000; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; HVALBY O, 1990, PROG BRAIN RES, V83, P131; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Korngreen A, 2004, J NEUROPHYSIOL, V91, P2400, DOI 10.1152/jn.00115.2004; Korogod SM, 1996, NEUROSCIENCE, V75, P1153, DOI 10.1016/0306-4522(96)00265-5; London M, 2002, NAT NEUROSCI, V5, P332, DOI 10.1038/nn826; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; OVIEDO H, 2002, NAT NEUROSCI, P261; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Reig R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000670; ROBINSON HPC, 1994, TRENDS NEUROSCI, V17, P147, DOI 10.1016/0166-2236(94)90088-4; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schwindt PC, 1997, J NEUROPHYSIOL, V77, P2466, DOI 10.1152/jn.1997.77.5.2466; SHARP AA, 1993, TRENDS NEUROSCI, V16, P389, DOI 10.1016/0166-2236(93)90004-6; Sickmann T, 2002, BRAIN RES, V929, P166, DOI 10.1016/S0006-8993(01)03386-8; Silberberg G, 2004, J PHYSIOL-LONDON, V556, P19, DOI 10.1113/jphysiol.2004.060962; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STUART G, 1995, CURR OPIN NEUROBIOL, V5, P389, DOI 10.1016/0959-4388(95)80053-0; Stuart G., 1999, DENDRITES; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Takigawa T, 1999, J PHYSIOL-LONDON, V517, P385, DOI 10.1111/j.1469-7793.1999.0385t.x; Williams SR, 2005, J NEUROSCI, V25, P5894, DOI 10.1523/JNEUROSCI.0502-05.2005; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; Zhang ZW, 2003, J NEUROSCI, V23, P3373; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x	52	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1209	10.1371/journal.pone.0001209	http://dx.doi.org/10.1371/journal.pone.0001209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030343	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459200022
J	Kumar, S; Chaudhary, K; Foster, JM; Novelli, JF; Zhang, YH; Wang, SL; Spiro, D; Ghedin, E; Carlow, CKS				Kumar, Sanjay; Chaudhary, Kshitiz; Foster, Jeremy M.; Novelli, Jacopo F.; Zhang, Yinhua; Wang, Shiliang; Spiro, David; Ghedin, Elodie; Carlow, Clotilde K. S.			Mining Predicted Essential Genes of Brugia malayi for Nematode Drug Targets	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; ONCHOCERCA-VOLVULUS; LITOMOSOIDES-SIGMODONTIS; RNA INTERFERENCE; CHITIN SYNTHASE; EXPRESSION; FAMILY; RESISTANCE; IVERMECTIN; REGULATOR	We report results from the first genome-wide application of a rational drug target selection methodology to a metazoan pathogen genome, the completed draft sequence of Brugia malayi, a parasitic nematode responsible for human lymphatic filariasis. More than 1.5 billion people worldwide are at risk of contracting lymphatic filariasis and onchocerciasis, a related filarial disease. Drug treatments for filariasis have not changed significantly in over 20 years, and with the risk of resistance rising, there is an urgent need for the development of new anti-filarial drug therapies. The recent publication of the draft genomic sequence for B. malayi enables a genome-wide search for new drug targets. However, there is no functional genomics data in B. malayi to guide the selection of potential drug targets. To circumvent this problem, we have utilized the free-living model nematode Caenorhabditis elegans as a surrogate for B. malayi. Sequence comparisons between the two genomes allow us to map C. elegans orthologs to B. malayi genes. Using these orthology mappings and by incorporating the extensive genomic and functional genomic data, including genome-wide RNAi screens, that already exist for C. elegans, we identify potentially essential genes in B. malayi. Further incorporation of human host genome sequence data and a custom algorithm for prioritization enables us to collect and rank nearly 600 drug target candidates. Previously identified potential drug targets cluster near the top of our prioritized list, lending credibility to our methodology. Over-represented Gene Ontology terms, predicted InterPro domains, and RNAi phenotypes of C. elegans orthologs associated with the potential target pool are identified. By virtue of the selection procedure, the potential B. malayi drug targets highlight components of key processes in nematode biology such as central metabolism, molting and regulation of gene expression.	[Kumar, Sanjay; Chaudhary, Kshitiz; Foster, Jeremy M.; Novelli, Jacopo F.; Zhang, Yinhua; Carlow, Clotilde K. S.] New England Biolabs Inc, Div Parasitol, Ipswich, MA USA; [Wang, Shiliang; Spiro, David; Ghedin, Elodie] Inst Genom Res, Rockville, MD USA; [Ghedin, Elodie] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA USA	New England Biolabs; J. Craig Venter Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carlow, CKS (corresponding author), New England Biolabs Inc, Div Parasitol, Ipswich, MA USA.	carlow@neb.com	Ghedin, Elodie/Y-5654-2019; Kumar, Sanjay/AAO-2593-2021	Ghedin, Elodie/0000-0002-1515-725X; Zhang, Yinhua/0000-0003-0592-9153	New England Biolabs; National Institute for Allergy and Infectious Diseases (NIAID/NIH)	New England Biolabs; National Institute for Allergy and Infectious Diseases (NIAID/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by New England Biolabs. Funding for portions of this work was also provided by a grant from the National Institute for Allergy and Infectious Diseases (NIAID/NIH) awarded to E.G.	AbdelWahab N, 1996, MOL BIOCHEM PARASIT, V76, P187, DOI 10.1016/0166-6851(95)02558-8; Aboobaker AA, 2003, MOL BIOCHEM PARASIT, V129, P41, DOI 10.1016/S0166-6851(03)00092-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barnes TM, 1997, J NEUROCHEM, V69, P2251; Behm CA, 2005, TRENDS PARASITOL, V21, P97, DOI 10.1016/j.pt.2004.12.003; Behm CA, 1997, INT J PARASITOL, V27, P215, DOI 10.1016/S0020-7519(96)00151-8; Beverley SM, 2005, EUKARYOT CELL, V4, P1147, DOI 10.1128/EC.4.6.1147-1154.2005; Bieri T, 2007, NUCLEIC ACIDS RES, V35, pD506, DOI 10.1093/nar/gkl818; Bird AF, 1991, STRUCTURE NEMATODES; BLUMENTHAL T, 1995, TRENDS GENET, V11, P132, DOI 10.1016/S0168-9525(00)89026-5; Brooks DR, 2002, PARASITOL INT, V51, P319, DOI 10.1016/S1383-5769(02)00063-6; Burglin TR, 1998, INT J PARASITOL, V28, P395, DOI 10.1016/S0020-7519(97)00208-7; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Craig H, 2007, TRENDS PARASITOL, V23, P248, DOI 10.1016/j.pt.2007.04.003; Denker JA, 2002, NATURE, V417, P667, DOI 10.1038/nature00783; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Filarial Genome Project, 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene, V96, P7, DOI 10.1016/S0035-9203(02)90224-5; Ford L, 2005, J BIOL CHEM, V280, P40845, DOI 10.1074/jbc.M504434200; Foster JM, 2005, TRENDS PARASITOL, V21, P101, DOI 10.1016/j.pt.2004.12.002; Foster JM, 2005, MOL BIOCHEM PARASIT, V142, P126, DOI 10.1016/j.molbiopara.2005.03.011; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Galperin MY, 1999, CURR OPIN BIOTECH, V10, P571, DOI 10.1016/S0958-1669(99)00035-X; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Grossmann S, 2006, LECT NOTES COMPUT SC, V3909, P85; Hao LM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-280; Hao LM, 2006, DEV DYNAM, V235, P1469, DOI 10.1002/dvdy.20721; Harris MT, 2000, MOL BIOCHEM PARASIT, V111, P351, DOI 10.1016/S0166-6851(00)00328-5; Hasan S, 2006, PLOS COMPUT BIOL, V2, P539, DOI 10.1371/journal.pcbi.0020061; Hashmi S, 2001, TRENDS PARASITOL, V17, P387, DOI 10.1016/S1471-4922(01)01986-9; Heid PJ, 2001, DEV BIOL, V236, P165, DOI 10.1006/dbio.2001.0315; Heider U, 2006, INT J MED MICROBIOL, V296, P287, DOI 10.1016/j.ijmm.2005.12.019; Hoerauf Achim, 2006, Expert Rev Anti Infect Ther, V4, P211, DOI 10.1586/14787210.4.2.211; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hristova M, 2005, MOL CELL BIOL, V25, P11059, DOI 10.1128/MCB.25.24.11059-11072.2005; Kleczka B, 2007, J BIOL CHEM, V282, P10498, DOI 10.1074/jbc.M700023200; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Kormish JD, 2005, DEV BIOL, V287, P35, DOI 10.1016/j.ydbio.2005.08.027; Korswagen HC, 2002, GENE DEV, V16, P1291, DOI 10.1101/gad.981802; Kostrouchova M, 2001, P NATL ACAD SCI USA, V98, P7360, DOI 10.1073/pnas.131171898; Kuervers LM, 2003, MOL GENET GENOMICS, V270, P121, DOI 10.1007/s00438-003-0900-9; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LABOUESSE M, 2006, WORMBOOK; Luan CH, 2004, GENOME RES, V14, P2102, DOI 10.1101/gr.2520504; Lustigmana S, 2004, MOL BIOCHEM PARASIT, V138, P165, DOI 10.1016/j.molbiopara.2004.08.003; MacMorris M, 2007, RNA, V13, P511, DOI 10.1261/rna.426707; Maine EM, 2005, CURR BIOL, V15, P1972, DOI 10.1016/j.cub.2005.09.049; Maloof JN, 1999, DEVELOPMENT, V126, P37; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; McCarter JP, 2004, TRENDS PARASITOL, V20, P462, DOI 10.1016/j.pt.2004.07.008; McMahon L, 2001, J CELL SCI, V114, P2265; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Page AP, 2006, INT J PARASITOL, V36, P681, DOI 10.1016/j.ijpara.2006.01.004; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Pfarr K, 2006, INT J PARASITOL, V36, P661, DOI 10.1016/j.ijpara.2006.01.010; Phelan P, 2005, BBA-BIOMEMBRANES, V1711, P225, DOI 10.1016/j.bbamem.2004.10.004; POWELL JW, 1986, MOL BIOCHEM PARASIT, V18, P171, DOI 10.1016/0166-6851(86)90036-8; QIAO L, 1995, GENETICS, V141, P551; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; Rosamond L, 2000, SCIENCE, V287, P1973, DOI 10.1126/science.287.5460.1973; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Schwab AE, 2005, AM J TROP MED HYG, V73, P234, DOI 10.4269/ajtmh.2005.73.234; SINGH RN, 1978, NEMATOLOGICA, V24, P63, DOI 10.1163/187529278X00074; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Starich T, 2001, CELL COMMUN ADHES, V8, P311, DOI 10.3109/15419060109080744; Starich TA, 1996, J CELL BIOL, V134, P537, DOI 10.1083/jcb.134.2.537; TAYLOR MJ, 1995, INFECT IMMUN, V63, P4417, DOI 10.1128/IAI.63.11.4417-4422.1995; Tsuboi D, 2002, BIOCHEM BIOPH RES CO, V292, P697, DOI 10.1006/bbrc.2002.6717; Vought VE, 2005, GENETICS, V170, P1121, DOI 10.1534/genetics.105.042135; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Whitten SJ, 2007, DEV BIOL, V301, P432, DOI 10.1016/j.ydbio.2006.08.038; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; World Health Organization, 2004, WORLD HLTH REP 2004; Zhang YH, 2005, DEV BIOL, V285, P330, DOI 10.1016/j.ydbio.2005.06.037; Zhang YH, 2004, J BIOL CHEM, V279, P37185, DOI 10.1074/jbc.M405877200; Zugasti O, 2005, GENOME RES, V15, P1402, DOI 10.1101/gr.3935405	78	75	77	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1189	10.1371/journal.pone.0001189	http://dx.doi.org/10.1371/journal.pone.0001189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000556	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000207459100027
J	Li, W; Ashok, M; Li, JH; Yang, H; Sama, AE; Wang, HC				Li, Wei; Ashok, Mala; Li, Jianhua; Yang, Huan; Sama, Andrew E.; Wang, Haichao			A Major Ingredient of Green Tea Rescues Mice from Lethal Sepsis Partly by Inhibiting HMGB1	PLOS ONE			English	Article							GROUP BOX-1 PROTEIN; TOLL-LIKE RECEPTOR-2; CECAL LIGATION; PROINFLAMMATORY CYTOKINE; STIMULATES MACROPHAGES; PLASMA-MEMBRANE; NITRIC-OXIDE; LIPID RAFTS; RELEASE; PUNCTURE	Background. The pathogenesis of sepsis is mediated in part by bacterial endotoxin, which stimulates macrophages/monocytes to sequentially release early (e.g., TNF, IL-1, and IFN-gamma) and late (e.g., HMGB1) pro-inflammatory cytokines. Our recent discovery of HMGB1 as a late mediator of lethal sepsis has prompted investigation for development of new experimental therapeutics. We previously reported that green tea brewed from the leaves of the plant Camellia sinensis is effective in inhibiting endotoxin-induced HMGB1 release. Methods and Findings. Here we demonstrate that its major component, (-)-epigallocatechin-3-gallate (EGCG), but not catechin or ethyl gallate, dose-dependently abrogated HMGB1 release in macrophage/monocyte cultures, even when given 2-6 hours post LPS stimulation. Intraperitoneal administration of EGCG protected mice against lethal endotoxemia, and rescued mice from lethal sepsis even when the first dose was given 24 hours after cecal ligation and puncture. The therapeutic effects were partly attributable to: 1) attenuation of systemic accumulation of proinflammatory mediator (e.g., HMGB1) and surrogate marker (e.g., IL-6 and KC) of lethal sepsis; and 2) suppression of HMGB1-mediated inflammatory responses by preventing clustering of exogenous HMGB1 on macrophage cell surface. Conclusions. Taken together, these data suggest a novel mechanism by which the major green tea component, EGCG, protects against lethal endotoxemia and sepsis.	[Li, Wei; Ashok, Mala; Sama, Andrew E.; Wang, Haichao] NYU, Sch Med, N Shore Univ Hosp, Dept Emergency Med, Manhasset, NY 11030 USA; [Li, Jianhua; Yang, Huan; Wang, Haichao] Feinstein Inst Med Res, Manhasset, NY USA	New York University; Northwell Health; North Shore University Hospital; Northwell Health	Wang, HC (corresponding author), NYU, Sch Med, N Shore Univ Hosp, Dept Emergency Med, Manhasset, NY 11030 USA.	hwang@nshs.edu	Wang, Haichao/AAU-2237-2021; Wang, Haichao/K-6310-2012	Wang, Haichao/0000-0002-0211-9000; Wang, Haichao/0000-0002-0211-9000; Li, Wei/0000-0002-7941-7022	National Institute of General Medical Sciences [R01GM063075, R01GM070817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070817, R01GM063075] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institute of General Medical Sciences grants (R01GM063075 and R01GM070817, to H. W.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Agnello D, 2002, CYTOKINE, V18, P231, DOI 10.1006/cyto.2002.0890; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Angus DC, 2007, CRIT CARE MED, V35, P1061, DOI 10.1097/01.CCM.0000259534.68873.2A; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; Chen GQ, 2005, J LIPID RES, V46, P623, DOI 10.1194/jlr.C400018-JLR200; Chen GQ, 2004, J LEUKOCYTE BIOL, V76, P994, DOI 10.1189/jlb.0404242; Chen XT, 2006, MED HYPOTHESES, V66, P660, DOI 10.1016/j.mehy.2005.09.025; Crespy V, 2004, J NUTR, V134, p3431S, DOI 10.1093/jn/134.12.3431S; DINARELLO CA, 1991, IMMUNOL TODAY, V12, P404, DOI 10.1016/0167-5699(91)90142-G; Elbling L, 2005, FASEB J, V19, P807, DOI 10.1096/fj.04-2915fje; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; Fink MP, 1996, INTENS CARE MED, V22, P158, DOI 10.1007/BF01720723; Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S; Fujimura Y, 2004, FEBS LETT, V556, P204, DOI 10.1016/S0014-5793(03)01432-7; Gaini S, 2007, CRIT CARE, V11, DOI 10.1186/cc5715; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Heuer JG, 2004, CRIT CARE MED, V32, P1570, DOI 10.1097/01.CCM.0000129488.54282.1A; Hong J, 2002, CANCER RES, V62, P7241; Ichikawa D, 2004, BIOL PHARM BULL, V27, P1353, DOI 10.1248/bpb.27.1353; IVANOV S, 2007, BLOOD IN PRESS; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019; Li W, 2007, J IMMUNOL, V178, P3856, DOI 10.4049/jimmunol.178.6.3856; Lyu SY, 2005, ARCH PHARM RES, V28, P573, DOI 10.1007/BF02977761; Mercer-Jones MA, 1999, INFLAMMATION, V23, P305; O'Connor KA, 2003, CYTOKINE, V24, P254, DOI 10.1016/j.cyto.2003.08.001; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; Rendon-Mitchell B, 2003, J IMMUNOL, V170, P3890, DOI 10.4049/jimmunol.170.7.3890; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rogers J, 2005, EXP BIOL MED, V230, P645; Sappington PL, 2002, GASTROENTEROLOGY, V123, P790, DOI 10.1053/gast.2002.35391; Tachibana H, 2004, BIOFACTORS, V21, P383, DOI 10.1002/biof.552210174; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Tang DL, 2007, J LEUKOCYTE BIOL, V81, P741, DOI 10.1189/jlb.0806540; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Triantafilou M, 2004, J BIOL CHEM, V279, P40882, DOI 10.1074/jbc.M400466200; Triantafilou M, 2002, J CELL SCI, V115, P2603; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; VILLA P, 1995, CLIN DIAGN LAB IMMUN, V2, P549, DOI 10.1128/CDLI.2.5.549-553.1995; Vincent JL, 2000, AM J RESP CRIT CARE, V161, P1781, DOI 10.1164/ajrccm.161.6.9812004; Vita JA, 2003, J NUTR, V133, p3293S, DOI 10.1093/jn/133.10.3293S; Vyas D, 2005, AM J PHYSIOL-REG I, V289, pR1048, DOI 10.1152/ajpregu.00312.2005; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang HC, 2006, J NUTR, V136, P360, DOI 10.1093/jn/136.2.360; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yang CS, 1998, CANCER EPIDEM BIOMAR, V7, P351; Yang CS, 2000, J NUTR, V130, P2409, DOI 10.1093/jn/130.10.2409; Yang FJ, 1998, J NUTR, V128, P2334, DOI 10.1093/jn/128.12.2334; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yin KS, 2005, SHOCK, V24, P396, DOI 10.1097/01.shk.0000175556.03300.c6; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82	58	114	127	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1153	10.1371/journal.pone.0001153	http://dx.doi.org/10.1371/journal.pone.0001153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987129	Green Published, gold			2022-12-27	WOS:000207459000035
J	Theveneau, E; Duband, JL; Altabef, M				Theveneau, Eric; Duband, Jean-Loup; Altabef, Muriel			Ets-1 Confers Cranial Features on Neural Crest Delamination	PLOS ONE			English	Article								Neural crest cells (NCC) have the particularity to invade the environment where they differentiate after separation from the neuroepithelium. This process, called delamination, is strikingly different between cranial and trunk NCCs. If signalings controlling slow trunk delamination start being deciphered, mechanisms leading to massive and rapid cranial outflow are poorly documented. Here, we show that the chick cranial NCCs delamination is the result of two events: a substantial cell mobilization and an epithelium to mesenchyme transition (EMT). We demonstrate that ets-1, a transcription factor specifically expressed in cranial NCCs, is responsible for the former event by recruiting massively cranial premigratory NCCs independently of the S-phase of the cell cycle and by leading the gathered cells to straddle the basal lamina. However, it does not promote the EMT process alone but can cooperate with snail-2 (previously called slug) to this event. Altogether, these data lead us to propose that ets-1 plays a pivotal role in conferring specific cephalic characteristics on NCC delamination.	[Theveneau, Eric; Duband, Jean-Loup; Altabef, Muriel] Univ Paris 06, Dev Biol Lab, UMR 7622, Paris, France; [Theveneau, Eric; Duband, Jean-Loup; Altabef, Muriel] CNRS, Dev Biol Lab, UMR 7622, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Altabef, M (corresponding author), Univ Paris 06, Dev Biol Lab, UMR 7622, Paris, France.	Muriel.Altabef@snv.jussieu.fr		Duband, Jean-Loup/0000-0002-1831-6420; Theveneau, Eric/0000-0001-6510-5717	CNRS; Universite P. et M. Curie; Association pour la Recherche contre le Cancer [ARC 5590]; Ministere de la Recherche; ARC	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite P. et M. Curie; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); ARC(Australian Research Council)	This work was supported by the CNRS, the Universite P. et M. Curie, and the Association pour la Recherche contre le Cancer (ARC 5590). ET is a recipient of doctoral fellowships from the Ministere de la Recherche and from ARC.	Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684; Burstyn-Cohen T, 2004, DEVELOPMENT, V131, P5327, DOI 10.1242/dev.01424; Burstyn-Cohen T, 2002, DEV CELL, V3, P383, DOI 10.1016/S1534-5807(02)00221-6; Chen ZQ, 1997, CANCER RES, V57, P2013; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; CHRYSOGELOS S, 1989, J BIOL CHEM, V264, P1232; del Barrio MG, 2002, DEVELOPMENT, V129, P1583; Delannoy-Courdent A, 1998, J CELL SCI, V111, P1521; Dottori M, 2001, DEVELOPMENT, V128, P4127; Duband JL, 1995, ACTA ANAT, V154, P63; DUBAND JL, 1991, J CELL SCI, V98, P517; Fafeur V, 1997, CELL GROWTH DIFFER, V8, P655; Giudicelli F, 2001, GENE DEV, V15, P567, DOI 10.1101/gad.189801; GRAHAM A, 1993, DEVELOPMENT, V119, P233; Graham A, 1996, MOL CELL NEUROSCI, V8, P76, DOI 10.1006/mcne.1996.0046; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hirsinger E, 1997, DEVELOPMENT, V124, P4605; Iwasaka C, 1996, J CELL PHYSIOL, V169, P522, DOI 10.1002/(SICI)1097-4652(199612)169:3<522::AID-JCP12>3.3.CO;2-Q; Kalcheim C, 2005, INT J DEV BIOL, V49, P105, DOI 10.1387/ijdb.041949ck; Knecht AK, 2002, NAT REV GENET, V3, P453, DOI 10.1038/nrg819; Le Douarin NM, 1999, NEURAL CREST, V2; Lelievre E, 2001, INT J BIOCHEM CELL B, V33, P391, DOI 10.1016/S1357-2725(01)00025-5; Liu JP, 1998, DEVELOPMENT, V125, P5055; Marcelle C, 1997, DEVELOPMENT, V124, P3955; MAROULAKOU IG, 1994, ONCOGENE, V9, P1551; MAVROTHALASSITIS G, 1994, ONCOGENE, V9, P425; Meyer D, 1997, INT J DEV BIOL, V41, P607; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Nieto MA, 2001, MECH DEVELOP, V105, P27, DOI 10.1016/S0925-4773(01)00394-X; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Paumelle R, 2002, ONCOGENE, V21, P2309, DOI 10.1038/sj.onc.1205297; Pietri T, 2003, DEV DYNAM, V227, P309, DOI 10.1002/dvdy.10299; QUEVA C, 1993, ONCOGENE, V8, P2511; Rottinger E, 2004, DEVELOPMENT, V131, P1075, DOI 10.1242/dev.01000; Sela-Donenfeld D, 1999, DEVELOPMENT, V126, P4749; Sela-Donenfeld D, 2000, DEVELOPMENT, V127, P4845; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Shoval I, 2007, DEVELOPMENT, V134, P491, DOI 10.1242/dev.02742; Tahtakran SA, 2003, GENE EXPR PATTERNS, V3, P455, DOI 10.1016/S1567-133X(03)00065-6; Taki M, 2006, INT J ONCOL, V28, P487; Tanaka H, 2004, J AM SOC NEPHROL, V15, P3083, DOI 10.1097/01.ASN.0000145459.54236.D3; Tanaka K, 1998, J CELL PHYSIOL, V176, P235, DOI 10.1002/(SICI)1097-4652(199808)176:2<235::AID-JCP2>3.0.CO;2-P; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tucker RP, 2001, DEV DYNAM, V222, P115, DOI 10.1002/dvdy.1171; VANDENBUNDER B, 1989, DEVELOPMENT, V107, P265; WANG CY, 1992, J EXP MED, V175, P1391, DOI 10.1084/jem.175.5.1391; WILKINSON DG, 1992, SITU HYBRIDISATION P, P939; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zhao JJ, 1998, DEVELOPMENT, V125, P1899	53	92	92	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1142	10.1371/journal.pone.0001142	http://dx.doi.org/10.1371/journal.pone.0001142			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987123	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459000025
J	Kurata, H; Tanaka, T; Ohnishi, F				Kurata, Hiroyuki; Tanaka, Takayuki; Ohnishi, Fumitaka			Mathematical Identification of Critical Reactions in the Interlocked Feedback Model	PLOS ONE			English	Article								Dynamic simulations are necessary for understanding the mechanism of how biochemical networks generate robust properties to environmental stresses or genetic changes. Sensitivity analysis allows the linking of robustness to network structure. However, it yields only local properties regarding a particular choice of plausible parameter values, because it is hard to know the exact parameter values in vivo. Global and firm results are needed that do not depend on particular parameter values. We propose mathematical analysis for robustness (MAR) that consists of the novel evolutionary search that explores all possible solution vectors of kinetic parameters satisfying the target dynamics and robustness analysis. New criteria, parameter spectrum width and the variability of solution vectors for parameters, are introduced to determine whether the search is exhaustive. In robustness analysis, in addition to single parameter sensitivity analysis, robustness to multiple parameter perturbation is defined. Combining the sensitivity analysis and the robustness analysis to multiple parameter perturbation enables identifying critical reactions. Use of MAR clearly identified the critical reactions responsible for determining the circadian cycle in the Drosophila interlocked circadian clock model. In highly robust models, while the parameter vectors are greatly varied, the critical reactions with a high sensitivity are uniquely determined. Interestingly, not only the per-tim loop but also the dclk-cyc loop strongly affect the period of PER, although the dclk-cyc loop hardly changes its amplitude and it is not potentially influential. In conclusion, MAR is a powerful method to explore wide parameter space without human-biases and to link a robust property to network architectures without knowing the exact parameter values. MAR identifies the reactions critically responsible for determining the period and amplitude in the interlocked feedback model and suggests that the circadian clock intensively evolves or designs the kinetic parameters so that it creates a highly robust cycle.	[Kurata, Hiroyuki; Tanaka, Takayuki; Ohnishi, Fumitaka] Kyushu Inst Technol, Dept Biosci & Bioinformat, Fukuoka, Japan	Kyushu Institute of Technology	Kurata, H (corresponding author), Kyushu Inst Technol, Dept Biosci & Bioinformat, Fukuoka, Japan.	kurata@bio.kyutech.ac.jp			The Ministry of Education, Science, Sports and Culture [18300098]	The Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding: The Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (B), 2006, 18300098	Alves R, 2000, BIOINFORMATICS, V16, P786, DOI 10.1093/bioinformatics/16.9.786; Bagheri N, 2007, BIOINFORMATICS, V23, P358, DOI 10.1093/bioinformatics/btl627; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; El-Samad H, 2005, P NATL ACAD SCI USA, V102, P2736, DOI 10.1073/pnas.0403510102; ESHELMAN LJ, 1993, FDN GENETIC ALGORITH, V2, P187; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Kimura S, 2004, BIOINFORMATICS, V20, P1646, DOI 10.1093/bioinformatics/bth122; Kurata H, 2005, GENOME RES, V15, P590, DOI 10.1101/gr.3463705; Kurata H, 2003, NUCLEIC ACIDS RES, V31, P4071, DOI 10.1093/nar/gkg461; Kurata H, 2006, PLOS COMPUT BIOL, V2, P663, DOI 10.1371/journal.pcbi.0020059; Leloup JC, 2000, BIOESSAYS, V22, P84; Ma L, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-38; Ono I., 1997, P 7 ICGA, P246; SAVAGEAU MA, 1971, NATURE, V229, P542, DOI 10.1038/229542a0; SAVAGEAU MA, 1971, ARCH BIOCHEM BIOPHYS, V145, P612, DOI 10.1016/S0003-9861(71)80021-8; Smolen P, 2001, J NEUROSCI, V21, P6644, DOI 10.1523/JNEUROSCI.21-17-06644.2001; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Suri V, 2000, J NEUROSCI, V20, P7547; Ueda HR, 2001, J THEOR BIOL, V210, P401, DOI 10.1006/jtbi.2000.2226	22	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1103	10.1371/journal.pone.0001103	http://dx.doi.org/10.1371/journal.pone.0001103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971866	Green Submitted, Green Published, gold			2022-12-27	WOS:000207458700020
J	Smith, CM; Gill, MB; May, JS; Stevenson, PG				Smith, Christopher M.; Gill, Michael B.; May, Janet S.; Stevenson, Philip G.			Murine Gammaherpesvirus-68 Inhibits Antigen Presentation by Dendritic Cells	PLOS ONE			English	Article								Dendritic cells (DCs) play a central role in initiating adaptive immunity. Murine gammaherpesvirus-68 (MHV-68), like many persistent viruses, infects DCs during normal host colonization. It therefore provides a means to understanding what host and viral genes contribute to this aspect of pathogenesis. The infected DC phenotype is likely to depend on whether viral gene expression is lytic or latent and whether antigen presentation is maintained. For MHV-68, neither parameter has been well defined. Here we show that MHV-68 infects immature but not mature bone marrow-derived DCs. Infection was predominantly latent and these DCs showed no obvious defect in antigen presentation. Lytically infected DCs were very different. These down-regulated CD86 and MHC class I expression and presented a viral epitope poorly to CD8(+) T cells. Antigen presentation improved markedly when the MHV-68 K3 gene was disrupted, indicating that K3 fulfils an important function in infected DCs. MHV-68 infects only a small fraction of the DCs present in lymphoid tissue, so K3 expression is unlikely to compromise significantly global CD8(+) T cell priming. Instead it probably helps to maintain lytic gene expression in DCs once CD8(+) T cell priming has occurred.	[Smith, Christopher M.; Gill, Michael B.; May, Janet S.; Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	University of Cambridge	Stevenson, PG (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	pgs27@cam.ac.uk	Stevenson, Philip/F-6651-2011; Stevenson, Philip g/F-9688-2014	Stevenson, Philip g/0000-0002-3520-5060	C.J. Martin fellowship; Wellcome Trust [GR076956MA]; Cancer Research UK [C19612/A6189]; Medical Research Council [G0400427, G9800903]; MRC [G0400427] Funding Source: UKRI	C.J. Martin fellowship(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CMS was supported by a C.J. Martin fellowship and PGS by a Wellcome Trust Senior Clinical Research Fellowship (GR076956MA). This work was also supported by grants from Cancer Research UK (C19612/A6189) and the Medical Research Council (G0400427 and G9800903).	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Belz GT, 2007, P NATL ACAD SCI USA, V104, P6341, DOI 10.1073/pnas.0609990104; Bennett NJ, 2005, PLOS BIOL, V3, P638, DOI 10.1371/journal.pbio.0030120; BHARDWAJ N, 1994, J CLIN INVEST, V94, P797, DOI 10.1172/JCI117399; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Coleman HM, 2005, J GEN VIROL, V86, P561, DOI 10.1099/vir.0.80565-0; Coleman HM, 2003, J VIROL, V77, P13093, DOI 10.1128/JVI.77.24.13093-13105.2003; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Davenport MG, 1999, J VIROL, V73, P3154, DOI 10.1128/JVI.73.4.3154-3161.1999; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1365, DOI 10.1099/0022-1317-71-6-1365; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1355, DOI 10.1099/0022-1317-71-6-1355; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Flano E, 2005, J IMMUNOL, V175, P3225, DOI 10.4049/jimmunol.175.5.3225; Fowler P, 2003, J GEN VIROL, V84, P3405, DOI 10.1099/vir.0.19594-0; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Hochreiter R, 2007, J GEN VIROL, V88, P1896, DOI 10.1099/vir.0.82931-0; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Husain SM, 1999, P NATL ACAD SCI USA, V96, P7508, DOI 10.1073/pnas.96.13.7508; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; KOZUCH O, 1993, ACTA VIROL, V37, P101; Kushnir N, 1998, J IMMUNOL, V160, P1774; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Liu LZ, 1999, J IMMUNOL, V163, P868; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; MACATONIA SE, 1989, J EXP MED, V169, P1255, DOI 10.1084/jem.169.4.1255; Marques S, 2003, J VIROL, V77, P7308, DOI 10.1128/JVI.77.13.7308-7318.2003; Martinez-Guzman D, 2003, J VIROL, V77, P10488, DOI 10.1128/JVI.77.19.10488-10503.2003; May JS, 2005, J VIROL, V79, P3459, DOI 10.1128/JVI.79.6.3459-3467.2005; Moorman NJ, 2003, J VIROL, V77, P10295, DOI 10.1128/JVI.77.19.10295-10303.2003; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Rainbow L, 1997, J VIROL, V71, P5915, DOI 10.1128/JVI.71.8.5915-5921.1997; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Rice J, 2002, EUR J IMMUNOL, V32, P3481, DOI 10.1002/1521-4141(200212)32:12<3481::AID-IMMU3481>3.0.CO;2-J; Rosa GT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000560; Skepper JN, 2001, J VIROL, V75, P5697, DOI 10.1128/JVI.75.12.5697-5702.2001; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Stevenson PG, 2004, CURR OPIN IMMUNOL, V16, P456, DOI 10.1016/j.coi.2004.05.002; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; Stevenson PG, 1999, EUR J IMMUNOL, V29, P1059, DOI 10.1002/(SICI)1521-4141(199904)29:04<1059::AID-IMMU1059>3.0.CO;2-L; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; Taylor JL, 2005, J VIROL, V79, P15099, DOI 10.1128/JVI.79.24.15099-15106.2005; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Yin Y, 2003, SCIENCE, V301, P1371, DOI 10.1126/science.1088902	51	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1048	10.1371/journal.pone.0001048	http://dx.doi.org/10.1371/journal.pone.0001048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940612	Green Published, gold, Green Submitted			2022-12-27	WOS:000207456100016
J	Gopalan, S				Gopalan, Suresh			A Multidirectional Non-Cell Autonomous Control and a Genetic Interaction Restricting Tobacco Etch Virus Susceptibility in Arabidopsis	PLOS ONE			English	Article								Background. Viruses constitute a major class of pathogens that infect a variety of hosts. Understanding the intricacies of signaling during host-virus interactions should aid in designing disease prevention strategies and in understanding mechanistic aspects of host and pathogen signaling machinery. Methodology/Principal Findings. An Arabidopsis mutant, B149, impaired in susceptibility to Tobacco etch virus (TEV), a positive strand RNA virus of picoRNA family, was identified using a high-throughput genetic screen and a counterselection scheme. The defects include initiation of infection foci, rate of cell-to-cell movement and long distance movement. Conclusions/Significance. The defect in infectivity is conferred by a recessive locus. Molecular genetic analysis and complementation analysis with three alleles of a previously published mutant lsp1 (loss of susceptibility to potyviruses) indicate a genetic interaction conferring haploinsufficiency between the B149 locus and certain alleles of lsp1 resulting in impaired host susceptibility. The pattern of restriction of TEV foci on leaves at or near the boundaries of certain cell types and leaf boundaries suggest dysregulation of a multidirectional non-cell autonomous regulatory mechanism. Understanding the nature of this multidirectional signal and the molecular genetic mechanism conferring it should potentially reveal a novel arsenal in the cellular machinery.	[Gopalan, Suresh] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Washington State University	Gopalan, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02115 USA.	gopalans2@hotmail.com			National Institutes of Health [AI43288, AI27832]; United States Department of Agriculture [NRI 2002-3531911560]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043288, R29AI027832, R01AI027832, R01AI043288, R21AI043288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by grants from National Institutes of Health (AI43288 and AI27832) and the United States Department of Agriculture (NRI 2002-3531911560) to James C. Carrington while at the Institute of Biological Chemistry, Washington State University, USA.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ALLISON R, 1986, VIROLOGY, V154, P9, DOI 10.1016/0042-6822(86)90425-3; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Browning KS, 1996, PLANT MOL BIOL, V32, P107, DOI 10.1007/BF00039380; CARRINGTON JC, 1988, P NATL ACAD SCI USA, V85, P3391, DOI 10.1073/pnas.85.10.3391; Carrington JC, 1996, PLANT CELL, V8, P1669, DOI 10.1105/tpc.8.10.1669; Chisholm ST, 2000, P NATL ACAD SCI USA, V97, P489, DOI 10.1073/pnas.97.1.489; COCKERHAM G, 1970, HEREDITY, V25, P309, DOI 10.1038/hdy.1970.35; CULVER JN, 1991, MOL PLANT MICROBE IN, V4, P458, DOI 10.1094/MPMI-4-458; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; DOLJA VV, 1992, P NATL ACAD SCI USA, V89, P10208, DOI 10.1073/pnas.89.21.10208; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; ISHIKAWA M, 1991, MOL GEN GENET, V230, P33, DOI 10.1007/BF00290647; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; KLEMENT Z, 1964, PHYTOPATHOLOGY, V54, P474; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Lartey RT, 1998, MOL PLANT MICROBE IN, V11, P706, DOI 10.1094/MPMI.1998.11.7.706; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lellis AD, 2002, CURR BIOL, V12, P1046, DOI 10.1016/S0960-9822(02)00898-9; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Lucas WJ, 2004, NAT REV MOL CELL BIO, V5, P712, DOI 10.1038/nrm1470; Mahajan SK, 1998, PLANT J, V14, P177, DOI 10.1046/j.1365-313X.1998.00105.x; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Ohshima K, 1998, VIROLOGY, V243, P472, DOI 10.1006/viro.1998.9078; OKEEFE DP, 1994, PLANT PHYSIOL, V105, P473, DOI 10.1104/pp.105.2.473; PADGETT HS, 1993, PLANT CELL, V5, P577, DOI 10.1105/tpc.5.5.577; Palauqui JC, 1998, P NATL ACAD SCI USA, V95, P9675, DOI 10.1073/pnas.95.16.9675; Ruud KA, 1998, J BIOL CHEM, V273, P10325, DOI 10.1074/jbc.273.17.10325; Schaad MC, 2000, VIROLOGY, V273, P300, DOI 10.1006/viro.2000.0416; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Sheng JS, 1998, VIROLOGY, V249, P119, DOI 10.1006/viro.1998.9238; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Vernoux T, 2005, CURR OPIN GENET DEV, V15, P388, DOI 10.1016/j.gde.2005.06.008; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Whitham SA, 1999, P NATL ACAD SCI USA, V96, P772, DOI 10.1073/pnas.96.2.772; Whitham SA, 2000, PLANT CELL, V12, P569, DOI 10.1105/tpc.12.4.569; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wittmann S, 1997, VIROLOGY, V234, P84, DOI 10.1006/viro.1997.8634; Yoshii M, 1998, PLANT J, V13, P211, DOI 10.1046/j.1365-313X.1998.00024.x; Yoshii M, 1998, J VIROL, V72, P8731, DOI 10.1128/JVI.72.11.8731-8737.1998	57	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e985	10.1371/journal.pone.0000985	http://dx.doi.org/10.1371/journal.pone.0000985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912362	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455900021
J	Denning, L; Anderson, JA; Davis, R; Gregg, JP; Kuzdenyi, J; Maselli, RA				Denning, Lisa; Anderson, Jennifer A.; Davis, Ryan; Gregg, Jeffrey P.; Kuzdenyi, Jennifer; Maselli, Ricardo A.			High Throughput Genetic Analysis of Congenital Myasthenic Syndromes Using Resequencing Microarrays	PLOS ONE			English	Article								Background. The use of resequencing microarrays for screening multiple, candidate disease loci is a promising alternative to conventional capillary sequencing. We describe the performance of a custom resequencing microarray for mutational analysis of Congenital Myasthenic Syndromes (CMSs), a group of disorders in which the normal process of neuromuscular transmission is impaired. Methodology/Principal Findings. Our microarray was designed to assay the exons and flanking intronic regions of 8 genes linked to CMSs. A total of 31 microarrays were hybridized with genomic DNA from either individuals with known CMS mutations or from healthy controls. We estimated an overall microarray call rate of 93.61%, and we found the percentage agreement between the microarray and capillary sequencing techniques to be 99.95%. In addition, our microarray exhibited 100% specificity and 99.99% reproducibility. Finally, the microarray detected 22 out of the 23 known missense mutations, but it failed to detect all 7 known insertion and deletion (indels) mutations, indicating an overall sensitivity of 73.33% and a sensitivity with respect to missense mutations of 95.65%. Conclusions/Significance. Overall, our microarray prototype exhibited strong performance and proved highly efficient for screening genes associated with CMSs. Until indels can be efficiently assayed with this technology, however, we recommend using resequencing microarrays for screening CMS mutations after common indels have been first assayed by capillary sequencing.	[Denning, Lisa; Anderson, Jennifer A.; Kuzdenyi, Jennifer; Maselli, Ricardo A.] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; [Davis, Ryan; Gregg, Jeffrey P.] Univ Calif Davis, Dept Pathol, Med Invest Neurodev Disorders Inst, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Maselli, RA (corresponding author), Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA.	ramaselli@ucdavis.edu		Davis, Ryan/0000-0001-7439-6683	Muscular Dystrophy Association; Myasthenia Gravis Foundation of America; NIEHS [1 P01 ES11269-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011269] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); Myasthenia Gravis Foundation of America; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by awards from the Muscular Dystrophy Association and the Myasthenia Gravis Foundation of America. In addition, the microarray core facility at the UC Davis M. I. N. D. Institute was supported by NIEHS 1 P01 ES11269-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Beeson David, 2005, Neuromuscul Disord, V15, P498, DOI 10.1016/j.nmd.2005.05.001; Chevessier F, 2004, HUM MOL GENET, V13, P3229, DOI 10.1093/hmg/ddh333; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Engel AG, 2005, CURR OPIN PHARMACOL, V5, P308, DOI 10.1016/j.coph.2004.12.007; Engel AG, 2003, MUSCLE NERVE, V27, P4, DOI 10.1002/mus.10269; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Huentelman MJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-149; Karaman MW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni034; Mandal MNA, 2005, INVEST OPHTH VIS SCI, V46, P3355, DOI 10.1167/iovs.05-0007; Muller JS, 2004, NEUROMUSCULAR DISORD, V14, P744, DOI 10.1016/j.nmd.2004.06.010; Nichols P, 1999, ANN NEUROL, V45, P439, DOI 10.1002/1531-8249(199904)45:4<439::AID-ANA4>3.0.CO;2-W; Ohno K, 2002, AM J HUM GENET, V70, P875, DOI 10.1086/339465; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017; Ohno Kinji, 2005, Acta Myol, V24, P50; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; TENGS T, 2005, CANC LETT, V229, P227; Webster R, 2004, NEUROLOGY, V62, P1090, DOI 10.1212/01.WNL.0000118205.99701.41; Xu N, 2005, AM J OBSTET GYNECOL, V192, P1274, DOI 10.1016/j.ajog.2004.12.066	21	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e918	10.1371/journal.pone.0000918	http://dx.doi.org/10.1371/journal.pone.0000918			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878953	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455700026
J	Heikkinen, E; Kallonen, T; Saarinen, L; Sara, R; King, AJ; Mooi, FR; Soini, JT; Mertsola, J; He, QS				Heikkinen, Eriikka; Kallonen, Teemu; Saarinen, Lilli; Sara, Rolf; King, Audrey J.; Mooi, Frits R.; Soini, Juhani T.; Mertsola, Jussi; He, Qiushui			Comparative Genomics of Bordetella pertussis Reveals Progressive Gene Loss in Finnish Strains	PLOS ONE			English	Article								Background. Bordetella pertussis is a Gram-negative bacterium that infects the human respiratory tract and causes pertussis or whooping cough. The disease has resurged in many countries including Finland where the whole-cell pertussis vaccine has been used for more than 50 years. Antigenic divergence has been observed between vaccine strains and clinical isolates in Finland. To better understand genome evolution in B. pertussis circulating in the immunized population, we developed an oligonucleotide-based microarray for comparative genomic analysis of Finnish strains isolated during the period of 50 years. Methodology/Principal Findings. The microarray consisted of 3,582 oligonucleotides (70-mer) and covered 94% of 3,816 ORFs of Tohama I, the strain of which the genome has been sequenced [1]. Twenty isolates from 1953 to 2004 were studied together with two Finnish vaccine strains and two international reference strains. The isolates were selected according to their characteristics, e. g. the year and place of isolation and pulsed-field gel electrophoresis profiles. Genomic DNA of the tested strains, along with reference DNA of Tohama I strain, was labelled and hybridized. The absence of genes as established with microarrays, was confirmed by PCR. Compared with the Tohama I strain, Finnish isolates lost 7 (8.6 kb) to 49 (55.3 kb) genes, clustered in one to four distinct loci. The number of lost genes increased with time, and one third of lost genes had functions related to inorganic ion transport and metabolism, or energy production and conversion. All four loci of lost genes were flanked by the insertion sequence element IS481. Conclusion/Significance. Our results showed that the progressive gene loss occurred in Finnish B. pertussis strains isolated during a period of 50 years and confirmed that B. pertussis is dynamic and is continuously evolving, suggesting that the bacterium may use gene loss as one strategy to adapt to highly immunized populations.	[Heikkinen, Eriikka; Kallonen, Teemu; He, Qiushui] Natl Publ Hlth Inst, Pertussis Reference Lab, Turku, Finland; Natl Publ Hlth Inst, Pertussis Reference Lab, Turku, Finland; [Kallonen, Teemu] Univ Turku, Turku Grad Sch Biomed Sci, Turku, Finland; [Saarinen, Lilli; Sara, Rolf; Soini, Juhani T.] Abo Akad Univ, Univ Turku, Turku Ctr Biotechnol, Finnish DNA Microarray Ctr, Turku, Finland; [King, Audrey J.; Mooi, Frits R.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [Mertsola, Jussi] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Turku; Abo Akademi University; University of Turku; Netherlands National Institute for Public Health & the Environment; University of Turku	He, QS (corresponding author), Natl Publ Hlth Inst, Pertussis Reference Lab, Turku, Finland.	qiushui.he@ktl.fi	Kallonen, Teemu/B-5507-2008; Mertsola, Jussi/AAE-3460-2021	Kallonen, Teemu/0000-0003-1741-6486; Soini, Juhani/0000-0002-5574-0650	Turku University Foundation; Turku Graduate School of Biomedical Sciences; Special Governmental Fund for University Hospitals (EVO), Turku, Finland	Turku University Foundation; Turku Graduate School of Biomedical Sciences; Special Governmental Fund for University Hospitals (EVO), Turku, Finland	The research was supported by a grant from the Turku University Foundation, the Turku Graduate School of Biomedical Sciences, and the Special Governmental Fund for University Hospitals (EVO), Turku, Finland.	Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; Brickman TJ, 2007, BIOMETALS, V20, P303, DOI 10.1007/s10534-006-9031-1; Brinig MM, 2006, J BACTERIOL, V188, P2375, DOI 10.1128/JB.188.7.2375-2382.2006; BULLEN JJ, 1981, REV INFECT DIS, V3, P1127; Caro V, 2005, MICROBES INFECT, V7, P976, DOI 10.1016/j.micinf.2005.04.005; Caro V, 2006, MICROBES INFECT, V8, P2228, DOI 10.1016/j.micinf.2006.04.014; Cassiday P, 2000, J INFECT DIS, V182, P1402, DOI 10.1086/315881; Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; Elomaa A, 2005, J CLIN MICROBIOL, V43, P3681, DOI 10.1128/JCM.43.8.3681-3687.2005; Elomaa A, 2007, VACCINE, V25, P918, DOI 10.1016/j.vaccine.2006.09.012; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Gzyl A, 2004, INT J EPIDEMIOL, V33, P358, DOI 10.1093/ije/dyh012; Hallander HO, 2005, J CLIN MICROBIOL, V43, P2856, DOI 10.1128/JCM.43.6.2856-2865.2005; Halperin SA, 2007, NEW ENGL J MED, V356, P110, DOI 10.1056/NEJMp068288; Leavis HL, 2007, PLOS PATHOG, V3, P75, DOI 10.1371/journal.ppat.0030007; Lee YS, 2003, MICROBIOL IMMUNOL, V47, P903, DOI 10.1111/j.1348-0421.2003.tb03463.x; MCINTYRE P, 2002, COMMUN DIS INTELL S, V1, P1; Moerman L, 2006, ISRAEL MED ASSOC J, V8, P308; Mooi FR, 1999, INFECT IMMUN, V67, P3133, DOI 10.1128/IAI.67.6.3133-3134.1999; Mooi FR, 1998, INFECT IMMUN, V66, P670, DOI 10.1128/IAI.66.2.670-675.1998; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; Mooi FR, 2000, EUR J CLIN MICROBIOL, V19, P174, DOI 10.1007/s100960050455; MOORE CH, 1995, J BACTERIOL, V177, P1116, DOI 10.1128/jb.177.4.1116-1118.1995; Ntezayabo B, 2003, PEDIATR INFECT DIS J, V22, P22, DOI 10.1097/00006454-200301000-00009; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Sebaihia M, 2006, J BACTERIOL, V188, P6002, DOI 10.1128/JB.01927-05; Tsang RSW, 2004, J CLIN MICROBIOL, V42, P5364, DOI 10.1128/JCM.42.11.5364-5367.2004; van Amersfoorth SCM, 2005, J CLIN MICROBIOL, V43, P2837, DOI 10.1128/JCM.43.6.2837-2843.2005; Weber C, 2001, J CLIN MICROBIOL, V39, P4396, DOI 10.1128/JCM.39.12.4396-4403.2001	34	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e904	10.1371/journal.pone.0000904	http://dx.doi.org/10.1371/journal.pone.0000904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878939	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455700012
J	Tanaka, SC; Schweighofer, N; Asahi, S; Shishida, K; Okamoto, Y; Yamawaki, S; Doya, K				Tanaka, Saori C.; Schweighofer, Nicolas; Asahi, Shuji; Shishida, Kazuhiro; Okamoto, Yasumasa; Yamawaki, Shigeto; Doya, Kenji			Serotonin Differentially Regulates Short- and Long-Term Prediction of Rewards in the Ventral and Dorsal Striatum	PLOS ONE			English	Article								Background. The ability to select an action by considering both delays and amount of reward outcome is critical for maximizing long-term benefits. Although previous animal experiments on impulsivity have suggested a role of serotonin in behaviors requiring prediction of delayed rewards, the underlying neural mechanism is unclear. Methodology/Principal Findings. To elucidate the role of serotonin in the evaluation of delayed rewards, we performed a functional brain imaging experiment in which subjects chose small-immediate or large-delayed liquid rewards under dietary regulation of tryptophan, a precursor of serotonin. A model-based analysis revealed that the activity of the ventral part of the striatum was correlated with reward prediction at shorter time scales, and this correlated activity was stronger at low serotonin levels. By contrast, the activity of the dorsal part of the striatum was correlated with reward prediction at longer time scales, and this correlated activity was stronger at high serotonin levels. Conclusions/Significance. Our results suggest that serotonin controls the time scale of reward prediction by differentially regulating activities within the striatum.	[Tanaka, Saori C.; Schweighofer, Nicolas; Doya, Kenji] ATR Computat Neurosci Labs, Dept Computat Neurobiol, Kyoto, Japan; [Tanaka, Saori C.; Schweighofer, Nicolas; Asahi, Shuji; Shishida, Kazuhiro; Okamoto, Yasumasa; Yamawaki, Shigeto; Doya, Kenji] Japan Sci & Technol Agcy, CREST, Kyoto, Japan; [Schweighofer, Nicolas] Univ So Calif, Dept Biokinesiol & Phys Therapy, Los Angeles, CA USA; [Asahi, Shuji; Shishida, Kazuhiro; Okamoto, Yasumasa; Yamawaki, Shigeto] Hiroshima Univ, Dept Psychiat & Neurosci, Hiroshima, Japan; [Doya, Kenji] Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa, Japan	Japan Science & Technology Agency (JST); University of Southern California; Hiroshima University; Okinawa Institute of Science & Technology Graduate University	Tanaka, SC (corresponding author), ATR Computat Neurosci Labs, Dept Computat Neurobiol, Kyoto, Japan.	xsaori@atr.jp; doya@oist.jp	Doya, Kenji/B-5841-2015; Schweighofer, Nicolas/A-3675-2008	Doya, Kenji/0000-0002-2446-6820; Schweighofer, Nicolas/0000-0003-3362-6088; Tanaka, Saori/0000-0002-7001-5051	"Creating the Brain," the Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency; Japan Society for the Promotion of Science for Young Scientists	"Creating the Brain," the Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research is supported by "Creating the Brain,'' the Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency. ST is funded by research fellowships from the Japan Society for the Promotion of Science for Young Scientists.	AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Bizot JC, 1999, PSYCHOPHARMACOLOGY, V146, P400, DOI 10.1007/PL00005485; Bjork JM, 1999, PSYCHOPHARMACOLOGY, V142, P24, DOI 10.1007/s002130050858; Bjork JM, 2000, NEUROPSYCHOPHARMACOL, V22, P357, DOI 10.1016/S0893-133X(99)00136-0; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cardinal RN, 2006, NEURAL NETWORKS, V19, P1277, DOI 10.1016/j.neunet.2006.03.004; Carpenter LL, 1998, NEUROPSYCHOPHARMACOL, V19, P26; Compan V, 1998, BRAIN RES, V793, P103, DOI 10.1016/S0006-8993(98)00168-1; Crean J, 2002, BEHAV BRAIN RES, V136, P349, DOI 10.1016/S0166-4328(02)00132-8; DELGADO PL, 1990, ARCH GEN PSYCHIAT, V47, P411; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Huang YY, 2005, BIOORG MED CHEM LETT, V15, P4786, DOI 10.1016/j.bmcl.2005.07.024; KAGEL JH, 1986, ANIM BEHAV, V34, P271, DOI 10.1016/0003-3472(86)90032-1; Larisch R, 2003, BEHAV BRAIN RES, V139, P21, DOI 10.1016/S0166-4328(01)00412-0; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; Mazur JE, 2001, PSYCHOL REV, V108, P96, DOI 10.1037/0033-295X.108.1.96; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Mobini S, 2000, PSYCHOPHARMACOLOGY, V152, P390, DOI 10.1007/s002130000542; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; Pothuizen HHJ, 2005, EUR J NEUROSCI, V22, P2605, DOI 10.1111/j.1460-9568.2005.04388.x; Poulos CX, 1996, BEHAV PHARMACOL, V7, P395, DOI 10.1097/00008877-199608000-00011; Samuelson Paul, 1937, REV ECON STUD, V4, P155, DOI [DOI 10.2307/2967612, 10.2307/2967612]; Schweighofer N, 2006, PLOS COMPUT BIOL, V2, P1349, DOI 10.1371/journal.pcbi.0020152; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Varnas K, 2004, HUM BRAIN MAPP, V22, P246, DOI 10.1002/hbm.20035; Williams WA, 1999, J NEUROCHEM, V72, P1641, DOI 10.1046/j.1471-4159.1999.721641.x; Winstanley CA, 2004, NEUROPSYCHOPHARMACOL, V29, P1331, DOI 10.1038/sj.npp.1300434; WOGAR MA, 1993, PSYCHOPHARMACOLOGY, V111, P239, DOI 10.1007/BF02245530; YOUNG SN, 1981, J NEUROL NEUROSUR PS, V44, P323, DOI 10.1136/jnnp.44.4.323; YOUNG SN, 1985, PSYCHOPHARMACOLOGY, V87, P173, DOI 10.1007/BF00431803	34	127	128	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1333	10.1371/journal.pone.0001333	http://dx.doi.org/10.1371/journal.pone.0001333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091999	Green Submitted, gold, Green Published			2022-12-27	WOS:000207459600017
J	Beste, C; Saft, C; Andrich, J; Muller, T; Gold, R; Falkenstein, M				Beste, Christian; Saft, Carsten; Andrich, Juergen; Mueller, Thomas; Gold, Ralf; Falkenstein, Michael			Time Processing in Huntington's Disease: A Group-Control Study	PLOS ONE			English	Article							ONSET; DYSFUNCTION	Background. "Timing'' processes are mediated via a disturbed neuronal network including the basal ganglia. Brain structures important for "timing'' are also discussed to be critical for the deterioration of movements in Huntington's disease (HD). Changes in "timing processes'' are found in HD, but no study has varied the degree of motor demands in timing functions in parallel in HD. It may be hypothesized that timing functions may be deteriorated to a different extent in motor and non-motor timing, because in motor timing the underlying brain structures may be more demanding than in non-motor timing. Methodology/Principle Findings. We assessed timing in two different experiments: a time-estimation (TE) and a time-discrimination (TD) task. The demand on motor functions is high in the TE-task and low in the TD-task. Furthermore, general motor ability was assessed at different complexity levels. A presymptomatic (pHD), a symptomatic ( HD) and a control group were investigated. We found a decline in timing functions when demands on the motor system were high (TE-task), in HD and even in pHD, compared to controls. In non-motor timing ( TD task) and in the assessment of general motor ability, performance in the pHD-group was comparable to the controls and better than in the symptomatic group. Performance in both timing tasks was related to the duration until the estimated age of onset in pHDs. Conclusions/Significance. The study shows a selective deterioration of time-estimation processes in symptomatic and even presymptomatic Huntington's disease. Time-discrimination processes were not affected in both patient groups. The relation of timing performance to the duration until the estimated age of onset in pHD is of clinical importance.	[Beste, Christian; Saft, Carsten; Andrich, Juergen; Mueller, Thomas; Gold, Ralf] Ruhr Univ Bochum, St Josef Hosp, Huntington Ctr NRW, Dept Neurol, D-4630 Bochum, Germany; [Beste, Christian; Falkenstein, Michael] World Hlth Org WHO Collaborating Ctr Occupat Hlth, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Beste, Christian] Univ Munster, Dept Clin Radiol, Munster, Germany	Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); World Health Organization; University of Munster	Beste, C (corresponding author), Ruhr Univ Bochum, St Josef Hosp, Huntington Ctr NRW, Dept Neurol, D-4630 Bochum, Germany.	christian.beste@cityweb.de	Falkenstein, Michael/ABA-7497-2020; Müller, Thomas/C-9317-2011	Saft, Carsten/0000-0002-3983-7292	FoRUM, Ruhr University Bochum [AZ-F479-2005]	FoRUM, Ruhr University Bochum	This work was supported by a grant from FoRUM AZ-F479-2005, Ruhr University Bochum.	Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Bartenstein P, 1997, BRAIN, V120, P1553, DOI 10.1093/brain/120.9.1553; Beste C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000086; Beste C, 2007, NEUROPSYCHOLOGIA, V45, P2922, DOI 10.1016/j.neuropsychologia.2007.06.004; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Cepeda C, 2007, PROG NEUROBIOL, V81, P253, DOI 10.1016/j.pneurobio.2006.11.001; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Friedrich J, 2020, HUM BRAIN MAPP, V41, P726, DOI 10.1002/hbm.24835; Hinton SC, 2007, J INT NEUROPSYCH SOC, V13, P539, DOI 10.1017/S1355617707070671; Kendall A L, 2000, Prog Brain Res, V127, P381; KREMER, 2002, HUNTINGTONS DIS, P28; Macar Francoise, 2006, Cogn Process, V7, P89, DOI 10.1007/s10339-005-0025-7; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Mitchell IJ, 1999, PROG NEUROBIOL, V59, P691, DOI 10.1016/S0301-0082(99)00019-2; Paulsen JS, 2001, NEUROLOGY, V57, P658, DOI 10.1212/WNL.57.4.658; Paulsen JS, 2004, AM J NEURORADIOL, V25, P1715; RANEN NG, 1995, AM J HUM GENET, V57, P593; Rosas H D, 2004, NeuroRx, V1, P263, DOI 10.1602/neurorx.1.2.263; Saft C, 2006, MOVEMENT DISORD, V21, P1208, DOI 10.1002/mds.20939; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; van Vugt JPP, 2004, MOVEMENT DISORD, V19, P285, DOI 10.1002/mds.10718	22	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1263	10.1371/journal.pone.0001263	http://dx.doi.org/10.1371/journal.pone.0001263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060059	Green Submitted, gold, Green Published			2022-12-27	WOS:000207459400012
J	Cook, DM; Boyd, EA; Grossmann, C; Bero, LA				Cook, Daniel M.; Boyd, Elizabeth A.; Grossmann, Claudia; Bero, Lisa A.			Reporting Science and Conflicts of Interest in the Lay Press	PLOS ONE			English	Article								Background. Forthright reporting of financial ties and conflicts of interest of researchers is associated with public trust in and esteem for the scientific enterprise. Methods/Principal Findings. We searched Lexis/Nexis Academic News for the top news stories in science published in 2004 and 2005. We conducted a content analysis of 1152 newspaper stories. Funders of the research were identified in 38% of stories, financial ties of the researchers were reported in 11% of stories, and 5% reported financial ties of sources quoted. Of 73 stories not reporting on financial ties, 27% had financial ties publicly disclosed in scholarly journals. Conclusions/Significance. Because science journalists often did not report conflict of interest information, adherence to gold-standard recommendations for science journalism was low. Journalists work under many different constraints, but nonetheless news reports of scientific research were incomplete, potentially eroding public trust in science.	[Cook, Daniel M.] Univ Nevada, Sch Publ Hlth, Reno, NV 89557 USA; [Boyd, Elizabeth A.; Bero, Lisa A.] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California San Francisco	Cook, DM (corresponding author), Univ Nevada, Sch Publ Hlth, Reno, NV 89557 USA.	dmcook@unr.edu		Bero, Lisa/0000-0003-1893-6651; Cook, Daniel/0000-0002-6967-018X	National Science Foundation [0520691]	National Science Foundation(National Science Foundation (NSF))	This research was supported by the National Science Foundation, Award Number 0520691.	Ancker JS, 2007, SCI ENG ETHICS, V13, P147, DOI 10.1007/s11948-007-9011-z; BALTIMORE D, 1989, TECHNOL REV, V92, P22; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; BERGREEN J, 2005, CANC PATIENTS SING H, pA1; Bero LA, 2005, PUBLIC HEALTH REP, V120, P200, DOI 10.1177/003335490512000215; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Boyd EA, 2000, JAMA-J AM MED ASSOC, V284, P2209, DOI 10.1001/jama.284.17.2209; Boyd EA, 2003, ACAD MED, V78, P769, DOI 10.1097/00001888-200308000-00002; BRANAM C, 2005, TINY TECHNOLOGY HOLD; Campbell P, 2001, NATURE, V412, P751, DOI 10.1038/35090688; Caulfield T, 2004, PLOS MED, V1, P178, DOI 10.1371/journal.pmed.0010038; Chaudhry S, 2002, BRIT MED J, V325, P1391, DOI 10.1136/bmj.325.7377.1391; Cho MK, 2000, JAMA-J AM MED ASSOC, V284, P2203, DOI 10.1001/jama.284.17.2203; Clark F, 2006, SCI COMMUN, V27, P496, DOI 10.1177/1075547006288010; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; Drazen JM, 2000, NEW ENGL J MED, V343, P1643, DOI 10.1056/NEJM200011303432212; Friedman PJ, 2002, SCI ENG ETHICS, V8, P413, DOI 10.1007/s11948-002-0063-9; Geller G, 2005, GENET MED, V7, P198, DOI 10.1097/01.GIM.0000156699.78856.23; HIVELY S, 2005, CLEVELAND PLAIN DEAL, pE13; Holtzman NA, 2005, COMMUNITY GENET, V8, P133, DOI 10.1159/000086756; HUNT S, 2005, DUPONT STUDY FINDS N; Jernigan DH, 1996, J PUBLIC HEALTH POL, V17, P306, DOI 10.2307/3343268; Kennedy D, 2004, SCIENCE, V303, P15, DOI 10.1126/science.303.5654.15; Kua E, 2004, PUBLIC UNDERST SCI, V13, P309, DOI 10.1177/0963662504045539; Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; MASSEY B, 2004, ICELAND CO PARTNERS; McComas KA, 2003, SCI COMMUN, V24, P395, DOI 10.1177/1075547003024004001; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; Moynihan R, 2000, MED J AUSTRALIA, V173, P631, DOI 10.5694/j.1326-5377.2000.tb139366.x; MOYNIHAN R, 2001, TIPSHEET REPORTING D; Nelkin D., 1987, SELLING SCI PRESS CO; OXMAN AD, 1993, J CLIN EPIDEMIOL, V46, P987, DOI 10.1016/0895-4356(93)90166-X; Pellechia MG, 1997, PUBLIC UNDERST SCI, V6, P49, DOI 10.1088/0963-6625/6/1/004; PHILLIPS DP, 1991, NEW ENGL J MED, V325, P1180, DOI 10.1056/NEJM199110173251620; Rosenstock L, 2002, AM J PUBLIC HEALTH, V92, P14, DOI 10.2105/AJPH.92.1.14; Shuchman M, 1997, ANN INTERN MED, V126, P976, DOI 10.7326/0003-4819-126-12-199706150-00008; Winsten J A, 1985, Health Aff (Millwood), V4, P5, DOI 10.1377/hlthaff.4.1.5; WRIGHT D, 2005, TESTS VAPOR LEVELS T	39	25	25	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1266	10.1371/journal.pone.0001266	http://dx.doi.org/10.1371/journal.pone.0001266			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060060	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459400013
J	Gwinn, K; Corriveau, RA; Mitsumoto, H; Bednarz, K; Brown, RH; Cudkowicz, M; Gordon, PH; Hardy, J; Kasarskis, EJ; Kaufmann, P; Miller, R; Sorenson, E; Tandan, R; Traynor, BJ; Nash, J; Sherman, A; Mailman, MD; Ostell, J; Bruijn, L; Cwik, V; Rich, SS; Singleton, A; Refolo, L; Andrews, J; Zhang, R; Conwit, R; Keller, MA				Gwinn, Katrina; Corriveau, Roderick A.; Mitsumoto, Hiroshi; Bednarz, Kate; Brown, Robert H., Jr.; Cudkowicz, Merit; Gordon, Paul H.; Hardy, John; Kasarskis, Edward J.; Kaufmann, Petra; Miller, Robert; Sorenson, Eric; Tandan, Rup; Traynor, Bryan J.; Nash, Josefina; Sherman, Alex; Mailman, Matthew D.; Ostell, James; Bruijn, Lucie; Cwik, Valerie; Rich, Stephen S.; Singleton, Andrew; Refolo, Larry; Andrews, Jaime; Zhang, Ran; Conwit, Robin; Keller, Margaret A.		ALS Res Grp	Amyotrophic Lateral Sclerosis: An Emerging Era of Collaborative Gene Discovery	PLOS ONE			English	Article							FAMILIAL ALS; SOD1 GENE; MUTATIONS; DISEASE; COMPLEX; LINKAGE; FORM; LOCALIZATION; PENETRANCE; DIAGNOSIS	Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). It is currently incurable and treatment is largely limited to supportive care. Family history is associated with an increased risk of ALS, and many Mendelian causes have been discovered. However, most forms of the disease are not obviously familial. Recent advances in human genetics have enabled genome-wide analyses of single nucleotide polymorphisms ( SNPs) that make it possible to study complex genetic contributions to human disease. Genome-wide SNP analyses require a large sample size and thus depend upon collaborative efforts to collect and manage the biological samples and corresponding data. Public availability of biological samples ( such as DNA), phenotypic and genotypic data further enhances research endeavors. Here we discuss a large collaboration among academic investigators, government, and non-government organizations which has created a public repository of human DNA, immortalized cell lines, and clinical data to further gene discovery in ALS. This resource currently maintains samples and associated phenotypic data from 2332 MND subjects and 4692 controls. This resource should facilitate genetic discoveries which we anticipate will ultimately provide a better understanding of the biological mechanisms of neurodegeneration in ALS.	[Gwinn, Katrina; Refolo, Larry; Zhang, Ran; Conwit, Robin] NINDS, NIH, Bethesda, MD 20892 USA; [Corriveau, Roderick A.; Nash, Josefina; Andrews, Jaime; Keller, Margaret A.] Coriell Inst Med Res, Camden, NJ USA; [Mitsumoto, Hiroshi; Bednarz, Kate; Gordon, Paul H.; Kaufmann, Petra] Columbia Univ, Eleanor & Lou Gehrig MDA ALS Res Ctr, New York, NY USA; [Brown, Robert H., Jr.; Cudkowicz, Merit; Sherman, Alex] Massachusetts Gen Hosp, Charlestown, MA USA; [Hardy, John; Singleton, Andrew] NIA, NIH, Bethesda, MD 20892 USA; [Kasarskis, Edward J.] Univ Kentucky, Lexington, KY USA; [Miller, Robert] Calif Pacific Med Ctr, San Francisco, CA USA; [Sorenson, Eric] Mayo Med Ctr, Rochester, MN USA; [Tandan, Rup] Univ Vermont, Burlington, VT USA; [Traynor, Bryan J.] NIMH, NIH, Bethesda, MD 20892 USA; [Mailman, Matthew D.; Ostell, James] NIH, Natl Ctr Bioinformat, Bethesda, MD 20892 USA; [Bruijn, Lucie] ALS Assoc, Calabasas Hills, CA USA; [Cwik, Valerie] Muscular Dystrophy Assoc, Tucson, AZ USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Coriell Institute for Medical Research; Columbia University; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Kentucky; California Pacific Medical Center; Mayo Clinic; University of Vermont; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; University of Virginia	Gwinn, K (corresponding author), NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	GwinnK@ninds.nih.gov	CUDKOWICZ, MERIT/GWM-6585-2022; Hardy, John/C-2451-2009; Singleton, Andrew B/C-3010-2009; Sander-Effron, Samuel/AAX-2231-2020; Traynor, Bryan J/G-5690-2010; Resource Center, NINDS Human Genetics/AGF-2474-2022	CUDKOWICZ, MERIT/0000-0002-7075-1681; Hardy, John/0000-0002-3122-0423; Thakore, Nimish/0000-0003-3418-3362; Bedlack, Richard/0000-0003-4666-7495; Peltier, Amanda/0000-0003-1097-7715; Gordon, Paul/0000-0001-5714-9875; Caress, James/0000-0002-5814-6083; Trivedi, Jaya/0000-0001-6112-2325; Gutmann, Laurie/0000-0003-3926-4209; Carter, Gregory/0000-0001-7617-4750; Rich, Stephen/0000-0003-3872-7793; Gwinn, Katrina/0000-0002-8277-651X	NINDS [N01-NS-2-2349, NOT-03-016, R01 NS049640-01, R01 NS045294-01, R01 NS045087-01, R01 NS048125-01, R01 NS044887-01, R01 NS042759-01]; ALS Association; NIA Intramural Laboratory of Neurogenetics; NIMH Intramural; NIH [RR-00109]; NCBI dbGaP; MRC [G0701075] Funding Source: UKRI; Medical Research Council [G0701075] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042759, R01NS049640, R01NS044887, R01NS045294, R01NS045087, R01NS048125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000933] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ALS Association; NIA Intramural Laboratory of Neurogenetics; NIMH Intramural(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCBI dbGaP; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work described herein was created with funding by NINDS (RAC, JN, JA, MK, Repository, Contract NINDS N01-NS-2-2349, NINDS Supplement Notice NOT-03-016), The ALS Association, NINDS R01 grants (RHB, R01 NS049640-01; MC, R01 NS049640-01; PHG R01 NS045294-01; EK R01 NS045087-01; PK R01 NS048125-01; RM R01 NS044887-01; ES R01 NS042759-01), NIA Intramural Laboratory of Neurogenetics, (JH, AS), NIMH Intramural (BT), NIH RR-00109 ( RT), and NCBI dbGaP ( http://www.ncbi.nlm.nih.gov/sites/entrez?db = gap).	Beskow LM, 2001, JAMA-J AM MED ASSOC, V286, P2315, DOI 10.1001/jama.286.18.2315; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Bowser R, 2006, EXPERT REV MOL DIAGN, V6, P387, DOI 10.1586/14737159.6.3.387; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Conwit RA, 2006, J NEUROL SCI, V251, P1, DOI 10.1016/j.jns.2006.07.009; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; Hand CK, 2002, AM J HUM GENET, V70, P251, DOI 10.1086/337945; Hand CK, 2002, MUSCLE NERVE, V25, P135; HANDO S, 2001, NAT GENET, V29, P160; Hentati A, 1998, NEUROGENETICS, V2, P55, DOI 10.1007/s100480050052; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Kaufmann P, 2006, AMYOTROPH LATERAL SC, V7, P252, DOI 10.1080/07853890601012096; Kovach MJ, 2001, MOL GENET METAB, V74, P458, DOI 10.1006/mgme.2001.3256; Kunst CB, 2004, AM J HUM GENET, V75, P933, DOI 10.1086/426001; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Miller RG, 1999, J NEUROL SCI, V169, P2, DOI 10.1016/S0022-510X(99)00209-9; Mitchell JD, 2000, J NEUROL, V247, P7; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; Murakami T, 2001, J NEUROL SCI, V189, P45, DOI 10.1016/S0022-510X(01)00558-5; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nogales-Gadea G, 2004, J NEUROL SCI, V219, P1, DOI 10.1016/j.jns.2003.10.018; Ostell James, 2005, ACM Queue, V3, P40, DOI 10.1145/1059791.1059806; Palmer LJ, 2005, LANCET, V366, P1223, DOI 10.1016/S0140-6736(05)67485-5; Przedborski S, 2003, J CLIN INVEST, V111, P3, DOI 10.1172/JCI200317522; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Rezania K, 2003, AMYOTROPH LATERAL SC, V4, P162, DOI 10.1080/aml.4.3.162.166; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sapp PC, 2003, AM J HUM GENET, V73, P397, DOI 10.1086/377158; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Varmus Harold, 2003, Nat Genet, V35 Suppl 1, P3, DOI 10.1038/ng1186; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; WILHELMSEN KC, 1994, AM J HUM GENET, V55, P1159; WILHELMSEN KC, 2004, ARCH NEUROL-CHICAGO, V61, P318; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; YATA J, 1975, INT J CANCER, V15, P377, DOI 10.1002/ijc.2910150303	47	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1254	10.1371/journal.pone.0001254	http://dx.doi.org/10.1371/journal.pone.0001254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060051	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459400003
J	Tejiokem, MC; Gouandjika, I; Beniguel, L; Zanga, MCE; Tene, G; Gody, JC; Njamkepo, E; Kfutwah, A; Penda, I; Bilong, C; Rousset, D; Pouillot, R; Tangy, F; Baril, L				Tejiokem, Mathurin C.; Gouandjika, Ionela; Beniguel, Lydie; Zanga, Marie-Claire Endegue; Tene, Gilbert; Gody, Jean C.; Njamkepo, Elisabeth; Kfutwah, Anfumbom; Penda, Ida; Bilong, Catherine; Rousset, Dominique; Pouillot, Regis; Tangy, Frederic; Baril, Laurence			HIV-Infected Children Living in Central Africa Have Low Persistence of Antibodies to Vaccines Used in the Expanded Program on Immunization	PLOS ONE			English	Article							MEASLES ANTIBODY; HIV-1-INFECTED CHILDREN; ANTIRETROVIRAL THERAPY; POLIO VACCINE; IMMUNODEFICIENCY; INFANTS; MORTALITY; DISEASE; RISK; IMMUNOGENICITY	Background. The Expanded Program on Immunization (EPI) is the most cost-effective measures to control vaccine-preventable diseases. Currently, the EPI schedule is similar for HIV-infected children; the introduction of antiretroviral therapy ( ART) should considerably prolong their life expectancy. Methods and Principal Findings. To evaluate the persistence of antibodies to the EPI vaccines in HIV-infected and HIV-exposed uninfected children who previously received these vaccines in routine clinical practice, we conducted a cross-sectional study of children, aged 18 to 36 months, born to HIV-infected mothers and living in Central Africa. We tested blood samples for antibodies to the combined diphtheria, tetanus, and whole-cell pertussis ( DTwP), the measles and the oral polio (OPV) vaccines. We enrolled 51 HIV-infected children of whom 33 were receiving ART, and 78 HIV-uninfected children born to HIV-infected women. A lower proportion of HIV-infected children than uninfected children had antibodies to the tested antigens with the exception of the OPV types 1 and 2. This difference was substantial for the measles vaccine (20% of the HIV-infected children and 56% of the HIV-exposed uninfected children, p<0.0001). We observed a high risk of low antibody levels for all EPI vaccines, except OPV types 1 and 2, in HIV-infected children with severe immunodeficiency (CD4+ T cells,25%). Conclusions and Significance. Children were examined at a time when their antibody concentrations to EPI vaccines would have still not undergone significant decay. However, we showed that the antibody concentrations were lowered in HIV-infected children. Moreover, antibody concentration after a single dose of the measles vaccine was substantially lower than expected, particularly low in HIV-infected children with low CD4+ T cell counts. This study supports the need for a second dose of the measles vaccine and for a booster dose of the DTwP and OPV vaccines to maintain the antibody concentrations in HIV-infected and HIV-exposed uninfected children.	[Baril, Laurence] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France; [Penda, Ida] Hop Laquintinie, Serv Pediat, Douala, Cameroon; [Tejiokem, Mathurin C.; Pouillot, Regis] Ctr Pasteur Cameroun, Lab Epidemiol & Sante Publ, Yaounde, Cameroon; [Zanga, Marie-Claire Endegue; Kfutwah, Anfumbom; Rousset, Dominique] Ctr Pasteur Cameroun, Virol Lab, Yaounde, Cameroon; [Bilong, Catherine] Ctr Pasteur Cameroun, Lab Anal Med, Yaounde, Cameroon; [Gouandjika, Ionela] Inst Pasteur, Lab Enterovirus, Bangui, Cent Afr Republ; [Beniguel, Lydie] Inst Pasteur, Retrovirus Lab, Bangui, Cent Afr Republ; [Tene, Gilbert] Ctr Mere & Enfant Fdn Chantal Biya, Yaounde, Cameroon; [Njamkepo, Elisabeth] Inst Pasteur, Ctr Natl Reference Bordetella, Paris, France; [Tangy, Frederic] Inst Pasteur, Lab Genom Virale & Vaccinat, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre Pasteur du Cameroun; Centre Pasteur du Cameroun; Centre Pasteur du Cameroun; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Baril, L (corresponding author), Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France.	laurence_baril@yahoo.com	Gouandjika, Ionela/AGR-0778-2022; Pouillot, Regis/E-8103-2010; Rousset, Dominique/S-5400-2019	Gouandjika, Ionela/0000-0002-2498-8725; Pouillot, Regis/0000-0002-6107-5212; Rousset, Dominique/0000-0002-1473-3147; Baril, Laurence/0000-0003-2346-883X; Penda, Calixte Ida/0000-0002-1070-2108	Department of International Affairs (DIA) at the Institut Pasteur ( Paris, France)	Department of International Affairs (DIA) at the Institut Pasteur ( Paris, France)	This study was funded by the Department of International Affairs (DIA) at the Institut Pasteur ( Paris, France). The DIA was informed at regular intervals about the progress of the study. The DIA had no role in study design, data collection and analysis, or preparation of the manuscript.	ALATTAR I, 1995, PEDIATR INFECT DIS J, V14, P149, DOI 10.1097/00006454-199502000-00013; Arpadi SM, 1996, PEDIATRICS, V97, P653; BARBI M, 1992, AIDS, V6, P1465, DOI 10.1097/00002030-199212000-00007; Bautista-Lopez N, 2000, VACCINE, V18, P1393, DOI 10.1016/S0264-410X(99)00396-5; Bekker V, 2006, PEDIATRICS, V118, pE315, DOI 10.1542/peds.2005-2616; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; BRUNELL PA, 1995, J ACQ IMMUN DEF SYND, V10, P540, DOI 10.1097/00042560-199510050-00007; Chiappini E, 2006, AIDS, V20, P207, DOI 10.1097/01.aids.0000200529.64113.3e; Clerici M, 2000, BLOOD, V96, P3866, DOI 10.1182/blood.V96.12.3866.h8003866_3866_3871; Cohen BJ, 2006, J VIROL METHODS, V131, P209, DOI 10.1016/j.jviromet.2005.08.001; deOnis M, 1997, B WORLD HEALTH ORGAN, V75, P11; Dunn DT, 2003, LANCET, V362, P1605, DOI 10.1016/S0140-6736(03)14793-9; Fassinou P, 2004, AIDS, V18, P1905, DOI 10.1097/00002030-200409240-00006; Faye A, 2004, CLIN INFECT DIS, V39, P1692, DOI 10.1086/425739; Gans H, 2001, J INFECT DIS, V184, P817, DOI 10.1086/323346; GARENNE M, 1991, LANCET, V338, P903, DOI 10.1016/0140-6736(91)91771-L; Grais RF, 2007, PLOS MED, V4, P122, DOI 10.1371/journal.pmed.0040016; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Helfand RF, 2005, B WORLD HEALTH ORGAN, V83, P329; Lepage P, 1996, PEDIATR INFECT DIS J, V15, P479, DOI 10.1097/00006454-199606000-00003; LEPAGE P, 1992, AM J DIS CHILD, V146, P550, DOI 10.1001/archpedi.1992.02160170030011; Lindgren-Alves C R, 2001, J Pediatr (Rio J), V77, P496; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Moss WJ, 2007, PLOS MED, V4, P9, DOI 10.1371/journal.pmed.0040024; Moss WJ, 2003, B WORLD HEALTH ORGAN, V81, P61; Naniche D, 2004, J INFECT DIS, V190, P1387, DOI 10.1086/424571; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Pancharoen C, 2004, CURR HIV RES, V2, P293, DOI 10.2174/1570162043351084; RELYVELD E, 1991, VACCINE, V9, P843, DOI 10.1016/0264-410X(91)90224-T; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; RUDY BT, 1994, J PEDIATR-US, V125, P72, DOI 10.1016/S0022-3476(94)70125-3; RYDER RW, 1993, J PEDIATR-US, V122, P697, DOI 10.1016/S0022-3476(06)80007-7; Scott S, 2005, J INFECT DIS, V191, P1854, DOI 10.1086/429963; Setse RW, 2006, J TROP PEDIATRICS, V52, P324, DOI 10.1093/tropej/fmk002; Sutter RW, 2000, NEW ENGL J MED, V343, P767, DOI 10.1056/NEJM200009143431103; Taha T E, 2000, Pediatrics, V106, pE77, DOI 10.1542/peds.106.6.e77; Triki H, 1997, VACCINE, V15, P1123, DOI 10.1016/S0264-410X(97)00001-7; Vigano A, 2007, AIDS, V21, P245, DOI 10.1097/QAD.0b013e328011d7d3; Waibale P, 1999, INT J EPIDEMIOL, V28, P341, DOI 10.1093/ije/28.2.341; *WHO, IMM SERV DEL ACC DIS; *WHO, 1997, MAN VIR INV POL, P44; *WHO UNAIDS, 2006, REP GLOB AIDS EP; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; World Health Organization, ANT THER HIV INF INF	44	33	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1260	10.1371/journal.pone.0001260	http://dx.doi.org/10.1371/journal.pone.0001260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060056	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459400009
J	Garbuzova-Davis, S; Saporta, S; Haller, E; Kolomey, I; Bennett, SP; Potter, H; Sanberg, PR				Garbuzova-Davis, Svitlana; Saporta, Samuel; Haller, Edward; Kolomey, Irina; Bennett, Steven P.; Potter, Huntington; Sanberg, Paul R.			Evidence of Compromised Blood-Spinal Cord Barrier in Early and Late Symptomatic SOD1 Mice Modeling ALS	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; BRAIN-BARRIER; MOUSE MODEL; CEREBROSPINAL-FLUID; GLUCOSE-TRANSPORTER; DISEASE ONSET; HNT NEURONS; SCLEROSIS; IMMUNE; CELLS	Background. The blood-brain barrier (BBB), blood-spinal cord barrier (BSCB), and blood-cerebrospinal fluid barrier (BCSFB) control cerebral/spinal cord homeostasis by selective transport of molecules and cells from the systemic compartment. In the spinal cord and brain of both ALS patients and animal models, infiltration of T-cell lymphocytes, monocyte-derived macrophages and dendritic cells, and IgG deposits have been observed that may have a critical role in motor neuron damage. Additionally, increased levels of albumin and IgG have been found in the cerebrospinal fluid in ALS patients. These findings suggest altered barrier permeability in ALS. Recently, we showed disruption of the BBB and BSCB in areas of motor neuron degeneration in the brain and spinal cord in G93A SOD1 mice modeling ALS at both early and late stages of disease using electron microscopy. Examination of capillary ultrastructure revealed endothelial cell degeneration, which, along with astrocyte alteration, compromised the BBB and BSCB. However, the effect of these alterations upon barrier function in ALS is still unclear. The aim of this study was to determine the functional competence of the BSCB in G93A mice at different stages of disease. Methodology/Principal Findings. Evans Blue (EB) dye was intravenously injected into ALS mice at early or late stage disease. Vascular leakage and the condition of basement membranes, endothelial cells, and astrocytes were investigated in cervical and lumbar spinal cords using immunohistochemistry. Results showed EB leakage in spinal cord microvessels from all G93A mice, indicating dysfunction in endothelia and basement membranes and confirming our previous ultrastructural findings on BSCB disruption. Additionally, downregulation of Glut-1 and CD146 expressions in the endothelial cells of the BSCB were found which may relate to vascular leakage. Conclusions/Significance. Results suggest that the BSCB is compromised in areas of motor neuron degeneration in ALS mice at both early and late stages of the disease.	[Garbuzova-Davis, Svitlana; Saporta, Samuel; Kolomey, Irina; Sanberg, Paul R.] Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Garbuzova-Davis, Svitlana; Saporta, Samuel; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Neurosurg, Tampa, FL USA; [Garbuzova-Davis, Svitlana; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Garbuzova-Davis, Svitlana; Saporta, Samuel; Haller, Edward; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL USA; [Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Psychiat, Tampa, FL USA; [Bennett, Steven P.; Potter, Huntington] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL USA; [Bennett, Steven P.; Potter, Huntington] Johnnie B Byrds Alzheimer Ctr, Tampa, FL USA; [Bennett, Steven P.; Potter, Huntington] Res Inst, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Garbuzova-Davis, S (corresponding author), Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	sgarbuzo@health.usf.edu	Garbuzova-Davis, Svitlana/Q-3687-2019; Lecuit, Marc/J-4073-2013; Bennett, Steven/GLV-6597-2022; Lecuit, Marc/M-4126-2019	Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063; Sanberg, Paul/0000-0001-9130-4592; Haller, Edward/0000-0002-8535-2181	USF Internal Awards Program	USF Internal Awards Program	This work was supported by the USF Internal Awards Program.	Alexianu Maria E., 1995, Romanian Journal of Neurology and Psychiatry, V33, P215; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Almer G, 2001, ANN NEUROL, V49, P176, DOI 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.3.CO;2-O; ANNUNZIATA P, 1985, ACTA NEUROL SCAND, V72, P61; APOSTOLSKI S, 1991, ACTA NEUROL SCAND, V83, P96, DOI 10.1111/j.1600-0404.1991.tb04656.x; APPEL SH, 1994, J NEUROL SCI, V124, P14, DOI 10.1016/0022-510X(94)90171-6; Aschner M, 1998, NEUROTOXICOLOGY, V19, P269; AVATA C, 2002, J CLIN NEUROSCI, V9, P113; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barneoud P, 1997, NEUROREPORT, V8, P2861, DOI 10.1097/00001756-199709080-00012; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; CHIU AY, 1995, MOL CELL NEUROSCI, V6, P349, DOI 10.1006/mcne.1995.1027; Claudio L, 1996, ACTA NEUROPATHOL, V91, P6; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; DERMIETZEL R, 1991, INT REV CYTOL, V127, P57; DONNENFELD H, 1984, J NEUROIMMUNOL, V6, P51, DOI 10.1016/0165-5728(84)90042-0; Dwyer DS, 2002, INT REV NEUROBIOL, V51, P159, DOI 10.1016/S0074-7742(02)51005-9; Engelhardt Britta, 2006, V43, P259, DOI 10.1007/020; Engelhardt JI, 2005, ACTA NEUROL SCAND, V112, P126, DOI 10.1111/j.1600-0404.2005.00445.x; ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P30, DOI 10.1001/archneur.1993.00540010026013; ENGELHARDT JI, 1990, ARCH NEUROL-CHICAGO, V47, P1210, DOI 10.1001/archneur.1990.00530110068019; FARRELL CL, 1991, P NATL ACAD SCI USA, V88, P5779, DOI 10.1073/pnas.88.13.5779; Garbuzova-Davis S, 2001, AMYOTROPH LATERAL SC, V2, P175, DOI 10.1080/14660820152882179; Garbuzova-Davis S, 2002, EXP NEUROL, V174, P169, DOI 10.1006/exnr.2002.7860; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Garbuzova-Davis S, 2007, BRAIN RES, V1157, P126, DOI 10.1016/j.brainres.2007.04.044; Ge SJ, 2006, J NEUROIMMUNOL, V177, P209, DOI 10.1016/j.jneuroim.2006.05.012; GERHART DZ, 1989, J NEUROSCI RES, V22, P464, DOI 10.1002/jnr.490220413; Gordh T, 2006, PAIN, V124, P211, DOI 10.1016/j.pain.2006.05.020; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Hensley K, 2006, ANTIOXID REDOX SIGN, V8, P2075, DOI 10.1089/ars.2006.8.2075; Ince PG, 1996, ACTA NEUROPATHOL, V92, P395, DOI 10.1007/s004010050535; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kirk J, 2003, J PATHOL, V201, P319, DOI 10.1002/path.1434; Kirkinezos IG, 2004, J NEUROCHEM, V88, P821, DOI 10.1046/j.1471-4159.2003.02181.x; KWON EE, 1994, J NEUROPATH EXP NEUR, V53, P625, DOI 10.1097/00005072-199411000-00010; LEONARDI A, 1984, J NEUROL, V231, P75, DOI 10.1007/BF00313720; MEUCCI G, 1993, J NEUROL SCI, V118, P73, DOI 10.1016/0022-510X(93)90248-W; Miller RG, 2000, NEUROLOGY, V54, P53, DOI 10.1212/WNL.54.1.53; Mohamed HA, 2002, J NEUROSCI RES, V69, P110, DOI 10.1002/jnr.10271; MUCKE L, 1993, FASEB J, V7, P1226, DOI 10.1096/fasebj.7.13.8405808; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; OLSSON Y, 1992, PROG BRAIN RES, V91, P197; Ono S, 1998, J NEUROL SCI, V160, P140, DOI 10.1016/S0022-510X(98)00223-8; Pardridge W M, 1991, Semin Cell Biol, V2, P419; Pardridge William M, 2005, NeuroRx, V2, P1, DOI 10.1602/neurorx.2.1.1; Pardridge WM, 1999, J NEUROVIROL, V5, P556, DOI 10.3109/13550289909021285; PARDRIDGE WM, 1988, ANNU REV PHARMACOL, V28, P25; Pirttila T, 2004, ACTA NEUROL SCAND, V109, P337, DOI 10.1111/j.1600-0404.2004.00223.x; Prat A, 2001, GLIA, V36, P145, DOI 10.1002/glia.1104; Rebenko-Moll NM, 2006, CURR OPIN IMMUNOL, V18, P683, DOI 10.1016/j.coi.2006.09.005; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; RUTKA JT, 1988, J NEUROSURG, V69, P155, DOI 10.3171/jns.1988.69.2.0155; SARIA A, 1983, J NEUROSCI METH, V8, P41, DOI 10.1016/0165-0270(83)90050-X; Sasaki S, 2000, NEUROSCI LETT, V291, P44, DOI 10.1016/S0304-3940(00)01370-7; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; STEWART PA, 1994, MICROSC RES TECHNIQ, V27, P516, DOI 10.1002/jemt.1070270606; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; TROOST D, 1990, NEUROPATH APPL NEURO, V16, P401, DOI 10.1111/j.1365-2990.1990.tb01276.x; Vorbrodt AW, 2003, BRAIN RES REV, V42, P221, DOI 10.1016/S0165-0173(03)00177-2; Vos CMP, 2005, NEUROBIOL DIS, V20, P953, DOI 10.1016/j.nbd.2005.06.012; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89; Yenari MA, 2006, STROKE, V37, P1087, DOI 10.1161/01.STR.0000206281.77178.ac	65	174	175	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1205	10.1371/journal.pone.0001205	http://dx.doi.org/10.1371/journal.pone.0001205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030339	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459200018
J	Matsumoto, T; Sasaki, JI; Alsberg, E; Egusa, H; Yatani, H; Sohmura, T				Matsumoto, Takuya; Sasaki, Jun-Ichi; Alsberg, Eben; Egusa, Hiroshi; Yatani, Hirofumi; Sohmura, Taiji			Three-Dimensional Cell and Tissue Patterning in a Strained Fibrin Gel System	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; CONTROLLED-RELEASE; CYCLIC STRAIN; STIFFNESS; ALIGNMENT; DELIVERY; MATRICES	Techniques developed for the in vitro reproduction of three-dimensional (3D) biomimetic tissue will be valuable for investigating changes in cell function in tissues and for fabricating cell/matrix composites for applications in tissue engineering techniques. In this study, we show that the simple application of a continuous strain to a fibrin gel facilitates the development of fibril alignment and bundle-like structures in the fibrin gel in the direction of the applied strain. Myoblasts cultured in this gel also exhibited well-aligned cell patterning in a direction parallel to the direction of the strain. Interestingly, the direction of cell proliferation was identical to that of cell alignment. Finally, the oriented cells formed linear groups that were aligned parallel to the direction of the strain and replicated the native skeletal muscle cell patterning. In addition, vein endothelial cells formed a linear, aligned vessel-like structure in this system. Thus, the system enables the in vitro reproduction of 3D aligned cell sets replicating biological tissue patterns.	[Matsumoto, Takuya; Sasaki, Jun-Ichi; Egusa, Hiroshi; Yatani, Hirofumi; Sohmura, Taiji] Osaka Univ, Dept Oromaxillofacial Regenerat, Suita, Osaka, Japan; [Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Osaka University; Case Western Reserve University	Matsumoto, T (corresponding author), Osaka Univ, Dept Oromaxillofacial Regenerat, Suita, Osaka, Japan.	tmatsu@dent.osaka-u.ac.jp	Egusa, Hiroshi/AFT-9694-2022	Egusa, Hiroshi/0000-0002-0200-8132; Alsberg, Eben/0000-0002-3487-4625	JSPS [18680039, 19659503]; COE program	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); COE program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grants-in-Aid 18680039 and 19659503 from JSPS and young investigator grant from COE program.	Alsberg E, 2006, TISSUE ENG, V12, P3247, DOI 10.1089/ten.2006.12.3247; Bhang SH, 2007, J BIOMED MATER RES A, V80A, P998, DOI 10.1002/jbm.a.31050; Boontheekul T, 2007, TISSUE ENG, V13, P1431, DOI 10.1089/ten.2006.0356; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen QH, 2003, J VASC SURG, V37, P660, DOI 10.1067/mva.2003.95; Dubey N, 2001, BIOMATERIALS, V22, P1065, DOI 10.1016/S0142-9612(00)00341-0; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027; FISCHBACH C, 2007, NAT METHODS IN PRESS; Huang YC, 2005, J APPL PHYSIOL, V98, P706, DOI 10.1152/japplphysiol.00273.2004; Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8; Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671; Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392; LEE RC, 1998, Patent No. 5756350; Matsumoto T, 2007, TISSUE ENG, V13, P207, DOI 10.1089/ten.2006.0058; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2; Peretti GM, 2006, TISSUE ENG, V12, P1151, DOI 10.1089/ten.2006.12.1151; Powell CA, 2002, AM J PHYSIOL-CELL PH, V283, pC1557, DOI 10.1152/ajpcell.00595.2001; Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104; Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0; Tan W, 2005, J BIOMED MATER RES A, V72A, P146, DOI 10.1002/jbm.a.30182; Thomas AC, 2004, J CONTROL RELEASE, V100, P357, DOI 10.1016/j.jconrel.2004.09.004; Tranquillo RT, 1996, BIOMATERIALS, V17, P349, DOI 10.1016/0142-9612(96)85573-6; Webb K, 2006, J BIOMECH, V39, P1136, DOI 10.1016/j.jbiomech.2004.08.026; Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011; Zhu XY, 2005, NAT MATER, V4, P403, DOI 10.1038/nmat1365	27	83	83	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1211	10.1371/journal.pone.0001211	http://dx.doi.org/10.1371/journal.pone.0001211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030345	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459200024
J	Das, U; Hariprasad, G; Ethayathulla, AS; Manral, P; Das, TK; Pasha, S; Mann, A; Ganguli, M; Verma, AK; Bhat, R; Chandrayan, SK; Ahmed, S; Sharma, S; Kaur, P; Singh, TP; Srinivasan, A				Das, Utpal; Hariprasad, Gururao; Ethayathulla, Abdul S.; Manral, Pallavi; Das, Taposh K.; Pasha, Santosh; Mann, Anita; Ganguli, Munia; Verma, Amit K.; Bhat, Rajiv; Chandrayan, Sanjeev Kumar; Ahmed, Shubbir; Sharma, Sujata; Kaur, Punit; Singh, Tej P.; Srinivasan, Alagiri			Inhibition of Protein Aggregation: Supramolecular Assemblies of Arginine Hold the Key	PLOS ONE			English	Article								Background. Aggregation of unfolded proteins occurs mainly through the exposed hydrophobic surfaces. Any mechanism of inhibition of this aggregation should explain the prevention of these hydrophobic interactions. Though arginine is prevalently used as an aggregation suppressor, its mechanism of action is not clearly understood. We propose a mechanism based on the hydrophobic interactions of arginine. Methodology. We have analyzed arginine solution for its hydrotropic effect by pyrene solubility and the presence of hydrophobic environment by 1-anilino-8-naphthalene sulfonic acid fluorescence. Mass spectroscopic analyses show that arginine forms molecular clusters in the gas phase and the cluster composition is dependent on the solution conditions. Light scattering studies indicate that arginine exists as clusters in solution. In the presence of arginine, the reverse phase chromatographic elution profile of Alzheimer's amyloid beta 1-42 (A beta(1-42)) peptide is modified. Changes in the hydrodynamic volume of A beta(1-42) in the presence of arginine measured by size exclusion chromatography show that arginine binds to A beta(1-42). Arginine increases the solubility of A beta(1-42) peptide in aqueous medium. It decreases the aggregation of A beta(1-42) as observed by atomic force microscopy. Conclusions. Based on our experimental results we propose that molecular clusters of arginine in aqueous solutions display a hydrophobic surface by the alignment of its three methylene groups. The hydrophobic surfaces present on the proteins interact with the hydrophobic surface presented by the arginine clusters. The masking of hydrophobic surface inhibits protein-protein aggregation. This mechanism is also responsible for the hydrotropic effect of arginine on various compounds. It is also explained why other amino acids fail to inhibit the protein aggregation.	[Das, Utpal; Hariprasad, Gururao; Ethayathulla, Abdul S.; Manral, Pallavi; Sharma, Sujata; Kaur, Punit; Singh, Tej P.; Srinivasan, Alagiri] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Das, Taposh K.] All India Inst Med Sci, Dept Anat, New Delhi 110029, India; [Pasha, Santosh] Univ Delhi, Peptide Chem Lab, Inst Genom & Integrat Biol, Delhi 110007, India; [Mann, Anita; Ganguli, Munia] Univ Delhi, Atom Force Microscopy Lab, Inst Genom & Integrat Biol, Delhi 110007, India; [Verma, Amit K.; Bhat, Rajiv] Jawaharlal Nehru Univ, Sch Biotechnol, Ctr Biotechnol, New Delhi 110067, India; [Chandrayan, Sanjeev Kumar; Ahmed, Shubbir] Inst Microbial Technol, Div Prot Sci & Engn, Chandigarh, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi; Jawaharlal Nehru University, New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Srinivasan, A (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	srini@aiims.ac.in	CHANDRAYAN, SANJEEV/M-1662-2016; Ahmed, Shubbir/AAC-4289-2019; Das, Utpal/E-4692-2013; Mann, Anita/GQP-9814-2022	CHANDRAYAN, SANJEEV/0000-0003-2219-4654; Ahmed, Shubbir/0000-0003-1655-6735; Verma, Amit Kumar/0000-0002-9836-881X	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work has been supported by a research grant to AS from the Department of Biotechnology, Government of India.	Arakawa T, 2003, BIOCHEM BIOPH RES CO, V304, P148, DOI 10.1016/S0006-291X(03)00578-3; Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Armstrong N, 1999, PROTEIN SCI, V8, P1475, DOI 10.1110/ps.8.7.1475; Arora D, 1996, J BIOTECHNOL, V52, P127, DOI 10.1016/S0168-1656(96)01636-7; Baynes BM, 2005, BIOCHEMISTRY-US, V44, P4919, DOI 10.1021/bi047528r; Baynes BM, 2004, BIOPHYS J, V87, P1631, DOI 10.1529/biophysj.104.042473; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; BREMS DN, 1987, BIOCHEMISTRY-US, V26, P7774, DOI 10.1021/bi00398a036; BUCHNER J, 1991, BIO-TECHNOL, V9, P157, DOI 10.1038/nbt0291-157; Charvat A, 2002, EUR PHYS J D, V20, P573, DOI 10.1140/epjd/e2002-00169-0; [陈启宏 CHEN Qihong], 2006, [华中师范大学学报. 自然科学版, Journal of Central China Normal University. Natural Sciences edition], V40, P42; COLOMBO MF, 1992, SCIENCE, V256, P655, DOI 10.1126/science.1585178; D'Agostino L, 2005, FEBS J, V272, P3777, DOI 10.1111/j.1742-4658.2005.04782.x; D'Agostino L, 2002, EUR J BIOCHEM, V269, P4317, DOI 10.1046/j.1432-1033.2002.03128.x; GOLDBERG ME, 1985, TRENDS BIOCHEM SCI, V10, P388, DOI 10.1016/0968-0004(85)90066-0; Gursky O, 2000, BBA-PROTEIN STRUCT M, V1476, P93, DOI 10.1016/S0167-4838(99)00228-9; Hirai A, 2006, COLLOID POLYM SCI, V284, P520, DOI 10.1007/s00396-005-1423-1; Ho JGS, 2003, PROTEIN SCI, V12, P708, DOI 10.1110/ps.0233703; Hsih MH, 1997, APPL MICROBIOL BIOT, V48, P66, DOI 10.1007/s002530051016; ICHIMURA S, 1977, BIOPOLYMERS, V16, P1449, DOI 10.1002/bip.1977.360160706; Ishibashi MI, 2005, PROTEIN PEPTIDE LETT, V12, P649, DOI 10.2174/0929866054696136; Julian RR, 2001, J AM CHEM SOC, V123, P3577, DOI 10.1021/ja003105a; KARLE IL, 1964, ACTA CRYSTALLOGR, V17, P835, DOI 10.1107/S0365110X64002250; KIRKWOOD JG, 1951, J CHEM PHYS, V19, P774, DOI 10.1063/1.1748352; KOETZLE TF, 1973, ACTA CRYSTALLOGR B, V29, P2571, DOI 10.1107/S0567740873007028; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; Lee SH, 2006, PROTEIN SCI, V15, P304, DOI 10.1110/ps.051813506; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Macrae CF, 2006, J APPL CRYSTALLOGR, V39, P453, DOI [10.1107/S002188980600731X, 10.1107/S0021 88980600731X]; MELANDER W, 1977, ARCH BIOCHEM BIOPHYS, V183, P200, DOI 10.1016/0003-9861(77)90434-9; Myung S, 2006, J AM CHEM SOC, V128, P10833, DOI 10.1021/ja0622711; Ory JJ, 1999, BIOPHYS J, V77, P1107, DOI 10.1016/S0006-3495(99)76961-4; Recacha R, 1997, J PEPT RES, V50, P388; Reddy RC, 2005, PROTEIN SCI, V14, P929, DOI 10.1110/ps.041085005; RINAS U, 1990, BIOL CHEM H-S, V371, P49, DOI 10.1515/bchm3.1990.371.1.49; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; SAENGER W, 1972, ACTA CRYSTALL B-STRU, VB 28, P2237, DOI 10.1107/S0567740872005862; Samuel D, 2000, PROTEIN SCI, V9, P344; Samuel D, 1997, BIOCHEM MOL BIOL INT, V41, P235; SCHOBERT B, 1978, BIOCHIM BIOPHYS ACTA, V541, P270, DOI 10.1016/0304-4165(78)90400-2; Schonbrunn E, 2000, P NATL ACAD SCI USA, V97, P6345, DOI 10.1073/pnas.120120397; Shimizu S, 2004, P NATL ACAD SCI USA, V101, P1195, DOI 10.1073/pnas.0305836101; Shiraki K, 2002, J BIOCHEM, V132, P591, DOI 10.1093/oxfordjournals.jbchem.a003261; SRINIVAS V, 1995, LANGMUIR, V11, P2830, DOI 10.1021/la00007a077; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; SUBRAMANIAN E, 1967, ACTA CRYSTALLOGR, V22, P910, DOI 10.1107/S0365110X67001768; SURESH CG, 1983, INT J PEPT PROT RES, V21, P223; TANEJA S, 1994, BIOCHEM J, V303, P147, DOI 10.1042/bj3030147; Timasheff SN, 1998, ADV PROTEIN CHEM, V51, P355; TORII K, 1970, ACTA CRYSTALL B-STRU, VB 26, P1317, DOI 10.1107/S0567740870004065; TORII K, 1971, ACTA CRYSTALL B-STRU, VB 27, P2237, DOI 10.1107/S0567740871005612; TORII K, 1973, ACTA CRYSTALLOGR B, V29, P2799, DOI 10.1107/S0567740873007569; Tsumoto K, 2005, PROTEIN PEPTIDE LETT, V12, P613, DOI 10.2174/0929866054696109; Valente JJ, 2005, BIOPHYS J, V89, P4211, DOI 10.1529/biophysj.105.068551; WRIGHT DA, 1962, ACTA CRYSTALLOGR, V15, P54, DOI 10.1107/S0365110X62000122	56	154	164	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1176	10.1371/journal.pone.0001176	http://dx.doi.org/10.1371/journal.pone.0001176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000547	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459100018
J	Nancarrow, DJ; Handoko, HY; Stark, MS; Whiteman, DC; Hayward, NK				Nancarrow, Derek J.; Handoko, Herlina Y.; Stark, Mitchell S.; Whiteman, David C.; Hayward, Nicholas K.			SiDCoN: A Tool to Aid Scoring of DNA Copy Number Changes in SNP Chip Data	PLOS ONE			English	Article								The recent application of genome-wide, single nucleotide polymorphism (SNP) microarrays to investigate DNA copy number aberrations in cancer has provided unparalleled sensitivity for identifying genomic changes. In some instances the complexity of these changes makes them difficult to interpret, particularly when tumour samples are contaminated with normal (stromal) tissue. Current automated scoring algorithms require considerable manual data checking and correction, especially when assessing uncultured tumour specimens. To address these limitations we have developed a visual tool to aid in the analysis of DNA copy number data. Simulated DNA Copy Number (SiDCoN) is a spreadsheet-based application designed to simulate the appearance of B-allele and logR plots for all known types of tumour DNA copy number changes, in the presence or absence of stromal contamination. The system allows the user to determine the level of stromal contamination, as well as specify up to 3 different DNA copy number aberrations for up to 5000 data points (representing individual SNPs). This allows users great flexibility to assess simple or complex DNA copy number combinations. We demonstrate how this utility can be used to estimate the level of stromal contamination within tumour samples and its application in deciphering the complex heterogeneous copy number changes we have observed in a series of tumours. We believe this tool will prove useful to others working in the area, both as a training tool, and to aid in the interpretation of complex copy number changes.	[Nancarrow, Derek J.; Handoko, Herlina Y.; Stark, Mitchell S.; Whiteman, David C.; Hayward, Nicholas K.] Queensland Inst Med Res, Herston, Qld 4006, Australia	QIMR Berghofer Medical Research Institute	Nancarrow, DJ (corresponding author), Queensland Inst Med Res, Bramston Terrace, Herston, Qld 4006, Australia.	derekN@qimr.edu.au	Stark, Mitchell/K-3874-2019; hayward, nicholas k/C-1367-2015; Stark, Mitchell/K-6794-2019; Whiteman, David C/P-2728-2014; Stark, Mitchell S/E-3542-2010; hayward, nick/AAV-8802-2020; , Herlina/F-4193-2015	hayward, nicholas k/0000-0003-4760-1033; Stark, Mitchell/0000-0002-4510-2161; Whiteman, David C/0000-0003-2563-9559; Stark, Mitchell S/0000-0002-4510-2161; , Herlina/0000-0003-3153-2248	United States National Cancer Institute [CA 001833-03]; Queensland Cancer Fund; National Health and Medical Research Council (NHMRC) of Australia [199600]; National Health and Medical Research Council of Australia; NATIONAL CANCER INSTITUTE [R01CA001833] Funding Source: NIH RePORTER	United States National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Queensland Cancer Fund; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This research was supported by grant number CA 001833-03 from the United States National Cancer Institute, the Queensland Cancer Fund and the National Health and Medical Research Council (NHMRC) of Australia (Program no. 199600). David Whiteman is supported by Senior Research Fellowships from the National Health and Medical Research Council of Australia. The funding bodies played no role in the design or conduct of the study; the collection, management, analysis, or interpretation of the data; or the preparation, review, or approval of the manuscript.	Andersen CL, 2007, CARCINOGENESIS, V28, P38, DOI 10.1093/carcin/bgl086; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Gibbs JR, 2006, PLOS GENET, V2, P1511, DOI 10.1371/journal.pgen.0020150; Huang J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-83; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152	7	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1093	10.1371/journal.pone.0001093	http://dx.doi.org/10.1371/journal.pone.0001093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971856	Green Published, gold, Green Submitted			2022-12-27	WOS:000207458700010
J	Genovesi, S; Leita, L; Sequi, P; Andrighetto, I; Sorgato, MC; Bertoli, A				Genovesi, Sacha; Leita, Liviana; Sequi, Paolo; Andrighetto, Igino; Sorgato, M. Catia; Bertoli, Alessandro			Direct Detection of Soil-Bound Prions	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; SCRAPIE; TRANSMISSION; PROTEIN; FATE; ADSORPTION; EXTRACTION; INFECTION; SHEEP; DEER	Scrapie and chronic wasting disease are contagious prion diseases affecting sheep and cervids, respectively. Studies have indicated that horizontal transmission is important in sustaining these epidemics, and that environmental contamination plays an important role in this. In the perspective of detecting prions in soil samples from the field by more direct methods than animal-based bioassays, we have developed a novel immuno-based approach that visualises in situ the major component (PrPSc) of prions sorbed onto agricultural soil particles. Importantly, the protocol needs no extraction of the protein from soil. Using a cell-based assay of infectivity, we also report that samples of agricultural soil, or quartz sand, acquire prion infectivity after exposure to whole brain homogenates from prion-infected mice. Our data provide further support to the notion that prion-exposed soils retain infectivity, as recently determined in Syrian hamsters intracerebrally or orally challanged with contaminated soils. The cell approach of the potential infectivity of contaminated soil is faster and cheaper than classical animal-based bioassays. Although it suffers from limitations, e. g. it can currently test only a few mouse prion strains, the cell model can nevertheless be applied in its present form to understand how soil composition influences infectivity, and to test prion-inactivating procedures.	[Genovesi, Sacha; Sorgato, M. Catia; Bertoli, Alessandro] Univ Padua, Dipartimento Chim Biol, Padua, Italy; [Leita, Liviana] Ist Sperimentale Nutr Piante, Gorizia, Italy; [Sequi, Paolo] Ist Sperimentale Nutr Piante, Rome, Italy; [Andrighetto, Igino] Ist Zooprofilatt Sperimentale Venezie, Legnaro, Italy; [Sorgato, M. Catia] CNR Ist Neurosci, Padua, Italy	University of Padua; IZS delle Venezie; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Bertoli, A (corresponding author), Univ Padua, Dipartimento Chim Biol, Padua, Italy.	alessandro.bertoli@unipd.it	Andrighetto, Igino/ABF-4296-2020; Bertoli, Alessandro/C-1903-2014	BERTOLI, ALESSANDRO/0000-0003-1202-0191	Prin 2006, Ministero dell'Universita e della Ricerca (MCS); RIFAFERT, Ministero delle Politiche Agricole e Forestali (LL)	Prin 2006, Ministero dell'Universita e della Ricerca (MCS)(Ministry of Education, Universities and Research (MIUR)); RIFAFERT, Ministero delle Politiche Agricole e Forestali (LL)	This work was supported by grants Prin 2006, Ministero dell'Universita e della Ricerca (MCS), and RIFAFERT, Ministero delle Politiche Agricole e Forestali (LL).	Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Aringhieri R, 2001, EUR J SOIL SCI, V52, P449, DOI 10.1046/j.1365-2389.2001.00404.x; Belay ED, 2004, EMERG INFECT DIS, V10, P977, DOI 10.3201/eid1006.031082; Brini M, 2005, MOL BIOL CELL, V16, P2799, DOI 10.1091/mbc.E04-10-0915; Brown P, 1998, LANCET, V351, P1146, DOI 10.1016/S0140-6736(05)79115-7; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Carter D. L., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P413; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Chung HH, 2004, CHEMOSPHERE, V57, P1383, DOI 10.1016/j.chemosphere.2004.09.025; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Connan H, 2007, J THERM ANAL CALORIM, V88, P115, DOI 10.1007/s10973-006-8108-y; Cooke CM, 2007, ENVIRON SCI TECHNOL, V41, P811, DOI 10.1021/es0618189; Cooke CM, 2007, SOIL BIOL BIOCHEM, V39, P1181, DOI 10.1016/j.soilbio.2006.12.030; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Fries GF, 1996, SCI TOTAL ENVIRON, V185, P93, DOI 10.1016/0048-9697(96)05045-0; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Hoinville LJ, 1996, REV SCI TECH OIE, V15, P827, DOI 10.20506/rst.15.3.959; Hui CA, 2004, REV ENVIRON CONTAM T, V183, P115; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Leita L, 2006, SOIL BIOL BIOCHEM, V38, P1638, DOI 10.1016/j.soilbio.2005.11.018; Ma X, 2007, ENVIRON SCI TECHNOL, V41, P2324, DOI 10.1021/es062122i; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; MaWhinney S, 2006, EMERG INFECT DIS, V12, P1527, DOI 10.3201/eid1210.060019; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Palsson P. A., 1979, Slow transmissible diseases of the nervous system. Volume 1., P357; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rao MA, 2007, SOIL BIOL BIOCHEM, V39, P493, DOI 10.1016/j.soilbio.2006.08.020; Revault M, 2005, BBA-GEN SUBJECTS, V1724, P367, DOI 10.1016/j.bbagen.2005.05.005; Rigou P, 2006, ENVIRON SCI TECHNOL, V40, P1497, DOI 10.1021/es0516965; Ryder S, 2004, RES VET SCI, V76, P211, DOI 10.1016/j.rvsc.2003.11.007; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Shaw LJ, 1999, APPL SOIL ECOL, V11, P217, DOI 10.1016/S0929-1393(98)00149-8; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Vasina EN, 2005, BIOMACROMOLECULES, V6, P3425, DOI 10.1021/bm050492d; Weissmann C, 2002, P NATL ACAD SCI USA, V99, P16378, DOI 10.1073/pnas.172403799; WOLF DC, 1989, J ENVIRON QUAL, V18, P39, DOI 10.2134/jeq1989.00472425001800010007x	41	26	26	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1069	10.1371/journal.pone.0001069	http://dx.doi.org/10.1371/journal.pone.0001069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957252	Green Submitted, Green Published, gold			2022-12-27	WOS:000207458500015
J	Lam, JS; Huang, HB; Levitz, SM				Lam, Jennifer S.; Huang, Haibin; Levitz, Stuart M.			Effect of Differential N-linked and O-linked Mannosylation on Recognition of Fungal Antigens by Dendritic Cells	PLOS ONE			English	Article								Background. An experimental approach for improving vaccine efficacy involves targeting antigens to mannose receptors (MRs) on dendritic cells (DCs) and other professional antigen presenting cells. Previously, we demonstrated that mannosylated Pichia pastoris-derived recombinant proteins exhibited increased immunogenicity compared to proteins lacking mannosylation. In order to gain insight into the mechanisms responsible for this observation, the present study examined the cellular uptake of the mannosylated and deglycosylated recombinant proteins. Methodology/ Principal Findings. Utilizing transfected cell lines, roles for the macrophage mannose receptor (MMR, CD206) and DC-SIGN (CD209) in the recognition of the mannosylated, but not deglycosylated, antigens were demonstrated. The uptake of mannosylated antigens into murine bone marrow-derived DCs (BMDCs) was inhibited by yeast mannans (YMs), suggesting a mannose-specific C-type lectin receptor-dependent process, while the uptake of deglycosylated antigens remained unaffected. In particular, antigens with both N-linked and extensive O-linked mannosylation showed the highest binding and uptake by BMDCs. Finally, confocal microscopy studies revealed that both mannosylated and deglycosylated P. pastoris-derived recombinant proteins localized in MHC class II+ compartments within BMDCs. Conclusions/ Significance. Taken together with our previous results, these data suggest that increased uptake by mannose-specific C-type lectin receptors is the major mechanism responsible for the enhanced antigenicity seen with mannosylated proteins. These findings have important implications for vaccine design and contribute to our understanding of how glycosylation affects the immune response to eukaryotic pathogens.	[Huang, Haibin; Levitz, Stuart M.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Lam, Jennifer S.; Levitz, Stuart M.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Lam, Jennifer S.; Levitz, Stuart M.] Boston Univ, Sch Med, Immunol Training Program, Boston, MA 02118 USA; [Lam, Jennifer S.; Levitz, Stuart M.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	University of Massachusetts System; University of Massachusetts Worcester; Boston University; Boston University; Boston University	Levitz, SM (corresponding author), Univ Massachusetts, Med Ctr, Worcester, MA 01605 USA.	Stuart.Levitz@Umassmed.edu	Huang, Haibin/G-7364-2011		National Institutes of Health [RO1 AI25780, RO1 AI37532]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037532, R01AI066087, R01AI025780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by National Institutes of Health grants RO1 AI25780 and RO1 AI37532.	Apostolopoulos V, 1996, VACCINE, V14, P930, DOI 10.1016/0264-410X(95)00258-3; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Frison N, 2003, J BIOL CHEM, V278, P23922, DOI 10.1074/jbc.M302483200; Keler T, 2004, EXPERT OPIN BIOL TH, V4, P1953, DOI 10.1517/14712598.4.12.1953; Lam JS, 2005, J IMMUNOL, V175, P7496, DOI 10.4049/jimmunol.175.11.7496; Levitz SM, 2001, P NATL ACAD SCI USA, V98, P10422, DOI 10.1073/pnas.181331398; Luong M, 2007, VACCINE, V25, P4340, DOI 10.1016/j.vaccine.2007.03.027; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 1997, J IMMUNOL, V159, P3707; Mansour MK, 2006, J IMMUNOL, V176, P3053, DOI 10.4049/jimmunol.176.5.3053; Mansour MK, 2002, J IMMUNOL, V168, P2872, DOI 10.4049/jimmunol.168.6.2872; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Napper CE, 2001, J BIOL CHEM, V276, P14759, DOI 10.1074/jbc.M100425200; Ramakrishna V, 2004, J IMMUNOL, V172, P2845, DOI 10.4049/jimmunol.172.5.2845; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Specht CA, 2007, J INFECT DIS, V196, P796, DOI 10.1086/520536; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; STEINMAN RM, 1995, J EXP MED, V182, P283, DOI 10.1084/jem.182.2.283; Strahl-Bolsinger S, 1999, BBA-GEN SUBJECTS, V1426, P297, DOI 10.1016/S0304-4165(98)00131-7; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182	32	48	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1009	10.1371/journal.pone.0001009	http://dx.doi.org/10.1371/journal.pone.0001009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925857	Green Published, gold			2022-12-27	WOS:000207456000008
J	Hartman, MCT; Josephson, K; Lin, CW; Szostak, JW				Hartman, Matthew C. T.; Josephson, Kristopher; Lin, Chi-Wang; Szostak, Jack W.			An Expanded Set of Amino Acid Analogs for the Ribosomal Translation of Unnatural Peptides	PLOS ONE			English	Article								Background. The application of in vitro translation to the synthesis of unnatural peptides may allow the production of extremely large libraries of highly modified peptides, which are a potential source of lead compounds in the search for new pharmaceutical agents. The specificity of the translation apparatus, however, limits the diversity of unnatural amino acids that can be incorporated into peptides by ribosomal translation. We have previously shown that over 90 unnatural amino acids can be enzymatically loaded onto tRNA. Methodology/Principal Findings. We have now used a competition assay to assess the efficiency of tRNA-aminoacylation of these analogs. We have also used a series of peptide translation assays to measure the efficiency with which these analogs are incorporated into peptides. The translation apparatus tolerates most side chain derivatives, a few alpha,alpha disubstituted, N-methyl and alpha-hydroxy derivatives, but no beta-amino acids. We show that over 50 unnatural amino acids can be incorporated into peptides by ribosomal translation. Using a set of analogs that are efficiently charged and translated we were able to prepare individual peptides containing up to 13 different unnatural amino acids. Conclusions/Significance. Our results demonstrate that a diverse array of unnatural building blocks can be translationally incorporated into peptides. These building blocks provide new opportunities for in vitro selections with highly modified drug-like peptides.	[Hartman, Matthew C. T.; Josephson, Kristopher; Lin, Chi-Wang; Szostak, Jack W.] Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Ctr Computat & Integrat Biol,Simches Res Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Ctr Computat & Integrat Biol,Simches Res Ctr, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Howard Hughes Medical Institute. Jack Szostak is an Investigator, and Matthew Hartman, Kris Josephson, and Chi-Wang Lin are/were HHMI Research Associates.	AHLUWALIA GS, 1990, PHARMACOL THERAPEUT, V46, P243, DOI 10.1016/0163-7258(90)90094-I; Asahara H, 2005, BIOCHEMISTRY-US, V44, P11254, DOI 10.1021/bi050204y; BAIN JD, 1991, TETRAHEDRON, V47, P2389, DOI 10.1016/S0040-4020(01)81776-2; BAIN JD, 1989, J AM CHEM SOC, V111, P8013, DOI 10.1021/ja00202a052; Beiboer SHW, 1996, PROTEIN ENG, V9, P345, DOI 10.1093/protein/9.4.345; Bemis GW, 1999, J MED CHEM, V42, P5095, DOI 10.1021/jm9903996; Blount KF, 2007, NAT CHEM BIOL, V3, P44, DOI 10.1038/nchembio842; Budisa N, 2001, PROTEIN SCI, V10, P1281, DOI 10.1110/ps.51601; BUSIELLO V, 1979, BIOCHIM BIOPHYS ACTA, V564, P311, DOI 10.1016/0005-2787(79)90228-4; CHRISTNE.PJ, 1971, J BIOL CHEM, V246, P7551; Cleland TA, 1996, MOL NEUROBIOL, V13, P97, DOI 10.1007/BF02740637; Deming TJ, 1996, MACROMOLECULES, V29, P1442, DOI 10.1021/ma9510698; ELLMAN JA, 1992, SCIENCE, V255, P197, DOI 10.1126/science.1553546; FAHNESTOCK S, 1971, SCIENCE, V173, P340, DOI 10.1126/science.173.3994.340; Fahnestock S, 1974, Methods Enzymol, V30, P489; Forster AC, 2003, P NATL ACAD SCI USA, V100, P6353, DOI 10.1073/pnas.1132122100; Forster AC, 2001, ANAL BIOCHEM, V297, P60, DOI 10.1006/abio.2001.5329; FOWDEN L, 1963, NATURE, V199, P35, DOI 10.1038/199035a0; HALL LE, 1974, RES COMMUN CHEM PATH, V9, P145; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Hartman MCT, 2006, P NATL ACAD SCI USA, V103, P4356, DOI 10.1073/pnas.0509219103; HECKLER TG, 1988, BIOCHEMISTRY-US, V27, P7254, DOI 10.1021/bi00419a012; HECKLER TG, 1984, BIOCHEMISTRY-US, V23, P1468, DOI 10.1021/bi00302a020; HOHSAKA T, 1993, FEBS LETT, V335, P47, DOI 10.1016/0014-5793(93)80436-X; Hohsaka T, 1999, J AM CHEM SOC, V121, P34, DOI 10.1021/ja9813109; HORTIN G, 1983, METHOD ENZYMOL, V96, P777; Ikeda Y, 2003, PROTEIN ENG, V16, P699, DOI 10.1093/protein/gzg084; Josephson K, 2005, J AM CHEM SOC, V127, P11727, DOI 10.1021/ja0515809; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Kiick KL, 2001, FEBS LETT, V502, P25, DOI 10.1016/S0014-5793(01)02657-6; Kilz S, 1999, J MASS SPECTROM, V34, P281, DOI 10.1002/(SICI)1096-9888(199904)34:4<281::AID-JMS750>3.0.CO;2-M; Kirshenbaum K, 2002, CHEMBIOCHEM, V3, P235, DOI 10.1002/1439-7633(20020301)3:2/3<235::AID-CBIC235>3.0.CO;2-7; Koh JT, 1997, BIOCHEMISTRY-US, V36, P11314, DOI 10.1021/bi9707685; LEA PJ, 1973, PHYTOCHEMISTRY, V12, P1903, DOI 10.1016/S0031-9422(00)91509-7; LEMEIGNAN B, 1993, J MOL BIOL, V231, P161, DOI 10.1006/jmbi.1993.1269; Levengood J, 2004, J BIOL CHEM, V279, P17707, DOI 10.1074/jbc.M313665200; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Martinez JS, 2000, SCIENCE, V287, P1245, DOI 10.1126/science.287.5456.1245; MATTHEAKIS LC, 1994, P NATL ACAD SCI USA, V91, P9022, DOI 10.1073/pnas.91.19.9022; Mayer C, 2003, BIOCHEMISTRY-US, V42, P4787, DOI 10.1021/bi034011r; MCLENNAN H, 1983, PROG NEUROBIOL, V20, P251, DOI 10.1016/0301-0082(83)90004-7; Merryman C, 2004, CHEM BIOL, V11, P575, DOI 10.1016/j.chembiol.2004.03.009; Millward SW, 2005, J AM CHEM SOC, V127, P14142, DOI 10.1021/ja054373h; Minks C, 2000, TETRAHEDRON, V56, P9431, DOI 10.1016/S0040-4020(00)00827-9; MORRIS H, 1972, Journal of Bacteriology, V111, P203; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Murakami M, 1997, PHYTOCHEMISTRY, V45, P1197, DOI 10.1016/S0031-9422(97)00131-3; Mursinna RS, 2004, BIOCHEMISTRY-US, V43, P155, DOI 10.1021/bi034919h; NEAL AL, 1968, ARCH BIOCHEM BIOPHYS, V127, P426, DOI 10.1016/0003-9861(68)90246-4; Ninomiya K, 2004, J AM CHEM SOC, V126, P15984, DOI 10.1021/ja048200o; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; OFARRELL PH, 1978, CELL, V14, P545, DOI 10.1016/0092-8674(78)90241-6; PAPAS TS, 1970, J BIOL CHEM, V245, P1588; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; ROESSER JR, 1989, BIOCHEMISTRY-US, V28, P5185, DOI 10.1021/bi00438a041; Sabina J, 2003, J BACTERIOL, V185, P6158, DOI 10.1128/JB.185.20.6158-6170.2003; Sando S, 2007, J AM CHEM SOC, V129, P6180, DOI 10.1021/ja068033n; SCHLESIN.S, 1967, J BIOL CHEM, V242, P3369; SCHWEIZER EE, 1968, J ORG CHEM, V34, P207; Sever S, 1996, BIOCHEMISTRY-US, V35, P32, DOI 10.1021/bi952103d; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Soutourina J, 2000, J BIOL CHEM, V275, P32535, DOI 10.1074/jbc.M005166200; SPIZEK J, 1969, BIOCHEM BIOPH RES CO, V34, P17; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Tan ZP, 2004, J AM CHEM SOC, V126, P12752, DOI 10.1021/ja0472174; Tang Y, 2002, BIOCHEMISTRY-US, V41, P10635, DOI 10.1021/bi026130x; Tsao ML, 2006, J AM CHEM SOC, V128, P4572, DOI 10.1021/ja058262u; van Hest JCM, 2000, J AM CHEM SOC, V122, P1282, DOI 10.1021/ja992749j; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507	70	122	141	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e972	10.1371/journal.pone.0000972	http://dx.doi.org/10.1371/journal.pone.0000972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912351	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455900010
J	Ferreira, RA; Lazzari, CR; Lorenzo, MG; Pereira, MH				Ferreira, Raquel A.; Lazzari, Claudio R.; Lorenzo, Marcelo G.; Pereira, Marcos H.			Do Haematophagous Bugs Assess Skin Surface Temperature to Detect Blood Vessels?	PLOS ONE			English	Article							RHODNIUS-PROLIXUS HEMIPTERA; DROSOPHILA; ORIENTATION; ANTENNAE; PAINLESS	Background. It is known that some blood-sucking insects have the ability to reach vessels under the host skin with their mouthparts to feed blood from inside them. However, the process by which they locate these vessels remains largely unknown. Less than 5% of the skin is occupied by blood vessels and thus, it is not likely that insects rely on a "random search strategy", since it would increase the probability of being killed by their hosts. Indeed, heterogeneities along the skin surface might offer exploitable information for guiding insect's bites. Methodology/Principal Findings. We tested whether the bug Rhodnius prolixus can evaluate temperature discontinuities along the body surface in order to locate vessels before piercing the host skin. When placed over a rabbit ear, the bug's first bites were mostly directed towards the main vessels. When insects were confronted to artificial linear heat sources presenting a temperature gradient against the background, most bites were directly addressed to the warmer linear source, notwithstanding the temperature of both, the source and the background. Finally, tests performed using uni- and bilaterally antennectomized insects revealed that the bilateral integration of thermal inputs from both antennae is necessary for precisely directing bites. Conclusions/Significance. R. prolixus may be able to exploit the temperature differences observed over the skin surface to locate blood vessles. Bugs bite the warmest targets regardless of the target/background temperatures, suggesting that they do not bite choosing a preferred temperature, but select temperature discontinuities along the skin. This strategy seems to be an efficient one for finding blood vessels within a wide temperature range, allowing finding them on different hosts, as well as on different areas of the host body. Our study also adds new insight about the use of antennal thermal inputs by blood sucking bugs.	[Ferreira, Raquel A.; Lorenzo, Marcelo G.] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Triatomineos & Epidemiol Doenca Chagas, BR-30190 Belo Horizonte, MG, Brazil; [Lazzari, Claudio R.] Univ Tours, CNRS, UMR 6035, Inst Rech Biol Insecte, Tours, France; [Pereira, Marcos H.] Univ Fed Minas Gerais, Lab Fisiol Insetos Hematofagos, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universidade Federal de Minas Gerais	Lorenzo, MG (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Triatomineos & Epidemiol Doenca Chagas, BR-30190 Belo Horizonte, MG, Brazil.	marcelo@cpqrr.fiocruz.br	Lazzari, Claudio R/D-2869-2009; Lorenzo, Marcelo Gustavo/R-1301-2018; Lazzari, Claudio/H-6286-2019; Lorenzo, Marcelo/B-7674-2008; Pereira, Marcos H/A-3774-2012; Ferreira, Raquel Conceição/J-5236-2015; Pereira, Marcos Horácio/AAE-7076-2021	Lazzari, Claudio R/0000-0003-3703-0302; Lorenzo, Marcelo Gustavo/0000-0002-4000-5514; Lazzari, Claudio/0000-0003-3703-0302; Pereira, Marcos H/0000-0003-4843-0088; Ferreira, Raquel Conceição/0000-0001-8897-9345; Pereira, Marcos Horácio/0000-0003-4843-0088	IRR/FIOCRUZ; FAPEMIG; CAPES; CNPq; FAPEBIO/UFMG; CNRS; Universite Francois Rabelais	IRR/FIOCRUZ; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEBIO/UFMG; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Francois Rabelais	Funding was provided by IRR/FIOCRUZ, FAPEMIG, CAPES, CNPq and FAPEBIO/UFMG, CNRS and Universite Francois Rabelais.	BERNARD J, 1974, THESIS U RENNES FRAN; Catala S, 1996, J MORPHOL, V228, P195, DOI 10.1002/(SICI)1097-4687(199605)228:2<195::AID-JMOR8>3.3.CO;2-O; CHAGAS C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; Flores GB, 1996, J INSECT PHYSIOL, V42, P433, DOI 10.1016/0022-1910(95)00137-9; FLORES GB, 2001, THESIS U BUENOS AIRE; Guarneri AA, 2003, ACTA TROP, V87, P361, DOI 10.1016/S0001-706X(03)00121-9; LAVOIPIERRE M. M. J., 1959, ANN TROP MED AND PARASITOL, V53, P235; LAZZARI CR, 1992, J INSECT PHYSIOL, V38, P895, DOI 10.1016/0022-1910(92)90101-I; LAZZARI CR, 1989, ENTOMOL GEN, V14, P183; LAZZARI CR, 1989, J INSECT PHYSIOL, V35, P525, DOI 10.1016/0022-1910(89)90060-7; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; Reisenman CE, 2002, J EXP BIOL, V205, P201; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Schmitz H, 2000, J INSECT PHYSIOL, V46, P745, DOI 10.1016/S0022-1910(99)00163-8; Schofield CJ, 1994, TRIATOMINAEBIOLOGY C; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Wigglesworth VB, 1934, J EXP BIOL, V11, P120; World Health Organization, 2005, REP SCI WORK GROUP C; Xu SY, 2006, GENES BRAIN BEHAV, V5, P602, DOI 10.1111/j.1601-183X.2006.00213.x; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194; ZELEDON R, 1981, ANNU REV ENTOMOL, V26, P101, DOI 10.1146/annurev.en.26.010181.000533	23	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e932	10.1371/journal.pone.0000932	http://dx.doi.org/10.1371/journal.pone.0000932			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895973	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455800011
J	Chen, CX; Wells, AD				Chen, Chunxia; Wells, Andrew D.			Comparative Analysis of E2F Family Member Oncogenic Activity	PLOS ONE			English	Article								The E2F family of transcription factors consists of nine members with both distinct and overlapping functions. These factors are situated downstream of growth factor signaling cascades, where they play a central role in cell growth and proliferation through their ability to regulate genes involved in cell cycle progression. For this reason, it is likely that the members of the E2F family play a critical role during oncogenesis. Consistent with this idea is the observation that some tumors exhibit deregulated expression of E2F proteins. In order to systematically compare the oncogenic capacity of these family members, we stably over-expressed E2F1 through 6 in non-transformed 3T3 fibroblasts and assessed the ability of these transgenic cell lines to grow under conditions of low serum, as well as to form colonies in soft agar. Our results show that these six E2F family members can be divided into three groups that exhibit differential oncogenic capacity. The first group consists of E2F2 and E2F3a, both of which have strong oncogenic capacity. The second group consists of E2F1 and E2F6, which were neutral in our assays when compared to control cells transduced with vector alone. The third group consists of E2F4 and E2F5, which generally act to repress E2F-responsive genes, and in our assays demonstrated a strong capacity to inhibit transformation. Our results imply that the pattern of expression of these six E2F family members in a cell could exert a strong influence over its susceptibility to oncogenic transformation.	[Chen, Chunxia; Wells, Andrew D.] Childrens Hosp Philadelphia, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA; [Wells, Andrew D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Wells, AD (corresponding author), Childrens Hosp Philadelphia, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA.	adwells@mail.med.upenn.edu			NIH/NIAID [AI054643]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054643] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH/NIAID grant AI054643	Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; BEIJERSBERGEN RL, 1994, GENE DEV, V8, P2680, DOI 10.1101/gad.8.22.2680; BUCK V, 1995, ONCOGENE, V11, P31; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; Conner EA, 2000, ONCOGENE, V19, P5054, DOI 10.1038/sj.onc.1203885; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; Gaubatz S, 1998, P NATL ACAD SCI USA, V95, P9190, DOI 10.1073/pnas.95.16.9190; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; GINSBERG D, 1994, GENE DEV, V8, P2665, DOI 10.1101/gad.8.22.2665; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; HIJMANS EM, 1995, MOL CELL BIOL, V15, P3082; JOHNSON DG, 1994, P NATL ACAD SCI USA, V91, P12823, DOI 10.1073/pnas.91.26.12823; Lee TA, 2000, ONCOGENE, V19, P2257, DOI 10.1038/sj.onc.1203556; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Maiti B, 2005, J BIOL CHEM, V280, P18211, DOI 10.1074/jbc.M501410200; Martelli F, 2001, P NATL ACAD SCI USA, V98, P4455, DOI 10.1073/pnas.081061398; Morkel M, 1997, NATURE, V390, P567, DOI 10.1038/37507; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pierce AM, 1998, ONCOGENE, V16, P1267, DOI 10.1038/sj.onc.1201666; Pierce AM, 1999, MOL CELL BIOL, V19, P6408; Pierce AM, 1998, P NATL ACAD SCI USA, V95, P8858, DOI 10.1073/pnas.95.15.8858; Polanowska J, 2000, GENE CHROMOSOME CANC, V28, P126, DOI 10.1002/(SICI)1098-2264(200005)28:1<126::AID-GCC15>3.0.CO;2-G; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Saavedra HI, 2003, CANCER CELL, V3, P333, DOI 10.1016/S1535-6108(03)00083-7; Scheijen B, 2004, J BIOL CHEM, V279, P10476, DOI 10.1074/jbc.M313682200; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; SINGH P, 1994, EMBO J, V13, P3329, DOI 10.1002/j.1460-2075.1994.tb06635.x; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Trimarchi JM, 1998, P NATL ACAD SCI USA, V95, P2850, DOI 10.1073/pnas.95.6.2850; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Volante M, 2002, MODERN PATHOL, V15, P1038, DOI 10.1097/01.MP.0000028645.36632.A8; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; XU GF, 1995, P NATL ACAD SCI USA, V92, P1357, DOI 10.1073/pnas.92.5.1357	46	31	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e912	10.1371/journal.pone.0000912	http://dx.doi.org/10.1371/journal.pone.0000912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878947	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455700020
J	Six, C; Finkel, ZV; Irwin, AJ; Campbell, DA				Six, Christophe; Finkel, Zoe V.; Irwin, Andrew J.; Campbell, Douglas A.			Light Variability Illuminates Niche-Partitioning among Marine Picocyanobacteria	PLOS ONE			English	Article								Prochlorococcus and Synechococcus picocyanobacteria are dominant contributors to marine primary production over large areas of the ocean. Phytoplankton cells are entrained in the water column and are thus often exposed to rapid changes in irradiance within the upper mixed layer of the ocean. An upward fluctuation in irradiance can result in photosystem II photoinactivation exceeding counteracting repair rates through protein turnover, thereby leading to net photoinhibition of primary productivity, and potentially cell death. Here we show that the effective cross-section for photosystem II photoinactivation is conserved across the picocyanobacteria, but that their photosystem II repair capacity and protein-specific photosystem II light capture are negatively correlated and vary widely across the strains. The differences in repair rate correspond to the light and nutrient conditions that characterize the site of origin of the Prochlorococcus and Synechococcus isolates, and determine the upward fluctuation in irradiance they can tolerate, indicating that photoinhibition due to transient high-light exposure influences their distribution in the ocean.	[Six, Christophe; Finkel, Zoe V.; Irwin, Andrew J.; Campbell, Douglas A.] Mt Allison Univ, Sackville, NB E0A 3C0, Canada	Mount Allison University	Campbell, DA (corresponding author), Mt Allison Univ, Sackville, NB E0A 3C0, Canada.	dcampbell@mta.ca	Campbell, Douglas A./B-3768-2010; Finkel, Zoe V/B-9626-2008; Irwin, Andrew/B-2245-2008	Campbell, Douglas A./0000-0001-8996-5463; Finkel, Zoe V/0000-0003-4212-3917; Irwin, Andrew/0000-0001-7784-2319	The Natural Sciences and Engineering Research Council of Canada; University Faculty Award; Canada Research Chair; New Brunswick Innovation Foundations	The Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University Faculty Award; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); New Brunswick Innovation Foundations	The Natural Sciences and Engineering Research Council of Canada provided Discovery grant (DAC, ZVF, AJI), University Faculty Award (ZVF) and Canada Research Chair (DAC) funding, while the Canada and New Brunswick Innovation Foundations (DAC, ZVF) provided equipment funding.	Bailey S, 2005, FEBS LETT, V579, P275, DOI 10.1016/j.febslet.2004.11.091; Barnett A. B, 2007, FIREWORX; Bibby TS, 2003, NATURE, V424, P1051, DOI 10.1038/nature01933; Boucher NP, 1996, MAR ECOL PROG SER, V144, P223, DOI 10.3354/meps144223; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; Burns RA, 2006, J PHYCOL, V42, P610, DOI 10.1111/j.1529-8817.2006.00220.x; CULLEN JJ, 1992, SCIENCE, V258, P646, DOI 10.1126/science.258.5082.646; Everroad C, 2006, J BACTERIOL, V188, P3345, DOI 10.1128/JB.188.9.3345-3356.2006; FELDMAN GC, 2007, OCEAN COLOR WEB AQUA; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Fuller NJ, 2003, APPL ENVIRON MICROB, V69, P2430, DOI 10.1128/AEM.69.5.2430-2443.2003; Gorbunov MY, 1999, PHOTOSYNTH RES, V62, P141, DOI 10.1023/A:1006360005033; Hakala M, 2005, BBA-BIOENERGETICS, V1706, P68, DOI 10.1016/j.bbabio.2004.09.001; Heraud P, 2005, J PHYCOL, V41, P1212, DOI 10.1111/j.1529-8817.2005.00149.x; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; KANA TM, 1987, DEEP-SEA RES, V34, P479, DOI 10.1016/0198-0149(87)90001-X; Lantoine F, 1997, DEEP-SEA RES PT I, V44, P223, DOI 10.1016/S0967-0637(96)00094-5; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; MOREL A, 1993, J MAR RES, V51, P617, DOI 10.1357/0022240933223963; Neale PJ, 2001, J PHOTOCH PHOTOBIO B, V62, P1, DOI 10.1016/S1011-1344(01)00159-2; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; Not F, 2005, LIMNOL OCEANOGR, V50, P1677, DOI 10.4319/lo.2005.50.5.1677; OLSON RJ, 1990, LIMNOL OCEANOGR, V35, P45, DOI 10.4319/lo.1990.35.1.0045; Palenik B, 2001, APPL ENVIRON MICROB, V67, P991, DOI 10.1128/AEM.67.2.991-994.2001; PARK YI, 1995, PLANTA, V196, P401, DOI 10.1007/BF00203636; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Partensky F., 2003, PHOTOSYNTHESIS ALGAE, P29; Richardson TL, 2007, SCIENCE, V315, P838, DOI 10.1126/science.1133471; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; Sarvikas P, 2006, PLANT CELL PHYSIOL, V47, P391, DOI 10.1093/pcp/pcj006; Schubert H, 2001, HELGOLAND MAR RES, V55, P12, DOI 10.1007/s101520000064; Shelly K, 2002, J PHYCOL, V38, P713, DOI 10.1046/j.1529-8817.2002.01147.x; Sherry ND, 2001, DEEP-SEA RES PT II, V48, P1263, DOI 10.1016/S0967-0645(00)00138-7; Sicora C, 2003, PHOTOSYNTH RES, V75, P127, DOI 10.1023/A:1022852631339; Sinclair J, 1996, PHOTOSYNTH RES, V50, P33, DOI 10.1007/BF00018219; Six C, 2004, AQUAT MICROB ECOL, V35, P17, DOI 10.3354/ame035017; Stomp M, 2004, NATURE, V432, P104, DOI 10.1038/nature03044; Ting CS, 2002, TRENDS MICROBIOL, V10, P134, DOI 10.1016/S0966-842X(02)02319-3; Tyystjarvi E, 1996, P NATL ACAD SCI USA, V93, P2213, DOI 10.1073/pnas.93.5.2213; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Wood AM, 1998, MAR ECOL PROG SER, V162, P25, DOI 10.3354/meps162025; Wood AM, 1999, DEEP-SEA RES PT II, V46, P1769; Zwirglmaier K, 2007, ENVIRON MICROBIOL, V9, P1278, DOI 10.1111/j.1462-2920.2007.01246.x	46	92	97	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1341	10.1371/journal.pone.0001341	http://dx.doi.org/10.1371/journal.pone.0001341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18092006	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459600024
J	Sharma, S; Brosh, RM				Sharma, Sudha; Brosh, Robert M., Jr.			Human RECQ1 Is a DNA Damage Responsive Protein Required for Genotoxic Stress Resistance and Suppression of Sister Chromatid Exchanges	PLOS ONE			English	Article							BLOOMS-SYNDROME HELICASE; TOPOISOMERASE-III-ALPHA; FAMILY HELICASES; BLM HELICASE; HOMOLOGOUS RECOMBINATION; UNWINDING ACTIVITY; MISMATCH REPAIR; REPLICATION; GENE; LOCALIZATION	Background. DNA helicases are ubiquitous enzymes that unwind DNA in an ATP-dependent and directionally specific manner. Unwinding of double-stranded DNA is essential for the processes of DNA repair, recombination, transcription, and DNA replication. Five human DNA helicases sharing sequence similarity with the E. coli RecQ helicase have been identified. Three of the human RecQ helicases are implicated in hereditary diseases (Bloom syndrome, Werner syndrome, and Rothmund-Thomson syndrome) which display clinical symptoms of premature aging and cancer. RECQ1 helicase is the most highly expressed of the human RecQ helicases; however, a genetic disease has yet not been linked to mutations in the RECQ1 gene, and the biological functions of human RECQ1 in cellular DNA metabolism are not known. Methodology/Principal Findings. In this study, we report that RECQ1 becomes phosphorylated upon DNA damage and forms irradiation-induced nuclear foci that associate with chromatin in human cells. Depletion of RECQ1 renders human cells sensitive to DNA damage induced by ionizing radiation or the topoisomerase inhibitor camptothecin, and results in spontaneous gamma-H2AX foci and elevated sister chromatid exchanges, indicating aberrant repair of DNA breaks. Consistent with a role in homologous recombinational repair, endogenous RECQ1 is associated with the strand exchange protein Rad51 and the two proteins directly interact with high affinity. Conclusion/Significance. Collectively, these results provide the first evidence for a role of human RECQ1 in the response to DNA damage and chromosomal stability maintenance and point to the vital importance of RECQ1 in genome homeostasis.	[Sharma, Sudha; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, Dept Hlth & Human Serv, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, Dept Hlth & Human Serv, NIH, Baltimore, MD 21224 USA.	BroshR@grc.nia.nih.gov	Sharma, Sudha/AAV-6152-2021	Sharma, Sudha/0000-0003-2765-2482	Intramural Research Program of the NIH-NIA; NATIONAL INSTITUTE ON AGING [Z01AG000741, ZIAAG000741] Funding Source: NIH RePORTER	Intramural Research Program of the NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the NIH-NIA.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bateman JR, 2007, BIOESSAYS, V29, P382, DOI 10.1002/bies.20557; Bischof O, 2001, J CELL BIOL, V153, P367, DOI 10.1083/jcb.153.2.367; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Cheng NC, 2000, HUM MOL GENET, V9, P1805, DOI 10.1093/hmg/9.12.1805; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cui S, 2003, J BIOL CHEM, V278, P1424, DOI 10.1074/jbc.M209407200; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; Davies SL, 2007, NAT STRUCT MOL BIOL, V14, P677, DOI 10.1038/nsmb1267; Davies SL, 2004, MOL CELL BIOL, V24, P1279, DOI 10.1128/MCB.24.3.1279-1291.2004; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; Doherty KM, 2005, J BIOL CHEM, V280, P28085, DOI 10.1074/jbc.M500265200; Goldfarb T, 2005, GENETICS, V169, P563, DOI 10.1534/genetics.104.035204; Gray MD, 1998, EXP CELL RES, V242, P487, DOI 10.1006/excr.1998.4124; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hope JC, 2006, P NATL ACAD SCI USA, V103, P5875, DOI 10.1073/pnas.0601571103; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Hu YD, 2005, MOL CELL BIOL, V25, P3431, DOI 10.1128/MCB.25.9.3431-3442.2005; Johnson FB, 2000, CANCER RES, V60, P1162; Kato A, 2006, GENETICS, V172, P113, DOI 10.1534/genetics.105.041756; Kato A, 2004, CURR GENET, V45, P37, DOI 10.1007/s00294-003-0459-3; Kawabe T, 2000, ONCOGENE, V19, P4764, DOI 10.1038/sj.onc.1203841; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Laursen LV, 2003, MOL CELL BIOL, V23, P3692, DOI 10.1128/MCB.23.10.3692-3705.2003; LeRoy G, 2005, NUCLEIC ACIDS RES, V33, P6251, DOI 10.1093/nar/gki929; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li DH, 2006, J CLIN ONCOL, V24, P1720, DOI 10.1200/JCO.2005.04.4206; Li DH, 2006, CANCER RES, V66, P3323, DOI 10.1158/0008-5472.CAN-05-3032; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Multani AS, 2007, J CELL SCI, V120, P713, DOI 10.1242/jcs.03397; Muzzolini L, 2007, PLOS BIOL, V5, P157, DOI 10.1371/journal.pbio.0050020; Nakayama H, 2002, ONCOGENE, V21, P9008, DOI 10.1038/sj.onc.1205959; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Petkovic M, 2005, J CELL SCI, V118, P4261, DOI 10.1242/jcs.02556; Pickford A, 2003, CURR GENET, V42, P220, DOI 10.1007/s00294-002-0351-6; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; PURANAM KL, 1995, GENOMICS, V26, P595, DOI 10.1016/0888-7543(95)80181-K; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; Rao VA, 2005, MOL CELL BIOL, V25, P8925, DOI 10.1128/MCB.25.20.8925-8937.2005; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; SEKI M, 1994, NUCLEIC ACIDS RES, V22, P4566, DOI 10.1093/nar/22.22.4566; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2007, MOL CELL BIOL, V27, P1784, DOI 10.1128/MCB.01620-06; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; SUIJKERBUIJK RF, 1993, CANCER GENET CYTOGEN, V70, P85, DOI 10.1016/0165-4608(93)90173-J; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wang WS, 2003, MOL CELL BIOL, V23, P3527, DOI 10.1128/MCB.23.10.3527-3535.2003; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2005, EMBO J, V24, P2679, DOI 10.1038/sj.emboj.7600740; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622	62	85	87	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1297	10.1371/journal.pone.0001297	http://dx.doi.org/10.1371/journal.pone.0001297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074021	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459500016
J	Li, HY; Huang, ZW; Gai, JY; Wu, S; Zeng, YR; Li, Q; Wu, RL				Li, Hongying; Huang, Zhongwen; Gai, Junyi; Wu, Song; Zeng, Yanru; Li, Qin; Wu, Rongling			A Conceptual Framework for Mapping Quantitative Trait Loci Regulating Ontogenetic Allometry	PLOS ONE			English	Article								Although ontogenetic changes in body shape and its associated allometry has been studied for over a century, essentially nothing is known about their underlying genetic and developmental mechanisms. One of the reasons for this ignorance is the unavailability of a conceptual framework to formulate the experimental design for data collection and statistical models for data analyses. We developed a framework model for unraveling the genetic machinery for ontogenetic changes of allometry. The model incorporates the mathematical aspects of ontogenetic growth and allometry into a maximum likelihood framework for quantitative trait locus (QTL) mapping. As a quantitative platform, the model allows for the testing of a number of biologically meaningful hypotheses to explore the pleiotropic basis of the QTL that regulate ontogeny and allometry. Simulation studies and real data analysis of a live example in soybean have been performed to investigate the statistical behavior of the model and validate its practical utilization. The statistical model proposed will help to study the genetic architecture of complex phenotypes and, therefore, gain better insights into the mechanistic regulation for developmental patterns and processes in organisms.	[Li, Hongying; Wu, Song; Li, Qin; Wu, Rongling] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [Huang, Zhongwen; Gai, Junyi] Nanjing Agr Univ, Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China; [Huang, Zhongwen] Henan Inst Sci & Technol, Dept Agron, Xinxiang, Henan, Peoples R China; [Zeng, Yanru] Zhejiang Forestry Univ, Sch Forestry & Biotechnol, Linan, Zhejiang, Peoples R China	State University System of Florida; University of Florida; Nanjing Agricultural University; Henan Institute of Science & Technology; Zhejiang A&F University	Wu, RL (corresponding author), Univ Florida, Dept Stat, Gainesville, FL 32611 USA.	sri@njau.edu.cn; rwu@stat.ufl.edu	tian, dong/G-5509-2011		Natural Science Foundation of China [30490250, 0540745]; National 973 Program [2002CB111304, 2004CB7206, 2006CB101708]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program(National Basic Research Program of China)	Funding: Natural Science Foundation of China (No. 30490250), the National 973 Program (2002CB111304, 2004CB7206 and 2006CB101708) and NSF grant (No. 0540745)	Banavar JR, 2002, P NATL ACAD SCI USA, V99, P10506, DOI 10.1073/pnas.162216899; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Breuker CJ, 2006, TRENDS ECOL EVOL, V21, P488, DOI 10.1016/j.tree.2006.06.003; Broman KW, 2002, J R STAT SOC B, V64, P641, DOI 10.1111/1467-9868.00354; Calder WA., 1984, SIZE FUNCTION LIFE H; CHURCHILL GA, 1994, GENETICS, V138, P963; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Frankino WA, 2005, SCIENCE, V307, P718, DOI 10.1126/science.1105409; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hou W, 2005, BIOSTATISTICS, V6, P420, DOI 10.1093/biostatistics/kxi019; Jiang CJ, 1997, GENETICA, V101, P47, DOI 10.1023/A:1018394410659; JIANG CJ, 1995, GENETICS, V140, P1111; Jin CF, 2007, J AM STAT ASSOC, V102, P56, DOI 10.1198/016214506000000834; Kao CH, 1999, GENETICS, V152, P1203; KLEIBER MAX, 1932, HILGARDIA, V6, P315; KLINGENBERG CP, 1992, AM NAT, V140, P601, DOI 10.1086/285430; Knott SA, 2000, GENETICS, V156, P899; Korol AB, 2001, GENETICS, V157, P1789; LANDER ES, 1989, GENETICS, V121, P185; Long F, 2006, GENET RES, V87, P207, DOI 10.1017/S0016672306008172; LOUIS TA, 1982, J ROY STAT SOC B MET, V44, P226; Lynch M., 1998, GENETICS ANAL QUANTI; Ma CX, 2003, J MATH BIOL, V47, P313, DOI 10.1007/s00285-003-0212-z; Ma CX, 2002, GENETICS, V161, P1751; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; Niklas KJ, 2006, NEW PHYTOL, V171, P27, DOI 10.1111/j.1469-8137.2006.01760.x; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; Nunez-Anton V, 2000, BIOMETRICS, V56, P699, DOI 10.1111/j.0006-341X.2000.00699.x; Peter R. H, 1983, ECOLOGICAL IMPLICATI; Reis RE, 1998, COPEIA, P177, DOI 10.2307/1447715; Riisgard HU, 1998, ECOL LETT, V1, P71; Rohlf FJ, 1998, SYST BIOL, V47, P147, DOI 10.1080/106351598261094; Rombough P, 2003, NATURE, V424, P268, DOI 10.1038/424268a; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; SHAW RG, 1991, EVOLUTION, V45, P143, DOI 10.1111/j.1558-5646.1991.tb05273.x; Stern DL, 1999, DEVELOPMENT, V126, P1091; Vieira C, 2000, GENETICS, V154, P213; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; Wu R., 2007, STAT GENETICS QUANTI; Wu R. L., 2006, Journal of Nanjing Forestry University (Natural Sciences Edition), V30, P1; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804; Wu RL, 2006, GENETICS, V172, P627, DOI 10.1534/genetics.105.045310; Wu RL, 2004, GENETICS, V166, P1541, DOI 10.1534/genetics.166.3.1541; Wu RL, 2002, J THEOR BIOL, V217, P275; Yap JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000554; Yi NJ, 2007, GENETICS, V176, P1865, DOI 10.1534/genetics.107.071365; Yi NJ, 2005, GENETICS, V170, P1333, DOI 10.1534/genetics.104.040386; Zelditch ML, 1998, SYST BIOL, V47, P159, DOI 10.1080/106351598261102; ZELDITCH ML, 1995, J MORPHOL, V223, P341, DOI 10.1002/jmor.1052230309; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2; Zhao W, 2004, GENETICS, V168, P1751, DOI 10.1534/genetics.104.031484; Zimmerman DL, 2001, TEST-SPAIN, V10, P1, DOI 10.1007/BF02595823	64	18	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1245	10.1371/journal.pone.0001245	http://dx.doi.org/10.1371/journal.pone.0001245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043752	gold, Green Submitted, Green Published			2022-12-27	WOS:000207459300026
J	Niault, T; Hached, K; Sotillo, R; Sorger, PK; Maro, B; Benezra, R; Wassmann, K				Niault, Theodora; Hached, Khaled; Sotillo, Rocio; Sorger, Peter K.; Maro, Bernard; Benezra, Robert; Wassmann, Katja			Changing Mad2 Levels Affects Chromosome Segregation and Spindle Assembly Checkpoint Control in Female Mouse Meiosis I	PLOS ONE			English	Article								The spindle assembly checkpoint (SAC) ensures correct separation of sister chromatids in somatic cells and provokes a cell cycle arrest in metaphase if one chromatid is not correctly attached to the bipolar spindle. Prolonged metaphase arrest due to overexpression of Mad2 has been shown to be deleterious to the ensuing anaphase, leading to the generation of aneuploidies and tumorigenesis. Additionally, some SAC components are essential for correct timing of prometaphase. In meiosis, we and others have shown previously that the Mad2-dependent SAC is functional during the first meiotic division in mouse oocytes. Expression of a dominant-negative form of Mad2 interferes with the SAC in metaphase I, and a knock-down approach using RNA interference accelerates anaphase onset in meiosis I. To prove unambigiously the importance of SAC control for mammalian female meiosis I we analyzed oocyte maturation in Mad2 heterozygote mice, and in oocytes overexpressing a GFP-tagged version of Mad2. In this study we show for the first time that loss of one Mad2 allele, as well as overexpression of Mad2 lead to chromosome missegregation events in meiosis I, and therefore the generation of aneuploid metaphase II oocytes. Furthermore, SAC control is impaired in mad2+/- oocytes, also leading to the generation of aneuploidies in meiosis I.	[Niault, Theodora; Hached, Khaled; Maro, Bernard; Wassmann, Katja] CNRS, UMR Biol Dev 7622, Paris, France; [Niault, Theodora; Hached, Khaled; Maro, Bernard; Wassmann, Katja] Univ Paris 06, Paris, France; [Hached, Khaled; Wassmann, Katja] INSERM, Avenir Team, Cell Div & Associated Checkpoints, Paris, France; [Sotillo, Rocio; Benezra, Robert] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Sorger, Peter K.] MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; [Sorger, Peter K.] MIT, Biol Engn Div, Cambridge, MA 02139 USA; [Sorger, Peter K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Maro, Bernard] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, Ramat Aviv, Israel	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Memorial Sloan Kettering Cancer Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Tel Aviv University; Sackler Faculty of Medicine	Wassmann, K (corresponding author), CNRS, UMR Biol Dev 7622, Paris, France.	katja.wassmann@snv.jussieu.fr	Maro, Bernard/AAL-2220-2020	Wassmann, Katja/0000-0001-5442-5192; Sotillo, Rocio/0000-0002-0855-7917; Sorger, Peter/0000-0002-3364-1838; Hached, Khaled/0000-0003-1143-6929	CNRS; ARC [3571, 3356, 3883]; FRM; Programme Avenir (Inserm); PNRRE (Inserm);  [UMR7622]	CNRS(Centre National de la Recherche Scientifique (CNRS)); ARC(Australian Research Council); FRM(Fondation pour la Recherche Medicale); Programme Avenir (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); PNRRE (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); 	C. Jessus (UMR7622) provided lab space and funding. This work was supported by the CNRS, an ARC grant to C. Jessus (Nu 3571) and BM (Nu 3356), an ARC and an FRM postdoctoral fellowship to KW, and a Programme Avenir (Inserm), a PNRRE (Inserm), and an ARC grant (Nu 3883) to KW.	Brunet S, 1998, CURR BIOL, V8, P1231, DOI 10.1016/S0960-9822(07)00516-7; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Brunet S, 2003, REPRODUCTION, V126, P443, DOI 10.1530/rep.0.1260443; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Furuta T, 2000, MOL BIOL CELL, V11, P1401, DOI 10.1091/mbc.11.4.1401; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Gorr IH, 2006, NAT CELL BIOL, V8, P1035, DOI 10.1038/ncb1467; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Hodges CA, 2002, CHROMOSOMA, V111, P165, DOI 10.1007/s00412-002-0195-3; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Irniger S, 2006, CELL CYCLE, V5, P405, DOI 10.4161/cc.5.4.2476; KUBIAK JZ, 1992, J CELL SCI, V102, P457; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Ledan E, 2001, DEV BIOL, V232, P400, DOI 10.1006/dbio.2001.0188; Lemaire-Adkins R, 1997, J CELL BIOL, V139, P1611, DOI 10.1083/jcb.139.7.1611; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stemmann O, 2006, CELL CYCLE, V5, P11, DOI 10.4161/cc.5.1.2296; Steuerwald N, 2001, MOL HUM REPROD, V7, P49, DOI 10.1093/molehr/7.1.49; Terret ME, 2003, CURR BIOL, V13, P1797, DOI 10.1016/j.cub.2003.09.032; Tsurumi C, 2004, J CELL BIOL, V167, P1037, DOI 10.1083/jcb.200405165; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052	30	92	95	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1165	10.1371/journal.pone.0001165	http://dx.doi.org/10.1371/journal.pone.0001165			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043727	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459300001
J	Zhang, KL; Sridhar, VV; Zhu, JH; Kapoor, A; Zhu, JK				Zhang, Kangling; Sridhar, Vaniyambadi V.; Zhu, Jianhua; Kapoor, Avnish; Zhu, Jian-Kang			Distinctive Core Histone Post-Translational Modification Patterns in Arabidopsis thaliana	PLOS ONE			English	Article							DNA METHYLATION; UBIQUITINATION SITES; MASS-SPECTROMETRY; H3; ACETYLATION; CHROMATIN; IDENTIFICATION; VERNALIZATION; LYSINE-9; H2B	Post-translational modifications of histones play crucial roles in the genetic and epigenetic regulation of gene expression from chromatin. Studies in mammals and yeast have found conserved modifications at some residues of histones as well as non-conserved modifications at some other sites. Although plants have been excellent systems to study epigenetic regulation, and histone modifications are known to play critical roles, the histone modification sites and patterns in plants are poorly defined. In the present study we have used mass spectrometry in combination with high performance liquid chromatography (HPLC) separation and phospho-peptide enrichment to identify histone modification sites in the reference plant, Arabidopsis thaliana. We found not only modifications at many sites that are conserved in mammalian and yeast cells, but also modifications at many sites that are unique to plants. These unique modifications include H4 K20 acetylation (in contrast to H4 K20 methylation in non-plant systems), H2B K6, K11, K27 and K32 acetylation, S15 phosphorylation and K143 ubiquitination, and H2A K144 acetylation and S129, S141 and S145 phosphorylation, and H2A. X S138 phosphorylation. In addition, we found that lysine 79 of H3 which is highly conserved and modified by methylation and plays important roles in telomeric silencing in non-plant systems, is not modified in Arabidopsis. These results suggest distinctive histone modification patterns in plants and provide an invaluable foundation for future studies on histone modifications in plants.	[Zhang, Kangling] Loma Linda Univ, Sch Med, Mass Spectrometry Facil, Loma Linda, CA 92350 USA; [Sridhar, Vaniyambadi V.; Zhu, Jianhua; Kapoor, Avnish; Zhu, Jian-Kang] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	Loma Linda University; University of California System; University of California Riverside	Zhang, KL (corresponding author), Loma Linda Univ, Sch Med, Mass Spectrometry Facil, Loma Linda, CA 92350 USA.	kzhang@llu.edu; jian-kang.zhu@ucr.edu	Zhu, Jian-Kang/F-7658-2011; Zhu, Jianhua/F-7127-2013	Zhu, Jian-Kang/0000-0001-5134-731X; 	NIH [R01GM070795]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070795] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH grant R01GM070795 to JKZ.	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Aihara H, 2004, GENE DEV, V18, P877, DOI 10.1101/gad.1184604; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Beck HC, 2006, MOL CELL PROTEOMICS, V5, P1314, DOI 10.1074/mcp.M600007-MCP200; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Fleury D, 2007, PLANT CELL, V19, P417, DOI 10.1105/tpc.106.041319; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; GILBERT N, 2004, MOL CELL, V15, P844; Hatakeyama S, 2005, METHOD ENZYMOL, V399, P277, DOI 10.1016/S0076-6879(05)99019-8; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang GC, 2004, J CELL BIOCHEM, V93, P286, DOI 10.1002/jcb.20146; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kaiser P, 2005, METHOD ENZYMOL, V399, P266, DOI 10.1016/S0076-6879(05)99018-6; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MARVIN KW, 1990, J BIOL CHEM, V265, P19839; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Meluh PB, 1999, METHOD ENZYMOL, V304, P414; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; SCHOTTA G, 2006, GENE DEV, V18, P1251; Sridhar VV, 2007, NATURE, V447, P735, DOI 10.1038/nature05864; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; THORNE AW, 1990, EUR J BIOCHEM, V193, P701, DOI 10.1111/j.1432-1033.1990.tb19390.x; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; WATERBORG JH, 1987, ARCH BIOCHEM BIOPHYS, V256, P167, DOI 10.1016/0003-9861(87)90435-8; WATERBORG JH, 1992, BIOCHEMISTRY-US, V31, P6211, DOI 10.1021/bi00142a006; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Zhang KL, 2006, ANAL BIOCHEM, V357, P225, DOI 10.1016/j.ab.2006.07.001; Zhang KL, 2004, PROTEOMICS, V4, P3765, DOI 10.1002/pmic.200400819; Zhang KL, 2004, PROTEOMICS, V4, P1, DOI 10.1002/pmic.200300503; Zhang KL, 2002, ANAL BIOCHEM, V306, P259, DOI 10.1006/abio.2002.5719	51	169	176	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1210	10.1371/journal.pone.0001210	http://dx.doi.org/10.1371/journal.pone.0001210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030344	Green Submitted, gold, Green Published			2022-12-27	WOS:000207459200023
J	Rosell, R; Skrzypski, M; Jassem, E; Taron, M; Bartolucci, R; Sanchez, JJ; Mendez, P; Chaib, I; Perez-Roca, L; Szymanowska, A; Rzyman, W; Puma, F; Kobierska-Gulida, G; Farabi, R; Jassem, J				Rosell, Rafael; Skrzypski, Marcin; Jassem, Ewa; Taron, Miquel; Bartolucci, Roberta; Javier Sanchez, Jose; Mendez, Pedro; Chaib, Imane; Perez-Roca, Laia; Szymanowska, Amelia; Rzyman, Witold; Puma, Francesco; Kobierska-Gulida, Grazyna; Farabi, Raffaele; Jassem, Jacek			BRCA1: A Novel Prognostic Factor in Resected Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; ZINC-FINGER GENE; PROTEIN EXPRESSION; EXCISION-REPAIR; DNA-REPAIR; CISPLATIN; ERCC1; INACTIVATION; CHEMOTHERAPY; THIOREDOXIN	Background. Although early-stage non-small-cell lung cancer (NSCLC) is considered a potentially curable disease following complete resection, patients have a wide spectrum of survival according to stage (IB, II, IIIA). Within each stage, gene expression profiles can identify patients with a higher risk of recurrence. We hypothesized that altered mRNA expression in nine genes could help to predict disease outcome: excision repair cross-complementing 1 (ERCC1), myeloid zinc finger 1 (MZF1) and Twist1 (which regulate N-cadherin expression), ribonucleotide reductase subunit M1 (RRM1), thioredoxin-1 (TRX1), tyrosyl-DNA phosphodiesterase (Tdp1), nuclear factor of activated T cells (NFAT), BRCA1, and the human homolog of yeast budding uninhibited by benzimidazole (BubR1). Methodology and Principal Findings. We performed real-time quantitative polymerase chain reaction (RT-QPCR) in frozen lung cancer tissue specimens from 126 chemonaive NSCLC patients who had undergone surgical resection and evaluated the association between gene expression levels and survival. For validation, we used paraffin-embedded specimens from 58 other NSCLC patients. A strong inter-gene correlation was observed between expression levels of all genes except NFAT. A Cox proportional hazards model indicated that along with disease stage, BRCA1 mRNA expression significantly correlated with overall survival (hazard ratio [HR], 1.98 [95% confidence interval (CI), 1.11-6]; P = 0.02). In the independent cohort of 58 patients, BRCA1 mRNA expression also significantly correlated with survival (HR, 2.4 [95% CI, 1.01-5.92]; P = 0.04). Conclusions. Overexpression of BRCA1 mRNA was strongly associated with poor survival in NSCLC patients, and the validation of this finding in an independent data set further strengthened this association. Since BRCA1 mRNA expression has previously been linked to differential sensitivity to cisplatin and antimicrotubule drugs, BRCA1 mRNA expression may provide additional information for customizing adjuvant antimicrotubule-based chemotherapy, especially in stage IB, where the role of adjuvant chemotherapy has not been clearly demonstrated.	[Rosell, Rafael; Skrzypski, Marcin; Taron, Miquel; Mendez, Pedro; Chaib, Imane; Perez-Roca, Laia] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona, Spain; [Skrzypski, Marcin; Jassem, Ewa; Szymanowska, Amelia; Rzyman, Witold; Kobierska-Gulida, Grazyna; Jassem, Jacek] Med Univ Gdansk, Gdansk, Poland; [Javier Sanchez, Jose] Autonomous Univ Madrid, E-28049 Madrid, Spain; [Bartolucci, Roberta; Puma, Francesco; Farabi, Raffaele] Azienda Osped Santa Maria, Terni, Italy	Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Fahrenheit Universities; Medical University Gdansk; Autonomous University of Madrid	Rosell, R (corresponding author), Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona, Spain.	rrosell@ico.scs.es		Skrzypski, Marcin/0000-0002-4391-4318; Puma, Francesco/0000-0002-6861-168X; Jassem, Ewa/0000-0003-4239-4776; Rzyman, Witold/0000-0002-9044-7791	Spanish Lung Cancer Group; Medical University of Gdansk; Spanish Ministry of Health [FIS 05/1621]	Spanish Lung Cancer Group; Medical University of Gdansk(Medical University Gdansk); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	The research reported here was funded by the Spanish Lung Cancer Group and the Medical University of Gdansk. It was partially funded by the Spanish Ministry of Health grant FIS 05/1621. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Bae I, 2005, CELL CYCLE, V4, P1641, DOI 10.4161/cc.4.11.2152; Barthelmes HU, 2004, J BIOL CHEM, V279, P55618, DOI 10.1074/jbc.M405042200; Chabalier C, 2006, CELL CYCLE, V5, P1001, DOI 10.4161/cc.5.9.2726; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Cobo M, 2007, J CLIN ONCOL, V25, P2747, DOI 10.1200/JCO.2006.09.7915; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Furuta T, 2002, CANCER RES, V62, P4899; Grushko TA, 2004, CLIN CANCER RES, V10, P499, DOI 10.1158/1078-0432.CCR-0976-03; HROMAS R, 1991, J BIOL CHEM, V266, P14183; Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Kakolyris S, 2001, CLIN CANCER RES, V7, P3087; LAUSEN B, 1992, BIOMETRICS, V48, P73, DOI 10.2307/2532740; Le Mee S, 2005, EXP CELL RES, V302, P129, DOI 10.1016/j.yexcr.2004.08.028; Liu CY, 2007, LUNG CANCER, V55, P303, DOI 10.1016/j.lungcan.2006.10.019; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Marsit CJ, 2004, ONCOGENE, V23, P1000, DOI 10.1038/sj.onc.1207256; Metzger R, 1998, J CLIN ONCOL, V16, P309, DOI 10.1200/JCO.1998.16.1.309; Moorehead RA, 2000, BIOCHEM PHARMACOL, V59, P337, DOI 10.1016/S0006-2952(99)00333-0; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Nakamura H, 2004, ANTIOXID REDOX SIGN, V6, P15, DOI 10.1089/152308604771978309; NEVINS JR, 2007, NAT REV GENET; Niedernhofer LJ, 2007, NEW ENGL J MED, V356, P2538; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Parmigiani G, 2004, CLIN CANCER RES, V10, P2922, DOI 10.1158/1078-0432.CCR-03-0490; Potapova O, 1997, J BIOL CHEM, V272, P14041, DOI 10.1074/jbc.272.22.14041; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; Quinn JE, 2003, CANCER RES, V63, P6221; Rice JC, 1998, ONCOGENE, V17, P1807, DOI 10.1038/sj.onc.1202086; Rosell R, 2004, CLIN CANCER RES, V10, p4215S, DOI 10.1158/1078-0432.CCR-040006; Rosell R, 2003, ONCOGENE, V22, P3548, DOI 10.1038/sj.onc.1206419; Shichiri M, 2002, CANCER RES, V62, P13; Strauss GM, 2005, HEMATOL ONCOL CLIN N, V19, P263, DOI 10.1016/j.hoc.2005.02.008; Taron M, 2004, HUM MOL GENET, V13, P2443, DOI 10.1093/hmg/ddh260; Wachters FM, 2005, LUNG CANCER-J IASLC, V50, P211, DOI 10.1016/j.lungcan.2005.06.013; Welsh SJ, 2002, CANCER RES, V62, P5089; Wisnivesky JP, 2004, CHEST, V126, P761, DOI 10.1378/chest.126.3.761; Yan QW, 2006, BIOCHEM PHARMACOL, V71, P761, DOI 10.1016/j.bcp.2005.12.015; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Yoshida T, 2005, ANN NY ACAD SCI, V1055, P1, DOI 10.1196/annals.1323.002; ZHAO R, 1995, ANTI-CANCER DRUG, V6, P657, DOI 10.1097/00001813-199510000-00005; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411	47	164	180	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1129	10.1371/journal.pone.0001129	http://dx.doi.org/10.1371/journal.pone.0001129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987116	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459000013
J	Zhang, XH; Tseng, H				Zhang, Xiaohong; Tseng, Hung			Basonuclin-Null Mutation Impairs Homeostasis and Wound Repair in Mouse Corneal Epithelium	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; RIBOSOMAL-RNA GENES; NUCLEAR-LOCALIZATION; MURINE CORNEAL; STEM-CELLS; EXPRESSION; KERATINOCYTES; TRANSCRIPTION; ADHERENS; PHOSPHORYLATION	At least two cellular processes are required for corneal epithelium homeostasis and wound repair: cell proliferation and cell-cell adhesion. These processes are delicately balanced to ensure the maintenance of normal epithelial function. During wound healing, these processes must be reprogrammed in coordination to achieve a rapid re-epithelialization. Basonuclin (Bnc1) is a cell-type-specific transcription factor expressed mainly in the proliferative keratinocytes of stratified epithelium (e.g., corneal epithelium, epidermis and esophageal epithelium) and the gametogenic cells in testis and ovary. Our previous work suggested that basonuclin could regulate transcription of ribosomal RNA genes (rDNA) and genes involved in chromatin structure, transcription regulation, cell-cell junction/communication, ion-channels and intracelllular transportation. However, basonuclin's role in keratinocytes has not been demonstrated in vivo. Here we show that basonuclin-null mutation disrupts corneal epithelium homeostasis and delays wound healing by impairing cell proliferation. In basonuclin-null cornea epithelium, RNA polymerase I (Pol I) transcription is perturbed. This perturbation is unique because it affects transcripts from a subset of rDNA. Basonuclin-null mutation also perturbs RNA polymerase II (Pol II) transcripts from genes encoding chromatin structure proteins histone 3 and HMG2, transcription factor Gli2, gap-junction protein connexin 43 and adheren E-cadherin. In most cases, a concerted change in mRNA and protein level is observed. However, for E-cadherin, despite a notable increase in its mRNA level, its protein level was reduced. In conclusion, our study establishes basonuclin as a regulator of corneal epithelium homeostasis and maintenance. Basonuclin likely coordinates functions of a subset of ribosomal RNA genes (rDNA) and a group of protein coding genes in cellular processes critical for the regulation of cell proliferation.	[Zhang, Xiaohong; Tseng, Hung] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Tseng, Hung] Univ Penn, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Tseng, H (corresponding author), Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA.	htsengpe@mail.med.upenn.edu			National Eye Institute [EY13637]; NATIONAL EYE INSTITUTE [R01EY013637] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This work was supported by a National Eye Institute grant (EY13637). The funding agency has no role in the design, conduct and report of this study.	Anderson SC, 2002, INVEST OPHTH VIS SCI, V43, P978; Ban Y, 2003, EXP EYE RES, V76, P663, DOI 10.1016/S0014-4835(03)00054-X; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Birger Y, 2006, DIFFERENTIATION, V74, P19, DOI 10.1111/j.1432-0436.2006.00054.x; CHEN JJY, 1990, INVEST OPHTH VIS SCI, V31, P1301; Chung EH, 1999, INVEST OPHTH VIS SCI, V40, P1952; Collinson JM, 2002, DEV DYNAM, V224, P432, DOI 10.1002/dvdy.10124; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Danjo Y, 1998, J CELL SCI, V111, P3323; Davis J, 2003, J CELL SCI, V116, P2157, DOI 10.1242/jcs.00441; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Dwivedi DJ, 2005, INVEST OPHTH VIS SCI, V46, P3623, DOI 10.1167/iovs.05-0028; Green H, 2005, MOL B INT U, P207; Hanakawa Y, 2002, J INVEST DERMATOL, V119, P27, DOI 10.1046/j.1523-1747.2002.01780.x; HUANG AJW, 1991, INVEST OPHTH VIS SCI, V32, P96; Iuchi S, 1997, P NATL ACAD SCI USA, V94, P7948, DOI 10.1073/pnas.94.15.7948; Iuchi S, 1999, P NATL ACAD SCI USA, V96, P9628, DOI 10.1073/pnas.96.17.9628; Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008; Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Ma J, 2006, DEVELOPMENT, V133, P2053, DOI 10.1242/dev.02371; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; O'Malley BW, 2006, SCIENCE, V313, P1749, DOI 10.1126/science.1132509; Orsulic S, 2000, J CELL SCI, V113, P1793; Orsulic S, 1999, J CELL SCI, V112, P1237; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Qian JC, 2006, DEV DYNAM, V235, P1984, DOI 10.1002/dvdy.20827; Romano RA, 2004, GENOMICS, V83, P821, DOI 10.1016/j.ygeno.2003.11.009; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P2577, DOI 10.1167/iovs.04-0001; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; STEPP MA, 1993, INVEST OPHTH VIS SCI, V34, P1829; Sugrue SP, 1997, EXP EYE RES, V64, P11, DOI 10.1006/exer.1996.0175; Sun TT, 2004, J INVEST DERM SYMP P, V9, P202, DOI 10.1111/j.1087-0024.2004.09311.x; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Tian QJ, 2001, DEVELOPMENT, V128, P407; Tseng H, 1999, DIFFERENTIATION, V65, P221, DOI 10.1046/j.1432-0436.1999.6540221.x; TSENG H, 1994, J CELL BIOL, V126, P495, DOI 10.1083/jcb.126.2.495; TSENG H, 1992, P NATL ACAD SCI USA, V89, P10311, DOI 10.1073/pnas.89.21.10311; Tseng H, 1998, FRONT BIOSCI, V3, pD985; TSENG H, 1999, J CELL SCI, P112; Tseng H, 2006, BIOESSAYS, V28, P719, DOI 10.1002/bies.20430; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22; Vanhoutteghem A, 2004, P NATL ACAD SCI USA, V101, P3468, DOI 10.1073/pnas.0400268101; Vanhoutteghem A, 2006, P NATL ACAD SCI USA, V103, P12423, DOI 10.1073/pnas.0605086103; Wang JW, 2006, BIOCHEM BIOPH RES CO, V348, P1261, DOI 10.1016/j.bbrc.2006.07.198; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zantek ND, 1999, CELL GROWTH DIFFER, V10, P629; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zhang L, 2003, MOL VIS, V9, P584; Zhang SL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000902; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	54	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1087	10.1371/journal.pone.0001087	http://dx.doi.org/10.1371/journal.pone.0001087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971852	Green Published, Green Submitted, gold			2022-12-27	WOS:000207458700006
J	Tran-Hung, L; Tran-Thi, N; Aboudharam, G; Raoult, D; Drancourt, M				Tran-Hung, Lam; Tran-Thi, Ny; Aboudharam, Gerard; Raoult, Didier; Drancourt, Michel			A New Method to Extract Dental Pulp DNA: Application to Universal Detection of Bacteria	PLOS ONE			English	Article								Background. Dental pulp is used for PCR-based detection of DNA derived from host and bacteremic microorganims. Current protocols require odontology expertise for proper recovery of the dental pulp. Dental pulp specimen exposed to laboratory environment yields contaminants detected using universal 16S rDNA-based detection of bacteria. Methodology/Principal Findings. We developed a new protocol by encasing decontaminated tooth into sterile resin, extracting DNA into the dental pulp chamber itself and decontaminating PCR reagents by filtration and double restriction enzyme digestion. Application to 16S rDNA-based detection of bacteria in 144 teeth collected in 86 healthy people yielded a unique sequence in only 14 teeth (9.7%) from 12 individuals (14%). Each individual yielded a unique 16S rDNA sequence in 1-2 teeth per individual. Negative controls remained negative. Bacterial identifications were all confirmed by amplification and sequencing of specific rpoB sequence. Conclusions/Significance. The new protocol prevented laboratory contamination of the dental pulp. It allowed the detection of bacteria responsible for dental pulp colonization from blood and periodontal tissue. Only 10% such samples contained 16S rDNA. It provides a new tool for the retrospective diagnostic of bacteremia by allowing the universal detection of bacterial DNA in animal and human, contemporary or ancient tooth. It could be further applied to identification of host DNA in forensic medicine and anthropology.	[Tran-Hung, Lam; Tran-Thi, Ny; Aboudharam, Gerard; Raoult, Didier; Drancourt, Michel] Univ Aix Marseille 2, CNRS UMR 6020, IFR 48, Unite Rickettsies,Fac Med, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Raoult, D (corresponding author), Univ Aix Marseille 2, CNRS UMR 6020, IFR 48, Unite Rickettsies,Fac Med, Marseille, France.	Didier.Raoult@gmail.com	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974; Tran-Hung, Lam/0000-0002-9598-7543	Unite des Rickettsies	Unite des Rickettsies	Unite des Rickettsies	Aboudharam G, 2004, EUR J CLIN MICROBIOL, V23, P920, DOI 10.1007/s10096-004-1244-z; Aboudharam G, 2004, MICROB PATHOGENESIS, V36, P349, DOI 10.1016/j.micpath.2004.02.002; Aboudharam G, 2000, MICROB PATHOGENESIS, V28, P249, DOI 10.1006/mpat.1999.0343; Berger P, 2005, RES MICROBIOL, V156, P967, DOI 10.1016/j.resmic.2005.05.008; Borst A, 2004, EUR J CLIN MICROBIOL, V23, P289, DOI 10.1007/s10096-004-1100-1; CALVO F, 2001, ANTHROPO, V1, P21; DELIVANIS PD, 1981, ORAL SURG ORAL MED O, V52, P430, DOI 10.1016/0030-4220(81)90344-3; Doyuk E, 2002, J INFECTION, V45, P39, DOI 10.1053/jinf.2002.1004; Drancourt M, 2005, J INFECT DIS, V191, P607, DOI 10.1086/427041; Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063; Drancourt M, 2004, MICROBIOL-SGM, V150, P263, DOI 10.1099/mic.0.26885-0; Drancourt M, 1998, P NATL ACAD SCI USA, V95, P12637, DOI 10.1073/pnas.95.21.12637; Fernandez-Baca V, 2001, J HOSP INFECT, V49, P173, DOI 10.1053/jhin.2001.1053; Gilbert MTP, 2004, MICROBIOL-SGM, V150, P341, DOI 10.1099/mic.0.26594-0; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; GLICK M, 1991, ORAL SURG ORAL MED O, V71, P733, DOI 10.1016/0030-4220(91)90284-J; GLICK M, 1989, J AM DENT ASSOC, V119, P649, DOI 10.1016/S0002-8177(89)95019-8; Grahn N, 2003, FEMS MICROBIOL LETT, V219, P87, DOI 10.1016/S0378-1097(02)01190-4; Hoffmann H, 2003, APPL ENVIRON MICROB, V69, P5306, DOI 10.1128/AEM.69.9.5306-5318.2003; HOSHINO E, 1992, INT ENDOD J, V25, P2, DOI 10.1111/j.1365-2591.1992.tb00941.x; HUGHES MS, 1994, J CLIN MICROBIOL, V32, P2007, DOI 10.1128/JCM.32.8.2007-2008.1994; Kim BN, 2002, EUR J CLIN MICROBIOL, V21, P419, DOI 10.1007/s10096-002-0738-9; Kim KS, 2003, FEMS MICROBIOL LETT, V226, P299, DOI 10.1016/S0378-1097(03)00618-9; La VD, 2004, CLIN INFECT DIS, V39, P1391, DOI 10.1086/424884; Leonard H, 2005, LANCET, V366, P1584, DOI 10.1016/S0140-6736(05)67631-3; Mollet C, 1997, MOL MICROBIOL, V26, P1005, DOI 10.1046/j.1365-2958.1997.6382009.x; Papagrigorakis MJ, 2006, INT J INFECT DIS, V10, P206, DOI 10.1016/j.ijid.2005.09.001; RAND KH, 1990, MOL CELL PROBE, V4, P445, DOI 10.1016/0890-8508(90)90003-I; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; RESTAGNO G, 1995, PRENATAL DIAG, V15, P672, DOI 10.1002/pd.1970150715; Rocas IN, 2004, J ENDODONT, V30, P504, DOI 10.1097/00004770-200407000-00011; Rothman RE, 2002, J INFECT DIS, V186, P1677, DOI 10.1086/345367; Rudbeck L, 2005, AM J PHYS ANTHROPOL, V128, P424, DOI 10.1002/ajpa.20294; Rupf S, 2000, ENDOD DENT TRAUMATOL, V16, P269; Sambrook J., 2002, MOL CLONING LAB MANU; SEIFERT H, 1993, CLIN INFECT DIS, V17, P632, DOI 10.1093/clinids/17.4.632; TZIAFAS D, 1989, J ENDODONT, V15, P591, DOI 10.1016/S0099-2399(89)80157-8; WAGES JM, 1994, BIOTECHNIQUES, V16, P1014; Wiechmann I, 2005, AM J PHYS ANTHROPOL, V126, P48, DOI 10.1002/ajpa.10276; WOODWARD SR, 1994, PCR METH APPL, V3, P244	40	17	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1062	10.1371/journal.pone.0001062	http://dx.doi.org/10.1371/journal.pone.0001062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957246	gold, Green Published, Green Submitted			2022-12-27	WOS:000207458500009
J	Kolla, RV; Chintalapati, S; Sabet, M; Santelli, E; Liddington, RC; David, M; Fierer, J; Guiney, D; Rickert, RC				Kolla, Ravi V.; Chintalapati, Suresh; Sabet, Mojgan; Santelli, Eugenio; Liddington, Robert C.; David, Michael; Fierer, Joshua; Guiney, Donald; Rickert, Robert C.			Complement C3d Conjugation to Anthrax Protective Antigen Promotes a Rapid, Sustained, and Protective Antibody Response	PLOS ONE			English	Article								B. anthracis is the causative agent of anthrax. Pathogenesis is primarily mediated through the exotoxins lethal factor and edema factor, which bind protective antigen (PA) to gain entry into the host cell. The current anthrax vaccine (AVA, Biothrax (TM)) consists of aluminum-adsorbed cell-free filtrates of unencapsulated B. anthracis, wherein PA is thought to be the principle target of neutralization. In this study, we evaluated the efficacy of the natural adjuvant, C3d, versus alum in eliciting an anti-PA humoral response and found that C3d conjugation to PA and emulsion in incomplete Freund's adjuvant (IFA) imparted superior protection from anthrax challenge relative to PA in IFA or PA adsorbed to alum. Relative to alum-PA, immunization of mice with C3d-PA/IFA augmented both the onset and sustained production of PA-specific antibodies, including neutralizing antibodies to the receptor-binding portion (domain 4) of PA. C3d-PA/IFA was efficacious when administered either i.p. or s.c., and in adolescent mice lacking a fully mature B cell compartment. Induction of PA-specific antibodies by C3d-PA/IFA correlated with increased efficiency of germinal center formation and plasma cell generation. Importantly, C3d-PA immunization effectively protected mice from intranasal challenge with B. anthracis spores, and was approximately 10-fold more effective than alum-PA immunization or PA/IFA based on dose challenge. These data suggest that incorporation of C3d as an adjuvant may overcome shortcomings of the currently licensed aluminum-based vaccine, and may confer protection in the early days following acute anthrax exposure.	[Kolla, Ravi V.; Chintalapati, Suresh; Santelli, Eugenio; Liddington, Robert C.; Rickert, Robert C.] Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Sabet, Mojgan; Guiney, Donald] Univ Calif San Diego, Dept Med, Div Infect Dis, San Diego, CA 92103 USA; [David, Michael] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Fierer, Joshua] San Diego Vet Affairs Med Ctr, Dept Med, San Diego, CA USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Rickert, RC (corresponding author), Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA USA.	robert@burnham.org	, jfierer/W-2823-2019		NIH [AI41649, AI59363, AI055789]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055789, R01AI041649, R21AI059363] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI41649 and AI59363 (to RCR) and AI055789 (to RCL).	Berthold I, 2005, VACCINE, V23, P1993, DOI 10.1016/j.vaccine.2004.10.014; Brey RN, 2005, ADV DRUG DELIVER REV, V57, P1266, DOI 10.1016/j.addr.2005.01.028; Carroll MC, 1997, CURR OPIN IMMUNOL, V9, P64, DOI 10.1016/S0952-7915(97)80160-4; Chabot DJ, 2004, VACCINE, V23, P43, DOI 10.1016/j.vaccine.2004.05.029; Cherukuri A, 2001, J IMMUNOL, V167, P163, DOI 10.4049/jimmunol.167.1.163; Cozine CL, 2005, CURR OPIN IMMUNOL, V17, P298, DOI 10.1016/j.coi.2005.04.007; Del Nagro CJ, 2005, J IMMUNOL, V175, P5379, DOI 10.4049/jimmunol.175.8.5379; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Fang YF, 1998, J IMMUNOL, V160, P5273; Fischer MB, 1998, J IMMUNOL, V160, P2619; Flick-Smith HC, 2002, INFECT IMMUN, V70, P1653, DOI 10.1128/IAI.70.3.1653-1656.2002; GORSE GJ, 2006, VACCINE; Green TD, 2001, VACCINE, V20, P242, DOI 10.1016/S0264-410X(01)00266-3; Haas KM, 2004, J IMMUNOL, V172, P5833, DOI 10.4049/jimmunol.172.10.5833; Haas KM, 2002, IMMUNITY, V17, P713, DOI 10.1016/S1074-7613(02)00483-1; Hannan J, 2002, BIOCHEM SOC T, V30, P983, DOI 10.1042/bst0300983; Henson SE, 2001, J IMMUNOL METHODS, V258, P97, DOI 10.1016/S0022-1759(01)00471-9; Hess MW, 2000, BLOOD, V95, P2617, DOI 10.1182/blood.V95.8.2617.008k20_2617_2623; HogenEsch H, 2002, VACCINE, V20, pS34, DOI 10.1016/S0264-410X(02)00169-X; Hughes MA, 2005, INFECT IMMUN, V73, P7535, DOI 10.1128/IAI.73.11.7535-7540.2005; Jendrek S, 2003, VACCINE, V21, P3011, DOI 10.1016/S0264-410X(03)00109-9; Joellenbeck LM, 2002, ANTHRAX VACCINE IS I; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; Koch M, 2005, VIROLOGY, V340, P277, DOI 10.1016/j.virol.2005.06.034; Leppla SH, 2002, J CLIN INVEST, V110, P141, DOI [10.1172/JCI200216204, 10.1172/JCI0216204]; Liddington R, 1999, J APPL MICROBIOL, V87, P282, DOI 10.1046/j.1365-2672.1999.00888.x; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; Mikszta JA, 2005, J INFECT DIS, V191, P278, DOI 10.1086/426865; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Nemazee D, 2006, NATURE, V441, pE4, DOI 10.1038/nature04875; Oliver AM, 1999, J IMMUNOL, V162, P7198; Oncu Serkan, 2003, Med Sci Monit, V9, pRA276; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Rickert RC, 2005, CURR OPIN IMMUNOL, V17, P237, DOI 10.1016/j.coi.2005.03.001; Rosovitz MJ, 2003, J BIOL CHEM, V278, P30936, DOI 10.1074/jbc.M301154200; Sabet M, 2006, FEMS IMMUNOL MED MIC, V47, P369, DOI 10.1111/j.1574-695X.2006.00096.x; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Sever JL, 2002, PHARMACOEPIDEM DR S, V11, P189, DOI 10.1002/pds.712; Suradhat S, 2001, VET IMMUNOL IMMUNOP, V83, P79, DOI 10.1016/S0165-2427(01)00369-5; Takahashi K, 1997, J IMMUNOL, V159, P1557; Turnbull PCB, 2000, CURR OPIN INFECT DIS, V13, P113, DOI 10.1097/00001432-200004000-00004; 2000, MMWR MORB MORTAL WKL, V49, P341	43	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1044	10.1371/journal.pone.0001044	http://dx.doi.org/10.1371/journal.pone.0001044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940608	Green Published, gold, Green Submitted			2022-12-27	WOS:000207456100012
J	Khanam, T; Raabe, CA; Kiefmann, M; Handel, S; Skryabin, BV; Brosius, J				Khanam, Tasneem; Raabe, Carsten A.; Kiefmann, Martin; Handel, Sergej; Skryabin, Boris V.; Brosius, Juergen			Can ID Repetitive Elements Serve as Cis-acting Dendritic Targeting Elements? An In Vivo Study	PLOS ONE			English	Article								Dendritic localization of mRNA/RNA involves interaction of cis-elements and trans-factors. Small, non-protein coding dendritic BC1 RNA is thought to regulate translation in dendritic microdomains. Following microinjections into cultured cells, BC1 RNA fused to larger mRNAs appeared to impart transport competence to these chimeras, and its 5' ID region was proposed as the cis-acting dendritic targeting element. As these ID elements move around rodent genomes and, if transcribed, form a long RNA stem-loop, they might, thereby, lead to new localizations for targeted gene products. To test their targeting ability in vivo we created transgenic mice expressing various ID elements fused to the 3' UTR of reporter mRNA for Enhanced Green Fluorescent Protein. In vivo, neither ID elements nor the BC1 RNA coding region were capable of transporting EGFP RNA to dendrites, although the 3' UTR of alpha-CaMKII mRNA, an established cis-acting element did produce positive results. Other mRNAs containing naturally inserted ID elements are also not found in neuronal dendrites. We conclude that the 5' ID domain from BC1 RNA is not a sufficient dendritic targeting element for mRNAs in vivo.	[Khanam, Tasneem; Raabe, Carsten A.; Kiefmann, Martin; Handel, Sergej; Skryabin, Boris V.; Brosius, Juergen] Univ Munster, Inst Expt Pathol, Munster, Germany	University of Munster	Khanam, T (corresponding author), Univ Munster, Inst Expt Pathol, Munster, Germany.	tasneem@uni-muenster.de; RNA.world@uni-muenster.de	Skryabin, Boris/AAL-3100-2020; Brosius, Jürgen/F-5029-2016	Skryabin, Boris/0000-0002-4392-185X; Brosius, Jürgen/0000-0003-1650-2059	Nationales Genomforschungsnetz (NGFN) [0313358A]	Nationales Genomforschungsnetz (NGFN)	This work was supported by Nationales Genomforschungsnetz (NGFN, 0313358A) to J.B.	Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; Barbieri Marcello, 2003, ORGANIC CODES INTRO; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Blichenberg A, 2001, EUR J NEUROSCI, V13, P1881, DOI 10.1046/j.0953-816x.2001.01565.x; BODIAN D, 1965, P NATL ACAD SCI USA, V53, P418, DOI 10.1073/pnas.53.2.418; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Cristofanilli M, 2006, J MOL BIOL, V356, P1118, DOI 10.1016/j.jmb.2005.11.090; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; Du TG, 2007, SEMIN CELL DEV BIOL, V18, P171, DOI 10.1016/j.semcdb.2007.01.010; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/ng0501-77; FREGIEN N, 1986, GENE, V48, P1, DOI 10.1016/0378-1119(86)90346-X; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; HOGAN B, 1986, MANIPULATING MOUSE E; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Inaba Y, 2004, J NEUROCHEM, V89, P1347, DOI 10.1111/j.1471-4159.2004.02440.x; Khanam T, 2007, NUCLEIC ACIDS RES, V35, P529, DOI 10.1093/nar/gkl1082; KIM J, 1995, NUCLEIC ACIDS RES, V23, P2245, DOI 10.1093/nar/23.12.2245; KIM JM, 1994, P NATL ACAD SCI USA, V91, P3607, DOI 10.1073/pnas.91.9.3607; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; KLEIMAN R, 1993, MOL BRAIN RES, V20, P305, DOI 10.1016/0169-328X(93)90057-V; KOENIG E, 1965, J NEUROCHEM, V12, P357, DOI 10.1111/j.1471-4159.1965.tb04236.x; KOENIG E, 1965, J NEUROCHEM, V12, P343, DOI 10.1111/j.1471-4159.1965.tb04235.x; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; KRESS M, 1984, SCIENCE, V226, P974, DOI 10.1126/science.6095445; Krull M, 2005, MOL BIOL EVOL, V22, P1702, DOI 10.1093/molbev/msi164; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Ludwig A, 2005, J MOL BIOL, V350, P200, DOI 10.1016/j.jmb.2005.03.058; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Mori Y, 2000, NAT NEUROSCI, V3, P1079, DOI 10.1038/80591; Muslimov IA, 2004, J BIOL CHEM, V279, P52613, DOI 10.1074/jbc.M409240200; Muslimov IA, 1997, J NEUROSCI, V17, P4722; Muslimov IA, 2006, J CELL BIOL, V175, P427, DOI 10.1083/jcb.200607008; Rozhdestvensky TS, 2001, RNA, V7, P722, DOI 10.1017/S1355838201002485; RYSKOV A P, 1984, Molekulyarnaya Biologiya (Moscow), V18, P92; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; STEWARD O, 1982, J NEUROSCI, V2, P284; Suda S, 2002, BIOCHEM BIOPH RES CO, V291, P1265, DOI 10.1006/bbrc.2002.6592; TIEDGE H, 1991, P NATL ACAD SCI USA, V88, P2093, DOI 10.1073/pnas.88.6.2093; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; Tiedge H, 1996, J NEUROSCI, V16, P7171; Tiedge Henri, 2006, RNA Biol, V3, P133; Wang HD, 2005, J CELL BIOL, V171, P811, DOI 10.1083/jcb.200506006; Wang HD, 2002, J NEUROSCI, V22, P10232; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215	52	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e961	10.1371/journal.pone.0000961	http://dx.doi.org/10.1371/journal.pone.0000961			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17896001	gold, Green Published			2022-12-27	WOS:000207455800039
J	Miller, WG; Parker, CT; Rubenfield, M; Mendz, GL; Wosten, MMSM; Ussery, DW; Stolz, JF; Binnewies, TT; Hallin, PF; Wang, GL; Malek, JA; Rogosin, A; Stanker, LH; Mandrell, RE				Miller, William G.; Parker, Craig T.; Rubenfield, Marc; Mendz, George L.; Woesten, Marc M. S. M.; Ussery, David W.; Stolz, John F.; Binnewies, Tim T.; Hallin, Peter F.; Wang, Guilin; Malek, Joel A.; Rogosin, Andrea; Stanker, Larry H.; Mandrell, Robert E.			The Complete Genome Sequence and Analysis of the Epsilonproteobacterium Arcobacter butzleri	PLOS ONE			English	Article							CAMPYLOBACTER-JEJUNI; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; SP-NOV.; COASTAL ENVIRONMENT; AMINE DEHYDROGENASE; NUCLEOTIDE-SEQUENCE; SULFUR OXIDATION; MISMATCH REPAIR; COMB-NOV	Background. Arcobacter butzleri is a member of the epsilon subdivision of the Proteobacteria and a close taxonomic relative of established pathogens, such as Campylobacter jejuni and Helicobacter pylori. Here we present the complete genome sequence of the human clinical isolate, A. butzleri strain RM4018. Methodology/Principal Findings. Arcobacter butzleri is a member of the Campylobacteraceae, but the majority of its proteome is most similar to those of Sulfuromonas denitrificans and Wolinella succinogenes, both members of the Helicobacteraceae, and those of the deep-sea vent Epsilonproteobacteria Sulfurovum and Nitratiruptor. In addition, many of the genes and pathways described here, e.g. those involved in signal transduction and sulfur metabolism, have been identified previously within the epsilon subdivision only in S. denitrificans, W. succinogenes, Sulfurovum, and/or Nitratiruptor, or are unique to the subdivision. In addition, the analyses indicated also that a substantial proportion of the A. butzleri genome is devoted to growth and survival under diverse environmental conditions, with a large number of respiration-associated proteins, signal transduction and chemotaxis proteins and proteins involved in DNA repair and adaptation. To investigate the genomic diversity of A. butzleri strains, we constructed an A. butzleri DNA microarray comprising 2238 genes from strain RM4018. Comparative genomic indexing analysis of 12 additional A. butzleri strains identified both the core genes of A. butzleri and intraspecies hypervariable regions, where <70% of the genes were present in at least two strains. Conclusion/Significance. The presence of pathways and loci associated often with non-host-associated organisms, as well as genes associated with virulence, suggests that A. butzleri is a free-living, water-borne organism that might be classified rightfully as an emerging pathogen. The genome sequence and analyses presented in this study are an important first step in understanding the physiology and genetics of this organism, which constitutes a bridge between the environment and mammalian hosts.	[Miller, William G.; Parker, Craig T.; Wang, Guilin; Mandrell, Robert E.] ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA; [Rubenfield, Marc; Malek, Joel A.; Rogosin, Andrea] Agencourt Biosci Corp, Beverly, MA USA; [Mendz, George L.] Univ Notre Dame Australia, Broadway, NSW, Australia; [Mendz, George L.] Univ New S Wales, Sch Med, Sydney, NSW, Australia; [Woesten, Marc M. S. M.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Ussery, David W.; Binnewies, Tim T.; Hallin, Peter F.] Tech Univ Denmark, Ctr Biol Sequence, DK-2800 Lyngby, Denmark; [Stolz, John F.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15219 USA; [Stanker, Larry H.] ARS, Foodborne Contaminants Res Unit, USDA, Albany, CA USA	United States Department of Agriculture (USDA); University of Notre Dame Australia; University of New South Wales Sydney; Utrecht University; Technical University of Denmark; Duquesne University; United States Department of Agriculture (USDA)	Miller, WG (corresponding author), ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA.	bmiller@pw.usda.gov	Mandrell, Robert E/O-9814-2018; Ussery, David/J-2026-2019	Ussery, David/0000-0003-3632-5512; Wosten, Marc/0000-0002-7464-7232; Parker, Craig/0000-0002-7719-8882	United States Department of Agriculture, Agricultural Research Service, CRIS [5325-42000-230-043, 5325-42000-230-045]	United States Department of Agriculture, Agricultural Research Service, CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding: This work was funded by the United States Department of Agriculture, Agricultural Research Service, CRIS projects 5325-42000-230-043 and 5325-42000-230-045.	Abdelbaqi K, 2007, FEMS IMMUNOL MED MIC, V49, P337, DOI 10.1111/j.1574-695X.2006.00208.x; Adachi O, 2003, BIOSCI BIOTECH BIOCH, V67, P2115, DOI 10.1271/bbb.67.2115; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Anantharaman V, 2000, TRENDS BIOCHEM SCI, V25, P535, DOI 10.1016/S0968-0004(00)01672-8; Appia-Ayme C, 2002, BIOCHEM BIOPH RES CO, V296, P737, DOI 10.1016/S0006-291X(02)00936-1; Appia-Ayme C, 2001, J BACTERIOL, V183, P6107, DOI 10.1128/JB.183.20.6107-6118.2001; Assanta MA, 2002, J FOOD PROTECT, V65, P1240, DOI 10.4315/0362-028X-65.8.1240; Atabay HI, 2003, INT J FOOD MICROBIOL, V81, P21, DOI 10.1016/S0168-1605(02)00163-0; Atabay HI, 2001, LETT APPL MICROBIOL, V33, P430, DOI 10.1046/j.1472-765X.2001.01025.x; Baar C, 2003, P NATL ACAD SCI USA, V100, P11690, DOI 10.1073/pnas.1932838100; Bagchi A, 2006, BIOPHYS CHEM, V119, P7, DOI 10.1016/j.bpc.2005.08.011; Bayles KW, 2000, TRENDS MICROBIOL, V8, P274, DOI 10.1016/S0966-842X(00)01762-5; Berg IA, 2002, FEMS MICROBIOL LETT, V216, P49, DOI 10.1111/j.1574-6968.2002.tb11413.x; Bick JA, 2000, J BACTERIOL, V182, P135, DOI 10.1128/JB.182.1.135-142.2000; Burrows LL, 1996, MOL MICROBIOL, V22, P481, DOI 10.1046/j.1365-2958.1996.1351503.x; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Collins CI, 1996, J FOOD PROTECT, V59, P448, DOI 10.4315/0362-028X-59.5.448; Da Re S, 2006, J BACTERIOL, V188, P3073, DOI 10.1128/JB.188.8.3073-3087.2006; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Dhamabutra Narathorn, 1992, Journal of the Medical Association of Thailand, V75, P350; Donachie SP, 2005, INT J SYST EVOL MICR, V55, P1271, DOI 10.1099/ijs.0.63581-0; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Engberg J, 2000, J CLIN MICROBIOL, V38, P286; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fera MT, 2004, APPL ENVIRON MICROB, V70, P1271, DOI 10.1128/AEM.70.3.1271-1276.2004; Forsythe SJ, 2006, WOODHEAD PUBL FOOD S, P181, DOI 10.1533/9781845691394.2.181; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; FOX JG, 1988, INFECT IMMUN, V56, P2994, DOI 10.1128/IAI.56.11.2994-2996.1988; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Friedmann S, 2006, J BACTERIOL, V188, P2646, DOI 10.1128/JB.188.7.2646-2655.2006; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Friedrich CG, 2000, J BACTERIOL, V182, P4677, DOI 10.1128/JB.182.17.4677-4687.2000; Gilbert M, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P219; GJERMANSEN M, 2006, FEMS MICROBIOL LETT; Glaab WE, 2005, MUTAT RES-FUND MOL M, V578, P238, DOI 10.1016/j.mrfmmm.2005.05.021; GOLDBERG MB, 1990, INFECT IMMUN, V58, P55, DOI 10.1128/IAI.58.1.55-60.1990; GOLDIE J, 1989, J CLIN MICROBIOL, V27, P2080, DOI 10.1128/JCM.27.9.2080-2082.1989; Golla SC, 2002, J FOOD PROTECT, V65, P1849, DOI 10.4315/0362-028X-65.12.1849; Grabowski A, 2005, FEMS MICROBIOL ECOL, V54, P427, DOI 10.1016/j.femsec.2005.05.007; Grimek TL, 2004, J BACTERIOL, V186, P454, DOI 10.1128/JB.186.2.454-462.2004; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Hacisalihoglu A, 1997, MICROBIOL-UK, V143, P505, DOI 10.1099/00221287-143-2-505; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hawkins TL, 1997, SCIENCE, V276, P1887, DOI 10.1126/science.276.5320.1887; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Houf K, 2005, INT J SYST EVOL MICR, V55, P713, DOI 10.1099/ijs.0.63103-0; Houf K, 2001, INT J FOOD MICROBIOL, V71, P189, DOI 10.1016/S0168-1605(01)00605-5; Houf K, 2000, FEMS MICROBIOL LETT, V193, P89, DOI 10.1111/j.1574-6968.2000.tb09407.x; Houf K, 2007, J MICROBIOL METH, V68, P408, DOI 10.1016/j.mimet.2006.09.020; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Hume ME, 2001, J FOOD PROTECT, V64, P645, DOI 10.4315/0362-028X-64.5.645; Ivanovsky RN, 1997, FEMS MICROBIOL LETT, V153, P399, DOI 10.1016/S0378-1097(97)00280-2; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; JACOB J, 1993, ZBL HYG UMWELTMED, V193, P557; Jacob J, 1998, ZBL HYG UMWELTMED, V201, P189; Jin SM, 2001, MOL MICROBIOL, V39, P1225, DOI 10.1046/j.1365-2958.2001.02294.x; Johnson JR, 2005, INFECT IMMUN, V73, P965, DOI 10.1128/IAI.73.2.965-971.2005; Johnson LG, 2002, J FOOD PROTECT, V65, P1789, DOI 10.4315/0362-028X-65.11.1789; Kaniuk NA, 2002, MOL MICROBIOL, V46, P1305, DOI 10.1046/j.1365-2958.2002.03243.x; Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; KIEHLBAUCH JA, 1991, J CLIN MICROBIOL, V29, P376, DOI 10.1128/JCM.29.2.376-385.1991; Korolik V, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P349; KREDICH NM, 1996, ESCHERICHIA COLI SAL, V2, P514; Larsen NA, 2006, BIOCHEMISTRY-US, V45, P10184, DOI 10.1021/bi060950i; LASTOVICA AJ, 2000, CAMPYLOBACTER, P89; Lau SKP, 2002, J CLIN PATHOL-MOL PA, V55, P182, DOI 10.1136/mp.55.3.182; LERNER J, 1994, EUR J CLIN MICROBIOL, V13, P660, DOI 10.1007/BF01973994; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Malik HS, 2000, TRENDS BIOCHEM SCI, V25, P414, DOI 10.1016/S0968-0004(00)01623-6; Mandrell RE, 2006, WOODHEAD PUBL FOOD S, P476, DOI 10.1533/9781845691394.2.476; Manke TR, 1998, J FOOD PROTECT, V61, P1623, DOI 10.4315/0362-028X-61.12.1623; Marshall B.J., 2001, HELICOBACTER PYLORI; MARTINUSSEN J, 1994, J BACTERIOL, V176, P6457, DOI 10.1128/JB.176.21.6457-6463.1994; Maugeri TL, 2005, NEW MICROBIOL, V28, P177; Maugeri TL, 2000, MICROBIOLOGICA, V23, P143; MCCLUNG CR, 1983, INT J SYST BACTERIOL, V33, P605, DOI 10.1099/00207713-33-3-605; McGarvey JA, 2005, J APPL MICROBIOL, V99, P867, DOI 10.1111/j.1365-2672.2005.02662.x; Miller WG, 2005, MICROBIOL-SGM, V151, P337, DOI 10.1099/mic.0.27327-0; Morgan GJ, 2002, J MOL BIOL, V317, P337, DOI 10.1006/jmbi.2002.5437; MOUSSARD H, 2006, E PACIFIC RISE; Naganuma Takeshi, 1997, Journal of Oceanography, V53, P193; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; NEILL SD, 1985, INT J SYST BACTERIOL, V35, P342, DOI 10.1099/00207713-35-3-342; NEUWALD AF, 1992, J BACTERIOL, V174, P415, DOI 10.1128/jb.174.2.415-425.1992; Niehus E, 2004, MOL MICROBIOL, V52, P947, DOI 10.1111/j.1365-2958.2004.04006.x; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Ono K, 2006, J BIOL CHEM, V281, P13672, DOI 10.1074/jbc.M600029200; OSHEA TM, 2006, J BACTERIOL; Parker CT, 2006, J CLIN MICROBIOL, V44, P4125, DOI 10.1128/JCM.01231-06; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2003, FEBS LETT, V554, P224, DOI 10.1016/S0014-5793(03)01164-5; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; PEI ZH, 1993, J BIOL CHEM, V268, P18717; Pickett CL, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P385; Pin C, 2006, APPL MICROBIOL BIOT, V72, P852, DOI 10.1007/s00253-006-0536-x; PRABAGARAN SR, 2006, FEMS MICROBIOL ECOL; Prouzet-Mauleon V, 2006, EMERG INFECT DIS, V12, P307; Rice EW, 1999, LETT APPL MICROBIOL, V28, P31, DOI 10.1046/j.1365-2672.1999.00483.x; Rivas L, 2004, INT J FOOD MICROBIOL, V91, P31, DOI 10.1016/S0168-1605(03)00328-3; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SANDSTEDT K, 1983, CURR MICROBIOL, V8, P209, DOI 10.1007/BF01579548; Skirrow M.B., 2000, CAMPYLOBACTER, V2nd ed., P69; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Sourjik V, 2000, J BACTERIOL, V182, P782, DOI 10.1128/JB.182.3.782-788.2000; Stampi S, 1999, ZBL HYG UMWELTMED, V202, P19, DOI 10.1016/S0934-8859(99)80048-0; Stoeva K, 2006, FEMS MICROBIOL LETT, V256, P290, DOI 10.1111/j.1574-6968.2006.00135.x; Suerbaum S, 2003, P NATL ACAD SCI USA, V100, P7901, DOI 10.1073/pnas.1332093100; Summer EJ, 2004, J MOL BIOL, V340, P49, DOI 10.1016/j.jmb.2004.04.053; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Takagi K, 1999, BIOCHEMISTRY-US, V38, P6935, DOI 10.1021/bi9828268; Takagi K, 2001, EUR J BIOCHEM, V268, P470, DOI 10.1046/j.1432-1033.2001.01912.x; Takai K, 2006, INT J SYST EVOL MICR, V56, P1725, DOI 10.1099/ijs.0.64255-0; Taylor DE, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P193; TAYLOR DN, 1991, J INFECT DIS, V163, P1062, DOI 10.1093/infdis/163.5.1062; Thamdrup B, 2000, APPL ENVIRON MICROB, V66, P2888, DOI 10.1128/AEM.66.7.2888-2897.2000; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; TSANG N, 1973, SCIENCE, V181, P60, DOI 10.1126/science.181.4094.60; Valdes J, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-51; Van Driessche E, 2003, FEMS MICROBIOL LETT, V229, P243, DOI 10.1016/S0378-1097(03)00840-1; VANDAMME P, 1992, J CLIN MICROBIOL, V30, P2335, DOI 10.1128/JCM.30.9.2335-2337.1992; VANDAMME P, 1992, INT J SYST BACTERIOL, V42, P344, DOI 10.1099/00207713-42-3-344; Vandamme P., 2000, CAMPYLOBACTER, P3; Vandenberg O, 2004, EMERG INFECT DIS, V10, P1863, DOI 10.3201/eid1010.040241; Vandenberghe I, 2001, J BIOL CHEM, V276, P42923, DOI 10.1074/jbc.M107164200; Viswanathan M, 1999, J BIOL CHEM, V274, P30094, DOI 10.1074/jbc.274.42.30094; Viswanathan M, 1998, GENETICS, V149, P7; Wesley IV, 2000, APPL ENVIRON MICROB, V66, P1994, DOI 10.1128/AEM.66.5.1994-2000.2000; Williams SJ, 2002, J BIOL CHEM, V277, P32606, DOI 10.1074/jbc.M204613200; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002; Wodara C, 1997, J BACTERIOL, V179, P5014, DOI 10.1128/jb.179.16.5014-5023.1997; Wosten MMSM, 2004, J BIOL CHEM, V279, P16214, DOI 10.1074/jbc.M400357200; Yan JJ, 2000, J FORMOS MED ASSOC, V99, P166; YOSHIDA H, 1990, J BACTERIOL, V172, P6942, DOI 10.1128/jb.172.12.6942-6949.1990; ZOOMABLE ARCOBACTER; BASYS BACTERIAL ANNO; ARTEMIS RELEASE 8 0; TRNASCAN SE V 1 23	146	164	395	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1358	10.1371/journal.pone.0001358	http://dx.doi.org/10.1371/journal.pone.0001358			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159241	Green Submitted, gold, Green Published			2022-12-27	WOS:000207459700015
J	Breen, RAM; Hardy, GAD; Perrin, FMR; Lear, S; Kinloch, S; Smith, CJ; Cropley, I; Janossy, G; Lipman, MCI				Breen, Ronan A. M.; Hardy, Gareth A. D.; Perrin, Felicity M. R.; Lear, Sara; Kinloch, Sabine; Smith, Colette J.; Cropley, Ian; Janossy, George; Lipman, Marc C. I.			Rapid Diagnosis of Smear-Negative Tuberculosis Using Immunology and Microbiology with Induced Sputum in HIV-Infected and Uninfected Individuals	PLOS ONE			English	Article								Rationale and Objectives. Blood-based studies have demonstrated the potential of immunological assays to detect tuberculosis. However lung fluid sampling may prove superior as it enables simultaneous microbiological detection of mycobacteria to be performed. Until now this has only been possible using the expensive and invasive technique of broncho-alveolar lavage. We sought to evaluate an immunoassay using non-invasive induced-sputum to diagnose active tuberculosis. Methods and Results. Prospective cohort study of forty-two spontaneous sputum smear-negative or sputum non-producing adults under investigation for tuberculosis. CD4 lymphocytes specific to purified-protein-derivative of Mycobacterium tuberculosis actively synthesising interferon-gamma were measured by flow cytometry and final diagnosis compared to immunoassay using a cut-off of 0.5%. Sixteen subjects (38%) were HIV-infected (median CD4 count [range] = 332 cells/mu l [103748]). Thirty-eight (90%) were BCG-vaccinated. In 27 subjects diagnosed with active tuberculosis, the median [range] percentage of interferon-gamma synthetic CD4+ lymphocytes was 2.77% [0-23.93%] versus 0% [0-2.10%] in 15 negative for active infection (p<0.0001). Sensitivity and specificity of the immunoassay versus final diagnosis of active tuberculosis were 89% (24 of 27) and 80% (12 of 15) respectively. The 3 positive assays in the latter group occurred in subjects diagnosed with quiescent/latent tuberculosis. Assay performance was unaffected by HIV-status, BCG-vaccination or disease site. Combining this approach with traditional microbiological methods increased the diagnostic yield to 93% (25 of 27) alongside acid-fast bacilli smear and 96% (26 of 27) alongside tuberculosis culture. Conclusions. These data demonstrate for the first time that a rapid immunological assay to diagnose active tuberculosis can be performed successfully in combination with microbiological methods on a single induced-sputum sample.	[Breen, Ronan A. M.; Hardy, Gareth A. D.; Lear, Sara; Kinloch, Sabine; Janossy, George] Royal Free & Univ Coll Med Sch, Dept Immunol, London WC1E 6BT, England; [Breen, Ronan A. M.; Perrin, Felicity M. R.; Kinloch, Sabine; Cropley, Ian; Lipman, Marc C. I.] Royal Free Hosp, Dept Thorac, London NW3 2QG, England; [Breen, Ronan A. M.; Perrin, Felicity M. R.; Kinloch, Sabine; Cropley, Ian; Lipman, Marc C. I.] Royal Free Hosp, Dept HIV Med, London NW3 2QG, England; [Smith, Colette J.] Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London WC1E 6BT, England; [Perrin, Felicity M. R.] Royal Free & Univ Coll Med Sch, Ctr Med Microbiol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of London; University College London	Breen, RAM (corresponding author), Royal Free & Univ Coll Med Sch, Dept Immunol, London WC1E 6BT, England.	ronan.breen@gstt.nhs.uk	Abrams, William R/A-5782-2008	Lipman, Marc/0000-0001-7501-4448; Smith, Colette/0000-0003-2847-3355	Henry Smith Charity	Henry Smith Charity	RAMB and MCIL are in a receipt of a grant from the Henry Smith Charity. The Charity had no role in the execution of this study or production of the manuscript.	Barry SM, 2004, J IMMUNOL METHODS, V285, P15, DOI 10.1016/j.jim.2003.10.016; Barry SM, 2003, J INFECT DIS, V187, P243, DOI 10.1086/346112; BREEN RA, 2007, THORAX; Breen RAM, 2006, AIDS, V20, P1330, DOI 10.1097/01.aids.0000232243.51286.32; Brock L, 2004, AM J RESP CRIT CARE, V170, P65, DOI 10.1164/rccm.200402-232OC; Brown M, 2007, CLIN INFECT DIS, V44, P1415, DOI 10.1086/516782; Conde MB, 2000, AM J RESP CRIT CARE, V162, P2238, DOI 10.1164/ajrccm.162.6.2003125; Dewan PK, 2007, CLIN INFECT DIS, V44, P69, DOI 10.1086/509928; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Fireman E, 1999, RESP MED, V93, P827, DOI 10.1016/S0954-6111(99)90269-X; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Hoft DF, 2000, CLIN INFECT DIS, V30, pS217, DOI 10.1086/313864; Jafari C, 2006, AM J RESP CRIT CARE, V174, P1048, DOI 10.1164/rccm.200604-465OC; Kang YA, 2007, CHEST, V132, P959, DOI 10.1378/chest.06-2805; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; McWilliams T, 2002, THORAX, V57, P1010, DOI 10.1136/thorax.57.12.1010; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2007, CLIN INFECT DIS, V44, P74, DOI 10.1086/509927; Perrin FMR, 2007, LANCET INFECT DIS, V7, P481, DOI 10.1016/S1473-3099(07)70112-3; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Raviglione M, 2006, INT J TUBERC LUNG D, V10, P1185; Schwander SK, 1998, J INFECT DIS, V178, P1434, DOI 10.1086/314454; Schwander SK, 2000, J IMMUNOL, V165, P1479, DOI 10.4049/jimmunol.165.3.1479; Streitz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000735; Zaharatos GJ, 2001, CLIN INFECT DIS, V33, pE125, DOI 10.1086/324086	31	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1335	10.1371/journal.pone.0001335	http://dx.doi.org/10.1371/journal.pone.0001335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18092001	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459600019
J	Claudino, M; Ceolin, DS; Alberti, S; Cestari, TM; Spadella, CT; Rubira-Bullen, IRF; Garlet, GP; de Assis, GF				Claudino, Marcela; Ceolin, Danielle Santi; Alberti, Sandra; Cestari, Tania Mary; Spadella, Cesar Tadeu; Fischer Rubira-Bullen, Izabel Regina; Garlet, Gustavo Pompermaier; de Assis, Gerson Francisco			Alloxan-Induced Diabetes Triggers the Development of Periodontal Disease in Rats	PLOS ONE			English	Article								Background. Periodontal disease in diabetic patients presents higher severity and prevalence; and increased severity of ligature-induced periodontal disease has been verified in diabetic rats. However, in absence of aggressive stimuli such as ligatures, the influence of diabetes on rat periodontal tissues is incompletely explored. The aim of this study was to evaluate the establishment and progression of periodontal diseases in rats only with diabetes induction. Methodology/Principal Findings. Diabetes was induced in Wistar rats (n = 25) by intravenous administration of alloxan (42 mg/kg) and were analyzed at 1, 3, 6, 9 and 12 months after diabetes induction. The hemimandibles were removed and submitted to radiographical and histopathological procedures. A significant reduction was observed in height of bone crest in diabetic animals at 3, 6, 9 and 12 months, which was associated with increased numbers of osteoclasts and inflammatory cells. The histopathological analyses of diabetic rats also showed a reduction in density of collagen fibers, fibroblasts and blood vessels. Severe caries were also detected in the diabetic group. Conclusions/Significance. The results demonstrate that diabetes induction triggers, or even co-induces the onset of alterations which are typical of periodontal diseases even in the absence of aggressive factors such as ligatures. Therefore, diabetes induction renders a previously resistant host into a susceptible phenotype, and hence diabetes can be considered a very important risk factor to the development of periodontal disease.	[Claudino, Marcela; Ceolin, Danielle Santi; Cestari, Tania Mary; Garlet, Gustavo Pompermaier; de Assis, Gerson Francisco] Univ Sao Paulo, Dept Biol Sci, Sch Dent Bauru, Sao Paulo, Brazil; [Fischer Rubira-Bullen, Izabel Regina] Univ Sao Paulo, Dept Stomatol, Sch Dent Bauru, Sao Paulo, Brazil; [Alberti, Sandra; Spadella, Cesar Tadeu] Sao Paulo State Univ, Sch Med Botucatu, Dept Surg & Orthoped, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista	de Assis, GF (corresponding author), Univ Sao Paulo, Dept Biol Sci, Sch Dent Bauru, Sao Paulo, Brazil.	gfassis@fob.usp.br	Spadella, César/C-3442-2009; Assis, Gerson Francisco/E-5871-2012; Garlet, Gustavo Pompermaier/E-6762-2012; Rubira-Bullen, Izabel R. F./A-8537-2008; Cestari, Tania Mary/E-7060-2012	Assis, Gerson Francisco/0000-0001-8225-3164; Garlet, Gustavo Pompermaier/0000-0002-5071-8382; Rubira-Bullen, Izabel R. F./0000-0002-5069-9433; Cestari, Tania Mary/0000-0003-1287-5974				Alpagot T, 2001, J PERIODONTAL RES, V36, P169, DOI 10.1034/j.1600-0765.2001.360305.x; Anderson JLR, 2006, MOL BIOSYST, V2, P350, DOI 10.1039/b607813c; BARNETT ML, 1984, J PERIODONTOL, V55, P402, DOI 10.1902/jop.1984.55.7.402; BENVENIS.R, 1967, J PERIODONTOL, V38, P271, DOI 10.1902/jop.1967.38.4.271; Chung AWY, 2006, CIRC RES, V99, P140, DOI 10.1161/01.RES.0000232352.90786.fa; Engebretson SP, 2004, J PERIODONTOL, V75, P1203, DOI 10.1902/jop.2004.75.9.1203; Garlet GP, 2006, ORAL MICROBIOL IMMUN, V21, P12, DOI 10.1111/j.1399-302X.2005.00245.x; Garlet GP, 2005, MICROBES INFECT, V7, P738, DOI 10.1016/j.micinf.2005.01.012; Genco R.J., 1998, COMP CONT ED DENT, V19, P40; GOLUB LM, 1978, J DENT RES, V57, P520, DOI 10.1177/00220345780570032101; Golub LM, 2006, J DENT RES, V85, P102, DOI 10.1177/154405910608500201; Graves DT, 2006, J DENT RES, V85, P15, DOI 10.1177/154405910608500103; Graves DT, 2005, J DENT RES, V84, P324, DOI 10.1177/154405910508400406; Holzhausen M, 2004, J PERIODONTAL RES, V39, P188, DOI 10.1111/j.1600-0765.2004.00723.x; JOHNSON RB, 1992, J PERIODONTAL RES, V27, P40, DOI 10.1111/j.1600-0765.1992.tb02084.x; Kusuyama T, 2006, J PHARMACOL SCI, V102, P96, DOI 10.1254/jphs.FP0060256; Lalla E, 1998, Ann Periodontol, V3, P13, DOI 10.1902/annals.1998.3.1.13; Lalla E, 2000, J CLIN INVEST, V105, P1117, DOI 10.1172/JCI8942; Lalla E, 1998, J PERIODONTAL RES, V33, P387; Liu R, 2006, J DENT RES, V85, P510, DOI 10.1177/154405910608500606; Liu RK, 2004, ENDOCRINOLOGY, V145, P2997, DOI 10.1210/en.2003-1601; LOE H, 1993, DIABETES CARE, V16, P329, DOI 10.2337/diacare.16.1.329; Mahay S, 2004, MOL CELL BIOCHEM, V261, P175, DOI 10.1023/B:MCBI.0000028753.33225.68; Mata AD, 2004, MOL CELL BIOCHEM, V261, P137, DOI 10.1023/B:MCBI.0000028748.40917.6f; Miley DD, 2005, QUINTESSENCE INT, V36, P779; Miralles Lucia, 2006, Med Oral Patol Oral Cir Bucal, V11, pE256; Moore PA, 2001, ORAL SURG ORAL MED O, V92, P281, DOI 10.1067/moe.2001.117815; Nagasawa T, 2007, PERIODONTOL 2000, V43, P65, DOI 10.1111/j.1600-0757.2006.00185.x; Naguib G, 2004, J INVEST DERMATOL, V123, P87, DOI 10.1111/j.0022-202X.2004.22711.x; Ogasawara T, 2004, J PERIODONTAL RES, V39, P42, DOI 10.1111/j.1600-0765.2004.00699.x; OLIVER RC, 1994, J PERIODONTOL, V65, P530, DOI 10.1902/jop.1994.65.5s.530; Pucher Jeffery J, 2002, J Calif Dent Assoc, V30, P312; RAMAMURTHY NS, 1983, J PERIODONTAL RES, V18, P23, DOI 10.1111/j.1600-0765.1983.tb00331.x; RAMAMURTHY NS, 1974, J PERIODONTAL RES, V9, P199, DOI 10.1111/j.1600-0765.1974.tb00673.x; REUTERVING CO, 1986, J DENT RES, V65, P689, DOI 10.1177/00220345860650051201; RUSSELL BG, 1966, ACTA PATHOL MIC SC, V68, P161, DOI 10.1111/apm.1966.68.2.161; SAFKANSEPPALA B, 1992, J CLIN PERIODONTOL, V19, P24, DOI 10.1111/j.1600-051X.1992.tb01144.x; Salvi G E, 1998, Ann Periodontol, V3, P40, DOI 10.1902/annals.1998.3.1.40; Salvi GE, 2005, J CLIN PERIODONTOL, V32, P310, DOI 10.1111/j.1600-051X.2005.00682.x; Seppala B, 1997, J PERIODONTOL, V68, P1237, DOI 10.1902/jop.1997.68.12.1237; Shoji T, 2006, DIABETES, V55, P2245, DOI 10.2337/db05-1375; Siudikiene J, 2006, EUR J ORAL SCI, V114, P8, DOI 10.1111/j.1600-0722.2006.00277.x; Soskolne W A, 2001, Ann Periodontol, V6, P91, DOI 10.1902/annals.2001.6.1.91; STALLARD RE, 1970, J PERIODONTOL, V41, P620, DOI 10.1902/jop.1970.41.11.620	44	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1320	10.1371/journal.pone.0001320	http://dx.doi.org/10.1371/journal.pone.0001320			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091993	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459600008
J	Haas-Stapleton, EJ; Lu, Y; Hong, S; Arita, M; Favoreto, S; Nigam, S; Serhan, CN; Agabian, N				Haas-Stapleton, Eric J.; Lu, Yan; Hong, Song; Arita, Makoto; Favoreto, Silvio; Nigam, Santosh; Serhan, Charles N.; Agabian, Nina			Candida albicans Modulates Host Defense by Biosynthesizing the Pro-Resolving Mediator Resolvin E1	PLOS ONE			English	Article								Candida albicans is an opportunistic fungal pathogen of humans that resides commensally on epithelial surfaces, but can cause inflammation when pathogenic. Resolvins are a class of anti-inflammatory lipids derived from omega-3 polyunsaturated fatty acids (PUFA) that attenuate neutrophil migration during the resolution phase of inflammation. In this report we demonstrate that C. albicans biosynthesizes resolvins that are chemically identical to those produced by human cells. In contrast to the trans-cellular biosynthesis of human Resolvin E1 (RvE1), RvE1 biosynthesis in C. albicans occurs in the absence of other cellular partners. C. albicans biosynthesis of RvE1 is sensitive to lipoxygenase and cytochrome P450 monoxygenase inhibitors. We show that 10nM RvE1 reduces neutrophil chemotaxis in response to IL-8; 1nM RvE1 enhanced phagocytosis of Candida by human neutrophils, as well as intracellular ROS generation and killing, while having no direct affect on neutrophil motility. In a mouse model of systemic candidiasis, RvE1 stimulated clearance of the fungus from circulating blood. These results reveal an inter-species chemical signaling system that modulates host immune functions and may play a role in balancing host carriage of commensal and pathogenic C. albicans.	[Haas-Stapleton, Eric J.; Favoreto, Silvio; Agabian, Nina] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Lu, Yan; Hong, Song; Arita, Makoto; Serhan, Charles N.] Harvard Univ, Sch Dent Med, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med,Brigham &, Boston, MA 02115 USA; [Lu, Yan; Hong, Song; Arita, Makoto; Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lu, Yan; Hong, Song; Arita, Makoto; Serhan, Charles N.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Nigam, Santosh] Charite, Ctr Benjamin Franklin, Eicosanoid & Lipid Res Div, Ctr Expt Gynecol & Breast Res, D-13353 Berlin, Germany	University of California System; University of California San Francisco; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Agabian, N (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.	agabian@itsa.ucsf.edu		Arita, Makoto/0000-0001-9902-0463	University-wide AIDS Research Projects [F04-SF-211 to EHS]; National Institutes of Health [R21 DE15290, PO1 DE0794, GM38765, DK074448, P50-DE01619]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE007946, R21DE015290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038765, R01GM038765, R29GM038765] Funding Source: NIH RePORTER	University-wide AIDS Research Projects; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The present work in Nina Agabian's laboratory is supported in part by University-wide AIDS Research Projects postdoctoral fellowship F04-SF-211 to EHS and by NIH/NIDCR grants R21 DE15290 and PO1 DE07946 to NA from the National Institutes of Health. The present work in Charles Serhan's laboratory is supported in part by NIH Grants GM38765, DK074448 and P50-DE01619.	Ali A, 2006, ORAL MICROBIOL IMMUN, V21, P223, DOI 10.1111/j.1399-302X.2006.00280.x; Arita M, 2005, BIOCHEM BIOPH RES CO, V338, P149, DOI 10.1016/j.bbrc.2005.07.181; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Busetto S, 2004, CYTOM PART A, V58A, P201, DOI 10.1002/cyto.a.20014; Chiang N, 2006, METH MOL B, V341, P227; CREELMAN RA, 1997, BIOSYNTHESIS, V48, P355; Decleva E, 2006, J LEUKOCYTE BIOL, V79, P87, DOI 10.1189/jlb.0605338; Erb-Downward JR, 2007, INFECT IMMUN, V75, P3498, DOI 10.1128/IAI.00232-07; Erb-Downward JR, 2007, EUKARYOT CELL, V6, P346, DOI 10.1128/EC.00336-06; Fidel P L Jr, 2006, Adv Dent Res, V19, P80; Fidel PL, 2004, INFECT IMMUN, V72, P2939, DOI 10.1128/IAI.72.5.2939-2946.2004; Fidel PL, 2002, ORAL DIS, V8, P69, DOI 10.1034/j.1601-0825.2002.00015.x; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Hillyer P, 2003, CLIN EXP IMMUNOL, V134, P431, DOI 10.1111/j.1365-2249.2003.02323.x; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Jones SA, 1996, P NATL ACAD SCI USA, V93, P6682, DOI 10.1073/pnas.93.13.6682; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; La Camera S, 2004, IMMUNOL REV, V198, P267, DOI 10.1111/j.0105-2896.2004.0129.x; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Rotstein D, 2000, SHOCK, V14, P278, DOI 10.1097/00024382-200014030-00006; Scheel-Toellner D, 2004, BLOOD, V104, P2557, DOI 10.1182/blood-2004-01-0191; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2004, PROSTAG OTH LIPID M, V73, P155, DOI 10.1016/j.prostaglandins.2004.03.005; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Shen L, 2006, IMMUNOLOGY, V117, P205, DOI 10.1111/j.1365-2567.2005.02280.x; Sheng WH, 2007, J FORMOS MED ASSOC, V106, P110, DOI 10.1016/S0929-6646(09)60226-6; Simons MP, 2005, INFECT IMMUN, V73, P1971, DOI 10.1128/IAI.73.4.1971-1977.2005; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Weerasuriya N, 2006, DIS ESOPHAGUS, V19, P189, DOI 10.1111/j.1442-2050.2006.00563.x; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922	41	79	82	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1316	10.1371/journal.pone.0001316	http://dx.doi.org/10.1371/journal.pone.0001316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091990	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459600004
J	Thorpe, JD; Duan, XB; Forrest, R; Lowe, K; Brown, L; Segal, E; Nelson, B; Anderson, GL; McIntosh, M; Urban, N				Thorpe, Jason D.; Duan, Xiaobo; Forrest, Robin; Lowe, Kimberly; Brown, Lauren; Segal, Elliot; Nelson, Brad; Anderson, Garnet L.; McIntosh, Martin; Urban, Nicole			Effects of Blood Collection Conditions on Ovarian Cancer Serum Markers	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; FACTOR MIF; PROLACTIN; ANGIOGENESIS; SURGERY; BINDING; PLASMA; P53	Background. Evaluating diagnostic and early detection biomarkers requires comparing serum protein concentrations among biosamples ascertained from subjects with and without cancer. Efforts are generally made to standardize blood processing and storage conditions for cases and controls, but blood sample collection conditions cannot be completely controlled. For example, blood samples from cases are often obtained from persons aware of their diagnoses, and collected after fasting or in surgery, whereas blood samples from some controls may be obtained in different conditions, such as a clinic visit. By measuring the effects of differences in collection conditions on three different markers, we investigated the potential of these effects to bias validation studies. Methodology and Principle Findings. We analyzed serum concentrations of three previously studied putative ovarian cancer serum biomarkers-CA 125, Prolactin and MIF-in healthy women, women with ovarian cancer undergoing gynecologic surgery, women undergoing surgery for benign ovary pathology, and women undergoing surgery with pathologically normal ovaries. For women undergoing surgery, a blood sample was collected either in the clinic 1 to 39 days prior to surgery, or on the day of surgery after anesthesia was administered but prior to the surgical procedure, or both. We found that one marker, prolactin, was dramatically affected by collection conditions, while CA 125 and MIF were unaffected. Prolactin levels were not different between case and control groups after accounting for the conditions of sample collection, suggesting that sample ascertainment could explain some or all of the previously reported results about its potential as a biomarker for ovarian cancer. Conclusions. Biomarker validation studies should use standardized collection conditions, use multiple control groups, and/or collect samples from cases prior to influence of diagnosis whenever feasible to detect and correct for potential biases associated with sample collection.	[Thorpe, Jason D.; Anderson, Garnet L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Segal, Elliot] Onco Detectors Int LLC, Bethesda, MD USA; [Duan, Xiaobo; Nelson, Brad] BC Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada	Fred Hutchinson Cancer Center; British Columbia Cancer Agency	Thorpe, JD (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	jthorpe@fhcrc.org		Anderson, Garnet/0000-0001-5087-7837; Nelson, Brad/0000-0002-4445-5539	Pacific Ovarian Cancer Research Consortium (POCRC)/SPORE in Ovarian Cancer [P50 CA83636]; Department of Defense/CDMRP [DAMD17-02-1-0691]; Canary Foundation; NATIONAL CANCER INSTITUTE [P50CA083636] Funding Source: NIH RePORTER	Pacific Ovarian Cancer Research Consortium (POCRC)/SPORE in Ovarian Cancer; Department of Defense/CDMRP(United States Department of Defense); Canary Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful for generous funding from the Pacific Ovarian Cancer Research Consortium (POCRC)/SPORE in Ovarian Cancer (P50 CA83636, N.U.), the Department of Defense/CDMRP (DAMD17-02-1-0691, N.U.), and the Canary Foundation.	Andersen MR, 2003, CANCER EPIDEM BIOMAR, V12, P314; Bjorge T, 2004, BRIT J CANCER, V91, P1829, DOI 10.1038/sj.bjc.6602199; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; DAOUD E, 1991, CLIN CHEM, V37, P1968; DONNERER J, 1990, ENDOCRINOLOGY, V126, P921, DOI 10.1210/endo-126-2-921; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; HAGEN C, 1980, ACTA ENDOCRINOL-COP, V94, P151, DOI 10.1530/acta.0.0940151; Hira E, 2005, CANCER, V103, P588, DOI 10.1002/cncr.20818; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Indinnimeo M, 2001, ONCOL REP, V8, P1351; Lolis Elias, 2001, Current Opinion in Pharmacology, V1, P662, DOI 10.1016/S1471-4892(01)00112-6; Metz CE, 1998, MED DECIS MAKING, V18, P110, DOI 10.1177/0272989X9801800118; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Mujagic Z, 2004, CROAT MED J, V45, P176; Mujagic Zlata, 2005, Med Arh, V59, P33; Nevalainen MT, 1997, J CLIN INVEST, V99, P618, DOI 10.1172/JCI119204; NILOFF JM, 1986, AM J OBSTET GYNECOL, V155, P56, DOI 10.1016/0002-9378(86)90077-3; Pauler DK, 2001, CANCER EPIDEM BIOMAR, V10, P489; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Pepe MS, 2005, STAT MED, V24, P3687, DOI 10.1002/sim.2431; Rosenthal AN, 2006, CLIN OBSTET GYNECOL, V49, P433, DOI 10.1097/00003081-200609000-00004; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Rustin GJS, 1996, J CLIN ONCOL, V14, P1545, DOI 10.1200/JCO.1996.14.5.1545; Scholler N, 2006, CLIN CANCER RES, V12, P2117, DOI 10.1158/1078-0432.CCR-05-2007; Singh RJ, 2005, GEN RESOUR CHROM ENG, V1, P1; Skates SJ, 2003, J CLIN ONCOL S, V21, P206, DOI DOI 10.1200/JC0.2003.02.955; Team RDC, 2006, R LANG ENV STAT COMP; Tworoger SS, 2004, CANCER RES, V64, P6814, DOI 10.1158/0008-5472.CAN-04-1870; [No title captured]; [No title captured]; [No title captured]	34	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1281	10.1371/journal.pone.0001281	http://dx.doi.org/10.1371/journal.pone.0001281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060075	gold, Green Submitted, Green Published			2022-12-27	WOS:000207459400028
J	Sawalha, RM; Brotherstone, S; Conington, J; Villanueva, B				Sawalha, Rami M.; Brotherstone, Susan; Conington, Joanne; Villanueva, Beatriz			Lambs with Scrapie Susceptible Genotypes Have Higher Postnatal Survival	PLOS ONE			English	Article								Background. Prion protein (PrP) alleles associated with scrapie susceptibility persist in many sheep populations even with high frequencies despite centuries of selection against them. This suggests that scrapie susceptibility alleles have a pleiotropic effect or are associated with fitness or other traits that have been subject to selection. Methodology/Principal Findings. We genotyped all lambs in two scrapie-free Scottish Blackface sheep flocks for polymorphisms at codons 136, 154 and 171 of the PrP gene. We tested potential associations of the PrP genotype with lamb viability at birth and postnatal survival using a complementary log-log link function and a Weibull proportional hazard model, respectively. Here we show there is an association between PrP genotype, as defined by polymorphisms at codons 154 ad 171, and postnatal lamb survival in the absence of scrapie. Sheep carrying the wild-type ARQ allele have higher postnatal survival rates than sheep carrying the more scrapie-resistant alleles (ARR or AHQ). Conclusion. The PrP genotypes associated with higher susceptibility to scrapie are associated with improved postnatal survival in the absence of the disease. This association helps to explain the existence, and in many instances the high frequency, of the ARQ allele in sheep populations.	[Sawalha, Rami M.; Conington, Joanne; Villanueva, Beatriz] Scottish Agr Coll, Edinburgh, Midlothian, Scotland; [Brotherstone, Susan] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland	Scottish Agricultural College; University of Edinburgh	Sawalha, RM (corresponding author), Scottish Agr Coll, Edinburgh, Midlothian, Scotland.	rami.sawalha@sac.uk		Conington, Joanne/0000-0002-2387-3555	DEFRA (Department for Environment, Food and Rural Affairs); SEERAD (Scottish Executive Environment and Rural Affairs Department)	DEFRA (Department for Environment, Food and Rural Affairs)(Department for Environment, Food & Rural Affairs (DEFRA)); SEERAD (Scottish Executive Environment and Rural Affairs Department)	Funding for this project was mainly from DEFRA (Department for Environment, Food and Rural Affairs). SAC also receives funding from SEERAD (Scottish Executive Environment and Rural Affairs Department). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylis M, 2004, J GEN VIROL, V85, P2735, DOI 10.1099/vir.0.79876-0; Baylis M, 2002, J GEN VIROL, V83, P2907, DOI 10.1099/0022-1317-83-11-2907; Binns SH, 2002, PREV VET MED, V52, P287, DOI 10.1016/S0167-5877(01)00255-0; Brandsma JH, 2005, LIVEST PROD SCI, V95, P89, DOI 10.1016/j.livprodsci.2004.12.011; Burkin DJ, 1996, CYTOGENET CELL GENET, V74, P86, DOI 10.1159/000134388; Cagampang FRA, 1999, NEUROSCIENCE, V91, P1201, DOI 10.1016/S0306-4522(99)00092-5; Chase-Topping ME, 2005, J GEN VIROL, V86, P1229, DOI 10.1099/vir.0.80277-0; CLARK AM, 1994, VET REC, V134, P650, DOI 10.1136/vr.134.25.650; Conington J, 1998, ANIM SCI, V67, P299, DOI 10.1017/S1357729800010067; CRAWFORD AM, 1995, GENETICS, V140, P703; De Vries F, 2004, VET REC, V155, P140, DOI 10.1136/vr.155.5.140; DUCROCQ V, 1998, SURVIVAL KIT V3 0 PA, P447; Eales F. A., 1983, Sheep production. Proceedings of the 35th Easter School in Agricultural Science, University of Nottingham, P289; Eglin RD, 2005, VET REC, V156, P433, DOI 10.1136/vr.156.14.433; Gilmour A. R., 2002, ASREML USER GUIDE RE; Hunter N, 1996, ARCH VIROL, V141, P809, DOI 10.1007/BF01718157; Isler BJ, 2006, J ANIM SCI, V84, P783, DOI 10.2527/2006.844783x; Katamine S, 1998, CELL MOL NEUROBIOL, V18, P731, DOI 10.1023/A:1020234321879; Leeman MF, 2002, CRIT REV BIOCHEM MOL, V37, P149, DOI 10.1080/10409230290771483; Maddox JF, 2001, ANIM GENET, V32, P329, DOI 10.1046/j.1365-2052.2001.0730k.x; Man WYN, 2006, ANIM SCI, V82, P607, DOI 10.1079/ASC200673; MATTHEW P, 1994, ANIM GENET, V25, P200, DOI 10.1111/j.1365-2052.1994.tb00121.x; McLean AR, 1999, P ROY SOC B-BIOL SCI, V266, P2531, DOI 10.1098/rspb.1999.0956; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Nicholls N, 2006, VET REC, V158, P732, DOI 10.1136/vr.158.21.732; Nishida N, 1999, LAB INVEST, V79, P689; Sawalha RM, 2007, ANIMAL, V1, P151, DOI 10.1017/S1751731107340056; Sawalha RM, 2007, J ANIM SCI, V85, P632, DOI 10.2527/jas.2006-372; Slate J, 2005, P ROY SOC B-BIOL SCI, V272, P2371, DOI 10.1098/rspb.2005.3259; Vitezica ZG, 2005, ANIM SCI, V81, P325, DOI 10.1079/ASC42110325; Woolhouse MEJ, 2001, TRENDS MICROBIOL, V9, P67, DOI 10.1016/S0966-842X(00)01912-0	31	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1236	10.1371/journal.pone.0001236	http://dx.doi.org/10.1371/journal.pone.0001236			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043743	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459300017
J	Chiuman, W; Li, YF				Chiuman, William; Li, Yingfu			Simple Fluorescent Sensors Engineered with Catalytic DNA 'MgZ' Based on a Non-Classic Allosteric Design	PLOS ONE			English	Article							IN-VITRO SELECTION; RESONANCE ENERGY-TRANSFER; MOLECULAR RECOGNITION; SIGNALING APTAMERS; RATIONAL DESIGN; RNA APTAMERS; RIBOZYMES; DEOXYRIBOZYME; EVOLUTION; ENZYME	Most NAE (nucleic acid enzyme) sensors are composed of an RNA-cleaving catalytic motif and an aptameric receptor. They operate by activating or repressing the catalytic activity of a relevant NAE through the conformational change in the aptamer upon target binding. To transduce a molecular recognition event to a fluorescence signal, a fluorophore-quencher pair is attached to opposite ends of the RNA substrate such that when the NAE cleaves the substrate, an increased level of fluorescence can be generated. However, almost all NAE sensors to date harbor either NAEs that cannot accommodate a fluorophore-quencher pair near the cleavage site or those that can accept such a modification but require divalent transition metal ions for catalysis. Therefore, the signaling magnitude and the versatility of current NAE sensors might not suffice for analytical and biological applications. Here we report an RNA-cleaving DNA enzyme, termed 'MgZ', which depends on Mg2+ for its activity and can accommodate bulky dye moieties next to the cleavage site. MgZ was created by in vitro selection. The selection scheme entailed acidic buffering and ethanol-based reaction stoppage to remove selfish DNAs. Characterization of MgZ revealed a three-way junction structure, a cleavage rate of 1 min(-1), and 26-fold fluorescence enhancement. Two ligand-responsive NAE sensors were rationally designed by linking an aptamer sequence to the substrate of MgZ. In the absence of the target, the aptamer-linked substrate is locked into a conformation that prohibits MgZ from accessing the substrate. In the presence of the target, the aptamer releases the substrate, which induces MgZ-mediated RNA cleavage. The discovery of MgZ and the introduction of the above NAE sensor design strategy should facilitate future efforts in sensor engineering.	[Chiuman, William; Li, Yingfu] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University	Li, YF (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	liying@mcmaster.ca			Canadian Institutes for Health Research [MOP37964]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a research grant from Canadian Institutes for Health Research (grant number MOP37964).	Amontov S, 2006, NUCLEIC ACIDS RES, V34, P5032, DOI 10.1093/nar/gkl613; BREAKER RR, 1995, CHEM BIOL, V2, P655, DOI 10.1016/1074-5521(95)90028-4; BREAKER RR, 1994, P NATL ACAD SCI USA, V91, P6093, DOI 10.1073/pnas.91.13.6093; Chiuman W, 2006, J MOL BIOL, V357, P748, DOI 10.1016/j.jmb.2006.01.036; Chiuman W, 2007, NUCLEIC ACIDS RES, V35, P401, DOI 10.1093/nar/gkl1056; Chiuman W, 2006, CHEM BIOL, V13, P1061, DOI 10.1016/j.chembiol.2006.08.009; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Frauendorf C, 2001, BIOORGAN MED CHEM, V9, P2521, DOI 10.1016/S0968-0896(01)00027-X; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hamaguchi N, 2001, ANAL BIOCHEM, V294, P126, DOI 10.1006/abio.2001.5169; Hartig JS, 2002, NAT BIOTECHNOL, V20, P717, DOI 10.1038/nbt0702-717; HUIZENGA DE, 1995, BIOCHEMISTRY-US, V34, P656, DOI 10.1021/bi00002a033; Jenne A, 1999, ANGEW CHEM INT EDIT, V38, P1300, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1300::AID-ANIE1300>3.0.CO;2-Q; Jhaveri SD, 2000, J AM CHEM SOC, V122, P2469, DOI 10.1021/ja992393b; Koizumi M, 1999, NAT STRUCT BIOL, V6, P1062; Lee JF, 2006, CURR OPIN CHEM BIOL, V10, P282, DOI 10.1016/j.cbpa.2006.03.015; Lee JF, 2004, NUCLEIC ACIDS RES, V32, pD95, DOI 10.1093/nar/gkh094; Levy M, 2002, CHEM BIOL, V9, P417, DOI 10.1016/S1074-5521(02)00123-0; Li J, 2000, NUCLEIC ACIDS RES, V28, P481, DOI 10.1093/nar/28.2.481; Lin CH, 1997, CHEM BIOL, V4, P817, DOI 10.1016/S1074-5521(97)90115-0; Liu JW, 2007, P NATL ACAD SCI USA, V104, P2056, DOI 10.1073/pnas.0607875104; Liu JW, 2003, ANAL CHEM, V75, P6666, DOI 10.1021/AC034924r; Liu ZJ, 2003, J AM CHEM SOC, V125, P7539, DOI 10.1021/ja035208+; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; Mei SHJ, 2003, J AM CHEM SOC, V125, P412, DOI 10.1021/ja0281232; Najafi-Shoushtari SH, 2007, BLOOD CELL MOL DIS, V38, P19, DOI 10.1016/j.bcmd.2006.10.007; Najafi-Shoushtari SH, 2005, RNA, V11, P1514, DOI 10.1261/rna.2840805; Nutiu R, 2003, J AM CHEM SOC, V125, P4771, DOI 10.1021/ja028962o; Peracchi A, 2000, J BIOL CHEM, V275, P11693, DOI 10.1074/jbc.275.16.11693; Piganeau N, 2001, J MOL BIOL, V312, P1177, DOI 10.1006/jmbi.2001.4981; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Robertson MP, 2004, RNA, V10, P114, DOI 10.1261/rna.5900204; Robertson MP, 1999, NAT BIOTECHNOL, V17, P62, DOI 10.1038/5236; Robertson MP, 2001, NAT BIOTECHNOL, V19, P650, DOI 10.1038/90256; Rupcich N, 2006, J AM CHEM SOC, V128, P780, DOI 10.1021/ja053336n; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Shen Y, 2006, CHEMBIOCHEM, V7, P1343, DOI 10.1002/cbic.200600195; Silverman SK, 2005, NUCLEIC ACIDS RES, V33, P6151, DOI 10.1093/nar/gki930; Soukup GA, 2000, J MOL BIOL, V298, P623, DOI 10.1006/jmbi.2000.3704; Soukup GA, 1999, P NATL ACAD SCI USA, V96, P3584, DOI 10.1073/pnas.96.7.3584; Soukup GA, 2001, RNA, V7, P524, DOI 10.1017/S1355838201002175; Srinivasan J, 2004, CHEM BIOL, V11, P499, DOI 10.1016/j.chembiol.2004.03.014; Stojanovic MN, 2004, J AM CHEM SOC, V126, P9266, DOI 10.1021/ja032013t; Stojanovic MN, 2000, NUCLEIC ACIDS RES, V28, P2915, DOI 10.1093/nar/28.15.2915; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tang J, 1997, CHEM BIOL, V4, P453, DOI 10.1016/S1074-5521(97)90197-6; Thodima V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S6; Thompson Kristin M, 2002, BMC Biotechnol, V2, P21, DOI 10.1186/1472-6750-2-21; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vaish NK, 2002, NAT BIOTECHNOL, V20, P810, DOI 10.1038/nbt719; Vitiello D, 2000, RNA, V6, P628, DOI 10.1017/S1355838200990964; Wang DY, 2002, J MOL BIOL, V318, P33, DOI 10.1016/S0022-2836(02)00046-3; Wang W, 2002, CHEM BIOL, V9, P507, DOI 10.1016/S1074-5521(02)00127-8; Yamazaki S, 2007, CHEM BIOL, V14, P804, DOI 10.1016/j.chembiol.2007.06.003; Yang CJ, 2005, P NATL ACAD SCI USA, V102, P17278, DOI 10.1073/pnas.0508821102; Zivarts M, 2005, NUCLEIC ACIDS RES, V33, P622, DOI 10.1093/nar/gki182	58	39	40	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1224	10.1371/journal.pone.0001224	http://dx.doi.org/10.1371/journal.pone.0001224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030352	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459200031
J	Blanchard, JL; Wholey, WY; Conlon, EM; Pomposiello, PJ				Blanchard, Jeffrey L.; Wholey, Wei-Yun; Conlon, Erin M.; Pomposiello, Pablo J.			Rapid Changes in Gene Expression Dynamics in Response to Superoxide Reveal SoxRS-Dependent and Independent Transcriptional Networks	PLOS ONE			English	Article							ESCHERICHIA-COLI SOXS; SMALL-RNA REGULATOR; DNA-BINDING; HYDROGEN-PEROXIDE; 2FE-2S CLUSTERS; ACTIVATOR SOXS; IRON; PROTEIN; SEQUENCE; INHIBITION	Background. SoxR and SoxS constitute an intracellular signal response system that rapidly detects changes in superoxide levels and modulates gene expression in E. coli. A time series microarray design was used to identify co-regulated SoxRS-dependent and independent genes modulated by superoxide minutes after exposure to stress. Methodology/Principal Findings. soxS mRNA levels surged to near maximal levels within the first few minutes of exposure to paraquat, a superoxide-producing compound, followed by a rise in mRNA levels of known SoxS-regulated genes. Based on a new method for determining the biological significance of clustering results, a total of 138 genic regions, including several transcription factors and putative sRNAs were identified as being regulated through the SoxRS signaling pathway within 10 minutes of paraquat treatment. A statistically significant two-block SoxS motif was identified through analysis of the SoxS-regulated genes. The SoxRS-independent response included members of the OxyR, CysB, IscR, BirA and Fur regulons. Finally, the relative sensitivity to superoxide was measured in 94 strains carrying deletions in individual, superoxide-regulated genes. Conclusions/Significance. By integrating our microarray time series results with other microarray data, E. coli databases and the primary literature, we propose a model of the primary transcriptional response containing 226 protein-coding and sRNA sequences. From the SoxS dependent network the first statistically significant SoxS-related motif was identified.	[Blanchard, Jeffrey L.; Wholey, Wei-Yun; Pomposiello, Pablo J.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Conlon, Erin M.] Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Blanchard, JL (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	blanchard@microbio.umass.edu	Blanchard, Jeffrey/AAA-5173-2020	Blanchard, Jeffrey/0000-0002-7310-9678	University of Massachusetts	University of Massachusetts	This research was funded by a University of Massachusetts faculty research starter grant to Jeffrey Blanchard and a University of Massachusetts Commonwealth College Research Grant to Wei-Yun Chen. Wei-Yun Chen was supported by the University of Massachusetts Life Science Fellows Program and a University of Massachusetts Commonwealth College Research Fellowship.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BARBOSA T, 2005, MAR REGULON ESCHERIC; Bennik MHJ, 2000, J BACTERIOL, V182, P3794, DOI 10.1128/JB.182.13.3794-3801.2000; Bockhorst J, 2003, BIOINFORMATICS, V19, P1227, DOI 10.1093/bioinformatics/btg147; Bolstad BM, 2005, STAT BIOL HEALTH, P33; Brumaghim JL, 2003, J BIOL CHEM, V278, P42495, DOI 10.1074/jbc.M306251200; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chen S, 2004, J BACTERIOL, V186, P6689, DOI 10.1128/JB.186.20.6689-6697.2004; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DENK D, 1987, J GEN MICROBIOL, V133, P515; Ding HG, 1996, J BIOL CHEM, V271, P33173, DOI 10.1074/jbc.271.52.33173; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; FAWCETT WP, 1995, J BACTERIOL, V177, P1742, DOI 10.1128/jb.177.7.1742-1750.1995; FRIDOVICH I, 1984, METHOD ENZYMOL, V105, P59; Gaudu P, 1996, P NATL ACAD SCI USA, V93, P10094, DOI 10.1073/pnas.93.19.10094; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; GREENBERG JT, 1989, J BACTERIOL, V171, P3933, DOI 10.1128/jb.171.7.3933-3939.1989; Griffith KL, 2002, BIOCHEM BIOPH RES CO, V291, P979, DOI 10.1006/bbrc.2002.6559; Grose JH, 2006, P NATL ACAD SCI USA, V103, P7601, DOI 10.1073/pnas.0602494103; HIDALGO E, 1995, J BIOL CHEM, V270, P20908, DOI 10.1074/jbc.270.36.20908; IRIZARRY R, 2003, ANAL GENE EXPRESSION; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensen ST, 2004, BIOINFORMATICS, V20, P1557, DOI 10.1093/bioinformatics/bth127; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; KREDICH NM, 1996, ESCHERICHIA COLI SAL, P514; Li ZY, 1996, MOL MICROBIOL, V20, P937, DOI 10.1111/j.1365-2958.1996.tb02535.x; LIOCHEV SI, 1994, P NATL ACAD SCI USA, V91, P1328, DOI 10.1073/pnas.91.4.1328; Liu X, 2001, Pac Symp Biocomput, P127; Martin RG, 2000, MOL MICROBIOL, V37, P978, DOI 10.1046/j.1365-2958.2000.02043.x; Martin RG, 2000, MOL MICROBIOL, V35, P623, DOI 10.1046/j.1365-2958.2000.01732.x; Martin RG, 2002, MOL MICROBIOL, V43, P355, DOI 10.1046/j.1365-2958.2002.02748.x; Martin RG, 2002, MOL MICROBIOL, V44, P1611, DOI 10.1046/j.1365-2958.2002.02985.x; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Opdyke JA, 2004, J BACTERIOL, V186, P6698, DOI 10.1128/JB.186.20.6698-6705.2004; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Pomposiello PJ, 2002, ADV MICROB PHYSIOL, V46, P319, DOI 10.1016/S0065-2911(02)46007-9; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Rasmussen AA, 2005, MOL MICROBIOL, V58, P1421, DOI 10.1111/j.1365-2958.2005.04911.x; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Shah IM, 2006, J MOL BIOL, V357, P718, DOI 10.1016/j.jmb.2005.12.088; Shah IM, 2006, MOL MICROBIOL, V60, P199, DOI 10.1111/j.1365-2958.2006.05086.x; Shah IM, 2004, J MOL BIOL, V343, P513, DOI 10.1016/j.jmb.2004.08.057; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Wood TI, 1999, MOL MICROBIOL, V34, P414, DOI 10.1046/j.1365-2958.1999.01598.x; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zheng M, 2000, BIOCHEM PHARMACOL, V59, P1, DOI 10.1016/S0006-2952(99)00289-0; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999	60	96	99	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1186	10.1371/journal.pone.0001186	http://dx.doi.org/10.1371/journal.pone.0001186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000553	Green Published, gold			2022-12-27	WOS:000207459100024
J	Fenton, A; Brockhurst, MA				Fenton, Andy; Brockhurst, Michael A.			Epistatic Interactions Alter Dynamics of Multilocus Gene-for-Gene Coevolution	PLOS ONE			English	Article							ANTAGONISTIC COEVOLUTION; RESISTANCE; EVOLUTION; PLANTS; COST	Fitness costs associated with resistance or virulence genes are thought to play a key role in determining the dynamics of gene-for-gene (GFG) host-parasite coevolution. However, the nature of interactions between fitness effects of multiple resistance or virulence genes (epistasis) has received less attention. To examine effects of the functional form of epistasis on the dynamics of GFG host-parasite coevolution we modified a classic multilocus GFG model framework. We show that the type of epistasis between virulence genes largely determines coevolutionary dynamics, and that coevolutionary fluctuations are more likely with acceleratingly costly (negative) than with linear or deceleratingly costly (positive) epistasis. Our results demonstrate that the specific forms of interaction between multiple resistance or virulence genes are a crucial determinant of host-parasite coevolutionary dynamics.	[Fenton, Andy; Brockhurst, Michael A.] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Brockhurst, MA (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.	michael.brockhurst@liv.ac.uk	Brockhurst, Michael A/A-6247-2009; Fenton, Andy/B-5972-2009	Fenton, Andy/0000-0002-7676-917X; Brockhurst, Michael/0000-0003-0362-820X	Royal Society	Royal Society(Royal Society of London)	This work was funded by a research project grant from the Royal Society.	BERGELSON J, 2001, ANN REV GENET, V35; Bohannan BJM, 1999, EVOLUTION, V53, P292, DOI 10.1111/j.1558-5646.1999.tb05355.x; Boots M, 1999, AM NAT, V153, P359, DOI 10.1086/303181; Bowers RG, 2005, J THEOR BIOL, V233, P363, DOI 10.1016/j.jtbi.2004.10.017; Bowers RG, 2001, J THEOR BIOL, V212, P315, DOI 10.1006/jtbi.2001.2378; Buckling A, 2006, P ROY SOC B-BIOL SCI, V273, P45, DOI 10.1098/rspb.2005.3279; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Clay K, 1996, ANNU REV PHYTOPATHOL, V34, P29, DOI 10.1146/annurev.phyto.34.1.29; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; FRANK SA, 1993, EVOL ECOL, V7, P45, DOI 10.1007/BF01237734; Sanjuan R, 2006, P NATL ACAD SCI USA, V103, P14402, DOI 10.1073/pnas.0604543103; Sasaki A, 2000, P ROY SOC B-BIOL SCI, V267, P2183, DOI 10.1098/rspb.2000.1267; Thompson J. N., 2005, INTERSPEC INTERACT; THOMPSON JN, 1992, NATURE, V360, P121, DOI 10.1038/360121a0; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588	15	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1156	10.1371/journal.pone.0001156	http://dx.doi.org/10.1371/journal.pone.0001156			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17989777	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459000038
J	Zak, PJ; Stanton, AA; Ahmadi, S				Zak, Paul J.; Stanton, Angela A.; Ahmadi, Sheila			Oxytocin Increases Generosity in Humans	PLOS ONE			English	Article							STRONG RECIPROCITY; EVOLUTION; COOPERATION; RESPONSES; INTERACT; ALTRUISM; NETWORKS; FAIRNESS; BRAIN; TRUST	Human beings routinely help strangers at costs to themselves. Sometimes the help offered is generous-offering more than the other expects. The proximate mechanisms supporting generosity are not well-understood, but several lines of research suggest a role for empathy. In this study, participants were infused with 40 IU oxytocin (OT) or placebo and engaged in a blinded, one-shot decision on how to split a sum of money with a stranger that could be rejected. Those on OT were 80% more generous than those given a placebo. OT had no effect on a unilateral monetary transfer task dissociating generosity from altruism. OT and altruism together predicted almost half the interpersonal variation in generosity. Notably, OT had twofold larger impact on generosity compared to altruism. This indicates that generosity is associated with both altruism as well as an emotional identification with another person.	[Zak, Paul J.] Claremont Grad Univ, Ctr Neuroecon Studies, Claremont, CA 91711 USA; [Zak, Paul J.] Claremont Grad Univ, Dept Econ, Claremont, CA USA; [Zak, Paul J.] Loma Linda Univ, Med Ctr, Dept Neurol, Loma Linda, CA USA; [Stanton, Angela A.] Chapman Univ, Argyros Sch Business & Econ, Orange, CA USA; [Ahmadi, Sheila] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol, Los Angeles, CA 90095 USA	Claremont Colleges; Claremont Graduate School; Claremont Colleges; Claremont Graduate School; Loma Linda University; Chapman University System; Chapman University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zak, PJ (corresponding author), Claremont Grad Univ, Ctr Neuroecon Studies, Claremont, CA 91711 USA.	paul.zak@cgu.edu	Stanton, Angela A/H-8039-2015	Stanton, Angela A/0000-0003-4619-419X	Seaver Institute; John Templeton Foundation	Seaver Institute; John Templeton Foundation	PJZ thanks the Seaver Institute and the John Templeton Foundation for financial support. Neither the Seaver Institute nor the John Templeton Foundation had a role in the conduct of this study.	Alexander R., 2008, ESSAYS PEDAGOGY; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; [Anonymous], EMPATHY; AQUINAS T, 1999, AQUINAS SELECTED WRI; Batson CD, 2003, PERS SOC PSYCHOL B, V29, P1190, DOI 10.1177/0146167203254600; BATSON CD, 2002, ALTRUISM ALTRUISTIC; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Brooks A. C., 2005, GIFTS TIME MONEY ROL; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; CARTER CS, 2006, ATTACHMENT BONDING N; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety J, 2006, CURR DIR PSYCHOL SCI, V15, P54, DOI 10.1111/j.0963-7214.2006.00406.x; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; EISENBERG N, 2004, HDB EMOTION; Eisenberger NI, 2004, TRENDS COGN SCI, V8, P294, DOI 10.1016/j.tics.2004.05.010; Evans JJ, 1997, EUR J ENDOCRINOL, V137, P559, DOI 10.1530/eje.0.1370559; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; Frank R. H., 1988, PASSIONS REASON; Freedman LJ, 2000, J COMP NEUROL, V421, P172; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Glazer A, 1996, AM ECON REV, V86, P1019; Grafen A, 2007, P R SOC B, V274, P713, DOI 10.1098/rspb.2006.0140; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Hume David, ENQUIRY CONCERNING P; Insel TR, 1997, AM J PSYCHIAT, V154, P726; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; LARSEN RJ, 1987, J RES PERS, V21, P1, DOI 10.1016/0092-6566(87)90023-7; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; LOUP F, 1991, BRAIN RES, V555, P220, DOI 10.1016/0006-8993(91)90345-V; Macedo S, 2006, PRIMATES AND PHILOSOPHERS: HOW MORALITY EVOLVED, P1; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Morgane PJ, 2005, PROG NEUROBIOL, V75, P143, DOI 10.1016/j.pneurobio.2005.01.001; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; RABIN M, 1993, AM ECON REV, V83, P1281; Sally D, 2002, J LAW ECON ORGAN, V18, P455, DOI 10.1093/jleo/18.2.455; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SCHERVISH PG, 2002, INT J VOLUNTARY NONP, V13, P47; Smith Adam, THEORY MORAL SENTIME; Sober E., 1999, OTHERS EVOLUTION PSY; Sober E, 2002, ALTRUISM ALTRUISTIC; Tankersley D, 2007, NAT NEUROSCI, V10, P150, DOI 10.1038/nn1833; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Veelen M, 2006, J THEOR BIOL, V242, P790, DOI 10.1016/j.jtbi.2006.04.022; Verbalis JG, 1999, FRONT NEUROENDOCRIN, V20, P146, DOI 10.1006/frne.1999.0178; Xiao E, 2005, P NATL ACAD SCI USA, V102, P7398, DOI 10.1073/pnas.0502399102; Zak P. J., 2007, RENAISSANCE BEHAV EC; Zak PJ, 2004, ANN NY ACAD SCI, V1032, P224, DOI 10.1196/annals.1314.025; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009; Zak PJ, 2005, BEHAV BRAIN SCI, V28, P368; 2006, GIVING US; GENEROSITY	60	474	492	3	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1128	10.1371/journal.pone.0001128	http://dx.doi.org/10.1371/journal.pone.0001128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987115	Green Published, gold			2022-12-27	WOS:000207459000012
J	Le Mandat Schultz, A; Bonnard, A; Barreau, F; Aigrain, Y; Pierre-Louis, C; Berrebi, D; Peuchmaur, M				Le Mandat Schultz, Aurelie; Bonnard, Arnaud; Barreau, Frederick; Aigrain, Yves; Pierre-Louis, Coralie; Berrebi, Dominique; Peuchmaur, Michel			Expression of TLR-2, TLR-4, NOD2 and pNF-kappa B in a Neonatal Rat Model of Necrotizing Enterocolitis	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; PLATELET-ACTIVATING-FACTOR; EPIDERMAL GROWTH-FACTOR; INNATE IMMUNITY; ENDOTOXIN; APOPTOSIS; NECROSIS; INJURY; MILK; GUT	Background. The etiology of necrotizing enterocolitis (NEC) results from a combination of several risk factors that act synergistically and occurs in the same circumstances as those which lead to innate immunity activation. Pattern recognition molecules could be an important player in the initiation of an exaggerated inflammatory response leading to intestinal injury in NEC. Methodology/Principal Findings. We specifically evaluated intestinal epithelial cell (IEC) expression of Toll-like receptor 2 (TLR-2), TLR-4, NOD2 and phosphorylated NF-kappa B (pNF-kappa B) after mucosal injury in a rat model of NEC induced by prematurity, systemic hypoxia, and a rich protein formula. In the control group (group 1), neonatal rats were full-term and breast-fed; in the experimental groups, rat pups were preterm at day 21 of gestation and rat-milk fed (group 2) or hand-gavaged with a protein rich formula after a hypoxia-reoxygenation procedure (group 3). Morphological mucosal changes in the small bowel were scored on hematoxylin-and eosin-stained sections. Immunohistochemistry was performed on frozen tissue sections using anti TLR-2 and active pNF-kappa B p65 antibodies. Real-time RT-PCR was performed to assess mRNA expression of NOD2, TLR-2 and TLR-4. Proliferation and apoptosis were studied in paraffin sections using anti Ki-67 and caspase-3 antibodies, respectively. The combination of immaturity, protein rich formula and a hypoxia-reoxygenation procedure induces pathological mucosal damage consistent with NEC. There was an overexpression of TLR-2, and pNF-kappa B in IECs that was correlated with the severity of mucosal damage, together with an increase of apoptotic IECs and markedly impaired proliferation. In addition, these immunological alterations appeared before severe mucosal damage. TLR-2 mRNA were also increased in NEC together with TLR-4 mRNA using real-time RT-PCR whereas NOD2 expression was unchanged. Conclusions/Significance. These results show that this rat model of NEC induced mucosal injury, leading to a highly responsive IEC phenotype and suggesting that alterations in the innate immune system participates in the pathogenesis of NEC and are enhanced by prematurity.	[Le Mandat Schultz, Aurelie; Bonnard, Arnaud; Aigrain, Yves; Pierre-Louis, Coralie; Berrebi, Dominique; Peuchmaur, Michel] Univ Paris 07, EA3102, Paris, France; [Le Mandat Schultz, Aurelie; Bonnard, Arnaud; Aigrain, Yves] Hop Robert Debre, AP HP, Serv Chirurg Pediat, F-75019 Paris, France; [Aigrain, Yves] AP HP, Ecole Chirurg, Paris, France; [Pierre-Louis, Coralie; Berrebi, Dominique; Peuchmaur, Michel] Hop Robert Debre, AP HP, Serv Anat & Cytol Pathol, F-75019 Paris, France; [Barreau, Frederick] Hop Robert Debre, INSERM, U843, F-75019 Paris, France; [Barreau, Frederick] Univ Paris Diderot, UMR S843, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Berrebi, D (corresponding author), Univ Paris 07, EA3102, Paris, France.	dominique.berrebi@rdb.ap-hop-paris.fr	berrebi, dominique/B-1419-2014		APHP; Universite Paris 7	APHP; Universite Paris 7	Funding: APHP and Universite Paris 7	BARLOW B, 1974, J PEDIATR SURG, V9, P587, DOI 10.1016/0022-3468(74)90093-1; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Caplan Michael S, 2005, Semin Pediatr Surg, V14, P145, DOI 10.1053/j.sempedsurg.2005.05.002; Caplan MS, 1997, PEDIATR RES, V42, P779, DOI 10.1203/00006450-199712000-00010; Caplan MS, 2001, CURR OPIN PEDIATR, V13, P111, DOI 10.1097/00008480-200104000-00004; Caplan MS, 1999, GASTROENTEROLOGY, V117, P577, DOI 10.1016/S0016-5085(99)70450-6; CAPLAN MS, 1992, PEDIATR RES, V31, P428, DOI 10.1203/00006450-199205000-00002; Chan KL, 2002, J PEDIATR SURG, V37, P1435, DOI 10.1053/jpsu.2002.35407; Claud EC, 2003, PEDIATR RES, V53, P419, DOI 10.1203/01.PDR.0000050141.73528.AD; Dvorak B, 2002, AM J PHYSIOL-GASTR L, V282, pG156, DOI 10.1152/ajpgi.00196.2001; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; Fell JME, 2005, EARLY HUM DEV, V81, P117, DOI 10.1016/j.earlhumdev.2004.10.001; Fusunyan RD, 2001, PEDIATR RES, V49, P589, DOI 10.1203/00006450-200104000-00023; Hackam David J, 2005, Semin Pediatr Surg, V14, P49, DOI 10.1053/j.sempedsurg.2004.10.025; Halpern MD, 2003, J PEDIATR GASTR NUTR, V36, P126, DOI 10.1097/00005176-200301000-00024; Hsueh W, 2003, PEDIATR DEVEL PATHOL, V6, P6, DOI 10.1007/s10024-002-0602-z; Ikeda H, 1998, GUT, V42, P530, DOI 10.1136/gut.42.4.530; Jilling T, 2004, PEDIATR RES, V55, P622, DOI 10.1203/01.PDR.0000113463.70435.74; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; LIU SX, 2007, PEDIAT RES; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; OKUR H, 1995, J PEDIATR SURG, V30, P1416, DOI 10.1016/0022-3468(95)90395-X; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Zouali H, 2005, DIGEST DIS SCI, V50, P1684, DOI 10.1007/s10620-005-2915-z	32	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1102	10.1371/journal.pone.0001102	http://dx.doi.org/10.1371/journal.pone.0001102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971865	Green Published, gold, Green Submitted			2022-12-27	WOS:000207458700019
J	Pathan, AA; Sander, CR; Fletcher, HA; Poulton, I; Alder, NC; Beveridge, NER; Whelan, KT; Hill, AVS; McShane, H				Pathan, Ansar A.; Sander, Clare R.; Fletcher, Helen A.; Poulton, Ian; Alder, Nicola C.; Beveridge, Natalie E. R.; Whelan, Kathryn T.; Hill, Adrian V. S.; McShane, Helen			Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials	PLOS ONE			English	Article								Objectives. To investigate the safety and immunogenicity of boosting BCG with modified vaccinia Ankara expressing antigen 85A (MVA85A), shortly after BCG vaccination, and to compare this first with the immunogenicity of BCG vaccination alone and second with a previous clinical trial where MVA85A was administered more than 10 years after BCG vaccination. Design. There are two clinical trials reported here: a Phase I observational trial with MVA85A; and a Phase IV observational trial with BCG. These clinical trials were all conducted in the UK in healthy, HIV negative, BCG naive adults. Subjects were vaccinated with BCG alone; or BCG and then subsequently boosted with MVA85A four weeks later ( short interval). The outcome measures, safety and immunogenicity, were monitored for six months. The immunogenicity results from this short interval BCG prime-MVA85A boost trial were compared first with the BCG alone trial and second with a previous clinical trial where MVA85A vaccination was administered many years after vaccination with BCG. Results. MVA85A was safe and highly immunogenic when administered to subjects who had recently received BCG vaccination. When the short interval trial data presented here were compared with the previous long interval trial data, there were no significant differences in the magnitude of immune responses generated when MVA85A was administered shortly after, or many years after BCG vaccination. Conclusions. The clinical trial data presented here provides further evidence of the ability of MVA85A to boost BCG primed immune responses. This boosting potential is not influenced by the time interval between prior BCG vaccination and boosting with MVA85A. These findings have important implications for the design of efficacy trials with MVA85A. Boosting BCG induced anti-mycobacterial immunity in either infancy or adolescence are both potential applications for this vaccine, given the immunological data presented here. Trial Registration. ClinicalTrials.gov NCT00427453 ( short boosting interval), NCT00427830 ( long boosting interval), NCT00480714 ( BCG alone)	[Pathan, Ansar A.; Sander, Clare R.; Fletcher, Helen A.; Poulton, Ian; Beveridge, Natalie E. R.; Whelan, Kathryn T.; Hill, Adrian V. S.; McShane, Helen] Univ Oxford, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Alder, Nicola C.] Univ Oxford, Wolfson Coll Annexe, Ctr Stat Med, Oxford, England	University of Oxford; University of Oxford	McShane, H (corresponding author), Univ Oxford, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England.	helen.mcshane@ndm.ox.ac.uk	Fletcher, Helen/D-1470-2011	McShane, Helen/0000-0002-2126-5142; Beveridge, Natalie/0000-0002-1160-2600; Fletcher, Helen/0000-0002-0435-1006	Wellcome Trust Senior Clinical Research Fellow	Wellcome Trust Senior Clinical Research Fellow(Wellcome Trust)	HM is a Wellcome Trust Senior Clinical Research Fellow and AVSH is a Wellcome Trust Principal Research Fellow. Oxford University was the sponsor for all the clinical trials reported here.	[Anonymous], 2006, LANCET, V368, P1212; Cebere I, 2006, VACCINE, V24, P417, DOI 10.1016/j.vaccine.2005.08.041; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Dorman SE, 2004, LANCET, V364, P2113, DOI 10.1016/S0140-6736(04)17552-1; Dunachie SJ, 2006, INFECT IMMUN, V74, P5933, DOI 10.1128/IAI.00590-06; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gorak-Stolinska P, 2006, VACCINE, V24, P5726, DOI 10.1016/j.vaccine.2006.04.037; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; McShane H, 2001, INFECT IMMUN, V69, P681, DOI 10.1128/IAI.69.2.681-686.2001; Partnership ST, 2006, GLOB PLAN STOP TB 20; Rodrigues LC, 2005, LANCET, V366, P1290, DOI 10.1016/S0140-6736(05)67145-0; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Weir RE, 2003, CLIN EXP IMMUNOL, V134, P285, DOI 10.1046/j.1365-2249.2003.02272; Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2	21	52	53	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1052	10.1371/journal.pone.0001052	http://dx.doi.org/10.1371/journal.pone.0001052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957238	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000207458500001
J	Vogel, H; Kroymann, J; Mitchell-Olds, T				Vogel, Heiko; Kroymann, Juergen; Mitchell-Olds, Thomas			Different Transcript Patterns in Response to Specialist and Generalist Herbivores in the Wild Arabidopsis Relative Boechera divaricarpa	PLOS ONE			English	Article								Background. Plants defend themselves against herbivorous insects, utilizing both constitutive and inducible defenses. Induced defenses are controlled by several phytohormone-mediated signaling pathways. Here, we analyze transcriptional changes in the North American Arabidopsis relative Boechera divaricarpa in response to larval herbivory by the crucifer specialist lepidopteran Plutella xylostella (diamondback moth) and by the generalist lepidopteran Trichoplusia ni (cabbage semilooper), and compare them to wounding and exogenous phytohormone application. Methodology/Principal Findings. We use a custom macroarray constructed from B. divaricarpa herbivory-regulated cDNAs identified by suppression subtractive hybridization and from known stress-responsive A. thaliana genes for transcript profiling after insect herbivory, wounding and in response to jasmonate, salicylate and ethylene. In addition, we introduce path analysis as a novel approach to analyze transcript profiles. Path analyses reveal that transcriptional responses to the crucifer specialist P. xylostella are primarily determined by direct effects of the ethylene and salicylate pathways, whereas responses to the generalist T. ni are influenced by the ethylene and jasmonate pathways. Wound-induced transcriptional changes are influenced by all three pathways, with jasmonate having the strongest effect. Conclusions/Significance. Our results show that insect herbivory is distinct from simple mechanical plant damage, and that different lepidopteran herbivores elicit different transcriptional responses.	[Vogel, Heiko; Kroymann, Juergen; Mitchell-Olds, Thomas] Max Planck Inst Chem Ecol, Dept Genet & Evolut, Jena, Germany; [Vogel, Heiko] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany; [Mitchell-Olds, Thomas] Duke Univ, Dept Biol, Durham, NC USA	Max Planck Society; Max Planck Society; Duke University	Kroymann, J (corresponding author), Max Planck Inst Chem Ecol, Dept Genet & Evolut, Jena, Germany.	kroymann@ice.mpg.de	Kroymann, Juergen/B-4317-2013; Kroymann, Juergen/AAY-8562-2021; Mitchell-Olds, Thomas/K-8121-2012	Kroymann, Juergen/0000-0002-4573-6498; Mitchell-Olds, Thomas/0000-0003-3439-9921	Max Planck Society; European Union [QLRT-2000-01097]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission)	This work was supported by the Max Planck Society and by the European Union (QLRT-2000-01097).	Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; Alborn HT, 2003, J CHEM ECOL, V29, P1357, DOI 10.1023/A:1024209302628; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arondel V, 2000, PLANT SCI, V157, P1, DOI 10.1016/S0168-9452(00)00232-6; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; Bostock RM, 1999, PHYSIOL MOL PLANT P, V55, P99, DOI 10.1006/pmpp.1999.0218; Bostock RM, 2001, EUR J PLANT PATHOL, V107, P103, DOI 10.1023/A:1008703904253; Cameron RK, 2000, PHYSIOL MOL PLANT P, V56, P91, DOI 10.1006/pmpp.2000.0262; Clark AM, 1999, PLANT CELL PHYSIOL, V40, P69, DOI 10.1093/oxfordjournals.pcp.a029476; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Durrant WE, 2000, PLANT CELL, V12, P963, DOI 10.1105/tpc.12.6.963; Ellis C, 2001, PLANT CELL, V13, P1025, DOI 10.1105/tpc.13.5.1025; ESTADA U, 1994, APPL ENVIRON MICROB, V60, P3840, DOI 10.1128/AEM.60.10.3840-3846.1994; Felton GW, 2000, CURR OPIN PLANT BIOL, V3, P309, DOI 10.1016/S1369-5266(00)00086-8; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Feys BJ, 2000, TRENDS GENET, V16, P449, DOI 10.1016/S0168-9525(00)02107-7; Frey M, 2004, PHYTOCHEMISTRY, V65, P1047, DOI 10.1016/j.phytochem.2003.11.021; Frey M, 2000, P NATL ACAD SCI USA, V97, P14801, DOI 10.1073/pnas.260499897; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Heckel DG, 1999, P NATL ACAD SCI USA, V96, P8373, DOI 10.1073/pnas.96.15.8373; HILL DS, 1987, CULTURAL INSECT PEST; Howe GA, 1996, PLANT CELL, V8, P2067, DOI 10.1105/tpc.8.11.2067; Hughes P, 2000, J BIOL CHEM, V275, P823, DOI 10.1074/jbc.275.2.823; Iqbal M, 1997, B ENTOMOL RES, V87, P481, DOI 10.1017/S0007485300041341; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Laudert D, 1998, PLANT J, V15, P675, DOI 10.1046/j.1365-313x.1998.00245.x; Liechti R, 2002, SCIENCE, V296, P1649, DOI 10.1126/science.1071547; Liu YL, 2005, PLANT PHYSIOL, V139, P1545, DOI 10.1104/pp.105.066837; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; McDowell JM, 2000, TRENDS BIOCHEM SCI, V25, P79, DOI 10.1016/S0968-0004(99)01532-7; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; Mori N, 2001, J INSECT PHYSIOL, V47, P749, DOI 10.1016/S0022-1910(00)00171-2; O'Donnell PJ, 1998, PLANT J, V14, P137, DOI 10.1046/j.1365-313X.1998.00110.x; Pare PW, 1997, PLANT PHYSIOL, V114, P1161, DOI 10.1104/pp.114.4.1161; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pohnert G, 1999, TETRAHEDRON, V55, P11275, DOI 10.1016/S0040-4020(99)00639-0; RASKIN I, 1992, PLANT PHYSIOL, V99, P799, DOI 10.1104/pp.99.3.799; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Rojo E, 2003, J PLANT GROWTH REGUL, V22, P82, DOI 10.1007/s00344-003-0027-6; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; SHELTON AM, 1991, J ENTOMOL SCI, V26, P17, DOI 10.18474/0749-8004-26.1.17; Shipley B., 2000, CAUSE CORRELATIONS B; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tabashnik BE, 1997, P NATL ACAD SCI USA, V94, P12780, DOI 10.1073/pnas.94.24.12780; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tamaoki M, 2003, PLANT CELL PHYSIOL, V44, pS81; Thaler JS, 2002, ECOL LETT, V5, P764, DOI 10.1046/j.1461-0248.2002.00388.x; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Titarenko E, 1997, PLANT PHYSIOL, V115, P817, DOI 10.1104/pp.115.2.817; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Utsugi S, 1998, PLANT MOL BIOL, V38, P565, DOI 10.1023/A:1006072014605; van Poecke RMP, 2002, J EXP BOT, V53, P1793, DOI 10.1093/jxb/erf022; van Wees SCM, 2000, P NATL ACAD SCI USA, V97, P8711, DOI 10.1073/pnas.130425197; Voelckel C, 2004, ECOL LETT, V7, P770, DOI 10.1111/j.1461-0248.2004.00633.x; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Wright S, 1934, ANN MATH STAT, V5, P161, DOI 10.1214/aoms/1177732676; Wright SS, 1921, J AGR RES, V20, P557; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602	66	35	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1081	10.1371/journal.pone.0001081	http://dx.doi.org/10.1371/journal.pone.0001081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957263	gold, Green Published, Green Submitted			2022-12-27	WOS:000207458500026
J	Louie, GV; Baiga, TJ; Bowman, ME; Koeduka, T; Taylor, JH; Spassova, SM; Pichersky, E; Noel, JP				Louie, Gordon V.; Baiga, Thomas J.; Bowman, Marianne E.; Koeduka, Takao; Taylor, John H.; Spassova, Snejina M.; Pichersky, Eran; Noel, Joseph P.			Structure and Reaction Mechanism of Basil Eugenol Synthase	PLOS ONE			English	Article							BENZYLIC ETHER REDUCTASES; PINORESINOL-LARICIRESINOL; BIOSYNTHESIS; CHAIN; COENZYME; PROGRAM	Phenylpropenes, a large group of plant volatile compounds that serve in multiple roles in defense and pollinator attraction, contain a propenyl side chain. Eugenol synthase (EGS) catalyzes the reductive displacement of acetate from the propenyl side chain of the substrate coniferyl acetate to produce the allyl-phenylpropene eugenol. We report here the structure determination of EGS from basil (Ocimum basilicum) by protein x-ray crystallography. EGS is structurally related to the short-chain dehydrogenase/reductases (SDRs), and in particular, enzymes in the isoflavone-reductase-like subfamily. The structure of a ternary complex of EGS bound to the cofactor NADP(H) and a mixed competitive inhibitor EMDF ((7S,8S)-ethyl (7,8-methylene)-dihydroferulate) provides a detailed view of the binding interactions within the EGS active site and a starting point for mutagenic examination of the unusual reductive mechanism of EGS. The key interactions between EMDF and the EGS-holoenzyme include stacking of the phenyl ring of EMDF against the cofactor's nicotinamide ring and a water-mediated hydrogen-bonding interaction between the EMDF 4-hydroxy group and the side-chain amino moiety of a conserved lysine residue, Lys132. The C4 carbon of nicotinamide resides immediately adjacent to the site of hydride addition, the C7 carbon of cinnamyl acetate substrates. The inhibitor-bound EGS structure suggests a two-step reaction mechanism involving the formation of a quinone-methide prior to reduction. The formation of this intermediate is promoted by a hydrogen-bonding network that favors deprotonation of the substrate's 4-hydroxyl group and disfavors binding of the acetate moiety, akin to a push-pull catalytic mechanism. Notably, the catalytic involvement in EGS of the conserved Lys132 in preparing the phenolic substrate for quinone methide formation through the proton-relay network appears to be an adaptation of the analogous role in hydrogen bonding played by the equivalent lysine residue in other enzymes of the SDR family.	[Louie, Gordon V.; Baiga, Thomas J.; Bowman, Marianne E.; Taylor, John H.; Spassova, Snejina M.; Noel, Joseph P.] Salk Inst Biol Studies, Howard Hughes Med Inst, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Koeduka, Takao; Pichersky, Eran] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; Salk Institute; University of Michigan System; University of Michigan	Noel, JP (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA.	noel@salk.edu	Noel, Joseph P/A-9459-2009		National Science Foundation [0331353, 0312466, 0718152, 0236027, 0718064]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grants 0331353, 0312466 and 0718152 to EP and 0236027 and 0718064 to JNP. JPN is an investigator of the Howard Hughes Medical Institute.	Akashi T, 2006, FEBS LETT, V580, P5666, DOI 10.1016/j.febslet.2006.09.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carugo O, 1997, PROTEINS, V28, P10, DOI 10.1002/(SICI)1097-0134(199705)28:1<10::AID-PROT2>3.3.CO;2-R; Dexter R, 2007, PLANT J, V49, P265, DOI 10.1111/j.1365-313X.2006.02954.x; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fujita M, 1999, J BIOL CHEM, V274, P618, DOI 10.1074/jbc.274.2.618; Gang DR, 2001, PLANT PHYSIOL, V125, P539, DOI 10.1104/pp.125.2.539; Gang DR, 1999, J BIOL CHEM, V274, P7516, DOI 10.1074/jbc.274.11.7516; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Koeduka T, 2006, P NATL ACAD SCI USA, V103, P10128, DOI 10.1073/pnas.0603732103; Kolappan S, 2007, BIOCHEMISTRY-US, V46, P946, DOI 10.1021/bi0608515; Koumanov A, 2003, PROTEINS, V51, P289, DOI 10.1002/prot.10354; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Min TP, 2003, J BIOL CHEM, V278, P50714, DOI 10.1074/jbc.M308493200; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi R, 2004, J BIOL CHEM, V279, P16778, DOI 10.1074/jbc.M313156200; Tanaka M, 2005, PLOS BIOL, V3, P764, DOI 10.1371/journal.pbio.0030128; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P6294, DOI 10.1021/bi970025j; Toteva MM, 2003, J AM CHEM SOC, V125, P8814, DOI 10.1021/ja029588v; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vassao DG, 2006, ORG BIOMOL CHEM, V4, P2733, DOI 10.1039/b605407b; Wang XQ, 2006, J MOL BIOL, V358, P1341, DOI 10.1016/j.jmb.2006.03.022	30	35	36	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e993	10.1371/journal.pone.0000993	http://dx.doi.org/10.1371/journal.pone.0000993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912370	Green Published, gold			2022-12-27	WOS:000207455900029
J	Beck, CW; Promislow, DEL				Beck, Christopher W.; Promislow, Daniel E. L.			Evolution of Female Preference for Younger Males	PLOS ONE			English	Article							SONG REPERTOIRE SIZE; SEXUAL SELECTION; MATE CHOICE; MALE AGE; OLDER MALES; GOOD GENES; SPONTANEOUS MUTATION; PARENTAL AGE; ORNAMENTATION; MAINTENANCE	Previous theoretical work has suggested that females should prefer to mate with older males, as older males should have higher fitness than the average fitness of the cohort into which they were born. However, studies in humans and model organisms have shown that as males age, they accumulate deleterious mutations in their germ-line at an ever-increasing rate, thereby reducing the quality of genes passed on to the next generation. Thus, older males may produce relatively poor-quality offspring. To better understand how male age influences female mate preference and offspring quality, we used a genetic algorithm model to study the effect of age-related increases in male genetic load on female mate preference. When we incorporate age-related increases in mutation load in males into our model, we find that females evolve a preference for younger males. Females in this model could determine a male's age, but not his inherited genotype nor his mutation load. Nevertheless, females evolved age-preferences that led them to mate with males that had low mutation loads, but showed no preference for males with respect to their somatic quality. These results suggest that germ-line quality, rather than somatic quality, should be the focus of female preference in good genes models.	[Beck, Christopher W.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Promislow, Daniel E. L.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	Emory University; University System of Georgia; University of Georgia	Beck, CW (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	christopher.beck@emory.edu		Promislow, Daniel/0000-0001-7088-4495; Beck, Christopher/0000-0002-1073-1363	Ellison Medical Foundation	Ellison Medical Foundation(Lawrence Ellison Foundation)	Daniel Promislow was supported by a Senior Scholar Award from the Ellison Medical Foundation.	Agrawal AF, 2001, NATURE, V411, P692, DOI 10.1038/35079590; Andersson Malte, 1994; Beck CW, 2000, EVOL ECOL RES, V2, P107; Beck CW, 2002, EVOL ECOL RES, V4, P275; Bertram SM, 2000, ANIM BEHAV, V60, P333, DOI 10.1006/anbe.2000.1473; Brooks R, 2001, TRENDS ECOL EVOL, V16, P308, DOI 10.1016/S0169-5347(01)02147-4; Charlesworth B, 2001, J THEOR BIOL, V210, P47, DOI 10.1006/jtbi.2001.2296; Charlesworth B, 1987, SEXUAL SELECTION TES, P21; COSENS SE, 1986, CAN J ZOOL, V64, P1926, DOI 10.1139/z86-289; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Crow JF, 2006, J RADIAT RES, V47, pB75, DOI 10.1269/jrr.47.B75; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Dean R, 2007, SCIENCE, V316, P383, DOI 10.1126/science.1142201; Ellegren H, 2007, P ROY SOC B-BIOL SCI, V274, P1, DOI 10.1098/rspb.2006.3720; Felton A, 2006, BEHAV ECOL SOCIOBIOL, V59, P786, DOI 10.1007/s00265-005-0124-6; Fuller RC, 2005, AM NAT, V166, P437, DOI 10.1086/444443; Gavrilov LA, 1997, MUTAT RES-FUND MOL M, V377, P61, DOI 10.1016/S0027-5107(97)00058-4; Gil D, 2001, ANIM BEHAV, V62, P689, DOI 10.1006/anbe.2001.1812; GLASER RL, 2004, SCI AGING KNOWLEDGE, pRE1, DOI DOI 10.1126/SAGEKE.2004.3.RE1; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Hadfield JD, 2006, P ROY SOC B-BIOL SCI, V273, P1347, DOI 10.1098/rspb.2005.3459; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Hansen TF, 1995, J EVOLUTION BIOL, V8, P759, DOI 10.1046/j.1420-9101.1995.8060759.x; Hansen TF, 1999, GENETICA, V106, P251, DOI 10.1023/A:1003988101586; Houle D, 2002, P ROY SOC B-BIOL SCI, V269, P97, DOI 10.1098/rspb.2001.1823; Hunt J, 2004, TRENDS ECOL EVOL, V19, P329, DOI 10.1016/j.tree.2004.03.035; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI [10.1111/j.1558-5646.1991.tb02646.x, 10.2307/2409890]; Jones TM, 2007, BEHAV ECOL, V18, P251, DOI 10.1093/beheco/arl077; Jones TM, 2004, P ROY SOC B-BIOL SCI, V271, P1311, DOI 10.1098/rspb.2004.2723; Jones TM, 2000, P ROY SOC B-BIOL SCI, V267, P681, DOI 10.1098/rspb.2000.1056; Kirkpatrick M, 2004, EVOLUTION, V58, P683; Kirkpatrick M, 1996, EVOLUTION, V50, P2125, DOI [10.2307/2410684, 10.1111/j.1558-5646.1996.tb03603.x]; KIRKPATRICK M, 1987, ANNU REV ECOL SYST, V18, P43, DOI 10.1146/annurev.es.18.110187.000355; Kokko H, 1998, EVOL ECOL, V12, P739, DOI 10.1023/A:1006541701002; Kokko H, 1997, BEHAV ECOL SOCIOBIOL, V41, P99, DOI 10.1007/s002650050369; Kokko H, 1996, P ROY SOC B-BIOL SCI, V263, P1533, DOI 10.1098/rspb.1996.0224; Komdeur J, 2005, BEHAV ECOL, V16, P805, DOI 10.1093/beheco/ari059; Linder JE, 2005, J EVOLUTION BIOL, V18, P568, DOI 10.1111/j.1420-9101.2004.00872.x; Lopez P, 2003, BEHAV ECOL SOCIOBIOL, V55, P73, DOI 10.1007/s00265-003-0675-3; Madsen V, 2007, AM NAT, V169, pS93, DOI 10.1086/510096; Mank JE, 2006, P ROY SOC B-BIOL SCI, V273, P233, DOI 10.1098/rspb.2005.3334; MANNING JT, 1985, J THEOR BIOL, V116, P349, DOI 10.1016/S0022-5193(85)80273-3; MANNING JT, 1984, J THEOR BIOL, V108, P215, DOI 10.1016/S0022-5193(84)80067-3; Martin Joyce A, 2005, Natl Vital Stat Rep, V54, P1; MCLEAN KR, 1985, J THEOR BIOL, V116, P369, DOI 10.1016/S0022-5193(85)80275-7; Medawar P., 1952, UNSOLVED PROBLEM BIO; Miller LK, 2005, EVOLUTION, V59, P2414; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; NOTTEBOHM F, 1978, Z TIERPSYCHOL, V46, P298; O'Loghlen AL, 2003, BEHAV ECOL SOCIOBIOL, V53, P102, DOI 10.1007/s00265-002-0551-6; Oneal E, 2007, BIOL LETTERS, V3, P29, DOI 10.1098/rsbl.2006.0565; Osada K, 2003, P ROY SOC B-BIOL SCI, V270, P929, DOI 10.1098/rspb.2002.2308; Poesel A, 2006, ANIM BEHAV, V72, P531, DOI 10.1016/j.anbehav.2005.10.022; POMIANKOWSKI A, 1987, J THEOR BIOL, V128, P195, DOI 10.1016/S0022-5193(87)80169-8; Price DK, 1998, BEHAV GENET, V28, P395, DOI 10.1023/A:1021677804038; Priest NK, 2002, EVOLUTION, V56, P927, DOI 10.1111/j.0014-3820.2002.tb01405.x; Promislow D, 2003, BEHAV GENET, V33, P191, DOI 10.1023/A:1022562103669; Promislow DEL, 1998, GENETICA, V102-3, P299, DOI 10.1023/A:1017047212008; Radwan J, 2003, ECOL LETT, V6, P581, DOI 10.1046/j.1461-0248.2003.00484.x; RICE WR, 1988, EVOLUTION, V42, P817, DOI [10.2307/2408873, 10.1111/j.1558-5646.1988.tb02500.x]; RISCH N, 1987, AM J HUM GENET, V41, P218; SEARCY WA, 1985, CONDOR, V87, P222, DOI 10.2307/1366886; Siefferman L, 2005, J AVIAN BIOL, V36, P428, DOI 10.1111/j.0908-8857.2005.03401.x; Siller S, 2001, NATURE, V411, P689, DOI 10.1038/35079578; Sloter E, 2004, FERTIL STERIL, V81, P925, DOI 10.1016/j.fertnstert.2003.07.043; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Wyrobek AJ, 2006, P NATL ACAD SCI USA, V103, P9601, DOI 10.1073/pnas.0506468103; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	71	42	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e939	10.1371/journal.pone.0000939	http://dx.doi.org/10.1371/journal.pone.0000939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895980	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455800018
J	Thuiller, W; Slingsby, JA; Privett, SDJ; Cowling, RM				Thuiller, Wilfried; Slingsby, Jasper A.; Privett, Sean D. J.; Cowling, Richard M.			Stochastic Species Turnover and Stable Coexistence in a Species-Rich, Fire-Prone Plant Community	PLOS ONE			English	Article								Understanding the mechanisms that maintain diversity is important for managing ecosystems for species persistence. Here we used a long-term data set to understand mechanisms of coexistence at the local and regional scales in the Cape Floristic Region, a global hotspot of plant diversity. We used a dataset comprising 81 monitoring sites, sampled in 1966 and again in 1996, and containing 422 species for which growth form, regeneration mode, dispersal distance and abundances at both the local (site) and meta-community scales are known. We found that species presence and abundance were stable at the meta-community scale over the 30 year period but highly unstable at the local scale, and were not influenced by species' biological attributes. Moreover, rare species were no more likely to go extinct at the local scale than common species, and that alpha diversity in local communities was strongly influenced by habitat. We conclude that stochastic environmental fluctuations associated with recurrent fire buffer populations from extinction, thereby ensuring stable coexistence at the meta-community scale by creating a "neutral-like" pattern maintained by niche-differentiation.	[Thuiller, Wilfried] Univ Grenoble 1, CNRS, Lab Ecol Alpine, UMR 5553, Grenoble, France; [Slingsby, Jasper A.; Privett, Sean D. J.] Univ Cape Town, Dept Bot, ZA-7700 Rondebosch, South Africa; [Cowling, Richard M.] Nelson Mandela Metropolitan Univ, Dept Bot, Port Elizabeth, South Africa	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; University of Cape Town; Nelson Mandela University	Thuiller, W (corresponding author), Univ Grenoble 1, CNRS, Lab Ecol Alpine, UMR 5553, Grenoble, France.	wilfried.thuiller@ujf-grenoble.fr	Slingsby, Jasper/AAU-7259-2021; Cowling, Richard/AFU-6261-2022; Thuiller, Wilfried/G-3283-2010	Slingsby, Jasper/0000-0003-1246-1181; Thuiller, Wilfried/0000-0002-5388-5274	National Research Foundation; Nelson Mandela Metropolitan University; University of Cape Town; International Research Network	National Research Foundation; Nelson Mandela Metropolitan University; University of Cape Town; International Research Network	Funding for this research was provided by the National Research Foundation (RMC, JAS), the Nelson Mandela Metropolitan University (RMC) and the University of Cape Town (JAS). Funding for the publication cost came from the International Research Network (GDRI) project France South Africa-Dynamics of biodiversity in Southern African ecosystems and sustainable use in the context of global change: processes and mechanisms involved.	Adler PB, 2006, P NATL ACAD SCI USA, V103, P12793, DOI 10.1073/pnas.0600599103; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bell G, 2005, ECOLOGY, V86, P1757, DOI 10.1890/04-1028; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bond W. J., 1992, ECOLOGY FYNBOS NUTR, P206; Bond W. J., 1996, FIRE PLANTS, DOI DOI 10.2307/2404797; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; BOND WJ, 1995, ECOSCIENCE, V2, P252, DOI 10.1080/11956860.1995.11682291; BOND WJ, 1984, J ECOL, V72, P209, DOI 10.2307/2260014; BOND WJ, 1990, S AFR J BOT, V56, P326, DOI 10.1016/S0254-6299(16)31060-2; Bond WJ, 1999, OECOLOGIA, V120, P132, DOI 10.1007/s004420050841; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; Brook BW, 2006, ECOL LETT, V9, P375, DOI 10.1111/j.1461-0248.2006.00883.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; CHESSON PL, 1989, J MATH BIOL, V27, P117, DOI 10.1007/BF00276099; COWLING RM, 1987, S AFR J SCI, V83, P106; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Cowling RM, 2002, DIVERS DISTRIB, V8, P163, DOI 10.1046/j.1472-4642.2002.00143.x; COWLING RM, 1990, S AFR J ECOL, V1, P1; DOAK DF, 1994, ECOLOGY, V75, P615, DOI 10.2307/1941720; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Facelli JM, 2005, ECOLOGY, V86, P2998, DOI 10.1890/05-0304; Goldblatt P., 2000, CAPE PLANTS CONSPECT; Grigulis K, 2005, GLOBAL CHANGE BIOL, V11, P1042, DOI 10.1111/j.1365-2486.2005.00980.x; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hubbell Stephen P., 2001, V32, pi; Ives AR, 2006, ECOL APPL, V16, P20, DOI 10.1890/04-0702; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; LAURIE H, 1995, J VEG SCI, V6, P161, DOI 10.2307/3236210; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Linder R, 1992, ECOLOGY FYNBOS; Link WA, 2006, ECOLOGY, V87, P2626, DOI 10.1890/0012-9658(2006)87[2626:MWATFO]2.0.CO;2; MANDERS PT, 1992, FOREST ECOL MANAG, V48, P277, DOI 10.1016/0378-1127(92)90150-8; Midgley GF, 2006, DIVERS DISTRIB, V12, P555, DOI 10.1111/j.1366-9516.2006.00273.x; Midgley GF, 2003, BIOL CONSERV, V112, P87, DOI 10.1016/S0006-3207(02)00414-7; Pake CE, 1996, ECOLOGY, V77, P1427, DOI 10.2307/2265540; Pinheiro J, 2001, MIXED EFFECTS MODELS; Privett SDJ, 2001, BOTHALIA, V31, P99, DOI 10.4102/abc.v31i1.509; Richards MB, 1997, OIKOS, V79, P394, DOI 10.2307/3546024; Rozdilsky ID, 2001, ECOL RES, V16, P983, DOI 10.1046/j.1440-1703.2001.00446.x; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Simmons MT, 1996, BIODIVERS CONSERV, V5, P551, DOI 10.1007/BF00137609; TAYLOR H C, 1984, Bothalia, V15, P259; Thuiller W, 2004, ECOLOGY, V85, P1688, DOI 10.1890/03-0148; Thuiller W, 2006, ECOGRAPHY, V29, P733, DOI 10.1111/j.0906-7590.2006.04674.x; van Wilgen B.W., 1992, P345; VANWILGEN BW, 1985, J APPL ECOL, V22, P207, DOI 10.2307/2403338; VANWILGEN BW, 1985, J APPL ECOL, V22, P955, DOI 10.2307/2403243; Vlok J. H. J., 2000, Diversity and Distributions, V6, P273, DOI 10.1046/j.1472-4642.2000.00090.x; WARNER RR, 1985, AM NAT, V125, P769, DOI 10.1086/284379; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Wilgen B. W. van, 1981, South African Forestry Journal, P42; [No title captured]	56	68	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e938	10.1371/journal.pone.0000938	http://dx.doi.org/10.1371/journal.pone.0000938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895979	Green Published, gold			2022-12-27	WOS:000207455800017
J	Abdueva, D; Wing, MR; Schaub, B; Triche, TJ				Abdueva, Diana; Wing, Michele R.; Schaub, Betty; Triche, Timothy J.			Experimental Comparison and Evaluation of the Affymetrix Exon and U133Plus2 GeneChip Arrays	PLOS ONE			English	Article								Background. Affymetrix exon arrays offer scientists the only solution for exon-level expression profiling at the whole-genome scale on a single array. These arrays feature a new chip design with no mismatch probes and a radically new random primed protocol to generate sense DNA targets along the entire length of the transcript. In addition to these changes, a limited number of validating experiments and virtually no experimental data to rigorously address the comparability of all-exon arrays with conventional 3'-arrays result in a natural reluctance to replace conventional expression arrays with the new all-exon platform. Methodology. Using commercially available Affymetrix arrays, we assess the performance of the Human Exon 1.0 ST (HuEx) and U133 Plus 2.0 (U133Plus2) platforms directly through a series of 'spike-in' hybridizations containing 25 transcripts in the presence of a fixed eukaryotic background. Specifically, we compare the measures of expression for HuEx and U133Plus2 arrays to evaluate the precision of these measures as well as the specificity and sensitivity of the measures' ability to detect differential expression. Significance. This study presents an experimental comparison and systematic cross-validation of Affymetrix exon arrays and establishes high comparability of expression changes and probe performance characteristics between Affymetrix conventional and exon arrays. In addition, this study offers a reliable benchmark data set for the comparison of competing exon expression measures, the selection of methods suitable for mapping exon array measures to the wealth of previously generated microarray data, as well as the development of more advanced methods for exon- and transcript-level expression summarization.	[Abdueva, Diana; Wing, Michele R.; Schaub, Betty; Triche, Timothy J.] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; University of Southern California	Abdueva, D (corresponding author), Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90033 USA.	abdueva@usc.edu			NCI [U01CA114757]; NATIONAL CANCER INSTITUTE [U01CA114757] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by a U01CA114757 grant from the NCI.	Abdueva D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl435; Burden C.J., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1095, DOI 10.2202/1544-6115.1095]; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Halperin A, 2004, BIOPHYS J, V86, P718, DOI 10.1016/S0006-3495(04)74150-8; Hekstra D, 2003, NUCLEIC ACIDS RES, V31, P1962, DOI 10.1093/nar/gkg283; Okoniewski MJ, 2007, BIOTECHNIQUES, V42, P181, DOI 10.2144/000112315; Zhang L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1064; Zhang Yongqing, 2006, Appl Bioinformatics, V5, P151, DOI 10.2165/00822942-200605030-00003; GENECHIP EXON ARRAY	9	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e913	10.1371/journal.pone.0000913	http://dx.doi.org/10.1371/journal.pone.0000913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878948	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455700021
J	Chen, L; Jha, P; Stirling, B; Sgaier, SK; Daid, T; Kaul, R; Nagelkerke, N				Chen, Li; Jha, Prabhat; Stirling, Bridget; Sgaier, Sema K.; Daid, Tina; Kaul, Rupert; Nagelkerke, Nico		Int Studies HIV AIDS ISHA Investig	Sexual Risk Factors for HIV Infection in Early and Advanced HIV Epidemics in Sub-Saharan Africa: Systematic Overview of 68 Epidemiological Studies	PLOS ONE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; HERPES-SIMPLEX VIRUS-2; DAR-ES-SALAAM; REPRODUCTIVE-TRACT INFECTIONS; DISTANCE TRUCK-DRIVERS; GENITAL-ULCER-DISEASE; BASE-LINE SURVEY; TRANSMITTED-DISEASES; MALE CIRCUMCISION; PREGNANT-WOMEN	Background. It is commonly assumed that sexual risk factors for heterosexual HIV transmission in sub-Saharan Africa, such as multi-partner sex, paid sex and co-infections, become less important as HIV epidemics mature and prevalence increases. Methods and Findings. We conducted a systematic review of 68 African epidemiological studies from 1986 to 2006 involving 17,000 HIV positive adults and 73,000 controls. We used random-effects methods and stratified results by gender, time, background HIV prevalence rates and other variables. The number of sex partners, history of paid sex, and infection with herpes simplex virus (HSV-2) or other sexually-transmitted infections (STIs) each showed significant associations with HIV infection. Among the general population, the odds ratio (OR) of HIV infection for women reporting 3+ sex partners versus 0-2 was 3.64 (95% CI [2.87-4.62]), with similar risks for men. About 9% of infected women reported ever having been paid for sex, versus 4% of control women (OR = 2.29, [1.45-3.62]). About 31% of infected men reported ever paying for sex versus 18% of uninfected men (OR = 1.75, [1.30-2.36]). HSV-2 infection carried the largest risk of HIV infection: OR = 4.62, [2.85-7.47] in women, and OR = 6.97, [4.68-10.38] in men. These risks changed little over time and stratification by lower and higher HIV background prevalence showed that risk ratios for most variables were larger in high prevalence settings. Among uninfected controls, the male-female differences in the number of sex partners and in paid sex were more extreme in the higher HIV prevalence settings than in the lower prevalence settings. Significance. Multi-partner sex, paid sex, STIs and HSV-2 infection are as important to HIV transmission in advanced as in early HIV epidemics. Even in high prevalence settings, prevention among people with high rates of partner change, such as female sex workers and their male clients, is likely to reduce transmission overall.	[Chen, Li; Jha, Prabhat; Stirling, Bridget; Sgaier, Sema K.; Daid, Tina] Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; [Stirling, Bridget] Univ Victoria, Div Med Sci, Isl Med Program, Victoria, BC, Canada; [Kaul, Rupert] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Kaul, Rupert] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON, Canada; [Nagelkerke, Nico] Al Ain Univ, Dept Community Med, Al Ain, U Arab Emirates	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Victoria; University of Nairobi; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada.	prabhat.jha@utoronto.ca		Kaul, Rupert/0000-0002-1586-4093; Wang, Yu/0000-0001-7935-9902	Canadian Institutes of Health Research [123821]; Bill and Melinda Gates Foundation [39922]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Supported in part by research grants from the Canadian Institutes of Health Research (no 123821), and the Bill and Melinda Gates Foundation (no 39922). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams KR, 2000, METHODS METAANALYSIS; Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; ALLEN S, 1991, JAMA-J AM MED ASSOC, V266, P1657, DOI 10.1001/jama.266.12.1657; Ao TTH, 2006, SEX TRANSM DIS, V33, P163, DOI 10.1097/01.olq.0000187204.57006.b3; Aseffa A, 1998, EPIDEMIOL INFECT, V120, P171, DOI 10.1017/S0950268897008595; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2001, AIDS, V15, P885, DOI 10.1097/00002030-200105040-00009; BARONGO LR, 1992, AIDS, V6, P1521, DOI 10.1097/00002030-199212000-00016; BASSETT MT, 1992, J ACQ IMMUN DEF SYND, V5, P556; Bassett MT, 1996, J ACQ IMMUN DEF SYND, V13, P287, DOI 10.1097/00042560-199611010-00012; BERKLEY SF, 1989, J INFECT DIS, V160, P22, DOI 10.1093/infdis/160.1.22; Boerma JT, 2003, SEX TRANSM DIS, V30, P779, DOI 10.1097/01.OLQ.0000078820.62897.A6; Bogaerts J, 1998, INT J STD AIDS, V9, P706, DOI 10.1258/0956462981921242; Breslow NE, 1980, IARC SCI PUBL, V32; BULTERYS M, 1994, AIDS, V8, P1585, DOI 10.1097/00002030-199411000-00010; BWAYO J, 1994, ARCH INTERN MED, V154, P1391, DOI 10.1001/archinte.154.12.1391; BWAYO JJ, 1991, E AFR MED J, V68, P425; CARAEL M, 1988, AIDS, V2, P201; Carpenter LM, 2002, J ACQ IMMUN DEF SYND, V29, P174, DOI 10.1097/00042560-200202010-00011; CARSWELL JW, 1989, AIDS, V3, P759, DOI 10.1097/00002030-198911000-00013; CHAO A, 1994, INT J EPIDEMIOL, V23, P371, DOI 10.1093/ije/23.2.371; Chen CY, 2000, SEX TRANSM DIS, V27, P21, DOI 10.1097/00007435-200001000-00005; Cleland J, 2004, SEX TRANSM INFECT, V80, P1, DOI 10.1136/sti.2004.013151; Clift S, 2003, SEX TRANSM INFECT, V79, P307, DOI 10.1136/sti.79.4.307; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; COSSA HA, 1994, INT J STD AIDS, V5, P117, DOI 10.1177/095646249400500208; Cote AM, 2004, AIDS, V18, P917, DOI [10.1097/01.aids.0000111475.61782.98, 10.1097/00002030-200404090-00009]; Cowan FM, 2005, JAIDS-J ACQ IMM DEF, V40, P371, DOI 10.1097/01.qai.0000162420.93243.ff; DIALLO MO, 1992, AIDS, V6, P581, DOI 10.1097/00002030-199206000-00010; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Egger M., 2008, SYSTEMATIC REV HLTH; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gomo E., 1997, Central African Journal of Medicine, V43, P350; GREENBLATT RM, 1988, AIDS, V2, P47, DOI 10.1097/00002030-198802000-00008; GROSSKURTH H, 1995, AIDS, V9, P927, DOI 10.1097/00002030-199508000-00015; Gwanzura L, 1998, J INFECT DIS, V177, P481, DOI 10.1086/517381; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P793, DOI 10.1046/j.1365-3156.2002.00943.x; Hearst N, 1997, AIDS, V11, pS1; HIRA SK, 1990, J INFECT DIS, V161, P584, DOI 10.1093/infdis/161.3.584; HUDSON CP, 1988, AIDS, V2, P255, DOI 10.1097/00002030-198808000-00003; HUNTER DJ, 1994, AIDS, V8, P93, DOI 10.1097/00002030-199401000-00014; Jha P, 2001, SCIENCE, V292, P224, DOI 10.1126/science.1058187; Kapiga S H, 2000, Afr J Reprod Health, V4, P88, DOI 10.2307/3583246; Kapiga SH, 2003, SEX TRANSM DIS, V30, P187, DOI 10.1097/00007435-200303000-00001; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409, DOI 10.1097/00126334-200204010-00013; Kapiga SH, 1998, AIDS, V12, P75, DOI 10.1097/00002030-199801000-00009; KAPIGA SH, 1994, J ACQ IMMUN DEF SYND, V7, P301; Kaul R, 2004, JAMA-J AM MED ASSOC, V291, P2555, DOI 10.1001/jama.291.21.2555; Kelly R, 1999, AIDS, V13, P399, DOI 10.1097/00002030-199902250-00013; Kelly RJ, 2003, JAIDS-J ACQ IMM DEF, V32, P446, DOI 10.1097/00126334-200304010-00016; Keou FXM, 1999, AIDS, V13, P536, DOI 10.1097/00002030-199903110-00021; Korenromp EL, 2001, SEX TRANSM DIS, V28, P613, DOI 10.1097/00007435-200111000-00001; Kumwenda NI, 2002, SEX TRANSM DIS, V29, P366, DOI 10.1097/00007435-200206000-00010; Lagarde E, 2004, INT J STD AIDS, V15, P395, DOI 10.1258/095646204774195254; Lagarde E, 2003, INT J EPIDEMIOL, V32, P744, DOI 10.1093/ije/dyg111; Langeland N, 1998, INT J STD AIDS, V9, P104, DOI 10.1258/0956462981921765; Lankoande S, 1998, INT J STD AIDS, V9, P146, DOI 10.1258/0956462981921909; LEROY V, 1995, GENITOURIN MED, V71, P207; LINDAN C, 1991, AIDS, V5, P993, DOI 10.1097/00002030-199108000-00011; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; MacDonald KS, 2001, AIDS, V15, P635, DOI 10.1097/00002030-200103300-00014; MAGGWA BN, 1993, AIDS, V7, P733, DOI 10.1097/00002030-199305000-00019; MANN JM, 1988, AIDS, V2, P249, DOI 10.1097/00002030-198808000-00002; Marcelin AG, 2002, J MED VIROL, V68, P164, DOI 10.1002/jmv.10184; Mbizvo EM, 2002, INT J STD AIDS, V13, P343, DOI 10.1258/0956462021925171; Mbizvo EM, 2001, INT J STD AIDS, V12, P524, DOI 10.1258/0956462011923624; Mbizvo M. T., 1996, Central African Journal of Medicine, V42, P14; Mbopi-Keou FX, 2000, J INFECT DIS, V182, P1090, DOI 10.1086/315836; MCCARTHY MC, 1989, AIDS, V3, P725, DOI 10.1097/00002030-198911000-00006; MCCARTHY MC, 1995, J MED VIROL, V46, P18, DOI 10.1002/jmv.1890460105; McFarland W, 1999, J INFECT DIS, V180, P1459, DOI 10.1086/315076; MEDA N, 1995, INT J STD AIDS, V6, P273, DOI 10.1177/095646249500600410; Mihret W, 2002, SEX TRANSM DIS, V29, P175, DOI 10.1097/00007435-200203000-00008; MIOTTI PG, 1990, AIDS, V4, P733, DOI 10.1097/00002030-199008000-00003; Mnyika KS, 1996, J ACQ IMMUN DEF SYND, V11, P484, DOI 10.1097/00042560-199604150-00009; Msuya SE, 2003, SEX TRANSM DIS, V30, P588, DOI 10.1097/00007435-200307000-00011; Msuya SE, 2002, ACTA OBSTET GYN SCAN, V81, P886, DOI 10.1034/j.1600-0412.2002.810916.x; Nagelkerke NJD, 2002, B WORLD HEALTH ORGAN, V80, P89; Nagot N, 2005, JAIDS-J ACQ IMM DEF, V39, P454, DOI 10.1097/01.qai.0000152399.54648.b9; NdinyaAchola JO, 1997, INT J STD AIDS, V8, P506, DOI 10.1258/0956462971920668; NSUBUGA P, 1990, J ACQ IMMUN DEF SYND, V3, P1002; Nunn AJ, 1996, INT J STD AIDS, V7, P123, DOI 10.1258/0956462961917320; Nyambi P, 2002, JAIDS-J ACQ IMM DEF, V31, P506, DOI 10.1097/00126334-200212150-00008; NZILA N, 1991, AIDS, V5, P715, DOI 10.1097/00002030-199106000-00011; Obisesan KA, 1997, INT J GYNECOL OBSTET, V56, P271, DOI 10.1016/S0020-7292(96)02821-4; Petry KU, 1996, INT J STD AIDS, V7, P265, DOI 10.1258/0956462961917942; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; PISON G, 1993, J ACQ IMMUN DEF SYND, V6, P196; PLOURDE PJ, 1992, J INFECT DIS, V166, P86, DOI 10.1093/infdis/166.1.86; PUJADES RMM, 2002, AIDS, V16, P451; Quigley M, 1997, AIDS, V11, P237, DOI 10.1097/00002030-199702000-00015; Quigley MA, 2000, J ACQ IMMUN DEF SYND, V23, P418, DOI 10.1097/00042560-200004150-00009; Ramjee G, 2005, JAIDS-J ACQ IMM DEF, V39, P333, DOI 10.1097/01.qai.0000144445.44518.ea; Riedner G, 2003, SEX TRANSM INFECT, V79, P382, DOI 10.1136/sti.79.5.382; RYDER RW, 1990, AIDS, V4, P725, DOI 10.1097/00002030-199008000-00002; Sagay AS, 2005, INT J GYNECOL OBSTET, V90, P61, DOI 10.1016/j.ijgo.2005.03.030; SAMOAHADU C, 2001, J ACQ IMMUN DEF SYND, V28, P358; SassanMorokro M, 1996, J ACQ IMMUN DEF SYND, V11, P183, DOI 10.1097/00042560-199602010-00010; Seber G., 2003, LINEAR REGRESSION AN; SEED J, 1995, J ACQ IMMUN DEF SYND, V8, P83; Sentjens REJH, 2002, EPIDEMIOL INFECT, V128, P221, DOI 10.1017/S0950268801006604; SERWADDA D, 1992, AIDS, V6, P983, DOI 10.1097/00002030-199209000-00012; Siegfried N, 2005, LANCET INFECT DIS, V5, P165, DOI 10.1016/S1473-3099(05)01309-5; Siegfried N, 2005, BRIT MED J, V331, P742, DOI 10.1136/bmj.331.7519.742; SIMONSEN JN, 1988, NEW ENGL J MED, V319, P274, DOI 10.1056/NEJM198808043190504; Simooya OO, 2001, AIDS, V15, P1741, DOI 10.1097/00002030-200109070-00023; Sinei SKA, 1996, INT J STD AIDS, V7, P65, DOI 10.1258/0956462961917104; Siziya S., 1996, Central African Journal of Medicine, V42, P114; Smith J, 1999, INT J STD AIDS, V10, P452, DOI 10.1258/0956462991914456; Stringer EM, 2004, JAIDS-J ACQ IMM DEF, V35, P60, DOI 10.1097/00126334-200401010-00009; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sutcliffe S, 2002, JAIDS-J ACQ IMM DEF, V31, P90, DOI 10.1097/00126334-200209010-00012; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Tengia-Kessy A, 1998, E AFR MED J, V75, P528; TERMEULEN J, 1992, E AFR MED J, V69, P688; Thior I, 1997, Afr J Reprod Health, V1, P26, DOI 10.2307/3583374; Todd J, 2006, J INFECT DIS, V193, P458, DOI 10.1086/499313; *UNAIDS, 2006, AIDS EP UPD; *UNAIDS, 2005, AIDS EP UPD SPEC SEC; Urassa M, 1997, AIDS, V11, P73, DOI 10.1097/00002030-199701000-00011; VANDEPERRE P, 1987, AIDS, V1, P207; Wawer M., 2005, 12 C RETR OPP INF BO; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; *WHO UNAIDS, 2002, 13 WHOUNAIDS; *WHO UNAIDS, CONS STI IN IN PRESS; Zaba BW, 2000, AIDS, V14, P2741, DOI 10.1097/00002030-200012010-00014; Zuma K, 2003, INT J STD AIDS, V14, P814, DOI 10.1258/095646203322556147	130	199	208	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e1001	10.1371/journal.pone.0001001	http://dx.doi.org/10.1371/journal.pone.0001001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912340	Green Published, gold			2022-12-27	WOS:000207455900037
J	Chen, SX; Wang, Y; Chen, FY; Yang, HC; Gan, MH; Zheng, SJ				Chen, Shixi; Wang, Yu; Chen, Fuyong; Yang, Hanchun; Gan, Menghou; Zheng, Shijun J.			A Highly Pathogenic Strain of Staphylococcus sciuri Caused Fatal Exudative Epidermitis in Piglets	PLOS ONE			English	Article							HYICUS SUBSP HYICUS; EXFOLIATIVE TOXIN; MOLECULAR CHARACTERIZATION; MEMBERS; PIGS; SKIN; IDENTIFICATION; MASTITIS	Staphylococcus sciuri are important human pathogens responsible for endocarditis, peritonitis, septic shock, urinary tract infection, pelvic inflammatory disease and wound infections. However, little information is known regarding the pathogenicity of S. sciuri to animals. From the pericardial fluid of a diseased piglet with exudative epidermitis (EE), we isolated a strain of Staphylococcus in pure culture. Surprisingly, this isolate was a member of S. sciuri rather than S. hyicus as identified by its biochemical traits and also by analysis of 23S ribosomal DNA using Internal Transcribed Spacer PCR. In addition, inoculation of newborn piglets with 1x10(10) CFU of the isolate by oral feeding or intra-muscular injection successfully reproduced EE in piglets, which suggested that the oral intake of the pathogen by the animals is one of the major routes of exposure. These unexpected findings prioritized S. sciuri as important zoonotic agents, which may have ramifications for human medicine.	[Chen, Shixi; Wang, Yu; Chen, Fuyong; Yang, Hanchun; Gan, Menghou; Zheng, Shijun J.] China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Prevent Vet Med, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Zheng, SJ (corresponding author), China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Prevent Vet Med, Beijing 100094, Peoples R China.	sjzheng@cau.edu.cn		Kaul, Rupert/0000-0002-1586-4093; Wang, Yu/0000-0001-7935-9902	National Basic Research Program (Project 973) of China [2006CB504300]	National Basic Research Program (Project 973) of China(National Basic Research Program of China)	This work was supported by a grant from the National Basic Research Program (Project 973) of China (Grant 2006CB504300).	Ahrens P, 2004, J BACTERIOL, V186, P1833, DOI 10.1128/JB.186.6.1833-1837.2004; Amtsberg G, 1973, Dtsch Tierarztl Wochenschr, V80, P496; Andresen LO, 1998, FEMS IMMUNOL MED MIC, V20, P301, DOI 10.1111/j.1574-695X.1998.tb01140.x; Andresen LO, 2005, VET REC, V157, P376, DOI 10.1136/vr.157.13.376; Andresen LO, 2005, VET MICROBIOL, V105, P291, DOI 10.1016/j.vetmic.2004.12.006; Andresen LO, 2004, J APPL MICROBIOL, V96, P1265, DOI 10.1111/j.1365-2672.2004.02258.x; ANDRESEN LO, 1993, MICROB PATHOGENESIS, V15, P217, DOI 10.1006/mpat.1993.1072; Couto I, 1996, MICROB DRUG RESIST, V2, P377, DOI 10.1089/mdr.1996.2.377; Couto I, 2000, J CLIN MICROBIOL, V38, P1136, DOI 10.1128/JCM.38.3.1136-1143.2000; Couto I, 2001, J CLIN MICROBIOL, V39, P3099, DOI 10.1128/JCM.39.9.3099-3103.2001; Dakic I, 2005, J CLIN MICROBIOL, V43, P4875, DOI 10.1128/JCM.43.9.4875-4876.2005; Gianneechini R, 2002, ACTA VET SCAND, V43, P221, DOI 10.1186/1751-0147-43-221; Hanakawa Y, 2002, J CLIN INVEST, V110, P53, DOI 10.1172/JCI200215766; Hedin G, 1998, EUR J CLIN MICROBIOL, V17, P673, DOI 10.1007/s100960050157; Hill BD, 1996, AUST VET J, V73, P179, DOI 10.1111/j.1751-0813.1996.tb10022.x; Horii T, 2001, SCAND J INFECT DIS, V33, P930, DOI 10.1080/00365540110076750; LAMMLER C, 1990, BERL MUNCH TIERARZTL, V103, P60; ONET GE, 1991, J AM VET MED ASSOC, V199, P362; PHILLIPS WE, 1980, AM J VET RES, V41, P274; POUTREL B, 1984, AM J VET RES, V45, P2084; Rahman MT, 2005, MICROB DRUG RESIST, V11, P205, DOI 10.1089/mdr.2005.11.205; Sato H, 1990, Kitasato Arch Exp Med, V63, P119; Sato H, 2000, J BACTERIOL, V182, P4096, DOI 10.1128/JB.182.14.4096-4100.2000; SCHULZ W, 1969, Archiv fuer Experimentelle Veterinaermedizin, V23, P415; Shittu A, 2004, J MED MICROBIOL, V53, P51, DOI 10.1099/jmm.0.05294-0; Stepanovic S, 2005, INT J STD AIDS, V16, P452, DOI 10.1258/0956462054093999; Stepanovic S, 2005, SYST APPL MICROBIOL, V28, P353, DOI 10.1016/j.syapm.2005.02.001; Stepanovic S, 2005, J CLIN MICROBIOL, V43, P956, DOI 10.1128/JCM.43.2.956-958.2005; Stepanovic S, 2003, J CLIN MICROBIOL, V41, P5262, DOI 10.1128/JCM.41.11.5262-5264.2003; Stepanovic S, 2002, SCAND J INFECT DIS, V34, P685, DOI 10.1080/00365540110076949; Stepanovic S, 2001, VET MICROBIOL, V82, P177, DOI 10.1016/S0378-1135(01)00377-7; Stepanovic S, 2001, FEMS MICROBIOL LETT, V199, P47, DOI 10.1016/S0378-1097(01)00150-1; TAKEUCHI S, 1987, VET MICROBIOL, V14, P47, DOI 10.1016/0378-1135(87)90051-4; Waage S, 1999, J DAIRY SCI, V82, P712, DOI 10.3168/jds.S0022-0302(99)75288-4; Wallet F, 2000, SCAND J INFECT DIS, V32, P697, DOI 10.1080/003655400459667; Zheng SJ, 2004, J IMMUNOL, V173, P5652, DOI 10.4049/jimmunol.173.9.5652	36	199	208	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2007	2	1							e147	10.1371/journal.pone.0000147	http://dx.doi.org/10.1371/journal.pone.0000147			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DE	17912340	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443900001
